data_1so9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1so9 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.16 0 N-CA-C 103.312 -2.847 . . . . 0.0 103.312 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.1 m -152.41 38.82 0.56 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.719 0.69 . . . . 0.0 111.331 -176.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -159.07 -49.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 127.594 2.358 . . . . 0.0 106.62 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -61.4 -28.16 69.05 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.295 1.838 . . . . 0.0 111.482 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.4 mt -69.87 83.26 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 123.625 0.77 . . . . 0.0 109.518 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.25 152.18 23.0 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 161.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -78.68 55.09 1.61 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.28 0.945 . . . . 0.0 111.328 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.12 138.44 39.95 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 105.078 -2.194 . . . . 0.0 105.078 166.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -96.81 120.04 36.4 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 123.679 0.792 . . . . 0.0 109.043 -173.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -95.08 141.53 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 163.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.44 ' CE ' ' HB2' ' A' ' 55' ' ' ASP . 2.3 tmtp? -101.73 153.86 19.41 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 169.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 t -137.14 149.44 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 167.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.8 m -137.24 98.98 3.86 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 122.521 1.153 . . . . 0.0 108.132 -171.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -79.24 88.28 4.92 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 127.356 2.262 . . . . 0.0 110.306 -176.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -81.86 85.46 6.65 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 122.347 1.07 . . . . 0.0 109.584 175.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.59 101.01 8.91 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.918 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -99.84 148.99 23.85 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 176.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.0 p -139.83 144.36 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 124.709 1.203 . . . . 0.0 108.098 172.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.56 171.96 13.68 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.597 1.159 . . . . 0.0 108.334 174.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -32.72 -55.7 0.36 Allowed 'General case' 0 C--N 1.34 0.168 0 C-N-CA 126.384 1.873 . . . . 0.0 112.822 -176.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -36.69 -35.71 0.14 Allowed Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.906 2.193 . . . . 0.0 114.663 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.44 94.75 48.92 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 118.42 1.11 . . . . 0.0 109.269 170.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -82.32 42.33 1.29 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.417 2.745 . . . . 0.0 110.866 -173.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -113.84 141.66 47.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -172.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -79.42 80.07 5.82 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 -176.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -86.72 89.77 8.05 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.508 1.523 . . . . 0.0 108.368 -176.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.4 m -89.43 129.96 45.43 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -175.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -68.76 153.66 72.66 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 N-CA-C 108.156 -1.517 . . . . 0.0 108.156 163.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.41 -55.07 10.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -131.19 161.76 31.47 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 165.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -64.64 -28.45 69.62 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 118.482 0.583 . . . . 0.0 109.54 173.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.44 ' HB2' ' CE ' ' A' ' 34' ' ' LYS . 24.6 p-10 -145.97 168.87 19.81 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 125.301 1.441 . . . . 0.0 112.048 -165.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.6 pt -137.71 166.67 24.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 124.447 1.099 . . . . 0.0 108.337 169.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -110.09 144.01 39.31 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 160.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -135.53 137.34 49.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 166.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.434 ' HE ' ' CD ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -82.37 91.0 6.74 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 119.698 -1.876 . . . . 0.0 107.691 164.161 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.3 pt 21.76 63.39 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 127.398 2.279 . . . . 0.0 113.47 171.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.97 -36.82 1.88 Allowed Glycine 0 CA--C 1.526 0.725 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.751 -177.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.434 ' CD ' ' HE ' ' A' ' 59' ' ' ARG . 3.4 tt0 -40.81 104.87 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.225 1.41 . . . . 0.0 111.752 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.62 89.67 7.91 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.028 0.931 . . . . 0.0 109.473 -158.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.2 p -88.36 172.1 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 123.291 0.636 . . . . 0.0 111.503 -166.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -117.56 122.18 42.97 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 125.3 1.44 . . . . 0.0 107.575 171.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.91 109.06 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 175.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -78.1 166.47 22.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.478 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -136.17 150.03 48.86 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 169.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.1 ttm-85 -126.02 127.04 45.26 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.793 1.637 . . . . 0.0 107.287 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.63 108.74 10.75 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 125.741 1.617 . . . . 0.0 109.254 169.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -104.73 123.99 48.6 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.326 -0.859 . . . . 0.0 109.226 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -76.26 126.84 31.73 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 120.883 -1.136 . . . . 0.0 110.92 -172.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.4 mt -111.65 14.53 21.23 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.985 0.914 . . . . 0.0 112.627 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.99 175.3 10.7 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 121.301 -0.874 . . . . 0.0 110.979 175.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.2 t -108.25 3.78 23.97 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.931 0.893 . . . . 0.0 111.702 175.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 p -145.06 163.31 33.45 Favored Pre-proline 0 N--CA 1.45 -0.436 0 C-N-CA 126.886 2.074 . . . . 0.0 105.499 174.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.06 157.36 44.61 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.198 1.266 . . . . 0.0 110.925 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.99 172.88 10.09 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 122.617 0.367 . . . . 0.0 110.177 166.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.0 t -107.25 166.06 10.92 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 160.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.25 73.4 0.25 Allowed Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 108.205 -1.958 . . . . 0.0 108.205 -176.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.38 62.62 0.63 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.7 154.19 28.77 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.821 -1.081 . . . . 0.0 112.659 -164.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.4 m -83.99 144.86 28.85 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.72 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -131.4 153.37 49.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.302 1.041 . . . . 0.0 109.569 171.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.07 109.53 11.97 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 171.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -95.57 63.62 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.46 0.062 0 C-N-CA 122.769 0.427 . . . . 0.0 111.551 -175.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.6 t -165.54 142.5 4.63 Favored Pre-proline 0 N--CA 1.454 -0.231 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.929 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -65.8 -39.34 20.46 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 N-CA-C 107.983 -1.583 . . . . 0.0 107.983 167.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 7.9 ptp 179.81 -74.92 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.42 2.288 . . . . 0.0 107.739 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.01 98.08 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 124.8 1.24 . . . . 0.0 113.273 -164.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.6 -101.67 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.743 -164.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.93 -65.44 0.33 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 123.329 0.49 . . . . 0.0 112.065 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -44.34 -51.26 8.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.449 1.5 . . . . 0.0 111.207 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -73.64 11.14 0.88 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.475 1.11 . . . . 0.0 113.893 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -82.7 128.77 34.68 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 119.157 0.889 . . . . 0.0 109.741 172.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 . . . . . 0 N--CA 1.444 -0.728 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.494 176.048 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 . . . . . 0 CA--C 1.537 0.477 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.0 t -160.04 -71.28 0.07 Allowed 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -175.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.2 t -156.3 140.56 16.58 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.019 1.328 . . . . 0.0 108.701 -169.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 88.5 mt -148.69 146.34 28.1 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 118.581 0.628 . . . . 0.0 110.237 176.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -77.98 165.86 47.64 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 126.112 1.765 . . . . 0.0 110.783 168.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.75 80.01 2.14 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 124.493 3.462 . . . . 0.0 112.278 -166.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 159.38 -34.23 0.47 Allowed Glycine 0 CA--C 1.522 0.515 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.783 172.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.49 153.43 31.37 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -152.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.6 mp0 -91.2 107.23 19.06 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.764 2.425 . . . . 0.0 109.762 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.4 132.64 34.19 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 160.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -145.46 139.05 26.58 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 161.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 14.8 mmt -143.47 142.36 20.98 Favored Pre-proline 0 N--CA 1.453 -0.28 0 C-N-CA 124.262 1.025 . . . . 0.0 108.51 -168.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.01 147.37 38.47 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.504 2.136 . . . . 0.0 109.853 169.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.1 t -124.56 157.37 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 163.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 p -136.17 143.56 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -157.09 131.81 8.74 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -167.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -156.36 126.63 6.57 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.207 0.912 . . . . 0.0 108.654 173.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.1 t -76.85 142.92 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 119.127 -0.463 . . . . 0.0 110.151 -174.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -81.07 129.33 67.65 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 119.14 -0.457 . . . . 0.0 110.748 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -57.13 -20.1 36.51 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.335 2.023 . . . . 0.0 113.985 176.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -53.21 -22.29 6.46 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 120.068 1.304 . . . . 0.0 111.67 172.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.6 tt -49.69 -43.76 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 O-C-N 121.697 -0.627 . . . . 0.0 111.892 169.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.9 m -84.4 57.25 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 119.791 1.178 . . . . 0.0 110.753 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -127.07 -68.31 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 118.028 -0.987 . . . . 0.0 112.516 169.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -79.94 157.66 23.97 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 121.965 1.777 . . . . 0.0 114.09 -166.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 95.2 t -53.79 -34.18 24.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.725 1.61 . . . . 0.0 110.827 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -37.12 -53.92 1.0 Allowed 'General case' 0 C--N 1.338 0.103 0 C-N-CA 126.301 1.84 . . . . 0.0 112.194 172.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 19.2 p -107.01 -56.1 2.24 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -164.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 29.17 53.12 0.09 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 128.108 2.563 . . . . 0.0 115.271 171.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 136.12 -35.32 2.15 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -174.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.0 mm -52.92 115.75 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 123.187 0.595 . . . . 0.0 110.573 170.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 31.0 pttt -156.93 62.95 0.51 Allowed 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.786 170.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.4 m -142.97 96.69 2.97 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 160.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.26 83.06 4.53 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -172.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.12 123.29 26.19 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -168.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.0 tt -98.11 103.67 15.63 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.9 t -84.74 100.22 11.36 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 170.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.85 136.17 33.15 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 172.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.6 m -124.82 87.46 2.72 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.672 0.749 . . . . 0.0 109.437 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -72.59 88.88 1.27 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.838 175.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -154.43 52.4 0.75 Allowed Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 117.209 2.3 . . . . 0.0 117.209 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.2 -87.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.962 2.441 . . . . 0.0 112.565 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 57.7 mtm180 -149.98 126.51 10.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.008 0.822 . . . . 0.0 110.437 -175.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -108.04 135.79 19.84 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 125.038 1.335 . . . . 0.0 108.801 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -72.44 -67.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.443 2.095 . . . . 0.0 110.717 171.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.3 m -175.47 91.24 0.05 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.602 1.961 . . . . 0.0 108.484 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.492 0 CA-C-N 118.315 0.507 . . . . 0.0 110.517 173.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.03 22.01 0.41 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 128.53 2.732 . . . . 0.0 114.798 -159.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -76.64 -36.34 57.44 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 152.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 mp -92.21 -103.82 0.11 Allowed 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 125.89 1.676 . . . . 0.0 109.305 175.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.2 mt 31.95 71.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 126.613 1.965 . . . . 0.0 113.818 -172.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -79.4 157.16 27.65 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.779 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -81.76 78.14 8.52 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 122.566 1.174 . . . . 0.0 109.91 -176.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -137.42 -172.13 3.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.037 -1.892 . . . . 0.0 107.077 168.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -138.65 138.41 37.78 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.127 1.371 . . . . 0.0 110.187 171.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.0 tp -124.24 113.31 36.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.521 1.528 . . . . 0.0 108.457 -176.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -83.74 149.45 26.45 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.9 t -146.73 89.14 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 118.924 0.784 . . . . 0.0 109.154 -174.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.5 m -75.56 106.3 7.03 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.616 1.166 . . . . 0.0 108.467 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -81.52 159.61 24.12 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.252 1.421 . . . . 0.0 109.902 174.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -142.46 87.56 2.02 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.92 0.867 . . . . 0.0 112.034 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.26 126.82 35.36 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.37 -0.831 . . . . 0.0 110.897 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -130.67 149.7 52.2 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.941 1.296 . . . . 0.0 109.066 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.9 p -139.28 146.77 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 C-N-CA 124.714 1.206 . . . . 0.0 108.807 175.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.55 174.61 12.33 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.104 0.961 . . . . 0.0 110.004 -177.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.4 115.21 1.35 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 168.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 139.79 -34.51 2.02 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 108.934 -1.667 . . . . 0.0 108.934 -167.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.428 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -140.45 94.46 8.44 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 123.521 0.729 . . . . 0.0 109.126 173.654 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -80.33 50.82 3.67 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 124.086 3.191 . . . . 0.0 109.409 -177.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.492 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 35.5 m0 -116.96 148.64 41.23 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.427 1.091 . . . . 0.0 109.831 -168.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -75.09 89.83 2.48 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 104.781 -2.303 . . . . 0.0 104.781 173.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -113.08 118.68 35.45 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.213 1.805 . . . . 0.0 107.465 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.6 m -137.97 144.79 45.32 Favored Pre-proline 0 CA--C 1.53 0.192 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -177.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.23 162.4 38.69 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.992 1.795 . . . . 0.0 108.648 166.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.51 -51.38 12.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 123.207 0.603 . . . . 0.0 110.204 176.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -127.74 159.03 36.01 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 168.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.7 tpt180 -62.29 -39.93 94.58 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 167.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.63 144.97 44.33 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 123.941 0.896 . . . . 0.0 109.448 -171.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.2 mt -105.88 152.45 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 C-N-CA 126.057 1.743 . . . . 0.0 106.532 170.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -126.76 87.41 2.65 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.396 1.078 . . . . 0.0 108.599 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -90.08 151.27 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 -59.44 -103.87 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.861 -1.149 . . . . 0.0 109.411 164.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.2 mm -148.76 43.6 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 126.389 1.876 . . . . 0.0 106.123 -172.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.62 -7.88 5.56 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 116.087 -0.506 . . . . 0.0 113.712 -174.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -51.04 105.58 0.11 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.05 1.34 . . . . 0.0 109.588 171.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.94 106.55 0.72 Allowed 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.473 1.509 . . . . 0.0 109.304 175.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -105.23 137.36 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 173.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.13 123.99 29.46 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 173.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.6 pp -123.63 111.74 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 164.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -76.21 158.14 31.94 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.947 172.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -129.92 147.09 51.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 173.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.26 141.64 30.91 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 167.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.03 78.57 0.97 Allowed 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 122.192 0.996 . . . . 0.0 109.657 165.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -112.29 141.87 45.48 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.075 -155.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.492 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 22.6 t-20 -78.72 125.78 29.83 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.226 0.921 . . . . 0.0 112.751 -173.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.5 mt -127.49 53.13 1.77 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.344 1.457 . . . . 0.0 109.251 167.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -113.61 167.25 10.76 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 126.466 1.907 . . . . 0.0 110.712 -177.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.7 m -80.22 -22.77 41.45 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.4 1.08 . . . . 0.0 110.85 173.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.0 p -147.6 164.55 22.14 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 125.768 1.627 . . . . 0.0 107.758 -167.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.31 122.63 10.64 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.351 1.367 . . . . 0.0 110.21 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.59 177.08 9.14 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.477 0.656 . . . . 0.0 109.734 173.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.1 t -110.48 156.71 20.47 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 161.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -149.45 81.17 0.19 Allowed Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 106.473 -2.651 . . . . 0.0 106.473 -174.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.91 60.46 1.37 Allowed 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 168.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.7 167.3 3.66 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.258 -177.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 39.2 m -98.86 152.64 19.52 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -148.4 151.98 36.2 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 164.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.99 122.66 48.29 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 170.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.0 p -104.47 55.21 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 C-N-CA 123.733 0.813 . . . . 0.0 111.851 -164.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.9 t -178.79 147.9 0.55 Allowed Pre-proline 0 C--N 1.333 -0.139 0 O-C-N 121.068 -1.02 . . . . 0.0 109.895 -166.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.8 -34.01 41.57 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 N-CA-C 108.9 -1.231 . . . . 0.0 108.9 166.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.0 ptp 177.62 -72.41 0.01 OUTLIER 'General case' 0 C--N 1.342 0.241 0 C-N-CA 126.764 2.026 . . . . 0.0 107.846 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.43 -31.49 67.28 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 124.39 1.076 . . . . 0.0 113.677 -162.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.44 -102.54 0.07 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.452 0.168 . . . . 0.0 111.415 -164.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.7 -59.0 0.2 Allowed Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.566 1.079 . . . . 0.0 113.611 -173.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -45.94 -52.33 11.81 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.129 0.965 . . . . 0.0 110.205 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -74.71 13.25 0.66 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.964 1.706 . . . . 0.0 114.027 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -83.15 128.16 34.24 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 169.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . 0.319 2.2 m-80 . . . . . 0 C--N 1.342 0.268 0 CA-C-O 122.396 1.093 . . . . 0.0 111.887 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 . . . . . 0 CA--C 1.532 0.257 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . 0.352 10.1 t 57.84 -81.7 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 126.713 2.005 . . . . 0.0 113.563 171.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -160.92 148.07 15.36 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 -176.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 73.4 mt -148.48 133.27 17.95 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 175.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -63.44 159.62 49.1 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 126.793 2.037 . . . . 0.0 111.403 174.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -64.2 92.24 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.275 3.317 . . . . 0.0 112.415 -169.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 125.17 -6.1 8.2 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 124.725 1.155 . . . . 0.0 112.618 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -76.44 130.0 37.36 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 118.822 1.311 . . . . 0.0 111.845 -166.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -94.62 101.32 13.18 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.257 1.423 . . . . 0.0 110.05 -168.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 17.6 ttt -103.93 124.19 48.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.443 1.497 . . . . 0.0 109.765 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.14 153.06 41.74 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 156.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 42.8 mtm -155.06 151.32 22.72 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 123.214 0.606 . . . . 0.0 110.83 168.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -53.65 138.7 67.5 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 124.653 3.568 . . . . 0.0 112.39 162.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.6 t -119.49 151.39 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 157.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.8 p -112.14 143.52 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 124.002 0.921 . . . . 0.0 108.542 175.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -156.06 151.82 27.29 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.084 0.402 . . . . 0.0 111.916 -171.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -157.98 170.2 22.86 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.296 1.838 . . . . 0.0 109.029 165.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 88.5 t -92.84 146.93 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 170.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -88.01 126.11 62.16 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-O 118.676 -0.678 . . . . 0.0 111.339 174.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -60.23 -16.01 37.97 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.339 2.026 . . . . 0.0 113.806 174.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -49.01 -25.78 2.18 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 119.877 1.217 . . . . 0.0 111.147 166.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 10.9 tt -53.5 -43.02 51.71 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 O-C-N 121.133 -0.979 . . . . 0.0 112.914 172.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.1 m -84.87 53.48 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 119.753 1.16 . . . . 0.0 110.025 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -134.7 -67.03 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 117.693 -1.146 . . . . 0.0 112.337 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.6 154.46 31.0 Favored 'Trans proline' 0 C--N 1.347 0.492 0 CA-C-N 122.024 1.759 . . . . 0.0 113.467 -170.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 96.3 t -55.11 -33.89 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 125.478 1.511 . . . . 0.0 110.928 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -36.53 -55.52 0.84 Allowed 'General case' 0 C--N 1.339 0.124 0 C-N-CA 126.246 1.818 . . . . 0.0 112.238 173.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 17.4 p -104.22 -56.06 2.26 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -164.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 26.51 52.02 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 128.789 2.836 . . . . 0.0 115.329 170.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 141.66 -36.49 1.7 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -173.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 12.8 mm -51.87 121.26 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.124 0.57 . . . . 0.0 110.089 172.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -157.21 57.2 0.51 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.018 0.527 . . . . 0.0 111.659 177.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.7 m -149.08 90.8 1.78 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 161.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 tp -84.52 87.77 7.27 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.789 -161.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.9 t -79.77 175.17 10.86 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 122.278 1.037 . . . . 0.0 110.697 -171.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.8 tt -143.83 105.49 4.31 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 103.873 -2.64 . . . . 0.0 103.873 164.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.4 p -86.95 100.16 12.39 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 174.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.66 130.9 44.63 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 126.209 1.804 . . . . 0.0 108.284 -176.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.7 m -125.52 90.34 3.2 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.564 1.145 . . . . 0.0 109.608 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -69.3 88.11 0.44 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.421 0.688 . . . . 0.0 110.125 171.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.07 44.46 0.34 Allowed Pre-proline 0 CA--C 1.553 1.082 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 176.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.97 -82.98 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.593 2.195 . . . . 0.0 113.482 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 42.0 mmt180 -149.63 123.4 9.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.362 0.983 . . . . 0.0 110.332 -171.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.91 116.79 61.94 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 125.29 1.436 . . . . 0.0 109.234 -174.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -84.25 -36.03 0.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.051 2.501 . . . . 0.0 113.421 -176.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.3 t 158.62 138.33 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 128.055 2.542 . . . . 0.0 107.848 -169.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.279 0 C-N-CA 127.132 2.173 . . . . 0.0 107.755 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.398 0 N-CA-C 103.471 -2.789 . . . . 0.0 103.471 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.4 m -152.46 35.09 0.51 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.16 0.981 . . . . 0.0 110.347 177.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -159.33 -56.41 0.06 Allowed 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 127.993 2.517 . . . . 0.0 106.482 -157.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.7 pp -91.74 -7.51 49.48 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.134 1.374 . . . . 0.0 112.585 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.4 mt -72.2 104.19 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.222 0 CA-C-N 119.386 0.994 . . . . 0.0 110.035 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -95.24 171.42 8.73 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 155.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -80.73 30.51 0.31 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -163.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -83.02 111.2 18.64 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 122.77 1.271 . . . . 0.0 110.758 177.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -74.59 91.52 2.33 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 127.08 2.152 . . . . 0.0 106.165 171.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.8 tp -100.24 123.46 53.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.205 1.002 . . . . 0.0 108.835 -177.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -84.42 148.79 26.4 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.183 0.993 . . . . 0.0 108.962 -175.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.2 t -134.25 146.82 30.63 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.3 m -146.75 105.32 3.81 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -169.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -76.17 163.57 26.94 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.729 0.812 . . . . 0.0 110.02 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -136.36 85.53 2.15 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 122.678 1.227 . . . . 0.0 110.222 166.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.99 99.3 6.01 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 177.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -92.84 146.88 23.31 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.7 t -128.91 136.75 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 168.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -124.3 162.2 24.27 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -43.18 -44.22 5.04 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.025 0.93 . . . . 0.0 111.043 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -48.06 -30.72 7.63 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 126.77 2.128 . . . . 0.0 115.323 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.444 HD13 ' CD2' ' A' ' 144' ' ' PHE . 1.3 tt -121.99 101.75 41.58 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 120.478 2.139 . . . . 0.0 110.495 -178.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -85.51 38.68 0.65 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 124.114 3.21 . . . . 0.0 112.192 -171.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.428 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 42.5 m0 -114.74 140.83 48.57 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -177.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -79.97 80.43 6.38 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -175.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -85.11 94.59 8.89 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.6 m -88.09 135.46 33.28 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.54 156.25 66.39 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 N-CA-C 108.686 -1.313 . . . . 0.0 108.686 165.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -79.76 -59.7 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -176.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -128.22 168.3 15.65 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 157.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -62.99 -43.15 99.57 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 170.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -139.65 165.42 27.3 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 126.37 1.868 . . . . 0.0 109.546 -164.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.6 pt -138.95 177.22 5.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 171.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -124.33 159.2 30.85 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 150.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -129.43 143.38 41.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 173.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.5 mmt85 -79.44 97.16 6.28 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 161.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.4 pt -4.86 79.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 127.442 2.297 . . . . 0.0 114.978 -172.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.53 -37.11 2.03 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.717 -0.49 . . . . 0.0 112.593 -175.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -41.95 107.83 0.08 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.187 1.395 . . . . 0.0 111.911 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.37 105.2 2.09 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.695 0.798 . . . . 0.0 109.844 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.25 177.65 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.732 0.777 . . . . 0.0 110.079 177.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -145.04 89.65 1.98 Allowed 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.016 0.926 . . . . 0.0 108.626 172.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.3 pp -110.01 117.37 54.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 32.6 mtm -92.48 111.82 23.54 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.469 1.908 . . . . 0.0 111.927 -177.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -84.59 154.89 22.32 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.137 0.575 . . . . 0.0 109.739 174.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.2 ttm-85 -134.54 138.96 45.06 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.679 1.591 . . . . 0.0 108.021 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.8 106.82 4.7 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.794 1.638 . . . . 0.0 110.201 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER -112.52 129.45 56.35 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.044 0.537 . . . . 0.0 112.22 -174.057 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.428 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 36.2 t-20 -77.9 115.1 17.38 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.486 0.585 . . . . 0.0 111.379 -167.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 69.6 mt -107.95 39.1 2.02 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.688 1.195 . . . . 0.0 111.35 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -111.36 173.27 6.42 Favored 'General case' 0 CA--C 1.526 0.029 0 C-N-CA 124.263 1.025 . . . . 0.0 110.037 169.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.3 p -89.05 -5.47 57.86 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 125.048 1.339 . . . . 0.0 111.829 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 p -140.76 162.94 46.1 Favored Pre-proline 0 N--CA 1.449 -0.476 0 C-N-CA 124.618 1.167 . . . . 0.0 109.37 -171.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.96 111.0 3.06 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.16 1.907 . . . . 0.0 109.249 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.26 177.68 8.65 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.036 0.835 . . . . 0.0 109.569 174.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.9 t -124.17 137.26 54.56 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 165.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.05 117.61 4.19 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.804 1.669 . . . . 0.0 109.586 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.75 47.39 2.54 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 124.634 1.173 . . . . 0.0 108.566 175.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.2 144.52 15.64 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.15 -174.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.7 t -87.39 175.26 8.07 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 119.583 -0.847 . . . . 0.0 108.738 166.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -155.13 89.42 1.21 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -161.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -78.79 90.53 4.66 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.2 t -79.35 59.18 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 123.323 0.649 . . . . 0.0 110.965 -175.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.3 t -174.79 148.97 1.22 Allowed Pre-proline 0 N--CA 1.465 0.312 0 CA-C-N 119.505 1.048 . . . . 0.0 112.595 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -57.92 -52.75 5.36 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 121.627 1.551 . . . . 0.0 109.205 158.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.42 -83.64 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.345 1.858 . . . . 0.0 107.42 177.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.03 -32.15 69.48 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -172.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.56 -109.6 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -168.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.08 -51.9 1.68 Allowed Glycine 0 CA--C 1.53 0.981 0 O-C-N 121.506 -0.746 . . . . 0.0 113.051 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -52.95 -58.62 6.36 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.651 1.226 . . . . 0.0 109.16 170.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -74.19 49.04 0.34 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.993 1.317 . . . . 0.0 111.611 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -126.48 130.85 51.44 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 173.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 174.489 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.8 mp0 . . . . . 0 CA--C 1.538 0.504 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.1 t 39.25 -133.2 0.18 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.564 1.946 . . . . 0.0 113.06 168.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.2 t -125.34 153.65 43.0 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.621 1.968 . . . . 0.0 108.833 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 81.9 mt -136.96 123.35 20.73 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -58.8 154.71 35.32 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 171.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.71 94.58 0.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.996 3.131 . . . . 0.0 111.3 -170.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 137.8 -26.85 2.85 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 124.536 1.065 . . . . 0.0 110.873 -173.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -78.28 154.1 31.23 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 117.664 0.732 . . . . 0.0 111.264 -166.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -117.51 133.97 55.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.428 1.091 . . . . 0.0 110.651 -174.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.15 142.09 31.08 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 127.034 2.134 . . . . 0.0 106.815 169.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -146.98 133.31 19.54 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.202 1.401 . . . . 0.0 107.286 172.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 79.7 mtp -147.3 135.97 11.23 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 118.207 0.458 . . . . 0.0 110.937 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -73.34 147.27 41.47 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.735 2.29 . . . . 0.0 109.92 168.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.2 t -129.41 124.52 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 168.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.1 p -88.11 151.66 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 166.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -157.96 135.87 10.68 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -175.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -146.06 159.75 42.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.379 0.672 . . . . 0.0 110.249 153.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 39.4 t -100.78 119.24 48.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 169.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.37 139.62 78.67 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -74.05 29.46 0.33 Allowed 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.591 2.861 . . . . 0.0 114.297 -176.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -87.26 -24.58 24.32 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.426 1.09 . . . . 0.0 110.382 170.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 17.0 tt -56.09 -44.9 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 118.153 0.433 . . . . 0.0 112.053 -176.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.4 m -80.61 56.32 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 O-C-N 121.513 -0.742 . . . . 0.0 110.452 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 49.6 mttp -139.52 -67.03 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.608 0 CA-C-O 117.715 -1.136 . . . . 0.0 112.247 174.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.96 156.94 30.79 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.02 1.813 . . . . 0.0 113.539 -169.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 86.2 t -55.09 -35.09 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 125.495 1.518 . . . . 0.0 110.808 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -36.39 -56.75 0.77 Allowed 'General case' 0 C--N 1.338 0.1 0 C-N-CA 126.109 1.763 . . . . 0.0 111.908 174.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.2 p -102.62 -54.22 2.7 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.441 -164.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 22.11 53.6 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 128.932 2.893 . . . . 0.0 115.019 173.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 146.45 -41.45 0.99 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 -170.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.3 mm -58.09 119.62 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 169.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.02 39.29 0.31 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.86 0.362 . . . . 0.0 111.232 -178.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.4 94.49 1.71 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 177.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.58 147.02 32.27 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -169.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.5 t -136.5 172.44 13.01 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.0 tt -145.3 114.77 7.17 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 103.38 -2.822 . . . . 0.0 103.38 171.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.72 102.62 15.03 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 177.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -86.03 87.89 7.49 Favored 'General case' 0 CA--C 1.527 0.069 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.82 89.4 5.24 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 122.665 1.221 . . . . 0.0 110.596 177.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.444 ' CD2' HD13 ' A' ' 45' ' ' LEU . 4.0 m-30 -69.05 80.77 0.32 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.836 1.654 . . . . 0.0 110.46 175.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -125.86 84.21 61.35 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 125.446 1.499 . . . . 0.0 113.813 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -105.45 -118.82 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.931 1 C-N-CA 125.988 4.459 . . . . 0.0 109.643 168.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -143.59 149.14 36.93 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 123.674 0.789 . . . . 0.0 109.728 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -144.85 143.67 21.73 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 126.531 1.933 . . . . 0.0 106.445 -176.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -87.19 -51.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.592 2.195 . . . . 0.0 111.727 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.5 m 167.07 101.58 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 128.947 2.899 . . . . 0.0 107.364 -176.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt . . . . . 0 CA--C 1.544 0.723 0 C-N-CA 123.877 0.871 . . . . 0.0 109.505 -176.581 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.455 ' CB ' ' H ' ' A' ' 63' ' ' THR . . . . . . . . 0 N--CA 1.442 -0.831 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.9 t -164.94 34.63 0.06 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.855 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -160.13 -51.14 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -167.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.6 mp -77.95 -27.82 49.38 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.616 -172.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.0 mt -70.73 129.07 34.71 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.062 0 C-N-CA 123.897 0.879 . . . . 0.0 112.881 -156.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.15 162.97 14.38 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.819 1.248 . . . . 0.0 108.467 172.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -80.8 74.36 7.76 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 122.177 0.989 . . . . 0.0 110.205 -176.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.25 -174.19 4.22 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.909 1.684 . . . . 0.0 107.608 174.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.3 mtmt -126.83 156.3 41.54 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.882 1.273 . . . . 0.0 108.093 162.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 tp -137.28 155.5 32.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 162.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.35 156.01 30.86 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.409 1.084 . . . . 0.0 108.671 -167.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.7 t -139.08 142.11 34.62 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.6 m -136.43 106.03 6.15 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -173.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -85.68 93.47 8.85 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.389 2.276 . . . . 0.0 110.427 -174.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -79.96 85.96 5.52 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 174.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.88 110.74 19.63 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.196 0.598 . . . . 0.0 111.039 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -111.85 153.78 26.13 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.653 1.181 . . . . 0.0 109.986 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.4 p -144.71 147.03 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.416 1.086 . . . . 0.0 108.977 173.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -159.34 170.67 21.31 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.914 0.885 . . . . 0.0 109.896 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -37.7 113.11 0.25 Allowed 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.841 1.656 . . . . 0.0 110.25 171.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 135.46 -39.21 1.7 Allowed Glycine 0 CA--C 1.523 0.557 0 N-CA-C 108.235 -1.946 . . . . 0.0 108.235 -165.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.405 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 1.7 mt -139.96 111.32 7.33 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 125.089 1.355 . . . . 0.0 107.375 169.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.93 8.04 4.7 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.793 2.328 . . . . 0.0 111.512 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.405 ' CD2' ' CD2' ' A' ' 45' ' ' LEU . 38.8 m0 -77.34 139.72 39.82 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.214 -0.929 . . . . 0.0 109.914 -165.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -78.63 84.7 4.72 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -83.91 93.05 7.94 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 127.172 2.189 . . . . 0.0 109.003 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.5 m -88.31 127.17 58.05 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -176.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -68.18 143.38 58.91 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 N-CA-C 108.226 -1.49 . . . . 0.0 108.226 164.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.2 m -77.74 -49.51 21.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.284 0.564 . . . . 0.0 109.982 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -130.31 162.43 29.03 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 164.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -62.69 -41.42 99.11 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 165.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -149.6 166.86 28.01 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 124.28 1.032 . . . . 0.0 110.87 -160.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.4 pt -137.78 154.71 29.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 124.807 1.243 . . . . 0.0 108.708 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -89.39 143.79 26.55 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 156.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.0 m -128.1 130.54 69.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 162.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -63.66 76.28 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.168 1.387 . . . . 0.0 108.802 172.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.5 mm 60.04 -74.46 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 126.162 1.785 . . . . 0.0 111.146 -172.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -131.14 62.8 0.64 Allowed Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 -176.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -102.38 105.84 16.5 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.131 1.372 . . . . 0.0 110.236 -175.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.455 ' H ' ' CB ' ' A' ' 24' ' ' ALA . 50.2 m -69.94 88.86 0.58 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.366 1.466 . . . . 0.0 110.131 -171.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.5 p -98.81 147.99 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 121.262 0.553 . . . . 0.0 110.775 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.88 126.82 35.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.699 1.6 . . . . 0.0 108.981 173.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.6 pp -130.12 112.18 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 164.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.74 176.42 9.35 Favored 'General case' 0 C--N 1.333 -0.125 0 O-C-N 121.741 -0.599 . . . . 0.0 110.709 168.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -137.48 156.88 47.64 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 169.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 59.9 mtp85 -120.11 131.6 55.11 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 169.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.34 109.25 10.95 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.485 1.114 . . . . 0.0 109.286 174.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -96.54 124.82 40.66 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 119.011 -0.519 . . . . 0.0 110.081 -172.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -78.77 88.27 4.63 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -169.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.9 mt -78.04 65.93 3.55 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.166 0.986 . . . . 0.0 109.945 171.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -134.9 152.25 51.58 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.587 1.155 . . . . 0.0 109.299 173.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.8 p -91.93 -3.43 55.95 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.983 1.313 . . . . 0.0 112.399 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.9 p -142.53 166.84 18.56 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 174.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -58.61 157.48 27.33 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 CA-C-N 120.397 1.178 . . . . 0.0 111.627 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.08 177.65 5.96 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.363 1.065 . . . . 0.0 109.219 173.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 t -140.83 143.24 34.69 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -134.27 124.61 3.59 Favored Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 107.548 -2.221 . . . . 0.0 107.548 -175.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.81 55.18 1.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 166.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.51 154.37 41.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.484 -164.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.34 126.89 31.73 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.07 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -116.47 138.3 51.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 167.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -130.91 94.46 3.61 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.7 t -85.31 72.24 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 123.55 0.74 . . . . 0.0 110.153 -176.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.6 t -169.25 147.7 3.34 Favored Pre-proline 0 N--CA 1.45 -0.45 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 175.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.74 -44.91 12.14 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 N-CA-C 108.021 -1.569 . . . . 0.0 108.021 161.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 3.0 ptm -174.25 -84.12 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.806 1.642 . . . . 0.0 108.026 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.98 -31.64 71.23 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.362 1.865 . . . . 0.0 115.231 -168.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.18 -105.76 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 117.927 0.331 . . . . 0.0 111.326 -168.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.05 -58.48 0.56 Allowed Glycine 0 CA--C 1.534 1.277 0 O-C-N 121.804 -0.56 . . . . 0.0 113.171 -174.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.56 -41.67 73.61 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.193 1.497 . . . . 0.0 111.551 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -76.24 7.28 4.4 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.536 1.135 . . . . 0.0 113.893 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -82.5 144.69 30.25 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 165.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 . . . . . 0 N--CA 1.446 -0.661 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 172.211 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.449 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 1.7 pm0 . . . . . 0 N--CA 1.45 -0.451 0 CA-C-O 119.327 -0.368 . . . . 0.0 110.763 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.2 t 49.76 -149.79 0.23 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.042 1.337 . . . . 0.0 112.58 170.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.71 149.32 31.79 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.824 1.65 . . . . 0.0 109.199 -177.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.8 mt -143.09 146.07 33.45 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.658 0.783 . . . . 0.0 110.219 172.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -70.08 158.67 86.82 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 129.863 3.265 . . . . 0.0 110.75 171.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.51 105.98 1.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.565 2.843 . . . . 0.0 111.936 -168.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 116.87 -7.98 16.91 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 123.933 0.778 . . . . 0.0 111.824 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -77.81 164.84 24.84 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 117.635 0.717 . . . . 0.0 111.216 -175.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -119.32 126.45 51.47 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.584 0.754 . . . . 0.0 110.392 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 15.6 tpt -91.27 123.81 34.99 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -146.28 141.59 27.48 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 123.238 0.336 . . . . 0.0 110.507 158.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 87.2 mtp -150.42 149.65 27.0 Favored Pre-proline 0 N--CA 1.451 -0.385 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 166.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -73.32 137.32 25.61 Favored 'Trans proline' 0 N--CA 1.445 -1.343 0 C-N-CA 122.121 1.881 . . . . 0.0 111.76 172.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.4 t -99.34 150.05 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 159.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.77 138.72 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -152.96 137.07 16.41 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.237 0.472 . . . . 0.0 111.201 -165.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -155.78 158.9 38.92 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.275 1.83 . . . . 0.0 107.528 160.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.8 t -87.52 159.07 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 175.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -100.46 133.24 21.46 Favored Pre-proline 0 C--O 1.236 0.378 0 CA-C-N 118.692 0.678 . . . . 0.0 111.272 173.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -72.38 46.67 0.99 Allowed 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.937 2.425 . . . . 0.0 114.011 175.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.51 -7.69 11.62 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.263 1.025 . . . . 0.0 113.401 163.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.2 tt -51.65 -40.74 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 118.794 0.725 . . . . 0.0 111.068 170.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.3 m -83.2 56.26 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.331 1.052 . . . . 0.0 110.749 171.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -113.3 -79.22 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.462 0 CA-C-O 117.573 -1.204 . . . . 0.0 109.145 165.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -78.59 163.02 27.1 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.025 1.817 . . . . 0.0 111.901 -176.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.8 p -62.18 -44.29 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 123.737 0.815 . . . . 0.0 110.683 -174.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -46.34 -56.0 6.49 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.296 1.438 . . . . 0.0 111.704 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 35.0 p -88.69 -10.57 48.01 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 118.365 -0.826 . . . . 0.0 112.543 -174.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -48.07 -42.36 28.43 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.361 0.982 . . . . 0.0 111.766 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -76.65 -25.33 65.39 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 123.54 0.591 . . . . 0.0 112.612 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 24.8 mm -76.37 128.81 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 117.923 0.861 . . . . 0.0 108.84 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -156.66 56.38 0.55 Allowed 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.5 m -155.34 108.93 2.82 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 160.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.94 84.07 5.75 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -174.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.96 147.89 32.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.921 -171.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.6 tt -118.79 110.56 17.37 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.4 t -87.94 108.26 19.11 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 171.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.2 131.19 54.93 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.815 1.246 . . . . 0.0 108.112 177.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.4 m -129.47 89.84 2.9 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.423 0.63 . . . . 0.0 110.749 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -69.98 78.71 0.48 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 169.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.47 46.33 1.36 Allowed Pre-proline 0 CA--C 1.55 0.973 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 174.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.86 -89.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.222 2.614 . . . . 0.0 113.38 -176.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -157.8 112.81 2.69 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.241 -0.912 . . . . 0.0 110.487 -172.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -116.2 142.62 29.59 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 123.65 0.78 . . . . 0.0 109.465 176.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -76.4 66.56 7.19 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.914 1.742 . . . . 0.0 109.61 166.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.4 t 38.05 92.29 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 129.078 2.951 . . . . 0.0 114.846 172.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt . . . . . 0 CA--C 1.534 0.343 0 C-N-CA 123.738 0.815 . . . . 0.0 111.629 -178.421 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.216 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.8 p -157.38 40.66 0.3 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 122.064 0.935 . . . . 0.0 110.974 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -156.08 -52.26 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 127.297 2.239 . . . . 0.0 106.172 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.3 mt -56.93 -29.51 63.16 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.836 1.654 . . . . 0.0 111.502 174.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.2 mt -72.51 80.96 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 123.824 0.849 . . . . 0.0 110.85 -174.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -74.59 -168.95 0.76 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 151.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -71.78 -42.51 67.04 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.66 1.184 . . . . 0.0 111.322 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -40.61 128.1 2.49 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.301 1.44 . . . . 0.0 114.703 -161.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -97.5 88.21 4.32 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 125.538 1.535 . . . . 0.0 107.424 -168.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -82.35 119.9 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 175.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.49 138.42 31.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 -177.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 t -121.89 147.59 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.5 m -140.43 94.27 2.72 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 -174.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -76.0 163.21 27.38 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.204 1.402 . . . . 0.0 108.983 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -146.61 88.5 1.77 Allowed 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.875 0.845 . . . . 0.0 110.583 -167.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.62 111.06 16.7 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.793 0.837 . . . . 0.0 111.025 176.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -118.21 136.74 53.46 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.5 t -132.03 143.46 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -134.93 163.54 29.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 169.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -24.79 -59.05 0.06 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 127.233 2.213 . . . . 0.0 113.242 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -32.78 -42.89 0.16 Allowed Glycine 0 CA--C 1.532 1.106 0 C-N-CA 126.774 2.13 . . . . 0.0 114.71 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.15 106.62 59.0 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 118.86 1.33 . . . . 0.0 108.238 165.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -82.17 5.08 6.57 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.276 1.984 . . . . 0.0 112.498 -173.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 43.1 m0 -79.8 146.3 32.36 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 122.384 1.088 . . . . 0.0 111.792 -165.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -77.54 82.36 3.98 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -93.36 106.85 18.77 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.603 1.561 . . . . 0.0 108.192 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.0 m -101.44 118.92 58.92 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -70.81 166.68 28.11 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 121.186 1.257 . . . . 0.0 109.112 164.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -94.54 -58.32 3.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 C-N-CA 123.853 0.861 . . . . 0.0 110.762 -174.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -132.23 175.18 9.48 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 165.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.3 tpt85 -69.79 -43.03 72.96 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 165.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -135.98 170.08 16.57 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 125.842 1.657 . . . . 0.0 113.283 -158.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.6 pt -143.74 167.24 12.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 127.068 2.147 . . . . 0.0 107.502 173.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -117.92 140.85 49.14 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 161.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.4 t -131.58 129.95 62.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.651 1.58 . . . . 0.0 106.76 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.3 mmt-85 -76.35 94.84 3.67 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 168.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.6 pt -7.66 76.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 127.558 2.343 . . . . 0.0 115.806 -167.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 134.06 -27.04 3.35 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 124.558 1.075 . . . . 0.0 112.858 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -41.32 111.32 0.21 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.263 1.425 . . . . 0.0 111.65 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.49 99.67 1.65 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.17 1.388 . . . . 0.0 110.264 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.2 p -104.96 150.58 7.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 175.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.28 132.6 52.14 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.471 1.108 . . . . 0.0 109.584 178.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.1 pp -138.76 96.93 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 C-N-CA 125.008 1.323 . . . . 0.0 108.026 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.424 ' CB ' ' HA ' ' A' ' 117' ' ' PRO . 0.0 OUTLIER -78.29 166.49 22.63 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -174.272 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -134.25 149.14 50.92 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 26.3 ttt-85 -132.04 122.66 25.82 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -123.15 105.9 10.31 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.539 1.536 . . . . 0.0 109.154 174.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -95.6 131.91 41.31 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -75.45 142.68 42.92 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.042 0.837 . . . . 0.0 109.663 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.71 -7.26 6.78 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.462 1.905 . . . . 0.0 111.68 -174.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.35 151.14 33.03 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.174 0.897 . . . . 0.0 109.29 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.7 m -84.26 14.38 4.4 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -154.2 163.64 23.41 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 175.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.8 160.64 17.29 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.09 1.86 . . . . 0.0 112.212 -175.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.24 165.22 26.66 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 123.301 0.64 . . . . 0.0 110.126 176.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.7 t -111.17 145.45 38.62 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 168.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -138.0 83.9 0.24 Allowed Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -112.04 -21.93 11.28 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.018 0.927 . . . . 0.0 112.119 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.15 -175.97 0.12 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 165.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.5 t -124.11 168.78 12.43 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 118.214 -1.394 . . . . 0.0 107.987 141.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -148.24 88.75 1.67 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 122.726 1.251 . . . . 0.0 108.956 -166.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -78.22 88.98 4.28 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 120.847 -1.158 . . . . 0.0 107.882 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.6 p -78.75 69.48 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.473 0 C-N-CA 125.463 1.505 . . . . 0.0 110.691 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.6 t -176.53 142.05 0.55 Allowed Pre-proline 0 N--CA 1.464 0.252 0 CA-C-N 119.425 1.012 . . . . 0.0 109.736 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -67.05 -58.61 0.14 Allowed 'Trans proline' 0 N--CA 1.446 -1.314 0 N-CA-C 108.777 -1.278 . . . . 0.0 108.777 166.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 26.2 ptm -171.42 11.37 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -171.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -173.49 -51.93 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 119.163 0.892 . . . . 0.0 110.317 -162.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.25 -124.55 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.667 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.19 -44.09 1.07 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 120.417 -1.427 . . . . 0.0 112.762 -170.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.59 -58.18 4.06 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.408 1.083 . . . . 0.0 110.837 174.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -74.29 -25.1 59.39 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.258 1.023 . . . . 0.0 113.447 -177.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -41.04 120.68 1.39 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.745 1.218 . . . . 0.0 109.302 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 . . . . . 0 CA--C 1.532 0.277 0 CA-C-N 118.803 0.729 . . . . 0.0 111.422 -168.191 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.0 t 40.85 -131.51 0.37 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.538 1.535 . . . . 0.0 113.315 165.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.0 t -132.16 147.89 52.45 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.067 2.147 . . . . 0.0 108.167 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.1 mt -134.19 142.29 47.36 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.406 0.683 . . . . 0.0 109.883 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -68.98 164.25 49.2 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.365 1.866 . . . . 0.0 110.372 167.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.06 76.77 2.5 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 124.682 3.588 . . . . 0.0 112.735 -169.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 153.71 -21.22 0.7 Allowed Glycine 0 CA--C 1.521 0.433 0 CA-C-O 119.357 -0.691 . . . . 0.0 113.285 169.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.9 155.67 32.66 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 118.14 0.97 . . . . 0.0 111.772 -159.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -106.44 101.45 10.91 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.89 1.276 . . . . 0.0 110.887 -165.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.79 85.81 7.24 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -106.64 105.11 14.98 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.862 1.265 . . . . 0.0 108.851 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 46.7 mtt -146.87 141.49 16.09 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 119.729 1.15 . . . . 0.0 112.936 -174.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.424 ' HA ' ' CB ' ' A' ' 67' ' ' MET . 95.3 Cg_endo -83.87 145.51 11.37 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.138 2.559 . . . . 0.0 113.622 176.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 24.1 t -117.8 150.81 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 126.403 1.881 . . . . 0.0 106.512 170.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.2 m -118.74 147.44 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.868 1.267 . . . . 0.0 108.301 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -157.55 159.16 36.85 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.629 0.65 . . . . 0.0 112.747 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -163.17 158.19 21.43 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 126.661 1.984 . . . . 0.0 108.426 166.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 29.7 t -102.29 147.35 9.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 124.699 1.199 . . . . 0.0 108.768 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -80.97 161.78 62.0 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 123.398 0.679 . . . . 0.0 110.149 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -101.94 28.25 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.89 3.06 . . . . 0.0 112.425 166.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -84.41 -40.54 17.67 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 168.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.7 tt -39.3 -47.38 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.112 1.365 . . . . 0.0 113.681 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.8 m -79.27 55.7 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 O-C-N 121.553 -0.717 . . . . 0.0 110.627 175.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -140.99 -66.61 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.491 0 CA-C-O 117.485 -1.245 . . . . 0.0 111.711 175.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.4 158.43 44.46 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 CA-C-N 121.927 1.724 . . . . 0.0 112.54 -175.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.2 t -55.61 -46.8 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 124.7 1.2 . . . . 0.0 110.141 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -46.17 -50.33 15.77 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.985 1.314 . . . . 0.0 112.684 -175.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 27.2 p -101.52 -6.74 23.53 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -174.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -37.84 107.82 0.07 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.839 1.256 . . . . 0.0 112.152 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.03 -30.53 8.56 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.587 -1.118 . . . . 0.0 113.132 176.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 43.2 mm -58.79 129.3 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 C-N-CA 124.321 1.048 . . . . 0.0 109.863 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -158.54 49.13 0.37 Allowed 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.4 m -149.4 92.55 1.95 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 162.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.08 89.58 5.97 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -171.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 13.2 t -78.01 175.35 10.16 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 122.247 1.022 . . . . 0.0 109.383 -176.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.17 98.34 3.08 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 169.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.3 m -79.81 95.36 6.0 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 174.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -76.67 126.4 30.92 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 171.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 26.6 m -122.51 89.91 3.2 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -84.83 91.34 7.98 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.155 -173.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -151.04 47.39 0.44 Allowed Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 116.876 2.176 . . . . 0.0 116.876 -175.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.2 -111.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.398 2.732 . . . . 0.0 110.763 173.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -136.05 116.49 13.71 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.693 1.133 . . . . 0.0 108.928 -168.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -93.19 143.54 26.9 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 164.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -71.54 -55.36 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.882 1.721 . . . . 0.0 108.419 167.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.6 t -177.37 126.25 0.14 Allowed 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.158 1.783 . . . . 0.0 107.791 172.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 27.4 pttt . . . . . 0 CA--C 1.537 0.474 0 C-N-CA 123.144 0.577 . . . . 0.0 111.321 160.693 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.059 0 N-CA-C 102.015 -3.328 . . . . 0.0 102.015 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.3 t -155.5 35.12 0.37 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 121.508 1.958 . . . . 0.0 111.11 176.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -160.37 -60.74 0.06 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -164.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.43 39.94 0.62 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 112.628 -2.078 . . . . 0.0 112.246 -165.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.9 mt -119.37 62.59 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 123.486 0.714 . . . . 0.0 110.688 -167.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -76.96 149.63 35.95 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.024 1.33 . . . . 0.0 109.602 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.0 54.61 1.62 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -165.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.8 98.09 7.83 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 166.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.76 81.78 5.97 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 122.125 0.964 . . . . 0.0 108.65 -168.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.292 0.0 OUTLIER -79.92 131.83 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.629 -173.173 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.97 150.66 24.73 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 126.79 2.036 . . . . 0.0 106.999 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.7 m -135.94 120.11 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.26 111.92 18.79 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 176.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -79.48 89.69 5.05 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 176.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -78.35 80.58 4.75 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 122.608 1.194 . . . . 0.0 108.019 -174.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.91 126.05 30.51 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -133.8 147.33 51.23 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.3 p -145.25 147.98 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 124.097 0.959 . . . . 0.0 108.815 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -130.3 168.46 16.86 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 166.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.48 -34.86 11.91 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.235 1.014 . . . . 0.0 111.891 -178.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -34.93 -38.8 0.14 Allowed Glycine 0 CA--C 1.532 1.11 0 C-N-CA 126.28 1.895 . . . . 0.0 113.734 169.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.6 96.58 48.57 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 118.225 1.012 . . . . 0.0 108.283 163.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -82.92 42.55 1.31 Allowed 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 123.424 2.75 . . . . 0.0 111.332 -168.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 41.5 m0 -112.81 147.19 37.46 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 -176.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -77.14 80.93 3.65 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -90.9 87.04 6.47 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 m -95.64 128.39 38.08 Favored Pre-proline 0 N--CA 1.454 -0.257 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -67.4 153.15 77.62 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 N-CA-C 107.3 -1.846 . . . . 0.0 107.3 160.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -57.96 4.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.638 0.732 . . . . 0.0 109.092 -173.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -120.06 159.09 25.48 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 103.199 -2.889 . . . . 0.0 103.199 157.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -23.01 67.09 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.946 0.794 . . . . 0.0 110.652 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -139.88 167.6 21.74 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 125.561 1.545 . . . . 0.0 109.952 -171.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.41 168.95 21.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 172.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.3 p-10 -129.84 147.62 51.63 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.339 0.656 . . . . 0.0 111.218 166.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.2 m -141.84 122.99 12.54 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.57 56.27 3.89 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 121.413 1.915 . . . . 0.0 109.999 -173.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mt 58.8 116.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 124.642 1.177 . . . . 0.0 109.004 -164.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.28 -51.74 4.42 Favored Glycine 0 CA--C 1.525 0.718 0 O-C-N 119.994 -1.691 . . . . 0.0 113.945 172.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -26.39 100.5 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.444 2.298 . . . . 0.0 112.081 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.5 p -76.89 128.2 34.13 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.722 -0.612 . . . . 0.0 110.461 -172.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 p -123.62 149.43 27.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 C-N-CA 125.268 1.427 . . . . 0.0 109.041 177.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.02 122.86 36.96 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 125.164 1.385 . . . . 0.0 107.276 164.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.7 pp -114.67 130.74 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 157.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 35.8 ttp -76.97 140.53 40.46 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 169.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -109.29 158.71 17.61 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 166.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 43.7 ttm-85 -138.13 140.93 40.13 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.353 1.461 . . . . 0.0 108.727 -175.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.7 96.72 1.78 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.12 1.768 . . . . 0.0 108.846 166.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -95.09 126.11 40.21 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -79.94 121.41 25.42 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.607 1.094 . . . . 0.0 112.399 -170.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.4 mp -108.87 26.76 10.2 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.262 1.025 . . . . 0.0 111.598 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.17 171.66 14.62 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 120.987 -1.071 . . . . 0.0 112.223 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.4 p -79.47 -34.59 41.33 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.645 1.978 . . . . 0.0 110.479 170.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 66.5 p -123.99 179.84 0.99 Allowed Pre-proline 0 N--CA 1.456 -0.152 0 C-N-CA 127.149 2.18 . . . . 0.0 108.979 -174.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -54.41 161.51 5.48 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 CA-C-N 119.309 0.789 . . . . 0.0 111.345 160.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.47 173.9 10.4 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 157.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.6 t -102.85 162.11 13.19 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 151.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -151.41 60.27 0.41 Allowed Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -88.31 -39.11 14.63 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.537 0.735 . . . . 0.0 109.051 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.05 178.08 0.15 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.367 1.067 . . . . 0.0 112.841 169.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.5 m -125.87 148.09 49.28 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 173.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -137.98 160.85 38.24 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.619 0.768 . . . . 0.0 110.345 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.76 113.36 20.07 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 164.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.8 p -95.08 59.4 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 123.714 0.805 . . . . 0.0 112.127 -173.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.8 t -174.5 150.04 1.41 Allowed Pre-proline 0 C--N 1.333 -0.121 0 O-C-N 121.539 -0.725 . . . . 0.0 110.682 -175.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.21 -33.66 30.24 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 N-CA-C 108.99 -1.196 . . . . 0.0 108.99 162.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.3 ptp 174.99 -71.8 0.01 OUTLIER 'General case' 0 C--N 1.341 0.23 0 C-N-CA 127.023 2.129 . . . . 0.0 107.913 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.76 -31.02 51.78 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -163.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.33 -110.51 0.06 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.476 0.179 . . . . 0.0 111.264 -168.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.16 -56.28 0.1 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.312 0.958 . . . . 0.0 113.31 -169.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.83 -49.54 19.88 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.376 1.588 . . . . 0.0 112.287 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -72.74 -4.67 32.81 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.283 1.033 . . . . 0.0 113.41 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.401 ' CE1' ' CE2' ' A' ' 120' ' ' PHE . 6.1 t80 -62.64 131.92 50.6 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 . . . . . 0 N--CA 1.442 -0.837 0 O-C-N 123.515 0.51 . . . . 0.0 112.166 174.667 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 CA--C 1.538 0.494 0 CA-C-O 121.138 0.494 . . . . 0.0 112.207 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.8 t -156.33 -70.47 0.11 Allowed 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.009 0.924 . . . . 0.0 111.137 -176.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.6 m -159.69 135.0 8.23 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 -164.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 69.0 mt -149.47 146.37 27.38 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.926 0.89 . . . . 0.0 109.058 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.26 170.7 12.83 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 126.324 1.85 . . . . 0.0 109.567 167.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.01 88.16 1.27 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 124.607 3.538 . . . . 0.0 111.093 -173.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 151.23 -30.19 0.97 Allowed Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 173.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.27 145.87 41.52 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.688 -151.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -96.29 89.71 5.19 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.974 1.71 . . . . 0.0 110.975 -170.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.96 119.15 26.87 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 176.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -154.13 132.51 11.98 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 122.762 0.425 . . . . 0.0 109.869 168.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 39.2 mtt -156.01 156.93 31.05 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 123.589 0.756 . . . . 0.0 110.373 -168.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.23 140.57 22.33 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.801 3.0 . . . . 0.0 111.688 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.8 t -126.37 136.29 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 170.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.0 m -105.57 157.45 6.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 CA-C-N 117.849 0.295 . . . . 0.0 110.526 173.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.401 ' CE2' ' CE1' ' A' ' 95' ' ' PHE . 6.2 t80 -156.72 139.17 14.86 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -170.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -157.8 173.03 17.42 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.743 1.617 . . . . 0.0 109.779 169.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.4 p -129.59 143.39 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 118.743 -0.646 . . . . 0.0 110.229 169.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -76.18 153.59 84.36 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 118.671 0.669 . . . . 0.0 109.588 175.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -58.63 -21.26 54.49 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.325 2.684 . . . . 0.0 112.132 170.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -41.47 -33.85 0.48 Allowed 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 126.637 1.975 . . . . 0.0 113.258 176.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.4 tt -54.53 -42.46 59.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.896 0.771 . . . . 0.0 112.661 175.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.1 m -84.3 54.13 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 119.088 0.858 . . . . 0.0 109.901 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -135.74 -65.52 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 117.637 -1.173 . . . . 0.0 112.252 175.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -74.53 149.47 39.15 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 CA-C-N 121.977 1.742 . . . . 0.0 111.079 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.4 p -64.44 -35.38 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 124.124 0.969 . . . . 0.0 110.75 -174.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -45.45 -48.99 13.8 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.1 1.76 . . . . 0.0 112.245 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.9 p -91.23 -66.53 0.92 Allowed 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 41.56 -72.01 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.693 2.797 . . . . 0.0 115.87 -175.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -87.14 -23.01 42.5 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.319 1.438 . . . . 0.0 111.234 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.9 mm -56.95 126.69 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 117.816 0.808 . . . . 0.0 109.949 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -156.01 58.41 0.59 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.921 172.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.9 m -150.01 88.67 1.54 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 167.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.0 mp -74.64 85.98 2.12 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.5 t -83.68 140.07 32.38 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.634 -1.166 . . . . 0.0 107.867 174.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.9 tt -114.22 103.94 11.6 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 169.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.3 p -86.7 104.83 16.47 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.38 128.91 50.37 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.589 1.556 . . . . 0.0 108.401 -176.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.4 m -114.98 91.55 3.65 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.526 1.131 . . . . 0.0 109.324 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -71.41 88.17 0.88 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.599 1.159 . . . . 0.0 109.638 174.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -155.93 59.64 2.14 Favored Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 174.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -79.96 -78.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.936 2.424 . . . . 0.0 111.979 -176.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -146.79 132.72 19.13 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.553 0.615 . . . . 0.0 109.467 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -131.98 135.56 26.81 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 125.867 1.667 . . . . 0.0 106.611 175.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -77.21 -61.93 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.15 1.9 . . . . 0.0 109.97 171.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 41.8 t -176.84 97.67 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.639 1.575 . . . . 0.0 107.708 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.5 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.0 t -166.23 -136.59 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 144.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -73.03 -27.55 61.83 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.474 1.109 . . . . 0.0 109.413 168.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -68.76 6.47 0.85 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -173.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 81.7 mt -58.99 122.14 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 120.847 1.658 . . . . 0.0 110.043 177.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.68 157.21 17.22 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 118.785 0.721 . . . . 0.0 110.999 175.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.67 -27.65 69.06 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.074 0.95 . . . . 0.0 113.03 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -51.76 114.0 1.15 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.97 0.908 . . . . 0.0 111.953 -174.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.63 98.04 8.17 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 127.067 2.147 . . . . 0.0 108.747 -171.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.0 tt -109.13 136.62 44.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 126.277 1.831 . . . . 0.0 110.748 -170.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.9 tptp -98.64 157.53 16.19 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 124.918 1.287 . . . . 0.0 110.897 -168.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 82.3 t -133.65 160.68 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 C-N-CA 124.306 1.042 . . . . 0.0 108.63 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.4 m -145.46 102.48 3.71 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.615 1.166 . . . . 0.0 109.319 172.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -78.6 88.56 4.52 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.055 1.342 . . . . 0.0 108.13 175.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -80.06 85.36 5.65 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 121.415 -0.803 . . . . 0.0 109.191 -174.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.82 134.71 34.29 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 121.839 -0.538 . . . . 0.0 111.329 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -144.09 147.01 33.19 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 126.405 1.882 . . . . 0.0 109.66 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.9 t -132.77 147.97 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 125.34 1.456 . . . . 0.0 108.402 177.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -146.96 174.29 11.65 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.031 0.932 . . . . 0.0 109.931 174.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -49.28 121.81 5.36 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 169.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.77 -43.21 1.3 Allowed Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 108.078 -2.009 . . . . 0.0 108.078 -163.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.74 97.76 20.66 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 123.308 0.643 . . . . 0.0 111.067 177.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -84.72 41.71 1.02 Allowed 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.78 2.987 . . . . 0.0 110.271 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.436 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 43.2 m0 -114.77 136.9 52.57 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.601 0.76 . . . . 0.0 109.315 -171.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -79.16 80.81 5.48 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -89.98 89.36 7.68 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 124.238 1.015 . . . . 0.0 108.99 -176.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.9 m -84.81 129.7 55.65 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.22 166.18 30.46 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 121.436 1.424 . . . . 0.0 108.464 161.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.38 -56.21 5.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 123.862 0.865 . . . . 0.0 109.437 -176.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.79 164.44 24.06 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 161.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -63.55 -46.77 84.44 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 165.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -131.04 149.99 52.36 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 126.249 1.819 . . . . 0.0 110.108 -164.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.0 pt -134.81 167.97 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 167.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -110.56 134.24 52.57 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 166.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.0 157.91 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 165.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.5 mtm180 -109.15 114.27 27.84 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -37.8 117.34 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -147.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 111.43 -46.36 1.18 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 -172.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -53.63 109.59 0.47 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 117.767 0.784 . . . . 0.0 112.846 -166.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.2 p -56.44 122.03 10.99 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.938 1.295 . . . . 0.0 111.221 172.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.06 137.6 42.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 166.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -77.78 128.56 34.21 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.824 1.25 . . . . 0.0 108.569 167.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.1 pp -146.3 88.6 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.974 0.91 . . . . 0.0 108.971 174.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.93 147.16 41.19 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 121.385 -0.822 . . . . 0.0 110.276 -177.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -98.14 159.24 15.07 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 166.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -135.96 118.51 15.89 Favored 'General case' 0 C--O 1.227 -0.099 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 172.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -110.69 154.89 23.22 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 126.608 1.963 . . . . 0.0 109.081 172.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -154.95 123.74 6.15 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 -176.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.436 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 35.6 t30 -80.77 112.66 18.35 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 119.302 0.956 . . . . 0.0 110.836 -173.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.35 5.1 51.66 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.721 1.208 . . . . 0.0 112.742 -176.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.37 176.79 9.01 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.792 0.724 . . . . 0.0 110.538 175.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.6 t -105.64 20.73 18.43 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.739 0.816 . . . . 0.0 109.96 175.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.2 160.48 30.85 Favored Pre-proline 0 N--CA 1.447 -0.612 0 C-N-CA 127.086 2.154 . . . . 0.0 106.708 -174.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.71 160.44 40.44 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 C-N-CA 121.161 1.241 . . . . 0.0 109.442 172.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.38 164.18 26.25 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-O 120.776 0.322 . . . . 0.0 110.663 166.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.57 95.18 5.21 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.989 2.116 . . . . 0.0 105.693 -177.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.0 96.52 0.78 Allowed Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 107.756 -2.137 . . . . 0.0 107.756 177.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -125.05 50.33 1.77 Allowed 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 169.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.38 176.82 0.32 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.805 0.812 . . . . 0.0 110.872 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -146.04 162.48 37.8 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.91 169.82 17.33 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 123.578 0.751 . . . . 0.0 110.336 -172.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -119.91 111.52 18.04 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 163.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.2 t -95.43 77.59 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.177 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.1 t -176.07 145.55 0.75 Allowed Pre-proline 0 C--O 1.232 0.142 0 C-N-CA 124.153 0.981 . . . . 0.0 110.207 171.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.94 -38.0 40.68 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 121.259 1.306 . . . . 0.0 110.064 158.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.9 ptp 172.02 -68.08 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 127.835 2.454 . . . . 0.0 107.759 174.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.5 -39.5 46.1 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -167.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.74 -104.68 0.04 OUTLIER 'General case' 0 C--O 1.228 -0.055 0 C-N-CA 123.101 0.561 . . . . 0.0 110.427 -174.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.27 -58.78 2.8 Favored Glycine 0 CA--C 1.523 0.55 0 O-C-N 121.855 -0.528 . . . . 0.0 111.853 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -47.64 -48.95 28.52 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.927 0.864 . . . . 0.0 110.613 174.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -74.7 3.96 7.05 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.152 1.381 . . . . 0.0 113.882 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -76.95 107.92 9.63 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 171.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 . . . . . 0 N--CA 1.451 -0.382 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.644 179.365 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.5 t -177.08 -82.15 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.069 1.347 . . . . 0.0 111.504 172.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.8 t -155.47 149.92 26.05 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.962 1.305 . . . . 0.0 108.025 -169.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.1 mt -154.03 127.52 8.62 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 123.873 0.869 . . . . 0.0 109.437 175.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -63.2 158.15 58.02 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 126.401 1.88 . . . . 0.0 110.256 164.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.47 110.53 3.0 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.481 2.121 . . . . 0.0 111.38 -169.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 115.17 -15.75 18.15 Favored Glycine 0 C--N 1.334 0.467 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -77.86 156.32 30.46 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 117.476 0.638 . . . . 0.0 110.873 -174.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.61 153.56 39.15 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.753 1.221 . . . . 0.0 110.687 -167.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 42.4 ttm -149.47 88.58 1.57 Allowed 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.094 1.358 . . . . 0.0 108.687 -168.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -89.72 130.17 36.03 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 118.585 0.629 . . . . 0.0 109.888 164.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -126.48 92.58 44.9 Favored Pre-proline 0 N--CA 1.452 -0.358 0 C-N-CA 125.327 1.451 . . . . 0.0 107.908 -171.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -55.37 126.12 21.45 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.723 2.282 . . . . 0.0 110.184 169.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.1 t -121.57 147.38 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 170.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.8 p -119.75 142.02 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 171.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -145.81 148.79 33.29 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 118.161 0.437 . . . . 0.0 111.147 -172.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -157.88 141.91 15.87 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.55 1.14 . . . . 0.0 110.098 165.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 24.0 t -70.54 134.35 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 164.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.42 ' C ' ' H ' ' A' ' 125' ' ' GLU . 1.5 t70 -88.41 138.55 30.18 Favored Pre-proline 0 N--CA 1.451 -0.406 0 C-N-CA 123.971 0.908 . . . . 0.0 109.939 -173.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -72.02 34.53 0.29 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.09 2.527 . . . . 0.0 114.331 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.42 ' H ' ' C ' ' A' ' 123' ' ' ASP . 37.7 tt0 -107.55 -21.78 12.77 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 130.071 3.348 . . . . 0.0 108.507 172.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.7 tt -58.22 -39.12 72.18 Favored 'Isoleucine or valine' 0 C--N 1.345 0.372 0 O-C-N 121.117 -0.99 . . . . 0.0 111.249 172.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.1 m -77.27 61.62 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 123.37 0.668 . . . . 0.0 109.956 172.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -130.92 -78.48 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 117.359 -1.305 . . . . 0.0 111.403 173.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -73.04 160.21 46.19 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 CA-C-N 122.011 1.754 . . . . 0.0 111.105 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 84.5 t -65.07 -44.66 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 124.553 1.141 . . . . 0.0 109.113 -171.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -48.31 -64.38 0.81 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.335 1.854 . . . . 0.0 110.095 177.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 35.7 p -75.94 -19.96 58.34 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 118.357 -0.83 . . . . 0.0 111.63 -172.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -44.65 -39.31 4.96 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.932 0.787 . . . . 0.0 111.186 168.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -57.72 -54.6 36.01 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 175.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 21.9 mm -64.26 132.4 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 124.6 1.16 . . . . 0.0 111.728 -174.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -158.65 41.57 0.25 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.181 165.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.8 p -140.8 89.64 2.27 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 170.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.4 tp -84.79 144.88 28.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -166.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.5 t -149.61 153.02 36.42 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -176.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.06 145.8 41.1 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 146.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 26.6 t -98.84 116.97 32.28 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 164.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.23 124.9 49.48 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.137 1.375 . . . . 0.0 107.383 178.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.5 m -114.63 89.88 3.2 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -67.53 83.52 0.17 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 170.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.16 50.65 1.16 Allowed Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 178.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -74.73 -106.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.264 2.643 . . . . 0.0 110.254 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -147.22 123.52 10.93 Favored 'General case' 0 C--N 1.337 0.058 0 CA-C-N 119.363 0.983 . . . . 0.0 109.292 -175.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -111.3 143.67 28.91 Favored Pre-proline 0 N--CA 1.45 -0.463 0 C-N-CA 124.892 1.277 . . . . 0.0 108.353 175.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.0 -51.28 0.17 Allowed 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 121.939 1.759 . . . . 0.0 109.135 171.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 61.8 p -175.75 174.28 2.22 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.282 1.833 . . . . 0.0 107.147 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.4 pttt . . . . . 0 CA--C 1.535 0.377 0 C-N-CA 124.759 1.224 . . . . 0.0 109.201 172.576 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.933 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 t -77.42 23.95 0.2 Allowed 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.174 -1.579 . . . . 0.0 113.456 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -75.9 -30.91 58.96 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 153.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -107.21 -44.54 4.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.614 1.165 . . . . 0.0 112.822 -175.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.1 mt -19.22 115.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 126.432 1.893 . . . . 0.0 115.146 -164.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.7 mp -103.78 -178.26 3.61 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.262 -161.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -69.2 -48.12 62.94 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.685 1.994 . . . . 0.0 110.733 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.54 151.08 29.56 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.799 0.809 . . . . 0.0 111.814 -174.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.63 98.54 7.69 Favored 'General case' 0 N--CA 1.418 -2.051 0 C-N-CA 127.233 2.213 . . . . 0.0 107.285 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.31 0.0 OUTLIER -80.05 122.04 34.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 170.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.43 ' CE ' ' HB2' ' A' ' 55' ' ' ASP . 2.7 tmtp? -75.87 150.54 37.59 Favored 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.6 t -129.66 143.08 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 172.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.8 m -141.78 98.05 3.27 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -173.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -76.38 159.06 30.84 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.895 -172.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -131.05 84.0 2.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 122.761 1.267 . . . . 0.0 107.916 169.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.35 86.1 7.22 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 164.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -93.36 157.82 16.04 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.496 0.718 . . . . 0.0 109.089 170.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.2 p -140.2 110.98 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 123.499 0.72 . . . . 0.0 109.478 175.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.93 164.32 15.2 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.115 166.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.81 -39.44 8.39 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.921 1.288 . . . . 0.0 112.999 -176.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.19 -26.21 2.15 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.819 1.676 . . . . 0.0 113.985 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.05 97.18 48.16 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 162.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -82.73 47.54 2.48 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.207 1.938 . . . . 0.0 110.296 -170.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.484 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 43.6 m0 -112.54 148.33 34.72 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.471 1.108 . . . . 0.0 109.502 -170.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -76.79 80.55 3.39 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 175.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -93.29 101.72 13.98 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 124.329 1.052 . . . . 0.0 108.251 -177.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.7 m -101.97 132.47 21.56 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-O 119.26 -0.4 . . . . 0.0 110.058 -172.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.38 141.34 51.04 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 N-CA-C 107.802 -1.653 . . . . 0.0 107.802 162.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.2 p -77.58 -52.53 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 121.477 0.656 . . . . 0.0 110.031 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -127.55 158.96 36.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 104.122 -2.547 . . . . 0.0 104.122 153.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -66.88 -44.91 79.65 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 174.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.43 ' HB2' ' CE ' ' A' ' 34' ' ' LYS . 20.7 p-10 -130.24 167.22 18.8 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 126.361 1.864 . . . . 0.0 111.07 -170.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.8 pt -143.07 175.49 4.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 125.11 1.364 . . . . 0.0 108.114 169.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -119.31 132.33 55.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 169.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.6 m -124.46 126.14 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.638 0.775 . . . . 0.0 108.96 172.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -72.68 77.43 1.1 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 168.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.5 mt 28.29 58.54 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 127.877 2.471 . . . . 0.0 111.798 169.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.6 -27.47 2.83 Favored Glycine 0 CA--C 1.523 0.557 0 O-C-N 122.131 -0.355 . . . . 0.0 113.195 -174.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -50.02 118.39 2.88 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.038 0.535 . . . . 0.0 111.342 171.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.4 p -88.94 107.27 18.92 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.338 1.455 . . . . 0.0 109.951 -177.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -96.06 139.07 19.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 174.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.8 120.35 23.94 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 163.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.34 111.05 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 76.8 mtp -76.49 171.22 14.97 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.39 0.676 . . . . 0.0 110.747 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -141.31 151.14 43.36 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 163.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.4 ttm105 -127.02 139.07 53.28 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 172.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.88 112.16 8.61 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.554 1.942 . . . . 0.0 108.152 173.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.0 mtmt -103.98 130.09 51.6 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.721 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.484 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 52.6 t-20 -78.26 101.97 7.41 Favored 'General case' 0 C--N 1.339 0.12 0 CA-C-N 119.44 1.018 . . . . 0.0 111.512 -176.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.9 mt -91.62 7.92 39.21 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.761 0.824 . . . . 0.0 113.014 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.91 162.94 27.2 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.858 1.208 . . . . 0.0 109.714 171.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.0 p -79.1 -9.21 59.49 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.045 1.338 . . . . 0.0 111.543 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.58 165.2 29.93 Favored Pre-proline 0 N--CA 1.447 -0.603 0 C-N-CA 126.38 1.872 . . . . 0.0 107.686 -168.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -61.27 148.43 92.94 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 121.14 1.226 . . . . 0.0 109.764 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.7 p -126.79 169.52 13.13 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 165.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.3 t -90.32 173.57 8.05 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 159.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.49 57.07 0.19 Allowed Glycine 0 N--CA 1.438 -1.185 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 176.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.69 -42.56 34.12 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 169.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 64.34 179.24 0.17 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.679 1.192 . . . . 0.0 110.873 174.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.8 m -120.16 136.15 54.72 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 172.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -105.57 148.75 26.94 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.151 0.58 . . . . 0.0 110.354 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -124.66 102.85 7.8 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 156.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.9 t -92.44 59.36 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 124.12 0.968 . . . . 0.0 108.839 -170.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.3 t -171.19 147.29 2.19 Favored Pre-proline 0 N--CA 1.461 0.108 0 O-C-N 121.499 -0.751 . . . . 0.0 111.664 -176.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -64.77 -40.41 22.21 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.381 1.387 . . . . 0.0 109.316 160.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 11.7 ptp 173.73 -71.76 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 127.523 2.329 . . . . 0.0 108.291 173.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.23 -43.8 73.31 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 123.571 0.748 . . . . 0.0 112.801 -164.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.49 -102.84 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.248 0.619 . . . . 0.0 110.595 -170.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.9 -52.75 1.67 Allowed Glycine 0 CA--C 1.53 1.026 0 CA-C-O 119.425 -0.653 . . . . 0.0 112.809 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -48.3 -50.63 29.33 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.039 1.419 . . . . 0.0 111.016 174.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -72.38 -4.98 33.22 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.082 1.753 . . . . 0.0 113.792 178.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -75.45 108.14 8.05 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 . . . . . 0 N--CA 1.447 -0.581 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.631 -177.493 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.7 mp0 . . . . . 0 N--CA 1.449 -0.504 0 N-CA-C 111.529 0.196 . . . . 0.0 111.529 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . 0.325 5.0 t 57.98 -78.67 0.02 OUTLIER 'General case' 0 C--O 1.232 0.173 0 C-N-CA 126.268 1.827 . . . . 0.0 114.699 165.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.3 m -162.56 142.45 9.5 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 125.83 1.652 . . . . 0.0 107.53 -169.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 26.3 mt -149.67 140.69 22.93 Favored 'General case' 0 C--O 1.232 0.17 0 O-C-N 123.335 0.397 . . . . 0.0 111.255 174.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -52.39 161.45 1.06 Allowed Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 128.91 2.884 . . . . 0.0 111.413 159.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -77.23 125.29 7.72 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.454 2.769 . . . . 0.0 111.602 -173.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.59 -10.82 32.87 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 124.437 1.018 . . . . 0.0 111.167 175.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -79.0 144.77 34.37 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -164.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -93.04 101.18 13.51 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.054 1.742 . . . . 0.0 109.127 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.55 125.39 29.92 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 161.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -146.31 126.66 13.98 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.156 1.382 . . . . 0.0 107.536 172.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 68.1 mtp -148.89 151.43 34.9 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 118.113 0.415 . . . . 0.0 111.002 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -76.1 145.11 27.49 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 123.843 3.029 . . . . 0.0 110.378 165.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.2 t -116.59 156.4 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 155.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.0 m -122.47 141.73 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 171.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -153.9 148.12 25.86 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -171.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -157.62 175.84 13.4 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 128.501 2.72 . . . . 0.0 106.569 173.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 87.5 t -126.64 137.4 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 C-N-CA 123.111 0.564 . . . . 0.0 109.543 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -71.54 144.11 88.42 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 119.557 -0.259 . . . . 0.0 111.213 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -58.82 -25.14 75.23 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.0 2.467 . . . . 0.0 112.891 172.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -43.9 -30.16 0.66 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.663 1.185 . . . . 0.0 113.244 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.0 tt -52.52 -42.02 38.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 175.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.5 m -91.75 55.66 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 118.391 0.541 . . . . 0.0 110.332 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -129.71 -70.33 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.371 0 CA-C-O 117.224 -1.37 . . . . 0.0 111.331 167.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.2 156.77 63.81 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 CA-C-N 121.913 1.719 . . . . 0.0 111.47 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 83.9 t -66.75 -50.73 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.709 0.804 . . . . 0.0 110.076 -169.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -48.26 -45.15 34.1 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 124.616 1.166 . . . . 0.0 111.623 -174.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 61.2 p -92.19 -9.52 42.02 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 118.55 -0.738 . . . . 0.0 112.336 -174.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -50.21 -44.64 53.26 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.048 0.84 . . . . 0.0 111.602 -172.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.23 -24.99 75.55 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 123.388 0.518 . . . . 0.0 112.557 -177.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 13.2 mm -73.8 123.17 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 118.122 0.961 . . . . 0.0 109.773 -176.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -153.39 52.48 0.73 Allowed 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.719 165.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.4 m -146.95 99.7 3.21 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 153.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.81 134.17 38.06 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.3 t -125.48 161.65 26.65 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.6 tt -131.26 112.15 12.54 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 102.263 -3.236 . . . . 0.0 102.263 168.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.5 t -86.47 104.03 15.56 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 167.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.35 97.21 8.94 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.59 86.58 3.91 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 122.416 1.103 . . . . 0.0 108.272 -178.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -68.37 87.67 0.31 Allowed 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 167.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.03 35.9 0.09 OUTLIER Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.91 -79.19 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.977 1.784 . . . . 0.0 113.365 -174.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 71.2 mtm180 -155.94 117.37 3.92 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.815 0.846 . . . . 0.0 109.99 -172.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -88.01 147.86 41.8 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 123.252 0.621 . . . . 0.0 109.73 167.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.52 -47.38 0.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.647 2.231 . . . . 0.0 110.335 172.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.4 p 157.13 82.25 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 128.536 2.734 . . . . 0.0 107.9 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.542 0.662 0 O-C-N 121.615 -0.678 . . . . 0.0 109.177 -171.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.613 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.4 m -70.24 65.73 0.28 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 129.195 2.998 . . . . 0.0 110.536 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -153.79 -56.26 0.11 Allowed 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 130.972 3.709 . . . . 0.0 103.321 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.18 -20.84 19.49 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 116.691 -1.623 . . . . 0.0 113.958 174.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.7 mt -40.47 138.91 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 120.968 1.713 . . . . 0.0 115.064 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -122.41 173.25 7.77 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.505 1.922 . . . . 0.0 110.509 -171.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -86.04 -24.5 26.35 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.753 0.821 . . . . 0.0 112.673 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.93 148.05 22.14 Favored 'General case' 0 C--O 1.231 0.11 0 O-C-N 121.004 -1.06 . . . . 0.0 110.209 174.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -120.02 97.0 5.4 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.24 1.416 . . . . 0.0 108.562 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.9 142.64 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 124.736 1.214 . . . . 0.0 108.779 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.67 148.39 27.44 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.761 1.224 . . . . 0.0 109.099 -174.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.9 t -136.18 111.16 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 -171.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 m -91.82 122.78 34.67 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 173.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -96.01 107.85 20.19 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.629 1.172 . . . . 0.0 108.8 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -96.28 86.93 4.34 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 122.763 1.268 . . . . 0.0 110.027 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.96 136.91 37.38 Favored 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 120.744 -1.222 . . . . 0.0 108.419 173.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.93 146.14 50.24 Favored 'General case' 0 CA--C 1.523 -0.08 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.94 143.1 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.58 166.64 23.06 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.166 1.786 . . . . 0.0 106.983 168.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -42.56 -43.72 3.86 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 124.233 1.013 . . . . 0.0 112.285 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.56 -34.09 0.23 Allowed Glycine 0 CA--C 1.534 1.223 0 C-N-CA 126.214 1.864 . . . . 0.0 114.663 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.18 96.5 49.28 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 119.034 1.417 . . . . 0.0 107.961 162.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -84.73 43.2 1.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 124.095 3.197 . . . . 0.0 109.441 -169.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.425 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 41.1 m0 -115.5 144.42 43.87 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -169.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -76.74 79.93 3.36 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -175.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -89.36 98.44 11.77 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.236 1.014 . . . . 0.0 109.042 -174.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.9 m -102.45 138.21 19.61 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -70.44 163.03 40.28 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 121.622 1.548 . . . . 0.0 108.71 166.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.08 -61.92 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -175.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -131.7 156.99 44.94 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 162.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -23.95 64.99 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.072 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.57 162.59 41.12 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 119.078 0.854 . . . . 0.0 111.029 174.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.2 pt -135.33 166.55 27.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 126.074 1.75 . . . . 0.0 109.33 173.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -111.28 135.55 51.65 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.3 1.84 . . . . 0.0 109.435 164.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -137.42 128.98 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.369 1.867 . . . . 0.0 108.689 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -82.1 82.49 7.65 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 120.699 -1.25 . . . . 0.0 109.5 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.0 mt 17.38 69.58 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 128.768 2.827 . . . . 0.0 112.237 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.45 -25.64 4.76 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.239 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -48.7 108.54 0.18 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.839 0.455 . . . . 0.0 111.471 172.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.1 p -75.11 108.99 8.21 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.064 1.346 . . . . 0.0 109.801 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.8 p -114.57 145.46 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 122.841 0.456 . . . . 0.0 110.284 173.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.38 131.2 34.72 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 124.403 1.081 . . . . 0.0 110.253 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.6 pp -142.88 92.66 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.569 1.148 . . . . 0.0 109.887 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.36 133.22 37.6 Favored 'General case' 0 C--O 1.226 -0.144 0 O-C-N 121.432 -0.792 . . . . 0.0 111.618 -175.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -100.53 157.09 16.91 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 66.1 ttp85 -142.06 122.97 14.44 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.907 -0.568 . . . . 0.0 109.945 -175.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.43 154.77 36.1 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.52 1.128 . . . . 0.0 108.281 158.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -145.83 139.46 26.37 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 167.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.425 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 52.9 t-20 -82.8 118.53 23.47 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 120.177 1.353 . . . . 0.0 112.689 -172.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -100.83 -9.39 21.72 Favored 'General case' 0 C--N 1.346 0.442 0 C-N-CA 124.16 0.984 . . . . 0.0 113.222 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.37 142.44 36.01 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 119.857 1.208 . . . . 0.0 108.988 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.6 m -78.37 36.2 0.24 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.5 p -153.39 155.78 31.95 Favored Pre-proline 0 N--CA 1.451 -0.405 0 C-N-CA 125.591 1.557 . . . . 0.0 108.336 175.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.0 145.07 89.37 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 N-CA-C 108.235 -1.486 . . . . 0.0 108.235 169.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.0 p -117.55 178.14 4.5 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 168.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.1 t -124.27 126.43 46.06 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -98.26 109.17 3.75 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 107.167 -2.373 . . . . 0.0 107.167 175.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.58 49.37 1.8 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 162.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.82 143.89 55.64 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.375 0.67 . . . . 0.0 111.271 -175.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.12 155.89 27.27 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.754 174.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -151.66 147.22 26.47 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -103.4 100.77 10.65 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 170.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.6 p -89.06 83.52 2.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 CA-C-O 118.079 -0.962 . . . . 0.0 108.41 175.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.2 t 176.97 147.08 0.29 Allowed Pre-proline 0 C--O 1.232 0.162 0 C-N-CA 124.644 1.178 . . . . 0.0 109.496 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -64.26 -39.35 30.59 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 120.666 0.91 . . . . 0.0 110.342 156.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.1 ptp 177.9 -71.67 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.594 1.958 . . . . 0.0 107.976 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.15 -37.47 33.39 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.944 0.898 . . . . 0.0 112.859 -168.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.2 -118.05 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.315 0.646 . . . . 0.0 110.337 -174.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.0 -53.45 2.16 Favored Glycine 0 CA--C 1.526 0.72 0 O-C-N 121.216 -0.928 . . . . 0.0 112.652 -175.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -41.64 -58.86 1.81 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.844 1.258 . . . . 0.0 110.623 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -74.83 -8.61 56.97 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -53.67 117.72 3.36 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.36 0.982 . . . . 0.0 108.585 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 . . . . . 0 N--CA 1.45 -0.453 0 CA-C-O 121.264 0.555 . . . . 0.0 111.398 -159.9 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 CA--C 1.535 0.369 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.2 t 52.67 -143.52 0.7 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.173 0.989 . . . . 0.0 112.593 166.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.2 m -124.8 133.31 53.17 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 127.538 2.335 . . . . 0.0 105.864 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 86.8 mt -122.19 120.14 33.31 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 175.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -56.2 159.73 5.7 Favored Pre-proline 0 N--CA 1.447 -0.591 0 C-N-CA 123.864 0.865 . . . . 0.0 110.541 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -67.12 102.97 0.7 Allowed 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.202 2.601 . . . . 0.0 112.308 -169.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 122.63 -16.22 8.44 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -78.2 148.55 33.98 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 118.001 0.9 . . . . 0.0 110.877 -166.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.4 141.17 36.41 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.385 1.874 . . . . 0.0 109.173 -169.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 46.3 ttp -135.52 82.87 1.98 Allowed 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.621 1.168 . . . . 0.0 109.371 173.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -104.25 113.1 26.42 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.078 1.751 . . . . 0.0 107.725 171.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 40.4 mtm -137.29 126.62 15.26 Favored Pre-proline 0 C--O 1.235 0.337 0 CA-C-N 118.386 0.539 . . . . 0.0 111.748 -170.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -74.73 139.81 25.49 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.618 2.212 . . . . 0.0 112.517 173.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.7 t -128.99 151.04 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.1 p -118.28 142.16 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 170.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -144.53 158.31 43.82 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 118.948 0.795 . . . . 0.0 111.294 -175.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -162.28 168.61 22.03 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 127.671 2.389 . . . . 0.0 106.695 173.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 49.4 t -112.39 145.36 18.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 C-N-CA 124.252 1.021 . . . . 0.0 108.363 174.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -77.04 157.77 80.93 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 123.968 0.907 . . . . 0.0 110.924 -177.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -79.41 -22.65 7.96 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.723 2.282 . . . . 0.0 112.742 166.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -53.74 -37.12 63.03 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.234 1.013 . . . . 0.0 111.516 -171.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.2 tt -40.03 -34.09 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.534 1.934 . . . . 0.0 114.793 171.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.4 m -106.71 22.56 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 119.786 1.175 . . . . 0.0 112.956 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.1 -48.08 0.48 Allowed Pre-proline 0 CA--C 1.545 0.762 0 O-C-N 120.854 -1.154 . . . . 0.0 113.29 167.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -81.15 -165.73 0.36 Allowed 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.345 2.697 . . . . 0.0 110.374 -171.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.7 t -95.22 -51.23 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -31.85 -61.88 0.22 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 129.263 3.025 . . . . 0.0 113.499 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.2 p -92.5 -5.17 52.37 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 123.335 0.654 . . . . 0.0 112.641 -174.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -54.31 107.63 0.29 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.972 0.909 . . . . 0.0 111.295 -169.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 120.92 -27.22 6.54 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 123.98 0.8 . . . . 0.0 111.59 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 45.8 mm -64.7 125.67 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 118.168 0.984 . . . . 0.0 109.692 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -157.07 51.34 0.48 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.582 172.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.42 87.4 2.01 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 167.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.2 tp -88.88 89.31 7.93 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -160.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.6 t -102.01 171.95 7.21 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 122.443 1.116 . . . . 0.0 111.7 -171.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.97 108.33 2.38 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 -160.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.4 t -92.63 116.23 28.82 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 168.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -114.47 114.23 25.53 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 118.644 0.656 . . . . 0.0 109.579 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.4 m -100.63 87.17 3.28 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.392 0.677 . . . . 0.0 111.34 -167.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -67.87 84.16 0.21 Allowed 'General case' 0 CA--C 1.54 0.56 0 O-C-N 122.044 -0.41 . . . . 0.0 110.513 173.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.3 22.39 0.05 OUTLIER Pre-proline 0 CA--C 1.556 1.209 0 N-CA-C 118.448 2.759 . . . . 0.0 118.448 -175.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.87 -81.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.021 2.481 . . . . 0.0 113.424 -168.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.5 ptm85 -155.6 140.78 17.51 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 119.866 1.212 . . . . 0.0 113.102 177.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.62 147.83 44.17 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 125.765 1.626 . . . . 0.0 106.97 175.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.38 -37.02 0.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.371 2.048 . . . . 0.0 113.52 -176.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.8 m 155.26 96.52 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 129.533 3.133 . . . . 0.0 108.653 -174.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 18.2 pttp . . . . . 0 CA--C 1.538 0.484 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.501 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.598 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 83.4 p -153.72 172.93 16.52 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 156.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -79.06 -32.92 45.01 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.955 174.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -87.45 -41.47 13.52 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.279 1.031 . . . . 0.0 111.971 -170.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.1 mt 28.32 74.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 126.859 2.063 . . . . 0.0 112.655 -173.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -70.02 164.72 23.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.696 170.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -65.02 -31.69 73.04 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -176.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.23 129.78 10.29 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 122.276 1.036 . . . . 0.0 113.376 -165.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -91.74 83.28 5.27 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 122.374 1.083 . . . . 0.0 108.513 -169.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.65 120.48 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 171.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.82 170.63 9.54 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.558 1.143 . . . . 0.0 109.193 -170.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.6 t -144.94 146.42 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 169.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.7 m -141.3 104.12 4.55 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -176.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -82.15 125.09 30.49 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 125.596 1.559 . . . . 0.0 110.258 -174.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -102.51 89.05 3.41 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 163.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -99.96 89.11 3.95 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 172.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -111.69 151.32 29.02 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 123.805 0.842 . . . . 0.0 110.415 -171.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.39 105.71 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.985 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.22 150.96 36.98 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 163.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.82 -29.28 4.43 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.595 0.758 . . . . 0.0 112.901 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -36.97 -40.04 0.47 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.605 1.574 . . . . 0.0 113.791 170.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.32 120.13 46.38 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 162.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -84.33 14.62 2.39 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 121.451 1.434 . . . . 0.0 113.553 -169.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.463 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 41.1 m0 -79.25 156.64 28.03 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 121.969 0.89 . . . . 0.0 111.43 -177.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -74.9 138.81 42.66 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 104.262 -2.495 . . . . 0.0 104.262 158.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -143.99 128.87 18.42 Favored 'General case' 0 N--CA 1.458 -0.059 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.2 t -122.95 123.66 26.74 Favored Pre-proline 0 N--CA 1.444 -0.732 0 C-N-CA 125.311 1.444 . . . . 0.0 108.557 -168.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -74.81 146.64 33.73 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 123.958 3.106 . . . . 0.0 107.497 166.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.2 t -77.93 -58.59 3.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -170.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -122.51 163.91 19.06 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 103.41 -2.811 . . . . 0.0 103.41 155.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.1 tpt180 -58.07 -47.66 82.51 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 169.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -139.97 165.35 27.57 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 125.63 1.572 . . . . 0.0 110.27 -166.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.4 pt -141.79 162.8 20.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 C-N-CA 124.676 1.19 . . . . 0.0 108.226 175.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -106.4 139.41 40.92 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 162.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.05 81.33 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 175.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.7 mmm-85 -56.94 111.97 1.19 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.723 1.209 . . . . 0.0 110.687 -166.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.5 mm 16.4 56.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 126.239 1.816 . . . . 0.0 113.185 -160.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.45 -73.21 0.43 Allowed Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 22.19 86.52 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.347 2.259 . . . . 0.0 113.555 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.86 119.13 6.16 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.194 0.997 . . . . 0.0 111.541 -169.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.15 152.9 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 123.42 0.688 . . . . 0.0 110.481 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.75 126.09 51.84 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 126.471 1.908 . . . . 0.0 108.013 174.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.9 pp -125.36 113.49 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 168.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.87 106.49 10.93 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.27 0.628 . . . . 0.0 112.683 176.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -77.33 149.13 35.33 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 171.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 -139.01 138.28 37.08 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 123.418 0.449 . . . . 0.0 110.473 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.61 171.87 10.75 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.611 1.564 . . . . 0.0 110.046 164.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.6 136.45 15.36 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 177.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.463 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 37.6 t30 -78.12 128.49 33.88 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 120.258 1.39 . . . . 0.0 111.175 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 tp -118.95 26.01 9.82 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.671 1.988 . . . . 0.0 111.885 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -103.96 174.18 5.98 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.805 1.242 . . . . 0.0 110.201 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.3 p -97.06 11.37 36.42 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.043 1.337 . . . . 0.0 111.524 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.41 161.1 42.85 Favored Pre-proline 0 C--O 1.239 0.531 0 C-N-CA 125.071 1.348 . . . . 0.0 107.942 -177.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -56.4 158.7 14.9 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 121.382 1.388 . . . . 0.0 109.877 164.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.8 p -134.72 -177.83 4.79 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.848 2.459 . . . . 0.0 108.025 -176.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.1 t -138.6 140.46 38.97 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 159.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -94.46 93.73 1.7 Allowed Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 107.255 -2.338 . . . . 0.0 107.255 170.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -112.59 47.04 1.12 Allowed 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 167.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.62 170.4 16.39 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 171.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.5 t -144.6 158.96 43.54 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 166.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -84.9 155.17 21.8 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.242 1.417 . . . . 0.0 109.867 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -109.78 100.44 9.44 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 149.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.8 t -80.7 100.61 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 125.303 1.441 . . . . 0.0 107.477 174.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.6 t 172.27 151.25 0.21 Allowed Pre-proline 0 C--N 1.343 0.293 0 C-N-CA 126.825 2.05 . . . . 0.0 109.055 168.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -66.83 -49.31 1.57 Allowed 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 121.029 1.153 . . . . 0.0 109.584 153.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.1 ptt? -173.55 -72.7 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.989 1.715 . . . . 0.0 107.907 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.46 -40.47 85.35 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -171.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.46 -100.61 0.02 OUTLIER 'General case' 0 C--N 1.339 0.116 0 CA-C-N 117.912 0.324 . . . . 0.0 111.692 -170.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.09 -61.01 1.4 Allowed Glycine 0 CA--C 1.53 0.999 0 CA-C-O 119.447 -0.64 . . . . 0.0 111.799 -172.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.59 -56.67 5.69 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.837 1.255 . . . . 0.0 111.85 -176.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -72.97 5.0 3.6 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.405 1.082 . . . . 0.0 113.917 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -80.02 116.42 20.14 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 173.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 . . . . . 0 N--CA 1.45 -0.459 0 C-N-CA 119.253 -0.979 . . . . 0.0 112.055 -171.008 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . 0.255 6.3 t 50.16 -124.38 2.1 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.358 1.463 . . . . 0.0 111.962 170.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.0 m -145.16 151.28 38.19 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.66 2.384 . . . . 0.0 107.255 -172.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 70.5 mt -135.8 132.67 37.0 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 171.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -64.19 158.15 65.95 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 125.04 1.336 . . . . 0.0 109.959 169.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.18 93.68 0.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.712 2.941 . . . . 0.0 112.539 -169.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 140.25 -28.7 2.46 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -77.93 150.55 34.01 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 117.594 0.697 . . . . 0.0 112.531 -155.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -86.18 155.84 20.57 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.82 2.048 . . . . 0.0 110.527 -174.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 19.2 ttm -148.75 89.22 1.67 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.414 1.086 . . . . 0.0 109.417 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -106.89 143.9 34.31 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.167 0.894 . . . . 0.0 110.657 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -150.09 107.63 3.21 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 124.147 0.979 . . . . 0.0 112.33 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.71 108.61 0.27 Allowed 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 124.961 3.774 . . . . 0.0 112.541 165.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.3 t -100.97 117.86 46.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 171.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.8 p -79.19 142.02 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 168.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -154.78 159.33 40.56 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -175.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -177.7 160.79 1.58 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.322 2.249 . . . . 0.0 109.928 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 94.6 t -121.41 131.8 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.6 1.16 . . . . 0.0 109.689 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.1 148.17 38.78 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -176.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -74.76 57.81 4.52 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 124.202 3.268 . . . . 0.0 112.698 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -104.02 -41.67 5.78 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.053 0.941 . . . . 0.0 109.833 162.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.8 tt -47.89 -42.9 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 124.361 1.064 . . . . 0.0 113.846 -169.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.2 m -78.83 51.05 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 O-C-N 121.064 -1.022 . . . . 0.0 111.166 176.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -133.7 -72.28 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 124.796 1.239 . . . . 0.0 111.147 173.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.08 136.75 45.69 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 121.833 1.688 . . . . 0.0 112.675 -175.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 97.6 t -40.6 -53.23 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 126.4 1.88 . . . . 0.0 109.751 178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -33.19 -47.28 0.19 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 127.893 2.477 . . . . 0.0 113.759 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 35.1 p -106.42 -6.94 17.86 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -173.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -57.7 107.45 0.45 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.379 0.991 . . . . 0.0 111.031 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 132.14 -38.35 1.91 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.035 1.303 . . . . 0.0 109.895 -173.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 23.5 mm -70.17 121.94 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 O-C-N 122.186 -0.597 . . . . 0.0 111.045 -175.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -156.33 54.65 0.56 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 122.086 0.946 . . . . 0.0 111.016 166.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 66.6 m -146.84 93.4 2.27 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 159.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.1 tp -84.62 88.41 7.34 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.388 0.613 . . . . 0.0 109.677 -162.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.6 m -86.27 155.96 20.46 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.055 0.942 . . . . 0.0 110.88 -162.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 14.6 tp -123.06 131.18 53.59 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 170.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.0 p -114.01 107.45 15.69 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 165.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -109.77 91.89 3.83 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.927 0.891 . . . . 0.0 109.261 -175.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.5 p -78.93 93.11 5.0 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.458 0.703 . . . . 0.0 110.004 176.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -59.43 96.0 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 159.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.57 61.31 3.83 Favored Pre-proline 0 CA--C 1.549 0.928 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 172.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -86.94 -99.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 124.123 3.215 . . . . 0.0 110.149 174.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -127.72 133.86 49.55 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 124.47 1.108 . . . . 0.0 110.297 -176.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.86 117.23 42.25 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 126.831 2.052 . . . . 0.0 105.809 174.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.44 -26.77 6.96 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.836 2.358 . . . . 0.0 112.95 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.7 m 140.82 101.73 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 129.553 3.141 . . . . 0.0 108.927 -175.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.518 0 C-N-CA 123.58 0.752 . . . . 0.0 112.845 -178.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.418 0 CA-C-O 119.616 -0.23 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.1 t -146.55 58.43 1.19 Allowed 'General case' 0 C--N 1.344 0.363 0 C-N-CA 130.447 3.499 . . . . 0.0 107.91 13.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -157.24 -54.52 0.08 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.868 2.067 . . . . 0.0 105.677 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.1 mt -27.72 -24.03 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.564 1 C-N-CA 132.658 4.383 . . . . 0.0 116.946 174.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.4 mt -81.6 51.62 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 126.023 1.729 . . . . 0.0 110.649 -160.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.48 164.18 24.96 Favored 'General case' 0 C--N 1.334 -0.101 0 O-C-N 121.348 -0.845 . . . . 0.0 108.742 -176.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -74.86 73.88 2.12 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 122.558 1.17 . . . . 0.0 112.007 -175.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.46 160.37 40.28 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 129.854 3.262 . . . . 0.0 106.624 173.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -146.76 111.46 5.27 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -173.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.82 124.3 72.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -169.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.74 149.12 25.1 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 124.358 1.063 . . . . 0.0 109.336 -176.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.5 t -141.37 96.65 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -171.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.4 m -79.86 107.22 12.47 Favored 'General case' 0 C--O 1.221 -0.422 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 169.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -79.51 166.88 21.49 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 171.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -136.53 90.41 2.55 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 122.137 0.97 . . . . 0.0 111.972 167.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.81 127.25 32.39 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 158.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -132.42 150.87 52.08 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 124.497 1.119 . . . . 0.0 108.248 173.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.97 99.9 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 124.018 0.927 . . . . 0.0 109.339 -178.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.08 169.21 10.81 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.357 0.599 . . . . 0.0 110.058 168.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.29 147.5 35.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 169.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 113.77 -20.6 17.41 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -168.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.62 95.36 11.29 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 123.77 0.828 . . . . 0.0 109.523 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -84.31 45.82 1.81 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.679 2.919 . . . . 0.0 110.45 -169.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.488 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 44.4 m0 -113.89 147.03 39.18 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.935 0.894 . . . . 0.0 109.787 -165.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -76.63 81.87 3.28 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 104.588 -2.375 . . . . 0.0 104.588 173.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -90.89 108.83 20.1 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.06 121.54 16.86 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -171.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -81.53 166.3 17.83 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.631 2.221 . . . . 0.0 108.7 168.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -77.07 -40.41 30.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 122.114 -0.366 . . . . 0.0 111.249 177.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.64 175.26 13.89 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 172.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -60.35 -59.26 5.69 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 167.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -137.32 130.8 31.28 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 122.853 0.461 . . . . 0.0 112.098 -155.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.7 pt -99.86 175.85 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 169.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -126.97 150.89 49.18 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 152.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.6 m -130.35 131.31 65.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . 0.255 4.3 tpt180 -72.62 74.5 1.08 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 167.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.4 pt 15.68 51.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 131.111 3.764 . . . . 0.0 115.286 -176.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.12 -39.44 0.77 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.491 -169.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -36.01 109.58 0.09 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.743 1.217 . . . . 0.0 111.153 168.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.07 99.06 6.75 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.347 1.459 . . . . 0.0 109.068 -168.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 p -76.52 176.39 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.959 0.885 . . . . 0.0 110.809 -171.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.13 89.84 2.38 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 172.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.9 pp -105.48 118.98 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 173.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 89.6 mtp -77.27 140.56 40.09 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -111.73 145.08 39.94 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 168.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -140.86 135.32 31.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.956 0.902 . . . . 0.0 109.962 -177.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.39 90.97 1.7 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.691 1.996 . . . . 0.0 110.033 174.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -79.32 148.34 32.12 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 117.044 -1.455 . . . . 0.0 107.996 172.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.488 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 35.7 t30 -89.82 110.18 21.13 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 120.332 1.424 . . . . 0.0 111.469 172.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.3 tp -86.88 -4.65 59.2 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.379 1.071 . . . . 0.0 112.809 -176.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.2 171.17 14.96 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.397 -0.815 . . . . 0.0 109.873 -175.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.0 m -105.78 18.54 21.99 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.506 175.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.8 p -144.61 160.17 48.6 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 127.411 2.284 . . . . 0.0 106.428 170.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.07 152.77 79.6 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.523 1.482 . . . . 0.0 109.836 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.36 167.12 15.38 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.445 0.641 . . . . 0.0 111.146 166.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.4 t -98.64 168.24 10.29 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 113.888 -1.506 . . . . 0.0 107.834 156.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -145.26 63.8 0.46 Allowed Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 106.345 -2.702 . . . . 0.0 106.345 173.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.39 56.25 3.29 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 -176.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.51 147.66 32.11 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.148 -1.387 . . . . 0.0 111.177 -164.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 m -79.76 160.89 26.02 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 174.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -143.32 138.99 29.9 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 172.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.97 90.59 4.96 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 169.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.6 57.82 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 O-C-N 121.837 -0.539 . . . . 0.0 110.702 -176.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.1 t -171.17 145.0 1.8 Allowed Pre-proline 0 C--N 1.333 -0.144 0 O-C-N 121.538 -0.726 . . . . 0.0 111.484 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.87 -37.38 66.85 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 121.456 1.437 . . . . 0.0 108.763 164.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.5 ptm -179.95 -68.59 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.556 1.942 . . . . 0.0 107.617 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -90.25 -28.61 18.71 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.138 0.975 . . . . 0.0 112.831 -164.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.44 -114.56 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.396 0.278 . . . . 0.0 110.489 -168.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.27 -40.24 0.47 Allowed Glycine 0 CA--C 1.533 1.18 0 O-C-N 121.314 -0.866 . . . . 0.0 114.778 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -51.87 -65.15 0.61 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.11 1.455 . . . . 0.0 108.302 166.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -72.7 29.0 0.06 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.469 2.308 . . . . 0.0 112.173 177.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -105.18 101.3 10.86 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 168.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.8 p30 . . . . . 0 C--N 1.325 -0.491 0 C-N-CA 122.7 0.4 . . . . 0.0 111.313 177.971 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 CA--C 1.54 0.569 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . 0.32 13.2 t 52.5 -71.84 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 117.849 2.537 . . . . 0.0 117.849 161.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -159.65 143.75 14.78 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.592 1.557 . . . . 0.0 109.383 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.6 mt -151.77 140.95 21.32 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.217 1.007 . . . . 0.0 110.273 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.9 mp0 -74.89 161.28 78.27 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 127.085 2.154 . . . . 0.0 110.392 172.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -75.51 111.11 3.23 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.74 1.626 . . . . 0.0 113.21 -165.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 115.13 -12.13 19.8 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 176.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -85.77 152.09 23.31 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.2 -161.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -107.6 122.37 46.55 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.75 1.22 . . . . 0.0 109.311 -160.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.73 112.7 17.04 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 124.597 1.159 . . . . 0.0 110.213 177.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -143.05 145.87 33.3 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.759 0.709 . . . . 0.0 110.176 160.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 23.5 ptm -156.3 156.27 30.0 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-O 119.135 -0.46 . . . . 0.0 111.051 173.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.89 148.23 81.88 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.374 2.716 . . . . 0.0 111.996 171.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.6 t -126.23 134.6 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.93 1.692 . . . . 0.0 106.878 167.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.6 p -100.02 143.96 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.999 1.32 . . . . 0.0 108.015 174.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -158.95 146.85 17.85 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -176.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -164.77 95.34 0.71 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.034 0.533 . . . . 0.0 111.81 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.2 t -40.64 130.71 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 125.936 1.694 . . . . 0.0 112.99 -173.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.3 119.71 77.28 Favored Pre-proline 0 N--CA 1.44 -0.968 0 C-N-CA 125.277 1.431 . . . . 0.0 107.283 -169.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.13 55.8 4.67 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.147 2.565 . . . . 0.0 111.823 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -109.5 -28.68 8.78 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.997 2.119 . . . . 0.0 109.523 169.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.4 tt -54.98 -42.98 67.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -173.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.6 m -78.09 51.89 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 118.78 0.718 . . . . 0.0 111.037 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -139.42 -69.59 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.901 -177.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -73.48 152.41 48.9 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.295 1.996 . . . . 0.0 113.449 -175.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.5 p -55.27 -30.91 25.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.136 1.374 . . . . 0.0 111.886 175.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -36.23 -55.3 0.8 Allowed 'General case' 0 C--N 1.339 0.115 0 C-N-CA 126.691 1.996 . . . . 0.0 112.311 173.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.4 p -108.58 -54.93 2.45 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.121 -163.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 26.67 51.84 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.382 2.673 . . . . 0.0 115.229 169.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 144.57 -40.58 1.15 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -170.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 35.0 mm -55.64 119.55 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 169.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.96 45.35 0.39 Allowed 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 123.711 0.632 . . . . 0.0 109.737 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.43 91.6 1.99 Allowed 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 171.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.1 mp -76.07 150.06 37.36 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -172.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.7 t -148.21 175.57 10.95 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -178.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.5 tt -154.32 110.3 3.22 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 174.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.8 t -87.82 95.96 10.28 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.19 92.88 6.37 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -174.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.14 89.33 5.99 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 122.245 1.021 . . . . 0.0 110.584 -170.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -78.14 98.19 5.73 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.733 173.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -153.05 37.66 0.11 Allowed Pre-proline 0 CA--C 1.552 1.032 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 172.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -72.8 -90.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.694 0 CA-C-N 122.033 1.762 . . . . 0.0 113.557 -174.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 31.9 mtt85 -148.58 110.12 4.45 Favored 'General case' 0 C--N 1.34 0.187 0 O-C-N 121.352 -0.843 . . . . 0.0 109.211 -174.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.414 ' OE2' ' NZ ' ' A' ' 151' ' ' LYS . 10.9 pt-20 -97.26 122.07 56.96 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 172.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -79.46 -51.68 0.06 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.55 2.167 . . . . 0.0 110.512 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 44.6 p -171.67 111.23 0.31 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.993 -0.527 . . . . 0.0 109.587 -167.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.414 ' NZ ' ' OE2' ' A' ' 148' ' ' GLU . 21.7 pttm . . . . . 0 CA--C 1.538 0.506 0 C-N-CA 123.362 0.665 . . . . 0.0 112.398 172.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.639 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.8 t -164.7 47.03 0.1 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.377 1.071 . . . . 0.0 109.822 -171.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -156.4 -51.39 0.08 Allowed 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 124.494 1.118 . . . . 0.0 108.372 -175.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.31 -27.73 69.23 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.782 175.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.6 mt -80.81 131.73 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 C-N-CA 123.731 0.812 . . . . 0.0 112.165 -161.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.94 148.97 38.02 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 171.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -78.26 67.29 4.03 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 122.128 0.966 . . . . 0.0 112.154 -167.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.56 -169.54 1.66 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 129.556 3.142 . . . . 0.0 106.381 175.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -145.31 137.13 25.48 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.305 -0.872 . . . . 0.0 110.217 168.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.42 103.67 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 C-N-CA 126.162 1.785 . . . . 0.0 106.65 -177.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -79.4 131.1 36.0 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -177.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.1 t -113.1 132.76 61.03 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.2 m -106.7 101.53 10.97 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.299 1.44 . . . . 0.0 109.235 -173.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -79.05 84.22 5.07 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -171.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -84.19 83.61 7.91 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 122.931 1.348 . . . . 0.0 111.447 -172.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.74 123.49 31.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.699 176.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -131.22 142.87 50.23 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 173.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.7 t -135.78 141.91 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -117.71 157.09 27.12 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 161.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.95 -33.14 7.29 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.812 0.845 . . . . 0.0 112.299 -175.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -31.21 -44.69 0.11 Allowed Glycine 0 CA--C 1.531 1.089 0 C-N-CA 126.828 2.156 . . . . 0.0 114.323 165.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.37 108.57 57.79 Favored Pre-proline 0 N--CA 1.454 -0.225 0 CA-C-N 119.475 1.638 . . . . 0.0 107.008 161.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.76 -3.51 12.41 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 121.148 1.232 . . . . 0.0 113.3 -164.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.492 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 47.6 m0 -73.34 154.73 39.98 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.591 1.156 . . . . 0.0 111.297 -167.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -76.6 81.75 3.26 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 171.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -95.65 124.42 39.66 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.6 m -125.8 138.08 31.3 Favored Pre-proline 0 CA--C 1.532 0.256 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -70.18 161.47 45.88 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 N-CA-C 108.377 -1.432 . . . . 0.0 108.377 161.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -77.78 -46.73 26.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 175.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.77 174.81 14.77 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 166.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -67.11 -33.42 75.43 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.118 0.417 . . . . 0.0 111.836 -174.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.76 161.72 39.78 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.025 0.93 . . . . 0.0 110.346 -171.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.5 pt -130.37 160.28 41.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 172.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -106.65 95.37 5.69 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.221 1.008 . . . . 0.0 109.359 168.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.2 t -77.54 167.35 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 168.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 23.1 mtm180 -128.35 98.47 5.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 171.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.1 pt 9.05 69.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 127.76 2.424 . . . . 0.0 114.725 -175.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.27 -34.26 2.74 Favored Glycine 0 C--O 1.22 -0.768 0 C-N-CA 124.807 1.194 . . . . 0.0 111.33 173.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -50.08 106.52 0.12 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 118.83 1.315 . . . . 0.0 112.245 -166.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.2 m -67.82 108.94 3.17 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.648 1.179 . . . . 0.0 111.359 -171.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.1 p -86.81 176.48 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 123.299 0.64 . . . . 0.0 110.322 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -124.52 129.97 51.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.819 0.848 . . . . 0.0 109.471 161.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.5 pp -139.45 96.12 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.655 1.182 . . . . 0.0 110.661 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 35.7 ttm -77.59 100.05 5.97 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.934 0.894 . . . . 0.0 111.342 -174.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -77.65 164.52 25.23 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.886 -0.509 . . . . 0.0 110.92 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.8 ttm105 -144.94 138.39 26.85 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.542 1.137 . . . . 0.0 111.799 -177.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.19 149.51 48.96 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 130.041 3.336 . . . . 0.0 107.608 159.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -137.17 135.62 37.49 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 161.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.492 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 0.1 OUTLIER -79.89 83.6 5.79 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.644 1.111 . . . . 0.0 111.301 -172.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.42 75.98 8.36 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.923 1.289 . . . . 0.0 108.902 171.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.06 158.62 44.16 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 167.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.1 t -87.6 -1.22 57.8 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 119.148 -0.453 . . . . 0.0 111.88 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.11 160.83 41.79 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.788 1.235 . . . . 0.0 109.076 -175.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.37 139.93 32.66 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.18 2.587 . . . . 0.0 111.902 -170.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.3 p -105.59 -176.07 2.97 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.393 1.877 . . . . 0.0 110.69 -169.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.4 t -148.39 136.05 20.69 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 160.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -123.42 76.01 0.37 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -170.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.86 33.21 1.05 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.495 0.718 . . . . 0.0 110.812 -171.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.51 162.11 29.91 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.365 0.602 . . . . 0.0 111.733 -162.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.4 t -144.44 178.06 8.21 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.288 0.635 . . . . 0.0 109.802 175.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.17 164.85 26.75 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 125.955 1.702 . . . . 0.0 110.973 -167.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -120.82 86.73 2.62 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.927 1.691 . . . . 0.0 107.103 174.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.401 HG11 ' CD2' ' A' ' 95' ' ' PHE . 3.2 t -82.31 54.47 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.823 -164.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.2 t -171.47 143.21 1.48 Allowed Pre-proline 0 N--CA 1.457 -0.112 0 O-C-N 121.393 -0.817 . . . . 0.0 110.317 -169.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.02 -36.43 30.14 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 121.695 1.597 . . . . 0.0 108.044 169.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.5 ptp 177.31 -68.26 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 127.824 2.449 . . . . 0.0 106.745 176.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.87 -48.33 69.12 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.719 1.208 . . . . 0.0 113.055 -165.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.27 -102.3 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.669 -162.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.23 -61.04 0.25 Allowed Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.498 -0.612 . . . . 0.0 113.352 -173.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -45.59 -50.79 12.84 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.004 1.322 . . . . 0.0 111.216 177.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -72.93 5.19 3.45 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.906 1.283 . . . . 0.0 113.632 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.417 ' CE1' ' CZ ' ' A' ' 120' ' ' PHE . 9.6 t80 -72.35 131.39 42.58 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 121.098 -1.001 . . . . 0.0 109.8 174.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 . . . . . 0 N--CA 1.44 -0.954 0 C-N-CA 119.822 -0.751 . . . . 0.0 112.878 172.215 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 . . . . . 0 CA--C 1.538 0.495 0 CA-C-O 120.758 0.313 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.9 t 42.99 -145.17 0.08 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.104 1.762 . . . . 0.0 112.989 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -119.22 124.66 47.28 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 127.586 2.354 . . . . 0.0 106.101 177.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 97.3 mt -106.3 151.52 24.73 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 173.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -91.97 163.76 26.25 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 126.012 1.725 . . . . 0.0 108.394 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.73 79.88 1.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.647 2.898 . . . . 0.0 112.272 -167.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 157.85 -29.87 0.49 Allowed Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.821 -175.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -76.29 135.18 39.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.573 1.187 . . . . 0.0 112.034 -153.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -86.83 137.6 32.27 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.295 1.438 . . . . 0.0 110.57 -178.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 1.7 mmt -133.9 85.53 2.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.088 1.355 . . . . 0.0 109.532 176.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.68 128.25 45.12 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.35 0.66 . . . . 0.0 109.444 173.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 84.9 mtp -150.98 147.54 20.96 Favored Pre-proline 0 C--O 1.234 0.241 0 C-N-CA 123.399 0.68 . . . . 0.0 109.812 -165.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.18 146.28 63.25 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.785 2.323 . . . . 0.0 110.44 174.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.7 t -144.32 147.51 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.0 m -109.34 164.59 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 174.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.417 ' CZ ' ' CE1' ' A' ' 95' ' ' PHE . 4.1 t80 -156.1 129.49 8.22 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.65 168.83 23.13 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 122.904 0.482 . . . . 0.0 110.476 168.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 18.2 t -119.14 129.46 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.809 1.243 . . . . 0.0 109.709 176.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.89 133.54 58.19 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 118.923 0.783 . . . . 0.0 110.249 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -56.34 -23.03 44.29 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.328 2.685 . . . . 0.0 114.767 -171.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -56.75 -13.68 2.72 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 119.182 0.901 . . . . 0.0 112.861 176.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.4 tt -46.05 -42.32 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 O-C-N 121.087 -1.008 . . . . 0.0 111.718 165.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.2 m -87.09 63.15 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 119.372 0.987 . . . . 0.0 110.9 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 51.8 mttt -130.27 -67.8 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 124.184 0.994 . . . . 0.0 112.345 164.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -85.27 162.66 11.34 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 121.8 1.666 . . . . 0.0 114.188 -160.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 99.2 t -53.96 -35.1 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 125.754 1.622 . . . . 0.0 110.874 176.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -38.54 -57.12 1.2 Allowed 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.475 1.51 . . . . 0.0 111.169 173.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 14.1 p -102.8 -53.45 2.85 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 123.965 0.906 . . . . 0.0 109.197 -163.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 26.15 55.34 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.152 2.581 . . . . 0.0 115.175 174.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 134.99 -36.98 1.99 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -176.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.1 mm -51.43 125.97 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 123.182 0.593 . . . . 0.0 109.864 173.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.4 49.57 0.49 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.78 0.832 . . . . 0.0 109.79 175.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.18 89.91 1.77 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -178.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.0 mp -76.44 162.25 28.0 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 122.294 1.045 . . . . 0.0 108.81 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.4 t -155.03 178.79 9.8 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.94 88.53 1.47 Allowed 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 124.471 1.107 . . . . 0.0 109.029 165.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.1 t -75.72 107.26 7.77 Favored 'General case' 0 N--CA 1.457 -0.093 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -178.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -112.67 137.05 51.52 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 122.775 0.43 . . . . 0.0 109.888 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 32.2 m -118.45 91.51 3.58 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.532 1.533 . . . . 0.0 107.82 177.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -72.27 97.72 2.05 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.946 178.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -156.11 58.28 1.71 Allowed Pre-proline 0 CA--C 1.551 1.018 0 N-CA-C 116.894 2.183 . . . . 0.0 116.894 -177.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -80.68 -90.8 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.424 2.749 . . . . 0.0 112.445 175.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.17 104.97 2.85 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.658 0.663 . . . . 0.0 111.631 -171.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -79.3 140.12 56.4 Favored Pre-proline 0 N--CA 1.449 -0.522 0 O-C-N 121.547 -0.721 . . . . 0.0 109.173 174.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -84.35 60.17 6.08 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 121.981 1.787 . . . . 0.0 107.711 169.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 19.9 m 44.39 81.27 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.88 2.072 . . . . 0.0 113.514 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.7 pttt . . . . . 0 CA--C 1.543 0.677 0 CA-C-N 119.026 0.83 . . . . 0.0 112.111 -170.001 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.456 ' CB ' ' H ' ' A' ' 63' ' ' THR . . . . . . . . 0 N--CA 1.422 -1.845 0 N-CA-C 104.165 -2.532 . . . . 0.0 104.165 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.3 m -157.27 25.71 0.3 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -159.26 -55.13 0.06 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 -174.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.62 37.26 0.86 Allowed 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 112.699 -2.046 . . . . 0.0 110.892 -161.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.8 mt -111.85 107.7 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 122.745 0.418 . . . . 0.0 109.895 -168.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -103.49 140.98 36.77 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.22 -29.85 34.69 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.516 1.926 . . . . 0.0 113.857 -169.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.09 148.6 6.03 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.953 1.301 . . . . 0.0 110.648 -178.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.5 mmmt -120.48 89.33 3.11 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.891 1.676 . . . . 0.0 108.677 -158.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.45 141.83 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 123.42 0.688 . . . . 0.0 110.348 -176.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -99.14 145.8 26.8 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.509 1.524 . . . . 0.0 108.54 -172.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.1 t -136.14 98.12 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 -173.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.6 m -88.12 105.76 17.71 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -83.74 109.23 17.33 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.651 1.18 . . . . 0.0 108.202 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -107.01 86.24 2.28 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.553 0.692 . . . . 0.0 110.055 -173.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.96 112.2 23.05 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.453 -0.78 . . . . 0.0 110.382 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -111.65 122.21 47.21 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.117 0.967 . . . . 0.0 109.668 -177.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.6 t -100.46 108.76 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 170.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.14 154.65 31.03 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 162.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.45 -38.28 8.9 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.42 0.688 . . . . 0.0 111.655 177.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -39.15 -34.77 0.36 Allowed Glycine 0 CA--C 1.53 1.031 0 C-N-CA 126.992 2.234 . . . . 0.0 114.694 172.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.409 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 0.4 OUTLIER -108.95 101.1 43.07 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 119.567 1.684 . . . . 0.0 108.497 165.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -83.37 46.19 2.04 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.877 3.051 . . . . 0.0 110.857 -170.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.501 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 44.7 m0 -116.06 157.13 25.17 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 125.034 1.334 . . . . 0.0 108.735 -172.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -74.3 141.66 45.26 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 162.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -147.44 113.82 5.94 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 169.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.0 t -100.15 111.4 62.19 Favored Pre-proline 0 N--CA 1.439 -1.011 0 C-N-CA 127.036 2.134 . . . . 0.0 107.058 -172.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -62.77 146.67 95.16 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.533 2.156 . . . . 0.0 107.757 167.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -75.79 -46.8 34.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -170.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.82 165.97 32.86 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 152.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -57.42 -41.1 79.72 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 118.366 0.53 . . . . 0.0 111.048 -174.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.95 158.36 43.87 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 122.95 0.5 . . . . 0.0 110.223 -176.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.4 pt -126.62 168.4 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 C-N-CA 123.461 0.705 . . . . 0.0 109.613 168.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -95.47 146.35 24.49 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 154.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.25 141.23 45.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 104.183 -2.525 . . . . 0.0 104.183 156.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -64.47 164.91 10.71 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 120.541 1.519 . . . . 0.0 107.774 160.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.8 mm -63.74 91.61 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.9 33.22 5.33 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.802 1.667 . . . . 0.0 113.783 178.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -102.3 107.02 17.92 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.034 1.417 . . . . 0.0 112.694 176.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.456 ' H ' ' CB ' ' A' ' 24' ' ' ALA . 15.9 m -66.71 113.7 5.04 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.114 1.366 . . . . 0.0 111.318 177.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.1 p -126.51 146.69 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 118.45 0.568 . . . . 0.0 110.373 169.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.21 137.96 31.93 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 125.516 1.526 . . . . 0.0 110.552 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -141.94 97.71 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 17.1 tmm? -78.92 126.56 30.86 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.936 1.294 . . . . 0.0 111.678 -176.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -102.35 143.91 31.5 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.829 1.252 . . . . 0.0 109.682 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 42.8 ttt85 -126.24 141.19 52.02 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 125.025 1.33 . . . . 0.0 109.283 -176.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.91 166.15 27.63 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.284 1.833 . . . . 0.0 109.903 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -153.95 147.76 25.4 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.308 1.043 . . . . 0.0 108.738 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.501 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 46.2 t-20 -83.95 115.75 22.46 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 119.879 1.218 . . . . 0.0 111.215 175.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 81.5 mt -106.75 16.32 24.57 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.621 1.169 . . . . 0.0 112.582 -178.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.28 164.76 12.9 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.416 -0.802 . . . . 0.0 109.726 169.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.0 m -96.83 30.02 2.82 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.864 176.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.3 p -149.57 161.3 32.12 Favored Pre-proline 0 N--CA 1.448 -0.528 0 C-N-CA 125.082 1.353 . . . . 0.0 108.363 178.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.72 121.55 8.25 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 121.555 1.503 . . . . 0.0 109.032 170.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.5 159.3 15.26 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.334 0.587 . . . . 0.0 110.885 171.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.9 t -97.93 158.63 15.42 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 162.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -153.15 77.79 0.21 Allowed Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 105.366 -3.094 . . . . 0.0 105.366 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.52 66.26 0.68 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 175.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.19 168.34 19.32 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.482 -166.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 35.3 m -106.39 159.15 16.36 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -147.77 143.91 27.86 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.958 -0.464 . . . . 0.0 110.341 171.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.98 101.26 12.7 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 166.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.6 p -87.7 81.17 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.0 t 176.54 150.72 0.34 Allowed Pre-proline 0 CA--C 1.529 0.164 0 C-N-CA 125.556 1.542 . . . . 0.0 109.15 178.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.65 -35.21 22.92 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 CA-C-N 119.364 0.809 . . . . 0.0 110.383 157.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.5 ptp 176.68 -67.05 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 127.163 2.185 . . . . 0.0 107.545 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.18 -41.75 33.66 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -169.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.33 -104.07 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.88 0.372 . . . . 0.0 111.816 -166.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.14 -54.67 0.59 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 123.925 0.774 . . . . 0.0 113.26 -172.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -47.25 -52.83 14.95 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.987 1.394 . . . . 0.0 110.927 176.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -74.22 10.21 1.34 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -81.86 98.48 8.53 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 172.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 . . . . . 0 N--CA 1.452 -0.352 0 C-N-CA 117.66 -1.616 . . . . 0.0 109.752 179.541 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.2 pm0 . . . . . 0 CA--C 1.541 0.611 0 CA-C-O 120.569 0.223 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.4 -70.34 0.13 Allowed 'General case' 0 CA--C 1.529 0.163 0 O-C-N 121.623 -0.673 . . . . 0.0 112.121 178.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.1 t -157.46 146.87 20.09 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.186 0.994 . . . . 0.0 108.73 -176.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.6 mt -150.44 136.1 18.2 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.764 0.711 . . . . 0.0 110.589 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -76.29 163.65 64.98 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.487 1.115 . . . . 0.0 109.967 174.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.42 106.1 1.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.242 1.961 . . . . 0.0 111.651 -163.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 111.58 -3.05 27.73 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 124.098 0.856 . . . . 0.0 111.24 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -76.6 146.14 38.46 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 118.368 1.084 . . . . 0.0 110.888 -173.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -97.09 147.24 24.24 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.669 1.188 . . . . 0.0 109.25 -176.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 17.2 ttt -150.95 111.42 4.2 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 118.734 -0.651 . . . . 0.0 111.169 -173.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -132.28 146.55 52.07 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 119.74 1.155 . . . . 0.0 111.249 172.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 19.1 mmt -142.63 138.55 16.32 Favored Pre-proline 0 C--O 1.235 0.32 0 C-N-CA 125.18 1.392 . . . . 0.0 109.63 -171.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.89 144.3 27.29 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 121.933 1.756 . . . . 0.0 110.183 171.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.4 t -124.26 158.87 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 164.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.2 p -145.83 146.3 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -154.38 146.59 23.78 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -165.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -160.08 156.0 26.14 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 128.119 2.568 . . . . 0.0 108.776 164.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.6 p -78.45 150.31 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 O-C-N 121.796 -0.565 . . . . 0.0 109.672 171.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -82.64 125.42 75.92 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.175 167.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -70.92 41.77 0.4 Allowed 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.672 2.914 . . . . 0.0 115.775 -177.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -112.7 -21.2 11.35 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 125.718 1.607 . . . . 0.0 111.036 168.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 16.2 tt -43.48 -41.76 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 119.691 1.132 . . . . 0.0 113.572 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.8 m -76.46 61.61 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 O-C-N 121.815 -0.553 . . . . 0.0 111.341 172.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -137.51 -66.09 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 117.698 -1.144 . . . . 0.0 113.05 170.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -76.91 154.39 33.63 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 CA-C-N 121.802 1.679 . . . . 0.0 113.638 -169.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.4 t -54.93 -37.1 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 125.76 1.624 . . . . 0.0 110.826 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -52.58 -47.13 67.07 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.87 1.268 . . . . 0.0 111.829 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 35.4 p -91.85 -51.57 5.16 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -173.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 15.77 60.71 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 129.278 3.031 . . . . 0.0 115.911 175.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 136.29 -33.92 2.31 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-O 119.143 -0.81 . . . . 0.0 111.77 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 10.2 mm -51.07 128.27 8.39 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 C-N-CA 124.302 1.041 . . . . 0.0 110.433 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -157.76 48.22 0.39 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.43 0.692 . . . . 0.0 111.005 176.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.3 p -140.7 88.49 2.19 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 175.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.1 tp -88.06 84.93 6.9 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 118.899 -1.121 . . . . 0.0 109.026 -160.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.2 m -87.95 143.51 27.06 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.879 -169.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.5 tt -116.36 118.23 32.16 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 160.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.3 t -98.29 102.6 14.39 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 173.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.01 129.47 34.87 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.291 1.436 . . . . 0.0 107.559 -177.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.4 p -114.74 93.48 4.34 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.13 1.372 . . . . 0.0 109.212 174.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -76.18 95.52 3.71 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 167.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.69 46.67 0.3 Allowed Pre-proline 0 CA--C 1.556 1.174 0 N-CA-C 117.369 2.359 . . . . 0.0 117.369 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.39 -83.36 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.538 2.826 . . . . 0.0 113.013 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -149.29 136.68 20.1 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 118.904 0.774 . . . . 0.0 110.295 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -117.3 139.26 25.81 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 164.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -84.16 -52.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 121.917 1.745 . . . . 0.0 108.793 169.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.5 m -169.89 150.99 3.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.667 2.387 . . . . 0.0 106.676 177.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 12.9 pttt . . . . . 0 CA--C 1.535 0.381 0 C-N-CA 125.464 1.506 . . . . 0.0 108.54 174.602 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.065 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -113.85 36.26 3.74 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.952 0.901 . . . . 0.0 110.741 -169.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -159.81 -51.22 0.05 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.936 2.094 . . . . 0.0 107.051 -174.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.9 mt -72.13 -7.13 47.33 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.831 -168.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.6 mt -78.24 70.78 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 O-C-N 120.687 -1.258 . . . . 0.0 109.242 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.14 167.84 15.38 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 169.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -81.51 56.03 2.83 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 120.745 -1.222 . . . . 0.0 114.217 -166.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -113.74 104.54 12.31 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 122.788 1.28 . . . . 0.0 109.718 167.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.2 tttp -76.38 85.19 3.14 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 169.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.1 tp -83.52 162.88 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 174.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.44 150.22 46.25 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -167.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 81.0 t -142.85 126.28 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -172.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.5 m -95.56 109.02 21.31 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.499 1.52 . . . . 0.0 107.632 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.408 ' CE1' ' CD1' ' A' ' 56' ' ' ILE . 15.3 m-85 -81.21 131.67 35.31 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.839 1.256 . . . . 0.0 109.133 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -126.87 86.68 2.54 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 122.786 1.279 . . . . 0.0 110.378 -170.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.24 105.76 18.0 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.153 -0.967 . . . . 0.0 109.937 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -109.19 147.16 32.98 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 176.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.1 p -140.46 148.31 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.399 1.08 . . . . 0.0 108.166 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.69 168.95 18.32 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 167.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.62 -31.41 16.0 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -170.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.62 -34.82 3.88 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.217 1.389 . . . . 0.0 113.385 172.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.446 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -119.16 91.06 43.05 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 167.777 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -80.77 55.25 5.6 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.387 2.725 . . . . 0.0 109.255 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.506 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 41.4 m0 -114.65 147.86 38.99 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.609 1.163 . . . . 0.0 109.257 -174.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -75.47 80.42 2.51 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -89.49 100.0 12.89 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.868 0.867 . . . . 0.0 109.306 -170.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.1 t -103.43 122.08 46.27 Favored Pre-proline 0 N--CA 1.443 -0.817 0 C-N-CA 124.027 0.931 . . . . 0.0 109.6 -168.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -75.46 138.08 21.51 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 123.648 2.899 . . . . 0.0 107.8 163.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.2 t -79.69 -46.73 22.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.572 0.701 . . . . 0.0 109.407 -173.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -149.25 150.36 32.44 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.528 1.931 . . . . 0.0 106.772 173.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -61.77 -36.68 81.75 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 123.814 0.696 . . . . 0.0 110.617 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -146.68 151.12 36.71 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 122.652 0.381 . . . . 0.0 111.208 -174.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.408 ' CD1' ' CE1' ' A' ' 37' ' ' PHE . 64.5 mt -122.57 137.91 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 127.0 2.12 . . . . 0.0 106.866 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -98.42 152.43 19.5 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.238 1.015 . . . . 0.0 109.39 164.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -154.08 127.33 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 -170.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.9 mmt85 -74.75 86.84 2.2 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 166.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.7 pt 7.57 64.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 128.206 2.602 . . . . 0.0 115.008 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.79 -35.63 1.49 Allowed Glycine 0 CA--C 1.522 0.523 0 O-C-N 121.915 -0.491 . . . . 0.0 112.807 -174.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 62.7 tt0 -42.57 107.79 0.09 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.172 1.389 . . . . 0.0 111.999 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.56 102.76 8.09 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.425 1.09 . . . . 0.0 110.129 -177.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.0 p -76.31 178.74 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 122.036 0.922 . . . . 0.0 111.505 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.16 89.06 2.4 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 124.426 1.09 . . . . 0.0 108.676 168.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.5 pp -100.36 134.22 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 168.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 65.0 mtt -98.32 100.36 11.63 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 126.304 1.842 . . . . 0.0 110.913 -174.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -78.36 157.4 29.11 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -143.68 146.51 33.27 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.37 151.5 49.62 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 128.833 2.853 . . . . 0.0 106.173 166.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -143.81 139.53 29.38 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 166.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.506 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 43.5 t30 -79.1 114.83 18.36 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 120.039 1.291 . . . . 0.0 112.558 -177.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.7 mt -105.79 16.11 25.74 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 125.031 1.332 . . . . 0.0 112.548 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.6 175.44 9.87 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 163.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.8 t -103.57 17.3 24.39 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.103 0.561 . . . . 0.0 110.254 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -155.94 160.64 30.65 Favored Pre-proline 0 N--CA 1.45 -0.472 0 C-N-CA 127.075 2.15 . . . . 0.0 106.29 -174.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.27 124.81 11.22 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.481 1.454 . . . . 0.0 110.326 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.58 177.79 7.27 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.398 0.618 . . . . 0.0 109.553 168.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.8 t -113.61 161.68 17.14 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 154.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -147.38 69.37 0.36 Allowed Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 107.728 -2.149 . . . . 0.0 107.728 -177.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.47 62.65 0.61 Allowed 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 177.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.39 161.64 27.86 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.542 -163.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -83.22 152.08 25.36 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.839 174.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -148.51 148.7 30.53 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.338 0.255 . . . . 0.0 110.647 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -109.04 101.85 10.89 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 125.773 1.629 . . . . 0.0 106.904 171.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.8 p -88.66 58.13 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.474 0 C-N-CA 123.963 0.905 . . . . 0.0 111.086 -176.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.6 t -167.26 145.16 4.03 Favored Pre-proline 0 N--CA 1.468 0.448 0 O-C-N 120.994 -1.066 . . . . 0.0 112.032 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -62.83 -56.77 0.53 Allowed 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.258 1.305 . . . . 0.0 108.805 168.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 23.3 ptp -171.36 20.69 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.886 0.874 . . . . 0.0 111.689 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -170.43 -77.31 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.291 0 O-C-N 121.558 -0.714 . . . . 0.0 109.519 -168.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -46.3 -94.22 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 126.271 1.829 . . . . 0.0 113.238 -169.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 60.71 -52.23 0.03 OUTLIER Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.939 1.257 . . . . 0.0 115.939 -172.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -45.17 -48.97 12.36 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 119.762 1.781 . . . . 0.0 111.34 174.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -71.68 -12.69 61.45 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.256 1.022 . . . . 0.0 113.047 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -71.49 94.98 1.33 Allowed 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 . . . . . 0 N--CA 1.442 -0.872 0 C-N-CA 118.274 -1.37 . . . . 0.0 110.346 -171.074 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 CA--C 1.538 0.496 0 CA-C-O 120.431 0.158 . . . . 0.0 111.315 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.2 t -157.68 -74.41 0.09 Allowed 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.531 0.332 . . . . 0.0 110.606 -168.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -159.63 152.01 21.09 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -174.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 75.2 mt -148.48 137.69 21.85 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 124.225 1.01 . . . . 0.0 108.322 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -66.94 152.14 96.21 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 169.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.66 106.28 1.24 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.783 2.989 . . . . 0.0 111.136 -171.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 128.19 -23.38 5.21 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -176.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -78.14 142.5 38.0 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 117.808 0.804 . . . . 0.0 111.009 -162.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -100.18 128.92 46.17 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.34 1.856 . . . . 0.0 109.329 -173.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 52.7 ttp -126.87 85.84 2.43 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 126.104 1.761 . . . . 0.0 108.844 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.99 140.89 33.56 Favored 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 168.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 22.8 ptm -153.5 141.57 13.89 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 117.936 0.335 . . . . 0.0 111.887 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -72.22 148.11 49.14 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.717 2.278 . . . . 0.0 110.098 171.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.1 t -136.26 122.19 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 125.927 1.691 . . . . 0.0 107.026 174.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.1 p -99.45 143.15 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 125.762 1.625 . . . . 0.0 107.492 169.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.94 172.27 18.97 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 176.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -158.64 178.46 10.1 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.883 0.873 . . . . 0.0 109.715 164.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 73.5 t -110.22 135.32 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 123.74 0.816 . . . . 0.0 109.267 172.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.22 124.54 76.06 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 122.988 0.515 . . . . 0.0 112.068 -176.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.21 34.47 0.4 Allowed 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.199 2.599 . . . . 0.0 114.105 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.51 -15.04 21.89 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.04 0.936 . . . . 0.0 110.915 162.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 17.8 tt -52.1 -48.97 41.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 118.973 0.806 . . . . 0.0 112.586 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.8 m -80.52 64.08 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.081 0.552 . . . . 0.0 109.677 174.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 45.0 mttp -140.17 -65.21 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 124.271 1.028 . . . . 0.0 111.768 171.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.01 169.29 13.71 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 121.835 1.69 . . . . 0.0 111.443 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.9 t -71.96 -52.31 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 124.227 1.011 . . . . 0.0 109.843 -174.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -46.44 -51.69 14.63 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 125.197 1.399 . . . . 0.0 112.054 -173.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 17.2 p -86.14 -3.74 59.02 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -65.05 75.9 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.857 1.208 . . . . 0.0 111.607 -177.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 148.13 -34.54 1.2 Allowed Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -169.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 45.9 mm -66.86 114.24 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.3 pttt -156.1 47.17 0.47 Allowed 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.49 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.41 97.52 1.76 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 103.69 -2.708 . . . . 0.0 103.69 168.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.4 tp -78.04 162.66 26.55 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -170.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.5 t -151.69 171.61 17.4 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.599 -0.688 . . . . 0.0 109.488 173.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -149.5 100.04 2.96 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 103.908 -2.627 . . . . 0.0 103.908 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 31.1 m -87.5 93.79 9.52 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 173.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.13 134.13 36.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 172.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.7 m -120.06 87.33 2.72 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.992 0.917 . . . . 0.0 108.951 176.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -68.24 84.55 0.25 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.928 0.891 . . . . 0.0 109.614 175.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -151.49 46.4 0.37 Allowed Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 178.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.52 -79.36 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.584 2.189 . . . . 0.0 112.731 -175.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.46 107.79 2.23 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.622 -0.674 . . . . 0.0 111.537 -173.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -78.89 144.05 63.23 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 173.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.41 -50.18 0.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.972 1.782 . . . . 0.0 107.992 160.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.9 t -179.5 -168.71 0.12 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 128.869 2.868 . . . . 0.0 105.32 169.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.589 0 C-N-CA 124.241 1.017 . . . . 0.0 111.184 174.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.818 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.8 t -73.07 51.35 0.3 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.385 1.874 . . . . 0.0 114.85 -167.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -76.07 -34.86 59.59 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 131.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 63.1 mt -108.47 -44.49 4.08 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -172.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.2 mt -35.4 137.78 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 126.614 1.966 . . . . 0.0 115.501 -164.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.9 mp -111.71 -82.85 0.58 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.147 1.379 . . . . 0.0 109.141 -174.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -172.85 -66.22 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.35 1.46 . . . . 0.0 108.997 -178.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -36.67 132.65 0.61 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 126.678 1.991 . . . . 0.0 113.598 -168.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.468 ' HZ3' ' CB ' ' A' ' 57' ' ' ASP . 21.5 tttp -76.2 90.17 3.12 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.158 -1.837 . . . . 0.0 107.253 176.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.7 112.34 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 167.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.79 154.22 30.09 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.4 t -134.97 133.38 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 176.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 29.4 m -114.14 108.57 17.15 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -81.17 102.98 10.65 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.662 1.585 . . . . 0.0 108.945 176.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -98.42 87.1 3.77 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.857 0.836 . . . . 0.0 109.596 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.21 126.07 31.06 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.169 0.588 . . . . 0.0 110.614 175.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -129.65 146.44 51.43 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.797 1.239 . . . . 0.0 108.191 175.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.5 p -138.44 144.0 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 124.076 0.95 . . . . 0.0 108.991 177.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.21 165.48 19.54 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 166.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -43.62 -39.71 3.69 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.211 1.004 . . . . 0.0 112.185 -177.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -34.06 -36.55 0.06 OUTLIER Glycine 0 CA--C 1.535 1.282 0 C-N-CA 126.948 2.213 . . . . 0.0 115.01 171.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.43 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 0.2 OUTLIER -118.82 102.76 49.15 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 119.099 1.45 . . . . 0.0 107.871 161.645 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.43 40.94 1.05 Allowed 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.764 2.309 . . . . 0.0 111.223 -170.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.5 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 45.1 m0 -116.39 151.06 36.73 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.367 1.067 . . . . 0.0 110.614 -165.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -76.33 80.83 3.08 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -177.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -87.14 106.27 17.76 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.396 0.678 . . . . 0.0 109.35 -172.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.8 t -115.9 119.93 36.43 Favored Pre-proline 0 N--CA 1.443 -0.814 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -168.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.82 154.25 38.57 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 C-N-CA 124.118 3.212 . . . . 0.0 107.936 168.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 t -85.7 -58.95 3.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -168.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -132.45 162.19 31.79 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 162.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -61.46 -39.79 92.16 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 174.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.79 164.72 26.62 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.796 0.839 . . . . 0.0 112.496 -176.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.7 pt -132.47 162.0 40.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 124.521 1.129 . . . . 0.0 109.747 168.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.468 ' CB ' ' HZ3' ' A' ' 32' ' ' LYS . 21.0 p-10 -118.28 83.78 2.07 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 127.444 2.298 . . . . 0.0 110.067 -173.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.75 129.3 43.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 O-C-N 120.833 -1.167 . . . . 0.0 109.494 -178.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -78.37 96.32 5.3 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 174.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -10.06 87.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.068 1.747 . . . . 0.0 114.966 -159.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.59 -31.66 4.74 Favored Glycine 0 C--O 1.222 -0.641 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 176.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -53.11 118.38 3.71 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 -175.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.2 p -71.23 115.69 10.67 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.745 2.018 . . . . 0.0 111.71 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.0 p -97.68 161.92 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 123.514 0.726 . . . . 0.0 110.112 169.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -105.36 120.01 40.52 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.231 1.012 . . . . 0.0 110.727 164.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.8 pp -130.18 116.56 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 171.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 35.4 mtm -79.57 107.81 12.63 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.156 0.982 . . . . 0.0 111.633 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -81.55 155.56 25.66 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 170.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.0 ttp-105 -137.95 144.86 41.41 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 174.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.72 159.01 28.87 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.103 2.161 . . . . 0.0 107.05 156.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -144.17 145.04 31.84 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 161.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.5 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 51.9 t-20 -83.45 105.57 14.5 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 120.743 1.611 . . . . 0.0 112.103 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.1 mp -102.27 36.39 2.15 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.095 1.358 . . . . 0.0 110.861 176.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.03 170.63 7.84 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.72 1.208 . . . . 0.0 109.331 163.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.5 m -105.09 15.47 27.52 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.753 0.821 . . . . 0.0 111.411 -177.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.7 p -141.38 162.11 49.11 Favored Pre-proline 0 C--O 1.239 0.504 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 169.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.44 141.65 96.07 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 120.978 1.119 . . . . 0.0 109.312 171.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.43 169.03 9.01 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 118.468 0.576 . . . . 0.0 110.326 167.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.9 t -94.38 157.07 16.19 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 159.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -124.17 152.7 17.37 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 105.271 -3.132 . . . . 0.0 105.271 165.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.22 -53.86 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 117.426 0.613 . . . . 0.0 109.787 -160.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 60.57 -179.35 0.1 Allowed 'General case' 0 C--N 1.342 0.243 0 CA-C-O 122.938 1.351 . . . . 0.0 113.88 173.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.0 m -135.21 164.21 28.21 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 146.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -155.53 164.47 38.62 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -173.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.09 98.33 4.72 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 51.2 t -89.32 72.04 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 125.361 1.465 . . . . 0.0 107.129 -175.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.0 t 178.83 152.28 0.49 Allowed Pre-proline 0 C--N 1.34 0.157 0 C-N-CA 125.455 1.502 . . . . 0.0 109.233 -174.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -67.49 -47.8 1.93 Allowed 'Trans proline' 0 N--CA 1.448 -1.197 0 N-CA-C 108.457 -1.401 . . . . 0.0 108.457 156.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.2 ptm -174.52 -78.37 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.661 1.984 . . . . 0.0 107.802 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.19 -38.22 81.77 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -168.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.71 -105.45 0.02 OUTLIER 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.199 0.454 . . . . 0.0 111.022 -173.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.38 -53.94 1.92 Allowed Glycine 0 CA--C 1.526 0.768 0 CA-C-O 119.286 -0.73 . . . . 0.0 112.722 -177.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.26 -54.11 9.44 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.612 1.206 . . . . 0.0 111.636 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -74.06 -3.59 30.32 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.767 1.227 . . . . 0.0 113.659 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -70.4 96.62 1.17 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 174.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 . . . . . 0 CA--C 1.531 0.24 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -162.19 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.539 0.532 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.6 t -130.27 -63.39 0.9 Allowed 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 124.212 1.005 . . . . 0.0 109.114 -177.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.1 t -158.33 149.0 20.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 172.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 89.2 mt -149.17 135.6 19.34 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 176.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -73.59 159.81 83.7 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.738 1.215 . . . . 0.0 109.955 173.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.23 102.73 1.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.486 2.124 . . . . 0.0 110.905 -165.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 125.05 -14.35 7.47 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 124.202 0.906 . . . . 0.0 110.953 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -76.82 138.31 39.75 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 118.49 1.145 . . . . 0.0 110.773 -166.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.03 144.92 26.68 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.94 1.296 . . . . 0.0 108.694 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 17.1 ttt -140.01 80.39 1.76 Allowed 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 123.34 0.656 . . . . 0.0 109.265 173.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -95.02 123.44 38.5 Favored 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 124.325 1.05 . . . . 0.0 108.321 168.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 24.5 mmt -134.1 129.56 20.01 Favored Pre-proline 0 C--O 1.235 0.32 0 C-N-CA 124.106 0.963 . . . . 0.0 109.844 -171.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -68.8 135.58 33.21 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 121.871 1.714 . . . . 0.0 109.248 172.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.9 t -110.06 129.42 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 166.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.1 p -95.52 134.76 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 157.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -155.92 151.62 27.25 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -167.32 161.14 14.06 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 126.215 1.806 . . . . 0.0 107.206 -177.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 52.7 t -118.26 127.77 75.35 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 C-N-CA 125.669 1.588 . . . . 0.0 107.463 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.43 153.15 41.44 Favored Pre-proline 0 C--O 1.234 0.252 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -173.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.58 37.76 0.47 Allowed 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 124.359 3.373 . . . . 0.0 112.982 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -83.62 -37.66 22.59 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 165.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.3 tt -52.41 -35.46 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 123.878 0.871 . . . . 0.0 112.781 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.2 m -74.97 53.12 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 120.901 -1.124 . . . . 0.0 110.933 173.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -144.53 -70.65 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.748 1.619 . . . . 0.0 110.793 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.86 138.13 39.95 Favored 'Trans proline' 0 C--O 1.239 0.529 0 CA-C-N 122.148 1.803 . . . . 0.0 113.488 -176.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.9 t -55.94 -36.86 45.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 127.352 2.261 . . . . 0.0 109.602 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -47.7 -34.98 8.95 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.938 2.095 . . . . 0.0 112.744 174.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 72.1 p -107.09 -60.52 1.67 Allowed 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 123.013 0.196 . . . . 0.0 110.536 -174.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 28.28 49.75 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 129.088 2.955 . . . . 0.0 115.902 165.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 143.65 -29.3 2.0 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -172.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.8 mm -53.61 127.62 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.072 0 CA-C-N 117.863 0.831 . . . . 0.0 110.664 172.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.7 pttt -155.77 67.54 0.62 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 122.09 0.948 . . . . 0.0 111.547 169.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 42.4 m -147.94 105.08 3.63 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 141.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.1 tp -79.83 86.86 5.34 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -175.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -84.77 150.12 25.28 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.08 -168.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 28.5 tp -120.45 110.53 16.61 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 166.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.7 t -95.04 117.98 31.07 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 169.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.07 125.86 51.14 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -166.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.6 m -117.6 89.4 3.11 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.214 1.006 . . . . 0.0 109.98 -176.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 1.8 m-30 -67.1 94.59 0.35 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.603 0.761 . . . . 0.0 109.404 170.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -149.01 23.65 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.135 0 N-CA-C 118.08 2.622 . . . . 0.0 118.08 -176.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.49 -75.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.672 0 CA-C-N 122.77 2.025 . . . . 0.0 113.897 -165.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 86.6 mmt-85 -146.28 121.75 10.36 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.776 0.716 . . . . 0.0 109.177 -167.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.53 117.54 28.98 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 125.648 1.579 . . . . 0.0 107.358 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -78.6 -23.5 8.33 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.71 2.273 . . . . 0.0 112.41 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 39.9 t 137.69 109.38 0.0 OUTLIER 'General case' 0 C--N 1.343 0.302 0 C-N-CA 129.278 3.031 . . . . 0.0 107.777 -175.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.372 0 C-N-CA 124.319 1.047 . . . . 0.0 110.958 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.662 0 CA-C-O 120.777 0.322 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.2 t -162.25 45.92 0.15 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 123.882 0.873 . . . . 0.0 109.825 -171.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -155.67 -58.03 0.1 Allowed 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.51 26.36 0.94 Allowed 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.147 -169.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 73.3 mt -119.23 108.87 24.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -169.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -98.58 -61.54 1.36 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.129 -171.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . 0.25 0.3 OUTLIER 177.23 -6.89 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.672 1.589 . . . . 0.0 114.488 145.654 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -51.19 122.42 7.67 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 120.752 1.615 . . . . 0.0 112.869 -173.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -77.66 98.14 5.35 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 127.928 2.491 . . . . 0.0 107.547 -173.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.6 tp -106.56 122.74 60.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.913 1.285 . . . . 0.0 109.435 -172.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.414 ' CE ' ' HB2' ' A' ' 55' ' ' ASP . 4.0 tmtp? -79.19 151.62 31.14 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.952 1.701 . . . . 0.0 109.212 -174.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.2 t -133.79 148.74 30.39 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 165.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.7 m -136.25 104.7 5.73 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.414 1.102 . . . . 0.0 108.338 -174.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -77.56 121.32 23.74 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -118.32 82.44 1.84 Allowed 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.65 126.86 31.71 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -126.95 89.33 2.96 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.897 0.856 . . . . 0.0 109.043 -174.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.4 p -79.02 126.91 39.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.679 172.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.38 169.46 13.57 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 171.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.55 124.07 12.7 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 161.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 151.48 -48.19 0.56 Allowed Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 107.268 -2.333 . . . . 0.0 107.268 -160.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mp -129.28 142.38 45.02 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 160.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -79.97 2.72 8.2 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 123.911 3.074 . . . . 0.0 111.93 170.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 40.5 m0 -74.54 148.62 40.72 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.125 0.875 . . . . 0.0 111.745 -165.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -78.82 84.79 4.86 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 172.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -89.58 118.94 29.58 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 124.475 1.11 . . . . 0.0 108.709 177.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.0 m -124.86 139.29 33.11 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -74.67 171.49 18.1 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.339 2.026 . . . . 0.0 108.953 166.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -93.35 -53.66 8.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 123.763 0.825 . . . . 0.0 110.393 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -131.7 164.5 25.8 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 168.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -60.75 -43.6 97.76 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 168.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.414 ' HB2' ' CE ' ' A' ' 34' ' ' LYS . 22.4 p-10 -149.15 170.55 18.18 Favored 'General case' 0 N--CA 1.428 -1.551 0 C-N-CA 124.666 1.186 . . . . 0.0 110.805 -164.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.1 pt -137.65 176.39 7.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 167.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.88 161.58 23.83 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 148.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -131.22 148.23 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 102.158 -3.275 . . . . 0.0 102.158 170.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.72 118.51 27.27 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 120.855 1.661 . . . . 0.0 106.953 160.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.3 pt -15.57 89.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 C-N-CA 126.943 2.097 . . . . 0.0 113.255 -169.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.52 -43.91 1.32 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 124.37 0.986 . . . . 0.0 113.12 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -38.56 102.65 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.798 2.039 . . . . 0.0 113.431 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 94.5 m -73.19 104.44 4.25 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.677 1.591 . . . . 0.0 111.265 -174.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.5 p -102.07 169.56 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 121.615 0.722 . . . . 0.0 110.524 174.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -117.35 127.38 53.99 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 126.263 1.825 . . . . 0.0 107.208 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.7 pp -140.69 95.79 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 CA-C-O 121.864 0.84 . . . . 0.0 109.063 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 31.1 mtt -76.82 175.31 9.56 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.765 -0.584 . . . . 0.0 110.536 -175.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -133.28 170.47 15.4 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 124.228 1.011 . . . . 0.0 109.092 174.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -139.39 123.4 17.8 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 173.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.97 105.38 7.7 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.127 0.571 . . . . 0.0 110.869 168.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER -103.25 121.08 41.95 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.061 -0.4 . . . . 0.0 111.533 -171.759 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -82.12 85.07 6.84 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.114 0.483 . . . . 0.0 111.386 -173.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.3 mt -79.73 59.15 2.99 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.634 0.774 . . . . 0.0 109.958 171.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.91 155.23 47.12 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 170.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.8 m -79.55 -0.62 34.21 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.619 0.768 . . . . 0.0 112.369 177.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.1 p -128.83 163.29 46.33 Favored Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 124.761 1.224 . . . . 0.0 110.618 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -63.17 169.11 9.77 Favored 'Trans proline' 0 N--CA 1.444 -1.435 0 C-N-CA 121.041 1.161 . . . . 0.0 110.077 164.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.97 168.81 26.06 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 126.519 1.928 . . . . 0.0 107.152 -170.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.2 t -132.6 154.79 49.7 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.75 0.705 . . . . 0.0 111.622 176.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -125.57 64.42 0.57 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 127.248 2.356 . . . . 0.0 107.968 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.37 53.54 2.79 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 165.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.98 170.54 14.61 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.096 -171.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.1 m -125.19 162.21 25.17 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -146.93 159.02 44.06 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 118.764 0.711 . . . . 0.0 111.08 170.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.2 99.51 6.91 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 166.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.6 p -89.9 57.65 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.212 0 C-N-CA 124.154 0.982 . . . . 0.0 110.365 -175.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.5 t -165.95 148.18 6.27 Favored Pre-proline 0 N--CA 1.454 -0.249 0 O-C-N 121.506 -0.746 . . . . 0.0 110.699 -172.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.24 -30.68 30.5 Favored 'Trans proline' 0 N--CA 1.445 -1.38 0 N-CA-C 108.674 -1.318 . . . . 0.0 108.674 164.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.0 ptp 172.69 -63.85 0.01 OUTLIER 'General case' 0 C--N 1.347 0.462 0 C-N-CA 125.853 1.661 . . . . 0.0 109.759 -173.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -99.87 -33.25 10.62 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 124.776 1.23 . . . . 0.0 111.258 -164.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.16 -142.91 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.86 -47.58 0.78 Allowed Glycine 0 CA--C 1.531 1.075 0 O-C-N 121.278 -0.889 . . . . 0.0 112.434 -166.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -42.7 -54.08 4.21 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.047 1.339 . . . . 0.0 110.818 173.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -76.24 -16.2 59.87 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -48.91 137.41 12.77 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 118.79 0.723 . . . . 0.0 110.843 -173.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 . . . . . 0 N--CA 1.44 -0.972 0 O-C-N 123.583 0.552 . . . . 0.0 111.568 -173.453 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.9 t 52.7 -141.26 0.86 Allowed 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.493 1.517 . . . . 0.0 111.176 174.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.2 t -110.68 131.41 55.08 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 126.402 1.881 . . . . 0.0 106.741 172.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.6 tp -124.34 131.43 53.51 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 125.102 1.361 . . . . 0.0 107.651 -176.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -86.56 167.73 21.53 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 127.169 2.188 . . . . 0.0 111.273 -167.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -72.92 112.6 3.55 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.349 2.033 . . . . 0.0 112.446 -168.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 115.97 -12.72 17.27 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 124.403 1.002 . . . . 0.0 111.021 177.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -77.91 140.96 39.32 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 117.334 0.567 . . . . 0.0 112.438 -163.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -99.21 98.27 9.27 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.91 1.684 . . . . 0.0 108.787 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 11.0 ttp -77.56 85.98 3.91 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -94.28 59.59 2.62 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.994 0.902 . . . . 0.0 111.682 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 20.5 ttt -76.61 129.17 80.23 Favored Pre-proline 0 N--CA 1.437 -1.077 0 C-N-CA 123.814 0.846 . . . . 0.0 110.352 -171.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.66 150.88 31.73 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 121.93 1.753 . . . . 0.0 110.332 171.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.2 t -130.83 148.08 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 164.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.5 m -112.28 146.7 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -154.58 139.96 17.7 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 119.56 1.073 . . . . 0.0 112.635 -172.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -156.01 148.11 23.35 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.66 1.584 . . . . 0.0 108.069 163.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.6 t -88.26 141.45 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 166.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -75.51 155.46 85.55 Favored Pre-proline 0 N--CA 1.45 -0.467 0 C-N-CA 124.517 1.127 . . . . 0.0 110.061 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -65.03 -36.14 39.38 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.577 1.518 . . . . 0.0 112.17 166.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -44.77 -41.0 6.54 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 125.481 1.512 . . . . 0.0 113.395 -172.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -50.11 -37.94 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 125.021 1.329 . . . . 0.0 112.83 -177.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.0 m -89.3 51.26 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 119.17 0.896 . . . . 0.0 110.487 177.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . 0.35 0.0 OUTLIER -149.79 -53.5 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.823 0 CA-C-O 116.199 -1.858 . . . . 0.0 114.228 -175.221 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -83.33 169.89 12.27 Favored 'Trans proline' 0 C--N 1.351 0.67 0 CA-C-N 124.031 2.475 . . . . 0.0 111.838 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.2 t -67.59 -46.54 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.978 1.311 . . . . 0.0 110.871 -169.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -39.13 -54.58 1.73 Allowed 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 126.062 1.745 . . . . 0.0 112.225 -178.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 3.2 p -97.53 -41.03 8.36 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.128 -168.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 2.51 70.74 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 128.458 2.703 . . . . 0.0 115.882 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 134.27 -35.66 2.2 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 119.176 -0.791 . . . . 0.0 112.391 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 13.1 mm -49.33 138.27 4.78 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 C-N-CA 124.664 1.186 . . . . 0.0 109.948 173.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.3 pttm -157.67 51.97 0.45 Allowed 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.6 m -154.5 107.09 2.8 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 159.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.5 mp -75.78 85.72 2.77 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 169.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.1 t -81.14 150.98 28.48 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.3 tt -127.52 99.38 5.58 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.1 t -78.04 111.07 13.55 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 171.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -107.06 92.84 4.25 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.746 1.218 . . . . 0.0 108.537 -172.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.5 86.95 4.5 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 122.528 1.156 . . . . 0.0 109.48 -175.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -75.48 73.12 2.52 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 166.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -132.73 48.86 3.84 Favored Pre-proline 0 CA--C 1.552 1.044 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 174.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -77.61 -98.09 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 124.356 3.37 . . . . 0.0 113.752 -174.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.2 mmt180 -142.36 110.37 5.92 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.545 1.138 . . . . 0.0 109.315 -169.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -95.05 114.57 63.99 Favored Pre-proline 0 N--CA 1.451 -0.381 0 C-N-CA 124.793 1.237 . . . . 0.0 111.517 -167.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -74.2 -25.13 13.93 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.632 1.554 . . . . 0.0 111.138 165.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.6 t 80.33 127.18 0.04 OUTLIER 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.778 1.631 . . . . 0.0 109.824 -173.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 17.9 pttm . . . . . 0 CA--C 1.535 0.376 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.017 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.533 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.7 m -76.9 54.24 0.99 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.824 2.45 . . . . 0.0 112.253 -178.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -141.69 -54.19 0.45 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 130.275 3.43 . . . . 0.0 104.092 168.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 49.2 mt -63.73 -34.06 77.04 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.908 1.283 . . . . 0.0 113.119 168.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 76.7 mt -69.15 100.04 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 119.575 1.08 . . . . 0.0 110.221 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.03 -75.41 0.45 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 172.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.431 ' CG ' HH12 ' A' ' 59' ' ' ARG . 4.1 t70 -169.48 -28.63 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 164.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -59.05 128.25 36.28 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.46 1.104 . . . . 0.0 113.638 -163.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -79.93 109.79 14.7 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.924 -174.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.13 113.1 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 126.012 1.725 . . . . 0.0 108.679 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.35 157.07 21.59 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.054 -1.029 . . . . 0.0 109.084 -171.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.2 t -143.79 107.5 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-N 119.762 1.165 . . . . 0.0 109.596 -176.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.2 m -78.97 117.58 20.17 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.786 1.634 . . . . 0.0 107.816 167.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -79.61 156.32 27.72 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.337 0.655 . . . . 0.0 109.266 166.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -137.67 88.31 2.32 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.412 0.625 . . . . 0.0 111.511 170.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.06 128.9 36.4 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 120.939 -1.101 . . . . 0.0 110.507 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -133.73 150.21 51.49 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.186 0.994 . . . . 0.0 109.508 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.9 p -140.6 146.29 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 C-N-CA 123.518 0.727 . . . . 0.0 110.772 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.9 163.62 29.82 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.012 1.325 . . . . 0.0 107.463 168.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -37.75 -45.69 0.83 Allowed 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.989 1.715 . . . . 0.0 113.452 -172.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -36.88 -37.32 0.23 Allowed Glycine 0 CA--C 1.534 1.233 0 C-N-CA 126.482 1.991 . . . . 0.0 114.39 174.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.417 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 0.4 OUTLIER -113.48 105.88 54.71 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 161.15 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.93 9.56 3.26 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.138 1.892 . . . . 0.0 112.733 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.473 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 41.4 m0 -78.46 145.61 34.93 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 121.798 -0.564 . . . . 0.0 110.931 -168.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -78.56 85.39 4.62 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 103.338 -2.838 . . . . 0.0 103.338 172.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.71 88.18 3.0 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.625 1.17 . . . . 0.0 108.381 -168.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.0 m -91.37 136.59 26.77 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 119.182 -0.437 . . . . 0.0 110.381 -166.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -70.53 165.55 31.48 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 121.538 1.492 . . . . 0.0 108.595 161.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -97.67 -55.29 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.111 0 C-N-CA 123.573 0.749 . . . . 0.0 110.941 -176.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.22 152.76 47.6 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 170.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -64.99 -41.48 95.36 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.831 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.49 139.65 37.02 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.223 1.009 . . . . 0.0 110.027 -173.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.7 pt -104.99 164.02 4.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 125.352 1.461 . . . . 0.0 109.002 170.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -101.74 133.62 46.17 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 155.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.6 m -128.08 174.68 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 159.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.431 HH12 ' CG ' ' A' ' 30' ' ' ASP . 18.2 mtm180 -140.66 92.45 2.51 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -171.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.0 pt 8.22 87.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 127.66 2.384 . . . . 0.0 114.279 -171.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 107.86 -31.52 7.91 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 123.556 0.598 . . . . 0.0 112.949 -173.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -72.55 118.02 14.95 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 121.627 -0.925 . . . . 0.0 110.174 -168.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.3 p -68.3 126.83 30.81 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 127.431 2.293 . . . . 0.0 111.472 -174.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.9 p -113.74 160.07 13.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 157.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.62 125.34 49.32 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.737 1.215 . . . . 0.0 108.839 169.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -126.07 104.86 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 172.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -83.34 167.61 17.42 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.959 172.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -137.05 155.0 50.21 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 171.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -125.56 129.81 50.44 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 168.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.68 108.52 12.11 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.671 2.388 . . . . 0.0 107.556 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.3 mtpt -104.73 124.16 48.91 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 118.154 -0.927 . . . . 0.0 109.09 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.473 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 32.3 t30 -78.37 85.46 4.49 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 119.517 1.053 . . . . 0.0 110.983 -175.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -78.12 68.89 4.25 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 174.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.3 135.48 13.08 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.781 0.832 . . . . 0.0 108.975 173.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.9 m -78.4 41.82 0.4 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.272 0.629 . . . . 0.0 110.246 172.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.1 p -148.31 154.26 41.83 Favored Pre-proline 0 N--CA 1.446 -0.671 0 C-N-CA 124.526 1.131 . . . . 0.0 107.989 169.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -66.95 150.41 82.94 Favored 'Trans proline' 0 N--CA 1.442 -1.545 0 N-CA-C 108.03 -1.565 . . . . 0.0 108.03 166.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.8 p -135.59 163.76 29.39 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.577 0.751 . . . . 0.0 109.302 175.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.1 t -118.88 136.21 54.16 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.636 0.775 . . . . 0.0 109.405 167.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -96.14 81.24 0.78 Allowed Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 176.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -106.38 53.29 0.7 Allowed 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 172.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.1 174.6 5.27 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.785 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.59 154.64 46.87 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 173.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -145.97 147.3 31.54 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -101.23 115.69 31.08 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 166.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.9 p -99.81 73.2 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.498 0 C-N-CA 124.24 1.016 . . . . 0.0 109.264 -176.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.0 t 177.56 148.46 0.34 Allowed Pre-proline 0 C--O 1.232 0.163 0 C-N-CA 123.645 0.778 . . . . 0.0 109.461 -178.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -66.3 -33.41 38.94 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 121.336 1.357 . . . . 0.0 109.754 162.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.0 ptp 177.83 -69.41 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.639 1.976 . . . . 0.0 107.933 177.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.67 -46.53 45.89 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 123.827 0.851 . . . . 0.0 113.203 -165.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.25 -101.06 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -162.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.93 -52.69 0.38 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.191 0.9 . . . . 0.0 114.032 -171.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -48.09 -52.84 18.66 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.306 1.553 . . . . 0.0 110.732 176.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -75.22 12.25 0.97 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.54 1.536 . . . . 0.0 114.768 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -92.39 108.08 19.7 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 171.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 . . . . . 0 CA--C 1.534 0.357 0 C-N-CA 118.41 -1.316 . . . . 0.0 112.698 -173.292 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.0 pm0 . . . . . 0 CA--C 1.539 0.551 0 CA-C-O 120.667 0.27 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.4 t -168.65 -72.3 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.094 0.958 . . . . 0.0 110.962 -177.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -158.77 151.06 21.49 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.6 1.16 . . . . 0.0 108.303 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 82.6 mt -144.34 148.0 34.19 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -88.86 175.41 4.06 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 123.969 0.908 . . . . 0.0 109.132 176.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -69.4 90.32 0.48 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.842 2.361 . . . . 0.0 114.469 -162.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 138.98 -23.39 2.9 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 123.731 0.681 . . . . 0.0 112.264 170.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -78.32 141.1 38.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 119.691 -0.804 . . . . 0.0 112.49 -146.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -84.05 113.44 21.03 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.621 1.569 . . . . 0.0 110.806 177.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 14.4 tpt -104.12 131.04 51.81 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 125.374 1.47 . . . . 0.0 107.235 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -155.03 139.44 16.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.056 0.389 . . . . 0.0 110.82 168.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 80.7 mtp -155.03 148.89 18.89 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.291 1.036 . . . . 0.0 109.544 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -78.36 144.72 20.67 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.886 3.057 . . . . 0.0 112.701 170.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 25.0 t -118.83 121.53 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 168.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.2 p -79.54 146.32 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 169.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -155.19 146.99 23.32 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.256 0.48 . . . . 0.0 111.571 -171.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -156.62 153.22 28.22 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.271 1.429 . . . . 0.0 110.935 164.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 74.2 t -76.77 140.5 17.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 169.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.79 130.73 56.9 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 118.639 -0.696 . . . . 0.0 110.688 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -55.17 -30.46 71.22 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.191 2.594 . . . . 0.0 113.018 -178.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -36.28 -36.05 0.09 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.979 1.311 . . . . 0.0 113.418 172.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.7 tt -49.26 -36.72 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.4 m -87.67 54.31 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 119.24 0.927 . . . . 0.0 110.685 173.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -126.12 -74.67 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 117.508 -1.234 . . . . 0.0 111.983 171.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.67 156.37 40.05 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 CA-C-N 122.039 1.764 . . . . 0.0 112.538 -171.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 99.5 t -53.32 -44.21 53.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 125.137 1.375 . . . . 0.0 109.981 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -44.95 -51.58 9.62 Favored 'General case' 0 N--CA 1.426 -1.657 0 C-N-CA 128.216 2.606 . . . . 0.0 112.471 178.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 40.3 p -99.06 -8.07 25.83 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 119.052 -0.499 . . . . 0.0 111.869 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -44.41 112.38 0.41 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.989 0.916 . . . . 0.0 111.581 -178.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.47 -15.06 63.46 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 119.318 -0.712 . . . . 0.0 113.262 175.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 20.5 mm -64.97 123.78 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-N 119.016 1.408 . . . . 0.0 108.602 171.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 20.1 pttt -156.01 54.53 0.58 Allowed 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.032 0.444 . . . . 0.0 111.751 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.31 87.48 1.32 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 160.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.5 tp -82.79 88.16 6.77 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.242 -162.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 13.3 t -87.89 173.09 9.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.908 0.861 . . . . 0.0 111.329 -170.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.1 tt -145.39 111.15 5.46 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 171.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.6 p -91.81 97.97 11.32 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 124.999 1.32 . . . . 0.0 107.696 175.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.5 128.25 35.23 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 127.075 2.15 . . . . 0.0 108.71 -178.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.6 m -121.54 92.61 3.78 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 122.012 0.911 . . . . 0.0 109.494 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -75.77 90.49 2.89 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.014 -0.993 . . . . 0.0 110.068 174.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -148.02 41.38 0.25 Allowed Pre-proline 0 CA--C 1.553 1.068 0 N-CA-C 116.978 2.214 . . . . 0.0 116.978 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.79 -104.88 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.348 2.699 . . . . 0.0 112.859 -177.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -125.84 107.99 11.03 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.238 1.415 . . . . 0.0 110.661 -168.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -100.59 118.46 60.86 Favored Pre-proline 0 N--CA 1.453 -0.304 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 167.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.86 -50.02 0.07 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 121.781 1.654 . . . . 0.0 110.182 173.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.9 m -169.45 110.74 0.46 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.581 1.152 . . . . 0.0 110.981 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.543 0.679 0 C-N-CA 125.276 1.43 . . . . 0.0 112.808 170.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.989 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.3 t -156.08 42.95 0.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -158.34 -57.13 0.07 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 128.354 2.661 . . . . 0.0 104.709 -164.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 56.4 mt -75.75 -31.89 59.76 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 113.886 -1.506 . . . . 0.0 111.834 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.9 mt -66.0 112.62 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 O-C-N 121.964 -0.46 . . . . 0.0 111.753 -168.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.53 160.44 14.28 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 159.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -75.84 59.98 1.29 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.125 1.37 . . . . 0.0 111.323 -174.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.25 142.99 49.88 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.327 1.451 . . . . 0.0 107.496 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.3 mmmt -110.78 135.46 51.31 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.987 1.715 . . . . 0.0 109.252 -169.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.76 112.11 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-O 121.973 0.892 . . . . 0.0 109.878 -167.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.17 132.41 36.1 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.937 1.295 . . . . 0.0 109.295 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 t -113.36 121.28 65.25 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 C-N-CA 124.538 1.135 . . . . 0.0 108.209 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.63 126.7 31.1 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -102.46 95.89 6.56 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 173.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -118.46 81.07 1.62 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.895 0.855 . . . . 0.0 109.865 -178.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.72 148.3 22.24 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.751 0.821 . . . . 0.0 110.762 -174.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -132.99 152.59 51.94 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.407 1.083 . . . . 0.0 108.182 -172.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.6 t -135.91 146.26 29.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -146.46 174.64 11.21 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.239 0.542 . . . . 0.0 110.573 175.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.63 133.46 16.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 171.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 117.83 -45.98 1.2 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -162.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.34 87.37 51.71 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 123.592 0.757 . . . . 0.0 109.693 174.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -81.8 43.96 1.62 Allowed 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.634 2.889 . . . . 0.0 109.292 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.411 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 43.0 m0 -114.91 140.47 48.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -175.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -79.09 81.3 5.37 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -85.75 98.92 11.0 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.7 m -87.37 135.0 35.05 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -177.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -66.77 156.25 66.79 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 N-CA-C 108.316 -1.455 . . . . 0.0 108.316 167.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.7 t -76.62 -45.71 32.46 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -168.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.66 176.9 12.01 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 163.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.32 -45.08 44.95 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.63 0.772 . . . . 0.0 113.079 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -160.31 154.37 23.11 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 125.253 1.421 . . . . 0.0 107.797 -169.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.4 pt -113.12 164.67 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 C-N-CA 123.95 0.9 . . . . 0.0 109.022 175.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -121.43 118.56 29.7 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.848 1.259 . . . . 0.0 107.855 176.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.8 m -114.67 151.98 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 165.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -78.07 165.7 23.69 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 150.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.0 mm -6.69 -66.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 127.304 2.242 . . . . 0.0 114.136 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -130.14 21.3 4.92 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 118.868 -0.962 . . . . 0.0 114.723 -178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -70.23 119.22 14.1 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 120.641 2.22 . . . . 0.0 110.948 -176.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.9 p -60.92 117.12 5.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.371 0.668 . . . . 0.0 109.452 172.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.5 p -110.85 149.34 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 165.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -102.7 122.72 45.02 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.677 1.991 . . . . 0.0 107.972 -177.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.2 pp -141.5 100.25 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 121.938 0.875 . . . . 0.0 110.047 -177.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 65.7 mtt -77.17 126.34 30.78 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.985 1.314 . . . . 0.0 110.334 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -96.84 137.11 36.42 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 172.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 27.2 ttt85 -110.35 135.9 50.36 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.294 1.037 . . . . 0.0 109.652 -176.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.16 147.06 48.26 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.512 1.525 . . . . 0.0 109.608 175.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -136.29 121.62 19.26 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 117.784 -1.103 . . . . 0.0 108.267 171.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.411 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 43.0 t-20 -80.27 113.88 18.77 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.668 1.122 . . . . 0.0 111.798 -173.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.2 mt -99.21 16.74 21.87 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.741 1.216 . . . . 0.0 112.666 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.53 176.54 9.32 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.437 -0.789 . . . . 0.0 110.384 173.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.4 m -111.24 20.88 16.91 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.98 165.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.7 p -147.26 156.07 46.42 Favored Pre-proline 0 N--CA 1.449 -0.497 0 C-N-CA 125.521 1.528 . . . . 0.0 108.202 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.06 120.08 7.0 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 121.508 1.472 . . . . 0.0 108.586 175.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.66 163.64 15.05 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 118.898 0.772 . . . . 0.0 109.582 172.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.0 t -103.48 137.12 42.01 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 162.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.7 86.07 0.4 Allowed Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 103.497 -3.841 . . . . 0.0 103.497 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.05 46.57 0.91 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.93 177.04 2.78 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.169 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -148.49 178.33 8.7 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -128.16 161.42 29.32 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 166.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.7 128.39 56.28 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 103.441 -2.799 . . . . 0.0 103.441 155.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.0 t -111.55 79.46 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 O-C-N 124.502 1.126 . . . . 0.0 108.804 175.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -160.5 140.21 8.2 Favored Pre-proline 0 N--CA 1.444 -0.752 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.45 -38.59 19.2 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 N-CA-C 108.333 -1.449 . . . . 0.0 108.333 163.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.1 ptp -177.55 -57.3 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.645 1.578 . . . . 0.0 109.962 -177.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.5 -4.1 25.87 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 123.772 0.829 . . . . 0.0 113.222 -162.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -95.77 -109.27 0.14 Allowed 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -172.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.92 -61.89 0.2 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 123.742 0.687 . . . . 0.0 112.868 -174.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -51.04 -59.68 3.91 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.45 1.1 . . . . 0.0 110.687 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -73.24 51.03 0.31 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.508 1.123 . . . . 0.0 112.169 176.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -114.19 121.51 43.95 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 124.089 0.956 . . . . 0.0 108.434 172.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 . . . . . 0 N--CA 1.446 -0.636 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.953 171.978 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.8 t 155.24 -146.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 129.318 3.047 . . . . 0.0 107.072 176.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.0 t -117.18 137.77 52.12 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.168 1.787 . . . . 0.0 108.663 175.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.58 125.38 25.57 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.241 1.016 . . . . 0.0 110.372 -172.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -70.44 157.67 89.49 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.394 1.078 . . . . 0.0 111.636 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.18 114.1 3.71 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.636 2.224 . . . . 0.0 111.92 -167.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 116.57 -25.85 8.87 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -79.95 161.73 25.33 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 121.442 0.639 . . . . 0.0 112.583 -167.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -103.21 159.58 15.42 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.079 1.352 . . . . 0.0 111.288 -173.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 5.9 mtp -148.44 153.91 39.16 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.769 1.627 . . . . 0.0 109.165 174.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -147.01 153.8 40.48 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 150.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 11.9 mmt -128.02 124.93 23.37 Favored Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 124.527 1.131 . . . . 0.0 108.702 178.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -69.47 145.6 59.31 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 C-N-CA 122.008 1.805 . . . . 0.0 109.297 170.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.9 t -130.06 144.26 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 164.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.8 p -111.23 140.21 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 167.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -147.66 139.29 23.91 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 118.349 0.522 . . . . 0.0 109.646 -172.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -153.94 162.13 41.45 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 125.016 1.327 . . . . 0.0 108.84 164.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 96.1 t -87.34 176.51 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 123.254 0.622 . . . . 0.0 109.699 176.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -121.78 133.65 24.36 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 123.591 0.757 . . . . 0.0 110.75 172.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.18 -21.41 72.34 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.415 2.077 . . . . 0.0 113.473 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -59.89 -14.69 16.57 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 119.81 1.187 . . . . 0.0 111.953 -178.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.2 tt -56.58 -42.31 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 121.212 -0.93 . . . . 0.0 112.664 168.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.2 m -84.97 52.65 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 119.228 0.922 . . . . 0.0 110.84 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -123.62 -65.8 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 117.708 -1.139 . . . . 0.0 113.174 173.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.17 154.72 41.88 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 CA-C-N 121.836 1.692 . . . . 0.0 111.25 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.0 m -59.05 -36.5 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 124.744 1.218 . . . . 0.0 112.208 -173.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -61.73 -60.63 3.38 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.445 0.698 . . . . 0.0 110.138 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 82.1 p -83.1 -7.99 59.57 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 118.417 -0.801 . . . . 0.0 112.353 -173.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -33.98 -50.09 0.37 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.301 1.44 . . . . 0.0 113.703 175.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -84.55 -21.49 56.17 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 123.353 0.502 . . . . 0.0 112.155 -176.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 37.6 mm -77.79 118.11 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 O-C-N 122.054 -0.674 . . . . 0.0 109.777 -177.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.9 pttt -155.28 61.34 0.63 Allowed 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.719 168.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 24.9 p -144.39 87.98 1.91 Allowed 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 170.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.1 tp -83.35 78.07 9.69 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -162.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.5 m -79.18 122.68 26.57 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.098 -1.41 . . . . 0.0 109.818 -158.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.8 tt -79.07 129.48 34.49 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 168.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.5 t -153.69 122.51 6.38 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 165.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -158.24 171.0 21.0 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.481 0.712 . . . . 0.0 110.915 -177.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.4 m -115.69 117.55 30.6 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.099 1.76 . . . . 0.0 111.037 -176.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -79.61 100.32 7.75 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.959 1.304 . . . . 0.0 108.492 168.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -155.67 59.38 2.12 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -176.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -79.76 -94.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.658 2.905 . . . . 0.0 112.732 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 78.6 mtt-85 -152.02 96.12 2.16 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.497 -0.752 . . . . 0.0 110.22 -158.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -91.16 123.55 64.09 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 118.752 -0.642 . . . . 0.0 111.098 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -69.89 -61.38 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.743 1.629 . . . . 0.0 110.47 172.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.8 t -157.27 117.22 3.44 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 121.767 -0.583 . . . . 0.0 111.223 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.559 0 C-N-CA 125.36 1.464 . . . . 0.0 110.577 170.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 119.614 -0.232 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.1 p -163.13 -147.65 0.12 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 160.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -77.31 -22.57 51.74 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.955 2.102 . . . . 0.0 110.42 164.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.2 mt -56.34 -16.4 5.54 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.915 1.286 . . . . 0.0 113.885 -178.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 74.7 mt -52.03 118.51 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 124.373 1.069 . . . . 0.0 110.959 -173.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 mp -93.83 -83.76 0.32 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.943 0.497 . . . . 0.0 110.892 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -175.23 -56.82 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.033 0.933 . . . . 0.0 109.834 -164.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.44 ' CD ' ' HZ1' ' A' ' 136' ' ' LYS . 0.5 OUTLIER -47.32 145.4 2.4 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 125.542 1.537 . . . . 0.0 113.473 -165.87 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.9 tttt -96.93 90.78 5.33 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 126.062 1.745 . . . . 0.0 106.585 -170.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.68 107.5 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 176.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.16 146.06 35.29 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -177.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.5 t -130.46 144.4 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 -176.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 29.7 m -130.84 95.2 3.78 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -171.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -77.22 88.09 3.67 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 124.141 0.977 . . . . 0.0 108.986 -176.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -79.97 83.42 5.88 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 122.66 1.219 . . . . 0.0 109.699 -174.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.25 102.82 15.48 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.531 1.132 . . . . 0.0 110.594 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -106.05 111.17 23.69 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.296 0.639 . . . . 0.0 110.158 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.5 p -77.31 147.84 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 168.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.38 154.62 41.1 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 167.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.79 -41.23 22.97 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.062 0.945 . . . . 0.0 111.742 -175.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -30.69 -43.25 0.07 OUTLIER Glycine 0 CA--C 1.53 1.006 0 C-N-CA 126.898 2.189 . . . . 0.0 113.758 169.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.43 HD12 ' CD2' ' A' ' 144' ' ' PHE . 1.3 tt -116.14 98.54 51.48 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 170.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -74.89 13.8 0.94 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.008 2.472 . . . . 0.0 115.222 -161.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.5 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 42.0 m0 -79.27 156.2 28.19 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.58 1.552 . . . . 0.0 113.079 -168.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -75.98 79.79 2.85 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 170.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -99.56 121.66 41.5 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.022 0.929 . . . . 0.0 108.718 -177.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.08 141.87 41.14 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 118.047 0.385 . . . . 0.0 110.269 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.92 161.15 45.79 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.907 1.738 . . . . 0.0 108.857 163.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.44 -50.38 19.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 177.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.04 165.57 30.39 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 159.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -61.76 -41.57 97.87 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.689 0.677 . . . . 0.0 110.127 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -145.92 157.61 43.89 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 123.726 0.81 . . . . 0.0 112.444 -160.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 50.1 pt -136.54 171.33 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 125.12 1.368 . . . . 0.0 109.252 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -125.01 85.99 2.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.87 1.668 . . . . 0.0 110.814 -178.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.1 t -76.16 127.94 37.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -177.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.87 101.12 9.22 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 167.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 mm -6.21 84.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 127.579 2.352 . . . . 0.0 113.371 -171.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.5 -0.51 49.7 Favored Glycine 0 CA--C 1.539 1.546 0 N-CA-C 115.413 0.925 . . . . 0.0 115.413 171.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -59.69 124.34 19.81 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.023 1.729 . . . . 0.0 109.396 163.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.78 111.75 21.04 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.438 1.095 . . . . 0.0 110.995 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.22 143.27 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.85 128.39 49.63 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.1 pp -143.9 93.17 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.135 1.374 . . . . 0.0 109.308 -173.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 46.6 ttm -73.6 135.96 43.89 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.124 0.969 . . . . 0.0 110.059 -173.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -99.69 141.17 32.84 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 174.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.3 ttt180 -110.85 132.34 54.29 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 174.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.09 141.75 44.24 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 127.052 2.141 . . . . 0.0 107.241 162.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -140.71 145.98 37.18 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 166.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.5 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 34.6 t30 -83.38 87.27 6.98 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 119.024 0.829 . . . . 0.0 113.019 -170.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -79.92 73.53 6.69 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.197 0.999 . . . . 0.0 109.224 172.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.15 140.26 17.46 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 164.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.7 t -78.35 35.4 0.22 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.785 1.175 . . . . 0.0 111.347 174.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 p -146.41 154.57 49.29 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 126.392 1.877 . . . . 0.0 108.876 176.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.49 143.33 42.52 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.615 2.21 . . . . 0.0 109.242 176.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.5 p -117.44 176.72 5.03 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.51 1.124 . . . . 0.0 111.998 -175.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 m -133.43 126.08 30.42 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 103.18 -2.896 . . . . 0.0 103.18 -178.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -127.35 117.24 2.63 Favored Glycine 0 C--N 1.335 0.481 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -171.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? -139.54 -48.57 0.47 Allowed 'General case' 0 C--N 1.338 0.106 0 CA-C-N 117.738 0.769 . . . . 0.0 110.291 174.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 62.84 175.38 0.15 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.22 1.008 . . . . 0.0 110.408 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.3 t -111.3 146.8 36.39 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 165.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -122.18 89.67 3.16 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.254 1.422 . . . . 0.0 108.073 -173.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.73 85.25 4.75 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 174.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.7 t -79.04 70.09 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.844 1.258 . . . . 0.0 109.707 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.5 t -176.74 149.42 0.86 Allowed Pre-proline 0 N--CA 1.469 0.486 0 CA-C-N 119.325 0.966 . . . . 0.0 111.571 170.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -66.22 -37.31 25.14 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.266 1.31 . . . . 0.0 110.088 159.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 11.8 ptp 169.58 -68.67 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 128.305 2.642 . . . . 0.0 106.912 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.74 -45.35 65.01 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.94 0.896 . . . . 0.0 112.966 -170.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.19 -104.4 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.91 -166.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.97 -56.62 1.41 Allowed Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.47 -0.628 . . . . 0.0 112.488 -175.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -44.23 -55.08 5.13 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.594 1.158 . . . . 0.0 111.923 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -72.54 2.66 5.97 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.546 1.538 . . . . 0.0 114.014 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -73.89 90.84 1.94 Allowed 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.522 0.729 . . . . 0.0 109.55 -175.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 . . . . . 0 N--CA 1.447 -0.585 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.602 -167.896 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 . . . . . 0 CA--C 1.536 0.434 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.9 t 36.67 -124.15 0.17 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.987 1.715 . . . . 0.0 114.463 166.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.4 t -142.96 155.13 44.64 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.797 2.039 . . . . 0.0 107.624 -176.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.2 mt -142.63 141.78 31.97 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 170.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -76.34 170.65 15.07 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.588 1.555 . . . . 0.0 108.994 171.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.9 106.59 2.04 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 121.807 1.671 . . . . 0.0 113.666 -166.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 116.51 -13.77 15.45 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 124.932 1.253 . . . . 0.0 110.801 172.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -82.4 176.89 9.06 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 123.627 0.251 . . . . 0.0 111.548 -163.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -118.86 144.0 46.63 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.073 0.949 . . . . 0.0 113.194 -150.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.25 84.29 1.95 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.102 1.761 . . . . 0.0 110.027 168.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -101.95 87.79 3.2 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 120.612 -1.305 . . . . 0.0 109.243 171.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 13.2 ttt -102.82 118.82 57.43 Favored Pre-proline 0 N--CA 1.442 -0.869 0 O-C-N 121.454 -0.779 . . . . 0.0 110.275 -167.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.64 152.77 77.62 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.145 1.897 . . . . 0.0 110.358 171.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.5 t -145.43 135.44 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.6 p -99.46 148.08 6.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 166.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -152.43 156.27 39.15 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 118.282 0.492 . . . . 0.0 112.047 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -173.11 176.78 2.89 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 127.149 2.18 . . . . 0.0 108.467 176.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 78.7 t -131.86 138.66 52.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 124.0 0.92 . . . . 0.0 108.967 176.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -82.88 146.81 53.17 Favored Pre-proline 0 CA--C 1.54 0.593 0 O-C-N 123.452 0.47 . . . . 0.0 111.255 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -56.98 -25.25 61.8 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.95 3.1 . . . . 0.0 113.615 177.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -42.22 -31.13 0.35 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.637 1.575 . . . . 0.0 113.09 175.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.3 tt -49.3 -46.14 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.6 m -85.5 57.07 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 119.425 1.011 . . . . 0.0 110.52 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -132.59 -64.55 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.484 1.114 . . . . 0.0 113.456 173.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -63.86 164.7 20.87 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 121.932 1.754 . . . . 0.0 111.882 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 89.3 t -77.39 -43.8 30.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -173.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -37.8 -46.6 0.94 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 129.037 2.935 . . . . 0.0 112.957 177.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 19.1 p -87.23 -61.93 1.61 Allowed 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -0.97 79.7 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 129.506 3.123 . . . . 0.0 115.098 -171.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 134.82 -44.11 1.21 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 -171.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 12.4 mm -53.46 118.25 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 123.038 0.535 . . . . 0.0 110.075 170.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.44 ' HZ1' ' CD ' ' A' ' 31' ' ' GLU . 3.2 pttt -156.01 53.84 0.57 Allowed 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.881 168.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.83 91.87 2.4 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 167.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.5 mp -77.0 135.12 38.66 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 -176.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 6.7 t -136.9 150.46 48.24 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.76 106.35 10.43 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 102.785 -3.043 . . . . 0.0 102.785 170.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.6 t -79.61 92.98 5.4 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 172.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.37 121.82 27.19 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 174.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.63 108.85 13.04 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.894 0.878 . . . . 0.0 109.786 -178.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.43 ' CD2' HD12 ' A' ' 45' ' ' LEU . 3.9 m-30 -79.28 80.51 5.64 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.014 1.325 . . . . 0.0 112.792 -167.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -129.58 78.42 75.52 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -97.65 -106.98 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.873 1 C-N-CA 125.418 4.079 . . . . 0.0 111.223 167.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -137.85 113.06 9.25 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.083 1.753 . . . . 0.0 108.046 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -91.11 113.11 57.17 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 123.813 0.845 . . . . 0.0 108.756 170.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -77.23 65.38 7.91 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.131 1.887 . . . . 0.0 108.314 166.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.2 m 26.53 92.58 0.01 OUTLIER 'General case' 0 C--N 1.344 0.326 0 C-N-CA 128.688 2.795 . . . . 0.0 113.964 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.283 0 CA-C-N 119.038 0.835 . . . . 0.0 110.573 -156.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.351 0 N-CA-C 103.353 -2.832 . . . . 0.0 103.353 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.4 m -157.89 39.15 0.27 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.318 1.447 . . . . 0.0 109.145 162.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.18 -58.07 1.82 Allowed 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 104.767 -2.308 . . . . 0.0 104.767 -166.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.9 mt -124.87 41.55 3.49 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.432 1.493 . . . . 0.0 109.706 176.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 44.3 mt -75.07 110.06 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 162.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.17 -174.12 2.47 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 170.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.42 -32.96 70.66 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.363 1.465 . . . . 0.0 114.855 -163.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -53.23 95.95 0.01 OUTLIER 'General case' 0 C--N 1.34 0.178 0 CA-C-O 123.048 1.404 . . . . 0.0 112.72 -173.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.459 ' HZ1' ' CG ' ' A' ' 57' ' ' ASP . 9.3 ttpp -74.58 88.12 2.15 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 165.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.65 127.51 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.754 -172.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.44 134.28 33.62 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -174.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 t -118.03 139.18 46.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.5 m -113.2 104.55 12.46 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.825 1.25 . . . . 0.0 108.272 -174.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -79.96 148.22 31.29 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.764 173.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -144.19 86.96 1.86 Allowed 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 -175.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.64 90.66 8.5 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.983 1.313 . . . . 0.0 110.505 -173.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -93.09 106.55 18.5 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.513 0.673 . . . . 0.0 109.752 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.0 p -78.44 145.52 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 163.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -156.32 159.43 38.81 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 118.579 0.627 . . . . 0.0 110.266 176.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.31 132.69 29.13 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 172.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.21 -45.33 1.28 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 -160.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.25 97.37 19.94 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 123.699 0.799 . . . . 0.0 109.801 -178.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.82 11.29 2.8 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.525 2.817 . . . . 0.0 113.438 -174.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 42.0 m0 -76.29 145.66 39.46 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.074 -1.016 . . . . 0.0 111.352 -172.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -77.59 83.15 3.99 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 104.87 -2.271 . . . . 0.0 104.87 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -94.59 90.14 6.04 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.616 1.966 . . . . 0.0 108.514 -171.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.2 m -89.15 129.65 47.12 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -176.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.87 149.38 72.37 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 N-CA-C 108.165 -1.513 . . . . 0.0 108.165 164.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.3 -59.2 3.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -128.85 157.09 42.5 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 167.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.9 tpt85 -67.33 -34.36 77.18 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 173.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -134.3 169.47 17.17 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 125.576 1.55 . . . . 0.0 110.689 -174.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.5 pt -136.47 175.87 9.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 124.774 1.23 . . . . 0.0 107.88 166.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.459 ' CG ' ' HZ1' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -126.35 136.8 53.17 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 165.564 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.9 m -126.04 135.1 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 170.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.85 96.04 2.03 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 165.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.8 pt 0.23 73.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.994 2.117 . . . . 0.0 114.389 -173.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.28 -27.9 3.36 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 119.934 -0.37 . . . . 0.0 112.821 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -46.74 106.95 0.09 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.239 1.016 . . . . 0.0 111.414 176.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.1 p -65.0 113.48 3.91 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.83 0.852 . . . . 0.0 109.386 174.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.3 p -114.8 144.11 23.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 167.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.25 131.06 38.7 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.154 1.782 . . . . 0.0 107.978 176.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -145.67 93.49 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.37 144.61 34.0 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.979 -173.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -110.83 145.26 38.52 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 177.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.5 ttt-85 -118.84 121.29 39.68 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.667 1.187 . . . . 0.0 108.291 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.28 111.0 18.8 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.013 0.925 . . . . 0.0 109.653 169.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -107.98 118.36 36.54 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.975 0.91 . . . . 0.0 110.561 -176.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -79.73 94.32 5.72 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -162.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.5 mt -84.72 73.24 10.63 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.469 0.707 . . . . 0.0 110.556 168.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -127.94 167.83 16.09 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.168 0.987 . . . . 0.0 110.52 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.5 p -78.26 -29.62 48.12 Favored 'General case' 0 C--O 1.227 -0.127 0 C-N-CA 123.467 0.707 . . . . 0.0 111.466 174.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -147.92 162.32 31.67 Favored Pre-proline 0 N--CA 1.449 -0.508 0 C-N-CA 124.742 1.217 . . . . 0.0 108.456 -160.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -59.68 121.17 9.41 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.724 2.282 . . . . 0.0 111.044 -174.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.51 175.42 7.07 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.623 1.569 . . . . 0.0 110.113 -178.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.0 t -138.24 159.28 42.46 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 169.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -138.1 150.93 21.18 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 127.03 2.252 . . . . 0.0 108.551 -173.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.56 -39.22 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.21 0.604 . . . . 0.0 110.097 168.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.58 -179.52 0.12 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.873 0.869 . . . . 0.0 113.023 176.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.1 t -119.31 166.63 12.78 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 144.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -141.89 88.78 2.14 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.756 1.265 . . . . 0.0 108.015 -176.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -79.13 89.08 4.83 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -177.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.8 t -79.69 86.65 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 173.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.8 t -175.16 151.33 1.33 Allowed Pre-proline 0 C--O 1.232 0.143 0 C-N-CA 125.055 1.342 . . . . 0.0 109.411 170.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.52 -34.61 7.16 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 121.011 1.14 . . . . 0.0 109.156 156.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.8 ptp 171.99 -70.38 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.91 2.484 . . . . 0.0 107.869 -177.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.69 -30.79 26.51 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -165.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.38 -112.93 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.011 0.368 . . . . 0.0 110.086 -177.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.24 -58.62 0.84 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 123.737 0.684 . . . . 0.0 112.735 -174.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -49.44 -53.67 21.67 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.998 0.919 . . . . 0.0 110.365 175.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -73.19 40.4 0.1 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.494 1.118 . . . . 0.0 112.919 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -103.06 140.31 37.46 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 173.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 . . . . . 0 C--O 1.223 -0.341 0 C-N-CA 118.394 -1.322 . . . . 0.0 111.405 173.331 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.2 t -115.3 -61.05 1.8 Allowed 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 124.813 1.245 . . . . 0.0 110.56 -172.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -161.96 146.23 12.55 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.039 1.336 . . . . 0.0 107.427 -178.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.5 mt -147.79 134.46 19.93 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 174.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -64.55 156.4 77.7 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 127.382 2.273 . . . . 0.0 109.751 170.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.3 92.92 0.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.531 2.821 . . . . 0.0 111.65 -167.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 143.75 -27.32 2.06 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 124.562 1.077 . . . . 0.0 110.991 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -77.97 153.93 32.01 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -153.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -108.6 118.17 36.09 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.591 1.556 . . . . 0.0 110.19 -166.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 14.9 ttp -108.96 86.04 2.21 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 123.834 0.853 . . . . 0.0 110.868 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -77.26 129.39 35.84 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 156.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 25.6 mtp -143.35 136.58 13.97 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 118.587 0.63 . . . . 0.0 111.511 159.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -69.95 124.32 10.89 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 123.547 2.831 . . . . 0.0 111.296 171.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.2 t -91.18 152.24 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 160.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.8 p -121.46 143.7 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 167.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -148.65 135.53 19.93 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 118.633 0.651 . . . . 0.0 110.621 -173.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -159.55 149.05 18.31 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.156 1.382 . . . . 0.0 109.17 174.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 92.3 t -100.8 139.17 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.689 1.196 . . . . 0.0 111.441 -173.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -82.91 120.35 76.03 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 177.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.16 -16.31 27.07 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.827 2.351 . . . . 0.0 113.754 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.87 -27.4 2.09 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 119.518 1.054 . . . . 0.0 111.965 168.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.02 -45.7 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 O-C-N 121.643 -0.66 . . . . 0.0 111.63 175.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.9 m -87.36 56.34 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 O-C-N 121.185 -0.947 . . . . 0.0 109.952 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -138.1 -59.72 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 117.14 -1.409 . . . . 0.0 113.762 175.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.95 161.44 18.42 Favored 'Trans proline' 0 C--N 1.347 0.489 0 CA-C-N 122.573 1.955 . . . . 0.0 113.237 -172.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.1 t -56.2 -36.66 46.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 125.843 1.657 . . . . 0.0 111.0 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -38.84 -54.1 1.65 Allowed 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 126.377 1.871 . . . . 0.0 112.053 176.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.5 p -106.28 -46.19 4.11 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.529 -166.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 14.72 67.05 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.305 2.642 . . . . 0.0 115.652 175.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 127.84 -24.36 5.16 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.676 -0.57 . . . . 0.0 111.676 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.2 mm -60.58 132.02 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 170.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 42.5 pttt -159.51 64.72 0.38 Allowed 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.784 0.802 . . . . 0.0 110.282 167.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 27.7 m -149.19 98.28 2.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 162.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.66 82.75 4.88 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -175.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.1 m -76.7 152.9 35.54 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.985 -169.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.2 tt -136.96 104.47 5.47 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.3 m -86.98 98.25 11.15 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 169.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.92 128.07 33.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 170.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.3 m -135.95 98.44 3.89 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.463 0.649 . . . . 0.0 109.89 -168.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -72.98 92.09 1.62 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.118 1.367 . . . . 0.0 112.111 -174.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -132.25 90.61 33.97 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.394 1.078 . . . . 0.0 113.386 170.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -109.4 -105.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.318 1 C-N-CA 125.381 4.054 . . . . 0.0 109.731 164.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.4 ptt-85 -160.34 124.49 3.66 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.59 1.556 . . . . 0.0 108.25 -174.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -95.78 133.69 25.13 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 123.24 0.616 . . . . 0.0 109.493 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -73.53 -63.16 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.146 1.898 . . . . 0.0 108.729 174.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.5 t -167.41 175.22 7.37 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.827 1.251 . . . . 0.0 107.98 162.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.5 0 C-N-CA 124.5 1.12 . . . . 0.0 111.859 -178.227 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.4 t -160.33 -157.85 0.58 Allowed 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 164.2 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.0 -18.24 61.99 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.953 1.701 . . . . 0.0 109.574 175.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.1 mt -68.1 2.41 2.16 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.641 1.177 . . . . 0.0 113.511 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.4 mt -67.71 126.21 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 121.036 1.744 . . . . 0.0 108.888 172.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.4 mp -126.16 163.0 24.08 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.36 0.664 . . . . 0.0 110.669 -178.074 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -78.56 70.26 4.87 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.703 0.801 . . . . 0.0 111.786 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.15 162.19 27.5 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 153.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -130.84 110.27 11.18 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -174.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.13 125.14 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 -174.532 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -89.39 137.79 32.02 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -178.215 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.2 t -123.98 131.29 73.16 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.7 m -91.59 106.1 18.23 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.412 1.885 . . . . 0.0 108.087 -174.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -80.52 124.72 29.18 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -130.23 84.94 2.24 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 122.233 1.016 . . . . 0.0 111.617 -170.741 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.54 102.31 14.08 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.14 0.976 . . . . 0.0 109.706 177.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -99.18 122.25 42.12 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.6 p -113.01 133.56 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.089 0 C-N-CA 124.162 0.985 . . . . 0.0 109.071 174.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.11 176.15 8.95 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.543 1.137 . . . . 0.0 108.833 179.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.1 122.57 8.74 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 170.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.06 -32.52 1.16 Allowed Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -165.122 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mp -142.63 158.74 59.43 Favored Pre-proline 0 N--CA 1.456 -0.155 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 160.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -90.66 13.31 2.22 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.84 3.027 . . . . 0.0 112.171 165.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.438 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 41.7 m0 -78.63 139.76 38.51 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -162.49 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -76.72 83.78 3.34 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.415 ' CZ ' ' CE1' ' A' ' 144' ' ' PHE . 7.2 m-85 -87.71 89.34 7.96 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.317 175.04 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.5 m -87.9 112.9 52.06 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 171.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.1 142.02 54.66 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 N-CA-C 107.659 -1.708 . . . . 0.0 107.659 164.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 m -77.54 -41.37 29.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 O-C-N 122.396 -0.19 . . . . 0.0 111.408 -171.3 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.97 156.51 43.55 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 167.963 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -65.29 -36.62 84.64 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 177.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -151.6 143.75 23.96 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 122.762 0.425 . . . . 0.0 110.99 -174.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.0 pt -105.6 168.36 2.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 123.679 0.792 . . . . 0.0 109.416 174.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -94.05 141.92 27.98 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 152.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.76 123.61 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 157.808 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -75.52 78.82 2.54 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 172.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 pt 11.97 73.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 127.508 2.323 . . . . 0.0 112.923 -176.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.99 -33.44 3.7 Favored Glycine 0 C--O 1.222 -0.643 0 CA-C-O 118.448 -1.195 . . . . 0.0 112.054 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -62.1 140.78 58.39 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 120.225 2.012 . . . . 0.0 110.442 -178.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.13 112.15 16.05 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 127.942 2.497 . . . . 0.0 110.182 -174.041 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 p -79.67 169.01 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.104 0 O-C-N 121.818 -0.551 . . . . 0.0 109.63 174.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -116.39 113.76 23.35 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 124.947 1.299 . . . . 0.0 107.96 156.262 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.4 pp -121.54 126.9 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 159.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 33.1 ttp -79.31 151.05 31.29 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 167.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.77 155.61 27.5 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 167.348 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -134.23 145.35 49.07 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.448 1.099 . . . . 0.0 109.299 172.229 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.16 155.97 49.78 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 127.0 2.12 . . . . 0.0 105.943 151.072 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.0 mmmt -137.72 122.1 18.27 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 116.845 -1.55 . . . . 0.0 108.997 176.496 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.438 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 49.9 t-20 -78.22 85.49 4.38 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 121.472 1.942 . . . . 0.0 111.565 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.4 mt -79.1 68.89 5.18 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.788 1.235 . . . . 0.0 109.869 172.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.75 175.02 10.94 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 170.072 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.5 m -106.41 19.4 20.56 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.1 0.56 . . . . 0.0 110.346 173.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.4 p -146.6 161.05 39.6 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 125.777 1.631 . . . . 0.0 108.848 178.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -62.8 156.51 53.17 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 121.502 1.468 . . . . 0.0 110.247 173.568 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.37 162.91 31.27 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 171.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.9 t -116.61 108.22 15.67 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.2 121.61 5.59 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 105.625 -2.99 . . . . 0.0 105.625 162.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.66 -54.06 1.34 Allowed 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 170.734 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.39 178.41 0.16 Allowed 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.884 0.874 . . . . 0.0 110.984 172.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.62 141.63 33.43 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 153.055 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -107.4 162.85 13.55 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 122.681 0.392 . . . . 0.0 110.53 173.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -123.23 111.32 16.33 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 160.374 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.0 t -89.17 56.82 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.616 0.766 . . . . 0.0 110.008 -171.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.2 t -172.97 149.97 1.9 Allowed Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 119.911 1.232 . . . . 0.0 112.24 -177.56 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -64.84 -39.46 25.55 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 121.972 1.782 . . . . 0.0 109.676 162.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.4 ptp 173.49 -76.79 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 127.537 2.335 . . . . 0.0 108.044 176.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.16 -43.51 98.66 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 123.938 0.895 . . . . 0.0 112.666 -169.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.04 -103.82 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.718 -161.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.04 -53.91 1.4 Allowed Glycine 0 CA--C 1.527 0.829 0 CA-C-O 119.381 -0.677 . . . . 0.0 113.043 -177.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -45.84 -56.42 5.41 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.49 1.145 . . . . 0.0 110.984 176.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -74.35 4.72 5.42 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.606 1.162 . . . . 0.0 113.83 179.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -76.9 107.78 9.48 Favored 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 120.9 -1.125 . . . . 0.0 108.428 177.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 . . . . . 0 N--CA 1.447 -0.602 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.77 -172.712 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.474 0 CA-C-O 118.995 -0.526 . . . . 0.0 111.488 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.8 t 45.66 -148.36 0.11 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.499 1.52 . . . . 0.0 111.92 177.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -93.95 145.54 24.57 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.108 0.963 . . . . 0.0 108.913 176.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.1 mt -136.71 128.14 28.43 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 122.94 0.496 . . . . 0.0 109.897 177.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -54.74 165.21 0.97 Allowed Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 127.255 2.222 . . . . 0.0 110.738 160.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -76.25 126.17 8.99 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.244 1.963 . . . . 0.0 112.457 -172.027 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 98.02 5.16 57.46 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 124.012 0.815 . . . . 0.0 111.298 175.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -79.35 133.75 36.59 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 117.242 0.521 . . . . 0.0 110.737 -173.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -102.19 89.28 3.54 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.144 1.378 . . . . 0.0 109.694 -175.322 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.96 87.36 7.35 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -133.51 131.91 40.37 Favored 'General case' 0 CA--C 1.523 -0.075 0 CA-C-N 119.193 0.906 . . . . 0.0 111.411 169.506 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 60.0 mtt -153.07 147.11 18.57 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.173 0.989 . . . . 0.0 109.498 -170.519 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.29 146.84 40.96 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.678 2.919 . . . . 0.0 110.375 173.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 28.2 m -138.22 158.77 32.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 123.771 0.828 . . . . 0.0 108.891 165.319 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.6 m -114.6 161.01 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 124.097 0.959 . . . . 0.0 109.104 175.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -159.95 155.77 26.06 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.387 1.075 . . . . 0.0 108.164 -179.216 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -175.27 92.72 0.06 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.975 1.31 . . . . 0.0 111.529 -171.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.34 138.56 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 O-C-N 120.691 -1.256 . . . . 0.0 111.714 178.611 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.75 136.24 92.5 Favored Pre-proline 0 N--CA 1.469 0.51 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.487 173.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.57 -29.22 59.34 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.028 1.819 . . . . 0.0 112.104 172.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -44.6 -28.88 0.65 Allowed 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.534 1.533 . . . . 0.0 112.727 174.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 17.7 tt -47.69 -41.05 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 119.375 0.988 . . . . 0.0 112.817 174.345 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.3 m -87.01 58.39 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 119.573 1.079 . . . . 0.0 109.992 175.517 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . 0.486 1.0 OUTLIER -144.28 -52.63 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 117.933 2.568 . . . . 0.0 117.933 172.102 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.79 161.21 33.7 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 CA-C-N 123.368 2.239 . . . . 0.0 112.26 -177.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.78 -42.16 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 124.826 1.25 . . . . 0.0 109.468 -172.404 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -43.26 -47.74 6.58 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 127.528 2.331 . . . . 0.0 112.382 177.254 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 24.2 p -92.95 -53.16 4.26 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -175.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 12.59 62.41 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 129.117 2.967 . . . . 0.0 115.44 -178.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 140.98 -38.73 1.52 Allowed Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -174.133 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.8 mm -55.34 113.65 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-N 117.434 0.617 . . . . 0.0 109.864 175.206 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 7.9 pttt -156.52 61.56 0.54 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 121.99 0.9 . . . . 0.0 108.925 169.659 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.89 89.53 1.47 Allowed 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 162.735 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.5 tp -74.99 160.16 30.9 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -171.407 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 12.0 t -153.36 164.75 37.59 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 174.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 14.7 tp -138.06 98.27 3.6 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 102.253 -3.24 . . . . 0.0 102.253 173.303 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.9 p -84.24 93.18 8.14 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 177.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.27 131.36 36.14 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 175.324 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.94 96.24 4.98 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.003 0.921 . . . . 0.0 108.677 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.415 ' CE1' ' CZ ' ' A' ' 49' ' ' PHE . 50.4 m-85 -89.62 87.63 7.1 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 125.652 1.581 . . . . 0.0 109.531 178.607 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -135.71 37.35 0.34 Allowed Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 125.378 1.471 . . . . 0.0 114.379 175.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.45 -85.4 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.156 2.571 . . . . 0.0 114.346 -172.638 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.46 91.38 1.57 Allowed 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.592 0.757 . . . . 0.0 110.352 -163.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -78.5 117.74 68.17 Favored Pre-proline 0 N--CA 1.451 -0.387 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 168.378 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.57 -29.42 7.37 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.551 2.167 . . . . 0.0 110.788 172.102 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 36.9 m 130.01 144.0 0.0 OUTLIER 'General case' 0 C--N 1.342 0.263 0 C-N-CA 130.632 3.573 . . . . 0.0 107.36 -167.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.2 pttm . . . . . 0 CA--C 1.534 0.358 0 C-N-CA 124.927 1.291 . . . . 0.0 109.267 177.562 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.486 0 CA-C-O 122.025 0.917 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.79 -11.43 59.99 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.529 1.532 . . . . 0.0 114.757 -147.196 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.35 -31.96 64.25 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 173.879 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.1 mp -108.09 14.46 25.11 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.023 1.329 . . . . 0.0 112.074 -176.27 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.4 mt -77.98 77.31 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 120.005 -1.684 . . . . 0.0 108.839 173.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.76 179.75 5.93 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.531 0.681 . . . . 0.0 109.893 179.238 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -94.48 59.43 2.51 Favored 'General case' 0 C--N 1.337 0.031 0 C-N-CA 123.827 0.851 . . . . 0.0 112.667 -167.021 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -115.18 160.9 19.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 151.664 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -133.76 88.38 2.47 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.0 tt -94.47 137.91 21.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 C-N-CA 124.477 1.111 . . . . 0.0 111.637 -163.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.71 143.84 34.2 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.635 1.574 . . . . 0.0 109.781 -170.421 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.7 t -135.72 142.06 40.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.655 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 164.389 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.9 m -123.29 112.47 17.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 -177.721 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -78.52 89.76 4.48 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 172.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -78.23 85.25 4.4 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 118.492 -1.283 . . . . 0.0 108.395 178.576 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.5 115.78 17.54 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.832 174.758 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -122.94 175.54 6.52 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.595 1.158 . . . . 0.0 108.188 167.039 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.6 p -151.17 148.6 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 169.161 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -164.51 171.54 14.45 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.254 1.022 . . . . 0.0 108.869 -178.302 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.62 -165.36 0.22 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.354 1.462 . . . . 0.0 111.616 -175.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.73 52.98 4.26 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 112.123 -0.391 . . . . 0.0 112.123 -173.079 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.412 ' CD1' ' CD1' ' A' ' 144' ' ' PHE . 1.4 tt -111.7 83.77 4.77 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.122 0.969 . . . . 0.0 108.785 177.693 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -85.28 45.0 1.5 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.246 3.298 . . . . 0.0 109.736 -170.141 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.439 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 43.1 m0 -108.39 138.58 44.43 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -172.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.408 ' OE1' ' NZ ' ' A' ' 71' ' ' LYS . 73.2 tt0 -77.85 82.36 4.23 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 -178.503 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -90.26 122.01 32.79 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.715 1.206 . . . . 0.0 108.233 179.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 m -126.67 135.54 27.43 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.144 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -70.76 162.39 42.76 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 N-CA-C 108.146 -1.521 . . . . 0.0 108.146 161.433 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -60.18 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 175.117 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -144.06 154.13 42.91 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 164.773 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.03 -42.72 69.45 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 118.537 -0.744 . . . . 0.0 112.095 -175.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -145.35 159.69 42.67 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 119.382 0.992 . . . . 0.0 113.189 -166.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.8 pt -133.82 159.79 42.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 125.768 1.627 . . . . 0.0 107.847 178.193 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -128.29 85.41 2.34 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.316 1.446 . . . . 0.0 109.124 178.189 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.8 m -80.44 141.83 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 O-C-N 121.255 -0.903 . . . . 0.0 110.689 -171.281 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -78.22 72.16 4.74 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 173.078 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.5 pt 19.01 64.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 127.437 2.295 . . . . 0.0 113.489 176.368 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 139.0 -43.8 1.14 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -172.58 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -59.68 130.3 46.16 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.648 -173.467 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.6 m -106.69 87.28 2.49 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.003 -146.106 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.72 144.19 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 CA-C-O 121.094 0.473 . . . . 0.0 110.696 -170.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.93 115.54 24.4 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.239 1.016 . . . . 0.0 108.591 168.817 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.8 pp -115.57 115.04 48.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 164.044 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -87.49 155.23 20.09 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.939 -0.475 . . . . 0.0 110.966 178.387 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -127.0 153.78 45.46 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 172.73 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -134.69 141.79 46.64 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.877 1.671 . . . . 0.0 107.898 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.34 115.58 7.98 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.805 2.042 . . . . 0.0 107.681 174.387 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.408 ' NZ ' ' OE1' ' A' ' 48' ' ' GLU . 3.0 mtmp? -114.73 124.42 51.73 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.29 0.95 . . . . 0.0 110.652 -176.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.439 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 46.9 t-20 -80.92 107.2 13.53 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.79 0.723 . . . . 0.0 112.932 -167.583 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.3 mp -99.08 30.4 3.45 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.495 1.118 . . . . 0.0 111.974 176.649 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.85 176.81 9.39 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.021 -1.049 . . . . 0.0 110.401 168.084 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.1 t -114.07 18.1 17.37 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.221 0.608 . . . . 0.0 109.929 161.646 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 p -146.65 156.42 48.61 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 125.639 1.576 . . . . 0.0 107.736 174.405 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -63.23 145.1 93.05 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 N-CA-C 108.122 -1.53 . . . . 0.0 108.122 172.138 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.5 p -123.08 168.25 12.61 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.644 0.735 . . . . 0.0 111.299 178.716 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.8 m -93.63 144.88 24.98 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 168.354 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -168.74 56.9 0.21 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 176.525 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.91 57.78 0.86 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.018 1.727 . . . . 0.0 108.405 -174.374 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.62 166.46 23.52 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.94 0.876 . . . . 0.0 112.879 -168.036 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.48 97.55 8.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 176.512 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -77.23 140.24 40.05 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -85.76 88.61 7.57 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -172.634 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -76.97 77.91 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 C-N-CA 125.043 1.337 . . . . 0.0 110.435 -176.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.8 t 178.88 147.64 0.39 Allowed Pre-proline 0 N--CA 1.46 0.029 0 C-N-CA 124.932 1.293 . . . . 0.0 109.343 173.324 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -66.75 -35.19 28.86 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.146 1.23 . . . . 0.0 110.274 158.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.0 ptp 175.36 -70.78 0.01 OUTLIER 'General case' 0 C--N 1.341 0.206 0 C-N-CA 126.902 2.081 . . . . 0.0 107.571 179.244 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.0 -36.61 48.59 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.962 0.905 . . . . 0.0 113.011 -167.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.77 -109.62 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.608 0.242 . . . . 0.0 111.58 -167.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.79 -49.69 0.84 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.417 1.008 . . . . 0.0 113.528 -176.111 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.55 -57.52 4.66 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.594 1.197 . . . . 0.0 109.802 172.254 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -73.69 5.01 4.31 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.498 1.919 . . . . 0.0 113.895 -178.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -85.72 126.58 34.08 Favored 'General case' 0 C--N 1.344 0.343 0 O-C-N 121.232 -0.918 . . . . 0.0 108.649 174.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 . . . . . 0 N--CA 1.452 -0.327 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.179 -179.459 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 CA--C 1.538 0.496 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.1 t -88.5 -165.78 1.42 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.051 0.94 . . . . 0.0 110.05 174.687 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.5 t -76.69 144.15 39.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.198 0.999 . . . . 0.0 110.04 -175.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 81.0 mt -127.25 134.87 50.01 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.538 1.135 . . . . 0.0 108.15 -179.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -69.55 157.08 90.44 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 170.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.43 100.21 0.88 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.373 2.716 . . . . 0.0 110.438 -170.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.31 -23.44 3.31 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -175.208 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -78.95 135.78 37.05 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 118.254 1.027 . . . . 0.0 111.707 -160.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -92.61 104.56 16.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.4 1.48 . . . . 0.0 109.375 178.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -90.56 135.13 33.9 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 174.042 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -151.46 154.99 37.65 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.625 0.37 . . . . 0.0 110.639 156.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 78.6 mtp -151.77 146.05 18.36 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.161 0.984 . . . . 0.0 109.578 171.495 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -66.12 137.97 50.17 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.126 2.55 . . . . 0.0 110.443 161.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.8 t -107.96 130.47 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 159.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.3 m -98.49 140.82 17.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 171.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -154.43 149.37 26.72 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -162.322 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -164.5 170.29 16.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.415 1.886 . . . . 0.0 109.108 165.314 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 70.7 t -103.99 135.46 41.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 174.482 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -76.37 134.2 70.47 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 119.119 -0.467 . . . . 0.0 109.954 176.397 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -74.16 67.34 5.16 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.384 2.723 . . . . 0.0 110.292 171.42 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -133.52 -37.82 0.94 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 126.799 2.04 . . . . 0.0 111.027 176.565 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.4 tt -43.87 -41.66 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 125.012 1.325 . . . . 0.0 113.414 173.111 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.9 m -78.23 49.03 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 O-C-N 121.394 -0.816 . . . . 0.0 111.34 176.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.9 mttt -142.72 -64.51 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 117.521 -1.228 . . . . 0.0 111.617 -179.299 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.17 153.17 46.03 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 121.942 1.729 . . . . 0.0 112.736 -176.548 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.8 t -54.87 -35.54 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 125.838 1.655 . . . . 0.0 110.662 175.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -35.26 -59.16 0.53 Allowed 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 126.656 1.983 . . . . 0.0 112.309 175.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.5 p -106.94 -42.73 4.84 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.015 -166.068 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 14.07 63.15 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 128.389 2.675 . . . . 0.0 116.235 172.151 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 136.73 -36.73 1.95 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -177.272 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 29.8 mm -53.28 123.52 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 171.444 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.38 47.86 0.35 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.288 0.566 . . . . 0.0 112.102 177.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.5 p -143.65 89.04 2.03 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 105.809 -1.922 . . . . 0.0 105.809 174.025 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 tp -92.71 87.21 5.8 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.029 -159.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.5 t -97.86 155.85 16.87 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.457 0.703 . . . . 0.0 111.084 -166.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.76 133.25 55.98 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 160.704 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 44.5 m -90.94 105.77 18.06 Favored 'General case' 0 N--CA 1.46 0.043 0 O-C-N 123.902 0.751 . . . . 0.0 109.035 160.452 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -76.27 99.8 4.89 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 165.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 53.5 m -117.34 86.35 2.5 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.978 1.311 . . . . 0.0 107.524 175.18 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.412 ' CD1' ' CD1' ' A' ' 45' ' ' LEU . 48.2 m-85 -59.22 145.2 43.67 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.322 1.049 . . . . 0.0 112.828 174.392 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -166.85 52.69 0.25 Allowed Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.966 1.707 . . . . 0.0 112.342 -175.435 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.3 -90.04 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.679 2.252 . . . . 0.0 115.092 -168.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -155.16 179.55 9.04 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 129.697 3.199 . . . . 0.0 104.863 -175.119 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -147.13 94.56 4.54 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 118.488 0.585 . . . . 0.0 111.044 -171.462 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -91.94 -124.37 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.984 3.122 . . . . 0.0 108.954 176.664 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 85.5 p -123.2 123.76 41.5 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 120.356 1.435 . . . . 0.0 111.763 -172.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.595 0 C-N-CA 126.496 1.918 . . . . 0.0 109.237 174.333 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.631 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.75 11.9 0.95 Allowed 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 126.802 2.041 . . . . 0.0 115.322 -164.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -77.25 -39.12 49.44 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 159.452 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.4 mp -92.22 -37.91 12.41 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 117.209 -1.377 . . . . 0.0 113.016 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.2 mt -32.53 133.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -162.13 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -105.91 -104.15 0.33 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.159 -173.618 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -173.59 -49.2 0.01 OUTLIER 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.058 1.343 . . . . 0.0 108.855 -171.348 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -38.78 134.6 0.95 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.002 1.721 . . . . 0.0 110.678 -178.812 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -100.97 86.65 3.1 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -165.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.98 115.01 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.436 1.494 . . . . 0.0 107.953 -171.424 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.99 160.01 29.48 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -173.641 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.0 t -148.74 145.19 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.1 m -138.55 100.28 4.05 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -170.053 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -78.11 145.0 36.0 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.018 0.527 . . . . 0.0 109.919 -176.177 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -127.63 82.75 2.11 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.913 0.863 . . . . 0.0 110.007 178.22 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.49 102.16 14.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 172.118 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -116.89 128.37 55.18 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 122.292 1.044 . . . . 0.0 112.126 -174.666 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.0 p -99.83 96.29 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.564 -174.252 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.12 171.1 10.5 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 122.048 0.928 . . . . 0.0 111.406 174.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.41 132.07 52.0 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 169.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 128.33 -39.28 1.92 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -170.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.484 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -131.56 95.57 23.21 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 117.56 0.68 . . . . 0.0 110.277 -176.363 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -83.94 50.94 3.27 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.956 2.437 . . . . 0.0 109.651 -176.136 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.484 ' CD2' ' CD2' ' A' ' 45' ' ' LEU . 44.4 m0 -107.91 135.56 49.1 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -173.649 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -79.36 84.5 5.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 103.484 -2.784 . . . . 0.0 103.484 179.246 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -102.04 86.15 2.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -171.598 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.3 m -88.04 129.14 51.2 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -167.28 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.09 122.49 9.58 Favored 'Trans proline' 0 N--CA 1.446 -1.277 0 N-CA-C 106.261 -2.246 . . . . 0.0 106.261 162.466 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.1 m -72.73 -32.08 39.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.181 0.515 . . . . 0.0 110.691 -168.387 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.02 161.98 34.16 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 150.265 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -62.65 -46.72 86.89 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 172.532 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -147.38 153.54 39.77 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 124.415 1.086 . . . . 0.0 111.659 -159.647 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.4 pt -133.13 179.23 4.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 126.326 1.851 . . . . 0.0 108.251 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -125.47 160.18 30.11 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.345 0.593 . . . . 0.0 110.21 149.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.6 t -116.72 145.97 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 127.99 2.516 . . . . 0.0 105.679 171.014 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 49.5 mmm-85 -91.37 100.81 13.53 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 168.021 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mt -33.2 115.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -148.243 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.58 -25.2 26.49 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.071 1.319 . . . . 0.0 110.936 -179.386 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -64.9 133.45 51.86 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.806 1.303 . . . . 0.0 112.422 -172.33 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.15 101.53 7.97 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 130.05 3.34 . . . . 0.0 110.818 -175.38 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.9 p -113.78 153.75 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.292 1.437 . . . . 0.0 109.491 -178.597 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -112.51 125.15 53.93 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 125.404 1.482 . . . . 0.0 109.343 -177.38 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.0 pp -128.48 122.86 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 167.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 66.4 mtt -76.09 168.44 20.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.614 174.164 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -136.17 143.21 44.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 161.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.7 ttt85 -121.01 118.7 30.5 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 179.546 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.3 105.15 9.24 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 125.822 1.649 . . . . 0.0 110.035 -177.216 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.29 121.09 44.36 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.064 -0.398 . . . . 0.0 110.749 -168.603 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.435 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 47.8 t-20 -78.38 111.9 14.85 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.803 -0.561 . . . . 0.0 111.912 -167.783 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.2 tp -98.41 11.24 38.77 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.812 0.845 . . . . 0.0 112.381 179.564 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.46 166.67 22.33 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.272 -0.893 . . . . 0.0 109.95 173.44 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 70.0 m -103.3 7.0 38.35 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.968 0.907 . . . . 0.0 111.835 171.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.34 159.61 38.79 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 126.134 1.773 . . . . 0.0 107.041 177.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.97 126.04 12.11 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.171 1.914 . . . . 0.0 111.255 -173.208 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.49 173.53 12.51 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.821 0.849 . . . . 0.0 110.784 -178.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 50.7 p -131.45 72.03 1.49 Allowed 'General case' 0 C--O 1.232 0.137 0 C-N-CA 122.551 0.341 . . . . 0.0 110.426 -170.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.42 139.37 37.39 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.946 -0.462 . . . . 0.0 111.946 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -166.81 34.19 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.659 1.983 . . . . 0.0 109.44 169.222 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.58 159.08 34.47 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.33 0.652 . . . . 0.0 111.445 -165.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.9 t -87.77 131.51 34.48 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.704 0.764 . . . . 0.0 110.039 177.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -104.03 89.93 3.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.871 2.468 . . . . 0.0 105.572 175.509 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -77.0 91.92 3.67 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 120.882 -1.136 . . . . 0.0 107.935 -177.617 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.8 t -78.11 72.57 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.612 1.165 . . . . 0.0 109.973 -174.043 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.9 t -168.73 134.76 1.49 Allowed Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 119.901 1.228 . . . . 0.0 113.389 173.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -74.1 67.72 5.04 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 122.386 2.057 . . . . 0.0 107.243 156.257 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 22.2 ptm 44.19 25.47 0.11 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 170.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -171.41 -58.26 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 119.384 0.993 . . . . 0.0 110.594 -168.411 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.61 -101.2 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -177.282 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 64.05 -52.1 0.08 OUTLIER Glycine 0 CA--C 1.538 1.481 0 N-CA-C 115.413 0.925 . . . . 0.0 115.413 -175.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -45.73 -47.63 15.33 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.553 1.541 . . . . 0.0 110.808 172.217 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -73.85 -12.69 60.75 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 127.012 2.125 . . . . 0.0 113.471 178.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -67.55 140.0 56.95 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.119 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.4 p30 . . . . . 0 C--N 1.328 -0.361 0 C-N-CA 124.967 1.307 . . . . 0.0 110.765 -177.33 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.3 t 51.67 -146.64 0.47 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.441 1.096 . . . . 0.0 112.472 170.606 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.6 m -115.54 136.65 52.86 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.089 1.355 . . . . 0.0 108.542 -172.069 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 78.6 mt -128.44 147.95 50.69 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.39 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -73.29 156.42 89.15 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 172.354 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.23 85.87 0.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 124.88 3.72 . . . . 0.0 111.756 -173.064 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 152.74 -27.23 0.83 Allowed Glycine 0 CA--C 1.522 0.5 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.25 -177.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -77.86 143.45 37.79 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 118.085 0.942 . . . . 0.0 111.593 -157.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -105.21 96.9 6.84 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.811 1.244 . . . . 0.0 109.942 -175.603 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 15.4 tpt -83.92 89.21 7.18 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.114 1.365 . . . . 0.0 109.325 -177.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -99.21 134.21 42.4 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.256 0.622 . . . . 0.0 109.576 172.148 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 22.4 ptm -150.95 146.31 19.11 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.996 -0.526 . . . . 0.0 111.441 178.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.58 147.77 20.05 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.883 3.055 . . . . 0.0 111.049 171.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.5 t -126.53 114.89 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 165.199 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.5 p -79.41 143.47 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 168.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -155.61 149.11 24.98 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.163 0.585 . . . . 0.0 109.949 -165.411 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -171.18 118.98 0.48 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.36 1.464 . . . . 0.0 111.893 176.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.8 t -64.09 133.39 29.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 O-C-N 120.355 -1.466 . . . . 0.0 109.505 175.317 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -91.61 132.39 33.44 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 123.701 0.801 . . . . 0.0 109.8 -179.053 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -46.35 -31.52 9.55 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.402 3.401 . . . . 0.0 114.919 177.342 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -48.94 -24.2 1.4 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.783 1.633 . . . . 0.0 112.39 179.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.1 tt -49.01 -44.46 15.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 169.097 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.9 m -83.38 59.66 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 118.571 0.623 . . . . 0.0 109.895 174.354 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -111.0 -77.41 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 117.168 -1.396 . . . . 0.0 110.366 164.628 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.54 156.05 45.12 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 CA-C-N 121.885 1.709 . . . . 0.0 111.666 -177.384 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.6 m -62.16 -36.08 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 124.94 1.296 . . . . 0.0 112.045 -170.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -60.6 -64.46 0.94 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.147 0.979 . . . . 0.0 109.281 177.587 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 44.6 p -72.61 -15.43 61.73 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 118.509 -0.758 . . . . 0.0 111.568 -172.419 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.04 -41.52 5.53 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.768 0.713 . . . . 0.0 111.221 162.913 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.34 -29.17 74.38 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 112.237 -0.345 . . . . 0.0 112.237 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.3 mm -83.88 125.94 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 122.079 0.942 . . . . 0.0 110.39 -177.629 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 28.3 pttt -148.81 63.76 1.06 Allowed 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.506 153.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 11.7 m -150.15 95.33 2.26 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 158.416 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.2 tp -75.48 144.79 41.87 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -173.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.8 t -141.8 173.38 11.56 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.496 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.1 tt -150.63 111.28 4.25 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 177.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.45 92.94 8.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.515 1.126 . . . . 0.0 109.252 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.94 108.4 19.17 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.877 1.271 . . . . 0.0 108.783 179.406 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.66 89.09 3.58 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 122.009 0.909 . . . . 0.0 109.747 -177.358 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -71.23 85.57 0.77 Allowed 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.281 177.058 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.1 47.59 2.8 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -178.703 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -80.89 -105.74 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.279 2.653 . . . . 0.0 111.967 178.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -140.95 121.68 14.34 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.648 1.179 . . . . 0.0 108.528 -171.242 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.9 111.22 38.82 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 125.654 1.581 . . . . 0.0 107.118 -177.128 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -83.3 -4.85 11.07 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.293 2.662 . . . . 0.0 113.043 -172.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.9 t 131.51 103.71 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 129.972 3.309 . . . . 0.0 109.754 174.481 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.542 0.669 0 C-N-CA 125.256 1.423 . . . . 0.0 111.723 168.356 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.24 0 N-CA-C 104.354 -2.462 . . . . 0.0 104.354 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.6 t -147.88 49.54 1.06 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 122.493 1.14 . . . . 0.0 108.227 174.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -158.8 -57.42 0.07 Allowed 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 127.306 2.243 . . . . 0.0 106.309 -174.367 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.9 mt -65.53 -16.48 63.72 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.907 2.083 . . . . 0.0 112.878 -177.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.4 mt -75.67 78.51 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 O-C-N 121.21 -0.931 . . . . 0.0 110.267 -171.566 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.69 -127.7 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.555 1.142 . . . . 0.0 108.524 169.679 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -104.36 -51.33 3.13 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.57 1.548 . . . . 0.0 111.939 -164.506 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -43.1 102.07 0.03 OUTLIER 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.194 1.398 . . . . 0.0 113.351 -169.806 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.69 81.52 4.99 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 177.261 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -97.11 122.58 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -160.616 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.7 150.48 34.48 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.943 1.297 . . . . 0.0 108.199 -175.216 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.52 146.9 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 174.497 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.9 m -125.83 112.19 15.73 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -172.69 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -77.88 136.18 38.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -126.71 84.45 2.27 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 122.502 1.144 . . . . 0.0 108.965 177.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.91 95.75 10.28 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.374 1.07 . . . . 0.0 110.972 -176.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -98.63 109.5 22.24 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.375 0.67 . . . . 0.0 109.79 -177.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.0 p -79.24 148.86 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 164.388 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -151.04 158.71 44.44 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 171.216 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.05 -40.15 10.25 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.84 0.856 . . . . 0.0 112.109 -177.214 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -41.58 -31.98 0.76 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.812 1.672 . . . . 0.0 114.151 174.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.405 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -130.17 110.13 16.68 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 118.688 1.244 . . . . 0.0 108.471 170.488 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -75.27 0.95 8.4 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.294 1.996 . . . . 0.0 115.576 -164.035 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.51 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 42.2 m0 -79.57 153.45 29.46 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.38 1.472 . . . . 0.0 113.613 -159.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -77.47 77.46 4.0 Favored 'General case' 0 C--N 1.344 0.344 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.615 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -84.6 110.72 18.93 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.684 1.193 . . . . 0.0 109.098 -171.484 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.9 t -122.78 118.81 28.25 Favored Pre-proline 0 N--CA 1.444 -0.758 0 C-N-CA 124.4 1.08 . . . . 0.0 108.645 -163.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -81.87 174.56 10.13 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 124.543 3.495 . . . . 0.0 108.554 168.367 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -98.6 -53.12 8.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 123.949 0.9 . . . . 0.0 110.845 -173.622 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -134.16 175.15 9.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 166.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.6 tpt85 -68.45 -33.15 73.68 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.392 168.636 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -144.67 173.44 11.82 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.842 1.257 . . . . 0.0 112.694 -162.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.1 pt -141.65 178.2 2.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 127.206 2.203 . . . . 0.0 106.788 165.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -132.27 162.77 30.16 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 146.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.23 136.92 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 126.953 2.101 . . . . 0.0 105.836 -175.199 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.94 88.66 3.5 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 163.205 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.2 pt 8.81 69.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 127.74 2.416 . . . . 0.0 114.63 178.469 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.55 -37.55 1.78 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 123.41 0.529 . . . . 0.0 112.305 -176.594 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -39.24 104.43 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.383 1.473 . . . . 0.0 110.849 177.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m -87.46 88.45 7.68 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.353 -156.25 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 p -92.73 161.67 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 O-C-N 121.933 -0.479 . . . . 0.0 111.721 -168.434 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -102.98 126.74 50.28 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.959 1.303 . . . . 0.0 110.35 169.561 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.5 pp -131.33 114.03 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 107.319 -1.364 . . . . 0.0 107.319 167.443 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.0 ttp -77.86 161.52 27.55 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.378 0.671 . . . . 0.0 110.862 -176.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -134.57 150.96 50.78 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.436 1.094 . . . . 0.0 108.846 169.325 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 54.1 ttp85 -143.46 147.08 34.0 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.997 0.919 . . . . 0.0 110.111 -178.457 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.39 109.68 2.66 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.632 1.573 . . . . 0.0 111.765 -177.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -86.09 139.28 31.27 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.989 171.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.51 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 28.1 t30 -78.21 88.99 4.27 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.073 0.851 . . . . 0.0 112.127 168.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.9 mp -76.76 69.08 3.08 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 171.193 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -153.66 137.26 15.99 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 168.513 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.1 t -80.14 36.1 0.34 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.369 0.531 . . . . 0.0 110.754 178.083 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.8 p -149.91 155.47 37.98 Favored Pre-proline 0 C--O 1.237 0.395 0 C-N-CA 126.63 1.972 . . . . 0.0 106.995 174.307 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -63.23 148.14 93.3 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 N-CA-C 108.208 -1.497 . . . . 0.0 108.208 168.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.01 175.06 6.53 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.792 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.0 m -105.65 145.25 31.28 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.121 1.768 . . . . 0.0 106.875 175.39 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -133.65 126.14 4.2 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 107.096 -2.401 . . . . 0.0 107.096 172.494 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.18 54.77 0.12 Allowed 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 166.78 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.44 144.83 15.9 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.884 176.162 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.3 t -85.01 166.08 17.02 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 168.185 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -146.41 95.96 2.69 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -168.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.33 86.92 5.02 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 175.509 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.0 t -78.12 60.23 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.817 1.247 . . . . 0.0 108.776 -175.034 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.1 t -171.44 148.34 2.3 Favored Pre-proline 0 CA--C 1.522 -0.129 0 O-C-N 121.481 -0.762 . . . . 0.0 111.636 178.077 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -61.57 -41.26 40.99 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 121.758 1.639 . . . . 0.0 110.068 159.031 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.3 ptp 172.08 -77.72 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 127.124 2.17 . . . . 0.0 107.59 178.399 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.87 -29.87 63.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.634 1.174 . . . . 0.0 112.292 -170.287 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.9 -119.11 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -174.028 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.89 -50.56 2.25 Favored Glycine 0 CA--C 1.528 0.874 0 O-C-N 121.348 -0.845 . . . . 0.0 113.192 178.204 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -44.93 -54.54 6.38 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.159 0.984 . . . . 0.0 110.014 171.555 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -75.39 -4.26 38.41 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.508 1.923 . . . . 0.0 113.96 -179.053 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -69.37 133.55 47.95 Favored 'General case' 0 C--N 1.341 0.227 0 O-C-N 121.093 -1.004 . . . . 0.0 108.486 178.449 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 . . . . . 0 N--CA 1.453 -0.289 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.684 177.931 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 . . . . . 0 CA--C 1.535 0.403 0 CA-C-O 121.149 0.5 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.7 t -111.52 -57.68 2.22 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 128.711 2.804 . . . . 0.0 111.378 -167.6 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.8 t -163.65 140.34 6.97 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 122.849 0.46 . . . . 0.0 110.385 -170.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 39.7 mt -139.32 143.73 37.96 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.207 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -80.44 172.95 8.53 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.76 1.224 . . . . 0.0 109.349 -179.48 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -68.0 79.89 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.535 2.823 . . . . 0.0 114.465 -162.041 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 147.87 -29.89 1.39 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.307 0.956 . . . . 0.0 112.181 172.107 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -82.21 158.56 23.51 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 118.226 -1.39 . . . . 0.0 112.318 -139.61 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -84.61 123.26 30.13 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 124.64 1.176 . . . . 0.0 110.268 179.59 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -90.22 128.61 36.42 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 154.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -134.0 146.42 50.4 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 159.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 56.7 mtt -146.61 146.63 27.59 Favored Pre-proline 0 N--CA 1.453 -0.323 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 165.087 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -71.55 142.58 40.61 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 122.101 1.868 . . . . 0.0 109.412 160.232 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.4 t -115.77 143.83 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 164.026 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.0 p -102.28 145.49 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 174.608 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -145.9 138.09 25.36 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.335 0.516 . . . . 0.0 111.425 -176.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -159.07 162.25 36.56 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.569 1.548 . . . . 0.0 107.43 160.559 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 94.8 t -104.72 131.27 54.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 174.789 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.18 135.23 47.85 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 175.887 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -75.49 57.85 5.0 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 124.578 3.519 . . . . 0.0 112.673 -176.414 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.24 -36.47 7.63 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 125.57 1.548 . . . . 0.0 109.864 168.3 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.8 tt -47.75 -46.57 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -169.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.3 m -81.19 53.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.448 -0.783 . . . . 0.0 110.785 -178.444 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -138.28 -64.51 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 117.661 -1.161 . . . . 0.0 112.085 -179.371 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.67 156.33 35.64 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 CA-C-N 121.961 1.736 . . . . 0.0 113.406 -176.053 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.2 t -54.11 -39.46 42.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 126.201 1.8 . . . . 0.0 110.742 177.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -45.92 -55.72 6.38 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.697 1.599 . . . . 0.0 111.8 -178.523 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.3 p -92.37 -42.89 9.53 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 118.633 -0.699 . . . . 0.0 111.442 -176.313 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 7.93 65.13 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 128.403 2.681 . . . . 0.0 116.129 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 142.37 -41.34 1.2 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -173.709 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.7 mm -57.27 120.13 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 CA-C-N 117.689 0.744 . . . . 0.0 110.178 177.23 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -157.38 66.45 0.5 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.672 0.749 . . . . 0.0 110.173 162.578 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 10.6 m -147.51 102.72 3.48 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 152.206 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.68 151.76 34.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -175.243 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.7 t -154.08 175.13 13.79 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.408 0.623 . . . . 0.0 109.647 -177.269 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.9 tp -153.7 97.13 2.07 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 103.216 -2.883 . . . . 0.0 103.216 -169.278 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.5 t -81.78 88.09 6.32 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 171.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.79 124.4 27.64 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 176.809 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 23.8 m -133.38 95.52 3.53 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.412 1.101 . . . . 0.0 109.229 -164.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -74.22 74.42 1.8 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.041 1.736 . . . . 0.0 111.94 -171.007 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -128.35 68.48 77.23 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.349 1.06 . . . . 0.0 113.758 179.566 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -87.69 -103.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.775 2.983 . . . . 0.0 110.666 167.502 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -156.26 99.66 1.94 Allowed 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.8 1.24 . . . . 0.0 108.907 -172.117 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -104.56 134.0 19.89 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 126.432 1.893 . . . . 0.0 106.403 167.614 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.0 -47.3 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.445 2.097 . . . . 0.0 110.638 178.304 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.2 t 166.65 112.4 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 129.202 3.001 . . . . 0.0 104.822 178.486 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.7 pttt . . . . . 0 CA--C 1.535 0.4 0 CA-C-N 119.584 1.083 . . . . 0.0 110.409 -168.921 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.703 0 CA-C-O 122.711 1.244 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.4 p -76.49 1.66 15.93 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 128.075 2.55 . . . . 0.0 114.58 -164.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -78.56 -21.38 48.78 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 164.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.6 mt -115.32 -26.73 7.48 Favored 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 125.43 1.492 . . . . 0.0 113.134 -171.204 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.7 mt -40.55 -72.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.966 1.706 . . . . 0.0 115.389 -170.555 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 64.99 167.55 0.18 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 127.449 2.3 . . . . 0.0 113.096 -176.036 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -76.57 57.82 1.28 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.521 1.528 . . . . 0.0 111.537 -177.394 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.04 170.74 15.19 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 126.111 1.764 . . . . 0.0 107.041 173.525 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -150.38 111.61 4.4 Favored 'General case' 0 N--CA 1.422 -1.855 0 C-N-CA 124.462 1.105 . . . . 0.0 109.217 177.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.9 tt -93.26 144.34 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 174.018 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.73 152.18 20.39 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 125.83 1.652 . . . . 0.0 109.033 177.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.6 t -136.95 144.24 32.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 175.54 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.6 m -136.19 94.3 3.02 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -171.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -75.04 163.85 27.16 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -175.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -142.44 85.34 1.9 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 122.217 1.008 . . . . 0.0 109.406 -178.727 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.57 102.79 15.47 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 121.586 -0.696 . . . . 0.0 110.25 -179.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -95.46 168.32 10.78 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 123.432 0.693 . . . . 0.0 109.616 177.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.4 t -134.49 151.82 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 167.802 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.65 153.58 47.34 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 166.446 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.46 -35.89 13.89 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.856 0.862 . . . . 0.0 112.358 -174.643 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -37.19 -41.54 0.71 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.71 1.624 . . . . 0.0 113.511 172.111 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.455 HD23 ' CE3' ' A' ' 47' ' ' TRP . 3.9 tt -116.67 107.72 46.1 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 118.187 0.993 . . . . 0.0 108.388 175.023 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -78.35 21.1 0.71 Allowed 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.006 1.804 . . . . 0.0 114.92 -161.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.515 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 50.0 m0 -101.39 147.73 25.99 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.435 1.016 . . . . 0.0 113.212 -160.83 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -78.31 88.95 4.33 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 176.116 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -90.93 126.27 36.01 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 123.774 0.83 . . . . 0.0 109.053 -179.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.1 t -118.24 107.66 43.15 Favored Pre-proline 0 N--CA 1.439 -1.0 0 C-N-CA 125.73 1.612 . . . . 0.0 107.69 -167.324 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -66.14 128.59 19.86 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 122.773 2.316 . . . . 0.0 107.096 165.077 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.9 m -77.27 -36.84 24.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.125 0.488 . . . . 0.0 111.068 -174.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.77 171.11 15.25 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 158.726 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -76.17 -48.87 18.92 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 119.379 -0.928 . . . . 0.0 108.891 172.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -136.67 155.54 49.75 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 125.661 1.584 . . . . 0.0 111.251 -161.528 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.1 pt -135.52 172.92 15.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 125.723 1.609 . . . . 0.0 108.733 -179.454 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -122.21 143.67 49.44 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 126.251 1.82 . . . . 0.0 109.074 162.351 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.6 m -128.97 129.67 68.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 C-N-CA 125.378 1.471 . . . . 0.0 107.408 167.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.22 76.75 0.36 Allowed 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 166.647 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 9.06 59.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 129.393 3.077 . . . . 0.0 115.513 -172.868 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.65 -35.58 1.4 Allowed Glycine 0 C--N 1.335 0.503 0 O-C-N 121.427 -0.796 . . . . 0.0 111.898 -172.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -55.69 129.88 40.99 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 170.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.3 136.93 32.74 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 122.977 0.511 . . . . 0.0 112.345 -177.415 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.2 p -120.33 153.7 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 123.756 0.823 . . . . 0.0 109.108 168.115 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.88 116.51 32.42 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.254 1.821 . . . . 0.0 107.467 173.501 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.4 pp -122.18 119.37 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 168.07 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 85.2 mtp -76.57 166.26 23.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.693 170.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -130.25 149.8 51.78 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 160.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -134.08 132.56 40.1 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 124.121 0.888 . . . . 0.0 109.326 173.876 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.36 165.24 14.1 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 127.659 2.383 . . . . 0.0 106.942 167.208 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.6 mttt -154.02 133.88 13.06 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 119.226 0.921 . . . . 0.0 110.183 174.262 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.515 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 49.3 t30 -84.97 84.78 7.6 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.774 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.7 mp -83.32 63.66 7.37 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.707 167.417 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.26 163.96 25.6 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 165.211 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.7 m -93.95 20.11 8.2 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 123.063 0.227 . . . . 0.0 110.621 176.193 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.3 p -146.16 160.91 41.39 Favored Pre-proline 0 N--CA 1.45 -0.463 0 C-N-CA 125.687 1.595 . . . . 0.0 107.656 177.359 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -66.02 159.76 47.73 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 121.13 1.22 . . . . 0.0 108.972 169.534 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.65 174.32 10.63 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 122.44 0.296 . . . . 0.0 110.846 171.244 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -122.85 152.97 40.22 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.877 1.271 . . . . 0.0 108.85 171.035 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -127.68 129.87 6.55 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 177.336 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.11 40.65 1.49 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.078 0.951 . . . . 0.0 109.147 168.708 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -50.87 145.11 7.55 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.344 1.058 . . . . 0.0 111.616 -175.293 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.8 t -82.13 139.52 34.33 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 118.923 -1.111 . . . . 0.0 108.833 176.163 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -114.41 89.93 3.21 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 -175.142 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -78.39 85.38 4.51 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 177.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.3 t -78.36 67.96 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 125.51 1.524 . . . . 0.0 108.055 -178.377 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.6 t -166.68 144.11 4.18 Favored Pre-proline 0 C--N 1.338 0.094 0 O-C-N 121.59 -0.694 . . . . 0.0 112.49 174.106 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -64.31 -39.74 28.44 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 121.613 1.542 . . . . 0.0 109.428 159.09 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.0 ptp 170.7 -70.17 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 128.242 2.617 . . . . 0.0 107.123 178.706 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -90.98 -27.28 18.78 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 124.273 1.029 . . . . 0.0 112.884 -168.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.26 -123.4 0.01 OUTLIER 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.508 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.75 -54.82 2.97 Favored Glycine 0 CA--C 1.527 0.79 0 O-C-N 121.654 -0.654 . . . . 0.0 112.006 177.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -47.0 -49.48 20.82 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.543 1.172 . . . . 0.0 111.273 174.185 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -72.03 -16.25 62.05 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.445 1.098 . . . . 0.0 113.181 179.398 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -61.61 124.38 20.52 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -178.166 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 . . . . . 0 N--CA 1.449 -0.506 0 CA-C-O 121.889 0.852 . . . . 0.0 111.43 -173.515 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 CA--C 1.531 0.247 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . 0.317 11.1 t 48.05 -81.43 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 127.713 2.405 . . . . 0.0 114.633 168.728 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -158.95 149.35 19.61 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.082 1.353 . . . . 0.0 109.268 -178.564 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.0 mt -143.82 155.5 44.16 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 124.01 0.924 . . . . 0.0 108.835 174.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -94.72 166.55 14.89 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 125.468 1.507 . . . . 0.0 108.5 174.055 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.71 98.18 1.03 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.839 2.359 . . . . 0.0 111.67 -167.611 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.69 -24.57 2.46 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 123.551 0.596 . . . . 0.0 111.723 178.821 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -79.19 127.83 32.53 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 117.85 0.825 . . . . 0.0 111.826 -155.566 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -78.68 136.79 37.54 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 165.619 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 13.7 tpt -130.2 122.62 28.48 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 126.853 2.061 . . . . 0.0 107.863 -169.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -153.24 156.85 39.26 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 120.344 1.429 . . . . 0.0 112.299 177.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 6.2 ttt -155.07 142.38 13.8 Favored Pre-proline 0 N--CA 1.441 -0.898 0 C-N-CA 125.383 1.473 . . . . 0.0 107.149 -177.251 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -74.31 144.78 33.4 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.642 2.894 . . . . 0.0 111.565 165.519 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.9 t -123.09 128.73 75.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 168.598 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.3 p -91.05 141.22 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 170.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -147.23 143.97 28.54 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.413 0.551 . . . . 0.0 111.617 -176.108 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -168.91 120.62 0.76 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 128.322 2.649 . . . . 0.0 106.731 175.295 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.8 p -82.49 146.66 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 119.698 1.136 . . . . 0.0 109.825 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -72.16 139.05 81.82 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 118.117 0.417 . . . . 0.0 110.064 176.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -76.55 61.13 6.76 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.404 2.736 . . . . 0.0 111.547 173.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . 0.253 9.8 pt-20 -135.17 -4.87 2.37 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 169.739 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -48.28 -42.99 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 119.201 0.91 . . . . 0.0 111.677 174.525 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.2 m -76.51 63.81 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 123.306 0.642 . . . . 0.0 110.413 174.406 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -123.06 -70.94 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 124.795 1.238 . . . . 0.0 111.181 170.468 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.53 156.65 36.34 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.161 1.907 . . . . 0.0 113.354 -169.835 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 84.3 t -54.16 -36.17 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.76 1.624 . . . . 0.0 110.057 176.278 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -47.46 -48.06 26.86 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.956 1.702 . . . . 0.0 112.024 176.144 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 22.3 p -93.55 -57.63 2.52 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -173.289 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 18.23 54.5 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 129.532 3.133 . . . . 0.0 115.529 176.063 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 146.2 -36.49 1.29 Allowed Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 -170.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 23.5 mm -57.52 132.72 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 172.486 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -158.8 53.57 0.42 Allowed 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 123.619 0.574 . . . . 0.0 110.277 161.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.6 p -149.77 98.51 2.75 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 176.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.2 mp -77.95 152.58 33.11 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.446 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.5 t -142.34 176.66 8.82 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 125.58 1.552 . . . . 0.0 107.236 170.473 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.2 tt -150.43 101.06 2.93 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 175.527 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.3 t -84.26 89.23 7.3 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.319 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.11 120.07 23.13 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 179.21 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.6 m -132.7 106.35 7.72 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.787 1.235 . . . . 0.0 108.553 -165.44 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.428 ' CD2' HD11 ' A' ' 45' ' ' LEU . 4.8 m-30 -90.19 96.57 10.73 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.868 1.267 . . . . 0.0 112.85 -160.359 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -138.49 76.64 36.18 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 178.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -91.53 -121.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.055 1 C-N-CA 125.94 4.427 . . . . 0.0 108.169 163.631 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.2 mmp_? -134.1 138.33 45.19 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.448 1.899 . . . . 0.0 107.132 179.142 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.93 114.88 55.87 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 174.671 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.63 -27.04 6.49 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.949 2.432 . . . . 0.0 112.272 -179.322 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.8 m 145.41 112.93 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 129.481 3.112 . . . . 0.0 109.086 -175.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.544 0.737 0 C-N-CA 125.012 1.325 . . . . 0.0 114.198 171.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 119.356 -0.354 . . . . 0.0 111.544 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.423 ' C ' ' H ' ' A' ' 27' ' ' LEU . 5.8 t -169.55 -146.45 0.05 Allowed 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 149.373 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -78.97 38.7 0.35 Allowed 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 130.01 3.324 . . . . 0.0 108.808 -178.547 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.423 ' H ' ' C ' ' A' ' 25' ' ' SER . 10.4 mt -111.07 -21.29 12.04 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 127.969 2.508 . . . . 0.0 109.458 -170.896 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 27.6 mt -62.94 104.13 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 123.581 0.752 . . . . 0.0 111.839 -169.093 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.57 -150.87 0.17 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.889 0.876 . . . . 0.0 109.955 175.274 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -89.29 -37.41 14.94 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 129.237 3.015 . . . . 0.0 111.236 179.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -51.73 153.5 2.4 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.974 1.31 . . . . 0.0 113.493 -173.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -123.83 88.8 2.97 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 -176.951 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.19 131.93 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 125.19 1.396 . . . . 0.0 107.357 -179.538 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.434 ' CE ' ' OD2' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -97.48 152.94 18.48 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.348 1.059 . . . . 0.0 109.365 -168.906 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 65.4 t -131.27 132.59 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 174.758 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.7 m -110.54 112.4 24.29 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 173.009 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -81.56 86.21 6.4 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.642 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -88.27 84.49 6.86 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 122.241 1.02 . . . . 0.0 109.164 -173.781 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.3 105.23 17.21 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.361 0.664 . . . . 0.0 109.527 179.385 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -105.56 114.48 28.68 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.101 0.961 . . . . 0.0 108.828 -177.145 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.1 p -98.72 107.73 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 123.896 0.878 . . . . 0.0 109.865 176.623 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.06 155.59 19.37 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 167.565 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.25 -39.44 9.92 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.366 1.067 . . . . 0.0 111.741 178.47 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -40.18 -33.19 0.47 Allowed Glycine 0 CA--C 1.529 0.951 0 C-N-CA 126.144 1.83 . . . . 0.0 114.499 173.236 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.6 98.88 42.63 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 119.753 1.777 . . . . 0.0 108.523 168.312 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -83.86 45.53 1.81 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 124.057 3.171 . . . . 0.0 110.742 -167.533 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.508 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 44.7 m0 -115.69 145.92 42.32 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.571 1.148 . . . . 0.0 108.08 -172.999 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -76.4 82.58 3.14 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 175.782 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.99 116.26 31.62 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.736 1.214 . . . . 0.0 108.306 -172.718 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.3 m -129.52 147.48 65.39 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 118.233 0.469 . . . . 0.0 110.704 -173.276 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.89 160.53 47.53 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.264 1.976 . . . . 0.0 108.657 165.543 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -78.62 -59.44 3.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 -174.695 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -121.88 158.97 27.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 103.596 -2.742 . . . . 0.0 103.596 157.859 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -54.42 -38.73 66.59 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-O 120.943 0.401 . . . . 0.0 110.074 176.348 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.434 ' OD2' ' CE ' ' A' ' 34' ' ' LYS . 9.6 p-10 -153.3 163.12 40.47 Favored 'General case' 0 N--CA 1.424 -1.756 0 C-N-CA 126.423 1.889 . . . . 0.0 107.681 -166.739 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.6 pt -138.46 163.89 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 124.466 1.106 . . . . 0.0 108.205 170.256 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -106.93 133.05 52.16 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 104.535 -2.395 . . . . 0.0 104.535 165.415 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.2 m -119.57 129.06 75.8 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 172.704 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.5 mmm180 -76.21 74.88 3.04 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.203 -0.936 . . . . 0.0 108.702 175.281 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.0 mm 55.21 -95.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.911 1.284 . . . . 0.0 109.052 -173.613 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -97.51 30.52 9.08 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 124.559 1.076 . . . . 0.0 112.778 -169.455 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -83.63 95.79 8.47 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.949 1.7 . . . . 0.0 108.315 -177.195 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.11 89.68 0.13 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.831 1.253 . . . . 0.0 110.938 179.666 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.9 t -80.85 139.45 18.09 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.084 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 173.853 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.55 120.22 31.45 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 168.792 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.62 103.67 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.921 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 52.9 ttm -79.3 118.33 21.13 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.716 1.206 . . . . 0.0 111.81 -177.513 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -88.46 153.86 20.82 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.72 0.808 . . . . 0.0 110.462 175.841 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -125.82 133.76 51.89 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 124.317 1.047 . . . . 0.0 110.049 177.613 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -134.34 154.79 51.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 127.389 2.276 . . . . 0.0 107.104 158.213 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -157.54 136.1 11.31 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 104.937 -2.245 . . . . 0.0 104.937 175.884 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.508 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 59.6 t-20 -79.98 125.66 30.05 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.926 1.239 . . . . 0.0 111.807 -176.441 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.16 3.29 19.99 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.15 1.38 . . . . 0.0 112.27 -177.338 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.18 166.13 22.54 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.241 -0.912 . . . . 0.0 111.176 177.706 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.3 m -87.72 -8.77 55.63 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.988 0.915 . . . . 0.0 112.299 179.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.0 165.6 29.68 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 126.64 1.976 . . . . 0.0 106.362 178.409 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -57.41 154.96 32.59 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.949 1.766 . . . . 0.0 111.409 -177.19 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.34 164.59 20.06 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.42 0.629 . . . . 0.0 111.311 165.215 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.4 t -99.66 158.72 15.57 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 164.138 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.74 69.55 0.25 Allowed Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 107.973 -2.051 . . . . 0.0 107.973 -172.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -99.87 -58.82 1.83 Allowed 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.311 1.444 . . . . 0.0 108.546 178.863 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 64.33 -178.53 0.17 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.219 0.608 . . . . 0.0 111.62 178.146 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.0 m -136.61 134.93 37.89 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 168.588 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -114.83 170.82 8.05 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 126.197 1.799 . . . . 0.0 109.984 -173.06 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -131.4 107.97 9.29 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.927 1.291 . . . . 0.0 107.585 166.843 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.6 t -90.42 74.11 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.692 1.597 . . . . 0.0 108.569 179.655 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.8 t 177.15 148.27 0.32 Allowed Pre-proline 0 N--CA 1.466 0.366 0 C-N-CA 124.831 1.253 . . . . 0.0 110.776 177.88 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -65.33 -38.25 27.43 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 121.496 1.464 . . . . 0.0 110.482 159.539 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 11.1 ptp 171.55 -72.91 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 127.318 2.247 . . . . 0.0 107.547 175.225 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.58 -36.57 73.67 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.902 0.881 . . . . 0.0 112.908 -166.087 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.49 -105.94 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.302 0.241 . . . . 0.0 110.964 -173.863 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.86 -56.38 1.76 Allowed Glycine 0 CA--C 1.527 0.841 0 O-C-N 121.601 -0.687 . . . . 0.0 112.841 -176.287 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.5 -53.75 10.64 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.442 1.097 . . . . 0.0 111.476 -179.738 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -72.5 -8.44 55.12 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.332 1.453 . . . . 0.0 113.17 -178.128 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -64.02 117.14 6.63 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.492 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 121.977 0.894 . . . . 0.0 111.584 -165.855 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 CA--C 1.535 0.396 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.7 t -161.61 -71.54 0.06 Allowed 'General case' 0 C--O 1.23 0.078 0 O-C-N 121.605 -0.684 . . . . 0.0 111.477 -179.557 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.2 t -159.24 149.68 19.38 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.878 1.271 . . . . 0.0 107.783 -174.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.3 mt -155.28 145.59 21.9 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.513 0.725 . . . . 0.0 110.044 175.501 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -70.23 174.21 3.57 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 124.554 1.142 . . . . 0.0 110.966 168.488 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.08 97.78 1.08 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.934 3.089 . . . . 0.0 111.045 -171.284 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 125.16 -7.93 8.04 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-O 119.489 -0.617 . . . . 0.0 111.693 176.09 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -76.65 170.56 16.2 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 117.794 0.797 . . . . 0.0 111.114 -171.762 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.54 143.82 45.13 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.828 1.651 . . . . 0.0 110.125 -167.329 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 7.6 mtt -139.81 81.84 1.84 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.652 1.581 . . . . 0.0 109.3 170.289 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -103.98 118.79 37.51 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 120.845 -1.159 . . . . 0.0 108.014 169.729 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 77.2 mtp -141.23 140.68 21.38 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 118.816 0.734 . . . . 0.0 112.053 -174.384 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.72 140.61 32.65 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 123.06 2.506 . . . . 0.0 110.277 175.709 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 69.5 t -116.57 151.42 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 161.118 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.1 p -118.21 139.23 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 167.409 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -153.22 157.94 40.98 Favored 'General case' 0 N--CA 1.458 -0.062 0 CA-C-N 119.562 1.074 . . . . 0.0 113.189 -177.336 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -179.1 174.63 1.04 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 128.979 2.911 . . . . 0.0 106.168 -169.176 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 67.2 t -135.5 133.65 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 119.143 0.883 . . . . 0.0 110.862 178.583 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -76.66 138.16 66.7 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -71.01 -3.61 13.19 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.024 2.483 . . . . 0.0 111.799 -179.28 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.407 ' OE1' ' NZ ' ' A' ' 128' ' ' LYS . 13.8 mm-40 -36.0 -41.61 0.25 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.427 1.091 . . . . 0.0 111.313 159.484 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -58.23 -30.79 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 123.79 0.836 . . . . 0.0 113.063 -178.546 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.4 m -101.24 17.73 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.583 0.753 . . . . 0.0 111.816 175.897 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.407 ' NZ ' ' OE1' ' A' ' 125' ' ' GLU 0.354 6.3 pttt -79.83 -42.2 1.47 Allowed Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 170.927 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -86.95 -175.71 1.7 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.08 2.52 . . . . 0.0 110.981 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 94.7 t -80.71 -54.2 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 123.751 0.82 . . . . 0.0 109.684 173.099 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -46.11 -57.8 4.17 Favored 'General case' 0 N--CA 1.46 0.064 0 C-N-CA 124.848 1.259 . . . . 0.0 112.796 -169.067 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.7 p -82.95 -3.99 57.72 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 118.378 -0.82 . . . . 0.0 112.783 -175.608 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -47.49 -42.69 23.42 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.802 1.183 . . . . 0.0 112.814 -172.516 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.18 -25.03 76.19 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 122.858 0.266 . . . . 0.0 113.223 -179.205 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 25.6 mm -74.51 130.51 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 117.935 0.868 . . . . 0.0 110.734 -174.805 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.3 pttt -156.26 42.6 0.39 Allowed 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.213 164.666 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.1 p -134.05 84.28 2.1 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 106.536 -1.654 . . . . 0.0 106.536 170.965 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.8 tp -87.95 87.24 7.29 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -163.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.6 t -96.31 143.87 26.99 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.262 -166.292 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.4 tp -112.71 111.34 22.07 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 168.025 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.4 p -88.72 96.88 10.84 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 168.831 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.56 128.91 35.02 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 170.002 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.8 m -129.64 93.78 3.61 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.895 0.855 . . . . 0.0 109.482 -174.677 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -78.96 91.72 4.85 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.5 1.12 . . . . 0.0 111.121 -171.043 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.73 53.26 9.81 Favored Pre-proline 0 CA--C 1.549 0.923 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 179.542 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.66 -94.56 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.16 2.573 . . . . 0.0 111.27 175.78 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -157.43 140.43 15.21 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 118.089 -0.958 . . . . 0.0 109.164 178.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -109.91 150.61 41.62 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 165.187 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -74.64 -59.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.284 1.99 . . . . 0.0 109.224 169.919 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 37.1 p 179.32 94.41 0.02 OUTLIER 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.614 1.565 . . . . 0.0 107.922 -179.26 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 19.1 pttp . . . . . 0 CA--C 1.539 0.533 0 CA-C-N 118.281 0.491 . . . . 0.0 109.874 -178.968 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 79.0 p -109.38 62.13 0.6 Allowed 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 127.231 2.212 . . . . 0.0 110.735 -157.095 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -155.63 -60.33 0.11 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 102.887 -3.005 . . . . 0.0 102.887 172.384 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.41 ' H ' ' CD2' ' A' ' 27' ' ' LEU . 1.2 pt? -68.8 27.76 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 128.238 2.615 . . . . 0.0 114.316 177.22 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.5 mt -97.14 60.07 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.265 0 O-C-N 120.472 -1.393 . . . . 0.0 107.823 173.377 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.21 -179.43 2.86 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.607 -167.747 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -75.39 56.83 0.87 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.521 1.128 . . . . 0.0 110.324 177.306 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.94 145.26 41.82 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.833 1.653 . . . . 0.0 106.751 176.754 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -131.43 127.59 37.77 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.235 2.214 . . . . 0.0 105.292 -169.727 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.423 ' CG2' ' H ' ' A' ' 60' ' ' ILE . 1.3 tt -140.32 147.79 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 124.56 1.144 . . . . 0.0 108.587 -164.377 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.409 ' CE ' ' HB2' ' A' ' 55' ' ' ASP . 4.0 tmtp? -109.01 151.17 26.7 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.463 1.505 . . . . 0.0 109.782 -164.426 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.406 ' HB ' ' CG1' ' A' ' 56' ' ' ILE . 70.6 t -133.25 137.92 52.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 167.37 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.5 m -122.71 111.84 17.21 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -179.702 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -89.7 85.18 6.38 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 123.016 0.526 . . . . 0.0 110.246 -174.427 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -87.29 81.81 7.8 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 123.063 1.411 . . . . 0.0 110.909 -179.602 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.0 120.82 36.96 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 121.006 -1.059 . . . . 0.0 109.89 -176.597 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -125.8 160.69 29.18 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.259 1.024 . . . . 0.0 108.556 -179.892 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.93 151.25 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.077 0 C-N-CA 123.83 0.852 . . . . 0.0 109.249 -176.905 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.71 175.61 11.43 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.085 0.954 . . . . 0.0 110.437 178.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.51 124.11 6.57 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 170.251 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 127.38 -39.99 1.84 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -165.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.87 87.46 55.69 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 123.652 0.781 . . . . 0.0 110.017 174.169 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -81.72 38.75 0.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 124.356 3.371 . . . . 0.0 110.199 -176.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.45 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 41.3 m0 -110.11 146.77 34.88 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -171.347 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.41 78.34 3.93 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 -175.036 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -95.06 109.76 21.77 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -170.45 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.9 m -111.84 139.83 22.69 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.631 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.05 162.8 36.6 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 N-CA-C 108.444 -1.406 . . . . 0.0 108.444 162.659 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.7 t -78.33 -45.68 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -178.665 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -156.01 175.74 13.56 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 166.476 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -50.54 62.5 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.496 0.589 . . . . 0.0 111.619 171.474 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.409 ' HB2' ' CE ' ' A' ' 34' ' ' LYS . 23.1 p-10 -156.22 161.78 40.24 Favored 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 123.959 0.904 . . . . 0.0 111.482 -164.809 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.406 ' CG1' ' HB ' ' A' ' 35' ' ' VAL . 36.1 pt -129.4 162.06 37.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 169.324 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -116.31 142.6 46.62 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 161.475 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.7 m -131.63 159.15 43.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 126.361 1.865 . . . . 0.0 106.133 175.106 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.3 mtm-85 -100.66 85.42 2.91 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 158.414 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.423 ' H ' ' CG2' ' A' ' 33' ' ' ILE . 6.8 pt 35.87 43.7 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 127.379 2.271 . . . . 0.0 114.549 161.298 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 146.49 -29.81 1.59 Allowed Glycine 0 CA--C 1.525 0.687 0 O-C-N 121.004 -1.06 . . . . 0.0 111.618 -170.88 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -57.6 98.51 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.084 0.954 . . . . 0.0 110.137 173.755 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.45 107.51 1.69 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.925 2.09 . . . . 0.0 111.558 -176.565 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.95 147.32 12.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 166.56 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.39 128.03 39.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.475 1.91 . . . . 0.0 108.644 172.72 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.7 pp -129.83 111.48 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 167.468 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.84 126.39 36.9 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 123.126 0.571 . . . . 0.0 112.253 178.593 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -89.97 158.31 17.43 Favored 'General case' 0 C--O 1.23 0.062 0 C-N-CA 123.856 0.863 . . . . 0.0 108.709 177.272 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -133.83 129.84 37.07 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.846 1.258 . . . . 0.0 109.09 176.723 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.11 150.14 51.51 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 128.26 2.624 . . . . 0.0 107.131 163.74 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -150.96 129.02 11.79 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 117.365 -1.302 . . . . 0.0 107.7 174.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.45 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 52.8 t-20 -78.79 116.91 19.44 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 120.803 1.638 . . . . 0.0 111.642 -170.6 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.6 mt -117.04 34.43 5.11 Favored 'General case' 0 C--N 1.345 0.379 0 C-N-CA 124.575 1.15 . . . . 0.0 112.028 179.008 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.15 175.95 6.58 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 154.204 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.7 t -95.94 16.53 17.53 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.192 0.597 . . . . 0.0 110.483 172.616 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 p -145.41 154.32 52.97 Favored Pre-proline 0 N--CA 1.45 -0.46 0 C-N-CA 124.972 1.309 . . . . 0.0 109.025 -176.102 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.14 147.32 78.98 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 N-CA-C 108.132 -1.526 . . . . 0.0 108.132 171.168 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.4 p -119.39 178.93 4.36 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 170.24 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.4 t -124.41 109.45 13.31 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 173.015 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.32 101.59 0.64 Allowed Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 108.527 -1.829 . . . . 0.0 108.527 175.011 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -125.51 47.79 2.15 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 165.711 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.29 -178.84 1.43 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 122.181 0.991 . . . . 0.0 108.541 159.415 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.74 -173.56 4.62 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 178.055 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -144.21 146.47 32.71 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.247 0.93 . . . . 0.0 111.778 167.72 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.2 96.19 9.44 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 167.304 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.9 p -85.58 65.74 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 CA-C-N 118.045 0.384 . . . . 0.0 110.603 177.821 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.1 t -164.84 143.88 5.64 Favored Pre-proline 0 C--O 1.233 0.191 0 O-C-N 121.161 -0.962 . . . . 0.0 112.201 -179.497 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.19 -33.29 31.48 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 N-CA-C 108.776 -1.278 . . . . 0.0 108.776 162.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.405 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 7.8 ptm 175.58 -70.09 0.01 OUTLIER 'General case' 0 C--N 1.343 0.304 0 C-N-CA 126.406 1.883 . . . . 0.0 108.127 -171.161 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.405 ' H ' ' CG ' ' A' ' 89' ' ' MET . . . -99.72 -19.66 16.65 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.765 1.226 . . . . 0.0 112.743 -161.972 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.72 -133.24 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 178.892 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.3 -45.42 0.35 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.137 0.875 . . . . 0.0 114.442 -174.812 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -49.34 -61.02 2.32 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.608 1.204 . . . . 0.0 108.636 167.61 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -75.8 54.34 0.8 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.41 1.884 . . . . 0.0 110.147 171.017 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -110.7 156.89 20.38 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 162.274 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.6 m120 . . . . . 0 N--CA 1.441 -0.899 0 C-N-CA 127.006 2.122 . . . . 0.0 109.676 -175.376 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 CA--C 1.538 0.482 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.8 t 52.14 -146.79 0.48 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.681 1.192 . . . . 0.0 112.231 170.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.55 122.66 45.33 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.058 1.743 . . . . 0.0 107.095 177.111 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.35 129.38 56.22 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.904 1.681 . . . . 0.0 108.615 -170.203 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -77.49 152.42 81.04 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 123.462 0.705 . . . . 0.0 111.673 -177.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.75 110.71 2.83 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.457 2.771 . . . . 0.0 112.111 -167.645 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 126.0 -31.68 4.02 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 108.27 -1.932 . . . . 0.0 108.27 -176.658 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -86.32 171.29 11.32 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 121.363 0.601 . . . . 0.0 112.206 -161.173 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.08 145.5 41.52 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.237 1.815 . . . . 0.0 110.649 -163.081 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.62 86.92 2.14 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.163 1.785 . . . . 0.0 107.678 166.015 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -125.28 129.42 49.97 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 121.633 -0.667 . . . . 0.0 110.731 169.774 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 81.5 mtp -153.94 146.4 17.42 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 122.938 0.495 . . . . 0.0 111.054 -170.364 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -66.93 137.29 44.36 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.608 2.872 . . . . 0.0 112.105 172.561 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 34.5 t -116.59 155.96 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 161.674 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.0 m -121.27 151.76 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 176.09 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -151.42 139.29 19.91 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 119.18 -0.438 . . . . 0.0 110.477 -171.021 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -172.71 86.55 0.07 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.628 1.171 . . . . 0.0 110.462 -174.293 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.5 t -49.72 143.1 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -166.1 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 125' ' ' GLU . 1.5 m-20 -79.33 123.74 84.44 Favored Pre-proline 0 CA--C 1.537 0.478 0 O-C-N 121.308 -0.87 . . . . 0.0 110.821 -174.454 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -73.9 32.59 0.33 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.12 2.547 . . . . 0.0 113.483 177.339 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.41 ' H ' ' C ' ' A' ' 123' ' ' ASP . 11.5 mt-10 -87.28 -24.27 24.4 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.529 1.532 . . . . 0.0 108.67 160.585 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -46.46 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 C-N-CA 123.098 0.559 . . . . 0.0 111.576 -172.209 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.8 m -79.31 61.5 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 O-C-N 121.691 -0.63 . . . . 0.0 110.401 177.063 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -137.39 -65.01 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.597 0 CA-C-O 117.845 -1.074 . . . . 0.0 112.344 173.899 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.5 159.57 28.85 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 122.119 1.879 . . . . 0.0 113.917 -173.128 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 86.7 t -54.71 -35.94 34.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 126.024 1.73 . . . . 0.0 110.981 177.271 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -36.82 -55.95 0.87 Allowed 'General case' 0 C--N 1.34 0.157 0 C-N-CA 126.089 1.756 . . . . 0.0 111.817 175.27 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.0 p -105.9 -50.26 3.22 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 124.192 0.997 . . . . 0.0 109.826 -163.667 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 22.02 57.44 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 128.425 2.69 . . . . 0.0 115.508 173.501 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 135.26 -30.48 2.8 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 -177.298 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 13.0 mm -53.5 138.62 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-N 117.828 0.814 . . . . 0.0 109.274 173.691 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.8 pttt -158.87 54.96 0.42 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.571 0.701 . . . . 0.0 111.056 165.181 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.93 90.24 2.37 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -178.223 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.3 mp -76.44 85.57 3.17 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.089 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.2 m -77.3 107.25 9.57 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 176.527 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.2 tt -76.79 137.23 39.13 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 160.583 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 27.9 t -135.61 142.7 45.29 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 160.791 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -159.36 169.76 23.29 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 155.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 38.4 m -113.7 103.55 11.33 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 127.437 2.295 . . . . 0.0 108.333 173.366 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -71.12 100.2 2.0 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 172.367 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.07 50.47 0.69 Allowed Pre-proline 0 CA--C 1.553 1.072 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 -176.325 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -75.9 -82.27 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.504 2.803 . . . . 0.0 113.991 -175.886 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 74.0 mtt85 -149.74 106.77 3.57 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.41 1.005 . . . . 0.0 112.019 -164.655 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -156.49 135.63 7.95 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 126.043 1.737 . . . . 0.0 106.932 169.792 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.13 -53.59 0.3 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.139 1.893 . . . . 0.0 112.609 173.473 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.3 p 177.18 109.41 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.67 0.788 . . . . 0.0 110.493 -166.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 55.9 pttt . . . . . 0 CA--C 1.537 0.467 0 O-C-N 121.303 -0.873 . . . . 0.0 109.896 -177.859 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.486 0 CA-C-O 122.025 0.917 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.79 -11.43 59.99 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.529 1.532 . . . . 0.0 114.757 -147.196 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.35 -31.96 64.25 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 173.879 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.1 mp -108.09 14.46 25.11 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.023 1.329 . . . . 0.0 112.074 -176.27 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.4 mt -77.98 77.31 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 120.005 -1.684 . . . . 0.0 108.839 173.641 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.76 179.75 5.93 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.531 0.681 . . . . 0.0 109.893 179.238 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -94.48 59.43 2.51 Favored 'General case' 0 C--N 1.337 0.031 0 C-N-CA 123.827 0.851 . . . . 0.0 112.667 -167.021 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -115.18 160.9 19.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 151.664 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -133.76 88.38 2.47 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -179.898 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.0 tt -94.47 137.91 21.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 C-N-CA 124.477 1.111 . . . . 0.0 111.637 -163.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.71 143.84 34.2 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.635 1.574 . . . . 0.0 109.781 -170.421 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.7 t -135.72 142.06 40.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.655 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 164.389 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.9 m -123.29 112.47 17.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 -177.721 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -78.52 89.76 4.48 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 172.864 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -78.23 85.25 4.4 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 118.492 -1.283 . . . . 0.0 108.395 178.576 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.5 115.78 17.54 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.832 174.758 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -122.94 175.54 6.52 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.595 1.158 . . . . 0.0 108.188 167.039 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.6 p -151.17 148.6 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 169.161 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -164.51 171.54 14.45 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.254 1.022 . . . . 0.0 108.869 -178.302 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.62 -165.36 0.22 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.354 1.462 . . . . 0.0 111.616 -175.4 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.73 52.98 4.26 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 112.123 -0.391 . . . . 0.0 112.123 -173.079 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.412 ' CD1' ' CD1' ' A' ' 144' ' ' PHE . 1.4 tt -111.7 83.77 4.77 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.122 0.969 . . . . 0.0 108.785 177.693 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -85.28 45.0 1.5 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.246 3.298 . . . . 0.0 109.736 -170.141 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.439 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 43.1 m0 -108.39 138.58 44.43 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -172.909 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.408 ' OE1' ' NZ ' ' A' ' 71' ' ' LYS . 73.2 tt0 -77.85 82.36 4.23 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 -178.503 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -90.26 122.01 32.79 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.715 1.206 . . . . 0.0 108.233 179.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 m -126.67 135.54 27.43 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.144 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -70.76 162.39 42.76 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 N-CA-C 108.146 -1.521 . . . . 0.0 108.146 161.433 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -60.18 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 175.117 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -144.06 154.13 42.91 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 164.773 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.03 -42.72 69.45 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 118.537 -0.744 . . . . 0.0 112.095 -175.964 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -145.35 159.69 42.67 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 119.382 0.992 . . . . 0.0 113.189 -166.623 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.8 pt -133.82 159.79 42.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 125.768 1.627 . . . . 0.0 107.847 178.193 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -128.29 85.41 2.34 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.316 1.446 . . . . 0.0 109.124 178.189 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.8 m -80.44 141.83 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 O-C-N 121.255 -0.903 . . . . 0.0 110.689 -171.281 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -78.22 72.16 4.74 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 173.078 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.5 pt 19.01 64.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 127.437 2.295 . . . . 0.0 113.489 176.368 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 139.0 -43.8 1.14 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -172.58 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -59.68 130.3 46.16 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.648 -173.467 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.6 m -106.69 87.28 2.49 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.003 -146.106 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.72 144.19 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 CA-C-O 121.094 0.473 . . . . 0.0 110.696 -170.538 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.93 115.54 24.4 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.239 1.016 . . . . 0.0 108.591 168.817 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.8 pp -115.57 115.04 48.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 164.044 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -87.49 155.23 20.09 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.939 -0.475 . . . . 0.0 110.966 178.387 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -127.0 153.78 45.46 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 172.73 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -134.69 141.79 46.64 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.877 1.671 . . . . 0.0 107.898 179.904 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.34 115.58 7.98 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.805 2.042 . . . . 0.0 107.681 174.387 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.408 ' NZ ' ' OE1' ' A' ' 48' ' ' GLU . 3.0 mtmp? -114.73 124.42 51.73 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.29 0.95 . . . . 0.0 110.652 -176.99 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.439 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 46.9 t-20 -80.92 107.2 13.53 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.79 0.723 . . . . 0.0 112.932 -167.583 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.3 mp -99.08 30.4 3.45 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.495 1.118 . . . . 0.0 111.974 176.649 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.85 176.81 9.39 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.021 -1.049 . . . . 0.0 110.401 168.084 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.1 t -114.07 18.1 17.37 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.221 0.608 . . . . 0.0 109.929 161.646 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 p -146.65 156.42 48.61 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 125.639 1.576 . . . . 0.0 107.736 174.405 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -63.23 145.1 93.05 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 N-CA-C 108.122 -1.53 . . . . 0.0 108.122 172.138 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.5 p -123.08 168.25 12.61 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.644 0.735 . . . . 0.0 111.299 178.716 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.8 m -93.63 144.88 24.98 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 168.354 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -168.74 56.9 0.21 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 176.525 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.91 57.78 0.86 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.018 1.727 . . . . 0.0 108.405 -174.374 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.62 166.46 23.52 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.94 0.876 . . . . 0.0 112.879 -168.036 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.48 97.55 8.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 176.512 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -77.23 140.24 40.05 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.544 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -85.76 88.61 7.57 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -172.634 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -76.97 77.91 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 C-N-CA 125.043 1.337 . . . . 0.0 110.435 -176.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.8 t 178.88 147.64 0.39 Allowed Pre-proline 0 N--CA 1.46 0.029 0 C-N-CA 124.932 1.293 . . . . 0.0 109.343 173.324 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -66.75 -35.19 28.86 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.146 1.23 . . . . 0.0 110.274 158.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.0 ptp 175.36 -70.78 0.01 OUTLIER 'General case' 0 C--N 1.341 0.206 0 C-N-CA 126.902 2.081 . . . . 0.0 107.571 179.244 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.0 -36.61 48.59 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.962 0.905 . . . . 0.0 113.011 -167.788 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.77 -109.62 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.608 0.242 . . . . 0.0 111.58 -167.732 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.79 -49.69 0.84 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.417 1.008 . . . . 0.0 113.528 -176.111 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.55 -57.52 4.66 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.594 1.197 . . . . 0.0 109.802 172.254 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -73.69 5.01 4.31 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.498 1.919 . . . . 0.0 113.895 -178.898 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -85.72 126.58 34.08 Favored 'General case' 0 C--N 1.344 0.343 0 O-C-N 121.232 -0.918 . . . . 0.0 108.649 174.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 . . . . . 0 N--CA 1.452 -0.327 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.179 -179.459 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 CA--C 1.538 0.496 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.1 t -88.5 -165.78 1.42 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.051 0.94 . . . . 0.0 110.05 174.687 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.5 t -76.69 144.15 39.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.198 0.999 . . . . 0.0 110.04 -175.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 81.0 mt -127.25 134.87 50.01 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.538 1.135 . . . . 0.0 108.15 -179.791 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -69.55 157.08 90.44 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 170.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.43 100.21 0.88 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.373 2.716 . . . . 0.0 110.438 -170.711 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.31 -23.44 3.31 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -175.208 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -78.95 135.78 37.05 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 118.254 1.027 . . . . 0.0 111.707 -160.727 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -92.61 104.56 16.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.4 1.48 . . . . 0.0 109.375 178.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -90.56 135.13 33.9 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 174.042 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -151.46 154.99 37.65 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.625 0.37 . . . . 0.0 110.639 156.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 78.6 mtp -151.77 146.05 18.36 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.161 0.984 . . . . 0.0 109.578 171.495 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -66.12 137.97 50.17 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.126 2.55 . . . . 0.0 110.443 161.79 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.8 t -107.96 130.47 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 159.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.3 m -98.49 140.82 17.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 171.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -154.43 149.37 26.72 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -162.322 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -164.5 170.29 16.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.415 1.886 . . . . 0.0 109.108 165.314 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 70.7 t -103.99 135.46 41.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 174.482 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -76.37 134.2 70.47 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 119.119 -0.467 . . . . 0.0 109.954 176.397 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -74.16 67.34 5.16 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.384 2.723 . . . . 0.0 110.292 171.42 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -133.52 -37.82 0.94 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 126.799 2.04 . . . . 0.0 111.027 176.565 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.4 tt -43.87 -41.66 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 125.012 1.325 . . . . 0.0 113.414 173.111 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.9 m -78.23 49.03 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 O-C-N 121.394 -0.816 . . . . 0.0 111.34 176.825 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.9 mttt -142.72 -64.51 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 117.521 -1.228 . . . . 0.0 111.617 -179.299 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.17 153.17 46.03 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 121.942 1.729 . . . . 0.0 112.736 -176.548 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.8 t -54.87 -35.54 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 125.838 1.655 . . . . 0.0 110.662 175.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -35.26 -59.16 0.53 Allowed 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 126.656 1.983 . . . . 0.0 112.309 175.79 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.5 p -106.94 -42.73 4.84 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.015 -166.068 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 14.07 63.15 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 128.389 2.675 . . . . 0.0 116.235 172.151 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 136.73 -36.73 1.95 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -177.272 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 29.8 mm -53.28 123.52 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 171.444 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.38 47.86 0.35 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.288 0.566 . . . . 0.0 112.102 177.965 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.5 p -143.65 89.04 2.03 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 105.809 -1.922 . . . . 0.0 105.809 174.025 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 tp -92.71 87.21 5.8 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.029 -159.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.5 t -97.86 155.85 16.87 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.457 0.703 . . . . 0.0 111.084 -166.773 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.76 133.25 55.98 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 160.704 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 44.5 m -90.94 105.77 18.06 Favored 'General case' 0 N--CA 1.46 0.043 0 O-C-N 123.902 0.751 . . . . 0.0 109.035 160.452 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -76.27 99.8 4.89 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 165.708 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 53.5 m -117.34 86.35 2.5 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.978 1.311 . . . . 0.0 107.524 175.18 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.412 ' CD1' ' CD1' ' A' ' 45' ' ' LEU . 48.2 m-85 -59.22 145.2 43.67 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.322 1.049 . . . . 0.0 112.828 174.392 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -166.85 52.69 0.25 Allowed Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.966 1.707 . . . . 0.0 112.342 -175.435 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.3 -90.04 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.679 2.252 . . . . 0.0 115.092 -168.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -155.16 179.55 9.04 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 129.697 3.199 . . . . 0.0 104.863 -175.119 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -147.13 94.56 4.54 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 118.488 0.585 . . . . 0.0 111.044 -171.462 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -91.94 -124.37 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.984 3.122 . . . . 0.0 108.954 176.664 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 85.5 p -123.2 123.76 41.5 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 120.356 1.435 . . . . 0.0 111.763 -172.706 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.595 0 C-N-CA 126.496 1.918 . . . . 0.0 109.237 174.333 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.631 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.75 11.9 0.95 Allowed 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 126.802 2.041 . . . . 0.0 115.322 -164.9 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -77.25 -39.12 49.44 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 159.452 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.4 mp -92.22 -37.91 12.41 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 117.209 -1.377 . . . . 0.0 113.016 179.839 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.2 mt -32.53 133.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -162.13 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -105.91 -104.15 0.33 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.159 -173.618 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -173.59 -49.2 0.01 OUTLIER 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.058 1.343 . . . . 0.0 108.855 -171.348 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -38.78 134.6 0.95 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.002 1.721 . . . . 0.0 110.678 -178.812 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -100.97 86.65 3.1 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -165.883 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.98 115.01 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.436 1.494 . . . . 0.0 107.953 -171.424 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.99 160.01 29.48 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -173.641 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.0 t -148.74 145.19 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 179.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.1 m -138.55 100.28 4.05 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -170.053 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -78.11 145.0 36.0 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.018 0.527 . . . . 0.0 109.919 -176.177 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -127.63 82.75 2.11 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.913 0.863 . . . . 0.0 110.007 178.22 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.49 102.16 14.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 172.118 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -116.89 128.37 55.18 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 122.292 1.044 . . . . 0.0 112.126 -174.666 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.0 p -99.83 96.29 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.564 -174.252 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.12 171.1 10.5 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 122.048 0.928 . . . . 0.0 111.406 174.843 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.41 132.07 52.0 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 169.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 128.33 -39.28 1.92 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -170.579 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.484 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -131.56 95.57 23.21 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 117.56 0.68 . . . . 0.0 110.277 -176.363 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -83.94 50.94 3.27 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.956 2.437 . . . . 0.0 109.651 -176.136 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.484 ' CD2' ' CD2' ' A' ' 45' ' ' LEU . 44.4 m0 -107.91 135.56 49.1 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -173.649 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -79.36 84.5 5.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 103.484 -2.784 . . . . 0.0 103.484 179.246 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -102.04 86.15 2.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -171.598 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.3 m -88.04 129.14 51.2 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -167.28 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.09 122.49 9.58 Favored 'Trans proline' 0 N--CA 1.446 -1.277 0 N-CA-C 106.261 -2.246 . . . . 0.0 106.261 162.466 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.1 m -72.73 -32.08 39.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.181 0.515 . . . . 0.0 110.691 -168.387 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.02 161.98 34.16 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 150.265 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -62.65 -46.72 86.89 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 172.532 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -147.38 153.54 39.77 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 124.415 1.086 . . . . 0.0 111.659 -159.647 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.4 pt -133.13 179.23 4.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 126.326 1.851 . . . . 0.0 108.251 179.892 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -125.47 160.18 30.11 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.345 0.593 . . . . 0.0 110.21 149.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.6 t -116.72 145.97 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 127.99 2.516 . . . . 0.0 105.679 171.014 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 49.5 mmm-85 -91.37 100.81 13.53 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 168.021 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mt -33.2 115.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -148.243 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.58 -25.2 26.49 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.071 1.319 . . . . 0.0 110.936 -179.386 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -64.9 133.45 51.86 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.806 1.303 . . . . 0.0 112.422 -172.33 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.15 101.53 7.97 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 130.05 3.34 . . . . 0.0 110.818 -175.38 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.9 p -113.78 153.75 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.292 1.437 . . . . 0.0 109.491 -178.597 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -112.51 125.15 53.93 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 125.404 1.482 . . . . 0.0 109.343 -177.38 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.0 pp -128.48 122.86 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 167.861 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 66.4 mtt -76.09 168.44 20.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.614 174.164 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -136.17 143.21 44.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 161.864 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.7 ttt85 -121.01 118.7 30.5 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 179.546 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.3 105.15 9.24 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 125.822 1.649 . . . . 0.0 110.035 -177.216 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.29 121.09 44.36 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.064 -0.398 . . . . 0.0 110.749 -168.603 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.435 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 47.8 t-20 -78.38 111.9 14.85 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.803 -0.561 . . . . 0.0 111.912 -167.783 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.2 tp -98.41 11.24 38.77 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.812 0.845 . . . . 0.0 112.381 179.564 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.46 166.67 22.33 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.272 -0.893 . . . . 0.0 109.95 173.44 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 70.0 m -103.3 7.0 38.35 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.968 0.907 . . . . 0.0 111.835 171.73 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.34 159.61 38.79 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 126.134 1.773 . . . . 0.0 107.041 177.974 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.97 126.04 12.11 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.171 1.914 . . . . 0.0 111.255 -173.208 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.49 173.53 12.51 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.821 0.849 . . . . 0.0 110.784 -178.998 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 50.7 p -131.45 72.03 1.49 Allowed 'General case' 0 C--O 1.232 0.137 0 C-N-CA 122.551 0.341 . . . . 0.0 110.426 -170.893 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.42 139.37 37.39 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.946 -0.462 . . . . 0.0 111.946 -179.48 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -166.81 34.19 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.659 1.983 . . . . 0.0 109.44 169.222 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.58 159.08 34.47 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.33 0.652 . . . . 0.0 111.445 -165.445 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.9 t -87.77 131.51 34.48 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.704 0.764 . . . . 0.0 110.039 177.814 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -104.03 89.93 3.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.871 2.468 . . . . 0.0 105.572 175.509 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -77.0 91.92 3.67 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 120.882 -1.136 . . . . 0.0 107.935 -177.617 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.8 t -78.11 72.57 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.612 1.165 . . . . 0.0 109.973 -174.043 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.9 t -168.73 134.76 1.49 Allowed Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 119.901 1.228 . . . . 0.0 113.389 173.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -74.1 67.72 5.04 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 122.386 2.057 . . . . 0.0 107.243 156.257 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 22.2 ptm 44.19 25.47 0.11 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 170.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -171.41 -58.26 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 119.384 0.993 . . . . 0.0 110.594 -168.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.61 -101.2 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -177.282 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 64.05 -52.1 0.08 OUTLIER Glycine 0 CA--C 1.538 1.481 0 N-CA-C 115.413 0.925 . . . . 0.0 115.413 -175.534 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -45.73 -47.63 15.33 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.553 1.541 . . . . 0.0 110.808 172.217 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -73.85 -12.69 60.75 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 127.012 2.125 . . . . 0.0 113.471 178.975 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -67.55 140.0 56.95 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.119 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.4 p30 . . . . . 0 C--N 1.328 -0.361 0 C-N-CA 124.967 1.307 . . . . 0.0 110.765 -177.33 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.3 t 51.67 -146.64 0.47 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.441 1.096 . . . . 0.0 112.472 170.606 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.6 m -115.54 136.65 52.86 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.089 1.355 . . . . 0.0 108.542 -172.069 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 78.6 mt -128.44 147.95 50.69 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.39 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -73.29 156.42 89.15 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 172.354 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.23 85.87 0.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 124.88 3.72 . . . . 0.0 111.756 -173.064 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 152.74 -27.23 0.83 Allowed Glycine 0 CA--C 1.522 0.5 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.25 -177.777 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -77.86 143.45 37.79 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 118.085 0.942 . . . . 0.0 111.593 -157.925 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -105.21 96.9 6.84 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.811 1.244 . . . . 0.0 109.942 -175.603 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 15.4 tpt -83.92 89.21 7.18 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.114 1.365 . . . . 0.0 109.325 -177.951 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -99.21 134.21 42.4 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.256 0.622 . . . . 0.0 109.576 172.148 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 22.4 ptm -150.95 146.31 19.11 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.996 -0.526 . . . . 0.0 111.441 178.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.58 147.77 20.05 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.883 3.055 . . . . 0.0 111.049 171.852 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.5 t -126.53 114.89 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 165.199 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.5 p -79.41 143.47 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 168.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -155.61 149.11 24.98 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.163 0.585 . . . . 0.0 109.949 -165.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -171.18 118.98 0.48 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.36 1.464 . . . . 0.0 111.893 176.858 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.8 t -64.09 133.39 29.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 O-C-N 120.355 -1.466 . . . . 0.0 109.505 175.317 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -91.61 132.39 33.44 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 123.701 0.801 . . . . 0.0 109.8 -179.053 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -46.35 -31.52 9.55 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.402 3.401 . . . . 0.0 114.919 177.342 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -48.94 -24.2 1.4 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.783 1.633 . . . . 0.0 112.39 179.183 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.1 tt -49.01 -44.46 15.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 169.097 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.9 m -83.38 59.66 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 118.571 0.623 . . . . 0.0 109.895 174.354 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -111.0 -77.41 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 117.168 -1.396 . . . . 0.0 110.366 164.628 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.54 156.05 45.12 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 CA-C-N 121.885 1.709 . . . . 0.0 111.666 -177.384 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.6 m -62.16 -36.08 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 124.94 1.296 . . . . 0.0 112.045 -170.657 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -60.6 -64.46 0.94 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.147 0.979 . . . . 0.0 109.281 177.587 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 44.6 p -72.61 -15.43 61.73 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 118.509 -0.758 . . . . 0.0 111.568 -172.419 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.04 -41.52 5.53 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.768 0.713 . . . . 0.0 111.221 162.913 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.34 -29.17 74.38 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 112.237 -0.345 . . . . 0.0 112.237 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.3 mm -83.88 125.94 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 122.079 0.942 . . . . 0.0 110.39 -177.629 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 28.3 pttt -148.81 63.76 1.06 Allowed 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.506 153.751 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 11.7 m -150.15 95.33 2.26 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 158.416 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.2 tp -75.48 144.79 41.87 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -173.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.8 t -141.8 173.38 11.56 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.496 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.1 tt -150.63 111.28 4.25 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 177.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.45 92.94 8.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.515 1.126 . . . . 0.0 109.252 -179.545 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.94 108.4 19.17 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.877 1.271 . . . . 0.0 108.783 179.406 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.66 89.09 3.58 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 122.009 0.909 . . . . 0.0 109.747 -177.358 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -71.23 85.57 0.77 Allowed 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.281 177.058 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.1 47.59 2.8 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -178.703 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -80.89 -105.74 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.279 2.653 . . . . 0.0 111.967 178.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -140.95 121.68 14.34 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.648 1.179 . . . . 0.0 108.528 -171.242 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.9 111.22 38.82 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 125.654 1.581 . . . . 0.0 107.118 -177.128 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -83.3 -4.85 11.07 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.293 2.662 . . . . 0.0 113.043 -172.742 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.9 t 131.51 103.71 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 129.972 3.309 . . . . 0.0 109.754 174.481 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.542 0.669 0 C-N-CA 125.256 1.423 . . . . 0.0 111.723 168.356 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.24 0 N-CA-C 104.354 -2.462 . . . . 0.0 104.354 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.6 t -147.88 49.54 1.06 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 122.493 1.14 . . . . 0.0 108.227 174.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -158.8 -57.42 0.07 Allowed 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 127.306 2.243 . . . . 0.0 106.309 -174.367 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.9 mt -65.53 -16.48 63.72 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.907 2.083 . . . . 0.0 112.878 -177.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.4 mt -75.67 78.51 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 O-C-N 121.21 -0.931 . . . . 0.0 110.267 -171.566 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.69 -127.7 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.555 1.142 . . . . 0.0 108.524 169.679 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -104.36 -51.33 3.13 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.57 1.548 . . . . 0.0 111.939 -164.506 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -43.1 102.07 0.03 OUTLIER 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.194 1.398 . . . . 0.0 113.351 -169.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.69 81.52 4.99 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 177.261 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -97.11 122.58 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -160.616 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.7 150.48 34.48 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.943 1.297 . . . . 0.0 108.199 -175.216 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.52 146.9 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 174.497 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.9 m -125.83 112.19 15.73 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -172.69 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -77.88 136.18 38.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.754 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -126.71 84.45 2.27 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 122.502 1.144 . . . . 0.0 108.965 177.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.91 95.75 10.28 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.374 1.07 . . . . 0.0 110.972 -176.753 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -98.63 109.5 22.24 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.375 0.67 . . . . 0.0 109.79 -177.936 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.0 p -79.24 148.86 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 164.388 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -151.04 158.71 44.44 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 171.216 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.05 -40.15 10.25 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.84 0.856 . . . . 0.0 112.109 -177.214 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -41.58 -31.98 0.76 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.812 1.672 . . . . 0.0 114.151 174.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.405 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -130.17 110.13 16.68 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 118.688 1.244 . . . . 0.0 108.471 170.488 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -75.27 0.95 8.4 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.294 1.996 . . . . 0.0 115.576 -164.035 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.51 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 42.2 m0 -79.57 153.45 29.46 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.38 1.472 . . . . 0.0 113.613 -159.844 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -77.47 77.46 4.0 Favored 'General case' 0 C--N 1.344 0.344 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.615 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -84.6 110.72 18.93 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.684 1.193 . . . . 0.0 109.098 -171.484 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.9 t -122.78 118.81 28.25 Favored Pre-proline 0 N--CA 1.444 -0.758 0 C-N-CA 124.4 1.08 . . . . 0.0 108.645 -163.638 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -81.87 174.56 10.13 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 124.543 3.495 . . . . 0.0 108.554 168.367 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -98.6 -53.12 8.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 123.949 0.9 . . . . 0.0 110.845 -173.622 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -134.16 175.15 9.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 166.638 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.6 tpt85 -68.45 -33.15 73.68 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.392 168.636 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -144.67 173.44 11.82 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.842 1.257 . . . . 0.0 112.694 -162.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.1 pt -141.65 178.2 2.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 127.206 2.203 . . . . 0.0 106.788 165.567 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -132.27 162.77 30.16 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 146.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.23 136.92 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 126.953 2.101 . . . . 0.0 105.836 -175.199 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.94 88.66 3.5 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 163.205 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.2 pt 8.81 69.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 127.74 2.416 . . . . 0.0 114.63 178.469 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.55 -37.55 1.78 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 123.41 0.529 . . . . 0.0 112.305 -176.594 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -39.24 104.43 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.383 1.473 . . . . 0.0 110.849 177.101 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m -87.46 88.45 7.68 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.353 -156.25 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 p -92.73 161.67 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 O-C-N 121.933 -0.479 . . . . 0.0 111.721 -168.434 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -102.98 126.74 50.28 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.959 1.303 . . . . 0.0 110.35 169.561 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.5 pp -131.33 114.03 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 107.319 -1.364 . . . . 0.0 107.319 167.443 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.0 ttp -77.86 161.52 27.55 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.378 0.671 . . . . 0.0 110.862 -176.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -134.57 150.96 50.78 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.436 1.094 . . . . 0.0 108.846 169.325 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 54.1 ttp85 -143.46 147.08 34.0 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.997 0.919 . . . . 0.0 110.111 -178.457 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.39 109.68 2.66 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.632 1.573 . . . . 0.0 111.765 -177.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -86.09 139.28 31.27 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.989 171.721 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.51 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 28.1 t30 -78.21 88.99 4.27 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.073 0.851 . . . . 0.0 112.127 168.958 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.9 mp -76.76 69.08 3.08 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 171.193 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -153.66 137.26 15.99 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 168.513 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.1 t -80.14 36.1 0.34 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.369 0.531 . . . . 0.0 110.754 178.083 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.8 p -149.91 155.47 37.98 Favored Pre-proline 0 C--O 1.237 0.395 0 C-N-CA 126.63 1.972 . . . . 0.0 106.995 174.307 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -63.23 148.14 93.3 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 N-CA-C 108.208 -1.497 . . . . 0.0 108.208 168.522 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.01 175.06 6.53 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.792 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.0 m -105.65 145.25 31.28 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.121 1.768 . . . . 0.0 106.875 175.39 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -133.65 126.14 4.2 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 107.096 -2.401 . . . . 0.0 107.096 172.494 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.18 54.77 0.12 Allowed 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 166.78 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.44 144.83 15.9 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.884 176.162 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.3 t -85.01 166.08 17.02 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 168.185 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -146.41 95.96 2.69 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -168.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.33 86.92 5.02 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 175.509 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.0 t -78.12 60.23 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.817 1.247 . . . . 0.0 108.776 -175.034 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.1 t -171.44 148.34 2.3 Favored Pre-proline 0 CA--C 1.522 -0.129 0 O-C-N 121.481 -0.762 . . . . 0.0 111.636 178.077 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -61.57 -41.26 40.99 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 121.758 1.639 . . . . 0.0 110.068 159.031 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.3 ptp 172.08 -77.72 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 127.124 2.17 . . . . 0.0 107.59 178.399 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.87 -29.87 63.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.634 1.174 . . . . 0.0 112.292 -170.287 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.9 -119.11 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -174.028 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.89 -50.56 2.25 Favored Glycine 0 CA--C 1.528 0.874 0 O-C-N 121.348 -0.845 . . . . 0.0 113.192 178.204 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -44.93 -54.54 6.38 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.159 0.984 . . . . 0.0 110.014 171.555 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -75.39 -4.26 38.41 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.508 1.923 . . . . 0.0 113.96 -179.053 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -69.37 133.55 47.95 Favored 'General case' 0 C--N 1.341 0.227 0 O-C-N 121.093 -1.004 . . . . 0.0 108.486 178.449 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 . . . . . 0 N--CA 1.453 -0.289 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.684 177.931 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 . . . . . 0 CA--C 1.535 0.403 0 CA-C-O 121.149 0.5 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.7 t -111.52 -57.68 2.22 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 128.711 2.804 . . . . 0.0 111.378 -167.6 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.8 t -163.65 140.34 6.97 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 122.849 0.46 . . . . 0.0 110.385 -170.845 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 39.7 mt -139.32 143.73 37.96 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.207 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -80.44 172.95 8.53 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.76 1.224 . . . . 0.0 109.349 -179.48 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -68.0 79.89 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.535 2.823 . . . . 0.0 114.465 -162.041 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 147.87 -29.89 1.39 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.307 0.956 . . . . 0.0 112.181 172.107 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -82.21 158.56 23.51 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 118.226 -1.39 . . . . 0.0 112.318 -139.61 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -84.61 123.26 30.13 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 124.64 1.176 . . . . 0.0 110.268 179.59 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -90.22 128.61 36.42 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 154.89 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -134.0 146.42 50.4 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 159.698 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 56.7 mtt -146.61 146.63 27.59 Favored Pre-proline 0 N--CA 1.453 -0.323 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 165.087 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -71.55 142.58 40.61 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 122.101 1.868 . . . . 0.0 109.412 160.232 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.4 t -115.77 143.83 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 164.026 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.0 p -102.28 145.49 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 174.608 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -145.9 138.09 25.36 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.335 0.516 . . . . 0.0 111.425 -176.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -159.07 162.25 36.56 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.569 1.548 . . . . 0.0 107.43 160.559 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 94.8 t -104.72 131.27 54.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 174.789 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.18 135.23 47.85 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 175.887 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -75.49 57.85 5.0 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 124.578 3.519 . . . . 0.0 112.673 -176.414 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.24 -36.47 7.63 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 125.57 1.548 . . . . 0.0 109.864 168.3 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.8 tt -47.75 -46.57 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -169.724 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.3 m -81.19 53.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.448 -0.783 . . . . 0.0 110.785 -178.444 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -138.28 -64.51 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 117.661 -1.161 . . . . 0.0 112.085 -179.371 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.67 156.33 35.64 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 CA-C-N 121.961 1.736 . . . . 0.0 113.406 -176.053 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.2 t -54.11 -39.46 42.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 126.201 1.8 . . . . 0.0 110.742 177.934 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -45.92 -55.72 6.38 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.697 1.599 . . . . 0.0 111.8 -178.523 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.3 p -92.37 -42.89 9.53 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 118.633 -0.699 . . . . 0.0 111.442 -176.313 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 7.93 65.13 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 128.403 2.681 . . . . 0.0 116.129 179.536 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 142.37 -41.34 1.2 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -173.709 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.7 mm -57.27 120.13 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 CA-C-N 117.689 0.744 . . . . 0.0 110.178 177.23 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -157.38 66.45 0.5 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.672 0.749 . . . . 0.0 110.173 162.578 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 10.6 m -147.51 102.72 3.48 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 152.206 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.68 151.76 34.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -175.243 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.7 t -154.08 175.13 13.79 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.408 0.623 . . . . 0.0 109.647 -177.269 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.9 tp -153.7 97.13 2.07 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 103.216 -2.883 . . . . 0.0 103.216 -169.278 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.5 t -81.78 88.09 6.32 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 171.733 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.79 124.4 27.64 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 176.809 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 23.8 m -133.38 95.52 3.53 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.412 1.101 . . . . 0.0 109.229 -164.468 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -74.22 74.42 1.8 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.041 1.736 . . . . 0.0 111.94 -171.007 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -128.35 68.48 77.23 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.349 1.06 . . . . 0.0 113.758 179.566 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -87.69 -103.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.775 2.983 . . . . 0.0 110.666 167.502 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -156.26 99.66 1.94 Allowed 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.8 1.24 . . . . 0.0 108.907 -172.117 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -104.56 134.0 19.89 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 126.432 1.893 . . . . 0.0 106.403 167.614 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.0 -47.3 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.445 2.097 . . . . 0.0 110.638 178.304 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.2 t 166.65 112.4 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 129.202 3.001 . . . . 0.0 104.822 178.486 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.7 pttt . . . . . 0 CA--C 1.535 0.4 0 CA-C-N 119.584 1.083 . . . . 0.0 110.409 -168.921 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.3 m . . . . . 0 CA--C 1.534 0.341 0 CA-C-O 121.663 0.744 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 47.5 29.27 1.34 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.661 1.584 . . . . 0.0 111.966 -161.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.12 165.38 27.31 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 148.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -134.88 127.68 31.17 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 103.312 -2.847 . . . . 0.0 103.312 165.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.1 m -152.41 38.82 0.56 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.719 0.69 . . . . 0.0 111.331 -176.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -159.07 -49.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 127.594 2.358 . . . . 0.0 106.62 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -61.4 -28.16 69.05 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.295 1.838 . . . . 0.0 111.482 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.4 mt -69.87 83.26 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 123.625 0.77 . . . . 0.0 109.518 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.25 152.18 23.0 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 161.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -78.68 55.09 1.61 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.28 0.945 . . . . 0.0 111.328 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.12 138.44 39.95 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 105.078 -2.194 . . . . 0.0 105.078 166.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -96.81 120.04 36.4 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 123.679 0.792 . . . . 0.0 109.043 -173.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -95.08 141.53 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 163.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.44 ' CE ' ' HB2' ' A' ' 55' ' ' ASP . 2.3 tmtp? -101.73 153.86 19.41 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 169.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 t -137.14 149.44 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 167.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.8 m -137.24 98.98 3.86 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 122.521 1.153 . . . . 0.0 108.132 -171.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -79.24 88.28 4.92 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 127.356 2.262 . . . . 0.0 110.306 -176.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -81.86 85.46 6.65 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 122.347 1.07 . . . . 0.0 109.584 175.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.59 101.01 8.91 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.918 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -99.84 148.99 23.85 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 176.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.0 p -139.83 144.36 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 124.709 1.203 . . . . 0.0 108.098 172.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.56 171.96 13.68 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.597 1.159 . . . . 0.0 108.334 174.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -32.72 -55.7 0.36 Allowed 'General case' 0 C--N 1.34 0.168 0 C-N-CA 126.384 1.873 . . . . 0.0 112.822 -176.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -36.69 -35.71 0.14 Allowed Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.906 2.193 . . . . 0.0 114.663 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.44 94.75 48.92 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 118.42 1.11 . . . . 0.0 109.269 170.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -82.32 42.33 1.29 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.417 2.745 . . . . 0.0 110.866 -173.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -113.84 141.66 47.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -172.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -79.42 80.07 5.82 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 -176.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -86.72 89.77 8.05 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.508 1.523 . . . . 0.0 108.368 -176.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.4 m -89.43 129.96 45.43 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -175.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -68.76 153.66 72.66 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 N-CA-C 108.156 -1.517 . . . . 0.0 108.156 163.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.41 -55.07 10.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -131.19 161.76 31.47 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 165.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -64.64 -28.45 69.62 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 118.482 0.583 . . . . 0.0 109.54 173.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.44 ' HB2' ' CE ' ' A' ' 34' ' ' LYS . 24.6 p-10 -145.97 168.87 19.81 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 125.301 1.441 . . . . 0.0 112.048 -165.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.6 pt -137.71 166.67 24.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 124.447 1.099 . . . . 0.0 108.337 169.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -110.09 144.01 39.31 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 160.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -135.53 137.34 49.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 166.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.434 ' HE ' ' CD ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -82.37 91.0 6.74 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 119.698 -1.876 . . . . 0.0 107.691 164.161 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.3 pt 21.76 63.39 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 127.398 2.279 . . . . 0.0 113.47 171.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.97 -36.82 1.88 Allowed Glycine 0 CA--C 1.526 0.725 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.751 -177.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.434 ' CD ' ' HE ' ' A' ' 59' ' ' ARG . 3.4 tt0 -40.81 104.87 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.225 1.41 . . . . 0.0 111.752 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.62 89.67 7.91 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.028 0.931 . . . . 0.0 109.473 -158.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.2 p -88.36 172.1 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 123.291 0.636 . . . . 0.0 111.503 -166.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -117.56 122.18 42.97 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 125.3 1.44 . . . . 0.0 107.575 171.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.91 109.06 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 175.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -78.1 166.47 22.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.478 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -136.17 150.03 48.86 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 169.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.1 ttm-85 -126.02 127.04 45.26 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.793 1.637 . . . . 0.0 107.287 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.63 108.74 10.75 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 125.741 1.617 . . . . 0.0 109.254 169.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -104.73 123.99 48.6 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.326 -0.859 . . . . 0.0 109.226 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -76.26 126.84 31.73 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 120.883 -1.136 . . . . 0.0 110.92 -172.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.4 mt -111.65 14.53 21.23 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.985 0.914 . . . . 0.0 112.627 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.99 175.3 10.7 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 121.301 -0.874 . . . . 0.0 110.979 175.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.2 t -108.25 3.78 23.97 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.931 0.893 . . . . 0.0 111.702 175.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 p -145.06 163.31 33.45 Favored Pre-proline 0 N--CA 1.45 -0.436 0 C-N-CA 126.886 2.074 . . . . 0.0 105.499 174.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.06 157.36 44.61 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.198 1.266 . . . . 0.0 110.925 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.99 172.88 10.09 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 122.617 0.367 . . . . 0.0 110.177 166.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.0 t -107.25 166.06 10.92 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 160.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.25 73.4 0.25 Allowed Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 108.205 -1.958 . . . . 0.0 108.205 -176.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.38 62.62 0.63 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.7 154.19 28.77 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.821 -1.081 . . . . 0.0 112.659 -164.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.4 m -83.99 144.86 28.85 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.72 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -131.4 153.37 49.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.302 1.041 . . . . 0.0 109.569 171.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.07 109.53 11.97 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 171.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -95.57 63.62 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.46 0.062 0 C-N-CA 122.769 0.427 . . . . 0.0 111.551 -175.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.6 t -165.54 142.5 4.63 Favored Pre-proline 0 N--CA 1.454 -0.231 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.929 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -65.8 -39.34 20.46 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 N-CA-C 107.983 -1.583 . . . . 0.0 107.983 167.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 7.9 ptp 179.81 -74.92 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.42 2.288 . . . . 0.0 107.739 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.01 98.08 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 124.8 1.24 . . . . 0.0 113.273 -164.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.6 -101.67 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.743 -164.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.93 -65.44 0.33 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 123.329 0.49 . . . . 0.0 112.065 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -44.34 -51.26 8.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.449 1.5 . . . . 0.0 111.207 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -73.64 11.14 0.88 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.475 1.11 . . . . 0.0 113.893 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -82.7 128.77 34.68 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 119.157 0.889 . . . . 0.0 109.741 172.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -81.02 122.8 27.75 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.494 176.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 80.0 tttt 73.12 57.93 0.11 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.28 1.432 . . . . 0.0 110.546 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.4 p -58.4 -31.27 42.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.209 1.004 . . . . 0.0 113.006 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -152.74 175.2 13.1 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 171.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 12.2 t -163.95 165.51 22.55 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -67.96 165.37 17.92 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 167.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 75.1 m 61.43 67.51 0.78 Allowed 'General case' 0 C--O 1.23 0.044 0 C-N-CA 124.163 0.985 . . . . 0.0 110.425 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -54.58 134.46 46.65 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.9 p -64.29 -66.44 0.54 Allowed 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.213 1.005 . . . . 0.0 109.958 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -68.37 146.92 52.8 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.824 0.85 . . . . 0.0 109.29 175.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.0 t -160.04 -71.28 0.07 Allowed 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -175.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.2 t -156.3 140.56 16.58 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.019 1.328 . . . . 0.0 108.701 -169.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 88.5 mt -148.69 146.34 28.1 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 118.581 0.628 . . . . 0.0 110.237 176.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -77.98 165.86 47.64 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 126.112 1.765 . . . . 0.0 110.783 168.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.75 80.01 2.14 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 124.493 3.462 . . . . 0.0 112.278 -166.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 159.38 -34.23 0.47 Allowed Glycine 0 CA--C 1.522 0.515 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.783 172.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.49 153.43 31.37 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -152.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.6 mp0 -91.2 107.23 19.06 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.764 2.425 . . . . 0.0 109.762 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.4 132.64 34.19 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 160.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -145.46 139.05 26.58 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 161.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 14.8 mmt -143.47 142.36 20.98 Favored Pre-proline 0 N--CA 1.453 -0.28 0 C-N-CA 124.262 1.025 . . . . 0.0 108.51 -168.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.01 147.37 38.47 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.504 2.136 . . . . 0.0 109.853 169.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.1 t -124.56 157.37 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 163.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 p -136.17 143.56 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -157.09 131.81 8.74 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -167.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -156.36 126.63 6.57 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.207 0.912 . . . . 0.0 108.654 173.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.1 t -76.85 142.92 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 119.127 -0.463 . . . . 0.0 110.151 -174.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -81.07 129.33 67.65 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 119.14 -0.457 . . . . 0.0 110.748 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -57.13 -20.1 36.51 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.335 2.023 . . . . 0.0 113.985 176.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -53.21 -22.29 6.46 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 120.068 1.304 . . . . 0.0 111.67 172.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.6 tt -49.69 -43.76 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 O-C-N 121.697 -0.627 . . . . 0.0 111.892 169.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.9 m -84.4 57.25 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 119.791 1.178 . . . . 0.0 110.753 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -127.07 -68.31 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 118.028 -0.987 . . . . 0.0 112.516 169.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -79.94 157.66 23.97 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 121.965 1.777 . . . . 0.0 114.09 -166.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 95.2 t -53.79 -34.18 24.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.725 1.61 . . . . 0.0 110.827 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -37.12 -53.92 1.0 Allowed 'General case' 0 C--N 1.338 0.103 0 C-N-CA 126.301 1.84 . . . . 0.0 112.194 172.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 19.2 p -107.01 -56.1 2.24 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -164.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 29.17 53.12 0.09 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 128.108 2.563 . . . . 0.0 115.271 171.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 136.12 -35.32 2.15 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -174.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.0 mm -52.92 115.75 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 123.187 0.595 . . . . 0.0 110.573 170.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 31.0 pttt -156.93 62.95 0.51 Allowed 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.786 170.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.4 m -142.97 96.69 2.97 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 160.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.26 83.06 4.53 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -172.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.12 123.29 26.19 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -168.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.0 tt -98.11 103.67 15.63 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.9 t -84.74 100.22 11.36 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 170.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.85 136.17 33.15 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 172.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.6 m -124.82 87.46 2.72 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.672 0.749 . . . . 0.0 109.437 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -72.59 88.88 1.27 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.838 175.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -154.43 52.4 0.75 Allowed Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 117.209 2.3 . . . . 0.0 117.209 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.2 -87.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.962 2.441 . . . . 0.0 112.565 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 57.7 mtm180 -149.98 126.51 10.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.008 0.822 . . . . 0.0 110.437 -175.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -108.04 135.79 19.84 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 125.038 1.335 . . . . 0.0 108.801 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -72.44 -67.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.443 2.095 . . . . 0.0 110.717 171.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.3 m -175.47 91.24 0.05 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.602 1.961 . . . . 0.0 108.484 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.492 0 CA-C-N 118.315 0.507 . . . . 0.0 110.517 173.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.8 p . . . . . 0 C--O 1.234 0.266 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -75.75 61.15 1.37 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.279 0.945 . . . . 0.0 109.287 170.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 156.11 168.98 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.277 1 C-N-CA 131.99 4.116 . . . . 0.0 107.676 172.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -144.06 15.46 1.71 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.299 0.64 . . . . 0.0 112.154 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.03 22.01 0.41 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 128.53 2.732 . . . . 0.0 114.798 -159.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -76.64 -36.34 57.44 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 152.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 mp -92.21 -103.82 0.11 Allowed 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 125.89 1.676 . . . . 0.0 109.305 175.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.2 mt 31.95 71.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 126.613 1.965 . . . . 0.0 113.818 -172.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -79.4 157.16 27.65 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.779 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -81.76 78.14 8.52 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 122.566 1.174 . . . . 0.0 109.91 -176.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -137.42 -172.13 3.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.037 -1.892 . . . . 0.0 107.077 168.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -138.65 138.41 37.78 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.127 1.371 . . . . 0.0 110.187 171.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.0 tp -124.24 113.31 36.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.521 1.528 . . . . 0.0 108.457 -176.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -83.74 149.45 26.45 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.9 t -146.73 89.14 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 118.924 0.784 . . . . 0.0 109.154 -174.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.5 m -75.56 106.3 7.03 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.616 1.166 . . . . 0.0 108.467 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -81.52 159.61 24.12 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.252 1.421 . . . . 0.0 109.902 174.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -142.46 87.56 2.02 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.92 0.867 . . . . 0.0 112.034 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.26 126.82 35.36 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.37 -0.831 . . . . 0.0 110.897 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -130.67 149.7 52.2 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.941 1.296 . . . . 0.0 109.066 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.9 p -139.28 146.77 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 C-N-CA 124.714 1.206 . . . . 0.0 108.807 175.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.55 174.61 12.33 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.104 0.961 . . . . 0.0 110.004 -177.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.4 115.21 1.35 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 168.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 139.79 -34.51 2.02 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 108.934 -1.667 . . . . 0.0 108.934 -167.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.428 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -140.45 94.46 8.44 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 123.521 0.729 . . . . 0.0 109.126 173.654 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -80.33 50.82 3.67 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 124.086 3.191 . . . . 0.0 109.409 -177.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.492 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 35.5 m0 -116.96 148.64 41.23 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.427 1.091 . . . . 0.0 109.831 -168.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -75.09 89.83 2.48 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 104.781 -2.303 . . . . 0.0 104.781 173.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -113.08 118.68 35.45 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.213 1.805 . . . . 0.0 107.465 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.6 m -137.97 144.79 45.32 Favored Pre-proline 0 CA--C 1.53 0.192 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -177.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.23 162.4 38.69 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.992 1.795 . . . . 0.0 108.648 166.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.51 -51.38 12.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 123.207 0.603 . . . . 0.0 110.204 176.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -127.74 159.03 36.01 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 168.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.7 tpt180 -62.29 -39.93 94.58 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 167.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.63 144.97 44.33 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 123.941 0.896 . . . . 0.0 109.448 -171.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.2 mt -105.88 152.45 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 C-N-CA 126.057 1.743 . . . . 0.0 106.532 170.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -126.76 87.41 2.65 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.396 1.078 . . . . 0.0 108.599 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -90.08 151.27 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 -59.44 -103.87 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.861 -1.149 . . . . 0.0 109.411 164.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.2 mm -148.76 43.6 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 126.389 1.876 . . . . 0.0 106.123 -172.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.62 -7.88 5.56 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 116.087 -0.506 . . . . 0.0 113.712 -174.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -51.04 105.58 0.11 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.05 1.34 . . . . 0.0 109.588 171.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.94 106.55 0.72 Allowed 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.473 1.509 . . . . 0.0 109.304 175.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -105.23 137.36 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 173.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.13 123.99 29.46 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 173.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.6 pp -123.63 111.74 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 164.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -76.21 158.14 31.94 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.947 172.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -129.92 147.09 51.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 173.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.26 141.64 30.91 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 167.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.03 78.57 0.97 Allowed 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 122.192 0.996 . . . . 0.0 109.657 165.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -112.29 141.87 45.48 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.075 -155.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.492 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 22.6 t-20 -78.72 125.78 29.83 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.226 0.921 . . . . 0.0 112.751 -173.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.5 mt -127.49 53.13 1.77 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.344 1.457 . . . . 0.0 109.251 167.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -113.61 167.25 10.76 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 126.466 1.907 . . . . 0.0 110.712 -177.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.7 m -80.22 -22.77 41.45 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.4 1.08 . . . . 0.0 110.85 173.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.0 p -147.6 164.55 22.14 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 125.768 1.627 . . . . 0.0 107.758 -167.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.31 122.63 10.64 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.351 1.367 . . . . 0.0 110.21 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.59 177.08 9.14 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.477 0.656 . . . . 0.0 109.734 173.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.1 t -110.48 156.71 20.47 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 161.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -149.45 81.17 0.19 Allowed Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 106.473 -2.651 . . . . 0.0 106.473 -174.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.91 60.46 1.37 Allowed 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 168.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.7 167.3 3.66 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.258 -177.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 39.2 m -98.86 152.64 19.52 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -148.4 151.98 36.2 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 164.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.99 122.66 48.29 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 170.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.0 p -104.47 55.21 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 C-N-CA 123.733 0.813 . . . . 0.0 111.851 -164.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.9 t -178.79 147.9 0.55 Allowed Pre-proline 0 C--N 1.333 -0.139 0 O-C-N 121.068 -1.02 . . . . 0.0 109.895 -166.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.8 -34.01 41.57 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 N-CA-C 108.9 -1.231 . . . . 0.0 108.9 166.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.0 ptp 177.62 -72.41 0.01 OUTLIER 'General case' 0 C--N 1.342 0.241 0 C-N-CA 126.764 2.026 . . . . 0.0 107.846 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.43 -31.49 67.28 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 124.39 1.076 . . . . 0.0 113.677 -162.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.44 -102.54 0.07 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.452 0.168 . . . . 0.0 111.415 -164.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.7 -59.0 0.2 Allowed Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.566 1.079 . . . . 0.0 113.611 -173.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -45.94 -52.33 11.81 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.129 0.965 . . . . 0.0 110.205 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -74.71 13.25 0.66 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.964 1.706 . . . . 0.0 114.027 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -83.15 128.16 34.24 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 169.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . 0.319 2.2 m-80 -81.19 61.65 4.81 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-O 122.396 1.093 . . . . 0.0 111.887 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -73.84 125.25 27.74 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 164.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.7 p -168.99 143.17 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 127.448 2.299 . . . . 0.0 105.155 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 29.5 62.69 0.15 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.476 1.91 . . . . 0.0 113.251 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -179.0 -37.52 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.479 1.112 . . . . 0.0 110.361 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -39.32 -32.85 0.12 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.564 2.346 . . . . 0.0 115.959 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 44.2 t -48.94 140.03 9.41 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.921 0.888 . . . . 0.0 112.331 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -62.66 79.44 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.57 1.148 . . . . 0.0 111.502 175.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.0 t -71.27 64.39 0.38 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.124 1.77 . . . . 0.0 110.516 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -150.05 -66.31 0.21 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.833 1.653 . . . . 0.0 107.352 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . 0.352 10.1 t 57.84 -81.7 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 126.713 2.005 . . . . 0.0 113.563 171.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -160.92 148.07 15.36 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 -176.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 73.4 mt -148.48 133.27 17.95 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 175.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -63.44 159.62 49.1 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 126.793 2.037 . . . . 0.0 111.403 174.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -64.2 92.24 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.275 3.317 . . . . 0.0 112.415 -169.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 125.17 -6.1 8.2 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 124.725 1.155 . . . . 0.0 112.618 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -76.44 130.0 37.36 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 118.822 1.311 . . . . 0.0 111.845 -166.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -94.62 101.32 13.18 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.257 1.423 . . . . 0.0 110.05 -168.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 17.6 ttt -103.93 124.19 48.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.443 1.497 . . . . 0.0 109.765 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.14 153.06 41.74 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 156.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 42.8 mtm -155.06 151.32 22.72 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 123.214 0.606 . . . . 0.0 110.83 168.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -53.65 138.7 67.5 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 124.653 3.568 . . . . 0.0 112.39 162.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.6 t -119.49 151.39 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 157.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.8 p -112.14 143.52 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 124.002 0.921 . . . . 0.0 108.542 175.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -156.06 151.82 27.29 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.084 0.402 . . . . 0.0 111.916 -171.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -157.98 170.2 22.86 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.296 1.838 . . . . 0.0 109.029 165.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 88.5 t -92.84 146.93 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 170.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -88.01 126.11 62.16 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-O 118.676 -0.678 . . . . 0.0 111.339 174.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -60.23 -16.01 37.97 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.339 2.026 . . . . 0.0 113.806 174.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -49.01 -25.78 2.18 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 119.877 1.217 . . . . 0.0 111.147 166.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 10.9 tt -53.5 -43.02 51.71 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 O-C-N 121.133 -0.979 . . . . 0.0 112.914 172.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.1 m -84.87 53.48 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 119.753 1.16 . . . . 0.0 110.025 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -134.7 -67.03 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 117.693 -1.146 . . . . 0.0 112.337 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.6 154.46 31.0 Favored 'Trans proline' 0 C--N 1.347 0.492 0 CA-C-N 122.024 1.759 . . . . 0.0 113.467 -170.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 96.3 t -55.11 -33.89 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 125.478 1.511 . . . . 0.0 110.928 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -36.53 -55.52 0.84 Allowed 'General case' 0 C--N 1.339 0.124 0 C-N-CA 126.246 1.818 . . . . 0.0 112.238 173.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 17.4 p -104.22 -56.06 2.26 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -164.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 26.51 52.02 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 128.789 2.836 . . . . 0.0 115.329 170.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 141.66 -36.49 1.7 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -173.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 12.8 mm -51.87 121.26 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.124 0.57 . . . . 0.0 110.089 172.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -157.21 57.2 0.51 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.018 0.527 . . . . 0.0 111.659 177.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.7 m -149.08 90.8 1.78 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 161.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 tp -84.52 87.77 7.27 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.789 -161.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.9 t -79.77 175.17 10.86 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 122.278 1.037 . . . . 0.0 110.697 -171.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.8 tt -143.83 105.49 4.31 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 103.873 -2.64 . . . . 0.0 103.873 164.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.4 p -86.95 100.16 12.39 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 174.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.66 130.9 44.63 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 126.209 1.804 . . . . 0.0 108.284 -176.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.7 m -125.52 90.34 3.2 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.564 1.145 . . . . 0.0 109.608 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -69.3 88.11 0.44 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.421 0.688 . . . . 0.0 110.125 171.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.07 44.46 0.34 Allowed Pre-proline 0 CA--C 1.553 1.082 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 176.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.97 -82.98 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.593 2.195 . . . . 0.0 113.482 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 42.0 mmt180 -149.63 123.4 9.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.362 0.983 . . . . 0.0 110.332 -171.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.91 116.79 61.94 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 125.29 1.436 . . . . 0.0 109.234 -174.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -84.25 -36.03 0.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.051 2.501 . . . . 0.0 113.421 -176.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.3 t 158.62 138.33 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 128.055 2.542 . . . . 0.0 107.848 -169.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.279 0 C-N-CA 127.132 2.173 . . . . 0.0 107.755 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 CA--C 1.54 0.595 0 CA-C-O 120.854 0.359 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 36.12 44.01 0.24 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.863 1.665 . . . . 0.0 111.162 -159.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.91 171.11 18.82 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 129.872 3.269 . . . . 0.0 102.787 163.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -140.49 116.69 10.57 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 103.471 -2.789 . . . . 0.0 103.471 169.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.4 m -152.46 35.09 0.51 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.16 0.981 . . . . 0.0 110.347 177.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -159.33 -56.41 0.06 Allowed 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 127.993 2.517 . . . . 0.0 106.482 -157.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.7 pp -91.74 -7.51 49.48 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.134 1.374 . . . . 0.0 112.585 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.4 mt -72.2 104.19 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.222 0 CA-C-N 119.386 0.994 . . . . 0.0 110.035 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -95.24 171.42 8.73 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 155.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -80.73 30.51 0.31 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -163.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -83.02 111.2 18.64 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 122.77 1.271 . . . . 0.0 110.758 177.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -74.59 91.52 2.33 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 127.08 2.152 . . . . 0.0 106.165 171.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.8 tp -100.24 123.46 53.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.205 1.002 . . . . 0.0 108.835 -177.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -84.42 148.79 26.4 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.183 0.993 . . . . 0.0 108.962 -175.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.2 t -134.25 146.82 30.63 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.3 m -146.75 105.32 3.81 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -169.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -76.17 163.57 26.94 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.729 0.812 . . . . 0.0 110.02 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -136.36 85.53 2.15 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 122.678 1.227 . . . . 0.0 110.222 166.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.99 99.3 6.01 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 177.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -92.84 146.88 23.31 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.7 t -128.91 136.75 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 168.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -124.3 162.2 24.27 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -43.18 -44.22 5.04 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.025 0.93 . . . . 0.0 111.043 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -48.06 -30.72 7.63 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 126.77 2.128 . . . . 0.0 115.323 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.444 HD13 ' CD2' ' A' ' 144' ' ' PHE . 1.3 tt -121.99 101.75 41.58 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 120.478 2.139 . . . . 0.0 110.495 -178.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -85.51 38.68 0.65 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 124.114 3.21 . . . . 0.0 112.192 -171.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.428 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 42.5 m0 -114.74 140.83 48.57 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -177.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -79.97 80.43 6.38 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -175.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -85.11 94.59 8.89 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.6 m -88.09 135.46 33.28 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.54 156.25 66.39 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 N-CA-C 108.686 -1.313 . . . . 0.0 108.686 165.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -79.76 -59.7 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -176.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -128.22 168.3 15.65 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 157.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -62.99 -43.15 99.57 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 170.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -139.65 165.42 27.3 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 126.37 1.868 . . . . 0.0 109.546 -164.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.6 pt -138.95 177.22 5.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 171.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -124.33 159.2 30.85 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 150.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -129.43 143.38 41.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 173.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.5 mmt85 -79.44 97.16 6.28 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 161.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.4 pt -4.86 79.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 127.442 2.297 . . . . 0.0 114.978 -172.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.53 -37.11 2.03 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.717 -0.49 . . . . 0.0 112.593 -175.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -41.95 107.83 0.08 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.187 1.395 . . . . 0.0 111.911 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.37 105.2 2.09 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.695 0.798 . . . . 0.0 109.844 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.25 177.65 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.732 0.777 . . . . 0.0 110.079 177.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -145.04 89.65 1.98 Allowed 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.016 0.926 . . . . 0.0 108.626 172.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.3 pp -110.01 117.37 54.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 32.6 mtm -92.48 111.82 23.54 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.469 1.908 . . . . 0.0 111.927 -177.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -84.59 154.89 22.32 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.137 0.575 . . . . 0.0 109.739 174.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.2 ttm-85 -134.54 138.96 45.06 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.679 1.591 . . . . 0.0 108.021 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.8 106.82 4.7 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.794 1.638 . . . . 0.0 110.201 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER -112.52 129.45 56.35 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.044 0.537 . . . . 0.0 112.22 -174.057 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.428 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 36.2 t-20 -77.9 115.1 17.38 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.486 0.585 . . . . 0.0 111.379 -167.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 69.6 mt -107.95 39.1 2.02 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.688 1.195 . . . . 0.0 111.35 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -111.36 173.27 6.42 Favored 'General case' 0 CA--C 1.526 0.029 0 C-N-CA 124.263 1.025 . . . . 0.0 110.037 169.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.3 p -89.05 -5.47 57.86 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 125.048 1.339 . . . . 0.0 111.829 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 p -140.76 162.94 46.1 Favored Pre-proline 0 N--CA 1.449 -0.476 0 C-N-CA 124.618 1.167 . . . . 0.0 109.37 -171.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.96 111.0 3.06 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.16 1.907 . . . . 0.0 109.249 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.26 177.68 8.65 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.036 0.835 . . . . 0.0 109.569 174.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.9 t -124.17 137.26 54.56 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 165.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.05 117.61 4.19 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.804 1.669 . . . . 0.0 109.586 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.75 47.39 2.54 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 124.634 1.173 . . . . 0.0 108.566 175.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.2 144.52 15.64 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.15 -174.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.7 t -87.39 175.26 8.07 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 119.583 -0.847 . . . . 0.0 108.738 166.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -155.13 89.42 1.21 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -161.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -78.79 90.53 4.66 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.2 t -79.35 59.18 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 123.323 0.649 . . . . 0.0 110.965 -175.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.3 t -174.79 148.97 1.22 Allowed Pre-proline 0 N--CA 1.465 0.312 0 CA-C-N 119.505 1.048 . . . . 0.0 112.595 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -57.92 -52.75 5.36 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 121.627 1.551 . . . . 0.0 109.205 158.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.42 -83.64 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.345 1.858 . . . . 0.0 107.42 177.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.03 -32.15 69.48 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -172.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.56 -109.6 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -168.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.08 -51.9 1.68 Allowed Glycine 0 CA--C 1.53 0.981 0 O-C-N 121.506 -0.746 . . . . 0.0 113.051 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -52.95 -58.62 6.36 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.651 1.226 . . . . 0.0 109.16 170.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -74.19 49.04 0.34 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.993 1.317 . . . . 0.0 111.611 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -126.48 130.85 51.44 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 173.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -138.97 106.45 5.56 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 174.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -88.79 -80.88 0.28 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 150.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.7 p -151.62 65.68 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.618 1.167 . . . . 0.0 108.146 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 62.74 173.39 0.14 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.47 1.108 . . . . 0.0 110.332 -167.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 46.7 t -79.24 55.53 1.88 Allowed 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.489 -0.757 . . . . 0.0 109.869 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -83.65 105.23 14.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 9.9 p -61.6 154.64 24.43 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 172.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -155.69 161.36 40.77 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 175.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.5 p -142.96 122.59 13.29 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -170.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.8 mp0 -77.61 45.9 0.51 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.883 1.273 . . . . 0.0 112.999 -169.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.1 t 39.25 -133.2 0.18 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.564 1.946 . . . . 0.0 113.06 168.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.2 t -125.34 153.65 43.0 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.621 1.968 . . . . 0.0 108.833 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 81.9 mt -136.96 123.35 20.73 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -58.8 154.71 35.32 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 171.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.71 94.58 0.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.996 3.131 . . . . 0.0 111.3 -170.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 137.8 -26.85 2.85 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 124.536 1.065 . . . . 0.0 110.873 -173.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -78.28 154.1 31.23 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 117.664 0.732 . . . . 0.0 111.264 -166.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -117.51 133.97 55.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.428 1.091 . . . . 0.0 110.651 -174.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.15 142.09 31.08 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 127.034 2.134 . . . . 0.0 106.815 169.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -146.98 133.31 19.54 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.202 1.401 . . . . 0.0 107.286 172.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 79.7 mtp -147.3 135.97 11.23 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 118.207 0.458 . . . . 0.0 110.937 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -73.34 147.27 41.47 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.735 2.29 . . . . 0.0 109.92 168.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.2 t -129.41 124.52 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 168.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.1 p -88.11 151.66 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 166.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -157.96 135.87 10.68 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -175.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -146.06 159.75 42.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.379 0.672 . . . . 0.0 110.249 153.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 39.4 t -100.78 119.24 48.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 169.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.37 139.62 78.67 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -74.05 29.46 0.33 Allowed 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.591 2.861 . . . . 0.0 114.297 -176.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -87.26 -24.58 24.32 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.426 1.09 . . . . 0.0 110.382 170.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 17.0 tt -56.09 -44.9 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 118.153 0.433 . . . . 0.0 112.053 -176.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.4 m -80.61 56.32 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 O-C-N 121.513 -0.742 . . . . 0.0 110.452 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 49.6 mttp -139.52 -67.03 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.608 0 CA-C-O 117.715 -1.136 . . . . 0.0 112.247 174.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.96 156.94 30.79 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.02 1.813 . . . . 0.0 113.539 -169.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 86.2 t -55.09 -35.09 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 125.495 1.518 . . . . 0.0 110.808 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -36.39 -56.75 0.77 Allowed 'General case' 0 C--N 1.338 0.1 0 C-N-CA 126.109 1.763 . . . . 0.0 111.908 174.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.2 p -102.62 -54.22 2.7 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.441 -164.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 22.11 53.6 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 128.932 2.893 . . . . 0.0 115.019 173.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 146.45 -41.45 0.99 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 -170.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.3 mm -58.09 119.62 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 169.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.02 39.29 0.31 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.86 0.362 . . . . 0.0 111.232 -178.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.4 94.49 1.71 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 177.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.58 147.02 32.27 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -169.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.5 t -136.5 172.44 13.01 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.0 tt -145.3 114.77 7.17 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 103.38 -2.822 . . . . 0.0 103.38 171.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.72 102.62 15.03 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 177.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -86.03 87.89 7.49 Favored 'General case' 0 CA--C 1.527 0.069 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.82 89.4 5.24 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 122.665 1.221 . . . . 0.0 110.596 177.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.444 ' CD2' HD13 ' A' ' 45' ' ' LEU . 4.0 m-30 -69.05 80.77 0.32 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.836 1.654 . . . . 0.0 110.46 175.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -125.86 84.21 61.35 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 125.446 1.499 . . . . 0.0 113.813 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -105.45 -118.82 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.931 1 C-N-CA 125.988 4.459 . . . . 0.0 109.643 168.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -143.59 149.14 36.93 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 123.674 0.789 . . . . 0.0 109.728 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -144.85 143.67 21.73 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 126.531 1.933 . . . . 0.0 106.445 -176.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -87.19 -51.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.592 2.195 . . . . 0.0 111.727 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.5 m 167.07 101.58 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 128.947 2.899 . . . . 0.0 107.364 -176.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt . . . . . 0 CA--C 1.544 0.723 0 C-N-CA 123.877 0.871 . . . . 0.0 109.505 -176.581 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.3 m . . . . . 0 CA--C 1.535 0.398 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 41.69 56.72 3.27 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.376 1.47 . . . . 0.0 111.183 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -140.66 162.25 35.83 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.669 1.588 . . . . 0.0 110.045 -173.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.455 ' CB ' ' H ' ' A' ' 63' ' ' THR . . . -147.1 67.61 1.15 Allowed 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.859 1.664 . . . . 0.0 107.701 -177.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.9 t -164.94 34.63 0.06 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.855 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -160.13 -51.14 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -167.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.6 mp -77.95 -27.82 49.38 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.616 -172.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.0 mt -70.73 129.07 34.71 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.062 0 C-N-CA 123.897 0.879 . . . . 0.0 112.881 -156.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.15 162.97 14.38 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.819 1.248 . . . . 0.0 108.467 172.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -80.8 74.36 7.76 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 122.177 0.989 . . . . 0.0 110.205 -176.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.25 -174.19 4.22 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.909 1.684 . . . . 0.0 107.608 174.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.3 mtmt -126.83 156.3 41.54 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.882 1.273 . . . . 0.0 108.093 162.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 tp -137.28 155.5 32.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 162.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.35 156.01 30.86 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.409 1.084 . . . . 0.0 108.671 -167.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.7 t -139.08 142.11 34.62 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.6 m -136.43 106.03 6.15 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -173.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -85.68 93.47 8.85 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.389 2.276 . . . . 0.0 110.427 -174.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -79.96 85.96 5.52 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 174.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.88 110.74 19.63 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.196 0.598 . . . . 0.0 111.039 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -111.85 153.78 26.13 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.653 1.181 . . . . 0.0 109.986 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.4 p -144.71 147.03 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.416 1.086 . . . . 0.0 108.977 173.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -159.34 170.67 21.31 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.914 0.885 . . . . 0.0 109.896 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -37.7 113.11 0.25 Allowed 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.841 1.656 . . . . 0.0 110.25 171.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 135.46 -39.21 1.7 Allowed Glycine 0 CA--C 1.523 0.557 0 N-CA-C 108.235 -1.946 . . . . 0.0 108.235 -165.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.405 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 1.7 mt -139.96 111.32 7.33 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 125.089 1.355 . . . . 0.0 107.375 169.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.93 8.04 4.7 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.793 2.328 . . . . 0.0 111.512 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.405 ' CD2' ' CD2' ' A' ' 45' ' ' LEU . 38.8 m0 -77.34 139.72 39.82 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.214 -0.929 . . . . 0.0 109.914 -165.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -78.63 84.7 4.72 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -83.91 93.05 7.94 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 127.172 2.189 . . . . 0.0 109.003 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.5 m -88.31 127.17 58.05 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -176.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -68.18 143.38 58.91 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 N-CA-C 108.226 -1.49 . . . . 0.0 108.226 164.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.2 m -77.74 -49.51 21.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.284 0.564 . . . . 0.0 109.982 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -130.31 162.43 29.03 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 164.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -62.69 -41.42 99.11 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 165.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -149.6 166.86 28.01 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 124.28 1.032 . . . . 0.0 110.87 -160.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.4 pt -137.78 154.71 29.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 124.807 1.243 . . . . 0.0 108.708 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -89.39 143.79 26.55 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 156.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.0 m -128.1 130.54 69.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 162.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -63.66 76.28 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.168 1.387 . . . . 0.0 108.802 172.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.5 mm 60.04 -74.46 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 126.162 1.785 . . . . 0.0 111.146 -172.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -131.14 62.8 0.64 Allowed Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 -176.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -102.38 105.84 16.5 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.131 1.372 . . . . 0.0 110.236 -175.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.455 ' H ' ' CB ' ' A' ' 24' ' ' ALA . 50.2 m -69.94 88.86 0.58 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.366 1.466 . . . . 0.0 110.131 -171.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.5 p -98.81 147.99 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 121.262 0.553 . . . . 0.0 110.775 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.88 126.82 35.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.699 1.6 . . . . 0.0 108.981 173.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.6 pp -130.12 112.18 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 164.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.74 176.42 9.35 Favored 'General case' 0 C--N 1.333 -0.125 0 O-C-N 121.741 -0.599 . . . . 0.0 110.709 168.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -137.48 156.88 47.64 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 169.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 59.9 mtp85 -120.11 131.6 55.11 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 169.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.34 109.25 10.95 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.485 1.114 . . . . 0.0 109.286 174.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -96.54 124.82 40.66 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 119.011 -0.519 . . . . 0.0 110.081 -172.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -78.77 88.27 4.63 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -169.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.9 mt -78.04 65.93 3.55 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.166 0.986 . . . . 0.0 109.945 171.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -134.9 152.25 51.58 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.587 1.155 . . . . 0.0 109.299 173.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.8 p -91.93 -3.43 55.95 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.983 1.313 . . . . 0.0 112.399 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.9 p -142.53 166.84 18.56 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 174.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -58.61 157.48 27.33 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 CA-C-N 120.397 1.178 . . . . 0.0 111.627 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.08 177.65 5.96 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.363 1.065 . . . . 0.0 109.219 173.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 t -140.83 143.24 34.69 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -134.27 124.61 3.59 Favored Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 107.548 -2.221 . . . . 0.0 107.548 -175.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.81 55.18 1.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 166.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.51 154.37 41.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.484 -164.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.34 126.89 31.73 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.07 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -116.47 138.3 51.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 167.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -130.91 94.46 3.61 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.7 t -85.31 72.24 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 123.55 0.74 . . . . 0.0 110.153 -176.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.6 t -169.25 147.7 3.34 Favored Pre-proline 0 N--CA 1.45 -0.45 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 175.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.74 -44.91 12.14 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 N-CA-C 108.021 -1.569 . . . . 0.0 108.021 161.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 3.0 ptm -174.25 -84.12 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.806 1.642 . . . . 0.0 108.026 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.98 -31.64 71.23 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.362 1.865 . . . . 0.0 115.231 -168.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.18 -105.76 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 117.927 0.331 . . . . 0.0 111.326 -168.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.05 -58.48 0.56 Allowed Glycine 0 CA--C 1.534 1.277 0 O-C-N 121.804 -0.56 . . . . 0.0 113.171 -174.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.56 -41.67 73.61 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.193 1.497 . . . . 0.0 111.551 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -76.24 7.28 4.4 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.536 1.135 . . . . 0.0 113.893 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -82.5 144.69 30.25 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 165.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -97.24 109.09 21.92 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 172.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.4 tptp -155.65 39.71 0.39 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.457 0.703 . . . . 0.0 110.433 168.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 10.2 p -55.32 -44.87 77.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -167.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -155.76 149.51 25.19 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 170.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 14.0 t -175.89 173.21 2.33 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -172.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -47.1 134.87 10.36 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.373 0.669 . . . . 0.0 110.459 164.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 43.4 t -72.65 75.81 1.1 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.707 0.765 . . . . 0.0 110.094 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -63.23 134.87 56.61 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.623 173.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.7 t -162.9 165.9 24.6 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 169.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.449 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 1.7 pm0 -85.9 -25.35 26.2 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 127.277 2.231 . . . . 0.0 110.763 -173.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.2 t 49.76 -149.79 0.23 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.042 1.337 . . . . 0.0 112.58 170.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.71 149.32 31.79 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.824 1.65 . . . . 0.0 109.199 -177.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.8 mt -143.09 146.07 33.45 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.658 0.783 . . . . 0.0 110.219 172.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -70.08 158.67 86.82 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 129.863 3.265 . . . . 0.0 110.75 171.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.51 105.98 1.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.565 2.843 . . . . 0.0 111.936 -168.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 116.87 -7.98 16.91 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 123.933 0.778 . . . . 0.0 111.824 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -77.81 164.84 24.84 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 117.635 0.717 . . . . 0.0 111.216 -175.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -119.32 126.45 51.47 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.584 0.754 . . . . 0.0 110.392 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 15.6 tpt -91.27 123.81 34.99 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -146.28 141.59 27.48 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 123.238 0.336 . . . . 0.0 110.507 158.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 87.2 mtp -150.42 149.65 27.0 Favored Pre-proline 0 N--CA 1.451 -0.385 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 166.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -73.32 137.32 25.61 Favored 'Trans proline' 0 N--CA 1.445 -1.343 0 C-N-CA 122.121 1.881 . . . . 0.0 111.76 172.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.4 t -99.34 150.05 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 159.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.77 138.72 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -152.96 137.07 16.41 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.237 0.472 . . . . 0.0 111.201 -165.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -155.78 158.9 38.92 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.275 1.83 . . . . 0.0 107.528 160.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.8 t -87.52 159.07 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 175.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -100.46 133.24 21.46 Favored Pre-proline 0 C--O 1.236 0.378 0 CA-C-N 118.692 0.678 . . . . 0.0 111.272 173.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -72.38 46.67 0.99 Allowed 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.937 2.425 . . . . 0.0 114.011 175.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.51 -7.69 11.62 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.263 1.025 . . . . 0.0 113.401 163.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.2 tt -51.65 -40.74 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 118.794 0.725 . . . . 0.0 111.068 170.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.3 m -83.2 56.26 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.331 1.052 . . . . 0.0 110.749 171.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -113.3 -79.22 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.462 0 CA-C-O 117.573 -1.204 . . . . 0.0 109.145 165.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -78.59 163.02 27.1 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.025 1.817 . . . . 0.0 111.901 -176.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.8 p -62.18 -44.29 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 123.737 0.815 . . . . 0.0 110.683 -174.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -46.34 -56.0 6.49 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.296 1.438 . . . . 0.0 111.704 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 35.0 p -88.69 -10.57 48.01 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 118.365 -0.826 . . . . 0.0 112.543 -174.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -48.07 -42.36 28.43 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.361 0.982 . . . . 0.0 111.766 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -76.65 -25.33 65.39 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 123.54 0.591 . . . . 0.0 112.612 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 24.8 mm -76.37 128.81 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 117.923 0.861 . . . . 0.0 108.84 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -156.66 56.38 0.55 Allowed 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.5 m -155.34 108.93 2.82 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 160.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.94 84.07 5.75 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -174.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.96 147.89 32.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.921 -171.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.6 tt -118.79 110.56 17.37 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.4 t -87.94 108.26 19.11 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 171.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.2 131.19 54.93 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.815 1.246 . . . . 0.0 108.112 177.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.4 m -129.47 89.84 2.9 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.423 0.63 . . . . 0.0 110.749 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -69.98 78.71 0.48 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 169.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.47 46.33 1.36 Allowed Pre-proline 0 CA--C 1.55 0.973 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 174.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.86 -89.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.222 2.614 . . . . 0.0 113.38 -176.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -157.8 112.81 2.69 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.241 -0.912 . . . . 0.0 110.487 -172.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -116.2 142.62 29.59 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 123.65 0.78 . . . . 0.0 109.465 176.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -76.4 66.56 7.19 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.914 1.742 . . . . 0.0 109.61 166.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.4 t 38.05 92.29 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 129.078 2.951 . . . . 0.0 114.846 172.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt . . . . . 0 CA--C 1.534 0.343 0 C-N-CA 123.738 0.815 . . . . 0.0 111.629 -178.421 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 CA--C 1.535 0.369 0 CA-C-O 122.205 1.002 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 36.53 39.94 0.11 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.172 1.789 . . . . 0.0 111.505 -159.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -159.36 162.61 35.9 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 169.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -127.24 140.41 52.24 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 156.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.8 p -157.38 40.66 0.3 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 122.064 0.935 . . . . 0.0 110.974 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -156.08 -52.26 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 127.297 2.239 . . . . 0.0 106.172 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.3 mt -56.93 -29.51 63.16 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.836 1.654 . . . . 0.0 111.502 174.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.2 mt -72.51 80.96 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 123.824 0.849 . . . . 0.0 110.85 -174.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -74.59 -168.95 0.76 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 151.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -71.78 -42.51 67.04 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.66 1.184 . . . . 0.0 111.322 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -40.61 128.1 2.49 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.301 1.44 . . . . 0.0 114.703 -161.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -97.5 88.21 4.32 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 125.538 1.535 . . . . 0.0 107.424 -168.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -82.35 119.9 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 175.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.49 138.42 31.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 -177.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 t -121.89 147.59 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.5 m -140.43 94.27 2.72 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 -174.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -76.0 163.21 27.38 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.204 1.402 . . . . 0.0 108.983 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -146.61 88.5 1.77 Allowed 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.875 0.845 . . . . 0.0 110.583 -167.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.62 111.06 16.7 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.793 0.837 . . . . 0.0 111.025 176.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -118.21 136.74 53.46 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.5 t -132.03 143.46 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -134.93 163.54 29.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 169.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -24.79 -59.05 0.06 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 127.233 2.213 . . . . 0.0 113.242 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -32.78 -42.89 0.16 Allowed Glycine 0 CA--C 1.532 1.106 0 C-N-CA 126.774 2.13 . . . . 0.0 114.71 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.15 106.62 59.0 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 118.86 1.33 . . . . 0.0 108.238 165.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -82.17 5.08 6.57 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.276 1.984 . . . . 0.0 112.498 -173.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 43.1 m0 -79.8 146.3 32.36 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 122.384 1.088 . . . . 0.0 111.792 -165.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -77.54 82.36 3.98 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -93.36 106.85 18.77 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.603 1.561 . . . . 0.0 108.192 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.0 m -101.44 118.92 58.92 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -70.81 166.68 28.11 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 121.186 1.257 . . . . 0.0 109.112 164.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -94.54 -58.32 3.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 C-N-CA 123.853 0.861 . . . . 0.0 110.762 -174.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -132.23 175.18 9.48 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 165.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.3 tpt85 -69.79 -43.03 72.96 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 165.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -135.98 170.08 16.57 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 125.842 1.657 . . . . 0.0 113.283 -158.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.6 pt -143.74 167.24 12.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 127.068 2.147 . . . . 0.0 107.502 173.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -117.92 140.85 49.14 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 161.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.4 t -131.58 129.95 62.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.651 1.58 . . . . 0.0 106.76 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.3 mmt-85 -76.35 94.84 3.67 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 168.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.6 pt -7.66 76.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 127.558 2.343 . . . . 0.0 115.806 -167.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 134.06 -27.04 3.35 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 124.558 1.075 . . . . 0.0 112.858 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -41.32 111.32 0.21 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.263 1.425 . . . . 0.0 111.65 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.49 99.67 1.65 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.17 1.388 . . . . 0.0 110.264 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.2 p -104.96 150.58 7.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 175.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.28 132.6 52.14 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.471 1.108 . . . . 0.0 109.584 178.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.1 pp -138.76 96.93 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 C-N-CA 125.008 1.323 . . . . 0.0 108.026 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.424 ' CB ' ' HA ' ' A' ' 117' ' ' PRO . 0.0 OUTLIER -78.29 166.49 22.63 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -174.272 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -134.25 149.14 50.92 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 26.3 ttt-85 -132.04 122.66 25.82 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -123.15 105.9 10.31 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.539 1.536 . . . . 0.0 109.154 174.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -95.6 131.91 41.31 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -75.45 142.68 42.92 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.042 0.837 . . . . 0.0 109.663 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.71 -7.26 6.78 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.462 1.905 . . . . 0.0 111.68 -174.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.35 151.14 33.03 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.174 0.897 . . . . 0.0 109.29 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.7 m -84.26 14.38 4.4 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -154.2 163.64 23.41 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 175.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.8 160.64 17.29 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.09 1.86 . . . . 0.0 112.212 -175.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.24 165.22 26.66 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 123.301 0.64 . . . . 0.0 110.126 176.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.7 t -111.17 145.45 38.62 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 168.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -138.0 83.9 0.24 Allowed Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -112.04 -21.93 11.28 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.018 0.927 . . . . 0.0 112.119 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.15 -175.97 0.12 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 165.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.5 t -124.11 168.78 12.43 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 118.214 -1.394 . . . . 0.0 107.987 141.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -148.24 88.75 1.67 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 122.726 1.251 . . . . 0.0 108.956 -166.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -78.22 88.98 4.28 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 120.847 -1.158 . . . . 0.0 107.882 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.6 p -78.75 69.48 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.473 0 C-N-CA 125.463 1.505 . . . . 0.0 110.691 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.6 t -176.53 142.05 0.55 Allowed Pre-proline 0 N--CA 1.464 0.252 0 CA-C-N 119.425 1.012 . . . . 0.0 109.736 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -67.05 -58.61 0.14 Allowed 'Trans proline' 0 N--CA 1.446 -1.314 0 N-CA-C 108.777 -1.278 . . . . 0.0 108.777 166.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 26.2 ptm -171.42 11.37 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -171.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -173.49 -51.93 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 119.163 0.892 . . . . 0.0 110.317 -162.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.25 -124.55 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.667 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.19 -44.09 1.07 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 120.417 -1.427 . . . . 0.0 112.762 -170.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.59 -58.18 4.06 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.408 1.083 . . . . 0.0 110.837 174.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -74.29 -25.1 59.39 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.258 1.023 . . . . 0.0 113.447 -177.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -41.04 120.68 1.39 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.745 1.218 . . . . 0.0 109.302 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -76.95 68.61 3.14 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.803 0.729 . . . . 0.0 111.422 -168.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.17 125.95 21.04 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 172.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 43.3 t -40.8 -56.2 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 125.551 1.54 . . . . 0.0 110.992 -165.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -111.14 -85.52 0.56 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 170.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 48.8 t -171.65 -39.55 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.229 1.011 . . . . 0.0 111.255 -172.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -58.44 158.98 6.77 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.353 0.661 . . . . 0.0 111.975 -177.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 5.1 p -64.0 164.37 10.62 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.292 1.037 . . . . 0.0 111.963 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -93.4 122.45 35.84 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 174.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.6 m -162.35 102.7 1.09 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.017 0.927 . . . . 0.0 109.086 -176.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -73.38 54.33 0.43 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.567 1.147 . . . . 0.0 112.285 172.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.0 t 40.85 -131.51 0.37 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.538 1.535 . . . . 0.0 113.315 165.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.0 t -132.16 147.89 52.45 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.067 2.147 . . . . 0.0 108.167 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.1 mt -134.19 142.29 47.36 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.406 0.683 . . . . 0.0 109.883 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -68.98 164.25 49.2 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.365 1.866 . . . . 0.0 110.372 167.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.06 76.77 2.5 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 124.682 3.588 . . . . 0.0 112.735 -169.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 153.71 -21.22 0.7 Allowed Glycine 0 CA--C 1.521 0.433 0 CA-C-O 119.357 -0.691 . . . . 0.0 113.285 169.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.9 155.67 32.66 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 118.14 0.97 . . . . 0.0 111.772 -159.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -106.44 101.45 10.91 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.89 1.276 . . . . 0.0 110.887 -165.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.79 85.81 7.24 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -106.64 105.11 14.98 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.862 1.265 . . . . 0.0 108.851 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 46.7 mtt -146.87 141.49 16.09 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 119.729 1.15 . . . . 0.0 112.936 -174.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.424 ' HA ' ' CB ' ' A' ' 67' ' ' MET . 95.3 Cg_endo -83.87 145.51 11.37 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.138 2.559 . . . . 0.0 113.622 176.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 24.1 t -117.8 150.81 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 126.403 1.881 . . . . 0.0 106.512 170.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.2 m -118.74 147.44 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.868 1.267 . . . . 0.0 108.301 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -157.55 159.16 36.85 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.629 0.65 . . . . 0.0 112.747 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -163.17 158.19 21.43 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 126.661 1.984 . . . . 0.0 108.426 166.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 29.7 t -102.29 147.35 9.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 124.699 1.199 . . . . 0.0 108.768 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -80.97 161.78 62.0 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 123.398 0.679 . . . . 0.0 110.149 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -101.94 28.25 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.89 3.06 . . . . 0.0 112.425 166.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -84.41 -40.54 17.67 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 168.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.7 tt -39.3 -47.38 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.112 1.365 . . . . 0.0 113.681 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.8 m -79.27 55.7 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 O-C-N 121.553 -0.717 . . . . 0.0 110.627 175.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -140.99 -66.61 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.491 0 CA-C-O 117.485 -1.245 . . . . 0.0 111.711 175.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.4 158.43 44.46 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 CA-C-N 121.927 1.724 . . . . 0.0 112.54 -175.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.2 t -55.61 -46.8 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 124.7 1.2 . . . . 0.0 110.141 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -46.17 -50.33 15.77 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.985 1.314 . . . . 0.0 112.684 -175.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 27.2 p -101.52 -6.74 23.53 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -174.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -37.84 107.82 0.07 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.839 1.256 . . . . 0.0 112.152 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.03 -30.53 8.56 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.587 -1.118 . . . . 0.0 113.132 176.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 43.2 mm -58.79 129.3 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 C-N-CA 124.321 1.048 . . . . 0.0 109.863 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -158.54 49.13 0.37 Allowed 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.4 m -149.4 92.55 1.95 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 162.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.08 89.58 5.97 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -171.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 13.2 t -78.01 175.35 10.16 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 122.247 1.022 . . . . 0.0 109.383 -176.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.17 98.34 3.08 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 169.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.3 m -79.81 95.36 6.0 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 174.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -76.67 126.4 30.92 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 171.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 26.6 m -122.51 89.91 3.2 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -84.83 91.34 7.98 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.155 -173.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -151.04 47.39 0.44 Allowed Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 116.876 2.176 . . . . 0.0 116.876 -175.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.2 -111.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.398 2.732 . . . . 0.0 110.763 173.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -136.05 116.49 13.71 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.693 1.133 . . . . 0.0 108.928 -168.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -93.19 143.54 26.9 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 164.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -71.54 -55.36 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.882 1.721 . . . . 0.0 108.419 167.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.6 t -177.37 126.25 0.14 Allowed 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.158 1.783 . . . . 0.0 107.791 172.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 27.4 pttt . . . . . 0 CA--C 1.537 0.474 0 C-N-CA 123.144 0.577 . . . . 0.0 111.321 160.693 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.456 -0.167 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 39.68 36.87 0.28 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.931 1.692 . . . . 0.0 112.559 -172.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -155.64 165.71 35.73 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 177.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -144.05 136.62 26.93 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 102.015 -3.328 . . . . 0.0 102.015 160.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.3 t -155.5 35.12 0.37 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 121.508 1.958 . . . . 0.0 111.11 176.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -160.37 -60.74 0.06 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -164.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.43 39.94 0.62 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 112.628 -2.078 . . . . 0.0 112.246 -165.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.9 mt -119.37 62.59 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 123.486 0.714 . . . . 0.0 110.688 -167.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -76.96 149.63 35.95 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.024 1.33 . . . . 0.0 109.602 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.0 54.61 1.62 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -165.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.8 98.09 7.83 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 166.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.76 81.78 5.97 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 122.125 0.964 . . . . 0.0 108.65 -168.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.292 0.0 OUTLIER -79.92 131.83 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.629 -173.173 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.97 150.66 24.73 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 126.79 2.036 . . . . 0.0 106.999 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.7 m -135.94 120.11 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.26 111.92 18.79 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 176.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -79.48 89.69 5.05 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 176.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -78.35 80.58 4.75 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 122.608 1.194 . . . . 0.0 108.019 -174.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.91 126.05 30.51 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -133.8 147.33 51.23 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.3 p -145.25 147.98 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 124.097 0.959 . . . . 0.0 108.815 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -130.3 168.46 16.86 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 166.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.48 -34.86 11.91 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.235 1.014 . . . . 0.0 111.891 -178.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -34.93 -38.8 0.14 Allowed Glycine 0 CA--C 1.532 1.11 0 C-N-CA 126.28 1.895 . . . . 0.0 113.734 169.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.6 96.58 48.57 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 118.225 1.012 . . . . 0.0 108.283 163.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -82.92 42.55 1.31 Allowed 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 123.424 2.75 . . . . 0.0 111.332 -168.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 41.5 m0 -112.81 147.19 37.46 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 -176.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -77.14 80.93 3.65 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -90.9 87.04 6.47 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 m -95.64 128.39 38.08 Favored Pre-proline 0 N--CA 1.454 -0.257 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -67.4 153.15 77.62 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 N-CA-C 107.3 -1.846 . . . . 0.0 107.3 160.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -57.96 4.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.638 0.732 . . . . 0.0 109.092 -173.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -120.06 159.09 25.48 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 103.199 -2.889 . . . . 0.0 103.199 157.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -23.01 67.09 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.946 0.794 . . . . 0.0 110.652 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -139.88 167.6 21.74 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 125.561 1.545 . . . . 0.0 109.952 -171.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.41 168.95 21.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 172.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.3 p-10 -129.84 147.62 51.63 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.339 0.656 . . . . 0.0 111.218 166.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.2 m -141.84 122.99 12.54 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.57 56.27 3.89 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 121.413 1.915 . . . . 0.0 109.999 -173.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mt 58.8 116.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 124.642 1.177 . . . . 0.0 109.004 -164.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.28 -51.74 4.42 Favored Glycine 0 CA--C 1.525 0.718 0 O-C-N 119.994 -1.691 . . . . 0.0 113.945 172.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -26.39 100.5 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.444 2.298 . . . . 0.0 112.081 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.5 p -76.89 128.2 34.13 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.722 -0.612 . . . . 0.0 110.461 -172.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 p -123.62 149.43 27.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 C-N-CA 125.268 1.427 . . . . 0.0 109.041 177.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.02 122.86 36.96 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 125.164 1.385 . . . . 0.0 107.276 164.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.7 pp -114.67 130.74 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 157.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 35.8 ttp -76.97 140.53 40.46 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 169.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -109.29 158.71 17.61 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 166.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 43.7 ttm-85 -138.13 140.93 40.13 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.353 1.461 . . . . 0.0 108.727 -175.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.7 96.72 1.78 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.12 1.768 . . . . 0.0 108.846 166.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -95.09 126.11 40.21 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -79.94 121.41 25.42 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.607 1.094 . . . . 0.0 112.399 -170.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.4 mp -108.87 26.76 10.2 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.262 1.025 . . . . 0.0 111.598 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.17 171.66 14.62 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 120.987 -1.071 . . . . 0.0 112.223 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.4 p -79.47 -34.59 41.33 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.645 1.978 . . . . 0.0 110.479 170.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 66.5 p -123.99 179.84 0.99 Allowed Pre-proline 0 N--CA 1.456 -0.152 0 C-N-CA 127.149 2.18 . . . . 0.0 108.979 -174.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -54.41 161.51 5.48 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 CA-C-N 119.309 0.789 . . . . 0.0 111.345 160.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.47 173.9 10.4 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 157.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.6 t -102.85 162.11 13.19 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 151.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -151.41 60.27 0.41 Allowed Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -88.31 -39.11 14.63 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.537 0.735 . . . . 0.0 109.051 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.05 178.08 0.15 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.367 1.067 . . . . 0.0 112.841 169.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.5 m -125.87 148.09 49.28 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 173.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -137.98 160.85 38.24 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.619 0.768 . . . . 0.0 110.345 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.76 113.36 20.07 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 164.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.8 p -95.08 59.4 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 123.714 0.805 . . . . 0.0 112.127 -173.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.8 t -174.5 150.04 1.41 Allowed Pre-proline 0 C--N 1.333 -0.121 0 O-C-N 121.539 -0.725 . . . . 0.0 110.682 -175.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.21 -33.66 30.24 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 N-CA-C 108.99 -1.196 . . . . 0.0 108.99 162.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.3 ptp 174.99 -71.8 0.01 OUTLIER 'General case' 0 C--N 1.341 0.23 0 C-N-CA 127.023 2.129 . . . . 0.0 107.913 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.76 -31.02 51.78 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -163.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.33 -110.51 0.06 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.476 0.179 . . . . 0.0 111.264 -168.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.16 -56.28 0.1 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.312 0.958 . . . . 0.0 113.31 -169.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.83 -49.54 19.88 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.376 1.588 . . . . 0.0 112.287 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -72.74 -4.67 32.81 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.283 1.033 . . . . 0.0 113.41 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.401 ' CE1' ' CE2' ' A' ' 120' ' ' PHE . 6.1 t80 -62.64 131.92 50.6 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -116.05 127.84 55.22 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 123.515 0.51 . . . . 0.0 112.166 174.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.3 -43.02 0.33 Allowed 'General case' 0 C--O 1.227 -0.087 0 C-N-CA 123.101 0.56 . . . . 0.0 110.597 160.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . 0.338 4.9 p 48.3 -83.02 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 125.897 1.679 . . . . 0.0 111.753 -168.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 38.76 -109.93 0.08 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.032 2.133 . . . . 0.0 111.351 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 42.3 t -107.84 143.48 36.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 170.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -46.43 -62.08 1.52 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.617 0.644 . . . . 0.0 109.81 171.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 11.8 t -63.55 126.73 28.49 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.71 1.204 . . . . 0.0 109.997 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -74.39 56.09 0.64 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.227 1.811 . . . . 0.0 109.551 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.299 3.1 p 60.34 -68.49 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.159 1.784 . . . . 0.0 114.016 177.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -53.6 143.26 20.48 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.511 1.124 . . . . 0.0 112.207 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.8 t -156.33 -70.47 0.11 Allowed 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.009 0.924 . . . . 0.0 111.137 -176.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.6 m -159.69 135.0 8.23 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 -164.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 69.0 mt -149.47 146.37 27.38 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.926 0.89 . . . . 0.0 109.058 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.26 170.7 12.83 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 126.324 1.85 . . . . 0.0 109.567 167.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.01 88.16 1.27 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 124.607 3.538 . . . . 0.0 111.093 -173.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 151.23 -30.19 0.97 Allowed Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 173.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.27 145.87 41.52 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.688 -151.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -96.29 89.71 5.19 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.974 1.71 . . . . 0.0 110.975 -170.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.96 119.15 26.87 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 176.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -154.13 132.51 11.98 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 122.762 0.425 . . . . 0.0 109.869 168.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 39.2 mtt -156.01 156.93 31.05 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 123.589 0.756 . . . . 0.0 110.373 -168.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.23 140.57 22.33 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.801 3.0 . . . . 0.0 111.688 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.8 t -126.37 136.29 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 170.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.0 m -105.57 157.45 6.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 CA-C-N 117.849 0.295 . . . . 0.0 110.526 173.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.401 ' CE2' ' CE1' ' A' ' 95' ' ' PHE . 6.2 t80 -156.72 139.17 14.86 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -170.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -157.8 173.03 17.42 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.743 1.617 . . . . 0.0 109.779 169.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.4 p -129.59 143.39 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 118.743 -0.646 . . . . 0.0 110.229 169.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -76.18 153.59 84.36 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 118.671 0.669 . . . . 0.0 109.588 175.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -58.63 -21.26 54.49 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.325 2.684 . . . . 0.0 112.132 170.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -41.47 -33.85 0.48 Allowed 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 126.637 1.975 . . . . 0.0 113.258 176.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.4 tt -54.53 -42.46 59.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.896 0.771 . . . . 0.0 112.661 175.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.1 m -84.3 54.13 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 119.088 0.858 . . . . 0.0 109.901 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -135.74 -65.52 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 117.637 -1.173 . . . . 0.0 112.252 175.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -74.53 149.47 39.15 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 CA-C-N 121.977 1.742 . . . . 0.0 111.079 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.4 p -64.44 -35.38 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 124.124 0.969 . . . . 0.0 110.75 -174.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -45.45 -48.99 13.8 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.1 1.76 . . . . 0.0 112.245 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.9 p -91.23 -66.53 0.92 Allowed 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 41.56 -72.01 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.693 2.797 . . . . 0.0 115.87 -175.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -87.14 -23.01 42.5 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.319 1.438 . . . . 0.0 111.234 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.9 mm -56.95 126.69 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 117.816 0.808 . . . . 0.0 109.949 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -156.01 58.41 0.59 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.921 172.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.9 m -150.01 88.67 1.54 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 167.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.0 mp -74.64 85.98 2.12 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.5 t -83.68 140.07 32.38 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.634 -1.166 . . . . 0.0 107.867 174.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.9 tt -114.22 103.94 11.6 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 169.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.3 p -86.7 104.83 16.47 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.38 128.91 50.37 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.589 1.556 . . . . 0.0 108.401 -176.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.4 m -114.98 91.55 3.65 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.526 1.131 . . . . 0.0 109.324 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -71.41 88.17 0.88 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.599 1.159 . . . . 0.0 109.638 174.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -155.93 59.64 2.14 Favored Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 174.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -79.96 -78.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.936 2.424 . . . . 0.0 111.979 -176.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -146.79 132.72 19.13 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.553 0.615 . . . . 0.0 109.467 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -131.98 135.56 26.81 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 125.867 1.667 . . . . 0.0 106.611 175.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -77.21 -61.93 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.15 1.9 . . . . 0.0 109.97 171.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 41.8 t -176.84 97.67 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.639 1.575 . . . . 0.0 107.708 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.454 -0.266 0 N-CA-C 104.15 -2.537 . . . . 0.0 104.15 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -77.7 58.19 1.78 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.679 0.752 . . . . 0.0 110.616 -177.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.87 -67.53 0.22 Allowed 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 126.729 2.011 . . . . 0.0 107.628 160.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -163.69 -70.36 0.04 OUTLIER 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 138.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.0 t -166.23 -136.59 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 144.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -73.03 -27.55 61.83 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.474 1.109 . . . . 0.0 109.413 168.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -68.76 6.47 0.85 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -173.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 81.7 mt -58.99 122.14 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 120.847 1.658 . . . . 0.0 110.043 177.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.68 157.21 17.22 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 118.785 0.721 . . . . 0.0 110.999 175.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.67 -27.65 69.06 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.074 0.95 . . . . 0.0 113.03 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -51.76 114.0 1.15 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.97 0.908 . . . . 0.0 111.953 -174.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.63 98.04 8.17 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 127.067 2.147 . . . . 0.0 108.747 -171.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.0 tt -109.13 136.62 44.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 126.277 1.831 . . . . 0.0 110.748 -170.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.9 tptp -98.64 157.53 16.19 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 124.918 1.287 . . . . 0.0 110.897 -168.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 82.3 t -133.65 160.68 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 C-N-CA 124.306 1.042 . . . . 0.0 108.63 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.4 m -145.46 102.48 3.71 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.615 1.166 . . . . 0.0 109.319 172.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -78.6 88.56 4.52 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.055 1.342 . . . . 0.0 108.13 175.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -80.06 85.36 5.65 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 121.415 -0.803 . . . . 0.0 109.191 -174.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.82 134.71 34.29 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 121.839 -0.538 . . . . 0.0 111.329 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -144.09 147.01 33.19 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 126.405 1.882 . . . . 0.0 109.66 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.9 t -132.77 147.97 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 125.34 1.456 . . . . 0.0 108.402 177.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -146.96 174.29 11.65 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.031 0.932 . . . . 0.0 109.931 174.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -49.28 121.81 5.36 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 169.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.77 -43.21 1.3 Allowed Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 108.078 -2.009 . . . . 0.0 108.078 -163.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.74 97.76 20.66 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 123.308 0.643 . . . . 0.0 111.067 177.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -84.72 41.71 1.02 Allowed 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.78 2.987 . . . . 0.0 110.271 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.436 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 43.2 m0 -114.77 136.9 52.57 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.601 0.76 . . . . 0.0 109.315 -171.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -79.16 80.81 5.48 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -89.98 89.36 7.68 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 124.238 1.015 . . . . 0.0 108.99 -176.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.9 m -84.81 129.7 55.65 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.22 166.18 30.46 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 121.436 1.424 . . . . 0.0 108.464 161.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.38 -56.21 5.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 123.862 0.865 . . . . 0.0 109.437 -176.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.79 164.44 24.06 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 161.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -63.55 -46.77 84.44 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 165.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -131.04 149.99 52.36 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 126.249 1.819 . . . . 0.0 110.108 -164.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.0 pt -134.81 167.97 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 167.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -110.56 134.24 52.57 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 166.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.0 157.91 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 165.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.5 mtm180 -109.15 114.27 27.84 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -37.8 117.34 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -147.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 111.43 -46.36 1.18 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 -172.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -53.63 109.59 0.47 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 117.767 0.784 . . . . 0.0 112.846 -166.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.2 p -56.44 122.03 10.99 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.938 1.295 . . . . 0.0 111.221 172.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.06 137.6 42.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 166.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -77.78 128.56 34.21 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.824 1.25 . . . . 0.0 108.569 167.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.1 pp -146.3 88.6 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.974 0.91 . . . . 0.0 108.971 174.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.93 147.16 41.19 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 121.385 -0.822 . . . . 0.0 110.276 -177.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -98.14 159.24 15.07 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 166.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -135.96 118.51 15.89 Favored 'General case' 0 C--O 1.227 -0.099 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 172.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -110.69 154.89 23.22 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 126.608 1.963 . . . . 0.0 109.081 172.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -154.95 123.74 6.15 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 -176.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.436 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 35.6 t30 -80.77 112.66 18.35 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 119.302 0.956 . . . . 0.0 110.836 -173.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.35 5.1 51.66 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.721 1.208 . . . . 0.0 112.742 -176.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.37 176.79 9.01 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.792 0.724 . . . . 0.0 110.538 175.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.6 t -105.64 20.73 18.43 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.739 0.816 . . . . 0.0 109.96 175.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.2 160.48 30.85 Favored Pre-proline 0 N--CA 1.447 -0.612 0 C-N-CA 127.086 2.154 . . . . 0.0 106.708 -174.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.71 160.44 40.44 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 C-N-CA 121.161 1.241 . . . . 0.0 109.442 172.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.38 164.18 26.25 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-O 120.776 0.322 . . . . 0.0 110.663 166.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.57 95.18 5.21 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.989 2.116 . . . . 0.0 105.693 -177.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.0 96.52 0.78 Allowed Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 107.756 -2.137 . . . . 0.0 107.756 177.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -125.05 50.33 1.77 Allowed 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 169.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.38 176.82 0.32 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.805 0.812 . . . . 0.0 110.872 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -146.04 162.48 37.8 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.91 169.82 17.33 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 123.578 0.751 . . . . 0.0 110.336 -172.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -119.91 111.52 18.04 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 163.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.2 t -95.43 77.59 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.177 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.1 t -176.07 145.55 0.75 Allowed Pre-proline 0 C--O 1.232 0.142 0 C-N-CA 124.153 0.981 . . . . 0.0 110.207 171.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.94 -38.0 40.68 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 121.259 1.306 . . . . 0.0 110.064 158.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.9 ptp 172.02 -68.08 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 127.835 2.454 . . . . 0.0 107.759 174.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.5 -39.5 46.1 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -167.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.74 -104.68 0.04 OUTLIER 'General case' 0 C--O 1.228 -0.055 0 C-N-CA 123.101 0.561 . . . . 0.0 110.427 -174.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.27 -58.78 2.8 Favored Glycine 0 CA--C 1.523 0.55 0 O-C-N 121.855 -0.528 . . . . 0.0 111.853 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -47.64 -48.95 28.52 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.927 0.864 . . . . 0.0 110.613 174.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -74.7 3.96 7.05 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.152 1.381 . . . . 0.0 113.882 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -76.95 107.92 9.63 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 171.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -71.06 80.86 0.67 Allowed 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.644 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -63.84 143.84 57.53 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 164.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.1 t -52.4 138.29 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.554 0.742 . . . . 0.0 111.57 -172.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -69.15 66.81 0.16 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.813 1.245 . . . . 0.0 111.574 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 34.9 t -150.11 140.26 22.12 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 125.385 1.474 . . . . 0.0 108.847 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -76.38 67.82 2.65 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.725 1.21 . . . . 0.0 108.993 176.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 38.2 t -159.79 153.98 23.53 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 174.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -97.19 -3.36 41.06 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.543 -0.742 . . . . 0.0 112.495 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.7 m 95.43 161.83 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 128.823 2.849 . . . . 0.0 108.467 -168.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 62.15 -178.38 0.13 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.818 2.047 . . . . 0.0 113.066 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.5 t -177.08 -82.15 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.069 1.347 . . . . 0.0 111.504 172.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.8 t -155.47 149.92 26.05 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.962 1.305 . . . . 0.0 108.025 -169.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.1 mt -154.03 127.52 8.62 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 123.873 0.869 . . . . 0.0 109.437 175.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -63.2 158.15 58.02 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 126.401 1.88 . . . . 0.0 110.256 164.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.47 110.53 3.0 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.481 2.121 . . . . 0.0 111.38 -169.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 115.17 -15.75 18.15 Favored Glycine 0 C--N 1.334 0.467 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -77.86 156.32 30.46 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 117.476 0.638 . . . . 0.0 110.873 -174.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.61 153.56 39.15 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.753 1.221 . . . . 0.0 110.687 -167.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 42.4 ttm -149.47 88.58 1.57 Allowed 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.094 1.358 . . . . 0.0 108.687 -168.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -89.72 130.17 36.03 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 118.585 0.629 . . . . 0.0 109.888 164.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -126.48 92.58 44.9 Favored Pre-proline 0 N--CA 1.452 -0.358 0 C-N-CA 125.327 1.451 . . . . 0.0 107.908 -171.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -55.37 126.12 21.45 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.723 2.282 . . . . 0.0 110.184 169.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.1 t -121.57 147.38 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 170.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.8 p -119.75 142.02 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 171.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -145.81 148.79 33.29 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 118.161 0.437 . . . . 0.0 111.147 -172.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -157.88 141.91 15.87 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.55 1.14 . . . . 0.0 110.098 165.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 24.0 t -70.54 134.35 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 164.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.42 ' C ' ' H ' ' A' ' 125' ' ' GLU . 1.5 t70 -88.41 138.55 30.18 Favored Pre-proline 0 N--CA 1.451 -0.406 0 C-N-CA 123.971 0.908 . . . . 0.0 109.939 -173.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -72.02 34.53 0.29 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.09 2.527 . . . . 0.0 114.331 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.42 ' H ' ' C ' ' A' ' 123' ' ' ASP . 37.7 tt0 -107.55 -21.78 12.77 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 130.071 3.348 . . . . 0.0 108.507 172.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.7 tt -58.22 -39.12 72.18 Favored 'Isoleucine or valine' 0 C--N 1.345 0.372 0 O-C-N 121.117 -0.99 . . . . 0.0 111.249 172.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.1 m -77.27 61.62 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 123.37 0.668 . . . . 0.0 109.956 172.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -130.92 -78.48 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 117.359 -1.305 . . . . 0.0 111.403 173.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -73.04 160.21 46.19 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 CA-C-N 122.011 1.754 . . . . 0.0 111.105 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 84.5 t -65.07 -44.66 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 124.553 1.141 . . . . 0.0 109.113 -171.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -48.31 -64.38 0.81 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.335 1.854 . . . . 0.0 110.095 177.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 35.7 p -75.94 -19.96 58.34 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 118.357 -0.83 . . . . 0.0 111.63 -172.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -44.65 -39.31 4.96 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.932 0.787 . . . . 0.0 111.186 168.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -57.72 -54.6 36.01 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 175.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 21.9 mm -64.26 132.4 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 124.6 1.16 . . . . 0.0 111.728 -174.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -158.65 41.57 0.25 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.181 165.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.8 p -140.8 89.64 2.27 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 170.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.4 tp -84.79 144.88 28.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -166.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.5 t -149.61 153.02 36.42 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -176.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.06 145.8 41.1 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 146.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 26.6 t -98.84 116.97 32.28 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 164.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.23 124.9 49.48 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.137 1.375 . . . . 0.0 107.383 178.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.5 m -114.63 89.88 3.2 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -67.53 83.52 0.17 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 170.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.16 50.65 1.16 Allowed Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 178.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -74.73 -106.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.264 2.643 . . . . 0.0 110.254 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -147.22 123.52 10.93 Favored 'General case' 0 C--N 1.337 0.058 0 CA-C-N 119.363 0.983 . . . . 0.0 109.292 -175.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -111.3 143.67 28.91 Favored Pre-proline 0 N--CA 1.45 -0.463 0 C-N-CA 124.892 1.277 . . . . 0.0 108.353 175.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.0 -51.28 0.17 Allowed 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 121.939 1.759 . . . . 0.0 109.135 171.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 61.8 p -175.75 174.28 2.22 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.282 1.833 . . . . 0.0 107.147 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.4 pttt . . . . . 0 CA--C 1.535 0.377 0 C-N-CA 124.759 1.224 . . . . 0.0 109.201 172.576 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.535 0.372 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -76.24 52.3 0.74 Allowed 'General case' 0 CA--C 1.539 0.525 0 O-C-N 120.585 -1.322 . . . . 0.0 107.47 154.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 168.67 164.74 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 128.393 2.677 . . . . 0.0 108.893 -173.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -155.03 19.67 0.44 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.814 1.246 . . . . 0.0 113.238 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 t -77.42 23.95 0.2 Allowed 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.174 -1.579 . . . . 0.0 113.456 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -75.9 -30.91 58.96 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 153.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -107.21 -44.54 4.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.614 1.165 . . . . 0.0 112.822 -175.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.1 mt -19.22 115.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 126.432 1.893 . . . . 0.0 115.146 -164.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.7 mp -103.78 -178.26 3.61 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.262 -161.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -69.2 -48.12 62.94 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.685 1.994 . . . . 0.0 110.733 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.54 151.08 29.56 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.799 0.809 . . . . 0.0 111.814 -174.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.63 98.54 7.69 Favored 'General case' 0 N--CA 1.418 -2.051 0 C-N-CA 127.233 2.213 . . . . 0.0 107.285 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.31 0.0 OUTLIER -80.05 122.04 34.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 170.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.43 ' CE ' ' HB2' ' A' ' 55' ' ' ASP . 2.7 tmtp? -75.87 150.54 37.59 Favored 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.6 t -129.66 143.08 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 172.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.8 m -141.78 98.05 3.27 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -173.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -76.38 159.06 30.84 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.895 -172.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -131.05 84.0 2.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 122.761 1.267 . . . . 0.0 107.916 169.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.35 86.1 7.22 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 164.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -93.36 157.82 16.04 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.496 0.718 . . . . 0.0 109.089 170.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.2 p -140.2 110.98 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 123.499 0.72 . . . . 0.0 109.478 175.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.93 164.32 15.2 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.115 166.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.81 -39.44 8.39 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.921 1.288 . . . . 0.0 112.999 -176.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.19 -26.21 2.15 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.819 1.676 . . . . 0.0 113.985 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.05 97.18 48.16 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 162.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -82.73 47.54 2.48 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.207 1.938 . . . . 0.0 110.296 -170.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.484 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 43.6 m0 -112.54 148.33 34.72 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.471 1.108 . . . . 0.0 109.502 -170.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -76.79 80.55 3.39 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 175.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -93.29 101.72 13.98 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 124.329 1.052 . . . . 0.0 108.251 -177.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.7 m -101.97 132.47 21.56 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-O 119.26 -0.4 . . . . 0.0 110.058 -172.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.38 141.34 51.04 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 N-CA-C 107.802 -1.653 . . . . 0.0 107.802 162.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.2 p -77.58 -52.53 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 121.477 0.656 . . . . 0.0 110.031 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -127.55 158.96 36.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 104.122 -2.547 . . . . 0.0 104.122 153.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -66.88 -44.91 79.65 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 174.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.43 ' HB2' ' CE ' ' A' ' 34' ' ' LYS . 20.7 p-10 -130.24 167.22 18.8 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 126.361 1.864 . . . . 0.0 111.07 -170.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.8 pt -143.07 175.49 4.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 125.11 1.364 . . . . 0.0 108.114 169.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -119.31 132.33 55.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 169.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.6 m -124.46 126.14 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.638 0.775 . . . . 0.0 108.96 172.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -72.68 77.43 1.1 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 168.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.5 mt 28.29 58.54 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 127.877 2.471 . . . . 0.0 111.798 169.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.6 -27.47 2.83 Favored Glycine 0 CA--C 1.523 0.557 0 O-C-N 122.131 -0.355 . . . . 0.0 113.195 -174.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -50.02 118.39 2.88 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.038 0.535 . . . . 0.0 111.342 171.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.4 p -88.94 107.27 18.92 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.338 1.455 . . . . 0.0 109.951 -177.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -96.06 139.07 19.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 174.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.8 120.35 23.94 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 163.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.34 111.05 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 76.8 mtp -76.49 171.22 14.97 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.39 0.676 . . . . 0.0 110.747 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -141.31 151.14 43.36 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 163.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.4 ttm105 -127.02 139.07 53.28 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 172.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.88 112.16 8.61 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.554 1.942 . . . . 0.0 108.152 173.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.0 mtmt -103.98 130.09 51.6 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.721 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.484 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 52.6 t-20 -78.26 101.97 7.41 Favored 'General case' 0 C--N 1.339 0.12 0 CA-C-N 119.44 1.018 . . . . 0.0 111.512 -176.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.9 mt -91.62 7.92 39.21 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.761 0.824 . . . . 0.0 113.014 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.91 162.94 27.2 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.858 1.208 . . . . 0.0 109.714 171.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.0 p -79.1 -9.21 59.49 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.045 1.338 . . . . 0.0 111.543 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.58 165.2 29.93 Favored Pre-proline 0 N--CA 1.447 -0.603 0 C-N-CA 126.38 1.872 . . . . 0.0 107.686 -168.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -61.27 148.43 92.94 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 121.14 1.226 . . . . 0.0 109.764 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.7 p -126.79 169.52 13.13 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 165.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.3 t -90.32 173.57 8.05 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 159.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.49 57.07 0.19 Allowed Glycine 0 N--CA 1.438 -1.185 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 176.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.69 -42.56 34.12 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 169.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 64.34 179.24 0.17 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.679 1.192 . . . . 0.0 110.873 174.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.8 m -120.16 136.15 54.72 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 172.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -105.57 148.75 26.94 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.151 0.58 . . . . 0.0 110.354 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -124.66 102.85 7.8 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 156.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.9 t -92.44 59.36 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 124.12 0.968 . . . . 0.0 108.839 -170.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.3 t -171.19 147.29 2.19 Favored Pre-proline 0 N--CA 1.461 0.108 0 O-C-N 121.499 -0.751 . . . . 0.0 111.664 -176.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -64.77 -40.41 22.21 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.381 1.387 . . . . 0.0 109.316 160.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 11.7 ptp 173.73 -71.76 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 127.523 2.329 . . . . 0.0 108.291 173.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.23 -43.8 73.31 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 123.571 0.748 . . . . 0.0 112.801 -164.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.49 -102.84 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.248 0.619 . . . . 0.0 110.595 -170.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.9 -52.75 1.67 Allowed Glycine 0 CA--C 1.53 1.026 0 CA-C-O 119.425 -0.653 . . . . 0.0 112.809 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -48.3 -50.63 29.33 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.039 1.419 . . . . 0.0 111.016 174.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -72.38 -4.98 33.22 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.082 1.753 . . . . 0.0 113.792 178.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -75.45 108.14 8.05 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -76.18 167.77 21.26 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.631 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -133.69 -179.59 5.63 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 174.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.9 p -73.14 68.79 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 122.118 0.961 . . . . 0.0 108.498 171.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 29.93 43.63 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 130.131 3.372 . . . . 0.0 114.543 -177.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 11.5 t 157.4 -69.39 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 127.462 2.305 . . . . 0.0 109.413 177.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -72.06 136.53 46.67 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.115 0.483 . . . . 0.0 112.035 -154.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 78.5 m -73.15 -39.44 65.67 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.68 0.792 . . . . 0.0 110.739 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 175.24 -171.25 0.06 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 130.63 3.572 . . . . 0.0 103.822 -175.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 41.5 m -150.45 -5.73 0.31 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.258 1.39 . . . . 0.0 113.372 -174.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.7 mp0 -57.43 -40.26 78.0 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.682 1.993 . . . . 0.0 111.529 -167.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . 0.325 5.0 t 57.98 -78.67 0.02 OUTLIER 'General case' 0 C--O 1.232 0.173 0 C-N-CA 126.268 1.827 . . . . 0.0 114.699 165.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.3 m -162.56 142.45 9.5 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 125.83 1.652 . . . . 0.0 107.53 -169.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 26.3 mt -149.67 140.69 22.93 Favored 'General case' 0 C--O 1.232 0.17 0 O-C-N 123.335 0.397 . . . . 0.0 111.255 174.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -52.39 161.45 1.06 Allowed Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 128.91 2.884 . . . . 0.0 111.413 159.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -77.23 125.29 7.72 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.454 2.769 . . . . 0.0 111.602 -173.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.59 -10.82 32.87 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 124.437 1.018 . . . . 0.0 111.167 175.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -79.0 144.77 34.37 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -164.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -93.04 101.18 13.51 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.054 1.742 . . . . 0.0 109.127 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.55 125.39 29.92 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 161.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -146.31 126.66 13.98 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.156 1.382 . . . . 0.0 107.536 172.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 68.1 mtp -148.89 151.43 34.9 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 118.113 0.415 . . . . 0.0 111.002 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -76.1 145.11 27.49 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 123.843 3.029 . . . . 0.0 110.378 165.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.2 t -116.59 156.4 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 155.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.0 m -122.47 141.73 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 171.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -153.9 148.12 25.86 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -171.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -157.62 175.84 13.4 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 128.501 2.72 . . . . 0.0 106.569 173.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 87.5 t -126.64 137.4 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 C-N-CA 123.111 0.564 . . . . 0.0 109.543 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -71.54 144.11 88.42 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 119.557 -0.259 . . . . 0.0 111.213 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -58.82 -25.14 75.23 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.0 2.467 . . . . 0.0 112.891 172.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -43.9 -30.16 0.66 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.663 1.185 . . . . 0.0 113.244 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.0 tt -52.52 -42.02 38.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 175.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.5 m -91.75 55.66 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 118.391 0.541 . . . . 0.0 110.332 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -129.71 -70.33 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.371 0 CA-C-O 117.224 -1.37 . . . . 0.0 111.331 167.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.2 156.77 63.81 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 CA-C-N 121.913 1.719 . . . . 0.0 111.47 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 83.9 t -66.75 -50.73 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.709 0.804 . . . . 0.0 110.076 -169.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -48.26 -45.15 34.1 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 124.616 1.166 . . . . 0.0 111.623 -174.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 61.2 p -92.19 -9.52 42.02 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 118.55 -0.738 . . . . 0.0 112.336 -174.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -50.21 -44.64 53.26 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.048 0.84 . . . . 0.0 111.602 -172.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.23 -24.99 75.55 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 123.388 0.518 . . . . 0.0 112.557 -177.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 13.2 mm -73.8 123.17 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 118.122 0.961 . . . . 0.0 109.773 -176.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -153.39 52.48 0.73 Allowed 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.719 165.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.4 m -146.95 99.7 3.21 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 153.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.81 134.17 38.06 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.3 t -125.48 161.65 26.65 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.6 tt -131.26 112.15 12.54 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 102.263 -3.236 . . . . 0.0 102.263 168.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.5 t -86.47 104.03 15.56 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 167.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.35 97.21 8.94 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.59 86.58 3.91 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 122.416 1.103 . . . . 0.0 108.272 -178.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -68.37 87.67 0.31 Allowed 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 167.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.03 35.9 0.09 OUTLIER Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.91 -79.19 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.977 1.784 . . . . 0.0 113.365 -174.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 71.2 mtm180 -155.94 117.37 3.92 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.815 0.846 . . . . 0.0 109.99 -172.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -88.01 147.86 41.8 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 123.252 0.621 . . . . 0.0 109.73 167.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.52 -47.38 0.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.647 2.231 . . . . 0.0 110.335 172.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.4 p 157.13 82.25 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 128.536 2.734 . . . . 0.0 107.9 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.542 0.662 0 O-C-N 121.615 -0.678 . . . . 0.0 109.177 -171.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 CA--C 1.533 0.32 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -67.67 66.49 0.09 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.16 0.891 . . . . 0.0 109.969 161.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 171.36 91.83 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 130.04 3.336 . . . . 0.0 106.577 169.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.58 15.65 9.09 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -170.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.4 m -70.24 65.73 0.28 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 129.195 2.998 . . . . 0.0 110.536 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -153.79 -56.26 0.11 Allowed 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 130.972 3.709 . . . . 0.0 103.321 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.18 -20.84 19.49 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 116.691 -1.623 . . . . 0.0 113.958 174.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.7 mt -40.47 138.91 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 120.968 1.713 . . . . 0.0 115.064 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -122.41 173.25 7.77 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.505 1.922 . . . . 0.0 110.509 -171.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -86.04 -24.5 26.35 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.753 0.821 . . . . 0.0 112.673 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.93 148.05 22.14 Favored 'General case' 0 C--O 1.231 0.11 0 O-C-N 121.004 -1.06 . . . . 0.0 110.209 174.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -120.02 97.0 5.4 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.24 1.416 . . . . 0.0 108.562 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.9 142.64 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 124.736 1.214 . . . . 0.0 108.779 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.67 148.39 27.44 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.761 1.224 . . . . 0.0 109.099 -174.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.9 t -136.18 111.16 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 -171.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 m -91.82 122.78 34.67 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 173.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -96.01 107.85 20.19 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.629 1.172 . . . . 0.0 108.8 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -96.28 86.93 4.34 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 122.763 1.268 . . . . 0.0 110.027 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.96 136.91 37.38 Favored 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 120.744 -1.222 . . . . 0.0 108.419 173.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.93 146.14 50.24 Favored 'General case' 0 CA--C 1.523 -0.08 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.94 143.1 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.58 166.64 23.06 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.166 1.786 . . . . 0.0 106.983 168.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -42.56 -43.72 3.86 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 124.233 1.013 . . . . 0.0 112.285 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.56 -34.09 0.23 Allowed Glycine 0 CA--C 1.534 1.223 0 C-N-CA 126.214 1.864 . . . . 0.0 114.663 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.18 96.5 49.28 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 119.034 1.417 . . . . 0.0 107.961 162.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -84.73 43.2 1.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 124.095 3.197 . . . . 0.0 109.441 -169.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.425 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 41.1 m0 -115.5 144.42 43.87 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -169.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -76.74 79.93 3.36 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -175.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -89.36 98.44 11.77 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.236 1.014 . . . . 0.0 109.042 -174.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.9 m -102.45 138.21 19.61 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -70.44 163.03 40.28 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 121.622 1.548 . . . . 0.0 108.71 166.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.08 -61.92 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -175.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -131.7 156.99 44.94 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 162.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -23.95 64.99 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.072 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.57 162.59 41.12 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 119.078 0.854 . . . . 0.0 111.029 174.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.2 pt -135.33 166.55 27.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 126.074 1.75 . . . . 0.0 109.33 173.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -111.28 135.55 51.65 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.3 1.84 . . . . 0.0 109.435 164.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -137.42 128.98 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.369 1.867 . . . . 0.0 108.689 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -82.1 82.49 7.65 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 120.699 -1.25 . . . . 0.0 109.5 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.0 mt 17.38 69.58 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 128.768 2.827 . . . . 0.0 112.237 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.45 -25.64 4.76 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.239 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -48.7 108.54 0.18 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.839 0.455 . . . . 0.0 111.471 172.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.1 p -75.11 108.99 8.21 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.064 1.346 . . . . 0.0 109.801 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.8 p -114.57 145.46 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 122.841 0.456 . . . . 0.0 110.284 173.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.38 131.2 34.72 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 124.403 1.081 . . . . 0.0 110.253 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.6 pp -142.88 92.66 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.569 1.148 . . . . 0.0 109.887 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.36 133.22 37.6 Favored 'General case' 0 C--O 1.226 -0.144 0 O-C-N 121.432 -0.792 . . . . 0.0 111.618 -175.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -100.53 157.09 16.91 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 66.1 ttp85 -142.06 122.97 14.44 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.907 -0.568 . . . . 0.0 109.945 -175.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.43 154.77 36.1 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.52 1.128 . . . . 0.0 108.281 158.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -145.83 139.46 26.37 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 167.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.425 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 52.9 t-20 -82.8 118.53 23.47 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 120.177 1.353 . . . . 0.0 112.689 -172.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -100.83 -9.39 21.72 Favored 'General case' 0 C--N 1.346 0.442 0 C-N-CA 124.16 0.984 . . . . 0.0 113.222 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.37 142.44 36.01 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 119.857 1.208 . . . . 0.0 108.988 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.6 m -78.37 36.2 0.24 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.5 p -153.39 155.78 31.95 Favored Pre-proline 0 N--CA 1.451 -0.405 0 C-N-CA 125.591 1.557 . . . . 0.0 108.336 175.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.0 145.07 89.37 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 N-CA-C 108.235 -1.486 . . . . 0.0 108.235 169.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.0 p -117.55 178.14 4.5 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 168.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.1 t -124.27 126.43 46.06 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -98.26 109.17 3.75 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 107.167 -2.373 . . . . 0.0 107.167 175.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.58 49.37 1.8 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 162.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.82 143.89 55.64 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.375 0.67 . . . . 0.0 111.271 -175.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.12 155.89 27.27 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.754 174.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -151.66 147.22 26.47 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -103.4 100.77 10.65 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 170.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.6 p -89.06 83.52 2.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 CA-C-O 118.079 -0.962 . . . . 0.0 108.41 175.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.2 t 176.97 147.08 0.29 Allowed Pre-proline 0 C--O 1.232 0.162 0 C-N-CA 124.644 1.178 . . . . 0.0 109.496 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -64.26 -39.35 30.59 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 120.666 0.91 . . . . 0.0 110.342 156.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.1 ptp 177.9 -71.67 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.594 1.958 . . . . 0.0 107.976 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.15 -37.47 33.39 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.944 0.898 . . . . 0.0 112.859 -168.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.2 -118.05 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.315 0.646 . . . . 0.0 110.337 -174.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.0 -53.45 2.16 Favored Glycine 0 CA--C 1.526 0.72 0 O-C-N 121.216 -0.928 . . . . 0.0 112.652 -175.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -41.64 -58.86 1.81 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.844 1.258 . . . . 0.0 110.623 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -74.83 -8.61 56.97 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -53.67 117.72 3.36 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.36 0.982 . . . . 0.0 108.585 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -65.65 131.19 45.73 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.264 0.555 . . . . 0.0 111.398 -159.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -83.75 79.74 9.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -172.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.4 m -51.78 147.47 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.55 1.14 . . . . 0.0 112.91 -174.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 36.85 -114.16 0.1 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.376 2.27 . . . . 0.0 111.904 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 29.4 p -156.3 138.42 14.59 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 51.79 60.78 3.6 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -169.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 15.2 p -53.79 147.02 12.53 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.712 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 48.94 64.43 1.72 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.832 0.853 . . . . 0.0 110.664 -174.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.32 58.92 0.4 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.988 1.315 . . . . 0.0 110.851 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -63.28 -32.52 73.95 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.348 1.059 . . . . 0.0 112.838 -169.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.2 t 52.67 -143.52 0.7 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.173 0.989 . . . . 0.0 112.593 166.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.2 m -124.8 133.31 53.17 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 127.538 2.335 . . . . 0.0 105.864 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 86.8 mt -122.19 120.14 33.31 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 175.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -56.2 159.73 5.7 Favored Pre-proline 0 N--CA 1.447 -0.591 0 C-N-CA 123.864 0.865 . . . . 0.0 110.541 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -67.12 102.97 0.7 Allowed 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.202 2.601 . . . . 0.0 112.308 -169.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 122.63 -16.22 8.44 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -78.2 148.55 33.98 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 118.001 0.9 . . . . 0.0 110.877 -166.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.4 141.17 36.41 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.385 1.874 . . . . 0.0 109.173 -169.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 46.3 ttp -135.52 82.87 1.98 Allowed 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.621 1.168 . . . . 0.0 109.371 173.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -104.25 113.1 26.42 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.078 1.751 . . . . 0.0 107.725 171.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 40.4 mtm -137.29 126.62 15.26 Favored Pre-proline 0 C--O 1.235 0.337 0 CA-C-N 118.386 0.539 . . . . 0.0 111.748 -170.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -74.73 139.81 25.49 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.618 2.212 . . . . 0.0 112.517 173.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.7 t -128.99 151.04 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.1 p -118.28 142.16 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 170.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -144.53 158.31 43.82 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 118.948 0.795 . . . . 0.0 111.294 -175.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -162.28 168.61 22.03 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 127.671 2.389 . . . . 0.0 106.695 173.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 49.4 t -112.39 145.36 18.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 C-N-CA 124.252 1.021 . . . . 0.0 108.363 174.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -77.04 157.77 80.93 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 123.968 0.907 . . . . 0.0 110.924 -177.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -79.41 -22.65 7.96 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.723 2.282 . . . . 0.0 112.742 166.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -53.74 -37.12 63.03 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.234 1.013 . . . . 0.0 111.516 -171.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.2 tt -40.03 -34.09 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.534 1.934 . . . . 0.0 114.793 171.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.4 m -106.71 22.56 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 119.786 1.175 . . . . 0.0 112.956 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.1 -48.08 0.48 Allowed Pre-proline 0 CA--C 1.545 0.762 0 O-C-N 120.854 -1.154 . . . . 0.0 113.29 167.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -81.15 -165.73 0.36 Allowed 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.345 2.697 . . . . 0.0 110.374 -171.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.7 t -95.22 -51.23 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -31.85 -61.88 0.22 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 129.263 3.025 . . . . 0.0 113.499 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.2 p -92.5 -5.17 52.37 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 123.335 0.654 . . . . 0.0 112.641 -174.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -54.31 107.63 0.29 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.972 0.909 . . . . 0.0 111.295 -169.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 120.92 -27.22 6.54 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 123.98 0.8 . . . . 0.0 111.59 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 45.8 mm -64.7 125.67 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 118.168 0.984 . . . . 0.0 109.692 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -157.07 51.34 0.48 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.582 172.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.42 87.4 2.01 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 167.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.2 tp -88.88 89.31 7.93 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -160.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.6 t -102.01 171.95 7.21 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 122.443 1.116 . . . . 0.0 111.7 -171.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.97 108.33 2.38 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 -160.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.4 t -92.63 116.23 28.82 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 168.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -114.47 114.23 25.53 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 118.644 0.656 . . . . 0.0 109.579 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.4 m -100.63 87.17 3.28 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.392 0.677 . . . . 0.0 111.34 -167.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -67.87 84.16 0.21 Allowed 'General case' 0 CA--C 1.54 0.56 0 O-C-N 122.044 -0.41 . . . . 0.0 110.513 173.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.3 22.39 0.05 OUTLIER Pre-proline 0 CA--C 1.556 1.209 0 N-CA-C 118.448 2.759 . . . . 0.0 118.448 -175.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.87 -81.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.021 2.481 . . . . 0.0 113.424 -168.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.5 ptm85 -155.6 140.78 17.51 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 119.866 1.212 . . . . 0.0 113.102 177.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.62 147.83 44.17 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 125.765 1.626 . . . . 0.0 106.97 175.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.38 -37.02 0.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.371 2.048 . . . . 0.0 113.52 -176.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.8 m 155.26 96.52 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 129.533 3.133 . . . . 0.0 108.653 -174.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 18.2 pttp . . . . . 0 CA--C 1.538 0.484 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.501 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 CA--C 1.532 0.268 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . 0.255 3.3 tt0 27.78 64.57 0.1 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.491 2.316 . . . . 0.0 112.775 -174.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -173.06 141.34 0.96 Allowed 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 100.601 -3.851 . . . . 0.0 100.601 -168.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.91 -57.37 3.95 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 118.441 -1.304 . . . . 0.0 113.053 -143.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 83.4 p -153.72 172.93 16.52 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 156.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -79.06 -32.92 45.01 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.955 174.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -87.45 -41.47 13.52 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.279 1.031 . . . . 0.0 111.971 -170.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.1 mt 28.32 74.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 126.859 2.063 . . . . 0.0 112.655 -173.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -70.02 164.72 23.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.696 170.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -65.02 -31.69 73.04 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -176.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.23 129.78 10.29 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 122.276 1.036 . . . . 0.0 113.376 -165.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -91.74 83.28 5.27 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 122.374 1.083 . . . . 0.0 108.513 -169.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.65 120.48 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 171.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.82 170.63 9.54 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.558 1.143 . . . . 0.0 109.193 -170.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.6 t -144.94 146.42 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 169.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.7 m -141.3 104.12 4.55 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -176.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -82.15 125.09 30.49 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 125.596 1.559 . . . . 0.0 110.258 -174.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -102.51 89.05 3.41 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 163.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -99.96 89.11 3.95 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 172.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -111.69 151.32 29.02 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 123.805 0.842 . . . . 0.0 110.415 -171.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.39 105.71 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.985 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.22 150.96 36.98 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 163.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.82 -29.28 4.43 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.595 0.758 . . . . 0.0 112.901 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -36.97 -40.04 0.47 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.605 1.574 . . . . 0.0 113.791 170.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.32 120.13 46.38 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 162.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -84.33 14.62 2.39 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 121.451 1.434 . . . . 0.0 113.553 -169.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.463 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 41.1 m0 -79.25 156.64 28.03 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 121.969 0.89 . . . . 0.0 111.43 -177.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -74.9 138.81 42.66 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 104.262 -2.495 . . . . 0.0 104.262 158.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -143.99 128.87 18.42 Favored 'General case' 0 N--CA 1.458 -0.059 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.2 t -122.95 123.66 26.74 Favored Pre-proline 0 N--CA 1.444 -0.732 0 C-N-CA 125.311 1.444 . . . . 0.0 108.557 -168.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -74.81 146.64 33.73 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 123.958 3.106 . . . . 0.0 107.497 166.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.2 t -77.93 -58.59 3.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -170.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -122.51 163.91 19.06 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 103.41 -2.811 . . . . 0.0 103.41 155.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.1 tpt180 -58.07 -47.66 82.51 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 169.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -139.97 165.35 27.57 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 125.63 1.572 . . . . 0.0 110.27 -166.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.4 pt -141.79 162.8 20.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 C-N-CA 124.676 1.19 . . . . 0.0 108.226 175.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -106.4 139.41 40.92 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 162.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.05 81.33 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 175.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.7 mmm-85 -56.94 111.97 1.19 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.723 1.209 . . . . 0.0 110.687 -166.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.5 mm 16.4 56.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 126.239 1.816 . . . . 0.0 113.185 -160.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.45 -73.21 0.43 Allowed Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 22.19 86.52 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.347 2.259 . . . . 0.0 113.555 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.86 119.13 6.16 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.194 0.997 . . . . 0.0 111.541 -169.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.15 152.9 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 123.42 0.688 . . . . 0.0 110.481 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.75 126.09 51.84 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 126.471 1.908 . . . . 0.0 108.013 174.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.9 pp -125.36 113.49 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 168.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.87 106.49 10.93 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.27 0.628 . . . . 0.0 112.683 176.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -77.33 149.13 35.33 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 171.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 -139.01 138.28 37.08 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 123.418 0.449 . . . . 0.0 110.473 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.61 171.87 10.75 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.611 1.564 . . . . 0.0 110.046 164.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.6 136.45 15.36 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 177.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.463 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 37.6 t30 -78.12 128.49 33.88 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 120.258 1.39 . . . . 0.0 111.175 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 tp -118.95 26.01 9.82 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.671 1.988 . . . . 0.0 111.885 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -103.96 174.18 5.98 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.805 1.242 . . . . 0.0 110.201 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.3 p -97.06 11.37 36.42 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.043 1.337 . . . . 0.0 111.524 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.41 161.1 42.85 Favored Pre-proline 0 C--O 1.239 0.531 0 C-N-CA 125.071 1.348 . . . . 0.0 107.942 -177.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -56.4 158.7 14.9 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 121.382 1.388 . . . . 0.0 109.877 164.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.8 p -134.72 -177.83 4.79 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.848 2.459 . . . . 0.0 108.025 -176.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.1 t -138.6 140.46 38.97 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 159.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -94.46 93.73 1.7 Allowed Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 107.255 -2.338 . . . . 0.0 107.255 170.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -112.59 47.04 1.12 Allowed 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 167.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.62 170.4 16.39 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 171.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.5 t -144.6 158.96 43.54 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 166.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -84.9 155.17 21.8 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.242 1.417 . . . . 0.0 109.867 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -109.78 100.44 9.44 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 149.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.8 t -80.7 100.61 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 125.303 1.441 . . . . 0.0 107.477 174.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.6 t 172.27 151.25 0.21 Allowed Pre-proline 0 C--N 1.343 0.293 0 C-N-CA 126.825 2.05 . . . . 0.0 109.055 168.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -66.83 -49.31 1.57 Allowed 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 121.029 1.153 . . . . 0.0 109.584 153.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.1 ptt? -173.55 -72.7 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.989 1.715 . . . . 0.0 107.907 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.46 -40.47 85.35 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -171.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.46 -100.61 0.02 OUTLIER 'General case' 0 C--N 1.339 0.116 0 CA-C-N 117.912 0.324 . . . . 0.0 111.692 -170.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.09 -61.01 1.4 Allowed Glycine 0 CA--C 1.53 0.999 0 CA-C-O 119.447 -0.64 . . . . 0.0 111.799 -172.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.59 -56.67 5.69 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.837 1.255 . . . . 0.0 111.85 -176.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -72.97 5.0 3.6 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.405 1.082 . . . . 0.0 113.917 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -80.02 116.42 20.14 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 173.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -72.19 88.34 1.13 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 119.253 -0.979 . . . . 0.0 112.055 -171.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm 136.66 72.16 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 129.854 3.262 . . . . 0.0 109.309 167.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 15.2 t -97.67 -56.91 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 124.195 0.998 . . . . 0.0 111.978 -175.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -76.44 75.04 3.19 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -157.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 13.6 t -149.06 51.15 0.97 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.996 0.903 . . . . 0.0 109.454 164.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -80.67 61.72 4.46 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.59 0.71 . . . . 0.0 110.245 -176.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 51.1 t -164.99 51.09 0.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 172.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -85.67 165.52 16.91 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.045 -156.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.8 t -159.44 152.42 21.95 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -119.74 44.52 2.37 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.011 1.324 . . . . 0.0 108.124 162.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . 0.255 6.3 t 50.16 -124.38 2.1 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.358 1.463 . . . . 0.0 111.962 170.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.0 m -145.16 151.28 38.19 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.66 2.384 . . . . 0.0 107.255 -172.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 70.5 mt -135.8 132.67 37.0 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 171.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -64.19 158.15 65.95 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 125.04 1.336 . . . . 0.0 109.959 169.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.18 93.68 0.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.712 2.941 . . . . 0.0 112.539 -169.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 140.25 -28.7 2.46 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -77.93 150.55 34.01 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 117.594 0.697 . . . . 0.0 112.531 -155.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -86.18 155.84 20.57 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.82 2.048 . . . . 0.0 110.527 -174.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 19.2 ttm -148.75 89.22 1.67 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.414 1.086 . . . . 0.0 109.417 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -106.89 143.9 34.31 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.167 0.894 . . . . 0.0 110.657 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -150.09 107.63 3.21 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 124.147 0.979 . . . . 0.0 112.33 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.71 108.61 0.27 Allowed 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 124.961 3.774 . . . . 0.0 112.541 165.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.3 t -100.97 117.86 46.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 171.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.8 p -79.19 142.02 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 168.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -154.78 159.33 40.56 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -175.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -177.7 160.79 1.58 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.322 2.249 . . . . 0.0 109.928 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 94.6 t -121.41 131.8 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.6 1.16 . . . . 0.0 109.689 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.1 148.17 38.78 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -176.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -74.76 57.81 4.52 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 124.202 3.268 . . . . 0.0 112.698 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -104.02 -41.67 5.78 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.053 0.941 . . . . 0.0 109.833 162.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.8 tt -47.89 -42.9 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 124.361 1.064 . . . . 0.0 113.846 -169.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.2 m -78.83 51.05 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 O-C-N 121.064 -1.022 . . . . 0.0 111.166 176.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -133.7 -72.28 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 124.796 1.239 . . . . 0.0 111.147 173.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.08 136.75 45.69 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 121.833 1.688 . . . . 0.0 112.675 -175.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 97.6 t -40.6 -53.23 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 126.4 1.88 . . . . 0.0 109.751 178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -33.19 -47.28 0.19 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 127.893 2.477 . . . . 0.0 113.759 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 35.1 p -106.42 -6.94 17.86 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -173.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -57.7 107.45 0.45 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.379 0.991 . . . . 0.0 111.031 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 132.14 -38.35 1.91 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.035 1.303 . . . . 0.0 109.895 -173.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 23.5 mm -70.17 121.94 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 O-C-N 122.186 -0.597 . . . . 0.0 111.045 -175.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -156.33 54.65 0.56 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 122.086 0.946 . . . . 0.0 111.016 166.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 66.6 m -146.84 93.4 2.27 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 159.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.1 tp -84.62 88.41 7.34 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.388 0.613 . . . . 0.0 109.677 -162.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.6 m -86.27 155.96 20.46 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.055 0.942 . . . . 0.0 110.88 -162.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 14.6 tp -123.06 131.18 53.59 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 170.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.0 p -114.01 107.45 15.69 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 165.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -109.77 91.89 3.83 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.927 0.891 . . . . 0.0 109.261 -175.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.5 p -78.93 93.11 5.0 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.458 0.703 . . . . 0.0 110.004 176.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -59.43 96.0 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 159.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.57 61.31 3.83 Favored Pre-proline 0 CA--C 1.549 0.928 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 172.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -86.94 -99.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 124.123 3.215 . . . . 0.0 110.149 174.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -127.72 133.86 49.55 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 124.47 1.108 . . . . 0.0 110.297 -176.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.86 117.23 42.25 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 126.831 2.052 . . . . 0.0 105.809 174.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.44 -26.77 6.96 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.836 2.358 . . . . 0.0 112.95 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.7 m 140.82 101.73 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 129.553 3.141 . . . . 0.0 108.927 -175.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.518 0 C-N-CA 123.58 0.752 . . . . 0.0 112.845 -178.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.6 m . . . . . 0 C--O 1.232 0.169 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -74.27 67.65 1.41 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 122.306 1.05 . . . . 0.0 109.642 176.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.81 -76.79 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 128.53 2.732 . . . . 0.0 104.365 173.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -165.68 -58.06 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.374 1.87 . . . . 0.0 110.979 147.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.1 t -146.55 58.43 1.19 Allowed 'General case' 0 C--N 1.344 0.363 0 C-N-CA 130.447 3.499 . . . . 0.0 107.91 13.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -157.24 -54.52 0.08 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.868 2.067 . . . . 0.0 105.677 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.1 mt -27.72 -24.03 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.564 1 C-N-CA 132.658 4.383 . . . . 0.0 116.946 174.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.4 mt -81.6 51.62 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 126.023 1.729 . . . . 0.0 110.649 -160.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.48 164.18 24.96 Favored 'General case' 0 C--N 1.334 -0.101 0 O-C-N 121.348 -0.845 . . . . 0.0 108.742 -176.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -74.86 73.88 2.12 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 122.558 1.17 . . . . 0.0 112.007 -175.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.46 160.37 40.28 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 129.854 3.262 . . . . 0.0 106.624 173.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -146.76 111.46 5.27 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -173.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.82 124.3 72.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -169.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.74 149.12 25.1 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 124.358 1.063 . . . . 0.0 109.336 -176.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.5 t -141.37 96.65 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -171.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.4 m -79.86 107.22 12.47 Favored 'General case' 0 C--O 1.221 -0.422 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 169.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -79.51 166.88 21.49 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 171.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -136.53 90.41 2.55 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 122.137 0.97 . . . . 0.0 111.972 167.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.81 127.25 32.39 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 158.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -132.42 150.87 52.08 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 124.497 1.119 . . . . 0.0 108.248 173.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.97 99.9 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 124.018 0.927 . . . . 0.0 109.339 -178.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.08 169.21 10.81 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.357 0.599 . . . . 0.0 110.058 168.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.29 147.5 35.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 169.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 113.77 -20.6 17.41 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -168.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.62 95.36 11.29 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 123.77 0.828 . . . . 0.0 109.523 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -84.31 45.82 1.81 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.679 2.919 . . . . 0.0 110.45 -169.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.488 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 44.4 m0 -113.89 147.03 39.18 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.935 0.894 . . . . 0.0 109.787 -165.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -76.63 81.87 3.28 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 104.588 -2.375 . . . . 0.0 104.588 173.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -90.89 108.83 20.1 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.06 121.54 16.86 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -171.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -81.53 166.3 17.83 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.631 2.221 . . . . 0.0 108.7 168.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -77.07 -40.41 30.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 122.114 -0.366 . . . . 0.0 111.249 177.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.64 175.26 13.89 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 172.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -60.35 -59.26 5.69 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 167.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -137.32 130.8 31.28 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 122.853 0.461 . . . . 0.0 112.098 -155.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.7 pt -99.86 175.85 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 169.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -126.97 150.89 49.18 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 152.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.6 m -130.35 131.31 65.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . 0.255 4.3 tpt180 -72.62 74.5 1.08 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 167.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.4 pt 15.68 51.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 131.111 3.764 . . . . 0.0 115.286 -176.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.12 -39.44 0.77 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.491 -169.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -36.01 109.58 0.09 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.743 1.217 . . . . 0.0 111.153 168.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.07 99.06 6.75 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.347 1.459 . . . . 0.0 109.068 -168.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 p -76.52 176.39 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.959 0.885 . . . . 0.0 110.809 -171.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.13 89.84 2.38 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 172.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.9 pp -105.48 118.98 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 173.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 89.6 mtp -77.27 140.56 40.09 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -111.73 145.08 39.94 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 168.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -140.86 135.32 31.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.956 0.902 . . . . 0.0 109.962 -177.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.39 90.97 1.7 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.691 1.996 . . . . 0.0 110.033 174.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -79.32 148.34 32.12 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 117.044 -1.455 . . . . 0.0 107.996 172.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.488 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 35.7 t30 -89.82 110.18 21.13 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 120.332 1.424 . . . . 0.0 111.469 172.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.3 tp -86.88 -4.65 59.2 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.379 1.071 . . . . 0.0 112.809 -176.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.2 171.17 14.96 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.397 -0.815 . . . . 0.0 109.873 -175.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.0 m -105.78 18.54 21.99 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.506 175.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.8 p -144.61 160.17 48.6 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 127.411 2.284 . . . . 0.0 106.428 170.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.07 152.77 79.6 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.523 1.482 . . . . 0.0 109.836 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.36 167.12 15.38 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.445 0.641 . . . . 0.0 111.146 166.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.4 t -98.64 168.24 10.29 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 113.888 -1.506 . . . . 0.0 107.834 156.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -145.26 63.8 0.46 Allowed Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 106.345 -2.702 . . . . 0.0 106.345 173.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.39 56.25 3.29 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 -176.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.51 147.66 32.11 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.148 -1.387 . . . . 0.0 111.177 -164.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 m -79.76 160.89 26.02 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 174.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -143.32 138.99 29.9 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 172.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.97 90.59 4.96 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 169.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.6 57.82 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 O-C-N 121.837 -0.539 . . . . 0.0 110.702 -176.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.1 t -171.17 145.0 1.8 Allowed Pre-proline 0 C--N 1.333 -0.144 0 O-C-N 121.538 -0.726 . . . . 0.0 111.484 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.87 -37.38 66.85 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 121.456 1.437 . . . . 0.0 108.763 164.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.5 ptm -179.95 -68.59 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.556 1.942 . . . . 0.0 107.617 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -90.25 -28.61 18.71 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.138 0.975 . . . . 0.0 112.831 -164.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.44 -114.56 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.396 0.278 . . . . 0.0 110.489 -168.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.27 -40.24 0.47 Allowed Glycine 0 CA--C 1.533 1.18 0 O-C-N 121.314 -0.866 . . . . 0.0 114.778 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -51.87 -65.15 0.61 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.11 1.455 . . . . 0.0 108.302 166.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -72.7 29.0 0.06 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.469 2.308 . . . . 0.0 112.173 177.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -105.18 101.3 10.86 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 168.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -53.88 139.38 33.83 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 122.7 0.4 . . . . 0.0 111.313 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -121.5 135.63 55.01 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.9 m -75.21 -40.17 43.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 122.691 0.396 . . . . 0.0 111.625 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -120.45 -59.33 1.78 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.266 1.026 . . . . 0.0 110.248 -169.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 19.2 t 54.09 50.15 17.23 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.926 0.891 . . . . 0.0 111.668 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -157.9 -69.47 0.09 Allowed 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 59.7 m -101.54 172.81 6.74 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 166.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -137.56 176.37 8.77 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 126.185 1.794 . . . . 0.0 106.331 167.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.9 t -87.94 -17.63 30.9 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.748 0.703 . . . . 0.0 112.212 -159.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -85.5 -59.73 2.23 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.208 0.603 . . . . 0.0 109.885 -169.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . 0.32 13.2 t 52.5 -71.84 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 117.849 2.537 . . . . 0.0 117.849 161.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -159.65 143.75 14.78 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.592 1.557 . . . . 0.0 109.383 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.6 mt -151.77 140.95 21.32 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.217 1.007 . . . . 0.0 110.273 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.9 mp0 -74.89 161.28 78.27 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 127.085 2.154 . . . . 0.0 110.392 172.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -75.51 111.11 3.23 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.74 1.626 . . . . 0.0 113.21 -165.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 115.13 -12.13 19.8 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 176.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -85.77 152.09 23.31 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.2 -161.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -107.6 122.37 46.55 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.75 1.22 . . . . 0.0 109.311 -160.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.73 112.7 17.04 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 124.597 1.159 . . . . 0.0 110.213 177.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -143.05 145.87 33.3 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.759 0.709 . . . . 0.0 110.176 160.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 23.5 ptm -156.3 156.27 30.0 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-O 119.135 -0.46 . . . . 0.0 111.051 173.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.89 148.23 81.88 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.374 2.716 . . . . 0.0 111.996 171.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.6 t -126.23 134.6 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.93 1.692 . . . . 0.0 106.878 167.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.6 p -100.02 143.96 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.999 1.32 . . . . 0.0 108.015 174.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -158.95 146.85 17.85 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -176.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -164.77 95.34 0.71 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.034 0.533 . . . . 0.0 111.81 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.2 t -40.64 130.71 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 125.936 1.694 . . . . 0.0 112.99 -173.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.3 119.71 77.28 Favored Pre-proline 0 N--CA 1.44 -0.968 0 C-N-CA 125.277 1.431 . . . . 0.0 107.283 -169.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.13 55.8 4.67 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.147 2.565 . . . . 0.0 111.823 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -109.5 -28.68 8.78 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.997 2.119 . . . . 0.0 109.523 169.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.4 tt -54.98 -42.98 67.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -173.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.6 m -78.09 51.89 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 118.78 0.718 . . . . 0.0 111.037 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -139.42 -69.59 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.901 -177.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -73.48 152.41 48.9 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.295 1.996 . . . . 0.0 113.449 -175.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.5 p -55.27 -30.91 25.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.136 1.374 . . . . 0.0 111.886 175.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -36.23 -55.3 0.8 Allowed 'General case' 0 C--N 1.339 0.115 0 C-N-CA 126.691 1.996 . . . . 0.0 112.311 173.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.4 p -108.58 -54.93 2.45 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.121 -163.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 26.67 51.84 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.382 2.673 . . . . 0.0 115.229 169.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 144.57 -40.58 1.15 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -170.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 35.0 mm -55.64 119.55 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 169.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.96 45.35 0.39 Allowed 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 123.711 0.632 . . . . 0.0 109.737 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.43 91.6 1.99 Allowed 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 171.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.1 mp -76.07 150.06 37.36 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -172.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.7 t -148.21 175.57 10.95 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -178.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.5 tt -154.32 110.3 3.22 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 174.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.8 t -87.82 95.96 10.28 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.19 92.88 6.37 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -174.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.14 89.33 5.99 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 122.245 1.021 . . . . 0.0 110.584 -170.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -78.14 98.19 5.73 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.733 173.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -153.05 37.66 0.11 Allowed Pre-proline 0 CA--C 1.552 1.032 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 172.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -72.8 -90.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.694 0 CA-C-N 122.033 1.762 . . . . 0.0 113.557 -174.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 31.9 mtt85 -148.58 110.12 4.45 Favored 'General case' 0 C--N 1.34 0.187 0 O-C-N 121.352 -0.843 . . . . 0.0 109.211 -174.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.414 ' OE2' ' NZ ' ' A' ' 151' ' ' LYS . 10.9 pt-20 -97.26 122.07 56.96 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 172.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -79.46 -51.68 0.06 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.55 2.167 . . . . 0.0 110.512 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 44.6 p -171.67 111.23 0.31 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.993 -0.527 . . . . 0.0 109.587 -167.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.414 ' NZ ' ' OE2' ' A' ' 148' ' ' GLU . 21.7 pttm . . . . . 0 CA--C 1.538 0.506 0 C-N-CA 123.362 0.665 . . . . 0.0 112.398 172.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.1 t . . . . . 0 CA--C 1.539 0.53 0 N-CA-C 110.751 -0.092 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 48.06 63.73 1.93 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.572 1.149 . . . . 0.0 112.102 173.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.0 -4.12 2.21 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 124.257 1.023 . . . . 0.0 112.691 -177.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.77 120.59 15.75 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 116.758 -1.977 . . . . 0.0 108.263 -107.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.8 t -164.7 47.03 0.1 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.377 1.071 . . . . 0.0 109.822 -171.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -156.4 -51.39 0.08 Allowed 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 124.494 1.118 . . . . 0.0 108.372 -175.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.31 -27.73 69.23 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.782 175.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.6 mt -80.81 131.73 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 C-N-CA 123.731 0.812 . . . . 0.0 112.165 -161.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.94 148.97 38.02 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 171.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -78.26 67.29 4.03 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 122.128 0.966 . . . . 0.0 112.154 -167.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.56 -169.54 1.66 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 129.556 3.142 . . . . 0.0 106.381 175.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -145.31 137.13 25.48 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.305 -0.872 . . . . 0.0 110.217 168.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.42 103.67 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 C-N-CA 126.162 1.785 . . . . 0.0 106.65 -177.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -79.4 131.1 36.0 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -177.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.1 t -113.1 132.76 61.03 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.2 m -106.7 101.53 10.97 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.299 1.44 . . . . 0.0 109.235 -173.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -79.05 84.22 5.07 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -171.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -84.19 83.61 7.91 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 122.931 1.348 . . . . 0.0 111.447 -172.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.74 123.49 31.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.699 176.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -131.22 142.87 50.23 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 173.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.7 t -135.78 141.91 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -117.71 157.09 27.12 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 161.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.95 -33.14 7.29 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.812 0.845 . . . . 0.0 112.299 -175.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -31.21 -44.69 0.11 Allowed Glycine 0 CA--C 1.531 1.089 0 C-N-CA 126.828 2.156 . . . . 0.0 114.323 165.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.37 108.57 57.79 Favored Pre-proline 0 N--CA 1.454 -0.225 0 CA-C-N 119.475 1.638 . . . . 0.0 107.008 161.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.76 -3.51 12.41 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 121.148 1.232 . . . . 0.0 113.3 -164.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.492 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 47.6 m0 -73.34 154.73 39.98 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.591 1.156 . . . . 0.0 111.297 -167.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -76.6 81.75 3.26 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 171.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -95.65 124.42 39.66 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.6 m -125.8 138.08 31.3 Favored Pre-proline 0 CA--C 1.532 0.256 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -70.18 161.47 45.88 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 N-CA-C 108.377 -1.432 . . . . 0.0 108.377 161.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -77.78 -46.73 26.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 175.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.77 174.81 14.77 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 166.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -67.11 -33.42 75.43 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.118 0.417 . . . . 0.0 111.836 -174.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.76 161.72 39.78 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.025 0.93 . . . . 0.0 110.346 -171.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.5 pt -130.37 160.28 41.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 172.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -106.65 95.37 5.69 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.221 1.008 . . . . 0.0 109.359 168.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.2 t -77.54 167.35 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 168.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 23.1 mtm180 -128.35 98.47 5.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 171.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.1 pt 9.05 69.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 127.76 2.424 . . . . 0.0 114.725 -175.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.27 -34.26 2.74 Favored Glycine 0 C--O 1.22 -0.768 0 C-N-CA 124.807 1.194 . . . . 0.0 111.33 173.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -50.08 106.52 0.12 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 118.83 1.315 . . . . 0.0 112.245 -166.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.2 m -67.82 108.94 3.17 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.648 1.179 . . . . 0.0 111.359 -171.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.1 p -86.81 176.48 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 123.299 0.64 . . . . 0.0 110.322 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -124.52 129.97 51.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.819 0.848 . . . . 0.0 109.471 161.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.5 pp -139.45 96.12 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.655 1.182 . . . . 0.0 110.661 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 35.7 ttm -77.59 100.05 5.97 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.934 0.894 . . . . 0.0 111.342 -174.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -77.65 164.52 25.23 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.886 -0.509 . . . . 0.0 110.92 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.8 ttm105 -144.94 138.39 26.85 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.542 1.137 . . . . 0.0 111.799 -177.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.19 149.51 48.96 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 130.041 3.336 . . . . 0.0 107.608 159.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -137.17 135.62 37.49 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 161.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.492 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 0.1 OUTLIER -79.89 83.6 5.79 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.644 1.111 . . . . 0.0 111.301 -172.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.42 75.98 8.36 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.923 1.289 . . . . 0.0 108.902 171.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.06 158.62 44.16 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 167.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.1 t -87.6 -1.22 57.8 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 119.148 -0.453 . . . . 0.0 111.88 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.11 160.83 41.79 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.788 1.235 . . . . 0.0 109.076 -175.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.37 139.93 32.66 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.18 2.587 . . . . 0.0 111.902 -170.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.3 p -105.59 -176.07 2.97 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.393 1.877 . . . . 0.0 110.69 -169.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.4 t -148.39 136.05 20.69 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 160.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -123.42 76.01 0.37 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -170.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.86 33.21 1.05 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.495 0.718 . . . . 0.0 110.812 -171.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.51 162.11 29.91 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.365 0.602 . . . . 0.0 111.733 -162.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.4 t -144.44 178.06 8.21 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.288 0.635 . . . . 0.0 109.802 175.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.17 164.85 26.75 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 125.955 1.702 . . . . 0.0 110.973 -167.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -120.82 86.73 2.62 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.927 1.691 . . . . 0.0 107.103 174.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.401 HG11 ' CD2' ' A' ' 95' ' ' PHE . 3.2 t -82.31 54.47 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.823 -164.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.2 t -171.47 143.21 1.48 Allowed Pre-proline 0 N--CA 1.457 -0.112 0 O-C-N 121.393 -0.817 . . . . 0.0 110.317 -169.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.02 -36.43 30.14 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 121.695 1.597 . . . . 0.0 108.044 169.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.5 ptp 177.31 -68.26 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 127.824 2.449 . . . . 0.0 106.745 176.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.87 -48.33 69.12 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.719 1.208 . . . . 0.0 113.055 -165.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.27 -102.3 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.669 -162.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.23 -61.04 0.25 Allowed Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.498 -0.612 . . . . 0.0 113.352 -173.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -45.59 -50.79 12.84 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.004 1.322 . . . . 0.0 111.216 177.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -72.93 5.19 3.45 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.906 1.283 . . . . 0.0 113.632 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.417 ' CE1' ' CZ ' ' A' ' 120' ' ' PHE . 9.6 t80 -72.35 131.39 42.58 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 121.098 -1.001 . . . . 0.0 109.8 174.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -81.41 95.64 7.12 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 119.822 -0.751 . . . . 0.0 112.878 172.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -119.73 176.17 5.52 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.865 1.266 . . . . 0.0 109.981 164.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.9 m -79.69 -154.0 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 124.194 0.998 . . . . 0.0 108.906 162.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -77.08 -179.57 5.66 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.332 -0.855 . . . . 0.0 110.857 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.8 t 64.72 -163.28 0.26 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.538 1.135 . . . . 0.0 111.431 174.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -171.11 -178.01 2.33 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.409 1.884 . . . . 0.0 107.311 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 65.4 m 75.32 168.81 0.28 Allowed 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 126.481 1.913 . . . . 0.0 111.555 -175.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -122.97 68.36 0.98 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 164.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 21.0 p -75.89 78.13 2.79 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 173.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -78.46 43.34 0.46 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.807 1.243 . . . . 0.0 111.168 -175.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.9 t 42.99 -145.17 0.08 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.104 1.762 . . . . 0.0 112.989 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -119.22 124.66 47.28 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 127.586 2.354 . . . . 0.0 106.101 177.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 97.3 mt -106.3 151.52 24.73 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 173.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -91.97 163.76 26.25 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 126.012 1.725 . . . . 0.0 108.394 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.73 79.88 1.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.647 2.898 . . . . 0.0 112.272 -167.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 157.85 -29.87 0.49 Allowed Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.821 -175.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -76.29 135.18 39.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.573 1.187 . . . . 0.0 112.034 -153.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -86.83 137.6 32.27 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.295 1.438 . . . . 0.0 110.57 -178.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 1.7 mmt -133.9 85.53 2.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.088 1.355 . . . . 0.0 109.532 176.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.68 128.25 45.12 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.35 0.66 . . . . 0.0 109.444 173.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 84.9 mtp -150.98 147.54 20.96 Favored Pre-proline 0 C--O 1.234 0.241 0 C-N-CA 123.399 0.68 . . . . 0.0 109.812 -165.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.18 146.28 63.25 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.785 2.323 . . . . 0.0 110.44 174.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.7 t -144.32 147.51 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.0 m -109.34 164.59 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 174.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.417 ' CZ ' ' CE1' ' A' ' 95' ' ' PHE . 4.1 t80 -156.1 129.49 8.22 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.65 168.83 23.13 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 122.904 0.482 . . . . 0.0 110.476 168.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 18.2 t -119.14 129.46 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.809 1.243 . . . . 0.0 109.709 176.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.89 133.54 58.19 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 118.923 0.783 . . . . 0.0 110.249 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -56.34 -23.03 44.29 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.328 2.685 . . . . 0.0 114.767 -171.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -56.75 -13.68 2.72 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 119.182 0.901 . . . . 0.0 112.861 176.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.4 tt -46.05 -42.32 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 O-C-N 121.087 -1.008 . . . . 0.0 111.718 165.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.2 m -87.09 63.15 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 119.372 0.987 . . . . 0.0 110.9 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 51.8 mttt -130.27 -67.8 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 124.184 0.994 . . . . 0.0 112.345 164.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -85.27 162.66 11.34 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 121.8 1.666 . . . . 0.0 114.188 -160.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 99.2 t -53.96 -35.1 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 125.754 1.622 . . . . 0.0 110.874 176.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -38.54 -57.12 1.2 Allowed 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.475 1.51 . . . . 0.0 111.169 173.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 14.1 p -102.8 -53.45 2.85 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 123.965 0.906 . . . . 0.0 109.197 -163.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 26.15 55.34 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.152 2.581 . . . . 0.0 115.175 174.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 134.99 -36.98 1.99 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -176.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.1 mm -51.43 125.97 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 123.182 0.593 . . . . 0.0 109.864 173.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.4 49.57 0.49 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.78 0.832 . . . . 0.0 109.79 175.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.18 89.91 1.77 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -178.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.0 mp -76.44 162.25 28.0 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 122.294 1.045 . . . . 0.0 108.81 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.4 t -155.03 178.79 9.8 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.94 88.53 1.47 Allowed 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 124.471 1.107 . . . . 0.0 109.029 165.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.1 t -75.72 107.26 7.77 Favored 'General case' 0 N--CA 1.457 -0.093 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -178.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -112.67 137.05 51.52 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 122.775 0.43 . . . . 0.0 109.888 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 32.2 m -118.45 91.51 3.58 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.532 1.533 . . . . 0.0 107.82 177.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -72.27 97.72 2.05 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.946 178.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -156.11 58.28 1.71 Allowed Pre-proline 0 CA--C 1.551 1.018 0 N-CA-C 116.894 2.183 . . . . 0.0 116.894 -177.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -80.68 -90.8 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.424 2.749 . . . . 0.0 112.445 175.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.17 104.97 2.85 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.658 0.663 . . . . 0.0 111.631 -171.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -79.3 140.12 56.4 Favored Pre-proline 0 N--CA 1.449 -0.522 0 O-C-N 121.547 -0.721 . . . . 0.0 109.173 174.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -84.35 60.17 6.08 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 121.981 1.787 . . . . 0.0 107.711 169.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 19.9 m 44.39 81.27 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.88 2.072 . . . . 0.0 113.514 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.7 pttt . . . . . 0 CA--C 1.543 0.677 0 CA-C-N 119.026 0.83 . . . . 0.0 112.111 -170.001 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 38.92 57.03 1.95 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.782 1.633 . . . . 0.0 112.194 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -143.47 165.69 26.85 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 122.82 1.295 . . . . 0.0 111.076 176.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.456 ' CB ' ' H ' ' A' ' 63' ' ' THR . . . -149.16 95.17 2.34 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 110.829 -2.896 . . . . 0.0 104.165 175.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.3 m -157.27 25.71 0.3 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -159.26 -55.13 0.06 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 -174.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.62 37.26 0.86 Allowed 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 112.699 -2.046 . . . . 0.0 110.892 -161.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.8 mt -111.85 107.7 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 122.745 0.418 . . . . 0.0 109.895 -168.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -103.49 140.98 36.77 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.22 -29.85 34.69 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.516 1.926 . . . . 0.0 113.857 -169.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.09 148.6 6.03 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.953 1.301 . . . . 0.0 110.648 -178.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.5 mmmt -120.48 89.33 3.11 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.891 1.676 . . . . 0.0 108.677 -158.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.45 141.83 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 123.42 0.688 . . . . 0.0 110.348 -176.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -99.14 145.8 26.8 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.509 1.524 . . . . 0.0 108.54 -172.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.1 t -136.14 98.12 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 -173.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.6 m -88.12 105.76 17.71 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -83.74 109.23 17.33 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.651 1.18 . . . . 0.0 108.202 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -107.01 86.24 2.28 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.553 0.692 . . . . 0.0 110.055 -173.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.96 112.2 23.05 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.453 -0.78 . . . . 0.0 110.382 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -111.65 122.21 47.21 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.117 0.967 . . . . 0.0 109.668 -177.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.6 t -100.46 108.76 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 170.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.14 154.65 31.03 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 162.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.45 -38.28 8.9 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.42 0.688 . . . . 0.0 111.655 177.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -39.15 -34.77 0.36 Allowed Glycine 0 CA--C 1.53 1.031 0 C-N-CA 126.992 2.234 . . . . 0.0 114.694 172.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.409 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 0.4 OUTLIER -108.95 101.1 43.07 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 119.567 1.684 . . . . 0.0 108.497 165.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -83.37 46.19 2.04 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.877 3.051 . . . . 0.0 110.857 -170.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.501 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 44.7 m0 -116.06 157.13 25.17 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 125.034 1.334 . . . . 0.0 108.735 -172.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -74.3 141.66 45.26 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 162.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -147.44 113.82 5.94 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 169.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.0 t -100.15 111.4 62.19 Favored Pre-proline 0 N--CA 1.439 -1.011 0 C-N-CA 127.036 2.134 . . . . 0.0 107.058 -172.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -62.77 146.67 95.16 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.533 2.156 . . . . 0.0 107.757 167.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -75.79 -46.8 34.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -170.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.82 165.97 32.86 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 152.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -57.42 -41.1 79.72 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 118.366 0.53 . . . . 0.0 111.048 -174.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.95 158.36 43.87 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 122.95 0.5 . . . . 0.0 110.223 -176.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.4 pt -126.62 168.4 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 C-N-CA 123.461 0.705 . . . . 0.0 109.613 168.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -95.47 146.35 24.49 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 154.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.25 141.23 45.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 104.183 -2.525 . . . . 0.0 104.183 156.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -64.47 164.91 10.71 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 120.541 1.519 . . . . 0.0 107.774 160.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.8 mm -63.74 91.61 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.9 33.22 5.33 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.802 1.667 . . . . 0.0 113.783 178.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -102.3 107.02 17.92 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.034 1.417 . . . . 0.0 112.694 176.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.456 ' H ' ' CB ' ' A' ' 24' ' ' ALA . 15.9 m -66.71 113.7 5.04 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.114 1.366 . . . . 0.0 111.318 177.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.1 p -126.51 146.69 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 118.45 0.568 . . . . 0.0 110.373 169.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.21 137.96 31.93 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 125.516 1.526 . . . . 0.0 110.552 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -141.94 97.71 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 17.1 tmm? -78.92 126.56 30.86 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.936 1.294 . . . . 0.0 111.678 -176.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -102.35 143.91 31.5 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.829 1.252 . . . . 0.0 109.682 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 42.8 ttt85 -126.24 141.19 52.02 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 125.025 1.33 . . . . 0.0 109.283 -176.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.91 166.15 27.63 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.284 1.833 . . . . 0.0 109.903 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -153.95 147.76 25.4 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.308 1.043 . . . . 0.0 108.738 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.501 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 46.2 t-20 -83.95 115.75 22.46 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 119.879 1.218 . . . . 0.0 111.215 175.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 81.5 mt -106.75 16.32 24.57 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.621 1.169 . . . . 0.0 112.582 -178.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.28 164.76 12.9 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.416 -0.802 . . . . 0.0 109.726 169.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.0 m -96.83 30.02 2.82 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.864 176.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.3 p -149.57 161.3 32.12 Favored Pre-proline 0 N--CA 1.448 -0.528 0 C-N-CA 125.082 1.353 . . . . 0.0 108.363 178.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.72 121.55 8.25 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 121.555 1.503 . . . . 0.0 109.032 170.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.5 159.3 15.26 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.334 0.587 . . . . 0.0 110.885 171.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.9 t -97.93 158.63 15.42 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 162.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -153.15 77.79 0.21 Allowed Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 105.366 -3.094 . . . . 0.0 105.366 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.52 66.26 0.68 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 175.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.19 168.34 19.32 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.482 -166.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 35.3 m -106.39 159.15 16.36 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -147.77 143.91 27.86 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.958 -0.464 . . . . 0.0 110.341 171.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.98 101.26 12.7 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 166.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.6 p -87.7 81.17 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.0 t 176.54 150.72 0.34 Allowed Pre-proline 0 CA--C 1.529 0.164 0 C-N-CA 125.556 1.542 . . . . 0.0 109.15 178.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.65 -35.21 22.92 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 CA-C-N 119.364 0.809 . . . . 0.0 110.383 157.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.5 ptp 176.68 -67.05 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 127.163 2.185 . . . . 0.0 107.545 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.18 -41.75 33.66 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -169.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.33 -104.07 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.88 0.372 . . . . 0.0 111.816 -166.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.14 -54.67 0.59 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 123.925 0.774 . . . . 0.0 113.26 -172.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -47.25 -52.83 14.95 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.987 1.394 . . . . 0.0 110.927 176.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -74.22 10.21 1.34 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -81.86 98.48 8.53 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 172.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -67.49 148.73 51.12 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 117.66 -1.616 . . . . 0.0 109.752 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? 61.87 69.17 0.65 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.294 1.038 . . . . 0.0 110.116 -176.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.8 m -71.27 153.07 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.374 166.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 51.13 -138.58 1.04 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.18 0.992 . . . . 0.0 111.068 175.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 7.4 t -167.62 60.97 0.08 Allowed 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 44.4 t80 48.62 -111.03 0.41 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.642 0.777 . . . . 0.0 109.777 -172.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 19.6 p -70.86 4.52 2.51 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.941 1.696 . . . . 0.0 114.156 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.6 t80 101.75 156.5 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 127.989 2.516 . . . . 0.0 110.78 168.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 28.1 m -80.25 -94.7 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.341 1.056 . . . . 0.0 109.777 -173.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.2 pm0 -61.72 162.23 8.92 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.93 0.892 . . . . 0.0 111.273 171.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.4 -70.34 0.13 Allowed 'General case' 0 CA--C 1.529 0.163 0 O-C-N 121.623 -0.673 . . . . 0.0 112.121 178.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.1 t -157.46 146.87 20.09 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.186 0.994 . . . . 0.0 108.73 -176.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.6 mt -150.44 136.1 18.2 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.764 0.711 . . . . 0.0 110.589 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -76.29 163.65 64.98 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.487 1.115 . . . . 0.0 109.967 174.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.42 106.1 1.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.242 1.961 . . . . 0.0 111.651 -163.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 111.58 -3.05 27.73 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 124.098 0.856 . . . . 0.0 111.24 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -76.6 146.14 38.46 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 118.368 1.084 . . . . 0.0 110.888 -173.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -97.09 147.24 24.24 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.669 1.188 . . . . 0.0 109.25 -176.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 17.2 ttt -150.95 111.42 4.2 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 118.734 -0.651 . . . . 0.0 111.169 -173.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -132.28 146.55 52.07 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 119.74 1.155 . . . . 0.0 111.249 172.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 19.1 mmt -142.63 138.55 16.32 Favored Pre-proline 0 C--O 1.235 0.32 0 C-N-CA 125.18 1.392 . . . . 0.0 109.63 -171.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.89 144.3 27.29 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 121.933 1.756 . . . . 0.0 110.183 171.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.4 t -124.26 158.87 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 164.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.2 p -145.83 146.3 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -154.38 146.59 23.78 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -165.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -160.08 156.0 26.14 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 128.119 2.568 . . . . 0.0 108.776 164.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.6 p -78.45 150.31 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 O-C-N 121.796 -0.565 . . . . 0.0 109.672 171.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -82.64 125.42 75.92 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.175 167.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -70.92 41.77 0.4 Allowed 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.672 2.914 . . . . 0.0 115.775 -177.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -112.7 -21.2 11.35 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 125.718 1.607 . . . . 0.0 111.036 168.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 16.2 tt -43.48 -41.76 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 119.691 1.132 . . . . 0.0 113.572 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.8 m -76.46 61.61 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 O-C-N 121.815 -0.553 . . . . 0.0 111.341 172.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -137.51 -66.09 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 117.698 -1.144 . . . . 0.0 113.05 170.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -76.91 154.39 33.63 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 CA-C-N 121.802 1.679 . . . . 0.0 113.638 -169.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.4 t -54.93 -37.1 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 125.76 1.624 . . . . 0.0 110.826 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -52.58 -47.13 67.07 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.87 1.268 . . . . 0.0 111.829 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 35.4 p -91.85 -51.57 5.16 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -173.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 15.77 60.71 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 129.278 3.031 . . . . 0.0 115.911 175.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 136.29 -33.92 2.31 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-O 119.143 -0.81 . . . . 0.0 111.77 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 10.2 mm -51.07 128.27 8.39 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 C-N-CA 124.302 1.041 . . . . 0.0 110.433 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -157.76 48.22 0.39 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.43 0.692 . . . . 0.0 111.005 176.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.3 p -140.7 88.49 2.19 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 175.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.1 tp -88.06 84.93 6.9 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 118.899 -1.121 . . . . 0.0 109.026 -160.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.2 m -87.95 143.51 27.06 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.879 -169.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.5 tt -116.36 118.23 32.16 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 160.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.3 t -98.29 102.6 14.39 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 173.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.01 129.47 34.87 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.291 1.436 . . . . 0.0 107.559 -177.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.4 p -114.74 93.48 4.34 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.13 1.372 . . . . 0.0 109.212 174.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -76.18 95.52 3.71 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 167.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.69 46.67 0.3 Allowed Pre-proline 0 CA--C 1.556 1.174 0 N-CA-C 117.369 2.359 . . . . 0.0 117.369 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.39 -83.36 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.538 2.826 . . . . 0.0 113.013 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -149.29 136.68 20.1 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 118.904 0.774 . . . . 0.0 110.295 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -117.3 139.26 25.81 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 164.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -84.16 -52.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 121.917 1.745 . . . . 0.0 108.793 169.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.5 m -169.89 150.99 3.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.667 2.387 . . . . 0.0 106.676 177.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 12.9 pttt . . . . . 0 CA--C 1.535 0.381 0 C-N-CA 125.464 1.506 . . . . 0.0 108.54 174.602 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 0 N--CA 1.467 0.411 0 CA-C-O 122.209 1.004 . . . . 0.0 108.965 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 25.42 49.28 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.163 1.785 . . . . 0.0 111.764 -149.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -169.06 162.4 10.91 Favored 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 130.205 3.402 . . . . 0.0 104.67 177.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.95 98.91 3.88 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 175.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -113.85 36.26 3.74 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.952 0.901 . . . . 0.0 110.741 -169.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -159.81 -51.22 0.05 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.936 2.094 . . . . 0.0 107.051 -174.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.9 mt -72.13 -7.13 47.33 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.831 -168.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.6 mt -78.24 70.78 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 O-C-N 120.687 -1.258 . . . . 0.0 109.242 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.14 167.84 15.38 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 169.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -81.51 56.03 2.83 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 120.745 -1.222 . . . . 0.0 114.217 -166.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -113.74 104.54 12.31 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 122.788 1.28 . . . . 0.0 109.718 167.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.2 tttp -76.38 85.19 3.14 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 169.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.1 tp -83.52 162.88 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 174.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.44 150.22 46.25 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -167.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 81.0 t -142.85 126.28 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -172.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.5 m -95.56 109.02 21.31 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.499 1.52 . . . . 0.0 107.632 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.408 ' CE1' ' CD1' ' A' ' 56' ' ' ILE . 15.3 m-85 -81.21 131.67 35.31 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.839 1.256 . . . . 0.0 109.133 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -126.87 86.68 2.54 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 122.786 1.279 . . . . 0.0 110.378 -170.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.24 105.76 18.0 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.153 -0.967 . . . . 0.0 109.937 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -109.19 147.16 32.98 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 176.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.1 p -140.46 148.31 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.399 1.08 . . . . 0.0 108.166 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.69 168.95 18.32 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 167.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.62 -31.41 16.0 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -170.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.62 -34.82 3.88 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.217 1.389 . . . . 0.0 113.385 172.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.446 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -119.16 91.06 43.05 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 167.777 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -80.77 55.25 5.6 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.387 2.725 . . . . 0.0 109.255 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.506 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 41.4 m0 -114.65 147.86 38.99 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.609 1.163 . . . . 0.0 109.257 -174.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -75.47 80.42 2.51 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -89.49 100.0 12.89 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.868 0.867 . . . . 0.0 109.306 -170.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.1 t -103.43 122.08 46.27 Favored Pre-proline 0 N--CA 1.443 -0.817 0 C-N-CA 124.027 0.931 . . . . 0.0 109.6 -168.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -75.46 138.08 21.51 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 123.648 2.899 . . . . 0.0 107.8 163.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.2 t -79.69 -46.73 22.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.572 0.701 . . . . 0.0 109.407 -173.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -149.25 150.36 32.44 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.528 1.931 . . . . 0.0 106.772 173.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -61.77 -36.68 81.75 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 123.814 0.696 . . . . 0.0 110.617 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -146.68 151.12 36.71 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 122.652 0.381 . . . . 0.0 111.208 -174.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.408 ' CD1' ' CE1' ' A' ' 37' ' ' PHE . 64.5 mt -122.57 137.91 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 127.0 2.12 . . . . 0.0 106.866 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -98.42 152.43 19.5 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.238 1.015 . . . . 0.0 109.39 164.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -154.08 127.33 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 -170.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.9 mmt85 -74.75 86.84 2.2 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 166.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.7 pt 7.57 64.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 128.206 2.602 . . . . 0.0 115.008 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.79 -35.63 1.49 Allowed Glycine 0 CA--C 1.522 0.523 0 O-C-N 121.915 -0.491 . . . . 0.0 112.807 -174.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 62.7 tt0 -42.57 107.79 0.09 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.172 1.389 . . . . 0.0 111.999 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.56 102.76 8.09 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.425 1.09 . . . . 0.0 110.129 -177.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.0 p -76.31 178.74 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 122.036 0.922 . . . . 0.0 111.505 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.16 89.06 2.4 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 124.426 1.09 . . . . 0.0 108.676 168.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.5 pp -100.36 134.22 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 168.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 65.0 mtt -98.32 100.36 11.63 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 126.304 1.842 . . . . 0.0 110.913 -174.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -78.36 157.4 29.11 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -143.68 146.51 33.27 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.37 151.5 49.62 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 128.833 2.853 . . . . 0.0 106.173 166.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -143.81 139.53 29.38 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 166.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.506 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 43.5 t30 -79.1 114.83 18.36 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 120.039 1.291 . . . . 0.0 112.558 -177.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.7 mt -105.79 16.11 25.74 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 125.031 1.332 . . . . 0.0 112.548 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.6 175.44 9.87 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 163.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.8 t -103.57 17.3 24.39 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.103 0.561 . . . . 0.0 110.254 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -155.94 160.64 30.65 Favored Pre-proline 0 N--CA 1.45 -0.472 0 C-N-CA 127.075 2.15 . . . . 0.0 106.29 -174.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.27 124.81 11.22 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.481 1.454 . . . . 0.0 110.326 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.58 177.79 7.27 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.398 0.618 . . . . 0.0 109.553 168.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.8 t -113.61 161.68 17.14 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 154.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -147.38 69.37 0.36 Allowed Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 107.728 -2.149 . . . . 0.0 107.728 -177.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.47 62.65 0.61 Allowed 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 177.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.39 161.64 27.86 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.542 -163.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -83.22 152.08 25.36 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.839 174.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -148.51 148.7 30.53 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.338 0.255 . . . . 0.0 110.647 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -109.04 101.85 10.89 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 125.773 1.629 . . . . 0.0 106.904 171.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.8 p -88.66 58.13 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.474 0 C-N-CA 123.963 0.905 . . . . 0.0 111.086 -176.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.6 t -167.26 145.16 4.03 Favored Pre-proline 0 N--CA 1.468 0.448 0 O-C-N 120.994 -1.066 . . . . 0.0 112.032 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -62.83 -56.77 0.53 Allowed 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.258 1.305 . . . . 0.0 108.805 168.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 23.3 ptp -171.36 20.69 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.886 0.874 . . . . 0.0 111.689 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -170.43 -77.31 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.291 0 O-C-N 121.558 -0.714 . . . . 0.0 109.519 -168.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -46.3 -94.22 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 126.271 1.829 . . . . 0.0 113.238 -169.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 60.71 -52.23 0.03 OUTLIER Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.939 1.257 . . . . 0.0 115.939 -172.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -45.17 -48.97 12.36 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 119.762 1.781 . . . . 0.0 111.34 174.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -71.68 -12.69 61.45 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.256 1.022 . . . . 0.0 113.047 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -71.49 94.98 1.33 Allowed 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -80.51 92.02 5.84 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 118.274 -1.37 . . . . 0.0 110.346 -171.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.99 61.99 1.19 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.356 0.598 . . . . 0.0 109.838 163.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.8 p -71.65 138.18 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 169.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -174.76 121.0 0.23 Allowed 'General case' 0 CA--C 1.526 0.056 0 C-N-CA 125.091 1.357 . . . . 0.0 107.802 167.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 71.3 m 45.01 -119.17 0.74 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.424 1.09 . . . . 0.0 109.864 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -144.72 10.67 1.39 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.429 1.092 . . . . 0.0 111.102 171.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 45.7 t -174.81 125.63 0.28 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 -169.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -87.72 68.56 9.48 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 119.416 1.007 . . . . 0.0 110.658 -157.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.6 m 73.61 -43.63 0.55 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.931 1.692 . . . . 0.0 112.019 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -37.15 130.42 0.86 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.932 1.693 . . . . 0.0 111.315 167.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.2 t -157.68 -74.41 0.09 Allowed 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.531 0.332 . . . . 0.0 110.606 -168.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -159.63 152.01 21.09 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -174.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 75.2 mt -148.48 137.69 21.85 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 124.225 1.01 . . . . 0.0 108.322 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -66.94 152.14 96.21 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 169.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.66 106.28 1.24 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.783 2.989 . . . . 0.0 111.136 -171.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 128.19 -23.38 5.21 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -176.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -78.14 142.5 38.0 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 117.808 0.804 . . . . 0.0 111.009 -162.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -100.18 128.92 46.17 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.34 1.856 . . . . 0.0 109.329 -173.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 52.7 ttp -126.87 85.84 2.43 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 126.104 1.761 . . . . 0.0 108.844 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.99 140.89 33.56 Favored 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 168.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 22.8 ptm -153.5 141.57 13.89 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 117.936 0.335 . . . . 0.0 111.887 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -72.22 148.11 49.14 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.717 2.278 . . . . 0.0 110.098 171.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.1 t -136.26 122.19 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 125.927 1.691 . . . . 0.0 107.026 174.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.1 p -99.45 143.15 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 125.762 1.625 . . . . 0.0 107.492 169.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.94 172.27 18.97 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 176.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -158.64 178.46 10.1 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.883 0.873 . . . . 0.0 109.715 164.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 73.5 t -110.22 135.32 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 123.74 0.816 . . . . 0.0 109.267 172.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.22 124.54 76.06 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 122.988 0.515 . . . . 0.0 112.068 -176.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.21 34.47 0.4 Allowed 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.199 2.599 . . . . 0.0 114.105 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.51 -15.04 21.89 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.04 0.936 . . . . 0.0 110.915 162.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 17.8 tt -52.1 -48.97 41.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 118.973 0.806 . . . . 0.0 112.586 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.8 m -80.52 64.08 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.081 0.552 . . . . 0.0 109.677 174.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 45.0 mttp -140.17 -65.21 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 124.271 1.028 . . . . 0.0 111.768 171.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.01 169.29 13.71 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 121.835 1.69 . . . . 0.0 111.443 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.9 t -71.96 -52.31 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 124.227 1.011 . . . . 0.0 109.843 -174.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -46.44 -51.69 14.63 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 125.197 1.399 . . . . 0.0 112.054 -173.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 17.2 p -86.14 -3.74 59.02 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -65.05 75.9 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.857 1.208 . . . . 0.0 111.607 -177.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 148.13 -34.54 1.2 Allowed Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -169.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 45.9 mm -66.86 114.24 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.3 pttt -156.1 47.17 0.47 Allowed 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.49 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.41 97.52 1.76 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 103.69 -2.708 . . . . 0.0 103.69 168.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.4 tp -78.04 162.66 26.55 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -170.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.5 t -151.69 171.61 17.4 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.599 -0.688 . . . . 0.0 109.488 173.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -149.5 100.04 2.96 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 103.908 -2.627 . . . . 0.0 103.908 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 31.1 m -87.5 93.79 9.52 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 173.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.13 134.13 36.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 172.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.7 m -120.06 87.33 2.72 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.992 0.917 . . . . 0.0 108.951 176.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -68.24 84.55 0.25 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.928 0.891 . . . . 0.0 109.614 175.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -151.49 46.4 0.37 Allowed Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 178.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.52 -79.36 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.584 2.189 . . . . 0.0 112.731 -175.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.46 107.79 2.23 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.622 -0.674 . . . . 0.0 111.537 -173.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -78.89 144.05 63.23 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 173.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.41 -50.18 0.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.972 1.782 . . . . 0.0 107.992 160.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.9 t -179.5 -168.71 0.12 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 128.869 2.868 . . . . 0.0 105.32 169.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.589 0 C-N-CA 124.241 1.017 . . . . 0.0 111.184 174.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.456 -0.159 0 CA-C-O 122.205 1.002 . . . . 0.0 108.77 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 74.31 158.77 0.21 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.64 1.576 . . . . 0.0 111.227 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 60.65 -113.62 0.58 Allowed 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 -168.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -175.24 4.67 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.562 1.545 . . . . 0.0 111.862 136.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.8 t -73.07 51.35 0.3 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.385 1.874 . . . . 0.0 114.85 -167.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -76.07 -34.86 59.59 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 131.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 63.1 mt -108.47 -44.49 4.08 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -172.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.2 mt -35.4 137.78 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 126.614 1.966 . . . . 0.0 115.501 -164.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.9 mp -111.71 -82.85 0.58 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.147 1.379 . . . . 0.0 109.141 -174.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -172.85 -66.22 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.35 1.46 . . . . 0.0 108.997 -178.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -36.67 132.65 0.61 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 126.678 1.991 . . . . 0.0 113.598 -168.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.468 ' HZ3' ' CB ' ' A' ' 57' ' ' ASP . 21.5 tttp -76.2 90.17 3.12 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.158 -1.837 . . . . 0.0 107.253 176.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.7 112.34 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 167.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.79 154.22 30.09 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.4 t -134.97 133.38 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 176.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 29.4 m -114.14 108.57 17.15 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -81.17 102.98 10.65 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.662 1.585 . . . . 0.0 108.945 176.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -98.42 87.1 3.77 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.857 0.836 . . . . 0.0 109.596 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.21 126.07 31.06 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.169 0.588 . . . . 0.0 110.614 175.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -129.65 146.44 51.43 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.797 1.239 . . . . 0.0 108.191 175.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.5 p -138.44 144.0 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 124.076 0.95 . . . . 0.0 108.991 177.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.21 165.48 19.54 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 166.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -43.62 -39.71 3.69 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.211 1.004 . . . . 0.0 112.185 -177.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -34.06 -36.55 0.06 OUTLIER Glycine 0 CA--C 1.535 1.282 0 C-N-CA 126.948 2.213 . . . . 0.0 115.01 171.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.43 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 0.2 OUTLIER -118.82 102.76 49.15 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 119.099 1.45 . . . . 0.0 107.871 161.645 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.43 40.94 1.05 Allowed 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.764 2.309 . . . . 0.0 111.223 -170.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.5 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 45.1 m0 -116.39 151.06 36.73 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.367 1.067 . . . . 0.0 110.614 -165.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -76.33 80.83 3.08 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -177.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -87.14 106.27 17.76 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.396 0.678 . . . . 0.0 109.35 -172.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.8 t -115.9 119.93 36.43 Favored Pre-proline 0 N--CA 1.443 -0.814 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -168.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.82 154.25 38.57 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 C-N-CA 124.118 3.212 . . . . 0.0 107.936 168.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 t -85.7 -58.95 3.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -168.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -132.45 162.19 31.79 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 162.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -61.46 -39.79 92.16 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 174.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.79 164.72 26.62 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.796 0.839 . . . . 0.0 112.496 -176.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.7 pt -132.47 162.0 40.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 124.521 1.129 . . . . 0.0 109.747 168.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.468 ' CB ' ' HZ3' ' A' ' 32' ' ' LYS . 21.0 p-10 -118.28 83.78 2.07 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 127.444 2.298 . . . . 0.0 110.067 -173.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.75 129.3 43.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 O-C-N 120.833 -1.167 . . . . 0.0 109.494 -178.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -78.37 96.32 5.3 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 174.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -10.06 87.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.068 1.747 . . . . 0.0 114.966 -159.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.59 -31.66 4.74 Favored Glycine 0 C--O 1.222 -0.641 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 176.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -53.11 118.38 3.71 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 -175.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.2 p -71.23 115.69 10.67 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.745 2.018 . . . . 0.0 111.71 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.0 p -97.68 161.92 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 123.514 0.726 . . . . 0.0 110.112 169.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -105.36 120.01 40.52 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.231 1.012 . . . . 0.0 110.727 164.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.8 pp -130.18 116.56 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 171.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 35.4 mtm -79.57 107.81 12.63 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.156 0.982 . . . . 0.0 111.633 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -81.55 155.56 25.66 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 170.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.0 ttp-105 -137.95 144.86 41.41 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 174.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.72 159.01 28.87 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.103 2.161 . . . . 0.0 107.05 156.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -144.17 145.04 31.84 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 161.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.5 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 51.9 t-20 -83.45 105.57 14.5 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 120.743 1.611 . . . . 0.0 112.103 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.1 mp -102.27 36.39 2.15 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.095 1.358 . . . . 0.0 110.861 176.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.03 170.63 7.84 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.72 1.208 . . . . 0.0 109.331 163.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.5 m -105.09 15.47 27.52 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.753 0.821 . . . . 0.0 111.411 -177.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.7 p -141.38 162.11 49.11 Favored Pre-proline 0 C--O 1.239 0.504 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 169.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.44 141.65 96.07 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 120.978 1.119 . . . . 0.0 109.312 171.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.43 169.03 9.01 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 118.468 0.576 . . . . 0.0 110.326 167.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.9 t -94.38 157.07 16.19 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 159.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -124.17 152.7 17.37 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 105.271 -3.132 . . . . 0.0 105.271 165.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.22 -53.86 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 117.426 0.613 . . . . 0.0 109.787 -160.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 60.57 -179.35 0.1 Allowed 'General case' 0 C--N 1.342 0.243 0 CA-C-O 122.938 1.351 . . . . 0.0 113.88 173.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.0 m -135.21 164.21 28.21 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 146.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -155.53 164.47 38.62 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -173.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.09 98.33 4.72 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 51.2 t -89.32 72.04 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 125.361 1.465 . . . . 0.0 107.129 -175.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.0 t 178.83 152.28 0.49 Allowed Pre-proline 0 C--N 1.34 0.157 0 C-N-CA 125.455 1.502 . . . . 0.0 109.233 -174.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -67.49 -47.8 1.93 Allowed 'Trans proline' 0 N--CA 1.448 -1.197 0 N-CA-C 108.457 -1.401 . . . . 0.0 108.457 156.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.2 ptm -174.52 -78.37 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.661 1.984 . . . . 0.0 107.802 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.19 -38.22 81.77 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -168.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.71 -105.45 0.02 OUTLIER 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.199 0.454 . . . . 0.0 111.022 -173.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.38 -53.94 1.92 Allowed Glycine 0 CA--C 1.526 0.768 0 CA-C-O 119.286 -0.73 . . . . 0.0 112.722 -177.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.26 -54.11 9.44 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.612 1.206 . . . . 0.0 111.636 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -74.06 -3.59 30.32 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.767 1.227 . . . . 0.0 113.659 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -70.4 96.62 1.17 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 174.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -49.69 -44.79 48.23 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -162.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -73.41 74.48 1.39 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.886 0.766 . . . . 0.0 109.148 172.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.9 p -67.98 -39.01 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 123.774 0.83 . . . . 0.0 110.033 173.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -167.12 173.14 9.39 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 127.848 2.459 . . . . 0.0 105.958 177.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 52.7 t -164.04 137.3 5.28 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 177.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -54.87 -47.27 74.46 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.311 0.505 . . . . 0.0 110.183 175.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 57.5 m -75.55 67.25 2.03 Favored 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 172.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -66.2 158.91 27.59 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 169.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.7 m -84.38 -120.92 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -175.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -30.76 105.89 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.024 2.13 . . . . 0.0 113.479 174.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.6 t -130.27 -63.39 0.9 Allowed 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 124.212 1.005 . . . . 0.0 109.114 -177.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.1 t -158.33 149.0 20.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 172.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 89.2 mt -149.17 135.6 19.34 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 176.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -73.59 159.81 83.7 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.738 1.215 . . . . 0.0 109.955 173.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.23 102.73 1.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.486 2.124 . . . . 0.0 110.905 -165.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 125.05 -14.35 7.47 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 124.202 0.906 . . . . 0.0 110.953 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -76.82 138.31 39.75 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 118.49 1.145 . . . . 0.0 110.773 -166.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.03 144.92 26.68 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.94 1.296 . . . . 0.0 108.694 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 17.1 ttt -140.01 80.39 1.76 Allowed 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 123.34 0.656 . . . . 0.0 109.265 173.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -95.02 123.44 38.5 Favored 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 124.325 1.05 . . . . 0.0 108.321 168.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 24.5 mmt -134.1 129.56 20.01 Favored Pre-proline 0 C--O 1.235 0.32 0 C-N-CA 124.106 0.963 . . . . 0.0 109.844 -171.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -68.8 135.58 33.21 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 121.871 1.714 . . . . 0.0 109.248 172.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.9 t -110.06 129.42 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 166.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.1 p -95.52 134.76 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 157.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -155.92 151.62 27.25 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -167.32 161.14 14.06 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 126.215 1.806 . . . . 0.0 107.206 -177.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 52.7 t -118.26 127.77 75.35 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 C-N-CA 125.669 1.588 . . . . 0.0 107.463 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.43 153.15 41.44 Favored Pre-proline 0 C--O 1.234 0.252 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -173.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.58 37.76 0.47 Allowed 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 124.359 3.373 . . . . 0.0 112.982 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -83.62 -37.66 22.59 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 165.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.3 tt -52.41 -35.46 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 123.878 0.871 . . . . 0.0 112.781 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.2 m -74.97 53.12 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 120.901 -1.124 . . . . 0.0 110.933 173.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -144.53 -70.65 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.748 1.619 . . . . 0.0 110.793 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.86 138.13 39.95 Favored 'Trans proline' 0 C--O 1.239 0.529 0 CA-C-N 122.148 1.803 . . . . 0.0 113.488 -176.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.9 t -55.94 -36.86 45.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 127.352 2.261 . . . . 0.0 109.602 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -47.7 -34.98 8.95 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.938 2.095 . . . . 0.0 112.744 174.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 72.1 p -107.09 -60.52 1.67 Allowed 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 123.013 0.196 . . . . 0.0 110.536 -174.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 28.28 49.75 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 129.088 2.955 . . . . 0.0 115.902 165.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 143.65 -29.3 2.0 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -172.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.8 mm -53.61 127.62 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.072 0 CA-C-N 117.863 0.831 . . . . 0.0 110.664 172.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.7 pttt -155.77 67.54 0.62 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 122.09 0.948 . . . . 0.0 111.547 169.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 42.4 m -147.94 105.08 3.63 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 141.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.1 tp -79.83 86.86 5.34 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -175.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -84.77 150.12 25.28 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.08 -168.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 28.5 tp -120.45 110.53 16.61 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 166.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.7 t -95.04 117.98 31.07 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 169.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.07 125.86 51.14 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -166.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.6 m -117.6 89.4 3.11 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.214 1.006 . . . . 0.0 109.98 -176.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 1.8 m-30 -67.1 94.59 0.35 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.603 0.761 . . . . 0.0 109.404 170.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -149.01 23.65 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.135 0 N-CA-C 118.08 2.622 . . . . 0.0 118.08 -176.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.49 -75.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.672 0 CA-C-N 122.77 2.025 . . . . 0.0 113.897 -165.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 86.6 mmt-85 -146.28 121.75 10.36 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.776 0.716 . . . . 0.0 109.177 -167.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.53 117.54 28.98 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 125.648 1.579 . . . . 0.0 107.358 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -78.6 -23.5 8.33 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.71 2.273 . . . . 0.0 112.41 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 39.9 t 137.69 109.38 0.0 OUTLIER 'General case' 0 C--N 1.343 0.302 0 C-N-CA 129.278 3.031 . . . . 0.0 107.777 -175.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.372 0 C-N-CA 124.319 1.047 . . . . 0.0 110.958 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.3 t . . . . . 0 N--CA 1.456 -0.154 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -79.78 101.24 8.35 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.532 -0.73 . . . . 0.0 109.67 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.58 -9.57 0.22 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 166.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.45 126.0 28.43 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 115.872 -2.331 . . . . 0.0 110.22 -92.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.2 t -162.25 45.92 0.15 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 123.882 0.873 . . . . 0.0 109.825 -171.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -155.67 -58.03 0.1 Allowed 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.51 26.36 0.94 Allowed 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.147 -169.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 73.3 mt -119.23 108.87 24.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -169.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -98.58 -61.54 1.36 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.129 -171.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . 0.25 0.3 OUTLIER 177.23 -6.89 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.672 1.589 . . . . 0.0 114.488 145.654 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -51.19 122.42 7.67 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 120.752 1.615 . . . . 0.0 112.869 -173.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -77.66 98.14 5.35 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 127.928 2.491 . . . . 0.0 107.547 -173.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.6 tp -106.56 122.74 60.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.913 1.285 . . . . 0.0 109.435 -172.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.414 ' CE ' ' HB2' ' A' ' 55' ' ' ASP . 4.0 tmtp? -79.19 151.62 31.14 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.952 1.701 . . . . 0.0 109.212 -174.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.2 t -133.79 148.74 30.39 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 165.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.7 m -136.25 104.7 5.73 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.414 1.102 . . . . 0.0 108.338 -174.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -77.56 121.32 23.74 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -118.32 82.44 1.84 Allowed 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.65 126.86 31.71 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -126.95 89.33 2.96 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.897 0.856 . . . . 0.0 109.043 -174.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.4 p -79.02 126.91 39.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.679 172.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.38 169.46 13.57 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 171.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.55 124.07 12.7 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 161.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 151.48 -48.19 0.56 Allowed Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 107.268 -2.333 . . . . 0.0 107.268 -160.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mp -129.28 142.38 45.02 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 160.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -79.97 2.72 8.2 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 123.911 3.074 . . . . 0.0 111.93 170.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 40.5 m0 -74.54 148.62 40.72 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.125 0.875 . . . . 0.0 111.745 -165.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -78.82 84.79 4.86 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 172.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -89.58 118.94 29.58 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 124.475 1.11 . . . . 0.0 108.709 177.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.0 m -124.86 139.29 33.11 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -74.67 171.49 18.1 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.339 2.026 . . . . 0.0 108.953 166.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -93.35 -53.66 8.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 123.763 0.825 . . . . 0.0 110.393 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -131.7 164.5 25.8 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 168.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -60.75 -43.6 97.76 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 168.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.414 ' HB2' ' CE ' ' A' ' 34' ' ' LYS . 22.4 p-10 -149.15 170.55 18.18 Favored 'General case' 0 N--CA 1.428 -1.551 0 C-N-CA 124.666 1.186 . . . . 0.0 110.805 -164.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.1 pt -137.65 176.39 7.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 167.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.88 161.58 23.83 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 148.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -131.22 148.23 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 102.158 -3.275 . . . . 0.0 102.158 170.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.72 118.51 27.27 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 120.855 1.661 . . . . 0.0 106.953 160.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.3 pt -15.57 89.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 C-N-CA 126.943 2.097 . . . . 0.0 113.255 -169.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.52 -43.91 1.32 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 124.37 0.986 . . . . 0.0 113.12 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -38.56 102.65 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.798 2.039 . . . . 0.0 113.431 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 94.5 m -73.19 104.44 4.25 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.677 1.591 . . . . 0.0 111.265 -174.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.5 p -102.07 169.56 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 121.615 0.722 . . . . 0.0 110.524 174.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -117.35 127.38 53.99 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 126.263 1.825 . . . . 0.0 107.208 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.7 pp -140.69 95.79 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 CA-C-O 121.864 0.84 . . . . 0.0 109.063 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 31.1 mtt -76.82 175.31 9.56 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.765 -0.584 . . . . 0.0 110.536 -175.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -133.28 170.47 15.4 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 124.228 1.011 . . . . 0.0 109.092 174.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -139.39 123.4 17.8 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 173.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.97 105.38 7.7 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.127 0.571 . . . . 0.0 110.869 168.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER -103.25 121.08 41.95 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.061 -0.4 . . . . 0.0 111.533 -171.759 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -82.12 85.07 6.84 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.114 0.483 . . . . 0.0 111.386 -173.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.3 mt -79.73 59.15 2.99 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.634 0.774 . . . . 0.0 109.958 171.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.91 155.23 47.12 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 170.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.8 m -79.55 -0.62 34.21 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.619 0.768 . . . . 0.0 112.369 177.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.1 p -128.83 163.29 46.33 Favored Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 124.761 1.224 . . . . 0.0 110.618 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -63.17 169.11 9.77 Favored 'Trans proline' 0 N--CA 1.444 -1.435 0 C-N-CA 121.041 1.161 . . . . 0.0 110.077 164.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.97 168.81 26.06 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 126.519 1.928 . . . . 0.0 107.152 -170.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.2 t -132.6 154.79 49.7 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.75 0.705 . . . . 0.0 111.622 176.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -125.57 64.42 0.57 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 127.248 2.356 . . . . 0.0 107.968 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.37 53.54 2.79 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 165.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.98 170.54 14.61 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.096 -171.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.1 m -125.19 162.21 25.17 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -146.93 159.02 44.06 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 118.764 0.711 . . . . 0.0 111.08 170.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.2 99.51 6.91 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 166.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.6 p -89.9 57.65 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.212 0 C-N-CA 124.154 0.982 . . . . 0.0 110.365 -175.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.5 t -165.95 148.18 6.27 Favored Pre-proline 0 N--CA 1.454 -0.249 0 O-C-N 121.506 -0.746 . . . . 0.0 110.699 -172.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.24 -30.68 30.5 Favored 'Trans proline' 0 N--CA 1.445 -1.38 0 N-CA-C 108.674 -1.318 . . . . 0.0 108.674 164.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.0 ptp 172.69 -63.85 0.01 OUTLIER 'General case' 0 C--N 1.347 0.462 0 C-N-CA 125.853 1.661 . . . . 0.0 109.759 -173.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -99.87 -33.25 10.62 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 124.776 1.23 . . . . 0.0 111.258 -164.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.16 -142.91 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.86 -47.58 0.78 Allowed Glycine 0 CA--C 1.531 1.075 0 O-C-N 121.278 -0.889 . . . . 0.0 112.434 -166.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -42.7 -54.08 4.21 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.047 1.339 . . . . 0.0 110.818 173.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -76.24 -16.2 59.87 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -48.91 137.41 12.77 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 118.79 0.723 . . . . 0.0 110.843 -173.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -67.42 112.8 4.83 Favored 'General case' 0 N--CA 1.44 -0.972 0 O-C-N 123.583 0.552 . . . . 0.0 111.568 -173.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.5 pttm -152.73 136.91 16.49 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.103 0.961 . . . . 0.0 108.522 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.9 m -154.11 -179.75 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 127.321 2.248 . . . . 0.0 106.846 -176.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.2 tp60 62.63 37.19 13.1 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.194 0.997 . . . . 0.0 112.384 167.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 38.1 t 70.41 145.67 0.06 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.91 1.684 . . . . 0.0 111.917 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -52.1 -43.92 64.16 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.733 -0.605 . . . . 0.0 111.35 175.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 13.7 t 33.76 55.47 0.55 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.593 1.957 . . . . 0.0 112.333 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -115.04 108.26 16.44 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.081 -164.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 t -179.77 153.25 0.53 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.71 2.004 . . . . 0.0 105.984 160.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.65 17.58 4.58 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 123.574 0.547 . . . . 0.0 109.882 168.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.9 t 52.7 -141.26 0.86 Allowed 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.493 1.517 . . . . 0.0 111.176 174.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.2 t -110.68 131.41 55.08 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 126.402 1.881 . . . . 0.0 106.741 172.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.6 tp -124.34 131.43 53.51 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 125.102 1.361 . . . . 0.0 107.651 -176.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -86.56 167.73 21.53 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 127.169 2.188 . . . . 0.0 111.273 -167.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -72.92 112.6 3.55 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.349 2.033 . . . . 0.0 112.446 -168.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 115.97 -12.72 17.27 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 124.403 1.002 . . . . 0.0 111.021 177.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -77.91 140.96 39.32 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 117.334 0.567 . . . . 0.0 112.438 -163.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -99.21 98.27 9.27 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.91 1.684 . . . . 0.0 108.787 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 11.0 ttp -77.56 85.98 3.91 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -94.28 59.59 2.62 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.994 0.902 . . . . 0.0 111.682 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 20.5 ttt -76.61 129.17 80.23 Favored Pre-proline 0 N--CA 1.437 -1.077 0 C-N-CA 123.814 0.846 . . . . 0.0 110.352 -171.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.66 150.88 31.73 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 121.93 1.753 . . . . 0.0 110.332 171.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.2 t -130.83 148.08 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 164.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.5 m -112.28 146.7 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -154.58 139.96 17.7 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 119.56 1.073 . . . . 0.0 112.635 -172.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -156.01 148.11 23.35 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.66 1.584 . . . . 0.0 108.069 163.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.6 t -88.26 141.45 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 166.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -75.51 155.46 85.55 Favored Pre-proline 0 N--CA 1.45 -0.467 0 C-N-CA 124.517 1.127 . . . . 0.0 110.061 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -65.03 -36.14 39.38 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.577 1.518 . . . . 0.0 112.17 166.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -44.77 -41.0 6.54 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 125.481 1.512 . . . . 0.0 113.395 -172.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -50.11 -37.94 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 125.021 1.329 . . . . 0.0 112.83 -177.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.0 m -89.3 51.26 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 119.17 0.896 . . . . 0.0 110.487 177.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . 0.35 0.0 OUTLIER -149.79 -53.5 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.823 0 CA-C-O 116.199 -1.858 . . . . 0.0 114.228 -175.221 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -83.33 169.89 12.27 Favored 'Trans proline' 0 C--N 1.351 0.67 0 CA-C-N 124.031 2.475 . . . . 0.0 111.838 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.2 t -67.59 -46.54 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.978 1.311 . . . . 0.0 110.871 -169.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -39.13 -54.58 1.73 Allowed 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 126.062 1.745 . . . . 0.0 112.225 -178.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 3.2 p -97.53 -41.03 8.36 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.128 -168.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 2.51 70.74 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 128.458 2.703 . . . . 0.0 115.882 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 134.27 -35.66 2.2 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 119.176 -0.791 . . . . 0.0 112.391 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 13.1 mm -49.33 138.27 4.78 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 C-N-CA 124.664 1.186 . . . . 0.0 109.948 173.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.3 pttm -157.67 51.97 0.45 Allowed 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.6 m -154.5 107.09 2.8 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 159.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.5 mp -75.78 85.72 2.77 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 169.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.1 t -81.14 150.98 28.48 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.3 tt -127.52 99.38 5.58 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.1 t -78.04 111.07 13.55 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 171.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -107.06 92.84 4.25 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.746 1.218 . . . . 0.0 108.537 -172.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.5 86.95 4.5 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 122.528 1.156 . . . . 0.0 109.48 -175.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -75.48 73.12 2.52 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 166.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -132.73 48.86 3.84 Favored Pre-proline 0 CA--C 1.552 1.044 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 174.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -77.61 -98.09 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 124.356 3.37 . . . . 0.0 113.752 -174.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.2 mmt180 -142.36 110.37 5.92 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.545 1.138 . . . . 0.0 109.315 -169.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -95.05 114.57 63.99 Favored Pre-proline 0 N--CA 1.451 -0.381 0 C-N-CA 124.793 1.237 . . . . 0.0 111.517 -167.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -74.2 -25.13 13.93 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.632 1.554 . . . . 0.0 111.138 165.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.6 t 80.33 127.18 0.04 OUTLIER 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.778 1.631 . . . . 0.0 109.824 -173.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 17.9 pttm . . . . . 0 CA--C 1.535 0.376 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.017 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.45 -0.435 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -63.25 96.72 0.11 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 170.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 98.09 71.69 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 129.91 3.284 . . . . 0.0 110.018 174.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.37 57.13 2.72 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -162.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.7 m -76.9 54.24 0.99 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.824 2.45 . . . . 0.0 112.253 -178.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -141.69 -54.19 0.45 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 130.275 3.43 . . . . 0.0 104.092 168.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 49.2 mt -63.73 -34.06 77.04 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.908 1.283 . . . . 0.0 113.119 168.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 76.7 mt -69.15 100.04 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 119.575 1.08 . . . . 0.0 110.221 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.03 -75.41 0.45 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 172.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.431 ' CG ' HH12 ' A' ' 59' ' ' ARG . 4.1 t70 -169.48 -28.63 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 164.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -59.05 128.25 36.28 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.46 1.104 . . . . 0.0 113.638 -163.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -79.93 109.79 14.7 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.924 -174.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.13 113.1 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 126.012 1.725 . . . . 0.0 108.679 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.35 157.07 21.59 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.054 -1.029 . . . . 0.0 109.084 -171.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.2 t -143.79 107.5 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-N 119.762 1.165 . . . . 0.0 109.596 -176.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.2 m -78.97 117.58 20.17 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.786 1.634 . . . . 0.0 107.816 167.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -79.61 156.32 27.72 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.337 0.655 . . . . 0.0 109.266 166.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -137.67 88.31 2.32 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.412 0.625 . . . . 0.0 111.511 170.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.06 128.9 36.4 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 120.939 -1.101 . . . . 0.0 110.507 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -133.73 150.21 51.49 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.186 0.994 . . . . 0.0 109.508 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.9 p -140.6 146.29 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 C-N-CA 123.518 0.727 . . . . 0.0 110.772 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.9 163.62 29.82 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.012 1.325 . . . . 0.0 107.463 168.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -37.75 -45.69 0.83 Allowed 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.989 1.715 . . . . 0.0 113.452 -172.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -36.88 -37.32 0.23 Allowed Glycine 0 CA--C 1.534 1.233 0 C-N-CA 126.482 1.991 . . . . 0.0 114.39 174.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.417 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 0.4 OUTLIER -113.48 105.88 54.71 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 161.15 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.93 9.56 3.26 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.138 1.892 . . . . 0.0 112.733 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.473 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 41.4 m0 -78.46 145.61 34.93 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 121.798 -0.564 . . . . 0.0 110.931 -168.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -78.56 85.39 4.62 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 103.338 -2.838 . . . . 0.0 103.338 172.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.71 88.18 3.0 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.625 1.17 . . . . 0.0 108.381 -168.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.0 m -91.37 136.59 26.77 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 119.182 -0.437 . . . . 0.0 110.381 -166.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -70.53 165.55 31.48 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 121.538 1.492 . . . . 0.0 108.595 161.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -97.67 -55.29 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.111 0 C-N-CA 123.573 0.749 . . . . 0.0 110.941 -176.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.22 152.76 47.6 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 170.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -64.99 -41.48 95.36 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.831 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.49 139.65 37.02 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.223 1.009 . . . . 0.0 110.027 -173.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.7 pt -104.99 164.02 4.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 125.352 1.461 . . . . 0.0 109.002 170.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -101.74 133.62 46.17 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 155.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.6 m -128.08 174.68 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 159.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.431 HH12 ' CG ' ' A' ' 30' ' ' ASP . 18.2 mtm180 -140.66 92.45 2.51 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -171.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.0 pt 8.22 87.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 127.66 2.384 . . . . 0.0 114.279 -171.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 107.86 -31.52 7.91 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 123.556 0.598 . . . . 0.0 112.949 -173.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -72.55 118.02 14.95 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 121.627 -0.925 . . . . 0.0 110.174 -168.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.3 p -68.3 126.83 30.81 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 127.431 2.293 . . . . 0.0 111.472 -174.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.9 p -113.74 160.07 13.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 157.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.62 125.34 49.32 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.737 1.215 . . . . 0.0 108.839 169.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -126.07 104.86 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 172.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -83.34 167.61 17.42 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.959 172.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -137.05 155.0 50.21 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 171.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -125.56 129.81 50.44 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 168.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.68 108.52 12.11 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.671 2.388 . . . . 0.0 107.556 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.3 mtpt -104.73 124.16 48.91 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 118.154 -0.927 . . . . 0.0 109.09 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.473 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 32.3 t30 -78.37 85.46 4.49 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 119.517 1.053 . . . . 0.0 110.983 -175.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -78.12 68.89 4.25 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 174.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.3 135.48 13.08 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.781 0.832 . . . . 0.0 108.975 173.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.9 m -78.4 41.82 0.4 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.272 0.629 . . . . 0.0 110.246 172.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.1 p -148.31 154.26 41.83 Favored Pre-proline 0 N--CA 1.446 -0.671 0 C-N-CA 124.526 1.131 . . . . 0.0 107.989 169.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -66.95 150.41 82.94 Favored 'Trans proline' 0 N--CA 1.442 -1.545 0 N-CA-C 108.03 -1.565 . . . . 0.0 108.03 166.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.8 p -135.59 163.76 29.39 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.577 0.751 . . . . 0.0 109.302 175.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.1 t -118.88 136.21 54.16 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.636 0.775 . . . . 0.0 109.405 167.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -96.14 81.24 0.78 Allowed Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 176.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -106.38 53.29 0.7 Allowed 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 172.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.1 174.6 5.27 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.785 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.59 154.64 46.87 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 173.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -145.97 147.3 31.54 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -101.23 115.69 31.08 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 166.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.9 p -99.81 73.2 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.498 0 C-N-CA 124.24 1.016 . . . . 0.0 109.264 -176.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.0 t 177.56 148.46 0.34 Allowed Pre-proline 0 C--O 1.232 0.163 0 C-N-CA 123.645 0.778 . . . . 0.0 109.461 -178.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -66.3 -33.41 38.94 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 121.336 1.357 . . . . 0.0 109.754 162.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.0 ptp 177.83 -69.41 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.639 1.976 . . . . 0.0 107.933 177.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.67 -46.53 45.89 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 123.827 0.851 . . . . 0.0 113.203 -165.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.25 -101.06 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -162.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.93 -52.69 0.38 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.191 0.9 . . . . 0.0 114.032 -171.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -48.09 -52.84 18.66 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.306 1.553 . . . . 0.0 110.732 176.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -75.22 12.25 0.97 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.54 1.536 . . . . 0.0 114.768 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -92.39 108.08 19.7 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 171.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -78.36 78.16 4.83 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 118.41 -1.316 . . . . 0.0 112.698 -173.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -124.17 89.11 3.02 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 125.168 1.387 . . . . 0.0 107.583 162.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.6 m -137.6 131.35 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 170.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -165.68 127.87 2.02 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 90.9 m -78.3 63.28 3.16 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -165.47 -166.4 0.97 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -176.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 28.3 p -58.17 103.05 0.12 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 122.27 1.033 . . . . 0.0 110.878 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -41.58 -44.25 2.97 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 126.713 2.005 . . . . 0.0 111.902 177.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 67.5 m -152.35 -95.08 0.05 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 127.56 2.344 . . . . 0.0 106.913 168.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.0 pm0 -83.99 -167.78 1.88 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.816 0.846 . . . . 0.0 111.7 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.4 t -168.65 -72.3 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.094 0.958 . . . . 0.0 110.962 -177.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -158.77 151.06 21.49 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.6 1.16 . . . . 0.0 108.303 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 82.6 mt -144.34 148.0 34.19 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -88.86 175.41 4.06 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 123.969 0.908 . . . . 0.0 109.132 176.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -69.4 90.32 0.48 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.842 2.361 . . . . 0.0 114.469 -162.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 138.98 -23.39 2.9 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 123.731 0.681 . . . . 0.0 112.264 170.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -78.32 141.1 38.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 119.691 -0.804 . . . . 0.0 112.49 -146.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -84.05 113.44 21.03 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.621 1.569 . . . . 0.0 110.806 177.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 14.4 tpt -104.12 131.04 51.81 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 125.374 1.47 . . . . 0.0 107.235 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -155.03 139.44 16.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.056 0.389 . . . . 0.0 110.82 168.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 80.7 mtp -155.03 148.89 18.89 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.291 1.036 . . . . 0.0 109.544 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -78.36 144.72 20.67 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.886 3.057 . . . . 0.0 112.701 170.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 25.0 t -118.83 121.53 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 168.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.2 p -79.54 146.32 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 169.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -155.19 146.99 23.32 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.256 0.48 . . . . 0.0 111.571 -171.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -156.62 153.22 28.22 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.271 1.429 . . . . 0.0 110.935 164.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 74.2 t -76.77 140.5 17.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 169.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.79 130.73 56.9 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 118.639 -0.696 . . . . 0.0 110.688 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -55.17 -30.46 71.22 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.191 2.594 . . . . 0.0 113.018 -178.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -36.28 -36.05 0.09 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.979 1.311 . . . . 0.0 113.418 172.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.7 tt -49.26 -36.72 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.4 m -87.67 54.31 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 119.24 0.927 . . . . 0.0 110.685 173.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -126.12 -74.67 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 117.508 -1.234 . . . . 0.0 111.983 171.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.67 156.37 40.05 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 CA-C-N 122.039 1.764 . . . . 0.0 112.538 -171.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 99.5 t -53.32 -44.21 53.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 125.137 1.375 . . . . 0.0 109.981 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -44.95 -51.58 9.62 Favored 'General case' 0 N--CA 1.426 -1.657 0 C-N-CA 128.216 2.606 . . . . 0.0 112.471 178.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 40.3 p -99.06 -8.07 25.83 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 119.052 -0.499 . . . . 0.0 111.869 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -44.41 112.38 0.41 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.989 0.916 . . . . 0.0 111.581 -178.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.47 -15.06 63.46 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 119.318 -0.712 . . . . 0.0 113.262 175.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 20.5 mm -64.97 123.78 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-N 119.016 1.408 . . . . 0.0 108.602 171.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 20.1 pttt -156.01 54.53 0.58 Allowed 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.032 0.444 . . . . 0.0 111.751 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.31 87.48 1.32 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 160.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.5 tp -82.79 88.16 6.77 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.242 -162.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 13.3 t -87.89 173.09 9.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.908 0.861 . . . . 0.0 111.329 -170.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.1 tt -145.39 111.15 5.46 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 171.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.6 p -91.81 97.97 11.32 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 124.999 1.32 . . . . 0.0 107.696 175.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.5 128.25 35.23 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 127.075 2.15 . . . . 0.0 108.71 -178.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.6 m -121.54 92.61 3.78 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 122.012 0.911 . . . . 0.0 109.494 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -75.77 90.49 2.89 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.014 -0.993 . . . . 0.0 110.068 174.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -148.02 41.38 0.25 Allowed Pre-proline 0 CA--C 1.553 1.068 0 N-CA-C 116.978 2.214 . . . . 0.0 116.978 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.79 -104.88 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.348 2.699 . . . . 0.0 112.859 -177.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -125.84 107.99 11.03 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.238 1.415 . . . . 0.0 110.661 -168.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -100.59 118.46 60.86 Favored Pre-proline 0 N--CA 1.453 -0.304 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 167.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.86 -50.02 0.07 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 121.781 1.654 . . . . 0.0 110.182 173.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.9 m -169.45 110.74 0.46 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.581 1.152 . . . . 0.0 110.981 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.543 0.679 0 C-N-CA 125.276 1.43 . . . . 0.0 112.808 170.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -78.08 59.57 2.23 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.289 -1.507 . . . . 0.0 107.976 166.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 172.18 160.04 0.1 Allowed 'General case' 0 N--CA 1.445 -0.71 1 C-N-CA 132.703 4.401 . . . . 0.0 105.646 177.137 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -130.51 129.5 42.96 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 155.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.3 t -156.08 42.95 0.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -158.34 -57.13 0.07 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 128.354 2.661 . . . . 0.0 104.709 -164.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 56.4 mt -75.75 -31.89 59.76 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 113.886 -1.506 . . . . 0.0 111.834 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.9 mt -66.0 112.62 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 O-C-N 121.964 -0.46 . . . . 0.0 111.753 -168.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.53 160.44 14.28 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 159.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -75.84 59.98 1.29 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.125 1.37 . . . . 0.0 111.323 -174.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.25 142.99 49.88 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.327 1.451 . . . . 0.0 107.496 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.3 mmmt -110.78 135.46 51.31 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.987 1.715 . . . . 0.0 109.252 -169.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.76 112.11 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-O 121.973 0.892 . . . . 0.0 109.878 -167.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.17 132.41 36.1 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.937 1.295 . . . . 0.0 109.295 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 t -113.36 121.28 65.25 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 C-N-CA 124.538 1.135 . . . . 0.0 108.209 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.63 126.7 31.1 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -102.46 95.89 6.56 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 173.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -118.46 81.07 1.62 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.895 0.855 . . . . 0.0 109.865 -178.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.72 148.3 22.24 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.751 0.821 . . . . 0.0 110.762 -174.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -132.99 152.59 51.94 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.407 1.083 . . . . 0.0 108.182 -172.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.6 t -135.91 146.26 29.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -146.46 174.64 11.21 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.239 0.542 . . . . 0.0 110.573 175.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.63 133.46 16.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 171.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 117.83 -45.98 1.2 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -162.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.34 87.37 51.71 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 123.592 0.757 . . . . 0.0 109.693 174.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -81.8 43.96 1.62 Allowed 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.634 2.889 . . . . 0.0 109.292 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.411 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 43.0 m0 -114.91 140.47 48.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -175.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -79.09 81.3 5.37 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -85.75 98.92 11.0 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.7 m -87.37 135.0 35.05 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -177.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -66.77 156.25 66.79 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 N-CA-C 108.316 -1.455 . . . . 0.0 108.316 167.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.7 t -76.62 -45.71 32.46 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -168.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.66 176.9 12.01 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 163.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.32 -45.08 44.95 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.63 0.772 . . . . 0.0 113.079 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -160.31 154.37 23.11 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 125.253 1.421 . . . . 0.0 107.797 -169.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.4 pt -113.12 164.67 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 C-N-CA 123.95 0.9 . . . . 0.0 109.022 175.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -121.43 118.56 29.7 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.848 1.259 . . . . 0.0 107.855 176.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.8 m -114.67 151.98 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 165.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -78.07 165.7 23.69 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 150.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.0 mm -6.69 -66.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 127.304 2.242 . . . . 0.0 114.136 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -130.14 21.3 4.92 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 118.868 -0.962 . . . . 0.0 114.723 -178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -70.23 119.22 14.1 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 120.641 2.22 . . . . 0.0 110.948 -176.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.9 p -60.92 117.12 5.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.371 0.668 . . . . 0.0 109.452 172.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.5 p -110.85 149.34 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 165.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -102.7 122.72 45.02 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.677 1.991 . . . . 0.0 107.972 -177.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.2 pp -141.5 100.25 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 121.938 0.875 . . . . 0.0 110.047 -177.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 65.7 mtt -77.17 126.34 30.78 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.985 1.314 . . . . 0.0 110.334 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -96.84 137.11 36.42 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 172.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 27.2 ttt85 -110.35 135.9 50.36 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.294 1.037 . . . . 0.0 109.652 -176.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.16 147.06 48.26 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.512 1.525 . . . . 0.0 109.608 175.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -136.29 121.62 19.26 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 117.784 -1.103 . . . . 0.0 108.267 171.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.411 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 43.0 t-20 -80.27 113.88 18.77 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.668 1.122 . . . . 0.0 111.798 -173.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.2 mt -99.21 16.74 21.87 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.741 1.216 . . . . 0.0 112.666 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.53 176.54 9.32 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.437 -0.789 . . . . 0.0 110.384 173.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.4 m -111.24 20.88 16.91 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.98 165.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.7 p -147.26 156.07 46.42 Favored Pre-proline 0 N--CA 1.449 -0.497 0 C-N-CA 125.521 1.528 . . . . 0.0 108.202 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.06 120.08 7.0 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 121.508 1.472 . . . . 0.0 108.586 175.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.66 163.64 15.05 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 118.898 0.772 . . . . 0.0 109.582 172.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.0 t -103.48 137.12 42.01 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 162.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.7 86.07 0.4 Allowed Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 103.497 -3.841 . . . . 0.0 103.497 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.05 46.57 0.91 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.93 177.04 2.78 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.169 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -148.49 178.33 8.7 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -128.16 161.42 29.32 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 166.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.7 128.39 56.28 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 103.441 -2.799 . . . . 0.0 103.441 155.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.0 t -111.55 79.46 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 O-C-N 124.502 1.126 . . . . 0.0 108.804 175.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -160.5 140.21 8.2 Favored Pre-proline 0 N--CA 1.444 -0.752 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.45 -38.59 19.2 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 N-CA-C 108.333 -1.449 . . . . 0.0 108.333 163.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.1 ptp -177.55 -57.3 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.645 1.578 . . . . 0.0 109.962 -177.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.5 -4.1 25.87 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 123.772 0.829 . . . . 0.0 113.222 -162.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -95.77 -109.27 0.14 Allowed 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -172.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.92 -61.89 0.2 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 123.742 0.687 . . . . 0.0 112.868 -174.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -51.04 -59.68 3.91 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.45 1.1 . . . . 0.0 110.687 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -73.24 51.03 0.31 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.508 1.123 . . . . 0.0 112.169 176.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -114.19 121.51 43.95 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 124.089 0.956 . . . . 0.0 108.434 172.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -78.18 66.08 3.7 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.953 171.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -73.45 76.24 1.42 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 164.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.5 p -61.27 167.88 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 165.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 76.53 148.57 0.1 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.534 1.934 . . . . 0.0 113.116 176.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 14.4 p -71.48 -24.83 62.06 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.794 174.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -48.66 142.78 5.73 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.71 1.204 . . . . 0.0 112.191 -173.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 79.0 m -127.55 146.67 50.44 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 125.804 1.642 . . . . 0.0 107.412 -175.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -81.58 21.79 0.77 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -168.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.6 p -80.89 71.46 7.84 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 175.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -8.76 -76.25 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 128.583 2.753 . . . . 0.0 113.713 -177.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.8 t 155.24 -146.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 129.318 3.047 . . . . 0.0 107.072 176.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.0 t -117.18 137.77 52.12 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.168 1.787 . . . . 0.0 108.663 175.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.58 125.38 25.57 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.241 1.016 . . . . 0.0 110.372 -172.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -70.44 157.67 89.49 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.394 1.078 . . . . 0.0 111.636 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.18 114.1 3.71 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.636 2.224 . . . . 0.0 111.92 -167.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 116.57 -25.85 8.87 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -79.95 161.73 25.33 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 121.442 0.639 . . . . 0.0 112.583 -167.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -103.21 159.58 15.42 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.079 1.352 . . . . 0.0 111.288 -173.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 5.9 mtp -148.44 153.91 39.16 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.769 1.627 . . . . 0.0 109.165 174.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -147.01 153.8 40.48 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 150.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 11.9 mmt -128.02 124.93 23.37 Favored Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 124.527 1.131 . . . . 0.0 108.702 178.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -69.47 145.6 59.31 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 C-N-CA 122.008 1.805 . . . . 0.0 109.297 170.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.9 t -130.06 144.26 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 164.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.8 p -111.23 140.21 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 167.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -147.66 139.29 23.91 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 118.349 0.522 . . . . 0.0 109.646 -172.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -153.94 162.13 41.45 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 125.016 1.327 . . . . 0.0 108.84 164.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 96.1 t -87.34 176.51 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 123.254 0.622 . . . . 0.0 109.699 176.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -121.78 133.65 24.36 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 123.591 0.757 . . . . 0.0 110.75 172.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.18 -21.41 72.34 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.415 2.077 . . . . 0.0 113.473 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -59.89 -14.69 16.57 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 119.81 1.187 . . . . 0.0 111.953 -178.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.2 tt -56.58 -42.31 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 121.212 -0.93 . . . . 0.0 112.664 168.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.2 m -84.97 52.65 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 119.228 0.922 . . . . 0.0 110.84 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -123.62 -65.8 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 117.708 -1.139 . . . . 0.0 113.174 173.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.17 154.72 41.88 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 CA-C-N 121.836 1.692 . . . . 0.0 111.25 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.0 m -59.05 -36.5 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 124.744 1.218 . . . . 0.0 112.208 -173.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -61.73 -60.63 3.38 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.445 0.698 . . . . 0.0 110.138 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 82.1 p -83.1 -7.99 59.57 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 118.417 -0.801 . . . . 0.0 112.353 -173.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -33.98 -50.09 0.37 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.301 1.44 . . . . 0.0 113.703 175.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -84.55 -21.49 56.17 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 123.353 0.502 . . . . 0.0 112.155 -176.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 37.6 mm -77.79 118.11 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 O-C-N 122.054 -0.674 . . . . 0.0 109.777 -177.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.9 pttt -155.28 61.34 0.63 Allowed 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.719 168.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 24.9 p -144.39 87.98 1.91 Allowed 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 170.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.1 tp -83.35 78.07 9.69 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -162.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.5 m -79.18 122.68 26.57 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.098 -1.41 . . . . 0.0 109.818 -158.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.8 tt -79.07 129.48 34.49 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 168.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.5 t -153.69 122.51 6.38 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 165.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -158.24 171.0 21.0 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.481 0.712 . . . . 0.0 110.915 -177.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.4 m -115.69 117.55 30.6 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.099 1.76 . . . . 0.0 111.037 -176.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -79.61 100.32 7.75 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.959 1.304 . . . . 0.0 108.492 168.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -155.67 59.38 2.12 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -176.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -79.76 -94.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.658 2.905 . . . . 0.0 112.732 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 78.6 mtt-85 -152.02 96.12 2.16 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.497 -0.752 . . . . 0.0 110.22 -158.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -91.16 123.55 64.09 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 118.752 -0.642 . . . . 0.0 111.098 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -69.89 -61.38 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.743 1.629 . . . . 0.0 110.47 172.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.8 t -157.27 117.22 3.44 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 121.767 -0.583 . . . . 0.0 111.223 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.559 0 C-N-CA 125.36 1.464 . . . . 0.0 110.577 170.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.1 t . . . . . 0 CA--C 1.537 0.445 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 40.43 40.39 0.86 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.584 1.554 . . . . 0.0 111.708 -164.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 176.0 135.65 0.05 Allowed 'General case' 0 N--CA 1.447 -0.583 2 N-CA-C 99.725 -4.176 . . . . 0.0 99.725 -174.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.02 -57.15 4.82 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 116.832 -1.947 . . . . 0.0 111.047 -154.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.1 p -163.13 -147.65 0.12 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 160.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -77.31 -22.57 51.74 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.955 2.102 . . . . 0.0 110.42 164.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.2 mt -56.34 -16.4 5.54 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.915 1.286 . . . . 0.0 113.885 -178.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 74.7 mt -52.03 118.51 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 124.373 1.069 . . . . 0.0 110.959 -173.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 mp -93.83 -83.76 0.32 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.943 0.497 . . . . 0.0 110.892 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -175.23 -56.82 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.033 0.933 . . . . 0.0 109.834 -164.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.44 ' CD ' ' HZ1' ' A' ' 136' ' ' LYS . 0.5 OUTLIER -47.32 145.4 2.4 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 125.542 1.537 . . . . 0.0 113.473 -165.87 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.9 tttt -96.93 90.78 5.33 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 126.062 1.745 . . . . 0.0 106.585 -170.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.68 107.5 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 176.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.16 146.06 35.29 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -177.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.5 t -130.46 144.4 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 -176.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 29.7 m -130.84 95.2 3.78 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -171.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -77.22 88.09 3.67 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 124.141 0.977 . . . . 0.0 108.986 -176.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -79.97 83.42 5.88 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 122.66 1.219 . . . . 0.0 109.699 -174.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.25 102.82 15.48 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.531 1.132 . . . . 0.0 110.594 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -106.05 111.17 23.69 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.296 0.639 . . . . 0.0 110.158 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.5 p -77.31 147.84 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 168.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.38 154.62 41.1 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 167.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.79 -41.23 22.97 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.062 0.945 . . . . 0.0 111.742 -175.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -30.69 -43.25 0.07 OUTLIER Glycine 0 CA--C 1.53 1.006 0 C-N-CA 126.898 2.189 . . . . 0.0 113.758 169.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.43 HD12 ' CD2' ' A' ' 144' ' ' PHE . 1.3 tt -116.14 98.54 51.48 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 170.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -74.89 13.8 0.94 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.008 2.472 . . . . 0.0 115.222 -161.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.5 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 42.0 m0 -79.27 156.2 28.19 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.58 1.552 . . . . 0.0 113.079 -168.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -75.98 79.79 2.85 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 170.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -99.56 121.66 41.5 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.022 0.929 . . . . 0.0 108.718 -177.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.08 141.87 41.14 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 118.047 0.385 . . . . 0.0 110.269 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.92 161.15 45.79 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.907 1.738 . . . . 0.0 108.857 163.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.44 -50.38 19.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 177.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.04 165.57 30.39 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 159.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -61.76 -41.57 97.87 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.689 0.677 . . . . 0.0 110.127 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -145.92 157.61 43.89 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 123.726 0.81 . . . . 0.0 112.444 -160.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 50.1 pt -136.54 171.33 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 125.12 1.368 . . . . 0.0 109.252 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -125.01 85.99 2.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.87 1.668 . . . . 0.0 110.814 -178.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.1 t -76.16 127.94 37.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -177.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.87 101.12 9.22 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 167.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 mm -6.21 84.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 127.579 2.352 . . . . 0.0 113.371 -171.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.5 -0.51 49.7 Favored Glycine 0 CA--C 1.539 1.546 0 N-CA-C 115.413 0.925 . . . . 0.0 115.413 171.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -59.69 124.34 19.81 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.023 1.729 . . . . 0.0 109.396 163.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.78 111.75 21.04 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.438 1.095 . . . . 0.0 110.995 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.22 143.27 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.85 128.39 49.63 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.1 pp -143.9 93.17 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.135 1.374 . . . . 0.0 109.308 -173.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 46.6 ttm -73.6 135.96 43.89 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.124 0.969 . . . . 0.0 110.059 -173.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -99.69 141.17 32.84 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 174.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.3 ttt180 -110.85 132.34 54.29 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 174.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.09 141.75 44.24 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 127.052 2.141 . . . . 0.0 107.241 162.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -140.71 145.98 37.18 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 166.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.5 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 34.6 t30 -83.38 87.27 6.98 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 119.024 0.829 . . . . 0.0 113.019 -170.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -79.92 73.53 6.69 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.197 0.999 . . . . 0.0 109.224 172.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.15 140.26 17.46 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 164.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.7 t -78.35 35.4 0.22 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.785 1.175 . . . . 0.0 111.347 174.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 p -146.41 154.57 49.29 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 126.392 1.877 . . . . 0.0 108.876 176.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.49 143.33 42.52 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.615 2.21 . . . . 0.0 109.242 176.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.5 p -117.44 176.72 5.03 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.51 1.124 . . . . 0.0 111.998 -175.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 m -133.43 126.08 30.42 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 103.18 -2.896 . . . . 0.0 103.18 -178.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -127.35 117.24 2.63 Favored Glycine 0 C--N 1.335 0.481 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -171.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? -139.54 -48.57 0.47 Allowed 'General case' 0 C--N 1.338 0.106 0 CA-C-N 117.738 0.769 . . . . 0.0 110.291 174.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 62.84 175.38 0.15 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.22 1.008 . . . . 0.0 110.408 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.3 t -111.3 146.8 36.39 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 165.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -122.18 89.67 3.16 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.254 1.422 . . . . 0.0 108.073 -173.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.73 85.25 4.75 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 174.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.7 t -79.04 70.09 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.844 1.258 . . . . 0.0 109.707 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.5 t -176.74 149.42 0.86 Allowed Pre-proline 0 N--CA 1.469 0.486 0 CA-C-N 119.325 0.966 . . . . 0.0 111.571 170.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -66.22 -37.31 25.14 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.266 1.31 . . . . 0.0 110.088 159.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 11.8 ptp 169.58 -68.67 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 128.305 2.642 . . . . 0.0 106.912 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.74 -45.35 65.01 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.94 0.896 . . . . 0.0 112.966 -170.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.19 -104.4 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.91 -166.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.97 -56.62 1.41 Allowed Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.47 -0.628 . . . . 0.0 112.488 -175.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -44.23 -55.08 5.13 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.594 1.158 . . . . 0.0 111.923 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -72.54 2.66 5.97 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.546 1.538 . . . . 0.0 114.014 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -73.89 90.84 1.94 Allowed 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.522 0.729 . . . . 0.0 109.55 -175.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -82.99 80.82 8.91 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.602 -167.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.0 -60.78 1.84 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 123.766 0.827 . . . . 0.0 110.14 171.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.5 p -133.27 149.88 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 124.123 0.969 . . . . 0.0 109.067 -168.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -78.79 -51.65 9.46 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.526 0.731 . . . . 0.0 109.441 176.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 16.3 t -82.45 99.47 9.47 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 173.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -69.29 65.1 0.16 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.882 1.273 . . . . 0.0 112.9 -177.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 51.4 t -163.31 68.46 0.2 Allowed 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 124.978 1.311 . . . . 0.0 108.663 172.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -73.6 145.6 45.3 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -163.31 111.96 1.26 Allowed 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 -161.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -80.23 50.27 1.23 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.02 0.928 . . . . 0.0 112.315 -171.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.9 t 36.67 -124.15 0.17 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.987 1.715 . . . . 0.0 114.463 166.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.4 t -142.96 155.13 44.64 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.797 2.039 . . . . 0.0 107.624 -176.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.2 mt -142.63 141.78 31.97 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 170.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -76.34 170.65 15.07 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.588 1.555 . . . . 0.0 108.994 171.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.9 106.59 2.04 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 121.807 1.671 . . . . 0.0 113.666 -166.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 116.51 -13.77 15.45 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 124.932 1.253 . . . . 0.0 110.801 172.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -82.4 176.89 9.06 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 123.627 0.251 . . . . 0.0 111.548 -163.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -118.86 144.0 46.63 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.073 0.949 . . . . 0.0 113.194 -150.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.25 84.29 1.95 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.102 1.761 . . . . 0.0 110.027 168.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -101.95 87.79 3.2 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 120.612 -1.305 . . . . 0.0 109.243 171.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 13.2 ttt -102.82 118.82 57.43 Favored Pre-proline 0 N--CA 1.442 -0.869 0 O-C-N 121.454 -0.779 . . . . 0.0 110.275 -167.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.64 152.77 77.62 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.145 1.897 . . . . 0.0 110.358 171.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.5 t -145.43 135.44 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.6 p -99.46 148.08 6.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 166.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -152.43 156.27 39.15 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 118.282 0.492 . . . . 0.0 112.047 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -173.11 176.78 2.89 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 127.149 2.18 . . . . 0.0 108.467 176.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 78.7 t -131.86 138.66 52.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 124.0 0.92 . . . . 0.0 108.967 176.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -82.88 146.81 53.17 Favored Pre-proline 0 CA--C 1.54 0.593 0 O-C-N 123.452 0.47 . . . . 0.0 111.255 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -56.98 -25.25 61.8 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.95 3.1 . . . . 0.0 113.615 177.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -42.22 -31.13 0.35 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.637 1.575 . . . . 0.0 113.09 175.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.3 tt -49.3 -46.14 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.6 m -85.5 57.07 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 119.425 1.011 . . . . 0.0 110.52 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -132.59 -64.55 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.484 1.114 . . . . 0.0 113.456 173.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -63.86 164.7 20.87 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 121.932 1.754 . . . . 0.0 111.882 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 89.3 t -77.39 -43.8 30.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -173.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -37.8 -46.6 0.94 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 129.037 2.935 . . . . 0.0 112.957 177.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 19.1 p -87.23 -61.93 1.61 Allowed 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -0.97 79.7 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 129.506 3.123 . . . . 0.0 115.098 -171.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 134.82 -44.11 1.21 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 -171.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 12.4 mm -53.46 118.25 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 123.038 0.535 . . . . 0.0 110.075 170.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.44 ' HZ1' ' CD ' ' A' ' 31' ' ' GLU . 3.2 pttt -156.01 53.84 0.57 Allowed 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.881 168.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.83 91.87 2.4 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 167.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.5 mp -77.0 135.12 38.66 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 -176.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 6.7 t -136.9 150.46 48.24 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.76 106.35 10.43 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 102.785 -3.043 . . . . 0.0 102.785 170.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.6 t -79.61 92.98 5.4 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 172.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.37 121.82 27.19 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 174.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.63 108.85 13.04 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.894 0.878 . . . . 0.0 109.786 -178.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.43 ' CD2' HD12 ' A' ' 45' ' ' LEU . 3.9 m-30 -79.28 80.51 5.64 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.014 1.325 . . . . 0.0 112.792 -167.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -129.58 78.42 75.52 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -97.65 -106.98 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.873 1 C-N-CA 125.418 4.079 . . . . 0.0 111.223 167.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -137.85 113.06 9.25 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.083 1.753 . . . . 0.0 108.046 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -91.11 113.11 57.17 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 123.813 0.845 . . . . 0.0 108.756 170.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -77.23 65.38 7.91 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.131 1.887 . . . . 0.0 108.314 166.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.2 m 26.53 92.58 0.01 OUTLIER 'General case' 0 C--N 1.344 0.326 0 C-N-CA 128.688 2.795 . . . . 0.0 113.964 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.283 0 CA-C-N 119.038 0.835 . . . . 0.0 110.573 -156.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.6 p . . . . . 0 CA--C 1.537 0.469 0 N-CA-C 102.603 -3.11 . . . . 0.0 102.603 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -79.26 61.17 3.29 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 122.648 2.476 . . . . 0.0 109.17 168.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.06 159.99 1.37 Allowed 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 131.657 3.983 . . . . 0.0 104.703 178.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.36 133.59 36.96 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 103.353 -2.832 . . . . 0.0 103.353 149.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.4 m -157.89 39.15 0.27 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.318 1.447 . . . . 0.0 109.145 162.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.18 -58.07 1.82 Allowed 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 104.767 -2.308 . . . . 0.0 104.767 -166.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.9 mt -124.87 41.55 3.49 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.432 1.493 . . . . 0.0 109.706 176.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 44.3 mt -75.07 110.06 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 162.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.17 -174.12 2.47 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 170.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.42 -32.96 70.66 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.363 1.465 . . . . 0.0 114.855 -163.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -53.23 95.95 0.01 OUTLIER 'General case' 0 C--N 1.34 0.178 0 CA-C-O 123.048 1.404 . . . . 0.0 112.72 -173.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.459 ' HZ1' ' CG ' ' A' ' 57' ' ' ASP . 9.3 ttpp -74.58 88.12 2.15 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 165.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.65 127.51 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.754 -172.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.44 134.28 33.62 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -174.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 t -118.03 139.18 46.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.5 m -113.2 104.55 12.46 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.825 1.25 . . . . 0.0 108.272 -174.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -79.96 148.22 31.29 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.764 173.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -144.19 86.96 1.86 Allowed 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 -175.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.64 90.66 8.5 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.983 1.313 . . . . 0.0 110.505 -173.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -93.09 106.55 18.5 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.513 0.673 . . . . 0.0 109.752 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.0 p -78.44 145.52 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 163.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -156.32 159.43 38.81 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 118.579 0.627 . . . . 0.0 110.266 176.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.31 132.69 29.13 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 172.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.21 -45.33 1.28 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 -160.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.25 97.37 19.94 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 123.699 0.799 . . . . 0.0 109.801 -178.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.82 11.29 2.8 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.525 2.817 . . . . 0.0 113.438 -174.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 42.0 m0 -76.29 145.66 39.46 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.074 -1.016 . . . . 0.0 111.352 -172.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -77.59 83.15 3.99 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 104.87 -2.271 . . . . 0.0 104.87 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -94.59 90.14 6.04 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.616 1.966 . . . . 0.0 108.514 -171.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.2 m -89.15 129.65 47.12 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -176.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.87 149.38 72.37 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 N-CA-C 108.165 -1.513 . . . . 0.0 108.165 164.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.3 -59.2 3.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -128.85 157.09 42.5 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 167.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.9 tpt85 -67.33 -34.36 77.18 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 173.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -134.3 169.47 17.17 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 125.576 1.55 . . . . 0.0 110.689 -174.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.5 pt -136.47 175.87 9.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 124.774 1.23 . . . . 0.0 107.88 166.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.459 ' CG ' ' HZ1' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -126.35 136.8 53.17 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 165.564 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.9 m -126.04 135.1 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 170.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.85 96.04 2.03 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 165.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.8 pt 0.23 73.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.994 2.117 . . . . 0.0 114.389 -173.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.28 -27.9 3.36 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 119.934 -0.37 . . . . 0.0 112.821 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -46.74 106.95 0.09 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.239 1.016 . . . . 0.0 111.414 176.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.1 p -65.0 113.48 3.91 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.83 0.852 . . . . 0.0 109.386 174.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.3 p -114.8 144.11 23.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 167.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.25 131.06 38.7 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.154 1.782 . . . . 0.0 107.978 176.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -145.67 93.49 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.37 144.61 34.0 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.979 -173.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -110.83 145.26 38.52 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 177.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.5 ttt-85 -118.84 121.29 39.68 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.667 1.187 . . . . 0.0 108.291 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.28 111.0 18.8 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.013 0.925 . . . . 0.0 109.653 169.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -107.98 118.36 36.54 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.975 0.91 . . . . 0.0 110.561 -176.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -79.73 94.32 5.72 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -162.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.5 mt -84.72 73.24 10.63 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.469 0.707 . . . . 0.0 110.556 168.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -127.94 167.83 16.09 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.168 0.987 . . . . 0.0 110.52 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.5 p -78.26 -29.62 48.12 Favored 'General case' 0 C--O 1.227 -0.127 0 C-N-CA 123.467 0.707 . . . . 0.0 111.466 174.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -147.92 162.32 31.67 Favored Pre-proline 0 N--CA 1.449 -0.508 0 C-N-CA 124.742 1.217 . . . . 0.0 108.456 -160.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -59.68 121.17 9.41 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.724 2.282 . . . . 0.0 111.044 -174.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.51 175.42 7.07 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.623 1.569 . . . . 0.0 110.113 -178.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.0 t -138.24 159.28 42.46 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 169.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -138.1 150.93 21.18 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 127.03 2.252 . . . . 0.0 108.551 -173.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.56 -39.22 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.21 0.604 . . . . 0.0 110.097 168.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.58 -179.52 0.12 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.873 0.869 . . . . 0.0 113.023 176.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.1 t -119.31 166.63 12.78 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 144.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -141.89 88.78 2.14 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.756 1.265 . . . . 0.0 108.015 -176.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -79.13 89.08 4.83 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -177.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.8 t -79.69 86.65 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 173.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.8 t -175.16 151.33 1.33 Allowed Pre-proline 0 C--O 1.232 0.143 0 C-N-CA 125.055 1.342 . . . . 0.0 109.411 170.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.52 -34.61 7.16 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 121.011 1.14 . . . . 0.0 109.156 156.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.8 ptp 171.99 -70.38 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.91 2.484 . . . . 0.0 107.869 -177.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.69 -30.79 26.51 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -165.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.38 -112.93 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.011 0.368 . . . . 0.0 110.086 -177.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.24 -58.62 0.84 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 123.737 0.684 . . . . 0.0 112.735 -174.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -49.44 -53.67 21.67 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.998 0.919 . . . . 0.0 110.365 175.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -73.19 40.4 0.1 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.494 1.118 . . . . 0.0 112.919 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -103.06 140.31 37.46 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 173.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -74.21 162.72 28.65 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 118.394 -1.322 . . . . 0.0 111.405 173.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? 54.13 56.47 6.97 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.111 0.958 . . . . 0.0 109.714 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.9 p -72.55 146.08 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 170.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 70.7 153.7 0.12 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.383 1.873 . . . . 0.0 113.608 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 67.02 142.7 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.874 1.669 . . . . 0.0 111.705 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -61.52 -179.74 0.19 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.837 0.855 . . . . 0.0 111.592 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 13.4 t -153.29 51.31 0.72 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 167.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 6.5 p90 179.19 164.25 0.91 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.591 1.956 . . . . 0.0 105.835 -164.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.8 t -126.69 49.9 1.99 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 122.736 1.255 . . . . 0.0 109.188 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.39 69.85 1.66 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 173.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.2 t -115.3 -61.05 1.8 Allowed 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 124.813 1.245 . . . . 0.0 110.56 -172.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -161.96 146.23 12.55 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.039 1.336 . . . . 0.0 107.427 -178.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.5 mt -147.79 134.46 19.93 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 174.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -64.55 156.4 77.7 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 127.382 2.273 . . . . 0.0 109.751 170.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.3 92.92 0.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.531 2.821 . . . . 0.0 111.65 -167.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 143.75 -27.32 2.06 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 124.562 1.077 . . . . 0.0 110.991 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -77.97 153.93 32.01 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -153.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -108.6 118.17 36.09 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.591 1.556 . . . . 0.0 110.19 -166.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 14.9 ttp -108.96 86.04 2.21 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 123.834 0.853 . . . . 0.0 110.868 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -77.26 129.39 35.84 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 156.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 25.6 mtp -143.35 136.58 13.97 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 118.587 0.63 . . . . 0.0 111.511 159.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -69.95 124.32 10.89 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 123.547 2.831 . . . . 0.0 111.296 171.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.2 t -91.18 152.24 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 160.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.8 p -121.46 143.7 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 167.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -148.65 135.53 19.93 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 118.633 0.651 . . . . 0.0 110.621 -173.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -159.55 149.05 18.31 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.156 1.382 . . . . 0.0 109.17 174.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 92.3 t -100.8 139.17 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.689 1.196 . . . . 0.0 111.441 -173.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -82.91 120.35 76.03 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 177.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.16 -16.31 27.07 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.827 2.351 . . . . 0.0 113.754 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.87 -27.4 2.09 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 119.518 1.054 . . . . 0.0 111.965 168.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.02 -45.7 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 O-C-N 121.643 -0.66 . . . . 0.0 111.63 175.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.9 m -87.36 56.34 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 O-C-N 121.185 -0.947 . . . . 0.0 109.952 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -138.1 -59.72 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 117.14 -1.409 . . . . 0.0 113.762 175.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.95 161.44 18.42 Favored 'Trans proline' 0 C--N 1.347 0.489 0 CA-C-N 122.573 1.955 . . . . 0.0 113.237 -172.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.1 t -56.2 -36.66 46.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 125.843 1.657 . . . . 0.0 111.0 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -38.84 -54.1 1.65 Allowed 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 126.377 1.871 . . . . 0.0 112.053 176.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.5 p -106.28 -46.19 4.11 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.529 -166.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 14.72 67.05 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.305 2.642 . . . . 0.0 115.652 175.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 127.84 -24.36 5.16 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.676 -0.57 . . . . 0.0 111.676 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.2 mm -60.58 132.02 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 170.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 42.5 pttt -159.51 64.72 0.38 Allowed 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.784 0.802 . . . . 0.0 110.282 167.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 27.7 m -149.19 98.28 2.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 162.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.66 82.75 4.88 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -175.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.1 m -76.7 152.9 35.54 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.985 -169.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.2 tt -136.96 104.47 5.47 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.3 m -86.98 98.25 11.15 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 169.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.92 128.07 33.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 170.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.3 m -135.95 98.44 3.89 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.463 0.649 . . . . 0.0 109.89 -168.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -72.98 92.09 1.62 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.118 1.367 . . . . 0.0 112.111 -174.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -132.25 90.61 33.97 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.394 1.078 . . . . 0.0 113.386 170.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -109.4 -105.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.318 1 C-N-CA 125.381 4.054 . . . . 0.0 109.731 164.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.4 ptt-85 -160.34 124.49 3.66 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.59 1.556 . . . . 0.0 108.25 -174.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -95.78 133.69 25.13 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 123.24 0.616 . . . . 0.0 109.493 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -73.53 -63.16 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.146 1.898 . . . . 0.0 108.729 174.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.5 t -167.41 175.22 7.37 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.827 1.251 . . . . 0.0 107.98 162.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.5 0 C-N-CA 124.5 1.12 . . . . 0.0 111.859 -178.227 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.7 t . . . . . 0 CA--C 1.537 0.467 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 18.45 54.3 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.924 2.49 . . . . 0.0 114.039 -162.524 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.43 -80.66 0.15 Allowed 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 102.406 -3.183 . . . . 0.0 102.406 167.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -161.24 -80.07 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 126.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.4 t -160.33 -157.85 0.58 Allowed 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 164.2 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.0 -18.24 61.99 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.953 1.701 . . . . 0.0 109.574 175.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.1 mt -68.1 2.41 2.16 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.641 1.177 . . . . 0.0 113.511 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.4 mt -67.71 126.21 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 121.036 1.744 . . . . 0.0 108.888 172.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.4 mp -126.16 163.0 24.08 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.36 0.664 . . . . 0.0 110.669 -178.074 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -78.56 70.26 4.87 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.703 0.801 . . . . 0.0 111.786 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.15 162.19 27.5 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 153.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -130.84 110.27 11.18 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -174.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.13 125.14 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 -174.532 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -89.39 137.79 32.02 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -178.215 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.2 t -123.98 131.29 73.16 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.7 m -91.59 106.1 18.23 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.412 1.885 . . . . 0.0 108.087 -174.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -80.52 124.72 29.18 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -130.23 84.94 2.24 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 122.233 1.016 . . . . 0.0 111.617 -170.741 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.54 102.31 14.08 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.14 0.976 . . . . 0.0 109.706 177.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -99.18 122.25 42.12 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.6 p -113.01 133.56 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.089 0 C-N-CA 124.162 0.985 . . . . 0.0 109.071 174.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.11 176.15 8.95 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.543 1.137 . . . . 0.0 108.833 179.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.1 122.57 8.74 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 170.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.06 -32.52 1.16 Allowed Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -165.122 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mp -142.63 158.74 59.43 Favored Pre-proline 0 N--CA 1.456 -0.155 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 160.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -90.66 13.31 2.22 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.84 3.027 . . . . 0.0 112.171 165.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.438 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 41.7 m0 -78.63 139.76 38.51 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -162.49 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -76.72 83.78 3.34 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.415 ' CZ ' ' CE1' ' A' ' 144' ' ' PHE . 7.2 m-85 -87.71 89.34 7.96 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.317 175.04 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.5 m -87.9 112.9 52.06 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 171.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.1 142.02 54.66 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 N-CA-C 107.659 -1.708 . . . . 0.0 107.659 164.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 m -77.54 -41.37 29.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 O-C-N 122.396 -0.19 . . . . 0.0 111.408 -171.3 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.97 156.51 43.55 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 167.963 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -65.29 -36.62 84.64 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 177.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -151.6 143.75 23.96 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 122.762 0.425 . . . . 0.0 110.99 -174.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.0 pt -105.6 168.36 2.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 123.679 0.792 . . . . 0.0 109.416 174.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -94.05 141.92 27.98 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 152.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.76 123.61 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 157.808 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -75.52 78.82 2.54 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 172.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 pt 11.97 73.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 127.508 2.323 . . . . 0.0 112.923 -176.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.99 -33.44 3.7 Favored Glycine 0 C--O 1.222 -0.643 0 CA-C-O 118.448 -1.195 . . . . 0.0 112.054 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -62.1 140.78 58.39 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 120.225 2.012 . . . . 0.0 110.442 -178.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.13 112.15 16.05 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 127.942 2.497 . . . . 0.0 110.182 -174.041 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 p -79.67 169.01 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.104 0 O-C-N 121.818 -0.551 . . . . 0.0 109.63 174.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -116.39 113.76 23.35 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 124.947 1.299 . . . . 0.0 107.96 156.262 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.4 pp -121.54 126.9 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 159.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 33.1 ttp -79.31 151.05 31.29 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 167.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.77 155.61 27.5 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 167.348 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -134.23 145.35 49.07 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.448 1.099 . . . . 0.0 109.299 172.229 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.16 155.97 49.78 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 127.0 2.12 . . . . 0.0 105.943 151.072 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.0 mmmt -137.72 122.1 18.27 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 116.845 -1.55 . . . . 0.0 108.997 176.496 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.438 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 49.9 t-20 -78.22 85.49 4.38 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 121.472 1.942 . . . . 0.0 111.565 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.4 mt -79.1 68.89 5.18 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.788 1.235 . . . . 0.0 109.869 172.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.75 175.02 10.94 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 170.072 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.5 m -106.41 19.4 20.56 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.1 0.56 . . . . 0.0 110.346 173.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.4 p -146.6 161.05 39.6 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 125.777 1.631 . . . . 0.0 108.848 178.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -62.8 156.51 53.17 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 121.502 1.468 . . . . 0.0 110.247 173.568 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.37 162.91 31.27 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 171.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.9 t -116.61 108.22 15.67 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.2 121.61 5.59 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 105.625 -2.99 . . . . 0.0 105.625 162.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.66 -54.06 1.34 Allowed 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 170.734 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.39 178.41 0.16 Allowed 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.884 0.874 . . . . 0.0 110.984 172.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.62 141.63 33.43 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 153.055 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -107.4 162.85 13.55 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 122.681 0.392 . . . . 0.0 110.53 173.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -123.23 111.32 16.33 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 160.374 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.0 t -89.17 56.82 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.616 0.766 . . . . 0.0 110.008 -171.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.2 t -172.97 149.97 1.9 Allowed Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 119.911 1.232 . . . . 0.0 112.24 -177.56 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -64.84 -39.46 25.55 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 121.972 1.782 . . . . 0.0 109.676 162.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.4 ptp 173.49 -76.79 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 127.537 2.335 . . . . 0.0 108.044 176.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.16 -43.51 98.66 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 123.938 0.895 . . . . 0.0 112.666 -169.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.04 -103.82 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.718 -161.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.04 -53.91 1.4 Allowed Glycine 0 CA--C 1.527 0.829 0 CA-C-O 119.381 -0.677 . . . . 0.0 113.043 -177.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -45.84 -56.42 5.41 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.49 1.145 . . . . 0.0 110.984 176.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -74.35 4.72 5.42 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.606 1.162 . . . . 0.0 113.83 179.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -76.9 107.78 9.48 Favored 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 120.9 -1.125 . . . . 0.0 108.428 177.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -83.7 77.42 9.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.77 -172.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.35 163.97 0.36 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.175 158.128 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.8 t -77.53 -103.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 176.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -164.65 171.42 14.44 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -168.252 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 3.7 t 66.33 -157.91 0.25 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.254 1.022 . . . . 0.0 109.658 -179.232 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -72.05 -11.99 61.01 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.409 1.004 . . . . 0.0 113.213 -170.177 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 50.5 t 72.38 -51.49 0.7 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.74 1.616 . . . . 0.0 113.327 177.013 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -61.06 77.24 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.353 1.461 . . . . 0.0 111.132 174.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.8 m -78.07 -21.18 50.96 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.762 1.625 . . . . 0.0 109.931 178.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.9 -60.91 2.7 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.26 1.424 . . . . 0.0 111.488 171.483 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.8 t 45.66 -148.36 0.11 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.499 1.52 . . . . 0.0 111.92 177.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -93.95 145.54 24.57 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.108 0.963 . . . . 0.0 108.913 176.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.1 mt -136.71 128.14 28.43 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 122.94 0.496 . . . . 0.0 109.897 177.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -54.74 165.21 0.97 Allowed Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 127.255 2.222 . . . . 0.0 110.738 160.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -76.25 126.17 8.99 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.244 1.963 . . . . 0.0 112.457 -172.027 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 98.02 5.16 57.46 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 124.012 0.815 . . . . 0.0 111.298 175.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -79.35 133.75 36.59 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 117.242 0.521 . . . . 0.0 110.737 -173.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -102.19 89.28 3.54 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.144 1.378 . . . . 0.0 109.694 -175.322 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.96 87.36 7.35 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -133.51 131.91 40.37 Favored 'General case' 0 CA--C 1.523 -0.075 0 CA-C-N 119.193 0.906 . . . . 0.0 111.411 169.506 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 60.0 mtt -153.07 147.11 18.57 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.173 0.989 . . . . 0.0 109.498 -170.519 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.29 146.84 40.96 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.678 2.919 . . . . 0.0 110.375 173.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 28.2 m -138.22 158.77 32.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 123.771 0.828 . . . . 0.0 108.891 165.319 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.6 m -114.6 161.01 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 124.097 0.959 . . . . 0.0 109.104 175.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -159.95 155.77 26.06 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.387 1.075 . . . . 0.0 108.164 -179.216 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -175.27 92.72 0.06 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.975 1.31 . . . . 0.0 111.529 -171.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.34 138.56 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 O-C-N 120.691 -1.256 . . . . 0.0 111.714 178.611 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.75 136.24 92.5 Favored Pre-proline 0 N--CA 1.469 0.51 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.487 173.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.57 -29.22 59.34 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.028 1.819 . . . . 0.0 112.104 172.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -44.6 -28.88 0.65 Allowed 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.534 1.533 . . . . 0.0 112.727 174.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 17.7 tt -47.69 -41.05 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 119.375 0.988 . . . . 0.0 112.817 174.345 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.3 m -87.01 58.39 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 119.573 1.079 . . . . 0.0 109.992 175.517 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . 0.486 1.0 OUTLIER -144.28 -52.63 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 117.933 2.568 . . . . 0.0 117.933 172.102 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.79 161.21 33.7 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 CA-C-N 123.368 2.239 . . . . 0.0 112.26 -177.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.78 -42.16 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 124.826 1.25 . . . . 0.0 109.468 -172.404 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -43.26 -47.74 6.58 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 127.528 2.331 . . . . 0.0 112.382 177.254 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 24.2 p -92.95 -53.16 4.26 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -175.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 12.59 62.41 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 129.117 2.967 . . . . 0.0 115.44 -178.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 140.98 -38.73 1.52 Allowed Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -174.133 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.8 mm -55.34 113.65 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-N 117.434 0.617 . . . . 0.0 109.864 175.206 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 7.9 pttt -156.52 61.56 0.54 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 121.99 0.9 . . . . 0.0 108.925 169.659 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.89 89.53 1.47 Allowed 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 162.735 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.5 tp -74.99 160.16 30.9 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -171.407 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 12.0 t -153.36 164.75 37.59 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 174.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 14.7 tp -138.06 98.27 3.6 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 102.253 -3.24 . . . . 0.0 102.253 173.303 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.9 p -84.24 93.18 8.14 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 177.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.27 131.36 36.14 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 175.324 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.94 96.24 4.98 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.003 0.921 . . . . 0.0 108.677 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.415 ' CE1' ' CZ ' ' A' ' 49' ' ' PHE . 50.4 m-85 -89.62 87.63 7.1 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 125.652 1.581 . . . . 0.0 109.531 178.607 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -135.71 37.35 0.34 Allowed Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 125.378 1.471 . . . . 0.0 114.379 175.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.45 -85.4 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.156 2.571 . . . . 0.0 114.346 -172.638 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.46 91.38 1.57 Allowed 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.592 0.757 . . . . 0.0 110.352 -163.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -78.5 117.74 68.17 Favored Pre-proline 0 N--CA 1.451 -0.387 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 168.378 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.57 -29.42 7.37 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.551 2.167 . . . . 0.0 110.788 172.102 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 36.9 m 130.01 144.0 0.0 OUTLIER 'General case' 0 C--N 1.342 0.263 0 C-N-CA 130.632 3.573 . . . . 0.0 107.36 -167.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.2 pttm . . . . . 0 CA--C 1.534 0.358 0 C-N-CA 124.927 1.291 . . . . 0.0 109.267 177.562 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.1 t . . . . . 0 CA--C 1.537 0.461 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -73.62 67.11 1.09 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 159.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 146.46 154.08 0.0 OUTLIER 'General case' 0 C--N 1.339 0.132 1 C-N-CA 132.349 4.26 . . . . 0.0 108.096 -171.868 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -153.2 28.55 0.51 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 122.025 0.917 . . . . 0.0 110.126 -167.389 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.79 -11.43 59.99 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.529 1.532 . . . . 0.0 114.757 -147.196 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.35 -31.96 64.25 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 173.879 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.1 mp -108.09 14.46 25.11 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.023 1.329 . . . . 0.0 112.074 -176.27 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.4 mt -77.98 77.31 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 120.005 -1.684 . . . . 0.0 108.839 173.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.76 179.75 5.93 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.531 0.681 . . . . 0.0 109.893 179.238 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -94.48 59.43 2.51 Favored 'General case' 0 C--N 1.337 0.031 0 C-N-CA 123.827 0.851 . . . . 0.0 112.667 -167.021 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -115.18 160.9 19.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 151.664 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -133.76 88.38 2.47 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.0 tt -94.47 137.91 21.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 C-N-CA 124.477 1.111 . . . . 0.0 111.637 -163.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.71 143.84 34.2 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.635 1.574 . . . . 0.0 109.781 -170.421 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.7 t -135.72 142.06 40.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.655 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 164.389 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.9 m -123.29 112.47 17.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 -177.721 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -78.52 89.76 4.48 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 172.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -78.23 85.25 4.4 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 118.492 -1.283 . . . . 0.0 108.395 178.576 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.5 115.78 17.54 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.832 174.758 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -122.94 175.54 6.52 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.595 1.158 . . . . 0.0 108.188 167.039 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.6 p -151.17 148.6 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 169.161 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -164.51 171.54 14.45 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.254 1.022 . . . . 0.0 108.869 -178.302 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.62 -165.36 0.22 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.354 1.462 . . . . 0.0 111.616 -175.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.73 52.98 4.26 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 112.123 -0.391 . . . . 0.0 112.123 -173.079 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.412 ' CD1' ' CD1' ' A' ' 144' ' ' PHE . 1.4 tt -111.7 83.77 4.77 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.122 0.969 . . . . 0.0 108.785 177.693 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -85.28 45.0 1.5 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.246 3.298 . . . . 0.0 109.736 -170.141 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.439 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 43.1 m0 -108.39 138.58 44.43 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -172.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.408 ' OE1' ' NZ ' ' A' ' 71' ' ' LYS . 73.2 tt0 -77.85 82.36 4.23 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 -178.503 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -90.26 122.01 32.79 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.715 1.206 . . . . 0.0 108.233 179.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 m -126.67 135.54 27.43 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.144 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -70.76 162.39 42.76 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 N-CA-C 108.146 -1.521 . . . . 0.0 108.146 161.433 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -60.18 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 175.117 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -144.06 154.13 42.91 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 164.773 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.03 -42.72 69.45 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 118.537 -0.744 . . . . 0.0 112.095 -175.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -145.35 159.69 42.67 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 119.382 0.992 . . . . 0.0 113.189 -166.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.8 pt -133.82 159.79 42.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 125.768 1.627 . . . . 0.0 107.847 178.193 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -128.29 85.41 2.34 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.316 1.446 . . . . 0.0 109.124 178.189 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.8 m -80.44 141.83 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 O-C-N 121.255 -0.903 . . . . 0.0 110.689 -171.281 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -78.22 72.16 4.74 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 173.078 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.5 pt 19.01 64.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 127.437 2.295 . . . . 0.0 113.489 176.368 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 139.0 -43.8 1.14 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -172.58 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -59.68 130.3 46.16 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.648 -173.467 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.6 m -106.69 87.28 2.49 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.003 -146.106 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.72 144.19 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 CA-C-O 121.094 0.473 . . . . 0.0 110.696 -170.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.93 115.54 24.4 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.239 1.016 . . . . 0.0 108.591 168.817 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.8 pp -115.57 115.04 48.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 164.044 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -87.49 155.23 20.09 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.939 -0.475 . . . . 0.0 110.966 178.387 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -127.0 153.78 45.46 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 172.73 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -134.69 141.79 46.64 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.877 1.671 . . . . 0.0 107.898 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.34 115.58 7.98 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.805 2.042 . . . . 0.0 107.681 174.387 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.408 ' NZ ' ' OE1' ' A' ' 48' ' ' GLU . 3.0 mtmp? -114.73 124.42 51.73 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.29 0.95 . . . . 0.0 110.652 -176.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.439 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 46.9 t-20 -80.92 107.2 13.53 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.79 0.723 . . . . 0.0 112.932 -167.583 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.3 mp -99.08 30.4 3.45 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.495 1.118 . . . . 0.0 111.974 176.649 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.85 176.81 9.39 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.021 -1.049 . . . . 0.0 110.401 168.084 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.1 t -114.07 18.1 17.37 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.221 0.608 . . . . 0.0 109.929 161.646 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 p -146.65 156.42 48.61 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 125.639 1.576 . . . . 0.0 107.736 174.405 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -63.23 145.1 93.05 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 N-CA-C 108.122 -1.53 . . . . 0.0 108.122 172.138 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.5 p -123.08 168.25 12.61 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.644 0.735 . . . . 0.0 111.299 178.716 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.8 m -93.63 144.88 24.98 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 168.354 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -168.74 56.9 0.21 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 176.525 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.91 57.78 0.86 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.018 1.727 . . . . 0.0 108.405 -174.374 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.62 166.46 23.52 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.94 0.876 . . . . 0.0 112.879 -168.036 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.48 97.55 8.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 176.512 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -77.23 140.24 40.05 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -85.76 88.61 7.57 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -172.634 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -76.97 77.91 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 C-N-CA 125.043 1.337 . . . . 0.0 110.435 -176.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.8 t 178.88 147.64 0.39 Allowed Pre-proline 0 N--CA 1.46 0.029 0 C-N-CA 124.932 1.293 . . . . 0.0 109.343 173.324 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -66.75 -35.19 28.86 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.146 1.23 . . . . 0.0 110.274 158.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.0 ptp 175.36 -70.78 0.01 OUTLIER 'General case' 0 C--N 1.341 0.206 0 C-N-CA 126.902 2.081 . . . . 0.0 107.571 179.244 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.0 -36.61 48.59 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.962 0.905 . . . . 0.0 113.011 -167.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.77 -109.62 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.608 0.242 . . . . 0.0 111.58 -167.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.79 -49.69 0.84 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.417 1.008 . . . . 0.0 113.528 -176.111 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.55 -57.52 4.66 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.594 1.197 . . . . 0.0 109.802 172.254 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -73.69 5.01 4.31 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.498 1.919 . . . . 0.0 113.895 -178.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -85.72 126.58 34.08 Favored 'General case' 0 C--N 1.344 0.343 0 O-C-N 121.232 -0.918 . . . . 0.0 108.649 174.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -72.71 91.0 1.43 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.179 -179.459 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.77 -20.22 64.35 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.833 1.253 . . . . 0.0 113.24 177.732 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.1 t 37.84 61.61 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 126.75 2.02 . . . . 0.0 111.992 177.464 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.38 68.78 0.36 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.133 1.373 . . . . 0.0 110.301 -177.109 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 17.6 p 177.73 -30.79 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.652 2.381 . . . . 0.0 109.972 -172.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -143.43 67.79 1.29 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 176.07 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 14.2 p -151.67 173.78 14.27 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.803 1.241 . . . . 0.0 109.024 179.595 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -67.48 114.51 6.21 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.173 0.589 . . . . 0.0 110.372 -165.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.7 t -80.73 -28.7 36.48 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.916 0.486 . . . . 0.0 112.062 -175.438 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 34.87 62.81 0.5 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.335 1.854 . . . . 0.0 114.081 176.039 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.1 t -88.5 -165.78 1.42 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.051 0.94 . . . . 0.0 110.05 174.687 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.5 t -76.69 144.15 39.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.198 0.999 . . . . 0.0 110.04 -175.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 81.0 mt -127.25 134.87 50.01 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.538 1.135 . . . . 0.0 108.15 -179.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -69.55 157.08 90.44 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 170.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.43 100.21 0.88 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.373 2.716 . . . . 0.0 110.438 -170.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.31 -23.44 3.31 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -175.208 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -78.95 135.78 37.05 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 118.254 1.027 . . . . 0.0 111.707 -160.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -92.61 104.56 16.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.4 1.48 . . . . 0.0 109.375 178.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -90.56 135.13 33.9 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 174.042 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -151.46 154.99 37.65 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.625 0.37 . . . . 0.0 110.639 156.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 78.6 mtp -151.77 146.05 18.36 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.161 0.984 . . . . 0.0 109.578 171.495 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -66.12 137.97 50.17 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.126 2.55 . . . . 0.0 110.443 161.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.8 t -107.96 130.47 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 159.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.3 m -98.49 140.82 17.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 171.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -154.43 149.37 26.72 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -162.322 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -164.5 170.29 16.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.415 1.886 . . . . 0.0 109.108 165.314 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 70.7 t -103.99 135.46 41.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 174.482 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -76.37 134.2 70.47 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 119.119 -0.467 . . . . 0.0 109.954 176.397 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -74.16 67.34 5.16 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.384 2.723 . . . . 0.0 110.292 171.42 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -133.52 -37.82 0.94 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 126.799 2.04 . . . . 0.0 111.027 176.565 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.4 tt -43.87 -41.66 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 125.012 1.325 . . . . 0.0 113.414 173.111 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.9 m -78.23 49.03 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 O-C-N 121.394 -0.816 . . . . 0.0 111.34 176.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.9 mttt -142.72 -64.51 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 117.521 -1.228 . . . . 0.0 111.617 -179.299 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.17 153.17 46.03 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 121.942 1.729 . . . . 0.0 112.736 -176.548 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.8 t -54.87 -35.54 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 125.838 1.655 . . . . 0.0 110.662 175.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -35.26 -59.16 0.53 Allowed 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 126.656 1.983 . . . . 0.0 112.309 175.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.5 p -106.94 -42.73 4.84 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.015 -166.068 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 14.07 63.15 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 128.389 2.675 . . . . 0.0 116.235 172.151 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 136.73 -36.73 1.95 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -177.272 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 29.8 mm -53.28 123.52 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 171.444 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.38 47.86 0.35 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.288 0.566 . . . . 0.0 112.102 177.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.5 p -143.65 89.04 2.03 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 105.809 -1.922 . . . . 0.0 105.809 174.025 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 tp -92.71 87.21 5.8 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.029 -159.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.5 t -97.86 155.85 16.87 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.457 0.703 . . . . 0.0 111.084 -166.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.76 133.25 55.98 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 160.704 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 44.5 m -90.94 105.77 18.06 Favored 'General case' 0 N--CA 1.46 0.043 0 O-C-N 123.902 0.751 . . . . 0.0 109.035 160.452 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -76.27 99.8 4.89 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 165.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 53.5 m -117.34 86.35 2.5 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.978 1.311 . . . . 0.0 107.524 175.18 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.412 ' CD1' ' CD1' ' A' ' 45' ' ' LEU . 48.2 m-85 -59.22 145.2 43.67 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.322 1.049 . . . . 0.0 112.828 174.392 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -166.85 52.69 0.25 Allowed Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.966 1.707 . . . . 0.0 112.342 -175.435 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.3 -90.04 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.679 2.252 . . . . 0.0 115.092 -168.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -155.16 179.55 9.04 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 129.697 3.199 . . . . 0.0 104.863 -175.119 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -147.13 94.56 4.54 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 118.488 0.585 . . . . 0.0 111.044 -171.462 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -91.94 -124.37 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.984 3.122 . . . . 0.0 108.954 176.664 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 85.5 p -123.2 123.76 41.5 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 120.356 1.435 . . . . 0.0 111.763 -172.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.595 0 C-N-CA 126.496 1.918 . . . . 0.0 109.237 174.333 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.3 p . . . . . 0 N--CA 1.464 0.265 0 CA-C-O 122.042 0.925 . . . . 0.0 112.026 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 46.38 34.06 2.14 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.894 1.678 . . . . 0.0 112.276 176.482 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 166.68 157.1 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 128.332 2.653 . . . . 0.0 105.903 -172.58 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -151.74 2.55 0.39 Allowed 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -172.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.75 11.9 0.95 Allowed 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 126.802 2.041 . . . . 0.0 115.322 -164.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -77.25 -39.12 49.44 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 159.452 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.4 mp -92.22 -37.91 12.41 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 117.209 -1.377 . . . . 0.0 113.016 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.2 mt -32.53 133.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -162.13 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -105.91 -104.15 0.33 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.159 -173.618 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -173.59 -49.2 0.01 OUTLIER 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.058 1.343 . . . . 0.0 108.855 -171.348 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -38.78 134.6 0.95 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.002 1.721 . . . . 0.0 110.678 -178.812 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -100.97 86.65 3.1 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -165.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.98 115.01 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.436 1.494 . . . . 0.0 107.953 -171.424 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.99 160.01 29.48 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -173.641 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.0 t -148.74 145.19 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.1 m -138.55 100.28 4.05 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -170.053 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -78.11 145.0 36.0 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.018 0.527 . . . . 0.0 109.919 -176.177 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -127.63 82.75 2.11 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.913 0.863 . . . . 0.0 110.007 178.22 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.49 102.16 14.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 172.118 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -116.89 128.37 55.18 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 122.292 1.044 . . . . 0.0 112.126 -174.666 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.0 p -99.83 96.29 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.564 -174.252 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.12 171.1 10.5 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 122.048 0.928 . . . . 0.0 111.406 174.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.41 132.07 52.0 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 169.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 128.33 -39.28 1.92 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -170.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.484 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -131.56 95.57 23.21 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 117.56 0.68 . . . . 0.0 110.277 -176.363 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -83.94 50.94 3.27 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.956 2.437 . . . . 0.0 109.651 -176.136 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.484 ' CD2' ' CD2' ' A' ' 45' ' ' LEU . 44.4 m0 -107.91 135.56 49.1 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -173.649 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -79.36 84.5 5.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 103.484 -2.784 . . . . 0.0 103.484 179.246 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -102.04 86.15 2.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -171.598 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.3 m -88.04 129.14 51.2 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -167.28 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.09 122.49 9.58 Favored 'Trans proline' 0 N--CA 1.446 -1.277 0 N-CA-C 106.261 -2.246 . . . . 0.0 106.261 162.466 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.1 m -72.73 -32.08 39.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.181 0.515 . . . . 0.0 110.691 -168.387 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.02 161.98 34.16 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 150.265 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -62.65 -46.72 86.89 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 172.532 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -147.38 153.54 39.77 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 124.415 1.086 . . . . 0.0 111.659 -159.647 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.4 pt -133.13 179.23 4.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 126.326 1.851 . . . . 0.0 108.251 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -125.47 160.18 30.11 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.345 0.593 . . . . 0.0 110.21 149.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.6 t -116.72 145.97 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 127.99 2.516 . . . . 0.0 105.679 171.014 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 49.5 mmm-85 -91.37 100.81 13.53 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 168.021 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mt -33.2 115.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -148.243 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.58 -25.2 26.49 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.071 1.319 . . . . 0.0 110.936 -179.386 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -64.9 133.45 51.86 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.806 1.303 . . . . 0.0 112.422 -172.33 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.15 101.53 7.97 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 130.05 3.34 . . . . 0.0 110.818 -175.38 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.9 p -113.78 153.75 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.292 1.437 . . . . 0.0 109.491 -178.597 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -112.51 125.15 53.93 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 125.404 1.482 . . . . 0.0 109.343 -177.38 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.0 pp -128.48 122.86 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 167.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 66.4 mtt -76.09 168.44 20.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.614 174.164 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -136.17 143.21 44.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 161.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.7 ttt85 -121.01 118.7 30.5 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 179.546 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.3 105.15 9.24 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 125.822 1.649 . . . . 0.0 110.035 -177.216 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.29 121.09 44.36 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.064 -0.398 . . . . 0.0 110.749 -168.603 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.435 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 47.8 t-20 -78.38 111.9 14.85 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.803 -0.561 . . . . 0.0 111.912 -167.783 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.2 tp -98.41 11.24 38.77 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.812 0.845 . . . . 0.0 112.381 179.564 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.46 166.67 22.33 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.272 -0.893 . . . . 0.0 109.95 173.44 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 70.0 m -103.3 7.0 38.35 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.968 0.907 . . . . 0.0 111.835 171.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.34 159.61 38.79 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 126.134 1.773 . . . . 0.0 107.041 177.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.97 126.04 12.11 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.171 1.914 . . . . 0.0 111.255 -173.208 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.49 173.53 12.51 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.821 0.849 . . . . 0.0 110.784 -178.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 50.7 p -131.45 72.03 1.49 Allowed 'General case' 0 C--O 1.232 0.137 0 C-N-CA 122.551 0.341 . . . . 0.0 110.426 -170.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.42 139.37 37.39 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.946 -0.462 . . . . 0.0 111.946 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -166.81 34.19 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.659 1.983 . . . . 0.0 109.44 169.222 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.58 159.08 34.47 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.33 0.652 . . . . 0.0 111.445 -165.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.9 t -87.77 131.51 34.48 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.704 0.764 . . . . 0.0 110.039 177.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -104.03 89.93 3.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.871 2.468 . . . . 0.0 105.572 175.509 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -77.0 91.92 3.67 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 120.882 -1.136 . . . . 0.0 107.935 -177.617 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.8 t -78.11 72.57 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.612 1.165 . . . . 0.0 109.973 -174.043 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.9 t -168.73 134.76 1.49 Allowed Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 119.901 1.228 . . . . 0.0 113.389 173.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -74.1 67.72 5.04 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 122.386 2.057 . . . . 0.0 107.243 156.257 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 22.2 ptm 44.19 25.47 0.11 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 170.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -171.41 -58.26 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 119.384 0.993 . . . . 0.0 110.594 -168.411 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.61 -101.2 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -177.282 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 64.05 -52.1 0.08 OUTLIER Glycine 0 CA--C 1.538 1.481 0 N-CA-C 115.413 0.925 . . . . 0.0 115.413 -175.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -45.73 -47.63 15.33 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.553 1.541 . . . . 0.0 110.808 172.217 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -73.85 -12.69 60.75 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 127.012 2.125 . . . . 0.0 113.471 178.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -67.55 140.0 56.95 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.119 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -71.21 127.95 34.29 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.967 1.307 . . . . 0.0 110.765 -177.33 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -161.06 -50.45 0.05 OUTLIER 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 122.478 0.311 . . . . 0.0 110.65 -174.793 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . 0.326 2.4 p 47.8 -95.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.985 1.314 . . . . 0.0 111.809 -175.875 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -165.18 178.75 6.74 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.201 1.401 . . . . 0.0 107.336 173.526 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 90.3 m 54.52 42.61 31.22 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.382 1.073 . . . . 0.0 111.469 175.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -106.18 163.73 12.57 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.385 1.074 . . . . 0.0 108.505 171.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 59.6 m -134.39 139.39 45.56 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 177.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -166.79 -42.46 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.853 0.861 . . . . 0.0 109.083 175.403 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.3 p -22.85 109.2 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 127.808 2.443 . . . . 0.0 111.855 162.783 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -78.41 -15.98 58.09 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -159.359 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.3 t 51.67 -146.64 0.47 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.441 1.096 . . . . 0.0 112.472 170.606 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.6 m -115.54 136.65 52.86 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.089 1.355 . . . . 0.0 108.542 -172.069 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 78.6 mt -128.44 147.95 50.69 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.39 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -73.29 156.42 89.15 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 172.354 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.23 85.87 0.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 124.88 3.72 . . . . 0.0 111.756 -173.064 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 152.74 -27.23 0.83 Allowed Glycine 0 CA--C 1.522 0.5 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.25 -177.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -77.86 143.45 37.79 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 118.085 0.942 . . . . 0.0 111.593 -157.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -105.21 96.9 6.84 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.811 1.244 . . . . 0.0 109.942 -175.603 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 15.4 tpt -83.92 89.21 7.18 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.114 1.365 . . . . 0.0 109.325 -177.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -99.21 134.21 42.4 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.256 0.622 . . . . 0.0 109.576 172.148 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 22.4 ptm -150.95 146.31 19.11 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.996 -0.526 . . . . 0.0 111.441 178.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.58 147.77 20.05 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.883 3.055 . . . . 0.0 111.049 171.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.5 t -126.53 114.89 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 165.199 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.5 p -79.41 143.47 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 168.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -155.61 149.11 24.98 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.163 0.585 . . . . 0.0 109.949 -165.411 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -171.18 118.98 0.48 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.36 1.464 . . . . 0.0 111.893 176.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.8 t -64.09 133.39 29.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 O-C-N 120.355 -1.466 . . . . 0.0 109.505 175.317 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -91.61 132.39 33.44 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 123.701 0.801 . . . . 0.0 109.8 -179.053 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -46.35 -31.52 9.55 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.402 3.401 . . . . 0.0 114.919 177.342 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -48.94 -24.2 1.4 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.783 1.633 . . . . 0.0 112.39 179.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.1 tt -49.01 -44.46 15.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 169.097 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.9 m -83.38 59.66 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 118.571 0.623 . . . . 0.0 109.895 174.354 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -111.0 -77.41 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 117.168 -1.396 . . . . 0.0 110.366 164.628 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.54 156.05 45.12 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 CA-C-N 121.885 1.709 . . . . 0.0 111.666 -177.384 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.6 m -62.16 -36.08 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 124.94 1.296 . . . . 0.0 112.045 -170.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -60.6 -64.46 0.94 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.147 0.979 . . . . 0.0 109.281 177.587 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 44.6 p -72.61 -15.43 61.73 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 118.509 -0.758 . . . . 0.0 111.568 -172.419 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.04 -41.52 5.53 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.768 0.713 . . . . 0.0 111.221 162.913 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.34 -29.17 74.38 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 112.237 -0.345 . . . . 0.0 112.237 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.3 mm -83.88 125.94 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 122.079 0.942 . . . . 0.0 110.39 -177.629 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 28.3 pttt -148.81 63.76 1.06 Allowed 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.506 153.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 11.7 m -150.15 95.33 2.26 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 158.416 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.2 tp -75.48 144.79 41.87 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -173.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.8 t -141.8 173.38 11.56 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.496 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.1 tt -150.63 111.28 4.25 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 177.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.45 92.94 8.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.515 1.126 . . . . 0.0 109.252 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.94 108.4 19.17 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.877 1.271 . . . . 0.0 108.783 179.406 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.66 89.09 3.58 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 122.009 0.909 . . . . 0.0 109.747 -177.358 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -71.23 85.57 0.77 Allowed 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.281 177.058 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.1 47.59 2.8 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -178.703 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -80.89 -105.74 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.279 2.653 . . . . 0.0 111.967 178.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -140.95 121.68 14.34 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.648 1.179 . . . . 0.0 108.528 -171.242 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.9 111.22 38.82 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 125.654 1.581 . . . . 0.0 107.118 -177.128 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -83.3 -4.85 11.07 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.293 2.662 . . . . 0.0 113.043 -172.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.9 t 131.51 103.71 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 129.972 3.309 . . . . 0.0 109.754 174.481 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.542 0.669 0 C-N-CA 125.256 1.423 . . . . 0.0 111.723 168.356 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 122.31 1.052 . . . . 0.0 108.427 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 23.08 50.72 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.94 1.696 . . . . 0.0 112.229 -146.308 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.21 155.29 11.35 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 127.879 2.471 . . . . 0.0 104.405 174.542 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -122.32 125.96 47.07 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 104.354 -2.462 . . . . 0.0 104.354 156.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.6 t -147.88 49.54 1.06 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 122.493 1.14 . . . . 0.0 108.227 174.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -158.8 -57.42 0.07 Allowed 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 127.306 2.243 . . . . 0.0 106.309 -174.367 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.9 mt -65.53 -16.48 63.72 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.907 2.083 . . . . 0.0 112.878 -177.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.4 mt -75.67 78.51 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 O-C-N 121.21 -0.931 . . . . 0.0 110.267 -171.566 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.69 -127.7 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.555 1.142 . . . . 0.0 108.524 169.679 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -104.36 -51.33 3.13 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.57 1.548 . . . . 0.0 111.939 -164.506 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -43.1 102.07 0.03 OUTLIER 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.194 1.398 . . . . 0.0 113.351 -169.806 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.69 81.52 4.99 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 177.261 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -97.11 122.58 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -160.616 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.7 150.48 34.48 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.943 1.297 . . . . 0.0 108.199 -175.216 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.52 146.9 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 174.497 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.9 m -125.83 112.19 15.73 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -172.69 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -77.88 136.18 38.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -126.71 84.45 2.27 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 122.502 1.144 . . . . 0.0 108.965 177.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.91 95.75 10.28 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.374 1.07 . . . . 0.0 110.972 -176.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -98.63 109.5 22.24 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.375 0.67 . . . . 0.0 109.79 -177.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.0 p -79.24 148.86 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 164.388 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -151.04 158.71 44.44 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 171.216 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.05 -40.15 10.25 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.84 0.856 . . . . 0.0 112.109 -177.214 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -41.58 -31.98 0.76 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.812 1.672 . . . . 0.0 114.151 174.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.405 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -130.17 110.13 16.68 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 118.688 1.244 . . . . 0.0 108.471 170.488 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -75.27 0.95 8.4 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.294 1.996 . . . . 0.0 115.576 -164.035 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.51 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 42.2 m0 -79.57 153.45 29.46 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.38 1.472 . . . . 0.0 113.613 -159.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -77.47 77.46 4.0 Favored 'General case' 0 C--N 1.344 0.344 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.615 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -84.6 110.72 18.93 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.684 1.193 . . . . 0.0 109.098 -171.484 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.9 t -122.78 118.81 28.25 Favored Pre-proline 0 N--CA 1.444 -0.758 0 C-N-CA 124.4 1.08 . . . . 0.0 108.645 -163.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -81.87 174.56 10.13 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 124.543 3.495 . . . . 0.0 108.554 168.367 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -98.6 -53.12 8.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 123.949 0.9 . . . . 0.0 110.845 -173.622 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -134.16 175.15 9.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 166.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.6 tpt85 -68.45 -33.15 73.68 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.392 168.636 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -144.67 173.44 11.82 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.842 1.257 . . . . 0.0 112.694 -162.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.1 pt -141.65 178.2 2.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 127.206 2.203 . . . . 0.0 106.788 165.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -132.27 162.77 30.16 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 146.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.23 136.92 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 126.953 2.101 . . . . 0.0 105.836 -175.199 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.94 88.66 3.5 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 163.205 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.2 pt 8.81 69.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 127.74 2.416 . . . . 0.0 114.63 178.469 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.55 -37.55 1.78 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 123.41 0.529 . . . . 0.0 112.305 -176.594 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -39.24 104.43 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.383 1.473 . . . . 0.0 110.849 177.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m -87.46 88.45 7.68 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.353 -156.25 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 p -92.73 161.67 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 O-C-N 121.933 -0.479 . . . . 0.0 111.721 -168.434 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -102.98 126.74 50.28 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.959 1.303 . . . . 0.0 110.35 169.561 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.5 pp -131.33 114.03 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 107.319 -1.364 . . . . 0.0 107.319 167.443 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.0 ttp -77.86 161.52 27.55 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.378 0.671 . . . . 0.0 110.862 -176.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -134.57 150.96 50.78 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.436 1.094 . . . . 0.0 108.846 169.325 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 54.1 ttp85 -143.46 147.08 34.0 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.997 0.919 . . . . 0.0 110.111 -178.457 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.39 109.68 2.66 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.632 1.573 . . . . 0.0 111.765 -177.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -86.09 139.28 31.27 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.989 171.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.51 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 28.1 t30 -78.21 88.99 4.27 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.073 0.851 . . . . 0.0 112.127 168.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.9 mp -76.76 69.08 3.08 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 171.193 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -153.66 137.26 15.99 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 168.513 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.1 t -80.14 36.1 0.34 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.369 0.531 . . . . 0.0 110.754 178.083 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.8 p -149.91 155.47 37.98 Favored Pre-proline 0 C--O 1.237 0.395 0 C-N-CA 126.63 1.972 . . . . 0.0 106.995 174.307 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -63.23 148.14 93.3 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 N-CA-C 108.208 -1.497 . . . . 0.0 108.208 168.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.01 175.06 6.53 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.792 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.0 m -105.65 145.25 31.28 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.121 1.768 . . . . 0.0 106.875 175.39 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -133.65 126.14 4.2 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 107.096 -2.401 . . . . 0.0 107.096 172.494 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.18 54.77 0.12 Allowed 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 166.78 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.44 144.83 15.9 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.884 176.162 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.3 t -85.01 166.08 17.02 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 168.185 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -146.41 95.96 2.69 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -168.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.33 86.92 5.02 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 175.509 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.0 t -78.12 60.23 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.817 1.247 . . . . 0.0 108.776 -175.034 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.1 t -171.44 148.34 2.3 Favored Pre-proline 0 CA--C 1.522 -0.129 0 O-C-N 121.481 -0.762 . . . . 0.0 111.636 178.077 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -61.57 -41.26 40.99 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 121.758 1.639 . . . . 0.0 110.068 159.031 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.3 ptp 172.08 -77.72 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 127.124 2.17 . . . . 0.0 107.59 178.399 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.87 -29.87 63.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.634 1.174 . . . . 0.0 112.292 -170.287 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.9 -119.11 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -174.028 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.89 -50.56 2.25 Favored Glycine 0 CA--C 1.528 0.874 0 O-C-N 121.348 -0.845 . . . . 0.0 113.192 178.204 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -44.93 -54.54 6.38 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.159 0.984 . . . . 0.0 110.014 171.555 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -75.39 -4.26 38.41 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.508 1.923 . . . . 0.0 113.96 -179.053 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -69.37 133.55 47.95 Favored 'General case' 0 C--N 1.341 0.227 0 O-C-N 121.093 -1.004 . . . . 0.0 108.486 178.449 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -75.8 85.66 2.79 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.684 177.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -54.57 123.11 12.11 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 166.228 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.2 t -58.71 126.27 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -177.572 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -82.31 48.47 1.28 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.87 0.868 . . . . 0.0 110.001 -169.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 44.2 t -167.13 143.11 4.28 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.58 1.552 . . . . 0.0 108.589 -173.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -75.96 72.57 2.83 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.914 0.485 . . . . 0.0 110.278 -178.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 26.9 p -135.17 53.03 2.0 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 124.904 1.282 . . . . 0.0 109.355 178.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -155.17 145.54 22.0 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -170.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 47.0 m 58.99 88.14 0.07 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.876 1.67 . . . . 0.0 112.17 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -53.9 154.34 4.1 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.568 1.147 . . . . 0.0 111.7 176.414 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.7 t -111.52 -57.68 2.22 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 128.711 2.804 . . . . 0.0 111.378 -167.6 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.8 t -163.65 140.34 6.97 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 122.849 0.46 . . . . 0.0 110.385 -170.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 39.7 mt -139.32 143.73 37.96 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.207 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -80.44 172.95 8.53 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.76 1.224 . . . . 0.0 109.349 -179.48 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -68.0 79.89 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.535 2.823 . . . . 0.0 114.465 -162.041 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 147.87 -29.89 1.39 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.307 0.956 . . . . 0.0 112.181 172.107 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -82.21 158.56 23.51 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 118.226 -1.39 . . . . 0.0 112.318 -139.61 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -84.61 123.26 30.13 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 124.64 1.176 . . . . 0.0 110.268 179.59 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -90.22 128.61 36.42 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 154.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -134.0 146.42 50.4 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 159.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 56.7 mtt -146.61 146.63 27.59 Favored Pre-proline 0 N--CA 1.453 -0.323 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 165.087 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -71.55 142.58 40.61 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 122.101 1.868 . . . . 0.0 109.412 160.232 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.4 t -115.77 143.83 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 164.026 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.0 p -102.28 145.49 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 174.608 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -145.9 138.09 25.36 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.335 0.516 . . . . 0.0 111.425 -176.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -159.07 162.25 36.56 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.569 1.548 . . . . 0.0 107.43 160.559 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 94.8 t -104.72 131.27 54.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 174.789 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.18 135.23 47.85 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 175.887 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -75.49 57.85 5.0 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 124.578 3.519 . . . . 0.0 112.673 -176.414 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.24 -36.47 7.63 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 125.57 1.548 . . . . 0.0 109.864 168.3 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.8 tt -47.75 -46.57 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -169.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.3 m -81.19 53.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.448 -0.783 . . . . 0.0 110.785 -178.444 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -138.28 -64.51 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 117.661 -1.161 . . . . 0.0 112.085 -179.371 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.67 156.33 35.64 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 CA-C-N 121.961 1.736 . . . . 0.0 113.406 -176.053 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.2 t -54.11 -39.46 42.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 126.201 1.8 . . . . 0.0 110.742 177.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -45.92 -55.72 6.38 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.697 1.599 . . . . 0.0 111.8 -178.523 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.3 p -92.37 -42.89 9.53 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 118.633 -0.699 . . . . 0.0 111.442 -176.313 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 7.93 65.13 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 128.403 2.681 . . . . 0.0 116.129 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 142.37 -41.34 1.2 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -173.709 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.7 mm -57.27 120.13 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 CA-C-N 117.689 0.744 . . . . 0.0 110.178 177.23 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -157.38 66.45 0.5 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.672 0.749 . . . . 0.0 110.173 162.578 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 10.6 m -147.51 102.72 3.48 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 152.206 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.68 151.76 34.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -175.243 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.7 t -154.08 175.13 13.79 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.408 0.623 . . . . 0.0 109.647 -177.269 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.9 tp -153.7 97.13 2.07 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 103.216 -2.883 . . . . 0.0 103.216 -169.278 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.5 t -81.78 88.09 6.32 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 171.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.79 124.4 27.64 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 176.809 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 23.8 m -133.38 95.52 3.53 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.412 1.101 . . . . 0.0 109.229 -164.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -74.22 74.42 1.8 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.041 1.736 . . . . 0.0 111.94 -171.007 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -128.35 68.48 77.23 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.349 1.06 . . . . 0.0 113.758 179.566 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -87.69 -103.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.775 2.983 . . . . 0.0 110.666 167.502 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -156.26 99.66 1.94 Allowed 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.8 1.24 . . . . 0.0 108.907 -172.117 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -104.56 134.0 19.89 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 126.432 1.893 . . . . 0.0 106.403 167.614 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.0 -47.3 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.445 2.097 . . . . 0.0 110.638 178.304 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.2 t 166.65 112.4 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 129.202 3.001 . . . . 0.0 104.822 178.486 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.7 pttt . . . . . 0 CA--C 1.535 0.4 0 CA-C-N 119.584 1.083 . . . . 0.0 110.409 -168.921 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 94.8 t . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 67.49 -148.04 0.15 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.992 0.917 . . . . 0.0 110.907 -178.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.435 ' NE2' ' H ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -71.7 98.95 2.02 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 125.127 1.371 . . . . 0.0 108.878 -170.483 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.43 59.46 2.96 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 122.711 1.244 . . . . 0.0 111.04 -152.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.4 p -76.49 1.66 15.93 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 128.075 2.55 . . . . 0.0 114.58 -164.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -78.56 -21.38 48.78 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 164.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.6 mt -115.32 -26.73 7.48 Favored 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 125.43 1.492 . . . . 0.0 113.134 -171.204 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.7 mt -40.55 -72.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.966 1.706 . . . . 0.0 115.389 -170.555 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 64.99 167.55 0.18 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 127.449 2.3 . . . . 0.0 113.096 -176.036 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -76.57 57.82 1.28 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.521 1.528 . . . . 0.0 111.537 -177.394 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.04 170.74 15.19 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 126.111 1.764 . . . . 0.0 107.041 173.525 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -150.38 111.61 4.4 Favored 'General case' 0 N--CA 1.422 -1.855 0 C-N-CA 124.462 1.105 . . . . 0.0 109.217 177.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.9 tt -93.26 144.34 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 174.018 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.73 152.18 20.39 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 125.83 1.652 . . . . 0.0 109.033 177.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.6 t -136.95 144.24 32.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 175.54 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.6 m -136.19 94.3 3.02 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -171.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -75.04 163.85 27.16 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -175.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -142.44 85.34 1.9 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 122.217 1.008 . . . . 0.0 109.406 -178.727 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.57 102.79 15.47 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 121.586 -0.696 . . . . 0.0 110.25 -179.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -95.46 168.32 10.78 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 123.432 0.693 . . . . 0.0 109.616 177.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.4 t -134.49 151.82 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 167.802 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.65 153.58 47.34 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 166.446 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.46 -35.89 13.89 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.856 0.862 . . . . 0.0 112.358 -174.643 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -37.19 -41.54 0.71 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.71 1.624 . . . . 0.0 113.511 172.111 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.455 HD23 ' CE3' ' A' ' 47' ' ' TRP . 3.9 tt -116.67 107.72 46.1 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 118.187 0.993 . . . . 0.0 108.388 175.023 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -78.35 21.1 0.71 Allowed 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.006 1.804 . . . . 0.0 114.92 -161.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.515 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 50.0 m0 -101.39 147.73 25.99 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.435 1.016 . . . . 0.0 113.212 -160.83 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -78.31 88.95 4.33 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 176.116 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -90.93 126.27 36.01 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 123.774 0.83 . . . . 0.0 109.053 -179.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.1 t -118.24 107.66 43.15 Favored Pre-proline 0 N--CA 1.439 -1.0 0 C-N-CA 125.73 1.612 . . . . 0.0 107.69 -167.324 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -66.14 128.59 19.86 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 122.773 2.316 . . . . 0.0 107.096 165.077 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.9 m -77.27 -36.84 24.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.125 0.488 . . . . 0.0 111.068 -174.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.77 171.11 15.25 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 158.726 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -76.17 -48.87 18.92 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 119.379 -0.928 . . . . 0.0 108.891 172.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -136.67 155.54 49.75 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 125.661 1.584 . . . . 0.0 111.251 -161.528 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.1 pt -135.52 172.92 15.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 125.723 1.609 . . . . 0.0 108.733 -179.454 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -122.21 143.67 49.44 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 126.251 1.82 . . . . 0.0 109.074 162.351 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.6 m -128.97 129.67 68.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 C-N-CA 125.378 1.471 . . . . 0.0 107.408 167.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.22 76.75 0.36 Allowed 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 166.647 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 9.06 59.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 129.393 3.077 . . . . 0.0 115.513 -172.868 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.65 -35.58 1.4 Allowed Glycine 0 C--N 1.335 0.503 0 O-C-N 121.427 -0.796 . . . . 0.0 111.898 -172.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -55.69 129.88 40.99 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 170.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.3 136.93 32.74 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 122.977 0.511 . . . . 0.0 112.345 -177.415 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.2 p -120.33 153.7 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 123.756 0.823 . . . . 0.0 109.108 168.115 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.88 116.51 32.42 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.254 1.821 . . . . 0.0 107.467 173.501 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.4 pp -122.18 119.37 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 168.07 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 85.2 mtp -76.57 166.26 23.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.693 170.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -130.25 149.8 51.78 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 160.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -134.08 132.56 40.1 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 124.121 0.888 . . . . 0.0 109.326 173.876 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.36 165.24 14.1 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 127.659 2.383 . . . . 0.0 106.942 167.208 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.6 mttt -154.02 133.88 13.06 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 119.226 0.921 . . . . 0.0 110.183 174.262 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.515 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 49.3 t30 -84.97 84.78 7.6 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.774 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.7 mp -83.32 63.66 7.37 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.707 167.417 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.26 163.96 25.6 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 165.211 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.7 m -93.95 20.11 8.2 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 123.063 0.227 . . . . 0.0 110.621 176.193 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.3 p -146.16 160.91 41.39 Favored Pre-proline 0 N--CA 1.45 -0.463 0 C-N-CA 125.687 1.595 . . . . 0.0 107.656 177.359 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -66.02 159.76 47.73 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 121.13 1.22 . . . . 0.0 108.972 169.534 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.65 174.32 10.63 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 122.44 0.296 . . . . 0.0 110.846 171.244 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -122.85 152.97 40.22 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.877 1.271 . . . . 0.0 108.85 171.035 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -127.68 129.87 6.55 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 177.336 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.11 40.65 1.49 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.078 0.951 . . . . 0.0 109.147 168.708 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -50.87 145.11 7.55 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.344 1.058 . . . . 0.0 111.616 -175.293 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.8 t -82.13 139.52 34.33 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 118.923 -1.111 . . . . 0.0 108.833 176.163 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -114.41 89.93 3.21 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 -175.142 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -78.39 85.38 4.51 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 177.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.3 t -78.36 67.96 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 125.51 1.524 . . . . 0.0 108.055 -178.377 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.6 t -166.68 144.11 4.18 Favored Pre-proline 0 C--N 1.338 0.094 0 O-C-N 121.59 -0.694 . . . . 0.0 112.49 174.106 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -64.31 -39.74 28.44 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 121.613 1.542 . . . . 0.0 109.428 159.09 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.0 ptp 170.7 -70.17 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 128.242 2.617 . . . . 0.0 107.123 178.706 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -90.98 -27.28 18.78 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 124.273 1.029 . . . . 0.0 112.884 -168.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.26 -123.4 0.01 OUTLIER 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.508 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.75 -54.82 2.97 Favored Glycine 0 CA--C 1.527 0.79 0 O-C-N 121.654 -0.654 . . . . 0.0 112.006 177.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -47.0 -49.48 20.82 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.543 1.172 . . . . 0.0 111.273 174.185 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -72.03 -16.25 62.05 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.445 1.098 . . . . 0.0 113.181 179.398 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -61.61 124.38 20.52 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -178.166 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -79.43 78.64 5.94 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.889 0.852 . . . . 0.0 111.43 -173.515 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -55.75 146.82 20.23 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.837 1.255 . . . . 0.0 110.75 167.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.4 p -153.72 158.36 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 173.001 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -156.33 151.51 26.49 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 -174.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 31.9 p -87.08 -56.69 3.26 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 123.32 0.387 . . . . 0.0 110.574 172.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -171.83 98.02 0.17 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.749 1.219 . . . . 0.0 108.072 179.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 45.5 t 59.61 89.54 0.06 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.054 1.341 . . . . 0.0 112.576 176.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 62.23 -169.7 0.18 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.237 0.615 . . . . 0.0 111.532 176.611 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.8 t -149.72 48.32 0.94 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 122.603 1.192 . . . . 0.0 108.407 163.194 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -138.91 -55.27 0.6 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.062 1.345 . . . . 0.0 107.411 175.598 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . 0.317 11.1 t 48.05 -81.43 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 127.713 2.405 . . . . 0.0 114.633 168.728 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -158.95 149.35 19.61 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.082 1.353 . . . . 0.0 109.268 -178.564 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.0 mt -143.82 155.5 44.16 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 124.01 0.924 . . . . 0.0 108.835 174.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -94.72 166.55 14.89 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 125.468 1.507 . . . . 0.0 108.5 174.055 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.71 98.18 1.03 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.839 2.359 . . . . 0.0 111.67 -167.611 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.69 -24.57 2.46 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 123.551 0.596 . . . . 0.0 111.723 178.821 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -79.19 127.83 32.53 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 117.85 0.825 . . . . 0.0 111.826 -155.566 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -78.68 136.79 37.54 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 165.619 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 13.7 tpt -130.2 122.62 28.48 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 126.853 2.061 . . . . 0.0 107.863 -169.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -153.24 156.85 39.26 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 120.344 1.429 . . . . 0.0 112.299 177.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 6.2 ttt -155.07 142.38 13.8 Favored Pre-proline 0 N--CA 1.441 -0.898 0 C-N-CA 125.383 1.473 . . . . 0.0 107.149 -177.251 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -74.31 144.78 33.4 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.642 2.894 . . . . 0.0 111.565 165.519 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.9 t -123.09 128.73 75.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 168.598 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.3 p -91.05 141.22 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 170.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -147.23 143.97 28.54 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.413 0.551 . . . . 0.0 111.617 -176.108 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -168.91 120.62 0.76 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 128.322 2.649 . . . . 0.0 106.731 175.295 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.8 p -82.49 146.66 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 119.698 1.136 . . . . 0.0 109.825 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -72.16 139.05 81.82 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 118.117 0.417 . . . . 0.0 110.064 176.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -76.55 61.13 6.76 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.404 2.736 . . . . 0.0 111.547 173.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . 0.253 9.8 pt-20 -135.17 -4.87 2.37 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 169.739 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -48.28 -42.99 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 119.201 0.91 . . . . 0.0 111.677 174.525 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.2 m -76.51 63.81 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 123.306 0.642 . . . . 0.0 110.413 174.406 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -123.06 -70.94 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 124.795 1.238 . . . . 0.0 111.181 170.468 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.53 156.65 36.34 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.161 1.907 . . . . 0.0 113.354 -169.835 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 84.3 t -54.16 -36.17 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.76 1.624 . . . . 0.0 110.057 176.278 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -47.46 -48.06 26.86 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.956 1.702 . . . . 0.0 112.024 176.144 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 22.3 p -93.55 -57.63 2.52 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -173.289 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 18.23 54.5 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 129.532 3.133 . . . . 0.0 115.529 176.063 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 146.2 -36.49 1.29 Allowed Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 -170.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 23.5 mm -57.52 132.72 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 172.486 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -158.8 53.57 0.42 Allowed 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 123.619 0.574 . . . . 0.0 110.277 161.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.6 p -149.77 98.51 2.75 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 176.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.2 mp -77.95 152.58 33.11 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.446 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.5 t -142.34 176.66 8.82 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 125.58 1.552 . . . . 0.0 107.236 170.473 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.2 tt -150.43 101.06 2.93 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 175.527 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.3 t -84.26 89.23 7.3 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.319 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.11 120.07 23.13 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 179.21 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.6 m -132.7 106.35 7.72 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.787 1.235 . . . . 0.0 108.553 -165.44 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.428 ' CD2' HD11 ' A' ' 45' ' ' LEU . 4.8 m-30 -90.19 96.57 10.73 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.868 1.267 . . . . 0.0 112.85 -160.359 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -138.49 76.64 36.18 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 178.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -91.53 -121.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.055 1 C-N-CA 125.94 4.427 . . . . 0.0 108.169 163.631 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.2 mmp_? -134.1 138.33 45.19 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.448 1.899 . . . . 0.0 107.132 179.142 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.93 114.88 55.87 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 174.671 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.63 -27.04 6.49 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.949 2.432 . . . . 0.0 112.272 -179.322 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.8 m 145.41 112.93 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 129.481 3.112 . . . . 0.0 109.086 -175.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.544 0.737 0 C-N-CA 125.012 1.325 . . . . 0.0 114.198 171.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 CA--C 1.54 0.588 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -70.89 85.43 0.68 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.425 1.012 . . . . 0.0 110.113 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 109.46 117.6 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.391 1 C-N-CA 133.055 4.542 . . . . 0.0 102.798 -170.143 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.39 -56.85 6.28 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 115.029 -2.668 . . . . 0.0 111.544 -135.26 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.423 ' C ' ' H ' ' A' ' 27' ' ' LEU . 5.8 t -169.55 -146.45 0.05 Allowed 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 149.373 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -78.97 38.7 0.35 Allowed 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 130.01 3.324 . . . . 0.0 108.808 -178.547 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.423 ' H ' ' C ' ' A' ' 25' ' ' SER . 10.4 mt -111.07 -21.29 12.04 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 127.969 2.508 . . . . 0.0 109.458 -170.896 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 27.6 mt -62.94 104.13 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 123.581 0.752 . . . . 0.0 111.839 -169.093 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.57 -150.87 0.17 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.889 0.876 . . . . 0.0 109.955 175.274 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -89.29 -37.41 14.94 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 129.237 3.015 . . . . 0.0 111.236 179.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -51.73 153.5 2.4 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.974 1.31 . . . . 0.0 113.493 -173.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -123.83 88.8 2.97 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 -176.951 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.19 131.93 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 125.19 1.396 . . . . 0.0 107.357 -179.538 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.434 ' CE ' ' OD2' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -97.48 152.94 18.48 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.348 1.059 . . . . 0.0 109.365 -168.906 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 65.4 t -131.27 132.59 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 174.758 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.7 m -110.54 112.4 24.29 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 173.009 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -81.56 86.21 6.4 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.642 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -88.27 84.49 6.86 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 122.241 1.02 . . . . 0.0 109.164 -173.781 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.3 105.23 17.21 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.361 0.664 . . . . 0.0 109.527 179.385 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -105.56 114.48 28.68 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.101 0.961 . . . . 0.0 108.828 -177.145 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.1 p -98.72 107.73 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 123.896 0.878 . . . . 0.0 109.865 176.623 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.06 155.59 19.37 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 167.565 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.25 -39.44 9.92 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.366 1.067 . . . . 0.0 111.741 178.47 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -40.18 -33.19 0.47 Allowed Glycine 0 CA--C 1.529 0.951 0 C-N-CA 126.144 1.83 . . . . 0.0 114.499 173.236 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.6 98.88 42.63 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 119.753 1.777 . . . . 0.0 108.523 168.312 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -83.86 45.53 1.81 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 124.057 3.171 . . . . 0.0 110.742 -167.533 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.508 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 44.7 m0 -115.69 145.92 42.32 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.571 1.148 . . . . 0.0 108.08 -172.999 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -76.4 82.58 3.14 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 175.782 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.99 116.26 31.62 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.736 1.214 . . . . 0.0 108.306 -172.718 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.3 m -129.52 147.48 65.39 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 118.233 0.469 . . . . 0.0 110.704 -173.276 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.89 160.53 47.53 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.264 1.976 . . . . 0.0 108.657 165.543 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -78.62 -59.44 3.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 -174.695 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -121.88 158.97 27.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 103.596 -2.742 . . . . 0.0 103.596 157.859 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -54.42 -38.73 66.59 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-O 120.943 0.401 . . . . 0.0 110.074 176.348 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.434 ' OD2' ' CE ' ' A' ' 34' ' ' LYS . 9.6 p-10 -153.3 163.12 40.47 Favored 'General case' 0 N--CA 1.424 -1.756 0 C-N-CA 126.423 1.889 . . . . 0.0 107.681 -166.739 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.6 pt -138.46 163.89 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 124.466 1.106 . . . . 0.0 108.205 170.256 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -106.93 133.05 52.16 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 104.535 -2.395 . . . . 0.0 104.535 165.415 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.2 m -119.57 129.06 75.8 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 172.704 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.5 mmm180 -76.21 74.88 3.04 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.203 -0.936 . . . . 0.0 108.702 175.281 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.0 mm 55.21 -95.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.911 1.284 . . . . 0.0 109.052 -173.613 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -97.51 30.52 9.08 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 124.559 1.076 . . . . 0.0 112.778 -169.455 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -83.63 95.79 8.47 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.949 1.7 . . . . 0.0 108.315 -177.195 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.11 89.68 0.13 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.831 1.253 . . . . 0.0 110.938 179.666 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.9 t -80.85 139.45 18.09 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.084 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 173.853 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.55 120.22 31.45 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 168.792 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.62 103.67 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.921 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 52.9 ttm -79.3 118.33 21.13 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.716 1.206 . . . . 0.0 111.81 -177.513 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -88.46 153.86 20.82 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.72 0.808 . . . . 0.0 110.462 175.841 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -125.82 133.76 51.89 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 124.317 1.047 . . . . 0.0 110.049 177.613 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -134.34 154.79 51.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 127.389 2.276 . . . . 0.0 107.104 158.213 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -157.54 136.1 11.31 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 104.937 -2.245 . . . . 0.0 104.937 175.884 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.508 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 59.6 t-20 -79.98 125.66 30.05 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.926 1.239 . . . . 0.0 111.807 -176.441 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.16 3.29 19.99 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.15 1.38 . . . . 0.0 112.27 -177.338 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.18 166.13 22.54 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.241 -0.912 . . . . 0.0 111.176 177.706 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.3 m -87.72 -8.77 55.63 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.988 0.915 . . . . 0.0 112.299 179.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.0 165.6 29.68 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 126.64 1.976 . . . . 0.0 106.362 178.409 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -57.41 154.96 32.59 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.949 1.766 . . . . 0.0 111.409 -177.19 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.34 164.59 20.06 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.42 0.629 . . . . 0.0 111.311 165.215 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.4 t -99.66 158.72 15.57 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 164.138 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.74 69.55 0.25 Allowed Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 107.973 -2.051 . . . . 0.0 107.973 -172.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -99.87 -58.82 1.83 Allowed 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.311 1.444 . . . . 0.0 108.546 178.863 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 64.33 -178.53 0.17 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.219 0.608 . . . . 0.0 111.62 178.146 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.0 m -136.61 134.93 37.89 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 168.588 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -114.83 170.82 8.05 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 126.197 1.799 . . . . 0.0 109.984 -173.06 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -131.4 107.97 9.29 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.927 1.291 . . . . 0.0 107.585 166.843 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.6 t -90.42 74.11 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.692 1.597 . . . . 0.0 108.569 179.655 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.8 t 177.15 148.27 0.32 Allowed Pre-proline 0 N--CA 1.466 0.366 0 C-N-CA 124.831 1.253 . . . . 0.0 110.776 177.88 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -65.33 -38.25 27.43 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 121.496 1.464 . . . . 0.0 110.482 159.539 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 11.1 ptp 171.55 -72.91 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 127.318 2.247 . . . . 0.0 107.547 175.225 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.58 -36.57 73.67 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.902 0.881 . . . . 0.0 112.908 -166.087 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.49 -105.94 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.302 0.241 . . . . 0.0 110.964 -173.863 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.86 -56.38 1.76 Allowed Glycine 0 CA--C 1.527 0.841 0 O-C-N 121.601 -0.687 . . . . 0.0 112.841 -176.287 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.5 -53.75 10.64 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.442 1.097 . . . . 0.0 111.476 -179.738 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -72.5 -8.44 55.12 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.332 1.453 . . . . 0.0 113.17 -178.128 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -64.02 117.14 6.63 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.492 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -78.46 74.17 5.01 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.977 0.894 . . . . 0.0 111.584 -165.855 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -56.5 124.22 17.46 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.097 1.359 . . . . 0.0 110.103 179.149 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.1 t -75.57 71.41 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.706 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 62.64 -77.47 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.156 1.782 . . . . 0.0 111.218 -177.465 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 15.4 t -179.65 -63.69 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 125.869 1.668 . . . . 0.0 108.327 -175.741 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -78.28 59.74 2.37 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.661 1.184 . . . . 0.0 110.997 -173.96 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 9.9 t -118.84 -65.26 1.19 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.226 1.41 . . . . 0.0 108.243 175.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.46 -51.18 70.5 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.184 0.594 . . . . 0.0 110.529 177.731 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 51.0 46.16 26.79 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.876 1.67 . . . . 0.0 115.384 165.039 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -71.7 153.13 42.24 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 118.62 -1.232 . . . . 0.0 108.384 157.854 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.7 t -161.61 -71.54 0.06 Allowed 'General case' 0 C--O 1.23 0.078 0 O-C-N 121.605 -0.684 . . . . 0.0 111.477 -179.557 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.2 t -159.24 149.68 19.38 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.878 1.271 . . . . 0.0 107.783 -174.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.3 mt -155.28 145.59 21.9 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.513 0.725 . . . . 0.0 110.044 175.501 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -70.23 174.21 3.57 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 124.554 1.142 . . . . 0.0 110.966 168.488 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.08 97.78 1.08 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.934 3.089 . . . . 0.0 111.045 -171.284 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 125.16 -7.93 8.04 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-O 119.489 -0.617 . . . . 0.0 111.693 176.09 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -76.65 170.56 16.2 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 117.794 0.797 . . . . 0.0 111.114 -171.762 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.54 143.82 45.13 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.828 1.651 . . . . 0.0 110.125 -167.329 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 7.6 mtt -139.81 81.84 1.84 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.652 1.581 . . . . 0.0 109.3 170.289 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -103.98 118.79 37.51 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 120.845 -1.159 . . . . 0.0 108.014 169.729 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 77.2 mtp -141.23 140.68 21.38 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 118.816 0.734 . . . . 0.0 112.053 -174.384 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.72 140.61 32.65 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 123.06 2.506 . . . . 0.0 110.277 175.709 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 69.5 t -116.57 151.42 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 161.118 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.1 p -118.21 139.23 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 167.409 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -153.22 157.94 40.98 Favored 'General case' 0 N--CA 1.458 -0.062 0 CA-C-N 119.562 1.074 . . . . 0.0 113.189 -177.336 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -179.1 174.63 1.04 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 128.979 2.911 . . . . 0.0 106.168 -169.176 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 67.2 t -135.5 133.65 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 119.143 0.883 . . . . 0.0 110.862 178.583 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -76.66 138.16 66.7 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -71.01 -3.61 13.19 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.024 2.483 . . . . 0.0 111.799 -179.28 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.407 ' OE1' ' NZ ' ' A' ' 128' ' ' LYS . 13.8 mm-40 -36.0 -41.61 0.25 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.427 1.091 . . . . 0.0 111.313 159.484 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -58.23 -30.79 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 123.79 0.836 . . . . 0.0 113.063 -178.546 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.4 m -101.24 17.73 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.583 0.753 . . . . 0.0 111.816 175.897 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.407 ' NZ ' ' OE1' ' A' ' 125' ' ' GLU 0.354 6.3 pttt -79.83 -42.2 1.47 Allowed Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 170.927 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -86.95 -175.71 1.7 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.08 2.52 . . . . 0.0 110.981 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 94.7 t -80.71 -54.2 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 123.751 0.82 . . . . 0.0 109.684 173.099 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -46.11 -57.8 4.17 Favored 'General case' 0 N--CA 1.46 0.064 0 C-N-CA 124.848 1.259 . . . . 0.0 112.796 -169.067 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.7 p -82.95 -3.99 57.72 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 118.378 -0.82 . . . . 0.0 112.783 -175.608 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -47.49 -42.69 23.42 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.802 1.183 . . . . 0.0 112.814 -172.516 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.18 -25.03 76.19 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 122.858 0.266 . . . . 0.0 113.223 -179.205 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 25.6 mm -74.51 130.51 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 117.935 0.868 . . . . 0.0 110.734 -174.805 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.3 pttt -156.26 42.6 0.39 Allowed 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.213 164.666 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.1 p -134.05 84.28 2.1 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 106.536 -1.654 . . . . 0.0 106.536 170.965 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.8 tp -87.95 87.24 7.29 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -163.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.6 t -96.31 143.87 26.99 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.262 -166.292 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.4 tp -112.71 111.34 22.07 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 168.025 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.4 p -88.72 96.88 10.84 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 168.831 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.56 128.91 35.02 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 170.002 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.8 m -129.64 93.78 3.61 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.895 0.855 . . . . 0.0 109.482 -174.677 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -78.96 91.72 4.85 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.5 1.12 . . . . 0.0 111.121 -171.043 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.73 53.26 9.81 Favored Pre-proline 0 CA--C 1.549 0.923 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 179.542 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.66 -94.56 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.16 2.573 . . . . 0.0 111.27 175.78 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -157.43 140.43 15.21 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 118.089 -0.958 . . . . 0.0 109.164 178.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -109.91 150.61 41.62 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 165.187 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -74.64 -59.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.284 1.99 . . . . 0.0 109.224 169.919 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 37.1 p 179.32 94.41 0.02 OUTLIER 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.614 1.565 . . . . 0.0 107.922 -179.26 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 19.1 pttp . . . . . 0 CA--C 1.539 0.533 0 CA-C-N 118.281 0.491 . . . . 0.0 109.874 -178.968 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 CA--C 1.541 0.612 0 CA-C-O 120.588 0.232 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 45.31 39.4 4.28 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.214 1.406 . . . . 0.0 111.563 -169.725 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 164.69 62.52 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 129.963 3.305 . . . . 0.0 104.063 -175.151 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.79 73.29 6.53 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.218 -169.536 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 79.0 p -109.38 62.13 0.6 Allowed 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 127.231 2.212 . . . . 0.0 110.735 -157.095 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -155.63 -60.33 0.11 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 102.887 -3.005 . . . . 0.0 102.887 172.384 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.41 ' H ' ' CD2' ' A' ' 27' ' ' LEU . 1.2 pt? -68.8 27.76 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 128.238 2.615 . . . . 0.0 114.316 177.22 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.5 mt -97.14 60.07 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.265 0 O-C-N 120.472 -1.393 . . . . 0.0 107.823 173.377 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.21 -179.43 2.86 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.607 -167.747 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -75.39 56.83 0.87 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.521 1.128 . . . . 0.0 110.324 177.306 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.94 145.26 41.82 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.833 1.653 . . . . 0.0 106.751 176.754 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -131.43 127.59 37.77 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.235 2.214 . . . . 0.0 105.292 -169.727 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.423 ' CG2' ' H ' ' A' ' 60' ' ' ILE . 1.3 tt -140.32 147.79 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 124.56 1.144 . . . . 0.0 108.587 -164.377 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.409 ' CE ' ' HB2' ' A' ' 55' ' ' ASP . 4.0 tmtp? -109.01 151.17 26.7 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.463 1.505 . . . . 0.0 109.782 -164.426 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.406 ' HB ' ' CG1' ' A' ' 56' ' ' ILE . 70.6 t -133.25 137.92 52.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 167.37 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.5 m -122.71 111.84 17.21 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -179.702 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -89.7 85.18 6.38 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 123.016 0.526 . . . . 0.0 110.246 -174.427 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -87.29 81.81 7.8 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 123.063 1.411 . . . . 0.0 110.909 -179.602 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.0 120.82 36.96 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 121.006 -1.059 . . . . 0.0 109.89 -176.597 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -125.8 160.69 29.18 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.259 1.024 . . . . 0.0 108.556 -179.892 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.93 151.25 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.077 0 C-N-CA 123.83 0.852 . . . . 0.0 109.249 -176.905 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.71 175.61 11.43 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.085 0.954 . . . . 0.0 110.437 178.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.51 124.11 6.57 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 170.251 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 127.38 -39.99 1.84 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -165.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.87 87.46 55.69 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 123.652 0.781 . . . . 0.0 110.017 174.169 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -81.72 38.75 0.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 124.356 3.371 . . . . 0.0 110.199 -176.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.45 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 41.3 m0 -110.11 146.77 34.88 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -171.347 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.41 78.34 3.93 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 -175.036 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -95.06 109.76 21.77 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -170.45 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.9 m -111.84 139.83 22.69 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.631 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.05 162.8 36.6 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 N-CA-C 108.444 -1.406 . . . . 0.0 108.444 162.659 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.7 t -78.33 -45.68 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -178.665 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -156.01 175.74 13.56 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 166.476 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -50.54 62.5 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.496 0.589 . . . . 0.0 111.619 171.474 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.409 ' HB2' ' CE ' ' A' ' 34' ' ' LYS . 23.1 p-10 -156.22 161.78 40.24 Favored 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 123.959 0.904 . . . . 0.0 111.482 -164.809 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.406 ' CG1' ' HB ' ' A' ' 35' ' ' VAL . 36.1 pt -129.4 162.06 37.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 169.324 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -116.31 142.6 46.62 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 161.475 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.7 m -131.63 159.15 43.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 126.361 1.865 . . . . 0.0 106.133 175.106 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.3 mtm-85 -100.66 85.42 2.91 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 158.414 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.423 ' H ' ' CG2' ' A' ' 33' ' ' ILE . 6.8 pt 35.87 43.7 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 127.379 2.271 . . . . 0.0 114.549 161.298 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 146.49 -29.81 1.59 Allowed Glycine 0 CA--C 1.525 0.687 0 O-C-N 121.004 -1.06 . . . . 0.0 111.618 -170.88 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -57.6 98.51 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.084 0.954 . . . . 0.0 110.137 173.755 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.45 107.51 1.69 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.925 2.09 . . . . 0.0 111.558 -176.565 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.95 147.32 12.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 166.56 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.39 128.03 39.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.475 1.91 . . . . 0.0 108.644 172.72 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.7 pp -129.83 111.48 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 167.468 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.84 126.39 36.9 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 123.126 0.571 . . . . 0.0 112.253 178.593 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -89.97 158.31 17.43 Favored 'General case' 0 C--O 1.23 0.062 0 C-N-CA 123.856 0.863 . . . . 0.0 108.709 177.272 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -133.83 129.84 37.07 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.846 1.258 . . . . 0.0 109.09 176.723 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.11 150.14 51.51 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 128.26 2.624 . . . . 0.0 107.131 163.74 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -150.96 129.02 11.79 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 117.365 -1.302 . . . . 0.0 107.7 174.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.45 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 52.8 t-20 -78.79 116.91 19.44 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 120.803 1.638 . . . . 0.0 111.642 -170.6 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.6 mt -117.04 34.43 5.11 Favored 'General case' 0 C--N 1.345 0.379 0 C-N-CA 124.575 1.15 . . . . 0.0 112.028 179.008 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.15 175.95 6.58 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 154.204 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.7 t -95.94 16.53 17.53 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.192 0.597 . . . . 0.0 110.483 172.616 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 p -145.41 154.32 52.97 Favored Pre-proline 0 N--CA 1.45 -0.46 0 C-N-CA 124.972 1.309 . . . . 0.0 109.025 -176.102 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.14 147.32 78.98 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 N-CA-C 108.132 -1.526 . . . . 0.0 108.132 171.168 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.4 p -119.39 178.93 4.36 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 170.24 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.4 t -124.41 109.45 13.31 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 173.015 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.32 101.59 0.64 Allowed Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 108.527 -1.829 . . . . 0.0 108.527 175.011 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -125.51 47.79 2.15 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 165.711 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.29 -178.84 1.43 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 122.181 0.991 . . . . 0.0 108.541 159.415 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.74 -173.56 4.62 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 178.055 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -144.21 146.47 32.71 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.247 0.93 . . . . 0.0 111.778 167.72 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.2 96.19 9.44 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 167.304 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.9 p -85.58 65.74 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 CA-C-N 118.045 0.384 . . . . 0.0 110.603 177.821 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.1 t -164.84 143.88 5.64 Favored Pre-proline 0 C--O 1.233 0.191 0 O-C-N 121.161 -0.962 . . . . 0.0 112.201 -179.497 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.19 -33.29 31.48 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 N-CA-C 108.776 -1.278 . . . . 0.0 108.776 162.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.405 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 7.8 ptm 175.58 -70.09 0.01 OUTLIER 'General case' 0 C--N 1.343 0.304 0 C-N-CA 126.406 1.883 . . . . 0.0 108.127 -171.161 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.405 ' H ' ' CG ' ' A' ' 89' ' ' MET . . . -99.72 -19.66 16.65 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.765 1.226 . . . . 0.0 112.743 -161.972 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.72 -133.24 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 178.892 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.3 -45.42 0.35 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.137 0.875 . . . . 0.0 114.442 -174.812 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -49.34 -61.02 2.32 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.608 1.204 . . . . 0.0 108.636 167.61 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -75.8 54.34 0.8 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.41 1.884 . . . . 0.0 110.147 171.017 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -110.7 156.89 20.38 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 162.274 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -51.12 -50.26 59.19 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 127.006 2.122 . . . . 0.0 109.676 -175.376 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt 55.12 44.41 27.93 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.884 159.615 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.0 p -60.34 128.36 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.782 -176.288 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -78.6 65.6 3.91 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -178.573 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 32.9 t -158.61 151.79 22.69 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 125.163 1.385 . . . . 0.0 107.601 -175.199 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -71.29 53.08 0.19 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.404 1.482 . . . . 0.0 112.409 -177.788 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 68.6 m -81.54 66.92 7.29 Favored 'General case' 0 C--N 1.334 -0.081 0 C-N-CA 124.221 1.008 . . . . 0.0 108.571 -179.132 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 64.0 t80 116.05 117.09 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 129.587 3.155 . . . . 0.0 107.812 -172.108 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 91.3 m -152.19 87.97 1.35 Allowed 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 174.577 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -53.22 -28.77 28.69 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.935 1.694 . . . . 0.0 114.408 -173.364 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.8 t 52.14 -146.79 0.48 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.681 1.192 . . . . 0.0 112.231 170.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.55 122.66 45.33 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.058 1.743 . . . . 0.0 107.095 177.111 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.35 129.38 56.22 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.904 1.681 . . . . 0.0 108.615 -170.203 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -77.49 152.42 81.04 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 123.462 0.705 . . . . 0.0 111.673 -177.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.75 110.71 2.83 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.457 2.771 . . . . 0.0 112.111 -167.645 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 126.0 -31.68 4.02 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 108.27 -1.932 . . . . 0.0 108.27 -176.658 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -86.32 171.29 11.32 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 121.363 0.601 . . . . 0.0 112.206 -161.173 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.08 145.5 41.52 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.237 1.815 . . . . 0.0 110.649 -163.081 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.62 86.92 2.14 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.163 1.785 . . . . 0.0 107.678 166.015 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -125.28 129.42 49.97 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 121.633 -0.667 . . . . 0.0 110.731 169.774 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 81.5 mtp -153.94 146.4 17.42 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 122.938 0.495 . . . . 0.0 111.054 -170.364 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -66.93 137.29 44.36 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.608 2.872 . . . . 0.0 112.105 172.561 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 34.5 t -116.59 155.96 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 161.674 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.0 m -121.27 151.76 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 176.09 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -151.42 139.29 19.91 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 119.18 -0.438 . . . . 0.0 110.477 -171.021 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -172.71 86.55 0.07 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.628 1.171 . . . . 0.0 110.462 -174.293 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 41.5 t -49.72 143.1 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -166.1 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 125' ' ' GLU . 1.5 m-20 -79.33 123.74 84.44 Favored Pre-proline 0 CA--C 1.537 0.478 0 O-C-N 121.308 -0.87 . . . . 0.0 110.821 -174.454 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -73.9 32.59 0.33 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.12 2.547 . . . . 0.0 113.483 177.339 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.41 ' H ' ' C ' ' A' ' 123' ' ' ASP . 11.5 mt-10 -87.28 -24.27 24.4 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.529 1.532 . . . . 0.0 108.67 160.585 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -46.46 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 C-N-CA 123.098 0.559 . . . . 0.0 111.576 -172.209 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.8 m -79.31 61.5 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 O-C-N 121.691 -0.63 . . . . 0.0 110.401 177.063 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -137.39 -65.01 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.597 0 CA-C-O 117.845 -1.074 . . . . 0.0 112.344 173.899 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.5 159.57 28.85 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 122.119 1.879 . . . . 0.0 113.917 -173.128 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 86.7 t -54.71 -35.94 34.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 126.024 1.73 . . . . 0.0 110.981 177.271 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -36.82 -55.95 0.87 Allowed 'General case' 0 C--N 1.34 0.157 0 C-N-CA 126.089 1.756 . . . . 0.0 111.817 175.27 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.0 p -105.9 -50.26 3.22 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 124.192 0.997 . . . . 0.0 109.826 -163.667 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 22.02 57.44 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 128.425 2.69 . . . . 0.0 115.508 173.501 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 135.26 -30.48 2.8 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 -177.298 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 13.0 mm -53.5 138.62 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-N 117.828 0.814 . . . . 0.0 109.274 173.691 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.8 pttt -158.87 54.96 0.42 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.571 0.701 . . . . 0.0 111.056 165.181 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.93 90.24 2.37 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -178.223 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.3 mp -76.44 85.57 3.17 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.089 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.2 m -77.3 107.25 9.57 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 176.527 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.2 tt -76.79 137.23 39.13 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 160.583 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 27.9 t -135.61 142.7 45.29 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 160.791 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -159.36 169.76 23.29 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 155.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 38.4 m -113.7 103.55 11.33 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 127.437 2.295 . . . . 0.0 108.333 173.366 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -71.12 100.2 2.0 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 172.367 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.07 50.47 0.69 Allowed Pre-proline 0 CA--C 1.553 1.072 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 -176.325 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -75.9 -82.27 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.504 2.803 . . . . 0.0 113.991 -175.886 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 74.0 mtt85 -149.74 106.77 3.57 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.41 1.005 . . . . 0.0 112.019 -164.655 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -156.49 135.63 7.95 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 126.043 1.737 . . . . 0.0 106.932 169.792 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.13 -53.59 0.3 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.139 1.893 . . . . 0.0 112.609 173.473 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.3 p 177.18 109.41 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.67 0.788 . . . . 0.0 110.493 -166.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 55.9 pttt . . . . . 0 CA--C 1.537 0.467 0 O-C-N 121.303 -0.873 . . . . 0.0 109.896 -177.859 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.1 t . . . . . 0 CA--C 1.537 0.461 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -73.62 67.11 1.09 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 159.511 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 146.46 154.08 0.0 OUTLIER 'General case' 0 C--N 1.339 0.132 1 C-N-CA 132.349 4.26 . . . . 0.0 108.096 -171.868 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -153.2 28.55 0.51 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 122.025 0.917 . . . . 0.0 110.126 -167.389 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.79 -11.43 59.99 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.529 1.532 . . . . 0.0 114.757 -147.196 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.35 -31.96 64.25 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 173.879 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.1 mp -108.09 14.46 25.11 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.023 1.329 . . . . 0.0 112.074 -176.27 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.4 mt -77.98 77.31 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 120.005 -1.684 . . . . 0.0 108.839 173.641 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.76 179.75 5.93 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.531 0.681 . . . . 0.0 109.893 179.238 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -94.48 59.43 2.51 Favored 'General case' 0 C--N 1.337 0.031 0 C-N-CA 123.827 0.851 . . . . 0.0 112.667 -167.021 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -115.18 160.9 19.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 151.664 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -133.76 88.38 2.47 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -179.898 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.0 tt -94.47 137.91 21.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 C-N-CA 124.477 1.111 . . . . 0.0 111.637 -163.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.71 143.84 34.2 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.635 1.574 . . . . 0.0 109.781 -170.421 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.7 t -135.72 142.06 40.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.655 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 164.389 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.9 m -123.29 112.47 17.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 -177.721 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -78.52 89.76 4.48 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 172.864 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -78.23 85.25 4.4 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 118.492 -1.283 . . . . 0.0 108.395 178.576 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.5 115.78 17.54 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.832 174.758 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -122.94 175.54 6.52 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.595 1.158 . . . . 0.0 108.188 167.039 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.6 p -151.17 148.6 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 169.161 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -164.51 171.54 14.45 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.254 1.022 . . . . 0.0 108.869 -178.302 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.62 -165.36 0.22 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.354 1.462 . . . . 0.0 111.616 -175.4 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.73 52.98 4.26 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 112.123 -0.391 . . . . 0.0 112.123 -173.079 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.412 ' CD1' ' CD1' ' A' ' 144' ' ' PHE . 1.4 tt -111.7 83.77 4.77 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.122 0.969 . . . . 0.0 108.785 177.693 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -85.28 45.0 1.5 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.246 3.298 . . . . 0.0 109.736 -170.141 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.439 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 43.1 m0 -108.39 138.58 44.43 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -172.909 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.408 ' OE1' ' NZ ' ' A' ' 71' ' ' LYS . 73.2 tt0 -77.85 82.36 4.23 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 -178.503 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -90.26 122.01 32.79 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.715 1.206 . . . . 0.0 108.233 179.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 m -126.67 135.54 27.43 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.144 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -70.76 162.39 42.76 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 N-CA-C 108.146 -1.521 . . . . 0.0 108.146 161.433 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -60.18 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 175.117 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -144.06 154.13 42.91 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 164.773 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.03 -42.72 69.45 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 118.537 -0.744 . . . . 0.0 112.095 -175.964 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -145.35 159.69 42.67 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 119.382 0.992 . . . . 0.0 113.189 -166.623 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.8 pt -133.82 159.79 42.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 125.768 1.627 . . . . 0.0 107.847 178.193 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -128.29 85.41 2.34 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.316 1.446 . . . . 0.0 109.124 178.189 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.8 m -80.44 141.83 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 O-C-N 121.255 -0.903 . . . . 0.0 110.689 -171.281 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -78.22 72.16 4.74 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 173.078 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.5 pt 19.01 64.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 127.437 2.295 . . . . 0.0 113.489 176.368 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 139.0 -43.8 1.14 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -172.58 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -59.68 130.3 46.16 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.648 -173.467 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.6 m -106.69 87.28 2.49 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.003 -146.106 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.72 144.19 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 CA-C-O 121.094 0.473 . . . . 0.0 110.696 -170.538 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.93 115.54 24.4 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.239 1.016 . . . . 0.0 108.591 168.817 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.8 pp -115.57 115.04 48.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 164.044 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -87.49 155.23 20.09 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.939 -0.475 . . . . 0.0 110.966 178.387 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -127.0 153.78 45.46 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 172.73 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -134.69 141.79 46.64 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.877 1.671 . . . . 0.0 107.898 179.904 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.34 115.58 7.98 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.805 2.042 . . . . 0.0 107.681 174.387 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.408 ' NZ ' ' OE1' ' A' ' 48' ' ' GLU . 3.0 mtmp? -114.73 124.42 51.73 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.29 0.95 . . . . 0.0 110.652 -176.99 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.439 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 46.9 t-20 -80.92 107.2 13.53 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.79 0.723 . . . . 0.0 112.932 -167.583 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.3 mp -99.08 30.4 3.45 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.495 1.118 . . . . 0.0 111.974 176.649 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.85 176.81 9.39 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.021 -1.049 . . . . 0.0 110.401 168.084 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.1 t -114.07 18.1 17.37 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.221 0.608 . . . . 0.0 109.929 161.646 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 p -146.65 156.42 48.61 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 125.639 1.576 . . . . 0.0 107.736 174.405 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -63.23 145.1 93.05 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 N-CA-C 108.122 -1.53 . . . . 0.0 108.122 172.138 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.5 p -123.08 168.25 12.61 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.644 0.735 . . . . 0.0 111.299 178.716 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.8 m -93.63 144.88 24.98 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 168.354 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -168.74 56.9 0.21 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 176.525 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.91 57.78 0.86 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.018 1.727 . . . . 0.0 108.405 -174.374 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.62 166.46 23.52 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.94 0.876 . . . . 0.0 112.879 -168.036 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.48 97.55 8.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 176.512 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -77.23 140.24 40.05 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.544 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -85.76 88.61 7.57 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -172.634 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -76.97 77.91 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 C-N-CA 125.043 1.337 . . . . 0.0 110.435 -176.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.8 t 178.88 147.64 0.39 Allowed Pre-proline 0 N--CA 1.46 0.029 0 C-N-CA 124.932 1.293 . . . . 0.0 109.343 173.324 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -66.75 -35.19 28.86 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.146 1.23 . . . . 0.0 110.274 158.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.0 ptp 175.36 -70.78 0.01 OUTLIER 'General case' 0 C--N 1.341 0.206 0 C-N-CA 126.902 2.081 . . . . 0.0 107.571 179.244 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.0 -36.61 48.59 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.962 0.905 . . . . 0.0 113.011 -167.788 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.77 -109.62 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.608 0.242 . . . . 0.0 111.58 -167.732 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.79 -49.69 0.84 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.417 1.008 . . . . 0.0 113.528 -176.111 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.55 -57.52 4.66 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.594 1.197 . . . . 0.0 109.802 172.254 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -73.69 5.01 4.31 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.498 1.919 . . . . 0.0 113.895 -178.898 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -85.72 126.58 34.08 Favored 'General case' 0 C--N 1.344 0.343 0 O-C-N 121.232 -0.918 . . . . 0.0 108.649 174.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -72.71 91.0 1.43 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.179 -179.459 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.77 -20.22 64.35 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.833 1.253 . . . . 0.0 113.24 177.732 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.1 t 37.84 61.61 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 126.75 2.02 . . . . 0.0 111.992 177.464 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.38 68.78 0.36 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.133 1.373 . . . . 0.0 110.301 -177.109 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 17.6 p 177.73 -30.79 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.652 2.381 . . . . 0.0 109.972 -172.629 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -143.43 67.79 1.29 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 176.07 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 14.2 p -151.67 173.78 14.27 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.803 1.241 . . . . 0.0 109.024 179.595 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -67.48 114.51 6.21 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.173 0.589 . . . . 0.0 110.372 -165.635 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.7 t -80.73 -28.7 36.48 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.916 0.486 . . . . 0.0 112.062 -175.438 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 34.87 62.81 0.5 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.335 1.854 . . . . 0.0 114.081 176.039 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.1 t -88.5 -165.78 1.42 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.051 0.94 . . . . 0.0 110.05 174.687 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.5 t -76.69 144.15 39.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.198 0.999 . . . . 0.0 110.04 -175.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 81.0 mt -127.25 134.87 50.01 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.538 1.135 . . . . 0.0 108.15 -179.791 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -69.55 157.08 90.44 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 170.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.43 100.21 0.88 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.373 2.716 . . . . 0.0 110.438 -170.711 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.31 -23.44 3.31 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -175.208 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -78.95 135.78 37.05 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 118.254 1.027 . . . . 0.0 111.707 -160.727 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -92.61 104.56 16.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.4 1.48 . . . . 0.0 109.375 178.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -90.56 135.13 33.9 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 174.042 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -151.46 154.99 37.65 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.625 0.37 . . . . 0.0 110.639 156.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 78.6 mtp -151.77 146.05 18.36 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.161 0.984 . . . . 0.0 109.578 171.495 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -66.12 137.97 50.17 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.126 2.55 . . . . 0.0 110.443 161.79 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.8 t -107.96 130.47 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 159.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.3 m -98.49 140.82 17.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 171.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -154.43 149.37 26.72 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -162.322 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -164.5 170.29 16.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.415 1.886 . . . . 0.0 109.108 165.314 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 70.7 t -103.99 135.46 41.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 174.482 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -76.37 134.2 70.47 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 119.119 -0.467 . . . . 0.0 109.954 176.397 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -74.16 67.34 5.16 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.384 2.723 . . . . 0.0 110.292 171.42 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -133.52 -37.82 0.94 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 126.799 2.04 . . . . 0.0 111.027 176.565 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.4 tt -43.87 -41.66 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 125.012 1.325 . . . . 0.0 113.414 173.111 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.9 m -78.23 49.03 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 O-C-N 121.394 -0.816 . . . . 0.0 111.34 176.825 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.9 mttt -142.72 -64.51 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 117.521 -1.228 . . . . 0.0 111.617 -179.299 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.17 153.17 46.03 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 121.942 1.729 . . . . 0.0 112.736 -176.548 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.8 t -54.87 -35.54 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 125.838 1.655 . . . . 0.0 110.662 175.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -35.26 -59.16 0.53 Allowed 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 126.656 1.983 . . . . 0.0 112.309 175.79 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.5 p -106.94 -42.73 4.84 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.015 -166.068 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 14.07 63.15 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 128.389 2.675 . . . . 0.0 116.235 172.151 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 136.73 -36.73 1.95 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -177.272 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 29.8 mm -53.28 123.52 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 171.444 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.38 47.86 0.35 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.288 0.566 . . . . 0.0 112.102 177.965 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.5 p -143.65 89.04 2.03 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 105.809 -1.922 . . . . 0.0 105.809 174.025 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 tp -92.71 87.21 5.8 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.029 -159.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.5 t -97.86 155.85 16.87 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.457 0.703 . . . . 0.0 111.084 -166.773 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.76 133.25 55.98 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 160.704 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 44.5 m -90.94 105.77 18.06 Favored 'General case' 0 N--CA 1.46 0.043 0 O-C-N 123.902 0.751 . . . . 0.0 109.035 160.452 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -76.27 99.8 4.89 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 165.708 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 53.5 m -117.34 86.35 2.5 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.978 1.311 . . . . 0.0 107.524 175.18 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.412 ' CD1' ' CD1' ' A' ' 45' ' ' LEU . 48.2 m-85 -59.22 145.2 43.67 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.322 1.049 . . . . 0.0 112.828 174.392 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -166.85 52.69 0.25 Allowed Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.966 1.707 . . . . 0.0 112.342 -175.435 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.3 -90.04 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.679 2.252 . . . . 0.0 115.092 -168.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -155.16 179.55 9.04 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 129.697 3.199 . . . . 0.0 104.863 -175.119 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -147.13 94.56 4.54 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 118.488 0.585 . . . . 0.0 111.044 -171.462 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -91.94 -124.37 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.984 3.122 . . . . 0.0 108.954 176.664 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 85.5 p -123.2 123.76 41.5 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 120.356 1.435 . . . . 0.0 111.763 -172.706 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.595 0 C-N-CA 126.496 1.918 . . . . 0.0 109.237 174.333 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.3 p . . . . . 0 N--CA 1.464 0.265 0 CA-C-O 122.042 0.925 . . . . 0.0 112.026 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 46.38 34.06 2.14 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.894 1.678 . . . . 0.0 112.276 176.482 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 166.68 157.1 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 128.332 2.653 . . . . 0.0 105.903 -172.58 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -151.74 2.55 0.39 Allowed 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -172.502 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.75 11.9 0.95 Allowed 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 126.802 2.041 . . . . 0.0 115.322 -164.9 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -77.25 -39.12 49.44 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 159.452 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.4 mp -92.22 -37.91 12.41 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 117.209 -1.377 . . . . 0.0 113.016 179.839 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.2 mt -32.53 133.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -162.13 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -105.91 -104.15 0.33 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.159 -173.618 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -173.59 -49.2 0.01 OUTLIER 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.058 1.343 . . . . 0.0 108.855 -171.348 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -38.78 134.6 0.95 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.002 1.721 . . . . 0.0 110.678 -178.812 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -100.97 86.65 3.1 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -165.883 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.98 115.01 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.436 1.494 . . . . 0.0 107.953 -171.424 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.99 160.01 29.48 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -173.641 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.0 t -148.74 145.19 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 179.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.1 m -138.55 100.28 4.05 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -170.053 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -78.11 145.0 36.0 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.018 0.527 . . . . 0.0 109.919 -176.177 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -127.63 82.75 2.11 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.913 0.863 . . . . 0.0 110.007 178.22 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.49 102.16 14.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 172.118 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -116.89 128.37 55.18 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 122.292 1.044 . . . . 0.0 112.126 -174.666 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.0 p -99.83 96.29 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.564 -174.252 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.12 171.1 10.5 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 122.048 0.928 . . . . 0.0 111.406 174.843 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.41 132.07 52.0 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 169.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 128.33 -39.28 1.92 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -170.579 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.484 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -131.56 95.57 23.21 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 117.56 0.68 . . . . 0.0 110.277 -176.363 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -83.94 50.94 3.27 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.956 2.437 . . . . 0.0 109.651 -176.136 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.484 ' CD2' ' CD2' ' A' ' 45' ' ' LEU . 44.4 m0 -107.91 135.56 49.1 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -173.649 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -79.36 84.5 5.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 103.484 -2.784 . . . . 0.0 103.484 179.246 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -102.04 86.15 2.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -171.598 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.3 m -88.04 129.14 51.2 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -167.28 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.09 122.49 9.58 Favored 'Trans proline' 0 N--CA 1.446 -1.277 0 N-CA-C 106.261 -2.246 . . . . 0.0 106.261 162.466 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.1 m -72.73 -32.08 39.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.181 0.515 . . . . 0.0 110.691 -168.387 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.02 161.98 34.16 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 150.265 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -62.65 -46.72 86.89 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 172.532 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -147.38 153.54 39.77 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 124.415 1.086 . . . . 0.0 111.659 -159.647 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.4 pt -133.13 179.23 4.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 126.326 1.851 . . . . 0.0 108.251 179.892 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -125.47 160.18 30.11 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.345 0.593 . . . . 0.0 110.21 149.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.6 t -116.72 145.97 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 127.99 2.516 . . . . 0.0 105.679 171.014 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 49.5 mmm-85 -91.37 100.81 13.53 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 168.021 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mt -33.2 115.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -148.243 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.58 -25.2 26.49 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.071 1.319 . . . . 0.0 110.936 -179.386 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -64.9 133.45 51.86 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.806 1.303 . . . . 0.0 112.422 -172.33 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.15 101.53 7.97 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 130.05 3.34 . . . . 0.0 110.818 -175.38 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.9 p -113.78 153.75 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.292 1.437 . . . . 0.0 109.491 -178.597 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -112.51 125.15 53.93 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 125.404 1.482 . . . . 0.0 109.343 -177.38 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.0 pp -128.48 122.86 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 167.861 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 66.4 mtt -76.09 168.44 20.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.614 174.164 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -136.17 143.21 44.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 161.864 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.7 ttt85 -121.01 118.7 30.5 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 179.546 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.3 105.15 9.24 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 125.822 1.649 . . . . 0.0 110.035 -177.216 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.29 121.09 44.36 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.064 -0.398 . . . . 0.0 110.749 -168.603 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.435 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 47.8 t-20 -78.38 111.9 14.85 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.803 -0.561 . . . . 0.0 111.912 -167.783 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.2 tp -98.41 11.24 38.77 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.812 0.845 . . . . 0.0 112.381 179.564 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.46 166.67 22.33 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.272 -0.893 . . . . 0.0 109.95 173.44 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 70.0 m -103.3 7.0 38.35 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.968 0.907 . . . . 0.0 111.835 171.73 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.34 159.61 38.79 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 126.134 1.773 . . . . 0.0 107.041 177.974 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.97 126.04 12.11 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.171 1.914 . . . . 0.0 111.255 -173.208 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.49 173.53 12.51 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.821 0.849 . . . . 0.0 110.784 -178.998 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 50.7 p -131.45 72.03 1.49 Allowed 'General case' 0 C--O 1.232 0.137 0 C-N-CA 122.551 0.341 . . . . 0.0 110.426 -170.893 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.42 139.37 37.39 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.946 -0.462 . . . . 0.0 111.946 -179.48 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -166.81 34.19 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.659 1.983 . . . . 0.0 109.44 169.222 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.58 159.08 34.47 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.33 0.652 . . . . 0.0 111.445 -165.445 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.9 t -87.77 131.51 34.48 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.704 0.764 . . . . 0.0 110.039 177.814 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -104.03 89.93 3.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.871 2.468 . . . . 0.0 105.572 175.509 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -77.0 91.92 3.67 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 120.882 -1.136 . . . . 0.0 107.935 -177.617 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.8 t -78.11 72.57 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.612 1.165 . . . . 0.0 109.973 -174.043 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.9 t -168.73 134.76 1.49 Allowed Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 119.901 1.228 . . . . 0.0 113.389 173.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -74.1 67.72 5.04 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 122.386 2.057 . . . . 0.0 107.243 156.257 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 22.2 ptm 44.19 25.47 0.11 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 170.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -171.41 -58.26 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 119.384 0.993 . . . . 0.0 110.594 -168.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.61 -101.2 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -177.282 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 64.05 -52.1 0.08 OUTLIER Glycine 0 CA--C 1.538 1.481 0 N-CA-C 115.413 0.925 . . . . 0.0 115.413 -175.534 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -45.73 -47.63 15.33 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.553 1.541 . . . . 0.0 110.808 172.217 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -73.85 -12.69 60.75 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 127.012 2.125 . . . . 0.0 113.471 178.975 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -67.55 140.0 56.95 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.119 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -71.21 127.95 34.29 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.967 1.307 . . . . 0.0 110.765 -177.33 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -161.06 -50.45 0.05 OUTLIER 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 122.478 0.311 . . . . 0.0 110.65 -174.793 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . 0.326 2.4 p 47.8 -95.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.985 1.314 . . . . 0.0 111.809 -175.875 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -165.18 178.75 6.74 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.201 1.401 . . . . 0.0 107.336 173.526 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 90.3 m 54.52 42.61 31.22 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.382 1.073 . . . . 0.0 111.469 175.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -106.18 163.73 12.57 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.385 1.074 . . . . 0.0 108.505 171.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 59.6 m -134.39 139.39 45.56 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 177.663 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -166.79 -42.46 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.853 0.861 . . . . 0.0 109.083 175.403 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.3 p -22.85 109.2 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 127.808 2.443 . . . . 0.0 111.855 162.783 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -78.41 -15.98 58.09 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -159.359 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.3 t 51.67 -146.64 0.47 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.441 1.096 . . . . 0.0 112.472 170.606 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.6 m -115.54 136.65 52.86 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.089 1.355 . . . . 0.0 108.542 -172.069 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 78.6 mt -128.44 147.95 50.69 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.39 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -73.29 156.42 89.15 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 172.354 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.23 85.87 0.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 124.88 3.72 . . . . 0.0 111.756 -173.064 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 152.74 -27.23 0.83 Allowed Glycine 0 CA--C 1.522 0.5 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.25 -177.777 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -77.86 143.45 37.79 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 118.085 0.942 . . . . 0.0 111.593 -157.925 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -105.21 96.9 6.84 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.811 1.244 . . . . 0.0 109.942 -175.603 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 15.4 tpt -83.92 89.21 7.18 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.114 1.365 . . . . 0.0 109.325 -177.951 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -99.21 134.21 42.4 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.256 0.622 . . . . 0.0 109.576 172.148 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 22.4 ptm -150.95 146.31 19.11 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.996 -0.526 . . . . 0.0 111.441 178.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.58 147.77 20.05 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.883 3.055 . . . . 0.0 111.049 171.852 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.5 t -126.53 114.89 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 165.199 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.5 p -79.41 143.47 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 168.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -155.61 149.11 24.98 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.163 0.585 . . . . 0.0 109.949 -165.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -171.18 118.98 0.48 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.36 1.464 . . . . 0.0 111.893 176.858 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.8 t -64.09 133.39 29.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 O-C-N 120.355 -1.466 . . . . 0.0 109.505 175.317 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -91.61 132.39 33.44 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 123.701 0.801 . . . . 0.0 109.8 -179.053 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -46.35 -31.52 9.55 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.402 3.401 . . . . 0.0 114.919 177.342 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -48.94 -24.2 1.4 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.783 1.633 . . . . 0.0 112.39 179.183 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.1 tt -49.01 -44.46 15.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 169.097 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.9 m -83.38 59.66 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 118.571 0.623 . . . . 0.0 109.895 174.354 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -111.0 -77.41 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 117.168 -1.396 . . . . 0.0 110.366 164.628 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.54 156.05 45.12 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 CA-C-N 121.885 1.709 . . . . 0.0 111.666 -177.384 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.6 m -62.16 -36.08 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 124.94 1.296 . . . . 0.0 112.045 -170.657 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -60.6 -64.46 0.94 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.147 0.979 . . . . 0.0 109.281 177.587 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 44.6 p -72.61 -15.43 61.73 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 118.509 -0.758 . . . . 0.0 111.568 -172.419 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.04 -41.52 5.53 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.768 0.713 . . . . 0.0 111.221 162.913 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.34 -29.17 74.38 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 112.237 -0.345 . . . . 0.0 112.237 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.3 mm -83.88 125.94 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 122.079 0.942 . . . . 0.0 110.39 -177.629 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 28.3 pttt -148.81 63.76 1.06 Allowed 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.506 153.751 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 11.7 m -150.15 95.33 2.26 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 158.416 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.2 tp -75.48 144.79 41.87 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -173.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.8 t -141.8 173.38 11.56 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.496 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.1 tt -150.63 111.28 4.25 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 177.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.45 92.94 8.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.515 1.126 . . . . 0.0 109.252 -179.545 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.94 108.4 19.17 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.877 1.271 . . . . 0.0 108.783 179.406 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.66 89.09 3.58 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 122.009 0.909 . . . . 0.0 109.747 -177.358 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -71.23 85.57 0.77 Allowed 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.281 177.058 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.1 47.59 2.8 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -178.703 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -80.89 -105.74 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.279 2.653 . . . . 0.0 111.967 178.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -140.95 121.68 14.34 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.648 1.179 . . . . 0.0 108.528 -171.242 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.9 111.22 38.82 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 125.654 1.581 . . . . 0.0 107.118 -177.128 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -83.3 -4.85 11.07 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.293 2.662 . . . . 0.0 113.043 -172.742 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.9 t 131.51 103.71 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 129.972 3.309 . . . . 0.0 109.754 174.481 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.542 0.669 0 C-N-CA 125.256 1.423 . . . . 0.0 111.723 168.356 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 122.31 1.052 . . . . 0.0 108.427 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 23.08 50.72 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.94 1.696 . . . . 0.0 112.229 -146.308 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.21 155.29 11.35 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 127.879 2.471 . . . . 0.0 104.405 174.542 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -122.32 125.96 47.07 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 104.354 -2.462 . . . . 0.0 104.354 156.676 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.6 t -147.88 49.54 1.06 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 122.493 1.14 . . . . 0.0 108.227 174.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -158.8 -57.42 0.07 Allowed 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 127.306 2.243 . . . . 0.0 106.309 -174.367 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.9 mt -65.53 -16.48 63.72 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.907 2.083 . . . . 0.0 112.878 -177.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.4 mt -75.67 78.51 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 O-C-N 121.21 -0.931 . . . . 0.0 110.267 -171.566 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.69 -127.7 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.555 1.142 . . . . 0.0 108.524 169.679 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -104.36 -51.33 3.13 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.57 1.548 . . . . 0.0 111.939 -164.506 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -43.1 102.07 0.03 OUTLIER 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.194 1.398 . . . . 0.0 113.351 -169.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.69 81.52 4.99 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 177.261 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -97.11 122.58 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -160.616 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.7 150.48 34.48 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.943 1.297 . . . . 0.0 108.199 -175.216 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.52 146.9 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 174.497 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.9 m -125.83 112.19 15.73 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -172.69 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -77.88 136.18 38.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.754 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -126.71 84.45 2.27 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 122.502 1.144 . . . . 0.0 108.965 177.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.91 95.75 10.28 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.374 1.07 . . . . 0.0 110.972 -176.753 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -98.63 109.5 22.24 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.375 0.67 . . . . 0.0 109.79 -177.936 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.0 p -79.24 148.86 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 164.388 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -151.04 158.71 44.44 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 171.216 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.05 -40.15 10.25 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.84 0.856 . . . . 0.0 112.109 -177.214 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -41.58 -31.98 0.76 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.812 1.672 . . . . 0.0 114.151 174.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.405 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -130.17 110.13 16.68 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 118.688 1.244 . . . . 0.0 108.471 170.488 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -75.27 0.95 8.4 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.294 1.996 . . . . 0.0 115.576 -164.035 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.51 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 42.2 m0 -79.57 153.45 29.46 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.38 1.472 . . . . 0.0 113.613 -159.844 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -77.47 77.46 4.0 Favored 'General case' 0 C--N 1.344 0.344 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.615 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -84.6 110.72 18.93 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.684 1.193 . . . . 0.0 109.098 -171.484 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.9 t -122.78 118.81 28.25 Favored Pre-proline 0 N--CA 1.444 -0.758 0 C-N-CA 124.4 1.08 . . . . 0.0 108.645 -163.638 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -81.87 174.56 10.13 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 124.543 3.495 . . . . 0.0 108.554 168.367 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -98.6 -53.12 8.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 123.949 0.9 . . . . 0.0 110.845 -173.622 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -134.16 175.15 9.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 166.638 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.6 tpt85 -68.45 -33.15 73.68 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.392 168.636 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -144.67 173.44 11.82 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.842 1.257 . . . . 0.0 112.694 -162.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.1 pt -141.65 178.2 2.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 127.206 2.203 . . . . 0.0 106.788 165.567 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -132.27 162.77 30.16 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 146.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.23 136.92 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 126.953 2.101 . . . . 0.0 105.836 -175.199 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.94 88.66 3.5 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 163.205 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.2 pt 8.81 69.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 127.74 2.416 . . . . 0.0 114.63 178.469 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.55 -37.55 1.78 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 123.41 0.529 . . . . 0.0 112.305 -176.594 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -39.24 104.43 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.383 1.473 . . . . 0.0 110.849 177.101 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m -87.46 88.45 7.68 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.353 -156.25 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 p -92.73 161.67 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 O-C-N 121.933 -0.479 . . . . 0.0 111.721 -168.434 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -102.98 126.74 50.28 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.959 1.303 . . . . 0.0 110.35 169.561 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.5 pp -131.33 114.03 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 107.319 -1.364 . . . . 0.0 107.319 167.443 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.0 ttp -77.86 161.52 27.55 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.378 0.671 . . . . 0.0 110.862 -176.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -134.57 150.96 50.78 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.436 1.094 . . . . 0.0 108.846 169.325 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 54.1 ttp85 -143.46 147.08 34.0 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.997 0.919 . . . . 0.0 110.111 -178.457 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.39 109.68 2.66 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.632 1.573 . . . . 0.0 111.765 -177.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -86.09 139.28 31.27 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.989 171.721 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.51 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 28.1 t30 -78.21 88.99 4.27 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.073 0.851 . . . . 0.0 112.127 168.958 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.9 mp -76.76 69.08 3.08 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 171.193 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -153.66 137.26 15.99 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 168.513 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.1 t -80.14 36.1 0.34 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.369 0.531 . . . . 0.0 110.754 178.083 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.8 p -149.91 155.47 37.98 Favored Pre-proline 0 C--O 1.237 0.395 0 C-N-CA 126.63 1.972 . . . . 0.0 106.995 174.307 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -63.23 148.14 93.3 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 N-CA-C 108.208 -1.497 . . . . 0.0 108.208 168.522 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.01 175.06 6.53 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.792 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.0 m -105.65 145.25 31.28 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.121 1.768 . . . . 0.0 106.875 175.39 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -133.65 126.14 4.2 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 107.096 -2.401 . . . . 0.0 107.096 172.494 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.18 54.77 0.12 Allowed 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 166.78 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.44 144.83 15.9 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.884 176.162 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.3 t -85.01 166.08 17.02 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 168.185 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -146.41 95.96 2.69 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -168.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.33 86.92 5.02 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 175.509 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.0 t -78.12 60.23 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.817 1.247 . . . . 0.0 108.776 -175.034 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.1 t -171.44 148.34 2.3 Favored Pre-proline 0 CA--C 1.522 -0.129 0 O-C-N 121.481 -0.762 . . . . 0.0 111.636 178.077 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -61.57 -41.26 40.99 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 121.758 1.639 . . . . 0.0 110.068 159.031 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.3 ptp 172.08 -77.72 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 127.124 2.17 . . . . 0.0 107.59 178.399 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.87 -29.87 63.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.634 1.174 . . . . 0.0 112.292 -170.287 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.9 -119.11 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -174.028 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.89 -50.56 2.25 Favored Glycine 0 CA--C 1.528 0.874 0 O-C-N 121.348 -0.845 . . . . 0.0 113.192 178.204 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -44.93 -54.54 6.38 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.159 0.984 . . . . 0.0 110.014 171.555 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -75.39 -4.26 38.41 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.508 1.923 . . . . 0.0 113.96 -179.053 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -69.37 133.55 47.95 Favored 'General case' 0 C--N 1.341 0.227 0 O-C-N 121.093 -1.004 . . . . 0.0 108.486 178.449 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -75.8 85.66 2.79 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.684 177.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -54.57 123.11 12.11 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 166.228 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.2 t -58.71 126.27 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -177.572 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -82.31 48.47 1.28 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.87 0.868 . . . . 0.0 110.001 -169.857 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 44.2 t -167.13 143.11 4.28 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.58 1.552 . . . . 0.0 108.589 -173.904 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -75.96 72.57 2.83 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.914 0.485 . . . . 0.0 110.278 -178.577 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 26.9 p -135.17 53.03 2.0 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 124.904 1.282 . . . . 0.0 109.355 178.625 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -155.17 145.54 22.0 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -170.753 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 47.0 m 58.99 88.14 0.07 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.876 1.67 . . . . 0.0 112.17 -179.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -53.9 154.34 4.1 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.568 1.147 . . . . 0.0 111.7 176.414 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.7 t -111.52 -57.68 2.22 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 128.711 2.804 . . . . 0.0 111.378 -167.6 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.8 t -163.65 140.34 6.97 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 122.849 0.46 . . . . 0.0 110.385 -170.845 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 39.7 mt -139.32 143.73 37.96 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.207 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -80.44 172.95 8.53 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.76 1.224 . . . . 0.0 109.349 -179.48 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -68.0 79.89 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.535 2.823 . . . . 0.0 114.465 -162.041 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 147.87 -29.89 1.39 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.307 0.956 . . . . 0.0 112.181 172.107 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -82.21 158.56 23.51 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 118.226 -1.39 . . . . 0.0 112.318 -139.61 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -84.61 123.26 30.13 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 124.64 1.176 . . . . 0.0 110.268 179.59 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -90.22 128.61 36.42 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 154.89 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -134.0 146.42 50.4 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 159.698 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 56.7 mtt -146.61 146.63 27.59 Favored Pre-proline 0 N--CA 1.453 -0.323 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 165.087 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -71.55 142.58 40.61 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 122.101 1.868 . . . . 0.0 109.412 160.232 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.4 t -115.77 143.83 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 164.026 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.0 p -102.28 145.49 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 174.608 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -145.9 138.09 25.36 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.335 0.516 . . . . 0.0 111.425 -176.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -159.07 162.25 36.56 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.569 1.548 . . . . 0.0 107.43 160.559 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 94.8 t -104.72 131.27 54.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 174.789 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.18 135.23 47.85 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 175.887 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -75.49 57.85 5.0 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 124.578 3.519 . . . . 0.0 112.673 -176.414 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.24 -36.47 7.63 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 125.57 1.548 . . . . 0.0 109.864 168.3 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.8 tt -47.75 -46.57 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -169.724 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.3 m -81.19 53.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.448 -0.783 . . . . 0.0 110.785 -178.444 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -138.28 -64.51 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 117.661 -1.161 . . . . 0.0 112.085 -179.371 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.67 156.33 35.64 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 CA-C-N 121.961 1.736 . . . . 0.0 113.406 -176.053 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.2 t -54.11 -39.46 42.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 126.201 1.8 . . . . 0.0 110.742 177.934 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -45.92 -55.72 6.38 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.697 1.599 . . . . 0.0 111.8 -178.523 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.3 p -92.37 -42.89 9.53 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 118.633 -0.699 . . . . 0.0 111.442 -176.313 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 7.93 65.13 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 128.403 2.681 . . . . 0.0 116.129 179.536 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 142.37 -41.34 1.2 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -173.709 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.7 mm -57.27 120.13 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 CA-C-N 117.689 0.744 . . . . 0.0 110.178 177.23 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -157.38 66.45 0.5 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.672 0.749 . . . . 0.0 110.173 162.578 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 10.6 m -147.51 102.72 3.48 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 152.206 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.68 151.76 34.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -175.243 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.7 t -154.08 175.13 13.79 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.408 0.623 . . . . 0.0 109.647 -177.269 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.9 tp -153.7 97.13 2.07 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 103.216 -2.883 . . . . 0.0 103.216 -169.278 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.5 t -81.78 88.09 6.32 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 171.733 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.79 124.4 27.64 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 176.809 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 23.8 m -133.38 95.52 3.53 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.412 1.101 . . . . 0.0 109.229 -164.468 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -74.22 74.42 1.8 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.041 1.736 . . . . 0.0 111.94 -171.007 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -128.35 68.48 77.23 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.349 1.06 . . . . 0.0 113.758 179.566 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -87.69 -103.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.775 2.983 . . . . 0.0 110.666 167.502 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -156.26 99.66 1.94 Allowed 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.8 1.24 . . . . 0.0 108.907 -172.117 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -104.56 134.0 19.89 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 126.432 1.893 . . . . 0.0 106.403 167.614 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.0 -47.3 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.445 2.097 . . . . 0.0 110.638 178.304 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.2 t 166.65 112.4 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 129.202 3.001 . . . . 0.0 104.822 178.486 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.7 pttt . . . . . 0 CA--C 1.535 0.4 0 CA-C-N 119.584 1.083 . . . . 0.0 110.409 -168.921 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.16 0 N-CA-C 103.312 -2.847 . . . . 0.0 103.312 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.1 m -152.41 38.82 0.56 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.719 0.69 . . . . 0.0 111.331 -176.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -159.07 -49.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 127.594 2.358 . . . . 0.0 106.62 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.531 ' H ' HD22 ' A' ' 27' ' ' LEU . 2.7 mm? -61.4 -28.16 69.05 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.295 1.838 . . . . 0.0 111.482 178.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.4 mt -69.87 83.26 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 123.625 0.77 . . . . 0.0 109.518 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.25 152.18 23.0 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 161.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -78.68 55.09 1.61 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.28 0.945 . . . . 0.0 111.328 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.12 138.44 39.95 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 105.078 -2.194 . . . . 0.0 105.078 166.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -96.81 120.04 36.4 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 123.679 0.792 . . . . 0.0 109.043 -173.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -95.08 141.53 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 163.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.551 ' CE ' ' HB2' ' A' ' 55' ' ' ASP . 2.3 tmtp? -101.73 153.86 19.41 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 169.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 t -137.14 149.44 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 167.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.8 m -137.24 98.98 3.86 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 122.521 1.153 . . . . 0.0 108.132 -171.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -79.24 88.28 4.92 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 127.356 2.262 . . . . 0.0 110.306 -176.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -81.86 85.46 6.65 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 122.347 1.07 . . . . 0.0 109.584 175.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.59 101.01 8.91 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.918 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -99.84 148.99 23.85 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 176.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.0 p -139.83 144.36 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 124.709 1.203 . . . . 0.0 108.098 172.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.56 171.96 13.68 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.597 1.159 . . . . 0.0 108.334 174.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -32.72 -55.7 0.36 Allowed 'General case' 0 C--N 1.34 0.168 0 C-N-CA 126.384 1.873 . . . . 0.0 112.822 -176.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -36.69 -35.71 0.14 Allowed Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.906 2.193 . . . . 0.0 114.663 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.63 HD13 ' CD2' ' A' ' 144' ' ' PHE . 0.3 OUTLIER -120.44 94.75 48.92 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 118.42 1.11 . . . . 0.0 109.269 170.15 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -82.32 42.33 1.29 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.417 2.745 . . . . 0.0 110.866 -173.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.422 ' CE3' HD21 ' A' ' 45' ' ' LEU . 42.9 m0 -113.84 141.66 47.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -172.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -79.42 80.07 5.82 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 -176.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -86.72 89.77 8.05 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.508 1.523 . . . . 0.0 108.368 -176.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.4 m -89.43 129.96 45.43 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -175.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -68.76 153.66 72.66 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 N-CA-C 108.156 -1.517 . . . . 0.0 108.156 163.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.41 -55.07 10.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -131.19 161.76 31.47 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 165.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -64.64 -28.45 69.62 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 118.482 0.583 . . . . 0.0 109.54 173.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.551 ' HB2' ' CE ' ' A' ' 34' ' ' LYS . 24.6 p-10 -145.97 168.87 19.81 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 125.301 1.441 . . . . 0.0 112.048 -165.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.6 pt -137.71 166.67 24.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 124.447 1.099 . . . . 0.0 108.337 169.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -110.09 144.01 39.31 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 160.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -135.53 137.34 49.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 166.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.37 91.0 6.74 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 119.698 -1.876 . . . . 0.0 107.691 164.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.3 pt 21.76 63.39 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 127.398 2.279 . . . . 0.0 113.47 171.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.97 -36.82 1.88 Allowed Glycine 0 CA--C 1.526 0.725 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.751 -177.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -40.81 104.87 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.225 1.41 . . . . 0.0 111.752 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.594 HG23 ' CD1' ' A' ' 121' ' ' PHE . 0.2 OUTLIER -89.62 89.67 7.91 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.028 0.931 . . . . 0.0 109.473 -158.822 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.2 p -88.36 172.1 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 123.291 0.636 . . . . 0.0 111.503 -166.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -117.56 122.18 42.97 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 125.3 1.44 . . . . 0.0 107.575 171.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.91 109.06 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 175.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -78.1 166.47 22.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.478 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -136.17 150.03 48.86 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 169.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.1 ttm-85 -126.02 127.04 45.26 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.793 1.637 . . . . 0.0 107.287 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.63 108.74 10.75 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 125.741 1.617 . . . . 0.0 109.254 169.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -104.73 123.99 48.6 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.326 -0.859 . . . . 0.0 109.226 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -76.26 126.84 31.73 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 120.883 -1.136 . . . . 0.0 110.92 -172.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.4 mt -111.65 14.53 21.23 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.985 0.914 . . . . 0.0 112.627 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.99 175.3 10.7 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 121.301 -0.874 . . . . 0.0 110.979 175.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.2 t -108.25 3.78 23.97 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.931 0.893 . . . . 0.0 111.702 175.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 p -145.06 163.31 33.45 Favored Pre-proline 0 N--CA 1.45 -0.436 0 C-N-CA 126.886 2.074 . . . . 0.0 105.499 174.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.06 157.36 44.61 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.198 1.266 . . . . 0.0 110.925 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.99 172.88 10.09 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 122.617 0.367 . . . . 0.0 110.177 166.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.0 t -107.25 166.06 10.92 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 160.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.534 ' HA2' HD11 ' A' ' 45' ' ' LEU . . . -155.25 73.4 0.25 Allowed Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 108.205 -1.958 . . . . 0.0 108.205 -176.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.38 62.62 0.63 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.7 154.19 28.77 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.821 -1.081 . . . . 0.0 112.659 -164.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.4 m -83.99 144.86 28.85 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.72 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -131.4 153.37 49.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.302 1.041 . . . . 0.0 109.569 171.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.07 109.53 11.97 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 171.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.48 HG11 ' CD2' ' A' ' 95' ' ' PHE . 2.7 t -95.57 63.62 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.46 0.062 0 C-N-CA 122.769 0.427 . . . . 0.0 111.551 -175.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.6 t -165.54 142.5 4.63 Favored Pre-proline 0 N--CA 1.454 -0.231 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.929 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -65.8 -39.34 20.46 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 N-CA-C 107.983 -1.583 . . . . 0.0 107.983 167.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 7.9 ptp 179.81 -74.92 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.42 2.288 . . . . 0.0 107.739 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.01 98.08 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 124.8 1.24 . . . . 0.0 113.273 -164.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.6 -101.67 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.743 -164.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.93 -65.44 0.33 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 123.329 0.49 . . . . 0.0 112.065 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -44.34 -51.26 8.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.449 1.5 . . . . 0.0 111.207 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -73.64 11.14 0.88 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.475 1.11 . . . . 0.0 113.893 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.48 ' CD2' HG11 ' A' ' 86' ' ' VAL . 8.8 t80 -82.7 128.77 34.68 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 119.157 0.889 . . . . 0.0 109.741 172.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 . . . . . 0 N--CA 1.444 -0.728 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.494 176.048 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 . . . . . 0 CA--C 1.537 0.477 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.0 t -160.04 -71.28 0.07 Allowed 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -175.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.2 t -156.3 140.56 16.58 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.019 1.328 . . . . 0.0 108.701 -169.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.433 HD11 ' HB2' ' A' ' 114' ' ' MET . 88.5 mt -148.69 146.34 28.1 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 118.581 0.628 . . . . 0.0 110.237 176.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -77.98 165.86 47.64 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 126.112 1.765 . . . . 0.0 110.783 168.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.75 80.01 2.14 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 124.493 3.462 . . . . 0.0 112.278 -166.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 159.38 -34.23 0.47 Allowed Glycine 0 CA--C 1.522 0.515 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.783 172.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.49 153.43 31.37 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -152.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.6 mp0 -91.2 107.23 19.06 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.764 2.425 . . . . 0.0 109.762 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.433 ' HB2' HD11 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -85.4 132.64 34.19 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 160.259 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -145.46 139.05 26.58 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 161.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 14.8 mmt -143.47 142.36 20.98 Favored Pre-proline 0 N--CA 1.453 -0.28 0 C-N-CA 124.262 1.025 . . . . 0.0 108.51 -168.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.01 147.37 38.47 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.504 2.136 . . . . 0.0 109.853 169.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.1 t -124.56 157.37 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 163.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 p -136.17 143.56 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -157.09 131.81 8.74 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -167.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.594 ' CD1' HG23 ' A' ' 63' ' ' THR . 14.3 p90 -156.36 126.63 6.57 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.207 0.912 . . . . 0.0 108.654 173.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.1 t -76.85 142.92 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 119.127 -0.463 . . . . 0.0 110.151 -174.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -81.07 129.33 67.65 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 119.14 -0.457 . . . . 0.0 110.748 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -57.13 -20.1 36.51 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.335 2.023 . . . . 0.0 113.985 176.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -53.21 -22.29 6.46 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 120.068 1.304 . . . . 0.0 111.67 172.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.6 tt -49.69 -43.76 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 O-C-N 121.697 -0.627 . . . . 0.0 111.892 169.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.9 m -84.4 57.25 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 119.791 1.178 . . . . 0.0 110.753 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -127.07 -68.31 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 118.028 -0.987 . . . . 0.0 112.516 169.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -79.94 157.66 23.97 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 121.965 1.777 . . . . 0.0 114.09 -166.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 95.2 t -53.79 -34.18 24.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.725 1.61 . . . . 0.0 110.827 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -37.12 -53.92 1.0 Allowed 'General case' 0 C--N 1.338 0.103 0 C-N-CA 126.301 1.84 . . . . 0.0 112.194 172.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 19.2 p -107.01 -56.1 2.24 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -164.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 29.17 53.12 0.09 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 128.108 2.563 . . . . 0.0 115.271 171.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 136.12 -35.32 2.15 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -174.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.0 mm -52.92 115.75 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 123.187 0.595 . . . . 0.0 110.573 170.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 31.0 pttt -156.93 62.95 0.51 Allowed 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.786 170.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.4 m -142.97 96.69 2.97 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 160.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.26 83.06 4.53 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -172.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.12 123.29 26.19 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -168.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.0 tt -98.11 103.67 15.63 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.9 t -84.74 100.22 11.36 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 170.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.85 136.17 33.15 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 172.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.6 m -124.82 87.46 2.72 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.672 0.749 . . . . 0.0 109.437 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.63 ' CD2' HD13 ' A' ' 45' ' ' LEU . 2.3 m-85 -72.59 88.88 1.27 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.838 175.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -154.43 52.4 0.75 Allowed Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 117.209 2.3 . . . . 0.0 117.209 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.404 ' HD3' HD12 ' A' ' 45' ' ' LEU . 59.7 Cg_endo -75.2 -87.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.962 2.441 . . . . 0.0 112.565 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 57.7 mtm180 -149.98 126.51 10.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.008 0.822 . . . . 0.0 110.437 -175.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -108.04 135.79 19.84 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 125.038 1.335 . . . . 0.0 108.801 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -72.44 -67.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.443 2.095 . . . . 0.0 110.717 171.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.3 m -175.47 91.24 0.05 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.602 1.961 . . . . 0.0 108.484 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.492 0 CA-C-N 118.315 0.507 . . . . 0.0 110.517 173.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.03 22.01 0.41 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 128.53 2.732 . . . . 0.0 114.798 -159.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -76.64 -36.34 57.44 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 152.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 mp -92.21 -103.82 0.11 Allowed 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 125.89 1.676 . . . . 0.0 109.305 175.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.2 mt 31.95 71.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 126.613 1.965 . . . . 0.0 113.818 -172.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -79.4 157.16 27.65 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.779 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -81.76 78.14 8.52 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 122.566 1.174 . . . . 0.0 109.91 -176.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.694 ' HB3' HD11 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -137.42 -172.13 3.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.037 -1.892 . . . . 0.0 107.077 168.088 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -138.65 138.41 37.78 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.127 1.371 . . . . 0.0 110.187 171.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.44 HG23 HG13 ' A' ' 58' ' ' VAL . 5.0 tp -124.24 113.31 36.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.521 1.528 . . . . 0.0 108.457 -176.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -83.74 149.45 26.45 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 138' ' ' LEU . 27.9 t -146.73 89.14 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 118.924 0.784 . . . . 0.0 109.154 -174.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.5 m -75.56 106.3 7.03 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.616 1.166 . . . . 0.0 108.467 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.457 ' CZ ' HD12 ' A' ' 56' ' ' ILE . 2.8 m-30 -81.52 159.61 24.12 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.252 1.421 . . . . 0.0 109.902 174.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -142.46 87.56 2.02 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.92 0.867 . . . . 0.0 112.034 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.26 126.82 35.36 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.37 -0.831 . . . . 0.0 110.897 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -130.67 149.7 52.2 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.941 1.296 . . . . 0.0 109.066 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.9 p -139.28 146.77 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 C-N-CA 124.714 1.206 . . . . 0.0 108.807 175.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.55 174.61 12.33 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.104 0.961 . . . . 0.0 110.004 -177.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.4 115.21 1.35 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 168.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 139.79 -34.51 2.02 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 108.934 -1.667 . . . . 0.0 108.934 -167.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.552 HD12 ' CD ' ' A' ' 146' ' ' PRO . 0.6 OUTLIER -140.45 94.46 8.44 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 123.521 0.729 . . . . 0.0 109.126 173.654 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.486 ' HD2' HG21 ' A' ' 78' ' ' THR . 58.0 Cg_endo -80.33 50.82 3.67 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 124.086 3.191 . . . . 0.0 109.409 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.489 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 35.5 m0 -116.96 148.64 41.23 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.427 1.091 . . . . 0.0 109.831 -168.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -75.09 89.83 2.48 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 104.781 -2.303 . . . . 0.0 104.781 173.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -113.08 118.68 35.45 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.213 1.805 . . . . 0.0 107.465 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.6 m -137.97 144.79 45.32 Favored Pre-proline 0 CA--C 1.53 0.192 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -177.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.23 162.4 38.69 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.992 1.795 . . . . 0.0 108.648 166.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.51 -51.38 12.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 123.207 0.603 . . . . 0.0 110.204 176.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -127.74 159.03 36.01 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 168.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.7 tpt180 -62.29 -39.93 94.58 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 167.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.63 144.97 44.33 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 123.941 0.896 . . . . 0.0 109.448 -171.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.503 HD11 HG21 ' A' ' 66' ' ' ILE . 70.2 mt -105.88 152.45 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 C-N-CA 126.057 1.743 . . . . 0.0 106.532 170.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -126.76 87.41 2.65 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.396 1.078 . . . . 0.0 108.599 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.44 HG13 HG23 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -90.08 151.27 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.412 ' O ' HD13 ' A' ' 60' ' ' ILE . 19.3 mmt180 -59.44 -103.87 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.861 -1.149 . . . . 0.0 109.411 164.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.694 HD11 ' HB3' ' A' ' 31' ' ' GLU . 26.2 mm -148.76 43.6 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 126.389 1.876 . . . . 0.0 106.123 -172.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.62 -7.88 5.56 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 116.087 -0.506 . . . . 0.0 113.712 -174.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -51.04 105.58 0.11 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.05 1.34 . . . . 0.0 109.588 171.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.94 106.55 0.72 Allowed 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.473 1.509 . . . . 0.0 109.304 175.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -105.23 137.36 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 173.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.13 123.99 29.46 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 173.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.503 HG21 HD11 ' A' ' 56' ' ' ILE . 1.6 pp -123.63 111.74 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 164.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.409 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 0.7 OUTLIER -76.21 158.14 31.94 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.947 172.742 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -129.92 147.09 51.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 173.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.26 141.64 30.91 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 167.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.03 78.57 0.97 Allowed 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 122.192 0.996 . . . . 0.0 109.657 165.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -112.29 141.87 45.48 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.075 -155.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.489 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 22.6 t-20 -78.72 125.78 29.83 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.226 0.921 . . . . 0.0 112.751 -173.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.5 mt -127.49 53.13 1.77 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.344 1.457 . . . . 0.0 109.251 167.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -113.61 167.25 10.76 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 126.466 1.907 . . . . 0.0 110.712 -177.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.7 m -80.22 -22.77 41.45 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.4 1.08 . . . . 0.0 110.85 173.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.0 p -147.6 164.55 22.14 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 125.768 1.627 . . . . 0.0 107.758 -167.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.31 122.63 10.64 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.351 1.367 . . . . 0.0 110.21 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.486 HG21 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -81.59 177.08 9.14 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.477 0.656 . . . . 0.0 109.734 173.16 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.1 t -110.48 156.71 20.47 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 161.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -149.45 81.17 0.19 Allowed Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 106.473 -2.651 . . . . 0.0 106.473 -174.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.91 60.46 1.37 Allowed 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 168.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.7 167.3 3.66 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.258 -177.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 39.2 m -98.86 152.64 19.52 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -148.4 151.98 36.2 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 164.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.99 122.66 48.29 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 170.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.0 p -104.47 55.21 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 C-N-CA 123.733 0.813 . . . . 0.0 111.851 -164.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.9 t -178.79 147.9 0.55 Allowed Pre-proline 0 C--N 1.333 -0.139 0 O-C-N 121.068 -1.02 . . . . 0.0 109.895 -166.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.8 -34.01 41.57 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 N-CA-C 108.9 -1.231 . . . . 0.0 108.9 166.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.0 ptp 177.62 -72.41 0.01 OUTLIER 'General case' 0 C--N 1.342 0.241 0 C-N-CA 126.764 2.026 . . . . 0.0 107.846 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.43 -31.49 67.28 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 124.39 1.076 . . . . 0.0 113.677 -162.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.44 -102.54 0.07 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.452 0.168 . . . . 0.0 111.415 -164.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.7 -59.0 0.2 Allowed Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.566 1.079 . . . . 0.0 113.611 -173.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -45.94 -52.33 11.81 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.129 0.965 . . . . 0.0 110.205 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -74.71 13.25 0.66 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.964 1.706 . . . . 0.0 114.027 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -83.15 128.16 34.24 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 169.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . 0.319 2.2 m-80 . . . . . 0 C--N 1.342 0.268 0 CA-C-O 122.396 1.093 . . . . 0.0 111.887 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 . . . . . 0 CA--C 1.532 0.257 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . 0.352 10.1 t 57.84 -81.7 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 126.713 2.005 . . . . 0.0 113.563 171.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -160.92 148.07 15.36 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 -176.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 73.4 mt -148.48 133.27 17.95 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 175.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -63.44 159.62 49.1 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 126.793 2.037 . . . . 0.0 111.403 174.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -64.2 92.24 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.275 3.317 . . . . 0.0 112.415 -169.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 125.17 -6.1 8.2 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 124.725 1.155 . . . . 0.0 112.618 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -76.44 130.0 37.36 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 118.822 1.311 . . . . 0.0 111.845 -166.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -94.62 101.32 13.18 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.257 1.423 . . . . 0.0 110.05 -168.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 17.6 ttt -103.93 124.19 48.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.443 1.497 . . . . 0.0 109.765 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.14 153.06 41.74 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 156.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 42.8 mtm -155.06 151.32 22.72 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 123.214 0.606 . . . . 0.0 110.83 168.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 67' ' ' MET . 70.2 Cg_exo -53.65 138.7 67.5 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 124.653 3.568 . . . . 0.0 112.39 162.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.6 t -119.49 151.39 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 157.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.8 p -112.14 143.52 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 124.002 0.921 . . . . 0.0 108.542 175.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -156.06 151.82 27.29 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.084 0.402 . . . . 0.0 111.916 -171.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -157.98 170.2 22.86 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.296 1.838 . . . . 0.0 109.029 165.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.413 ' HB ' HG21 ' A' ' 33' ' ' ILE . 88.5 t -92.84 146.93 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 170.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -88.01 126.11 62.16 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-O 118.676 -0.678 . . . . 0.0 111.339 174.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -60.23 -16.01 37.97 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.339 2.026 . . . . 0.0 113.806 174.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -49.01 -25.78 2.18 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 119.877 1.217 . . . . 0.0 111.147 166.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 10.9 tt -53.5 -43.02 51.71 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 O-C-N 121.133 -0.979 . . . . 0.0 112.914 172.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.1 m -84.87 53.48 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 119.753 1.16 . . . . 0.0 110.025 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -134.7 -67.03 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 117.693 -1.146 . . . . 0.0 112.337 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.6 154.46 31.0 Favored 'Trans proline' 0 C--N 1.347 0.492 0 CA-C-N 122.024 1.759 . . . . 0.0 113.467 -170.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 96.3 t -55.11 -33.89 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 125.478 1.511 . . . . 0.0 110.928 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -36.53 -55.52 0.84 Allowed 'General case' 0 C--N 1.339 0.124 0 C-N-CA 126.246 1.818 . . . . 0.0 112.238 173.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 17.4 p -104.22 -56.06 2.26 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -164.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 26.51 52.02 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 128.789 2.836 . . . . 0.0 115.329 170.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 141.66 -36.49 1.7 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -173.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 12.8 mm -51.87 121.26 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.124 0.57 . . . . 0.0 110.089 172.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -157.21 57.2 0.51 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.018 0.527 . . . . 0.0 111.659 177.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.7 m -149.08 90.8 1.78 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 161.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.55 ' O ' HG13 ' A' ' 35' ' ' VAL . 2.5 tp -84.52 87.77 7.27 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.789 -161.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.9 t -79.77 175.17 10.86 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 122.278 1.037 . . . . 0.0 110.697 -171.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.8 tt -143.83 105.49 4.31 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 103.873 -2.64 . . . . 0.0 103.873 164.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.4 p -86.95 100.16 12.39 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 174.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.66 130.9 44.63 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 126.209 1.804 . . . . 0.0 108.284 -176.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.7 m -125.52 90.34 3.2 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.564 1.145 . . . . 0.0 109.608 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.513 ' CG ' HD13 ' A' ' 45' ' ' LEU . 2.0 m-30 -69.3 88.11 0.44 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.421 0.688 . . . . 0.0 110.125 171.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.07 44.46 0.34 Allowed Pre-proline 0 CA--C 1.553 1.082 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 176.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.552 ' CD ' HD12 ' A' ' 45' ' ' LEU . 58.0 Cg_endo -73.97 -82.98 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.593 2.195 . . . . 0.0 113.482 -177.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 42.0 mmt180 -149.63 123.4 9.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.362 0.983 . . . . 0.0 110.332 -171.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.91 116.79 61.94 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 125.29 1.436 . . . . 0.0 109.234 -174.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.482 ' HD3' HG23 ' A' ' 78' ' ' THR . 83.8 Cg_endo -84.25 -36.03 0.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.051 2.501 . . . . 0.0 113.421 -176.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.3 t 158.62 138.33 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 128.055 2.542 . . . . 0.0 107.848 -169.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.279 0 C-N-CA 127.132 2.173 . . . . 0.0 107.755 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.398 0 N-CA-C 103.471 -2.789 . . . . 0.0 103.471 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.4 m -152.46 35.09 0.51 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.16 0.981 . . . . 0.0 110.347 177.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -159.33 -56.41 0.06 Allowed 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 127.993 2.517 . . . . 0.0 106.482 -157.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.7 pp -91.74 -7.51 49.48 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.134 1.374 . . . . 0.0 112.585 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.4 mt -72.2 104.19 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.222 0 CA-C-N 119.386 0.994 . . . . 0.0 110.035 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -95.24 171.42 8.73 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 155.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -80.73 30.51 0.31 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -163.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -83.02 111.2 18.64 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 122.77 1.271 . . . . 0.0 110.758 177.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -74.59 91.52 2.33 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 127.08 2.152 . . . . 0.0 106.165 171.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.8 tp -100.24 123.46 53.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.205 1.002 . . . . 0.0 108.835 -177.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -84.42 148.79 26.4 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.183 0.993 . . . . 0.0 108.962 -175.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.2 t -134.25 146.82 30.63 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.3 m -146.75 105.32 3.81 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -169.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -76.17 163.57 26.94 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.729 0.812 . . . . 0.0 110.02 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -136.36 85.53 2.15 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 122.678 1.227 . . . . 0.0 110.222 166.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.99 99.3 6.01 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 177.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -92.84 146.88 23.31 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.7 t -128.91 136.75 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 168.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -124.3 162.2 24.27 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -43.18 -44.22 5.04 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.025 0.93 . . . . 0.0 111.043 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -48.06 -30.72 7.63 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 126.77 2.128 . . . . 0.0 115.323 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.447 HD13 ' CD2' ' A' ' 144' ' ' PHE . 1.3 tt -121.99 101.75 41.58 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 120.478 2.139 . . . . 0.0 110.495 -178.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -85.51 38.68 0.65 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 124.114 3.21 . . . . 0.0 112.192 -171.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.45 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 42.5 m0 -114.74 140.83 48.57 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -177.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -79.97 80.43 6.38 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -175.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -85.11 94.59 8.89 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.6 m -88.09 135.46 33.28 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.54 156.25 66.39 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 N-CA-C 108.686 -1.313 . . . . 0.0 108.686 165.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -79.76 -59.7 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -176.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 -128.22 168.3 15.65 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 157.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -62.99 -43.15 99.57 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 170.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -139.65 165.42 27.3 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 126.37 1.868 . . . . 0.0 109.546 -164.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.6 pt -138.95 177.22 5.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 171.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -124.33 159.2 30.85 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 150.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -129.43 143.38 41.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 173.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.5 mmt85 -79.44 97.16 6.28 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 161.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.4 pt -4.86 79.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 127.442 2.297 . . . . 0.0 114.978 -172.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.53 -37.11 2.03 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.717 -0.49 . . . . 0.0 112.593 -175.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -41.95 107.83 0.08 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.187 1.395 . . . . 0.0 111.911 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.37 105.2 2.09 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.695 0.798 . . . . 0.0 109.844 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.25 177.65 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.732 0.777 . . . . 0.0 110.079 177.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -145.04 89.65 1.98 Allowed 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.016 0.926 . . . . 0.0 108.626 172.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.3 pp -110.01 117.37 54.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 32.6 mtm -92.48 111.82 23.54 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.469 1.908 . . . . 0.0 111.927 -177.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -84.59 154.89 22.32 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.137 0.575 . . . . 0.0 109.739 174.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.2 ttm-85 -134.54 138.96 45.06 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.679 1.591 . . . . 0.0 108.021 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.8 106.82 4.7 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.794 1.638 . . . . 0.0 110.201 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER -112.52 129.45 56.35 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.044 0.537 . . . . 0.0 112.22 -174.057 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.45 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 36.2 t-20 -77.9 115.1 17.38 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.486 0.585 . . . . 0.0 111.379 -167.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 69.6 mt -107.95 39.1 2.02 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.688 1.195 . . . . 0.0 111.35 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -111.36 173.27 6.42 Favored 'General case' 0 CA--C 1.526 0.029 0 C-N-CA 124.263 1.025 . . . . 0.0 110.037 169.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.3 p -89.05 -5.47 57.86 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 125.048 1.339 . . . . 0.0 111.829 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 p -140.76 162.94 46.1 Favored Pre-proline 0 N--CA 1.449 -0.476 0 C-N-CA 124.618 1.167 . . . . 0.0 109.37 -171.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.96 111.0 3.06 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.16 1.907 . . . . 0.0 109.249 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.26 177.68 8.65 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.036 0.835 . . . . 0.0 109.569 174.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.9 t -124.17 137.26 54.56 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 165.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.05 117.61 4.19 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.804 1.669 . . . . 0.0 109.586 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.75 47.39 2.54 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 124.634 1.173 . . . . 0.0 108.566 175.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.2 144.52 15.64 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.15 -174.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.7 t -87.39 175.26 8.07 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 119.583 -0.847 . . . . 0.0 108.738 166.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -155.13 89.42 1.21 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -161.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -78.79 90.53 4.66 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.2 t -79.35 59.18 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 123.323 0.649 . . . . 0.0 110.965 -175.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.3 t -174.79 148.97 1.22 Allowed Pre-proline 0 N--CA 1.465 0.312 0 CA-C-N 119.505 1.048 . . . . 0.0 112.595 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -57.92 -52.75 5.36 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 121.627 1.551 . . . . 0.0 109.205 158.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.42 -83.64 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.345 1.858 . . . . 0.0 107.42 177.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.49 ' HB3' HG13 ' A' ' 135' ' ' ILE . . . -59.03 -32.15 69.48 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -172.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.56 -109.6 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -168.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.08 -51.9 1.68 Allowed Glycine 0 CA--C 1.53 0.981 0 O-C-N 121.506 -0.746 . . . . 0.0 113.051 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -52.95 -58.62 6.36 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.651 1.226 . . . . 0.0 109.16 170.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -74.19 49.04 0.34 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.993 1.317 . . . . 0.0 111.611 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -126.48 130.85 51.44 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 173.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 174.489 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.8 mp0 . . . . . 0 CA--C 1.538 0.504 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.1 t 39.25 -133.2 0.18 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.564 1.946 . . . . 0.0 113.06 168.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.2 t -125.34 153.65 43.0 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.621 1.968 . . . . 0.0 108.833 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.442 HD11 ' HB2' ' A' ' 114' ' ' MET . 81.9 mt -136.96 123.35 20.73 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 176.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -58.8 154.71 35.32 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 171.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.71 94.58 0.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.996 3.131 . . . . 0.0 111.3 -170.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 137.8 -26.85 2.85 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 124.536 1.065 . . . . 0.0 110.873 -173.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -78.28 154.1 31.23 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 117.664 0.732 . . . . 0.0 111.264 -166.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -117.51 133.97 55.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.428 1.091 . . . . 0.0 110.651 -174.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.442 ' HB2' HD11 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -99.15 142.09 31.08 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 127.034 2.134 . . . . 0.0 106.815 169.639 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -146.98 133.31 19.54 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.202 1.401 . . . . 0.0 107.286 172.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 79.7 mtp -147.3 135.97 11.23 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 118.207 0.458 . . . . 0.0 110.937 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -73.34 147.27 41.47 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.735 2.29 . . . . 0.0 109.92 168.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.2 t -129.41 124.52 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 168.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.1 p -88.11 151.66 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 166.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -157.96 135.87 10.68 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -175.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -146.06 159.75 42.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.379 0.672 . . . . 0.0 110.249 153.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 39.4 t -100.78 119.24 48.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 169.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.37 139.62 78.67 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -74.05 29.46 0.33 Allowed 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.591 2.861 . . . . 0.0 114.297 -176.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -87.26 -24.58 24.32 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.426 1.09 . . . . 0.0 110.382 170.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 17.0 tt -56.09 -44.9 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 118.153 0.433 . . . . 0.0 112.053 -176.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.4 m -80.61 56.32 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 O-C-N 121.513 -0.742 . . . . 0.0 110.452 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 49.6 mttp -139.52 -67.03 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.608 0 CA-C-O 117.715 -1.136 . . . . 0.0 112.247 174.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.96 156.94 30.79 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.02 1.813 . . . . 0.0 113.539 -169.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 86.2 t -55.09 -35.09 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 125.495 1.518 . . . . 0.0 110.808 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -36.39 -56.75 0.77 Allowed 'General case' 0 C--N 1.338 0.1 0 C-N-CA 126.109 1.763 . . . . 0.0 111.908 174.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.2 p -102.62 -54.22 2.7 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.441 -164.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 22.11 53.6 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 128.932 2.893 . . . . 0.0 115.019 173.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 146.45 -41.45 0.99 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 -170.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.49 HG13 ' HB3' ' A' ' 90' ' ' ALA . 19.3 mm -58.09 119.62 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 169.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.02 39.29 0.31 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.86 0.362 . . . . 0.0 111.232 -178.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.4 94.49 1.71 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 177.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.58 147.02 32.27 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -169.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.5 t -136.5 172.44 13.01 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.0 tt -145.3 114.77 7.17 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 103.38 -2.822 . . . . 0.0 103.38 171.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.72 102.62 15.03 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 177.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -86.03 87.89 7.49 Favored 'General case' 0 CA--C 1.527 0.069 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.82 89.4 5.24 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 122.665 1.221 . . . . 0.0 110.596 177.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.447 ' CD2' HD13 ' A' ' 45' ' ' LEU . 4.0 m-30 -69.05 80.77 0.32 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.836 1.654 . . . . 0.0 110.46 175.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -125.86 84.21 61.35 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 125.446 1.499 . . . . 0.0 113.813 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -105.45 -118.82 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.931 1 C-N-CA 125.988 4.459 . . . . 0.0 109.643 168.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -143.59 149.14 36.93 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 123.674 0.789 . . . . 0.0 109.728 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -144.85 143.67 21.73 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 126.531 1.933 . . . . 0.0 106.445 -176.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -87.19 -51.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.592 2.195 . . . . 0.0 111.727 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.5 m 167.07 101.58 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 128.947 2.899 . . . . 0.0 107.364 -176.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt . . . . . 0 CA--C 1.544 0.723 0 C-N-CA 123.877 0.871 . . . . 0.0 109.505 -176.581 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.462 ' HB2' ' OG1' ' A' ' 63' ' ' THR . . . . . . . . 0 N--CA 1.442 -0.831 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.9 t -164.94 34.63 0.06 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.855 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -160.13 -51.14 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -167.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.6 mp -77.95 -27.82 49.38 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.616 -172.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.0 mt -70.73 129.07 34.71 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.062 0 C-N-CA 123.897 0.879 . . . . 0.0 112.881 -156.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.15 162.97 14.38 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.819 1.248 . . . . 0.0 108.467 172.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -80.8 74.36 7.76 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 122.177 0.989 . . . . 0.0 110.205 -176.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.25 -174.19 4.22 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.909 1.684 . . . . 0.0 107.608 174.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.3 mtmt -126.83 156.3 41.54 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.882 1.273 . . . . 0.0 108.093 162.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 tp -137.28 155.5 32.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 162.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.35 156.01 30.86 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.409 1.084 . . . . 0.0 108.671 -167.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.511 HG21 ' CE1' ' A' ' 120' ' ' PHE . 4.7 t -139.08 142.11 34.62 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.6 m -136.43 106.03 6.15 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -173.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -85.68 93.47 8.85 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.389 2.276 . . . . 0.0 110.427 -174.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -79.96 85.96 5.52 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 174.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.88 110.74 19.63 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.196 0.598 . . . . 0.0 111.039 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -111.85 153.78 26.13 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.653 1.181 . . . . 0.0 109.986 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.4 p -144.71 147.03 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.416 1.086 . . . . 0.0 108.977 173.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -159.34 170.67 21.31 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.914 0.885 . . . . 0.0 109.896 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -37.7 113.11 0.25 Allowed 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.841 1.656 . . . . 0.0 110.25 171.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 135.46 -39.21 1.7 Allowed Glycine 0 CA--C 1.523 0.557 0 N-CA-C 108.235 -1.946 . . . . 0.0 108.235 -165.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.405 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 1.7 mt -139.96 111.32 7.33 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 125.089 1.355 . . . . 0.0 107.375 169.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.93 8.04 4.7 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.793 2.328 . . . . 0.0 111.512 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.405 ' CD2' ' CD2' ' A' ' 45' ' ' LEU . 38.8 m0 -77.34 139.72 39.82 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.214 -0.929 . . . . 0.0 109.914 -165.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -78.63 84.7 4.72 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -83.91 93.05 7.94 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 127.172 2.189 . . . . 0.0 109.003 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.5 m -88.31 127.17 58.05 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -176.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -68.18 143.38 58.91 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 N-CA-C 108.226 -1.49 . . . . 0.0 108.226 164.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.2 m -77.74 -49.51 21.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.284 0.564 . . . . 0.0 109.982 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -130.31 162.43 29.03 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 164.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -62.69 -41.42 99.11 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 165.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -149.6 166.86 28.01 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 124.28 1.032 . . . . 0.0 110.87 -160.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.4 pt -137.78 154.71 29.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 124.807 1.243 . . . . 0.0 108.708 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -89.39 143.79 26.55 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 156.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.0 m -128.1 130.54 69.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 162.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -63.66 76.28 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.168 1.387 . . . . 0.0 108.802 172.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.5 mm 60.04 -74.46 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 126.162 1.785 . . . . 0.0 111.146 -172.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -131.14 62.8 0.64 Allowed Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 -176.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -102.38 105.84 16.5 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.131 1.372 . . . . 0.0 110.236 -175.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.462 ' OG1' ' HB2' ' A' ' 24' ' ' ALA . 50.2 m -69.94 88.86 0.58 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.366 1.466 . . . . 0.0 110.131 -171.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.5 p -98.81 147.99 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 121.262 0.553 . . . . 0.0 110.775 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.88 126.82 35.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.699 1.6 . . . . 0.0 108.981 173.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.6 pp -130.12 112.18 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 164.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.74 176.42 9.35 Favored 'General case' 0 C--N 1.333 -0.125 0 O-C-N 121.741 -0.599 . . . . 0.0 110.709 168.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -137.48 156.88 47.64 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 169.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 59.9 mtp85 -120.11 131.6 55.11 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 169.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.34 109.25 10.95 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.485 1.114 . . . . 0.0 109.286 174.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -96.54 124.82 40.66 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 119.011 -0.519 . . . . 0.0 110.081 -172.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -78.77 88.27 4.63 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -169.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.9 mt -78.04 65.93 3.55 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.166 0.986 . . . . 0.0 109.945 171.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -134.9 152.25 51.58 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.587 1.155 . . . . 0.0 109.299 173.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.8 p -91.93 -3.43 55.95 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.983 1.313 . . . . 0.0 112.399 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.9 p -142.53 166.84 18.56 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 174.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -58.61 157.48 27.33 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 CA-C-N 120.397 1.178 . . . . 0.0 111.627 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.08 177.65 5.96 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.363 1.065 . . . . 0.0 109.219 173.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 t -140.83 143.24 34.69 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -134.27 124.61 3.59 Favored Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 107.548 -2.221 . . . . 0.0 107.548 -175.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.81 55.18 1.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 166.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.51 154.37 41.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.484 -164.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.34 126.89 31.73 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.07 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -116.47 138.3 51.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 167.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -130.91 94.46 3.61 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.478 HG11 ' CE2' ' A' ' 95' ' ' PHE . 3.7 t -85.31 72.24 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 123.55 0.74 . . . . 0.0 110.153 -176.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.6 t -169.25 147.7 3.34 Favored Pre-proline 0 N--CA 1.45 -0.45 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 175.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.74 -44.91 12.14 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 N-CA-C 108.021 -1.569 . . . . 0.0 108.021 161.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 3.0 ptm -174.25 -84.12 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.806 1.642 . . . . 0.0 108.026 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.98 -31.64 71.23 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.362 1.865 . . . . 0.0 115.231 -168.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.18 -105.76 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 117.927 0.331 . . . . 0.0 111.326 -168.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.05 -58.48 0.56 Allowed Glycine 0 CA--C 1.534 1.277 0 O-C-N 121.804 -0.56 . . . . 0.0 113.171 -174.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.56 -41.67 73.61 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.193 1.497 . . . . 0.0 111.551 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -76.24 7.28 4.4 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.536 1.135 . . . . 0.0 113.893 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.478 ' CE2' HG11 ' A' ' 86' ' ' VAL . 8.8 t80 -82.5 144.69 30.25 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 165.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 . . . . . 0 N--CA 1.446 -0.661 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 172.211 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 N--CA 1.45 -0.451 0 CA-C-O 119.327 -0.368 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.2 t 49.76 -149.79 0.23 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.042 1.337 . . . . 0.0 112.58 170.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.71 149.32 31.79 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.824 1.65 . . . . 0.0 109.199 -177.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.8 mt -143.09 146.07 33.45 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.658 0.783 . . . . 0.0 110.219 172.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -70.08 158.67 86.82 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 129.863 3.265 . . . . 0.0 110.75 171.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.51 105.98 1.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.565 2.843 . . . . 0.0 111.936 -168.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 116.87 -7.98 16.91 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 123.933 0.778 . . . . 0.0 111.824 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -77.81 164.84 24.84 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 117.635 0.717 . . . . 0.0 111.216 -175.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -119.32 126.45 51.47 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.584 0.754 . . . . 0.0 110.392 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 15.6 tpt -91.27 123.81 34.99 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -146.28 141.59 27.48 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 123.238 0.336 . . . . 0.0 110.507 158.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 87.2 mtp -150.42 149.65 27.0 Favored Pre-proline 0 N--CA 1.451 -0.385 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 166.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -73.32 137.32 25.61 Favored 'Trans proline' 0 N--CA 1.445 -1.343 0 C-N-CA 122.121 1.881 . . . . 0.0 111.76 172.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.4 t -99.34 150.05 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 159.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.77 138.72 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.511 ' CE1' HG21 ' A' ' 35' ' ' VAL . 3.3 t80 -152.96 137.07 16.41 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.237 0.472 . . . . 0.0 111.201 -165.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -155.78 158.9 38.92 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.275 1.83 . . . . 0.0 107.528 160.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.8 t -87.52 159.07 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 175.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -100.46 133.24 21.46 Favored Pre-proline 0 C--O 1.236 0.378 0 CA-C-N 118.692 0.678 . . . . 0.0 111.272 173.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -72.38 46.67 0.99 Allowed 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.937 2.425 . . . . 0.0 114.011 175.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.51 -7.69 11.62 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.263 1.025 . . . . 0.0 113.401 163.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.2 tt -51.65 -40.74 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 118.794 0.725 . . . . 0.0 111.068 170.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.3 m -83.2 56.26 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.331 1.052 . . . . 0.0 110.749 171.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -113.3 -79.22 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.462 0 CA-C-O 117.573 -1.204 . . . . 0.0 109.145 165.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -78.59 163.02 27.1 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.025 1.817 . . . . 0.0 111.901 -176.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.8 p -62.18 -44.29 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 123.737 0.815 . . . . 0.0 110.683 -174.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -46.34 -56.0 6.49 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.296 1.438 . . . . 0.0 111.704 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 35.0 p -88.69 -10.57 48.01 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 118.365 -0.826 . . . . 0.0 112.543 -174.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -48.07 -42.36 28.43 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.361 0.982 . . . . 0.0 111.766 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -76.65 -25.33 65.39 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 123.54 0.591 . . . . 0.0 112.612 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 24.8 mm -76.37 128.81 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 117.923 0.861 . . . . 0.0 108.84 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -156.66 56.38 0.55 Allowed 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.5 m -155.34 108.93 2.82 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 160.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.94 84.07 5.75 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -174.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.96 147.89 32.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.921 -171.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.6 tt -118.79 110.56 17.37 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.4 t -87.94 108.26 19.11 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 171.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.2 131.19 54.93 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.815 1.246 . . . . 0.0 108.112 177.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.4 m -129.47 89.84 2.9 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.423 0.63 . . . . 0.0 110.749 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -69.98 78.71 0.48 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 169.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.47 46.33 1.36 Allowed Pre-proline 0 CA--C 1.55 0.973 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 174.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.86 -89.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.222 2.614 . . . . 0.0 113.38 -176.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -157.8 112.81 2.69 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.241 -0.912 . . . . 0.0 110.487 -172.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -116.2 142.62 29.59 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 123.65 0.78 . . . . 0.0 109.465 176.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -76.4 66.56 7.19 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.914 1.742 . . . . 0.0 109.61 166.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.4 t 38.05 92.29 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 129.078 2.951 . . . . 0.0 114.846 172.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt . . . . . 0 CA--C 1.534 0.343 0 C-N-CA 123.738 0.815 . . . . 0.0 111.629 -178.421 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.216 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.8 p -157.38 40.66 0.3 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 122.064 0.935 . . . . 0.0 110.974 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -156.08 -52.26 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 127.297 2.239 . . . . 0.0 106.172 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.3 mt -56.93 -29.51 63.16 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.836 1.654 . . . . 0.0 111.502 174.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.2 mt -72.51 80.96 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 123.824 0.849 . . . . 0.0 110.85 -174.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.531 ' HB2' HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -74.59 -168.95 0.76 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 151.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -71.78 -42.51 67.04 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.66 1.184 . . . . 0.0 111.322 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -40.61 128.1 2.49 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.301 1.44 . . . . 0.0 114.703 -161.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -97.5 88.21 4.32 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 125.538 1.535 . . . . 0.0 107.424 -168.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -82.35 119.9 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 175.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.49 138.42 31.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 -177.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.419 ' HB ' ' CG1' ' A' ' 56' ' ' ILE . 3.8 t -121.89 147.59 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 176.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.5 m -140.43 94.27 2.72 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 -174.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -76.0 163.21 27.38 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.204 1.402 . . . . 0.0 108.983 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -146.61 88.5 1.77 Allowed 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.875 0.845 . . . . 0.0 110.583 -167.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.62 111.06 16.7 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.793 0.837 . . . . 0.0 111.025 176.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -118.21 136.74 53.46 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.5 t -132.03 143.46 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -134.93 163.54 29.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 169.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -24.79 -59.05 0.06 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 127.233 2.213 . . . . 0.0 113.242 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -32.78 -42.89 0.16 Allowed Glycine 0 CA--C 1.532 1.106 0 C-N-CA 126.774 2.13 . . . . 0.0 114.71 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.584 HD13 ' CD2' ' A' ' 144' ' ' PHE . 0.2 OUTLIER -109.15 106.62 59.0 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 118.86 1.33 . . . . 0.0 108.238 165.079 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -82.17 5.08 6.57 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.276 1.984 . . . . 0.0 112.498 -173.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.407 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 43.1 m0 -79.8 146.3 32.36 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 122.384 1.088 . . . . 0.0 111.792 -165.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -77.54 82.36 3.98 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -93.36 106.85 18.77 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.603 1.561 . . . . 0.0 108.192 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.0 m -101.44 118.92 58.92 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -70.81 166.68 28.11 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 121.186 1.257 . . . . 0.0 109.112 164.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -94.54 -58.32 3.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 C-N-CA 123.853 0.861 . . . . 0.0 110.762 -174.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -132.23 175.18 9.48 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 165.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.3 tpt85 -69.79 -43.03 72.96 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 165.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -135.98 170.08 16.57 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 125.842 1.657 . . . . 0.0 113.283 -158.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.419 ' CG1' ' HB ' ' A' ' 35' ' ' VAL . 30.6 pt -143.74 167.24 12.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 127.068 2.147 . . . . 0.0 107.502 173.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -117.92 140.85 49.14 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 161.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.4 t -131.58 129.95 62.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.651 1.58 . . . . 0.0 106.76 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.3 mmt-85 -76.35 94.84 3.67 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 168.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.531 HD11 ' HB2' ' A' ' 29' ' ' LEU . 5.6 pt -7.66 76.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 127.558 2.343 . . . . 0.0 115.806 -167.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 134.06 -27.04 3.35 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 124.558 1.075 . . . . 0.0 112.858 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -41.32 111.32 0.21 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.263 1.425 . . . . 0.0 111.65 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.49 99.67 1.65 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.17 1.388 . . . . 0.0 110.264 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.2 p -104.96 150.58 7.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 175.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.28 132.6 52.14 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.471 1.108 . . . . 0.0 109.584 178.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.1 pp -138.76 96.93 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 C-N-CA 125.008 1.323 . . . . 0.0 108.026 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.404 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 0.0 OUTLIER -78.29 166.49 22.63 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -174.272 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -134.25 149.14 50.92 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 26.3 ttt-85 -132.04 122.66 25.82 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -123.15 105.9 10.31 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.539 1.536 . . . . 0.0 109.154 174.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -95.6 131.91 41.31 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.407 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 49.3 t-20 -75.45 142.68 42.92 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.042 0.837 . . . . 0.0 109.663 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.71 -7.26 6.78 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.462 1.905 . . . . 0.0 111.68 -174.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.35 151.14 33.03 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.174 0.897 . . . . 0.0 109.29 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.7 m -84.26 14.38 4.4 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -154.2 163.64 23.41 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 175.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.8 160.64 17.29 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.09 1.86 . . . . 0.0 112.212 -175.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.24 165.22 26.66 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 123.301 0.64 . . . . 0.0 110.126 176.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.7 t -111.17 145.45 38.62 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 168.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -138.0 83.9 0.24 Allowed Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.04 -21.93 11.28 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.018 0.927 . . . . 0.0 112.119 -178.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.15 -175.97 0.12 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 165.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.5 t -124.11 168.78 12.43 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 118.214 -1.394 . . . . 0.0 107.987 141.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -148.24 88.75 1.67 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 122.726 1.251 . . . . 0.0 108.956 -166.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -78.22 88.98 4.28 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 120.847 -1.158 . . . . 0.0 107.882 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.6 p -78.75 69.48 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.473 0 C-N-CA 125.463 1.505 . . . . 0.0 110.691 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.6 t -176.53 142.05 0.55 Allowed Pre-proline 0 N--CA 1.464 0.252 0 CA-C-N 119.425 1.012 . . . . 0.0 109.736 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -67.05 -58.61 0.14 Allowed 'Trans proline' 0 N--CA 1.446 -1.314 0 N-CA-C 108.777 -1.278 . . . . 0.0 108.777 166.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 26.2 ptm -171.42 11.37 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -171.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -173.49 -51.93 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 119.163 0.892 . . . . 0.0 110.317 -162.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.25 -124.55 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.667 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.19 -44.09 1.07 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 120.417 -1.427 . . . . 0.0 112.762 -170.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.59 -58.18 4.06 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.408 1.083 . . . . 0.0 110.837 174.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -74.29 -25.1 59.39 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.258 1.023 . . . . 0.0 113.447 -177.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -41.04 120.68 1.39 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.745 1.218 . . . . 0.0 109.302 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 . . . . . 0 CA--C 1.532 0.277 0 CA-C-N 118.803 0.729 . . . . 0.0 111.422 -168.191 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.0 t 40.85 -131.51 0.37 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.538 1.535 . . . . 0.0 113.315 165.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.0 t -132.16 147.89 52.45 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.067 2.147 . . . . 0.0 108.167 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.402 HD11 ' HB2' ' A' ' 114' ' ' MET . 95.1 mt -134.19 142.29 47.36 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.406 0.683 . . . . 0.0 109.883 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -68.98 164.25 49.2 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.365 1.866 . . . . 0.0 110.372 167.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.06 76.77 2.5 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 124.682 3.588 . . . . 0.0 112.735 -169.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 153.71 -21.22 0.7 Allowed Glycine 0 CA--C 1.521 0.433 0 CA-C-O 119.357 -0.691 . . . . 0.0 113.285 169.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.9 155.67 32.66 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 118.14 0.97 . . . . 0.0 111.772 -159.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -106.44 101.45 10.91 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.89 1.276 . . . . 0.0 110.887 -165.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.402 ' HB2' HD11 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -83.79 85.81 7.24 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.136 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -106.64 105.11 14.98 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.862 1.265 . . . . 0.0 108.851 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 46.7 mtt -146.87 141.49 16.09 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 119.729 1.15 . . . . 0.0 112.936 -174.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 67' ' ' MET . 95.3 Cg_endo -83.87 145.51 11.37 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.138 2.559 . . . . 0.0 113.622 176.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 24.1 t -117.8 150.81 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 126.403 1.881 . . . . 0.0 106.512 170.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.2 m -118.74 147.44 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.868 1.267 . . . . 0.0 108.301 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -157.55 159.16 36.85 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.629 0.65 . . . . 0.0 112.747 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -163.17 158.19 21.43 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 126.661 1.984 . . . . 0.0 108.426 166.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 29.7 t -102.29 147.35 9.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 124.699 1.199 . . . . 0.0 108.768 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -80.97 161.78 62.0 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 123.398 0.679 . . . . 0.0 110.149 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.467 ' HB3' HD12 ' A' ' 60' ' ' ILE . 87.4 Cg_endo -101.94 28.25 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.89 3.06 . . . . 0.0 112.425 166.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -84.41 -40.54 17.67 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 168.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.7 tt -39.3 -47.38 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.112 1.365 . . . . 0.0 113.681 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.8 m -79.27 55.7 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 O-C-N 121.553 -0.717 . . . . 0.0 110.627 175.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -140.99 -66.61 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.491 0 CA-C-O 117.485 -1.245 . . . . 0.0 111.711 175.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.4 158.43 44.46 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 CA-C-N 121.927 1.724 . . . . 0.0 112.54 -175.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.2 t -55.61 -46.8 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 124.7 1.2 . . . . 0.0 110.141 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -46.17 -50.33 15.77 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.985 1.314 . . . . 0.0 112.684 -175.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 27.2 p -101.52 -6.74 23.53 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -174.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -37.84 107.82 0.07 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.839 1.256 . . . . 0.0 112.152 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.03 -30.53 8.56 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.587 -1.118 . . . . 0.0 113.132 176.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 43.2 mm -58.79 129.3 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 C-N-CA 124.321 1.048 . . . . 0.0 109.863 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -158.54 49.13 0.37 Allowed 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.4 m -149.4 92.55 1.95 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 162.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.08 89.58 5.97 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -171.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 13.2 t -78.01 175.35 10.16 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 122.247 1.022 . . . . 0.0 109.383 -176.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.17 98.34 3.08 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 169.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.3 m -79.81 95.36 6.0 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 174.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -76.67 126.4 30.92 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 171.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 26.6 m -122.51 89.91 3.2 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.584 ' CD2' HD13 ' A' ' 45' ' ' LEU . 3.1 m-85 -84.83 91.34 7.98 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.155 -173.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -151.04 47.39 0.44 Allowed Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 116.876 2.176 . . . . 0.0 116.876 -175.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.2 -111.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.398 2.732 . . . . 0.0 110.763 173.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -136.05 116.49 13.71 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.693 1.133 . . . . 0.0 108.928 -168.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -93.19 143.54 26.9 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 164.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -71.54 -55.36 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.882 1.721 . . . . 0.0 108.419 167.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.6 t -177.37 126.25 0.14 Allowed 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.158 1.783 . . . . 0.0 107.791 172.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 27.4 pttt . . . . . 0 CA--C 1.537 0.474 0 C-N-CA 123.144 0.577 . . . . 0.0 111.321 160.693 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.059 0 N-CA-C 102.015 -3.328 . . . . 0.0 102.015 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.3 t -155.5 35.12 0.37 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 121.508 1.958 . . . . 0.0 111.11 176.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -160.37 -60.74 0.06 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -164.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.43 39.94 0.62 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 112.628 -2.078 . . . . 0.0 112.246 -165.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.9 mt -119.37 62.59 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 123.486 0.714 . . . . 0.0 110.688 -167.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -76.96 149.63 35.95 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.024 1.33 . . . . 0.0 109.602 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.0 54.61 1.62 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -165.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.8 98.09 7.83 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 166.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.76 81.78 5.97 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 122.125 0.964 . . . . 0.0 108.65 -168.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.292 0.0 OUTLIER -79.92 131.83 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.629 -173.173 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.97 150.66 24.73 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 126.79 2.036 . . . . 0.0 106.999 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.7 m -135.94 120.11 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.26 111.92 18.79 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 176.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -79.48 89.69 5.05 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 176.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -78.35 80.58 4.75 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 122.608 1.194 . . . . 0.0 108.019 -174.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.91 126.05 30.51 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -133.8 147.33 51.23 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.3 p -145.25 147.98 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 124.097 0.959 . . . . 0.0 108.815 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -130.3 168.46 16.86 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 166.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.48 -34.86 11.91 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.235 1.014 . . . . 0.0 111.891 -178.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -34.93 -38.8 0.14 Allowed Glycine 0 CA--C 1.532 1.11 0 C-N-CA 126.28 1.895 . . . . 0.0 113.734 169.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.758 HD13 ' CD2' ' A' ' 144' ' ' PHE . 0.6 OUTLIER -116.6 96.58 48.57 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 118.225 1.012 . . . . 0.0 108.283 163.638 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -82.92 42.55 1.31 Allowed 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 123.424 2.75 . . . . 0.0 111.332 -168.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 41.5 m0 -112.81 147.19 37.46 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 -176.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.401 ' CD ' ' HZ2' ' A' ' 71' ' ' LYS . 12.0 tt0 -77.14 80.93 3.65 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 -178.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -90.9 87.04 6.47 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 m -95.64 128.39 38.08 Favored Pre-proline 0 N--CA 1.454 -0.257 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -67.4 153.15 77.62 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 N-CA-C 107.3 -1.846 . . . . 0.0 107.3 160.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -57.96 4.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.638 0.732 . . . . 0.0 109.092 -173.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -120.06 159.09 25.48 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 103.199 -2.889 . . . . 0.0 103.199 157.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -23.01 67.09 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.946 0.794 . . . . 0.0 110.652 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -139.88 167.6 21.74 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 125.561 1.545 . . . . 0.0 109.952 -171.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.41 168.95 21.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 172.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.3 p-10 -129.84 147.62 51.63 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.339 0.656 . . . . 0.0 111.218 166.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.2 m -141.84 122.99 12.54 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.57 56.27 3.89 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 121.413 1.915 . . . . 0.0 109.999 -173.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mt 58.8 116.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 124.642 1.177 . . . . 0.0 109.004 -164.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.28 -51.74 4.42 Favored Glycine 0 CA--C 1.525 0.718 0 O-C-N 119.994 -1.691 . . . . 0.0 113.945 172.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -26.39 100.5 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.444 2.298 . . . . 0.0 112.081 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.5 p -76.89 128.2 34.13 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.722 -0.612 . . . . 0.0 110.461 -172.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 p -123.62 149.43 27.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 C-N-CA 125.268 1.427 . . . . 0.0 109.041 177.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.02 122.86 36.96 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 125.164 1.385 . . . . 0.0 107.276 164.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.7 pp -114.67 130.74 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 157.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 35.8 ttp -76.97 140.53 40.46 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 169.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -109.29 158.71 17.61 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 166.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 43.7 ttm-85 -138.13 140.93 40.13 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.353 1.461 . . . . 0.0 108.727 -175.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.7 96.72 1.78 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.12 1.768 . . . . 0.0 108.846 166.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.401 ' HZ2' ' CD ' ' A' ' 48' ' ' GLU . 4.7 mtmp? -95.09 126.11 40.21 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -79.94 121.41 25.42 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.607 1.094 . . . . 0.0 112.399 -170.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.4 mp -108.87 26.76 10.2 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.262 1.025 . . . . 0.0 111.598 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.17 171.66 14.62 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 120.987 -1.071 . . . . 0.0 112.223 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.4 p -79.47 -34.59 41.33 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.645 1.978 . . . . 0.0 110.479 170.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 66.5 p -123.99 179.84 0.99 Allowed Pre-proline 0 N--CA 1.456 -0.152 0 C-N-CA 127.149 2.18 . . . . 0.0 108.979 -174.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -54.41 161.51 5.48 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 CA-C-N 119.309 0.789 . . . . 0.0 111.345 160.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.47 173.9 10.4 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 157.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.6 t -102.85 162.11 13.19 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 151.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.603 ' HA2' HD11 ' A' ' 45' ' ' LEU . . . -151.41 60.27 0.41 Allowed Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -88.31 -39.11 14.63 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.537 0.735 . . . . 0.0 109.051 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.05 178.08 0.15 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.367 1.067 . . . . 0.0 112.841 169.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.5 m -125.87 148.09 49.28 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 173.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -137.98 160.85 38.24 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.619 0.768 . . . . 0.0 110.345 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.76 113.36 20.07 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 164.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.8 p -95.08 59.4 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 123.714 0.805 . . . . 0.0 112.127 -173.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.8 t -174.5 150.04 1.41 Allowed Pre-proline 0 C--N 1.333 -0.121 0 O-C-N 121.539 -0.725 . . . . 0.0 110.682 -175.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.21 -33.66 30.24 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 N-CA-C 108.99 -1.196 . . . . 0.0 108.99 162.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.3 ptp 174.99 -71.8 0.01 OUTLIER 'General case' 0 C--N 1.341 0.23 0 C-N-CA 127.023 2.129 . . . . 0.0 107.913 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.76 -31.02 51.78 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -163.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.33 -110.51 0.06 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.476 0.179 . . . . 0.0 111.264 -168.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.16 -56.28 0.1 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.312 0.958 . . . . 0.0 113.31 -169.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.83 -49.54 19.88 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.376 1.588 . . . . 0.0 112.287 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -72.74 -4.67 32.81 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.283 1.033 . . . . 0.0 113.41 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.401 ' CE1' ' CE2' ' A' ' 120' ' ' PHE . 6.1 t80 -62.64 131.92 50.6 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 . . . . . 0 N--CA 1.442 -0.837 0 O-C-N 123.515 0.51 . . . . 0.0 112.166 174.667 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 CA--C 1.538 0.494 0 CA-C-O 121.138 0.494 . . . . 0.0 112.207 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.8 t -156.33 -70.47 0.11 Allowed 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.009 0.924 . . . . 0.0 111.137 -176.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.6 m -159.69 135.0 8.23 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 -164.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 69.0 mt -149.47 146.37 27.38 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.926 0.89 . . . . 0.0 109.058 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.26 170.7 12.83 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 126.324 1.85 . . . . 0.0 109.567 167.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.01 88.16 1.27 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 124.607 3.538 . . . . 0.0 111.093 -173.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 151.23 -30.19 0.97 Allowed Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 173.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.27 145.87 41.52 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.688 -151.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -96.29 89.71 5.19 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.974 1.71 . . . . 0.0 110.975 -170.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.96 119.15 26.87 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 176.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -154.13 132.51 11.98 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 122.762 0.425 . . . . 0.0 109.869 168.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 39.2 mtt -156.01 156.93 31.05 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 123.589 0.756 . . . . 0.0 110.373 -168.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.23 140.57 22.33 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.801 3.0 . . . . 0.0 111.688 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.8 t -126.37 136.29 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 170.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.0 m -105.57 157.45 6.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 CA-C-N 117.849 0.295 . . . . 0.0 110.526 173.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.401 ' CE2' ' CE1' ' A' ' 95' ' ' PHE . 6.2 t80 -156.72 139.17 14.86 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -170.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -157.8 173.03 17.42 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.743 1.617 . . . . 0.0 109.779 169.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.4 p -129.59 143.39 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 118.743 -0.646 . . . . 0.0 110.229 169.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -76.18 153.59 84.36 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 118.671 0.669 . . . . 0.0 109.588 175.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -58.63 -21.26 54.49 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.325 2.684 . . . . 0.0 112.132 170.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -41.47 -33.85 0.48 Allowed 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 126.637 1.975 . . . . 0.0 113.258 176.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.4 tt -54.53 -42.46 59.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.896 0.771 . . . . 0.0 112.661 175.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.1 m -84.3 54.13 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 119.088 0.858 . . . . 0.0 109.901 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -135.74 -65.52 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 117.637 -1.173 . . . . 0.0 112.252 175.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -74.53 149.47 39.15 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 CA-C-N 121.977 1.742 . . . . 0.0 111.079 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.4 p -64.44 -35.38 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 124.124 0.969 . . . . 0.0 110.75 -174.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -45.45 -48.99 13.8 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.1 1.76 . . . . 0.0 112.245 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.9 p -91.23 -66.53 0.92 Allowed 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 41.56 -72.01 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.693 2.797 . . . . 0.0 115.87 -175.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -87.14 -23.01 42.5 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.319 1.438 . . . . 0.0 111.234 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.9 mm -56.95 126.69 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 117.816 0.808 . . . . 0.0 109.949 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -156.01 58.41 0.59 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.921 172.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.9 m -150.01 88.67 1.54 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 167.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.0 mp -74.64 85.98 2.12 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.5 t -83.68 140.07 32.38 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.634 -1.166 . . . . 0.0 107.867 174.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.9 tt -114.22 103.94 11.6 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 169.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.3 p -86.7 104.83 16.47 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.38 128.91 50.37 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.589 1.556 . . . . 0.0 108.401 -176.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.4 m -114.98 91.55 3.65 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.526 1.131 . . . . 0.0 109.324 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.758 ' CD2' HD13 ' A' ' 45' ' ' LEU . 2.4 m-85 -71.41 88.17 0.88 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.599 1.159 . . . . 0.0 109.638 174.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -155.93 59.64 2.14 Favored Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 174.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.492 ' HD3' HD12 ' A' ' 45' ' ' LEU . 62.6 Cg_endo -79.96 -78.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.936 2.424 . . . . 0.0 111.979 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -146.79 132.72 19.13 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.553 0.615 . . . . 0.0 109.467 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -131.98 135.56 26.81 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 125.867 1.667 . . . . 0.0 106.611 175.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -77.21 -61.93 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.15 1.9 . . . . 0.0 109.97 171.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 41.8 t -176.84 97.67 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.639 1.575 . . . . 0.0 107.708 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' A' ' 61' ' ' GLY . . . . . . . . 0 CA--C 1.512 -0.5 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.0 t -166.23 -136.59 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 144.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -73.03 -27.55 61.83 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.474 1.109 . . . . 0.0 109.413 168.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -68.76 6.47 0.85 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -173.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.435 ' CG1' ' HB3' ' A' ' 24' ' ' ALA . 81.7 mt -58.99 122.14 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 120.847 1.658 . . . . 0.0 110.043 177.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.68 157.21 17.22 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 118.785 0.721 . . . . 0.0 110.999 175.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.67 -27.65 69.06 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.074 0.95 . . . . 0.0 113.03 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -51.76 114.0 1.15 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.97 0.908 . . . . 0.0 111.953 -174.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.63 98.04 8.17 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 127.067 2.147 . . . . 0.0 108.747 -171.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.0 tt -109.13 136.62 44.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 126.277 1.831 . . . . 0.0 110.748 -170.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.9 tptp -98.64 157.53 16.19 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 124.918 1.287 . . . . 0.0 110.897 -168.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.426 HG11 ' CZ ' ' A' ' 37' ' ' PHE . 82.3 t -133.65 160.68 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 C-N-CA 124.306 1.042 . . . . 0.0 108.63 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.4 m -145.46 102.48 3.71 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.615 1.166 . . . . 0.0 109.319 172.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.426 ' CZ ' HG11 ' A' ' 35' ' ' VAL . 90.0 m-85 -78.6 88.56 4.52 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.055 1.342 . . . . 0.0 108.13 175.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -80.06 85.36 5.65 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 121.415 -0.803 . . . . 0.0 109.191 -174.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.82 134.71 34.29 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 121.839 -0.538 . . . . 0.0 111.329 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -144.09 147.01 33.19 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 126.405 1.882 . . . . 0.0 109.66 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.9 t -132.77 147.97 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 125.34 1.456 . . . . 0.0 108.402 177.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -146.96 174.29 11.65 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.031 0.932 . . . . 0.0 109.931 174.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -49.28 121.81 5.36 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 169.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.77 -43.21 1.3 Allowed Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 108.078 -2.009 . . . . 0.0 108.078 -163.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.537 HD13 ' CG ' ' A' ' 144' ' ' PHE . 0.6 OUTLIER -130.74 97.76 20.66 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 123.308 0.643 . . . . 0.0 111.067 177.183 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -84.72 41.71 1.02 Allowed 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.78 2.987 . . . . 0.0 110.271 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.456 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 43.2 m0 -114.77 136.9 52.57 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.601 0.76 . . . . 0.0 109.315 -171.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -79.16 80.81 5.48 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -89.98 89.36 7.68 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 124.238 1.015 . . . . 0.0 108.99 -176.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.9 m -84.81 129.7 55.65 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.22 166.18 30.46 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 121.436 1.424 . . . . 0.0 108.464 161.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.38 -56.21 5.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 123.862 0.865 . . . . 0.0 109.437 -176.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.2 mp0 -129.79 164.44 24.06 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 161.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -63.55 -46.77 84.44 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 165.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -131.04 149.99 52.36 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 126.249 1.819 . . . . 0.0 110.108 -164.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.0 pt -134.81 167.97 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 167.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -110.56 134.24 52.57 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 166.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.0 157.91 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 165.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.5 mtm180 -109.15 114.27 27.84 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.422 HD13 HG21 ' A' ' 60' ' ' ILE . 0.9 OUTLIER -37.8 117.34 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -147.117 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.694 ' O ' ' HB2' ' A' ' 24' ' ' ALA . . . 111.43 -46.36 1.18 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 -172.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -53.63 109.59 0.47 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 117.767 0.784 . . . . 0.0 112.846 -166.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.2 p -56.44 122.03 10.99 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.938 1.295 . . . . 0.0 111.221 172.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.06 137.6 42.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 166.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -77.78 128.56 34.21 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.824 1.25 . . . . 0.0 108.569 167.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.1 pp -146.3 88.6 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.974 0.91 . . . . 0.0 108.971 174.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.93 147.16 41.19 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 121.385 -0.822 . . . . 0.0 110.276 -177.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -98.14 159.24 15.07 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 166.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -135.96 118.51 15.89 Favored 'General case' 0 C--O 1.227 -0.099 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 172.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -110.69 154.89 23.22 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 126.608 1.963 . . . . 0.0 109.081 172.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -154.95 123.74 6.15 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 -176.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.456 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 35.6 t30 -80.77 112.66 18.35 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 119.302 0.956 . . . . 0.0 110.836 -173.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.35 5.1 51.66 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.721 1.208 . . . . 0.0 112.742 -176.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.37 176.79 9.01 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.792 0.724 . . . . 0.0 110.538 175.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.6 t -105.64 20.73 18.43 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.739 0.816 . . . . 0.0 109.96 175.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.2 160.48 30.85 Favored Pre-proline 0 N--CA 1.447 -0.612 0 C-N-CA 127.086 2.154 . . . . 0.0 106.708 -174.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.71 160.44 40.44 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 C-N-CA 121.161 1.241 . . . . 0.0 109.442 172.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.38 164.18 26.25 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-O 120.776 0.322 . . . . 0.0 110.663 166.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.57 95.18 5.21 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.989 2.116 . . . . 0.0 105.693 -177.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.0 96.52 0.78 Allowed Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 107.756 -2.137 . . . . 0.0 107.756 177.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -125.05 50.33 1.77 Allowed 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 169.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.38 176.82 0.32 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.805 0.812 . . . . 0.0 110.872 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -146.04 162.48 37.8 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.91 169.82 17.33 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 123.578 0.751 . . . . 0.0 110.336 -172.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -119.91 111.52 18.04 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 163.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.2 t -95.43 77.59 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.177 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.1 t -176.07 145.55 0.75 Allowed Pre-proline 0 C--O 1.232 0.142 0 C-N-CA 124.153 0.981 . . . . 0.0 110.207 171.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.94 -38.0 40.68 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 121.259 1.306 . . . . 0.0 110.064 158.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.9 ptp 172.02 -68.08 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 127.835 2.454 . . . . 0.0 107.759 174.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.5 -39.5 46.1 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -167.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.74 -104.68 0.04 OUTLIER 'General case' 0 C--O 1.228 -0.055 0 C-N-CA 123.101 0.561 . . . . 0.0 110.427 -174.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.27 -58.78 2.8 Favored Glycine 0 CA--C 1.523 0.55 0 O-C-N 121.855 -0.528 . . . . 0.0 111.853 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -47.64 -48.95 28.52 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.927 0.864 . . . . 0.0 110.613 174.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -74.7 3.96 7.05 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.152 1.381 . . . . 0.0 113.882 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -76.95 107.92 9.63 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 171.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 . . . . . 0 N--CA 1.451 -0.382 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.644 179.365 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.431 HG23 ' H ' ' A' ' 107' ' ' THR . 2.5 t -177.08 -82.15 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.069 1.347 . . . . 0.0 111.504 172.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.431 ' H ' HG23 ' A' ' 106' ' ' THR . 14.8 t -155.47 149.92 26.05 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.962 1.305 . . . . 0.0 108.025 -169.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.1 mt -154.03 127.52 8.62 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 123.873 0.869 . . . . 0.0 109.437 175.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -63.2 158.15 58.02 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 126.401 1.88 . . . . 0.0 110.256 164.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.47 110.53 3.0 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.481 2.121 . . . . 0.0 111.38 -169.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 115.17 -15.75 18.15 Favored Glycine 0 C--N 1.334 0.467 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -77.86 156.32 30.46 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 117.476 0.638 . . . . 0.0 110.873 -174.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.61 153.56 39.15 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.753 1.221 . . . . 0.0 110.687 -167.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 42.4 ttm -149.47 88.58 1.57 Allowed 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.094 1.358 . . . . 0.0 108.687 -168.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -89.72 130.17 36.03 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 118.585 0.629 . . . . 0.0 109.888 164.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -126.48 92.58 44.9 Favored Pre-proline 0 N--CA 1.452 -0.358 0 C-N-CA 125.327 1.451 . . . . 0.0 107.908 -171.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -55.37 126.12 21.45 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.723 2.282 . . . . 0.0 110.184 169.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.1 t -121.57 147.38 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 170.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.8 p -119.75 142.02 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 171.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -145.81 148.79 33.29 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 118.161 0.437 . . . . 0.0 111.147 -172.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -157.88 141.91 15.87 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.55 1.14 . . . . 0.0 110.098 165.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 24.0 t -70.54 134.35 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 164.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.422 ' C ' ' H ' ' A' ' 125' ' ' GLU . 1.5 t70 -88.41 138.55 30.18 Favored Pre-proline 0 N--CA 1.451 -0.406 0 C-N-CA 123.971 0.908 . . . . 0.0 109.939 -173.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -72.02 34.53 0.29 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.09 2.527 . . . . 0.0 114.331 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.422 ' H ' ' C ' ' A' ' 123' ' ' ASP . 37.7 tt0 -107.55 -21.78 12.77 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 130.071 3.348 . . . . 0.0 108.507 172.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.7 tt -58.22 -39.12 72.18 Favored 'Isoleucine or valine' 0 C--N 1.345 0.372 0 O-C-N 121.117 -0.99 . . . . 0.0 111.249 172.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.1 m -77.27 61.62 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 123.37 0.668 . . . . 0.0 109.956 172.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -130.92 -78.48 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 117.359 -1.305 . . . . 0.0 111.403 173.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -73.04 160.21 46.19 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 CA-C-N 122.011 1.754 . . . . 0.0 111.105 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 84.5 t -65.07 -44.66 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 124.553 1.141 . . . . 0.0 109.113 -171.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -48.31 -64.38 0.81 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.335 1.854 . . . . 0.0 110.095 177.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 35.7 p -75.94 -19.96 58.34 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 118.357 -0.83 . . . . 0.0 111.63 -172.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -44.65 -39.31 4.96 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.932 0.787 . . . . 0.0 111.186 168.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -57.72 -54.6 36.01 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 175.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 21.9 mm -64.26 132.4 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 124.6 1.16 . . . . 0.0 111.728 -174.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -158.65 41.57 0.25 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.181 165.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.8 p -140.8 89.64 2.27 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 170.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.4 tp -84.79 144.88 28.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -166.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.5 t -149.61 153.02 36.42 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -176.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.493 ' H ' HD13 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -114.06 145.8 41.1 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 146.477 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 26.6 t -98.84 116.97 32.28 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 164.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.23 124.9 49.48 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.137 1.375 . . . . 0.0 107.383 178.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.5 m -114.63 89.88 3.2 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.537 ' CG ' HD13 ' A' ' 45' ' ' LEU . 2.1 m-30 -67.53 83.52 0.17 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 170.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.16 50.65 1.16 Allowed Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 178.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.471 ' CD ' HD12 ' A' ' 45' ' ' LEU . 87.9 Cg_endo -74.73 -106.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.264 2.643 . . . . 0.0 110.254 176.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -147.22 123.52 10.93 Favored 'General case' 0 C--N 1.337 0.058 0 CA-C-N 119.363 0.983 . . . . 0.0 109.292 -175.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -111.3 143.67 28.91 Favored Pre-proline 0 N--CA 1.45 -0.463 0 C-N-CA 124.892 1.277 . . . . 0.0 108.353 175.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.0 -51.28 0.17 Allowed 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 121.939 1.759 . . . . 0.0 109.135 171.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 61.8 p -175.75 174.28 2.22 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.282 1.833 . . . . 0.0 107.147 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.4 pttt . . . . . 0 CA--C 1.535 0.377 0 C-N-CA 124.759 1.224 . . . . 0.0 109.201 172.576 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.933 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 t -77.42 23.95 0.2 Allowed 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.174 -1.579 . . . . 0.0 113.456 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -75.9 -30.91 58.96 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 153.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -107.21 -44.54 4.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.614 1.165 . . . . 0.0 112.822 -175.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.1 mt -19.22 115.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 126.432 1.893 . . . . 0.0 115.146 -164.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.561 ' HB2' HD12 ' A' ' 60' ' ' ILE . 5.7 mp -103.78 -178.26 3.61 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.262 -161.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -69.2 -48.12 62.94 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.685 1.994 . . . . 0.0 110.733 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.599 ' HB3' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -60.54 151.08 29.56 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.799 0.809 . . . . 0.0 111.814 -174.779 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.63 98.54 7.69 Favored 'General case' 0 N--CA 1.418 -2.051 0 C-N-CA 127.233 2.213 . . . . 0.0 107.285 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.31 0.0 OUTLIER -80.05 122.04 34.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 170.668 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.544 ' CE ' ' HB2' ' A' ' 55' ' ' ASP . 2.7 tmtp? -75.87 150.54 37.59 Favored 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.6 t -129.66 143.08 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 172.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.8 m -141.78 98.05 3.27 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -173.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -76.38 159.06 30.84 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.895 -172.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -131.05 84.0 2.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 122.761 1.267 . . . . 0.0 107.916 169.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.35 86.1 7.22 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 164.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -93.36 157.82 16.04 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.496 0.718 . . . . 0.0 109.089 170.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.2 p -140.2 110.98 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 123.499 0.72 . . . . 0.0 109.478 175.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.93 164.32 15.2 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.115 166.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.81 -39.44 8.39 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.921 1.288 . . . . 0.0 112.999 -176.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.19 -26.21 2.15 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.819 1.676 . . . . 0.0 113.985 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.731 HD11 ' HA2' ' A' ' 80' ' ' GLY . 0.3 OUTLIER -121.05 97.18 48.16 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 162.936 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -82.73 47.54 2.48 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.207 1.938 . . . . 0.0 110.296 -170.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.496 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 43.6 m0 -112.54 148.33 34.72 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.471 1.108 . . . . 0.0 109.502 -170.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -76.79 80.55 3.39 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 175.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -93.29 101.72 13.98 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 124.329 1.052 . . . . 0.0 108.251 -177.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.7 m -101.97 132.47 21.56 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-O 119.26 -0.4 . . . . 0.0 110.058 -172.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.38 141.34 51.04 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 N-CA-C 107.802 -1.653 . . . . 0.0 107.802 162.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.474 HG13 ' H ' ' A' ' 53' ' ' GLN . 13.2 p -77.58 -52.53 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 121.477 0.656 . . . . 0.0 110.031 -177.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.474 ' H ' HG13 ' A' ' 52' ' ' VAL . 3.1 mp0 -127.55 158.96 36.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 104.122 -2.547 . . . . 0.0 104.122 153.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -66.88 -44.91 79.65 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 174.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.544 ' HB2' ' CE ' ' A' ' 34' ' ' LYS . 20.7 p-10 -130.24 167.22 18.8 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 126.361 1.864 . . . . 0.0 111.07 -170.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.8 pt -143.07 175.49 4.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 125.11 1.364 . . . . 0.0 108.114 169.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -119.31 132.33 55.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 169.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.6 m -124.46 126.14 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.638 0.775 . . . . 0.0 108.96 172.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -72.68 77.43 1.1 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 168.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.599 HD11 ' HB3' ' A' ' 31' ' ' GLU . 19.5 mt 28.29 58.54 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 127.877 2.471 . . . . 0.0 111.798 169.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.6 -27.47 2.83 Favored Glycine 0 CA--C 1.523 0.557 0 O-C-N 122.131 -0.355 . . . . 0.0 113.195 -174.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -50.02 118.39 2.88 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.038 0.535 . . . . 0.0 111.342 171.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.4 p -88.94 107.27 18.92 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.338 1.455 . . . . 0.0 109.951 -177.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -96.06 139.07 19.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 174.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.8 120.35 23.94 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 163.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.34 111.05 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.413 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 76.8 mtp -76.49 171.22 14.97 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.39 0.676 . . . . 0.0 110.747 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -141.31 151.14 43.36 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 163.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.4 ttm105 -127.02 139.07 53.28 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 172.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.88 112.16 8.61 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.554 1.942 . . . . 0.0 108.152 173.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.0 mtmt -103.98 130.09 51.6 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.721 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.496 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 52.6 t-20 -78.26 101.97 7.41 Favored 'General case' 0 C--N 1.339 0.12 0 CA-C-N 119.44 1.018 . . . . 0.0 111.512 -176.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.9 mt -91.62 7.92 39.21 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.761 0.824 . . . . 0.0 113.014 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.91 162.94 27.2 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.858 1.208 . . . . 0.0 109.714 171.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.0 p -79.1 -9.21 59.49 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.045 1.338 . . . . 0.0 111.543 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.58 165.2 29.93 Favored Pre-proline 0 N--CA 1.447 -0.603 0 C-N-CA 126.38 1.872 . . . . 0.0 107.686 -168.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -61.27 148.43 92.94 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 121.14 1.226 . . . . 0.0 109.764 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.7 p -126.79 169.52 13.13 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 165.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.3 t -90.32 173.57 8.05 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 159.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.731 ' HA2' HD11 ' A' ' 45' ' ' LEU . . . -170.49 57.07 0.19 Allowed Glycine 0 N--CA 1.438 -1.185 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 176.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.69 -42.56 34.12 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 169.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 64.34 179.24 0.17 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.679 1.192 . . . . 0.0 110.873 174.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.8 m -120.16 136.15 54.72 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 172.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -105.57 148.75 26.94 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.151 0.58 . . . . 0.0 110.354 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -124.66 102.85 7.8 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 156.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.9 t -92.44 59.36 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 124.12 0.968 . . . . 0.0 108.839 -170.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.3 t -171.19 147.29 2.19 Favored Pre-proline 0 N--CA 1.461 0.108 0 O-C-N 121.499 -0.751 . . . . 0.0 111.664 -176.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -64.77 -40.41 22.21 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.381 1.387 . . . . 0.0 109.316 160.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 11.7 ptp 173.73 -71.76 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 127.523 2.329 . . . . 0.0 108.291 173.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.402 ' HB3' HG13 ' A' ' 135' ' ' ILE . . . -69.23 -43.8 73.31 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 123.571 0.748 . . . . 0.0 112.801 -164.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.49 -102.84 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.248 0.619 . . . . 0.0 110.595 -170.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.9 -52.75 1.67 Allowed Glycine 0 CA--C 1.53 1.026 0 CA-C-O 119.425 -0.653 . . . . 0.0 112.809 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -48.3 -50.63 29.33 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.039 1.419 . . . . 0.0 111.016 174.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -72.38 -4.98 33.22 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.082 1.753 . . . . 0.0 113.792 178.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -75.45 108.14 8.05 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 . . . . . 0 N--CA 1.447 -0.581 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.631 -177.493 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.7 mp0 . . . . . 0 N--CA 1.449 -0.504 0 N-CA-C 111.529 0.196 . . . . 0.0 111.529 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . 0.325 5.0 t 57.98 -78.67 0.02 OUTLIER 'General case' 0 C--O 1.232 0.173 0 C-N-CA 126.268 1.827 . . . . 0.0 114.699 165.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.3 m -162.56 142.45 9.5 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 125.83 1.652 . . . . 0.0 107.53 -169.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 26.3 mt -149.67 140.69 22.93 Favored 'General case' 0 C--O 1.232 0.17 0 O-C-N 123.335 0.397 . . . . 0.0 111.255 174.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -52.39 161.45 1.06 Allowed Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 128.91 2.884 . . . . 0.0 111.413 159.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -77.23 125.29 7.72 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.454 2.769 . . . . 0.0 111.602 -173.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.59 -10.82 32.87 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 124.437 1.018 . . . . 0.0 111.167 175.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -79.0 144.77 34.37 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -164.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -93.04 101.18 13.51 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.054 1.742 . . . . 0.0 109.127 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.55 125.39 29.92 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 161.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -146.31 126.66 13.98 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.156 1.382 . . . . 0.0 107.536 172.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 68.1 mtp -148.89 151.43 34.9 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 118.113 0.415 . . . . 0.0 111.002 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 67' ' ' MET . 84.0 Cg_endo -76.1 145.11 27.49 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 123.843 3.029 . . . . 0.0 110.378 165.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.2 t -116.59 156.4 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 155.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.0 m -122.47 141.73 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 171.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -153.9 148.12 25.86 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -171.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -157.62 175.84 13.4 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 128.501 2.72 . . . . 0.0 106.569 173.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 87.5 t -126.64 137.4 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 C-N-CA 123.111 0.564 . . . . 0.0 109.543 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -71.54 144.11 88.42 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 119.557 -0.259 . . . . 0.0 111.213 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -58.82 -25.14 75.23 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.0 2.467 . . . . 0.0 112.891 172.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -43.9 -30.16 0.66 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.663 1.185 . . . . 0.0 113.244 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.0 tt -52.52 -42.02 38.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 175.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.5 m -91.75 55.66 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 118.391 0.541 . . . . 0.0 110.332 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -129.71 -70.33 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.371 0 CA-C-O 117.224 -1.37 . . . . 0.0 111.331 167.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.2 156.77 63.81 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 CA-C-N 121.913 1.719 . . . . 0.0 111.47 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 83.9 t -66.75 -50.73 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.709 0.804 . . . . 0.0 110.076 -169.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -48.26 -45.15 34.1 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 124.616 1.166 . . . . 0.0 111.623 -174.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 61.2 p -92.19 -9.52 42.02 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 118.55 -0.738 . . . . 0.0 112.336 -174.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -50.21 -44.64 53.26 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.048 0.84 . . . . 0.0 111.602 -172.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.23 -24.99 75.55 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 123.388 0.518 . . . . 0.0 112.557 -177.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.402 HG13 ' HB3' ' A' ' 90' ' ' ALA . 13.2 mm -73.8 123.17 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 118.122 0.961 . . . . 0.0 109.773 -176.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -153.39 52.48 0.73 Allowed 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.719 165.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.4 m -146.95 99.7 3.21 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 153.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.81 134.17 38.06 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.3 t -125.48 161.65 26.65 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.6 tt -131.26 112.15 12.54 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 102.263 -3.236 . . . . 0.0 102.263 168.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.5 t -86.47 104.03 15.56 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 167.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.35 97.21 8.94 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.59 86.58 3.91 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 122.416 1.103 . . . . 0.0 108.272 -178.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.616 ' CD2' HD13 ' A' ' 45' ' ' LEU . 3.1 m-85 -68.37 87.67 0.31 Allowed 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 167.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.03 35.9 0.09 OUTLIER Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.91 -79.19 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.977 1.784 . . . . 0.0 113.365 -174.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 71.2 mtm180 -155.94 117.37 3.92 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.815 0.846 . . . . 0.0 109.99 -172.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -88.01 147.86 41.8 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 123.252 0.621 . . . . 0.0 109.73 167.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.52 -47.38 0.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.647 2.231 . . . . 0.0 110.335 172.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.4 p 157.13 82.25 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 128.536 2.734 . . . . 0.0 107.9 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.542 0.662 0 O-C-N 121.615 -0.678 . . . . 0.0 109.177 -171.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.613 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.4 m -70.24 65.73 0.28 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 129.195 2.998 . . . . 0.0 110.536 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -153.79 -56.26 0.11 Allowed 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 130.972 3.709 . . . . 0.0 103.321 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.18 -20.84 19.49 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 116.691 -1.623 . . . . 0.0 113.958 174.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.7 mt -40.47 138.91 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 120.968 1.713 . . . . 0.0 115.064 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -122.41 173.25 7.77 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.505 1.922 . . . . 0.0 110.509 -171.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -86.04 -24.5 26.35 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.753 0.821 . . . . 0.0 112.673 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.93 148.05 22.14 Favored 'General case' 0 C--O 1.231 0.11 0 O-C-N 121.004 -1.06 . . . . 0.0 110.209 174.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -120.02 97.0 5.4 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.24 1.416 . . . . 0.0 108.562 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.9 142.64 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 124.736 1.214 . . . . 0.0 108.779 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.67 148.39 27.44 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.761 1.224 . . . . 0.0 109.099 -174.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.9 t -136.18 111.16 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 -171.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 m -91.82 122.78 34.67 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 173.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -96.01 107.85 20.19 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.629 1.172 . . . . 0.0 108.8 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -96.28 86.93 4.34 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 122.763 1.268 . . . . 0.0 110.027 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.96 136.91 37.38 Favored 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 120.744 -1.222 . . . . 0.0 108.419 173.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.93 146.14 50.24 Favored 'General case' 0 CA--C 1.523 -0.08 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.94 143.1 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.58 166.64 23.06 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.166 1.786 . . . . 0.0 106.983 168.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -42.56 -43.72 3.86 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 124.233 1.013 . . . . 0.0 112.285 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.56 -34.09 0.23 Allowed Glycine 0 CA--C 1.534 1.223 0 C-N-CA 126.214 1.864 . . . . 0.0 114.663 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.18 96.5 49.28 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 119.034 1.417 . . . . 0.0 107.961 162.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -84.73 43.2 1.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 124.095 3.197 . . . . 0.0 109.441 -169.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.424 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 41.1 m0 -115.5 144.42 43.87 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -169.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -76.74 79.93 3.36 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -175.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -89.36 98.44 11.77 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.236 1.014 . . . . 0.0 109.042 -174.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.9 m -102.45 138.21 19.61 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -70.44 163.03 40.28 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 121.622 1.548 . . . . 0.0 108.71 166.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 67' ' ' MET . 2.4 t -80.08 -61.92 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -175.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.3 mp0 -131.7 156.99 44.94 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 162.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -23.95 64.99 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.072 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.57 162.59 41.12 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 119.078 0.854 . . . . 0.0 111.029 174.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.2 pt -135.33 166.55 27.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 126.074 1.75 . . . . 0.0 109.33 173.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -111.28 135.55 51.65 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.3 1.84 . . . . 0.0 109.435 164.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -137.42 128.98 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.369 1.867 . . . . 0.0 108.689 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -82.1 82.49 7.65 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 120.699 -1.25 . . . . 0.0 109.5 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.0 mt 17.38 69.58 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 128.768 2.827 . . . . 0.0 112.237 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.45 -25.64 4.76 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.239 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -48.7 108.54 0.18 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.839 0.455 . . . . 0.0 111.471 172.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.1 p -75.11 108.99 8.21 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.064 1.346 . . . . 0.0 109.801 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.8 p -114.57 145.46 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 122.841 0.456 . . . . 0.0 110.284 173.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.38 131.2 34.72 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 124.403 1.081 . . . . 0.0 110.253 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.6 pp -142.88 92.66 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.569 1.148 . . . . 0.0 109.887 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.408 ' O ' HG22 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -78.36 133.22 37.6 Favored 'General case' 0 C--O 1.226 -0.144 0 O-C-N 121.432 -0.792 . . . . 0.0 111.618 -175.595 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -100.53 157.09 16.91 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 66.1 ttp85 -142.06 122.97 14.44 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.907 -0.568 . . . . 0.0 109.945 -175.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.43 154.77 36.1 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.52 1.128 . . . . 0.0 108.281 158.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -145.83 139.46 26.37 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 167.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.424 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 52.9 t-20 -82.8 118.53 23.47 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 120.177 1.353 . . . . 0.0 112.689 -172.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -100.83 -9.39 21.72 Favored 'General case' 0 C--N 1.346 0.442 0 C-N-CA 124.16 0.984 . . . . 0.0 113.222 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.37 142.44 36.01 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 119.857 1.208 . . . . 0.0 108.988 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.6 m -78.37 36.2 0.24 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.5 p -153.39 155.78 31.95 Favored Pre-proline 0 N--CA 1.451 -0.405 0 C-N-CA 125.591 1.557 . . . . 0.0 108.336 175.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.0 145.07 89.37 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 N-CA-C 108.235 -1.486 . . . . 0.0 108.235 169.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.0 p -117.55 178.14 4.5 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 168.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.1 t -124.27 126.43 46.06 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -98.26 109.17 3.75 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 107.167 -2.373 . . . . 0.0 107.167 175.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.58 49.37 1.8 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 162.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 143' ' ' THR . . . -61.82 143.89 55.64 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.375 0.67 . . . . 0.0 111.271 -175.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.12 155.89 27.27 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.754 174.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -151.66 147.22 26.47 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -103.4 100.77 10.65 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 170.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.6 p -89.06 83.52 2.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 CA-C-O 118.079 -0.962 . . . . 0.0 108.41 175.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.2 t 176.97 147.08 0.29 Allowed Pre-proline 0 C--O 1.232 0.162 0 C-N-CA 124.644 1.178 . . . . 0.0 109.496 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -64.26 -39.35 30.59 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 120.666 0.91 . . . . 0.0 110.342 156.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.1 ptp 177.9 -71.67 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.594 1.958 . . . . 0.0 107.976 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.15 -37.47 33.39 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.944 0.898 . . . . 0.0 112.859 -168.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.2 -118.05 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.315 0.646 . . . . 0.0 110.337 -174.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.0 -53.45 2.16 Favored Glycine 0 CA--C 1.526 0.72 0 O-C-N 121.216 -0.928 . . . . 0.0 112.652 -175.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -41.64 -58.86 1.81 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.844 1.258 . . . . 0.0 110.623 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -74.83 -8.61 56.97 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -53.67 117.72 3.36 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.36 0.982 . . . . 0.0 108.585 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 . . . . . 0 N--CA 1.45 -0.453 0 CA-C-O 121.264 0.555 . . . . 0.0 111.398 -159.9 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 CA--C 1.535 0.369 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.2 t 52.67 -143.52 0.7 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.173 0.989 . . . . 0.0 112.593 166.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.2 m -124.8 133.31 53.17 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 127.538 2.335 . . . . 0.0 105.864 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 86.8 mt -122.19 120.14 33.31 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 175.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -56.2 159.73 5.7 Favored Pre-proline 0 N--CA 1.447 -0.591 0 C-N-CA 123.864 0.865 . . . . 0.0 110.541 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -67.12 102.97 0.7 Allowed 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.202 2.601 . . . . 0.0 112.308 -169.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 122.63 -16.22 8.44 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -78.2 148.55 33.98 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 118.001 0.9 . . . . 0.0 110.877 -166.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.4 141.17 36.41 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.385 1.874 . . . . 0.0 109.173 -169.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 46.3 ttp -135.52 82.87 1.98 Allowed 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.621 1.168 . . . . 0.0 109.371 173.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -104.25 113.1 26.42 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.078 1.751 . . . . 0.0 107.725 171.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 40.4 mtm -137.29 126.62 15.26 Favored Pre-proline 0 C--O 1.235 0.337 0 CA-C-N 118.386 0.539 . . . . 0.0 111.748 -170.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -74.73 139.81 25.49 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.618 2.212 . . . . 0.0 112.517 173.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.7 t -128.99 151.04 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.1 p -118.28 142.16 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 170.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -144.53 158.31 43.82 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 118.948 0.795 . . . . 0.0 111.294 -175.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -162.28 168.61 22.03 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 127.671 2.389 . . . . 0.0 106.695 173.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 49.4 t -112.39 145.36 18.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 C-N-CA 124.252 1.021 . . . . 0.0 108.363 174.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -77.04 157.77 80.93 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 123.968 0.907 . . . . 0.0 110.924 -177.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -79.41 -22.65 7.96 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.723 2.282 . . . . 0.0 112.742 166.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -53.74 -37.12 63.03 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.234 1.013 . . . . 0.0 111.516 -171.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.2 tt -40.03 -34.09 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.534 1.934 . . . . 0.0 114.793 171.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.4 m -106.71 22.56 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 119.786 1.175 . . . . 0.0 112.956 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.1 -48.08 0.48 Allowed Pre-proline 0 CA--C 1.545 0.762 0 O-C-N 120.854 -1.154 . . . . 0.0 113.29 167.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -81.15 -165.73 0.36 Allowed 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.345 2.697 . . . . 0.0 110.374 -171.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.7 t -95.22 -51.23 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -31.85 -61.88 0.22 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 129.263 3.025 . . . . 0.0 113.499 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.2 p -92.5 -5.17 52.37 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 123.335 0.654 . . . . 0.0 112.641 -174.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -54.31 107.63 0.29 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.972 0.909 . . . . 0.0 111.295 -169.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 120.92 -27.22 6.54 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 123.98 0.8 . . . . 0.0 111.59 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 45.8 mm -64.7 125.67 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 118.168 0.984 . . . . 0.0 109.692 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -157.07 51.34 0.48 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.582 172.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.42 87.4 2.01 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 167.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.2 tp -88.88 89.31 7.93 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -160.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.6 t -102.01 171.95 7.21 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 122.443 1.116 . . . . 0.0 111.7 -171.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.97 108.33 2.38 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 -160.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.4 t -92.63 116.23 28.82 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 168.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.417 ' HE1' ' HB3' ' A' ' 82' ' ' ALA . 0.6 OUTLIER -114.47 114.23 25.53 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 118.644 0.656 . . . . 0.0 109.579 -179.05 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.466 ' O ' ' HB1' ' A' ' 82' ' ' ALA . 1.4 m -100.63 87.17 3.28 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.392 0.677 . . . . 0.0 111.34 -167.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -67.87 84.16 0.21 Allowed 'General case' 0 CA--C 1.54 0.56 0 O-C-N 122.044 -0.41 . . . . 0.0 110.513 173.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.3 22.39 0.05 OUTLIER Pre-proline 0 CA--C 1.556 1.209 0 N-CA-C 118.448 2.759 . . . . 0.0 118.448 -175.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.87 -81.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.021 2.481 . . . . 0.0 113.424 -168.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.5 ptm85 -155.6 140.78 17.51 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 119.866 1.212 . . . . 0.0 113.102 177.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.62 147.83 44.17 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 125.765 1.626 . . . . 0.0 106.97 175.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.38 -37.02 0.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.371 2.048 . . . . 0.0 113.52 -176.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.8 m 155.26 96.52 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 129.533 3.133 . . . . 0.0 108.653 -174.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 18.2 pttp . . . . . 0 CA--C 1.538 0.484 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.501 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.668 ' HB3' HD11 ' A' ' 28' ' ' ILE . . . . . . . . 0 N--CA 1.447 -0.598 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 83.4 p -153.72 172.93 16.52 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 156.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -79.06 -32.92 45.01 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.955 174.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -87.45 -41.47 13.52 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.279 1.031 . . . . 0.0 111.971 -170.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.668 HD11 ' HB3' ' A' ' 24' ' ' ALA . 61.1 mt 28.32 74.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 126.859 2.063 . . . . 0.0 112.655 -173.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.419 HD22 ' H ' ' A' ' 29' ' ' LEU . 2.3 mm? -70.02 164.72 23.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.696 170.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -65.02 -31.69 73.04 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -176.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.23 129.78 10.29 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 122.276 1.036 . . . . 0.0 113.376 -165.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -91.74 83.28 5.27 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 122.374 1.083 . . . . 0.0 108.513 -169.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.65 120.48 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 171.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.82 170.63 9.54 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.558 1.143 . . . . 0.0 109.193 -170.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.6 t -144.94 146.42 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 169.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.7 m -141.3 104.12 4.55 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -176.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -82.15 125.09 30.49 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 125.596 1.559 . . . . 0.0 110.258 -174.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -102.51 89.05 3.41 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 163.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -99.96 89.11 3.95 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 172.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -111.69 151.32 29.02 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 123.805 0.842 . . . . 0.0 110.415 -171.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.39 105.71 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.985 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.22 150.96 36.98 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 163.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.82 -29.28 4.43 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.595 0.758 . . . . 0.0 112.901 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -36.97 -40.04 0.47 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.605 1.574 . . . . 0.0 113.791 170.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.403 HD21 ' CD2' ' A' ' 47' ' ' TRP . 0.9 OUTLIER -109.32 120.13 46.38 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 162.524 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -84.33 14.62 2.39 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 121.451 1.434 . . . . 0.0 113.553 -169.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.49 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 41.1 m0 -79.25 156.64 28.03 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 121.969 0.89 . . . . 0.0 111.43 -177.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -74.9 138.81 42.66 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 104.262 -2.495 . . . . 0.0 104.262 158.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -143.99 128.87 18.42 Favored 'General case' 0 N--CA 1.458 -0.059 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.2 t -122.95 123.66 26.74 Favored Pre-proline 0 N--CA 1.444 -0.732 0 C-N-CA 125.311 1.444 . . . . 0.0 108.557 -168.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -74.81 146.64 33.73 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 123.958 3.106 . . . . 0.0 107.497 166.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.443 HG21 ' HB ' ' A' ' 66' ' ' ILE . 2.2 t -77.93 -58.59 3.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -170.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -122.51 163.91 19.06 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 103.41 -2.811 . . . . 0.0 103.41 155.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.1 tpt180 -58.07 -47.66 82.51 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 169.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -139.97 165.35 27.57 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 125.63 1.572 . . . . 0.0 110.27 -166.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.4 pt -141.79 162.8 20.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 C-N-CA 124.676 1.19 . . . . 0.0 108.226 175.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -106.4 139.41 40.92 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 162.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.05 81.33 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 175.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.7 mmm-85 -56.94 111.97 1.19 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.723 1.209 . . . . 0.0 110.687 -166.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.477 ' O ' HG22 ' A' ' 60' ' ' ILE . 33.5 mm 16.4 56.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 126.239 1.816 . . . . 0.0 113.185 -160.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.581 ' C ' ' HB1' ' A' ' 24' ' ' ALA . . . 125.45 -73.21 0.43 Allowed Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 22.19 86.52 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.347 2.259 . . . . 0.0 113.555 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.86 119.13 6.16 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.194 0.997 . . . . 0.0 111.541 -169.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.15 152.9 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 123.42 0.688 . . . . 0.0 110.481 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.75 126.09 51.84 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 126.471 1.908 . . . . 0.0 108.013 174.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.443 ' HB ' HG21 ' A' ' 52' ' ' VAL . 1.9 pp -125.36 113.49 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 168.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.87 106.49 10.93 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.27 0.628 . . . . 0.0 112.683 176.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -77.33 149.13 35.33 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 171.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 -139.01 138.28 37.08 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 123.418 0.449 . . . . 0.0 110.473 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.61 171.87 10.75 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.611 1.564 . . . . 0.0 110.046 164.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.6 136.45 15.36 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 177.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.49 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 37.6 t30 -78.12 128.49 33.88 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 120.258 1.39 . . . . 0.0 111.175 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 tp -118.95 26.01 9.82 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.671 1.988 . . . . 0.0 111.885 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -103.96 174.18 5.98 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.805 1.242 . . . . 0.0 110.201 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.3 p -97.06 11.37 36.42 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.043 1.337 . . . . 0.0 111.524 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.41 161.1 42.85 Favored Pre-proline 0 C--O 1.239 0.531 0 C-N-CA 125.071 1.348 . . . . 0.0 107.942 -177.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -56.4 158.7 14.9 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 121.382 1.388 . . . . 0.0 109.877 164.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.431 ' HG1' ' HE1' ' A' ' 47' ' ' TRP . 6.8 p -134.72 -177.83 4.79 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.848 2.459 . . . . 0.0 108.025 -176.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.1 t -138.6 140.46 38.97 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 159.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -94.46 93.73 1.7 Allowed Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 107.255 -2.338 . . . . 0.0 107.255 170.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -112.59 47.04 1.12 Allowed 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 167.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.62 170.4 16.39 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 171.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.5 t -144.6 158.96 43.54 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 166.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -84.9 155.17 21.8 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.242 1.417 . . . . 0.0 109.867 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -109.78 100.44 9.44 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 149.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.8 t -80.7 100.61 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 125.303 1.441 . . . . 0.0 107.477 174.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.6 t 172.27 151.25 0.21 Allowed Pre-proline 0 C--N 1.343 0.293 0 C-N-CA 126.825 2.05 . . . . 0.0 109.055 168.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -66.83 -49.31 1.57 Allowed 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 121.029 1.153 . . . . 0.0 109.584 153.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.1 ptt? -173.55 -72.7 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.989 1.715 . . . . 0.0 107.907 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.46 -40.47 85.35 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -171.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.46 -100.61 0.02 OUTLIER 'General case' 0 C--N 1.339 0.116 0 CA-C-N 117.912 0.324 . . . . 0.0 111.692 -170.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.09 -61.01 1.4 Allowed Glycine 0 CA--C 1.53 0.999 0 CA-C-O 119.447 -0.64 . . . . 0.0 111.799 -172.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.59 -56.67 5.69 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.837 1.255 . . . . 0.0 111.85 -176.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -72.97 5.0 3.6 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.405 1.082 . . . . 0.0 113.917 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -80.02 116.42 20.14 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 173.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 . . . . . 0 N--CA 1.45 -0.459 0 C-N-CA 119.253 -0.979 . . . . 0.0 112.055 -171.008 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . 0.255 6.3 t 50.16 -124.38 2.1 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.358 1.463 . . . . 0.0 111.962 170.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.0 m -145.16 151.28 38.19 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.66 2.384 . . . . 0.0 107.255 -172.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.533 HD11 ' HB2' ' A' ' 114' ' ' MET . 70.5 mt -135.8 132.67 37.0 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 171.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -64.19 158.15 65.95 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 125.04 1.336 . . . . 0.0 109.959 169.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.18 93.68 0.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.712 2.941 . . . . 0.0 112.539 -169.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 140.25 -28.7 2.46 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -77.93 150.55 34.01 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 117.594 0.697 . . . . 0.0 112.531 -155.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -86.18 155.84 20.57 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.82 2.048 . . . . 0.0 110.527 -174.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.533 ' HB2' HD11 ' A' ' 108' ' ' LEU . 19.2 ttm -148.75 89.22 1.67 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.414 1.086 . . . . 0.0 109.417 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -106.89 143.9 34.31 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.167 0.894 . . . . 0.0 110.657 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -150.09 107.63 3.21 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 124.147 0.979 . . . . 0.0 112.33 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.71 108.61 0.27 Allowed 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 124.961 3.774 . . . . 0.0 112.541 165.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.3 t -100.97 117.86 46.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 171.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.8 p -79.19 142.02 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 168.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -154.78 159.33 40.56 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -175.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -177.7 160.79 1.58 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.322 2.249 . . . . 0.0 109.928 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 94.6 t -121.41 131.8 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.6 1.16 . . . . 0.0 109.689 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.1 148.17 38.78 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -176.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -74.76 57.81 4.52 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 124.202 3.268 . . . . 0.0 112.698 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -104.02 -41.67 5.78 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.053 0.941 . . . . 0.0 109.833 162.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.8 tt -47.89 -42.9 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 124.361 1.064 . . . . 0.0 113.846 -169.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.2 m -78.83 51.05 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 O-C-N 121.064 -1.022 . . . . 0.0 111.166 176.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -133.7 -72.28 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 124.796 1.239 . . . . 0.0 111.147 173.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.08 136.75 45.69 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 121.833 1.688 . . . . 0.0 112.675 -175.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 97.6 t -40.6 -53.23 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 126.4 1.88 . . . . 0.0 109.751 178.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -33.19 -47.28 0.19 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 127.893 2.477 . . . . 0.0 113.759 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 35.1 p -106.42 -6.94 17.86 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -173.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -57.7 107.45 0.45 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.379 0.991 . . . . 0.0 111.031 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 132.14 -38.35 1.91 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.035 1.303 . . . . 0.0 109.895 -173.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 23.5 mm -70.17 121.94 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 O-C-N 122.186 -0.597 . . . . 0.0 111.045 -175.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -156.33 54.65 0.56 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 122.086 0.946 . . . . 0.0 111.016 166.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 66.6 m -146.84 93.4 2.27 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 159.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.1 tp -84.62 88.41 7.34 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.388 0.613 . . . . 0.0 109.677 -162.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.6 m -86.27 155.96 20.46 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.055 0.942 . . . . 0.0 110.88 -162.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 14.6 tp -123.06 131.18 53.59 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 170.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.0 p -114.01 107.45 15.69 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 165.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -109.77 91.89 3.83 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.927 0.891 . . . . 0.0 109.261 -175.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.5 p -78.93 93.11 5.0 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.458 0.703 . . . . 0.0 110.004 176.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -59.43 96.0 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 159.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.57 61.31 3.83 Favored Pre-proline 0 CA--C 1.549 0.928 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 172.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -86.94 -99.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 124.123 3.215 . . . . 0.0 110.149 174.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -127.72 133.86 49.55 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 124.47 1.108 . . . . 0.0 110.297 -176.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.86 117.23 42.25 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 126.831 2.052 . . . . 0.0 105.809 174.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.44 -26.77 6.96 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.836 2.358 . . . . 0.0 112.95 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.7 m 140.82 101.73 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 129.553 3.141 . . . . 0.0 108.927 -175.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.518 0 C-N-CA 123.58 0.752 . . . . 0.0 112.845 -178.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.418 0 CA-C-O 119.616 -0.23 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.1 t -146.55 58.43 1.19 Allowed 'General case' 0 C--N 1.344 0.363 0 C-N-CA 130.447 3.499 . . . . 0.0 107.91 13.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -157.24 -54.52 0.08 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.868 2.067 . . . . 0.0 105.677 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.1 mt -27.72 -24.03 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.564 1 C-N-CA 132.658 4.383 . . . . 0.0 116.946 174.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.4 mt -81.6 51.62 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 126.023 1.729 . . . . 0.0 110.649 -160.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.48 164.18 24.96 Favored 'General case' 0 C--N 1.334 -0.101 0 O-C-N 121.348 -0.845 . . . . 0.0 108.742 -176.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -74.86 73.88 2.12 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 122.558 1.17 . . . . 0.0 112.007 -175.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.46 160.37 40.28 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 129.854 3.262 . . . . 0.0 106.624 173.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -146.76 111.46 5.27 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -173.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.82 124.3 72.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -169.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.74 149.12 25.1 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 124.358 1.063 . . . . 0.0 109.336 -176.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.5 t -141.37 96.65 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -171.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.4 m -79.86 107.22 12.47 Favored 'General case' 0 C--O 1.221 -0.422 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 169.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -79.51 166.88 21.49 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 171.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -136.53 90.41 2.55 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 122.137 0.97 . . . . 0.0 111.972 167.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.81 127.25 32.39 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 158.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -132.42 150.87 52.08 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 124.497 1.119 . . . . 0.0 108.248 173.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.97 99.9 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 124.018 0.927 . . . . 0.0 109.339 -178.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.08 169.21 10.81 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.357 0.599 . . . . 0.0 110.058 168.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.29 147.5 35.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 169.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 113.77 -20.6 17.41 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -168.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.56 HD13 ' CD2' ' A' ' 144' ' ' PHE . 0.3 OUTLIER -137.62 95.36 11.29 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 123.77 0.828 . . . . 0.0 109.523 178.046 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -84.31 45.82 1.81 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.679 2.919 . . . . 0.0 110.45 -169.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.497 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 44.4 m0 -113.89 147.03 39.18 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.935 0.894 . . . . 0.0 109.787 -165.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -76.63 81.87 3.28 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 104.588 -2.375 . . . . 0.0 104.588 173.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -90.89 108.83 20.1 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.06 121.54 16.86 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -171.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -81.53 166.3 17.83 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.631 2.221 . . . . 0.0 108.7 168.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.402 ' H ' HG22 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -77.07 -40.41 30.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 122.114 -0.366 . . . . 0.0 111.249 177.96 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -154.64 175.26 13.89 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 172.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -60.35 -59.26 5.69 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 167.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -137.32 130.8 31.28 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 122.853 0.461 . . . . 0.0 112.098 -155.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.7 pt -99.86 175.85 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 169.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -126.97 150.89 49.18 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 152.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.6 m -130.35 131.31 65.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . 0.255 4.3 tpt180 -72.62 74.5 1.08 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 167.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.4 pt 15.68 51.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 131.111 3.764 . . . . 0.0 115.286 -176.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.12 -39.44 0.77 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.491 -169.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -36.01 109.58 0.09 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.743 1.217 . . . . 0.0 111.153 168.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.07 99.06 6.75 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.347 1.459 . . . . 0.0 109.068 -168.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 p -76.52 176.39 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.959 0.885 . . . . 0.0 110.809 -171.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.13 89.84 2.38 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 172.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.9 pp -105.48 118.98 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 173.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 89.6 mtp -77.27 140.56 40.09 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -111.73 145.08 39.94 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 168.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -140.86 135.32 31.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.956 0.902 . . . . 0.0 109.962 -177.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.39 90.97 1.7 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.691 1.996 . . . . 0.0 110.033 174.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -79.32 148.34 32.12 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 117.044 -1.455 . . . . 0.0 107.996 172.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.497 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 35.7 t30 -89.82 110.18 21.13 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 120.332 1.424 . . . . 0.0 111.469 172.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.3 tp -86.88 -4.65 59.2 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.379 1.071 . . . . 0.0 112.809 -176.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.2 171.17 14.96 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.397 -0.815 . . . . 0.0 109.873 -175.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.0 m -105.78 18.54 21.99 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.506 175.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.8 p -144.61 160.17 48.6 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 127.411 2.284 . . . . 0.0 106.428 170.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.07 152.77 79.6 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.523 1.482 . . . . 0.0 109.836 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.36 167.12 15.38 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.445 0.641 . . . . 0.0 111.146 166.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.4 t -98.64 168.24 10.29 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 113.888 -1.506 . . . . 0.0 107.834 156.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -145.26 63.8 0.46 Allowed Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 106.345 -2.702 . . . . 0.0 106.345 173.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.39 56.25 3.29 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 -176.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.51 147.66 32.11 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.148 -1.387 . . . . 0.0 111.177 -164.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 m -79.76 160.89 26.02 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 174.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -143.32 138.99 29.9 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 172.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.97 90.59 4.96 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 169.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.6 57.82 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 O-C-N 121.837 -0.539 . . . . 0.0 110.702 -176.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.1 t -171.17 145.0 1.8 Allowed Pre-proline 0 C--N 1.333 -0.144 0 O-C-N 121.538 -0.726 . . . . 0.0 111.484 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.87 -37.38 66.85 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 121.456 1.437 . . . . 0.0 108.763 164.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.5 ptm -179.95 -68.59 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.556 1.942 . . . . 0.0 107.617 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -90.25 -28.61 18.71 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.138 0.975 . . . . 0.0 112.831 -164.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.44 -114.56 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.396 0.278 . . . . 0.0 110.489 -168.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.27 -40.24 0.47 Allowed Glycine 0 CA--C 1.533 1.18 0 O-C-N 121.314 -0.866 . . . . 0.0 114.778 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -51.87 -65.15 0.61 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.11 1.455 . . . . 0.0 108.302 166.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -72.7 29.0 0.06 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.469 2.308 . . . . 0.0 112.173 177.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -105.18 101.3 10.86 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 168.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.8 p30 . . . . . 0 C--N 1.325 -0.491 0 C-N-CA 122.7 0.4 . . . . 0.0 111.313 177.971 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 CA--C 1.54 0.569 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . 0.32 13.2 t 52.5 -71.84 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 117.849 2.537 . . . . 0.0 117.849 161.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -159.65 143.75 14.78 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.592 1.557 . . . . 0.0 109.383 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.6 mt -151.77 140.95 21.32 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.217 1.007 . . . . 0.0 110.273 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.9 mp0 -74.89 161.28 78.27 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 127.085 2.154 . . . . 0.0 110.392 172.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -75.51 111.11 3.23 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.74 1.626 . . . . 0.0 113.21 -165.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 115.13 -12.13 19.8 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 176.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -85.77 152.09 23.31 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.2 -161.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -107.6 122.37 46.55 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.75 1.22 . . . . 0.0 109.311 -160.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.73 112.7 17.04 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 124.597 1.159 . . . . 0.0 110.213 177.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -143.05 145.87 33.3 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.759 0.709 . . . . 0.0 110.176 160.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 23.5 ptm -156.3 156.27 30.0 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-O 119.135 -0.46 . . . . 0.0 111.051 173.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.89 148.23 81.88 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.374 2.716 . . . . 0.0 111.996 171.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.6 t -126.23 134.6 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.93 1.692 . . . . 0.0 106.878 167.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.6 p -100.02 143.96 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.999 1.32 . . . . 0.0 108.015 174.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -158.95 146.85 17.85 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -176.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -164.77 95.34 0.71 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.034 0.533 . . . . 0.0 111.81 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.2 t -40.64 130.71 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 125.936 1.694 . . . . 0.0 112.99 -173.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.3 119.71 77.28 Favored Pre-proline 0 N--CA 1.44 -0.968 0 C-N-CA 125.277 1.431 . . . . 0.0 107.283 -169.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.13 55.8 4.67 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.147 2.565 . . . . 0.0 111.823 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -109.5 -28.68 8.78 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.997 2.119 . . . . 0.0 109.523 169.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.4 tt -54.98 -42.98 67.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -173.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.6 m -78.09 51.89 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 118.78 0.718 . . . . 0.0 111.037 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -139.42 -69.59 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.901 -177.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -73.48 152.41 48.9 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.295 1.996 . . . . 0.0 113.449 -175.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.5 p -55.27 -30.91 25.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.136 1.374 . . . . 0.0 111.886 175.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -36.23 -55.3 0.8 Allowed 'General case' 0 C--N 1.339 0.115 0 C-N-CA 126.691 1.996 . . . . 0.0 112.311 173.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.4 p -108.58 -54.93 2.45 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.121 -163.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 26.67 51.84 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.382 2.673 . . . . 0.0 115.229 169.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 144.57 -40.58 1.15 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -170.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 35.0 mm -55.64 119.55 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 169.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.96 45.35 0.39 Allowed 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 123.711 0.632 . . . . 0.0 109.737 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.43 91.6 1.99 Allowed 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 171.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.1 mp -76.07 150.06 37.36 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -172.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.7 t -148.21 175.57 10.95 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -178.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.5 tt -154.32 110.3 3.22 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 174.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.8 t -87.82 95.96 10.28 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.19 92.88 6.37 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -174.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.14 89.33 5.99 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 122.245 1.021 . . . . 0.0 110.584 -170.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.56 ' CD2' HD13 ' A' ' 45' ' ' LEU . 4.1 m-30 -78.14 98.19 5.73 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.733 173.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -153.05 37.66 0.11 Allowed Pre-proline 0 CA--C 1.552 1.032 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 172.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.54 ' CD ' HD12 ' A' ' 45' ' ' LEU . 69.6 Cg_endo -72.8 -90.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.694 0 CA-C-N 122.033 1.762 . . . . 0.0 113.557 -174.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 31.9 mtt85 -148.58 110.12 4.45 Favored 'General case' 0 C--N 1.34 0.187 0 O-C-N 121.352 -0.843 . . . . 0.0 109.211 -174.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -97.26 122.07 56.96 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 172.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -79.46 -51.68 0.06 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.55 2.167 . . . . 0.0 110.512 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 44.6 p -171.67 111.23 0.31 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.993 -0.527 . . . . 0.0 109.587 -167.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.7 pttm . . . . . 0 CA--C 1.538 0.506 0 C-N-CA 123.362 0.665 . . . . 0.0 112.398 172.621 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.624 ' N ' ' HG1' ' A' ' 63' ' ' THR . . . . . . . . 0 N--CA 1.446 -0.639 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.8 t -164.7 47.03 0.1 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.377 1.071 . . . . 0.0 109.822 -171.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -156.4 -51.39 0.08 Allowed 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 124.494 1.118 . . . . 0.0 108.372 -175.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.31 -27.73 69.23 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.782 175.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.531 ' C ' HD13 ' A' ' 29' ' ' LEU . 3.6 mt -80.81 131.73 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 C-N-CA 123.731 0.812 . . . . 0.0 112.165 -161.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.531 HD13 ' C ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -114.94 148.97 38.02 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 171.18 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -78.26 67.29 4.03 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 122.128 0.966 . . . . 0.0 112.154 -167.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.405 ' OE2' ' NZ ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -103.56 -169.54 1.66 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 129.556 3.142 . . . . 0.0 106.381 175.397 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -145.31 137.13 25.48 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.305 -0.872 . . . . 0.0 110.217 168.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.556 HD12 HG21 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -132.42 103.67 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 C-N-CA 126.162 1.785 . . . . 0.0 106.65 -177.903 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -79.4 131.1 36.0 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -177.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.421 HG11 ' CE1' ' A' ' 120' ' ' PHE . 52.1 t -113.1 132.76 61.03 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -177.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.2 m -106.7 101.53 10.97 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.299 1.44 . . . . 0.0 109.235 -173.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -79.05 84.22 5.07 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -171.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -84.19 83.61 7.91 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 122.931 1.348 . . . . 0.0 111.447 -172.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.74 123.49 31.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.699 176.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -131.22 142.87 50.23 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 173.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.7 t -135.78 141.91 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -117.71 157.09 27.12 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 161.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.95 -33.14 7.29 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.812 0.845 . . . . 0.0 112.299 -175.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -31.21 -44.69 0.11 Allowed Glycine 0 CA--C 1.531 1.089 0 C-N-CA 126.828 2.156 . . . . 0.0 114.323 165.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.646 HD13 ' CD2' ' A' ' 144' ' ' PHE . 0.5 OUTLIER -102.37 108.57 57.79 Favored Pre-proline 0 N--CA 1.454 -0.225 0 CA-C-N 119.475 1.638 . . . . 0.0 107.008 161.978 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.76 -3.51 12.41 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 121.148 1.232 . . . . 0.0 113.3 -164.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.512 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 47.6 m0 -73.34 154.73 39.98 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.591 1.156 . . . . 0.0 111.297 -167.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -76.6 81.75 3.26 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 171.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -95.65 124.42 39.66 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.6 m -125.8 138.08 31.3 Favored Pre-proline 0 CA--C 1.532 0.256 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -70.18 161.47 45.88 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 N-CA-C 108.377 -1.432 . . . . 0.0 108.377 161.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -77.78 -46.73 26.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 175.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -155.77 174.81 14.77 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 166.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -67.11 -33.42 75.43 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.118 0.417 . . . . 0.0 111.836 -174.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.76 161.72 39.78 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.025 0.93 . . . . 0.0 110.346 -171.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.5 pt -130.37 160.28 41.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 172.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -106.65 95.37 5.69 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.221 1.008 . . . . 0.0 109.359 168.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.2 t -77.54 167.35 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 168.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 23.1 mtm180 -128.35 98.47 5.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 171.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.1 pt 9.05 69.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 127.76 2.424 . . . . 0.0 114.725 -175.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.27 -34.26 2.74 Favored Glycine 0 C--O 1.22 -0.768 0 C-N-CA 124.807 1.194 . . . . 0.0 111.33 173.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -50.08 106.52 0.12 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 118.83 1.315 . . . . 0.0 112.245 -166.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.624 ' HG1' ' N ' ' A' ' 24' ' ' ALA . 87.2 m -67.82 108.94 3.17 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.648 1.179 . . . . 0.0 111.359 -171.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.1 p -86.81 176.48 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 123.299 0.64 . . . . 0.0 110.322 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -124.52 129.97 51.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.819 0.848 . . . . 0.0 109.471 161.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.5 pp -139.45 96.12 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.655 1.182 . . . . 0.0 110.661 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 35.7 ttm -77.59 100.05 5.97 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.934 0.894 . . . . 0.0 111.342 -174.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -77.65 164.52 25.23 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.886 -0.509 . . . . 0.0 110.92 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.8 ttm105 -144.94 138.39 26.85 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.542 1.137 . . . . 0.0 111.799 -177.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.19 149.51 48.96 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 130.041 3.336 . . . . 0.0 107.608 159.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -137.17 135.62 37.49 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 161.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.512 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 0.1 OUTLIER -79.89 83.6 5.79 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.644 1.111 . . . . 0.0 111.301 -172.906 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.42 75.98 8.36 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.923 1.289 . . . . 0.0 108.902 171.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.06 158.62 44.16 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 167.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.1 t -87.6 -1.22 57.8 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 119.148 -0.453 . . . . 0.0 111.88 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.11 160.83 41.79 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.788 1.235 . . . . 0.0 109.076 -175.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.37 139.93 32.66 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.18 2.587 . . . . 0.0 111.902 -170.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.3 p -105.59 -176.07 2.97 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.393 1.877 . . . . 0.0 110.69 -169.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.4 t -148.39 136.05 20.69 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 160.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -123.42 76.01 0.37 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -170.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.86 33.21 1.05 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.495 0.718 . . . . 0.0 110.812 -171.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.51 162.11 29.91 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.365 0.602 . . . . 0.0 111.733 -162.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.4 t -144.44 178.06 8.21 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.288 0.635 . . . . 0.0 109.802 175.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.17 164.85 26.75 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 125.955 1.702 . . . . 0.0 110.973 -167.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -120.82 86.73 2.62 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.927 1.691 . . . . 0.0 107.103 174.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.56 HG11 ' CD2' ' A' ' 95' ' ' PHE . 3.2 t -82.31 54.47 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.823 -164.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.2 t -171.47 143.21 1.48 Allowed Pre-proline 0 N--CA 1.457 -0.112 0 O-C-N 121.393 -0.817 . . . . 0.0 110.317 -169.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.02 -36.43 30.14 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 121.695 1.597 . . . . 0.0 108.044 169.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.5 ptp 177.31 -68.26 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 127.824 2.449 . . . . 0.0 106.745 176.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.87 -48.33 69.12 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.719 1.208 . . . . 0.0 113.055 -165.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.27 -102.3 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.669 -162.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.23 -61.04 0.25 Allowed Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.498 -0.612 . . . . 0.0 113.352 -173.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -45.59 -50.79 12.84 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.004 1.322 . . . . 0.0 111.216 177.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -72.93 5.19 3.45 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.906 1.283 . . . . 0.0 113.632 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.56 ' CD2' HG11 ' A' ' 86' ' ' VAL . 9.6 t80 -72.35 131.39 42.58 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 121.098 -1.001 . . . . 0.0 109.8 174.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 . . . . . 0 N--CA 1.44 -0.954 0 C-N-CA 119.822 -0.751 . . . . 0.0 112.878 172.215 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 . . . . . 0 CA--C 1.538 0.495 0 CA-C-O 120.758 0.313 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.9 t 42.99 -145.17 0.08 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.104 1.762 . . . . 0.0 112.989 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -119.22 124.66 47.28 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 127.586 2.354 . . . . 0.0 106.101 177.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.453 HD11 ' HG3' ' A' ' 114' ' ' MET . 97.3 mt -106.3 151.52 24.73 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 173.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.421 ' HB3' ' HD2' ' A' ' 110' ' ' PRO . 17.7 mt-10 -91.97 163.76 26.25 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 126.012 1.725 . . . . 0.0 108.394 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 109' ' ' GLU . 69.8 Cg_endo -70.73 79.88 1.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.647 2.898 . . . . 0.0 112.272 -167.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 157.85 -29.87 0.49 Allowed Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.821 -175.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -76.29 135.18 39.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.573 1.187 . . . . 0.0 112.034 -153.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -86.83 137.6 32.27 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.295 1.438 . . . . 0.0 110.57 -178.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.453 ' HG3' HD11 ' A' ' 108' ' ' LEU . 1.7 mmt -133.9 85.53 2.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.088 1.355 . . . . 0.0 109.532 176.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.68 128.25 45.12 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.35 0.66 . . . . 0.0 109.444 173.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 84.9 mtp -150.98 147.54 20.96 Favored Pre-proline 0 C--O 1.234 0.241 0 C-N-CA 123.399 0.68 . . . . 0.0 109.812 -165.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.18 146.28 63.25 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.785 2.323 . . . . 0.0 110.44 174.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.7 t -144.32 147.51 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.0 m -109.34 164.59 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 174.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.421 ' CE1' HG11 ' A' ' 35' ' ' VAL . 4.1 t80 -156.1 129.49 8.22 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.65 168.83 23.13 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 122.904 0.482 . . . . 0.0 110.476 168.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.556 HG21 HD12 ' A' ' 33' ' ' ILE . 18.2 t -119.14 129.46 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.809 1.243 . . . . 0.0 109.709 176.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.89 133.54 58.19 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 118.923 0.783 . . . . 0.0 110.249 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -56.34 -23.03 44.29 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.328 2.685 . . . . 0.0 114.767 -171.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -56.75 -13.68 2.72 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 119.182 0.901 . . . . 0.0 112.861 176.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.4 tt -46.05 -42.32 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 O-C-N 121.087 -1.008 . . . . 0.0 111.718 165.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.2 m -87.09 63.15 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 119.372 0.987 . . . . 0.0 110.9 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 51.8 mttt -130.27 -67.8 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 124.184 0.994 . . . . 0.0 112.345 164.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -85.27 162.66 11.34 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 121.8 1.666 . . . . 0.0 114.188 -160.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 99.2 t -53.96 -35.1 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 125.754 1.622 . . . . 0.0 110.874 176.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -38.54 -57.12 1.2 Allowed 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.475 1.51 . . . . 0.0 111.169 173.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 14.1 p -102.8 -53.45 2.85 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 123.965 0.906 . . . . 0.0 109.197 -163.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 26.15 55.34 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.152 2.581 . . . . 0.0 115.175 174.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 134.99 -36.98 1.99 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -176.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.1 mm -51.43 125.97 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 123.182 0.593 . . . . 0.0 109.864 173.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.405 ' NZ ' ' OE2' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -156.4 49.57 0.49 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.78 0.832 . . . . 0.0 109.79 175.726 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.18 89.91 1.77 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -178.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.431 HD22 HG22 ' A' ' 122' ' ' VAL . 2.0 mp -76.44 162.25 28.0 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 122.294 1.045 . . . . 0.0 108.81 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.4 t -155.03 178.79 9.8 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.94 88.53 1.47 Allowed 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 124.471 1.107 . . . . 0.0 109.029 165.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.1 t -75.72 107.26 7.77 Favored 'General case' 0 N--CA 1.457 -0.093 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -178.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -112.67 137.05 51.52 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 122.775 0.43 . . . . 0.0 109.888 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 32.2 m -118.45 91.51 3.58 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.532 1.533 . . . . 0.0 107.82 177.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.646 ' CD2' HD13 ' A' ' 45' ' ' LEU . 3.5 m-85 -72.27 97.72 2.05 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.946 178.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -156.11 58.28 1.71 Allowed Pre-proline 0 CA--C 1.551 1.018 0 N-CA-C 116.894 2.183 . . . . 0.0 116.894 -177.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.415 ' HD3' HD12 ' A' ' 45' ' ' LEU . 74.5 Cg_endo -80.68 -90.8 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.424 2.749 . . . . 0.0 112.445 175.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.17 104.97 2.85 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.658 0.663 . . . . 0.0 111.631 -171.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -79.3 140.12 56.4 Favored Pre-proline 0 N--CA 1.449 -0.522 0 O-C-N 121.547 -0.721 . . . . 0.0 109.173 174.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -84.35 60.17 6.08 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 121.981 1.787 . . . . 0.0 107.711 169.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 19.9 m 44.39 81.27 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.88 2.072 . . . . 0.0 113.514 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.7 pttt . . . . . 0 CA--C 1.543 0.677 0 CA-C-N 119.026 0.83 . . . . 0.0 112.111 -170.001 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.468 ' CB ' ' H ' ' A' ' 63' ' ' THR . . . . . . . . 0 N--CA 1.422 -1.845 0 N-CA-C 104.165 -2.532 . . . . 0.0 104.165 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.3 m -157.27 25.71 0.3 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -159.26 -55.13 0.06 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 -174.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.62 37.26 0.86 Allowed 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 112.699 -2.046 . . . . 0.0 110.892 -161.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.406 HD11 ' C ' ' A' ' 24' ' ' ALA . 7.8 mt -111.85 107.7 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 122.745 0.418 . . . . 0.0 109.895 -168.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -103.49 140.98 36.77 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.22 -29.85 34.69 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.516 1.926 . . . . 0.0 113.857 -169.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.09 148.6 6.03 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.953 1.301 . . . . 0.0 110.648 -178.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.5 mmmt -120.48 89.33 3.11 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.891 1.676 . . . . 0.0 108.677 -158.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.45 141.83 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 123.42 0.688 . . . . 0.0 110.348 -176.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -99.14 145.8 26.8 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.509 1.524 . . . . 0.0 108.54 -172.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.1 t -136.14 98.12 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 -173.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.6 m -88.12 105.76 17.71 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -83.74 109.23 17.33 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.651 1.18 . . . . 0.0 108.202 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -107.01 86.24 2.28 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.553 0.692 . . . . 0.0 110.055 -173.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.96 112.2 23.05 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.453 -0.78 . . . . 0.0 110.382 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -111.65 122.21 47.21 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.117 0.967 . . . . 0.0 109.668 -177.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.6 t -100.46 108.76 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 170.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.14 154.65 31.03 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 162.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.45 -38.28 8.9 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.42 0.688 . . . . 0.0 111.655 177.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -39.15 -34.77 0.36 Allowed Glycine 0 CA--C 1.53 1.031 0 C-N-CA 126.992 2.234 . . . . 0.0 114.694 172.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.445 HD21 ' CE3' ' A' ' 47' ' ' TRP . 0.4 OUTLIER -108.95 101.1 43.07 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 119.567 1.684 . . . . 0.0 108.497 165.873 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -83.37 46.19 2.04 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.877 3.051 . . . . 0.0 110.857 -170.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.522 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 44.7 m0 -116.06 157.13 25.17 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 125.034 1.334 . . . . 0.0 108.735 -172.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -74.3 141.66 45.26 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 162.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -147.44 113.82 5.94 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 169.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.0 t -100.15 111.4 62.19 Favored Pre-proline 0 N--CA 1.439 -1.011 0 C-N-CA 127.036 2.134 . . . . 0.0 107.058 -172.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -62.77 146.67 95.16 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.533 2.156 . . . . 0.0 107.757 167.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -75.79 -46.8 34.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -170.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -151.82 165.97 32.86 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 152.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -57.42 -41.1 79.72 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 118.366 0.53 . . . . 0.0 111.048 -174.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.95 158.36 43.87 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 122.95 0.5 . . . . 0.0 110.223 -176.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.4 pt -126.62 168.4 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 C-N-CA 123.461 0.705 . . . . 0.0 109.613 168.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -95.47 146.35 24.49 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 154.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.25 141.23 45.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 104.183 -2.525 . . . . 0.0 104.183 156.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -64.47 164.91 10.71 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 120.541 1.519 . . . . 0.0 107.774 160.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.422 HG22 ' HB3' ' A' ' 124' ' ' PRO . 3.8 mm -63.74 91.61 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.9 33.22 5.33 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.802 1.667 . . . . 0.0 113.783 178.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -102.3 107.02 17.92 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.034 1.417 . . . . 0.0 112.694 176.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.468 ' H ' ' CB ' ' A' ' 24' ' ' ALA . 15.9 m -66.71 113.7 5.04 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.114 1.366 . . . . 0.0 111.318 177.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.1 p -126.51 146.69 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 118.45 0.568 . . . . 0.0 110.373 169.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.21 137.96 31.93 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 125.516 1.526 . . . . 0.0 110.552 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -141.94 97.71 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 17.1 tmm? -78.92 126.56 30.86 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.936 1.294 . . . . 0.0 111.678 -176.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -102.35 143.91 31.5 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.829 1.252 . . . . 0.0 109.682 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 42.8 ttt85 -126.24 141.19 52.02 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 125.025 1.33 . . . . 0.0 109.283 -176.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.91 166.15 27.63 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.284 1.833 . . . . 0.0 109.903 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -153.95 147.76 25.4 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.308 1.043 . . . . 0.0 108.738 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.522 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 46.2 t-20 -83.95 115.75 22.46 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 119.879 1.218 . . . . 0.0 111.215 175.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 81.5 mt -106.75 16.32 24.57 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.621 1.169 . . . . 0.0 112.582 -178.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.28 164.76 12.9 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.416 -0.802 . . . . 0.0 109.726 169.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.0 m -96.83 30.02 2.82 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.864 176.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.3 p -149.57 161.3 32.12 Favored Pre-proline 0 N--CA 1.448 -0.528 0 C-N-CA 125.082 1.353 . . . . 0.0 108.363 178.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.72 121.55 8.25 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 121.555 1.503 . . . . 0.0 109.032 170.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.5 159.3 15.26 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.334 0.587 . . . . 0.0 110.885 171.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.9 t -97.93 158.63 15.42 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 162.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -153.15 77.79 0.21 Allowed Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 105.366 -3.094 . . . . 0.0 105.366 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.52 66.26 0.68 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 175.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.19 168.34 19.32 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.482 -166.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 35.3 m -106.39 159.15 16.36 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -147.77 143.91 27.86 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.958 -0.464 . . . . 0.0 110.341 171.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.98 101.26 12.7 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 166.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.6 p -87.7 81.17 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.0 t 176.54 150.72 0.34 Allowed Pre-proline 0 CA--C 1.529 0.164 0 C-N-CA 125.556 1.542 . . . . 0.0 109.15 178.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.65 -35.21 22.92 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 CA-C-N 119.364 0.809 . . . . 0.0 110.383 157.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.5 ptp 176.68 -67.05 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 127.163 2.185 . . . . 0.0 107.545 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.18 -41.75 33.66 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -169.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.33 -104.07 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.88 0.372 . . . . 0.0 111.816 -166.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.14 -54.67 0.59 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 123.925 0.774 . . . . 0.0 113.26 -172.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -47.25 -52.83 14.95 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.987 1.394 . . . . 0.0 110.927 176.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -74.22 10.21 1.34 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.401 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . 29.5 t80 -81.86 98.48 8.53 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 172.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 . . . . . 0 N--CA 1.452 -0.352 0 C-N-CA 117.66 -1.616 . . . . 0.0 109.752 179.541 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.2 pm0 . . . . . 0 CA--C 1.541 0.611 0 CA-C-O 120.569 0.223 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.4 -70.34 0.13 Allowed 'General case' 0 CA--C 1.529 0.163 0 O-C-N 121.623 -0.673 . . . . 0.0 112.121 178.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.1 t -157.46 146.87 20.09 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.186 0.994 . . . . 0.0 108.73 -176.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.6 mt -150.44 136.1 18.2 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.764 0.711 . . . . 0.0 110.589 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -76.29 163.65 64.98 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.487 1.115 . . . . 0.0 109.967 174.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.42 106.1 1.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.242 1.961 . . . . 0.0 111.651 -163.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 111.58 -3.05 27.73 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 124.098 0.856 . . . . 0.0 111.24 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -76.6 146.14 38.46 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 118.368 1.084 . . . . 0.0 110.888 -173.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -97.09 147.24 24.24 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.669 1.188 . . . . 0.0 109.25 -176.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 17.2 ttt -150.95 111.42 4.2 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 118.734 -0.651 . . . . 0.0 111.169 -173.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -132.28 146.55 52.07 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 119.74 1.155 . . . . 0.0 111.249 172.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 19.1 mmt -142.63 138.55 16.32 Favored Pre-proline 0 C--O 1.235 0.32 0 C-N-CA 125.18 1.392 . . . . 0.0 109.63 -171.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.89 144.3 27.29 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 121.933 1.756 . . . . 0.0 110.183 171.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.4 t -124.26 158.87 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 164.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.2 p -145.83 146.3 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -154.38 146.59 23.78 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -165.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -160.08 156.0 26.14 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 128.119 2.568 . . . . 0.0 108.776 164.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.6 p -78.45 150.31 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 O-C-N 121.796 -0.565 . . . . 0.0 109.672 171.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -82.64 125.42 75.92 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.175 167.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.422 ' HB3' HG22 ' A' ' 60' ' ' ILE . 37.9 Cg_endo -70.92 41.77 0.4 Allowed 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.672 2.914 . . . . 0.0 115.775 -177.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -112.7 -21.2 11.35 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 125.718 1.607 . . . . 0.0 111.036 168.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 16.2 tt -43.48 -41.76 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 119.691 1.132 . . . . 0.0 113.572 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.8 m -76.46 61.61 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 O-C-N 121.815 -0.553 . . . . 0.0 111.341 172.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -137.51 -66.09 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 117.698 -1.144 . . . . 0.0 113.05 170.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -76.91 154.39 33.63 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 CA-C-N 121.802 1.679 . . . . 0.0 113.638 -169.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.4 t -54.93 -37.1 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 125.76 1.624 . . . . 0.0 110.826 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -52.58 -47.13 67.07 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.87 1.268 . . . . 0.0 111.829 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 35.4 p -91.85 -51.57 5.16 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -173.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 15.77 60.71 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 129.278 3.031 . . . . 0.0 115.911 175.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 136.29 -33.92 2.31 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-O 119.143 -0.81 . . . . 0.0 111.77 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 10.2 mm -51.07 128.27 8.39 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 C-N-CA 124.302 1.041 . . . . 0.0 110.433 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -157.76 48.22 0.39 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.43 0.692 . . . . 0.0 111.005 176.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.3 p -140.7 88.49 2.19 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 175.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' A' ' 95' ' ' PHE . 2.1 tp -88.06 84.93 6.9 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 118.899 -1.121 . . . . 0.0 109.026 -160.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.2 m -87.95 143.51 27.06 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.879 -169.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.5 tt -116.36 118.23 32.16 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 160.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.3 t -98.29 102.6 14.39 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 173.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.01 129.47 34.87 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.291 1.436 . . . . 0.0 107.559 -177.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.4 p -114.74 93.48 4.34 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.13 1.372 . . . . 0.0 109.212 174.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -76.18 95.52 3.71 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 167.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.69 46.67 0.3 Allowed Pre-proline 0 CA--C 1.556 1.174 0 N-CA-C 117.369 2.359 . . . . 0.0 117.369 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.39 -83.36 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.538 2.826 . . . . 0.0 113.013 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -149.29 136.68 20.1 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 118.904 0.774 . . . . 0.0 110.295 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -117.3 139.26 25.81 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 164.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -84.16 -52.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 121.917 1.745 . . . . 0.0 108.793 169.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.5 m -169.89 150.99 3.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.667 2.387 . . . . 0.0 106.676 177.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 12.9 pttt . . . . . 0 CA--C 1.535 0.381 0 C-N-CA 125.464 1.506 . . . . 0.0 108.54 174.602 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.065 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -113.85 36.26 3.74 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.952 0.901 . . . . 0.0 110.741 -169.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -159.81 -51.22 0.05 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.936 2.094 . . . . 0.0 107.051 -174.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.9 mt -72.13 -7.13 47.33 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.831 -168.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.6 mt -78.24 70.78 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 O-C-N 120.687 -1.258 . . . . 0.0 109.242 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.452 HD13 ' N ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -85.14 167.84 15.38 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 169.329 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -81.51 56.03 2.83 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 120.745 -1.222 . . . . 0.0 114.217 -166.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -113.74 104.54 12.31 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 122.788 1.28 . . . . 0.0 109.718 167.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.2 tttp -76.38 85.19 3.14 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 169.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.1 tp -83.52 162.88 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 174.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.44 150.22 46.25 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -167.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 81.0 t -142.85 126.28 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -172.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.5 m -95.56 109.02 21.31 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.499 1.52 . . . . 0.0 107.632 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.809 ' CE1' HD12 ' A' ' 56' ' ' ILE . 15.3 m-85 -81.21 131.67 35.31 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.839 1.256 . . . . 0.0 109.133 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -126.87 86.68 2.54 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 122.786 1.279 . . . . 0.0 110.378 -170.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.24 105.76 18.0 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.153 -0.967 . . . . 0.0 109.937 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -109.19 147.16 32.98 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 176.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.1 p -140.46 148.31 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.399 1.08 . . . . 0.0 108.166 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.69 168.95 18.32 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 167.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.62 -31.41 16.0 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -170.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.62 -34.82 3.88 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.217 1.389 . . . . 0.0 113.385 172.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.621 HD13 ' CD2' ' A' ' 144' ' ' PHE . 0.5 OUTLIER -119.16 91.06 43.05 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 167.777 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -80.77 55.25 5.6 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.387 2.725 . . . . 0.0 109.255 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.519 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 41.4 m0 -114.65 147.86 38.99 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.609 1.163 . . . . 0.0 109.257 -174.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -75.47 80.42 2.51 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -89.49 100.0 12.89 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.868 0.867 . . . . 0.0 109.306 -170.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.1 t -103.43 122.08 46.27 Favored Pre-proline 0 N--CA 1.443 -0.817 0 C-N-CA 124.027 0.931 . . . . 0.0 109.6 -168.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -75.46 138.08 21.51 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 123.648 2.899 . . . . 0.0 107.8 163.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.2 t -79.69 -46.73 22.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.572 0.701 . . . . 0.0 109.407 -173.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -149.25 150.36 32.44 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.528 1.931 . . . . 0.0 106.772 173.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -61.77 -36.68 81.75 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 123.814 0.696 . . . . 0.0 110.617 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -146.68 151.12 36.71 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 122.652 0.381 . . . . 0.0 111.208 -174.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.809 HD12 ' CE1' ' A' ' 37' ' ' PHE . 64.5 mt -122.57 137.91 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 127.0 2.12 . . . . 0.0 106.866 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -98.42 152.43 19.5 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.238 1.015 . . . . 0.0 109.39 164.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -154.08 127.33 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 -170.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.9 mmt85 -74.75 86.84 2.2 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 166.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.7 pt 7.57 64.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 128.206 2.602 . . . . 0.0 115.008 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.79 -35.63 1.49 Allowed Glycine 0 CA--C 1.522 0.523 0 O-C-N 121.915 -0.491 . . . . 0.0 112.807 -174.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 62.7 tt0 -42.57 107.79 0.09 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.172 1.389 . . . . 0.0 111.999 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.56 102.76 8.09 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.425 1.09 . . . . 0.0 110.129 -177.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.0 p -76.31 178.74 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 122.036 0.922 . . . . 0.0 111.505 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -137.16 89.06 2.4 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 124.426 1.09 . . . . 0.0 108.676 168.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.751 HG12 HD11 ' A' ' 56' ' ' ILE . 2.5 pp -100.36 134.22 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 168.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 65.0 mtt -98.32 100.36 11.63 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 126.304 1.842 . . . . 0.0 110.913 -174.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -78.36 157.4 29.11 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -143.68 146.51 33.27 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.37 151.5 49.62 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 128.833 2.853 . . . . 0.0 106.173 166.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -143.81 139.53 29.38 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 166.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.519 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 43.5 t30 -79.1 114.83 18.36 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 120.039 1.291 . . . . 0.0 112.558 -177.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.7 mt -105.79 16.11 25.74 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 125.031 1.332 . . . . 0.0 112.548 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.6 175.44 9.87 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 163.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.8 t -103.57 17.3 24.39 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.103 0.561 . . . . 0.0 110.254 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -155.94 160.64 30.65 Favored Pre-proline 0 N--CA 1.45 -0.472 0 C-N-CA 127.075 2.15 . . . . 0.0 106.29 -174.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.27 124.81 11.22 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.481 1.454 . . . . 0.0 110.326 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.416 HG23 ' HD3' ' A' ' 149' ' ' PRO . 0.2 OUTLIER -86.58 177.79 7.27 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.398 0.618 . . . . 0.0 109.553 168.042 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.8 t -113.61 161.68 17.14 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 154.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.597 ' HA2' HD11 ' A' ' 45' ' ' LEU . . . -147.38 69.37 0.36 Allowed Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 107.728 -2.149 . . . . 0.0 107.728 -177.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.47 62.65 0.61 Allowed 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 177.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.39 161.64 27.86 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.542 -163.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -83.22 152.08 25.36 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.839 174.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -148.51 148.7 30.53 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.338 0.255 . . . . 0.0 110.647 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -109.04 101.85 10.89 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 125.773 1.629 . . . . 0.0 106.904 171.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.8 p -88.66 58.13 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.474 0 C-N-CA 123.963 0.905 . . . . 0.0 111.086 -176.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.6 t -167.26 145.16 4.03 Favored Pre-proline 0 N--CA 1.468 0.448 0 O-C-N 120.994 -1.066 . . . . 0.0 112.032 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -62.83 -56.77 0.53 Allowed 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.258 1.305 . . . . 0.0 108.805 168.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 23.3 ptp -171.36 20.69 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.886 0.874 . . . . 0.0 111.689 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -170.43 -77.31 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.291 0 O-C-N 121.558 -0.714 . . . . 0.0 109.519 -168.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -46.3 -94.22 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 126.271 1.829 . . . . 0.0 113.238 -169.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 60.71 -52.23 0.03 OUTLIER Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.939 1.257 . . . . 0.0 115.939 -172.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -45.17 -48.97 12.36 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 119.762 1.781 . . . . 0.0 111.34 174.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -71.68 -12.69 61.45 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.256 1.022 . . . . 0.0 113.047 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -71.49 94.98 1.33 Allowed 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 . . . . . 0 N--CA 1.442 -0.872 0 C-N-CA 118.274 -1.37 . . . . 0.0 110.346 -171.074 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 CA--C 1.538 0.496 0 CA-C-O 120.431 0.158 . . . . 0.0 111.315 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.541 HG23 ' H ' ' A' ' 107' ' ' THR . 9.2 t -157.68 -74.41 0.09 Allowed 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.531 0.332 . . . . 0.0 110.606 -168.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.541 ' H ' HG23 ' A' ' 106' ' ' THR . 0.9 OUTLIER -159.63 152.01 21.09 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -174.441 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 75.2 mt -148.48 137.69 21.85 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 124.225 1.01 . . . . 0.0 108.322 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -66.94 152.14 96.21 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 169.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.66 106.28 1.24 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.783 2.989 . . . . 0.0 111.136 -171.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 128.19 -23.38 5.21 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -176.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -78.14 142.5 38.0 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 117.808 0.804 . . . . 0.0 111.009 -162.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -100.18 128.92 46.17 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.34 1.856 . . . . 0.0 109.329 -173.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 52.7 ttp -126.87 85.84 2.43 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 126.104 1.761 . . . . 0.0 108.844 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.99 140.89 33.56 Favored 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 168.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 22.8 ptm -153.5 141.57 13.89 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 117.936 0.335 . . . . 0.0 111.887 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -72.22 148.11 49.14 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.717 2.278 . . . . 0.0 110.098 171.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.1 t -136.26 122.19 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 125.927 1.691 . . . . 0.0 107.026 174.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.1 p -99.45 143.15 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 125.762 1.625 . . . . 0.0 107.492 169.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.94 172.27 18.97 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 176.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -158.64 178.46 10.1 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.883 0.873 . . . . 0.0 109.715 164.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 73.5 t -110.22 135.32 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 123.74 0.816 . . . . 0.0 109.267 172.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.22 124.54 76.06 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 122.988 0.515 . . . . 0.0 112.068 -176.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.21 34.47 0.4 Allowed 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.199 2.599 . . . . 0.0 114.105 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.51 -15.04 21.89 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.04 0.936 . . . . 0.0 110.915 162.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 17.8 tt -52.1 -48.97 41.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 118.973 0.806 . . . . 0.0 112.586 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.8 m -80.52 64.08 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.081 0.552 . . . . 0.0 109.677 174.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 45.0 mttp -140.17 -65.21 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 124.271 1.028 . . . . 0.0 111.768 171.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.01 169.29 13.71 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 121.835 1.69 . . . . 0.0 111.443 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.9 t -71.96 -52.31 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 124.227 1.011 . . . . 0.0 109.843 -174.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -46.44 -51.69 14.63 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 125.197 1.399 . . . . 0.0 112.054 -173.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 17.2 p -86.14 -3.74 59.02 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -65.05 75.9 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.857 1.208 . . . . 0.0 111.607 -177.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 148.13 -34.54 1.2 Allowed Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -169.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 45.9 mm -66.86 114.24 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.3 pttt -156.1 47.17 0.47 Allowed 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.49 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.41 97.52 1.76 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 103.69 -2.708 . . . . 0.0 103.69 168.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.4 tp -78.04 162.66 26.55 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -170.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.5 t -151.69 171.61 17.4 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.599 -0.688 . . . . 0.0 109.488 173.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -149.5 100.04 2.96 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 103.908 -2.627 . . . . 0.0 103.908 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 31.1 m -87.5 93.79 9.52 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 173.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.13 134.13 36.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 172.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.7 m -120.06 87.33 2.72 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.992 0.917 . . . . 0.0 108.951 176.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.621 ' CD2' HD13 ' A' ' 45' ' ' LEU . 2.0 m-85 -68.24 84.55 0.25 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.928 0.891 . . . . 0.0 109.614 175.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -151.49 46.4 0.37 Allowed Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 178.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.52 -79.36 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.584 2.189 . . . . 0.0 112.731 -175.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.46 107.79 2.23 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.622 -0.674 . . . . 0.0 111.537 -173.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -78.89 144.05 63.23 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 173.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.416 ' HD3' HG23 ' A' ' 78' ' ' THR . 61.0 Cg_endo -72.41 -50.18 0.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.972 1.782 . . . . 0.0 107.992 160.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.9 t -179.5 -168.71 0.12 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 128.869 2.868 . . . . 0.0 105.32 169.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.589 0 C-N-CA 124.241 1.017 . . . . 0.0 111.184 174.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.818 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.8 t -73.07 51.35 0.3 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.385 1.874 . . . . 0.0 114.85 -167.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -76.07 -34.86 59.59 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 131.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 63.1 mt -108.47 -44.49 4.08 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -172.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.2 mt -35.4 137.78 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 126.614 1.966 . . . . 0.0 115.501 -164.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.9 mp -111.71 -82.85 0.58 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.147 1.379 . . . . 0.0 109.141 -174.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -172.85 -66.22 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.35 1.46 . . . . 0.0 108.997 -178.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -36.67 132.65 0.61 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 126.678 1.991 . . . . 0.0 113.598 -168.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -76.2 90.17 3.12 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.158 -1.837 . . . . 0.0 107.253 176.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.7 112.34 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 167.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.79 154.22 30.09 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.4 t -134.97 133.38 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 176.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 29.4 m -114.14 108.57 17.15 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -81.17 102.98 10.65 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.662 1.585 . . . . 0.0 108.945 176.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -98.42 87.1 3.77 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.857 0.836 . . . . 0.0 109.596 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.21 126.07 31.06 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.169 0.588 . . . . 0.0 110.614 175.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -129.65 146.44 51.43 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.797 1.239 . . . . 0.0 108.191 175.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.5 p -138.44 144.0 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 124.076 0.95 . . . . 0.0 108.991 177.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.21 165.48 19.54 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 166.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -43.62 -39.71 3.69 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.211 1.004 . . . . 0.0 112.185 -177.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -34.06 -36.55 0.06 OUTLIER Glycine 0 CA--C 1.535 1.282 0 C-N-CA 126.948 2.213 . . . . 0.0 115.01 171.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.45 HD13 ' CG ' ' A' ' 144' ' ' PHE . 0.2 OUTLIER -118.82 102.76 49.15 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 119.099 1.45 . . . . 0.0 107.871 161.645 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.43 40.94 1.05 Allowed 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.764 2.309 . . . . 0.0 111.223 -170.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.509 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 45.1 m0 -116.39 151.06 36.73 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.367 1.067 . . . . 0.0 110.614 -165.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -76.33 80.83 3.08 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -177.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -87.14 106.27 17.76 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.396 0.678 . . . . 0.0 109.35 -172.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.8 t -115.9 119.93 36.43 Favored Pre-proline 0 N--CA 1.443 -0.814 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -168.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.82 154.25 38.57 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 C-N-CA 124.118 3.212 . . . . 0.0 107.936 168.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 t -85.7 -58.95 3.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -168.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.6 mp0 -132.45 162.19 31.79 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 162.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -61.46 -39.79 92.16 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 174.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.79 164.72 26.62 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.796 0.839 . . . . 0.0 112.496 -176.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.7 pt -132.47 162.0 40.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 124.521 1.129 . . . . 0.0 109.747 168.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -118.28 83.78 2.07 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 127.444 2.298 . . . . 0.0 110.067 -173.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.75 129.3 43.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 O-C-N 120.833 -1.167 . . . . 0.0 109.494 -178.016 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -78.37 96.32 5.3 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 174.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.447 HD13 HG21 ' A' ' 60' ' ' ILE . 0.7 OUTLIER -10.06 87.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.068 1.747 . . . . 0.0 114.966 -159.392 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.59 -31.66 4.74 Favored Glycine 0 C--O 1.222 -0.641 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 176.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -53.11 118.38 3.71 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 -175.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.67 HG22 ' CD1' ' A' ' 121' ' ' PHE . 20.2 p -71.23 115.69 10.67 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.745 2.018 . . . . 0.0 111.71 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.0 p -97.68 161.92 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 123.514 0.726 . . . . 0.0 110.112 169.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -105.36 120.01 40.52 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.231 1.012 . . . . 0.0 110.727 164.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.8 pp -130.18 116.56 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 171.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 35.4 mtm -79.57 107.81 12.63 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.156 0.982 . . . . 0.0 111.633 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -81.55 155.56 25.66 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 170.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.0 ttp-105 -137.95 144.86 41.41 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 174.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.72 159.01 28.87 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.103 2.161 . . . . 0.0 107.05 156.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -144.17 145.04 31.84 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 161.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.509 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 51.9 t-20 -83.45 105.57 14.5 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 120.743 1.611 . . . . 0.0 112.103 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.1 mp -102.27 36.39 2.15 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.095 1.358 . . . . 0.0 110.861 176.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.03 170.63 7.84 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.72 1.208 . . . . 0.0 109.331 163.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.5 m -105.09 15.47 27.52 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.753 0.821 . . . . 0.0 111.411 -177.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.7 p -141.38 162.11 49.11 Favored Pre-proline 0 C--O 1.239 0.504 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 169.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.44 141.65 96.07 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 120.978 1.119 . . . . 0.0 109.312 171.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.43 169.03 9.01 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 118.468 0.576 . . . . 0.0 110.326 167.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.9 t -94.38 157.07 16.19 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 159.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -124.17 152.7 17.37 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 105.271 -3.132 . . . . 0.0 105.271 165.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -174.22 -53.86 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 117.426 0.613 . . . . 0.0 109.787 -160.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 60.57 -179.35 0.1 Allowed 'General case' 0 C--N 1.342 0.243 0 CA-C-O 122.938 1.351 . . . . 0.0 113.88 173.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.0 m -135.21 164.21 28.21 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 146.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -155.53 164.47 38.62 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -173.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.09 98.33 4.72 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.629 HG22 HD13 ' A' ' 140' ' ' LEU . 51.2 t -89.32 72.04 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 125.361 1.465 . . . . 0.0 107.129 -175.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.0 t 178.83 152.28 0.49 Allowed Pre-proline 0 C--N 1.34 0.157 0 C-N-CA 125.455 1.502 . . . . 0.0 109.233 -174.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -67.49 -47.8 1.93 Allowed 'Trans proline' 0 N--CA 1.448 -1.197 0 N-CA-C 108.457 -1.401 . . . . 0.0 108.457 156.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.2 ptm -174.52 -78.37 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.661 1.984 . . . . 0.0 107.802 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.19 -38.22 81.77 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -168.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.71 -105.45 0.02 OUTLIER 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.199 0.454 . . . . 0.0 111.022 -173.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.38 -53.94 1.92 Allowed Glycine 0 CA--C 1.526 0.768 0 CA-C-O 119.286 -0.73 . . . . 0.0 112.722 -177.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.26 -54.11 9.44 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.612 1.206 . . . . 0.0 111.636 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -74.06 -3.59 30.32 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.767 1.227 . . . . 0.0 113.659 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -70.4 96.62 1.17 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 174.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 . . . . . 0 CA--C 1.531 0.24 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -162.19 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.539 0.532 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.6 t -130.27 -63.39 0.9 Allowed 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 124.212 1.005 . . . . 0.0 109.114 -177.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.1 t -158.33 149.0 20.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 172.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 89.2 mt -149.17 135.6 19.34 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 176.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -73.59 159.81 83.7 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.738 1.215 . . . . 0.0 109.955 173.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.23 102.73 1.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.486 2.124 . . . . 0.0 110.905 -165.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 125.05 -14.35 7.47 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 124.202 0.906 . . . . 0.0 110.953 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -76.82 138.31 39.75 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 118.49 1.145 . . . . 0.0 110.773 -166.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.03 144.92 26.68 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.94 1.296 . . . . 0.0 108.694 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 17.1 ttt -140.01 80.39 1.76 Allowed 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 123.34 0.656 . . . . 0.0 109.265 173.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -95.02 123.44 38.5 Favored 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 124.325 1.05 . . . . 0.0 108.321 168.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 24.5 mmt -134.1 129.56 20.01 Favored Pre-proline 0 C--O 1.235 0.32 0 C-N-CA 124.106 0.963 . . . . 0.0 109.844 -171.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -68.8 135.58 33.21 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 121.871 1.714 . . . . 0.0 109.248 172.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.9 t -110.06 129.42 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 166.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.1 p -95.52 134.76 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 157.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -155.92 151.62 27.25 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.67 ' CD1' HG22 ' A' ' 63' ' ' THR . 12.7 p90 -167.32 161.14 14.06 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 126.215 1.806 . . . . 0.0 107.206 -177.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 52.7 t -118.26 127.77 75.35 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 C-N-CA 125.669 1.588 . . . . 0.0 107.463 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.43 153.15 41.44 Favored Pre-proline 0 C--O 1.234 0.252 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -173.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.58 37.76 0.47 Allowed 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 124.359 3.373 . . . . 0.0 112.982 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -83.62 -37.66 22.59 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 165.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.3 tt -52.41 -35.46 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 123.878 0.871 . . . . 0.0 112.781 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.2 m -74.97 53.12 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 120.901 -1.124 . . . . 0.0 110.933 173.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -144.53 -70.65 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.748 1.619 . . . . 0.0 110.793 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.86 138.13 39.95 Favored 'Trans proline' 0 C--O 1.239 0.529 0 CA-C-N 122.148 1.803 . . . . 0.0 113.488 -176.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.9 t -55.94 -36.86 45.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 127.352 2.261 . . . . 0.0 109.602 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -47.7 -34.98 8.95 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.938 2.095 . . . . 0.0 112.744 174.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 72.1 p -107.09 -60.52 1.67 Allowed 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 123.013 0.196 . . . . 0.0 110.536 -174.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 28.28 49.75 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 129.088 2.955 . . . . 0.0 115.902 165.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 143.65 -29.3 2.0 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -172.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.8 mm -53.61 127.62 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.072 0 CA-C-N 117.863 0.831 . . . . 0.0 110.664 172.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.7 pttt -155.77 67.54 0.62 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 122.09 0.948 . . . . 0.0 111.547 169.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 42.4 m -147.94 105.08 3.63 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 141.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.1 tp -79.83 86.86 5.34 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -175.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -84.77 150.12 25.28 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.08 -168.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.629 HD13 HG22 ' A' ' 86' ' ' VAL . 28.5 tp -120.45 110.53 16.61 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 166.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.7 t -95.04 117.98 31.07 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 169.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.07 125.86 51.14 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -166.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.6 m -117.6 89.4 3.11 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.214 1.006 . . . . 0.0 109.98 -176.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.45 ' CG ' HD13 ' A' ' 45' ' ' LEU . 1.8 m-30 -67.1 94.59 0.35 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.603 0.761 . . . . 0.0 109.404 170.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -149.01 23.65 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.135 0 N-CA-C 118.08 2.622 . . . . 0.0 118.08 -176.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.445 ' CD ' HD12 ' A' ' 45' ' ' LEU . 59.5 Cg_endo -71.49 -75.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.672 0 CA-C-N 122.77 2.025 . . . . 0.0 113.897 -165.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 86.6 mmt-85 -146.28 121.75 10.36 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.776 0.716 . . . . 0.0 109.177 -167.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.53 117.54 28.98 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 125.648 1.579 . . . . 0.0 107.358 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -78.6 -23.5 8.33 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.71 2.273 . . . . 0.0 112.41 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 39.9 t 137.69 109.38 0.0 OUTLIER 'General case' 0 C--N 1.343 0.302 0 C-N-CA 129.278 3.031 . . . . 0.0 107.777 -175.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.372 0 C-N-CA 124.319 1.047 . . . . 0.0 110.958 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.607 ' N ' ' HG1' ' A' ' 63' ' ' THR . . . . . . . . 0 N--CA 1.446 -0.662 0 CA-C-O 120.777 0.322 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.2 t -162.25 45.92 0.15 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 123.882 0.873 . . . . 0.0 109.825 -171.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -155.67 -58.03 0.1 Allowed 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.411 ' H ' HD23 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -85.51 26.36 0.94 Allowed 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.147 -169.534 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 73.3 mt -119.23 108.87 24.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -169.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -98.58 -61.54 1.36 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.129 -171.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . 0.25 0.3 OUTLIER 177.23 -6.89 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.672 1.589 . . . . 0.0 114.488 145.654 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -51.19 122.42 7.67 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 120.752 1.615 . . . . 0.0 112.869 -173.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -77.66 98.14 5.35 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 127.928 2.491 . . . . 0.0 107.547 -173.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.407 HG12 HG11 ' A' ' 122' ' ' VAL . 5.6 tp -106.56 122.74 60.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.913 1.285 . . . . 0.0 109.435 -172.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.513 ' CE ' ' HB2' ' A' ' 55' ' ' ASP . 4.0 tmtp? -79.19 151.62 31.14 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.952 1.701 . . . . 0.0 109.212 -174.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.423 ' HB ' ' CG1' ' A' ' 56' ' ' ILE . 5.2 t -133.79 148.74 30.39 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 165.135 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.7 m -136.25 104.7 5.73 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.414 1.102 . . . . 0.0 108.338 -174.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -77.56 121.32 23.74 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -118.32 82.44 1.84 Allowed 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.65 126.86 31.71 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -126.95 89.33 2.96 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.897 0.856 . . . . 0.0 109.043 -174.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.4 p -79.02 126.91 39.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.679 172.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.38 169.46 13.57 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 171.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.55 124.07 12.7 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 161.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 151.48 -48.19 0.56 Allowed Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 107.268 -2.333 . . . . 0.0 107.268 -160.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mp -129.28 142.38 45.02 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 160.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.439 ' HD2' HG21 ' A' ' 78' ' ' THR . 83.0 Cg_endo -79.97 2.72 8.2 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 123.911 3.074 . . . . 0.0 111.93 170.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.42 ' CZ2' ' HB3' ' A' ' 108' ' ' LEU . 40.5 m0 -74.54 148.62 40.72 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.125 0.875 . . . . 0.0 111.745 -165.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -78.82 84.79 4.86 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 172.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -89.58 118.94 29.58 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 124.475 1.11 . . . . 0.0 108.709 177.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.0 m -124.86 139.29 33.11 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -74.67 171.49 18.1 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.339 2.026 . . . . 0.0 108.953 166.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -93.35 -53.66 8.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 123.763 0.825 . . . . 0.0 110.393 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -131.7 164.5 25.8 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 168.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -60.75 -43.6 97.76 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 168.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.513 ' HB2' ' CE ' ' A' ' 34' ' ' LYS . 22.4 p-10 -149.15 170.55 18.18 Favored 'General case' 0 N--CA 1.428 -1.551 0 C-N-CA 124.666 1.186 . . . . 0.0 110.805 -164.228 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.423 ' CG1' ' HB ' ' A' ' 35' ' ' VAL . 37.1 pt -137.65 176.39 7.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 167.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.88 161.58 23.83 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 148.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -131.22 148.23 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 102.158 -3.275 . . . . 0.0 102.158 170.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.72 118.51 27.27 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 120.855 1.661 . . . . 0.0 106.953 160.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.3 pt -15.57 89.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 C-N-CA 126.943 2.097 . . . . 0.0 113.255 -169.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.52 -43.91 1.32 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 124.37 0.986 . . . . 0.0 113.12 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -38.56 102.65 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.798 2.039 . . . . 0.0 113.431 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.607 ' HG1' ' N ' ' A' ' 24' ' ' ALA . 94.5 m -73.19 104.44 4.25 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.677 1.591 . . . . 0.0 111.265 -174.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.5 p -102.07 169.56 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 121.615 0.722 . . . . 0.0 110.524 174.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -117.35 127.38 53.99 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 126.263 1.825 . . . . 0.0 107.208 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.444 HD12 ' O ' ' A' ' 66' ' ' ILE . 1.7 pp -140.69 95.79 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 CA-C-O 121.864 0.84 . . . . 0.0 109.063 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 31.1 mtt -76.82 175.31 9.56 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.765 -0.584 . . . . 0.0 110.536 -175.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -133.28 170.47 15.4 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 124.228 1.011 . . . . 0.0 109.092 174.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -139.39 123.4 17.8 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 173.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.97 105.38 7.7 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.127 0.571 . . . . 0.0 110.869 168.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER -103.25 121.08 41.95 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.061 -0.4 . . . . 0.0 111.533 -171.759 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -82.12 85.07 6.84 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.114 0.483 . . . . 0.0 111.386 -173.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.3 mt -79.73 59.15 2.99 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.634 0.774 . . . . 0.0 109.958 171.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.91 155.23 47.12 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 170.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.8 m -79.55 -0.62 34.21 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.619 0.768 . . . . 0.0 112.369 177.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.1 p -128.83 163.29 46.33 Favored Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 124.761 1.224 . . . . 0.0 110.618 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -63.17 169.11 9.77 Favored 'Trans proline' 0 N--CA 1.444 -1.435 0 C-N-CA 121.041 1.161 . . . . 0.0 110.077 164.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.439 HG21 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -155.97 168.81 26.06 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 126.519 1.928 . . . . 0.0 107.152 -170.829 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.2 t -132.6 154.79 49.7 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.75 0.705 . . . . 0.0 111.622 176.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -125.57 64.42 0.57 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 127.248 2.356 . . . . 0.0 107.968 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.37 53.54 2.79 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 165.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.98 170.54 14.61 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.096 -171.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.1 m -125.19 162.21 25.17 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -146.93 159.02 44.06 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 118.764 0.711 . . . . 0.0 111.08 170.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.2 99.51 6.91 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 166.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.6 p -89.9 57.65 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.212 0 C-N-CA 124.154 0.982 . . . . 0.0 110.365 -175.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.5 t -165.95 148.18 6.27 Favored Pre-proline 0 N--CA 1.454 -0.249 0 O-C-N 121.506 -0.746 . . . . 0.0 110.699 -172.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.24 -30.68 30.5 Favored 'Trans proline' 0 N--CA 1.445 -1.38 0 N-CA-C 108.674 -1.318 . . . . 0.0 108.674 164.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.0 ptp 172.69 -63.85 0.01 OUTLIER 'General case' 0 C--N 1.347 0.462 0 C-N-CA 125.853 1.661 . . . . 0.0 109.759 -173.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -99.87 -33.25 10.62 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 124.776 1.23 . . . . 0.0 111.258 -164.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.16 -142.91 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.86 -47.58 0.78 Allowed Glycine 0 CA--C 1.531 1.075 0 O-C-N 121.278 -0.889 . . . . 0.0 112.434 -166.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -42.7 -54.08 4.21 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.047 1.339 . . . . 0.0 110.818 173.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -76.24 -16.2 59.87 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -48.91 137.41 12.77 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 118.79 0.723 . . . . 0.0 110.843 -173.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 . . . . . 0 N--CA 1.44 -0.972 0 O-C-N 123.583 0.552 . . . . 0.0 111.568 -173.453 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.9 t 52.7 -141.26 0.86 Allowed 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.493 1.517 . . . . 0.0 111.176 174.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.2 t -110.68 131.41 55.08 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 126.402 1.881 . . . . 0.0 106.741 172.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.42 ' HB3' ' CZ2' ' A' ' 47' ' ' TRP . 1.6 tp -124.34 131.43 53.51 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 125.102 1.361 . . . . 0.0 107.651 -176.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.456 ' HB3' ' HD2' ' A' ' 110' ' ' PRO . 10.5 mp0 -86.56 167.73 21.53 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 127.169 2.188 . . . . 0.0 111.273 -167.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 109' ' ' GLU . 49.9 Cg_endo -72.92 112.6 3.55 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.349 2.033 . . . . 0.0 112.446 -168.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 115.97 -12.72 17.27 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 124.403 1.002 . . . . 0.0 111.021 177.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -77.91 140.96 39.32 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 117.334 0.567 . . . . 0.0 112.438 -163.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -99.21 98.27 9.27 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.91 1.684 . . . . 0.0 108.787 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 11.0 ttp -77.56 85.98 3.91 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -94.28 59.59 2.62 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.994 0.902 . . . . 0.0 111.682 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 20.5 ttt -76.61 129.17 80.23 Favored Pre-proline 0 N--CA 1.437 -1.077 0 C-N-CA 123.814 0.846 . . . . 0.0 110.352 -171.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.66 150.88 31.73 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 121.93 1.753 . . . . 0.0 110.332 171.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.2 t -130.83 148.08 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 164.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.5 m -112.28 146.7 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -154.58 139.96 17.7 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 119.56 1.073 . . . . 0.0 112.635 -172.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -156.01 148.11 23.35 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.66 1.584 . . . . 0.0 108.069 163.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.407 HG11 HG12 ' A' ' 33' ' ' ILE . 61.6 t -88.26 141.45 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 166.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -75.51 155.46 85.55 Favored Pre-proline 0 N--CA 1.45 -0.467 0 C-N-CA 124.517 1.127 . . . . 0.0 110.061 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -65.03 -36.14 39.38 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.577 1.518 . . . . 0.0 112.17 166.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -44.77 -41.0 6.54 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 125.481 1.512 . . . . 0.0 113.395 -172.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -50.11 -37.94 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 125.021 1.329 . . . . 0.0 112.83 -177.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.0 m -89.3 51.26 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 119.17 0.896 . . . . 0.0 110.487 177.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . 0.35 0.0 OUTLIER -149.79 -53.5 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.823 0 CA-C-O 116.199 -1.858 . . . . 0.0 114.228 -175.221 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -83.33 169.89 12.27 Favored 'Trans proline' 0 C--N 1.351 0.67 0 CA-C-N 124.031 2.475 . . . . 0.0 111.838 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.2 t -67.59 -46.54 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.978 1.311 . . . . 0.0 110.871 -169.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.423 ' CD ' ' H ' ' A' ' 131' ' ' GLU . 2.1 mp0 -39.13 -54.58 1.73 Allowed 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 126.062 1.745 . . . . 0.0 112.225 -178.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 3.2 p -97.53 -41.03 8.36 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.128 -168.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 2.51 70.74 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 128.458 2.703 . . . . 0.0 115.882 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 134.27 -35.66 2.2 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 119.176 -0.791 . . . . 0.0 112.391 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 13.1 mm -49.33 138.27 4.78 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 C-N-CA 124.664 1.186 . . . . 0.0 109.948 173.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.3 pttm -157.67 51.97 0.45 Allowed 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.6 m -154.5 107.09 2.8 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 159.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.5 mp -75.78 85.72 2.77 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 169.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.1 t -81.14 150.98 28.48 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.3 tt -127.52 99.38 5.58 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.1 t -78.04 111.07 13.55 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 171.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -107.06 92.84 4.25 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.746 1.218 . . . . 0.0 108.537 -172.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.5 86.95 4.5 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 122.528 1.156 . . . . 0.0 109.48 -175.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -75.48 73.12 2.52 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 166.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -132.73 48.86 3.84 Favored Pre-proline 0 CA--C 1.552 1.044 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 174.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -77.61 -98.09 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 124.356 3.37 . . . . 0.0 113.752 -174.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.2 mmt180 -142.36 110.37 5.92 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.545 1.138 . . . . 0.0 109.315 -169.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -95.05 114.57 63.99 Favored Pre-proline 0 N--CA 1.451 -0.381 0 C-N-CA 124.793 1.237 . . . . 0.0 111.517 -167.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -74.2 -25.13 13.93 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.632 1.554 . . . . 0.0 111.138 165.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.6 t 80.33 127.18 0.04 OUTLIER 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.778 1.631 . . . . 0.0 109.824 -173.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 17.9 pttm . . . . . 0 CA--C 1.535 0.376 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.017 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.533 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.7 m -76.9 54.24 0.99 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.824 2.45 . . . . 0.0 112.253 -178.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -141.69 -54.19 0.45 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 130.275 3.43 . . . . 0.0 104.092 168.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.511 ' O ' HD22 ' A' ' 29' ' ' LEU . 49.2 mt -63.73 -34.06 77.04 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.908 1.283 . . . . 0.0 113.119 168.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 76.7 mt -69.15 100.04 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 119.575 1.08 . . . . 0.0 110.221 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.511 HD22 ' O ' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -90.03 -75.41 0.45 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 172.554 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -169.48 -28.63 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 164.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -59.05 128.25 36.28 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.46 1.104 . . . . 0.0 113.638 -163.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -79.93 109.79 14.7 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.924 -174.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.13 113.1 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 126.012 1.725 . . . . 0.0 108.679 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.35 157.07 21.59 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.054 -1.029 . . . . 0.0 109.084 -171.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.2 t -143.79 107.5 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-N 119.762 1.165 . . . . 0.0 109.596 -176.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.2 m -78.97 117.58 20.17 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.786 1.634 . . . . 0.0 107.816 167.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -79.61 156.32 27.72 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.337 0.655 . . . . 0.0 109.266 166.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -137.67 88.31 2.32 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.412 0.625 . . . . 0.0 111.511 170.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.06 128.9 36.4 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 120.939 -1.101 . . . . 0.0 110.507 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -133.73 150.21 51.49 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.186 0.994 . . . . 0.0 109.508 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.9 p -140.6 146.29 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 C-N-CA 123.518 0.727 . . . . 0.0 110.772 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.9 163.62 29.82 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.012 1.325 . . . . 0.0 107.463 168.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -37.75 -45.69 0.83 Allowed 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.989 1.715 . . . . 0.0 113.452 -172.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -36.88 -37.32 0.23 Allowed Glycine 0 CA--C 1.534 1.233 0 C-N-CA 126.482 1.991 . . . . 0.0 114.39 174.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.417 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 0.4 OUTLIER -113.48 105.88 54.71 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 161.15 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.93 9.56 3.26 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.138 1.892 . . . . 0.0 112.733 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.493 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 41.4 m0 -78.46 145.61 34.93 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 121.798 -0.564 . . . . 0.0 110.931 -168.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -78.56 85.39 4.62 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 103.338 -2.838 . . . . 0.0 103.338 172.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.71 88.18 3.0 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.625 1.17 . . . . 0.0 108.381 -168.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.0 m -91.37 136.59 26.77 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 119.182 -0.437 . . . . 0.0 110.381 -166.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -70.53 165.55 31.48 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 121.538 1.492 . . . . 0.0 108.595 161.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -97.67 -55.29 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.111 0 C-N-CA 123.573 0.749 . . . . 0.0 110.941 -176.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.22 152.76 47.6 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 170.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -64.99 -41.48 95.36 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.831 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.49 139.65 37.02 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.223 1.009 . . . . 0.0 110.027 -173.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.42 HD12 HG11 ' A' ' 64' ' ' VAL . 32.7 pt -104.99 164.02 4.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 125.352 1.461 . . . . 0.0 109.002 170.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -101.74 133.62 46.17 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 155.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.6 m -128.08 174.68 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 159.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -140.66 92.45 2.51 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -171.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.0 pt 8.22 87.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 127.66 2.384 . . . . 0.0 114.279 -171.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 107.86 -31.52 7.91 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 123.556 0.598 . . . . 0.0 112.949 -173.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -72.55 118.02 14.95 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 121.627 -0.925 . . . . 0.0 110.174 -168.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.3 p -68.3 126.83 30.81 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 127.431 2.293 . . . . 0.0 111.472 -174.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.42 HG11 HD12 ' A' ' 56' ' ' ILE . 9.9 p -113.74 160.07 13.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 157.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.62 125.34 49.32 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.737 1.215 . . . . 0.0 108.839 169.087 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -126.07 104.86 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 172.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.41 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 5.3 ppp? -83.34 167.61 17.42 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.959 172.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -137.05 155.0 50.21 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 171.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -125.56 129.81 50.44 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 168.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.68 108.52 12.11 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.671 2.388 . . . . 0.0 107.556 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.3 mtpt -104.73 124.16 48.91 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 118.154 -0.927 . . . . 0.0 109.09 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.493 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 32.3 t30 -78.37 85.46 4.49 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 119.517 1.053 . . . . 0.0 110.983 -175.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -78.12 68.89 4.25 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 174.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.3 135.48 13.08 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.781 0.832 . . . . 0.0 108.975 173.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.9 m -78.4 41.82 0.4 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.272 0.629 . . . . 0.0 110.246 172.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.1 p -148.31 154.26 41.83 Favored Pre-proline 0 N--CA 1.446 -0.671 0 C-N-CA 124.526 1.131 . . . . 0.0 107.989 169.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -66.95 150.41 82.94 Favored 'Trans proline' 0 N--CA 1.442 -1.545 0 N-CA-C 108.03 -1.565 . . . . 0.0 108.03 166.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.413 ' HG1' ' HE1' ' A' ' 47' ' ' TRP . 2.8 p -135.59 163.76 29.39 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.577 0.751 . . . . 0.0 109.302 175.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.1 t -118.88 136.21 54.16 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.636 0.775 . . . . 0.0 109.405 167.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -96.14 81.24 0.78 Allowed Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 176.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 50.4 mm-40 -106.38 53.29 0.7 Allowed 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 172.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.1 174.6 5.27 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.785 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.59 154.64 46.87 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 173.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -145.97 147.3 31.54 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -101.23 115.69 31.08 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 166.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.9 p -99.81 73.2 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.498 0 C-N-CA 124.24 1.016 . . . . 0.0 109.264 -176.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.0 t 177.56 148.46 0.34 Allowed Pre-proline 0 C--O 1.232 0.163 0 C-N-CA 123.645 0.778 . . . . 0.0 109.461 -178.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -66.3 -33.41 38.94 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 121.336 1.357 . . . . 0.0 109.754 162.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.0 ptp 177.83 -69.41 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.639 1.976 . . . . 0.0 107.933 177.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.67 -46.53 45.89 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 123.827 0.851 . . . . 0.0 113.203 -165.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.25 -101.06 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -162.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.93 -52.69 0.38 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.191 0.9 . . . . 0.0 114.032 -171.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -48.09 -52.84 18.66 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.306 1.553 . . . . 0.0 110.732 176.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 125' ' ' GLU . 15.1 m-85 -75.22 12.25 0.97 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.54 1.536 . . . . 0.0 114.768 176.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -92.39 108.08 19.7 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 171.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 . . . . . 0 CA--C 1.534 0.357 0 C-N-CA 118.41 -1.316 . . . . 0.0 112.698 -173.292 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.0 pm0 . . . . . 0 CA--C 1.539 0.551 0 CA-C-O 120.667 0.27 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.4 t -168.65 -72.3 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.094 0.958 . . . . 0.0 110.962 -177.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -158.77 151.06 21.49 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.6 1.16 . . . . 0.0 108.303 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 82.6 mt -144.34 148.0 34.19 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.443 ' HB3' ' HD2' ' A' ' 110' ' ' PRO . 3.6 mt-10 -88.86 175.41 4.06 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 123.969 0.908 . . . . 0.0 109.132 176.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 109' ' ' GLU . 33.2 Cg_endo -69.4 90.32 0.48 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.842 2.361 . . . . 0.0 114.469 -162.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 138.98 -23.39 2.9 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 123.731 0.681 . . . . 0.0 112.264 170.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -78.32 141.1 38.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 119.691 -0.804 . . . . 0.0 112.49 -146.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -84.05 113.44 21.03 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.621 1.569 . . . . 0.0 110.806 177.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 14.4 tpt -104.12 131.04 51.81 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 125.374 1.47 . . . . 0.0 107.235 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -155.03 139.44 16.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.056 0.389 . . . . 0.0 110.82 168.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 80.7 mtp -155.03 148.89 18.89 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.291 1.036 . . . . 0.0 109.544 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 67' ' ' MET . 49.5 Cg_endo -78.36 144.72 20.67 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.886 3.057 . . . . 0.0 112.701 170.322 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 25.0 t -118.83 121.53 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 168.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.2 p -79.54 146.32 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 169.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -155.19 146.99 23.32 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.256 0.48 . . . . 0.0 111.571 -171.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -156.62 153.22 28.22 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.271 1.429 . . . . 0.0 110.935 164.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 74.2 t -76.77 140.5 17.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 169.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.79 130.73 56.9 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 118.639 -0.696 . . . . 0.0 110.688 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -55.17 -30.46 71.22 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.191 2.594 . . . . 0.0 113.018 -178.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 16.0 mm-40 -36.28 -36.05 0.09 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.979 1.311 . . . . 0.0 113.418 172.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.7 tt -49.26 -36.72 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.4 m -87.67 54.31 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 119.24 0.927 . . . . 0.0 110.685 173.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -126.12 -74.67 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 117.508 -1.234 . . . . 0.0 111.983 171.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.67 156.37 40.05 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 CA-C-N 122.039 1.764 . . . . 0.0 112.538 -171.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 99.5 t -53.32 -44.21 53.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 125.137 1.375 . . . . 0.0 109.981 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -44.95 -51.58 9.62 Favored 'General case' 0 N--CA 1.426 -1.657 0 C-N-CA 128.216 2.606 . . . . 0.0 112.471 178.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 40.3 p -99.06 -8.07 25.83 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 119.052 -0.499 . . . . 0.0 111.869 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -44.41 112.38 0.41 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.989 0.916 . . . . 0.0 111.581 -178.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.47 -15.06 63.46 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 119.318 -0.712 . . . . 0.0 113.262 175.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 20.5 mm -64.97 123.78 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-N 119.016 1.408 . . . . 0.0 108.602 171.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 20.1 pttt -156.01 54.53 0.58 Allowed 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.032 0.444 . . . . 0.0 111.751 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.31 87.48 1.32 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 160.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.5 tp -82.79 88.16 6.77 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.242 -162.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 13.3 t -87.89 173.09 9.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.908 0.861 . . . . 0.0 111.329 -170.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.1 tt -145.39 111.15 5.46 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 171.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.6 p -91.81 97.97 11.32 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 124.999 1.32 . . . . 0.0 107.696 175.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.5 128.25 35.23 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 127.075 2.15 . . . . 0.0 108.71 -178.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.6 m -121.54 92.61 3.78 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 122.012 0.911 . . . . 0.0 109.494 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -75.77 90.49 2.89 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.014 -0.993 . . . . 0.0 110.068 174.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -148.02 41.38 0.25 Allowed Pre-proline 0 CA--C 1.553 1.068 0 N-CA-C 116.978 2.214 . . . . 0.0 116.978 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.79 -104.88 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.348 2.699 . . . . 0.0 112.859 -177.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -125.84 107.99 11.03 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.238 1.415 . . . . 0.0 110.661 -168.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -100.59 118.46 60.86 Favored Pre-proline 0 N--CA 1.453 -0.304 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 167.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.86 -50.02 0.07 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 121.781 1.654 . . . . 0.0 110.182 173.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.9 m -169.45 110.74 0.46 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.581 1.152 . . . . 0.0 110.981 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.543 0.679 0 C-N-CA 125.276 1.43 . . . . 0.0 112.808 170.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 61' ' ' GLY . . . . . . . . 0 N--CA 1.439 -0.989 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.3 t -156.08 42.95 0.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -158.34 -57.13 0.07 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 128.354 2.661 . . . . 0.0 104.709 -164.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 56.4 mt -75.75 -31.89 59.76 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 113.886 -1.506 . . . . 0.0 111.834 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.9 mt -66.0 112.62 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 O-C-N 121.964 -0.46 . . . . 0.0 111.753 -168.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.53 160.44 14.28 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 159.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -75.84 59.98 1.29 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.125 1.37 . . . . 0.0 111.323 -174.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.25 142.99 49.88 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.327 1.451 . . . . 0.0 107.496 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.3 mmmt -110.78 135.46 51.31 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.987 1.715 . . . . 0.0 109.252 -169.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.566 HG23 HG23 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -145.76 112.11 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-O 121.973 0.892 . . . . 0.0 109.878 -167.228 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.17 132.41 36.1 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.937 1.295 . . . . 0.0 109.295 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 t -113.36 121.28 65.25 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 C-N-CA 124.538 1.135 . . . . 0.0 108.209 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.63 126.7 31.1 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -102.46 95.89 6.56 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 173.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.417 ' CB ' HH22 ' A' ' 54' ' ' ARG . 6.4 t70 -118.46 81.07 1.62 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.895 0.855 . . . . 0.0 109.865 -178.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.72 148.3 22.24 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.751 0.821 . . . . 0.0 110.762 -174.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -132.99 152.59 51.94 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.407 1.083 . . . . 0.0 108.182 -172.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.6 t -135.91 146.26 29.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -146.46 174.64 11.21 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.239 0.542 . . . . 0.0 110.573 175.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.63 133.46 16.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 171.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 117.83 -45.98 1.2 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -162.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.501 HD12 ' HD3' ' A' ' 146' ' ' PRO . 0.5 OUTLIER -123.34 87.37 51.71 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 123.592 0.757 . . . . 0.0 109.693 174.491 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -81.8 43.96 1.62 Allowed 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.634 2.889 . . . . 0.0 109.292 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.436 ' CH2' ' HB2' ' A' ' 108' ' ' LEU . 43.0 m0 -114.91 140.47 48.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -175.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -79.09 81.3 5.37 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -85.75 98.92 11.0 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.7 m -87.37 135.0 35.05 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -177.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -66.77 156.25 66.79 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 N-CA-C 108.316 -1.455 . . . . 0.0 108.316 167.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.7 t -76.62 -45.71 32.46 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -168.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.66 176.9 12.01 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 163.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.417 HH22 ' CB ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -49.32 -45.08 44.95 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.63 0.772 . . . . 0.0 113.079 179.233 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -160.31 154.37 23.11 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 125.253 1.421 . . . . 0.0 107.797 -169.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.4 pt -113.12 164.67 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 C-N-CA 123.95 0.9 . . . . 0.0 109.022 175.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -121.43 118.56 29.7 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.848 1.259 . . . . 0.0 107.855 176.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.566 HG23 HG23 ' A' ' 33' ' ' ILE . 31.8 m -114.67 151.98 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 165.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -78.07 165.7 23.69 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 150.213 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.0 mm -6.69 -66.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 127.304 2.242 . . . . 0.0 114.136 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -130.14 21.3 4.92 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 118.868 -0.962 . . . . 0.0 114.723 -178.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -70.23 119.22 14.1 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 120.641 2.22 . . . . 0.0 110.948 -176.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.9 p -60.92 117.12 5.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.371 0.668 . . . . 0.0 109.452 172.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.5 p -110.85 149.34 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 165.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 39.5 tp60 -102.7 122.72 45.02 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.677 1.991 . . . . 0.0 107.972 -177.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.2 pp -141.5 100.25 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 121.938 0.875 . . . . 0.0 110.047 -177.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 65.7 mtt -77.17 126.34 30.78 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.985 1.314 . . . . 0.0 110.334 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -96.84 137.11 36.42 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 172.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 27.2 ttt85 -110.35 135.9 50.36 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.294 1.037 . . . . 0.0 109.652 -176.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.16 147.06 48.26 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.512 1.525 . . . . 0.0 109.608 175.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -136.29 121.62 19.26 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 117.784 -1.103 . . . . 0.0 108.267 171.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.416 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 43.0 t-20 -80.27 113.88 18.77 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.668 1.122 . . . . 0.0 111.798 -173.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.2 mt -99.21 16.74 21.87 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.741 1.216 . . . . 0.0 112.666 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.53 176.54 9.32 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.437 -0.789 . . . . 0.0 110.384 173.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.4 m -111.24 20.88 16.91 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.98 165.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.7 p -147.26 156.07 46.42 Favored Pre-proline 0 N--CA 1.449 -0.497 0 C-N-CA 125.521 1.528 . . . . 0.0 108.202 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.06 120.08 7.0 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 121.508 1.472 . . . . 0.0 108.586 175.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.66 163.64 15.05 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 118.898 0.772 . . . . 0.0 109.582 172.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.0 t -103.48 137.12 42.01 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 162.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.7 86.07 0.4 Allowed Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 103.497 -3.841 . . . . 0.0 103.497 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.05 46.57 0.91 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.93 177.04 2.78 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.169 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -148.49 178.33 8.7 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -128.16 161.42 29.32 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 166.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.464 ' OD1' HG22 ' A' ' 87' ' ' THR . 0.6 OUTLIER -114.7 128.39 56.28 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 103.441 -2.799 . . . . 0.0 103.441 155.187 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.0 t -111.55 79.46 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 O-C-N 124.502 1.126 . . . . 0.0 108.804 175.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.464 HG22 ' OD1' ' A' ' 85' ' ' ASN . 0.7 OUTLIER -160.5 140.21 8.2 Favored Pre-proline 0 N--CA 1.444 -0.752 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.289 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.45 -38.59 19.2 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 N-CA-C 108.333 -1.449 . . . . 0.0 108.333 163.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.1 ptp -177.55 -57.3 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.645 1.578 . . . . 0.0 109.962 -177.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.5 -4.1 25.87 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 123.772 0.829 . . . . 0.0 113.222 -162.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -95.77 -109.27 0.14 Allowed 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -172.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.92 -61.89 0.2 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 123.742 0.687 . . . . 0.0 112.868 -174.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -51.04 -59.68 3.91 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.45 1.1 . . . . 0.0 110.687 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -73.24 51.03 0.31 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.508 1.123 . . . . 0.0 112.169 176.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -114.19 121.51 43.95 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 124.089 0.956 . . . . 0.0 108.434 172.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 . . . . . 0 N--CA 1.446 -0.636 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.953 171.978 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.8 t 155.24 -146.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 129.318 3.047 . . . . 0.0 107.072 176.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.0 t -117.18 137.77 52.12 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.168 1.787 . . . . 0.0 108.663 175.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.436 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -135.58 125.38 25.57 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.241 1.016 . . . . 0.0 110.372 -172.453 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -70.44 157.67 89.49 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.394 1.078 . . . . 0.0 111.636 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.18 114.1 3.71 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.636 2.224 . . . . 0.0 111.92 -167.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 116.57 -25.85 8.87 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -79.95 161.73 25.33 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 121.442 0.639 . . . . 0.0 112.583 -167.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -103.21 159.58 15.42 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.079 1.352 . . . . 0.0 111.288 -173.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 5.9 mtp -148.44 153.91 39.16 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.769 1.627 . . . . 0.0 109.165 174.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -147.01 153.8 40.48 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 150.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 11.9 mmt -128.02 124.93 23.37 Favored Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 124.527 1.131 . . . . 0.0 108.702 178.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -69.47 145.6 59.31 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 C-N-CA 122.008 1.805 . . . . 0.0 109.297 170.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.9 t -130.06 144.26 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 164.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.8 p -111.23 140.21 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 167.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -147.66 139.29 23.91 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 118.349 0.522 . . . . 0.0 109.646 -172.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -153.94 162.13 41.45 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 125.016 1.327 . . . . 0.0 108.84 164.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.483 HG21 HD12 ' A' ' 33' ' ' ILE . 96.1 t -87.34 176.51 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 123.254 0.622 . . . . 0.0 109.699 176.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -121.78 133.65 24.36 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 123.591 0.757 . . . . 0.0 110.75 172.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.18 -21.41 72.34 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.415 2.077 . . . . 0.0 113.473 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -59.89 -14.69 16.57 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 119.81 1.187 . . . . 0.0 111.953 -178.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.2 tt -56.58 -42.31 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 121.212 -0.93 . . . . 0.0 112.664 168.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.2 m -84.97 52.65 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 119.228 0.922 . . . . 0.0 110.84 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -123.62 -65.8 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 117.708 -1.139 . . . . 0.0 113.174 173.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.17 154.72 41.88 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 CA-C-N 121.836 1.692 . . . . 0.0 111.25 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.0 m -59.05 -36.5 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 124.744 1.218 . . . . 0.0 112.208 -173.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -61.73 -60.63 3.38 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.445 0.698 . . . . 0.0 110.138 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 82.1 p -83.1 -7.99 59.57 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 118.417 -0.801 . . . . 0.0 112.353 -173.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -33.98 -50.09 0.37 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.301 1.44 . . . . 0.0 113.703 175.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -84.55 -21.49 56.17 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 123.353 0.502 . . . . 0.0 112.155 -176.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 37.6 mm -77.79 118.11 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 O-C-N 122.054 -0.674 . . . . 0.0 109.777 -177.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.9 pttt -155.28 61.34 0.63 Allowed 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.719 168.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 24.9 p -144.39 87.98 1.91 Allowed 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 170.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.1 tp -83.35 78.07 9.69 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -162.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.5 m -79.18 122.68 26.57 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.098 -1.41 . . . . 0.0 109.818 -158.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.8 tt -79.07 129.48 34.49 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 168.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.5 t -153.69 122.51 6.38 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 165.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -158.24 171.0 21.0 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.481 0.712 . . . . 0.0 110.915 -177.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.4 m -115.69 117.55 30.6 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.099 1.76 . . . . 0.0 111.037 -176.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -79.61 100.32 7.75 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.959 1.304 . . . . 0.0 108.492 168.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -155.67 59.38 2.12 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -176.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.501 ' HD3' HD12 ' A' ' 45' ' ' LEU . 72.8 Cg_endo -79.76 -94.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.658 2.905 . . . . 0.0 112.732 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 78.6 mtt-85 -152.02 96.12 2.16 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.497 -0.752 . . . . 0.0 110.22 -158.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -91.16 123.55 64.09 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 118.752 -0.642 . . . . 0.0 111.098 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -69.89 -61.38 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.743 1.629 . . . . 0.0 110.47 172.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.8 t -157.27 117.22 3.44 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 121.767 -0.583 . . . . 0.0 111.223 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.559 0 C-N-CA 125.36 1.464 . . . . 0.0 110.577 170.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 119.614 -0.232 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.1 p -163.13 -147.65 0.12 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 160.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -77.31 -22.57 51.74 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.955 2.102 . . . . 0.0 110.42 164.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.2 mt -56.34 -16.4 5.54 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.915 1.286 . . . . 0.0 113.885 -178.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 74.7 mt -52.03 118.51 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 124.373 1.069 . . . . 0.0 110.959 -173.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 mp -93.83 -83.76 0.32 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.943 0.497 . . . . 0.0 110.892 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -175.23 -56.82 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.033 0.933 . . . . 0.0 109.834 -164.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.32 145.4 2.4 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 125.542 1.537 . . . . 0.0 113.473 -165.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.9 tttt -96.93 90.78 5.33 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 126.062 1.745 . . . . 0.0 106.585 -170.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.68 107.5 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 176.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.16 146.06 35.29 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -177.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.5 t -130.46 144.4 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 -176.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 29.7 m -130.84 95.2 3.78 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -171.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -77.22 88.09 3.67 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 124.141 0.977 . . . . 0.0 108.986 -176.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -79.97 83.42 5.88 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 122.66 1.219 . . . . 0.0 109.699 -174.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.25 102.82 15.48 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.531 1.132 . . . . 0.0 110.594 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -106.05 111.17 23.69 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.296 0.639 . . . . 0.0 110.158 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.5 p -77.31 147.84 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 168.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.38 154.62 41.1 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 167.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.79 -41.23 22.97 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.062 0.945 . . . . 0.0 111.742 -175.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -30.69 -43.25 0.07 OUTLIER Glycine 0 CA--C 1.53 1.006 0 C-N-CA 126.898 2.189 . . . . 0.0 113.758 169.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.449 HD21 ' CE3' ' A' ' 47' ' ' TRP . 1.3 tt -116.14 98.54 51.48 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 170.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -74.89 13.8 0.94 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.008 2.472 . . . . 0.0 115.222 -161.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.504 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 42.0 m0 -79.27 156.2 28.19 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.58 1.552 . . . . 0.0 113.079 -168.04 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -75.98 79.79 2.85 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 170.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -99.56 121.66 41.5 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.022 0.929 . . . . 0.0 108.718 -177.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.08 141.87 41.14 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 118.047 0.385 . . . . 0.0 110.269 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.92 161.15 45.79 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.907 1.738 . . . . 0.0 108.857 163.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.44 -50.38 19.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 177.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -148.04 165.57 30.39 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 159.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -61.76 -41.57 97.87 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.689 0.677 . . . . 0.0 110.127 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -145.92 157.61 43.89 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 123.726 0.81 . . . . 0.0 112.444 -160.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 50.1 pt -136.54 171.33 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 125.12 1.368 . . . . 0.0 109.252 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -125.01 85.99 2.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.87 1.668 . . . . 0.0 110.814 -178.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.1 t -76.16 127.94 37.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -177.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.87 101.12 9.22 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 167.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 mm -6.21 84.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 127.579 2.352 . . . . 0.0 113.371 -171.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.5 -0.51 49.7 Favored Glycine 0 CA--C 1.539 1.546 0 N-CA-C 115.413 0.925 . . . . 0.0 115.413 171.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -59.69 124.34 19.81 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.023 1.729 . . . . 0.0 109.396 163.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.78 111.75 21.04 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.438 1.095 . . . . 0.0 110.995 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.22 143.27 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.85 128.39 49.63 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.1 pp -143.9 93.17 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.135 1.374 . . . . 0.0 109.308 -173.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 46.6 ttm -73.6 135.96 43.89 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.124 0.969 . . . . 0.0 110.059 -173.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -99.69 141.17 32.84 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 174.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.3 ttt180 -110.85 132.34 54.29 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 174.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.09 141.75 44.24 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 127.052 2.141 . . . . 0.0 107.241 162.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -140.71 145.98 37.18 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 166.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.504 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 34.6 t30 -83.38 87.27 6.98 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 119.024 0.829 . . . . 0.0 113.019 -170.044 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -79.92 73.53 6.69 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.197 0.999 . . . . 0.0 109.224 172.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.15 140.26 17.46 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 164.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.7 t -78.35 35.4 0.22 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.785 1.175 . . . . 0.0 111.347 174.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.404 ' N ' ' HB3' ' A' ' 110' ' ' PRO . 1.3 p -146.41 154.57 49.29 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 126.392 1.877 . . . . 0.0 108.876 176.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.49 143.33 42.52 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.615 2.21 . . . . 0.0 109.242 176.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.483 ' HG1' ' HE1' ' A' ' 47' ' ' TRP . 4.5 p -117.44 176.72 5.03 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.51 1.124 . . . . 0.0 111.998 -175.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 m -133.43 126.08 30.42 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 103.18 -2.896 . . . . 0.0 103.18 -178.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -127.35 117.24 2.63 Favored Glycine 0 C--N 1.335 0.481 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -171.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.54 -48.57 0.47 Allowed 'General case' 0 C--N 1.338 0.106 0 CA-C-N 117.738 0.769 . . . . 0.0 110.291 174.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 62.84 175.38 0.15 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.22 1.008 . . . . 0.0 110.408 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.3 t -111.3 146.8 36.39 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 165.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -122.18 89.67 3.16 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.254 1.422 . . . . 0.0 108.073 -173.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.73 85.25 4.75 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 174.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.7 t -79.04 70.09 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.844 1.258 . . . . 0.0 109.707 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.5 t -176.74 149.42 0.86 Allowed Pre-proline 0 N--CA 1.469 0.486 0 CA-C-N 119.325 0.966 . . . . 0.0 111.571 170.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -66.22 -37.31 25.14 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.266 1.31 . . . . 0.0 110.088 159.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 11.8 ptp 169.58 -68.67 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 128.305 2.642 . . . . 0.0 106.912 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.74 -45.35 65.01 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.94 0.896 . . . . 0.0 112.966 -170.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.19 -104.4 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.91 -166.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.97 -56.62 1.41 Allowed Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.47 -0.628 . . . . 0.0 112.488 -175.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -44.23 -55.08 5.13 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.594 1.158 . . . . 0.0 111.923 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -72.54 2.66 5.97 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.546 1.538 . . . . 0.0 114.014 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -73.89 90.84 1.94 Allowed 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.522 0.729 . . . . 0.0 109.55 -175.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 . . . . . 0 N--CA 1.447 -0.585 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.602 -167.896 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 . . . . . 0 CA--C 1.536 0.434 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.9 t 36.67 -124.15 0.17 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.987 1.715 . . . . 0.0 114.463 166.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.4 t -142.96 155.13 44.64 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.797 2.039 . . . . 0.0 107.624 -176.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.2 mt -142.63 141.78 31.97 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 170.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.442 ' HB3' ' HD2' ' A' ' 110' ' ' PRO . 2.5 mp0 -76.34 170.65 15.07 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.588 1.555 . . . . 0.0 108.994 171.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 109' ' ' GLU . 46.4 Cg_endo -71.9 106.59 2.04 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 121.807 1.671 . . . . 0.0 113.666 -166.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 116.51 -13.77 15.45 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 124.932 1.253 . . . . 0.0 110.801 172.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -82.4 176.89 9.06 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 123.627 0.251 . . . . 0.0 111.548 -163.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -118.86 144.0 46.63 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.073 0.949 . . . . 0.0 113.194 -150.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.25 84.29 1.95 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.102 1.761 . . . . 0.0 110.027 168.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -101.95 87.79 3.2 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 120.612 -1.305 . . . . 0.0 109.243 171.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 13.2 ttt -102.82 118.82 57.43 Favored Pre-proline 0 N--CA 1.442 -0.869 0 O-C-N 121.454 -0.779 . . . . 0.0 110.275 -167.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.64 152.77 77.62 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.145 1.897 . . . . 0.0 110.358 171.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.5 t -145.43 135.44 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.6 p -99.46 148.08 6.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 166.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -152.43 156.27 39.15 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 118.282 0.492 . . . . 0.0 112.047 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -173.11 176.78 2.89 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 127.149 2.18 . . . . 0.0 108.467 176.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.465 HG22 HD22 ' A' ' 138' ' ' LEU . 78.7 t -131.86 138.66 52.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 124.0 0.92 . . . . 0.0 108.967 176.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -82.88 146.81 53.17 Favored Pre-proline 0 CA--C 1.54 0.593 0 O-C-N 123.452 0.47 . . . . 0.0 111.255 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -56.98 -25.25 61.8 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.95 3.1 . . . . 0.0 113.615 177.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -42.22 -31.13 0.35 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.637 1.575 . . . . 0.0 113.09 175.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.3 tt -49.3 -46.14 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.6 m -85.5 57.07 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 119.425 1.011 . . . . 0.0 110.52 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -132.59 -64.55 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.484 1.114 . . . . 0.0 113.456 173.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -63.86 164.7 20.87 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 121.932 1.754 . . . . 0.0 111.882 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 89.3 t -77.39 -43.8 30.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -173.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -37.8 -46.6 0.94 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 129.037 2.935 . . . . 0.0 112.957 177.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 19.1 p -87.23 -61.93 1.61 Allowed 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -0.97 79.7 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 129.506 3.123 . . . . 0.0 115.098 -171.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 134.82 -44.11 1.21 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 -171.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 12.4 mm -53.46 118.25 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 123.038 0.535 . . . . 0.0 110.075 170.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -156.01 53.84 0.57 Allowed 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.881 168.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.83 91.87 2.4 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 167.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.465 HD22 HG22 ' A' ' 122' ' ' VAL . 1.5 mp -77.0 135.12 38.66 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 -176.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 6.7 t -136.9 150.46 48.24 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.76 106.35 10.43 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 102.785 -3.043 . . . . 0.0 102.785 170.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.6 t -79.61 92.98 5.4 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 172.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.37 121.82 27.19 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 174.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.63 108.85 13.04 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.894 0.878 . . . . 0.0 109.786 -178.012 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.449 ' CD2' HD13 ' A' ' 45' ' ' LEU . 3.9 m-30 -79.28 80.51 5.64 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.014 1.325 . . . . 0.0 112.792 -167.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -129.58 78.42 75.52 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -97.65 -106.98 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.873 1 C-N-CA 125.418 4.079 . . . . 0.0 111.223 167.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -137.85 113.06 9.25 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.083 1.753 . . . . 0.0 108.046 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -91.11 113.11 57.17 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 123.813 0.845 . . . . 0.0 108.756 170.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -77.23 65.38 7.91 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.131 1.887 . . . . 0.0 108.314 166.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.2 m 26.53 92.58 0.01 OUTLIER 'General case' 0 C--N 1.344 0.326 0 C-N-CA 128.688 2.795 . . . . 0.0 113.964 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.283 0 CA-C-N 119.038 0.835 . . . . 0.0 110.573 -156.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 61' ' ' GLY . . . . . . . . 0 N--CA 1.432 -1.351 0 N-CA-C 103.353 -2.832 . . . . 0.0 103.353 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.4 m -157.89 39.15 0.27 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.318 1.447 . . . . 0.0 109.145 162.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.18 -58.07 1.82 Allowed 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 104.767 -2.308 . . . . 0.0 104.767 -166.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.9 mt -124.87 41.55 3.49 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.432 1.493 . . . . 0.0 109.706 176.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.412 ' C ' HD13 ' A' ' 29' ' ' LEU . 44.3 mt -75.07 110.06 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 162.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.412 HD13 ' C ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -104.17 -174.12 2.47 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 170.963 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.42 -32.96 70.66 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.363 1.465 . . . . 0.0 114.855 -163.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -53.23 95.95 0.01 OUTLIER 'General case' 0 C--N 1.34 0.178 0 CA-C-O 123.048 1.404 . . . . 0.0 112.72 -173.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.3 ttpp -74.58 88.12 2.15 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 165.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.65 127.51 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.754 -172.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.44 134.28 33.62 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -174.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 t -118.03 139.18 46.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.5 m -113.2 104.55 12.46 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.825 1.25 . . . . 0.0 108.272 -174.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -79.96 148.22 31.29 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.764 173.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -144.19 86.96 1.86 Allowed 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 -175.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.64 90.66 8.5 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.983 1.313 . . . . 0.0 110.505 -173.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -93.09 106.55 18.5 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.513 0.673 . . . . 0.0 109.752 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.0 p -78.44 145.52 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 163.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -156.32 159.43 38.81 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 118.579 0.627 . . . . 0.0 110.266 176.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.31 132.69 29.13 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 172.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.21 -45.33 1.28 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 -160.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.25 97.37 19.94 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 123.699 0.799 . . . . 0.0 109.801 -178.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.82 11.29 2.8 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.525 2.817 . . . . 0.0 113.438 -174.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 42.0 m0 -76.29 145.66 39.46 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.074 -1.016 . . . . 0.0 111.352 -172.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -77.59 83.15 3.99 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 104.87 -2.271 . . . . 0.0 104.87 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -94.59 90.14 6.04 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.616 1.966 . . . . 0.0 108.514 -171.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.2 m -89.15 129.65 47.12 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -176.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.87 149.38 72.37 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 N-CA-C 108.165 -1.513 . . . . 0.0 108.165 164.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.3 -59.2 3.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -128.85 157.09 42.5 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 167.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.9 tpt85 -67.33 -34.36 77.18 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 173.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -134.3 169.47 17.17 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 125.576 1.55 . . . . 0.0 110.689 -174.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.5 pt -136.47 175.87 9.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 124.774 1.23 . . . . 0.0 107.88 166.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.35 136.8 53.17 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 165.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.9 m -126.04 135.1 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 170.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.85 96.04 2.03 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 165.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.438 HD12 ' HB3' ' A' ' 124' ' ' PRO . 4.8 pt 0.23 73.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.994 2.117 . . . . 0.0 114.389 -173.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . 133.28 -27.9 3.36 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 119.934 -0.37 . . . . 0.0 112.821 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -46.74 106.95 0.09 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.239 1.016 . . . . 0.0 111.414 176.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.434 HG22 ' CD1' ' A' ' 121' ' ' PHE . 1.1 p -65.0 113.48 3.91 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.83 0.852 . . . . 0.0 109.386 174.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.3 p -114.8 144.11 23.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 167.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.25 131.06 38.7 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.154 1.782 . . . . 0.0 107.978 176.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -145.67 93.49 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.37 144.61 34.0 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.979 -173.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -110.83 145.26 38.52 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 177.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.5 ttt-85 -118.84 121.29 39.68 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.667 1.187 . . . . 0.0 108.291 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.28 111.0 18.8 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.013 0.925 . . . . 0.0 109.653 169.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -107.98 118.36 36.54 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.975 0.91 . . . . 0.0 110.561 -176.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -79.73 94.32 5.72 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -162.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.5 mt -84.72 73.24 10.63 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.469 0.707 . . . . 0.0 110.556 168.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -127.94 167.83 16.09 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.168 0.987 . . . . 0.0 110.52 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.5 p -78.26 -29.62 48.12 Favored 'General case' 0 C--O 1.227 -0.127 0 C-N-CA 123.467 0.707 . . . . 0.0 111.466 174.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -147.92 162.32 31.67 Favored Pre-proline 0 N--CA 1.449 -0.508 0 C-N-CA 124.742 1.217 . . . . 0.0 108.456 -160.025 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -59.68 121.17 9.41 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.724 2.282 . . . . 0.0 111.044 -174.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.51 175.42 7.07 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.623 1.569 . . . . 0.0 110.113 -178.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.0 t -138.24 159.28 42.46 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 169.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -138.1 150.93 21.18 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 127.03 2.252 . . . . 0.0 108.551 -173.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.44 HE21 ' N ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -162.56 -39.22 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.21 0.604 . . . . 0.0 110.097 168.534 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.44 ' N ' HE21 ' A' ' 81' ' ' GLN . . . 61.58 -179.52 0.12 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.873 0.869 . . . . 0.0 113.023 176.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.1 t -119.31 166.63 12.78 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 144.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -141.89 88.78 2.14 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.756 1.265 . . . . 0.0 108.015 -176.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -79.13 89.08 4.83 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -177.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.8 t -79.69 86.65 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 173.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.8 t -175.16 151.33 1.33 Allowed Pre-proline 0 C--O 1.232 0.143 0 C-N-CA 125.055 1.342 . . . . 0.0 109.411 170.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.52 -34.61 7.16 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 121.011 1.14 . . . . 0.0 109.156 156.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.8 ptp 171.99 -70.38 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.91 2.484 . . . . 0.0 107.869 -177.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.69 -30.79 26.51 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -165.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.38 -112.93 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.011 0.368 . . . . 0.0 110.086 -177.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.24 -58.62 0.84 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 123.737 0.684 . . . . 0.0 112.735 -174.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -49.44 -53.67 21.67 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.998 0.919 . . . . 0.0 110.365 175.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -73.19 40.4 0.1 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.494 1.118 . . . . 0.0 112.919 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -103.06 140.31 37.46 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 173.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 16.8 m120 . . . . . 0 C--O 1.223 -0.341 0 C-N-CA 118.394 -1.322 . . . . 0.0 111.405 173.331 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.2 t -115.3 -61.05 1.8 Allowed 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 124.813 1.245 . . . . 0.0 110.56 -172.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -161.96 146.23 12.55 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.039 1.336 . . . . 0.0 107.427 -178.281 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.431 HD11 ' HB2' ' A' ' 114' ' ' MET . 94.5 mt -147.79 134.46 19.93 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 174.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -64.55 156.4 77.7 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 127.382 2.273 . . . . 0.0 109.751 170.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.3 92.92 0.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.531 2.821 . . . . 0.0 111.65 -167.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 143.75 -27.32 2.06 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 124.562 1.077 . . . . 0.0 110.991 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -77.97 153.93 32.01 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -153.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -108.6 118.17 36.09 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.591 1.556 . . . . 0.0 110.19 -166.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.431 ' HB2' HD11 ' A' ' 108' ' ' LEU . 14.9 ttp -108.96 86.04 2.21 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 123.834 0.853 . . . . 0.0 110.868 178.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -77.26 129.39 35.84 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 156.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 25.6 mtp -143.35 136.58 13.97 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 118.587 0.63 . . . . 0.0 111.511 159.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -69.95 124.32 10.89 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 123.547 2.831 . . . . 0.0 111.296 171.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.2 t -91.18 152.24 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 160.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.8 p -121.46 143.7 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 167.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -148.65 135.53 19.93 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 118.633 0.651 . . . . 0.0 110.621 -173.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.434 ' CD1' HG22 ' A' ' 63' ' ' THR . 1.0 OUTLIER -159.55 149.05 18.31 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.156 1.382 . . . . 0.0 109.17 174.348 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 92.3 t -100.8 139.17 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.689 1.196 . . . . 0.0 111.441 -173.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -82.91 120.35 76.03 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 177.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.438 ' HB3' HD12 ' A' ' 60' ' ' ILE . 36.4 Cg_endo -58.16 -16.31 27.07 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.827 2.351 . . . . 0.0 113.754 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.87 -27.4 2.09 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 119.518 1.054 . . . . 0.0 111.965 168.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.02 -45.7 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 O-C-N 121.643 -0.66 . . . . 0.0 111.63 175.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.9 m -87.36 56.34 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 O-C-N 121.185 -0.947 . . . . 0.0 109.952 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -138.1 -59.72 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 117.14 -1.409 . . . . 0.0 113.762 175.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.95 161.44 18.42 Favored 'Trans proline' 0 C--N 1.347 0.489 0 CA-C-N 122.573 1.955 . . . . 0.0 113.237 -172.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.1 t -56.2 -36.66 46.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 125.843 1.657 . . . . 0.0 111.0 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -38.84 -54.1 1.65 Allowed 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 126.377 1.871 . . . . 0.0 112.053 176.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.5 p -106.28 -46.19 4.11 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.529 -166.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 14.72 67.05 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.305 2.642 . . . . 0.0 115.652 175.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 127.84 -24.36 5.16 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.676 -0.57 . . . . 0.0 111.676 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.2 mm -60.58 132.02 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 170.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 42.5 pttt -159.51 64.72 0.38 Allowed 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.784 0.802 . . . . 0.0 110.282 167.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 27.7 m -149.19 98.28 2.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 162.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.66 82.75 4.88 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -175.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.1 m -76.7 152.9 35.54 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.985 -169.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.2 tt -136.96 104.47 5.47 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.3 m -86.98 98.25 11.15 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 169.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.92 128.07 33.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 170.063 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.3 m -135.95 98.44 3.89 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.463 0.649 . . . . 0.0 109.89 -168.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -72.98 92.09 1.62 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.118 1.367 . . . . 0.0 112.111 -174.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -132.25 90.61 33.97 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.394 1.078 . . . . 0.0 113.386 170.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -109.4 -105.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.318 1 C-N-CA 125.381 4.054 . . . . 0.0 109.731 164.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.4 ptt-85 -160.34 124.49 3.66 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.59 1.556 . . . . 0.0 108.25 -174.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -95.78 133.69 25.13 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 123.24 0.616 . . . . 0.0 109.493 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -73.53 -63.16 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.146 1.898 . . . . 0.0 108.729 174.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.5 t -167.41 175.22 7.37 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.827 1.251 . . . . 0.0 107.98 162.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.5 0 C-N-CA 124.5 1.12 . . . . 0.0 111.859 -178.227 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.4 t -160.33 -157.85 0.58 Allowed 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 164.2 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.0 -18.24 61.99 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.953 1.701 . . . . 0.0 109.574 175.828 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.1 mt -68.1 2.41 2.16 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.641 1.177 . . . . 0.0 113.511 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.4 mt -67.71 126.21 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 121.036 1.744 . . . . 0.0 108.888 172.93 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.4 mp -126.16 163.0 24.08 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.36 0.664 . . . . 0.0 110.669 -178.074 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -78.56 70.26 4.87 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.703 0.801 . . . . 0.0 111.786 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.15 162.19 27.5 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 153.945 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -130.84 110.27 11.18 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -174.312 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.411 ' CG2' HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -112.13 125.14 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 -174.532 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -89.39 137.79 32.02 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -178.215 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.2 t -123.98 131.29 73.16 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.534 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.7 m -91.59 106.1 18.23 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.412 1.885 . . . . 0.0 108.087 -174.165 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -80.52 124.72 29.18 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.79 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -130.23 84.94 2.24 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 122.233 1.016 . . . . 0.0 111.617 -170.741 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.54 102.31 14.08 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.14 0.976 . . . . 0.0 109.706 177.7 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -99.18 122.25 42.12 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.393 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.6 p -113.01 133.56 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.089 0 C-N-CA 124.162 0.985 . . . . 0.0 109.071 174.832 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.11 176.15 8.95 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.543 1.137 . . . . 0.0 108.833 179.682 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.1 122.57 8.74 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 170.195 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.06 -32.52 1.16 Allowed Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -165.122 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mp -142.63 158.74 59.43 Favored Pre-proline 0 N--CA 1.456 -0.155 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 160.791 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -90.66 13.31 2.22 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.84 3.027 . . . . 0.0 112.171 165.686 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.444 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 41.7 m0 -78.63 139.76 38.51 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -162.49 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -76.72 83.78 3.34 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.495 ' CZ ' ' HB2' ' A' ' 70' ' ' ALA . 7.2 m-85 -87.71 89.34 7.96 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.317 175.04 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.5 m -87.9 112.9 52.06 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 171.787 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.1 142.02 54.66 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 N-CA-C 107.659 -1.708 . . . . 0.0 107.659 164.94 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 m -77.54 -41.37 29.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 O-C-N 122.396 -0.19 . . . . 0.0 111.408 -171.3 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -145.97 156.51 43.55 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 167.963 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -65.29 -36.62 84.64 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 177.782 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -151.6 143.75 23.96 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 122.762 0.425 . . . . 0.0 110.99 -174.494 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.0 pt -105.6 168.36 2.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 123.679 0.792 . . . . 0.0 109.416 174.626 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -94.05 141.92 27.98 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 152.868 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.76 123.61 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 157.808 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -75.52 78.82 2.54 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 172.865 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.411 HG23 ' CG2' ' A' ' 33' ' ' ILE . 2.9 pt 11.97 73.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 127.508 2.323 . . . . 0.0 112.923 -176.497 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.99 -33.44 3.7 Favored Glycine 0 C--O 1.222 -0.643 0 CA-C-O 118.448 -1.195 . . . . 0.0 112.054 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -62.1 140.78 58.39 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 120.225 2.012 . . . . 0.0 110.442 -178.12 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.13 112.15 16.05 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 127.942 2.497 . . . . 0.0 110.182 -174.041 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 p -79.67 169.01 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.104 0 O-C-N 121.818 -0.551 . . . . 0.0 109.63 174.683 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.409 HE21 ' HA ' ' A' ' 65' ' ' GLN . 5.2 tp60 -116.39 113.76 23.35 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 124.947 1.299 . . . . 0.0 107.96 156.262 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.4 pp -121.54 126.9 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 159.533 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 33.1 ttp -79.31 151.05 31.29 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 167.548 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.77 155.61 27.5 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 167.348 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -134.23 145.35 49.07 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.448 1.099 . . . . 0.0 109.299 172.229 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 49' ' ' PHE . . . -135.16 155.97 49.78 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 127.0 2.12 . . . . 0.0 105.943 151.072 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.0 mmmt -137.72 122.1 18.27 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 116.845 -1.55 . . . . 0.0 108.997 176.496 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.444 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 49.9 t-20 -78.22 85.49 4.38 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 121.472 1.942 . . . . 0.0 111.565 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.4 mt -79.1 68.89 5.18 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.788 1.235 . . . . 0.0 109.869 172.541 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.75 175.02 10.94 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 170.072 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.5 m -106.41 19.4 20.56 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.1 0.56 . . . . 0.0 110.346 173.742 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.4 p -146.6 161.05 39.6 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 125.777 1.631 . . . . 0.0 108.848 178.921 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -62.8 156.51 53.17 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 121.502 1.468 . . . . 0.0 110.247 173.568 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.37 162.91 31.27 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 171.849 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.9 t -116.61 108.22 15.67 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.63 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.2 121.61 5.59 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 105.625 -2.99 . . . . 0.0 105.625 162.652 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -127.66 -54.06 1.34 Allowed 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 170.734 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.39 178.41 0.16 Allowed 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.884 0.874 . . . . 0.0 110.984 172.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.62 141.63 33.43 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 153.055 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -107.4 162.85 13.55 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 122.681 0.392 . . . . 0.0 110.53 173.924 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -123.23 111.32 16.33 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 160.374 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.0 t -89.17 56.82 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.616 0.766 . . . . 0.0 110.008 -171.365 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.2 t -172.97 149.97 1.9 Allowed Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 119.911 1.232 . . . . 0.0 112.24 -177.56 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -64.84 -39.46 25.55 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 121.972 1.782 . . . . 0.0 109.676 162.697 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.4 ptp 173.49 -76.79 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 127.537 2.335 . . . . 0.0 108.044 176.195 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.418 ' HB3' HG13 ' A' ' 135' ' ' ILE . . . -62.16 -43.51 98.66 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 123.938 0.895 . . . . 0.0 112.666 -169.99 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.04 -103.82 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.718 -161.522 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.04 -53.91 1.4 Allowed Glycine 0 CA--C 1.527 0.829 0 CA-C-O 119.381 -0.677 . . . . 0.0 113.043 -177.775 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -45.84 -56.42 5.41 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.49 1.145 . . . . 0.0 110.984 176.788 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -74.35 4.72 5.42 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.606 1.162 . . . . 0.0 113.83 179.355 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -76.9 107.78 9.48 Favored 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 120.9 -1.125 . . . . 0.0 108.428 177.235 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 . . . . . 0 N--CA 1.447 -0.602 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.77 -172.712 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.474 0 CA-C-O 118.995 -0.526 . . . . 0.0 111.488 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.8 t 45.66 -148.36 0.11 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.499 1.52 . . . . 0.0 111.92 177.447 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -93.95 145.54 24.57 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.108 0.963 . . . . 0.0 108.913 176.911 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.1 mt -136.71 128.14 28.43 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 122.94 0.496 . . . . 0.0 109.897 177.447 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -54.74 165.21 0.97 Allowed Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 127.255 2.222 . . . . 0.0 110.738 160.706 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -76.25 126.17 8.99 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.244 1.963 . . . . 0.0 112.457 -172.027 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 98.02 5.16 57.46 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 124.012 0.815 . . . . 0.0 111.298 175.489 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -79.35 133.75 36.59 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 117.242 0.521 . . . . 0.0 110.737 -173.753 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -102.19 89.28 3.54 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.144 1.378 . . . . 0.0 109.694 -175.322 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.96 87.36 7.35 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -133.51 131.91 40.37 Favored 'General case' 0 CA--C 1.523 -0.075 0 CA-C-N 119.193 0.906 . . . . 0.0 111.411 169.506 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 60.0 mtt -153.07 147.11 18.57 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.173 0.989 . . . . 0.0 109.498 -170.519 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.29 146.84 40.96 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.678 2.919 . . . . 0.0 110.375 173.525 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 28.2 m -138.22 158.77 32.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 123.771 0.828 . . . . 0.0 108.891 165.319 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.6 m -114.6 161.01 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 124.097 0.959 . . . . 0.0 109.104 175.788 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -159.95 155.77 26.06 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.387 1.075 . . . . 0.0 108.164 -179.216 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -175.27 92.72 0.06 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.975 1.31 . . . . 0.0 111.529 -171.648 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.34 138.56 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 O-C-N 120.691 -1.256 . . . . 0.0 111.714 178.611 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.75 136.24 92.5 Favored Pre-proline 0 N--CA 1.469 0.51 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.487 173.783 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.57 -29.22 59.34 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.028 1.819 . . . . 0.0 112.104 172.375 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -44.6 -28.88 0.65 Allowed 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.534 1.533 . . . . 0.0 112.727 174.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 17.7 tt -47.69 -41.05 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 119.375 0.988 . . . . 0.0 112.817 174.345 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.3 m -87.01 58.39 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 119.573 1.079 . . . . 0.0 109.992 175.517 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.401 ' HG2' ' HD3' ' A' ' 129' ' ' PRO 0.486 1.0 OUTLIER -144.28 -52.63 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 117.933 2.568 . . . . 0.0 117.933 172.102 . . . . . . . . 4 4 . 1 . 021 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.401 ' HD3' ' HG2' ' A' ' 128' ' ' LYS . 98.6 Cg_endo -76.79 161.21 33.7 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 CA-C-N 123.368 2.239 . . . . 0.0 112.26 -177.743 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.78 -42.16 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 124.826 1.25 . . . . 0.0 109.468 -172.404 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -43.26 -47.74 6.58 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 127.528 2.331 . . . . 0.0 112.382 177.254 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 24.2 p -92.95 -53.16 4.26 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -175.972 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 12.59 62.41 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 129.117 2.967 . . . . 0.0 115.44 -178.443 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 140.98 -38.73 1.52 Allowed Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -174.133 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.418 HG13 ' HB3' ' A' ' 90' ' ' ALA . 16.8 mm -55.34 113.65 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-N 117.434 0.617 . . . . 0.0 109.864 175.206 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 7.9 pttt -156.52 61.56 0.54 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 121.99 0.9 . . . . 0.0 108.925 169.659 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.89 89.53 1.47 Allowed 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 162.735 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.5 tp -74.99 160.16 30.9 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -171.407 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 12.0 t -153.36 164.75 37.59 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 174.242 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 14.7 tp -138.06 98.27 3.6 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 102.253 -3.24 . . . . 0.0 102.253 173.303 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.9 p -84.24 93.18 8.14 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 177.918 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.27 131.36 36.14 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 175.324 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.94 96.24 4.98 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.003 0.921 . . . . 0.0 108.677 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.415 ' CE1' ' CZ ' ' A' ' 49' ' ' PHE . 50.4 m-85 -89.62 87.63 7.1 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 125.652 1.581 . . . . 0.0 109.531 178.607 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -135.71 37.35 0.34 Allowed Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 125.378 1.471 . . . . 0.0 114.379 175.311 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.45 -85.4 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.156 2.571 . . . . 0.0 114.346 -172.638 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.46 91.38 1.57 Allowed 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.592 0.757 . . . . 0.0 110.352 -163.947 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -78.5 117.74 68.17 Favored Pre-proline 0 N--CA 1.451 -0.387 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 168.378 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.57 -29.42 7.37 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.551 2.167 . . . . 0.0 110.788 172.102 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 36.9 m 130.01 144.0 0.0 OUTLIER 'General case' 0 C--N 1.342 0.263 0 C-N-CA 130.632 3.573 . . . . 0.0 107.36 -167.799 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.2 pttm . . . . . 0 CA--C 1.534 0.358 0 C-N-CA 124.927 1.291 . . . . 0.0 109.267 177.562 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.486 0 CA-C-O 122.025 0.917 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.79 -11.43 59.99 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.529 1.532 . . . . 0.0 114.757 -147.196 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.35 -31.96 64.25 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 173.879 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.1 mp -108.09 14.46 25.11 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.023 1.329 . . . . 0.0 112.074 -176.27 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.4 mt -77.98 77.31 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 120.005 -1.684 . . . . 0.0 108.839 173.641 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.76 179.75 5.93 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.531 0.681 . . . . 0.0 109.893 179.238 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -94.48 59.43 2.51 Favored 'General case' 0 C--N 1.337 0.031 0 C-N-CA 123.827 0.851 . . . . 0.0 112.667 -167.021 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -115.18 160.9 19.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 151.664 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -133.76 88.38 2.47 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.0 tt -94.47 137.91 21.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 C-N-CA 124.477 1.111 . . . . 0.0 111.637 -163.997 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.441 ' HE2' ' CB ' ' A' ' 55' ' ' ASP . 0.1 OUTLIER -79.71 143.84 34.2 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.635 1.574 . . . . 0.0 109.781 -170.421 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.531 HG21 ' CE1' ' A' ' 120' ' ' PHE . 3.7 t -135.72 142.06 40.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.655 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 164.389 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.9 m -123.29 112.47 17.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 -177.721 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -78.52 89.76 4.48 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 172.864 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -78.23 85.25 4.4 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 118.492 -1.283 . . . . 0.0 108.395 178.576 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.5 115.78 17.54 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.832 174.758 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -122.94 175.54 6.52 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.595 1.158 . . . . 0.0 108.188 167.039 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.6 p -151.17 148.6 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 169.161 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -164.51 171.54 14.45 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.254 1.022 . . . . 0.0 108.869 -178.302 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.62 -165.36 0.22 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.354 1.462 . . . . 0.0 111.616 -175.4 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.73 52.98 4.26 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 112.123 -0.391 . . . . 0.0 112.123 -173.079 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.412 ' CD1' ' CD1' ' A' ' 144' ' ' PHE . 1.4 tt -111.7 83.77 4.77 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.122 0.969 . . . . 0.0 108.785 177.693 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -85.28 45.0 1.5 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.246 3.298 . . . . 0.0 109.736 -170.141 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.438 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 43.1 m0 -108.39 138.58 44.43 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -172.909 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.408 ' OE1' ' NZ ' ' A' ' 71' ' ' LYS . 73.2 tt0 -77.85 82.36 4.23 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 -178.503 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -90.26 122.01 32.79 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.715 1.206 . . . . 0.0 108.233 179.834 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 m -126.67 135.54 27.43 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.144 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -70.76 162.39 42.76 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 N-CA-C 108.146 -1.521 . . . . 0.0 108.146 161.433 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -60.18 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 175.117 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -144.06 154.13 42.91 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 164.773 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.03 -42.72 69.45 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 118.537 -0.744 . . . . 0.0 112.095 -175.964 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.441 ' CB ' ' HE2' ' A' ' 34' ' ' LYS . 23.7 p-10 -145.35 159.69 42.67 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 119.382 0.992 . . . . 0.0 113.189 -166.623 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.8 pt -133.82 159.79 42.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 125.768 1.627 . . . . 0.0 107.847 178.193 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -128.29 85.41 2.34 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.316 1.446 . . . . 0.0 109.124 178.189 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.8 m -80.44 141.83 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 O-C-N 121.255 -0.903 . . . . 0.0 110.689 -171.281 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -78.22 72.16 4.74 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 173.078 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.5 pt 19.01 64.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 127.437 2.295 . . . . 0.0 113.489 176.368 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 139.0 -43.8 1.14 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -172.58 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -59.68 130.3 46.16 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.648 -173.467 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.467 HG23 ' CD1' ' A' ' 121' ' ' PHE . 1.6 m -106.69 87.28 2.49 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.003 -146.106 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.72 144.19 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 CA-C-O 121.094 0.473 . . . . 0.0 110.696 -170.538 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.93 115.54 24.4 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.239 1.016 . . . . 0.0 108.591 168.817 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.8 pp -115.57 115.04 48.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 164.044 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -87.49 155.23 20.09 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.939 -0.475 . . . . 0.0 110.966 178.387 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -127.0 153.78 45.46 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 172.73 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -134.69 141.79 46.64 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.877 1.671 . . . . 0.0 107.898 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.34 115.58 7.98 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.805 2.042 . . . . 0.0 107.681 174.387 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.408 ' NZ ' ' OE1' ' A' ' 48' ' ' GLU . 3.0 mtmp? -114.73 124.42 51.73 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.29 0.95 . . . . 0.0 110.652 -176.99 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.438 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 46.9 t-20 -80.92 107.2 13.53 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.79 0.723 . . . . 0.0 112.932 -167.583 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.3 mp -99.08 30.4 3.45 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.495 1.118 . . . . 0.0 111.974 176.649 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.85 176.81 9.39 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.021 -1.049 . . . . 0.0 110.401 168.084 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.1 t -114.07 18.1 17.37 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.221 0.608 . . . . 0.0 109.929 161.646 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 p -146.65 156.42 48.61 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 125.639 1.576 . . . . 0.0 107.736 174.405 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -63.23 145.1 93.05 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 N-CA-C 108.122 -1.53 . . . . 0.0 108.122 172.138 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.5 p -123.08 168.25 12.61 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.644 0.735 . . . . 0.0 111.299 178.716 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.8 m -93.63 144.88 24.98 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 168.354 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -168.74 56.9 0.21 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 176.525 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.91 57.78 0.86 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.018 1.727 . . . . 0.0 108.405 -174.374 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.62 166.46 23.52 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.94 0.876 . . . . 0.0 112.879 -168.036 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.48 97.55 8.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 176.512 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -77.23 140.24 40.05 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.544 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -85.76 88.61 7.57 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -172.634 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -76.97 77.91 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 C-N-CA 125.043 1.337 . . . . 0.0 110.435 -176.983 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.8 t 178.88 147.64 0.39 Allowed Pre-proline 0 N--CA 1.46 0.029 0 C-N-CA 124.932 1.293 . . . . 0.0 109.343 173.324 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -66.75 -35.19 28.86 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.146 1.23 . . . . 0.0 110.274 158.963 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.0 ptp 175.36 -70.78 0.01 OUTLIER 'General case' 0 C--N 1.341 0.206 0 C-N-CA 126.902 2.081 . . . . 0.0 107.571 179.244 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.0 -36.61 48.59 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.962 0.905 . . . . 0.0 113.011 -167.788 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.77 -109.62 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.608 0.242 . . . . 0.0 111.58 -167.732 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.79 -49.69 0.84 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.417 1.008 . . . . 0.0 113.528 -176.111 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.55 -57.52 4.66 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.594 1.197 . . . . 0.0 109.802 172.254 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -73.69 5.01 4.31 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.498 1.919 . . . . 0.0 113.895 -178.898 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -85.72 126.58 34.08 Favored 'General case' 0 C--N 1.344 0.343 0 O-C-N 121.232 -0.918 . . . . 0.0 108.649 174.871 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 . . . . . 0 N--CA 1.452 -0.327 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.179 -179.459 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 CA--C 1.538 0.496 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.1 t -88.5 -165.78 1.42 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.051 0.94 . . . . 0.0 110.05 174.687 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.5 t -76.69 144.15 39.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.198 0.999 . . . . 0.0 110.04 -175.997 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 81.0 mt -127.25 134.87 50.01 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.538 1.135 . . . . 0.0 108.15 -179.791 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -69.55 157.08 90.44 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 170.942 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.43 100.21 0.88 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.373 2.716 . . . . 0.0 110.438 -170.711 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.31 -23.44 3.31 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -175.208 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -78.95 135.78 37.05 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 118.254 1.027 . . . . 0.0 111.707 -160.727 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -92.61 104.56 16.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.4 1.48 . . . . 0.0 109.375 178.906 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -90.56 135.13 33.9 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 174.042 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -151.46 154.99 37.65 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.625 0.37 . . . . 0.0 110.639 156.922 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 78.6 mtp -151.77 146.05 18.36 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.161 0.984 . . . . 0.0 109.578 171.495 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -66.12 137.97 50.17 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.126 2.55 . . . . 0.0 110.443 161.79 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.8 t -107.96 130.47 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 159.852 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.3 m -98.49 140.82 17.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 171.845 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.531 ' CE1' HG21 ' A' ' 35' ' ' VAL . 64.3 t80 -154.43 149.37 26.72 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -162.322 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.467 ' CD1' HG23 ' A' ' 63' ' ' THR . 41.1 p90 -164.5 170.29 16.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.415 1.886 . . . . 0.0 109.108 165.314 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 70.7 t -103.99 135.46 41.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 174.482 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -76.37 134.2 70.47 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 119.119 -0.467 . . . . 0.0 109.954 176.397 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -74.16 67.34 5.16 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.384 2.723 . . . . 0.0 110.292 171.42 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -133.52 -37.82 0.94 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 126.799 2.04 . . . . 0.0 111.027 176.565 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.4 tt -43.87 -41.66 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 125.012 1.325 . . . . 0.0 113.414 173.111 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.9 m -78.23 49.03 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 O-C-N 121.394 -0.816 . . . . 0.0 111.34 176.825 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.9 mttt -142.72 -64.51 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 117.521 -1.228 . . . . 0.0 111.617 -179.299 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.17 153.17 46.03 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 121.942 1.729 . . . . 0.0 112.736 -176.548 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.8 t -54.87 -35.54 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 125.838 1.655 . . . . 0.0 110.662 175.897 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -35.26 -59.16 0.53 Allowed 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 126.656 1.983 . . . . 0.0 112.309 175.79 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.5 p -106.94 -42.73 4.84 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.015 -166.068 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 14.07 63.15 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 128.389 2.675 . . . . 0.0 116.235 172.151 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 136.73 -36.73 1.95 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -177.272 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 29.8 mm -53.28 123.52 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 171.444 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.38 47.86 0.35 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.288 0.566 . . . . 0.0 112.102 177.965 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.5 p -143.65 89.04 2.03 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 105.809 -1.922 . . . . 0.0 105.809 174.025 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 tp -92.71 87.21 5.8 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.029 -159.957 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.5 t -97.86 155.85 16.87 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.457 0.703 . . . . 0.0 111.084 -166.773 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.76 133.25 55.98 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 160.704 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 44.5 m -90.94 105.77 18.06 Favored 'General case' 0 N--CA 1.46 0.043 0 O-C-N 123.902 0.751 . . . . 0.0 109.035 160.452 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -76.27 99.8 4.89 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 165.708 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 53.5 m -117.34 86.35 2.5 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.978 1.311 . . . . 0.0 107.524 175.18 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.412 ' CD1' ' CD1' ' A' ' 45' ' ' LEU . 48.2 m-85 -59.22 145.2 43.67 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.322 1.049 . . . . 0.0 112.828 174.392 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -166.85 52.69 0.25 Allowed Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.966 1.707 . . . . 0.0 112.342 -175.435 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.3 -90.04 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.679 2.252 . . . . 0.0 115.092 -168.958 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -155.16 179.55 9.04 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 129.697 3.199 . . . . 0.0 104.863 -175.119 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -147.13 94.56 4.54 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 118.488 0.585 . . . . 0.0 111.044 -171.462 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -91.94 -124.37 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.984 3.122 . . . . 0.0 108.954 176.664 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 85.5 p -123.2 123.76 41.5 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 120.356 1.435 . . . . 0.0 111.763 -172.706 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.595 0 C-N-CA 126.496 1.918 . . . . 0.0 109.237 174.333 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.631 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.75 11.9 0.95 Allowed 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 126.802 2.041 . . . . 0.0 115.322 -164.9 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -77.25 -39.12 49.44 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 159.452 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.4 mp -92.22 -37.91 12.41 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 117.209 -1.377 . . . . 0.0 113.016 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.2 mt -32.53 133.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -162.13 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 29' ' ' LEU . 2.5 mm? -105.91 -104.15 0.33 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.159 -173.618 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -173.59 -49.2 0.01 OUTLIER 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.058 1.343 . . . . 0.0 108.855 -171.348 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -38.78 134.6 0.95 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.002 1.721 . . . . 0.0 110.678 -178.812 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -100.97 86.65 3.1 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -165.883 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.98 115.01 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.436 1.494 . . . . 0.0 107.953 -171.424 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.99 160.01 29.48 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -173.641 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.0 t -148.74 145.19 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.1 m -138.55 100.28 4.05 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -170.053 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -78.11 145.0 36.0 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.018 0.527 . . . . 0.0 109.919 -176.177 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -127.63 82.75 2.11 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.913 0.863 . . . . 0.0 110.007 178.22 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.49 102.16 14.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 172.118 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -116.89 128.37 55.18 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 122.292 1.044 . . . . 0.0 112.126 -174.666 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.0 p -99.83 96.29 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.564 -174.252 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.12 171.1 10.5 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 122.048 0.928 . . . . 0.0 111.406 174.843 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.41 132.07 52.0 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 169.903 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 128.33 -39.28 1.92 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -170.579 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.484 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -131.56 95.57 23.21 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 117.56 0.68 . . . . 0.0 110.277 -176.363 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -83.94 50.94 3.27 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.956 2.437 . . . . 0.0 109.651 -176.136 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.484 ' CD2' ' CD2' ' A' ' 45' ' ' LEU . 44.4 m0 -107.91 135.56 49.1 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -173.649 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -79.36 84.5 5.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 103.484 -2.784 . . . . 0.0 103.484 179.246 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -102.04 86.15 2.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -171.598 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.3 m -88.04 129.14 51.2 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -167.28 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.09 122.49 9.58 Favored 'Trans proline' 0 N--CA 1.446 -1.277 0 N-CA-C 106.261 -2.246 . . . . 0.0 106.261 162.466 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.1 m -72.73 -32.08 39.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.181 0.515 . . . . 0.0 110.691 -168.387 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.02 161.98 34.16 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 150.265 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -62.65 -46.72 86.89 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 172.532 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -147.38 153.54 39.77 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 124.415 1.086 . . . . 0.0 111.659 -159.647 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.4 pt -133.13 179.23 4.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 126.326 1.851 . . . . 0.0 108.251 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -125.47 160.18 30.11 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.345 0.593 . . . . 0.0 110.21 149.881 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.6 t -116.72 145.97 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 127.99 2.516 . . . . 0.0 105.679 171.014 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 49.5 mmm-85 -91.37 100.81 13.53 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 168.021 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mt -33.2 115.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -148.243 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.58 -25.2 26.49 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.071 1.319 . . . . 0.0 110.936 -179.386 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -64.9 133.45 51.86 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.806 1.303 . . . . 0.0 112.422 -172.33 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.15 101.53 7.97 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 130.05 3.34 . . . . 0.0 110.818 -175.38 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.9 p -113.78 153.75 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.292 1.437 . . . . 0.0 109.491 -178.597 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -112.51 125.15 53.93 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 125.404 1.482 . . . . 0.0 109.343 -177.38 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.0 pp -128.48 122.86 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 167.861 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.412 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 66.4 mtt -76.09 168.44 20.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.614 174.164 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -136.17 143.21 44.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 161.864 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.7 ttt85 -121.01 118.7 30.5 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 179.546 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.3 105.15 9.24 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 125.822 1.649 . . . . 0.0 110.035 -177.216 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.29 121.09 44.36 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.064 -0.398 . . . . 0.0 110.749 -168.603 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.44 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 47.8 t-20 -78.38 111.9 14.85 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.803 -0.561 . . . . 0.0 111.912 -167.783 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.2 tp -98.41 11.24 38.77 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.812 0.845 . . . . 0.0 112.381 179.564 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.46 166.67 22.33 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.272 -0.893 . . . . 0.0 109.95 173.44 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 70.0 m -103.3 7.0 38.35 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.968 0.907 . . . . 0.0 111.835 171.73 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.34 159.61 38.79 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 126.134 1.773 . . . . 0.0 107.041 177.974 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.97 126.04 12.11 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.171 1.914 . . . . 0.0 111.255 -173.208 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.476 ' HG1' ' HE1' ' A' ' 47' ' ' TRP . 0.2 OUTLIER -80.49 173.53 12.51 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.821 0.849 . . . . 0.0 110.784 -178.998 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 50.7 p -131.45 72.03 1.49 Allowed 'General case' 0 C--O 1.232 0.137 0 C-N-CA 122.551 0.341 . . . . 0.0 110.426 -170.893 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.42 139.37 37.39 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.946 -0.462 . . . . 0.0 111.946 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.81 34.19 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.659 1.983 . . . . 0.0 109.44 169.222 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.58 159.08 34.47 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.33 0.652 . . . . 0.0 111.445 -165.445 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.9 t -87.77 131.51 34.48 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.704 0.764 . . . . 0.0 110.039 177.814 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.409 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -104.03 89.93 3.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.871 2.468 . . . . 0.0 105.572 175.509 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -77.0 91.92 3.67 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 120.882 -1.136 . . . . 0.0 107.935 -177.617 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 84' ' ' PHE . 7.8 t -78.11 72.57 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.612 1.165 . . . . 0.0 109.973 -174.043 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.9 t -168.73 134.76 1.49 Allowed Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 119.901 1.228 . . . . 0.0 113.389 173.997 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -74.1 67.72 5.04 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 122.386 2.057 . . . . 0.0 107.243 156.257 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 22.2 ptm 44.19 25.47 0.11 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 170.935 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -171.41 -58.26 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 119.384 0.993 . . . . 0.0 110.594 -168.411 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.61 -101.2 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -177.282 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 64.05 -52.1 0.08 OUTLIER Glycine 0 CA--C 1.538 1.481 0 N-CA-C 115.413 0.925 . . . . 0.0 115.413 -175.534 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -45.73 -47.63 15.33 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.553 1.541 . . . . 0.0 110.808 172.217 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -73.85 -12.69 60.75 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 127.012 2.125 . . . . 0.0 113.471 178.975 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.403 ' CD2' HD23 ' A' ' 138' ' ' LEU . 9.0 t80 -67.55 140.0 56.95 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.119 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 . . . . . 0 C--N 1.328 -0.361 0 C-N-CA 124.967 1.307 . . . . 0.0 110.765 -177.33 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.3 t 51.67 -146.64 0.47 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.441 1.096 . . . . 0.0 112.472 170.606 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.6 m -115.54 136.65 52.86 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.089 1.355 . . . . 0.0 108.542 -172.069 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 78.6 mt -128.44 147.95 50.69 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.39 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -73.29 156.42 89.15 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 172.354 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.23 85.87 0.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 124.88 3.72 . . . . 0.0 111.756 -173.064 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 152.74 -27.23 0.83 Allowed Glycine 0 CA--C 1.522 0.5 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.25 -177.777 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -77.86 143.45 37.79 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 118.085 0.942 . . . . 0.0 111.593 -157.925 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -105.21 96.9 6.84 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.811 1.244 . . . . 0.0 109.942 -175.603 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 15.4 tpt -83.92 89.21 7.18 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.114 1.365 . . . . 0.0 109.325 -177.951 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -99.21 134.21 42.4 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.256 0.622 . . . . 0.0 109.576 172.148 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 22.4 ptm -150.95 146.31 19.11 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.996 -0.526 . . . . 0.0 111.441 178.997 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 67' ' ' MET . 83.1 Cg_endo -79.58 147.77 20.05 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.883 3.055 . . . . 0.0 111.049 171.852 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.5 t -126.53 114.89 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 165.199 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.5 p -79.41 143.47 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 168.986 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -155.61 149.11 24.98 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.163 0.585 . . . . 0.0 109.949 -165.411 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -171.18 118.98 0.48 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.36 1.464 . . . . 0.0 111.893 176.858 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.8 t -64.09 133.39 29.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 O-C-N 120.355 -1.466 . . . . 0.0 109.505 175.317 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -91.61 132.39 33.44 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 123.701 0.801 . . . . 0.0 109.8 -179.053 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -46.35 -31.52 9.55 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.402 3.401 . . . . 0.0 114.919 177.342 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -48.94 -24.2 1.4 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.783 1.633 . . . . 0.0 112.39 179.183 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.1 tt -49.01 -44.46 15.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 169.097 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.9 m -83.38 59.66 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 118.571 0.623 . . . . 0.0 109.895 174.354 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -111.0 -77.41 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 117.168 -1.396 . . . . 0.0 110.366 164.628 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.54 156.05 45.12 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 CA-C-N 121.885 1.709 . . . . 0.0 111.666 -177.384 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.6 m -62.16 -36.08 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 124.94 1.296 . . . . 0.0 112.045 -170.657 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -60.6 -64.46 0.94 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.147 0.979 . . . . 0.0 109.281 177.587 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 44.6 p -72.61 -15.43 61.73 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 118.509 -0.758 . . . . 0.0 111.568 -172.419 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.04 -41.52 5.53 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.768 0.713 . . . . 0.0 111.221 162.913 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.34 -29.17 74.38 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 112.237 -0.345 . . . . 0.0 112.237 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.3 mm -83.88 125.94 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 122.079 0.942 . . . . 0.0 110.39 -177.629 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 28.3 pttt -148.81 63.76 1.06 Allowed 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.506 153.751 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 11.7 m -150.15 95.33 2.26 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 158.416 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.403 HD23 ' CD2' ' A' ' 95' ' ' PHE . 1.2 tp -75.48 144.79 41.87 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -173.978 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.8 t -141.8 173.38 11.56 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.496 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.1 tt -150.63 111.28 4.25 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 177.855 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.45 92.94 8.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.515 1.126 . . . . 0.0 109.252 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.94 108.4 19.17 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.877 1.271 . . . . 0.0 108.783 179.406 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.66 89.09 3.58 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 122.009 0.909 . . . . 0.0 109.747 -177.358 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -71.23 85.57 0.77 Allowed 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.281 177.058 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.1 47.59 2.8 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -178.703 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -80.89 -105.74 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.279 2.653 . . . . 0.0 111.967 178.914 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -140.95 121.68 14.34 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.648 1.179 . . . . 0.0 108.528 -171.242 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.9 111.22 38.82 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 125.654 1.581 . . . . 0.0 107.118 -177.128 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.431 ' HD3' HG23 ' A' ' 78' ' ' THR . 26.6 Cg_endo -83.3 -4.85 11.07 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.293 2.662 . . . . 0.0 113.043 -172.742 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.9 t 131.51 103.71 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 129.972 3.309 . . . . 0.0 109.754 174.481 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.542 0.669 0 C-N-CA 125.256 1.423 . . . . 0.0 111.723 168.356 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.24 0 N-CA-C 104.354 -2.462 . . . . 0.0 104.354 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.6 t -147.88 49.54 1.06 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 122.493 1.14 . . . . 0.0 108.227 174.962 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -158.8 -57.42 0.07 Allowed 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 127.306 2.243 . . . . 0.0 106.309 -174.367 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.9 mt -65.53 -16.48 63.72 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.907 2.083 . . . . 0.0 112.878 -177.777 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.4 mt -75.67 78.51 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 O-C-N 121.21 -0.931 . . . . 0.0 110.267 -171.566 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.69 -127.7 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.555 1.142 . . . . 0.0 108.524 169.679 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -104.36 -51.33 3.13 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.57 1.548 . . . . 0.0 111.939 -164.506 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -43.1 102.07 0.03 OUTLIER 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.194 1.398 . . . . 0.0 113.351 -169.806 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.69 81.52 4.99 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 177.261 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -97.11 122.58 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -160.616 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.7 150.48 34.48 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.943 1.297 . . . . 0.0 108.199 -175.216 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.52 146.9 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 174.497 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.9 m -125.83 112.19 15.73 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -172.69 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -77.88 136.18 38.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.754 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -126.71 84.45 2.27 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 122.502 1.144 . . . . 0.0 108.965 177.943 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.91 95.75 10.28 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.374 1.07 . . . . 0.0 110.972 -176.753 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -98.63 109.5 22.24 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.375 0.67 . . . . 0.0 109.79 -177.936 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.0 p -79.24 148.86 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 164.388 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -151.04 158.71 44.44 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 171.216 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.05 -40.15 10.25 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.84 0.856 . . . . 0.0 112.109 -177.214 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -41.58 -31.98 0.76 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.812 1.672 . . . . 0.0 114.151 174.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.487 HD21 ' CE3' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -130.17 110.13 16.68 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 118.688 1.244 . . . . 0.0 108.471 170.488 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -75.27 0.95 8.4 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.294 1.996 . . . . 0.0 115.576 -164.035 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.517 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 42.2 m0 -79.57 153.45 29.46 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.38 1.472 . . . . 0.0 113.613 -159.844 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.42 ' O ' HG23 ' A' ' 50' ' ' VAL . 4.1 tt0 -77.47 77.46 4.0 Favored 'General case' 0 C--N 1.344 0.344 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.615 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -84.6 110.72 18.93 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.684 1.193 . . . . 0.0 109.098 -171.484 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 48' ' ' GLU . 42.9 t -122.78 118.81 28.25 Favored Pre-proline 0 N--CA 1.444 -0.758 0 C-N-CA 124.4 1.08 . . . . 0.0 108.645 -163.638 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -81.87 174.56 10.13 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 124.543 3.495 . . . . 0.0 108.554 168.367 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -98.6 -53.12 8.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 123.949 0.9 . . . . 0.0 110.845 -173.622 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -134.16 175.15 9.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 166.638 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.6 tpt85 -68.45 -33.15 73.68 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.392 168.636 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -144.67 173.44 11.82 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.842 1.257 . . . . 0.0 112.694 -162.861 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.1 pt -141.65 178.2 2.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 127.206 2.203 . . . . 0.0 106.788 165.567 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -132.27 162.77 30.16 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 146.911 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.23 136.92 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 126.953 2.101 . . . . 0.0 105.836 -175.199 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.94 88.66 3.5 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 163.205 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.2 pt 8.81 69.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 127.74 2.416 . . . . 0.0 114.63 178.469 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.55 -37.55 1.78 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 123.41 0.529 . . . . 0.0 112.305 -176.594 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -39.24 104.43 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.383 1.473 . . . . 0.0 110.849 177.101 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.59 HG23 ' CD1' ' A' ' 121' ' ' PHE . 1.2 m -87.46 88.45 7.68 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.353 -156.25 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 p -92.73 161.67 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 O-C-N 121.933 -0.479 . . . . 0.0 111.721 -168.434 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -102.98 126.74 50.28 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.959 1.303 . . . . 0.0 110.35 169.561 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.5 pp -131.33 114.03 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 107.319 -1.364 . . . . 0.0 107.319 167.443 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.0 ttp -77.86 161.52 27.55 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.378 0.671 . . . . 0.0 110.862 -176.861 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -134.57 150.96 50.78 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.436 1.094 . . . . 0.0 108.846 169.325 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 54.1 ttp85 -143.46 147.08 34.0 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.997 0.919 . . . . 0.0 110.111 -178.457 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.39 109.68 2.66 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.632 1.573 . . . . 0.0 111.765 -177.995 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -86.09 139.28 31.27 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.989 171.721 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.517 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 28.1 t30 -78.21 88.99 4.27 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.073 0.851 . . . . 0.0 112.127 168.958 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.9 mp -76.76 69.08 3.08 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 171.193 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -153.66 137.26 15.99 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 168.513 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.1 t -80.14 36.1 0.34 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.369 0.531 . . . . 0.0 110.754 178.083 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.8 p -149.91 155.47 37.98 Favored Pre-proline 0 C--O 1.237 0.395 0 C-N-CA 126.63 1.972 . . . . 0.0 106.995 174.307 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -63.23 148.14 93.3 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 N-CA-C 108.208 -1.497 . . . . 0.0 108.208 168.522 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.01 175.06 6.53 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.792 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.0 m -105.65 145.25 31.28 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.121 1.768 . . . . 0.0 106.875 175.39 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -133.65 126.14 4.2 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 107.096 -2.401 . . . . 0.0 107.096 172.494 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.18 54.77 0.12 Allowed 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 166.78 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.44 144.83 15.9 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.884 176.162 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.3 t -85.01 166.08 17.02 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 168.185 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -146.41 95.96 2.69 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -168.978 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.33 86.92 5.02 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 175.509 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.0 t -78.12 60.23 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.817 1.247 . . . . 0.0 108.776 -175.034 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.1 t -171.44 148.34 2.3 Favored Pre-proline 0 CA--C 1.522 -0.129 0 O-C-N 121.481 -0.762 . . . . 0.0 111.636 178.077 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -61.57 -41.26 40.99 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 121.758 1.639 . . . . 0.0 110.068 159.031 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.3 ptp 172.08 -77.72 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 127.124 2.17 . . . . 0.0 107.59 178.399 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.87 -29.87 63.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.634 1.174 . . . . 0.0 112.292 -170.287 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.9 -119.11 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -174.028 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.89 -50.56 2.25 Favored Glycine 0 CA--C 1.528 0.874 0 O-C-N 121.348 -0.845 . . . . 0.0 113.192 178.204 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -44.93 -54.54 6.38 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.159 0.984 . . . . 0.0 110.014 171.555 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -75.39 -4.26 38.41 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.508 1.923 . . . . 0.0 113.96 -179.053 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -69.37 133.55 47.95 Favored 'General case' 0 C--N 1.341 0.227 0 O-C-N 121.093 -1.004 . . . . 0.0 108.486 178.449 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 . . . . . 0 N--CA 1.453 -0.289 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.684 177.931 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 . . . . . 0 CA--C 1.535 0.403 0 CA-C-O 121.149 0.5 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.7 t -111.52 -57.68 2.22 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 128.711 2.804 . . . . 0.0 111.378 -167.6 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.8 t -163.65 140.34 6.97 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 122.849 0.46 . . . . 0.0 110.385 -170.845 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.661 HD11 ' HB2' ' A' ' 114' ' ' MET . 39.7 mt -139.32 143.73 37.96 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.207 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.444 ' HB3' ' HD2' ' A' ' 110' ' ' PRO . 2.8 mt-10 -80.44 172.95 8.53 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.76 1.224 . . . . 0.0 109.349 -179.48 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 109' ' ' GLU . 35.2 Cg_endo -68.0 79.89 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.535 2.823 . . . . 0.0 114.465 -162.041 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 147.87 -29.89 1.39 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.307 0.956 . . . . 0.0 112.181 172.107 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -82.21 158.56 23.51 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 118.226 -1.39 . . . . 0.0 112.318 -139.61 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -84.61 123.26 30.13 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 124.64 1.176 . . . . 0.0 110.268 179.59 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.661 ' HB2' HD11 ' A' ' 108' ' ' LEU . 0.9 OUTLIER -90.22 128.61 36.42 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 154.89 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -134.0 146.42 50.4 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 159.698 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 56.7 mtt -146.61 146.63 27.59 Favored Pre-proline 0 N--CA 1.453 -0.323 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 165.087 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -71.55 142.58 40.61 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 122.101 1.868 . . . . 0.0 109.412 160.232 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.4 t -115.77 143.83 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 164.026 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.0 p -102.28 145.49 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 174.608 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -145.9 138.09 25.36 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.335 0.516 . . . . 0.0 111.425 -176.933 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.59 ' CD1' HG23 ' A' ' 63' ' ' THR . 5.9 p90 -159.07 162.25 36.56 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.569 1.548 . . . . 0.0 107.43 160.559 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 94.8 t -104.72 131.27 54.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 174.789 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.18 135.23 47.85 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 175.887 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -75.49 57.85 5.0 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 124.578 3.519 . . . . 0.0 112.673 -176.414 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.24 -36.47 7.63 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 125.57 1.548 . . . . 0.0 109.864 168.3 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.8 tt -47.75 -46.57 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -169.724 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.3 m -81.19 53.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.448 -0.783 . . . . 0.0 110.785 -178.444 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -138.28 -64.51 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 117.661 -1.161 . . . . 0.0 112.085 -179.371 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.67 156.33 35.64 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 CA-C-N 121.961 1.736 . . . . 0.0 113.406 -176.053 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.2 t -54.11 -39.46 42.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 126.201 1.8 . . . . 0.0 110.742 177.934 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -45.92 -55.72 6.38 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.697 1.599 . . . . 0.0 111.8 -178.523 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.3 p -92.37 -42.89 9.53 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 118.633 -0.699 . . . . 0.0 111.442 -176.313 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 7.93 65.13 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 128.403 2.681 . . . . 0.0 116.129 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 142.37 -41.34 1.2 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -173.709 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.7 mm -57.27 120.13 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 CA-C-N 117.689 0.744 . . . . 0.0 110.178 177.23 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -157.38 66.45 0.5 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.672 0.749 . . . . 0.0 110.173 162.578 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 10.6 m -147.51 102.72 3.48 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 152.206 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.68 151.76 34.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -175.243 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.7 t -154.08 175.13 13.79 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.408 0.623 . . . . 0.0 109.647 -177.269 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.9 tp -153.7 97.13 2.07 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 103.216 -2.883 . . . . 0.0 103.216 -169.278 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.5 t -81.78 88.09 6.32 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 171.733 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.79 124.4 27.64 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 176.809 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.423 HG22 ' CD1' ' A' ' 145' ' ' TYR . 23.8 m -133.38 95.52 3.53 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.412 1.101 . . . . 0.0 109.229 -164.468 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -74.22 74.42 1.8 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.041 1.736 . . . . 0.0 111.94 -171.007 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.423 ' CD1' HG22 ' A' ' 143' ' ' THR . 38.8 m-85 -128.35 68.48 77.23 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.349 1.06 . . . . 0.0 113.758 179.566 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -87.69 -103.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.775 2.983 . . . . 0.0 110.666 167.502 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -156.26 99.66 1.94 Allowed 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.8 1.24 . . . . 0.0 108.907 -172.117 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -104.56 134.0 19.89 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 126.432 1.893 . . . . 0.0 106.403 167.614 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.0 -47.3 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.445 2.097 . . . . 0.0 110.638 178.304 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.2 t 166.65 112.4 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 129.202 3.001 . . . . 0.0 104.822 178.486 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.7 pttt . . . . . 0 CA--C 1.535 0.4 0 CA-C-N 119.584 1.083 . . . . 0.0 110.409 -168.921 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.703 0 CA-C-O 122.711 1.244 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.4 p -76.49 1.66 15.93 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 128.075 2.55 . . . . 0.0 114.58 -164.881 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -78.56 -21.38 48.78 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 164.855 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.6 mt -115.32 -26.73 7.48 Favored 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 125.43 1.492 . . . . 0.0 113.134 -171.204 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.7 mt -40.55 -72.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.966 1.706 . . . . 0.0 115.389 -170.555 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.461 HD23 ' N ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER 64.99 167.55 0.18 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 127.449 2.3 . . . . 0.0 113.096 -176.036 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -76.57 57.82 1.28 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.521 1.528 . . . . 0.0 111.537 -177.394 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.53 ' HB3' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -134.04 170.74 15.19 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 126.111 1.764 . . . . 0.0 107.041 173.525 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -150.38 111.61 4.4 Favored 'General case' 0 N--CA 1.422 -1.855 0 C-N-CA 124.462 1.105 . . . . 0.0 109.217 177.948 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.9 tt -93.26 144.34 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 174.018 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.73 152.18 20.39 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 125.83 1.652 . . . . 0.0 109.033 177.766 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.6 t -136.95 144.24 32.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 175.54 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.6 m -136.19 94.3 3.02 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -171.774 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -75.04 163.85 27.16 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -175.932 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -142.44 85.34 1.9 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 122.217 1.008 . . . . 0.0 109.406 -178.727 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.457 ' HB1' ' CE2' ' A' ' 49' ' ' PHE . . . -89.57 102.79 15.47 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 121.586 -0.696 . . . . 0.0 110.25 -179.614 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -95.46 168.32 10.78 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 123.432 0.693 . . . . 0.0 109.616 177.913 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.4 t -134.49 151.82 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 167.802 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.65 153.58 47.34 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 166.446 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.46 -35.89 13.89 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.856 0.862 . . . . 0.0 112.358 -174.643 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -37.19 -41.54 0.71 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.71 1.624 . . . . 0.0 113.511 172.111 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.642 HD21 ' CE3' ' A' ' 47' ' ' TRP . 3.9 tt -116.67 107.72 46.1 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 118.187 0.993 . . . . 0.0 108.388 175.023 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -78.35 21.1 0.71 Allowed 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.006 1.804 . . . . 0.0 114.92 -161.704 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.642 ' CE3' HD21 ' A' ' 45' ' ' LEU . 50.0 m0 -101.39 147.73 25.99 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.435 1.016 . . . . 0.0 113.212 -160.83 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -78.31 88.95 4.33 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 176.116 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.457 ' CE2' ' HB1' ' A' ' 39' ' ' ALA . 11.2 t80 -90.93 126.27 36.01 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 123.774 0.83 . . . . 0.0 109.053 -179.786 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.1 t -118.24 107.66 43.15 Favored Pre-proline 0 N--CA 1.439 -1.0 0 C-N-CA 125.73 1.612 . . . . 0.0 107.69 -167.324 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -66.14 128.59 19.86 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 122.773 2.316 . . . . 0.0 107.096 165.077 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.9 m -77.27 -36.84 24.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.125 0.488 . . . . 0.0 111.068 -174.822 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.77 171.11 15.25 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 158.726 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -76.17 -48.87 18.92 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 119.379 -0.928 . . . . 0.0 108.891 172.993 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -136.67 155.54 49.75 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 125.661 1.584 . . . . 0.0 111.251 -161.528 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.1 pt -135.52 172.92 15.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 125.723 1.609 . . . . 0.0 108.733 -179.454 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -122.21 143.67 49.44 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 126.251 1.82 . . . . 0.0 109.074 162.351 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.6 m -128.97 129.67 68.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 C-N-CA 125.378 1.471 . . . . 0.0 107.408 167.935 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.22 76.75 0.36 Allowed 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 166.647 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.53 HD11 ' HB3' ' A' ' 31' ' ' GLU . 0.4 OUTLIER 9.06 59.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 129.393 3.077 . . . . 0.0 115.513 -172.868 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.65 -35.58 1.4 Allowed Glycine 0 C--N 1.335 0.503 0 O-C-N 121.427 -0.796 . . . . 0.0 111.898 -172.924 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -55.69 129.88 40.99 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 170.851 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.3 136.93 32.74 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 122.977 0.511 . . . . 0.0 112.345 -177.415 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.2 p -120.33 153.7 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 123.756 0.823 . . . . 0.0 109.108 168.115 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -103.88 116.51 32.42 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.254 1.821 . . . . 0.0 107.467 173.501 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.4 pp -122.18 119.37 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 168.07 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.425 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 85.2 mtp -76.57 166.26 23.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.693 170.766 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -130.25 149.8 51.78 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 160.78 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -134.08 132.56 40.1 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 124.121 0.888 . . . . 0.0 109.326 173.876 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.36 165.24 14.1 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 127.659 2.383 . . . . 0.0 106.942 167.208 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.6 mttt -154.02 133.88 13.06 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 119.226 0.921 . . . . 0.0 110.183 174.262 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.525 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 49.3 t30 -84.97 84.78 7.6 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.774 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.7 mp -83.32 63.66 7.37 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.707 167.417 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.26 163.96 25.6 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 165.211 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.7 m -93.95 20.11 8.2 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 123.063 0.227 . . . . 0.0 110.621 176.193 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.3 p -146.16 160.91 41.39 Favored Pre-proline 0 N--CA 1.45 -0.463 0 C-N-CA 125.687 1.595 . . . . 0.0 107.656 177.359 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -66.02 159.76 47.73 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 121.13 1.22 . . . . 0.0 108.972 169.534 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.65 174.32 10.63 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 122.44 0.296 . . . . 0.0 110.846 171.244 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -122.85 152.97 40.22 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.877 1.271 . . . . 0.0 108.85 171.035 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -127.68 129.87 6.55 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 177.336 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.11 40.65 1.49 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.078 0.951 . . . . 0.0 109.147 168.708 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -50.87 145.11 7.55 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.344 1.058 . . . . 0.0 111.616 -175.293 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.8 t -82.13 139.52 34.33 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 118.923 -1.111 . . . . 0.0 108.833 176.163 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -114.41 89.93 3.21 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 -175.142 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -78.39 85.38 4.51 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 177.881 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.3 t -78.36 67.96 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 125.51 1.524 . . . . 0.0 108.055 -178.377 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.6 t -166.68 144.11 4.18 Favored Pre-proline 0 C--N 1.338 0.094 0 O-C-N 121.59 -0.694 . . . . 0.0 112.49 174.106 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -64.31 -39.74 28.44 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 121.613 1.542 . . . . 0.0 109.428 159.09 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.0 ptp 170.7 -70.17 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 128.242 2.617 . . . . 0.0 107.123 178.706 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -90.98 -27.28 18.78 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 124.273 1.029 . . . . 0.0 112.884 -168.978 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.26 -123.4 0.01 OUTLIER 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.508 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.75 -54.82 2.97 Favored Glycine 0 CA--C 1.527 0.79 0 O-C-N 121.654 -0.654 . . . . 0.0 112.006 177.912 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -47.0 -49.48 20.82 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.543 1.172 . . . . 0.0 111.273 174.185 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -72.03 -16.25 62.05 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.445 1.098 . . . . 0.0 113.181 179.398 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -61.61 124.38 20.52 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -178.166 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 . . . . . 0 N--CA 1.449 -0.506 0 CA-C-O 121.889 0.852 . . . . 0.0 111.43 -173.515 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 CA--C 1.531 0.247 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.483 HG23 ' H ' ' A' ' 107' ' ' THR 0.317 11.1 t 48.05 -81.43 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 127.713 2.405 . . . . 0.0 114.633 168.728 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.483 ' H ' HG23 ' A' ' 106' ' ' THR . 0.6 OUTLIER -158.95 149.35 19.61 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.082 1.353 . . . . 0.0 109.268 -178.564 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.0 mt -143.82 155.5 44.16 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 124.01 0.924 . . . . 0.0 108.835 174.854 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -94.72 166.55 14.89 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 125.468 1.507 . . . . 0.0 108.5 174.055 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.71 98.18 1.03 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.839 2.359 . . . . 0.0 111.67 -167.611 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.69 -24.57 2.46 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 123.551 0.596 . . . . 0.0 111.723 178.821 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -79.19 127.83 32.53 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 117.85 0.825 . . . . 0.0 111.826 -155.566 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -78.68 136.79 37.54 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 165.619 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 13.7 tpt -130.2 122.62 28.48 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 126.853 2.061 . . . . 0.0 107.863 -169.893 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -153.24 156.85 39.26 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 120.344 1.429 . . . . 0.0 112.299 177.761 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 6.2 ttt -155.07 142.38 13.8 Favored Pre-proline 0 N--CA 1.441 -0.898 0 C-N-CA 125.383 1.473 . . . . 0.0 107.149 -177.251 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 67' ' ' MET . 93.5 Cg_endo -74.31 144.78 33.4 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.642 2.894 . . . . 0.0 111.565 165.519 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.9 t -123.09 128.73 75.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 168.598 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.3 p -91.05 141.22 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 170.89 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -147.23 143.97 28.54 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.413 0.551 . . . . 0.0 111.617 -176.108 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -168.91 120.62 0.76 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 128.322 2.649 . . . . 0.0 106.731 175.295 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.8 p -82.49 146.66 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 119.698 1.136 . . . . 0.0 109.825 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -72.16 139.05 81.82 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 118.117 0.417 . . . . 0.0 110.064 176.984 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -76.55 61.13 6.76 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.404 2.736 . . . . 0.0 111.547 173.892 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . 0.253 9.8 pt-20 -135.17 -4.87 2.37 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 169.739 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -48.28 -42.99 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 119.201 0.91 . . . . 0.0 111.677 174.525 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.2 m -76.51 63.81 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 123.306 0.642 . . . . 0.0 110.413 174.406 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -123.06 -70.94 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 124.795 1.238 . . . . 0.0 111.181 170.468 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.53 156.65 36.34 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.161 1.907 . . . . 0.0 113.354 -169.835 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 84.3 t -54.16 -36.17 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.76 1.624 . . . . 0.0 110.057 176.278 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -47.46 -48.06 26.86 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.956 1.702 . . . . 0.0 112.024 176.144 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 22.3 p -93.55 -57.63 2.52 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -173.289 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 18.23 54.5 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 129.532 3.133 . . . . 0.0 115.529 176.063 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 146.2 -36.49 1.29 Allowed Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 -170.924 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 23.5 mm -57.52 132.72 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 172.486 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -158.8 53.57 0.42 Allowed 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 123.619 0.574 . . . . 0.0 110.277 161.772 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.6 p -149.77 98.51 2.75 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 176.962 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.2 mp -77.95 152.58 33.11 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.446 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.5 t -142.34 176.66 8.82 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 125.58 1.552 . . . . 0.0 107.236 170.473 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.2 tt -150.43 101.06 2.93 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 175.527 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.3 t -84.26 89.23 7.3 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.319 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.11 120.07 23.13 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 179.21 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.6 m -132.7 106.35 7.72 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.787 1.235 . . . . 0.0 108.553 -165.44 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.445 ' CD2' HD13 ' A' ' 45' ' ' LEU . 4.8 m-30 -90.19 96.57 10.73 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.868 1.267 . . . . 0.0 112.85 -160.359 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -138.49 76.64 36.18 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 178.646 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -91.53 -121.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.055 1 C-N-CA 125.94 4.427 . . . . 0.0 108.169 163.631 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.2 mmp_? -134.1 138.33 45.19 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.448 1.899 . . . . 0.0 107.132 179.142 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.93 114.88 55.87 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 174.671 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.63 -27.04 6.49 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.949 2.432 . . . . 0.0 112.272 -179.322 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.8 m 145.41 112.93 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 129.481 3.112 . . . . 0.0 109.086 -175.613 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.544 0.737 0 C-N-CA 125.012 1.325 . . . . 0.0 114.198 171.85 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 119.356 -0.354 . . . . 0.0 111.544 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.8 t -169.55 -146.45 0.05 Allowed 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 149.373 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -78.97 38.7 0.35 Allowed 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 130.01 3.324 . . . . 0.0 108.808 -178.547 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.4 mt -111.07 -21.29 12.04 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 127.969 2.508 . . . . 0.0 109.458 -170.896 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 27.6 mt -62.94 104.13 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 123.581 0.752 . . . . 0.0 111.839 -169.093 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.57 -150.87 0.17 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.889 0.876 . . . . 0.0 109.955 175.274 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -89.29 -37.41 14.94 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 129.237 3.015 . . . . 0.0 111.236 179.894 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -51.73 153.5 2.4 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.974 1.31 . . . . 0.0 113.493 -173.807 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -123.83 88.8 2.97 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 -176.951 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.19 131.93 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 125.19 1.396 . . . . 0.0 107.357 -179.538 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.6 ' HE3' ' HB2' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -97.48 152.94 18.48 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.348 1.059 . . . . 0.0 109.365 -168.906 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.416 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 65.4 t -131.27 132.59 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 174.758 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.7 m -110.54 112.4 24.29 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 173.009 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -81.56 86.21 6.4 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.642 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -88.27 84.49 6.86 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 122.241 1.02 . . . . 0.0 109.164 -173.781 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.3 105.23 17.21 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.361 0.664 . . . . 0.0 109.527 179.385 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -105.56 114.48 28.68 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.101 0.961 . . . . 0.0 108.828 -177.145 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.1 p -98.72 107.73 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 123.896 0.878 . . . . 0.0 109.865 176.623 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.06 155.59 19.37 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 167.565 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.25 -39.44 9.92 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.366 1.067 . . . . 0.0 111.741 178.47 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -40.18 -33.19 0.47 Allowed Glycine 0 CA--C 1.529 0.951 0 C-N-CA 126.144 1.83 . . . . 0.0 114.499 173.236 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.433 HD21 ' CE3' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -111.6 98.88 42.63 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 119.753 1.777 . . . . 0.0 108.523 168.312 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -83.86 45.53 1.81 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 124.057 3.171 . . . . 0.0 110.742 -167.533 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.534 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 44.7 m0 -115.69 145.92 42.32 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.571 1.148 . . . . 0.0 108.08 -172.999 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -76.4 82.58 3.14 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 175.782 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.99 116.26 31.62 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.736 1.214 . . . . 0.0 108.306 -172.718 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.3 m -129.52 147.48 65.39 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 118.233 0.469 . . . . 0.0 110.704 -173.276 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.89 160.53 47.53 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.264 1.976 . . . . 0.0 108.657 165.543 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -78.62 -59.44 3.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 -174.695 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -121.88 158.97 27.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 103.596 -2.742 . . . . 0.0 103.596 157.859 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -54.42 -38.73 66.59 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-O 120.943 0.401 . . . . 0.0 110.074 176.348 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.6 ' HB2' ' HE3' ' A' ' 34' ' ' LYS . 9.6 p-10 -153.3 163.12 40.47 Favored 'General case' 0 N--CA 1.424 -1.756 0 C-N-CA 126.423 1.889 . . . . 0.0 107.681 -166.739 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.6 pt -138.46 163.89 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 124.466 1.106 . . . . 0.0 108.205 170.256 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -106.93 133.05 52.16 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 104.535 -2.395 . . . . 0.0 104.535 165.415 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.2 m -119.57 129.06 75.8 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 172.704 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.5 mmm180 -76.21 74.88 3.04 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.203 -0.936 . . . . 0.0 108.702 175.281 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.0 mm 55.21 -95.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.911 1.284 . . . . 0.0 109.052 -173.613 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -97.51 30.52 9.08 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 124.559 1.076 . . . . 0.0 112.778 -169.455 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -83.63 95.79 8.47 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.949 1.7 . . . . 0.0 108.315 -177.195 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.11 89.68 0.13 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.831 1.253 . . . . 0.0 110.938 179.666 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.9 t -80.85 139.45 18.09 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.084 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 173.853 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.55 120.22 31.45 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 168.792 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.62 103.67 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.921 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 52.9 ttm -79.3 118.33 21.13 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.716 1.206 . . . . 0.0 111.81 -177.513 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -88.46 153.86 20.82 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.72 0.808 . . . . 0.0 110.462 175.841 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -125.82 133.76 51.89 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 124.317 1.047 . . . . 0.0 110.049 177.613 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -134.34 154.79 51.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 127.389 2.276 . . . . 0.0 107.104 158.213 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -157.54 136.1 11.31 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 104.937 -2.245 . . . . 0.0 104.937 175.884 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.534 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 59.6 t-20 -79.98 125.66 30.05 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.926 1.239 . . . . 0.0 111.807 -176.441 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.16 3.29 19.99 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.15 1.38 . . . . 0.0 112.27 -177.338 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.18 166.13 22.54 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.241 -0.912 . . . . 0.0 111.176 177.706 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.3 m -87.72 -8.77 55.63 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.988 0.915 . . . . 0.0 112.299 179.797 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.0 165.6 29.68 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 126.64 1.976 . . . . 0.0 106.362 178.409 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -57.41 154.96 32.59 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.949 1.766 . . . . 0.0 111.409 -177.19 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.34 164.59 20.06 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.42 0.629 . . . . 0.0 111.311 165.215 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.4 t -99.66 158.72 15.57 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 164.138 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.74 69.55 0.25 Allowed Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 107.973 -2.051 . . . . 0.0 107.973 -172.977 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -99.87 -58.82 1.83 Allowed 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.311 1.444 . . . . 0.0 108.546 178.863 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 64.33 -178.53 0.17 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.219 0.608 . . . . 0.0 111.62 178.146 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.0 m -136.61 134.93 37.89 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 168.588 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -114.83 170.82 8.05 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 126.197 1.799 . . . . 0.0 109.984 -173.06 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -131.4 107.97 9.29 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.927 1.291 . . . . 0.0 107.585 166.843 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.689 HG22 HD13 ' A' ' 140' ' ' LEU . 39.6 t -90.42 74.11 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.692 1.597 . . . . 0.0 108.569 179.655 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.8 t 177.15 148.27 0.32 Allowed Pre-proline 0 N--CA 1.466 0.366 0 C-N-CA 124.831 1.253 . . . . 0.0 110.776 177.88 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -65.33 -38.25 27.43 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 121.496 1.464 . . . . 0.0 110.482 159.539 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 11.1 ptp 171.55 -72.91 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 127.318 2.247 . . . . 0.0 107.547 175.225 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.58 -36.57 73.67 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.902 0.881 . . . . 0.0 112.908 -166.087 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.49 -105.94 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.302 0.241 . . . . 0.0 110.964 -173.863 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.86 -56.38 1.76 Allowed Glycine 0 CA--C 1.527 0.841 0 O-C-N 121.601 -0.687 . . . . 0.0 112.841 -176.287 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.5 -53.75 10.64 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.442 1.097 . . . . 0.0 111.476 -179.738 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -72.5 -8.44 55.12 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.332 1.453 . . . . 0.0 113.17 -178.128 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -64.02 117.14 6.63 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.492 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 121.977 0.894 . . . . 0.0 111.584 -165.855 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 CA--C 1.535 0.396 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.7 t -161.61 -71.54 0.06 Allowed 'General case' 0 C--O 1.23 0.078 0 O-C-N 121.605 -0.684 . . . . 0.0 111.477 -179.557 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.2 t -159.24 149.68 19.38 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.878 1.271 . . . . 0.0 107.783 -174.939 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.3 mt -155.28 145.59 21.9 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.513 0.725 . . . . 0.0 110.044 175.501 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -70.23 174.21 3.57 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 124.554 1.142 . . . . 0.0 110.966 168.488 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.08 97.78 1.08 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.934 3.089 . . . . 0.0 111.045 -171.284 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 125.16 -7.93 8.04 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-O 119.489 -0.617 . . . . 0.0 111.693 176.09 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -76.65 170.56 16.2 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 117.794 0.797 . . . . 0.0 111.114 -171.762 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.54 143.82 45.13 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.828 1.651 . . . . 0.0 110.125 -167.329 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 7.6 mtt -139.81 81.84 1.84 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.652 1.581 . . . . 0.0 109.3 170.289 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -103.98 118.79 37.51 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 120.845 -1.159 . . . . 0.0 108.014 169.729 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 77.2 mtp -141.23 140.68 21.38 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 118.816 0.734 . . . . 0.0 112.053 -174.384 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.72 140.61 32.65 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 123.06 2.506 . . . . 0.0 110.277 175.709 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 69.5 t -116.57 151.42 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 161.118 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.1 p -118.21 139.23 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 167.409 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -153.22 157.94 40.98 Favored 'General case' 0 N--CA 1.458 -0.062 0 CA-C-N 119.562 1.074 . . . . 0.0 113.189 -177.336 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -179.1 174.63 1.04 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 128.979 2.911 . . . . 0.0 106.168 -169.176 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 67.2 t -135.5 133.65 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 119.143 0.883 . . . . 0.0 110.862 178.583 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -76.66 138.16 66.7 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.945 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -71.01 -3.61 13.19 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.024 2.483 . . . . 0.0 111.799 -179.28 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.407 ' OE1' ' NZ ' ' A' ' 128' ' ' LYS . 13.8 mm-40 -36.0 -41.61 0.25 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.427 1.091 . . . . 0.0 111.313 159.484 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -58.23 -30.79 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 123.79 0.836 . . . . 0.0 113.063 -178.546 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.4 m -101.24 17.73 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.583 0.753 . . . . 0.0 111.816 175.897 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.407 ' NZ ' ' OE1' ' A' ' 125' ' ' GLU 0.354 6.3 pttt -79.83 -42.2 1.47 Allowed Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 170.927 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -86.95 -175.71 1.7 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.08 2.52 . . . . 0.0 110.981 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 94.7 t -80.71 -54.2 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 123.751 0.82 . . . . 0.0 109.684 173.099 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -46.11 -57.8 4.17 Favored 'General case' 0 N--CA 1.46 0.064 0 C-N-CA 124.848 1.259 . . . . 0.0 112.796 -169.067 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.7 p -82.95 -3.99 57.72 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 118.378 -0.82 . . . . 0.0 112.783 -175.608 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -47.49 -42.69 23.42 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.802 1.183 . . . . 0.0 112.814 -172.516 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.18 -25.03 76.19 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 122.858 0.266 . . . . 0.0 113.223 -179.205 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 25.6 mm -74.51 130.51 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 117.935 0.868 . . . . 0.0 110.734 -174.805 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.3 pttt -156.26 42.6 0.39 Allowed 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.213 164.666 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.1 p -134.05 84.28 2.1 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 106.536 -1.654 . . . . 0.0 106.536 170.965 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.8 tp -87.95 87.24 7.29 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -163.93 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.6 t -96.31 143.87 26.99 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.262 -166.292 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.689 HD13 HG22 ' A' ' 86' ' ' VAL . 4.4 tp -112.71 111.34 22.07 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 168.025 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.4 p -88.72 96.88 10.84 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 168.831 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.56 128.91 35.02 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 170.002 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.8 m -129.64 93.78 3.61 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.895 0.855 . . . . 0.0 109.482 -174.677 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -78.96 91.72 4.85 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.5 1.12 . . . . 0.0 111.121 -171.043 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.73 53.26 9.81 Favored Pre-proline 0 CA--C 1.549 0.923 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 179.542 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.66 -94.56 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.16 2.573 . . . . 0.0 111.27 175.78 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -157.43 140.43 15.21 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 118.089 -0.958 . . . . 0.0 109.164 178.494 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -109.91 150.61 41.62 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 165.187 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -74.64 -59.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.284 1.99 . . . . 0.0 109.224 169.919 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 37.1 p 179.32 94.41 0.02 OUTLIER 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.614 1.565 . . . . 0.0 107.922 -179.26 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 19.1 pttp . . . . . 0 CA--C 1.539 0.533 0 CA-C-N 118.281 0.491 . . . . 0.0 109.874 -178.968 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 79.0 p -109.38 62.13 0.6 Allowed 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 127.231 2.212 . . . . 0.0 110.735 -157.095 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -155.63 -60.33 0.11 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 102.887 -3.005 . . . . 0.0 102.887 172.384 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.744 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.2 pt? -68.8 27.76 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 128.238 2.615 . . . . 0.0 114.316 177.22 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.5 mt -97.14 60.07 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.265 0 O-C-N 120.472 -1.393 . . . . 0.0 107.823 173.377 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.21 -179.43 2.86 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.607 -167.747 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -75.39 56.83 0.87 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.521 1.128 . . . . 0.0 110.324 177.306 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.94 145.26 41.82 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.833 1.653 . . . . 0.0 106.751 176.754 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -131.43 127.59 37.77 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.235 2.214 . . . . 0.0 105.292 -169.727 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.567 HG23 HG23 ' A' ' 58' ' ' VAL . 1.3 tt -140.32 147.79 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 124.56 1.144 . . . . 0.0 108.587 -164.377 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.519 ' CE ' ' HB2' ' A' ' 55' ' ' ASP . 4.0 tmtp? -109.01 151.17 26.7 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.463 1.505 . . . . 0.0 109.782 -164.426 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.416 ' HB ' ' CG1' ' A' ' 56' ' ' ILE . 70.6 t -133.25 137.92 52.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 167.37 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.5 m -122.71 111.84 17.21 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -179.702 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -89.7 85.18 6.38 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 123.016 0.526 . . . . 0.0 110.246 -174.427 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -87.29 81.81 7.8 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 123.063 1.411 . . . . 0.0 110.909 -179.602 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.0 120.82 36.96 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 121.006 -1.059 . . . . 0.0 109.89 -176.597 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -125.8 160.69 29.18 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.259 1.024 . . . . 0.0 108.556 -179.892 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.93 151.25 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.077 0 C-N-CA 123.83 0.852 . . . . 0.0 109.249 -176.905 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.71 175.61 11.43 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.085 0.954 . . . . 0.0 110.437 178.955 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.51 124.11 6.57 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 170.251 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 127.38 -39.99 1.84 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -165.712 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.479 HD12 ' CD ' ' A' ' 146' ' ' PRO . 0.5 OUTLIER -127.87 87.46 55.69 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 123.652 0.781 . . . . 0.0 110.017 174.169 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -81.72 38.75 0.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 124.356 3.371 . . . . 0.0 110.199 -176.973 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.465 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 41.3 m0 -110.11 146.77 34.88 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -171.347 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.41 78.34 3.93 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 -175.036 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -95.06 109.76 21.77 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -170.45 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.9 m -111.84 139.83 22.69 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.631 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.05 162.8 36.6 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 N-CA-C 108.444 -1.406 . . . . 0.0 108.444 162.659 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.7 t -78.33 -45.68 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -178.665 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -156.01 175.74 13.56 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 166.476 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -50.54 62.5 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.496 0.589 . . . . 0.0 111.619 171.474 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.519 ' HB2' ' CE ' ' A' ' 34' ' ' LYS . 23.1 p-10 -156.22 161.78 40.24 Favored 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 123.959 0.904 . . . . 0.0 111.482 -164.809 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.416 ' CG1' ' HB ' ' A' ' 35' ' ' VAL . 36.1 pt -129.4 162.06 37.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 169.324 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -116.31 142.6 46.62 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 161.475 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.567 HG23 HG23 ' A' ' 33' ' ' ILE . 29.7 m -131.63 159.15 43.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 126.361 1.865 . . . . 0.0 106.133 175.106 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.3 mtm-85 -100.66 85.42 2.91 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 158.414 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.543 HG23 HG21 ' A' ' 33' ' ' ILE . 6.8 pt 35.87 43.7 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 127.379 2.271 . . . . 0.0 114.549 161.298 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 146.49 -29.81 1.59 Allowed Glycine 0 CA--C 1.525 0.687 0 O-C-N 121.004 -1.06 . . . . 0.0 111.618 -170.88 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -57.6 98.51 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.084 0.954 . . . . 0.0 110.137 173.755 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.411 HG22 ' CD1' ' A' ' 121' ' ' PHE . 0.3 OUTLIER -65.45 107.51 1.69 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.925 2.09 . . . . 0.0 111.558 -176.565 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.95 147.32 12.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 166.56 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.39 128.03 39.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.475 1.91 . . . . 0.0 108.644 172.72 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.7 pp -129.83 111.48 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 167.468 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.84 126.39 36.9 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 123.126 0.571 . . . . 0.0 112.253 178.593 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -89.97 158.31 17.43 Favored 'General case' 0 C--O 1.23 0.062 0 C-N-CA 123.856 0.863 . . . . 0.0 108.709 177.272 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -133.83 129.84 37.07 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.846 1.258 . . . . 0.0 109.09 176.723 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.11 150.14 51.51 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 128.26 2.624 . . . . 0.0 107.131 163.74 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -150.96 129.02 11.79 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 117.365 -1.302 . . . . 0.0 107.7 174.967 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.465 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 52.8 t-20 -78.79 116.91 19.44 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 120.803 1.638 . . . . 0.0 111.642 -170.6 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.6 mt -117.04 34.43 5.11 Favored 'General case' 0 C--N 1.345 0.379 0 C-N-CA 124.575 1.15 . . . . 0.0 112.028 179.008 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.15 175.95 6.58 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 154.204 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.7 t -95.94 16.53 17.53 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.192 0.597 . . . . 0.0 110.483 172.616 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 p -145.41 154.32 52.97 Favored Pre-proline 0 N--CA 1.45 -0.46 0 C-N-CA 124.972 1.309 . . . . 0.0 109.025 -176.102 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.14 147.32 78.98 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 N-CA-C 108.132 -1.526 . . . . 0.0 108.132 171.168 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.4 p -119.39 178.93 4.36 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 170.24 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.4 t -124.41 109.45 13.31 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 173.015 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.32 101.59 0.64 Allowed Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 108.527 -1.829 . . . . 0.0 108.527 175.011 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -125.51 47.79 2.15 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 165.711 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.29 -178.84 1.43 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 122.181 0.991 . . . . 0.0 108.541 159.415 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.74 -173.56 4.62 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 178.055 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -144.21 146.47 32.71 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.247 0.93 . . . . 0.0 111.778 167.72 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.2 96.19 9.44 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 167.304 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.9 p -85.58 65.74 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 CA-C-N 118.045 0.384 . . . . 0.0 110.603 177.821 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.1 t -164.84 143.88 5.64 Favored Pre-proline 0 C--O 1.233 0.191 0 O-C-N 121.161 -0.962 . . . . 0.0 112.201 -179.497 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.19 -33.29 31.48 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 N-CA-C 108.776 -1.278 . . . . 0.0 108.776 162.907 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 7.8 ptm 175.58 -70.09 0.01 OUTLIER 'General case' 0 C--N 1.343 0.304 0 C-N-CA 126.406 1.883 . . . . 0.0 108.127 -171.161 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -99.72 -19.66 16.65 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.765 1.226 . . . . 0.0 112.743 -161.972 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.72 -133.24 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 178.892 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.3 -45.42 0.35 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.137 0.875 . . . . 0.0 114.442 -174.812 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -49.34 -61.02 2.32 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.608 1.204 . . . . 0.0 108.636 167.61 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -75.8 54.34 0.8 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.41 1.884 . . . . 0.0 110.147 171.017 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -110.7 156.89 20.38 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 162.274 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.6 m120 . . . . . 0 N--CA 1.441 -0.899 0 C-N-CA 127.006 2.122 . . . . 0.0 109.676 -175.376 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 CA--C 1.538 0.482 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.8 t 52.14 -146.79 0.48 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.681 1.192 . . . . 0.0 112.231 170.93 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.55 122.66 45.33 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.058 1.743 . . . . 0.0 107.095 177.111 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.41 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -116.35 129.38 56.22 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.904 1.681 . . . . 0.0 108.615 -170.203 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -77.49 152.42 81.04 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 123.462 0.705 . . . . 0.0 111.673 -177.935 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.75 110.71 2.83 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.457 2.771 . . . . 0.0 112.111 -167.645 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 126.0 -31.68 4.02 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 108.27 -1.932 . . . . 0.0 108.27 -176.658 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -86.32 171.29 11.32 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 121.363 0.601 . . . . 0.0 112.206 -161.173 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.08 145.5 41.52 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.237 1.815 . . . . 0.0 110.649 -163.081 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.62 86.92 2.14 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.163 1.785 . . . . 0.0 107.678 166.015 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -125.28 129.42 49.97 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 121.633 -0.667 . . . . 0.0 110.731 169.774 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 81.5 mtp -153.94 146.4 17.42 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 122.938 0.495 . . . . 0.0 111.054 -170.364 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -66.93 137.29 44.36 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.608 2.872 . . . . 0.0 112.105 172.561 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 34.5 t -116.59 155.96 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 161.674 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.0 m -121.27 151.76 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 176.09 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -151.42 139.29 19.91 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 119.18 -0.438 . . . . 0.0 110.477 -171.021 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.411 ' CD1' HG22 ' A' ' 63' ' ' THR . 8.3 p90 -172.71 86.55 0.07 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.628 1.171 . . . . 0.0 110.462 -174.293 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.478 ' H ' HG21 ' A' ' 58' ' ' VAL . 41.5 t -49.72 143.1 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -166.1 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.33 123.74 84.44 Favored Pre-proline 0 CA--C 1.537 0.478 0 O-C-N 121.308 -0.87 . . . . 0.0 110.821 -174.454 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.409 ' CD ' HD12 ' A' ' 27' ' ' LEU . 34.6 Cg_endo -73.9 32.59 0.33 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.12 2.547 . . . . 0.0 113.483 177.339 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -87.28 -24.27 24.4 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.529 1.532 . . . . 0.0 108.67 160.585 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -46.46 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 C-N-CA 123.098 0.559 . . . . 0.0 111.576 -172.209 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.8 m -79.31 61.5 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 O-C-N 121.691 -0.63 . . . . 0.0 110.401 177.063 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -137.39 -65.01 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.597 0 CA-C-O 117.845 -1.074 . . . . 0.0 112.344 173.899 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.5 159.57 28.85 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 122.119 1.879 . . . . 0.0 113.917 -173.128 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 86.7 t -54.71 -35.94 34.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 126.024 1.73 . . . . 0.0 110.981 177.271 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -36.82 -55.95 0.87 Allowed 'General case' 0 C--N 1.34 0.157 0 C-N-CA 126.089 1.756 . . . . 0.0 111.817 175.27 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.0 p -105.9 -50.26 3.22 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 124.192 0.997 . . . . 0.0 109.826 -163.667 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 22.02 57.44 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 128.425 2.69 . . . . 0.0 115.508 173.501 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 135.26 -30.48 2.8 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 -177.298 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 13.0 mm -53.5 138.62 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-N 117.828 0.814 . . . . 0.0 109.274 173.691 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.8 pttt -158.87 54.96 0.42 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.571 0.701 . . . . 0.0 111.056 165.181 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.93 90.24 2.37 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -178.223 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.3 mp -76.44 85.57 3.17 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.089 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.2 m -77.3 107.25 9.57 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 176.527 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.2 tt -76.79 137.23 39.13 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 160.583 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 27.9 t -135.61 142.7 45.29 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 160.791 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -159.36 169.76 23.29 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 155.925 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 38.4 m -113.7 103.55 11.33 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 127.437 2.295 . . . . 0.0 108.333 173.366 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -71.12 100.2 2.0 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 172.367 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.07 50.47 0.69 Allowed Pre-proline 0 CA--C 1.553 1.072 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 -176.325 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.479 ' CD ' HD12 ' A' ' 45' ' ' LEU . 59.2 Cg_endo -75.9 -82.27 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.504 2.803 . . . . 0.0 113.991 -175.886 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 74.0 mtt85 -149.74 106.77 3.57 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.41 1.005 . . . . 0.0 112.019 -164.655 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -156.49 135.63 7.95 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 126.043 1.737 . . . . 0.0 106.932 169.792 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.13 -53.59 0.3 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.139 1.893 . . . . 0.0 112.609 173.473 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.3 p 177.18 109.41 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.67 0.788 . . . . 0.0 110.493 -166.957 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 55.9 pttt . . . . . 0 CA--C 1.537 0.467 0 O-C-N 121.303 -0.873 . . . . 0.0 109.896 -177.859 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.486 0 CA-C-O 122.025 0.917 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.79 -11.43 59.99 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.529 1.532 . . . . 0.0 114.757 -147.196 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.35 -31.96 64.25 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 173.879 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.1 mp -108.09 14.46 25.11 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.023 1.329 . . . . 0.0 112.074 -176.27 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.4 mt -77.98 77.31 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 120.005 -1.684 . . . . 0.0 108.839 173.641 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.76 179.75 5.93 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.531 0.681 . . . . 0.0 109.893 179.238 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -94.48 59.43 2.51 Favored 'General case' 0 C--N 1.337 0.031 0 C-N-CA 123.827 0.851 . . . . 0.0 112.667 -167.021 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -115.18 160.9 19.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 151.664 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -133.76 88.38 2.47 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -179.898 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.0 tt -94.47 137.91 21.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 C-N-CA 124.477 1.111 . . . . 0.0 111.637 -163.997 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.441 ' HE2' ' CB ' ' A' ' 55' ' ' ASP . 0.1 OUTLIER -79.71 143.84 34.2 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.635 1.574 . . . . 0.0 109.781 -170.421 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.531 HG21 ' CE1' ' A' ' 120' ' ' PHE . 3.7 t -135.72 142.06 40.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.655 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 164.389 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.9 m -123.29 112.47 17.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 -177.721 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -78.52 89.76 4.48 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 172.864 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -78.23 85.25 4.4 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 118.492 -1.283 . . . . 0.0 108.395 178.576 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.5 115.78 17.54 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.832 174.758 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -122.94 175.54 6.52 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.595 1.158 . . . . 0.0 108.188 167.039 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.6 p -151.17 148.6 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 169.161 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -164.51 171.54 14.45 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.254 1.022 . . . . 0.0 108.869 -178.302 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.62 -165.36 0.22 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.354 1.462 . . . . 0.0 111.616 -175.4 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.73 52.98 4.26 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 112.123 -0.391 . . . . 0.0 112.123 -173.079 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.412 ' CD1' ' CD1' ' A' ' 144' ' ' PHE . 1.4 tt -111.7 83.77 4.77 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.122 0.969 . . . . 0.0 108.785 177.693 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -85.28 45.0 1.5 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.246 3.298 . . . . 0.0 109.736 -170.141 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.438 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 43.1 m0 -108.39 138.58 44.43 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -172.909 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.408 ' OE1' ' NZ ' ' A' ' 71' ' ' LYS . 73.2 tt0 -77.85 82.36 4.23 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 -178.503 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -90.26 122.01 32.79 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.715 1.206 . . . . 0.0 108.233 179.834 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 m -126.67 135.54 27.43 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.144 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -70.76 162.39 42.76 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 N-CA-C 108.146 -1.521 . . . . 0.0 108.146 161.433 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -60.18 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 175.117 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -144.06 154.13 42.91 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 164.773 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.03 -42.72 69.45 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 118.537 -0.744 . . . . 0.0 112.095 -175.964 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.441 ' CB ' ' HE2' ' A' ' 34' ' ' LYS . 23.7 p-10 -145.35 159.69 42.67 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 119.382 0.992 . . . . 0.0 113.189 -166.623 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.8 pt -133.82 159.79 42.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 125.768 1.627 . . . . 0.0 107.847 178.193 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -128.29 85.41 2.34 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.316 1.446 . . . . 0.0 109.124 178.189 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.8 m -80.44 141.83 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 O-C-N 121.255 -0.903 . . . . 0.0 110.689 -171.281 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -78.22 72.16 4.74 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 173.078 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.5 pt 19.01 64.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 127.437 2.295 . . . . 0.0 113.489 176.368 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 139.0 -43.8 1.14 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -172.58 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -59.68 130.3 46.16 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.648 -173.467 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.467 HG23 ' CD1' ' A' ' 121' ' ' PHE . 1.6 m -106.69 87.28 2.49 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.003 -146.106 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.72 144.19 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 CA-C-O 121.094 0.473 . . . . 0.0 110.696 -170.538 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.93 115.54 24.4 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.239 1.016 . . . . 0.0 108.591 168.817 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.8 pp -115.57 115.04 48.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 164.044 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -87.49 155.23 20.09 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.939 -0.475 . . . . 0.0 110.966 178.387 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -127.0 153.78 45.46 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 172.73 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -134.69 141.79 46.64 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.877 1.671 . . . . 0.0 107.898 179.904 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.34 115.58 7.98 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.805 2.042 . . . . 0.0 107.681 174.387 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.408 ' NZ ' ' OE1' ' A' ' 48' ' ' GLU . 3.0 mtmp? -114.73 124.42 51.73 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.29 0.95 . . . . 0.0 110.652 -176.99 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.438 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 46.9 t-20 -80.92 107.2 13.53 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.79 0.723 . . . . 0.0 112.932 -167.583 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.3 mp -99.08 30.4 3.45 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.495 1.118 . . . . 0.0 111.974 176.649 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.85 176.81 9.39 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.021 -1.049 . . . . 0.0 110.401 168.084 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.1 t -114.07 18.1 17.37 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.221 0.608 . . . . 0.0 109.929 161.646 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 p -146.65 156.42 48.61 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 125.639 1.576 . . . . 0.0 107.736 174.405 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -63.23 145.1 93.05 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 N-CA-C 108.122 -1.53 . . . . 0.0 108.122 172.138 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.5 p -123.08 168.25 12.61 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.644 0.735 . . . . 0.0 111.299 178.716 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.8 m -93.63 144.88 24.98 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 168.354 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -168.74 56.9 0.21 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 176.525 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.91 57.78 0.86 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.018 1.727 . . . . 0.0 108.405 -174.374 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.62 166.46 23.52 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.94 0.876 . . . . 0.0 112.879 -168.036 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.48 97.55 8.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 176.512 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -77.23 140.24 40.05 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.544 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -85.76 88.61 7.57 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -172.634 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -76.97 77.91 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 C-N-CA 125.043 1.337 . . . . 0.0 110.435 -176.983 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.8 t 178.88 147.64 0.39 Allowed Pre-proline 0 N--CA 1.46 0.029 0 C-N-CA 124.932 1.293 . . . . 0.0 109.343 173.324 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -66.75 -35.19 28.86 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.146 1.23 . . . . 0.0 110.274 158.963 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.0 ptp 175.36 -70.78 0.01 OUTLIER 'General case' 0 C--N 1.341 0.206 0 C-N-CA 126.902 2.081 . . . . 0.0 107.571 179.244 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.0 -36.61 48.59 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.962 0.905 . . . . 0.0 113.011 -167.788 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.77 -109.62 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.608 0.242 . . . . 0.0 111.58 -167.732 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.79 -49.69 0.84 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.417 1.008 . . . . 0.0 113.528 -176.111 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.55 -57.52 4.66 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.594 1.197 . . . . 0.0 109.802 172.254 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -73.69 5.01 4.31 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.498 1.919 . . . . 0.0 113.895 -178.898 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -85.72 126.58 34.08 Favored 'General case' 0 C--N 1.344 0.343 0 O-C-N 121.232 -0.918 . . . . 0.0 108.649 174.871 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 . . . . . 0 N--CA 1.452 -0.327 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.179 -179.459 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 CA--C 1.538 0.496 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.1 t -88.5 -165.78 1.42 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.051 0.94 . . . . 0.0 110.05 174.687 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.5 t -76.69 144.15 39.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.198 0.999 . . . . 0.0 110.04 -175.997 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 81.0 mt -127.25 134.87 50.01 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.538 1.135 . . . . 0.0 108.15 -179.791 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -69.55 157.08 90.44 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 170.942 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.43 100.21 0.88 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.373 2.716 . . . . 0.0 110.438 -170.711 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.31 -23.44 3.31 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -175.208 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -78.95 135.78 37.05 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 118.254 1.027 . . . . 0.0 111.707 -160.727 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -92.61 104.56 16.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.4 1.48 . . . . 0.0 109.375 178.906 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -90.56 135.13 33.9 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 174.042 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -151.46 154.99 37.65 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.625 0.37 . . . . 0.0 110.639 156.922 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 78.6 mtp -151.77 146.05 18.36 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.161 0.984 . . . . 0.0 109.578 171.495 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -66.12 137.97 50.17 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.126 2.55 . . . . 0.0 110.443 161.79 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.8 t -107.96 130.47 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 159.852 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.3 m -98.49 140.82 17.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 171.845 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.531 ' CE1' HG21 ' A' ' 35' ' ' VAL . 64.3 t80 -154.43 149.37 26.72 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -162.322 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.467 ' CD1' HG23 ' A' ' 63' ' ' THR . 41.1 p90 -164.5 170.29 16.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.415 1.886 . . . . 0.0 109.108 165.314 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 70.7 t -103.99 135.46 41.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 174.482 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -76.37 134.2 70.47 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 119.119 -0.467 . . . . 0.0 109.954 176.397 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -74.16 67.34 5.16 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.384 2.723 . . . . 0.0 110.292 171.42 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -133.52 -37.82 0.94 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 126.799 2.04 . . . . 0.0 111.027 176.565 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.4 tt -43.87 -41.66 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 125.012 1.325 . . . . 0.0 113.414 173.111 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.9 m -78.23 49.03 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 O-C-N 121.394 -0.816 . . . . 0.0 111.34 176.825 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.9 mttt -142.72 -64.51 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 117.521 -1.228 . . . . 0.0 111.617 -179.299 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.17 153.17 46.03 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 121.942 1.729 . . . . 0.0 112.736 -176.548 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.8 t -54.87 -35.54 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 125.838 1.655 . . . . 0.0 110.662 175.897 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -35.26 -59.16 0.53 Allowed 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 126.656 1.983 . . . . 0.0 112.309 175.79 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.5 p -106.94 -42.73 4.84 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.015 -166.068 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 14.07 63.15 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 128.389 2.675 . . . . 0.0 116.235 172.151 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 136.73 -36.73 1.95 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -177.272 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 29.8 mm -53.28 123.52 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 171.444 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.38 47.86 0.35 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.288 0.566 . . . . 0.0 112.102 177.965 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.5 p -143.65 89.04 2.03 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 105.809 -1.922 . . . . 0.0 105.809 174.025 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 tp -92.71 87.21 5.8 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.029 -159.957 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.5 t -97.86 155.85 16.87 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.457 0.703 . . . . 0.0 111.084 -166.773 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.76 133.25 55.98 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 160.704 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 44.5 m -90.94 105.77 18.06 Favored 'General case' 0 N--CA 1.46 0.043 0 O-C-N 123.902 0.751 . . . . 0.0 109.035 160.452 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -76.27 99.8 4.89 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 165.708 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 53.5 m -117.34 86.35 2.5 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.978 1.311 . . . . 0.0 107.524 175.18 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.412 ' CD1' ' CD1' ' A' ' 45' ' ' LEU . 48.2 m-85 -59.22 145.2 43.67 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.322 1.049 . . . . 0.0 112.828 174.392 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -166.85 52.69 0.25 Allowed Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.966 1.707 . . . . 0.0 112.342 -175.435 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.3 -90.04 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.679 2.252 . . . . 0.0 115.092 -168.958 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -155.16 179.55 9.04 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 129.697 3.199 . . . . 0.0 104.863 -175.119 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -147.13 94.56 4.54 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 118.488 0.585 . . . . 0.0 111.044 -171.462 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -91.94 -124.37 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.984 3.122 . . . . 0.0 108.954 176.664 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 85.5 p -123.2 123.76 41.5 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 120.356 1.435 . . . . 0.0 111.763 -172.706 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.595 0 C-N-CA 126.496 1.918 . . . . 0.0 109.237 174.333 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.631 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.75 11.9 0.95 Allowed 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 126.802 2.041 . . . . 0.0 115.322 -164.9 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -77.25 -39.12 49.44 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 159.452 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.4 mp -92.22 -37.91 12.41 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 117.209 -1.377 . . . . 0.0 113.016 179.839 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.2 mt -32.53 133.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -162.13 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 29' ' ' LEU . 2.5 mm? -105.91 -104.15 0.33 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.159 -173.618 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -173.59 -49.2 0.01 OUTLIER 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.058 1.343 . . . . 0.0 108.855 -171.348 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -38.78 134.6 0.95 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.002 1.721 . . . . 0.0 110.678 -178.812 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -100.97 86.65 3.1 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -165.883 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.98 115.01 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.436 1.494 . . . . 0.0 107.953 -171.424 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.99 160.01 29.48 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -173.641 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.0 t -148.74 145.19 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 179.836 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.1 m -138.55 100.28 4.05 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -170.053 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -78.11 145.0 36.0 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.018 0.527 . . . . 0.0 109.919 -176.177 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -127.63 82.75 2.11 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.913 0.863 . . . . 0.0 110.007 178.22 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.49 102.16 14.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 172.118 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -116.89 128.37 55.18 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 122.292 1.044 . . . . 0.0 112.126 -174.666 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.0 p -99.83 96.29 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.564 -174.252 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.12 171.1 10.5 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 122.048 0.928 . . . . 0.0 111.406 174.843 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.41 132.07 52.0 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 169.903 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 128.33 -39.28 1.92 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -170.579 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.484 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -131.56 95.57 23.21 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 117.56 0.68 . . . . 0.0 110.277 -176.363 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -83.94 50.94 3.27 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.956 2.437 . . . . 0.0 109.651 -176.136 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.484 ' CD2' ' CD2' ' A' ' 45' ' ' LEU . 44.4 m0 -107.91 135.56 49.1 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -173.649 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -79.36 84.5 5.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 103.484 -2.784 . . . . 0.0 103.484 179.246 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -102.04 86.15 2.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -171.598 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.3 m -88.04 129.14 51.2 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -167.28 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.09 122.49 9.58 Favored 'Trans proline' 0 N--CA 1.446 -1.277 0 N-CA-C 106.261 -2.246 . . . . 0.0 106.261 162.466 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.1 m -72.73 -32.08 39.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.181 0.515 . . . . 0.0 110.691 -168.387 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.02 161.98 34.16 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 150.265 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -62.65 -46.72 86.89 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 172.532 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -147.38 153.54 39.77 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 124.415 1.086 . . . . 0.0 111.659 -159.647 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.4 pt -133.13 179.23 4.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 126.326 1.851 . . . . 0.0 108.251 179.892 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -125.47 160.18 30.11 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.345 0.593 . . . . 0.0 110.21 149.881 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.6 t -116.72 145.97 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 127.99 2.516 . . . . 0.0 105.679 171.014 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 49.5 mmm-85 -91.37 100.81 13.53 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 168.021 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mt -33.2 115.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -148.243 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.58 -25.2 26.49 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.071 1.319 . . . . 0.0 110.936 -179.386 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -64.9 133.45 51.86 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.806 1.303 . . . . 0.0 112.422 -172.33 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.15 101.53 7.97 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 130.05 3.34 . . . . 0.0 110.818 -175.38 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.9 p -113.78 153.75 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.292 1.437 . . . . 0.0 109.491 -178.597 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -112.51 125.15 53.93 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 125.404 1.482 . . . . 0.0 109.343 -177.38 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.0 pp -128.48 122.86 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 167.861 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.412 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 66.4 mtt -76.09 168.44 20.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.614 174.164 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -136.17 143.21 44.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 161.864 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.7 ttt85 -121.01 118.7 30.5 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 179.546 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.3 105.15 9.24 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 125.822 1.649 . . . . 0.0 110.035 -177.216 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.29 121.09 44.36 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.064 -0.398 . . . . 0.0 110.749 -168.603 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.44 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 47.8 t-20 -78.38 111.9 14.85 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.803 -0.561 . . . . 0.0 111.912 -167.783 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.2 tp -98.41 11.24 38.77 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.812 0.845 . . . . 0.0 112.381 179.564 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.46 166.67 22.33 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.272 -0.893 . . . . 0.0 109.95 173.44 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 70.0 m -103.3 7.0 38.35 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.968 0.907 . . . . 0.0 111.835 171.73 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.34 159.61 38.79 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 126.134 1.773 . . . . 0.0 107.041 177.974 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.97 126.04 12.11 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.171 1.914 . . . . 0.0 111.255 -173.208 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.476 ' HG1' ' HE1' ' A' ' 47' ' ' TRP . 0.2 OUTLIER -80.49 173.53 12.51 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.821 0.849 . . . . 0.0 110.784 -178.998 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 50.7 p -131.45 72.03 1.49 Allowed 'General case' 0 C--O 1.232 0.137 0 C-N-CA 122.551 0.341 . . . . 0.0 110.426 -170.893 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.42 139.37 37.39 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.946 -0.462 . . . . 0.0 111.946 -179.48 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.81 34.19 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.659 1.983 . . . . 0.0 109.44 169.222 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.58 159.08 34.47 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.33 0.652 . . . . 0.0 111.445 -165.445 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.9 t -87.77 131.51 34.48 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.704 0.764 . . . . 0.0 110.039 177.814 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.409 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -104.03 89.93 3.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.871 2.468 . . . . 0.0 105.572 175.509 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -77.0 91.92 3.67 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 120.882 -1.136 . . . . 0.0 107.935 -177.617 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 84' ' ' PHE . 7.8 t -78.11 72.57 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.612 1.165 . . . . 0.0 109.973 -174.043 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.9 t -168.73 134.76 1.49 Allowed Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 119.901 1.228 . . . . 0.0 113.389 173.997 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -74.1 67.72 5.04 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 122.386 2.057 . . . . 0.0 107.243 156.257 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 22.2 ptm 44.19 25.47 0.11 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 170.935 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -171.41 -58.26 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 119.384 0.993 . . . . 0.0 110.594 -168.411 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.61 -101.2 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -177.282 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 64.05 -52.1 0.08 OUTLIER Glycine 0 CA--C 1.538 1.481 0 N-CA-C 115.413 0.925 . . . . 0.0 115.413 -175.534 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -45.73 -47.63 15.33 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.553 1.541 . . . . 0.0 110.808 172.217 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -73.85 -12.69 60.75 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 127.012 2.125 . . . . 0.0 113.471 178.975 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.403 ' CD2' HD23 ' A' ' 138' ' ' LEU . 9.0 t80 -67.55 140.0 56.95 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.119 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 . . . . . 0 C--N 1.328 -0.361 0 C-N-CA 124.967 1.307 . . . . 0.0 110.765 -177.33 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.3 t 51.67 -146.64 0.47 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.441 1.096 . . . . 0.0 112.472 170.606 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.6 m -115.54 136.65 52.86 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.089 1.355 . . . . 0.0 108.542 -172.069 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 78.6 mt -128.44 147.95 50.69 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.39 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -73.29 156.42 89.15 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 172.354 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.23 85.87 0.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 124.88 3.72 . . . . 0.0 111.756 -173.064 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 152.74 -27.23 0.83 Allowed Glycine 0 CA--C 1.522 0.5 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.25 -177.777 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -77.86 143.45 37.79 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 118.085 0.942 . . . . 0.0 111.593 -157.925 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -105.21 96.9 6.84 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.811 1.244 . . . . 0.0 109.942 -175.603 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 15.4 tpt -83.92 89.21 7.18 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.114 1.365 . . . . 0.0 109.325 -177.951 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -99.21 134.21 42.4 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.256 0.622 . . . . 0.0 109.576 172.148 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 22.4 ptm -150.95 146.31 19.11 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.996 -0.526 . . . . 0.0 111.441 178.997 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 67' ' ' MET . 83.1 Cg_endo -79.58 147.77 20.05 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.883 3.055 . . . . 0.0 111.049 171.852 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.5 t -126.53 114.89 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 165.199 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.5 p -79.41 143.47 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 168.986 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -155.61 149.11 24.98 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.163 0.585 . . . . 0.0 109.949 -165.411 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -171.18 118.98 0.48 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.36 1.464 . . . . 0.0 111.893 176.858 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.8 t -64.09 133.39 29.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 O-C-N 120.355 -1.466 . . . . 0.0 109.505 175.317 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -91.61 132.39 33.44 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 123.701 0.801 . . . . 0.0 109.8 -179.053 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -46.35 -31.52 9.55 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.402 3.401 . . . . 0.0 114.919 177.342 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -48.94 -24.2 1.4 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.783 1.633 . . . . 0.0 112.39 179.183 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.1 tt -49.01 -44.46 15.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 169.097 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.9 m -83.38 59.66 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 118.571 0.623 . . . . 0.0 109.895 174.354 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -111.0 -77.41 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 117.168 -1.396 . . . . 0.0 110.366 164.628 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.54 156.05 45.12 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 CA-C-N 121.885 1.709 . . . . 0.0 111.666 -177.384 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.6 m -62.16 -36.08 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 124.94 1.296 . . . . 0.0 112.045 -170.657 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -60.6 -64.46 0.94 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.147 0.979 . . . . 0.0 109.281 177.587 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 44.6 p -72.61 -15.43 61.73 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 118.509 -0.758 . . . . 0.0 111.568 -172.419 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.04 -41.52 5.53 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.768 0.713 . . . . 0.0 111.221 162.913 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.34 -29.17 74.38 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 112.237 -0.345 . . . . 0.0 112.237 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.3 mm -83.88 125.94 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 122.079 0.942 . . . . 0.0 110.39 -177.629 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 28.3 pttt -148.81 63.76 1.06 Allowed 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.506 153.751 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 11.7 m -150.15 95.33 2.26 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 158.416 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.403 HD23 ' CD2' ' A' ' 95' ' ' PHE . 1.2 tp -75.48 144.79 41.87 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -173.978 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.8 t -141.8 173.38 11.56 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.496 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.1 tt -150.63 111.28 4.25 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 177.855 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.45 92.94 8.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.515 1.126 . . . . 0.0 109.252 -179.545 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.94 108.4 19.17 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.877 1.271 . . . . 0.0 108.783 179.406 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.66 89.09 3.58 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 122.009 0.909 . . . . 0.0 109.747 -177.358 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -71.23 85.57 0.77 Allowed 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.281 177.058 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.1 47.59 2.8 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -178.703 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -80.89 -105.74 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.279 2.653 . . . . 0.0 111.967 178.914 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -140.95 121.68 14.34 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.648 1.179 . . . . 0.0 108.528 -171.242 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.9 111.22 38.82 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 125.654 1.581 . . . . 0.0 107.118 -177.128 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.431 ' HD3' HG23 ' A' ' 78' ' ' THR . 26.6 Cg_endo -83.3 -4.85 11.07 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.293 2.662 . . . . 0.0 113.043 -172.742 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.9 t 131.51 103.71 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 129.972 3.309 . . . . 0.0 109.754 174.481 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.542 0.669 0 C-N-CA 125.256 1.423 . . . . 0.0 111.723 168.356 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.24 0 N-CA-C 104.354 -2.462 . . . . 0.0 104.354 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.6 t -147.88 49.54 1.06 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 122.493 1.14 . . . . 0.0 108.227 174.962 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -158.8 -57.42 0.07 Allowed 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 127.306 2.243 . . . . 0.0 106.309 -174.367 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.9 mt -65.53 -16.48 63.72 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.907 2.083 . . . . 0.0 112.878 -177.777 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.4 mt -75.67 78.51 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 O-C-N 121.21 -0.931 . . . . 0.0 110.267 -171.566 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.69 -127.7 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.555 1.142 . . . . 0.0 108.524 169.679 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -104.36 -51.33 3.13 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.57 1.548 . . . . 0.0 111.939 -164.506 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -43.1 102.07 0.03 OUTLIER 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.194 1.398 . . . . 0.0 113.351 -169.806 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.69 81.52 4.99 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 177.261 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -97.11 122.58 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -160.616 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.7 150.48 34.48 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.943 1.297 . . . . 0.0 108.199 -175.216 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.52 146.9 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 174.497 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.9 m -125.83 112.19 15.73 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -172.69 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -77.88 136.18 38.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.754 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -126.71 84.45 2.27 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 122.502 1.144 . . . . 0.0 108.965 177.943 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.91 95.75 10.28 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.374 1.07 . . . . 0.0 110.972 -176.753 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -98.63 109.5 22.24 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.375 0.67 . . . . 0.0 109.79 -177.936 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.0 p -79.24 148.86 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 164.388 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -151.04 158.71 44.44 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 171.216 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.05 -40.15 10.25 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.84 0.856 . . . . 0.0 112.109 -177.214 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -41.58 -31.98 0.76 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.812 1.672 . . . . 0.0 114.151 174.999 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.487 HD21 ' CE3' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -130.17 110.13 16.68 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 118.688 1.244 . . . . 0.0 108.471 170.488 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -75.27 0.95 8.4 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.294 1.996 . . . . 0.0 115.576 -164.035 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.517 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 42.2 m0 -79.57 153.45 29.46 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.38 1.472 . . . . 0.0 113.613 -159.844 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.42 ' O ' HG23 ' A' ' 50' ' ' VAL . 4.1 tt0 -77.47 77.46 4.0 Favored 'General case' 0 C--N 1.344 0.344 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.615 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -84.6 110.72 18.93 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.684 1.193 . . . . 0.0 109.098 -171.484 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 48' ' ' GLU . 42.9 t -122.78 118.81 28.25 Favored Pre-proline 0 N--CA 1.444 -0.758 0 C-N-CA 124.4 1.08 . . . . 0.0 108.645 -163.638 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -81.87 174.56 10.13 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 124.543 3.495 . . . . 0.0 108.554 168.367 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -98.6 -53.12 8.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 123.949 0.9 . . . . 0.0 110.845 -173.622 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -134.16 175.15 9.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 166.638 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.6 tpt85 -68.45 -33.15 73.68 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.392 168.636 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -144.67 173.44 11.82 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.842 1.257 . . . . 0.0 112.694 -162.861 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.1 pt -141.65 178.2 2.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 127.206 2.203 . . . . 0.0 106.788 165.567 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -132.27 162.77 30.16 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 146.911 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.23 136.92 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 126.953 2.101 . . . . 0.0 105.836 -175.199 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.94 88.66 3.5 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 163.205 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.2 pt 8.81 69.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 127.74 2.416 . . . . 0.0 114.63 178.469 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.55 -37.55 1.78 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 123.41 0.529 . . . . 0.0 112.305 -176.594 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -39.24 104.43 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.383 1.473 . . . . 0.0 110.849 177.101 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.59 HG23 ' CD1' ' A' ' 121' ' ' PHE . 1.2 m -87.46 88.45 7.68 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.353 -156.25 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 p -92.73 161.67 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 O-C-N 121.933 -0.479 . . . . 0.0 111.721 -168.434 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -102.98 126.74 50.28 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.959 1.303 . . . . 0.0 110.35 169.561 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.5 pp -131.33 114.03 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 107.319 -1.364 . . . . 0.0 107.319 167.443 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.0 ttp -77.86 161.52 27.55 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.378 0.671 . . . . 0.0 110.862 -176.861 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -134.57 150.96 50.78 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.436 1.094 . . . . 0.0 108.846 169.325 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 54.1 ttp85 -143.46 147.08 34.0 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.997 0.919 . . . . 0.0 110.111 -178.457 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.39 109.68 2.66 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.632 1.573 . . . . 0.0 111.765 -177.995 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -86.09 139.28 31.27 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.989 171.721 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.517 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 28.1 t30 -78.21 88.99 4.27 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.073 0.851 . . . . 0.0 112.127 168.958 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.9 mp -76.76 69.08 3.08 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 171.193 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -153.66 137.26 15.99 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 168.513 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.1 t -80.14 36.1 0.34 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.369 0.531 . . . . 0.0 110.754 178.083 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.8 p -149.91 155.47 37.98 Favored Pre-proline 0 C--O 1.237 0.395 0 C-N-CA 126.63 1.972 . . . . 0.0 106.995 174.307 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -63.23 148.14 93.3 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 N-CA-C 108.208 -1.497 . . . . 0.0 108.208 168.522 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.01 175.06 6.53 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.792 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.0 m -105.65 145.25 31.28 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.121 1.768 . . . . 0.0 106.875 175.39 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -133.65 126.14 4.2 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 107.096 -2.401 . . . . 0.0 107.096 172.494 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.18 54.77 0.12 Allowed 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 166.78 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.44 144.83 15.9 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.884 176.162 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.3 t -85.01 166.08 17.02 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 168.185 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -146.41 95.96 2.69 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -168.978 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.33 86.92 5.02 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 175.509 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.0 t -78.12 60.23 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.817 1.247 . . . . 0.0 108.776 -175.034 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.1 t -171.44 148.34 2.3 Favored Pre-proline 0 CA--C 1.522 -0.129 0 O-C-N 121.481 -0.762 . . . . 0.0 111.636 178.077 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -61.57 -41.26 40.99 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 121.758 1.639 . . . . 0.0 110.068 159.031 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.3 ptp 172.08 -77.72 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 127.124 2.17 . . . . 0.0 107.59 178.399 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.87 -29.87 63.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.634 1.174 . . . . 0.0 112.292 -170.287 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.9 -119.11 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -174.028 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.89 -50.56 2.25 Favored Glycine 0 CA--C 1.528 0.874 0 O-C-N 121.348 -0.845 . . . . 0.0 113.192 178.204 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -44.93 -54.54 6.38 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.159 0.984 . . . . 0.0 110.014 171.555 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -75.39 -4.26 38.41 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.508 1.923 . . . . 0.0 113.96 -179.053 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -69.37 133.55 47.95 Favored 'General case' 0 C--N 1.341 0.227 0 O-C-N 121.093 -1.004 . . . . 0.0 108.486 178.449 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 . . . . . 0 N--CA 1.453 -0.289 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.684 177.931 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 . . . . . 0 CA--C 1.535 0.403 0 CA-C-O 121.149 0.5 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.7 t -111.52 -57.68 2.22 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 128.711 2.804 . . . . 0.0 111.378 -167.6 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.8 t -163.65 140.34 6.97 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 122.849 0.46 . . . . 0.0 110.385 -170.845 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.661 HD11 ' HB2' ' A' ' 114' ' ' MET . 39.7 mt -139.32 143.73 37.96 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.207 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.444 ' HB3' ' HD2' ' A' ' 110' ' ' PRO . 2.8 mt-10 -80.44 172.95 8.53 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.76 1.224 . . . . 0.0 109.349 -179.48 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 109' ' ' GLU . 35.2 Cg_endo -68.0 79.89 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.535 2.823 . . . . 0.0 114.465 -162.041 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 147.87 -29.89 1.39 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.307 0.956 . . . . 0.0 112.181 172.107 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -82.21 158.56 23.51 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 118.226 -1.39 . . . . 0.0 112.318 -139.61 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -84.61 123.26 30.13 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 124.64 1.176 . . . . 0.0 110.268 179.59 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.661 ' HB2' HD11 ' A' ' 108' ' ' LEU . 0.9 OUTLIER -90.22 128.61 36.42 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 154.89 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -134.0 146.42 50.4 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 159.698 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 56.7 mtt -146.61 146.63 27.59 Favored Pre-proline 0 N--CA 1.453 -0.323 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 165.087 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -71.55 142.58 40.61 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 122.101 1.868 . . . . 0.0 109.412 160.232 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.4 t -115.77 143.83 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 164.026 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.0 p -102.28 145.49 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 174.608 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -145.9 138.09 25.36 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.335 0.516 . . . . 0.0 111.425 -176.933 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.59 ' CD1' HG23 ' A' ' 63' ' ' THR . 5.9 p90 -159.07 162.25 36.56 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.569 1.548 . . . . 0.0 107.43 160.559 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 94.8 t -104.72 131.27 54.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 174.789 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.18 135.23 47.85 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 175.887 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -75.49 57.85 5.0 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 124.578 3.519 . . . . 0.0 112.673 -176.414 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.24 -36.47 7.63 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 125.57 1.548 . . . . 0.0 109.864 168.3 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.8 tt -47.75 -46.57 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -169.724 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.3 m -81.19 53.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.448 -0.783 . . . . 0.0 110.785 -178.444 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -138.28 -64.51 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 117.661 -1.161 . . . . 0.0 112.085 -179.371 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.67 156.33 35.64 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 CA-C-N 121.961 1.736 . . . . 0.0 113.406 -176.053 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.2 t -54.11 -39.46 42.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 126.201 1.8 . . . . 0.0 110.742 177.934 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -45.92 -55.72 6.38 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.697 1.599 . . . . 0.0 111.8 -178.523 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.3 p -92.37 -42.89 9.53 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 118.633 -0.699 . . . . 0.0 111.442 -176.313 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 7.93 65.13 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 128.403 2.681 . . . . 0.0 116.129 179.536 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 142.37 -41.34 1.2 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -173.709 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.7 mm -57.27 120.13 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 CA-C-N 117.689 0.744 . . . . 0.0 110.178 177.23 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -157.38 66.45 0.5 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.672 0.749 . . . . 0.0 110.173 162.578 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 10.6 m -147.51 102.72 3.48 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 152.206 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.68 151.76 34.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -175.243 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.7 t -154.08 175.13 13.79 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.408 0.623 . . . . 0.0 109.647 -177.269 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.9 tp -153.7 97.13 2.07 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 103.216 -2.883 . . . . 0.0 103.216 -169.278 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.5 t -81.78 88.09 6.32 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 171.733 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.79 124.4 27.64 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 176.809 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.423 HG22 ' CD1' ' A' ' 145' ' ' TYR . 23.8 m -133.38 95.52 3.53 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.412 1.101 . . . . 0.0 109.229 -164.468 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -74.22 74.42 1.8 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.041 1.736 . . . . 0.0 111.94 -171.007 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.423 ' CD1' HG22 ' A' ' 143' ' ' THR . 38.8 m-85 -128.35 68.48 77.23 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.349 1.06 . . . . 0.0 113.758 179.566 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -87.69 -103.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.775 2.983 . . . . 0.0 110.666 167.502 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -156.26 99.66 1.94 Allowed 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.8 1.24 . . . . 0.0 108.907 -172.117 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -104.56 134.0 19.89 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 126.432 1.893 . . . . 0.0 106.403 167.614 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.0 -47.3 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.445 2.097 . . . . 0.0 110.638 178.304 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.2 t 166.65 112.4 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 129.202 3.001 . . . . 0.0 104.822 178.486 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.7 pttt . . . . . 0 CA--C 1.535 0.4 0 CA-C-N 119.584 1.083 . . . . 0.0 110.409 -168.921 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.3 m . . . . . 0 CA--C 1.534 0.341 0 CA-C-O 121.663 0.744 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 47.5 29.27 1.34 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.661 1.584 . . . . 0.0 111.966 -161.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -139.12 165.38 27.31 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 148.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -134.88 127.68 31.17 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 103.312 -2.847 . . . . 0.0 103.312 165.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.1 m -152.41 38.82 0.56 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.719 0.69 . . . . 0.0 111.331 -176.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -159.07 -49.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 127.594 2.358 . . . . 0.0 106.62 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.531 ' H ' HD22 ' A' ' 27' ' ' LEU . 2.7 mm? -61.4 -28.16 69.05 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.295 1.838 . . . . 0.0 111.482 178.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.4 mt -69.87 83.26 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 123.625 0.77 . . . . 0.0 109.518 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.25 152.18 23.0 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 161.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -78.68 55.09 1.61 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.28 0.945 . . . . 0.0 111.328 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.12 138.44 39.95 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 105.078 -2.194 . . . . 0.0 105.078 166.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -96.81 120.04 36.4 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 123.679 0.792 . . . . 0.0 109.043 -173.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -95.08 141.53 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 163.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.551 ' CE ' ' HB2' ' A' ' 55' ' ' ASP . 2.3 tmtp? -101.73 153.86 19.41 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 169.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 t -137.14 149.44 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 167.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.8 m -137.24 98.98 3.86 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 122.521 1.153 . . . . 0.0 108.132 -171.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -79.24 88.28 4.92 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 127.356 2.262 . . . . 0.0 110.306 -176.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -81.86 85.46 6.65 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 122.347 1.07 . . . . 0.0 109.584 175.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.59 101.01 8.91 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.918 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -99.84 148.99 23.85 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 176.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.0 p -139.83 144.36 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 124.709 1.203 . . . . 0.0 108.098 172.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.56 171.96 13.68 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.597 1.159 . . . . 0.0 108.334 174.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -32.72 -55.7 0.36 Allowed 'General case' 0 C--N 1.34 0.168 0 C-N-CA 126.384 1.873 . . . . 0.0 112.822 -176.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -36.69 -35.71 0.14 Allowed Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.906 2.193 . . . . 0.0 114.663 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.63 HD13 ' CD2' ' A' ' 144' ' ' PHE . 0.3 OUTLIER -120.44 94.75 48.92 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 118.42 1.11 . . . . 0.0 109.269 170.15 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -82.32 42.33 1.29 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.417 2.745 . . . . 0.0 110.866 -173.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.422 ' CE3' HD21 ' A' ' 45' ' ' LEU . 42.9 m0 -113.84 141.66 47.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -172.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -79.42 80.07 5.82 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 -176.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -86.72 89.77 8.05 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.508 1.523 . . . . 0.0 108.368 -176.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.4 m -89.43 129.96 45.43 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -175.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -68.76 153.66 72.66 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 N-CA-C 108.156 -1.517 . . . . 0.0 108.156 163.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.41 -55.07 10.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -131.19 161.76 31.47 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 165.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -64.64 -28.45 69.62 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 118.482 0.583 . . . . 0.0 109.54 173.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.551 ' HB2' ' CE ' ' A' ' 34' ' ' LYS . 24.6 p-10 -145.97 168.87 19.81 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 125.301 1.441 . . . . 0.0 112.048 -165.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.6 pt -137.71 166.67 24.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 124.447 1.099 . . . . 0.0 108.337 169.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -110.09 144.01 39.31 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 160.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -135.53 137.34 49.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 166.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.37 91.0 6.74 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 119.698 -1.876 . . . . 0.0 107.691 164.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.3 pt 21.76 63.39 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 127.398 2.279 . . . . 0.0 113.47 171.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.97 -36.82 1.88 Allowed Glycine 0 CA--C 1.526 0.725 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.751 -177.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -40.81 104.87 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.225 1.41 . . . . 0.0 111.752 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.594 HG23 ' CD1' ' A' ' 121' ' ' PHE . 0.2 OUTLIER -89.62 89.67 7.91 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.028 0.931 . . . . 0.0 109.473 -158.822 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.2 p -88.36 172.1 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 123.291 0.636 . . . . 0.0 111.503 -166.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -117.56 122.18 42.97 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 125.3 1.44 . . . . 0.0 107.575 171.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.91 109.06 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 175.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -78.1 166.47 22.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.478 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -136.17 150.03 48.86 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 169.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.1 ttm-85 -126.02 127.04 45.26 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.793 1.637 . . . . 0.0 107.287 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.63 108.74 10.75 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 125.741 1.617 . . . . 0.0 109.254 169.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -104.73 123.99 48.6 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.326 -0.859 . . . . 0.0 109.226 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -76.26 126.84 31.73 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 120.883 -1.136 . . . . 0.0 110.92 -172.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.4 mt -111.65 14.53 21.23 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.985 0.914 . . . . 0.0 112.627 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.99 175.3 10.7 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 121.301 -0.874 . . . . 0.0 110.979 175.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.2 t -108.25 3.78 23.97 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.931 0.893 . . . . 0.0 111.702 175.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 p -145.06 163.31 33.45 Favored Pre-proline 0 N--CA 1.45 -0.436 0 C-N-CA 126.886 2.074 . . . . 0.0 105.499 174.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.06 157.36 44.61 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.198 1.266 . . . . 0.0 110.925 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.99 172.88 10.09 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 122.617 0.367 . . . . 0.0 110.177 166.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.0 t -107.25 166.06 10.92 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 160.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.534 ' HA2' HD11 ' A' ' 45' ' ' LEU . . . -155.25 73.4 0.25 Allowed Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 108.205 -1.958 . . . . 0.0 108.205 -176.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.38 62.62 0.63 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.7 154.19 28.77 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.821 -1.081 . . . . 0.0 112.659 -164.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.4 m -83.99 144.86 28.85 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.72 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -131.4 153.37 49.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.302 1.041 . . . . 0.0 109.569 171.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.07 109.53 11.97 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 171.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.48 HG11 ' CD2' ' A' ' 95' ' ' PHE . 2.7 t -95.57 63.62 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.46 0.062 0 C-N-CA 122.769 0.427 . . . . 0.0 111.551 -175.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.6 t -165.54 142.5 4.63 Favored Pre-proline 0 N--CA 1.454 -0.231 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.929 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -65.8 -39.34 20.46 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 N-CA-C 107.983 -1.583 . . . . 0.0 107.983 167.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 7.9 ptp 179.81 -74.92 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.42 2.288 . . . . 0.0 107.739 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.01 98.08 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 124.8 1.24 . . . . 0.0 113.273 -164.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.6 -101.67 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.743 -164.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.93 -65.44 0.33 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 123.329 0.49 . . . . 0.0 112.065 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -44.34 -51.26 8.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.449 1.5 . . . . 0.0 111.207 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -73.64 11.14 0.88 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.475 1.11 . . . . 0.0 113.893 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.48 ' CD2' HG11 ' A' ' 86' ' ' VAL . 8.8 t80 -82.7 128.77 34.68 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 119.157 0.889 . . . . 0.0 109.741 172.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -81.02 122.8 27.75 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.494 176.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 80.0 tttt 73.12 57.93 0.11 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.28 1.432 . . . . 0.0 110.546 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.4 p -58.4 -31.27 42.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.209 1.004 . . . . 0.0 113.006 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -152.74 175.2 13.1 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 171.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 12.2 t -163.95 165.51 22.55 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -67.96 165.37 17.92 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 167.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 75.1 m 61.43 67.51 0.78 Allowed 'General case' 0 C--O 1.23 0.044 0 C-N-CA 124.163 0.985 . . . . 0.0 110.425 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -54.58 134.46 46.65 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.9 p -64.29 -66.44 0.54 Allowed 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.213 1.005 . . . . 0.0 109.958 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -68.37 146.92 52.8 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.824 0.85 . . . . 0.0 109.29 175.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.0 t -160.04 -71.28 0.07 Allowed 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -175.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.2 t -156.3 140.56 16.58 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.019 1.328 . . . . 0.0 108.701 -169.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.433 HD11 ' HB2' ' A' ' 114' ' ' MET . 88.5 mt -148.69 146.34 28.1 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 118.581 0.628 . . . . 0.0 110.237 176.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -77.98 165.86 47.64 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 126.112 1.765 . . . . 0.0 110.783 168.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.75 80.01 2.14 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 124.493 3.462 . . . . 0.0 112.278 -166.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 159.38 -34.23 0.47 Allowed Glycine 0 CA--C 1.522 0.515 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.783 172.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.49 153.43 31.37 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -152.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.6 mp0 -91.2 107.23 19.06 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.764 2.425 . . . . 0.0 109.762 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.433 ' HB2' HD11 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -85.4 132.64 34.19 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 160.259 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -145.46 139.05 26.58 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 161.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 14.8 mmt -143.47 142.36 20.98 Favored Pre-proline 0 N--CA 1.453 -0.28 0 C-N-CA 124.262 1.025 . . . . 0.0 108.51 -168.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.01 147.37 38.47 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.504 2.136 . . . . 0.0 109.853 169.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.1 t -124.56 157.37 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 163.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 p -136.17 143.56 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -157.09 131.81 8.74 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -167.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.594 ' CD1' HG23 ' A' ' 63' ' ' THR . 14.3 p90 -156.36 126.63 6.57 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.207 0.912 . . . . 0.0 108.654 173.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.1 t -76.85 142.92 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 119.127 -0.463 . . . . 0.0 110.151 -174.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -81.07 129.33 67.65 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 119.14 -0.457 . . . . 0.0 110.748 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -57.13 -20.1 36.51 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.335 2.023 . . . . 0.0 113.985 176.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -53.21 -22.29 6.46 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 120.068 1.304 . . . . 0.0 111.67 172.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.6 tt -49.69 -43.76 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 O-C-N 121.697 -0.627 . . . . 0.0 111.892 169.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.9 m -84.4 57.25 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 119.791 1.178 . . . . 0.0 110.753 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -127.07 -68.31 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 118.028 -0.987 . . . . 0.0 112.516 169.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -79.94 157.66 23.97 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 121.965 1.777 . . . . 0.0 114.09 -166.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 95.2 t -53.79 -34.18 24.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.725 1.61 . . . . 0.0 110.827 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -37.12 -53.92 1.0 Allowed 'General case' 0 C--N 1.338 0.103 0 C-N-CA 126.301 1.84 . . . . 0.0 112.194 172.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 19.2 p -107.01 -56.1 2.24 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -164.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 29.17 53.12 0.09 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 128.108 2.563 . . . . 0.0 115.271 171.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 136.12 -35.32 2.15 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -174.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.0 mm -52.92 115.75 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 123.187 0.595 . . . . 0.0 110.573 170.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 31.0 pttt -156.93 62.95 0.51 Allowed 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.786 170.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.4 m -142.97 96.69 2.97 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 160.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.26 83.06 4.53 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -172.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.12 123.29 26.19 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -168.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.0 tt -98.11 103.67 15.63 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.9 t -84.74 100.22 11.36 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 170.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.85 136.17 33.15 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 172.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.6 m -124.82 87.46 2.72 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.672 0.749 . . . . 0.0 109.437 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.63 ' CD2' HD13 ' A' ' 45' ' ' LEU . 2.3 m-85 -72.59 88.88 1.27 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.838 175.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -154.43 52.4 0.75 Allowed Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 117.209 2.3 . . . . 0.0 117.209 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.404 ' HD3' HD12 ' A' ' 45' ' ' LEU . 59.7 Cg_endo -75.2 -87.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.962 2.441 . . . . 0.0 112.565 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 57.7 mtm180 -149.98 126.51 10.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.008 0.822 . . . . 0.0 110.437 -175.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -108.04 135.79 19.84 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 125.038 1.335 . . . . 0.0 108.801 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -72.44 -67.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.443 2.095 . . . . 0.0 110.717 171.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.3 m -175.47 91.24 0.05 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.602 1.961 . . . . 0.0 108.484 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.492 0 CA-C-N 118.315 0.507 . . . . 0.0 110.517 173.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.8 p . . . . . 0 C--O 1.234 0.266 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -75.75 61.15 1.37 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.279 0.945 . . . . 0.0 109.287 170.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 156.11 168.98 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.277 1 C-N-CA 131.99 4.116 . . . . 0.0 107.676 172.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -144.06 15.46 1.71 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.299 0.64 . . . . 0.0 112.154 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.03 22.01 0.41 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 128.53 2.732 . . . . 0.0 114.798 -159.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -76.64 -36.34 57.44 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 152.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 mp -92.21 -103.82 0.11 Allowed 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 125.89 1.676 . . . . 0.0 109.305 175.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.2 mt 31.95 71.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 126.613 1.965 . . . . 0.0 113.818 -172.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -79.4 157.16 27.65 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.779 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -81.76 78.14 8.52 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 122.566 1.174 . . . . 0.0 109.91 -176.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.694 ' HB3' HD11 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -137.42 -172.13 3.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.037 -1.892 . . . . 0.0 107.077 168.088 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -138.65 138.41 37.78 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.127 1.371 . . . . 0.0 110.187 171.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.44 HG23 HG13 ' A' ' 58' ' ' VAL . 5.0 tp -124.24 113.31 36.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.521 1.528 . . . . 0.0 108.457 -176.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -83.74 149.45 26.45 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 138' ' ' LEU . 27.9 t -146.73 89.14 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 118.924 0.784 . . . . 0.0 109.154 -174.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.5 m -75.56 106.3 7.03 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.616 1.166 . . . . 0.0 108.467 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.457 ' CZ ' HD12 ' A' ' 56' ' ' ILE . 2.8 m-30 -81.52 159.61 24.12 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.252 1.421 . . . . 0.0 109.902 174.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -142.46 87.56 2.02 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.92 0.867 . . . . 0.0 112.034 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.26 126.82 35.36 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.37 -0.831 . . . . 0.0 110.897 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -130.67 149.7 52.2 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.941 1.296 . . . . 0.0 109.066 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.9 p -139.28 146.77 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 C-N-CA 124.714 1.206 . . . . 0.0 108.807 175.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.55 174.61 12.33 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.104 0.961 . . . . 0.0 110.004 -177.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.4 115.21 1.35 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 168.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 139.79 -34.51 2.02 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 108.934 -1.667 . . . . 0.0 108.934 -167.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.552 HD12 ' CD ' ' A' ' 146' ' ' PRO . 0.6 OUTLIER -140.45 94.46 8.44 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 123.521 0.729 . . . . 0.0 109.126 173.654 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.486 ' HD2' HG21 ' A' ' 78' ' ' THR . 58.0 Cg_endo -80.33 50.82 3.67 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 124.086 3.191 . . . . 0.0 109.409 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.489 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 35.5 m0 -116.96 148.64 41.23 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.427 1.091 . . . . 0.0 109.831 -168.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -75.09 89.83 2.48 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 104.781 -2.303 . . . . 0.0 104.781 173.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -113.08 118.68 35.45 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.213 1.805 . . . . 0.0 107.465 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.6 m -137.97 144.79 45.32 Favored Pre-proline 0 CA--C 1.53 0.192 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -177.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.23 162.4 38.69 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.992 1.795 . . . . 0.0 108.648 166.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.51 -51.38 12.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 123.207 0.603 . . . . 0.0 110.204 176.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -127.74 159.03 36.01 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 168.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.7 tpt180 -62.29 -39.93 94.58 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 167.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.63 144.97 44.33 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 123.941 0.896 . . . . 0.0 109.448 -171.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.503 HD11 HG21 ' A' ' 66' ' ' ILE . 70.2 mt -105.88 152.45 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 C-N-CA 126.057 1.743 . . . . 0.0 106.532 170.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -126.76 87.41 2.65 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.396 1.078 . . . . 0.0 108.599 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.44 HG13 HG23 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -90.08 151.27 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.412 ' O ' HD13 ' A' ' 60' ' ' ILE . 19.3 mmt180 -59.44 -103.87 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.861 -1.149 . . . . 0.0 109.411 164.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.694 HD11 ' HB3' ' A' ' 31' ' ' GLU . 26.2 mm -148.76 43.6 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 126.389 1.876 . . . . 0.0 106.123 -172.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.62 -7.88 5.56 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 116.087 -0.506 . . . . 0.0 113.712 -174.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -51.04 105.58 0.11 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.05 1.34 . . . . 0.0 109.588 171.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.94 106.55 0.72 Allowed 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.473 1.509 . . . . 0.0 109.304 175.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -105.23 137.36 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 173.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.13 123.99 29.46 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 173.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.503 HG21 HD11 ' A' ' 56' ' ' ILE . 1.6 pp -123.63 111.74 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 164.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.409 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 0.7 OUTLIER -76.21 158.14 31.94 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.947 172.742 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -129.92 147.09 51.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 173.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.26 141.64 30.91 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 167.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.03 78.57 0.97 Allowed 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 122.192 0.996 . . . . 0.0 109.657 165.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -112.29 141.87 45.48 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.075 -155.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.489 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 22.6 t-20 -78.72 125.78 29.83 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.226 0.921 . . . . 0.0 112.751 -173.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.5 mt -127.49 53.13 1.77 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.344 1.457 . . . . 0.0 109.251 167.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -113.61 167.25 10.76 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 126.466 1.907 . . . . 0.0 110.712 -177.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.7 m -80.22 -22.77 41.45 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.4 1.08 . . . . 0.0 110.85 173.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.0 p -147.6 164.55 22.14 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 125.768 1.627 . . . . 0.0 107.758 -167.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.31 122.63 10.64 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.351 1.367 . . . . 0.0 110.21 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.486 HG21 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -81.59 177.08 9.14 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.477 0.656 . . . . 0.0 109.734 173.16 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.1 t -110.48 156.71 20.47 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 161.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -149.45 81.17 0.19 Allowed Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 106.473 -2.651 . . . . 0.0 106.473 -174.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.91 60.46 1.37 Allowed 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 168.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.7 167.3 3.66 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.258 -177.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 39.2 m -98.86 152.64 19.52 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -148.4 151.98 36.2 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 164.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.99 122.66 48.29 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 170.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.0 p -104.47 55.21 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 C-N-CA 123.733 0.813 . . . . 0.0 111.851 -164.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.9 t -178.79 147.9 0.55 Allowed Pre-proline 0 C--N 1.333 -0.139 0 O-C-N 121.068 -1.02 . . . . 0.0 109.895 -166.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.8 -34.01 41.57 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 N-CA-C 108.9 -1.231 . . . . 0.0 108.9 166.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.0 ptp 177.62 -72.41 0.01 OUTLIER 'General case' 0 C--N 1.342 0.241 0 C-N-CA 126.764 2.026 . . . . 0.0 107.846 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.43 -31.49 67.28 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 124.39 1.076 . . . . 0.0 113.677 -162.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.44 -102.54 0.07 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.452 0.168 . . . . 0.0 111.415 -164.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.7 -59.0 0.2 Allowed Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.566 1.079 . . . . 0.0 113.611 -173.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -45.94 -52.33 11.81 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.129 0.965 . . . . 0.0 110.205 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -74.71 13.25 0.66 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.964 1.706 . . . . 0.0 114.027 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -83.15 128.16 34.24 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 169.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . 0.319 2.2 m-80 -81.19 61.65 4.81 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-O 122.396 1.093 . . . . 0.0 111.887 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -73.84 125.25 27.74 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 164.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.7 p -168.99 143.17 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 127.448 2.299 . . . . 0.0 105.155 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 29.5 62.69 0.15 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.476 1.91 . . . . 0.0 113.251 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -179.0 -37.52 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.479 1.112 . . . . 0.0 110.361 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -39.32 -32.85 0.12 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.564 2.346 . . . . 0.0 115.959 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 44.2 t -48.94 140.03 9.41 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.921 0.888 . . . . 0.0 112.331 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -62.66 79.44 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.57 1.148 . . . . 0.0 111.502 175.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.0 t -71.27 64.39 0.38 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.124 1.77 . . . . 0.0 110.516 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -150.05 -66.31 0.21 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.833 1.653 . . . . 0.0 107.352 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . 0.352 10.1 t 57.84 -81.7 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 126.713 2.005 . . . . 0.0 113.563 171.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -160.92 148.07 15.36 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 -176.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 73.4 mt -148.48 133.27 17.95 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 175.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -63.44 159.62 49.1 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 126.793 2.037 . . . . 0.0 111.403 174.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -64.2 92.24 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.275 3.317 . . . . 0.0 112.415 -169.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 125.17 -6.1 8.2 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 124.725 1.155 . . . . 0.0 112.618 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -76.44 130.0 37.36 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 118.822 1.311 . . . . 0.0 111.845 -166.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -94.62 101.32 13.18 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.257 1.423 . . . . 0.0 110.05 -168.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 17.6 ttt -103.93 124.19 48.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.443 1.497 . . . . 0.0 109.765 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.14 153.06 41.74 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 156.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 42.8 mtm -155.06 151.32 22.72 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 123.214 0.606 . . . . 0.0 110.83 168.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 67' ' ' MET . 70.2 Cg_exo -53.65 138.7 67.5 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 124.653 3.568 . . . . 0.0 112.39 162.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.6 t -119.49 151.39 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 157.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.8 p -112.14 143.52 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 124.002 0.921 . . . . 0.0 108.542 175.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -156.06 151.82 27.29 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.084 0.402 . . . . 0.0 111.916 -171.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -157.98 170.2 22.86 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.296 1.838 . . . . 0.0 109.029 165.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.413 ' HB ' HG21 ' A' ' 33' ' ' ILE . 88.5 t -92.84 146.93 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 170.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -88.01 126.11 62.16 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-O 118.676 -0.678 . . . . 0.0 111.339 174.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -60.23 -16.01 37.97 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.339 2.026 . . . . 0.0 113.806 174.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -49.01 -25.78 2.18 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 119.877 1.217 . . . . 0.0 111.147 166.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 10.9 tt -53.5 -43.02 51.71 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 O-C-N 121.133 -0.979 . . . . 0.0 112.914 172.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.1 m -84.87 53.48 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 119.753 1.16 . . . . 0.0 110.025 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -134.7 -67.03 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 117.693 -1.146 . . . . 0.0 112.337 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.6 154.46 31.0 Favored 'Trans proline' 0 C--N 1.347 0.492 0 CA-C-N 122.024 1.759 . . . . 0.0 113.467 -170.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 96.3 t -55.11 -33.89 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 125.478 1.511 . . . . 0.0 110.928 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -36.53 -55.52 0.84 Allowed 'General case' 0 C--N 1.339 0.124 0 C-N-CA 126.246 1.818 . . . . 0.0 112.238 173.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 17.4 p -104.22 -56.06 2.26 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -164.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 26.51 52.02 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 128.789 2.836 . . . . 0.0 115.329 170.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 141.66 -36.49 1.7 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -173.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 12.8 mm -51.87 121.26 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.124 0.57 . . . . 0.0 110.089 172.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -157.21 57.2 0.51 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.018 0.527 . . . . 0.0 111.659 177.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.7 m -149.08 90.8 1.78 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 161.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.55 ' O ' HG13 ' A' ' 35' ' ' VAL . 2.5 tp -84.52 87.77 7.27 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.789 -161.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.9 t -79.77 175.17 10.86 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 122.278 1.037 . . . . 0.0 110.697 -171.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.8 tt -143.83 105.49 4.31 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 103.873 -2.64 . . . . 0.0 103.873 164.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.4 p -86.95 100.16 12.39 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 174.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.66 130.9 44.63 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 126.209 1.804 . . . . 0.0 108.284 -176.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.7 m -125.52 90.34 3.2 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.564 1.145 . . . . 0.0 109.608 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.513 ' CG ' HD13 ' A' ' 45' ' ' LEU . 2.0 m-30 -69.3 88.11 0.44 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.421 0.688 . . . . 0.0 110.125 171.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.07 44.46 0.34 Allowed Pre-proline 0 CA--C 1.553 1.082 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 176.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.552 ' CD ' HD12 ' A' ' 45' ' ' LEU . 58.0 Cg_endo -73.97 -82.98 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.593 2.195 . . . . 0.0 113.482 -177.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 42.0 mmt180 -149.63 123.4 9.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.362 0.983 . . . . 0.0 110.332 -171.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.91 116.79 61.94 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 125.29 1.436 . . . . 0.0 109.234 -174.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.482 ' HD3' HG23 ' A' ' 78' ' ' THR . 83.8 Cg_endo -84.25 -36.03 0.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.051 2.501 . . . . 0.0 113.421 -176.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.3 t 158.62 138.33 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 128.055 2.542 . . . . 0.0 107.848 -169.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.279 0 C-N-CA 127.132 2.173 . . . . 0.0 107.755 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 CA--C 1.54 0.595 0 CA-C-O 120.854 0.359 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 36.12 44.01 0.24 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.863 1.665 . . . . 0.0 111.162 -159.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -152.91 171.11 18.82 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 129.872 3.269 . . . . 0.0 102.787 163.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -140.49 116.69 10.57 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 103.471 -2.789 . . . . 0.0 103.471 169.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.4 m -152.46 35.09 0.51 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.16 0.981 . . . . 0.0 110.347 177.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -159.33 -56.41 0.06 Allowed 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 127.993 2.517 . . . . 0.0 106.482 -157.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.7 pp -91.74 -7.51 49.48 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.134 1.374 . . . . 0.0 112.585 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.4 mt -72.2 104.19 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.222 0 CA-C-N 119.386 0.994 . . . . 0.0 110.035 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -95.24 171.42 8.73 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 155.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -80.73 30.51 0.31 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -163.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -83.02 111.2 18.64 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 122.77 1.271 . . . . 0.0 110.758 177.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -74.59 91.52 2.33 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 127.08 2.152 . . . . 0.0 106.165 171.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.8 tp -100.24 123.46 53.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.205 1.002 . . . . 0.0 108.835 -177.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -84.42 148.79 26.4 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.183 0.993 . . . . 0.0 108.962 -175.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.2 t -134.25 146.82 30.63 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.3 m -146.75 105.32 3.81 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -169.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -76.17 163.57 26.94 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.729 0.812 . . . . 0.0 110.02 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -136.36 85.53 2.15 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 122.678 1.227 . . . . 0.0 110.222 166.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.99 99.3 6.01 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 177.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -92.84 146.88 23.31 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.7 t -128.91 136.75 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 168.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -124.3 162.2 24.27 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -43.18 -44.22 5.04 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.025 0.93 . . . . 0.0 111.043 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -48.06 -30.72 7.63 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 126.77 2.128 . . . . 0.0 115.323 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.447 HD13 ' CD2' ' A' ' 144' ' ' PHE . 1.3 tt -121.99 101.75 41.58 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 120.478 2.139 . . . . 0.0 110.495 -178.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -85.51 38.68 0.65 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 124.114 3.21 . . . . 0.0 112.192 -171.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.45 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 42.5 m0 -114.74 140.83 48.57 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -177.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -79.97 80.43 6.38 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -175.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -85.11 94.59 8.89 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.6 m -88.09 135.46 33.28 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.54 156.25 66.39 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 N-CA-C 108.686 -1.313 . . . . 0.0 108.686 165.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -79.76 -59.7 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -176.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 -128.22 168.3 15.65 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 157.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -62.99 -43.15 99.57 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 170.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -139.65 165.42 27.3 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 126.37 1.868 . . . . 0.0 109.546 -164.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.6 pt -138.95 177.22 5.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 171.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -124.33 159.2 30.85 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 150.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -129.43 143.38 41.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 173.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.5 mmt85 -79.44 97.16 6.28 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 161.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.4 pt -4.86 79.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 127.442 2.297 . . . . 0.0 114.978 -172.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.53 -37.11 2.03 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.717 -0.49 . . . . 0.0 112.593 -175.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -41.95 107.83 0.08 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.187 1.395 . . . . 0.0 111.911 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.37 105.2 2.09 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.695 0.798 . . . . 0.0 109.844 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.25 177.65 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.732 0.777 . . . . 0.0 110.079 177.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -145.04 89.65 1.98 Allowed 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.016 0.926 . . . . 0.0 108.626 172.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.3 pp -110.01 117.37 54.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 32.6 mtm -92.48 111.82 23.54 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.469 1.908 . . . . 0.0 111.927 -177.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -84.59 154.89 22.32 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.137 0.575 . . . . 0.0 109.739 174.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.2 ttm-85 -134.54 138.96 45.06 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.679 1.591 . . . . 0.0 108.021 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.8 106.82 4.7 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.794 1.638 . . . . 0.0 110.201 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER -112.52 129.45 56.35 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.044 0.537 . . . . 0.0 112.22 -174.057 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.45 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 36.2 t-20 -77.9 115.1 17.38 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.486 0.585 . . . . 0.0 111.379 -167.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 69.6 mt -107.95 39.1 2.02 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.688 1.195 . . . . 0.0 111.35 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -111.36 173.27 6.42 Favored 'General case' 0 CA--C 1.526 0.029 0 C-N-CA 124.263 1.025 . . . . 0.0 110.037 169.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.3 p -89.05 -5.47 57.86 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 125.048 1.339 . . . . 0.0 111.829 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 p -140.76 162.94 46.1 Favored Pre-proline 0 N--CA 1.449 -0.476 0 C-N-CA 124.618 1.167 . . . . 0.0 109.37 -171.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.96 111.0 3.06 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.16 1.907 . . . . 0.0 109.249 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.26 177.68 8.65 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.036 0.835 . . . . 0.0 109.569 174.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.9 t -124.17 137.26 54.56 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 165.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.05 117.61 4.19 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.804 1.669 . . . . 0.0 109.586 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.75 47.39 2.54 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 124.634 1.173 . . . . 0.0 108.566 175.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.2 144.52 15.64 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.15 -174.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.7 t -87.39 175.26 8.07 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 119.583 -0.847 . . . . 0.0 108.738 166.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -155.13 89.42 1.21 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -161.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -78.79 90.53 4.66 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.2 t -79.35 59.18 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 123.323 0.649 . . . . 0.0 110.965 -175.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.3 t -174.79 148.97 1.22 Allowed Pre-proline 0 N--CA 1.465 0.312 0 CA-C-N 119.505 1.048 . . . . 0.0 112.595 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -57.92 -52.75 5.36 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 121.627 1.551 . . . . 0.0 109.205 158.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.42 -83.64 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.345 1.858 . . . . 0.0 107.42 177.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.49 ' HB3' HG13 ' A' ' 135' ' ' ILE . . . -59.03 -32.15 69.48 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -172.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.56 -109.6 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -168.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.08 -51.9 1.68 Allowed Glycine 0 CA--C 1.53 0.981 0 O-C-N 121.506 -0.746 . . . . 0.0 113.051 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -52.95 -58.62 6.36 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.651 1.226 . . . . 0.0 109.16 170.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -74.19 49.04 0.34 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.993 1.317 . . . . 0.0 111.611 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -126.48 130.85 51.44 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 173.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -138.97 106.45 5.56 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 174.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -88.79 -80.88 0.28 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 150.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.7 p -151.62 65.68 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.618 1.167 . . . . 0.0 108.146 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 62.74 173.39 0.14 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.47 1.108 . . . . 0.0 110.332 -167.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 46.7 t -79.24 55.53 1.88 Allowed 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.489 -0.757 . . . . 0.0 109.869 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -83.65 105.23 14.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 9.9 p -61.6 154.64 24.43 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 172.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -155.69 161.36 40.77 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 175.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.5 p -142.96 122.59 13.29 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -170.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.8 mp0 -77.61 45.9 0.51 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.883 1.273 . . . . 0.0 112.999 -169.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.1 t 39.25 -133.2 0.18 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.564 1.946 . . . . 0.0 113.06 168.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.2 t -125.34 153.65 43.0 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.621 1.968 . . . . 0.0 108.833 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.442 HD11 ' HB2' ' A' ' 114' ' ' MET . 81.9 mt -136.96 123.35 20.73 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 176.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -58.8 154.71 35.32 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 171.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.71 94.58 0.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.996 3.131 . . . . 0.0 111.3 -170.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 137.8 -26.85 2.85 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 124.536 1.065 . . . . 0.0 110.873 -173.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -78.28 154.1 31.23 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 117.664 0.732 . . . . 0.0 111.264 -166.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -117.51 133.97 55.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.428 1.091 . . . . 0.0 110.651 -174.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.442 ' HB2' HD11 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -99.15 142.09 31.08 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 127.034 2.134 . . . . 0.0 106.815 169.639 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -146.98 133.31 19.54 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.202 1.401 . . . . 0.0 107.286 172.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 79.7 mtp -147.3 135.97 11.23 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 118.207 0.458 . . . . 0.0 110.937 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -73.34 147.27 41.47 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.735 2.29 . . . . 0.0 109.92 168.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.2 t -129.41 124.52 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 168.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.1 p -88.11 151.66 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 166.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -157.96 135.87 10.68 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -175.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -146.06 159.75 42.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.379 0.672 . . . . 0.0 110.249 153.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 39.4 t -100.78 119.24 48.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 169.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.37 139.62 78.67 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -74.05 29.46 0.33 Allowed 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.591 2.861 . . . . 0.0 114.297 -176.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -87.26 -24.58 24.32 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.426 1.09 . . . . 0.0 110.382 170.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 17.0 tt -56.09 -44.9 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 118.153 0.433 . . . . 0.0 112.053 -176.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.4 m -80.61 56.32 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 O-C-N 121.513 -0.742 . . . . 0.0 110.452 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 49.6 mttp -139.52 -67.03 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.608 0 CA-C-O 117.715 -1.136 . . . . 0.0 112.247 174.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.96 156.94 30.79 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.02 1.813 . . . . 0.0 113.539 -169.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 86.2 t -55.09 -35.09 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 125.495 1.518 . . . . 0.0 110.808 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -36.39 -56.75 0.77 Allowed 'General case' 0 C--N 1.338 0.1 0 C-N-CA 126.109 1.763 . . . . 0.0 111.908 174.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.2 p -102.62 -54.22 2.7 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.441 -164.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 22.11 53.6 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 128.932 2.893 . . . . 0.0 115.019 173.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 146.45 -41.45 0.99 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 -170.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.49 HG13 ' HB3' ' A' ' 90' ' ' ALA . 19.3 mm -58.09 119.62 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 169.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.02 39.29 0.31 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.86 0.362 . . . . 0.0 111.232 -178.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.4 94.49 1.71 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 177.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.58 147.02 32.27 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -169.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.5 t -136.5 172.44 13.01 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.0 tt -145.3 114.77 7.17 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 103.38 -2.822 . . . . 0.0 103.38 171.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.72 102.62 15.03 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 177.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -86.03 87.89 7.49 Favored 'General case' 0 CA--C 1.527 0.069 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.82 89.4 5.24 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 122.665 1.221 . . . . 0.0 110.596 177.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.447 ' CD2' HD13 ' A' ' 45' ' ' LEU . 4.0 m-30 -69.05 80.77 0.32 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.836 1.654 . . . . 0.0 110.46 175.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -125.86 84.21 61.35 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 125.446 1.499 . . . . 0.0 113.813 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -105.45 -118.82 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.931 1 C-N-CA 125.988 4.459 . . . . 0.0 109.643 168.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -143.59 149.14 36.93 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 123.674 0.789 . . . . 0.0 109.728 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -144.85 143.67 21.73 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 126.531 1.933 . . . . 0.0 106.445 -176.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -87.19 -51.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.592 2.195 . . . . 0.0 111.727 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.5 m 167.07 101.58 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 128.947 2.899 . . . . 0.0 107.364 -176.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt . . . . . 0 CA--C 1.544 0.723 0 C-N-CA 123.877 0.871 . . . . 0.0 109.505 -176.581 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.3 m . . . . . 0 CA--C 1.535 0.398 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.405 ' OE2' ' NZ ' ' A' ' 97' ' ' LYS . 10.5 tt0 41.69 56.72 3.27 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.376 1.47 . . . . 0.0 111.183 -177.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -140.66 162.25 35.83 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.669 1.588 . . . . 0.0 110.045 -173.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.462 ' HB2' ' OG1' ' A' ' 63' ' ' THR . . . -147.1 67.61 1.15 Allowed 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.859 1.664 . . . . 0.0 107.701 -177.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.9 t -164.94 34.63 0.06 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.855 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -160.13 -51.14 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -167.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.6 mp -77.95 -27.82 49.38 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.616 -172.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.0 mt -70.73 129.07 34.71 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.062 0 C-N-CA 123.897 0.879 . . . . 0.0 112.881 -156.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.15 162.97 14.38 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.819 1.248 . . . . 0.0 108.467 172.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -80.8 74.36 7.76 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 122.177 0.989 . . . . 0.0 110.205 -176.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.25 -174.19 4.22 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.909 1.684 . . . . 0.0 107.608 174.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.3 mtmt -126.83 156.3 41.54 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.882 1.273 . . . . 0.0 108.093 162.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 tp -137.28 155.5 32.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 162.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.35 156.01 30.86 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.409 1.084 . . . . 0.0 108.671 -167.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.511 HG21 ' CE1' ' A' ' 120' ' ' PHE . 4.7 t -139.08 142.11 34.62 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.6 m -136.43 106.03 6.15 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -173.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -85.68 93.47 8.85 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.389 2.276 . . . . 0.0 110.427 -174.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -79.96 85.96 5.52 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 174.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.88 110.74 19.63 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.196 0.598 . . . . 0.0 111.039 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -111.85 153.78 26.13 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.653 1.181 . . . . 0.0 109.986 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.4 p -144.71 147.03 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.416 1.086 . . . . 0.0 108.977 173.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -159.34 170.67 21.31 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.914 0.885 . . . . 0.0 109.896 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -37.7 113.11 0.25 Allowed 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.841 1.656 . . . . 0.0 110.25 171.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 135.46 -39.21 1.7 Allowed Glycine 0 CA--C 1.523 0.557 0 N-CA-C 108.235 -1.946 . . . . 0.0 108.235 -165.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.405 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 1.7 mt -139.96 111.32 7.33 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 125.089 1.355 . . . . 0.0 107.375 169.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.93 8.04 4.7 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.793 2.328 . . . . 0.0 111.512 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.405 ' CD2' ' CD2' ' A' ' 45' ' ' LEU . 38.8 m0 -77.34 139.72 39.82 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.214 -0.929 . . . . 0.0 109.914 -165.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -78.63 84.7 4.72 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -83.91 93.05 7.94 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 127.172 2.189 . . . . 0.0 109.003 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.5 m -88.31 127.17 58.05 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -176.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -68.18 143.38 58.91 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 N-CA-C 108.226 -1.49 . . . . 0.0 108.226 164.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.2 m -77.74 -49.51 21.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.284 0.564 . . . . 0.0 109.982 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -130.31 162.43 29.03 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 164.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -62.69 -41.42 99.11 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 165.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -149.6 166.86 28.01 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 124.28 1.032 . . . . 0.0 110.87 -160.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.4 pt -137.78 154.71 29.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 124.807 1.243 . . . . 0.0 108.708 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -89.39 143.79 26.55 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 156.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.0 m -128.1 130.54 69.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 162.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -63.66 76.28 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.168 1.387 . . . . 0.0 108.802 172.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.5 mm 60.04 -74.46 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 126.162 1.785 . . . . 0.0 111.146 -172.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -131.14 62.8 0.64 Allowed Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 -176.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -102.38 105.84 16.5 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.131 1.372 . . . . 0.0 110.236 -175.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.462 ' OG1' ' HB2' ' A' ' 24' ' ' ALA . 50.2 m -69.94 88.86 0.58 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.366 1.466 . . . . 0.0 110.131 -171.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.5 p -98.81 147.99 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 121.262 0.553 . . . . 0.0 110.775 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.88 126.82 35.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.699 1.6 . . . . 0.0 108.981 173.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.6 pp -130.12 112.18 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 164.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.74 176.42 9.35 Favored 'General case' 0 C--N 1.333 -0.125 0 O-C-N 121.741 -0.599 . . . . 0.0 110.709 168.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -137.48 156.88 47.64 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 169.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 59.9 mtp85 -120.11 131.6 55.11 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 169.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.34 109.25 10.95 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.485 1.114 . . . . 0.0 109.286 174.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -96.54 124.82 40.66 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 119.011 -0.519 . . . . 0.0 110.081 -172.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -78.77 88.27 4.63 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -169.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.9 mt -78.04 65.93 3.55 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.166 0.986 . . . . 0.0 109.945 171.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -134.9 152.25 51.58 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.587 1.155 . . . . 0.0 109.299 173.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.8 p -91.93 -3.43 55.95 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.983 1.313 . . . . 0.0 112.399 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.9 p -142.53 166.84 18.56 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 174.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -58.61 157.48 27.33 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 CA-C-N 120.397 1.178 . . . . 0.0 111.627 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.08 177.65 5.96 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.363 1.065 . . . . 0.0 109.219 173.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 t -140.83 143.24 34.69 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -134.27 124.61 3.59 Favored Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 107.548 -2.221 . . . . 0.0 107.548 -175.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.81 55.18 1.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 166.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.51 154.37 41.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.484 -164.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.34 126.89 31.73 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.07 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -116.47 138.3 51.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 167.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -130.91 94.46 3.61 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.478 HG11 ' CE2' ' A' ' 95' ' ' PHE . 3.7 t -85.31 72.24 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 123.55 0.74 . . . . 0.0 110.153 -176.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.6 t -169.25 147.7 3.34 Favored Pre-proline 0 N--CA 1.45 -0.45 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 175.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.74 -44.91 12.14 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 N-CA-C 108.021 -1.569 . . . . 0.0 108.021 161.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 3.0 ptm -174.25 -84.12 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.806 1.642 . . . . 0.0 108.026 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.98 -31.64 71.23 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.362 1.865 . . . . 0.0 115.231 -168.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.18 -105.76 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 117.927 0.331 . . . . 0.0 111.326 -168.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.05 -58.48 0.56 Allowed Glycine 0 CA--C 1.534 1.277 0 O-C-N 121.804 -0.56 . . . . 0.0 113.171 -174.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.56 -41.67 73.61 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.193 1.497 . . . . 0.0 111.551 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -76.24 7.28 4.4 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.536 1.135 . . . . 0.0 113.893 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.478 ' CE2' HG11 ' A' ' 86' ' ' VAL . 8.8 t80 -82.5 144.69 30.25 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 165.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -97.24 109.09 21.92 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 172.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.405 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 9.4 tptp -155.65 39.71 0.39 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.457 0.703 . . . . 0.0 110.433 168.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 10.2 p -55.32 -44.87 77.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -167.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -155.76 149.51 25.19 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 170.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 14.0 t -175.89 173.21 2.33 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -172.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -47.1 134.87 10.36 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.373 0.669 . . . . 0.0 110.459 164.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 43.4 t -72.65 75.81 1.1 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.707 0.765 . . . . 0.0 110.094 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -63.23 134.87 56.61 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.623 173.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.7 t -162.9 165.9 24.6 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 169.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.476 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 1.7 pm0 -85.9 -25.35 26.2 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 127.277 2.231 . . . . 0.0 110.763 -173.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.2 t 49.76 -149.79 0.23 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.042 1.337 . . . . 0.0 112.58 170.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.71 149.32 31.79 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.824 1.65 . . . . 0.0 109.199 -177.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.8 mt -143.09 146.07 33.45 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.658 0.783 . . . . 0.0 110.219 172.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -70.08 158.67 86.82 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 129.863 3.265 . . . . 0.0 110.75 171.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.51 105.98 1.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.565 2.843 . . . . 0.0 111.936 -168.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 116.87 -7.98 16.91 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 123.933 0.778 . . . . 0.0 111.824 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -77.81 164.84 24.84 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 117.635 0.717 . . . . 0.0 111.216 -175.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -119.32 126.45 51.47 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.584 0.754 . . . . 0.0 110.392 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 15.6 tpt -91.27 123.81 34.99 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -146.28 141.59 27.48 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 123.238 0.336 . . . . 0.0 110.507 158.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 87.2 mtp -150.42 149.65 27.0 Favored Pre-proline 0 N--CA 1.451 -0.385 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 166.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -73.32 137.32 25.61 Favored 'Trans proline' 0 N--CA 1.445 -1.343 0 C-N-CA 122.121 1.881 . . . . 0.0 111.76 172.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.4 t -99.34 150.05 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 159.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.77 138.72 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.511 ' CE1' HG21 ' A' ' 35' ' ' VAL . 3.3 t80 -152.96 137.07 16.41 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.237 0.472 . . . . 0.0 111.201 -165.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -155.78 158.9 38.92 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.275 1.83 . . . . 0.0 107.528 160.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.8 t -87.52 159.07 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 175.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -100.46 133.24 21.46 Favored Pre-proline 0 C--O 1.236 0.378 0 CA-C-N 118.692 0.678 . . . . 0.0 111.272 173.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -72.38 46.67 0.99 Allowed 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.937 2.425 . . . . 0.0 114.011 175.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.51 -7.69 11.62 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.263 1.025 . . . . 0.0 113.401 163.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.2 tt -51.65 -40.74 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 118.794 0.725 . . . . 0.0 111.068 170.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.3 m -83.2 56.26 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.331 1.052 . . . . 0.0 110.749 171.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -113.3 -79.22 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.462 0 CA-C-O 117.573 -1.204 . . . . 0.0 109.145 165.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -78.59 163.02 27.1 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.025 1.817 . . . . 0.0 111.901 -176.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.8 p -62.18 -44.29 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 123.737 0.815 . . . . 0.0 110.683 -174.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -46.34 -56.0 6.49 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.296 1.438 . . . . 0.0 111.704 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 35.0 p -88.69 -10.57 48.01 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 118.365 -0.826 . . . . 0.0 112.543 -174.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -48.07 -42.36 28.43 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.361 0.982 . . . . 0.0 111.766 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -76.65 -25.33 65.39 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 123.54 0.591 . . . . 0.0 112.612 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 24.8 mm -76.37 128.81 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 117.923 0.861 . . . . 0.0 108.84 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -156.66 56.38 0.55 Allowed 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.5 m -155.34 108.93 2.82 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 160.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.94 84.07 5.75 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -174.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.96 147.89 32.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.921 -171.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.6 tt -118.79 110.56 17.37 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.4 t -87.94 108.26 19.11 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 171.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.2 131.19 54.93 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.815 1.246 . . . . 0.0 108.112 177.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.4 m -129.47 89.84 2.9 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.423 0.63 . . . . 0.0 110.749 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -69.98 78.71 0.48 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 169.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.47 46.33 1.36 Allowed Pre-proline 0 CA--C 1.55 0.973 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 174.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.86 -89.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.222 2.614 . . . . 0.0 113.38 -176.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -157.8 112.81 2.69 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.241 -0.912 . . . . 0.0 110.487 -172.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -116.2 142.62 29.59 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 123.65 0.78 . . . . 0.0 109.465 176.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -76.4 66.56 7.19 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.914 1.742 . . . . 0.0 109.61 166.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.4 t 38.05 92.29 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 129.078 2.951 . . . . 0.0 114.846 172.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt . . . . . 0 CA--C 1.534 0.343 0 C-N-CA 123.738 0.815 . . . . 0.0 111.629 -178.421 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 CA--C 1.535 0.369 0 CA-C-O 122.205 1.002 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 36.53 39.94 0.11 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.172 1.789 . . . . 0.0 111.505 -159.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -159.36 162.61 35.9 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 169.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -127.24 140.41 52.24 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 156.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.8 p -157.38 40.66 0.3 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 122.064 0.935 . . . . 0.0 110.974 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -156.08 -52.26 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 127.297 2.239 . . . . 0.0 106.172 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.3 mt -56.93 -29.51 63.16 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.836 1.654 . . . . 0.0 111.502 174.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.2 mt -72.51 80.96 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 123.824 0.849 . . . . 0.0 110.85 -174.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.531 ' HB2' HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -74.59 -168.95 0.76 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 151.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -71.78 -42.51 67.04 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.66 1.184 . . . . 0.0 111.322 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -40.61 128.1 2.49 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.301 1.44 . . . . 0.0 114.703 -161.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -97.5 88.21 4.32 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 125.538 1.535 . . . . 0.0 107.424 -168.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -82.35 119.9 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 175.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.49 138.42 31.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 -177.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.419 ' HB ' ' CG1' ' A' ' 56' ' ' ILE . 3.8 t -121.89 147.59 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 176.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.5 m -140.43 94.27 2.72 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 -174.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -76.0 163.21 27.38 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.204 1.402 . . . . 0.0 108.983 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -146.61 88.5 1.77 Allowed 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.875 0.845 . . . . 0.0 110.583 -167.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.62 111.06 16.7 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.793 0.837 . . . . 0.0 111.025 176.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -118.21 136.74 53.46 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.5 t -132.03 143.46 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -134.93 163.54 29.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 169.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -24.79 -59.05 0.06 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 127.233 2.213 . . . . 0.0 113.242 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -32.78 -42.89 0.16 Allowed Glycine 0 CA--C 1.532 1.106 0 C-N-CA 126.774 2.13 . . . . 0.0 114.71 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.584 HD13 ' CD2' ' A' ' 144' ' ' PHE . 0.2 OUTLIER -109.15 106.62 59.0 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 118.86 1.33 . . . . 0.0 108.238 165.079 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -82.17 5.08 6.57 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.276 1.984 . . . . 0.0 112.498 -173.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.407 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 43.1 m0 -79.8 146.3 32.36 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 122.384 1.088 . . . . 0.0 111.792 -165.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -77.54 82.36 3.98 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -93.36 106.85 18.77 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.603 1.561 . . . . 0.0 108.192 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.0 m -101.44 118.92 58.92 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -70.81 166.68 28.11 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 121.186 1.257 . . . . 0.0 109.112 164.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -94.54 -58.32 3.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 C-N-CA 123.853 0.861 . . . . 0.0 110.762 -174.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -132.23 175.18 9.48 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 165.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.3 tpt85 -69.79 -43.03 72.96 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 165.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -135.98 170.08 16.57 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 125.842 1.657 . . . . 0.0 113.283 -158.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.419 ' CG1' ' HB ' ' A' ' 35' ' ' VAL . 30.6 pt -143.74 167.24 12.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 127.068 2.147 . . . . 0.0 107.502 173.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -117.92 140.85 49.14 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 161.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.4 t -131.58 129.95 62.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.651 1.58 . . . . 0.0 106.76 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.3 mmt-85 -76.35 94.84 3.67 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 168.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.531 HD11 ' HB2' ' A' ' 29' ' ' LEU . 5.6 pt -7.66 76.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 127.558 2.343 . . . . 0.0 115.806 -167.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 134.06 -27.04 3.35 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 124.558 1.075 . . . . 0.0 112.858 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -41.32 111.32 0.21 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.263 1.425 . . . . 0.0 111.65 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.49 99.67 1.65 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.17 1.388 . . . . 0.0 110.264 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.2 p -104.96 150.58 7.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 175.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.28 132.6 52.14 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.471 1.108 . . . . 0.0 109.584 178.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.1 pp -138.76 96.93 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 C-N-CA 125.008 1.323 . . . . 0.0 108.026 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.404 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 0.0 OUTLIER -78.29 166.49 22.63 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -174.272 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -134.25 149.14 50.92 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 26.3 ttt-85 -132.04 122.66 25.82 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -123.15 105.9 10.31 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.539 1.536 . . . . 0.0 109.154 174.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -95.6 131.91 41.31 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.407 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 49.3 t-20 -75.45 142.68 42.92 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.042 0.837 . . . . 0.0 109.663 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.71 -7.26 6.78 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.462 1.905 . . . . 0.0 111.68 -174.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.35 151.14 33.03 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.174 0.897 . . . . 0.0 109.29 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.7 m -84.26 14.38 4.4 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -154.2 163.64 23.41 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 175.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.8 160.64 17.29 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.09 1.86 . . . . 0.0 112.212 -175.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.24 165.22 26.66 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 123.301 0.64 . . . . 0.0 110.126 176.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.7 t -111.17 145.45 38.62 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 168.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -138.0 83.9 0.24 Allowed Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.04 -21.93 11.28 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.018 0.927 . . . . 0.0 112.119 -178.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.15 -175.97 0.12 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 165.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.5 t -124.11 168.78 12.43 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 118.214 -1.394 . . . . 0.0 107.987 141.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -148.24 88.75 1.67 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 122.726 1.251 . . . . 0.0 108.956 -166.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -78.22 88.98 4.28 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 120.847 -1.158 . . . . 0.0 107.882 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.6 p -78.75 69.48 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.473 0 C-N-CA 125.463 1.505 . . . . 0.0 110.691 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.6 t -176.53 142.05 0.55 Allowed Pre-proline 0 N--CA 1.464 0.252 0 CA-C-N 119.425 1.012 . . . . 0.0 109.736 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -67.05 -58.61 0.14 Allowed 'Trans proline' 0 N--CA 1.446 -1.314 0 N-CA-C 108.777 -1.278 . . . . 0.0 108.777 166.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 26.2 ptm -171.42 11.37 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -171.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -173.49 -51.93 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 119.163 0.892 . . . . 0.0 110.317 -162.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.25 -124.55 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.667 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.19 -44.09 1.07 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 120.417 -1.427 . . . . 0.0 112.762 -170.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.59 -58.18 4.06 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.408 1.083 . . . . 0.0 110.837 174.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -74.29 -25.1 59.39 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.258 1.023 . . . . 0.0 113.447 -177.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -41.04 120.68 1.39 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.745 1.218 . . . . 0.0 109.302 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -76.95 68.61 3.14 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.803 0.729 . . . . 0.0 111.422 -168.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.17 125.95 21.04 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 172.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 43.3 t -40.8 -56.2 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 125.551 1.54 . . . . 0.0 110.992 -165.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -111.14 -85.52 0.56 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 170.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 48.8 t -171.65 -39.55 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.229 1.011 . . . . 0.0 111.255 -172.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -58.44 158.98 6.77 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.353 0.661 . . . . 0.0 111.975 -177.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 5.1 p -64.0 164.37 10.62 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.292 1.037 . . . . 0.0 111.963 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -93.4 122.45 35.84 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 174.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.6 m -162.35 102.7 1.09 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.017 0.927 . . . . 0.0 109.086 -176.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -73.38 54.33 0.43 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.567 1.147 . . . . 0.0 112.285 172.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.0 t 40.85 -131.51 0.37 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.538 1.535 . . . . 0.0 113.315 165.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.0 t -132.16 147.89 52.45 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.067 2.147 . . . . 0.0 108.167 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.402 HD11 ' HB2' ' A' ' 114' ' ' MET . 95.1 mt -134.19 142.29 47.36 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.406 0.683 . . . . 0.0 109.883 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -68.98 164.25 49.2 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.365 1.866 . . . . 0.0 110.372 167.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.06 76.77 2.5 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 124.682 3.588 . . . . 0.0 112.735 -169.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 153.71 -21.22 0.7 Allowed Glycine 0 CA--C 1.521 0.433 0 CA-C-O 119.357 -0.691 . . . . 0.0 113.285 169.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.9 155.67 32.66 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 118.14 0.97 . . . . 0.0 111.772 -159.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -106.44 101.45 10.91 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.89 1.276 . . . . 0.0 110.887 -165.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.402 ' HB2' HD11 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -83.79 85.81 7.24 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.136 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -106.64 105.11 14.98 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.862 1.265 . . . . 0.0 108.851 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 46.7 mtt -146.87 141.49 16.09 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 119.729 1.15 . . . . 0.0 112.936 -174.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 67' ' ' MET . 95.3 Cg_endo -83.87 145.51 11.37 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.138 2.559 . . . . 0.0 113.622 176.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 24.1 t -117.8 150.81 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 126.403 1.881 . . . . 0.0 106.512 170.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.2 m -118.74 147.44 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.868 1.267 . . . . 0.0 108.301 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -157.55 159.16 36.85 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.629 0.65 . . . . 0.0 112.747 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -163.17 158.19 21.43 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 126.661 1.984 . . . . 0.0 108.426 166.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 29.7 t -102.29 147.35 9.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 124.699 1.199 . . . . 0.0 108.768 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -80.97 161.78 62.0 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 123.398 0.679 . . . . 0.0 110.149 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.467 ' HB3' HD12 ' A' ' 60' ' ' ILE . 87.4 Cg_endo -101.94 28.25 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.89 3.06 . . . . 0.0 112.425 166.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -84.41 -40.54 17.67 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 168.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.7 tt -39.3 -47.38 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.112 1.365 . . . . 0.0 113.681 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.8 m -79.27 55.7 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 O-C-N 121.553 -0.717 . . . . 0.0 110.627 175.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -140.99 -66.61 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.491 0 CA-C-O 117.485 -1.245 . . . . 0.0 111.711 175.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.4 158.43 44.46 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 CA-C-N 121.927 1.724 . . . . 0.0 112.54 -175.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.2 t -55.61 -46.8 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 124.7 1.2 . . . . 0.0 110.141 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -46.17 -50.33 15.77 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.985 1.314 . . . . 0.0 112.684 -175.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 27.2 p -101.52 -6.74 23.53 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -174.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -37.84 107.82 0.07 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.839 1.256 . . . . 0.0 112.152 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.03 -30.53 8.56 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.587 -1.118 . . . . 0.0 113.132 176.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 43.2 mm -58.79 129.3 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 C-N-CA 124.321 1.048 . . . . 0.0 109.863 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -158.54 49.13 0.37 Allowed 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.4 m -149.4 92.55 1.95 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 162.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.08 89.58 5.97 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -171.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 13.2 t -78.01 175.35 10.16 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 122.247 1.022 . . . . 0.0 109.383 -176.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.17 98.34 3.08 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 169.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.3 m -79.81 95.36 6.0 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 174.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -76.67 126.4 30.92 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 171.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 26.6 m -122.51 89.91 3.2 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.584 ' CD2' HD13 ' A' ' 45' ' ' LEU . 3.1 m-85 -84.83 91.34 7.98 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.155 -173.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -151.04 47.39 0.44 Allowed Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 116.876 2.176 . . . . 0.0 116.876 -175.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.2 -111.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.398 2.732 . . . . 0.0 110.763 173.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -136.05 116.49 13.71 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.693 1.133 . . . . 0.0 108.928 -168.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -93.19 143.54 26.9 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 164.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -71.54 -55.36 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.882 1.721 . . . . 0.0 108.419 167.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.6 t -177.37 126.25 0.14 Allowed 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.158 1.783 . . . . 0.0 107.791 172.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 27.4 pttt . . . . . 0 CA--C 1.537 0.474 0 C-N-CA 123.144 0.577 . . . . 0.0 111.321 160.693 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.456 -0.167 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 39.68 36.87 0.28 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.931 1.692 . . . . 0.0 112.559 -172.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 69.1 mm-40 -155.64 165.71 35.73 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 177.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -144.05 136.62 26.93 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 102.015 -3.328 . . . . 0.0 102.015 160.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.3 t -155.5 35.12 0.37 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 121.508 1.958 . . . . 0.0 111.11 176.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -160.37 -60.74 0.06 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -164.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.43 39.94 0.62 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 112.628 -2.078 . . . . 0.0 112.246 -165.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.9 mt -119.37 62.59 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 123.486 0.714 . . . . 0.0 110.688 -167.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -76.96 149.63 35.95 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.024 1.33 . . . . 0.0 109.602 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.0 54.61 1.62 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -165.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.8 98.09 7.83 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 166.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.76 81.78 5.97 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 122.125 0.964 . . . . 0.0 108.65 -168.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.292 0.0 OUTLIER -79.92 131.83 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.629 -173.173 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.97 150.66 24.73 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 126.79 2.036 . . . . 0.0 106.999 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.7 m -135.94 120.11 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.26 111.92 18.79 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 176.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -79.48 89.69 5.05 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 176.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -78.35 80.58 4.75 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 122.608 1.194 . . . . 0.0 108.019 -174.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.91 126.05 30.51 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -133.8 147.33 51.23 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.3 p -145.25 147.98 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 124.097 0.959 . . . . 0.0 108.815 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -130.3 168.46 16.86 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 166.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.48 -34.86 11.91 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.235 1.014 . . . . 0.0 111.891 -178.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -34.93 -38.8 0.14 Allowed Glycine 0 CA--C 1.532 1.11 0 C-N-CA 126.28 1.895 . . . . 0.0 113.734 169.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.758 HD13 ' CD2' ' A' ' 144' ' ' PHE . 0.6 OUTLIER -116.6 96.58 48.57 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 118.225 1.012 . . . . 0.0 108.283 163.638 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -82.92 42.55 1.31 Allowed 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 123.424 2.75 . . . . 0.0 111.332 -168.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 41.5 m0 -112.81 147.19 37.46 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 -176.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.401 ' CD ' ' HZ2' ' A' ' 71' ' ' LYS . 12.0 tt0 -77.14 80.93 3.65 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 -178.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -90.9 87.04 6.47 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 m -95.64 128.39 38.08 Favored Pre-proline 0 N--CA 1.454 -0.257 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -67.4 153.15 77.62 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 N-CA-C 107.3 -1.846 . . . . 0.0 107.3 160.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -57.96 4.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.638 0.732 . . . . 0.0 109.092 -173.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -120.06 159.09 25.48 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 103.199 -2.889 . . . . 0.0 103.199 157.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -23.01 67.09 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.946 0.794 . . . . 0.0 110.652 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -139.88 167.6 21.74 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 125.561 1.545 . . . . 0.0 109.952 -171.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.41 168.95 21.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 172.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.3 p-10 -129.84 147.62 51.63 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.339 0.656 . . . . 0.0 111.218 166.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.2 m -141.84 122.99 12.54 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.57 56.27 3.89 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 121.413 1.915 . . . . 0.0 109.999 -173.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mt 58.8 116.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 124.642 1.177 . . . . 0.0 109.004 -164.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.28 -51.74 4.42 Favored Glycine 0 CA--C 1.525 0.718 0 O-C-N 119.994 -1.691 . . . . 0.0 113.945 172.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -26.39 100.5 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.444 2.298 . . . . 0.0 112.081 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.5 p -76.89 128.2 34.13 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.722 -0.612 . . . . 0.0 110.461 -172.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 p -123.62 149.43 27.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 C-N-CA 125.268 1.427 . . . . 0.0 109.041 177.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.02 122.86 36.96 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 125.164 1.385 . . . . 0.0 107.276 164.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.7 pp -114.67 130.74 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 157.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 35.8 ttp -76.97 140.53 40.46 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 169.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -109.29 158.71 17.61 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 166.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 43.7 ttm-85 -138.13 140.93 40.13 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.353 1.461 . . . . 0.0 108.727 -175.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.7 96.72 1.78 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.12 1.768 . . . . 0.0 108.846 166.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.401 ' HZ2' ' CD ' ' A' ' 48' ' ' GLU . 4.7 mtmp? -95.09 126.11 40.21 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -79.94 121.41 25.42 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.607 1.094 . . . . 0.0 112.399 -170.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.4 mp -108.87 26.76 10.2 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.262 1.025 . . . . 0.0 111.598 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.17 171.66 14.62 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 120.987 -1.071 . . . . 0.0 112.223 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.4 p -79.47 -34.59 41.33 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.645 1.978 . . . . 0.0 110.479 170.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 66.5 p -123.99 179.84 0.99 Allowed Pre-proline 0 N--CA 1.456 -0.152 0 C-N-CA 127.149 2.18 . . . . 0.0 108.979 -174.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -54.41 161.51 5.48 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 CA-C-N 119.309 0.789 . . . . 0.0 111.345 160.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.47 173.9 10.4 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 157.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.6 t -102.85 162.11 13.19 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 151.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.603 ' HA2' HD11 ' A' ' 45' ' ' LEU . . . -151.41 60.27 0.41 Allowed Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -88.31 -39.11 14.63 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.537 0.735 . . . . 0.0 109.051 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.05 178.08 0.15 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.367 1.067 . . . . 0.0 112.841 169.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.5 m -125.87 148.09 49.28 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 173.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -137.98 160.85 38.24 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.619 0.768 . . . . 0.0 110.345 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.76 113.36 20.07 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 164.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.8 p -95.08 59.4 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 123.714 0.805 . . . . 0.0 112.127 -173.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.8 t -174.5 150.04 1.41 Allowed Pre-proline 0 C--N 1.333 -0.121 0 O-C-N 121.539 -0.725 . . . . 0.0 110.682 -175.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.21 -33.66 30.24 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 N-CA-C 108.99 -1.196 . . . . 0.0 108.99 162.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.3 ptp 174.99 -71.8 0.01 OUTLIER 'General case' 0 C--N 1.341 0.23 0 C-N-CA 127.023 2.129 . . . . 0.0 107.913 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.76 -31.02 51.78 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -163.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.33 -110.51 0.06 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.476 0.179 . . . . 0.0 111.264 -168.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.16 -56.28 0.1 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.312 0.958 . . . . 0.0 113.31 -169.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.83 -49.54 19.88 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.376 1.588 . . . . 0.0 112.287 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -72.74 -4.67 32.81 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.283 1.033 . . . . 0.0 113.41 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.401 ' CE1' ' CE2' ' A' ' 120' ' ' PHE . 6.1 t80 -62.64 131.92 50.6 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -116.05 127.84 55.22 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 123.515 0.51 . . . . 0.0 112.166 174.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.3 -43.02 0.33 Allowed 'General case' 0 C--O 1.227 -0.087 0 C-N-CA 123.101 0.56 . . . . 0.0 110.597 160.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . 0.338 4.9 p 48.3 -83.02 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 125.897 1.679 . . . . 0.0 111.753 -168.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 38.76 -109.93 0.08 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.032 2.133 . . . . 0.0 111.351 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 42.3 t -107.84 143.48 36.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 170.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -46.43 -62.08 1.52 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.617 0.644 . . . . 0.0 109.81 171.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 11.8 t -63.55 126.73 28.49 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.71 1.204 . . . . 0.0 109.997 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -74.39 56.09 0.64 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.227 1.811 . . . . 0.0 109.551 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.299 3.1 p 60.34 -68.49 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.159 1.784 . . . . 0.0 114.016 177.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -53.6 143.26 20.48 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.511 1.124 . . . . 0.0 112.207 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.8 t -156.33 -70.47 0.11 Allowed 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.009 0.924 . . . . 0.0 111.137 -176.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.6 m -159.69 135.0 8.23 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 -164.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 69.0 mt -149.47 146.37 27.38 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.926 0.89 . . . . 0.0 109.058 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.26 170.7 12.83 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 126.324 1.85 . . . . 0.0 109.567 167.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.01 88.16 1.27 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 124.607 3.538 . . . . 0.0 111.093 -173.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 151.23 -30.19 0.97 Allowed Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 173.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.27 145.87 41.52 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.688 -151.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -96.29 89.71 5.19 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.974 1.71 . . . . 0.0 110.975 -170.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.96 119.15 26.87 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 176.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -154.13 132.51 11.98 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 122.762 0.425 . . . . 0.0 109.869 168.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 39.2 mtt -156.01 156.93 31.05 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 123.589 0.756 . . . . 0.0 110.373 -168.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.23 140.57 22.33 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.801 3.0 . . . . 0.0 111.688 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.8 t -126.37 136.29 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 170.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.0 m -105.57 157.45 6.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 CA-C-N 117.849 0.295 . . . . 0.0 110.526 173.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.401 ' CE2' ' CE1' ' A' ' 95' ' ' PHE . 6.2 t80 -156.72 139.17 14.86 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -170.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -157.8 173.03 17.42 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.743 1.617 . . . . 0.0 109.779 169.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.4 p -129.59 143.39 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 118.743 -0.646 . . . . 0.0 110.229 169.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -76.18 153.59 84.36 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 118.671 0.669 . . . . 0.0 109.588 175.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -58.63 -21.26 54.49 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.325 2.684 . . . . 0.0 112.132 170.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -41.47 -33.85 0.48 Allowed 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 126.637 1.975 . . . . 0.0 113.258 176.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.4 tt -54.53 -42.46 59.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.896 0.771 . . . . 0.0 112.661 175.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.1 m -84.3 54.13 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 119.088 0.858 . . . . 0.0 109.901 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -135.74 -65.52 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 117.637 -1.173 . . . . 0.0 112.252 175.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -74.53 149.47 39.15 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 CA-C-N 121.977 1.742 . . . . 0.0 111.079 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.4 p -64.44 -35.38 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 124.124 0.969 . . . . 0.0 110.75 -174.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -45.45 -48.99 13.8 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.1 1.76 . . . . 0.0 112.245 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.9 p -91.23 -66.53 0.92 Allowed 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 41.56 -72.01 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.693 2.797 . . . . 0.0 115.87 -175.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -87.14 -23.01 42.5 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.319 1.438 . . . . 0.0 111.234 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.9 mm -56.95 126.69 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 117.816 0.808 . . . . 0.0 109.949 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -156.01 58.41 0.59 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.921 172.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.9 m -150.01 88.67 1.54 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 167.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.0 mp -74.64 85.98 2.12 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.5 t -83.68 140.07 32.38 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.634 -1.166 . . . . 0.0 107.867 174.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.9 tt -114.22 103.94 11.6 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 169.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.3 p -86.7 104.83 16.47 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.38 128.91 50.37 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.589 1.556 . . . . 0.0 108.401 -176.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.4 m -114.98 91.55 3.65 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.526 1.131 . . . . 0.0 109.324 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.758 ' CD2' HD13 ' A' ' 45' ' ' LEU . 2.4 m-85 -71.41 88.17 0.88 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.599 1.159 . . . . 0.0 109.638 174.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -155.93 59.64 2.14 Favored Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 174.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.492 ' HD3' HD12 ' A' ' 45' ' ' LEU . 62.6 Cg_endo -79.96 -78.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.936 2.424 . . . . 0.0 111.979 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -146.79 132.72 19.13 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.553 0.615 . . . . 0.0 109.467 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -131.98 135.56 26.81 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 125.867 1.667 . . . . 0.0 106.611 175.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -77.21 -61.93 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.15 1.9 . . . . 0.0 109.97 171.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 41.8 t -176.84 97.67 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.639 1.575 . . . . 0.0 107.708 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.454 -0.266 0 N-CA-C 104.15 -2.537 . . . . 0.0 104.15 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -77.7 58.19 1.78 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.679 0.752 . . . . 0.0 110.616 -177.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -148.87 -67.53 0.22 Allowed 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 126.729 2.011 . . . . 0.0 107.628 160.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' A' ' 61' ' ' GLY . . . -163.69 -70.36 0.04 OUTLIER 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 138.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.0 t -166.23 -136.59 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 144.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -73.03 -27.55 61.83 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.474 1.109 . . . . 0.0 109.413 168.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -68.76 6.47 0.85 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -173.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.435 ' CG1' ' HB3' ' A' ' 24' ' ' ALA . 81.7 mt -58.99 122.14 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 120.847 1.658 . . . . 0.0 110.043 177.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.68 157.21 17.22 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 118.785 0.721 . . . . 0.0 110.999 175.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.67 -27.65 69.06 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.074 0.95 . . . . 0.0 113.03 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -51.76 114.0 1.15 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.97 0.908 . . . . 0.0 111.953 -174.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.63 98.04 8.17 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 127.067 2.147 . . . . 0.0 108.747 -171.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.0 tt -109.13 136.62 44.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 126.277 1.831 . . . . 0.0 110.748 -170.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.9 tptp -98.64 157.53 16.19 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 124.918 1.287 . . . . 0.0 110.897 -168.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.426 HG11 ' CZ ' ' A' ' 37' ' ' PHE . 82.3 t -133.65 160.68 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 C-N-CA 124.306 1.042 . . . . 0.0 108.63 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.4 m -145.46 102.48 3.71 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.615 1.166 . . . . 0.0 109.319 172.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.426 ' CZ ' HG11 ' A' ' 35' ' ' VAL . 90.0 m-85 -78.6 88.56 4.52 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.055 1.342 . . . . 0.0 108.13 175.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -80.06 85.36 5.65 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 121.415 -0.803 . . . . 0.0 109.191 -174.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.82 134.71 34.29 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 121.839 -0.538 . . . . 0.0 111.329 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -144.09 147.01 33.19 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 126.405 1.882 . . . . 0.0 109.66 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.9 t -132.77 147.97 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 125.34 1.456 . . . . 0.0 108.402 177.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -146.96 174.29 11.65 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.031 0.932 . . . . 0.0 109.931 174.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -49.28 121.81 5.36 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 169.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.77 -43.21 1.3 Allowed Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 108.078 -2.009 . . . . 0.0 108.078 -163.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.537 HD13 ' CG ' ' A' ' 144' ' ' PHE . 0.6 OUTLIER -130.74 97.76 20.66 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 123.308 0.643 . . . . 0.0 111.067 177.183 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -84.72 41.71 1.02 Allowed 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.78 2.987 . . . . 0.0 110.271 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.456 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 43.2 m0 -114.77 136.9 52.57 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.601 0.76 . . . . 0.0 109.315 -171.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -79.16 80.81 5.48 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -89.98 89.36 7.68 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 124.238 1.015 . . . . 0.0 108.99 -176.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.9 m -84.81 129.7 55.65 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.22 166.18 30.46 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 121.436 1.424 . . . . 0.0 108.464 161.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.38 -56.21 5.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 123.862 0.865 . . . . 0.0 109.437 -176.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.2 mp0 -129.79 164.44 24.06 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 161.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -63.55 -46.77 84.44 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 165.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -131.04 149.99 52.36 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 126.249 1.819 . . . . 0.0 110.108 -164.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.0 pt -134.81 167.97 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 167.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -110.56 134.24 52.57 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 166.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.0 157.91 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 165.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.5 mtm180 -109.15 114.27 27.84 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.422 HD13 HG21 ' A' ' 60' ' ' ILE . 0.9 OUTLIER -37.8 117.34 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -147.117 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.694 ' O ' ' HB2' ' A' ' 24' ' ' ALA . . . 111.43 -46.36 1.18 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 -172.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -53.63 109.59 0.47 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 117.767 0.784 . . . . 0.0 112.846 -166.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.2 p -56.44 122.03 10.99 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.938 1.295 . . . . 0.0 111.221 172.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.06 137.6 42.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 166.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -77.78 128.56 34.21 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.824 1.25 . . . . 0.0 108.569 167.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.1 pp -146.3 88.6 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.974 0.91 . . . . 0.0 108.971 174.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.93 147.16 41.19 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 121.385 -0.822 . . . . 0.0 110.276 -177.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -98.14 159.24 15.07 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 166.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -135.96 118.51 15.89 Favored 'General case' 0 C--O 1.227 -0.099 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 172.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -110.69 154.89 23.22 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 126.608 1.963 . . . . 0.0 109.081 172.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -154.95 123.74 6.15 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 -176.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.456 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 35.6 t30 -80.77 112.66 18.35 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 119.302 0.956 . . . . 0.0 110.836 -173.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.35 5.1 51.66 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.721 1.208 . . . . 0.0 112.742 -176.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.37 176.79 9.01 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.792 0.724 . . . . 0.0 110.538 175.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.6 t -105.64 20.73 18.43 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.739 0.816 . . . . 0.0 109.96 175.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.2 160.48 30.85 Favored Pre-proline 0 N--CA 1.447 -0.612 0 C-N-CA 127.086 2.154 . . . . 0.0 106.708 -174.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.71 160.44 40.44 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 C-N-CA 121.161 1.241 . . . . 0.0 109.442 172.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.38 164.18 26.25 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-O 120.776 0.322 . . . . 0.0 110.663 166.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.57 95.18 5.21 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.989 2.116 . . . . 0.0 105.693 -177.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.0 96.52 0.78 Allowed Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 107.756 -2.137 . . . . 0.0 107.756 177.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -125.05 50.33 1.77 Allowed 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 169.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.38 176.82 0.32 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.805 0.812 . . . . 0.0 110.872 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -146.04 162.48 37.8 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.91 169.82 17.33 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 123.578 0.751 . . . . 0.0 110.336 -172.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -119.91 111.52 18.04 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 163.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.2 t -95.43 77.59 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.177 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.1 t -176.07 145.55 0.75 Allowed Pre-proline 0 C--O 1.232 0.142 0 C-N-CA 124.153 0.981 . . . . 0.0 110.207 171.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.94 -38.0 40.68 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 121.259 1.306 . . . . 0.0 110.064 158.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.9 ptp 172.02 -68.08 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 127.835 2.454 . . . . 0.0 107.759 174.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.5 -39.5 46.1 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -167.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.74 -104.68 0.04 OUTLIER 'General case' 0 C--O 1.228 -0.055 0 C-N-CA 123.101 0.561 . . . . 0.0 110.427 -174.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.27 -58.78 2.8 Favored Glycine 0 CA--C 1.523 0.55 0 O-C-N 121.855 -0.528 . . . . 0.0 111.853 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -47.64 -48.95 28.52 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.927 0.864 . . . . 0.0 110.613 174.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -74.7 3.96 7.05 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.152 1.381 . . . . 0.0 113.882 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -76.95 107.92 9.63 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 171.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -71.06 80.86 0.67 Allowed 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.644 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -63.84 143.84 57.53 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 164.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.1 t -52.4 138.29 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.554 0.742 . . . . 0.0 111.57 -172.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -69.15 66.81 0.16 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.813 1.245 . . . . 0.0 111.574 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 34.9 t -150.11 140.26 22.12 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 125.385 1.474 . . . . 0.0 108.847 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -76.38 67.82 2.65 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.725 1.21 . . . . 0.0 108.993 176.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 38.2 t -159.79 153.98 23.53 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 174.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -97.19 -3.36 41.06 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.543 -0.742 . . . . 0.0 112.495 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.7 m 95.43 161.83 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 128.823 2.849 . . . . 0.0 108.467 -168.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 62.15 -178.38 0.13 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.818 2.047 . . . . 0.0 113.066 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.431 HG23 ' H ' ' A' ' 107' ' ' THR . 2.5 t -177.08 -82.15 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.069 1.347 . . . . 0.0 111.504 172.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.431 ' H ' HG23 ' A' ' 106' ' ' THR . 14.8 t -155.47 149.92 26.05 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.962 1.305 . . . . 0.0 108.025 -169.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.1 mt -154.03 127.52 8.62 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 123.873 0.869 . . . . 0.0 109.437 175.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -63.2 158.15 58.02 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 126.401 1.88 . . . . 0.0 110.256 164.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.47 110.53 3.0 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.481 2.121 . . . . 0.0 111.38 -169.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 115.17 -15.75 18.15 Favored Glycine 0 C--N 1.334 0.467 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -77.86 156.32 30.46 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 117.476 0.638 . . . . 0.0 110.873 -174.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.61 153.56 39.15 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.753 1.221 . . . . 0.0 110.687 -167.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 42.4 ttm -149.47 88.58 1.57 Allowed 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.094 1.358 . . . . 0.0 108.687 -168.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -89.72 130.17 36.03 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 118.585 0.629 . . . . 0.0 109.888 164.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -126.48 92.58 44.9 Favored Pre-proline 0 N--CA 1.452 -0.358 0 C-N-CA 125.327 1.451 . . . . 0.0 107.908 -171.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -55.37 126.12 21.45 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.723 2.282 . . . . 0.0 110.184 169.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.1 t -121.57 147.38 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 170.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.8 p -119.75 142.02 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 171.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -145.81 148.79 33.29 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 118.161 0.437 . . . . 0.0 111.147 -172.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -157.88 141.91 15.87 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.55 1.14 . . . . 0.0 110.098 165.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 24.0 t -70.54 134.35 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 164.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.422 ' C ' ' H ' ' A' ' 125' ' ' GLU . 1.5 t70 -88.41 138.55 30.18 Favored Pre-proline 0 N--CA 1.451 -0.406 0 C-N-CA 123.971 0.908 . . . . 0.0 109.939 -173.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -72.02 34.53 0.29 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.09 2.527 . . . . 0.0 114.331 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.422 ' H ' ' C ' ' A' ' 123' ' ' ASP . 37.7 tt0 -107.55 -21.78 12.77 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 130.071 3.348 . . . . 0.0 108.507 172.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.7 tt -58.22 -39.12 72.18 Favored 'Isoleucine or valine' 0 C--N 1.345 0.372 0 O-C-N 121.117 -0.99 . . . . 0.0 111.249 172.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.1 m -77.27 61.62 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 123.37 0.668 . . . . 0.0 109.956 172.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -130.92 -78.48 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 117.359 -1.305 . . . . 0.0 111.403 173.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -73.04 160.21 46.19 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 CA-C-N 122.011 1.754 . . . . 0.0 111.105 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 84.5 t -65.07 -44.66 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 124.553 1.141 . . . . 0.0 109.113 -171.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -48.31 -64.38 0.81 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.335 1.854 . . . . 0.0 110.095 177.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 35.7 p -75.94 -19.96 58.34 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 118.357 -0.83 . . . . 0.0 111.63 -172.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -44.65 -39.31 4.96 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.932 0.787 . . . . 0.0 111.186 168.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -57.72 -54.6 36.01 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 175.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 21.9 mm -64.26 132.4 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 124.6 1.16 . . . . 0.0 111.728 -174.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -158.65 41.57 0.25 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.181 165.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.8 p -140.8 89.64 2.27 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 170.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.4 tp -84.79 144.88 28.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -166.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.5 t -149.61 153.02 36.42 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -176.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.493 ' H ' HD13 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -114.06 145.8 41.1 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 146.477 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 26.6 t -98.84 116.97 32.28 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 164.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.23 124.9 49.48 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.137 1.375 . . . . 0.0 107.383 178.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.5 m -114.63 89.88 3.2 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.537 ' CG ' HD13 ' A' ' 45' ' ' LEU . 2.1 m-30 -67.53 83.52 0.17 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 170.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.16 50.65 1.16 Allowed Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 178.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.471 ' CD ' HD12 ' A' ' 45' ' ' LEU . 87.9 Cg_endo -74.73 -106.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.264 2.643 . . . . 0.0 110.254 176.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -147.22 123.52 10.93 Favored 'General case' 0 C--N 1.337 0.058 0 CA-C-N 119.363 0.983 . . . . 0.0 109.292 -175.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -111.3 143.67 28.91 Favored Pre-proline 0 N--CA 1.45 -0.463 0 C-N-CA 124.892 1.277 . . . . 0.0 108.353 175.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.0 -51.28 0.17 Allowed 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 121.939 1.759 . . . . 0.0 109.135 171.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 61.8 p -175.75 174.28 2.22 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.282 1.833 . . . . 0.0 107.147 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.4 pttt . . . . . 0 CA--C 1.535 0.377 0 C-N-CA 124.759 1.224 . . . . 0.0 109.201 172.576 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.535 0.372 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -76.24 52.3 0.74 Allowed 'General case' 0 CA--C 1.539 0.525 0 O-C-N 120.585 -1.322 . . . . 0.0 107.47 154.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 168.67 164.74 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 128.393 2.677 . . . . 0.0 108.893 -173.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -155.03 19.67 0.44 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.814 1.246 . . . . 0.0 113.238 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 t -77.42 23.95 0.2 Allowed 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.174 -1.579 . . . . 0.0 113.456 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -75.9 -30.91 58.96 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 153.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -107.21 -44.54 4.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.614 1.165 . . . . 0.0 112.822 -175.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.1 mt -19.22 115.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 126.432 1.893 . . . . 0.0 115.146 -164.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.561 ' HB2' HD12 ' A' ' 60' ' ' ILE . 5.7 mp -103.78 -178.26 3.61 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.262 -161.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -69.2 -48.12 62.94 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.685 1.994 . . . . 0.0 110.733 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.599 ' HB3' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -60.54 151.08 29.56 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.799 0.809 . . . . 0.0 111.814 -174.779 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.63 98.54 7.69 Favored 'General case' 0 N--CA 1.418 -2.051 0 C-N-CA 127.233 2.213 . . . . 0.0 107.285 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.31 0.0 OUTLIER -80.05 122.04 34.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 170.668 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.544 ' CE ' ' HB2' ' A' ' 55' ' ' ASP . 2.7 tmtp? -75.87 150.54 37.59 Favored 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.6 t -129.66 143.08 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 172.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.8 m -141.78 98.05 3.27 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -173.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -76.38 159.06 30.84 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.895 -172.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -131.05 84.0 2.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 122.761 1.267 . . . . 0.0 107.916 169.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.35 86.1 7.22 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 164.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -93.36 157.82 16.04 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.496 0.718 . . . . 0.0 109.089 170.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.2 p -140.2 110.98 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 123.499 0.72 . . . . 0.0 109.478 175.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.93 164.32 15.2 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.115 166.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.81 -39.44 8.39 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.921 1.288 . . . . 0.0 112.999 -176.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.19 -26.21 2.15 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.819 1.676 . . . . 0.0 113.985 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.731 HD11 ' HA2' ' A' ' 80' ' ' GLY . 0.3 OUTLIER -121.05 97.18 48.16 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 162.936 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -82.73 47.54 2.48 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.207 1.938 . . . . 0.0 110.296 -170.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.496 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 43.6 m0 -112.54 148.33 34.72 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.471 1.108 . . . . 0.0 109.502 -170.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -76.79 80.55 3.39 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 175.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -93.29 101.72 13.98 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 124.329 1.052 . . . . 0.0 108.251 -177.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.7 m -101.97 132.47 21.56 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-O 119.26 -0.4 . . . . 0.0 110.058 -172.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.38 141.34 51.04 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 N-CA-C 107.802 -1.653 . . . . 0.0 107.802 162.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.474 HG13 ' H ' ' A' ' 53' ' ' GLN . 13.2 p -77.58 -52.53 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 121.477 0.656 . . . . 0.0 110.031 -177.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.474 ' H ' HG13 ' A' ' 52' ' ' VAL . 3.1 mp0 -127.55 158.96 36.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 104.122 -2.547 . . . . 0.0 104.122 153.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -66.88 -44.91 79.65 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 174.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.544 ' HB2' ' CE ' ' A' ' 34' ' ' LYS . 20.7 p-10 -130.24 167.22 18.8 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 126.361 1.864 . . . . 0.0 111.07 -170.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.8 pt -143.07 175.49 4.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 125.11 1.364 . . . . 0.0 108.114 169.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -119.31 132.33 55.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 169.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.6 m -124.46 126.14 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.638 0.775 . . . . 0.0 108.96 172.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -72.68 77.43 1.1 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 168.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.599 HD11 ' HB3' ' A' ' 31' ' ' GLU . 19.5 mt 28.29 58.54 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 127.877 2.471 . . . . 0.0 111.798 169.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.6 -27.47 2.83 Favored Glycine 0 CA--C 1.523 0.557 0 O-C-N 122.131 -0.355 . . . . 0.0 113.195 -174.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -50.02 118.39 2.88 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.038 0.535 . . . . 0.0 111.342 171.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.4 p -88.94 107.27 18.92 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.338 1.455 . . . . 0.0 109.951 -177.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -96.06 139.07 19.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 174.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.8 120.35 23.94 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 163.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.34 111.05 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.413 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 76.8 mtp -76.49 171.22 14.97 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.39 0.676 . . . . 0.0 110.747 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -141.31 151.14 43.36 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 163.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.4 ttm105 -127.02 139.07 53.28 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 172.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.88 112.16 8.61 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.554 1.942 . . . . 0.0 108.152 173.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.0 mtmt -103.98 130.09 51.6 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.721 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.496 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 52.6 t-20 -78.26 101.97 7.41 Favored 'General case' 0 C--N 1.339 0.12 0 CA-C-N 119.44 1.018 . . . . 0.0 111.512 -176.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.9 mt -91.62 7.92 39.21 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.761 0.824 . . . . 0.0 113.014 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.91 162.94 27.2 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.858 1.208 . . . . 0.0 109.714 171.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.0 p -79.1 -9.21 59.49 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.045 1.338 . . . . 0.0 111.543 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.58 165.2 29.93 Favored Pre-proline 0 N--CA 1.447 -0.603 0 C-N-CA 126.38 1.872 . . . . 0.0 107.686 -168.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -61.27 148.43 92.94 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 121.14 1.226 . . . . 0.0 109.764 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.7 p -126.79 169.52 13.13 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 165.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.3 t -90.32 173.57 8.05 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 159.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.731 ' HA2' HD11 ' A' ' 45' ' ' LEU . . . -170.49 57.07 0.19 Allowed Glycine 0 N--CA 1.438 -1.185 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 176.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.69 -42.56 34.12 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 169.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 64.34 179.24 0.17 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.679 1.192 . . . . 0.0 110.873 174.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.8 m -120.16 136.15 54.72 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 172.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -105.57 148.75 26.94 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.151 0.58 . . . . 0.0 110.354 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -124.66 102.85 7.8 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 156.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.9 t -92.44 59.36 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 124.12 0.968 . . . . 0.0 108.839 -170.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.3 t -171.19 147.29 2.19 Favored Pre-proline 0 N--CA 1.461 0.108 0 O-C-N 121.499 -0.751 . . . . 0.0 111.664 -176.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -64.77 -40.41 22.21 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.381 1.387 . . . . 0.0 109.316 160.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 11.7 ptp 173.73 -71.76 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 127.523 2.329 . . . . 0.0 108.291 173.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.402 ' HB3' HG13 ' A' ' 135' ' ' ILE . . . -69.23 -43.8 73.31 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 123.571 0.748 . . . . 0.0 112.801 -164.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.49 -102.84 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.248 0.619 . . . . 0.0 110.595 -170.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.9 -52.75 1.67 Allowed Glycine 0 CA--C 1.53 1.026 0 CA-C-O 119.425 -0.653 . . . . 0.0 112.809 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -48.3 -50.63 29.33 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.039 1.419 . . . . 0.0 111.016 174.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -72.38 -4.98 33.22 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.082 1.753 . . . . 0.0 113.792 178.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -75.45 108.14 8.05 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -76.18 167.77 21.26 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.631 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -133.69 -179.59 5.63 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 174.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.9 p -73.14 68.79 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 122.118 0.961 . . . . 0.0 108.498 171.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 29.93 43.63 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 130.131 3.372 . . . . 0.0 114.543 -177.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 11.5 t 157.4 -69.39 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 127.462 2.305 . . . . 0.0 109.413 177.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -72.06 136.53 46.67 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.115 0.483 . . . . 0.0 112.035 -154.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 78.5 m -73.15 -39.44 65.67 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.68 0.792 . . . . 0.0 110.739 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 175.24 -171.25 0.06 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 130.63 3.572 . . . . 0.0 103.822 -175.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 41.5 m -150.45 -5.73 0.31 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.258 1.39 . . . . 0.0 113.372 -174.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.7 mp0 -57.43 -40.26 78.0 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.682 1.993 . . . . 0.0 111.529 -167.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . 0.325 5.0 t 57.98 -78.67 0.02 OUTLIER 'General case' 0 C--O 1.232 0.173 0 C-N-CA 126.268 1.827 . . . . 0.0 114.699 165.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.3 m -162.56 142.45 9.5 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 125.83 1.652 . . . . 0.0 107.53 -169.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 26.3 mt -149.67 140.69 22.93 Favored 'General case' 0 C--O 1.232 0.17 0 O-C-N 123.335 0.397 . . . . 0.0 111.255 174.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -52.39 161.45 1.06 Allowed Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 128.91 2.884 . . . . 0.0 111.413 159.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -77.23 125.29 7.72 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.454 2.769 . . . . 0.0 111.602 -173.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.59 -10.82 32.87 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 124.437 1.018 . . . . 0.0 111.167 175.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -79.0 144.77 34.37 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -164.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -93.04 101.18 13.51 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.054 1.742 . . . . 0.0 109.127 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.55 125.39 29.92 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 161.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -146.31 126.66 13.98 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.156 1.382 . . . . 0.0 107.536 172.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 68.1 mtp -148.89 151.43 34.9 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 118.113 0.415 . . . . 0.0 111.002 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 67' ' ' MET . 84.0 Cg_endo -76.1 145.11 27.49 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 123.843 3.029 . . . . 0.0 110.378 165.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.2 t -116.59 156.4 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 155.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.0 m -122.47 141.73 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 171.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -153.9 148.12 25.86 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -171.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -157.62 175.84 13.4 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 128.501 2.72 . . . . 0.0 106.569 173.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 87.5 t -126.64 137.4 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 C-N-CA 123.111 0.564 . . . . 0.0 109.543 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -71.54 144.11 88.42 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 119.557 -0.259 . . . . 0.0 111.213 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -58.82 -25.14 75.23 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.0 2.467 . . . . 0.0 112.891 172.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -43.9 -30.16 0.66 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.663 1.185 . . . . 0.0 113.244 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.0 tt -52.52 -42.02 38.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 175.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.5 m -91.75 55.66 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 118.391 0.541 . . . . 0.0 110.332 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -129.71 -70.33 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.371 0 CA-C-O 117.224 -1.37 . . . . 0.0 111.331 167.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.2 156.77 63.81 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 CA-C-N 121.913 1.719 . . . . 0.0 111.47 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 83.9 t -66.75 -50.73 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.709 0.804 . . . . 0.0 110.076 -169.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -48.26 -45.15 34.1 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 124.616 1.166 . . . . 0.0 111.623 -174.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 61.2 p -92.19 -9.52 42.02 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 118.55 -0.738 . . . . 0.0 112.336 -174.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -50.21 -44.64 53.26 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.048 0.84 . . . . 0.0 111.602 -172.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.23 -24.99 75.55 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 123.388 0.518 . . . . 0.0 112.557 -177.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.402 HG13 ' HB3' ' A' ' 90' ' ' ALA . 13.2 mm -73.8 123.17 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 118.122 0.961 . . . . 0.0 109.773 -176.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -153.39 52.48 0.73 Allowed 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.719 165.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.4 m -146.95 99.7 3.21 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 153.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.81 134.17 38.06 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.3 t -125.48 161.65 26.65 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.6 tt -131.26 112.15 12.54 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 102.263 -3.236 . . . . 0.0 102.263 168.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.5 t -86.47 104.03 15.56 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 167.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.35 97.21 8.94 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.59 86.58 3.91 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 122.416 1.103 . . . . 0.0 108.272 -178.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.616 ' CD2' HD13 ' A' ' 45' ' ' LEU . 3.1 m-85 -68.37 87.67 0.31 Allowed 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 167.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.03 35.9 0.09 OUTLIER Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.91 -79.19 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.977 1.784 . . . . 0.0 113.365 -174.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 71.2 mtm180 -155.94 117.37 3.92 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.815 0.846 . . . . 0.0 109.99 -172.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -88.01 147.86 41.8 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 123.252 0.621 . . . . 0.0 109.73 167.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.52 -47.38 0.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.647 2.231 . . . . 0.0 110.335 172.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.4 p 157.13 82.25 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 128.536 2.734 . . . . 0.0 107.9 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.542 0.662 0 O-C-N 121.615 -0.678 . . . . 0.0 109.177 -171.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.448 HG22 ' H ' ' A' ' 22' ' ' GLU . 8.2 p . . . . . 0 CA--C 1.533 0.32 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.448 ' H ' HG22 ' A' ' 21' ' ' VAL . 61.0 mt-10 -67.67 66.49 0.09 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.16 0.891 . . . . 0.0 109.969 161.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 171.36 91.83 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 130.04 3.336 . . . . 0.0 106.577 169.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.58 15.65 9.09 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -170.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.4 m -70.24 65.73 0.28 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 129.195 2.998 . . . . 0.0 110.536 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -153.79 -56.26 0.11 Allowed 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 130.972 3.709 . . . . 0.0 103.321 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.18 -20.84 19.49 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 116.691 -1.623 . . . . 0.0 113.958 174.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.7 mt -40.47 138.91 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 120.968 1.713 . . . . 0.0 115.064 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -122.41 173.25 7.77 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.505 1.922 . . . . 0.0 110.509 -171.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -86.04 -24.5 26.35 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.753 0.821 . . . . 0.0 112.673 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.93 148.05 22.14 Favored 'General case' 0 C--O 1.231 0.11 0 O-C-N 121.004 -1.06 . . . . 0.0 110.209 174.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -120.02 97.0 5.4 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.24 1.416 . . . . 0.0 108.562 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.9 142.64 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 124.736 1.214 . . . . 0.0 108.779 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.67 148.39 27.44 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.761 1.224 . . . . 0.0 109.099 -174.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.9 t -136.18 111.16 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 -171.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 m -91.82 122.78 34.67 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 173.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -96.01 107.85 20.19 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.629 1.172 . . . . 0.0 108.8 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -96.28 86.93 4.34 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 122.763 1.268 . . . . 0.0 110.027 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.96 136.91 37.38 Favored 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 120.744 -1.222 . . . . 0.0 108.419 173.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.93 146.14 50.24 Favored 'General case' 0 CA--C 1.523 -0.08 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.94 143.1 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.58 166.64 23.06 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.166 1.786 . . . . 0.0 106.983 168.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -42.56 -43.72 3.86 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 124.233 1.013 . . . . 0.0 112.285 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.56 -34.09 0.23 Allowed Glycine 0 CA--C 1.534 1.223 0 C-N-CA 126.214 1.864 . . . . 0.0 114.663 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.18 96.5 49.28 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 119.034 1.417 . . . . 0.0 107.961 162.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -84.73 43.2 1.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 124.095 3.197 . . . . 0.0 109.441 -169.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.424 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 41.1 m0 -115.5 144.42 43.87 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -169.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -76.74 79.93 3.36 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -175.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -89.36 98.44 11.77 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.236 1.014 . . . . 0.0 109.042 -174.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.9 m -102.45 138.21 19.61 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -70.44 163.03 40.28 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 121.622 1.548 . . . . 0.0 108.71 166.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 67' ' ' MET . 2.4 t -80.08 -61.92 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -175.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.3 mp0 -131.7 156.99 44.94 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 162.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -23.95 64.99 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.072 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.57 162.59 41.12 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 119.078 0.854 . . . . 0.0 111.029 174.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.2 pt -135.33 166.55 27.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 126.074 1.75 . . . . 0.0 109.33 173.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -111.28 135.55 51.65 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.3 1.84 . . . . 0.0 109.435 164.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -137.42 128.98 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.369 1.867 . . . . 0.0 108.689 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -82.1 82.49 7.65 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 120.699 -1.25 . . . . 0.0 109.5 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.0 mt 17.38 69.58 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 128.768 2.827 . . . . 0.0 112.237 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.45 -25.64 4.76 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.239 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -48.7 108.54 0.18 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.839 0.455 . . . . 0.0 111.471 172.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.1 p -75.11 108.99 8.21 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.064 1.346 . . . . 0.0 109.801 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.8 p -114.57 145.46 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 122.841 0.456 . . . . 0.0 110.284 173.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.38 131.2 34.72 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 124.403 1.081 . . . . 0.0 110.253 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.6 pp -142.88 92.66 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.569 1.148 . . . . 0.0 109.887 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.408 ' O ' HG22 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -78.36 133.22 37.6 Favored 'General case' 0 C--O 1.226 -0.144 0 O-C-N 121.432 -0.792 . . . . 0.0 111.618 -175.595 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -100.53 157.09 16.91 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 66.1 ttp85 -142.06 122.97 14.44 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.907 -0.568 . . . . 0.0 109.945 -175.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.43 154.77 36.1 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.52 1.128 . . . . 0.0 108.281 158.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -145.83 139.46 26.37 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 167.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.424 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 52.9 t-20 -82.8 118.53 23.47 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 120.177 1.353 . . . . 0.0 112.689 -172.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -100.83 -9.39 21.72 Favored 'General case' 0 C--N 1.346 0.442 0 C-N-CA 124.16 0.984 . . . . 0.0 113.222 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.37 142.44 36.01 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 119.857 1.208 . . . . 0.0 108.988 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.6 m -78.37 36.2 0.24 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.5 p -153.39 155.78 31.95 Favored Pre-proline 0 N--CA 1.451 -0.405 0 C-N-CA 125.591 1.557 . . . . 0.0 108.336 175.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.0 145.07 89.37 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 N-CA-C 108.235 -1.486 . . . . 0.0 108.235 169.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.0 p -117.55 178.14 4.5 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 168.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.1 t -124.27 126.43 46.06 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -98.26 109.17 3.75 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 107.167 -2.373 . . . . 0.0 107.167 175.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.58 49.37 1.8 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 162.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 143' ' ' THR . . . -61.82 143.89 55.64 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.375 0.67 . . . . 0.0 111.271 -175.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.12 155.89 27.27 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.754 174.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -151.66 147.22 26.47 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -103.4 100.77 10.65 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 170.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.6 p -89.06 83.52 2.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 CA-C-O 118.079 -0.962 . . . . 0.0 108.41 175.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.2 t 176.97 147.08 0.29 Allowed Pre-proline 0 C--O 1.232 0.162 0 C-N-CA 124.644 1.178 . . . . 0.0 109.496 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -64.26 -39.35 30.59 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 120.666 0.91 . . . . 0.0 110.342 156.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.1 ptp 177.9 -71.67 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.594 1.958 . . . . 0.0 107.976 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.15 -37.47 33.39 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.944 0.898 . . . . 0.0 112.859 -168.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.2 -118.05 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.315 0.646 . . . . 0.0 110.337 -174.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.0 -53.45 2.16 Favored Glycine 0 CA--C 1.526 0.72 0 O-C-N 121.216 -0.928 . . . . 0.0 112.652 -175.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -41.64 -58.86 1.81 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.844 1.258 . . . . 0.0 110.623 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -74.83 -8.61 56.97 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -53.67 117.72 3.36 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.36 0.982 . . . . 0.0 108.585 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -65.65 131.19 45.73 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.264 0.555 . . . . 0.0 111.398 -159.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -83.75 79.74 9.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -172.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.4 m -51.78 147.47 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.55 1.14 . . . . 0.0 112.91 -174.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 36.85 -114.16 0.1 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.376 2.27 . . . . 0.0 111.904 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 29.4 p -156.3 138.42 14.59 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 51.79 60.78 3.6 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -169.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 15.2 p -53.79 147.02 12.53 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.712 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 48.94 64.43 1.72 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.832 0.853 . . . . 0.0 110.664 -174.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.32 58.92 0.4 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.988 1.315 . . . . 0.0 110.851 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -63.28 -32.52 73.95 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.348 1.059 . . . . 0.0 112.838 -169.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.2 t 52.67 -143.52 0.7 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.173 0.989 . . . . 0.0 112.593 166.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.2 m -124.8 133.31 53.17 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 127.538 2.335 . . . . 0.0 105.864 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 86.8 mt -122.19 120.14 33.31 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 175.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -56.2 159.73 5.7 Favored Pre-proline 0 N--CA 1.447 -0.591 0 C-N-CA 123.864 0.865 . . . . 0.0 110.541 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -67.12 102.97 0.7 Allowed 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.202 2.601 . . . . 0.0 112.308 -169.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 122.63 -16.22 8.44 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -78.2 148.55 33.98 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 118.001 0.9 . . . . 0.0 110.877 -166.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.4 141.17 36.41 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.385 1.874 . . . . 0.0 109.173 -169.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 46.3 ttp -135.52 82.87 1.98 Allowed 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.621 1.168 . . . . 0.0 109.371 173.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -104.25 113.1 26.42 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.078 1.751 . . . . 0.0 107.725 171.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 40.4 mtm -137.29 126.62 15.26 Favored Pre-proline 0 C--O 1.235 0.337 0 CA-C-N 118.386 0.539 . . . . 0.0 111.748 -170.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -74.73 139.81 25.49 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.618 2.212 . . . . 0.0 112.517 173.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.7 t -128.99 151.04 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.1 p -118.28 142.16 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 170.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -144.53 158.31 43.82 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 118.948 0.795 . . . . 0.0 111.294 -175.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -162.28 168.61 22.03 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 127.671 2.389 . . . . 0.0 106.695 173.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 49.4 t -112.39 145.36 18.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 C-N-CA 124.252 1.021 . . . . 0.0 108.363 174.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -77.04 157.77 80.93 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 123.968 0.907 . . . . 0.0 110.924 -177.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -79.41 -22.65 7.96 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.723 2.282 . . . . 0.0 112.742 166.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -53.74 -37.12 63.03 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.234 1.013 . . . . 0.0 111.516 -171.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.2 tt -40.03 -34.09 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.534 1.934 . . . . 0.0 114.793 171.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.4 m -106.71 22.56 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 119.786 1.175 . . . . 0.0 112.956 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.1 -48.08 0.48 Allowed Pre-proline 0 CA--C 1.545 0.762 0 O-C-N 120.854 -1.154 . . . . 0.0 113.29 167.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -81.15 -165.73 0.36 Allowed 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.345 2.697 . . . . 0.0 110.374 -171.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.7 t -95.22 -51.23 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -31.85 -61.88 0.22 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 129.263 3.025 . . . . 0.0 113.499 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.2 p -92.5 -5.17 52.37 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 123.335 0.654 . . . . 0.0 112.641 -174.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -54.31 107.63 0.29 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.972 0.909 . . . . 0.0 111.295 -169.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 120.92 -27.22 6.54 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 123.98 0.8 . . . . 0.0 111.59 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 45.8 mm -64.7 125.67 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 118.168 0.984 . . . . 0.0 109.692 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -157.07 51.34 0.48 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.582 172.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.42 87.4 2.01 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 167.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.2 tp -88.88 89.31 7.93 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -160.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.6 t -102.01 171.95 7.21 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 122.443 1.116 . . . . 0.0 111.7 -171.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.97 108.33 2.38 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 -160.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.4 t -92.63 116.23 28.82 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 168.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.417 ' HE1' ' HB3' ' A' ' 82' ' ' ALA . 0.6 OUTLIER -114.47 114.23 25.53 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 118.644 0.656 . . . . 0.0 109.579 -179.05 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.466 ' O ' ' HB1' ' A' ' 82' ' ' ALA . 1.4 m -100.63 87.17 3.28 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.392 0.677 . . . . 0.0 111.34 -167.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -67.87 84.16 0.21 Allowed 'General case' 0 CA--C 1.54 0.56 0 O-C-N 122.044 -0.41 . . . . 0.0 110.513 173.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.3 22.39 0.05 OUTLIER Pre-proline 0 CA--C 1.556 1.209 0 N-CA-C 118.448 2.759 . . . . 0.0 118.448 -175.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.87 -81.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.021 2.481 . . . . 0.0 113.424 -168.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.5 ptm85 -155.6 140.78 17.51 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 119.866 1.212 . . . . 0.0 113.102 177.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.62 147.83 44.17 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 125.765 1.626 . . . . 0.0 106.97 175.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.38 -37.02 0.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.371 2.048 . . . . 0.0 113.52 -176.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.8 m 155.26 96.52 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 129.533 3.133 . . . . 0.0 108.653 -174.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 18.2 pttp . . . . . 0 CA--C 1.538 0.484 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.501 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 CA--C 1.532 0.268 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . 0.255 3.3 tt0 27.78 64.57 0.1 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.491 2.316 . . . . 0.0 112.775 -174.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -173.06 141.34 0.96 Allowed 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 100.601 -3.851 . . . . 0.0 100.601 -168.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.668 ' HB3' HD11 ' A' ' 28' ' ' ILE . . . -74.91 -57.37 3.95 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 118.441 -1.304 . . . . 0.0 113.053 -143.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 83.4 p -153.72 172.93 16.52 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 156.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -79.06 -32.92 45.01 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.955 174.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -87.45 -41.47 13.52 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.279 1.031 . . . . 0.0 111.971 -170.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.668 HD11 ' HB3' ' A' ' 24' ' ' ALA . 61.1 mt 28.32 74.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 126.859 2.063 . . . . 0.0 112.655 -173.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.419 HD22 ' H ' ' A' ' 29' ' ' LEU . 2.3 mm? -70.02 164.72 23.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.696 170.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -65.02 -31.69 73.04 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -176.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.23 129.78 10.29 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 122.276 1.036 . . . . 0.0 113.376 -165.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -91.74 83.28 5.27 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 122.374 1.083 . . . . 0.0 108.513 -169.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.65 120.48 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 171.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.82 170.63 9.54 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.558 1.143 . . . . 0.0 109.193 -170.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.6 t -144.94 146.42 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 169.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.7 m -141.3 104.12 4.55 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -176.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -82.15 125.09 30.49 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 125.596 1.559 . . . . 0.0 110.258 -174.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -102.51 89.05 3.41 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 163.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -99.96 89.11 3.95 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 172.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -111.69 151.32 29.02 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 123.805 0.842 . . . . 0.0 110.415 -171.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.39 105.71 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.985 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.22 150.96 36.98 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 163.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.82 -29.28 4.43 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.595 0.758 . . . . 0.0 112.901 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -36.97 -40.04 0.47 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.605 1.574 . . . . 0.0 113.791 170.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.403 HD21 ' CD2' ' A' ' 47' ' ' TRP . 0.9 OUTLIER -109.32 120.13 46.38 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 162.524 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -84.33 14.62 2.39 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 121.451 1.434 . . . . 0.0 113.553 -169.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.49 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 41.1 m0 -79.25 156.64 28.03 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 121.969 0.89 . . . . 0.0 111.43 -177.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -74.9 138.81 42.66 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 104.262 -2.495 . . . . 0.0 104.262 158.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -143.99 128.87 18.42 Favored 'General case' 0 N--CA 1.458 -0.059 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.2 t -122.95 123.66 26.74 Favored Pre-proline 0 N--CA 1.444 -0.732 0 C-N-CA 125.311 1.444 . . . . 0.0 108.557 -168.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -74.81 146.64 33.73 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 123.958 3.106 . . . . 0.0 107.497 166.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.443 HG21 ' HB ' ' A' ' 66' ' ' ILE . 2.2 t -77.93 -58.59 3.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -170.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -122.51 163.91 19.06 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 103.41 -2.811 . . . . 0.0 103.41 155.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.1 tpt180 -58.07 -47.66 82.51 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 169.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -139.97 165.35 27.57 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 125.63 1.572 . . . . 0.0 110.27 -166.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.4 pt -141.79 162.8 20.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 C-N-CA 124.676 1.19 . . . . 0.0 108.226 175.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -106.4 139.41 40.92 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 162.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.05 81.33 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 175.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.7 mmm-85 -56.94 111.97 1.19 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.723 1.209 . . . . 0.0 110.687 -166.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.477 ' O ' HG22 ' A' ' 60' ' ' ILE . 33.5 mm 16.4 56.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 126.239 1.816 . . . . 0.0 113.185 -160.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.581 ' C ' ' HB1' ' A' ' 24' ' ' ALA . . . 125.45 -73.21 0.43 Allowed Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 22.19 86.52 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.347 2.259 . . . . 0.0 113.555 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.86 119.13 6.16 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.194 0.997 . . . . 0.0 111.541 -169.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.15 152.9 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 123.42 0.688 . . . . 0.0 110.481 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.75 126.09 51.84 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 126.471 1.908 . . . . 0.0 108.013 174.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.443 ' HB ' HG21 ' A' ' 52' ' ' VAL . 1.9 pp -125.36 113.49 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 168.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.87 106.49 10.93 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.27 0.628 . . . . 0.0 112.683 176.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -77.33 149.13 35.33 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 171.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 -139.01 138.28 37.08 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 123.418 0.449 . . . . 0.0 110.473 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.61 171.87 10.75 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.611 1.564 . . . . 0.0 110.046 164.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.6 136.45 15.36 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 177.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.49 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 37.6 t30 -78.12 128.49 33.88 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 120.258 1.39 . . . . 0.0 111.175 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 tp -118.95 26.01 9.82 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.671 1.988 . . . . 0.0 111.885 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -103.96 174.18 5.98 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.805 1.242 . . . . 0.0 110.201 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.3 p -97.06 11.37 36.42 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.043 1.337 . . . . 0.0 111.524 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.41 161.1 42.85 Favored Pre-proline 0 C--O 1.239 0.531 0 C-N-CA 125.071 1.348 . . . . 0.0 107.942 -177.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -56.4 158.7 14.9 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 121.382 1.388 . . . . 0.0 109.877 164.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.431 ' HG1' ' HE1' ' A' ' 47' ' ' TRP . 6.8 p -134.72 -177.83 4.79 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.848 2.459 . . . . 0.0 108.025 -176.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.1 t -138.6 140.46 38.97 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 159.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -94.46 93.73 1.7 Allowed Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 107.255 -2.338 . . . . 0.0 107.255 170.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -112.59 47.04 1.12 Allowed 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 167.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.62 170.4 16.39 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 171.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.5 t -144.6 158.96 43.54 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 166.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -84.9 155.17 21.8 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.242 1.417 . . . . 0.0 109.867 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -109.78 100.44 9.44 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 149.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.8 t -80.7 100.61 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 125.303 1.441 . . . . 0.0 107.477 174.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.6 t 172.27 151.25 0.21 Allowed Pre-proline 0 C--N 1.343 0.293 0 C-N-CA 126.825 2.05 . . . . 0.0 109.055 168.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -66.83 -49.31 1.57 Allowed 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 121.029 1.153 . . . . 0.0 109.584 153.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.1 ptt? -173.55 -72.7 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.989 1.715 . . . . 0.0 107.907 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.46 -40.47 85.35 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -171.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.46 -100.61 0.02 OUTLIER 'General case' 0 C--N 1.339 0.116 0 CA-C-N 117.912 0.324 . . . . 0.0 111.692 -170.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.09 -61.01 1.4 Allowed Glycine 0 CA--C 1.53 0.999 0 CA-C-O 119.447 -0.64 . . . . 0.0 111.799 -172.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.59 -56.67 5.69 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.837 1.255 . . . . 0.0 111.85 -176.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -72.97 5.0 3.6 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.405 1.082 . . . . 0.0 113.917 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -80.02 116.42 20.14 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 173.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -72.19 88.34 1.13 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 119.253 -0.979 . . . . 0.0 112.055 -171.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm 136.66 72.16 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 129.854 3.262 . . . . 0.0 109.309 167.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 15.2 t -97.67 -56.91 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 124.195 0.998 . . . . 0.0 111.978 -175.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -76.44 75.04 3.19 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -157.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 13.6 t -149.06 51.15 0.97 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.996 0.903 . . . . 0.0 109.454 164.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -80.67 61.72 4.46 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.59 0.71 . . . . 0.0 110.245 -176.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 51.1 t -164.99 51.09 0.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 172.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -85.67 165.52 16.91 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.045 -156.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.8 t -159.44 152.42 21.95 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -119.74 44.52 2.37 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.011 1.324 . . . . 0.0 108.124 162.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . 0.255 6.3 t 50.16 -124.38 2.1 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.358 1.463 . . . . 0.0 111.962 170.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.0 m -145.16 151.28 38.19 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.66 2.384 . . . . 0.0 107.255 -172.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.533 HD11 ' HB2' ' A' ' 114' ' ' MET . 70.5 mt -135.8 132.67 37.0 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 171.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -64.19 158.15 65.95 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 125.04 1.336 . . . . 0.0 109.959 169.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.18 93.68 0.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.712 2.941 . . . . 0.0 112.539 -169.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 140.25 -28.7 2.46 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -77.93 150.55 34.01 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 117.594 0.697 . . . . 0.0 112.531 -155.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -86.18 155.84 20.57 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.82 2.048 . . . . 0.0 110.527 -174.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.533 ' HB2' HD11 ' A' ' 108' ' ' LEU . 19.2 ttm -148.75 89.22 1.67 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.414 1.086 . . . . 0.0 109.417 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -106.89 143.9 34.31 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.167 0.894 . . . . 0.0 110.657 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -150.09 107.63 3.21 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 124.147 0.979 . . . . 0.0 112.33 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.71 108.61 0.27 Allowed 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 124.961 3.774 . . . . 0.0 112.541 165.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.3 t -100.97 117.86 46.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 171.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.8 p -79.19 142.02 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 168.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -154.78 159.33 40.56 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -175.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -177.7 160.79 1.58 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.322 2.249 . . . . 0.0 109.928 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 94.6 t -121.41 131.8 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.6 1.16 . . . . 0.0 109.689 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.1 148.17 38.78 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -176.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -74.76 57.81 4.52 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 124.202 3.268 . . . . 0.0 112.698 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -104.02 -41.67 5.78 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.053 0.941 . . . . 0.0 109.833 162.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.8 tt -47.89 -42.9 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 124.361 1.064 . . . . 0.0 113.846 -169.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.2 m -78.83 51.05 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 O-C-N 121.064 -1.022 . . . . 0.0 111.166 176.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -133.7 -72.28 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 124.796 1.239 . . . . 0.0 111.147 173.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.08 136.75 45.69 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 121.833 1.688 . . . . 0.0 112.675 -175.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 97.6 t -40.6 -53.23 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 126.4 1.88 . . . . 0.0 109.751 178.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -33.19 -47.28 0.19 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 127.893 2.477 . . . . 0.0 113.759 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 35.1 p -106.42 -6.94 17.86 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -173.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -57.7 107.45 0.45 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.379 0.991 . . . . 0.0 111.031 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 132.14 -38.35 1.91 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.035 1.303 . . . . 0.0 109.895 -173.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 23.5 mm -70.17 121.94 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 O-C-N 122.186 -0.597 . . . . 0.0 111.045 -175.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -156.33 54.65 0.56 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 122.086 0.946 . . . . 0.0 111.016 166.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 66.6 m -146.84 93.4 2.27 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 159.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.1 tp -84.62 88.41 7.34 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.388 0.613 . . . . 0.0 109.677 -162.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.6 m -86.27 155.96 20.46 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.055 0.942 . . . . 0.0 110.88 -162.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 14.6 tp -123.06 131.18 53.59 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 170.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.0 p -114.01 107.45 15.69 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 165.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -109.77 91.89 3.83 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.927 0.891 . . . . 0.0 109.261 -175.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.5 p -78.93 93.11 5.0 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.458 0.703 . . . . 0.0 110.004 176.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -59.43 96.0 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 159.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.57 61.31 3.83 Favored Pre-proline 0 CA--C 1.549 0.928 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 172.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -86.94 -99.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 124.123 3.215 . . . . 0.0 110.149 174.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -127.72 133.86 49.55 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 124.47 1.108 . . . . 0.0 110.297 -176.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.86 117.23 42.25 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 126.831 2.052 . . . . 0.0 105.809 174.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.44 -26.77 6.96 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.836 2.358 . . . . 0.0 112.95 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.7 m 140.82 101.73 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 129.553 3.141 . . . . 0.0 108.927 -175.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.518 0 C-N-CA 123.58 0.752 . . . . 0.0 112.845 -178.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.6 m . . . . . 0 C--O 1.232 0.169 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -74.27 67.65 1.41 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 122.306 1.05 . . . . 0.0 109.642 176.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -168.81 -76.79 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 128.53 2.732 . . . . 0.0 104.365 173.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.415 ' H ' ' HB2' ' A' ' 25' ' ' SER . . . -165.68 -58.06 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.374 1.87 . . . . 0.0 110.979 147.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.415 ' HB2' ' H ' ' A' ' 24' ' ' ALA . 25.1 t -146.55 58.43 1.19 Allowed 'General case' 0 C--N 1.344 0.363 0 C-N-CA 130.447 3.499 . . . . 0.0 107.91 13.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -157.24 -54.52 0.08 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.868 2.067 . . . . 0.0 105.677 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.1 mt -27.72 -24.03 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.564 1 C-N-CA 132.658 4.383 . . . . 0.0 116.946 174.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.4 mt -81.6 51.62 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 126.023 1.729 . . . . 0.0 110.649 -160.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.48 164.18 24.96 Favored 'General case' 0 C--N 1.334 -0.101 0 O-C-N 121.348 -0.845 . . . . 0.0 108.742 -176.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -74.86 73.88 2.12 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 122.558 1.17 . . . . 0.0 112.007 -175.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.46 160.37 40.28 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 129.854 3.262 . . . . 0.0 106.624 173.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -146.76 111.46 5.27 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -173.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.82 124.3 72.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -169.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.74 149.12 25.1 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 124.358 1.063 . . . . 0.0 109.336 -176.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.5 t -141.37 96.65 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -171.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.4 m -79.86 107.22 12.47 Favored 'General case' 0 C--O 1.221 -0.422 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 169.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -79.51 166.88 21.49 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 171.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -136.53 90.41 2.55 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 122.137 0.97 . . . . 0.0 111.972 167.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.81 127.25 32.39 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 158.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -132.42 150.87 52.08 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 124.497 1.119 . . . . 0.0 108.248 173.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.97 99.9 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 124.018 0.927 . . . . 0.0 109.339 -178.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.08 169.21 10.81 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.357 0.599 . . . . 0.0 110.058 168.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.29 147.5 35.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 169.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 113.77 -20.6 17.41 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -168.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.56 HD13 ' CD2' ' A' ' 144' ' ' PHE . 0.3 OUTLIER -137.62 95.36 11.29 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 123.77 0.828 . . . . 0.0 109.523 178.046 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -84.31 45.82 1.81 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.679 2.919 . . . . 0.0 110.45 -169.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.497 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 44.4 m0 -113.89 147.03 39.18 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.935 0.894 . . . . 0.0 109.787 -165.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -76.63 81.87 3.28 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 104.588 -2.375 . . . . 0.0 104.588 173.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -90.89 108.83 20.1 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.06 121.54 16.86 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -171.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -81.53 166.3 17.83 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.631 2.221 . . . . 0.0 108.7 168.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.402 ' H ' HG22 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -77.07 -40.41 30.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 122.114 -0.366 . . . . 0.0 111.249 177.96 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -154.64 175.26 13.89 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 172.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -60.35 -59.26 5.69 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 167.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -137.32 130.8 31.28 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 122.853 0.461 . . . . 0.0 112.098 -155.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.7 pt -99.86 175.85 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 169.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -126.97 150.89 49.18 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 152.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.6 m -130.35 131.31 65.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . 0.255 4.3 tpt180 -72.62 74.5 1.08 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 167.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.4 pt 15.68 51.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 131.111 3.764 . . . . 0.0 115.286 -176.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.12 -39.44 0.77 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.491 -169.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -36.01 109.58 0.09 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.743 1.217 . . . . 0.0 111.153 168.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.07 99.06 6.75 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.347 1.459 . . . . 0.0 109.068 -168.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 p -76.52 176.39 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.959 0.885 . . . . 0.0 110.809 -171.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.13 89.84 2.38 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 172.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.9 pp -105.48 118.98 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 173.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 89.6 mtp -77.27 140.56 40.09 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -111.73 145.08 39.94 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 168.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -140.86 135.32 31.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.956 0.902 . . . . 0.0 109.962 -177.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.39 90.97 1.7 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.691 1.996 . . . . 0.0 110.033 174.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -79.32 148.34 32.12 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 117.044 -1.455 . . . . 0.0 107.996 172.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.497 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 35.7 t30 -89.82 110.18 21.13 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 120.332 1.424 . . . . 0.0 111.469 172.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.3 tp -86.88 -4.65 59.2 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.379 1.071 . . . . 0.0 112.809 -176.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.2 171.17 14.96 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.397 -0.815 . . . . 0.0 109.873 -175.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.0 m -105.78 18.54 21.99 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.506 175.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.8 p -144.61 160.17 48.6 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 127.411 2.284 . . . . 0.0 106.428 170.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.07 152.77 79.6 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.523 1.482 . . . . 0.0 109.836 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.36 167.12 15.38 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.445 0.641 . . . . 0.0 111.146 166.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.4 t -98.64 168.24 10.29 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 113.888 -1.506 . . . . 0.0 107.834 156.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -145.26 63.8 0.46 Allowed Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 106.345 -2.702 . . . . 0.0 106.345 173.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.39 56.25 3.29 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 -176.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.51 147.66 32.11 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.148 -1.387 . . . . 0.0 111.177 -164.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 m -79.76 160.89 26.02 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 174.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -143.32 138.99 29.9 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 172.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.97 90.59 4.96 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 169.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.6 57.82 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 O-C-N 121.837 -0.539 . . . . 0.0 110.702 -176.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.1 t -171.17 145.0 1.8 Allowed Pre-proline 0 C--N 1.333 -0.144 0 O-C-N 121.538 -0.726 . . . . 0.0 111.484 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.87 -37.38 66.85 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 121.456 1.437 . . . . 0.0 108.763 164.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.5 ptm -179.95 -68.59 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.556 1.942 . . . . 0.0 107.617 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -90.25 -28.61 18.71 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.138 0.975 . . . . 0.0 112.831 -164.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.44 -114.56 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.396 0.278 . . . . 0.0 110.489 -168.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.27 -40.24 0.47 Allowed Glycine 0 CA--C 1.533 1.18 0 O-C-N 121.314 -0.866 . . . . 0.0 114.778 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -51.87 -65.15 0.61 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.11 1.455 . . . . 0.0 108.302 166.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -72.7 29.0 0.06 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.469 2.308 . . . . 0.0 112.173 177.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -105.18 101.3 10.86 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 168.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -53.88 139.38 33.83 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 122.7 0.4 . . . . 0.0 111.313 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -121.5 135.63 55.01 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.9 m -75.21 -40.17 43.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 122.691 0.396 . . . . 0.0 111.625 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -120.45 -59.33 1.78 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.266 1.026 . . . . 0.0 110.248 -169.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 19.2 t 54.09 50.15 17.23 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.926 0.891 . . . . 0.0 111.668 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -157.9 -69.47 0.09 Allowed 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 59.7 m -101.54 172.81 6.74 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 166.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -137.56 176.37 8.77 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 126.185 1.794 . . . . 0.0 106.331 167.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.9 t -87.94 -17.63 30.9 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.748 0.703 . . . . 0.0 112.212 -159.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -85.5 -59.73 2.23 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.208 0.603 . . . . 0.0 109.885 -169.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . 0.32 13.2 t 52.5 -71.84 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 117.849 2.537 . . . . 0.0 117.849 161.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -159.65 143.75 14.78 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.592 1.557 . . . . 0.0 109.383 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.6 mt -151.77 140.95 21.32 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.217 1.007 . . . . 0.0 110.273 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.9 mp0 -74.89 161.28 78.27 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 127.085 2.154 . . . . 0.0 110.392 172.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -75.51 111.11 3.23 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.74 1.626 . . . . 0.0 113.21 -165.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 115.13 -12.13 19.8 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 176.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -85.77 152.09 23.31 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.2 -161.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -107.6 122.37 46.55 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.75 1.22 . . . . 0.0 109.311 -160.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.73 112.7 17.04 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 124.597 1.159 . . . . 0.0 110.213 177.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -143.05 145.87 33.3 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.759 0.709 . . . . 0.0 110.176 160.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 23.5 ptm -156.3 156.27 30.0 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-O 119.135 -0.46 . . . . 0.0 111.051 173.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.89 148.23 81.88 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.374 2.716 . . . . 0.0 111.996 171.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.6 t -126.23 134.6 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.93 1.692 . . . . 0.0 106.878 167.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.6 p -100.02 143.96 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.999 1.32 . . . . 0.0 108.015 174.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -158.95 146.85 17.85 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -176.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -164.77 95.34 0.71 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.034 0.533 . . . . 0.0 111.81 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.2 t -40.64 130.71 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 125.936 1.694 . . . . 0.0 112.99 -173.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.3 119.71 77.28 Favored Pre-proline 0 N--CA 1.44 -0.968 0 C-N-CA 125.277 1.431 . . . . 0.0 107.283 -169.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.13 55.8 4.67 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.147 2.565 . . . . 0.0 111.823 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -109.5 -28.68 8.78 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.997 2.119 . . . . 0.0 109.523 169.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.4 tt -54.98 -42.98 67.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -173.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.6 m -78.09 51.89 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 118.78 0.718 . . . . 0.0 111.037 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -139.42 -69.59 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.901 -177.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -73.48 152.41 48.9 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.295 1.996 . . . . 0.0 113.449 -175.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.5 p -55.27 -30.91 25.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.136 1.374 . . . . 0.0 111.886 175.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -36.23 -55.3 0.8 Allowed 'General case' 0 C--N 1.339 0.115 0 C-N-CA 126.691 1.996 . . . . 0.0 112.311 173.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.4 p -108.58 -54.93 2.45 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.121 -163.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 26.67 51.84 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.382 2.673 . . . . 0.0 115.229 169.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 144.57 -40.58 1.15 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -170.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 35.0 mm -55.64 119.55 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 169.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.96 45.35 0.39 Allowed 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 123.711 0.632 . . . . 0.0 109.737 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.43 91.6 1.99 Allowed 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 171.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.1 mp -76.07 150.06 37.36 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -172.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.7 t -148.21 175.57 10.95 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -178.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.5 tt -154.32 110.3 3.22 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 174.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.8 t -87.82 95.96 10.28 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.19 92.88 6.37 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -174.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.14 89.33 5.99 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 122.245 1.021 . . . . 0.0 110.584 -170.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.56 ' CD2' HD13 ' A' ' 45' ' ' LEU . 4.1 m-30 -78.14 98.19 5.73 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.733 173.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -153.05 37.66 0.11 Allowed Pre-proline 0 CA--C 1.552 1.032 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 172.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.54 ' CD ' HD12 ' A' ' 45' ' ' LEU . 69.6 Cg_endo -72.8 -90.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.694 0 CA-C-N 122.033 1.762 . . . . 0.0 113.557 -174.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 31.9 mtt85 -148.58 110.12 4.45 Favored 'General case' 0 C--N 1.34 0.187 0 O-C-N 121.352 -0.843 . . . . 0.0 109.211 -174.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -97.26 122.07 56.96 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 172.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -79.46 -51.68 0.06 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.55 2.167 . . . . 0.0 110.512 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 44.6 p -171.67 111.23 0.31 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.993 -0.527 . . . . 0.0 109.587 -167.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.7 pttm . . . . . 0 CA--C 1.538 0.506 0 C-N-CA 123.362 0.665 . . . . 0.0 112.398 172.621 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.1 t . . . . . 0 CA--C 1.539 0.53 0 N-CA-C 110.751 -0.092 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 48.06 63.73 1.93 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.572 1.149 . . . . 0.0 112.102 173.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.0 -4.12 2.21 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 124.257 1.023 . . . . 0.0 112.691 -177.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.77 120.59 15.75 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 116.758 -1.977 . . . . 0.0 108.263 -107.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.8 t -164.7 47.03 0.1 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.377 1.071 . . . . 0.0 109.822 -171.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -156.4 -51.39 0.08 Allowed 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 124.494 1.118 . . . . 0.0 108.372 -175.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.31 -27.73 69.23 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.782 175.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.531 ' C ' HD13 ' A' ' 29' ' ' LEU . 3.6 mt -80.81 131.73 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 C-N-CA 123.731 0.812 . . . . 0.0 112.165 -161.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.531 HD13 ' C ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -114.94 148.97 38.02 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 171.18 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -78.26 67.29 4.03 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 122.128 0.966 . . . . 0.0 112.154 -167.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.405 ' OE2' ' NZ ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -103.56 -169.54 1.66 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 129.556 3.142 . . . . 0.0 106.381 175.397 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -145.31 137.13 25.48 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.305 -0.872 . . . . 0.0 110.217 168.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.556 HD12 HG21 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -132.42 103.67 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 C-N-CA 126.162 1.785 . . . . 0.0 106.65 -177.903 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -79.4 131.1 36.0 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -177.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.421 HG11 ' CE1' ' A' ' 120' ' ' PHE . 52.1 t -113.1 132.76 61.03 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -177.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.2 m -106.7 101.53 10.97 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.299 1.44 . . . . 0.0 109.235 -173.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -79.05 84.22 5.07 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -171.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -84.19 83.61 7.91 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 122.931 1.348 . . . . 0.0 111.447 -172.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.74 123.49 31.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.699 176.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -131.22 142.87 50.23 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 173.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.7 t -135.78 141.91 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -117.71 157.09 27.12 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 161.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.95 -33.14 7.29 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.812 0.845 . . . . 0.0 112.299 -175.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -31.21 -44.69 0.11 Allowed Glycine 0 CA--C 1.531 1.089 0 C-N-CA 126.828 2.156 . . . . 0.0 114.323 165.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.646 HD13 ' CD2' ' A' ' 144' ' ' PHE . 0.5 OUTLIER -102.37 108.57 57.79 Favored Pre-proline 0 N--CA 1.454 -0.225 0 CA-C-N 119.475 1.638 . . . . 0.0 107.008 161.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.76 -3.51 12.41 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 121.148 1.232 . . . . 0.0 113.3 -164.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.512 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 47.6 m0 -73.34 154.73 39.98 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.591 1.156 . . . . 0.0 111.297 -167.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -76.6 81.75 3.26 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 171.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -95.65 124.42 39.66 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.6 m -125.8 138.08 31.3 Favored Pre-proline 0 CA--C 1.532 0.256 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -70.18 161.47 45.88 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 N-CA-C 108.377 -1.432 . . . . 0.0 108.377 161.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -77.78 -46.73 26.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 175.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -155.77 174.81 14.77 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 166.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -67.11 -33.42 75.43 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.118 0.417 . . . . 0.0 111.836 -174.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.76 161.72 39.78 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.025 0.93 . . . . 0.0 110.346 -171.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.5 pt -130.37 160.28 41.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 172.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -106.65 95.37 5.69 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.221 1.008 . . . . 0.0 109.359 168.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.2 t -77.54 167.35 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 168.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 23.1 mtm180 -128.35 98.47 5.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 171.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.1 pt 9.05 69.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 127.76 2.424 . . . . 0.0 114.725 -175.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.27 -34.26 2.74 Favored Glycine 0 C--O 1.22 -0.768 0 C-N-CA 124.807 1.194 . . . . 0.0 111.33 173.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -50.08 106.52 0.12 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 118.83 1.315 . . . . 0.0 112.245 -166.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.2 m -67.82 108.94 3.17 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.648 1.179 . . . . 0.0 111.359 -171.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.1 p -86.81 176.48 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 123.299 0.64 . . . . 0.0 110.322 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -124.52 129.97 51.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.819 0.848 . . . . 0.0 109.471 161.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.5 pp -139.45 96.12 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.655 1.182 . . . . 0.0 110.661 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 35.7 ttm -77.59 100.05 5.97 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.934 0.894 . . . . 0.0 111.342 -174.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -77.65 164.52 25.23 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.886 -0.509 . . . . 0.0 110.92 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.8 ttm105 -144.94 138.39 26.85 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.542 1.137 . . . . 0.0 111.799 -177.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.19 149.51 48.96 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 130.041 3.336 . . . . 0.0 107.608 159.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -137.17 135.62 37.49 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 161.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.512 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 0.1 OUTLIER -79.89 83.6 5.79 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.644 1.111 . . . . 0.0 111.301 -172.906 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.42 75.98 8.36 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.923 1.289 . . . . 0.0 108.902 171.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.06 158.62 44.16 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 167.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.1 t -87.6 -1.22 57.8 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 119.148 -0.453 . . . . 0.0 111.88 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.11 160.83 41.79 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.788 1.235 . . . . 0.0 109.076 -175.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.37 139.93 32.66 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.18 2.587 . . . . 0.0 111.902 -170.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.3 p -105.59 -176.07 2.97 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.393 1.877 . . . . 0.0 110.69 -169.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.4 t -148.39 136.05 20.69 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 160.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -123.42 76.01 0.37 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -170.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.86 33.21 1.05 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.495 0.718 . . . . 0.0 110.812 -171.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.51 162.11 29.91 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.365 0.602 . . . . 0.0 111.733 -162.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.4 t -144.44 178.06 8.21 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.288 0.635 . . . . 0.0 109.802 175.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.17 164.85 26.75 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 125.955 1.702 . . . . 0.0 110.973 -167.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -120.82 86.73 2.62 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.927 1.691 . . . . 0.0 107.103 174.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.56 HG11 ' CD2' ' A' ' 95' ' ' PHE . 3.2 t -82.31 54.47 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.823 -164.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.2 t -171.47 143.21 1.48 Allowed Pre-proline 0 N--CA 1.457 -0.112 0 O-C-N 121.393 -0.817 . . . . 0.0 110.317 -169.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.02 -36.43 30.14 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 121.695 1.597 . . . . 0.0 108.044 169.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.5 ptp 177.31 -68.26 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 127.824 2.449 . . . . 0.0 106.745 176.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.87 -48.33 69.12 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.719 1.208 . . . . 0.0 113.055 -165.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.27 -102.3 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.669 -162.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.23 -61.04 0.25 Allowed Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.498 -0.612 . . . . 0.0 113.352 -173.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -45.59 -50.79 12.84 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.004 1.322 . . . . 0.0 111.216 177.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -72.93 5.19 3.45 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.906 1.283 . . . . 0.0 113.632 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.56 ' CD2' HG11 ' A' ' 86' ' ' VAL . 9.6 t80 -72.35 131.39 42.58 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 121.098 -1.001 . . . . 0.0 109.8 174.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -81.41 95.64 7.12 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 119.822 -0.751 . . . . 0.0 112.878 172.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -119.73 176.17 5.52 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.865 1.266 . . . . 0.0 109.981 164.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.9 m -79.69 -154.0 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 124.194 0.998 . . . . 0.0 108.906 162.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -77.08 -179.57 5.66 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.332 -0.855 . . . . 0.0 110.857 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.8 t 64.72 -163.28 0.26 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.538 1.135 . . . . 0.0 111.431 174.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -171.11 -178.01 2.33 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.409 1.884 . . . . 0.0 107.311 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 65.4 m 75.32 168.81 0.28 Allowed 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 126.481 1.913 . . . . 0.0 111.555 -175.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -122.97 68.36 0.98 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 164.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 21.0 p -75.89 78.13 2.79 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 173.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -78.46 43.34 0.46 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.807 1.243 . . . . 0.0 111.168 -175.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.9 t 42.99 -145.17 0.08 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.104 1.762 . . . . 0.0 112.989 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -119.22 124.66 47.28 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 127.586 2.354 . . . . 0.0 106.101 177.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.453 HD11 ' HG3' ' A' ' 114' ' ' MET . 97.3 mt -106.3 151.52 24.73 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 173.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.421 ' HB3' ' HD2' ' A' ' 110' ' ' PRO . 17.7 mt-10 -91.97 163.76 26.25 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 126.012 1.725 . . . . 0.0 108.394 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 109' ' ' GLU . 69.8 Cg_endo -70.73 79.88 1.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.647 2.898 . . . . 0.0 112.272 -167.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 157.85 -29.87 0.49 Allowed Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.821 -175.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -76.29 135.18 39.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.573 1.187 . . . . 0.0 112.034 -153.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -86.83 137.6 32.27 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.295 1.438 . . . . 0.0 110.57 -178.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.453 ' HG3' HD11 ' A' ' 108' ' ' LEU . 1.7 mmt -133.9 85.53 2.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.088 1.355 . . . . 0.0 109.532 176.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.68 128.25 45.12 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.35 0.66 . . . . 0.0 109.444 173.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 84.9 mtp -150.98 147.54 20.96 Favored Pre-proline 0 C--O 1.234 0.241 0 C-N-CA 123.399 0.68 . . . . 0.0 109.812 -165.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.18 146.28 63.25 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.785 2.323 . . . . 0.0 110.44 174.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.7 t -144.32 147.51 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.0 m -109.34 164.59 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 174.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.421 ' CE1' HG11 ' A' ' 35' ' ' VAL . 4.1 t80 -156.1 129.49 8.22 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.65 168.83 23.13 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 122.904 0.482 . . . . 0.0 110.476 168.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.556 HG21 HD12 ' A' ' 33' ' ' ILE . 18.2 t -119.14 129.46 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.809 1.243 . . . . 0.0 109.709 176.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.89 133.54 58.19 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 118.923 0.783 . . . . 0.0 110.249 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -56.34 -23.03 44.29 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.328 2.685 . . . . 0.0 114.767 -171.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -56.75 -13.68 2.72 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 119.182 0.901 . . . . 0.0 112.861 176.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.4 tt -46.05 -42.32 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 O-C-N 121.087 -1.008 . . . . 0.0 111.718 165.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.2 m -87.09 63.15 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 119.372 0.987 . . . . 0.0 110.9 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 51.8 mttt -130.27 -67.8 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 124.184 0.994 . . . . 0.0 112.345 164.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -85.27 162.66 11.34 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 121.8 1.666 . . . . 0.0 114.188 -160.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 99.2 t -53.96 -35.1 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 125.754 1.622 . . . . 0.0 110.874 176.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -38.54 -57.12 1.2 Allowed 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.475 1.51 . . . . 0.0 111.169 173.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 14.1 p -102.8 -53.45 2.85 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 123.965 0.906 . . . . 0.0 109.197 -163.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 26.15 55.34 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.152 2.581 . . . . 0.0 115.175 174.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 134.99 -36.98 1.99 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -176.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.1 mm -51.43 125.97 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 123.182 0.593 . . . . 0.0 109.864 173.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.405 ' NZ ' ' OE2' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -156.4 49.57 0.49 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.78 0.832 . . . . 0.0 109.79 175.726 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.18 89.91 1.77 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -178.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.431 HD22 HG22 ' A' ' 122' ' ' VAL . 2.0 mp -76.44 162.25 28.0 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 122.294 1.045 . . . . 0.0 108.81 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.4 t -155.03 178.79 9.8 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.94 88.53 1.47 Allowed 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 124.471 1.107 . . . . 0.0 109.029 165.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.1 t -75.72 107.26 7.77 Favored 'General case' 0 N--CA 1.457 -0.093 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -178.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -112.67 137.05 51.52 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 122.775 0.43 . . . . 0.0 109.888 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 32.2 m -118.45 91.51 3.58 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.532 1.533 . . . . 0.0 107.82 177.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.646 ' CD2' HD13 ' A' ' 45' ' ' LEU . 3.5 m-85 -72.27 97.72 2.05 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.946 178.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -156.11 58.28 1.71 Allowed Pre-proline 0 CA--C 1.551 1.018 0 N-CA-C 116.894 2.183 . . . . 0.0 116.894 -177.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.415 ' HD3' HD12 ' A' ' 45' ' ' LEU . 74.5 Cg_endo -80.68 -90.8 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.424 2.749 . . . . 0.0 112.445 175.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.17 104.97 2.85 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.658 0.663 . . . . 0.0 111.631 -171.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -79.3 140.12 56.4 Favored Pre-proline 0 N--CA 1.449 -0.522 0 O-C-N 121.547 -0.721 . . . . 0.0 109.173 174.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -84.35 60.17 6.08 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 121.981 1.787 . . . . 0.0 107.711 169.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 19.9 m 44.39 81.27 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.88 2.072 . . . . 0.0 113.514 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.7 pttt . . . . . 0 CA--C 1.543 0.677 0 CA-C-N 119.026 0.83 . . . . 0.0 112.111 -170.001 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 38.92 57.03 1.95 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.782 1.633 . . . . 0.0 112.194 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -143.47 165.69 26.85 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 122.82 1.295 . . . . 0.0 111.076 176.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.468 ' CB ' ' H ' ' A' ' 63' ' ' THR . . . -149.16 95.17 2.34 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 110.829 -2.896 . . . . 0.0 104.165 175.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.3 m -157.27 25.71 0.3 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -159.26 -55.13 0.06 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 -174.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.62 37.26 0.86 Allowed 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 112.699 -2.046 . . . . 0.0 110.892 -161.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.406 HD11 ' C ' ' A' ' 24' ' ' ALA . 7.8 mt -111.85 107.7 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 122.745 0.418 . . . . 0.0 109.895 -168.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -103.49 140.98 36.77 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.22 -29.85 34.69 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.516 1.926 . . . . 0.0 113.857 -169.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.09 148.6 6.03 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.953 1.301 . . . . 0.0 110.648 -178.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.5 mmmt -120.48 89.33 3.11 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.891 1.676 . . . . 0.0 108.677 -158.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.45 141.83 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 123.42 0.688 . . . . 0.0 110.348 -176.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -99.14 145.8 26.8 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.509 1.524 . . . . 0.0 108.54 -172.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.1 t -136.14 98.12 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 -173.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.6 m -88.12 105.76 17.71 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -83.74 109.23 17.33 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.651 1.18 . . . . 0.0 108.202 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -107.01 86.24 2.28 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.553 0.692 . . . . 0.0 110.055 -173.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.96 112.2 23.05 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.453 -0.78 . . . . 0.0 110.382 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -111.65 122.21 47.21 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.117 0.967 . . . . 0.0 109.668 -177.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.6 t -100.46 108.76 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 170.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.14 154.65 31.03 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 162.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.45 -38.28 8.9 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.42 0.688 . . . . 0.0 111.655 177.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -39.15 -34.77 0.36 Allowed Glycine 0 CA--C 1.53 1.031 0 C-N-CA 126.992 2.234 . . . . 0.0 114.694 172.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.445 HD21 ' CE3' ' A' ' 47' ' ' TRP . 0.4 OUTLIER -108.95 101.1 43.07 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 119.567 1.684 . . . . 0.0 108.497 165.873 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -83.37 46.19 2.04 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.877 3.051 . . . . 0.0 110.857 -170.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.522 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 44.7 m0 -116.06 157.13 25.17 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 125.034 1.334 . . . . 0.0 108.735 -172.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -74.3 141.66 45.26 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 162.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -147.44 113.82 5.94 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 169.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.0 t -100.15 111.4 62.19 Favored Pre-proline 0 N--CA 1.439 -1.011 0 C-N-CA 127.036 2.134 . . . . 0.0 107.058 -172.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -62.77 146.67 95.16 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.533 2.156 . . . . 0.0 107.757 167.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -75.79 -46.8 34.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -170.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -151.82 165.97 32.86 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 152.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -57.42 -41.1 79.72 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 118.366 0.53 . . . . 0.0 111.048 -174.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.95 158.36 43.87 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 122.95 0.5 . . . . 0.0 110.223 -176.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.4 pt -126.62 168.4 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 C-N-CA 123.461 0.705 . . . . 0.0 109.613 168.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -95.47 146.35 24.49 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 154.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.25 141.23 45.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 104.183 -2.525 . . . . 0.0 104.183 156.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -64.47 164.91 10.71 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 120.541 1.519 . . . . 0.0 107.774 160.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.422 HG22 ' HB3' ' A' ' 124' ' ' PRO . 3.8 mm -63.74 91.61 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.9 33.22 5.33 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.802 1.667 . . . . 0.0 113.783 178.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -102.3 107.02 17.92 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.034 1.417 . . . . 0.0 112.694 176.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.468 ' H ' ' CB ' ' A' ' 24' ' ' ALA . 15.9 m -66.71 113.7 5.04 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.114 1.366 . . . . 0.0 111.318 177.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.1 p -126.51 146.69 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 118.45 0.568 . . . . 0.0 110.373 169.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.21 137.96 31.93 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 125.516 1.526 . . . . 0.0 110.552 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -141.94 97.71 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 17.1 tmm? -78.92 126.56 30.86 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.936 1.294 . . . . 0.0 111.678 -176.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -102.35 143.91 31.5 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.829 1.252 . . . . 0.0 109.682 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 42.8 ttt85 -126.24 141.19 52.02 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 125.025 1.33 . . . . 0.0 109.283 -176.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.91 166.15 27.63 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.284 1.833 . . . . 0.0 109.903 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -153.95 147.76 25.4 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.308 1.043 . . . . 0.0 108.738 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.522 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 46.2 t-20 -83.95 115.75 22.46 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 119.879 1.218 . . . . 0.0 111.215 175.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 81.5 mt -106.75 16.32 24.57 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.621 1.169 . . . . 0.0 112.582 -178.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.28 164.76 12.9 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.416 -0.802 . . . . 0.0 109.726 169.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.0 m -96.83 30.02 2.82 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.864 176.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.3 p -149.57 161.3 32.12 Favored Pre-proline 0 N--CA 1.448 -0.528 0 C-N-CA 125.082 1.353 . . . . 0.0 108.363 178.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.72 121.55 8.25 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 121.555 1.503 . . . . 0.0 109.032 170.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.5 159.3 15.26 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.334 0.587 . . . . 0.0 110.885 171.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.9 t -97.93 158.63 15.42 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 162.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -153.15 77.79 0.21 Allowed Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 105.366 -3.094 . . . . 0.0 105.366 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.52 66.26 0.68 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 175.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.19 168.34 19.32 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.482 -166.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 35.3 m -106.39 159.15 16.36 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -147.77 143.91 27.86 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.958 -0.464 . . . . 0.0 110.341 171.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.98 101.26 12.7 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 166.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.6 p -87.7 81.17 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.0 t 176.54 150.72 0.34 Allowed Pre-proline 0 CA--C 1.529 0.164 0 C-N-CA 125.556 1.542 . . . . 0.0 109.15 178.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.65 -35.21 22.92 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 CA-C-N 119.364 0.809 . . . . 0.0 110.383 157.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.5 ptp 176.68 -67.05 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 127.163 2.185 . . . . 0.0 107.545 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.18 -41.75 33.66 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -169.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.33 -104.07 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.88 0.372 . . . . 0.0 111.816 -166.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.14 -54.67 0.59 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 123.925 0.774 . . . . 0.0 113.26 -172.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -47.25 -52.83 14.95 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.987 1.394 . . . . 0.0 110.927 176.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -74.22 10.21 1.34 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.401 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . 29.5 t80 -81.86 98.48 8.53 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 172.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -67.49 148.73 51.12 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 117.66 -1.616 . . . . 0.0 109.752 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? 61.87 69.17 0.65 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.294 1.038 . . . . 0.0 110.116 -176.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.8 m -71.27 153.07 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.374 166.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 51.13 -138.58 1.04 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.18 0.992 . . . . 0.0 111.068 175.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 7.4 t -167.62 60.97 0.08 Allowed 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 44.4 t80 48.62 -111.03 0.41 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.642 0.777 . . . . 0.0 109.777 -172.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 19.6 p -70.86 4.52 2.51 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.941 1.696 . . . . 0.0 114.156 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.6 t80 101.75 156.5 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 127.989 2.516 . . . . 0.0 110.78 168.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 28.1 m -80.25 -94.7 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.341 1.056 . . . . 0.0 109.777 -173.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 9.2 pm0 -61.72 162.23 8.92 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.93 0.892 . . . . 0.0 111.273 171.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.4 -70.34 0.13 Allowed 'General case' 0 CA--C 1.529 0.163 0 O-C-N 121.623 -0.673 . . . . 0.0 112.121 178.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.1 t -157.46 146.87 20.09 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.186 0.994 . . . . 0.0 108.73 -176.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.6 mt -150.44 136.1 18.2 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.764 0.711 . . . . 0.0 110.589 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -76.29 163.65 64.98 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.487 1.115 . . . . 0.0 109.967 174.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.42 106.1 1.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.242 1.961 . . . . 0.0 111.651 -163.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 111.58 -3.05 27.73 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 124.098 0.856 . . . . 0.0 111.24 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -76.6 146.14 38.46 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 118.368 1.084 . . . . 0.0 110.888 -173.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -97.09 147.24 24.24 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.669 1.188 . . . . 0.0 109.25 -176.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 17.2 ttt -150.95 111.42 4.2 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 118.734 -0.651 . . . . 0.0 111.169 -173.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -132.28 146.55 52.07 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 119.74 1.155 . . . . 0.0 111.249 172.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 19.1 mmt -142.63 138.55 16.32 Favored Pre-proline 0 C--O 1.235 0.32 0 C-N-CA 125.18 1.392 . . . . 0.0 109.63 -171.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.89 144.3 27.29 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 121.933 1.756 . . . . 0.0 110.183 171.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.4 t -124.26 158.87 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 164.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.2 p -145.83 146.3 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -154.38 146.59 23.78 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -165.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -160.08 156.0 26.14 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 128.119 2.568 . . . . 0.0 108.776 164.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.6 p -78.45 150.31 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 O-C-N 121.796 -0.565 . . . . 0.0 109.672 171.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -82.64 125.42 75.92 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.175 167.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.422 ' HB3' HG22 ' A' ' 60' ' ' ILE . 37.9 Cg_endo -70.92 41.77 0.4 Allowed 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.672 2.914 . . . . 0.0 115.775 -177.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -112.7 -21.2 11.35 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 125.718 1.607 . . . . 0.0 111.036 168.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 16.2 tt -43.48 -41.76 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 119.691 1.132 . . . . 0.0 113.572 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.8 m -76.46 61.61 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 O-C-N 121.815 -0.553 . . . . 0.0 111.341 172.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -137.51 -66.09 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 117.698 -1.144 . . . . 0.0 113.05 170.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -76.91 154.39 33.63 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 CA-C-N 121.802 1.679 . . . . 0.0 113.638 -169.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.4 t -54.93 -37.1 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 125.76 1.624 . . . . 0.0 110.826 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -52.58 -47.13 67.07 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.87 1.268 . . . . 0.0 111.829 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 35.4 p -91.85 -51.57 5.16 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -173.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 15.77 60.71 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 129.278 3.031 . . . . 0.0 115.911 175.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 136.29 -33.92 2.31 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-O 119.143 -0.81 . . . . 0.0 111.77 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 10.2 mm -51.07 128.27 8.39 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 C-N-CA 124.302 1.041 . . . . 0.0 110.433 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -157.76 48.22 0.39 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.43 0.692 . . . . 0.0 111.005 176.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.3 p -140.7 88.49 2.19 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 175.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' A' ' 95' ' ' PHE . 2.1 tp -88.06 84.93 6.9 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 118.899 -1.121 . . . . 0.0 109.026 -160.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.2 m -87.95 143.51 27.06 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.879 -169.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.5 tt -116.36 118.23 32.16 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 160.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.3 t -98.29 102.6 14.39 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 173.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.01 129.47 34.87 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.291 1.436 . . . . 0.0 107.559 -177.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.4 p -114.74 93.48 4.34 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.13 1.372 . . . . 0.0 109.212 174.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -76.18 95.52 3.71 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 167.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.69 46.67 0.3 Allowed Pre-proline 0 CA--C 1.556 1.174 0 N-CA-C 117.369 2.359 . . . . 0.0 117.369 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.39 -83.36 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.538 2.826 . . . . 0.0 113.013 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -149.29 136.68 20.1 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 118.904 0.774 . . . . 0.0 110.295 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -117.3 139.26 25.81 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 164.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -84.16 -52.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 121.917 1.745 . . . . 0.0 108.793 169.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.5 m -169.89 150.99 3.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.667 2.387 . . . . 0.0 106.676 177.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 12.9 pttt . . . . . 0 CA--C 1.535 0.381 0 C-N-CA 125.464 1.506 . . . . 0.0 108.54 174.602 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 0 N--CA 1.467 0.411 0 CA-C-O 122.209 1.004 . . . . 0.0 108.965 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 25.42 49.28 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.163 1.785 . . . . 0.0 111.764 -149.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -169.06 162.4 10.91 Favored 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 130.205 3.402 . . . . 0.0 104.67 177.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.95 98.91 3.88 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 175.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -113.85 36.26 3.74 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.952 0.901 . . . . 0.0 110.741 -169.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -159.81 -51.22 0.05 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.936 2.094 . . . . 0.0 107.051 -174.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.9 mt -72.13 -7.13 47.33 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.831 -168.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.6 mt -78.24 70.78 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 O-C-N 120.687 -1.258 . . . . 0.0 109.242 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.452 HD13 ' N ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -85.14 167.84 15.38 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 169.329 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -81.51 56.03 2.83 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 120.745 -1.222 . . . . 0.0 114.217 -166.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -113.74 104.54 12.31 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 122.788 1.28 . . . . 0.0 109.718 167.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.2 tttp -76.38 85.19 3.14 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 169.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.1 tp -83.52 162.88 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 174.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.44 150.22 46.25 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -167.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 81.0 t -142.85 126.28 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -172.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.5 m -95.56 109.02 21.31 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.499 1.52 . . . . 0.0 107.632 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.809 ' CE1' HD12 ' A' ' 56' ' ' ILE . 15.3 m-85 -81.21 131.67 35.31 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.839 1.256 . . . . 0.0 109.133 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -126.87 86.68 2.54 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 122.786 1.279 . . . . 0.0 110.378 -170.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.24 105.76 18.0 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.153 -0.967 . . . . 0.0 109.937 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -109.19 147.16 32.98 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 176.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.1 p -140.46 148.31 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.399 1.08 . . . . 0.0 108.166 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.69 168.95 18.32 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 167.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.62 -31.41 16.0 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -170.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.62 -34.82 3.88 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.217 1.389 . . . . 0.0 113.385 172.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.621 HD13 ' CD2' ' A' ' 144' ' ' PHE . 0.5 OUTLIER -119.16 91.06 43.05 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 167.777 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -80.77 55.25 5.6 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.387 2.725 . . . . 0.0 109.255 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.519 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 41.4 m0 -114.65 147.86 38.99 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.609 1.163 . . . . 0.0 109.257 -174.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -75.47 80.42 2.51 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -89.49 100.0 12.89 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.868 0.867 . . . . 0.0 109.306 -170.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.1 t -103.43 122.08 46.27 Favored Pre-proline 0 N--CA 1.443 -0.817 0 C-N-CA 124.027 0.931 . . . . 0.0 109.6 -168.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -75.46 138.08 21.51 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 123.648 2.899 . . . . 0.0 107.8 163.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.2 t -79.69 -46.73 22.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.572 0.701 . . . . 0.0 109.407 -173.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -149.25 150.36 32.44 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.528 1.931 . . . . 0.0 106.772 173.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -61.77 -36.68 81.75 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 123.814 0.696 . . . . 0.0 110.617 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -146.68 151.12 36.71 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 122.652 0.381 . . . . 0.0 111.208 -174.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.809 HD12 ' CE1' ' A' ' 37' ' ' PHE . 64.5 mt -122.57 137.91 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 127.0 2.12 . . . . 0.0 106.866 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -98.42 152.43 19.5 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.238 1.015 . . . . 0.0 109.39 164.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -154.08 127.33 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 -170.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.9 mmt85 -74.75 86.84 2.2 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 166.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.7 pt 7.57 64.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 128.206 2.602 . . . . 0.0 115.008 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.79 -35.63 1.49 Allowed Glycine 0 CA--C 1.522 0.523 0 O-C-N 121.915 -0.491 . . . . 0.0 112.807 -174.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 62.7 tt0 -42.57 107.79 0.09 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.172 1.389 . . . . 0.0 111.999 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.56 102.76 8.09 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.425 1.09 . . . . 0.0 110.129 -177.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.0 p -76.31 178.74 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 122.036 0.922 . . . . 0.0 111.505 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -137.16 89.06 2.4 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 124.426 1.09 . . . . 0.0 108.676 168.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.751 HG12 HD11 ' A' ' 56' ' ' ILE . 2.5 pp -100.36 134.22 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 168.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 65.0 mtt -98.32 100.36 11.63 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 126.304 1.842 . . . . 0.0 110.913 -174.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -78.36 157.4 29.11 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -143.68 146.51 33.27 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.37 151.5 49.62 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 128.833 2.853 . . . . 0.0 106.173 166.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -143.81 139.53 29.38 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 166.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.519 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 43.5 t30 -79.1 114.83 18.36 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 120.039 1.291 . . . . 0.0 112.558 -177.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.7 mt -105.79 16.11 25.74 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 125.031 1.332 . . . . 0.0 112.548 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.6 175.44 9.87 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 163.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.8 t -103.57 17.3 24.39 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.103 0.561 . . . . 0.0 110.254 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -155.94 160.64 30.65 Favored Pre-proline 0 N--CA 1.45 -0.472 0 C-N-CA 127.075 2.15 . . . . 0.0 106.29 -174.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.27 124.81 11.22 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.481 1.454 . . . . 0.0 110.326 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.416 HG23 ' HD3' ' A' ' 149' ' ' PRO . 0.2 OUTLIER -86.58 177.79 7.27 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.398 0.618 . . . . 0.0 109.553 168.042 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.8 t -113.61 161.68 17.14 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 154.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.597 ' HA2' HD11 ' A' ' 45' ' ' LEU . . . -147.38 69.37 0.36 Allowed Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 107.728 -2.149 . . . . 0.0 107.728 -177.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.47 62.65 0.61 Allowed 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 177.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.39 161.64 27.86 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.542 -163.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -83.22 152.08 25.36 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.839 174.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -148.51 148.7 30.53 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.338 0.255 . . . . 0.0 110.647 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -109.04 101.85 10.89 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 125.773 1.629 . . . . 0.0 106.904 171.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.8 p -88.66 58.13 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.474 0 C-N-CA 123.963 0.905 . . . . 0.0 111.086 -176.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.6 t -167.26 145.16 4.03 Favored Pre-proline 0 N--CA 1.468 0.448 0 O-C-N 120.994 -1.066 . . . . 0.0 112.032 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -62.83 -56.77 0.53 Allowed 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.258 1.305 . . . . 0.0 108.805 168.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 23.3 ptp -171.36 20.69 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.886 0.874 . . . . 0.0 111.689 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -170.43 -77.31 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.291 0 O-C-N 121.558 -0.714 . . . . 0.0 109.519 -168.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -46.3 -94.22 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 126.271 1.829 . . . . 0.0 113.238 -169.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 60.71 -52.23 0.03 OUTLIER Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.939 1.257 . . . . 0.0 115.939 -172.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -45.17 -48.97 12.36 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 119.762 1.781 . . . . 0.0 111.34 174.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -71.68 -12.69 61.45 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.256 1.022 . . . . 0.0 113.047 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -71.49 94.98 1.33 Allowed 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -80.51 92.02 5.84 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 118.274 -1.37 . . . . 0.0 110.346 -171.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.99 61.99 1.19 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.356 0.598 . . . . 0.0 109.838 163.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.8 p -71.65 138.18 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 169.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -174.76 121.0 0.23 Allowed 'General case' 0 CA--C 1.526 0.056 0 C-N-CA 125.091 1.357 . . . . 0.0 107.802 167.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 71.3 m 45.01 -119.17 0.74 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.424 1.09 . . . . 0.0 109.864 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -144.72 10.67 1.39 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.429 1.092 . . . . 0.0 111.102 171.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 45.7 t -174.81 125.63 0.28 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 -169.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -87.72 68.56 9.48 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 119.416 1.007 . . . . 0.0 110.658 -157.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.6 m 73.61 -43.63 0.55 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.931 1.692 . . . . 0.0 112.019 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -37.15 130.42 0.86 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.932 1.693 . . . . 0.0 111.315 167.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.541 HG23 ' H ' ' A' ' 107' ' ' THR . 9.2 t -157.68 -74.41 0.09 Allowed 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.531 0.332 . . . . 0.0 110.606 -168.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.541 ' H ' HG23 ' A' ' 106' ' ' THR . 0.9 OUTLIER -159.63 152.01 21.09 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -174.441 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 75.2 mt -148.48 137.69 21.85 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 124.225 1.01 . . . . 0.0 108.322 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -66.94 152.14 96.21 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 169.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.66 106.28 1.24 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.783 2.989 . . . . 0.0 111.136 -171.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 128.19 -23.38 5.21 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -176.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -78.14 142.5 38.0 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 117.808 0.804 . . . . 0.0 111.009 -162.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -100.18 128.92 46.17 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.34 1.856 . . . . 0.0 109.329 -173.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 52.7 ttp -126.87 85.84 2.43 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 126.104 1.761 . . . . 0.0 108.844 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.99 140.89 33.56 Favored 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 168.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 22.8 ptm -153.5 141.57 13.89 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 117.936 0.335 . . . . 0.0 111.887 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -72.22 148.11 49.14 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.717 2.278 . . . . 0.0 110.098 171.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.1 t -136.26 122.19 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 125.927 1.691 . . . . 0.0 107.026 174.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.1 p -99.45 143.15 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 125.762 1.625 . . . . 0.0 107.492 169.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.94 172.27 18.97 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 176.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -158.64 178.46 10.1 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.883 0.873 . . . . 0.0 109.715 164.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 73.5 t -110.22 135.32 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 123.74 0.816 . . . . 0.0 109.267 172.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.22 124.54 76.06 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 122.988 0.515 . . . . 0.0 112.068 -176.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.21 34.47 0.4 Allowed 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.199 2.599 . . . . 0.0 114.105 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.51 -15.04 21.89 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.04 0.936 . . . . 0.0 110.915 162.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 17.8 tt -52.1 -48.97 41.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 118.973 0.806 . . . . 0.0 112.586 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.8 m -80.52 64.08 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.081 0.552 . . . . 0.0 109.677 174.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 45.0 mttp -140.17 -65.21 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 124.271 1.028 . . . . 0.0 111.768 171.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.01 169.29 13.71 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 121.835 1.69 . . . . 0.0 111.443 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.9 t -71.96 -52.31 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 124.227 1.011 . . . . 0.0 109.843 -174.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -46.44 -51.69 14.63 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 125.197 1.399 . . . . 0.0 112.054 -173.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 17.2 p -86.14 -3.74 59.02 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -65.05 75.9 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.857 1.208 . . . . 0.0 111.607 -177.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 148.13 -34.54 1.2 Allowed Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -169.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 45.9 mm -66.86 114.24 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.3 pttt -156.1 47.17 0.47 Allowed 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.49 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.41 97.52 1.76 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 103.69 -2.708 . . . . 0.0 103.69 168.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.4 tp -78.04 162.66 26.55 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -170.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.5 t -151.69 171.61 17.4 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.599 -0.688 . . . . 0.0 109.488 173.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -149.5 100.04 2.96 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 103.908 -2.627 . . . . 0.0 103.908 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 31.1 m -87.5 93.79 9.52 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 173.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.13 134.13 36.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 172.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.7 m -120.06 87.33 2.72 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.992 0.917 . . . . 0.0 108.951 176.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.621 ' CD2' HD13 ' A' ' 45' ' ' LEU . 2.0 m-85 -68.24 84.55 0.25 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.928 0.891 . . . . 0.0 109.614 175.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -151.49 46.4 0.37 Allowed Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 178.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.52 -79.36 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.584 2.189 . . . . 0.0 112.731 -175.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.46 107.79 2.23 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.622 -0.674 . . . . 0.0 111.537 -173.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -78.89 144.05 63.23 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 173.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.416 ' HD3' HG23 ' A' ' 78' ' ' THR . 61.0 Cg_endo -72.41 -50.18 0.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.972 1.782 . . . . 0.0 107.992 160.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.9 t -179.5 -168.71 0.12 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 128.869 2.868 . . . . 0.0 105.32 169.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.589 0 C-N-CA 124.241 1.017 . . . . 0.0 111.184 174.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.456 -0.159 0 CA-C-O 122.205 1.002 . . . . 0.0 108.77 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 74.31 158.77 0.21 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.64 1.576 . . . . 0.0 111.227 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.578 ' O ' HG23 ' A' ' 63' ' ' THR . 3.0 mp0 60.65 -113.62 0.58 Allowed 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 -168.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -175.24 4.67 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.562 1.545 . . . . 0.0 111.862 136.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.8 t -73.07 51.35 0.3 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.385 1.874 . . . . 0.0 114.85 -167.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -76.07 -34.86 59.59 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 131.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 63.1 mt -108.47 -44.49 4.08 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -172.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.2 mt -35.4 137.78 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 126.614 1.966 . . . . 0.0 115.501 -164.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.9 mp -111.71 -82.85 0.58 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.147 1.379 . . . . 0.0 109.141 -174.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -172.85 -66.22 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.35 1.46 . . . . 0.0 108.997 -178.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -36.67 132.65 0.61 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 126.678 1.991 . . . . 0.0 113.598 -168.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -76.2 90.17 3.12 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.158 -1.837 . . . . 0.0 107.253 176.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.7 112.34 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 167.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.79 154.22 30.09 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.4 t -134.97 133.38 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 176.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 29.4 m -114.14 108.57 17.15 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -81.17 102.98 10.65 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.662 1.585 . . . . 0.0 108.945 176.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -98.42 87.1 3.77 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.857 0.836 . . . . 0.0 109.596 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.21 126.07 31.06 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.169 0.588 . . . . 0.0 110.614 175.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -129.65 146.44 51.43 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.797 1.239 . . . . 0.0 108.191 175.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.5 p -138.44 144.0 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 124.076 0.95 . . . . 0.0 108.991 177.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.21 165.48 19.54 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 166.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -43.62 -39.71 3.69 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.211 1.004 . . . . 0.0 112.185 -177.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -34.06 -36.55 0.06 OUTLIER Glycine 0 CA--C 1.535 1.282 0 C-N-CA 126.948 2.213 . . . . 0.0 115.01 171.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.45 HD13 ' CG ' ' A' ' 144' ' ' PHE . 0.2 OUTLIER -118.82 102.76 49.15 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 119.099 1.45 . . . . 0.0 107.871 161.645 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.43 40.94 1.05 Allowed 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.764 2.309 . . . . 0.0 111.223 -170.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.509 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 45.1 m0 -116.39 151.06 36.73 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.367 1.067 . . . . 0.0 110.614 -165.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -76.33 80.83 3.08 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -177.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -87.14 106.27 17.76 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.396 0.678 . . . . 0.0 109.35 -172.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.8 t -115.9 119.93 36.43 Favored Pre-proline 0 N--CA 1.443 -0.814 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -168.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.82 154.25 38.57 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 C-N-CA 124.118 3.212 . . . . 0.0 107.936 168.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 t -85.7 -58.95 3.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -168.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.6 mp0 -132.45 162.19 31.79 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 162.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -61.46 -39.79 92.16 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 174.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.79 164.72 26.62 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.796 0.839 . . . . 0.0 112.496 -176.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.7 pt -132.47 162.0 40.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 124.521 1.129 . . . . 0.0 109.747 168.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -118.28 83.78 2.07 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 127.444 2.298 . . . . 0.0 110.067 -173.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.75 129.3 43.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 O-C-N 120.833 -1.167 . . . . 0.0 109.494 -178.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -78.37 96.32 5.3 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 174.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.447 HD13 HG21 ' A' ' 60' ' ' ILE . 0.7 OUTLIER -10.06 87.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.068 1.747 . . . . 0.0 114.966 -159.392 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.59 -31.66 4.74 Favored Glycine 0 C--O 1.222 -0.641 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 176.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -53.11 118.38 3.71 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 -175.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.67 HG22 ' CD1' ' A' ' 121' ' ' PHE . 20.2 p -71.23 115.69 10.67 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.745 2.018 . . . . 0.0 111.71 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.0 p -97.68 161.92 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 123.514 0.726 . . . . 0.0 110.112 169.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -105.36 120.01 40.52 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.231 1.012 . . . . 0.0 110.727 164.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.8 pp -130.18 116.56 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 171.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 35.4 mtm -79.57 107.81 12.63 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.156 0.982 . . . . 0.0 111.633 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -81.55 155.56 25.66 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 170.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.0 ttp-105 -137.95 144.86 41.41 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 174.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.72 159.01 28.87 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.103 2.161 . . . . 0.0 107.05 156.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -144.17 145.04 31.84 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 161.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.509 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 51.9 t-20 -83.45 105.57 14.5 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 120.743 1.611 . . . . 0.0 112.103 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.1 mp -102.27 36.39 2.15 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.095 1.358 . . . . 0.0 110.861 176.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.03 170.63 7.84 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.72 1.208 . . . . 0.0 109.331 163.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.5 m -105.09 15.47 27.52 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.753 0.821 . . . . 0.0 111.411 -177.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.7 p -141.38 162.11 49.11 Favored Pre-proline 0 C--O 1.239 0.504 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 169.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.44 141.65 96.07 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 120.978 1.119 . . . . 0.0 109.312 171.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.43 169.03 9.01 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 118.468 0.576 . . . . 0.0 110.326 167.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.9 t -94.38 157.07 16.19 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 159.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -124.17 152.7 17.37 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 105.271 -3.132 . . . . 0.0 105.271 165.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -174.22 -53.86 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 117.426 0.613 . . . . 0.0 109.787 -160.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 60.57 -179.35 0.1 Allowed 'General case' 0 C--N 1.342 0.243 0 CA-C-O 122.938 1.351 . . . . 0.0 113.88 173.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.0 m -135.21 164.21 28.21 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 146.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -155.53 164.47 38.62 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -173.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.09 98.33 4.72 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.629 HG22 HD13 ' A' ' 140' ' ' LEU . 51.2 t -89.32 72.04 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 125.361 1.465 . . . . 0.0 107.129 -175.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.0 t 178.83 152.28 0.49 Allowed Pre-proline 0 C--N 1.34 0.157 0 C-N-CA 125.455 1.502 . . . . 0.0 109.233 -174.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -67.49 -47.8 1.93 Allowed 'Trans proline' 0 N--CA 1.448 -1.197 0 N-CA-C 108.457 -1.401 . . . . 0.0 108.457 156.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.2 ptm -174.52 -78.37 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.661 1.984 . . . . 0.0 107.802 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.19 -38.22 81.77 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -168.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.71 -105.45 0.02 OUTLIER 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.199 0.454 . . . . 0.0 111.022 -173.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.38 -53.94 1.92 Allowed Glycine 0 CA--C 1.526 0.768 0 CA-C-O 119.286 -0.73 . . . . 0.0 112.722 -177.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.26 -54.11 9.44 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.612 1.206 . . . . 0.0 111.636 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -74.06 -3.59 30.32 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.767 1.227 . . . . 0.0 113.659 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -70.4 96.62 1.17 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 174.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -49.69 -44.79 48.23 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -162.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -73.41 74.48 1.39 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.886 0.766 . . . . 0.0 109.148 172.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.9 p -67.98 -39.01 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 123.774 0.83 . . . . 0.0 110.033 173.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -167.12 173.14 9.39 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 127.848 2.459 . . . . 0.0 105.958 177.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 52.7 t -164.04 137.3 5.28 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 177.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -54.87 -47.27 74.46 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.311 0.505 . . . . 0.0 110.183 175.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 57.5 m -75.55 67.25 2.03 Favored 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 172.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -66.2 158.91 27.59 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 169.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.7 m -84.38 -120.92 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -175.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -30.76 105.89 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.024 2.13 . . . . 0.0 113.479 174.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.6 t -130.27 -63.39 0.9 Allowed 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 124.212 1.005 . . . . 0.0 109.114 -177.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.1 t -158.33 149.0 20.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 172.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 89.2 mt -149.17 135.6 19.34 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 176.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -73.59 159.81 83.7 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.738 1.215 . . . . 0.0 109.955 173.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.23 102.73 1.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.486 2.124 . . . . 0.0 110.905 -165.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 125.05 -14.35 7.47 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 124.202 0.906 . . . . 0.0 110.953 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -76.82 138.31 39.75 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 118.49 1.145 . . . . 0.0 110.773 -166.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.03 144.92 26.68 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.94 1.296 . . . . 0.0 108.694 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 17.1 ttt -140.01 80.39 1.76 Allowed 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 123.34 0.656 . . . . 0.0 109.265 173.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -95.02 123.44 38.5 Favored 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 124.325 1.05 . . . . 0.0 108.321 168.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 24.5 mmt -134.1 129.56 20.01 Favored Pre-proline 0 C--O 1.235 0.32 0 C-N-CA 124.106 0.963 . . . . 0.0 109.844 -171.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -68.8 135.58 33.21 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 121.871 1.714 . . . . 0.0 109.248 172.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.9 t -110.06 129.42 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 166.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.1 p -95.52 134.76 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 157.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -155.92 151.62 27.25 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.67 ' CD1' HG22 ' A' ' 63' ' ' THR . 12.7 p90 -167.32 161.14 14.06 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 126.215 1.806 . . . . 0.0 107.206 -177.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 52.7 t -118.26 127.77 75.35 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 C-N-CA 125.669 1.588 . . . . 0.0 107.463 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.43 153.15 41.44 Favored Pre-proline 0 C--O 1.234 0.252 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -173.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.58 37.76 0.47 Allowed 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 124.359 3.373 . . . . 0.0 112.982 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -83.62 -37.66 22.59 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 165.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.3 tt -52.41 -35.46 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 123.878 0.871 . . . . 0.0 112.781 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.2 m -74.97 53.12 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 120.901 -1.124 . . . . 0.0 110.933 173.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -144.53 -70.65 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.748 1.619 . . . . 0.0 110.793 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.86 138.13 39.95 Favored 'Trans proline' 0 C--O 1.239 0.529 0 CA-C-N 122.148 1.803 . . . . 0.0 113.488 -176.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.9 t -55.94 -36.86 45.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 127.352 2.261 . . . . 0.0 109.602 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -47.7 -34.98 8.95 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.938 2.095 . . . . 0.0 112.744 174.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 72.1 p -107.09 -60.52 1.67 Allowed 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 123.013 0.196 . . . . 0.0 110.536 -174.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 28.28 49.75 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 129.088 2.955 . . . . 0.0 115.902 165.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 143.65 -29.3 2.0 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -172.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.8 mm -53.61 127.62 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.072 0 CA-C-N 117.863 0.831 . . . . 0.0 110.664 172.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.7 pttt -155.77 67.54 0.62 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 122.09 0.948 . . . . 0.0 111.547 169.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 42.4 m -147.94 105.08 3.63 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 141.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.1 tp -79.83 86.86 5.34 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -175.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -84.77 150.12 25.28 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.08 -168.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.629 HD13 HG22 ' A' ' 86' ' ' VAL . 28.5 tp -120.45 110.53 16.61 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 166.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.7 t -95.04 117.98 31.07 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 169.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.07 125.86 51.14 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -166.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.6 m -117.6 89.4 3.11 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.214 1.006 . . . . 0.0 109.98 -176.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.45 ' CG ' HD13 ' A' ' 45' ' ' LEU . 1.8 m-30 -67.1 94.59 0.35 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.603 0.761 . . . . 0.0 109.404 170.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -149.01 23.65 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.135 0 N-CA-C 118.08 2.622 . . . . 0.0 118.08 -176.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.445 ' CD ' HD12 ' A' ' 45' ' ' LEU . 59.5 Cg_endo -71.49 -75.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.672 0 CA-C-N 122.77 2.025 . . . . 0.0 113.897 -165.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 86.6 mmt-85 -146.28 121.75 10.36 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.776 0.716 . . . . 0.0 109.177 -167.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.53 117.54 28.98 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 125.648 1.579 . . . . 0.0 107.358 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -78.6 -23.5 8.33 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.71 2.273 . . . . 0.0 112.41 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 39.9 t 137.69 109.38 0.0 OUTLIER 'General case' 0 C--N 1.343 0.302 0 C-N-CA 129.278 3.031 . . . . 0.0 107.777 -175.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.372 0 C-N-CA 124.319 1.047 . . . . 0.0 110.958 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.3 t . . . . . 0 N--CA 1.456 -0.154 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -79.78 101.24 8.35 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.532 -0.73 . . . . 0.0 109.67 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.58 -9.57 0.22 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 166.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.45 126.0 28.43 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 115.872 -2.331 . . . . 0.0 110.22 -92.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.2 t -162.25 45.92 0.15 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 123.882 0.873 . . . . 0.0 109.825 -171.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -155.67 -58.03 0.1 Allowed 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.411 ' H ' HD23 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -85.51 26.36 0.94 Allowed 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.147 -169.534 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 73.3 mt -119.23 108.87 24.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -169.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -98.58 -61.54 1.36 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.129 -171.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . 0.25 0.3 OUTLIER 177.23 -6.89 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.672 1.589 . . . . 0.0 114.488 145.654 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -51.19 122.42 7.67 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 120.752 1.615 . . . . 0.0 112.869 -173.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -77.66 98.14 5.35 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 127.928 2.491 . . . . 0.0 107.547 -173.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.407 HG12 HG11 ' A' ' 122' ' ' VAL . 5.6 tp -106.56 122.74 60.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.913 1.285 . . . . 0.0 109.435 -172.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.513 ' CE ' ' HB2' ' A' ' 55' ' ' ASP . 4.0 tmtp? -79.19 151.62 31.14 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.952 1.701 . . . . 0.0 109.212 -174.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.423 ' HB ' ' CG1' ' A' ' 56' ' ' ILE . 5.2 t -133.79 148.74 30.39 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 165.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.7 m -136.25 104.7 5.73 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.414 1.102 . . . . 0.0 108.338 -174.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -77.56 121.32 23.74 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -118.32 82.44 1.84 Allowed 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.65 126.86 31.71 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -126.95 89.33 2.96 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.897 0.856 . . . . 0.0 109.043 -174.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.4 p -79.02 126.91 39.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.679 172.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.38 169.46 13.57 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 171.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.55 124.07 12.7 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 161.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 151.48 -48.19 0.56 Allowed Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 107.268 -2.333 . . . . 0.0 107.268 -160.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mp -129.28 142.38 45.02 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 160.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.439 ' HD2' HG21 ' A' ' 78' ' ' THR . 83.0 Cg_endo -79.97 2.72 8.2 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 123.911 3.074 . . . . 0.0 111.93 170.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.42 ' CZ2' ' HB3' ' A' ' 108' ' ' LEU . 40.5 m0 -74.54 148.62 40.72 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.125 0.875 . . . . 0.0 111.745 -165.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -78.82 84.79 4.86 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 172.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -89.58 118.94 29.58 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 124.475 1.11 . . . . 0.0 108.709 177.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.0 m -124.86 139.29 33.11 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -74.67 171.49 18.1 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.339 2.026 . . . . 0.0 108.953 166.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -93.35 -53.66 8.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 123.763 0.825 . . . . 0.0 110.393 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -131.7 164.5 25.8 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 168.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -60.75 -43.6 97.76 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 168.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.513 ' HB2' ' CE ' ' A' ' 34' ' ' LYS . 22.4 p-10 -149.15 170.55 18.18 Favored 'General case' 0 N--CA 1.428 -1.551 0 C-N-CA 124.666 1.186 . . . . 0.0 110.805 -164.228 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.423 ' CG1' ' HB ' ' A' ' 35' ' ' VAL . 37.1 pt -137.65 176.39 7.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 167.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.88 161.58 23.83 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 148.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -131.22 148.23 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 102.158 -3.275 . . . . 0.0 102.158 170.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.72 118.51 27.27 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 120.855 1.661 . . . . 0.0 106.953 160.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.3 pt -15.57 89.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 C-N-CA 126.943 2.097 . . . . 0.0 113.255 -169.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.52 -43.91 1.32 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 124.37 0.986 . . . . 0.0 113.12 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -38.56 102.65 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.798 2.039 . . . . 0.0 113.431 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 94.5 m -73.19 104.44 4.25 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.677 1.591 . . . . 0.0 111.265 -174.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.5 p -102.07 169.56 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 121.615 0.722 . . . . 0.0 110.524 174.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -117.35 127.38 53.99 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 126.263 1.825 . . . . 0.0 107.208 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.444 HD12 ' O ' ' A' ' 66' ' ' ILE . 1.7 pp -140.69 95.79 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 CA-C-O 121.864 0.84 . . . . 0.0 109.063 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 31.1 mtt -76.82 175.31 9.56 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.765 -0.584 . . . . 0.0 110.536 -175.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -133.28 170.47 15.4 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 124.228 1.011 . . . . 0.0 109.092 174.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -139.39 123.4 17.8 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 173.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.97 105.38 7.7 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.127 0.571 . . . . 0.0 110.869 168.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER -103.25 121.08 41.95 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.061 -0.4 . . . . 0.0 111.533 -171.759 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -82.12 85.07 6.84 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.114 0.483 . . . . 0.0 111.386 -173.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.3 mt -79.73 59.15 2.99 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.634 0.774 . . . . 0.0 109.958 171.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.91 155.23 47.12 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 170.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.8 m -79.55 -0.62 34.21 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.619 0.768 . . . . 0.0 112.369 177.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.1 p -128.83 163.29 46.33 Favored Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 124.761 1.224 . . . . 0.0 110.618 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -63.17 169.11 9.77 Favored 'Trans proline' 0 N--CA 1.444 -1.435 0 C-N-CA 121.041 1.161 . . . . 0.0 110.077 164.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.439 HG21 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -155.97 168.81 26.06 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 126.519 1.928 . . . . 0.0 107.152 -170.829 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.2 t -132.6 154.79 49.7 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.75 0.705 . . . . 0.0 111.622 176.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -125.57 64.42 0.57 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 127.248 2.356 . . . . 0.0 107.968 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.37 53.54 2.79 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 165.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.98 170.54 14.61 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.096 -171.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.1 m -125.19 162.21 25.17 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -146.93 159.02 44.06 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 118.764 0.711 . . . . 0.0 111.08 170.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.2 99.51 6.91 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 166.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.6 p -89.9 57.65 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.212 0 C-N-CA 124.154 0.982 . . . . 0.0 110.365 -175.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.5 t -165.95 148.18 6.27 Favored Pre-proline 0 N--CA 1.454 -0.249 0 O-C-N 121.506 -0.746 . . . . 0.0 110.699 -172.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.24 -30.68 30.5 Favored 'Trans proline' 0 N--CA 1.445 -1.38 0 N-CA-C 108.674 -1.318 . . . . 0.0 108.674 164.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.0 ptp 172.69 -63.85 0.01 OUTLIER 'General case' 0 C--N 1.347 0.462 0 C-N-CA 125.853 1.661 . . . . 0.0 109.759 -173.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -99.87 -33.25 10.62 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 124.776 1.23 . . . . 0.0 111.258 -164.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.16 -142.91 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.86 -47.58 0.78 Allowed Glycine 0 CA--C 1.531 1.075 0 O-C-N 121.278 -0.889 . . . . 0.0 112.434 -166.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -42.7 -54.08 4.21 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.047 1.339 . . . . 0.0 110.818 173.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -76.24 -16.2 59.87 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -48.91 137.41 12.77 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 118.79 0.723 . . . . 0.0 110.843 -173.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -67.42 112.8 4.83 Favored 'General case' 0 N--CA 1.44 -0.972 0 O-C-N 123.583 0.552 . . . . 0.0 111.568 -173.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.5 pttm -152.73 136.91 16.49 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.103 0.961 . . . . 0.0 108.522 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.9 m -154.11 -179.75 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 127.321 2.248 . . . . 0.0 106.846 -176.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.2 tp60 62.63 37.19 13.1 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.194 0.997 . . . . 0.0 112.384 167.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 38.1 t 70.41 145.67 0.06 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.91 1.684 . . . . 0.0 111.917 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -52.1 -43.92 64.16 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.733 -0.605 . . . . 0.0 111.35 175.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 13.7 t 33.76 55.47 0.55 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.593 1.957 . . . . 0.0 112.333 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -115.04 108.26 16.44 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.081 -164.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 t -179.77 153.25 0.53 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.71 2.004 . . . . 0.0 105.984 160.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.65 17.58 4.58 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 123.574 0.547 . . . . 0.0 109.882 168.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.9 t 52.7 -141.26 0.86 Allowed 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.493 1.517 . . . . 0.0 111.176 174.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.2 t -110.68 131.41 55.08 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 126.402 1.881 . . . . 0.0 106.741 172.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.42 ' HB3' ' CZ2' ' A' ' 47' ' ' TRP . 1.6 tp -124.34 131.43 53.51 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 125.102 1.361 . . . . 0.0 107.651 -176.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.456 ' HB3' ' HD2' ' A' ' 110' ' ' PRO . 10.5 mp0 -86.56 167.73 21.53 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 127.169 2.188 . . . . 0.0 111.273 -167.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 109' ' ' GLU . 49.9 Cg_endo -72.92 112.6 3.55 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.349 2.033 . . . . 0.0 112.446 -168.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 115.97 -12.72 17.27 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 124.403 1.002 . . . . 0.0 111.021 177.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -77.91 140.96 39.32 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 117.334 0.567 . . . . 0.0 112.438 -163.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -99.21 98.27 9.27 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.91 1.684 . . . . 0.0 108.787 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 11.0 ttp -77.56 85.98 3.91 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -94.28 59.59 2.62 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.994 0.902 . . . . 0.0 111.682 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 20.5 ttt -76.61 129.17 80.23 Favored Pre-proline 0 N--CA 1.437 -1.077 0 C-N-CA 123.814 0.846 . . . . 0.0 110.352 -171.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.66 150.88 31.73 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 121.93 1.753 . . . . 0.0 110.332 171.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.2 t -130.83 148.08 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 164.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.5 m -112.28 146.7 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -154.58 139.96 17.7 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 119.56 1.073 . . . . 0.0 112.635 -172.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -156.01 148.11 23.35 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.66 1.584 . . . . 0.0 108.069 163.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.407 HG11 HG12 ' A' ' 33' ' ' ILE . 61.6 t -88.26 141.45 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 166.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -75.51 155.46 85.55 Favored Pre-proline 0 N--CA 1.45 -0.467 0 C-N-CA 124.517 1.127 . . . . 0.0 110.061 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -65.03 -36.14 39.38 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.577 1.518 . . . . 0.0 112.17 166.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -44.77 -41.0 6.54 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 125.481 1.512 . . . . 0.0 113.395 -172.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -50.11 -37.94 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 125.021 1.329 . . . . 0.0 112.83 -177.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.0 m -89.3 51.26 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 119.17 0.896 . . . . 0.0 110.487 177.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . 0.35 0.0 OUTLIER -149.79 -53.5 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.823 0 CA-C-O 116.199 -1.858 . . . . 0.0 114.228 -175.221 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -83.33 169.89 12.27 Favored 'Trans proline' 0 C--N 1.351 0.67 0 CA-C-N 124.031 2.475 . . . . 0.0 111.838 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.2 t -67.59 -46.54 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.978 1.311 . . . . 0.0 110.871 -169.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.423 ' CD ' ' H ' ' A' ' 131' ' ' GLU . 2.1 mp0 -39.13 -54.58 1.73 Allowed 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 126.062 1.745 . . . . 0.0 112.225 -178.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 3.2 p -97.53 -41.03 8.36 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.128 -168.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 2.51 70.74 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 128.458 2.703 . . . . 0.0 115.882 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 134.27 -35.66 2.2 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 119.176 -0.791 . . . . 0.0 112.391 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 13.1 mm -49.33 138.27 4.78 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 C-N-CA 124.664 1.186 . . . . 0.0 109.948 173.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.3 pttm -157.67 51.97 0.45 Allowed 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.6 m -154.5 107.09 2.8 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 159.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.5 mp -75.78 85.72 2.77 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 169.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.1 t -81.14 150.98 28.48 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.3 tt -127.52 99.38 5.58 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.1 t -78.04 111.07 13.55 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 171.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -107.06 92.84 4.25 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.746 1.218 . . . . 0.0 108.537 -172.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.5 86.95 4.5 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 122.528 1.156 . . . . 0.0 109.48 -175.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -75.48 73.12 2.52 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 166.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -132.73 48.86 3.84 Favored Pre-proline 0 CA--C 1.552 1.044 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 174.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -77.61 -98.09 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 124.356 3.37 . . . . 0.0 113.752 -174.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.2 mmt180 -142.36 110.37 5.92 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.545 1.138 . . . . 0.0 109.315 -169.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -95.05 114.57 63.99 Favored Pre-proline 0 N--CA 1.451 -0.381 0 C-N-CA 124.793 1.237 . . . . 0.0 111.517 -167.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -74.2 -25.13 13.93 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.632 1.554 . . . . 0.0 111.138 165.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.6 t 80.33 127.18 0.04 OUTLIER 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.778 1.631 . . . . 0.0 109.824 -173.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 17.9 pttm . . . . . 0 CA--C 1.535 0.376 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.017 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.45 -0.435 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -63.25 96.72 0.11 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 170.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.408 ' HA ' ' NE2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER 98.09 71.69 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 129.91 3.284 . . . . 0.0 110.018 174.571 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.37 57.13 2.72 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -162.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.7 m -76.9 54.24 0.99 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.824 2.45 . . . . 0.0 112.253 -178.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -141.69 -54.19 0.45 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 130.275 3.43 . . . . 0.0 104.092 168.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.511 ' O ' HD22 ' A' ' 29' ' ' LEU . 49.2 mt -63.73 -34.06 77.04 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.908 1.283 . . . . 0.0 113.119 168.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 76.7 mt -69.15 100.04 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 119.575 1.08 . . . . 0.0 110.221 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.511 HD22 ' O ' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -90.03 -75.41 0.45 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 172.554 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -169.48 -28.63 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 164.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -59.05 128.25 36.28 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.46 1.104 . . . . 0.0 113.638 -163.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -79.93 109.79 14.7 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.924 -174.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.13 113.1 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 126.012 1.725 . . . . 0.0 108.679 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.35 157.07 21.59 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.054 -1.029 . . . . 0.0 109.084 -171.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.2 t -143.79 107.5 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-N 119.762 1.165 . . . . 0.0 109.596 -176.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.2 m -78.97 117.58 20.17 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.786 1.634 . . . . 0.0 107.816 167.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -79.61 156.32 27.72 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.337 0.655 . . . . 0.0 109.266 166.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -137.67 88.31 2.32 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.412 0.625 . . . . 0.0 111.511 170.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.06 128.9 36.4 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 120.939 -1.101 . . . . 0.0 110.507 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -133.73 150.21 51.49 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.186 0.994 . . . . 0.0 109.508 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.9 p -140.6 146.29 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 C-N-CA 123.518 0.727 . . . . 0.0 110.772 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.9 163.62 29.82 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.012 1.325 . . . . 0.0 107.463 168.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -37.75 -45.69 0.83 Allowed 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.989 1.715 . . . . 0.0 113.452 -172.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -36.88 -37.32 0.23 Allowed Glycine 0 CA--C 1.534 1.233 0 C-N-CA 126.482 1.991 . . . . 0.0 114.39 174.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.417 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 0.4 OUTLIER -113.48 105.88 54.71 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 161.15 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.93 9.56 3.26 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.138 1.892 . . . . 0.0 112.733 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.493 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 41.4 m0 -78.46 145.61 34.93 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 121.798 -0.564 . . . . 0.0 110.931 -168.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -78.56 85.39 4.62 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 103.338 -2.838 . . . . 0.0 103.338 172.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.71 88.18 3.0 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.625 1.17 . . . . 0.0 108.381 -168.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.0 m -91.37 136.59 26.77 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 119.182 -0.437 . . . . 0.0 110.381 -166.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -70.53 165.55 31.48 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 121.538 1.492 . . . . 0.0 108.595 161.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -97.67 -55.29 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.111 0 C-N-CA 123.573 0.749 . . . . 0.0 110.941 -176.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.22 152.76 47.6 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 170.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -64.99 -41.48 95.36 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.831 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.49 139.65 37.02 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.223 1.009 . . . . 0.0 110.027 -173.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.42 HD12 HG11 ' A' ' 64' ' ' VAL . 32.7 pt -104.99 164.02 4.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 125.352 1.461 . . . . 0.0 109.002 170.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -101.74 133.62 46.17 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 155.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.6 m -128.08 174.68 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 159.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -140.66 92.45 2.51 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -171.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.0 pt 8.22 87.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 127.66 2.384 . . . . 0.0 114.279 -171.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 107.86 -31.52 7.91 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 123.556 0.598 . . . . 0.0 112.949 -173.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -72.55 118.02 14.95 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 121.627 -0.925 . . . . 0.0 110.174 -168.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.3 p -68.3 126.83 30.81 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 127.431 2.293 . . . . 0.0 111.472 -174.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.42 HG11 HD12 ' A' ' 56' ' ' ILE . 9.9 p -113.74 160.07 13.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 157.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.62 125.34 49.32 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.737 1.215 . . . . 0.0 108.839 169.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -126.07 104.86 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 172.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.41 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 5.3 ppp? -83.34 167.61 17.42 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.959 172.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -137.05 155.0 50.21 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 171.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -125.56 129.81 50.44 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 168.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.68 108.52 12.11 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.671 2.388 . . . . 0.0 107.556 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.3 mtpt -104.73 124.16 48.91 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 118.154 -0.927 . . . . 0.0 109.09 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.493 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 32.3 t30 -78.37 85.46 4.49 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 119.517 1.053 . . . . 0.0 110.983 -175.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -78.12 68.89 4.25 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 174.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.3 135.48 13.08 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.781 0.832 . . . . 0.0 108.975 173.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.9 m -78.4 41.82 0.4 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.272 0.629 . . . . 0.0 110.246 172.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.1 p -148.31 154.26 41.83 Favored Pre-proline 0 N--CA 1.446 -0.671 0 C-N-CA 124.526 1.131 . . . . 0.0 107.989 169.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -66.95 150.41 82.94 Favored 'Trans proline' 0 N--CA 1.442 -1.545 0 N-CA-C 108.03 -1.565 . . . . 0.0 108.03 166.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.413 ' HG1' ' HE1' ' A' ' 47' ' ' TRP . 2.8 p -135.59 163.76 29.39 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.577 0.751 . . . . 0.0 109.302 175.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.1 t -118.88 136.21 54.16 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.636 0.775 . . . . 0.0 109.405 167.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -96.14 81.24 0.78 Allowed Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 176.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 50.4 mm-40 -106.38 53.29 0.7 Allowed 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 172.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.1 174.6 5.27 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.785 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.59 154.64 46.87 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 173.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -145.97 147.3 31.54 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -101.23 115.69 31.08 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 166.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.9 p -99.81 73.2 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.498 0 C-N-CA 124.24 1.016 . . . . 0.0 109.264 -176.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.0 t 177.56 148.46 0.34 Allowed Pre-proline 0 C--O 1.232 0.163 0 C-N-CA 123.645 0.778 . . . . 0.0 109.461 -178.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -66.3 -33.41 38.94 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 121.336 1.357 . . . . 0.0 109.754 162.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.0 ptp 177.83 -69.41 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.639 1.976 . . . . 0.0 107.933 177.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.67 -46.53 45.89 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 123.827 0.851 . . . . 0.0 113.203 -165.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.25 -101.06 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -162.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.93 -52.69 0.38 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.191 0.9 . . . . 0.0 114.032 -171.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -48.09 -52.84 18.66 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.306 1.553 . . . . 0.0 110.732 176.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 125' ' ' GLU . 15.1 m-85 -75.22 12.25 0.97 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.54 1.536 . . . . 0.0 114.768 176.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -92.39 108.08 19.7 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 171.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -78.36 78.16 4.83 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 118.41 -1.316 . . . . 0.0 112.698 -173.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -124.17 89.11 3.02 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 125.168 1.387 . . . . 0.0 107.583 162.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.6 m -137.6 131.35 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 170.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -165.68 127.87 2.02 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 90.9 m -78.3 63.28 3.16 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -165.47 -166.4 0.97 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -176.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 28.3 p -58.17 103.05 0.12 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 122.27 1.033 . . . . 0.0 110.878 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -41.58 -44.25 2.97 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 126.713 2.005 . . . . 0.0 111.902 177.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 67.5 m -152.35 -95.08 0.05 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 127.56 2.344 . . . . 0.0 106.913 168.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.0 pm0 -83.99 -167.78 1.88 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.816 0.846 . . . . 0.0 111.7 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.4 t -168.65 -72.3 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.094 0.958 . . . . 0.0 110.962 -177.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -158.77 151.06 21.49 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.6 1.16 . . . . 0.0 108.303 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 82.6 mt -144.34 148.0 34.19 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.443 ' HB3' ' HD2' ' A' ' 110' ' ' PRO . 3.6 mt-10 -88.86 175.41 4.06 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 123.969 0.908 . . . . 0.0 109.132 176.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 109' ' ' GLU . 33.2 Cg_endo -69.4 90.32 0.48 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.842 2.361 . . . . 0.0 114.469 -162.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 138.98 -23.39 2.9 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 123.731 0.681 . . . . 0.0 112.264 170.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -78.32 141.1 38.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 119.691 -0.804 . . . . 0.0 112.49 -146.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -84.05 113.44 21.03 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.621 1.569 . . . . 0.0 110.806 177.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 14.4 tpt -104.12 131.04 51.81 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 125.374 1.47 . . . . 0.0 107.235 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -155.03 139.44 16.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.056 0.389 . . . . 0.0 110.82 168.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 80.7 mtp -155.03 148.89 18.89 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.291 1.036 . . . . 0.0 109.544 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 67' ' ' MET . 49.5 Cg_endo -78.36 144.72 20.67 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.886 3.057 . . . . 0.0 112.701 170.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 25.0 t -118.83 121.53 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 168.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.2 p -79.54 146.32 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 169.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -155.19 146.99 23.32 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.256 0.48 . . . . 0.0 111.571 -171.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -156.62 153.22 28.22 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.271 1.429 . . . . 0.0 110.935 164.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 74.2 t -76.77 140.5 17.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 169.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.79 130.73 56.9 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 118.639 -0.696 . . . . 0.0 110.688 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -55.17 -30.46 71.22 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.191 2.594 . . . . 0.0 113.018 -178.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 16.0 mm-40 -36.28 -36.05 0.09 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.979 1.311 . . . . 0.0 113.418 172.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.7 tt -49.26 -36.72 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.4 m -87.67 54.31 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 119.24 0.927 . . . . 0.0 110.685 173.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -126.12 -74.67 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 117.508 -1.234 . . . . 0.0 111.983 171.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.67 156.37 40.05 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 CA-C-N 122.039 1.764 . . . . 0.0 112.538 -171.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 99.5 t -53.32 -44.21 53.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 125.137 1.375 . . . . 0.0 109.981 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -44.95 -51.58 9.62 Favored 'General case' 0 N--CA 1.426 -1.657 0 C-N-CA 128.216 2.606 . . . . 0.0 112.471 178.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 40.3 p -99.06 -8.07 25.83 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 119.052 -0.499 . . . . 0.0 111.869 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -44.41 112.38 0.41 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.989 0.916 . . . . 0.0 111.581 -178.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.47 -15.06 63.46 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 119.318 -0.712 . . . . 0.0 113.262 175.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 20.5 mm -64.97 123.78 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-N 119.016 1.408 . . . . 0.0 108.602 171.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 20.1 pttt -156.01 54.53 0.58 Allowed 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.032 0.444 . . . . 0.0 111.751 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.31 87.48 1.32 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 160.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.5 tp -82.79 88.16 6.77 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.242 -162.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 13.3 t -87.89 173.09 9.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.908 0.861 . . . . 0.0 111.329 -170.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.1 tt -145.39 111.15 5.46 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 171.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.6 p -91.81 97.97 11.32 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 124.999 1.32 . . . . 0.0 107.696 175.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.5 128.25 35.23 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 127.075 2.15 . . . . 0.0 108.71 -178.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.6 m -121.54 92.61 3.78 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 122.012 0.911 . . . . 0.0 109.494 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -75.77 90.49 2.89 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.014 -0.993 . . . . 0.0 110.068 174.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -148.02 41.38 0.25 Allowed Pre-proline 0 CA--C 1.553 1.068 0 N-CA-C 116.978 2.214 . . . . 0.0 116.978 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.79 -104.88 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.348 2.699 . . . . 0.0 112.859 -177.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -125.84 107.99 11.03 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.238 1.415 . . . . 0.0 110.661 -168.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -100.59 118.46 60.86 Favored Pre-proline 0 N--CA 1.453 -0.304 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 167.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.86 -50.02 0.07 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 121.781 1.654 . . . . 0.0 110.182 173.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.9 m -169.45 110.74 0.46 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.581 1.152 . . . . 0.0 110.981 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.543 0.679 0 C-N-CA 125.276 1.43 . . . . 0.0 112.808 170.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.459 HG22 ' H ' ' A' ' 22' ' ' GLU . 8.7 p . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.459 ' H ' HG22 ' A' ' 21' ' ' VAL . 4.1 tt0 -78.08 59.57 2.23 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.289 -1.507 . . . . 0.0 107.976 166.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 172.18 160.04 0.1 Allowed 'General case' 0 N--CA 1.445 -0.71 1 C-N-CA 132.703 4.401 . . . . 0.0 105.646 177.137 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 61' ' ' GLY . . . -130.51 129.5 42.96 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 155.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.3 t -156.08 42.95 0.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -158.34 -57.13 0.07 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 128.354 2.661 . . . . 0.0 104.709 -164.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 56.4 mt -75.75 -31.89 59.76 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 113.886 -1.506 . . . . 0.0 111.834 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.9 mt -66.0 112.62 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 O-C-N 121.964 -0.46 . . . . 0.0 111.753 -168.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.53 160.44 14.28 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 159.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -75.84 59.98 1.29 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.125 1.37 . . . . 0.0 111.323 -174.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.25 142.99 49.88 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.327 1.451 . . . . 0.0 107.496 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.3 mmmt -110.78 135.46 51.31 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.987 1.715 . . . . 0.0 109.252 -169.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.566 HG23 HG23 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -145.76 112.11 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-O 121.973 0.892 . . . . 0.0 109.878 -167.228 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.17 132.41 36.1 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.937 1.295 . . . . 0.0 109.295 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 t -113.36 121.28 65.25 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 C-N-CA 124.538 1.135 . . . . 0.0 108.209 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.63 126.7 31.1 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -102.46 95.89 6.56 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 173.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.417 ' CB ' HH22 ' A' ' 54' ' ' ARG . 6.4 t70 -118.46 81.07 1.62 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.895 0.855 . . . . 0.0 109.865 -178.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.72 148.3 22.24 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.751 0.821 . . . . 0.0 110.762 -174.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -132.99 152.59 51.94 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.407 1.083 . . . . 0.0 108.182 -172.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.6 t -135.91 146.26 29.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -146.46 174.64 11.21 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.239 0.542 . . . . 0.0 110.573 175.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.63 133.46 16.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 171.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 117.83 -45.98 1.2 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -162.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.501 HD12 ' HD3' ' A' ' 146' ' ' PRO . 0.5 OUTLIER -123.34 87.37 51.71 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 123.592 0.757 . . . . 0.0 109.693 174.491 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -81.8 43.96 1.62 Allowed 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.634 2.889 . . . . 0.0 109.292 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.436 ' CH2' ' HB2' ' A' ' 108' ' ' LEU . 43.0 m0 -114.91 140.47 48.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -175.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -79.09 81.3 5.37 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -85.75 98.92 11.0 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.7 m -87.37 135.0 35.05 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -177.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -66.77 156.25 66.79 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 N-CA-C 108.316 -1.455 . . . . 0.0 108.316 167.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.7 t -76.62 -45.71 32.46 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -168.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.66 176.9 12.01 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 163.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.417 HH22 ' CB ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -49.32 -45.08 44.95 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.63 0.772 . . . . 0.0 113.079 179.233 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -160.31 154.37 23.11 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 125.253 1.421 . . . . 0.0 107.797 -169.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.4 pt -113.12 164.67 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 C-N-CA 123.95 0.9 . . . . 0.0 109.022 175.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -121.43 118.56 29.7 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.848 1.259 . . . . 0.0 107.855 176.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.566 HG23 HG23 ' A' ' 33' ' ' ILE . 31.8 m -114.67 151.98 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 165.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -78.07 165.7 23.69 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 150.213 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.0 mm -6.69 -66.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 127.304 2.242 . . . . 0.0 114.136 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -130.14 21.3 4.92 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 118.868 -0.962 . . . . 0.0 114.723 -178.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -70.23 119.22 14.1 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 120.641 2.22 . . . . 0.0 110.948 -176.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.9 p -60.92 117.12 5.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.371 0.668 . . . . 0.0 109.452 172.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.5 p -110.85 149.34 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 165.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 39.5 tp60 -102.7 122.72 45.02 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.677 1.991 . . . . 0.0 107.972 -177.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.2 pp -141.5 100.25 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 121.938 0.875 . . . . 0.0 110.047 -177.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 65.7 mtt -77.17 126.34 30.78 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.985 1.314 . . . . 0.0 110.334 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -96.84 137.11 36.42 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 172.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 27.2 ttt85 -110.35 135.9 50.36 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.294 1.037 . . . . 0.0 109.652 -176.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.16 147.06 48.26 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.512 1.525 . . . . 0.0 109.608 175.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -136.29 121.62 19.26 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 117.784 -1.103 . . . . 0.0 108.267 171.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.416 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 43.0 t-20 -80.27 113.88 18.77 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.668 1.122 . . . . 0.0 111.798 -173.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.2 mt -99.21 16.74 21.87 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.741 1.216 . . . . 0.0 112.666 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.53 176.54 9.32 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.437 -0.789 . . . . 0.0 110.384 173.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.4 m -111.24 20.88 16.91 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.98 165.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.7 p -147.26 156.07 46.42 Favored Pre-proline 0 N--CA 1.449 -0.497 0 C-N-CA 125.521 1.528 . . . . 0.0 108.202 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.06 120.08 7.0 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 121.508 1.472 . . . . 0.0 108.586 175.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.66 163.64 15.05 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 118.898 0.772 . . . . 0.0 109.582 172.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.0 t -103.48 137.12 42.01 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 162.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.7 86.07 0.4 Allowed Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 103.497 -3.841 . . . . 0.0 103.497 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.05 46.57 0.91 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.93 177.04 2.78 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.169 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -148.49 178.33 8.7 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -128.16 161.42 29.32 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 166.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.464 ' OD1' HG22 ' A' ' 87' ' ' THR . 0.6 OUTLIER -114.7 128.39 56.28 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 103.441 -2.799 . . . . 0.0 103.441 155.187 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.0 t -111.55 79.46 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 O-C-N 124.502 1.126 . . . . 0.0 108.804 175.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.464 HG22 ' OD1' ' A' ' 85' ' ' ASN . 0.7 OUTLIER -160.5 140.21 8.2 Favored Pre-proline 0 N--CA 1.444 -0.752 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.289 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.45 -38.59 19.2 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 N-CA-C 108.333 -1.449 . . . . 0.0 108.333 163.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.1 ptp -177.55 -57.3 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.645 1.578 . . . . 0.0 109.962 -177.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.5 -4.1 25.87 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 123.772 0.829 . . . . 0.0 113.222 -162.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -95.77 -109.27 0.14 Allowed 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -172.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.92 -61.89 0.2 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 123.742 0.687 . . . . 0.0 112.868 -174.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -51.04 -59.68 3.91 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.45 1.1 . . . . 0.0 110.687 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -73.24 51.03 0.31 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.508 1.123 . . . . 0.0 112.169 176.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -114.19 121.51 43.95 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 124.089 0.956 . . . . 0.0 108.434 172.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -78.18 66.08 3.7 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.953 171.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -73.45 76.24 1.42 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 164.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.5 p -61.27 167.88 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 165.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 76.53 148.57 0.1 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.534 1.934 . . . . 0.0 113.116 176.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 14.4 p -71.48 -24.83 62.06 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.794 174.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -48.66 142.78 5.73 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.71 1.204 . . . . 0.0 112.191 -173.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 79.0 m -127.55 146.67 50.44 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 125.804 1.642 . . . . 0.0 107.412 -175.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -81.58 21.79 0.77 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -168.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.6 p -80.89 71.46 7.84 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 175.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -8.76 -76.25 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 128.583 2.753 . . . . 0.0 113.713 -177.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.8 t 155.24 -146.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 129.318 3.047 . . . . 0.0 107.072 176.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.0 t -117.18 137.77 52.12 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.168 1.787 . . . . 0.0 108.663 175.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.436 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -135.58 125.38 25.57 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.241 1.016 . . . . 0.0 110.372 -172.453 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -70.44 157.67 89.49 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.394 1.078 . . . . 0.0 111.636 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.18 114.1 3.71 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.636 2.224 . . . . 0.0 111.92 -167.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 116.57 -25.85 8.87 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -79.95 161.73 25.33 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 121.442 0.639 . . . . 0.0 112.583 -167.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -103.21 159.58 15.42 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.079 1.352 . . . . 0.0 111.288 -173.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 5.9 mtp -148.44 153.91 39.16 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.769 1.627 . . . . 0.0 109.165 174.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -147.01 153.8 40.48 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 150.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 11.9 mmt -128.02 124.93 23.37 Favored Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 124.527 1.131 . . . . 0.0 108.702 178.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -69.47 145.6 59.31 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 C-N-CA 122.008 1.805 . . . . 0.0 109.297 170.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.9 t -130.06 144.26 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 164.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.8 p -111.23 140.21 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 167.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -147.66 139.29 23.91 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 118.349 0.522 . . . . 0.0 109.646 -172.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -153.94 162.13 41.45 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 125.016 1.327 . . . . 0.0 108.84 164.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.483 HG21 HD12 ' A' ' 33' ' ' ILE . 96.1 t -87.34 176.51 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 123.254 0.622 . . . . 0.0 109.699 176.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -121.78 133.65 24.36 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 123.591 0.757 . . . . 0.0 110.75 172.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.18 -21.41 72.34 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.415 2.077 . . . . 0.0 113.473 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -59.89 -14.69 16.57 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 119.81 1.187 . . . . 0.0 111.953 -178.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.2 tt -56.58 -42.31 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 121.212 -0.93 . . . . 0.0 112.664 168.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.2 m -84.97 52.65 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 119.228 0.922 . . . . 0.0 110.84 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -123.62 -65.8 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 117.708 -1.139 . . . . 0.0 113.174 173.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.17 154.72 41.88 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 CA-C-N 121.836 1.692 . . . . 0.0 111.25 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.0 m -59.05 -36.5 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 124.744 1.218 . . . . 0.0 112.208 -173.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -61.73 -60.63 3.38 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.445 0.698 . . . . 0.0 110.138 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 82.1 p -83.1 -7.99 59.57 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 118.417 -0.801 . . . . 0.0 112.353 -173.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -33.98 -50.09 0.37 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.301 1.44 . . . . 0.0 113.703 175.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -84.55 -21.49 56.17 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 123.353 0.502 . . . . 0.0 112.155 -176.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 37.6 mm -77.79 118.11 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 O-C-N 122.054 -0.674 . . . . 0.0 109.777 -177.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.9 pttt -155.28 61.34 0.63 Allowed 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.719 168.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 24.9 p -144.39 87.98 1.91 Allowed 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 170.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.1 tp -83.35 78.07 9.69 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -162.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.5 m -79.18 122.68 26.57 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.098 -1.41 . . . . 0.0 109.818 -158.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.8 tt -79.07 129.48 34.49 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 168.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.5 t -153.69 122.51 6.38 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 165.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -158.24 171.0 21.0 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.481 0.712 . . . . 0.0 110.915 -177.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.4 m -115.69 117.55 30.6 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.099 1.76 . . . . 0.0 111.037 -176.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -79.61 100.32 7.75 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.959 1.304 . . . . 0.0 108.492 168.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -155.67 59.38 2.12 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -176.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.501 ' HD3' HD12 ' A' ' 45' ' ' LEU . 72.8 Cg_endo -79.76 -94.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.658 2.905 . . . . 0.0 112.732 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 78.6 mtt-85 -152.02 96.12 2.16 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.497 -0.752 . . . . 0.0 110.22 -158.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -91.16 123.55 64.09 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 118.752 -0.642 . . . . 0.0 111.098 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -69.89 -61.38 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.743 1.629 . . . . 0.0 110.47 172.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.8 t -157.27 117.22 3.44 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 121.767 -0.583 . . . . 0.0 111.223 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.559 0 C-N-CA 125.36 1.464 . . . . 0.0 110.577 170.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.1 t . . . . . 0 CA--C 1.537 0.445 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 40.43 40.39 0.86 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.584 1.554 . . . . 0.0 111.708 -164.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 176.0 135.65 0.05 Allowed 'General case' 0 N--CA 1.447 -0.583 2 N-CA-C 99.725 -4.176 . . . . 0.0 99.725 -174.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.02 -57.15 4.82 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 116.832 -1.947 . . . . 0.0 111.047 -154.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.1 p -163.13 -147.65 0.12 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 160.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -77.31 -22.57 51.74 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.955 2.102 . . . . 0.0 110.42 164.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.2 mt -56.34 -16.4 5.54 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.915 1.286 . . . . 0.0 113.885 -178.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 74.7 mt -52.03 118.51 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 124.373 1.069 . . . . 0.0 110.959 -173.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 mp -93.83 -83.76 0.32 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.943 0.497 . . . . 0.0 110.892 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -175.23 -56.82 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.033 0.933 . . . . 0.0 109.834 -164.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.32 145.4 2.4 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 125.542 1.537 . . . . 0.0 113.473 -165.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.9 tttt -96.93 90.78 5.33 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 126.062 1.745 . . . . 0.0 106.585 -170.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.68 107.5 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 176.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.16 146.06 35.29 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -177.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.5 t -130.46 144.4 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 -176.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 29.7 m -130.84 95.2 3.78 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -171.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -77.22 88.09 3.67 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 124.141 0.977 . . . . 0.0 108.986 -176.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -79.97 83.42 5.88 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 122.66 1.219 . . . . 0.0 109.699 -174.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.25 102.82 15.48 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.531 1.132 . . . . 0.0 110.594 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -106.05 111.17 23.69 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.296 0.639 . . . . 0.0 110.158 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.5 p -77.31 147.84 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 168.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.38 154.62 41.1 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 167.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.79 -41.23 22.97 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.062 0.945 . . . . 0.0 111.742 -175.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -30.69 -43.25 0.07 OUTLIER Glycine 0 CA--C 1.53 1.006 0 C-N-CA 126.898 2.189 . . . . 0.0 113.758 169.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.449 HD21 ' CE3' ' A' ' 47' ' ' TRP . 1.3 tt -116.14 98.54 51.48 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 170.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -74.89 13.8 0.94 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.008 2.472 . . . . 0.0 115.222 -161.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.504 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 42.0 m0 -79.27 156.2 28.19 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.58 1.552 . . . . 0.0 113.079 -168.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -75.98 79.79 2.85 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 170.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -99.56 121.66 41.5 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.022 0.929 . . . . 0.0 108.718 -177.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.08 141.87 41.14 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 118.047 0.385 . . . . 0.0 110.269 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.92 161.15 45.79 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.907 1.738 . . . . 0.0 108.857 163.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.44 -50.38 19.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 177.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -148.04 165.57 30.39 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 159.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -61.76 -41.57 97.87 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.689 0.677 . . . . 0.0 110.127 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -145.92 157.61 43.89 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 123.726 0.81 . . . . 0.0 112.444 -160.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 50.1 pt -136.54 171.33 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 125.12 1.368 . . . . 0.0 109.252 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -125.01 85.99 2.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.87 1.668 . . . . 0.0 110.814 -178.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.1 t -76.16 127.94 37.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -177.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.87 101.12 9.22 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 167.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 mm -6.21 84.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 127.579 2.352 . . . . 0.0 113.371 -171.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.5 -0.51 49.7 Favored Glycine 0 CA--C 1.539 1.546 0 N-CA-C 115.413 0.925 . . . . 0.0 115.413 171.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -59.69 124.34 19.81 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.023 1.729 . . . . 0.0 109.396 163.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.78 111.75 21.04 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.438 1.095 . . . . 0.0 110.995 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.22 143.27 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.85 128.39 49.63 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.1 pp -143.9 93.17 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.135 1.374 . . . . 0.0 109.308 -173.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 46.6 ttm -73.6 135.96 43.89 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.124 0.969 . . . . 0.0 110.059 -173.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -99.69 141.17 32.84 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 174.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.3 ttt180 -110.85 132.34 54.29 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 174.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.09 141.75 44.24 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 127.052 2.141 . . . . 0.0 107.241 162.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -140.71 145.98 37.18 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 166.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.504 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 34.6 t30 -83.38 87.27 6.98 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 119.024 0.829 . . . . 0.0 113.019 -170.044 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -79.92 73.53 6.69 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.197 0.999 . . . . 0.0 109.224 172.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.15 140.26 17.46 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 164.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.7 t -78.35 35.4 0.22 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.785 1.175 . . . . 0.0 111.347 174.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.404 ' N ' ' HB3' ' A' ' 110' ' ' PRO . 1.3 p -146.41 154.57 49.29 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 126.392 1.877 . . . . 0.0 108.876 176.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.49 143.33 42.52 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.615 2.21 . . . . 0.0 109.242 176.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.483 ' HG1' ' HE1' ' A' ' 47' ' ' TRP . 4.5 p -117.44 176.72 5.03 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.51 1.124 . . . . 0.0 111.998 -175.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 m -133.43 126.08 30.42 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 103.18 -2.896 . . . . 0.0 103.18 -178.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -127.35 117.24 2.63 Favored Glycine 0 C--N 1.335 0.481 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -171.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.54 -48.57 0.47 Allowed 'General case' 0 C--N 1.338 0.106 0 CA-C-N 117.738 0.769 . . . . 0.0 110.291 174.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 62.84 175.38 0.15 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.22 1.008 . . . . 0.0 110.408 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.3 t -111.3 146.8 36.39 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 165.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -122.18 89.67 3.16 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.254 1.422 . . . . 0.0 108.073 -173.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.73 85.25 4.75 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 174.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.7 t -79.04 70.09 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.844 1.258 . . . . 0.0 109.707 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.5 t -176.74 149.42 0.86 Allowed Pre-proline 0 N--CA 1.469 0.486 0 CA-C-N 119.325 0.966 . . . . 0.0 111.571 170.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -66.22 -37.31 25.14 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.266 1.31 . . . . 0.0 110.088 159.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 11.8 ptp 169.58 -68.67 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 128.305 2.642 . . . . 0.0 106.912 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.74 -45.35 65.01 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.94 0.896 . . . . 0.0 112.966 -170.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.19 -104.4 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.91 -166.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.97 -56.62 1.41 Allowed Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.47 -0.628 . . . . 0.0 112.488 -175.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -44.23 -55.08 5.13 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.594 1.158 . . . . 0.0 111.923 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -72.54 2.66 5.97 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.546 1.538 . . . . 0.0 114.014 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -73.89 90.84 1.94 Allowed 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.522 0.729 . . . . 0.0 109.55 -175.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -82.99 80.82 8.91 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.602 -167.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.0 -60.78 1.84 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 123.766 0.827 . . . . 0.0 110.14 171.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.5 p -133.27 149.88 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 124.123 0.969 . . . . 0.0 109.067 -168.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -78.79 -51.65 9.46 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.526 0.731 . . . . 0.0 109.441 176.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 16.3 t -82.45 99.47 9.47 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 173.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -69.29 65.1 0.16 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.882 1.273 . . . . 0.0 112.9 -177.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 51.4 t -163.31 68.46 0.2 Allowed 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 124.978 1.311 . . . . 0.0 108.663 172.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -73.6 145.6 45.3 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -163.31 111.96 1.26 Allowed 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 -161.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -80.23 50.27 1.23 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.02 0.928 . . . . 0.0 112.315 -171.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.9 t 36.67 -124.15 0.17 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.987 1.715 . . . . 0.0 114.463 166.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.4 t -142.96 155.13 44.64 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.797 2.039 . . . . 0.0 107.624 -176.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.2 mt -142.63 141.78 31.97 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 170.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.442 ' HB3' ' HD2' ' A' ' 110' ' ' PRO . 2.5 mp0 -76.34 170.65 15.07 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.588 1.555 . . . . 0.0 108.994 171.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 109' ' ' GLU . 46.4 Cg_endo -71.9 106.59 2.04 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 121.807 1.671 . . . . 0.0 113.666 -166.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 116.51 -13.77 15.45 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 124.932 1.253 . . . . 0.0 110.801 172.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -82.4 176.89 9.06 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 123.627 0.251 . . . . 0.0 111.548 -163.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -118.86 144.0 46.63 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.073 0.949 . . . . 0.0 113.194 -150.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.25 84.29 1.95 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.102 1.761 . . . . 0.0 110.027 168.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -101.95 87.79 3.2 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 120.612 -1.305 . . . . 0.0 109.243 171.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 13.2 ttt -102.82 118.82 57.43 Favored Pre-proline 0 N--CA 1.442 -0.869 0 O-C-N 121.454 -0.779 . . . . 0.0 110.275 -167.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.64 152.77 77.62 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.145 1.897 . . . . 0.0 110.358 171.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.5 t -145.43 135.44 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.6 p -99.46 148.08 6.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 166.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -152.43 156.27 39.15 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 118.282 0.492 . . . . 0.0 112.047 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -173.11 176.78 2.89 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 127.149 2.18 . . . . 0.0 108.467 176.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.465 HG22 HD22 ' A' ' 138' ' ' LEU . 78.7 t -131.86 138.66 52.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 124.0 0.92 . . . . 0.0 108.967 176.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -82.88 146.81 53.17 Favored Pre-proline 0 CA--C 1.54 0.593 0 O-C-N 123.452 0.47 . . . . 0.0 111.255 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -56.98 -25.25 61.8 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.95 3.1 . . . . 0.0 113.615 177.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -42.22 -31.13 0.35 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.637 1.575 . . . . 0.0 113.09 175.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.3 tt -49.3 -46.14 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.6 m -85.5 57.07 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 119.425 1.011 . . . . 0.0 110.52 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -132.59 -64.55 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.484 1.114 . . . . 0.0 113.456 173.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -63.86 164.7 20.87 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 121.932 1.754 . . . . 0.0 111.882 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 89.3 t -77.39 -43.8 30.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -173.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -37.8 -46.6 0.94 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 129.037 2.935 . . . . 0.0 112.957 177.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 19.1 p -87.23 -61.93 1.61 Allowed 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -0.97 79.7 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 129.506 3.123 . . . . 0.0 115.098 -171.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 134.82 -44.11 1.21 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 -171.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 12.4 mm -53.46 118.25 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 123.038 0.535 . . . . 0.0 110.075 170.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -156.01 53.84 0.57 Allowed 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.881 168.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.83 91.87 2.4 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 167.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.465 HD22 HG22 ' A' ' 122' ' ' VAL . 1.5 mp -77.0 135.12 38.66 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 -176.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 6.7 t -136.9 150.46 48.24 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.76 106.35 10.43 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 102.785 -3.043 . . . . 0.0 102.785 170.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.6 t -79.61 92.98 5.4 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 172.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.37 121.82 27.19 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 174.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.63 108.85 13.04 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.894 0.878 . . . . 0.0 109.786 -178.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.449 ' CD2' HD13 ' A' ' 45' ' ' LEU . 3.9 m-30 -79.28 80.51 5.64 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.014 1.325 . . . . 0.0 112.792 -167.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -129.58 78.42 75.52 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -97.65 -106.98 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.873 1 C-N-CA 125.418 4.079 . . . . 0.0 111.223 167.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -137.85 113.06 9.25 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.083 1.753 . . . . 0.0 108.046 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -91.11 113.11 57.17 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 123.813 0.845 . . . . 0.0 108.756 170.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -77.23 65.38 7.91 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.131 1.887 . . . . 0.0 108.314 166.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.2 m 26.53 92.58 0.01 OUTLIER 'General case' 0 C--N 1.344 0.326 0 C-N-CA 128.688 2.795 . . . . 0.0 113.964 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.283 0 CA-C-N 119.038 0.835 . . . . 0.0 110.573 -156.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.6 p . . . . . 0 CA--C 1.537 0.469 0 N-CA-C 102.603 -3.11 . . . . 0.0 102.603 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -79.26 61.17 3.29 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 122.648 2.476 . . . . 0.0 109.17 168.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.06 159.99 1.37 Allowed 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 131.657 3.983 . . . . 0.0 104.703 178.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 61' ' ' GLY . . . -136.36 133.59 36.96 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 103.353 -2.832 . . . . 0.0 103.353 149.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.4 m -157.89 39.15 0.27 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.318 1.447 . . . . 0.0 109.145 162.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.18 -58.07 1.82 Allowed 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 104.767 -2.308 . . . . 0.0 104.767 -166.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.9 mt -124.87 41.55 3.49 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.432 1.493 . . . . 0.0 109.706 176.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.412 ' C ' HD13 ' A' ' 29' ' ' LEU . 44.3 mt -75.07 110.06 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 162.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.412 HD13 ' C ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -104.17 -174.12 2.47 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 170.963 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.42 -32.96 70.66 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.363 1.465 . . . . 0.0 114.855 -163.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -53.23 95.95 0.01 OUTLIER 'General case' 0 C--N 1.34 0.178 0 CA-C-O 123.048 1.404 . . . . 0.0 112.72 -173.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.3 ttpp -74.58 88.12 2.15 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 165.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.65 127.51 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.754 -172.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.44 134.28 33.62 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -174.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 t -118.03 139.18 46.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.5 m -113.2 104.55 12.46 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.825 1.25 . . . . 0.0 108.272 -174.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -79.96 148.22 31.29 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.764 173.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -144.19 86.96 1.86 Allowed 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 -175.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.64 90.66 8.5 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.983 1.313 . . . . 0.0 110.505 -173.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -93.09 106.55 18.5 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.513 0.673 . . . . 0.0 109.752 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.0 p -78.44 145.52 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 163.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -156.32 159.43 38.81 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 118.579 0.627 . . . . 0.0 110.266 176.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.31 132.69 29.13 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 172.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.21 -45.33 1.28 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 -160.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.25 97.37 19.94 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 123.699 0.799 . . . . 0.0 109.801 -178.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.82 11.29 2.8 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.525 2.817 . . . . 0.0 113.438 -174.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 42.0 m0 -76.29 145.66 39.46 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.074 -1.016 . . . . 0.0 111.352 -172.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -77.59 83.15 3.99 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 104.87 -2.271 . . . . 0.0 104.87 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -94.59 90.14 6.04 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.616 1.966 . . . . 0.0 108.514 -171.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.2 m -89.15 129.65 47.12 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -176.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.87 149.38 72.37 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 N-CA-C 108.165 -1.513 . . . . 0.0 108.165 164.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.3 -59.2 3.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -128.85 157.09 42.5 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 167.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.9 tpt85 -67.33 -34.36 77.18 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 173.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -134.3 169.47 17.17 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 125.576 1.55 . . . . 0.0 110.689 -174.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.5 pt -136.47 175.87 9.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 124.774 1.23 . . . . 0.0 107.88 166.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.35 136.8 53.17 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 165.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.9 m -126.04 135.1 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 170.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.85 96.04 2.03 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 165.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.438 HD12 ' HB3' ' A' ' 124' ' ' PRO . 4.8 pt 0.23 73.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.994 2.117 . . . . 0.0 114.389 -173.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . 133.28 -27.9 3.36 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 119.934 -0.37 . . . . 0.0 112.821 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -46.74 106.95 0.09 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.239 1.016 . . . . 0.0 111.414 176.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.434 HG22 ' CD1' ' A' ' 121' ' ' PHE . 1.1 p -65.0 113.48 3.91 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.83 0.852 . . . . 0.0 109.386 174.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.3 p -114.8 144.11 23.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 167.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.25 131.06 38.7 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.154 1.782 . . . . 0.0 107.978 176.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -145.67 93.49 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.37 144.61 34.0 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.979 -173.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -110.83 145.26 38.52 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 177.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.5 ttt-85 -118.84 121.29 39.68 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.667 1.187 . . . . 0.0 108.291 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.28 111.0 18.8 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.013 0.925 . . . . 0.0 109.653 169.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -107.98 118.36 36.54 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.975 0.91 . . . . 0.0 110.561 -176.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -79.73 94.32 5.72 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -162.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.5 mt -84.72 73.24 10.63 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.469 0.707 . . . . 0.0 110.556 168.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -127.94 167.83 16.09 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.168 0.987 . . . . 0.0 110.52 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.5 p -78.26 -29.62 48.12 Favored 'General case' 0 C--O 1.227 -0.127 0 C-N-CA 123.467 0.707 . . . . 0.0 111.466 174.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -147.92 162.32 31.67 Favored Pre-proline 0 N--CA 1.449 -0.508 0 C-N-CA 124.742 1.217 . . . . 0.0 108.456 -160.025 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -59.68 121.17 9.41 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.724 2.282 . . . . 0.0 111.044 -174.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.51 175.42 7.07 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.623 1.569 . . . . 0.0 110.113 -178.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.0 t -138.24 159.28 42.46 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 169.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -138.1 150.93 21.18 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 127.03 2.252 . . . . 0.0 108.551 -173.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.44 HE21 ' N ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -162.56 -39.22 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.21 0.604 . . . . 0.0 110.097 168.534 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.44 ' N ' HE21 ' A' ' 81' ' ' GLN . . . 61.58 -179.52 0.12 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.873 0.869 . . . . 0.0 113.023 176.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.1 t -119.31 166.63 12.78 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 144.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -141.89 88.78 2.14 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.756 1.265 . . . . 0.0 108.015 -176.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -79.13 89.08 4.83 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -177.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.8 t -79.69 86.65 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 173.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.8 t -175.16 151.33 1.33 Allowed Pre-proline 0 C--O 1.232 0.143 0 C-N-CA 125.055 1.342 . . . . 0.0 109.411 170.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.52 -34.61 7.16 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 121.011 1.14 . . . . 0.0 109.156 156.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.8 ptp 171.99 -70.38 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.91 2.484 . . . . 0.0 107.869 -177.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.69 -30.79 26.51 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -165.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.38 -112.93 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.011 0.368 . . . . 0.0 110.086 -177.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.24 -58.62 0.84 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 123.737 0.684 . . . . 0.0 112.735 -174.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -49.44 -53.67 21.67 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.998 0.919 . . . . 0.0 110.365 175.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -73.19 40.4 0.1 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.494 1.118 . . . . 0.0 112.919 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -103.06 140.31 37.46 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 173.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -74.21 162.72 28.65 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 118.394 -1.322 . . . . 0.0 111.405 173.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? 54.13 56.47 6.97 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.111 0.958 . . . . 0.0 109.714 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.9 p -72.55 146.08 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 170.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 70.7 153.7 0.12 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.383 1.873 . . . . 0.0 113.608 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 67.02 142.7 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.874 1.669 . . . . 0.0 111.705 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -61.52 -179.74 0.19 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.837 0.855 . . . . 0.0 111.592 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 13.4 t -153.29 51.31 0.72 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 167.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 6.5 p90 179.19 164.25 0.91 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.591 1.956 . . . . 0.0 105.835 -164.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.8 t -126.69 49.9 1.99 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 122.736 1.255 . . . . 0.0 109.188 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.39 69.85 1.66 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 173.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.2 t -115.3 -61.05 1.8 Allowed 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 124.813 1.245 . . . . 0.0 110.56 -172.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -161.96 146.23 12.55 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.039 1.336 . . . . 0.0 107.427 -178.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.431 HD11 ' HB2' ' A' ' 114' ' ' MET . 94.5 mt -147.79 134.46 19.93 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 174.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -64.55 156.4 77.7 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 127.382 2.273 . . . . 0.0 109.751 170.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.3 92.92 0.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.531 2.821 . . . . 0.0 111.65 -167.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 143.75 -27.32 2.06 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 124.562 1.077 . . . . 0.0 110.991 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -77.97 153.93 32.01 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -153.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -108.6 118.17 36.09 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.591 1.556 . . . . 0.0 110.19 -166.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.431 ' HB2' HD11 ' A' ' 108' ' ' LEU . 14.9 ttp -108.96 86.04 2.21 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 123.834 0.853 . . . . 0.0 110.868 178.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -77.26 129.39 35.84 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 156.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 25.6 mtp -143.35 136.58 13.97 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 118.587 0.63 . . . . 0.0 111.511 159.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -69.95 124.32 10.89 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 123.547 2.831 . . . . 0.0 111.296 171.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.2 t -91.18 152.24 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 160.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.8 p -121.46 143.7 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 167.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -148.65 135.53 19.93 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 118.633 0.651 . . . . 0.0 110.621 -173.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.434 ' CD1' HG22 ' A' ' 63' ' ' THR . 1.0 OUTLIER -159.55 149.05 18.31 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.156 1.382 . . . . 0.0 109.17 174.348 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 92.3 t -100.8 139.17 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.689 1.196 . . . . 0.0 111.441 -173.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -82.91 120.35 76.03 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 177.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.438 ' HB3' HD12 ' A' ' 60' ' ' ILE . 36.4 Cg_endo -58.16 -16.31 27.07 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.827 2.351 . . . . 0.0 113.754 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.87 -27.4 2.09 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 119.518 1.054 . . . . 0.0 111.965 168.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.02 -45.7 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 O-C-N 121.643 -0.66 . . . . 0.0 111.63 175.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.9 m -87.36 56.34 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 O-C-N 121.185 -0.947 . . . . 0.0 109.952 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -138.1 -59.72 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 117.14 -1.409 . . . . 0.0 113.762 175.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.95 161.44 18.42 Favored 'Trans proline' 0 C--N 1.347 0.489 0 CA-C-N 122.573 1.955 . . . . 0.0 113.237 -172.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.1 t -56.2 -36.66 46.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 125.843 1.657 . . . . 0.0 111.0 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -38.84 -54.1 1.65 Allowed 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 126.377 1.871 . . . . 0.0 112.053 176.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.5 p -106.28 -46.19 4.11 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.529 -166.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 14.72 67.05 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.305 2.642 . . . . 0.0 115.652 175.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 127.84 -24.36 5.16 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.676 -0.57 . . . . 0.0 111.676 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.2 mm -60.58 132.02 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 170.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 42.5 pttt -159.51 64.72 0.38 Allowed 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.784 0.802 . . . . 0.0 110.282 167.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 27.7 m -149.19 98.28 2.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 162.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.66 82.75 4.88 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -175.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.1 m -76.7 152.9 35.54 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.985 -169.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.2 tt -136.96 104.47 5.47 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.3 m -86.98 98.25 11.15 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 169.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.92 128.07 33.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 170.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.3 m -135.95 98.44 3.89 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.463 0.649 . . . . 0.0 109.89 -168.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -72.98 92.09 1.62 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.118 1.367 . . . . 0.0 112.111 -174.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -132.25 90.61 33.97 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.394 1.078 . . . . 0.0 113.386 170.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -109.4 -105.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.318 1 C-N-CA 125.381 4.054 . . . . 0.0 109.731 164.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.4 ptt-85 -160.34 124.49 3.66 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.59 1.556 . . . . 0.0 108.25 -174.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -95.78 133.69 25.13 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 123.24 0.616 . . . . 0.0 109.493 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -73.53 -63.16 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.146 1.898 . . . . 0.0 108.729 174.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.5 t -167.41 175.22 7.37 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.827 1.251 . . . . 0.0 107.98 162.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.5 0 C-N-CA 124.5 1.12 . . . . 0.0 111.859 -178.227 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.7 t . . . . . 0 CA--C 1.537 0.467 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 18.45 54.3 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.924 2.49 . . . . 0.0 114.039 -162.524 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.43 -80.66 0.15 Allowed 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 102.406 -3.183 . . . . 0.0 102.406 167.829 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -161.24 -80.07 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 126.917 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.4 t -160.33 -157.85 0.58 Allowed 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 164.2 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.0 -18.24 61.99 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.953 1.701 . . . . 0.0 109.574 175.828 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.1 mt -68.1 2.41 2.16 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.641 1.177 . . . . 0.0 113.511 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.4 mt -67.71 126.21 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 121.036 1.744 . . . . 0.0 108.888 172.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.4 mp -126.16 163.0 24.08 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.36 0.664 . . . . 0.0 110.669 -178.074 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -78.56 70.26 4.87 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.703 0.801 . . . . 0.0 111.786 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.15 162.19 27.5 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 153.945 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -130.84 110.27 11.18 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -174.312 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.411 ' CG2' HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -112.13 125.14 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 -174.532 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -89.39 137.79 32.02 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -178.215 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.2 t -123.98 131.29 73.16 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.534 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.7 m -91.59 106.1 18.23 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.412 1.885 . . . . 0.0 108.087 -174.165 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -80.52 124.72 29.18 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.79 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -130.23 84.94 2.24 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 122.233 1.016 . . . . 0.0 111.617 -170.741 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.54 102.31 14.08 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.14 0.976 . . . . 0.0 109.706 177.7 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -99.18 122.25 42.12 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.393 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.6 p -113.01 133.56 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.089 0 C-N-CA 124.162 0.985 . . . . 0.0 109.071 174.832 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.11 176.15 8.95 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.543 1.137 . . . . 0.0 108.833 179.682 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.1 122.57 8.74 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 170.195 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.06 -32.52 1.16 Allowed Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -165.122 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mp -142.63 158.74 59.43 Favored Pre-proline 0 N--CA 1.456 -0.155 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 160.791 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -90.66 13.31 2.22 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.84 3.027 . . . . 0.0 112.171 165.686 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.444 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 41.7 m0 -78.63 139.76 38.51 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -162.49 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -76.72 83.78 3.34 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.495 ' CZ ' ' HB2' ' A' ' 70' ' ' ALA . 7.2 m-85 -87.71 89.34 7.96 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.317 175.04 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.5 m -87.9 112.9 52.06 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 171.787 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.1 142.02 54.66 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 N-CA-C 107.659 -1.708 . . . . 0.0 107.659 164.94 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 m -77.54 -41.37 29.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 O-C-N 122.396 -0.19 . . . . 0.0 111.408 -171.3 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -145.97 156.51 43.55 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 167.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -65.29 -36.62 84.64 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 177.782 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -151.6 143.75 23.96 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 122.762 0.425 . . . . 0.0 110.99 -174.494 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.0 pt -105.6 168.36 2.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 123.679 0.792 . . . . 0.0 109.416 174.626 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -94.05 141.92 27.98 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 152.868 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.76 123.61 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 157.808 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -75.52 78.82 2.54 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 172.865 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.411 HG23 ' CG2' ' A' ' 33' ' ' ILE . 2.9 pt 11.97 73.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 127.508 2.323 . . . . 0.0 112.923 -176.497 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.99 -33.44 3.7 Favored Glycine 0 C--O 1.222 -0.643 0 CA-C-O 118.448 -1.195 . . . . 0.0 112.054 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -62.1 140.78 58.39 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 120.225 2.012 . . . . 0.0 110.442 -178.12 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.13 112.15 16.05 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 127.942 2.497 . . . . 0.0 110.182 -174.041 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 p -79.67 169.01 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.104 0 O-C-N 121.818 -0.551 . . . . 0.0 109.63 174.683 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.409 HE21 ' HA ' ' A' ' 65' ' ' GLN . 5.2 tp60 -116.39 113.76 23.35 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 124.947 1.299 . . . . 0.0 107.96 156.262 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.4 pp -121.54 126.9 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 159.533 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 33.1 ttp -79.31 151.05 31.29 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 167.548 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.77 155.61 27.5 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 167.348 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -134.23 145.35 49.07 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.448 1.099 . . . . 0.0 109.299 172.229 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 49' ' ' PHE . . . -135.16 155.97 49.78 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 127.0 2.12 . . . . 0.0 105.943 151.072 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.0 mmmt -137.72 122.1 18.27 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 116.845 -1.55 . . . . 0.0 108.997 176.496 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.444 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 49.9 t-20 -78.22 85.49 4.38 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 121.472 1.942 . . . . 0.0 111.565 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.4 mt -79.1 68.89 5.18 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.788 1.235 . . . . 0.0 109.869 172.541 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.75 175.02 10.94 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 170.072 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.5 m -106.41 19.4 20.56 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.1 0.56 . . . . 0.0 110.346 173.742 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.4 p -146.6 161.05 39.6 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 125.777 1.631 . . . . 0.0 108.848 178.921 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -62.8 156.51 53.17 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 121.502 1.468 . . . . 0.0 110.247 173.568 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.37 162.91 31.27 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 171.849 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.9 t -116.61 108.22 15.67 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.63 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.2 121.61 5.59 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 105.625 -2.99 . . . . 0.0 105.625 162.652 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -127.66 -54.06 1.34 Allowed 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 170.734 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.39 178.41 0.16 Allowed 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.884 0.874 . . . . 0.0 110.984 172.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.62 141.63 33.43 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 153.055 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -107.4 162.85 13.55 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 122.681 0.392 . . . . 0.0 110.53 173.924 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -123.23 111.32 16.33 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 160.374 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.0 t -89.17 56.82 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.616 0.766 . . . . 0.0 110.008 -171.365 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.2 t -172.97 149.97 1.9 Allowed Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 119.911 1.232 . . . . 0.0 112.24 -177.56 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -64.84 -39.46 25.55 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 121.972 1.782 . . . . 0.0 109.676 162.697 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.4 ptp 173.49 -76.79 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 127.537 2.335 . . . . 0.0 108.044 176.195 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.418 ' HB3' HG13 ' A' ' 135' ' ' ILE . . . -62.16 -43.51 98.66 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 123.938 0.895 . . . . 0.0 112.666 -169.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.04 -103.82 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.718 -161.522 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.04 -53.91 1.4 Allowed Glycine 0 CA--C 1.527 0.829 0 CA-C-O 119.381 -0.677 . . . . 0.0 113.043 -177.775 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -45.84 -56.42 5.41 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.49 1.145 . . . . 0.0 110.984 176.788 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -74.35 4.72 5.42 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.606 1.162 . . . . 0.0 113.83 179.355 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -76.9 107.78 9.48 Favored 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 120.9 -1.125 . . . . 0.0 108.428 177.235 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -83.7 77.42 9.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.77 -172.712 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.35 163.97 0.36 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.175 158.128 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.8 t -77.53 -103.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 176.739 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -164.65 171.42 14.44 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -168.252 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 3.7 t 66.33 -157.91 0.25 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.254 1.022 . . . . 0.0 109.658 -179.232 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -72.05 -11.99 61.01 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.409 1.004 . . . . 0.0 113.213 -170.177 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 50.5 t 72.38 -51.49 0.7 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.74 1.616 . . . . 0.0 113.327 177.013 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -61.06 77.24 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.353 1.461 . . . . 0.0 111.132 174.808 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.8 m -78.07 -21.18 50.96 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.762 1.625 . . . . 0.0 109.931 178.489 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.9 -60.91 2.7 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.26 1.424 . . . . 0.0 111.488 171.483 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.8 t 45.66 -148.36 0.11 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.499 1.52 . . . . 0.0 111.92 177.447 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -93.95 145.54 24.57 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.108 0.963 . . . . 0.0 108.913 176.911 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.1 mt -136.71 128.14 28.43 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 122.94 0.496 . . . . 0.0 109.897 177.447 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -54.74 165.21 0.97 Allowed Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 127.255 2.222 . . . . 0.0 110.738 160.706 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -76.25 126.17 8.99 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.244 1.963 . . . . 0.0 112.457 -172.027 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 98.02 5.16 57.46 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 124.012 0.815 . . . . 0.0 111.298 175.489 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -79.35 133.75 36.59 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 117.242 0.521 . . . . 0.0 110.737 -173.753 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -102.19 89.28 3.54 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.144 1.378 . . . . 0.0 109.694 -175.322 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.96 87.36 7.35 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -133.51 131.91 40.37 Favored 'General case' 0 CA--C 1.523 -0.075 0 CA-C-N 119.193 0.906 . . . . 0.0 111.411 169.506 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 60.0 mtt -153.07 147.11 18.57 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.173 0.989 . . . . 0.0 109.498 -170.519 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.29 146.84 40.96 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.678 2.919 . . . . 0.0 110.375 173.525 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 28.2 m -138.22 158.77 32.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 123.771 0.828 . . . . 0.0 108.891 165.319 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.6 m -114.6 161.01 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 124.097 0.959 . . . . 0.0 109.104 175.788 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -159.95 155.77 26.06 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.387 1.075 . . . . 0.0 108.164 -179.216 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -175.27 92.72 0.06 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.975 1.31 . . . . 0.0 111.529 -171.648 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.34 138.56 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 O-C-N 120.691 -1.256 . . . . 0.0 111.714 178.611 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.75 136.24 92.5 Favored Pre-proline 0 N--CA 1.469 0.51 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.487 173.783 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.57 -29.22 59.34 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.028 1.819 . . . . 0.0 112.104 172.375 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -44.6 -28.88 0.65 Allowed 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.534 1.533 . . . . 0.0 112.727 174.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 17.7 tt -47.69 -41.05 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 119.375 0.988 . . . . 0.0 112.817 174.345 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.3 m -87.01 58.39 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 119.573 1.079 . . . . 0.0 109.992 175.517 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.401 ' HG2' ' HD3' ' A' ' 129' ' ' PRO 0.486 1.0 OUTLIER -144.28 -52.63 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 117.933 2.568 . . . . 0.0 117.933 172.102 . . . . . . . . 4 4 . 1 . 021 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.401 ' HD3' ' HG2' ' A' ' 128' ' ' LYS . 98.6 Cg_endo -76.79 161.21 33.7 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 CA-C-N 123.368 2.239 . . . . 0.0 112.26 -177.743 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.78 -42.16 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 124.826 1.25 . . . . 0.0 109.468 -172.404 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -43.26 -47.74 6.58 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 127.528 2.331 . . . . 0.0 112.382 177.254 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 24.2 p -92.95 -53.16 4.26 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -175.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 12.59 62.41 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 129.117 2.967 . . . . 0.0 115.44 -178.443 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 140.98 -38.73 1.52 Allowed Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -174.133 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.418 HG13 ' HB3' ' A' ' 90' ' ' ALA . 16.8 mm -55.34 113.65 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-N 117.434 0.617 . . . . 0.0 109.864 175.206 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 7.9 pttt -156.52 61.56 0.54 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 121.99 0.9 . . . . 0.0 108.925 169.659 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.89 89.53 1.47 Allowed 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 162.735 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.5 tp -74.99 160.16 30.9 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -171.407 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 12.0 t -153.36 164.75 37.59 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 174.242 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 14.7 tp -138.06 98.27 3.6 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 102.253 -3.24 . . . . 0.0 102.253 173.303 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.9 p -84.24 93.18 8.14 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 177.918 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.27 131.36 36.14 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 175.324 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.94 96.24 4.98 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.003 0.921 . . . . 0.0 108.677 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.415 ' CE1' ' CZ ' ' A' ' 49' ' ' PHE . 50.4 m-85 -89.62 87.63 7.1 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 125.652 1.581 . . . . 0.0 109.531 178.607 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -135.71 37.35 0.34 Allowed Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 125.378 1.471 . . . . 0.0 114.379 175.311 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.45 -85.4 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.156 2.571 . . . . 0.0 114.346 -172.638 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.46 91.38 1.57 Allowed 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.592 0.757 . . . . 0.0 110.352 -163.947 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -78.5 117.74 68.17 Favored Pre-proline 0 N--CA 1.451 -0.387 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 168.378 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.57 -29.42 7.37 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.551 2.167 . . . . 0.0 110.788 172.102 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 36.9 m 130.01 144.0 0.0 OUTLIER 'General case' 0 C--N 1.342 0.263 0 C-N-CA 130.632 3.573 . . . . 0.0 107.36 -167.799 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.2 pttm . . . . . 0 CA--C 1.534 0.358 0 C-N-CA 124.927 1.291 . . . . 0.0 109.267 177.562 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.1 t . . . . . 0 CA--C 1.537 0.461 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -73.62 67.11 1.09 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 159.511 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 146.46 154.08 0.0 OUTLIER 'General case' 0 C--N 1.339 0.132 1 C-N-CA 132.349 4.26 . . . . 0.0 108.096 -171.868 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -153.2 28.55 0.51 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 122.025 0.917 . . . . 0.0 110.126 -167.389 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.79 -11.43 59.99 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.529 1.532 . . . . 0.0 114.757 -147.196 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.35 -31.96 64.25 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 173.879 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.1 mp -108.09 14.46 25.11 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.023 1.329 . . . . 0.0 112.074 -176.27 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.4 mt -77.98 77.31 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 120.005 -1.684 . . . . 0.0 108.839 173.641 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.76 179.75 5.93 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.531 0.681 . . . . 0.0 109.893 179.238 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -94.48 59.43 2.51 Favored 'General case' 0 C--N 1.337 0.031 0 C-N-CA 123.827 0.851 . . . . 0.0 112.667 -167.021 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -115.18 160.9 19.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 151.664 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -133.76 88.38 2.47 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.0 tt -94.47 137.91 21.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 C-N-CA 124.477 1.111 . . . . 0.0 111.637 -163.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.441 ' HE2' ' CB ' ' A' ' 55' ' ' ASP . 0.1 OUTLIER -79.71 143.84 34.2 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.635 1.574 . . . . 0.0 109.781 -170.421 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.531 HG21 ' CE1' ' A' ' 120' ' ' PHE . 3.7 t -135.72 142.06 40.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.655 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 164.389 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.9 m -123.29 112.47 17.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 -177.721 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -78.52 89.76 4.48 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 172.864 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -78.23 85.25 4.4 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 118.492 -1.283 . . . . 0.0 108.395 178.576 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.5 115.78 17.54 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.832 174.758 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -122.94 175.54 6.52 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.595 1.158 . . . . 0.0 108.188 167.039 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.6 p -151.17 148.6 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 169.161 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -164.51 171.54 14.45 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.254 1.022 . . . . 0.0 108.869 -178.302 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.62 -165.36 0.22 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.354 1.462 . . . . 0.0 111.616 -175.4 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.73 52.98 4.26 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 112.123 -0.391 . . . . 0.0 112.123 -173.079 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.412 ' CD1' ' CD1' ' A' ' 144' ' ' PHE . 1.4 tt -111.7 83.77 4.77 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.122 0.969 . . . . 0.0 108.785 177.693 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -85.28 45.0 1.5 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.246 3.298 . . . . 0.0 109.736 -170.141 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.438 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 43.1 m0 -108.39 138.58 44.43 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -172.909 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.408 ' OE1' ' NZ ' ' A' ' 71' ' ' LYS . 73.2 tt0 -77.85 82.36 4.23 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 -178.503 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -90.26 122.01 32.79 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.715 1.206 . . . . 0.0 108.233 179.834 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 m -126.67 135.54 27.43 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.144 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -70.76 162.39 42.76 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 N-CA-C 108.146 -1.521 . . . . 0.0 108.146 161.433 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -60.18 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 175.117 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -144.06 154.13 42.91 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 164.773 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.03 -42.72 69.45 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 118.537 -0.744 . . . . 0.0 112.095 -175.964 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.441 ' CB ' ' HE2' ' A' ' 34' ' ' LYS . 23.7 p-10 -145.35 159.69 42.67 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 119.382 0.992 . . . . 0.0 113.189 -166.623 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.8 pt -133.82 159.79 42.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 125.768 1.627 . . . . 0.0 107.847 178.193 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -128.29 85.41 2.34 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.316 1.446 . . . . 0.0 109.124 178.189 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.8 m -80.44 141.83 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 O-C-N 121.255 -0.903 . . . . 0.0 110.689 -171.281 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -78.22 72.16 4.74 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 173.078 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.5 pt 19.01 64.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 127.437 2.295 . . . . 0.0 113.489 176.368 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 139.0 -43.8 1.14 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -172.58 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -59.68 130.3 46.16 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.648 -173.467 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.467 HG23 ' CD1' ' A' ' 121' ' ' PHE . 1.6 m -106.69 87.28 2.49 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.003 -146.106 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.72 144.19 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 CA-C-O 121.094 0.473 . . . . 0.0 110.696 -170.538 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.93 115.54 24.4 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.239 1.016 . . . . 0.0 108.591 168.817 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.8 pp -115.57 115.04 48.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 164.044 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -87.49 155.23 20.09 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.939 -0.475 . . . . 0.0 110.966 178.387 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -127.0 153.78 45.46 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 172.73 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -134.69 141.79 46.64 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.877 1.671 . . . . 0.0 107.898 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.34 115.58 7.98 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.805 2.042 . . . . 0.0 107.681 174.387 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.408 ' NZ ' ' OE1' ' A' ' 48' ' ' GLU . 3.0 mtmp? -114.73 124.42 51.73 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.29 0.95 . . . . 0.0 110.652 -176.99 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.438 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 46.9 t-20 -80.92 107.2 13.53 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.79 0.723 . . . . 0.0 112.932 -167.583 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.3 mp -99.08 30.4 3.45 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.495 1.118 . . . . 0.0 111.974 176.649 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.85 176.81 9.39 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.021 -1.049 . . . . 0.0 110.401 168.084 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.1 t -114.07 18.1 17.37 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.221 0.608 . . . . 0.0 109.929 161.646 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 p -146.65 156.42 48.61 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 125.639 1.576 . . . . 0.0 107.736 174.405 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -63.23 145.1 93.05 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 N-CA-C 108.122 -1.53 . . . . 0.0 108.122 172.138 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.5 p -123.08 168.25 12.61 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.644 0.735 . . . . 0.0 111.299 178.716 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.8 m -93.63 144.88 24.98 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 168.354 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -168.74 56.9 0.21 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 176.525 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.91 57.78 0.86 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.018 1.727 . . . . 0.0 108.405 -174.374 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.62 166.46 23.52 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.94 0.876 . . . . 0.0 112.879 -168.036 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.48 97.55 8.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 176.512 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -77.23 140.24 40.05 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.544 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -85.76 88.61 7.57 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -172.634 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -76.97 77.91 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 C-N-CA 125.043 1.337 . . . . 0.0 110.435 -176.983 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.8 t 178.88 147.64 0.39 Allowed Pre-proline 0 N--CA 1.46 0.029 0 C-N-CA 124.932 1.293 . . . . 0.0 109.343 173.324 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -66.75 -35.19 28.86 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.146 1.23 . . . . 0.0 110.274 158.963 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.0 ptp 175.36 -70.78 0.01 OUTLIER 'General case' 0 C--N 1.341 0.206 0 C-N-CA 126.902 2.081 . . . . 0.0 107.571 179.244 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.0 -36.61 48.59 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.962 0.905 . . . . 0.0 113.011 -167.788 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.77 -109.62 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.608 0.242 . . . . 0.0 111.58 -167.732 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.79 -49.69 0.84 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.417 1.008 . . . . 0.0 113.528 -176.111 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.55 -57.52 4.66 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.594 1.197 . . . . 0.0 109.802 172.254 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -73.69 5.01 4.31 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.498 1.919 . . . . 0.0 113.895 -178.898 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -85.72 126.58 34.08 Favored 'General case' 0 C--N 1.344 0.343 0 O-C-N 121.232 -0.918 . . . . 0.0 108.649 174.871 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -72.71 91.0 1.43 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.179 -179.459 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.436 ' H ' ' HD2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -68.77 -20.22 64.35 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.833 1.253 . . . . 0.0 113.24 177.732 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.1 t 37.84 61.61 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 126.75 2.02 . . . . 0.0 111.992 177.464 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.38 68.78 0.36 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.133 1.373 . . . . 0.0 110.301 -177.109 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 17.6 p 177.73 -30.79 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.652 2.381 . . . . 0.0 109.972 -172.629 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -143.43 67.79 1.29 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 176.07 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 14.2 p -151.67 173.78 14.27 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.803 1.241 . . . . 0.0 109.024 179.595 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -67.48 114.51 6.21 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.173 0.589 . . . . 0.0 110.372 -165.635 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.7 t -80.73 -28.7 36.48 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.916 0.486 . . . . 0.0 112.062 -175.438 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 34.87 62.81 0.5 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.335 1.854 . . . . 0.0 114.081 176.039 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.1 t -88.5 -165.78 1.42 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.051 0.94 . . . . 0.0 110.05 174.687 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.5 t -76.69 144.15 39.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.198 0.999 . . . . 0.0 110.04 -175.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 81.0 mt -127.25 134.87 50.01 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.538 1.135 . . . . 0.0 108.15 -179.791 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -69.55 157.08 90.44 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 170.942 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.43 100.21 0.88 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.373 2.716 . . . . 0.0 110.438 -170.711 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.31 -23.44 3.31 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -175.208 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -78.95 135.78 37.05 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 118.254 1.027 . . . . 0.0 111.707 -160.727 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -92.61 104.56 16.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.4 1.48 . . . . 0.0 109.375 178.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -90.56 135.13 33.9 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 174.042 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -151.46 154.99 37.65 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.625 0.37 . . . . 0.0 110.639 156.922 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 78.6 mtp -151.77 146.05 18.36 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.161 0.984 . . . . 0.0 109.578 171.495 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -66.12 137.97 50.17 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.126 2.55 . . . . 0.0 110.443 161.79 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.8 t -107.96 130.47 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 159.852 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.3 m -98.49 140.82 17.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 171.845 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.531 ' CE1' HG21 ' A' ' 35' ' ' VAL . 64.3 t80 -154.43 149.37 26.72 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -162.322 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.467 ' CD1' HG23 ' A' ' 63' ' ' THR . 41.1 p90 -164.5 170.29 16.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.415 1.886 . . . . 0.0 109.108 165.314 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 70.7 t -103.99 135.46 41.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 174.482 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -76.37 134.2 70.47 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 119.119 -0.467 . . . . 0.0 109.954 176.397 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -74.16 67.34 5.16 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.384 2.723 . . . . 0.0 110.292 171.42 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -133.52 -37.82 0.94 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 126.799 2.04 . . . . 0.0 111.027 176.565 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.4 tt -43.87 -41.66 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 125.012 1.325 . . . . 0.0 113.414 173.111 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.9 m -78.23 49.03 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 O-C-N 121.394 -0.816 . . . . 0.0 111.34 176.825 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.9 mttt -142.72 -64.51 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 117.521 -1.228 . . . . 0.0 111.617 -179.299 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.17 153.17 46.03 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 121.942 1.729 . . . . 0.0 112.736 -176.548 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.8 t -54.87 -35.54 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 125.838 1.655 . . . . 0.0 110.662 175.897 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -35.26 -59.16 0.53 Allowed 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 126.656 1.983 . . . . 0.0 112.309 175.79 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.5 p -106.94 -42.73 4.84 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.015 -166.068 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 14.07 63.15 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 128.389 2.675 . . . . 0.0 116.235 172.151 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 136.73 -36.73 1.95 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -177.272 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 29.8 mm -53.28 123.52 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 171.444 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.38 47.86 0.35 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.288 0.566 . . . . 0.0 112.102 177.965 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.5 p -143.65 89.04 2.03 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 105.809 -1.922 . . . . 0.0 105.809 174.025 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 tp -92.71 87.21 5.8 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.029 -159.957 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.5 t -97.86 155.85 16.87 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.457 0.703 . . . . 0.0 111.084 -166.773 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.76 133.25 55.98 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 160.704 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 44.5 m -90.94 105.77 18.06 Favored 'General case' 0 N--CA 1.46 0.043 0 O-C-N 123.902 0.751 . . . . 0.0 109.035 160.452 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -76.27 99.8 4.89 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 165.708 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 53.5 m -117.34 86.35 2.5 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.978 1.311 . . . . 0.0 107.524 175.18 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.412 ' CD1' ' CD1' ' A' ' 45' ' ' LEU . 48.2 m-85 -59.22 145.2 43.67 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.322 1.049 . . . . 0.0 112.828 174.392 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -166.85 52.69 0.25 Allowed Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.966 1.707 . . . . 0.0 112.342 -175.435 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.3 -90.04 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.679 2.252 . . . . 0.0 115.092 -168.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -155.16 179.55 9.04 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 129.697 3.199 . . . . 0.0 104.863 -175.119 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -147.13 94.56 4.54 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 118.488 0.585 . . . . 0.0 111.044 -171.462 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -91.94 -124.37 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.984 3.122 . . . . 0.0 108.954 176.664 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 85.5 p -123.2 123.76 41.5 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 120.356 1.435 . . . . 0.0 111.763 -172.706 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.595 0 C-N-CA 126.496 1.918 . . . . 0.0 109.237 174.333 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.3 p . . . . . 0 N--CA 1.464 0.265 0 CA-C-O 122.042 0.925 . . . . 0.0 112.026 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 46.38 34.06 2.14 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.894 1.678 . . . . 0.0 112.276 176.482 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 166.68 157.1 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 128.332 2.653 . . . . 0.0 105.903 -172.58 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -151.74 2.55 0.39 Allowed 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -172.502 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.75 11.9 0.95 Allowed 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 126.802 2.041 . . . . 0.0 115.322 -164.9 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -77.25 -39.12 49.44 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 159.452 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.4 mp -92.22 -37.91 12.41 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 117.209 -1.377 . . . . 0.0 113.016 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.2 mt -32.53 133.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -162.13 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 29' ' ' LEU . 2.5 mm? -105.91 -104.15 0.33 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.159 -173.618 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -173.59 -49.2 0.01 OUTLIER 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.058 1.343 . . . . 0.0 108.855 -171.348 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -38.78 134.6 0.95 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.002 1.721 . . . . 0.0 110.678 -178.812 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -100.97 86.65 3.1 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -165.883 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.98 115.01 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.436 1.494 . . . . 0.0 107.953 -171.424 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.99 160.01 29.48 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -173.641 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.0 t -148.74 145.19 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.1 m -138.55 100.28 4.05 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -170.053 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -78.11 145.0 36.0 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.018 0.527 . . . . 0.0 109.919 -176.177 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -127.63 82.75 2.11 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.913 0.863 . . . . 0.0 110.007 178.22 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.49 102.16 14.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 172.118 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -116.89 128.37 55.18 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 122.292 1.044 . . . . 0.0 112.126 -174.666 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.0 p -99.83 96.29 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.564 -174.252 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.12 171.1 10.5 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 122.048 0.928 . . . . 0.0 111.406 174.843 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.41 132.07 52.0 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 169.903 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 128.33 -39.28 1.92 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -170.579 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.484 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -131.56 95.57 23.21 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 117.56 0.68 . . . . 0.0 110.277 -176.363 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -83.94 50.94 3.27 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.956 2.437 . . . . 0.0 109.651 -176.136 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.484 ' CD2' ' CD2' ' A' ' 45' ' ' LEU . 44.4 m0 -107.91 135.56 49.1 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -173.649 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -79.36 84.5 5.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 103.484 -2.784 . . . . 0.0 103.484 179.246 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -102.04 86.15 2.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -171.598 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.3 m -88.04 129.14 51.2 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -167.28 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.09 122.49 9.58 Favored 'Trans proline' 0 N--CA 1.446 -1.277 0 N-CA-C 106.261 -2.246 . . . . 0.0 106.261 162.466 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.1 m -72.73 -32.08 39.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.181 0.515 . . . . 0.0 110.691 -168.387 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.02 161.98 34.16 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 150.265 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -62.65 -46.72 86.89 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 172.532 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -147.38 153.54 39.77 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 124.415 1.086 . . . . 0.0 111.659 -159.647 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.4 pt -133.13 179.23 4.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 126.326 1.851 . . . . 0.0 108.251 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -125.47 160.18 30.11 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.345 0.593 . . . . 0.0 110.21 149.881 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.6 t -116.72 145.97 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 127.99 2.516 . . . . 0.0 105.679 171.014 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 49.5 mmm-85 -91.37 100.81 13.53 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 168.021 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mt -33.2 115.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -148.243 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.58 -25.2 26.49 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.071 1.319 . . . . 0.0 110.936 -179.386 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -64.9 133.45 51.86 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.806 1.303 . . . . 0.0 112.422 -172.33 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.15 101.53 7.97 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 130.05 3.34 . . . . 0.0 110.818 -175.38 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.9 p -113.78 153.75 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.292 1.437 . . . . 0.0 109.491 -178.597 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -112.51 125.15 53.93 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 125.404 1.482 . . . . 0.0 109.343 -177.38 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.0 pp -128.48 122.86 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 167.861 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.412 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 66.4 mtt -76.09 168.44 20.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.614 174.164 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -136.17 143.21 44.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 161.864 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.7 ttt85 -121.01 118.7 30.5 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 179.546 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.3 105.15 9.24 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 125.822 1.649 . . . . 0.0 110.035 -177.216 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.29 121.09 44.36 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.064 -0.398 . . . . 0.0 110.749 -168.603 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.44 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 47.8 t-20 -78.38 111.9 14.85 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.803 -0.561 . . . . 0.0 111.912 -167.783 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.2 tp -98.41 11.24 38.77 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.812 0.845 . . . . 0.0 112.381 179.564 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.46 166.67 22.33 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.272 -0.893 . . . . 0.0 109.95 173.44 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 70.0 m -103.3 7.0 38.35 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.968 0.907 . . . . 0.0 111.835 171.73 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.34 159.61 38.79 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 126.134 1.773 . . . . 0.0 107.041 177.974 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.97 126.04 12.11 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.171 1.914 . . . . 0.0 111.255 -173.208 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.476 ' HG1' ' HE1' ' A' ' 47' ' ' TRP . 0.2 OUTLIER -80.49 173.53 12.51 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.821 0.849 . . . . 0.0 110.784 -178.998 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 50.7 p -131.45 72.03 1.49 Allowed 'General case' 0 C--O 1.232 0.137 0 C-N-CA 122.551 0.341 . . . . 0.0 110.426 -170.893 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.42 139.37 37.39 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.946 -0.462 . . . . 0.0 111.946 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.81 34.19 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.659 1.983 . . . . 0.0 109.44 169.222 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.58 159.08 34.47 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.33 0.652 . . . . 0.0 111.445 -165.445 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.9 t -87.77 131.51 34.48 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.704 0.764 . . . . 0.0 110.039 177.814 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.409 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -104.03 89.93 3.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.871 2.468 . . . . 0.0 105.572 175.509 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -77.0 91.92 3.67 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 120.882 -1.136 . . . . 0.0 107.935 -177.617 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 84' ' ' PHE . 7.8 t -78.11 72.57 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.612 1.165 . . . . 0.0 109.973 -174.043 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.9 t -168.73 134.76 1.49 Allowed Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 119.901 1.228 . . . . 0.0 113.389 173.997 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -74.1 67.72 5.04 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 122.386 2.057 . . . . 0.0 107.243 156.257 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 22.2 ptm 44.19 25.47 0.11 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 170.935 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -171.41 -58.26 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 119.384 0.993 . . . . 0.0 110.594 -168.411 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.61 -101.2 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -177.282 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 64.05 -52.1 0.08 OUTLIER Glycine 0 CA--C 1.538 1.481 0 N-CA-C 115.413 0.925 . . . . 0.0 115.413 -175.534 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -45.73 -47.63 15.33 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.553 1.541 . . . . 0.0 110.808 172.217 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -73.85 -12.69 60.75 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 127.012 2.125 . . . . 0.0 113.471 178.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.403 ' CD2' HD23 ' A' ' 138' ' ' LEU . 9.0 t80 -67.55 140.0 56.95 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.119 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -71.21 127.95 34.29 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.967 1.307 . . . . 0.0 110.765 -177.33 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -161.06 -50.45 0.05 OUTLIER 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 122.478 0.311 . . . . 0.0 110.65 -174.793 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . 0.326 2.4 p 47.8 -95.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.985 1.314 . . . . 0.0 111.809 -175.875 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -165.18 178.75 6.74 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.201 1.401 . . . . 0.0 107.336 173.526 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 90.3 m 54.52 42.61 31.22 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.382 1.073 . . . . 0.0 111.469 175.982 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -106.18 163.73 12.57 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.385 1.074 . . . . 0.0 108.505 171.927 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 59.6 m -134.39 139.39 45.56 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 177.663 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -166.79 -42.46 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.853 0.861 . . . . 0.0 109.083 175.403 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.3 p -22.85 109.2 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 127.808 2.443 . . . . 0.0 111.855 162.783 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -78.41 -15.98 58.09 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -159.359 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.3 t 51.67 -146.64 0.47 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.441 1.096 . . . . 0.0 112.472 170.606 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.6 m -115.54 136.65 52.86 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.089 1.355 . . . . 0.0 108.542 -172.069 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 78.6 mt -128.44 147.95 50.69 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.39 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -73.29 156.42 89.15 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 172.354 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.23 85.87 0.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 124.88 3.72 . . . . 0.0 111.756 -173.064 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 152.74 -27.23 0.83 Allowed Glycine 0 CA--C 1.522 0.5 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.25 -177.777 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -77.86 143.45 37.79 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 118.085 0.942 . . . . 0.0 111.593 -157.925 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -105.21 96.9 6.84 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.811 1.244 . . . . 0.0 109.942 -175.603 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 15.4 tpt -83.92 89.21 7.18 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.114 1.365 . . . . 0.0 109.325 -177.951 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -99.21 134.21 42.4 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.256 0.622 . . . . 0.0 109.576 172.148 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 22.4 ptm -150.95 146.31 19.11 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.996 -0.526 . . . . 0.0 111.441 178.997 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 67' ' ' MET . 83.1 Cg_endo -79.58 147.77 20.05 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.883 3.055 . . . . 0.0 111.049 171.852 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.5 t -126.53 114.89 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 165.199 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.5 p -79.41 143.47 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 168.986 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -155.61 149.11 24.98 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.163 0.585 . . . . 0.0 109.949 -165.411 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -171.18 118.98 0.48 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.36 1.464 . . . . 0.0 111.893 176.858 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.8 t -64.09 133.39 29.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 O-C-N 120.355 -1.466 . . . . 0.0 109.505 175.317 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -91.61 132.39 33.44 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 123.701 0.801 . . . . 0.0 109.8 -179.053 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -46.35 -31.52 9.55 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.402 3.401 . . . . 0.0 114.919 177.342 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -48.94 -24.2 1.4 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.783 1.633 . . . . 0.0 112.39 179.183 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.1 tt -49.01 -44.46 15.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 169.097 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.9 m -83.38 59.66 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 118.571 0.623 . . . . 0.0 109.895 174.354 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -111.0 -77.41 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 117.168 -1.396 . . . . 0.0 110.366 164.628 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.54 156.05 45.12 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 CA-C-N 121.885 1.709 . . . . 0.0 111.666 -177.384 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.6 m -62.16 -36.08 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 124.94 1.296 . . . . 0.0 112.045 -170.657 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -60.6 -64.46 0.94 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.147 0.979 . . . . 0.0 109.281 177.587 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 44.6 p -72.61 -15.43 61.73 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 118.509 -0.758 . . . . 0.0 111.568 -172.419 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.04 -41.52 5.53 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.768 0.713 . . . . 0.0 111.221 162.913 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.34 -29.17 74.38 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 112.237 -0.345 . . . . 0.0 112.237 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.3 mm -83.88 125.94 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 122.079 0.942 . . . . 0.0 110.39 -177.629 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 28.3 pttt -148.81 63.76 1.06 Allowed 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.506 153.751 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 11.7 m -150.15 95.33 2.26 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 158.416 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.403 HD23 ' CD2' ' A' ' 95' ' ' PHE . 1.2 tp -75.48 144.79 41.87 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -173.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.8 t -141.8 173.38 11.56 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.496 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.1 tt -150.63 111.28 4.25 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 177.855 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.45 92.94 8.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.515 1.126 . . . . 0.0 109.252 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.94 108.4 19.17 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.877 1.271 . . . . 0.0 108.783 179.406 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.66 89.09 3.58 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 122.009 0.909 . . . . 0.0 109.747 -177.358 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -71.23 85.57 0.77 Allowed 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.281 177.058 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.1 47.59 2.8 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -178.703 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -80.89 -105.74 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.279 2.653 . . . . 0.0 111.967 178.914 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -140.95 121.68 14.34 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.648 1.179 . . . . 0.0 108.528 -171.242 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.9 111.22 38.82 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 125.654 1.581 . . . . 0.0 107.118 -177.128 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.431 ' HD3' HG23 ' A' ' 78' ' ' THR . 26.6 Cg_endo -83.3 -4.85 11.07 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.293 2.662 . . . . 0.0 113.043 -172.742 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.9 t 131.51 103.71 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 129.972 3.309 . . . . 0.0 109.754 174.481 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.542 0.669 0 C-N-CA 125.256 1.423 . . . . 0.0 111.723 168.356 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 122.31 1.052 . . . . 0.0 108.427 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 23.08 50.72 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.94 1.696 . . . . 0.0 112.229 -146.308 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.21 155.29 11.35 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 127.879 2.471 . . . . 0.0 104.405 174.542 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -122.32 125.96 47.07 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 104.354 -2.462 . . . . 0.0 104.354 156.676 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.6 t -147.88 49.54 1.06 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 122.493 1.14 . . . . 0.0 108.227 174.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -158.8 -57.42 0.07 Allowed 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 127.306 2.243 . . . . 0.0 106.309 -174.367 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.9 mt -65.53 -16.48 63.72 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.907 2.083 . . . . 0.0 112.878 -177.777 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.4 mt -75.67 78.51 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 O-C-N 121.21 -0.931 . . . . 0.0 110.267 -171.566 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.69 -127.7 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.555 1.142 . . . . 0.0 108.524 169.679 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -104.36 -51.33 3.13 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.57 1.548 . . . . 0.0 111.939 -164.506 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -43.1 102.07 0.03 OUTLIER 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.194 1.398 . . . . 0.0 113.351 -169.806 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.69 81.52 4.99 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 177.261 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -97.11 122.58 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -160.616 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.7 150.48 34.48 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.943 1.297 . . . . 0.0 108.199 -175.216 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.52 146.9 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 174.497 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.9 m -125.83 112.19 15.73 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -172.69 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -77.88 136.18 38.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.754 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -126.71 84.45 2.27 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 122.502 1.144 . . . . 0.0 108.965 177.943 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.91 95.75 10.28 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.374 1.07 . . . . 0.0 110.972 -176.753 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -98.63 109.5 22.24 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.375 0.67 . . . . 0.0 109.79 -177.936 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.0 p -79.24 148.86 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 164.388 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -151.04 158.71 44.44 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 171.216 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.05 -40.15 10.25 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.84 0.856 . . . . 0.0 112.109 -177.214 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -41.58 -31.98 0.76 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.812 1.672 . . . . 0.0 114.151 174.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.487 HD21 ' CE3' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -130.17 110.13 16.68 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 118.688 1.244 . . . . 0.0 108.471 170.488 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -75.27 0.95 8.4 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.294 1.996 . . . . 0.0 115.576 -164.035 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.517 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 42.2 m0 -79.57 153.45 29.46 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.38 1.472 . . . . 0.0 113.613 -159.844 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.42 ' O ' HG23 ' A' ' 50' ' ' VAL . 4.1 tt0 -77.47 77.46 4.0 Favored 'General case' 0 C--N 1.344 0.344 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.615 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -84.6 110.72 18.93 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.684 1.193 . . . . 0.0 109.098 -171.484 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 48' ' ' GLU . 42.9 t -122.78 118.81 28.25 Favored Pre-proline 0 N--CA 1.444 -0.758 0 C-N-CA 124.4 1.08 . . . . 0.0 108.645 -163.638 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -81.87 174.56 10.13 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 124.543 3.495 . . . . 0.0 108.554 168.367 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -98.6 -53.12 8.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 123.949 0.9 . . . . 0.0 110.845 -173.622 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -134.16 175.15 9.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 166.638 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.6 tpt85 -68.45 -33.15 73.68 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.392 168.636 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -144.67 173.44 11.82 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.842 1.257 . . . . 0.0 112.694 -162.861 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.1 pt -141.65 178.2 2.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 127.206 2.203 . . . . 0.0 106.788 165.567 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -132.27 162.77 30.16 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 146.911 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.23 136.92 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 126.953 2.101 . . . . 0.0 105.836 -175.199 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.94 88.66 3.5 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 163.205 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.2 pt 8.81 69.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 127.74 2.416 . . . . 0.0 114.63 178.469 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.55 -37.55 1.78 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 123.41 0.529 . . . . 0.0 112.305 -176.594 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -39.24 104.43 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.383 1.473 . . . . 0.0 110.849 177.101 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.59 HG23 ' CD1' ' A' ' 121' ' ' PHE . 1.2 m -87.46 88.45 7.68 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.353 -156.25 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 p -92.73 161.67 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 O-C-N 121.933 -0.479 . . . . 0.0 111.721 -168.434 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -102.98 126.74 50.28 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.959 1.303 . . . . 0.0 110.35 169.561 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.5 pp -131.33 114.03 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 107.319 -1.364 . . . . 0.0 107.319 167.443 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.0 ttp -77.86 161.52 27.55 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.378 0.671 . . . . 0.0 110.862 -176.861 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -134.57 150.96 50.78 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.436 1.094 . . . . 0.0 108.846 169.325 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 54.1 ttp85 -143.46 147.08 34.0 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.997 0.919 . . . . 0.0 110.111 -178.457 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.39 109.68 2.66 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.632 1.573 . . . . 0.0 111.765 -177.995 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -86.09 139.28 31.27 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.989 171.721 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.517 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 28.1 t30 -78.21 88.99 4.27 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.073 0.851 . . . . 0.0 112.127 168.958 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.9 mp -76.76 69.08 3.08 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 171.193 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -153.66 137.26 15.99 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 168.513 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.1 t -80.14 36.1 0.34 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.369 0.531 . . . . 0.0 110.754 178.083 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.8 p -149.91 155.47 37.98 Favored Pre-proline 0 C--O 1.237 0.395 0 C-N-CA 126.63 1.972 . . . . 0.0 106.995 174.307 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -63.23 148.14 93.3 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 N-CA-C 108.208 -1.497 . . . . 0.0 108.208 168.522 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.01 175.06 6.53 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.792 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.0 m -105.65 145.25 31.28 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.121 1.768 . . . . 0.0 106.875 175.39 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -133.65 126.14 4.2 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 107.096 -2.401 . . . . 0.0 107.096 172.494 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.18 54.77 0.12 Allowed 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 166.78 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.44 144.83 15.9 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.884 176.162 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.3 t -85.01 166.08 17.02 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 168.185 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -146.41 95.96 2.69 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -168.978 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.33 86.92 5.02 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 175.509 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.0 t -78.12 60.23 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.817 1.247 . . . . 0.0 108.776 -175.034 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.1 t -171.44 148.34 2.3 Favored Pre-proline 0 CA--C 1.522 -0.129 0 O-C-N 121.481 -0.762 . . . . 0.0 111.636 178.077 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -61.57 -41.26 40.99 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 121.758 1.639 . . . . 0.0 110.068 159.031 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.3 ptp 172.08 -77.72 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 127.124 2.17 . . . . 0.0 107.59 178.399 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.87 -29.87 63.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.634 1.174 . . . . 0.0 112.292 -170.287 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.9 -119.11 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -174.028 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.89 -50.56 2.25 Favored Glycine 0 CA--C 1.528 0.874 0 O-C-N 121.348 -0.845 . . . . 0.0 113.192 178.204 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -44.93 -54.54 6.38 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.159 0.984 . . . . 0.0 110.014 171.555 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -75.39 -4.26 38.41 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.508 1.923 . . . . 0.0 113.96 -179.053 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -69.37 133.55 47.95 Favored 'General case' 0 C--N 1.341 0.227 0 O-C-N 121.093 -1.004 . . . . 0.0 108.486 178.449 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -75.8 85.66 2.79 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.684 177.931 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -54.57 123.11 12.11 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 166.228 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.2 t -58.71 126.27 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -177.572 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -82.31 48.47 1.28 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.87 0.868 . . . . 0.0 110.001 -169.857 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 44.2 t -167.13 143.11 4.28 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.58 1.552 . . . . 0.0 108.589 -173.904 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -75.96 72.57 2.83 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.914 0.485 . . . . 0.0 110.278 -178.577 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 26.9 p -135.17 53.03 2.0 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 124.904 1.282 . . . . 0.0 109.355 178.625 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -155.17 145.54 22.0 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -170.753 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 47.0 m 58.99 88.14 0.07 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.876 1.67 . . . . 0.0 112.17 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -53.9 154.34 4.1 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.568 1.147 . . . . 0.0 111.7 176.414 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.7 t -111.52 -57.68 2.22 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 128.711 2.804 . . . . 0.0 111.378 -167.6 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.8 t -163.65 140.34 6.97 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 122.849 0.46 . . . . 0.0 110.385 -170.845 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.661 HD11 ' HB2' ' A' ' 114' ' ' MET . 39.7 mt -139.32 143.73 37.96 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.207 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.444 ' HB3' ' HD2' ' A' ' 110' ' ' PRO . 2.8 mt-10 -80.44 172.95 8.53 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.76 1.224 . . . . 0.0 109.349 -179.48 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 109' ' ' GLU . 35.2 Cg_endo -68.0 79.89 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.535 2.823 . . . . 0.0 114.465 -162.041 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 147.87 -29.89 1.39 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.307 0.956 . . . . 0.0 112.181 172.107 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -82.21 158.56 23.51 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 118.226 -1.39 . . . . 0.0 112.318 -139.61 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -84.61 123.26 30.13 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 124.64 1.176 . . . . 0.0 110.268 179.59 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.661 ' HB2' HD11 ' A' ' 108' ' ' LEU . 0.9 OUTLIER -90.22 128.61 36.42 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 154.89 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -134.0 146.42 50.4 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 159.698 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 56.7 mtt -146.61 146.63 27.59 Favored Pre-proline 0 N--CA 1.453 -0.323 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 165.087 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -71.55 142.58 40.61 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 122.101 1.868 . . . . 0.0 109.412 160.232 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.4 t -115.77 143.83 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 164.026 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.0 p -102.28 145.49 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 174.608 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -145.9 138.09 25.36 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.335 0.516 . . . . 0.0 111.425 -176.933 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.59 ' CD1' HG23 ' A' ' 63' ' ' THR . 5.9 p90 -159.07 162.25 36.56 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.569 1.548 . . . . 0.0 107.43 160.559 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 94.8 t -104.72 131.27 54.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 174.789 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.18 135.23 47.85 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 175.887 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -75.49 57.85 5.0 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 124.578 3.519 . . . . 0.0 112.673 -176.414 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.24 -36.47 7.63 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 125.57 1.548 . . . . 0.0 109.864 168.3 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.8 tt -47.75 -46.57 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -169.724 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.3 m -81.19 53.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.448 -0.783 . . . . 0.0 110.785 -178.444 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -138.28 -64.51 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 117.661 -1.161 . . . . 0.0 112.085 -179.371 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.67 156.33 35.64 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 CA-C-N 121.961 1.736 . . . . 0.0 113.406 -176.053 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.2 t -54.11 -39.46 42.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 126.201 1.8 . . . . 0.0 110.742 177.934 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -45.92 -55.72 6.38 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.697 1.599 . . . . 0.0 111.8 -178.523 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.3 p -92.37 -42.89 9.53 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 118.633 -0.699 . . . . 0.0 111.442 -176.313 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 7.93 65.13 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 128.403 2.681 . . . . 0.0 116.129 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 142.37 -41.34 1.2 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -173.709 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.7 mm -57.27 120.13 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 CA-C-N 117.689 0.744 . . . . 0.0 110.178 177.23 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -157.38 66.45 0.5 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.672 0.749 . . . . 0.0 110.173 162.578 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 10.6 m -147.51 102.72 3.48 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 152.206 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.68 151.76 34.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -175.243 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.7 t -154.08 175.13 13.79 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.408 0.623 . . . . 0.0 109.647 -177.269 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.9 tp -153.7 97.13 2.07 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 103.216 -2.883 . . . . 0.0 103.216 -169.278 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.5 t -81.78 88.09 6.32 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 171.733 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.79 124.4 27.64 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 176.809 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.423 HG22 ' CD1' ' A' ' 145' ' ' TYR . 23.8 m -133.38 95.52 3.53 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.412 1.101 . . . . 0.0 109.229 -164.468 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -74.22 74.42 1.8 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.041 1.736 . . . . 0.0 111.94 -171.007 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.423 ' CD1' HG22 ' A' ' 143' ' ' THR . 38.8 m-85 -128.35 68.48 77.23 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.349 1.06 . . . . 0.0 113.758 179.566 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -87.69 -103.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.775 2.983 . . . . 0.0 110.666 167.502 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -156.26 99.66 1.94 Allowed 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.8 1.24 . . . . 0.0 108.907 -172.117 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -104.56 134.0 19.89 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 126.432 1.893 . . . . 0.0 106.403 167.614 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.0 -47.3 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.445 2.097 . . . . 0.0 110.638 178.304 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.2 t 166.65 112.4 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 129.202 3.001 . . . . 0.0 104.822 178.486 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.7 pttt . . . . . 0 CA--C 1.535 0.4 0 CA-C-N 119.584 1.083 . . . . 0.0 110.409 -168.921 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 94.8 t . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 67.49 -148.04 0.15 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.992 0.917 . . . . 0.0 110.907 -178.849 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -71.7 98.95 2.02 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 125.127 1.371 . . . . 0.0 108.878 -170.483 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.43 59.46 2.96 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 122.711 1.244 . . . . 0.0 111.04 -152.979 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.4 p -76.49 1.66 15.93 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 128.075 2.55 . . . . 0.0 114.58 -164.881 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -78.56 -21.38 48.78 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 164.855 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.6 mt -115.32 -26.73 7.48 Favored 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 125.43 1.492 . . . . 0.0 113.134 -171.204 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.7 mt -40.55 -72.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.966 1.706 . . . . 0.0 115.389 -170.555 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.461 HD23 ' N ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER 64.99 167.55 0.18 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 127.449 2.3 . . . . 0.0 113.096 -176.036 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -76.57 57.82 1.28 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.521 1.528 . . . . 0.0 111.537 -177.394 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.53 ' HB3' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -134.04 170.74 15.19 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 126.111 1.764 . . . . 0.0 107.041 173.525 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -150.38 111.61 4.4 Favored 'General case' 0 N--CA 1.422 -1.855 0 C-N-CA 124.462 1.105 . . . . 0.0 109.217 177.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.9 tt -93.26 144.34 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 174.018 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.73 152.18 20.39 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 125.83 1.652 . . . . 0.0 109.033 177.766 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.6 t -136.95 144.24 32.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 175.54 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.6 m -136.19 94.3 3.02 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -171.774 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -75.04 163.85 27.16 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -175.932 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -142.44 85.34 1.9 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 122.217 1.008 . . . . 0.0 109.406 -178.727 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.457 ' HB1' ' CE2' ' A' ' 49' ' ' PHE . . . -89.57 102.79 15.47 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 121.586 -0.696 . . . . 0.0 110.25 -179.614 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -95.46 168.32 10.78 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 123.432 0.693 . . . . 0.0 109.616 177.913 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.4 t -134.49 151.82 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 167.802 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.65 153.58 47.34 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 166.446 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.46 -35.89 13.89 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.856 0.862 . . . . 0.0 112.358 -174.643 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -37.19 -41.54 0.71 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.71 1.624 . . . . 0.0 113.511 172.111 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.642 HD21 ' CE3' ' A' ' 47' ' ' TRP . 3.9 tt -116.67 107.72 46.1 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 118.187 0.993 . . . . 0.0 108.388 175.023 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -78.35 21.1 0.71 Allowed 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.006 1.804 . . . . 0.0 114.92 -161.704 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.642 ' CE3' HD21 ' A' ' 45' ' ' LEU . 50.0 m0 -101.39 147.73 25.99 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.435 1.016 . . . . 0.0 113.212 -160.83 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -78.31 88.95 4.33 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 176.116 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.457 ' CE2' ' HB1' ' A' ' 39' ' ' ALA . 11.2 t80 -90.93 126.27 36.01 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 123.774 0.83 . . . . 0.0 109.053 -179.786 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.1 t -118.24 107.66 43.15 Favored Pre-proline 0 N--CA 1.439 -1.0 0 C-N-CA 125.73 1.612 . . . . 0.0 107.69 -167.324 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -66.14 128.59 19.86 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 122.773 2.316 . . . . 0.0 107.096 165.077 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.9 m -77.27 -36.84 24.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.125 0.488 . . . . 0.0 111.068 -174.822 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.77 171.11 15.25 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 158.726 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -76.17 -48.87 18.92 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 119.379 -0.928 . . . . 0.0 108.891 172.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -136.67 155.54 49.75 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 125.661 1.584 . . . . 0.0 111.251 -161.528 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.1 pt -135.52 172.92 15.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 125.723 1.609 . . . . 0.0 108.733 -179.454 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -122.21 143.67 49.44 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 126.251 1.82 . . . . 0.0 109.074 162.351 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.6 m -128.97 129.67 68.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 C-N-CA 125.378 1.471 . . . . 0.0 107.408 167.935 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.22 76.75 0.36 Allowed 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 166.647 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.53 HD11 ' HB3' ' A' ' 31' ' ' GLU . 0.4 OUTLIER 9.06 59.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 129.393 3.077 . . . . 0.0 115.513 -172.868 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.65 -35.58 1.4 Allowed Glycine 0 C--N 1.335 0.503 0 O-C-N 121.427 -0.796 . . . . 0.0 111.898 -172.924 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -55.69 129.88 40.99 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 170.851 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.3 136.93 32.74 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 122.977 0.511 . . . . 0.0 112.345 -177.415 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.2 p -120.33 153.7 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 123.756 0.823 . . . . 0.0 109.108 168.115 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -103.88 116.51 32.42 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.254 1.821 . . . . 0.0 107.467 173.501 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.4 pp -122.18 119.37 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 168.07 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.425 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 85.2 mtp -76.57 166.26 23.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.693 170.766 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -130.25 149.8 51.78 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 160.78 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -134.08 132.56 40.1 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 124.121 0.888 . . . . 0.0 109.326 173.876 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.36 165.24 14.1 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 127.659 2.383 . . . . 0.0 106.942 167.208 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.6 mttt -154.02 133.88 13.06 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 119.226 0.921 . . . . 0.0 110.183 174.262 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.525 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 49.3 t30 -84.97 84.78 7.6 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.774 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.7 mp -83.32 63.66 7.37 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.707 167.417 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.26 163.96 25.6 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 165.211 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.7 m -93.95 20.11 8.2 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 123.063 0.227 . . . . 0.0 110.621 176.193 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.3 p -146.16 160.91 41.39 Favored Pre-proline 0 N--CA 1.45 -0.463 0 C-N-CA 125.687 1.595 . . . . 0.0 107.656 177.359 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -66.02 159.76 47.73 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 121.13 1.22 . . . . 0.0 108.972 169.534 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.65 174.32 10.63 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 122.44 0.296 . . . . 0.0 110.846 171.244 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -122.85 152.97 40.22 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.877 1.271 . . . . 0.0 108.85 171.035 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -127.68 129.87 6.55 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 177.336 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.11 40.65 1.49 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.078 0.951 . . . . 0.0 109.147 168.708 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -50.87 145.11 7.55 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.344 1.058 . . . . 0.0 111.616 -175.293 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.8 t -82.13 139.52 34.33 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 118.923 -1.111 . . . . 0.0 108.833 176.163 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -114.41 89.93 3.21 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 -175.142 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -78.39 85.38 4.51 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 177.881 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.3 t -78.36 67.96 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 125.51 1.524 . . . . 0.0 108.055 -178.377 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.6 t -166.68 144.11 4.18 Favored Pre-proline 0 C--N 1.338 0.094 0 O-C-N 121.59 -0.694 . . . . 0.0 112.49 174.106 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -64.31 -39.74 28.44 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 121.613 1.542 . . . . 0.0 109.428 159.09 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.0 ptp 170.7 -70.17 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 128.242 2.617 . . . . 0.0 107.123 178.706 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -90.98 -27.28 18.78 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 124.273 1.029 . . . . 0.0 112.884 -168.978 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.26 -123.4 0.01 OUTLIER 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.508 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.75 -54.82 2.97 Favored Glycine 0 CA--C 1.527 0.79 0 O-C-N 121.654 -0.654 . . . . 0.0 112.006 177.912 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -47.0 -49.48 20.82 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.543 1.172 . . . . 0.0 111.273 174.185 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -72.03 -16.25 62.05 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.445 1.098 . . . . 0.0 113.181 179.398 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -61.61 124.38 20.52 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -178.166 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -79.43 78.64 5.94 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.889 0.852 . . . . 0.0 111.43 -173.515 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -55.75 146.82 20.23 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.837 1.255 . . . . 0.0 110.75 167.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.4 p -153.72 158.36 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 173.001 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -156.33 151.51 26.49 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 -174.89 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 31.9 p -87.08 -56.69 3.26 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 123.32 0.387 . . . . 0.0 110.574 172.919 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -171.83 98.02 0.17 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.749 1.219 . . . . 0.0 108.072 179.603 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 45.5 t 59.61 89.54 0.06 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.054 1.341 . . . . 0.0 112.576 176.665 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 62.23 -169.7 0.18 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.237 0.615 . . . . 0.0 111.532 176.611 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.8 t -149.72 48.32 0.94 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 122.603 1.192 . . . . 0.0 108.407 163.194 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -138.91 -55.27 0.6 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.062 1.345 . . . . 0.0 107.411 175.598 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.483 HG23 ' H ' ' A' ' 107' ' ' THR 0.317 11.1 t 48.05 -81.43 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 127.713 2.405 . . . . 0.0 114.633 168.728 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.483 ' H ' HG23 ' A' ' 106' ' ' THR . 0.6 OUTLIER -158.95 149.35 19.61 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.082 1.353 . . . . 0.0 109.268 -178.564 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.0 mt -143.82 155.5 44.16 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 124.01 0.924 . . . . 0.0 108.835 174.854 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -94.72 166.55 14.89 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 125.468 1.507 . . . . 0.0 108.5 174.055 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.71 98.18 1.03 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.839 2.359 . . . . 0.0 111.67 -167.611 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.69 -24.57 2.46 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 123.551 0.596 . . . . 0.0 111.723 178.821 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -79.19 127.83 32.53 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 117.85 0.825 . . . . 0.0 111.826 -155.566 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -78.68 136.79 37.54 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 165.619 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 13.7 tpt -130.2 122.62 28.48 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 126.853 2.061 . . . . 0.0 107.863 -169.893 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -153.24 156.85 39.26 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 120.344 1.429 . . . . 0.0 112.299 177.761 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 6.2 ttt -155.07 142.38 13.8 Favored Pre-proline 0 N--CA 1.441 -0.898 0 C-N-CA 125.383 1.473 . . . . 0.0 107.149 -177.251 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 67' ' ' MET . 93.5 Cg_endo -74.31 144.78 33.4 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.642 2.894 . . . . 0.0 111.565 165.519 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.9 t -123.09 128.73 75.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 168.598 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.3 p -91.05 141.22 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 170.89 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -147.23 143.97 28.54 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.413 0.551 . . . . 0.0 111.617 -176.108 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -168.91 120.62 0.76 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 128.322 2.649 . . . . 0.0 106.731 175.295 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.8 p -82.49 146.66 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 119.698 1.136 . . . . 0.0 109.825 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -72.16 139.05 81.82 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 118.117 0.417 . . . . 0.0 110.064 176.984 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -76.55 61.13 6.76 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.404 2.736 . . . . 0.0 111.547 173.892 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . 0.253 9.8 pt-20 -135.17 -4.87 2.37 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 169.739 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -48.28 -42.99 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 119.201 0.91 . . . . 0.0 111.677 174.525 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.2 m -76.51 63.81 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 123.306 0.642 . . . . 0.0 110.413 174.406 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -123.06 -70.94 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 124.795 1.238 . . . . 0.0 111.181 170.468 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.53 156.65 36.34 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.161 1.907 . . . . 0.0 113.354 -169.835 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 84.3 t -54.16 -36.17 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.76 1.624 . . . . 0.0 110.057 176.278 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -47.46 -48.06 26.86 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.956 1.702 . . . . 0.0 112.024 176.144 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 22.3 p -93.55 -57.63 2.52 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -173.289 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 18.23 54.5 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 129.532 3.133 . . . . 0.0 115.529 176.063 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 146.2 -36.49 1.29 Allowed Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 -170.924 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 23.5 mm -57.52 132.72 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 172.486 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -158.8 53.57 0.42 Allowed 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 123.619 0.574 . . . . 0.0 110.277 161.772 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.6 p -149.77 98.51 2.75 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 176.962 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.2 mp -77.95 152.58 33.11 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.446 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.5 t -142.34 176.66 8.82 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 125.58 1.552 . . . . 0.0 107.236 170.473 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.2 tt -150.43 101.06 2.93 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 175.527 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.3 t -84.26 89.23 7.3 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.319 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.11 120.07 23.13 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 179.21 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.6 m -132.7 106.35 7.72 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.787 1.235 . . . . 0.0 108.553 -165.44 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.445 ' CD2' HD13 ' A' ' 45' ' ' LEU . 4.8 m-30 -90.19 96.57 10.73 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.868 1.267 . . . . 0.0 112.85 -160.359 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -138.49 76.64 36.18 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 178.646 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -91.53 -121.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.055 1 C-N-CA 125.94 4.427 . . . . 0.0 108.169 163.631 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.2 mmp_? -134.1 138.33 45.19 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.448 1.899 . . . . 0.0 107.132 179.142 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.93 114.88 55.87 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 174.671 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.63 -27.04 6.49 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.949 2.432 . . . . 0.0 112.272 -179.322 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.8 m 145.41 112.93 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 129.481 3.112 . . . . 0.0 109.086 -175.613 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.544 0.737 0 C-N-CA 125.012 1.325 . . . . 0.0 114.198 171.85 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.482 HG22 ' H ' ' A' ' 22' ' ' GLU . 8.2 p . . . . . 0 CA--C 1.54 0.588 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.482 ' H ' HG22 ' A' ' 21' ' ' VAL . 24.5 tt0 -70.89 85.43 0.68 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.425 1.012 . . . . 0.0 110.113 -179.983 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 109.46 117.6 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.391 1 C-N-CA 133.055 4.542 . . . . 0.0 102.798 -170.143 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.39 -56.85 6.28 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 115.029 -2.668 . . . . 0.0 111.544 -135.26 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.8 t -169.55 -146.45 0.05 Allowed 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 149.373 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -78.97 38.7 0.35 Allowed 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 130.01 3.324 . . . . 0.0 108.808 -178.547 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.4 mt -111.07 -21.29 12.04 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 127.969 2.508 . . . . 0.0 109.458 -170.896 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 27.6 mt -62.94 104.13 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 123.581 0.752 . . . . 0.0 111.839 -169.093 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.57 -150.87 0.17 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.889 0.876 . . . . 0.0 109.955 175.274 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -89.29 -37.41 14.94 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 129.237 3.015 . . . . 0.0 111.236 179.894 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -51.73 153.5 2.4 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.974 1.31 . . . . 0.0 113.493 -173.807 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -123.83 88.8 2.97 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 -176.951 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.19 131.93 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 125.19 1.396 . . . . 0.0 107.357 -179.538 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.6 ' HE3' ' HB2' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -97.48 152.94 18.48 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.348 1.059 . . . . 0.0 109.365 -168.906 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.416 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 65.4 t -131.27 132.59 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 174.758 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.7 m -110.54 112.4 24.29 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 173.009 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -81.56 86.21 6.4 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.642 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -88.27 84.49 6.86 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 122.241 1.02 . . . . 0.0 109.164 -173.781 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.3 105.23 17.21 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.361 0.664 . . . . 0.0 109.527 179.385 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -105.56 114.48 28.68 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.101 0.961 . . . . 0.0 108.828 -177.145 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.1 p -98.72 107.73 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 123.896 0.878 . . . . 0.0 109.865 176.623 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.06 155.59 19.37 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 167.565 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.25 -39.44 9.92 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.366 1.067 . . . . 0.0 111.741 178.47 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -40.18 -33.19 0.47 Allowed Glycine 0 CA--C 1.529 0.951 0 C-N-CA 126.144 1.83 . . . . 0.0 114.499 173.236 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.433 HD21 ' CE3' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -111.6 98.88 42.63 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 119.753 1.777 . . . . 0.0 108.523 168.312 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -83.86 45.53 1.81 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 124.057 3.171 . . . . 0.0 110.742 -167.533 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.534 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 44.7 m0 -115.69 145.92 42.32 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.571 1.148 . . . . 0.0 108.08 -172.999 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -76.4 82.58 3.14 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 175.782 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.99 116.26 31.62 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.736 1.214 . . . . 0.0 108.306 -172.718 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.3 m -129.52 147.48 65.39 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 118.233 0.469 . . . . 0.0 110.704 -173.276 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.89 160.53 47.53 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.264 1.976 . . . . 0.0 108.657 165.543 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -78.62 -59.44 3.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 -174.695 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -121.88 158.97 27.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 103.596 -2.742 . . . . 0.0 103.596 157.859 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -54.42 -38.73 66.59 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-O 120.943 0.401 . . . . 0.0 110.074 176.348 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.6 ' HB2' ' HE3' ' A' ' 34' ' ' LYS . 9.6 p-10 -153.3 163.12 40.47 Favored 'General case' 0 N--CA 1.424 -1.756 0 C-N-CA 126.423 1.889 . . . . 0.0 107.681 -166.739 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.6 pt -138.46 163.89 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 124.466 1.106 . . . . 0.0 108.205 170.256 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -106.93 133.05 52.16 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 104.535 -2.395 . . . . 0.0 104.535 165.415 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.2 m -119.57 129.06 75.8 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 172.704 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.5 mmm180 -76.21 74.88 3.04 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.203 -0.936 . . . . 0.0 108.702 175.281 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.0 mm 55.21 -95.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.911 1.284 . . . . 0.0 109.052 -173.613 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -97.51 30.52 9.08 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 124.559 1.076 . . . . 0.0 112.778 -169.455 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -83.63 95.79 8.47 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.949 1.7 . . . . 0.0 108.315 -177.195 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.11 89.68 0.13 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.831 1.253 . . . . 0.0 110.938 179.666 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.9 t -80.85 139.45 18.09 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.084 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 173.853 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.55 120.22 31.45 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 168.792 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.62 103.67 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.921 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 52.9 ttm -79.3 118.33 21.13 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.716 1.206 . . . . 0.0 111.81 -177.513 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -88.46 153.86 20.82 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.72 0.808 . . . . 0.0 110.462 175.841 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -125.82 133.76 51.89 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 124.317 1.047 . . . . 0.0 110.049 177.613 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -134.34 154.79 51.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 127.389 2.276 . . . . 0.0 107.104 158.213 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -157.54 136.1 11.31 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 104.937 -2.245 . . . . 0.0 104.937 175.884 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.534 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 59.6 t-20 -79.98 125.66 30.05 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.926 1.239 . . . . 0.0 111.807 -176.441 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.16 3.29 19.99 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.15 1.38 . . . . 0.0 112.27 -177.338 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.18 166.13 22.54 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.241 -0.912 . . . . 0.0 111.176 177.706 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.3 m -87.72 -8.77 55.63 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.988 0.915 . . . . 0.0 112.299 179.797 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.0 165.6 29.68 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 126.64 1.976 . . . . 0.0 106.362 178.409 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -57.41 154.96 32.59 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.949 1.766 . . . . 0.0 111.409 -177.19 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.34 164.59 20.06 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.42 0.629 . . . . 0.0 111.311 165.215 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.4 t -99.66 158.72 15.57 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 164.138 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.74 69.55 0.25 Allowed Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 107.973 -2.051 . . . . 0.0 107.973 -172.977 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -99.87 -58.82 1.83 Allowed 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.311 1.444 . . . . 0.0 108.546 178.863 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 64.33 -178.53 0.17 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.219 0.608 . . . . 0.0 111.62 178.146 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.0 m -136.61 134.93 37.89 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 168.588 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -114.83 170.82 8.05 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 126.197 1.799 . . . . 0.0 109.984 -173.06 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -131.4 107.97 9.29 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.927 1.291 . . . . 0.0 107.585 166.843 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.689 HG22 HD13 ' A' ' 140' ' ' LEU . 39.6 t -90.42 74.11 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.692 1.597 . . . . 0.0 108.569 179.655 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.8 t 177.15 148.27 0.32 Allowed Pre-proline 0 N--CA 1.466 0.366 0 C-N-CA 124.831 1.253 . . . . 0.0 110.776 177.88 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -65.33 -38.25 27.43 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 121.496 1.464 . . . . 0.0 110.482 159.539 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 11.1 ptp 171.55 -72.91 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 127.318 2.247 . . . . 0.0 107.547 175.225 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.58 -36.57 73.67 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.902 0.881 . . . . 0.0 112.908 -166.087 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.49 -105.94 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.302 0.241 . . . . 0.0 110.964 -173.863 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.86 -56.38 1.76 Allowed Glycine 0 CA--C 1.527 0.841 0 O-C-N 121.601 -0.687 . . . . 0.0 112.841 -176.287 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.5 -53.75 10.64 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.442 1.097 . . . . 0.0 111.476 -179.738 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -72.5 -8.44 55.12 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.332 1.453 . . . . 0.0 113.17 -178.128 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -64.02 117.14 6.63 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.492 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -78.46 74.17 5.01 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.977 0.894 . . . . 0.0 111.584 -165.855 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -56.5 124.22 17.46 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.097 1.359 . . . . 0.0 110.103 179.149 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.1 t -75.57 71.41 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.706 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 62.64 -77.47 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.156 1.782 . . . . 0.0 111.218 -177.465 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 15.4 t -179.65 -63.69 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 125.869 1.668 . . . . 0.0 108.327 -175.741 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -78.28 59.74 2.37 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.661 1.184 . . . . 0.0 110.997 -173.96 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 9.9 t -118.84 -65.26 1.19 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.226 1.41 . . . . 0.0 108.243 175.929 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.46 -51.18 70.5 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.184 0.594 . . . . 0.0 110.529 177.731 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 51.0 46.16 26.79 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.876 1.67 . . . . 0.0 115.384 165.039 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -71.7 153.13 42.24 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 118.62 -1.232 . . . . 0.0 108.384 157.854 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.7 t -161.61 -71.54 0.06 Allowed 'General case' 0 C--O 1.23 0.078 0 O-C-N 121.605 -0.684 . . . . 0.0 111.477 -179.557 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.2 t -159.24 149.68 19.38 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.878 1.271 . . . . 0.0 107.783 -174.939 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.3 mt -155.28 145.59 21.9 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.513 0.725 . . . . 0.0 110.044 175.501 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -70.23 174.21 3.57 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 124.554 1.142 . . . . 0.0 110.966 168.488 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.08 97.78 1.08 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.934 3.089 . . . . 0.0 111.045 -171.284 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 125.16 -7.93 8.04 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-O 119.489 -0.617 . . . . 0.0 111.693 176.09 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -76.65 170.56 16.2 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 117.794 0.797 . . . . 0.0 111.114 -171.762 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.54 143.82 45.13 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.828 1.651 . . . . 0.0 110.125 -167.329 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 7.6 mtt -139.81 81.84 1.84 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.652 1.581 . . . . 0.0 109.3 170.289 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -103.98 118.79 37.51 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 120.845 -1.159 . . . . 0.0 108.014 169.729 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 77.2 mtp -141.23 140.68 21.38 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 118.816 0.734 . . . . 0.0 112.053 -174.384 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.72 140.61 32.65 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 123.06 2.506 . . . . 0.0 110.277 175.709 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 69.5 t -116.57 151.42 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 161.118 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.1 p -118.21 139.23 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 167.409 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -153.22 157.94 40.98 Favored 'General case' 0 N--CA 1.458 -0.062 0 CA-C-N 119.562 1.074 . . . . 0.0 113.189 -177.336 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -179.1 174.63 1.04 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 128.979 2.911 . . . . 0.0 106.168 -169.176 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 67.2 t -135.5 133.65 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 119.143 0.883 . . . . 0.0 110.862 178.583 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -76.66 138.16 66.7 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.945 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -71.01 -3.61 13.19 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.024 2.483 . . . . 0.0 111.799 -179.28 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.407 ' OE1' ' NZ ' ' A' ' 128' ' ' LYS . 13.8 mm-40 -36.0 -41.61 0.25 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.427 1.091 . . . . 0.0 111.313 159.484 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -58.23 -30.79 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 123.79 0.836 . . . . 0.0 113.063 -178.546 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.4 m -101.24 17.73 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.583 0.753 . . . . 0.0 111.816 175.897 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.407 ' NZ ' ' OE1' ' A' ' 125' ' ' GLU 0.354 6.3 pttt -79.83 -42.2 1.47 Allowed Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 170.927 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -86.95 -175.71 1.7 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.08 2.52 . . . . 0.0 110.981 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 94.7 t -80.71 -54.2 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 123.751 0.82 . . . . 0.0 109.684 173.099 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -46.11 -57.8 4.17 Favored 'General case' 0 N--CA 1.46 0.064 0 C-N-CA 124.848 1.259 . . . . 0.0 112.796 -169.067 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.7 p -82.95 -3.99 57.72 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 118.378 -0.82 . . . . 0.0 112.783 -175.608 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -47.49 -42.69 23.42 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.802 1.183 . . . . 0.0 112.814 -172.516 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.18 -25.03 76.19 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 122.858 0.266 . . . . 0.0 113.223 -179.205 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 25.6 mm -74.51 130.51 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 117.935 0.868 . . . . 0.0 110.734 -174.805 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.3 pttt -156.26 42.6 0.39 Allowed 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.213 164.666 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.1 p -134.05 84.28 2.1 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 106.536 -1.654 . . . . 0.0 106.536 170.965 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.8 tp -87.95 87.24 7.29 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -163.93 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.6 t -96.31 143.87 26.99 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.262 -166.292 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.689 HD13 HG22 ' A' ' 86' ' ' VAL . 4.4 tp -112.71 111.34 22.07 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 168.025 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.4 p -88.72 96.88 10.84 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 168.831 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.56 128.91 35.02 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 170.002 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.8 m -129.64 93.78 3.61 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.895 0.855 . . . . 0.0 109.482 -174.677 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -78.96 91.72 4.85 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.5 1.12 . . . . 0.0 111.121 -171.043 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.73 53.26 9.81 Favored Pre-proline 0 CA--C 1.549 0.923 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 179.542 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.66 -94.56 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.16 2.573 . . . . 0.0 111.27 175.78 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -157.43 140.43 15.21 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 118.089 -0.958 . . . . 0.0 109.164 178.494 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -109.91 150.61 41.62 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 165.187 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -74.64 -59.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.284 1.99 . . . . 0.0 109.224 169.919 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 37.1 p 179.32 94.41 0.02 OUTLIER 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.614 1.565 . . . . 0.0 107.922 -179.26 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 19.1 pttp . . . . . 0 CA--C 1.539 0.533 0 CA-C-N 118.281 0.491 . . . . 0.0 109.874 -178.968 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 CA--C 1.541 0.612 0 CA-C-O 120.588 0.232 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 45.31 39.4 4.28 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.214 1.406 . . . . 0.0 111.563 -169.725 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 164.69 62.52 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 129.963 3.305 . . . . 0.0 104.063 -175.151 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.79 73.29 6.53 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.218 -169.536 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 79.0 p -109.38 62.13 0.6 Allowed 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 127.231 2.212 . . . . 0.0 110.735 -157.095 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -155.63 -60.33 0.11 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 102.887 -3.005 . . . . 0.0 102.887 172.384 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.744 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.2 pt? -68.8 27.76 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 128.238 2.615 . . . . 0.0 114.316 177.22 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.5 mt -97.14 60.07 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.265 0 O-C-N 120.472 -1.393 . . . . 0.0 107.823 173.377 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.21 -179.43 2.86 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.607 -167.747 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -75.39 56.83 0.87 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.521 1.128 . . . . 0.0 110.324 177.306 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.94 145.26 41.82 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.833 1.653 . . . . 0.0 106.751 176.754 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -131.43 127.59 37.77 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.235 2.214 . . . . 0.0 105.292 -169.727 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.567 HG23 HG23 ' A' ' 58' ' ' VAL . 1.3 tt -140.32 147.79 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 124.56 1.144 . . . . 0.0 108.587 -164.377 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.519 ' CE ' ' HB2' ' A' ' 55' ' ' ASP . 4.0 tmtp? -109.01 151.17 26.7 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.463 1.505 . . . . 0.0 109.782 -164.426 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.416 ' HB ' ' CG1' ' A' ' 56' ' ' ILE . 70.6 t -133.25 137.92 52.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 167.37 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.5 m -122.71 111.84 17.21 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -179.702 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -89.7 85.18 6.38 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 123.016 0.526 . . . . 0.0 110.246 -174.427 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -87.29 81.81 7.8 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 123.063 1.411 . . . . 0.0 110.909 -179.602 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.0 120.82 36.96 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 121.006 -1.059 . . . . 0.0 109.89 -176.597 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -125.8 160.69 29.18 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.259 1.024 . . . . 0.0 108.556 -179.892 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.93 151.25 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.077 0 C-N-CA 123.83 0.852 . . . . 0.0 109.249 -176.905 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.71 175.61 11.43 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.085 0.954 . . . . 0.0 110.437 178.955 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.51 124.11 6.57 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 170.251 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 127.38 -39.99 1.84 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -165.712 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.479 HD12 ' CD ' ' A' ' 146' ' ' PRO . 0.5 OUTLIER -127.87 87.46 55.69 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 123.652 0.781 . . . . 0.0 110.017 174.169 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -81.72 38.75 0.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 124.356 3.371 . . . . 0.0 110.199 -176.973 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.465 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 41.3 m0 -110.11 146.77 34.88 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -171.347 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.41 78.34 3.93 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 -175.036 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -95.06 109.76 21.77 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -170.45 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.9 m -111.84 139.83 22.69 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.631 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.05 162.8 36.6 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 N-CA-C 108.444 -1.406 . . . . 0.0 108.444 162.659 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.7 t -78.33 -45.68 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -178.665 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -156.01 175.74 13.56 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 166.476 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -50.54 62.5 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.496 0.589 . . . . 0.0 111.619 171.474 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.519 ' HB2' ' CE ' ' A' ' 34' ' ' LYS . 23.1 p-10 -156.22 161.78 40.24 Favored 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 123.959 0.904 . . . . 0.0 111.482 -164.809 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.416 ' CG1' ' HB ' ' A' ' 35' ' ' VAL . 36.1 pt -129.4 162.06 37.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 169.324 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -116.31 142.6 46.62 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 161.475 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.567 HG23 HG23 ' A' ' 33' ' ' ILE . 29.7 m -131.63 159.15 43.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 126.361 1.865 . . . . 0.0 106.133 175.106 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.3 mtm-85 -100.66 85.42 2.91 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 158.414 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.543 HG23 HG21 ' A' ' 33' ' ' ILE . 6.8 pt 35.87 43.7 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 127.379 2.271 . . . . 0.0 114.549 161.298 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 146.49 -29.81 1.59 Allowed Glycine 0 CA--C 1.525 0.687 0 O-C-N 121.004 -1.06 . . . . 0.0 111.618 -170.88 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -57.6 98.51 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.084 0.954 . . . . 0.0 110.137 173.755 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.411 HG22 ' CD1' ' A' ' 121' ' ' PHE . 0.3 OUTLIER -65.45 107.51 1.69 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.925 2.09 . . . . 0.0 111.558 -176.565 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.95 147.32 12.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 166.56 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.39 128.03 39.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.475 1.91 . . . . 0.0 108.644 172.72 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.7 pp -129.83 111.48 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 167.468 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.84 126.39 36.9 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 123.126 0.571 . . . . 0.0 112.253 178.593 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -89.97 158.31 17.43 Favored 'General case' 0 C--O 1.23 0.062 0 C-N-CA 123.856 0.863 . . . . 0.0 108.709 177.272 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -133.83 129.84 37.07 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.846 1.258 . . . . 0.0 109.09 176.723 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.11 150.14 51.51 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 128.26 2.624 . . . . 0.0 107.131 163.74 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -150.96 129.02 11.79 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 117.365 -1.302 . . . . 0.0 107.7 174.967 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.465 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 52.8 t-20 -78.79 116.91 19.44 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 120.803 1.638 . . . . 0.0 111.642 -170.6 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.6 mt -117.04 34.43 5.11 Favored 'General case' 0 C--N 1.345 0.379 0 C-N-CA 124.575 1.15 . . . . 0.0 112.028 179.008 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.15 175.95 6.58 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 154.204 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.7 t -95.94 16.53 17.53 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.192 0.597 . . . . 0.0 110.483 172.616 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 p -145.41 154.32 52.97 Favored Pre-proline 0 N--CA 1.45 -0.46 0 C-N-CA 124.972 1.309 . . . . 0.0 109.025 -176.102 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.14 147.32 78.98 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 N-CA-C 108.132 -1.526 . . . . 0.0 108.132 171.168 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.4 p -119.39 178.93 4.36 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 170.24 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.4 t -124.41 109.45 13.31 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 173.015 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.32 101.59 0.64 Allowed Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 108.527 -1.829 . . . . 0.0 108.527 175.011 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -125.51 47.79 2.15 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 165.711 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.29 -178.84 1.43 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 122.181 0.991 . . . . 0.0 108.541 159.415 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.74 -173.56 4.62 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 178.055 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -144.21 146.47 32.71 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.247 0.93 . . . . 0.0 111.778 167.72 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.2 96.19 9.44 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 167.304 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.9 p -85.58 65.74 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 CA-C-N 118.045 0.384 . . . . 0.0 110.603 177.821 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.1 t -164.84 143.88 5.64 Favored Pre-proline 0 C--O 1.233 0.191 0 O-C-N 121.161 -0.962 . . . . 0.0 112.201 -179.497 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.19 -33.29 31.48 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 N-CA-C 108.776 -1.278 . . . . 0.0 108.776 162.907 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 7.8 ptm 175.58 -70.09 0.01 OUTLIER 'General case' 0 C--N 1.343 0.304 0 C-N-CA 126.406 1.883 . . . . 0.0 108.127 -171.161 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -99.72 -19.66 16.65 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.765 1.226 . . . . 0.0 112.743 -161.972 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.72 -133.24 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 178.892 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.3 -45.42 0.35 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.137 0.875 . . . . 0.0 114.442 -174.812 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -49.34 -61.02 2.32 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.608 1.204 . . . . 0.0 108.636 167.61 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -75.8 54.34 0.8 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.41 1.884 . . . . 0.0 110.147 171.017 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -110.7 156.89 20.38 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 162.274 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -51.12 -50.26 59.19 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 127.006 2.122 . . . . 0.0 109.676 -175.376 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt 55.12 44.41 27.93 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.884 159.615 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.0 p -60.34 128.36 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.782 -176.288 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -78.6 65.6 3.91 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -178.573 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 32.9 t -158.61 151.79 22.69 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 125.163 1.385 . . . . 0.0 107.601 -175.199 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -71.29 53.08 0.19 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.404 1.482 . . . . 0.0 112.409 -177.788 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 68.6 m -81.54 66.92 7.29 Favored 'General case' 0 C--N 1.334 -0.081 0 C-N-CA 124.221 1.008 . . . . 0.0 108.571 -179.132 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 64.0 t80 116.05 117.09 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 129.587 3.155 . . . . 0.0 107.812 -172.108 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 91.3 m -152.19 87.97 1.35 Allowed 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 174.577 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -53.22 -28.77 28.69 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.935 1.694 . . . . 0.0 114.408 -173.364 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.8 t 52.14 -146.79 0.48 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.681 1.192 . . . . 0.0 112.231 170.93 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.55 122.66 45.33 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.058 1.743 . . . . 0.0 107.095 177.111 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.41 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -116.35 129.38 56.22 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.904 1.681 . . . . 0.0 108.615 -170.203 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -77.49 152.42 81.04 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 123.462 0.705 . . . . 0.0 111.673 -177.935 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.75 110.71 2.83 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.457 2.771 . . . . 0.0 112.111 -167.645 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 126.0 -31.68 4.02 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 108.27 -1.932 . . . . 0.0 108.27 -176.658 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -86.32 171.29 11.32 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 121.363 0.601 . . . . 0.0 112.206 -161.173 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.08 145.5 41.52 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.237 1.815 . . . . 0.0 110.649 -163.081 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.62 86.92 2.14 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.163 1.785 . . . . 0.0 107.678 166.015 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -125.28 129.42 49.97 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 121.633 -0.667 . . . . 0.0 110.731 169.774 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 81.5 mtp -153.94 146.4 17.42 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 122.938 0.495 . . . . 0.0 111.054 -170.364 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -66.93 137.29 44.36 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.608 2.872 . . . . 0.0 112.105 172.561 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 34.5 t -116.59 155.96 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 161.674 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.0 m -121.27 151.76 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 176.09 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -151.42 139.29 19.91 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 119.18 -0.438 . . . . 0.0 110.477 -171.021 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.411 ' CD1' HG22 ' A' ' 63' ' ' THR . 8.3 p90 -172.71 86.55 0.07 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.628 1.171 . . . . 0.0 110.462 -174.293 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.478 ' H ' HG21 ' A' ' 58' ' ' VAL . 41.5 t -49.72 143.1 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -166.1 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.33 123.74 84.44 Favored Pre-proline 0 CA--C 1.537 0.478 0 O-C-N 121.308 -0.87 . . . . 0.0 110.821 -174.454 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.409 ' CD ' HD12 ' A' ' 27' ' ' LEU . 34.6 Cg_endo -73.9 32.59 0.33 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.12 2.547 . . . . 0.0 113.483 177.339 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -87.28 -24.27 24.4 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.529 1.532 . . . . 0.0 108.67 160.585 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -46.46 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 C-N-CA 123.098 0.559 . . . . 0.0 111.576 -172.209 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.8 m -79.31 61.5 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 O-C-N 121.691 -0.63 . . . . 0.0 110.401 177.063 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -137.39 -65.01 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.597 0 CA-C-O 117.845 -1.074 . . . . 0.0 112.344 173.899 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.5 159.57 28.85 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 122.119 1.879 . . . . 0.0 113.917 -173.128 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 86.7 t -54.71 -35.94 34.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 126.024 1.73 . . . . 0.0 110.981 177.271 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -36.82 -55.95 0.87 Allowed 'General case' 0 C--N 1.34 0.157 0 C-N-CA 126.089 1.756 . . . . 0.0 111.817 175.27 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.0 p -105.9 -50.26 3.22 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 124.192 0.997 . . . . 0.0 109.826 -163.667 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 22.02 57.44 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 128.425 2.69 . . . . 0.0 115.508 173.501 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 135.26 -30.48 2.8 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 -177.298 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 13.0 mm -53.5 138.62 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-N 117.828 0.814 . . . . 0.0 109.274 173.691 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.8 pttt -158.87 54.96 0.42 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.571 0.701 . . . . 0.0 111.056 165.181 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.93 90.24 2.37 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -178.223 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.3 mp -76.44 85.57 3.17 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.089 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.2 m -77.3 107.25 9.57 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 176.527 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.2 tt -76.79 137.23 39.13 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 160.583 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 27.9 t -135.61 142.7 45.29 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 160.791 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -159.36 169.76 23.29 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 155.925 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 38.4 m -113.7 103.55 11.33 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 127.437 2.295 . . . . 0.0 108.333 173.366 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -71.12 100.2 2.0 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 172.367 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.07 50.47 0.69 Allowed Pre-proline 0 CA--C 1.553 1.072 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 -176.325 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.479 ' CD ' HD12 ' A' ' 45' ' ' LEU . 59.2 Cg_endo -75.9 -82.27 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.504 2.803 . . . . 0.0 113.991 -175.886 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 74.0 mtt85 -149.74 106.77 3.57 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.41 1.005 . . . . 0.0 112.019 -164.655 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -156.49 135.63 7.95 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 126.043 1.737 . . . . 0.0 106.932 169.792 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.13 -53.59 0.3 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.139 1.893 . . . . 0.0 112.609 173.473 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.3 p 177.18 109.41 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.67 0.788 . . . . 0.0 110.493 -166.957 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 55.9 pttt . . . . . 0 CA--C 1.537 0.467 0 O-C-N 121.303 -0.873 . . . . 0.0 109.896 -177.859 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.1 t . . . . . 0 CA--C 1.537 0.461 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -73.62 67.11 1.09 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 159.511 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 146.46 154.08 0.0 OUTLIER 'General case' 0 C--N 1.339 0.132 1 C-N-CA 132.349 4.26 . . . . 0.0 108.096 -171.868 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -153.2 28.55 0.51 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 122.025 0.917 . . . . 0.0 110.126 -167.389 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.79 -11.43 59.99 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.529 1.532 . . . . 0.0 114.757 -147.196 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.35 -31.96 64.25 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 173.879 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.1 mp -108.09 14.46 25.11 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.023 1.329 . . . . 0.0 112.074 -176.27 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.4 mt -77.98 77.31 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 120.005 -1.684 . . . . 0.0 108.839 173.641 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.76 179.75 5.93 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.531 0.681 . . . . 0.0 109.893 179.238 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -94.48 59.43 2.51 Favored 'General case' 0 C--N 1.337 0.031 0 C-N-CA 123.827 0.851 . . . . 0.0 112.667 -167.021 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -115.18 160.9 19.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 151.664 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -133.76 88.38 2.47 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -179.898 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.0 tt -94.47 137.91 21.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 C-N-CA 124.477 1.111 . . . . 0.0 111.637 -163.997 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.441 ' HE2' ' CB ' ' A' ' 55' ' ' ASP . 0.1 OUTLIER -79.71 143.84 34.2 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.635 1.574 . . . . 0.0 109.781 -170.421 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.531 HG21 ' CE1' ' A' ' 120' ' ' PHE . 3.7 t -135.72 142.06 40.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.655 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 164.389 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.9 m -123.29 112.47 17.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 -177.721 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -78.52 89.76 4.48 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 172.864 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -78.23 85.25 4.4 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 118.492 -1.283 . . . . 0.0 108.395 178.576 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.5 115.78 17.54 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.832 174.758 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -122.94 175.54 6.52 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.595 1.158 . . . . 0.0 108.188 167.039 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.6 p -151.17 148.6 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 169.161 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -164.51 171.54 14.45 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.254 1.022 . . . . 0.0 108.869 -178.302 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.62 -165.36 0.22 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.354 1.462 . . . . 0.0 111.616 -175.4 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.73 52.98 4.26 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 112.123 -0.391 . . . . 0.0 112.123 -173.079 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.412 ' CD1' ' CD1' ' A' ' 144' ' ' PHE . 1.4 tt -111.7 83.77 4.77 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.122 0.969 . . . . 0.0 108.785 177.693 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -85.28 45.0 1.5 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.246 3.298 . . . . 0.0 109.736 -170.141 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.438 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 43.1 m0 -108.39 138.58 44.43 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -172.909 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.408 ' OE1' ' NZ ' ' A' ' 71' ' ' LYS . 73.2 tt0 -77.85 82.36 4.23 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 -178.503 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -90.26 122.01 32.79 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.715 1.206 . . . . 0.0 108.233 179.834 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 m -126.67 135.54 27.43 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.144 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -70.76 162.39 42.76 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 N-CA-C 108.146 -1.521 . . . . 0.0 108.146 161.433 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -60.18 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 175.117 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -144.06 154.13 42.91 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 164.773 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.03 -42.72 69.45 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 118.537 -0.744 . . . . 0.0 112.095 -175.964 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.441 ' CB ' ' HE2' ' A' ' 34' ' ' LYS . 23.7 p-10 -145.35 159.69 42.67 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 119.382 0.992 . . . . 0.0 113.189 -166.623 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.8 pt -133.82 159.79 42.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 125.768 1.627 . . . . 0.0 107.847 178.193 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -128.29 85.41 2.34 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.316 1.446 . . . . 0.0 109.124 178.189 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.8 m -80.44 141.83 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 O-C-N 121.255 -0.903 . . . . 0.0 110.689 -171.281 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -78.22 72.16 4.74 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 173.078 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.5 pt 19.01 64.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 127.437 2.295 . . . . 0.0 113.489 176.368 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 139.0 -43.8 1.14 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -172.58 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -59.68 130.3 46.16 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.648 -173.467 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.467 HG23 ' CD1' ' A' ' 121' ' ' PHE . 1.6 m -106.69 87.28 2.49 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.003 -146.106 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.72 144.19 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 CA-C-O 121.094 0.473 . . . . 0.0 110.696 -170.538 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.93 115.54 24.4 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.239 1.016 . . . . 0.0 108.591 168.817 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.8 pp -115.57 115.04 48.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 164.044 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -87.49 155.23 20.09 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.939 -0.475 . . . . 0.0 110.966 178.387 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -127.0 153.78 45.46 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 172.73 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -134.69 141.79 46.64 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.877 1.671 . . . . 0.0 107.898 179.904 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.34 115.58 7.98 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.805 2.042 . . . . 0.0 107.681 174.387 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.408 ' NZ ' ' OE1' ' A' ' 48' ' ' GLU . 3.0 mtmp? -114.73 124.42 51.73 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.29 0.95 . . . . 0.0 110.652 -176.99 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.438 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 46.9 t-20 -80.92 107.2 13.53 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.79 0.723 . . . . 0.0 112.932 -167.583 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.3 mp -99.08 30.4 3.45 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.495 1.118 . . . . 0.0 111.974 176.649 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.85 176.81 9.39 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.021 -1.049 . . . . 0.0 110.401 168.084 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.1 t -114.07 18.1 17.37 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.221 0.608 . . . . 0.0 109.929 161.646 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 p -146.65 156.42 48.61 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 125.639 1.576 . . . . 0.0 107.736 174.405 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -63.23 145.1 93.05 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 N-CA-C 108.122 -1.53 . . . . 0.0 108.122 172.138 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.5 p -123.08 168.25 12.61 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.644 0.735 . . . . 0.0 111.299 178.716 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.8 m -93.63 144.88 24.98 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 168.354 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -168.74 56.9 0.21 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 176.525 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.91 57.78 0.86 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.018 1.727 . . . . 0.0 108.405 -174.374 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.62 166.46 23.52 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.94 0.876 . . . . 0.0 112.879 -168.036 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.48 97.55 8.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 176.512 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -77.23 140.24 40.05 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.544 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -85.76 88.61 7.57 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -172.634 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -76.97 77.91 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 C-N-CA 125.043 1.337 . . . . 0.0 110.435 -176.983 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.8 t 178.88 147.64 0.39 Allowed Pre-proline 0 N--CA 1.46 0.029 0 C-N-CA 124.932 1.293 . . . . 0.0 109.343 173.324 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -66.75 -35.19 28.86 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.146 1.23 . . . . 0.0 110.274 158.963 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.0 ptp 175.36 -70.78 0.01 OUTLIER 'General case' 0 C--N 1.341 0.206 0 C-N-CA 126.902 2.081 . . . . 0.0 107.571 179.244 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.0 -36.61 48.59 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.962 0.905 . . . . 0.0 113.011 -167.788 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.77 -109.62 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.608 0.242 . . . . 0.0 111.58 -167.732 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.79 -49.69 0.84 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.417 1.008 . . . . 0.0 113.528 -176.111 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.55 -57.52 4.66 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.594 1.197 . . . . 0.0 109.802 172.254 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -73.69 5.01 4.31 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.498 1.919 . . . . 0.0 113.895 -178.898 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -85.72 126.58 34.08 Favored 'General case' 0 C--N 1.344 0.343 0 O-C-N 121.232 -0.918 . . . . 0.0 108.649 174.871 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -72.71 91.0 1.43 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.179 -179.459 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.436 ' H ' ' HD2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -68.77 -20.22 64.35 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.833 1.253 . . . . 0.0 113.24 177.732 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.1 t 37.84 61.61 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 126.75 2.02 . . . . 0.0 111.992 177.464 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.38 68.78 0.36 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.133 1.373 . . . . 0.0 110.301 -177.109 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 17.6 p 177.73 -30.79 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.652 2.381 . . . . 0.0 109.972 -172.629 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -143.43 67.79 1.29 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 176.07 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 14.2 p -151.67 173.78 14.27 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.803 1.241 . . . . 0.0 109.024 179.595 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -67.48 114.51 6.21 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.173 0.589 . . . . 0.0 110.372 -165.635 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.7 t -80.73 -28.7 36.48 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.916 0.486 . . . . 0.0 112.062 -175.438 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 34.87 62.81 0.5 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.335 1.854 . . . . 0.0 114.081 176.039 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.1 t -88.5 -165.78 1.42 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.051 0.94 . . . . 0.0 110.05 174.687 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.5 t -76.69 144.15 39.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.198 0.999 . . . . 0.0 110.04 -175.997 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 81.0 mt -127.25 134.87 50.01 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.538 1.135 . . . . 0.0 108.15 -179.791 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -69.55 157.08 90.44 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 170.942 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.43 100.21 0.88 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.373 2.716 . . . . 0.0 110.438 -170.711 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.31 -23.44 3.31 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -175.208 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -78.95 135.78 37.05 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 118.254 1.027 . . . . 0.0 111.707 -160.727 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -92.61 104.56 16.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.4 1.48 . . . . 0.0 109.375 178.906 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -90.56 135.13 33.9 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 174.042 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -151.46 154.99 37.65 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.625 0.37 . . . . 0.0 110.639 156.922 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 78.6 mtp -151.77 146.05 18.36 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.161 0.984 . . . . 0.0 109.578 171.495 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -66.12 137.97 50.17 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.126 2.55 . . . . 0.0 110.443 161.79 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.8 t -107.96 130.47 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 159.852 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.3 m -98.49 140.82 17.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 171.845 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.531 ' CE1' HG21 ' A' ' 35' ' ' VAL . 64.3 t80 -154.43 149.37 26.72 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -162.322 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.467 ' CD1' HG23 ' A' ' 63' ' ' THR . 41.1 p90 -164.5 170.29 16.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.415 1.886 . . . . 0.0 109.108 165.314 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 70.7 t -103.99 135.46 41.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 174.482 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -76.37 134.2 70.47 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 119.119 -0.467 . . . . 0.0 109.954 176.397 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -74.16 67.34 5.16 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.384 2.723 . . . . 0.0 110.292 171.42 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -133.52 -37.82 0.94 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 126.799 2.04 . . . . 0.0 111.027 176.565 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.4 tt -43.87 -41.66 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 125.012 1.325 . . . . 0.0 113.414 173.111 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.9 m -78.23 49.03 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 O-C-N 121.394 -0.816 . . . . 0.0 111.34 176.825 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.9 mttt -142.72 -64.51 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 117.521 -1.228 . . . . 0.0 111.617 -179.299 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.17 153.17 46.03 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 121.942 1.729 . . . . 0.0 112.736 -176.548 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.8 t -54.87 -35.54 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 125.838 1.655 . . . . 0.0 110.662 175.897 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -35.26 -59.16 0.53 Allowed 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 126.656 1.983 . . . . 0.0 112.309 175.79 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.5 p -106.94 -42.73 4.84 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.015 -166.068 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 14.07 63.15 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 128.389 2.675 . . . . 0.0 116.235 172.151 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 136.73 -36.73 1.95 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -177.272 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 29.8 mm -53.28 123.52 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 171.444 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.38 47.86 0.35 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.288 0.566 . . . . 0.0 112.102 177.965 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.5 p -143.65 89.04 2.03 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 105.809 -1.922 . . . . 0.0 105.809 174.025 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 tp -92.71 87.21 5.8 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.029 -159.957 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.5 t -97.86 155.85 16.87 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.457 0.703 . . . . 0.0 111.084 -166.773 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.76 133.25 55.98 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 160.704 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 44.5 m -90.94 105.77 18.06 Favored 'General case' 0 N--CA 1.46 0.043 0 O-C-N 123.902 0.751 . . . . 0.0 109.035 160.452 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -76.27 99.8 4.89 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 165.708 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 53.5 m -117.34 86.35 2.5 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.978 1.311 . . . . 0.0 107.524 175.18 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.412 ' CD1' ' CD1' ' A' ' 45' ' ' LEU . 48.2 m-85 -59.22 145.2 43.67 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.322 1.049 . . . . 0.0 112.828 174.392 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -166.85 52.69 0.25 Allowed Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.966 1.707 . . . . 0.0 112.342 -175.435 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.3 -90.04 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.679 2.252 . . . . 0.0 115.092 -168.958 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -155.16 179.55 9.04 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 129.697 3.199 . . . . 0.0 104.863 -175.119 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -147.13 94.56 4.54 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 118.488 0.585 . . . . 0.0 111.044 -171.462 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -91.94 -124.37 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.984 3.122 . . . . 0.0 108.954 176.664 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 85.5 p -123.2 123.76 41.5 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 120.356 1.435 . . . . 0.0 111.763 -172.706 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.595 0 C-N-CA 126.496 1.918 . . . . 0.0 109.237 174.333 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.3 p . . . . . 0 N--CA 1.464 0.265 0 CA-C-O 122.042 0.925 . . . . 0.0 112.026 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 46.38 34.06 2.14 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.894 1.678 . . . . 0.0 112.276 176.482 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 166.68 157.1 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 128.332 2.653 . . . . 0.0 105.903 -172.58 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -151.74 2.55 0.39 Allowed 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -172.502 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.75 11.9 0.95 Allowed 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 126.802 2.041 . . . . 0.0 115.322 -164.9 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -77.25 -39.12 49.44 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 159.452 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.4 mp -92.22 -37.91 12.41 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 117.209 -1.377 . . . . 0.0 113.016 179.839 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.2 mt -32.53 133.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -162.13 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 29' ' ' LEU . 2.5 mm? -105.91 -104.15 0.33 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.159 -173.618 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -173.59 -49.2 0.01 OUTLIER 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.058 1.343 . . . . 0.0 108.855 -171.348 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -38.78 134.6 0.95 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.002 1.721 . . . . 0.0 110.678 -178.812 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -100.97 86.65 3.1 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -165.883 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.98 115.01 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.436 1.494 . . . . 0.0 107.953 -171.424 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.99 160.01 29.48 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -173.641 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.0 t -148.74 145.19 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 179.836 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.1 m -138.55 100.28 4.05 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -170.053 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -78.11 145.0 36.0 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.018 0.527 . . . . 0.0 109.919 -176.177 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -127.63 82.75 2.11 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.913 0.863 . . . . 0.0 110.007 178.22 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.49 102.16 14.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 172.118 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -116.89 128.37 55.18 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 122.292 1.044 . . . . 0.0 112.126 -174.666 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.0 p -99.83 96.29 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.564 -174.252 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.12 171.1 10.5 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 122.048 0.928 . . . . 0.0 111.406 174.843 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.41 132.07 52.0 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 169.903 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 128.33 -39.28 1.92 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -170.579 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.484 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -131.56 95.57 23.21 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 117.56 0.68 . . . . 0.0 110.277 -176.363 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -83.94 50.94 3.27 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.956 2.437 . . . . 0.0 109.651 -176.136 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.484 ' CD2' ' CD2' ' A' ' 45' ' ' LEU . 44.4 m0 -107.91 135.56 49.1 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -173.649 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -79.36 84.5 5.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 103.484 -2.784 . . . . 0.0 103.484 179.246 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -102.04 86.15 2.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -171.598 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.3 m -88.04 129.14 51.2 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -167.28 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.09 122.49 9.58 Favored 'Trans proline' 0 N--CA 1.446 -1.277 0 N-CA-C 106.261 -2.246 . . . . 0.0 106.261 162.466 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.1 m -72.73 -32.08 39.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.181 0.515 . . . . 0.0 110.691 -168.387 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.02 161.98 34.16 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 150.265 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -62.65 -46.72 86.89 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 172.532 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -147.38 153.54 39.77 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 124.415 1.086 . . . . 0.0 111.659 -159.647 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.4 pt -133.13 179.23 4.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 126.326 1.851 . . . . 0.0 108.251 179.892 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -125.47 160.18 30.11 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.345 0.593 . . . . 0.0 110.21 149.881 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.6 t -116.72 145.97 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 127.99 2.516 . . . . 0.0 105.679 171.014 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 49.5 mmm-85 -91.37 100.81 13.53 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 168.021 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mt -33.2 115.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -148.243 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.58 -25.2 26.49 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.071 1.319 . . . . 0.0 110.936 -179.386 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -64.9 133.45 51.86 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.806 1.303 . . . . 0.0 112.422 -172.33 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.15 101.53 7.97 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 130.05 3.34 . . . . 0.0 110.818 -175.38 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.9 p -113.78 153.75 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.292 1.437 . . . . 0.0 109.491 -178.597 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -112.51 125.15 53.93 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 125.404 1.482 . . . . 0.0 109.343 -177.38 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.0 pp -128.48 122.86 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 167.861 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.412 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 66.4 mtt -76.09 168.44 20.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.614 174.164 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -136.17 143.21 44.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 161.864 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.7 ttt85 -121.01 118.7 30.5 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 179.546 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.3 105.15 9.24 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 125.822 1.649 . . . . 0.0 110.035 -177.216 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.29 121.09 44.36 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.064 -0.398 . . . . 0.0 110.749 -168.603 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.44 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 47.8 t-20 -78.38 111.9 14.85 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.803 -0.561 . . . . 0.0 111.912 -167.783 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.2 tp -98.41 11.24 38.77 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.812 0.845 . . . . 0.0 112.381 179.564 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.46 166.67 22.33 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.272 -0.893 . . . . 0.0 109.95 173.44 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 70.0 m -103.3 7.0 38.35 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.968 0.907 . . . . 0.0 111.835 171.73 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.34 159.61 38.79 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 126.134 1.773 . . . . 0.0 107.041 177.974 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.97 126.04 12.11 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.171 1.914 . . . . 0.0 111.255 -173.208 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.476 ' HG1' ' HE1' ' A' ' 47' ' ' TRP . 0.2 OUTLIER -80.49 173.53 12.51 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.821 0.849 . . . . 0.0 110.784 -178.998 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 50.7 p -131.45 72.03 1.49 Allowed 'General case' 0 C--O 1.232 0.137 0 C-N-CA 122.551 0.341 . . . . 0.0 110.426 -170.893 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.42 139.37 37.39 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.946 -0.462 . . . . 0.0 111.946 -179.48 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.81 34.19 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.659 1.983 . . . . 0.0 109.44 169.222 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.58 159.08 34.47 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.33 0.652 . . . . 0.0 111.445 -165.445 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.9 t -87.77 131.51 34.48 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.704 0.764 . . . . 0.0 110.039 177.814 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.409 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -104.03 89.93 3.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.871 2.468 . . . . 0.0 105.572 175.509 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -77.0 91.92 3.67 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 120.882 -1.136 . . . . 0.0 107.935 -177.617 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 84' ' ' PHE . 7.8 t -78.11 72.57 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.612 1.165 . . . . 0.0 109.973 -174.043 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.9 t -168.73 134.76 1.49 Allowed Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 119.901 1.228 . . . . 0.0 113.389 173.997 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -74.1 67.72 5.04 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 122.386 2.057 . . . . 0.0 107.243 156.257 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 22.2 ptm 44.19 25.47 0.11 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 170.935 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -171.41 -58.26 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 119.384 0.993 . . . . 0.0 110.594 -168.411 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.61 -101.2 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -177.282 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 64.05 -52.1 0.08 OUTLIER Glycine 0 CA--C 1.538 1.481 0 N-CA-C 115.413 0.925 . . . . 0.0 115.413 -175.534 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -45.73 -47.63 15.33 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.553 1.541 . . . . 0.0 110.808 172.217 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -73.85 -12.69 60.75 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 127.012 2.125 . . . . 0.0 113.471 178.975 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.403 ' CD2' HD23 ' A' ' 138' ' ' LEU . 9.0 t80 -67.55 140.0 56.95 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.119 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -71.21 127.95 34.29 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.967 1.307 . . . . 0.0 110.765 -177.33 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -161.06 -50.45 0.05 OUTLIER 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 122.478 0.311 . . . . 0.0 110.65 -174.793 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . 0.326 2.4 p 47.8 -95.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.985 1.314 . . . . 0.0 111.809 -175.875 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -165.18 178.75 6.74 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.201 1.401 . . . . 0.0 107.336 173.526 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 90.3 m 54.52 42.61 31.22 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.382 1.073 . . . . 0.0 111.469 175.982 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -106.18 163.73 12.57 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.385 1.074 . . . . 0.0 108.505 171.927 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 59.6 m -134.39 139.39 45.56 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 177.663 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -166.79 -42.46 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.853 0.861 . . . . 0.0 109.083 175.403 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.3 p -22.85 109.2 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 127.808 2.443 . . . . 0.0 111.855 162.783 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -78.41 -15.98 58.09 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -159.359 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.3 t 51.67 -146.64 0.47 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.441 1.096 . . . . 0.0 112.472 170.606 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.6 m -115.54 136.65 52.86 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.089 1.355 . . . . 0.0 108.542 -172.069 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 78.6 mt -128.44 147.95 50.69 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.39 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -73.29 156.42 89.15 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 172.354 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.23 85.87 0.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 124.88 3.72 . . . . 0.0 111.756 -173.064 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 152.74 -27.23 0.83 Allowed Glycine 0 CA--C 1.522 0.5 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.25 -177.777 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -77.86 143.45 37.79 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 118.085 0.942 . . . . 0.0 111.593 -157.925 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -105.21 96.9 6.84 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.811 1.244 . . . . 0.0 109.942 -175.603 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 15.4 tpt -83.92 89.21 7.18 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.114 1.365 . . . . 0.0 109.325 -177.951 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -99.21 134.21 42.4 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.256 0.622 . . . . 0.0 109.576 172.148 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 22.4 ptm -150.95 146.31 19.11 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.996 -0.526 . . . . 0.0 111.441 178.997 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 67' ' ' MET . 83.1 Cg_endo -79.58 147.77 20.05 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.883 3.055 . . . . 0.0 111.049 171.852 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.5 t -126.53 114.89 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 165.199 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.5 p -79.41 143.47 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 168.986 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -155.61 149.11 24.98 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.163 0.585 . . . . 0.0 109.949 -165.411 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -171.18 118.98 0.48 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.36 1.464 . . . . 0.0 111.893 176.858 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.8 t -64.09 133.39 29.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 O-C-N 120.355 -1.466 . . . . 0.0 109.505 175.317 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -91.61 132.39 33.44 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 123.701 0.801 . . . . 0.0 109.8 -179.053 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -46.35 -31.52 9.55 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.402 3.401 . . . . 0.0 114.919 177.342 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -48.94 -24.2 1.4 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.783 1.633 . . . . 0.0 112.39 179.183 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.1 tt -49.01 -44.46 15.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 169.097 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.9 m -83.38 59.66 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 118.571 0.623 . . . . 0.0 109.895 174.354 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -111.0 -77.41 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 117.168 -1.396 . . . . 0.0 110.366 164.628 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.54 156.05 45.12 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 CA-C-N 121.885 1.709 . . . . 0.0 111.666 -177.384 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.6 m -62.16 -36.08 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 124.94 1.296 . . . . 0.0 112.045 -170.657 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -60.6 -64.46 0.94 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.147 0.979 . . . . 0.0 109.281 177.587 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 44.6 p -72.61 -15.43 61.73 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 118.509 -0.758 . . . . 0.0 111.568 -172.419 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.04 -41.52 5.53 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.768 0.713 . . . . 0.0 111.221 162.913 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.34 -29.17 74.38 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 112.237 -0.345 . . . . 0.0 112.237 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.3 mm -83.88 125.94 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 122.079 0.942 . . . . 0.0 110.39 -177.629 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 28.3 pttt -148.81 63.76 1.06 Allowed 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.506 153.751 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 11.7 m -150.15 95.33 2.26 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 158.416 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.403 HD23 ' CD2' ' A' ' 95' ' ' PHE . 1.2 tp -75.48 144.79 41.87 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -173.978 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.8 t -141.8 173.38 11.56 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.496 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.1 tt -150.63 111.28 4.25 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 177.855 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.45 92.94 8.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.515 1.126 . . . . 0.0 109.252 -179.545 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.94 108.4 19.17 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.877 1.271 . . . . 0.0 108.783 179.406 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.66 89.09 3.58 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 122.009 0.909 . . . . 0.0 109.747 -177.358 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -71.23 85.57 0.77 Allowed 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.281 177.058 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.1 47.59 2.8 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -178.703 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -80.89 -105.74 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.279 2.653 . . . . 0.0 111.967 178.914 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -140.95 121.68 14.34 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.648 1.179 . . . . 0.0 108.528 -171.242 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.9 111.22 38.82 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 125.654 1.581 . . . . 0.0 107.118 -177.128 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.431 ' HD3' HG23 ' A' ' 78' ' ' THR . 26.6 Cg_endo -83.3 -4.85 11.07 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.293 2.662 . . . . 0.0 113.043 -172.742 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.9 t 131.51 103.71 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 129.972 3.309 . . . . 0.0 109.754 174.481 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.542 0.669 0 C-N-CA 125.256 1.423 . . . . 0.0 111.723 168.356 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 122.31 1.052 . . . . 0.0 108.427 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 23.08 50.72 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.94 1.696 . . . . 0.0 112.229 -146.308 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.21 155.29 11.35 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 127.879 2.471 . . . . 0.0 104.405 174.542 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -122.32 125.96 47.07 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 104.354 -2.462 . . . . 0.0 104.354 156.676 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.6 t -147.88 49.54 1.06 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 122.493 1.14 . . . . 0.0 108.227 174.962 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -158.8 -57.42 0.07 Allowed 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 127.306 2.243 . . . . 0.0 106.309 -174.367 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.9 mt -65.53 -16.48 63.72 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.907 2.083 . . . . 0.0 112.878 -177.777 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.4 mt -75.67 78.51 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 O-C-N 121.21 -0.931 . . . . 0.0 110.267 -171.566 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.69 -127.7 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.555 1.142 . . . . 0.0 108.524 169.679 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -104.36 -51.33 3.13 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.57 1.548 . . . . 0.0 111.939 -164.506 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -43.1 102.07 0.03 OUTLIER 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.194 1.398 . . . . 0.0 113.351 -169.806 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.69 81.52 4.99 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 177.261 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -97.11 122.58 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -160.616 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.7 150.48 34.48 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.943 1.297 . . . . 0.0 108.199 -175.216 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.52 146.9 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 174.497 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.9 m -125.83 112.19 15.73 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -172.69 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -77.88 136.18 38.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.754 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -126.71 84.45 2.27 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 122.502 1.144 . . . . 0.0 108.965 177.943 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.91 95.75 10.28 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.374 1.07 . . . . 0.0 110.972 -176.753 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -98.63 109.5 22.24 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.375 0.67 . . . . 0.0 109.79 -177.936 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.0 p -79.24 148.86 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 164.388 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -151.04 158.71 44.44 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 171.216 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.05 -40.15 10.25 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.84 0.856 . . . . 0.0 112.109 -177.214 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -41.58 -31.98 0.76 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.812 1.672 . . . . 0.0 114.151 174.999 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.487 HD21 ' CE3' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -130.17 110.13 16.68 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 118.688 1.244 . . . . 0.0 108.471 170.488 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -75.27 0.95 8.4 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.294 1.996 . . . . 0.0 115.576 -164.035 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.517 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 42.2 m0 -79.57 153.45 29.46 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.38 1.472 . . . . 0.0 113.613 -159.844 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.42 ' O ' HG23 ' A' ' 50' ' ' VAL . 4.1 tt0 -77.47 77.46 4.0 Favored 'General case' 0 C--N 1.344 0.344 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.615 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -84.6 110.72 18.93 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.684 1.193 . . . . 0.0 109.098 -171.484 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 48' ' ' GLU . 42.9 t -122.78 118.81 28.25 Favored Pre-proline 0 N--CA 1.444 -0.758 0 C-N-CA 124.4 1.08 . . . . 0.0 108.645 -163.638 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -81.87 174.56 10.13 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 124.543 3.495 . . . . 0.0 108.554 168.367 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -98.6 -53.12 8.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 123.949 0.9 . . . . 0.0 110.845 -173.622 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -134.16 175.15 9.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 166.638 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.6 tpt85 -68.45 -33.15 73.68 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.392 168.636 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -144.67 173.44 11.82 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.842 1.257 . . . . 0.0 112.694 -162.861 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.1 pt -141.65 178.2 2.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 127.206 2.203 . . . . 0.0 106.788 165.567 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -132.27 162.77 30.16 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 146.911 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.23 136.92 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 126.953 2.101 . . . . 0.0 105.836 -175.199 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.94 88.66 3.5 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 163.205 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.2 pt 8.81 69.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 127.74 2.416 . . . . 0.0 114.63 178.469 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.55 -37.55 1.78 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 123.41 0.529 . . . . 0.0 112.305 -176.594 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -39.24 104.43 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.383 1.473 . . . . 0.0 110.849 177.101 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.59 HG23 ' CD1' ' A' ' 121' ' ' PHE . 1.2 m -87.46 88.45 7.68 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.353 -156.25 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 p -92.73 161.67 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 O-C-N 121.933 -0.479 . . . . 0.0 111.721 -168.434 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -102.98 126.74 50.28 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.959 1.303 . . . . 0.0 110.35 169.561 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.5 pp -131.33 114.03 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 107.319 -1.364 . . . . 0.0 107.319 167.443 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.0 ttp -77.86 161.52 27.55 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.378 0.671 . . . . 0.0 110.862 -176.861 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -134.57 150.96 50.78 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.436 1.094 . . . . 0.0 108.846 169.325 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 54.1 ttp85 -143.46 147.08 34.0 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.997 0.919 . . . . 0.0 110.111 -178.457 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.39 109.68 2.66 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.632 1.573 . . . . 0.0 111.765 -177.995 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -86.09 139.28 31.27 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.989 171.721 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.517 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 28.1 t30 -78.21 88.99 4.27 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.073 0.851 . . . . 0.0 112.127 168.958 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.9 mp -76.76 69.08 3.08 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 171.193 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -153.66 137.26 15.99 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 168.513 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.1 t -80.14 36.1 0.34 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.369 0.531 . . . . 0.0 110.754 178.083 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.8 p -149.91 155.47 37.98 Favored Pre-proline 0 C--O 1.237 0.395 0 C-N-CA 126.63 1.972 . . . . 0.0 106.995 174.307 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -63.23 148.14 93.3 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 N-CA-C 108.208 -1.497 . . . . 0.0 108.208 168.522 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.01 175.06 6.53 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.792 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.0 m -105.65 145.25 31.28 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.121 1.768 . . . . 0.0 106.875 175.39 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -133.65 126.14 4.2 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 107.096 -2.401 . . . . 0.0 107.096 172.494 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.18 54.77 0.12 Allowed 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 166.78 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.44 144.83 15.9 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.884 176.162 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.3 t -85.01 166.08 17.02 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 168.185 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -146.41 95.96 2.69 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -168.978 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.33 86.92 5.02 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 175.509 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.0 t -78.12 60.23 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.817 1.247 . . . . 0.0 108.776 -175.034 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.1 t -171.44 148.34 2.3 Favored Pre-proline 0 CA--C 1.522 -0.129 0 O-C-N 121.481 -0.762 . . . . 0.0 111.636 178.077 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -61.57 -41.26 40.99 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 121.758 1.639 . . . . 0.0 110.068 159.031 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.3 ptp 172.08 -77.72 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 127.124 2.17 . . . . 0.0 107.59 178.399 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.87 -29.87 63.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.634 1.174 . . . . 0.0 112.292 -170.287 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.9 -119.11 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -174.028 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.89 -50.56 2.25 Favored Glycine 0 CA--C 1.528 0.874 0 O-C-N 121.348 -0.845 . . . . 0.0 113.192 178.204 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -44.93 -54.54 6.38 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.159 0.984 . . . . 0.0 110.014 171.555 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -75.39 -4.26 38.41 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.508 1.923 . . . . 0.0 113.96 -179.053 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -69.37 133.55 47.95 Favored 'General case' 0 C--N 1.341 0.227 0 O-C-N 121.093 -1.004 . . . . 0.0 108.486 178.449 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -75.8 85.66 2.79 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.684 177.931 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -54.57 123.11 12.11 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 166.228 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.2 t -58.71 126.27 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -177.572 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -82.31 48.47 1.28 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.87 0.868 . . . . 0.0 110.001 -169.857 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 44.2 t -167.13 143.11 4.28 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.58 1.552 . . . . 0.0 108.589 -173.904 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -75.96 72.57 2.83 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.914 0.485 . . . . 0.0 110.278 -178.577 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 26.9 p -135.17 53.03 2.0 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 124.904 1.282 . . . . 0.0 109.355 178.625 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -155.17 145.54 22.0 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -170.753 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 47.0 m 58.99 88.14 0.07 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.876 1.67 . . . . 0.0 112.17 -179.924 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -53.9 154.34 4.1 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.568 1.147 . . . . 0.0 111.7 176.414 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.7 t -111.52 -57.68 2.22 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 128.711 2.804 . . . . 0.0 111.378 -167.6 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.8 t -163.65 140.34 6.97 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 122.849 0.46 . . . . 0.0 110.385 -170.845 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.661 HD11 ' HB2' ' A' ' 114' ' ' MET . 39.7 mt -139.32 143.73 37.96 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.207 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.444 ' HB3' ' HD2' ' A' ' 110' ' ' PRO . 2.8 mt-10 -80.44 172.95 8.53 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.76 1.224 . . . . 0.0 109.349 -179.48 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 109' ' ' GLU . 35.2 Cg_endo -68.0 79.89 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.535 2.823 . . . . 0.0 114.465 -162.041 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 147.87 -29.89 1.39 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.307 0.956 . . . . 0.0 112.181 172.107 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -82.21 158.56 23.51 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 118.226 -1.39 . . . . 0.0 112.318 -139.61 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -84.61 123.26 30.13 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 124.64 1.176 . . . . 0.0 110.268 179.59 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.661 ' HB2' HD11 ' A' ' 108' ' ' LEU . 0.9 OUTLIER -90.22 128.61 36.42 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 154.89 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -134.0 146.42 50.4 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 159.698 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 56.7 mtt -146.61 146.63 27.59 Favored Pre-proline 0 N--CA 1.453 -0.323 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 165.087 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -71.55 142.58 40.61 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 122.101 1.868 . . . . 0.0 109.412 160.232 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.4 t -115.77 143.83 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 164.026 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.0 p -102.28 145.49 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 174.608 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -145.9 138.09 25.36 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.335 0.516 . . . . 0.0 111.425 -176.933 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.59 ' CD1' HG23 ' A' ' 63' ' ' THR . 5.9 p90 -159.07 162.25 36.56 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.569 1.548 . . . . 0.0 107.43 160.559 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 94.8 t -104.72 131.27 54.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 174.789 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.18 135.23 47.85 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 175.887 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -75.49 57.85 5.0 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 124.578 3.519 . . . . 0.0 112.673 -176.414 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.24 -36.47 7.63 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 125.57 1.548 . . . . 0.0 109.864 168.3 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.8 tt -47.75 -46.57 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -169.724 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.3 m -81.19 53.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.448 -0.783 . . . . 0.0 110.785 -178.444 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -138.28 -64.51 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 117.661 -1.161 . . . . 0.0 112.085 -179.371 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.67 156.33 35.64 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 CA-C-N 121.961 1.736 . . . . 0.0 113.406 -176.053 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.2 t -54.11 -39.46 42.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 126.201 1.8 . . . . 0.0 110.742 177.934 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -45.92 -55.72 6.38 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.697 1.599 . . . . 0.0 111.8 -178.523 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.3 p -92.37 -42.89 9.53 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 118.633 -0.699 . . . . 0.0 111.442 -176.313 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 7.93 65.13 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 128.403 2.681 . . . . 0.0 116.129 179.536 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 142.37 -41.34 1.2 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -173.709 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.7 mm -57.27 120.13 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 CA-C-N 117.689 0.744 . . . . 0.0 110.178 177.23 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -157.38 66.45 0.5 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.672 0.749 . . . . 0.0 110.173 162.578 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 10.6 m -147.51 102.72 3.48 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 152.206 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.68 151.76 34.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -175.243 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.7 t -154.08 175.13 13.79 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.408 0.623 . . . . 0.0 109.647 -177.269 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.9 tp -153.7 97.13 2.07 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 103.216 -2.883 . . . . 0.0 103.216 -169.278 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.5 t -81.78 88.09 6.32 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 171.733 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.79 124.4 27.64 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 176.809 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.423 HG22 ' CD1' ' A' ' 145' ' ' TYR . 23.8 m -133.38 95.52 3.53 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.412 1.101 . . . . 0.0 109.229 -164.468 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -74.22 74.42 1.8 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.041 1.736 . . . . 0.0 111.94 -171.007 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.423 ' CD1' HG22 ' A' ' 143' ' ' THR . 38.8 m-85 -128.35 68.48 77.23 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.349 1.06 . . . . 0.0 113.758 179.566 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -87.69 -103.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.775 2.983 . . . . 0.0 110.666 167.502 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -156.26 99.66 1.94 Allowed 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.8 1.24 . . . . 0.0 108.907 -172.117 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -104.56 134.0 19.89 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 126.432 1.893 . . . . 0.0 106.403 167.614 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.0 -47.3 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.445 2.097 . . . . 0.0 110.638 178.304 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.2 t 166.65 112.4 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 129.202 3.001 . . . . 0.0 104.822 178.486 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.7 pttt . . . . . 0 CA--C 1.535 0.4 0 CA-C-N 119.584 1.083 . . . . 0.0 110.409 -168.921 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.16 0 N-CA-C 103.312 -2.847 . . . . 0.0 103.312 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.1 m -152.41 38.82 0.56 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.719 0.69 . . . . 0.0 111.331 -176.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -159.07 -49.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 127.594 2.358 . . . . 0.0 106.62 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.531 ' H ' HD22 ' A' ' 27' ' ' LEU . 2.7 mm? -61.4 -28.16 69.05 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.295 1.838 . . . . 0.0 111.482 178.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.4 mt -69.87 83.26 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 123.625 0.77 . . . . 0.0 109.518 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.25 152.18 23.0 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 161.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -78.68 55.09 1.61 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.28 0.945 . . . . 0.0 111.328 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.12 138.44 39.95 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 105.078 -2.194 . . . . 0.0 105.078 166.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -96.81 120.04 36.4 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 123.679 0.792 . . . . 0.0 109.043 -173.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -95.08 141.53 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 163.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.551 ' CE ' ' HB2' ' A' ' 55' ' ' ASP . 2.3 tmtp? -101.73 153.86 19.41 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 169.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 t -137.14 149.44 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 167.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.8 m -137.24 98.98 3.86 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 122.521 1.153 . . . . 0.0 108.132 -171.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -79.24 88.28 4.92 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 127.356 2.262 . . . . 0.0 110.306 -176.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -81.86 85.46 6.65 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 122.347 1.07 . . . . 0.0 109.584 175.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.59 101.01 8.91 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.918 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -99.84 148.99 23.85 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 176.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.0 p -139.83 144.36 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 124.709 1.203 . . . . 0.0 108.098 172.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.56 171.96 13.68 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.597 1.159 . . . . 0.0 108.334 174.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -32.72 -55.7 0.36 Allowed 'General case' 0 C--N 1.34 0.168 0 C-N-CA 126.384 1.873 . . . . 0.0 112.822 -176.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -36.69 -35.71 0.14 Allowed Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.906 2.193 . . . . 0.0 114.663 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.63 HD13 ' CD2' ' A' ' 144' ' ' PHE . 0.3 OUTLIER -120.44 94.75 48.92 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 118.42 1.11 . . . . 0.0 109.269 170.15 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -82.32 42.33 1.29 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.417 2.745 . . . . 0.0 110.866 -173.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.422 ' CE3' HD21 ' A' ' 45' ' ' LEU . 42.9 m0 -113.84 141.66 47.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -172.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -79.42 80.07 5.82 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 -176.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -86.72 89.77 8.05 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.508 1.523 . . . . 0.0 108.368 -176.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.4 m -89.43 129.96 45.43 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -175.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -68.76 153.66 72.66 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 N-CA-C 108.156 -1.517 . . . . 0.0 108.156 163.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.41 -55.07 10.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -131.19 161.76 31.47 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 165.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -64.64 -28.45 69.62 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 118.482 0.583 . . . . 0.0 109.54 173.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.551 ' HB2' ' CE ' ' A' ' 34' ' ' LYS . 24.6 p-10 -145.97 168.87 19.81 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 125.301 1.441 . . . . 0.0 112.048 -165.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.6 pt -137.71 166.67 24.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 124.447 1.099 . . . . 0.0 108.337 169.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -110.09 144.01 39.31 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 160.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -135.53 137.34 49.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 166.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.37 91.0 6.74 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 119.698 -1.876 . . . . 0.0 107.691 164.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.3 pt 21.76 63.39 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 127.398 2.279 . . . . 0.0 113.47 171.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.97 -36.82 1.88 Allowed Glycine 0 CA--C 1.526 0.725 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.751 -177.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -40.81 104.87 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.225 1.41 . . . . 0.0 111.752 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.594 HG23 ' CD1' ' A' ' 121' ' ' PHE . 0.2 OUTLIER -89.62 89.67 7.91 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.028 0.931 . . . . 0.0 109.473 -158.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.2 p -88.36 172.1 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 123.291 0.636 . . . . 0.0 111.503 -166.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -117.56 122.18 42.97 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 125.3 1.44 . . . . 0.0 107.575 171.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.91 109.06 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 175.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -78.1 166.47 22.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.478 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -136.17 150.03 48.86 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 169.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.1 ttm-85 -126.02 127.04 45.26 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.793 1.637 . . . . 0.0 107.287 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.63 108.74 10.75 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 125.741 1.617 . . . . 0.0 109.254 169.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -104.73 123.99 48.6 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.326 -0.859 . . . . 0.0 109.226 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -76.26 126.84 31.73 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 120.883 -1.136 . . . . 0.0 110.92 -172.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.4 mt -111.65 14.53 21.23 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.985 0.914 . . . . 0.0 112.627 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.99 175.3 10.7 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 121.301 -0.874 . . . . 0.0 110.979 175.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.2 t -108.25 3.78 23.97 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.931 0.893 . . . . 0.0 111.702 175.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 p -145.06 163.31 33.45 Favored Pre-proline 0 N--CA 1.45 -0.436 0 C-N-CA 126.886 2.074 . . . . 0.0 105.499 174.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.06 157.36 44.61 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.198 1.266 . . . . 0.0 110.925 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.99 172.88 10.09 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 122.617 0.367 . . . . 0.0 110.177 166.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.0 t -107.25 166.06 10.92 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 160.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.534 ' HA2' HD11 ' A' ' 45' ' ' LEU . . . -155.25 73.4 0.25 Allowed Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 108.205 -1.958 . . . . 0.0 108.205 -176.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.38 62.62 0.63 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.7 154.19 28.77 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.821 -1.081 . . . . 0.0 112.659 -164.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.4 m -83.99 144.86 28.85 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.72 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -131.4 153.37 49.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.302 1.041 . . . . 0.0 109.569 171.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.07 109.53 11.97 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 171.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.48 HG11 ' CD2' ' A' ' 95' ' ' PHE . 2.7 t -95.57 63.62 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.46 0.062 0 C-N-CA 122.769 0.427 . . . . 0.0 111.551 -175.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.6 t -165.54 142.5 4.63 Favored Pre-proline 0 N--CA 1.454 -0.231 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.929 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -65.8 -39.34 20.46 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 N-CA-C 107.983 -1.583 . . . . 0.0 107.983 167.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 7.9 ptp 179.81 -74.92 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.42 2.288 . . . . 0.0 107.739 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.01 98.08 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 124.8 1.24 . . . . 0.0 113.273 -164.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.6 -101.67 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.743 -164.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.93 -65.44 0.33 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 123.329 0.49 . . . . 0.0 112.065 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -44.34 -51.26 8.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.449 1.5 . . . . 0.0 111.207 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -73.64 11.14 0.88 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.475 1.11 . . . . 0.0 113.893 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.48 ' CD2' HG11 ' A' ' 86' ' ' VAL . 8.8 t80 -82.7 128.77 34.68 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 119.157 0.889 . . . . 0.0 109.741 172.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 . . . . . 0 N--CA 1.444 -0.728 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.494 176.048 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 . . . . . 0 CA--C 1.537 0.477 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.0 t -160.04 -71.28 0.07 Allowed 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -175.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.2 t -156.3 140.56 16.58 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.019 1.328 . . . . 0.0 108.701 -169.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.433 HD11 ' HB2' ' A' ' 114' ' ' MET . 88.5 mt -148.69 146.34 28.1 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 118.581 0.628 . . . . 0.0 110.237 176.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -77.98 165.86 47.64 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 126.112 1.765 . . . . 0.0 110.783 168.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.75 80.01 2.14 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 124.493 3.462 . . . . 0.0 112.278 -166.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 159.38 -34.23 0.47 Allowed Glycine 0 CA--C 1.522 0.515 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.783 172.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.49 153.43 31.37 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -152.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.6 mp0 -91.2 107.23 19.06 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.764 2.425 . . . . 0.0 109.762 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.433 ' HB2' HD11 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -85.4 132.64 34.19 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 160.259 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -145.46 139.05 26.58 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 161.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 14.8 mmt -143.47 142.36 20.98 Favored Pre-proline 0 N--CA 1.453 -0.28 0 C-N-CA 124.262 1.025 . . . . 0.0 108.51 -168.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.01 147.37 38.47 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.504 2.136 . . . . 0.0 109.853 169.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.1 t -124.56 157.37 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 163.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 p -136.17 143.56 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -157.09 131.81 8.74 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -167.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.594 ' CD1' HG23 ' A' ' 63' ' ' THR . 14.3 p90 -156.36 126.63 6.57 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.207 0.912 . . . . 0.0 108.654 173.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.1 t -76.85 142.92 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 119.127 -0.463 . . . . 0.0 110.151 -174.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -81.07 129.33 67.65 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 119.14 -0.457 . . . . 0.0 110.748 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -57.13 -20.1 36.51 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.335 2.023 . . . . 0.0 113.985 176.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -53.21 -22.29 6.46 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 120.068 1.304 . . . . 0.0 111.67 172.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.6 tt -49.69 -43.76 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 O-C-N 121.697 -0.627 . . . . 0.0 111.892 169.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.9 m -84.4 57.25 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 119.791 1.178 . . . . 0.0 110.753 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -127.07 -68.31 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 118.028 -0.987 . . . . 0.0 112.516 169.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -79.94 157.66 23.97 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 121.965 1.777 . . . . 0.0 114.09 -166.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 95.2 t -53.79 -34.18 24.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.725 1.61 . . . . 0.0 110.827 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -37.12 -53.92 1.0 Allowed 'General case' 0 C--N 1.338 0.103 0 C-N-CA 126.301 1.84 . . . . 0.0 112.194 172.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 19.2 p -107.01 -56.1 2.24 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -164.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 29.17 53.12 0.09 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 128.108 2.563 . . . . 0.0 115.271 171.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 136.12 -35.32 2.15 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -174.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.0 mm -52.92 115.75 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 123.187 0.595 . . . . 0.0 110.573 170.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 31.0 pttt -156.93 62.95 0.51 Allowed 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.786 170.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.4 m -142.97 96.69 2.97 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 160.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.26 83.06 4.53 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -172.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.12 123.29 26.19 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -168.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.0 tt -98.11 103.67 15.63 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.9 t -84.74 100.22 11.36 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 170.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.85 136.17 33.15 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 172.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.6 m -124.82 87.46 2.72 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.672 0.749 . . . . 0.0 109.437 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.63 ' CD2' HD13 ' A' ' 45' ' ' LEU . 2.3 m-85 -72.59 88.88 1.27 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.838 175.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -154.43 52.4 0.75 Allowed Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 117.209 2.3 . . . . 0.0 117.209 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.404 ' HD3' HD12 ' A' ' 45' ' ' LEU . 59.7 Cg_endo -75.2 -87.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.962 2.441 . . . . 0.0 112.565 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 57.7 mtm180 -149.98 126.51 10.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.008 0.822 . . . . 0.0 110.437 -175.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -108.04 135.79 19.84 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 125.038 1.335 . . . . 0.0 108.801 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -72.44 -67.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.443 2.095 . . . . 0.0 110.717 171.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.3 m -175.47 91.24 0.05 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.602 1.961 . . . . 0.0 108.484 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.492 0 CA-C-N 118.315 0.507 . . . . 0.0 110.517 173.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.03 22.01 0.41 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 128.53 2.732 . . . . 0.0 114.798 -159.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -76.64 -36.34 57.44 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 152.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 mp -92.21 -103.82 0.11 Allowed 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 125.89 1.676 . . . . 0.0 109.305 175.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.2 mt 31.95 71.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 126.613 1.965 . . . . 0.0 113.818 -172.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -79.4 157.16 27.65 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.779 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -81.76 78.14 8.52 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 122.566 1.174 . . . . 0.0 109.91 -176.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.694 ' HB3' HD11 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -137.42 -172.13 3.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.037 -1.892 . . . . 0.0 107.077 168.088 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -138.65 138.41 37.78 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.127 1.371 . . . . 0.0 110.187 171.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.44 HG23 HG13 ' A' ' 58' ' ' VAL . 5.0 tp -124.24 113.31 36.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.521 1.528 . . . . 0.0 108.457 -176.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -83.74 149.45 26.45 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 138' ' ' LEU . 27.9 t -146.73 89.14 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 118.924 0.784 . . . . 0.0 109.154 -174.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.5 m -75.56 106.3 7.03 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.616 1.166 . . . . 0.0 108.467 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.457 ' CZ ' HD12 ' A' ' 56' ' ' ILE . 2.8 m-30 -81.52 159.61 24.12 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.252 1.421 . . . . 0.0 109.902 174.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -142.46 87.56 2.02 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.92 0.867 . . . . 0.0 112.034 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.26 126.82 35.36 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.37 -0.831 . . . . 0.0 110.897 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -130.67 149.7 52.2 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.941 1.296 . . . . 0.0 109.066 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.9 p -139.28 146.77 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 C-N-CA 124.714 1.206 . . . . 0.0 108.807 175.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.55 174.61 12.33 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.104 0.961 . . . . 0.0 110.004 -177.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.4 115.21 1.35 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 168.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 139.79 -34.51 2.02 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 108.934 -1.667 . . . . 0.0 108.934 -167.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.552 HD12 ' CD ' ' A' ' 146' ' ' PRO . 0.6 OUTLIER -140.45 94.46 8.44 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 123.521 0.729 . . . . 0.0 109.126 173.654 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.486 ' HD2' HG21 ' A' ' 78' ' ' THR . 58.0 Cg_endo -80.33 50.82 3.67 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 124.086 3.191 . . . . 0.0 109.409 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.489 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 35.5 m0 -116.96 148.64 41.23 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.427 1.091 . . . . 0.0 109.831 -168.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -75.09 89.83 2.48 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 104.781 -2.303 . . . . 0.0 104.781 173.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -113.08 118.68 35.45 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.213 1.805 . . . . 0.0 107.465 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.6 m -137.97 144.79 45.32 Favored Pre-proline 0 CA--C 1.53 0.192 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -177.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.23 162.4 38.69 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.992 1.795 . . . . 0.0 108.648 166.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.51 -51.38 12.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 123.207 0.603 . . . . 0.0 110.204 176.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -127.74 159.03 36.01 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 168.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.7 tpt180 -62.29 -39.93 94.58 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 167.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.63 144.97 44.33 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 123.941 0.896 . . . . 0.0 109.448 -171.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.503 HD11 HG21 ' A' ' 66' ' ' ILE . 70.2 mt -105.88 152.45 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 C-N-CA 126.057 1.743 . . . . 0.0 106.532 170.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -126.76 87.41 2.65 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.396 1.078 . . . . 0.0 108.599 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.44 HG13 HG23 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -90.08 151.27 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.412 ' O ' HD13 ' A' ' 60' ' ' ILE . 19.3 mmt180 -59.44 -103.87 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.861 -1.149 . . . . 0.0 109.411 164.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.694 HD11 ' HB3' ' A' ' 31' ' ' GLU . 26.2 mm -148.76 43.6 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 126.389 1.876 . . . . 0.0 106.123 -172.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.62 -7.88 5.56 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 116.087 -0.506 . . . . 0.0 113.712 -174.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -51.04 105.58 0.11 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.05 1.34 . . . . 0.0 109.588 171.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.94 106.55 0.72 Allowed 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.473 1.509 . . . . 0.0 109.304 175.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -105.23 137.36 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 173.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.13 123.99 29.46 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 173.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.503 HG21 HD11 ' A' ' 56' ' ' ILE . 1.6 pp -123.63 111.74 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 164.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.409 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 0.7 OUTLIER -76.21 158.14 31.94 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.947 172.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -129.92 147.09 51.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 173.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.26 141.64 30.91 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 167.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.03 78.57 0.97 Allowed 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 122.192 0.996 . . . . 0.0 109.657 165.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -112.29 141.87 45.48 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.075 -155.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.489 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 22.6 t-20 -78.72 125.78 29.83 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.226 0.921 . . . . 0.0 112.751 -173.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.5 mt -127.49 53.13 1.77 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.344 1.457 . . . . 0.0 109.251 167.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -113.61 167.25 10.76 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 126.466 1.907 . . . . 0.0 110.712 -177.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.7 m -80.22 -22.77 41.45 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.4 1.08 . . . . 0.0 110.85 173.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.0 p -147.6 164.55 22.14 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 125.768 1.627 . . . . 0.0 107.758 -167.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.31 122.63 10.64 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.351 1.367 . . . . 0.0 110.21 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.486 HG21 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -81.59 177.08 9.14 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.477 0.656 . . . . 0.0 109.734 173.16 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.1 t -110.48 156.71 20.47 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 161.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -149.45 81.17 0.19 Allowed Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 106.473 -2.651 . . . . 0.0 106.473 -174.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.91 60.46 1.37 Allowed 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 168.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.7 167.3 3.66 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.258 -177.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 39.2 m -98.86 152.64 19.52 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -148.4 151.98 36.2 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 164.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.99 122.66 48.29 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 170.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.0 p -104.47 55.21 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 C-N-CA 123.733 0.813 . . . . 0.0 111.851 -164.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.9 t -178.79 147.9 0.55 Allowed Pre-proline 0 C--N 1.333 -0.139 0 O-C-N 121.068 -1.02 . . . . 0.0 109.895 -166.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.8 -34.01 41.57 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 N-CA-C 108.9 -1.231 . . . . 0.0 108.9 166.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.0 ptp 177.62 -72.41 0.01 OUTLIER 'General case' 0 C--N 1.342 0.241 0 C-N-CA 126.764 2.026 . . . . 0.0 107.846 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.43 -31.49 67.28 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 124.39 1.076 . . . . 0.0 113.677 -162.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.44 -102.54 0.07 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.452 0.168 . . . . 0.0 111.415 -164.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.7 -59.0 0.2 Allowed Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.566 1.079 . . . . 0.0 113.611 -173.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -45.94 -52.33 11.81 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.129 0.965 . . . . 0.0 110.205 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -74.71 13.25 0.66 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.964 1.706 . . . . 0.0 114.027 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -83.15 128.16 34.24 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 169.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . 0.319 2.2 m-80 . . . . . 0 C--N 1.342 0.268 0 CA-C-O 122.396 1.093 . . . . 0.0 111.887 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 . . . . . 0 CA--C 1.532 0.257 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . 0.352 10.1 t 57.84 -81.7 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 126.713 2.005 . . . . 0.0 113.563 171.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -160.92 148.07 15.36 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 -176.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 73.4 mt -148.48 133.27 17.95 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 175.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -63.44 159.62 49.1 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 126.793 2.037 . . . . 0.0 111.403 174.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -64.2 92.24 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.275 3.317 . . . . 0.0 112.415 -169.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 125.17 -6.1 8.2 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 124.725 1.155 . . . . 0.0 112.618 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -76.44 130.0 37.36 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 118.822 1.311 . . . . 0.0 111.845 -166.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -94.62 101.32 13.18 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.257 1.423 . . . . 0.0 110.05 -168.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 17.6 ttt -103.93 124.19 48.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.443 1.497 . . . . 0.0 109.765 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.14 153.06 41.74 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 156.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 42.8 mtm -155.06 151.32 22.72 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 123.214 0.606 . . . . 0.0 110.83 168.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 67' ' ' MET . 70.2 Cg_exo -53.65 138.7 67.5 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 124.653 3.568 . . . . 0.0 112.39 162.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.6 t -119.49 151.39 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 157.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.8 p -112.14 143.52 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 124.002 0.921 . . . . 0.0 108.542 175.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -156.06 151.82 27.29 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.084 0.402 . . . . 0.0 111.916 -171.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -157.98 170.2 22.86 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.296 1.838 . . . . 0.0 109.029 165.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.413 ' HB ' HG21 ' A' ' 33' ' ' ILE . 88.5 t -92.84 146.93 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 170.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -88.01 126.11 62.16 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-O 118.676 -0.678 . . . . 0.0 111.339 174.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -60.23 -16.01 37.97 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.339 2.026 . . . . 0.0 113.806 174.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -49.01 -25.78 2.18 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 119.877 1.217 . . . . 0.0 111.147 166.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 10.9 tt -53.5 -43.02 51.71 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 O-C-N 121.133 -0.979 . . . . 0.0 112.914 172.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.1 m -84.87 53.48 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 119.753 1.16 . . . . 0.0 110.025 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -134.7 -67.03 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 117.693 -1.146 . . . . 0.0 112.337 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.6 154.46 31.0 Favored 'Trans proline' 0 C--N 1.347 0.492 0 CA-C-N 122.024 1.759 . . . . 0.0 113.467 -170.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 96.3 t -55.11 -33.89 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 125.478 1.511 . . . . 0.0 110.928 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -36.53 -55.52 0.84 Allowed 'General case' 0 C--N 1.339 0.124 0 C-N-CA 126.246 1.818 . . . . 0.0 112.238 173.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 17.4 p -104.22 -56.06 2.26 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -164.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 26.51 52.02 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 128.789 2.836 . . . . 0.0 115.329 170.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 141.66 -36.49 1.7 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -173.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 12.8 mm -51.87 121.26 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.124 0.57 . . . . 0.0 110.089 172.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -157.21 57.2 0.51 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.018 0.527 . . . . 0.0 111.659 177.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.7 m -149.08 90.8 1.78 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 161.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.55 ' O ' HG13 ' A' ' 35' ' ' VAL . 2.5 tp -84.52 87.77 7.27 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.789 -161.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.9 t -79.77 175.17 10.86 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 122.278 1.037 . . . . 0.0 110.697 -171.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.8 tt -143.83 105.49 4.31 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 103.873 -2.64 . . . . 0.0 103.873 164.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.4 p -86.95 100.16 12.39 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 174.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.66 130.9 44.63 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 126.209 1.804 . . . . 0.0 108.284 -176.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.7 m -125.52 90.34 3.2 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.564 1.145 . . . . 0.0 109.608 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.513 ' CG ' HD13 ' A' ' 45' ' ' LEU . 2.0 m-30 -69.3 88.11 0.44 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.421 0.688 . . . . 0.0 110.125 171.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.07 44.46 0.34 Allowed Pre-proline 0 CA--C 1.553 1.082 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 176.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.552 ' CD ' HD12 ' A' ' 45' ' ' LEU . 58.0 Cg_endo -73.97 -82.98 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.593 2.195 . . . . 0.0 113.482 -177.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 42.0 mmt180 -149.63 123.4 9.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.362 0.983 . . . . 0.0 110.332 -171.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.91 116.79 61.94 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 125.29 1.436 . . . . 0.0 109.234 -174.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.482 ' HD3' HG23 ' A' ' 78' ' ' THR . 83.8 Cg_endo -84.25 -36.03 0.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.051 2.501 . . . . 0.0 113.421 -176.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.3 t 158.62 138.33 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 128.055 2.542 . . . . 0.0 107.848 -169.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.279 0 C-N-CA 127.132 2.173 . . . . 0.0 107.755 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.398 0 N-CA-C 103.471 -2.789 . . . . 0.0 103.471 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.4 m -152.46 35.09 0.51 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.16 0.981 . . . . 0.0 110.347 177.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -159.33 -56.41 0.06 Allowed 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 127.993 2.517 . . . . 0.0 106.482 -157.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.7 pp -91.74 -7.51 49.48 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.134 1.374 . . . . 0.0 112.585 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.4 mt -72.2 104.19 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.222 0 CA-C-N 119.386 0.994 . . . . 0.0 110.035 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -95.24 171.42 8.73 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 155.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -80.73 30.51 0.31 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -163.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -83.02 111.2 18.64 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 122.77 1.271 . . . . 0.0 110.758 177.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -74.59 91.52 2.33 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 127.08 2.152 . . . . 0.0 106.165 171.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.8 tp -100.24 123.46 53.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.205 1.002 . . . . 0.0 108.835 -177.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -84.42 148.79 26.4 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.183 0.993 . . . . 0.0 108.962 -175.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.2 t -134.25 146.82 30.63 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.3 m -146.75 105.32 3.81 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -169.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -76.17 163.57 26.94 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.729 0.812 . . . . 0.0 110.02 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -136.36 85.53 2.15 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 122.678 1.227 . . . . 0.0 110.222 166.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.99 99.3 6.01 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 177.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -92.84 146.88 23.31 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.7 t -128.91 136.75 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 168.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -124.3 162.2 24.27 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -43.18 -44.22 5.04 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.025 0.93 . . . . 0.0 111.043 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -48.06 -30.72 7.63 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 126.77 2.128 . . . . 0.0 115.323 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.447 HD13 ' CD2' ' A' ' 144' ' ' PHE . 1.3 tt -121.99 101.75 41.58 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 120.478 2.139 . . . . 0.0 110.495 -178.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -85.51 38.68 0.65 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 124.114 3.21 . . . . 0.0 112.192 -171.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.45 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 42.5 m0 -114.74 140.83 48.57 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -177.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -79.97 80.43 6.38 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -175.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -85.11 94.59 8.89 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.6 m -88.09 135.46 33.28 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.54 156.25 66.39 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 N-CA-C 108.686 -1.313 . . . . 0.0 108.686 165.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -79.76 -59.7 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -176.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -128.22 168.3 15.65 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 157.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -62.99 -43.15 99.57 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 170.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -139.65 165.42 27.3 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 126.37 1.868 . . . . 0.0 109.546 -164.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.6 pt -138.95 177.22 5.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 171.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -124.33 159.2 30.85 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 150.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -129.43 143.38 41.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 173.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.5 mmt85 -79.44 97.16 6.28 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 161.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.4 pt -4.86 79.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 127.442 2.297 . . . . 0.0 114.978 -172.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.53 -37.11 2.03 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.717 -0.49 . . . . 0.0 112.593 -175.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -41.95 107.83 0.08 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.187 1.395 . . . . 0.0 111.911 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.37 105.2 2.09 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.695 0.798 . . . . 0.0 109.844 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.25 177.65 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.732 0.777 . . . . 0.0 110.079 177.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -145.04 89.65 1.98 Allowed 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.016 0.926 . . . . 0.0 108.626 172.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.3 pp -110.01 117.37 54.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 32.6 mtm -92.48 111.82 23.54 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.469 1.908 . . . . 0.0 111.927 -177.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -84.59 154.89 22.32 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.137 0.575 . . . . 0.0 109.739 174.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.2 ttm-85 -134.54 138.96 45.06 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.679 1.591 . . . . 0.0 108.021 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.8 106.82 4.7 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.794 1.638 . . . . 0.0 110.201 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER -112.52 129.45 56.35 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.044 0.537 . . . . 0.0 112.22 -174.057 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.45 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 36.2 t-20 -77.9 115.1 17.38 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.486 0.585 . . . . 0.0 111.379 -167.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 69.6 mt -107.95 39.1 2.02 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.688 1.195 . . . . 0.0 111.35 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -111.36 173.27 6.42 Favored 'General case' 0 CA--C 1.526 0.029 0 C-N-CA 124.263 1.025 . . . . 0.0 110.037 169.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.3 p -89.05 -5.47 57.86 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 125.048 1.339 . . . . 0.0 111.829 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 p -140.76 162.94 46.1 Favored Pre-proline 0 N--CA 1.449 -0.476 0 C-N-CA 124.618 1.167 . . . . 0.0 109.37 -171.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.96 111.0 3.06 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.16 1.907 . . . . 0.0 109.249 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.26 177.68 8.65 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.036 0.835 . . . . 0.0 109.569 174.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.9 t -124.17 137.26 54.56 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 165.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.05 117.61 4.19 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.804 1.669 . . . . 0.0 109.586 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.75 47.39 2.54 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 124.634 1.173 . . . . 0.0 108.566 175.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.2 144.52 15.64 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.15 -174.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.7 t -87.39 175.26 8.07 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 119.583 -0.847 . . . . 0.0 108.738 166.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -155.13 89.42 1.21 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -161.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -78.79 90.53 4.66 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.2 t -79.35 59.18 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 123.323 0.649 . . . . 0.0 110.965 -175.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.3 t -174.79 148.97 1.22 Allowed Pre-proline 0 N--CA 1.465 0.312 0 CA-C-N 119.505 1.048 . . . . 0.0 112.595 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -57.92 -52.75 5.36 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 121.627 1.551 . . . . 0.0 109.205 158.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.42 -83.64 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.345 1.858 . . . . 0.0 107.42 177.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.49 ' HB3' HG13 ' A' ' 135' ' ' ILE . . . -59.03 -32.15 69.48 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -172.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.56 -109.6 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -168.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.08 -51.9 1.68 Allowed Glycine 0 CA--C 1.53 0.981 0 O-C-N 121.506 -0.746 . . . . 0.0 113.051 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -52.95 -58.62 6.36 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.651 1.226 . . . . 0.0 109.16 170.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -74.19 49.04 0.34 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.993 1.317 . . . . 0.0 111.611 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -126.48 130.85 51.44 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 173.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 174.489 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.8 mp0 . . . . . 0 CA--C 1.538 0.504 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.1 t 39.25 -133.2 0.18 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.564 1.946 . . . . 0.0 113.06 168.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.2 t -125.34 153.65 43.0 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.621 1.968 . . . . 0.0 108.833 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.442 HD11 ' HB2' ' A' ' 114' ' ' MET . 81.9 mt -136.96 123.35 20.73 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 176.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -58.8 154.71 35.32 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 171.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.71 94.58 0.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.996 3.131 . . . . 0.0 111.3 -170.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 137.8 -26.85 2.85 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 124.536 1.065 . . . . 0.0 110.873 -173.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -78.28 154.1 31.23 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 117.664 0.732 . . . . 0.0 111.264 -166.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -117.51 133.97 55.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.428 1.091 . . . . 0.0 110.651 -174.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.442 ' HB2' HD11 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -99.15 142.09 31.08 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 127.034 2.134 . . . . 0.0 106.815 169.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -146.98 133.31 19.54 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.202 1.401 . . . . 0.0 107.286 172.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 79.7 mtp -147.3 135.97 11.23 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 118.207 0.458 . . . . 0.0 110.937 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -73.34 147.27 41.47 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.735 2.29 . . . . 0.0 109.92 168.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.2 t -129.41 124.52 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 168.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.1 p -88.11 151.66 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 166.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -157.96 135.87 10.68 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -175.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -146.06 159.75 42.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.379 0.672 . . . . 0.0 110.249 153.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 39.4 t -100.78 119.24 48.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 169.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.37 139.62 78.67 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -74.05 29.46 0.33 Allowed 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.591 2.861 . . . . 0.0 114.297 -176.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -87.26 -24.58 24.32 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.426 1.09 . . . . 0.0 110.382 170.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 17.0 tt -56.09 -44.9 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 118.153 0.433 . . . . 0.0 112.053 -176.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.4 m -80.61 56.32 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 O-C-N 121.513 -0.742 . . . . 0.0 110.452 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 49.6 mttp -139.52 -67.03 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.608 0 CA-C-O 117.715 -1.136 . . . . 0.0 112.247 174.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.96 156.94 30.79 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.02 1.813 . . . . 0.0 113.539 -169.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 86.2 t -55.09 -35.09 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 125.495 1.518 . . . . 0.0 110.808 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -36.39 -56.75 0.77 Allowed 'General case' 0 C--N 1.338 0.1 0 C-N-CA 126.109 1.763 . . . . 0.0 111.908 174.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.2 p -102.62 -54.22 2.7 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.441 -164.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 22.11 53.6 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 128.932 2.893 . . . . 0.0 115.019 173.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 146.45 -41.45 0.99 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 -170.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.49 HG13 ' HB3' ' A' ' 90' ' ' ALA . 19.3 mm -58.09 119.62 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 169.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.02 39.29 0.31 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.86 0.362 . . . . 0.0 111.232 -178.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.4 94.49 1.71 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 177.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.58 147.02 32.27 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -169.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.5 t -136.5 172.44 13.01 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.0 tt -145.3 114.77 7.17 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 103.38 -2.822 . . . . 0.0 103.38 171.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.72 102.62 15.03 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 177.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -86.03 87.89 7.49 Favored 'General case' 0 CA--C 1.527 0.069 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.82 89.4 5.24 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 122.665 1.221 . . . . 0.0 110.596 177.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.447 ' CD2' HD13 ' A' ' 45' ' ' LEU . 4.0 m-30 -69.05 80.77 0.32 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.836 1.654 . . . . 0.0 110.46 175.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -125.86 84.21 61.35 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 125.446 1.499 . . . . 0.0 113.813 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -105.45 -118.82 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.931 1 C-N-CA 125.988 4.459 . . . . 0.0 109.643 168.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -143.59 149.14 36.93 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 123.674 0.789 . . . . 0.0 109.728 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -144.85 143.67 21.73 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 126.531 1.933 . . . . 0.0 106.445 -176.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -87.19 -51.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.592 2.195 . . . . 0.0 111.727 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.5 m 167.07 101.58 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 128.947 2.899 . . . . 0.0 107.364 -176.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt . . . . . 0 CA--C 1.544 0.723 0 C-N-CA 123.877 0.871 . . . . 0.0 109.505 -176.581 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.462 ' HB2' ' OG1' ' A' ' 63' ' ' THR . . . . . . . . 0 N--CA 1.442 -0.831 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.9 t -164.94 34.63 0.06 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.855 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -160.13 -51.14 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -167.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.6 mp -77.95 -27.82 49.38 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.616 -172.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.0 mt -70.73 129.07 34.71 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.062 0 C-N-CA 123.897 0.879 . . . . 0.0 112.881 -156.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.15 162.97 14.38 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.819 1.248 . . . . 0.0 108.467 172.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -80.8 74.36 7.76 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 122.177 0.989 . . . . 0.0 110.205 -176.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.25 -174.19 4.22 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.909 1.684 . . . . 0.0 107.608 174.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.3 mtmt -126.83 156.3 41.54 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.882 1.273 . . . . 0.0 108.093 162.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 tp -137.28 155.5 32.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 162.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.35 156.01 30.86 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.409 1.084 . . . . 0.0 108.671 -167.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.511 HG21 ' CE1' ' A' ' 120' ' ' PHE . 4.7 t -139.08 142.11 34.62 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.6 m -136.43 106.03 6.15 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -173.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -85.68 93.47 8.85 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.389 2.276 . . . . 0.0 110.427 -174.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -79.96 85.96 5.52 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 174.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.88 110.74 19.63 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.196 0.598 . . . . 0.0 111.039 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -111.85 153.78 26.13 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.653 1.181 . . . . 0.0 109.986 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.4 p -144.71 147.03 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.416 1.086 . . . . 0.0 108.977 173.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -159.34 170.67 21.31 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.914 0.885 . . . . 0.0 109.896 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -37.7 113.11 0.25 Allowed 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.841 1.656 . . . . 0.0 110.25 171.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 135.46 -39.21 1.7 Allowed Glycine 0 CA--C 1.523 0.557 0 N-CA-C 108.235 -1.946 . . . . 0.0 108.235 -165.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.405 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 1.7 mt -139.96 111.32 7.33 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 125.089 1.355 . . . . 0.0 107.375 169.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.93 8.04 4.7 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.793 2.328 . . . . 0.0 111.512 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.405 ' CD2' ' CD2' ' A' ' 45' ' ' LEU . 38.8 m0 -77.34 139.72 39.82 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.214 -0.929 . . . . 0.0 109.914 -165.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -78.63 84.7 4.72 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -83.91 93.05 7.94 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 127.172 2.189 . . . . 0.0 109.003 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.5 m -88.31 127.17 58.05 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -176.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -68.18 143.38 58.91 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 N-CA-C 108.226 -1.49 . . . . 0.0 108.226 164.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.2 m -77.74 -49.51 21.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.284 0.564 . . . . 0.0 109.982 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -130.31 162.43 29.03 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 164.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -62.69 -41.42 99.11 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 165.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -149.6 166.86 28.01 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 124.28 1.032 . . . . 0.0 110.87 -160.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.4 pt -137.78 154.71 29.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 124.807 1.243 . . . . 0.0 108.708 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -89.39 143.79 26.55 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 156.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.0 m -128.1 130.54 69.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 162.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -63.66 76.28 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.168 1.387 . . . . 0.0 108.802 172.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.5 mm 60.04 -74.46 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 126.162 1.785 . . . . 0.0 111.146 -172.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -131.14 62.8 0.64 Allowed Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 -176.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -102.38 105.84 16.5 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.131 1.372 . . . . 0.0 110.236 -175.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.462 ' OG1' ' HB2' ' A' ' 24' ' ' ALA . 50.2 m -69.94 88.86 0.58 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.366 1.466 . . . . 0.0 110.131 -171.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.5 p -98.81 147.99 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 121.262 0.553 . . . . 0.0 110.775 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.88 126.82 35.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.699 1.6 . . . . 0.0 108.981 173.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.6 pp -130.12 112.18 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 164.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.74 176.42 9.35 Favored 'General case' 0 C--N 1.333 -0.125 0 O-C-N 121.741 -0.599 . . . . 0.0 110.709 168.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -137.48 156.88 47.64 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 169.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 59.9 mtp85 -120.11 131.6 55.11 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 169.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.34 109.25 10.95 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.485 1.114 . . . . 0.0 109.286 174.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -96.54 124.82 40.66 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 119.011 -0.519 . . . . 0.0 110.081 -172.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -78.77 88.27 4.63 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -169.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.9 mt -78.04 65.93 3.55 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.166 0.986 . . . . 0.0 109.945 171.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -134.9 152.25 51.58 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.587 1.155 . . . . 0.0 109.299 173.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.8 p -91.93 -3.43 55.95 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.983 1.313 . . . . 0.0 112.399 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.9 p -142.53 166.84 18.56 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 174.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -58.61 157.48 27.33 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 CA-C-N 120.397 1.178 . . . . 0.0 111.627 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.08 177.65 5.96 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.363 1.065 . . . . 0.0 109.219 173.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 t -140.83 143.24 34.69 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -134.27 124.61 3.59 Favored Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 107.548 -2.221 . . . . 0.0 107.548 -175.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.81 55.18 1.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 166.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.51 154.37 41.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.484 -164.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.34 126.89 31.73 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.07 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -116.47 138.3 51.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 167.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -130.91 94.46 3.61 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.478 HG11 ' CE2' ' A' ' 95' ' ' PHE . 3.7 t -85.31 72.24 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 123.55 0.74 . . . . 0.0 110.153 -176.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.6 t -169.25 147.7 3.34 Favored Pre-proline 0 N--CA 1.45 -0.45 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 175.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.74 -44.91 12.14 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 N-CA-C 108.021 -1.569 . . . . 0.0 108.021 161.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 3.0 ptm -174.25 -84.12 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.806 1.642 . . . . 0.0 108.026 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.98 -31.64 71.23 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.362 1.865 . . . . 0.0 115.231 -168.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.18 -105.76 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 117.927 0.331 . . . . 0.0 111.326 -168.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.05 -58.48 0.56 Allowed Glycine 0 CA--C 1.534 1.277 0 O-C-N 121.804 -0.56 . . . . 0.0 113.171 -174.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.56 -41.67 73.61 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.193 1.497 . . . . 0.0 111.551 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -76.24 7.28 4.4 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.536 1.135 . . . . 0.0 113.893 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.478 ' CE2' HG11 ' A' ' 86' ' ' VAL . 8.8 t80 -82.5 144.69 30.25 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 165.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 . . . . . 0 N--CA 1.446 -0.661 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 172.211 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 N--CA 1.45 -0.451 0 CA-C-O 119.327 -0.368 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.2 t 49.76 -149.79 0.23 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.042 1.337 . . . . 0.0 112.58 170.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.71 149.32 31.79 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.824 1.65 . . . . 0.0 109.199 -177.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.8 mt -143.09 146.07 33.45 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.658 0.783 . . . . 0.0 110.219 172.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -70.08 158.67 86.82 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 129.863 3.265 . . . . 0.0 110.75 171.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.51 105.98 1.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.565 2.843 . . . . 0.0 111.936 -168.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 116.87 -7.98 16.91 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 123.933 0.778 . . . . 0.0 111.824 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -77.81 164.84 24.84 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 117.635 0.717 . . . . 0.0 111.216 -175.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -119.32 126.45 51.47 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.584 0.754 . . . . 0.0 110.392 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 15.6 tpt -91.27 123.81 34.99 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -146.28 141.59 27.48 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 123.238 0.336 . . . . 0.0 110.507 158.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 87.2 mtp -150.42 149.65 27.0 Favored Pre-proline 0 N--CA 1.451 -0.385 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 166.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -73.32 137.32 25.61 Favored 'Trans proline' 0 N--CA 1.445 -1.343 0 C-N-CA 122.121 1.881 . . . . 0.0 111.76 172.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.4 t -99.34 150.05 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 159.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.77 138.72 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.511 ' CE1' HG21 ' A' ' 35' ' ' VAL . 3.3 t80 -152.96 137.07 16.41 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.237 0.472 . . . . 0.0 111.201 -165.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -155.78 158.9 38.92 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.275 1.83 . . . . 0.0 107.528 160.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.8 t -87.52 159.07 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 175.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -100.46 133.24 21.46 Favored Pre-proline 0 C--O 1.236 0.378 0 CA-C-N 118.692 0.678 . . . . 0.0 111.272 173.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -72.38 46.67 0.99 Allowed 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.937 2.425 . . . . 0.0 114.011 175.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.51 -7.69 11.62 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.263 1.025 . . . . 0.0 113.401 163.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.2 tt -51.65 -40.74 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 118.794 0.725 . . . . 0.0 111.068 170.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.3 m -83.2 56.26 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.331 1.052 . . . . 0.0 110.749 171.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -113.3 -79.22 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.462 0 CA-C-O 117.573 -1.204 . . . . 0.0 109.145 165.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -78.59 163.02 27.1 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.025 1.817 . . . . 0.0 111.901 -176.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.8 p -62.18 -44.29 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 123.737 0.815 . . . . 0.0 110.683 -174.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -46.34 -56.0 6.49 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.296 1.438 . . . . 0.0 111.704 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 35.0 p -88.69 -10.57 48.01 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 118.365 -0.826 . . . . 0.0 112.543 -174.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -48.07 -42.36 28.43 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.361 0.982 . . . . 0.0 111.766 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -76.65 -25.33 65.39 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 123.54 0.591 . . . . 0.0 112.612 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 24.8 mm -76.37 128.81 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 117.923 0.861 . . . . 0.0 108.84 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -156.66 56.38 0.55 Allowed 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.5 m -155.34 108.93 2.82 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 160.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.94 84.07 5.75 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -174.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.96 147.89 32.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.921 -171.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.6 tt -118.79 110.56 17.37 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.4 t -87.94 108.26 19.11 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 171.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.2 131.19 54.93 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.815 1.246 . . . . 0.0 108.112 177.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.4 m -129.47 89.84 2.9 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.423 0.63 . . . . 0.0 110.749 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -69.98 78.71 0.48 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 169.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.47 46.33 1.36 Allowed Pre-proline 0 CA--C 1.55 0.973 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 174.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.86 -89.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.222 2.614 . . . . 0.0 113.38 -176.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -157.8 112.81 2.69 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.241 -0.912 . . . . 0.0 110.487 -172.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -116.2 142.62 29.59 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 123.65 0.78 . . . . 0.0 109.465 176.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -76.4 66.56 7.19 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.914 1.742 . . . . 0.0 109.61 166.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.4 t 38.05 92.29 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 129.078 2.951 . . . . 0.0 114.846 172.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt . . . . . 0 CA--C 1.534 0.343 0 C-N-CA 123.738 0.815 . . . . 0.0 111.629 -178.421 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.216 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.8 p -157.38 40.66 0.3 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 122.064 0.935 . . . . 0.0 110.974 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -156.08 -52.26 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 127.297 2.239 . . . . 0.0 106.172 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.3 mt -56.93 -29.51 63.16 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.836 1.654 . . . . 0.0 111.502 174.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.2 mt -72.51 80.96 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 123.824 0.849 . . . . 0.0 110.85 -174.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.531 ' HB2' HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -74.59 -168.95 0.76 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 151.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -71.78 -42.51 67.04 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.66 1.184 . . . . 0.0 111.322 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -40.61 128.1 2.49 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.301 1.44 . . . . 0.0 114.703 -161.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -97.5 88.21 4.32 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 125.538 1.535 . . . . 0.0 107.424 -168.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -82.35 119.9 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 175.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.49 138.42 31.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 -177.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.419 ' HB ' ' CG1' ' A' ' 56' ' ' ILE . 3.8 t -121.89 147.59 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 176.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.5 m -140.43 94.27 2.72 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 -174.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -76.0 163.21 27.38 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.204 1.402 . . . . 0.0 108.983 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -146.61 88.5 1.77 Allowed 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.875 0.845 . . . . 0.0 110.583 -167.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.62 111.06 16.7 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.793 0.837 . . . . 0.0 111.025 176.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -118.21 136.74 53.46 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.5 t -132.03 143.46 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -134.93 163.54 29.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 169.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -24.79 -59.05 0.06 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 127.233 2.213 . . . . 0.0 113.242 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -32.78 -42.89 0.16 Allowed Glycine 0 CA--C 1.532 1.106 0 C-N-CA 126.774 2.13 . . . . 0.0 114.71 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.584 HD13 ' CD2' ' A' ' 144' ' ' PHE . 0.2 OUTLIER -109.15 106.62 59.0 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 118.86 1.33 . . . . 0.0 108.238 165.079 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -82.17 5.08 6.57 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.276 1.984 . . . . 0.0 112.498 -173.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.407 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 43.1 m0 -79.8 146.3 32.36 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 122.384 1.088 . . . . 0.0 111.792 -165.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -77.54 82.36 3.98 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -93.36 106.85 18.77 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.603 1.561 . . . . 0.0 108.192 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.0 m -101.44 118.92 58.92 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -70.81 166.68 28.11 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 121.186 1.257 . . . . 0.0 109.112 164.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -94.54 -58.32 3.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 C-N-CA 123.853 0.861 . . . . 0.0 110.762 -174.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -132.23 175.18 9.48 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 165.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.3 tpt85 -69.79 -43.03 72.96 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 165.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -135.98 170.08 16.57 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 125.842 1.657 . . . . 0.0 113.283 -158.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.419 ' CG1' ' HB ' ' A' ' 35' ' ' VAL . 30.6 pt -143.74 167.24 12.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 127.068 2.147 . . . . 0.0 107.502 173.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -117.92 140.85 49.14 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 161.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.4 t -131.58 129.95 62.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.651 1.58 . . . . 0.0 106.76 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.3 mmt-85 -76.35 94.84 3.67 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 168.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.531 HD11 ' HB2' ' A' ' 29' ' ' LEU . 5.6 pt -7.66 76.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 127.558 2.343 . . . . 0.0 115.806 -167.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 134.06 -27.04 3.35 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 124.558 1.075 . . . . 0.0 112.858 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -41.32 111.32 0.21 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.263 1.425 . . . . 0.0 111.65 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.49 99.67 1.65 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.17 1.388 . . . . 0.0 110.264 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.2 p -104.96 150.58 7.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 175.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.28 132.6 52.14 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.471 1.108 . . . . 0.0 109.584 178.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.1 pp -138.76 96.93 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 C-N-CA 125.008 1.323 . . . . 0.0 108.026 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.404 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 0.0 OUTLIER -78.29 166.49 22.63 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -174.272 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -134.25 149.14 50.92 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 26.3 ttt-85 -132.04 122.66 25.82 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -123.15 105.9 10.31 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.539 1.536 . . . . 0.0 109.154 174.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -95.6 131.91 41.31 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.407 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 49.3 t-20 -75.45 142.68 42.92 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.042 0.837 . . . . 0.0 109.663 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.71 -7.26 6.78 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.462 1.905 . . . . 0.0 111.68 -174.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.35 151.14 33.03 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.174 0.897 . . . . 0.0 109.29 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.7 m -84.26 14.38 4.4 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -154.2 163.64 23.41 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 175.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.8 160.64 17.29 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.09 1.86 . . . . 0.0 112.212 -175.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.24 165.22 26.66 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 123.301 0.64 . . . . 0.0 110.126 176.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.7 t -111.17 145.45 38.62 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 168.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -138.0 83.9 0.24 Allowed Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -112.04 -21.93 11.28 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.018 0.927 . . . . 0.0 112.119 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.15 -175.97 0.12 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 165.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.5 t -124.11 168.78 12.43 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 118.214 -1.394 . . . . 0.0 107.987 141.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -148.24 88.75 1.67 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 122.726 1.251 . . . . 0.0 108.956 -166.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -78.22 88.98 4.28 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 120.847 -1.158 . . . . 0.0 107.882 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.6 p -78.75 69.48 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.473 0 C-N-CA 125.463 1.505 . . . . 0.0 110.691 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.6 t -176.53 142.05 0.55 Allowed Pre-proline 0 N--CA 1.464 0.252 0 CA-C-N 119.425 1.012 . . . . 0.0 109.736 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -67.05 -58.61 0.14 Allowed 'Trans proline' 0 N--CA 1.446 -1.314 0 N-CA-C 108.777 -1.278 . . . . 0.0 108.777 166.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 26.2 ptm -171.42 11.37 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -171.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -173.49 -51.93 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 119.163 0.892 . . . . 0.0 110.317 -162.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.25 -124.55 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.667 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.19 -44.09 1.07 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 120.417 -1.427 . . . . 0.0 112.762 -170.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.59 -58.18 4.06 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.408 1.083 . . . . 0.0 110.837 174.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -74.29 -25.1 59.39 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.258 1.023 . . . . 0.0 113.447 -177.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -41.04 120.68 1.39 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.745 1.218 . . . . 0.0 109.302 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 . . . . . 0 CA--C 1.532 0.277 0 CA-C-N 118.803 0.729 . . . . 0.0 111.422 -168.191 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.0 t 40.85 -131.51 0.37 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.538 1.535 . . . . 0.0 113.315 165.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.0 t -132.16 147.89 52.45 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.067 2.147 . . . . 0.0 108.167 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.402 HD11 ' HB2' ' A' ' 114' ' ' MET . 95.1 mt -134.19 142.29 47.36 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.406 0.683 . . . . 0.0 109.883 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -68.98 164.25 49.2 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.365 1.866 . . . . 0.0 110.372 167.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.06 76.77 2.5 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 124.682 3.588 . . . . 0.0 112.735 -169.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 153.71 -21.22 0.7 Allowed Glycine 0 CA--C 1.521 0.433 0 CA-C-O 119.357 -0.691 . . . . 0.0 113.285 169.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.9 155.67 32.66 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 118.14 0.97 . . . . 0.0 111.772 -159.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -106.44 101.45 10.91 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.89 1.276 . . . . 0.0 110.887 -165.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.402 ' HB2' HD11 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -83.79 85.81 7.24 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.136 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -106.64 105.11 14.98 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.862 1.265 . . . . 0.0 108.851 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 46.7 mtt -146.87 141.49 16.09 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 119.729 1.15 . . . . 0.0 112.936 -174.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 67' ' ' MET . 95.3 Cg_endo -83.87 145.51 11.37 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.138 2.559 . . . . 0.0 113.622 176.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 24.1 t -117.8 150.81 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 126.403 1.881 . . . . 0.0 106.512 170.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.2 m -118.74 147.44 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.868 1.267 . . . . 0.0 108.301 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -157.55 159.16 36.85 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.629 0.65 . . . . 0.0 112.747 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -163.17 158.19 21.43 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 126.661 1.984 . . . . 0.0 108.426 166.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 29.7 t -102.29 147.35 9.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 124.699 1.199 . . . . 0.0 108.768 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -80.97 161.78 62.0 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 123.398 0.679 . . . . 0.0 110.149 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.467 ' HB3' HD12 ' A' ' 60' ' ' ILE . 87.4 Cg_endo -101.94 28.25 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.89 3.06 . . . . 0.0 112.425 166.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -84.41 -40.54 17.67 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 168.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.7 tt -39.3 -47.38 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.112 1.365 . . . . 0.0 113.681 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.8 m -79.27 55.7 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 O-C-N 121.553 -0.717 . . . . 0.0 110.627 175.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -140.99 -66.61 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.491 0 CA-C-O 117.485 -1.245 . . . . 0.0 111.711 175.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.4 158.43 44.46 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 CA-C-N 121.927 1.724 . . . . 0.0 112.54 -175.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.2 t -55.61 -46.8 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 124.7 1.2 . . . . 0.0 110.141 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -46.17 -50.33 15.77 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.985 1.314 . . . . 0.0 112.684 -175.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 27.2 p -101.52 -6.74 23.53 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -174.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -37.84 107.82 0.07 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.839 1.256 . . . . 0.0 112.152 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.03 -30.53 8.56 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.587 -1.118 . . . . 0.0 113.132 176.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 43.2 mm -58.79 129.3 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 C-N-CA 124.321 1.048 . . . . 0.0 109.863 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -158.54 49.13 0.37 Allowed 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.4 m -149.4 92.55 1.95 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 162.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.08 89.58 5.97 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -171.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 13.2 t -78.01 175.35 10.16 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 122.247 1.022 . . . . 0.0 109.383 -176.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.17 98.34 3.08 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 169.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.3 m -79.81 95.36 6.0 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 174.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -76.67 126.4 30.92 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 171.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 26.6 m -122.51 89.91 3.2 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.584 ' CD2' HD13 ' A' ' 45' ' ' LEU . 3.1 m-85 -84.83 91.34 7.98 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.155 -173.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -151.04 47.39 0.44 Allowed Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 116.876 2.176 . . . . 0.0 116.876 -175.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.2 -111.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.398 2.732 . . . . 0.0 110.763 173.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -136.05 116.49 13.71 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.693 1.133 . . . . 0.0 108.928 -168.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -93.19 143.54 26.9 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 164.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -71.54 -55.36 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.882 1.721 . . . . 0.0 108.419 167.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.6 t -177.37 126.25 0.14 Allowed 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.158 1.783 . . . . 0.0 107.791 172.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 27.4 pttt . . . . . 0 CA--C 1.537 0.474 0 C-N-CA 123.144 0.577 . . . . 0.0 111.321 160.693 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.059 0 N-CA-C 102.015 -3.328 . . . . 0.0 102.015 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.3 t -155.5 35.12 0.37 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 121.508 1.958 . . . . 0.0 111.11 176.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -160.37 -60.74 0.06 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -164.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.43 39.94 0.62 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 112.628 -2.078 . . . . 0.0 112.246 -165.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.9 mt -119.37 62.59 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 123.486 0.714 . . . . 0.0 110.688 -167.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -76.96 149.63 35.95 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.024 1.33 . . . . 0.0 109.602 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.0 54.61 1.62 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -165.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.8 98.09 7.83 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 166.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.76 81.78 5.97 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 122.125 0.964 . . . . 0.0 108.65 -168.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.292 0.0 OUTLIER -79.92 131.83 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.629 -173.173 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.97 150.66 24.73 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 126.79 2.036 . . . . 0.0 106.999 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.7 m -135.94 120.11 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.26 111.92 18.79 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 176.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -79.48 89.69 5.05 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 176.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -78.35 80.58 4.75 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 122.608 1.194 . . . . 0.0 108.019 -174.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.91 126.05 30.51 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -133.8 147.33 51.23 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.3 p -145.25 147.98 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 124.097 0.959 . . . . 0.0 108.815 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -130.3 168.46 16.86 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 166.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.48 -34.86 11.91 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.235 1.014 . . . . 0.0 111.891 -178.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -34.93 -38.8 0.14 Allowed Glycine 0 CA--C 1.532 1.11 0 C-N-CA 126.28 1.895 . . . . 0.0 113.734 169.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.758 HD13 ' CD2' ' A' ' 144' ' ' PHE . 0.6 OUTLIER -116.6 96.58 48.57 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 118.225 1.012 . . . . 0.0 108.283 163.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -82.92 42.55 1.31 Allowed 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 123.424 2.75 . . . . 0.0 111.332 -168.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 41.5 m0 -112.81 147.19 37.46 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 -176.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.401 ' CD ' ' HZ2' ' A' ' 71' ' ' LYS . 12.0 tt0 -77.14 80.93 3.65 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 -178.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -90.9 87.04 6.47 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 m -95.64 128.39 38.08 Favored Pre-proline 0 N--CA 1.454 -0.257 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -67.4 153.15 77.62 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 N-CA-C 107.3 -1.846 . . . . 0.0 107.3 160.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -57.96 4.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.638 0.732 . . . . 0.0 109.092 -173.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -120.06 159.09 25.48 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 103.199 -2.889 . . . . 0.0 103.199 157.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -23.01 67.09 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.946 0.794 . . . . 0.0 110.652 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -139.88 167.6 21.74 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 125.561 1.545 . . . . 0.0 109.952 -171.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.41 168.95 21.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 172.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.3 p-10 -129.84 147.62 51.63 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.339 0.656 . . . . 0.0 111.218 166.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.2 m -141.84 122.99 12.54 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.57 56.27 3.89 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 121.413 1.915 . . . . 0.0 109.999 -173.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mt 58.8 116.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 124.642 1.177 . . . . 0.0 109.004 -164.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.28 -51.74 4.42 Favored Glycine 0 CA--C 1.525 0.718 0 O-C-N 119.994 -1.691 . . . . 0.0 113.945 172.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -26.39 100.5 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.444 2.298 . . . . 0.0 112.081 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.5 p -76.89 128.2 34.13 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.722 -0.612 . . . . 0.0 110.461 -172.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 p -123.62 149.43 27.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 C-N-CA 125.268 1.427 . . . . 0.0 109.041 177.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.02 122.86 36.96 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 125.164 1.385 . . . . 0.0 107.276 164.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.7 pp -114.67 130.74 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 157.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 35.8 ttp -76.97 140.53 40.46 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 169.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -109.29 158.71 17.61 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 166.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 43.7 ttm-85 -138.13 140.93 40.13 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.353 1.461 . . . . 0.0 108.727 -175.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.7 96.72 1.78 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.12 1.768 . . . . 0.0 108.846 166.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.401 ' HZ2' ' CD ' ' A' ' 48' ' ' GLU . 4.7 mtmp? -95.09 126.11 40.21 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -79.94 121.41 25.42 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.607 1.094 . . . . 0.0 112.399 -170.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.4 mp -108.87 26.76 10.2 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.262 1.025 . . . . 0.0 111.598 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.17 171.66 14.62 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 120.987 -1.071 . . . . 0.0 112.223 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.4 p -79.47 -34.59 41.33 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.645 1.978 . . . . 0.0 110.479 170.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 66.5 p -123.99 179.84 0.99 Allowed Pre-proline 0 N--CA 1.456 -0.152 0 C-N-CA 127.149 2.18 . . . . 0.0 108.979 -174.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -54.41 161.51 5.48 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 CA-C-N 119.309 0.789 . . . . 0.0 111.345 160.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.47 173.9 10.4 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 157.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.6 t -102.85 162.11 13.19 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 151.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.603 ' HA2' HD11 ' A' ' 45' ' ' LEU . . . -151.41 60.27 0.41 Allowed Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -88.31 -39.11 14.63 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.537 0.735 . . . . 0.0 109.051 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.05 178.08 0.15 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.367 1.067 . . . . 0.0 112.841 169.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.5 m -125.87 148.09 49.28 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 173.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -137.98 160.85 38.24 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.619 0.768 . . . . 0.0 110.345 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.76 113.36 20.07 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 164.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.8 p -95.08 59.4 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 123.714 0.805 . . . . 0.0 112.127 -173.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.8 t -174.5 150.04 1.41 Allowed Pre-proline 0 C--N 1.333 -0.121 0 O-C-N 121.539 -0.725 . . . . 0.0 110.682 -175.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.21 -33.66 30.24 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 N-CA-C 108.99 -1.196 . . . . 0.0 108.99 162.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.3 ptp 174.99 -71.8 0.01 OUTLIER 'General case' 0 C--N 1.341 0.23 0 C-N-CA 127.023 2.129 . . . . 0.0 107.913 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.76 -31.02 51.78 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -163.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.33 -110.51 0.06 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.476 0.179 . . . . 0.0 111.264 -168.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.16 -56.28 0.1 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.312 0.958 . . . . 0.0 113.31 -169.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.83 -49.54 19.88 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.376 1.588 . . . . 0.0 112.287 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -72.74 -4.67 32.81 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.283 1.033 . . . . 0.0 113.41 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.401 ' CE1' ' CE2' ' A' ' 120' ' ' PHE . 6.1 t80 -62.64 131.92 50.6 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 . . . . . 0 N--CA 1.442 -0.837 0 O-C-N 123.515 0.51 . . . . 0.0 112.166 174.667 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 CA--C 1.538 0.494 0 CA-C-O 121.138 0.494 . . . . 0.0 112.207 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.8 t -156.33 -70.47 0.11 Allowed 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.009 0.924 . . . . 0.0 111.137 -176.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.6 m -159.69 135.0 8.23 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 -164.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 69.0 mt -149.47 146.37 27.38 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.926 0.89 . . . . 0.0 109.058 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.26 170.7 12.83 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 126.324 1.85 . . . . 0.0 109.567 167.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.01 88.16 1.27 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 124.607 3.538 . . . . 0.0 111.093 -173.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 151.23 -30.19 0.97 Allowed Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 173.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.27 145.87 41.52 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.688 -151.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -96.29 89.71 5.19 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.974 1.71 . . . . 0.0 110.975 -170.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.96 119.15 26.87 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 176.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -154.13 132.51 11.98 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 122.762 0.425 . . . . 0.0 109.869 168.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 39.2 mtt -156.01 156.93 31.05 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 123.589 0.756 . . . . 0.0 110.373 -168.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.23 140.57 22.33 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.801 3.0 . . . . 0.0 111.688 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.8 t -126.37 136.29 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 170.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.0 m -105.57 157.45 6.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 CA-C-N 117.849 0.295 . . . . 0.0 110.526 173.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.401 ' CE2' ' CE1' ' A' ' 95' ' ' PHE . 6.2 t80 -156.72 139.17 14.86 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -170.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -157.8 173.03 17.42 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.743 1.617 . . . . 0.0 109.779 169.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.4 p -129.59 143.39 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 118.743 -0.646 . . . . 0.0 110.229 169.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -76.18 153.59 84.36 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 118.671 0.669 . . . . 0.0 109.588 175.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -58.63 -21.26 54.49 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.325 2.684 . . . . 0.0 112.132 170.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -41.47 -33.85 0.48 Allowed 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 126.637 1.975 . . . . 0.0 113.258 176.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.4 tt -54.53 -42.46 59.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.896 0.771 . . . . 0.0 112.661 175.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.1 m -84.3 54.13 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 119.088 0.858 . . . . 0.0 109.901 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -135.74 -65.52 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 117.637 -1.173 . . . . 0.0 112.252 175.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -74.53 149.47 39.15 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 CA-C-N 121.977 1.742 . . . . 0.0 111.079 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.4 p -64.44 -35.38 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 124.124 0.969 . . . . 0.0 110.75 -174.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -45.45 -48.99 13.8 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.1 1.76 . . . . 0.0 112.245 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.9 p -91.23 -66.53 0.92 Allowed 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 41.56 -72.01 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.693 2.797 . . . . 0.0 115.87 -175.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -87.14 -23.01 42.5 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.319 1.438 . . . . 0.0 111.234 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.9 mm -56.95 126.69 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 117.816 0.808 . . . . 0.0 109.949 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -156.01 58.41 0.59 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.921 172.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.9 m -150.01 88.67 1.54 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 167.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.0 mp -74.64 85.98 2.12 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.5 t -83.68 140.07 32.38 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.634 -1.166 . . . . 0.0 107.867 174.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.9 tt -114.22 103.94 11.6 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 169.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.3 p -86.7 104.83 16.47 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.38 128.91 50.37 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.589 1.556 . . . . 0.0 108.401 -176.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.4 m -114.98 91.55 3.65 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.526 1.131 . . . . 0.0 109.324 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.758 ' CD2' HD13 ' A' ' 45' ' ' LEU . 2.4 m-85 -71.41 88.17 0.88 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.599 1.159 . . . . 0.0 109.638 174.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -155.93 59.64 2.14 Favored Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 174.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.492 ' HD3' HD12 ' A' ' 45' ' ' LEU . 62.6 Cg_endo -79.96 -78.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.936 2.424 . . . . 0.0 111.979 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -146.79 132.72 19.13 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.553 0.615 . . . . 0.0 109.467 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -131.98 135.56 26.81 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 125.867 1.667 . . . . 0.0 106.611 175.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -77.21 -61.93 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.15 1.9 . . . . 0.0 109.97 171.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 41.8 t -176.84 97.67 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.639 1.575 . . . . 0.0 107.708 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' A' ' 61' ' ' GLY . . . . . . . . 0 CA--C 1.512 -0.5 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.0 t -166.23 -136.59 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 144.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -73.03 -27.55 61.83 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.474 1.109 . . . . 0.0 109.413 168.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -68.76 6.47 0.85 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -173.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.435 ' CG1' ' HB3' ' A' ' 24' ' ' ALA . 81.7 mt -58.99 122.14 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 120.847 1.658 . . . . 0.0 110.043 177.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.68 157.21 17.22 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 118.785 0.721 . . . . 0.0 110.999 175.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.67 -27.65 69.06 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.074 0.95 . . . . 0.0 113.03 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -51.76 114.0 1.15 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.97 0.908 . . . . 0.0 111.953 -174.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.63 98.04 8.17 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 127.067 2.147 . . . . 0.0 108.747 -171.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.0 tt -109.13 136.62 44.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 126.277 1.831 . . . . 0.0 110.748 -170.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.9 tptp -98.64 157.53 16.19 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 124.918 1.287 . . . . 0.0 110.897 -168.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.426 HG11 ' CZ ' ' A' ' 37' ' ' PHE . 82.3 t -133.65 160.68 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 C-N-CA 124.306 1.042 . . . . 0.0 108.63 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.4 m -145.46 102.48 3.71 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.615 1.166 . . . . 0.0 109.319 172.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.426 ' CZ ' HG11 ' A' ' 35' ' ' VAL . 90.0 m-85 -78.6 88.56 4.52 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.055 1.342 . . . . 0.0 108.13 175.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -80.06 85.36 5.65 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 121.415 -0.803 . . . . 0.0 109.191 -174.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.82 134.71 34.29 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 121.839 -0.538 . . . . 0.0 111.329 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -144.09 147.01 33.19 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 126.405 1.882 . . . . 0.0 109.66 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.9 t -132.77 147.97 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 125.34 1.456 . . . . 0.0 108.402 177.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -146.96 174.29 11.65 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.031 0.932 . . . . 0.0 109.931 174.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -49.28 121.81 5.36 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 169.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.77 -43.21 1.3 Allowed Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 108.078 -2.009 . . . . 0.0 108.078 -163.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.537 HD13 ' CG ' ' A' ' 144' ' ' PHE . 0.6 OUTLIER -130.74 97.76 20.66 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 123.308 0.643 . . . . 0.0 111.067 177.183 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -84.72 41.71 1.02 Allowed 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.78 2.987 . . . . 0.0 110.271 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.456 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 43.2 m0 -114.77 136.9 52.57 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.601 0.76 . . . . 0.0 109.315 -171.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -79.16 80.81 5.48 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -89.98 89.36 7.68 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 124.238 1.015 . . . . 0.0 108.99 -176.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.9 m -84.81 129.7 55.65 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.22 166.18 30.46 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 121.436 1.424 . . . . 0.0 108.464 161.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.38 -56.21 5.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 123.862 0.865 . . . . 0.0 109.437 -176.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.79 164.44 24.06 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 161.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -63.55 -46.77 84.44 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 165.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -131.04 149.99 52.36 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 126.249 1.819 . . . . 0.0 110.108 -164.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.0 pt -134.81 167.97 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 167.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -110.56 134.24 52.57 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 166.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.0 157.91 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 165.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.5 mtm180 -109.15 114.27 27.84 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.422 HD13 HG21 ' A' ' 60' ' ' ILE . 0.9 OUTLIER -37.8 117.34 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -147.117 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.694 ' O ' ' HB2' ' A' ' 24' ' ' ALA . . . 111.43 -46.36 1.18 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 -172.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -53.63 109.59 0.47 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 117.767 0.784 . . . . 0.0 112.846 -166.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.2 p -56.44 122.03 10.99 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.938 1.295 . . . . 0.0 111.221 172.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.06 137.6 42.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 166.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -77.78 128.56 34.21 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.824 1.25 . . . . 0.0 108.569 167.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.1 pp -146.3 88.6 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.974 0.91 . . . . 0.0 108.971 174.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.93 147.16 41.19 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 121.385 -0.822 . . . . 0.0 110.276 -177.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -98.14 159.24 15.07 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 166.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -135.96 118.51 15.89 Favored 'General case' 0 C--O 1.227 -0.099 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 172.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -110.69 154.89 23.22 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 126.608 1.963 . . . . 0.0 109.081 172.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -154.95 123.74 6.15 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 -176.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.456 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 35.6 t30 -80.77 112.66 18.35 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 119.302 0.956 . . . . 0.0 110.836 -173.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.35 5.1 51.66 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.721 1.208 . . . . 0.0 112.742 -176.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.37 176.79 9.01 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.792 0.724 . . . . 0.0 110.538 175.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.6 t -105.64 20.73 18.43 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.739 0.816 . . . . 0.0 109.96 175.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.2 160.48 30.85 Favored Pre-proline 0 N--CA 1.447 -0.612 0 C-N-CA 127.086 2.154 . . . . 0.0 106.708 -174.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.71 160.44 40.44 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 C-N-CA 121.161 1.241 . . . . 0.0 109.442 172.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.38 164.18 26.25 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-O 120.776 0.322 . . . . 0.0 110.663 166.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.57 95.18 5.21 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.989 2.116 . . . . 0.0 105.693 -177.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.0 96.52 0.78 Allowed Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 107.756 -2.137 . . . . 0.0 107.756 177.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -125.05 50.33 1.77 Allowed 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 169.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.38 176.82 0.32 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.805 0.812 . . . . 0.0 110.872 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -146.04 162.48 37.8 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.91 169.82 17.33 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 123.578 0.751 . . . . 0.0 110.336 -172.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -119.91 111.52 18.04 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 163.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.2 t -95.43 77.59 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.177 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.1 t -176.07 145.55 0.75 Allowed Pre-proline 0 C--O 1.232 0.142 0 C-N-CA 124.153 0.981 . . . . 0.0 110.207 171.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.94 -38.0 40.68 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 121.259 1.306 . . . . 0.0 110.064 158.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.9 ptp 172.02 -68.08 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 127.835 2.454 . . . . 0.0 107.759 174.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.5 -39.5 46.1 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -167.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.74 -104.68 0.04 OUTLIER 'General case' 0 C--O 1.228 -0.055 0 C-N-CA 123.101 0.561 . . . . 0.0 110.427 -174.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.27 -58.78 2.8 Favored Glycine 0 CA--C 1.523 0.55 0 O-C-N 121.855 -0.528 . . . . 0.0 111.853 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -47.64 -48.95 28.52 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.927 0.864 . . . . 0.0 110.613 174.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -74.7 3.96 7.05 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.152 1.381 . . . . 0.0 113.882 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -76.95 107.92 9.63 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 171.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 . . . . . 0 N--CA 1.451 -0.382 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.644 179.365 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.431 HG23 ' H ' ' A' ' 107' ' ' THR . 2.5 t -177.08 -82.15 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.069 1.347 . . . . 0.0 111.504 172.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.431 ' H ' HG23 ' A' ' 106' ' ' THR . 14.8 t -155.47 149.92 26.05 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.962 1.305 . . . . 0.0 108.025 -169.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.1 mt -154.03 127.52 8.62 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 123.873 0.869 . . . . 0.0 109.437 175.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -63.2 158.15 58.02 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 126.401 1.88 . . . . 0.0 110.256 164.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.47 110.53 3.0 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.481 2.121 . . . . 0.0 111.38 -169.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 115.17 -15.75 18.15 Favored Glycine 0 C--N 1.334 0.467 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -77.86 156.32 30.46 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 117.476 0.638 . . . . 0.0 110.873 -174.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.61 153.56 39.15 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.753 1.221 . . . . 0.0 110.687 -167.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 42.4 ttm -149.47 88.58 1.57 Allowed 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.094 1.358 . . . . 0.0 108.687 -168.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -89.72 130.17 36.03 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 118.585 0.629 . . . . 0.0 109.888 164.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -126.48 92.58 44.9 Favored Pre-proline 0 N--CA 1.452 -0.358 0 C-N-CA 125.327 1.451 . . . . 0.0 107.908 -171.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -55.37 126.12 21.45 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.723 2.282 . . . . 0.0 110.184 169.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.1 t -121.57 147.38 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 170.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.8 p -119.75 142.02 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 171.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -145.81 148.79 33.29 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 118.161 0.437 . . . . 0.0 111.147 -172.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -157.88 141.91 15.87 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.55 1.14 . . . . 0.0 110.098 165.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 24.0 t -70.54 134.35 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 164.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.422 ' C ' ' H ' ' A' ' 125' ' ' GLU . 1.5 t70 -88.41 138.55 30.18 Favored Pre-proline 0 N--CA 1.451 -0.406 0 C-N-CA 123.971 0.908 . . . . 0.0 109.939 -173.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -72.02 34.53 0.29 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.09 2.527 . . . . 0.0 114.331 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.422 ' H ' ' C ' ' A' ' 123' ' ' ASP . 37.7 tt0 -107.55 -21.78 12.77 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 130.071 3.348 . . . . 0.0 108.507 172.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.7 tt -58.22 -39.12 72.18 Favored 'Isoleucine or valine' 0 C--N 1.345 0.372 0 O-C-N 121.117 -0.99 . . . . 0.0 111.249 172.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.1 m -77.27 61.62 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 123.37 0.668 . . . . 0.0 109.956 172.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -130.92 -78.48 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 117.359 -1.305 . . . . 0.0 111.403 173.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -73.04 160.21 46.19 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 CA-C-N 122.011 1.754 . . . . 0.0 111.105 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 84.5 t -65.07 -44.66 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 124.553 1.141 . . . . 0.0 109.113 -171.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -48.31 -64.38 0.81 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.335 1.854 . . . . 0.0 110.095 177.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 35.7 p -75.94 -19.96 58.34 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 118.357 -0.83 . . . . 0.0 111.63 -172.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -44.65 -39.31 4.96 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.932 0.787 . . . . 0.0 111.186 168.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -57.72 -54.6 36.01 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 175.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 21.9 mm -64.26 132.4 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 124.6 1.16 . . . . 0.0 111.728 -174.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -158.65 41.57 0.25 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.181 165.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.8 p -140.8 89.64 2.27 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 170.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.4 tp -84.79 144.88 28.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -166.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.5 t -149.61 153.02 36.42 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -176.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.493 ' H ' HD13 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -114.06 145.8 41.1 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 146.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 26.6 t -98.84 116.97 32.28 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 164.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.23 124.9 49.48 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.137 1.375 . . . . 0.0 107.383 178.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.5 m -114.63 89.88 3.2 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.537 ' CG ' HD13 ' A' ' 45' ' ' LEU . 2.1 m-30 -67.53 83.52 0.17 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 170.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.16 50.65 1.16 Allowed Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 178.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.471 ' CD ' HD12 ' A' ' 45' ' ' LEU . 87.9 Cg_endo -74.73 -106.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.264 2.643 . . . . 0.0 110.254 176.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -147.22 123.52 10.93 Favored 'General case' 0 C--N 1.337 0.058 0 CA-C-N 119.363 0.983 . . . . 0.0 109.292 -175.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -111.3 143.67 28.91 Favored Pre-proline 0 N--CA 1.45 -0.463 0 C-N-CA 124.892 1.277 . . . . 0.0 108.353 175.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.0 -51.28 0.17 Allowed 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 121.939 1.759 . . . . 0.0 109.135 171.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 61.8 p -175.75 174.28 2.22 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.282 1.833 . . . . 0.0 107.147 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.4 pttt . . . . . 0 CA--C 1.535 0.377 0 C-N-CA 124.759 1.224 . . . . 0.0 109.201 172.576 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.933 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 t -77.42 23.95 0.2 Allowed 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.174 -1.579 . . . . 0.0 113.456 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -75.9 -30.91 58.96 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 153.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -107.21 -44.54 4.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.614 1.165 . . . . 0.0 112.822 -175.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.1 mt -19.22 115.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 126.432 1.893 . . . . 0.0 115.146 -164.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.561 ' HB2' HD12 ' A' ' 60' ' ' ILE . 5.7 mp -103.78 -178.26 3.61 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.262 -161.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -69.2 -48.12 62.94 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.685 1.994 . . . . 0.0 110.733 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.599 ' HB3' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -60.54 151.08 29.56 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.799 0.809 . . . . 0.0 111.814 -174.779 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.63 98.54 7.69 Favored 'General case' 0 N--CA 1.418 -2.051 0 C-N-CA 127.233 2.213 . . . . 0.0 107.285 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.31 0.0 OUTLIER -80.05 122.04 34.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 170.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.544 ' CE ' ' HB2' ' A' ' 55' ' ' ASP . 2.7 tmtp? -75.87 150.54 37.59 Favored 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.6 t -129.66 143.08 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 172.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.8 m -141.78 98.05 3.27 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -173.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -76.38 159.06 30.84 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.895 -172.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -131.05 84.0 2.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 122.761 1.267 . . . . 0.0 107.916 169.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.35 86.1 7.22 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 164.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -93.36 157.82 16.04 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.496 0.718 . . . . 0.0 109.089 170.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.2 p -140.2 110.98 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 123.499 0.72 . . . . 0.0 109.478 175.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.93 164.32 15.2 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.115 166.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.81 -39.44 8.39 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.921 1.288 . . . . 0.0 112.999 -176.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.19 -26.21 2.15 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.819 1.676 . . . . 0.0 113.985 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.731 HD11 ' HA2' ' A' ' 80' ' ' GLY . 0.3 OUTLIER -121.05 97.18 48.16 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 162.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -82.73 47.54 2.48 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.207 1.938 . . . . 0.0 110.296 -170.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.496 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 43.6 m0 -112.54 148.33 34.72 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.471 1.108 . . . . 0.0 109.502 -170.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -76.79 80.55 3.39 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 175.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -93.29 101.72 13.98 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 124.329 1.052 . . . . 0.0 108.251 -177.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.7 m -101.97 132.47 21.56 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-O 119.26 -0.4 . . . . 0.0 110.058 -172.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.38 141.34 51.04 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 N-CA-C 107.802 -1.653 . . . . 0.0 107.802 162.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.474 HG13 ' H ' ' A' ' 53' ' ' GLN . 13.2 p -77.58 -52.53 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 121.477 0.656 . . . . 0.0 110.031 -177.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.474 ' H ' HG13 ' A' ' 52' ' ' VAL . 3.1 mp0 -127.55 158.96 36.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 104.122 -2.547 . . . . 0.0 104.122 153.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -66.88 -44.91 79.65 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 174.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.544 ' HB2' ' CE ' ' A' ' 34' ' ' LYS . 20.7 p-10 -130.24 167.22 18.8 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 126.361 1.864 . . . . 0.0 111.07 -170.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.8 pt -143.07 175.49 4.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 125.11 1.364 . . . . 0.0 108.114 169.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -119.31 132.33 55.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 169.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.6 m -124.46 126.14 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.638 0.775 . . . . 0.0 108.96 172.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -72.68 77.43 1.1 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 168.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.599 HD11 ' HB3' ' A' ' 31' ' ' GLU . 19.5 mt 28.29 58.54 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 127.877 2.471 . . . . 0.0 111.798 169.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.6 -27.47 2.83 Favored Glycine 0 CA--C 1.523 0.557 0 O-C-N 122.131 -0.355 . . . . 0.0 113.195 -174.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -50.02 118.39 2.88 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.038 0.535 . . . . 0.0 111.342 171.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.4 p -88.94 107.27 18.92 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.338 1.455 . . . . 0.0 109.951 -177.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -96.06 139.07 19.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 174.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.8 120.35 23.94 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 163.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.34 111.05 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.413 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 76.8 mtp -76.49 171.22 14.97 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.39 0.676 . . . . 0.0 110.747 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -141.31 151.14 43.36 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 163.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.4 ttm105 -127.02 139.07 53.28 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 172.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.88 112.16 8.61 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.554 1.942 . . . . 0.0 108.152 173.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.0 mtmt -103.98 130.09 51.6 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.721 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.496 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 52.6 t-20 -78.26 101.97 7.41 Favored 'General case' 0 C--N 1.339 0.12 0 CA-C-N 119.44 1.018 . . . . 0.0 111.512 -176.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.9 mt -91.62 7.92 39.21 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.761 0.824 . . . . 0.0 113.014 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.91 162.94 27.2 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.858 1.208 . . . . 0.0 109.714 171.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.0 p -79.1 -9.21 59.49 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.045 1.338 . . . . 0.0 111.543 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.58 165.2 29.93 Favored Pre-proline 0 N--CA 1.447 -0.603 0 C-N-CA 126.38 1.872 . . . . 0.0 107.686 -168.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -61.27 148.43 92.94 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 121.14 1.226 . . . . 0.0 109.764 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.7 p -126.79 169.52 13.13 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 165.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.3 t -90.32 173.57 8.05 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 159.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.731 ' HA2' HD11 ' A' ' 45' ' ' LEU . . . -170.49 57.07 0.19 Allowed Glycine 0 N--CA 1.438 -1.185 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 176.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.69 -42.56 34.12 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 169.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 64.34 179.24 0.17 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.679 1.192 . . . . 0.0 110.873 174.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.8 m -120.16 136.15 54.72 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 172.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -105.57 148.75 26.94 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.151 0.58 . . . . 0.0 110.354 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -124.66 102.85 7.8 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 156.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.9 t -92.44 59.36 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 124.12 0.968 . . . . 0.0 108.839 -170.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.3 t -171.19 147.29 2.19 Favored Pre-proline 0 N--CA 1.461 0.108 0 O-C-N 121.499 -0.751 . . . . 0.0 111.664 -176.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -64.77 -40.41 22.21 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.381 1.387 . . . . 0.0 109.316 160.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 11.7 ptp 173.73 -71.76 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 127.523 2.329 . . . . 0.0 108.291 173.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.402 ' HB3' HG13 ' A' ' 135' ' ' ILE . . . -69.23 -43.8 73.31 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 123.571 0.748 . . . . 0.0 112.801 -164.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.49 -102.84 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.248 0.619 . . . . 0.0 110.595 -170.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.9 -52.75 1.67 Allowed Glycine 0 CA--C 1.53 1.026 0 CA-C-O 119.425 -0.653 . . . . 0.0 112.809 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -48.3 -50.63 29.33 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.039 1.419 . . . . 0.0 111.016 174.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -72.38 -4.98 33.22 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.082 1.753 . . . . 0.0 113.792 178.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -75.45 108.14 8.05 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 . . . . . 0 N--CA 1.447 -0.581 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.631 -177.493 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.7 mp0 . . . . . 0 N--CA 1.449 -0.504 0 N-CA-C 111.529 0.196 . . . . 0.0 111.529 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . 0.325 5.0 t 57.98 -78.67 0.02 OUTLIER 'General case' 0 C--O 1.232 0.173 0 C-N-CA 126.268 1.827 . . . . 0.0 114.699 165.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.3 m -162.56 142.45 9.5 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 125.83 1.652 . . . . 0.0 107.53 -169.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 26.3 mt -149.67 140.69 22.93 Favored 'General case' 0 C--O 1.232 0.17 0 O-C-N 123.335 0.397 . . . . 0.0 111.255 174.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -52.39 161.45 1.06 Allowed Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 128.91 2.884 . . . . 0.0 111.413 159.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -77.23 125.29 7.72 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.454 2.769 . . . . 0.0 111.602 -173.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.59 -10.82 32.87 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 124.437 1.018 . . . . 0.0 111.167 175.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -79.0 144.77 34.37 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -164.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -93.04 101.18 13.51 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.054 1.742 . . . . 0.0 109.127 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.55 125.39 29.92 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 161.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -146.31 126.66 13.98 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.156 1.382 . . . . 0.0 107.536 172.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 68.1 mtp -148.89 151.43 34.9 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 118.113 0.415 . . . . 0.0 111.002 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 67' ' ' MET . 84.0 Cg_endo -76.1 145.11 27.49 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 123.843 3.029 . . . . 0.0 110.378 165.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.2 t -116.59 156.4 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 155.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.0 m -122.47 141.73 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 171.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -153.9 148.12 25.86 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -171.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -157.62 175.84 13.4 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 128.501 2.72 . . . . 0.0 106.569 173.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 87.5 t -126.64 137.4 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 C-N-CA 123.111 0.564 . . . . 0.0 109.543 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -71.54 144.11 88.42 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 119.557 -0.259 . . . . 0.0 111.213 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -58.82 -25.14 75.23 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.0 2.467 . . . . 0.0 112.891 172.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -43.9 -30.16 0.66 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.663 1.185 . . . . 0.0 113.244 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.0 tt -52.52 -42.02 38.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 175.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.5 m -91.75 55.66 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 118.391 0.541 . . . . 0.0 110.332 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -129.71 -70.33 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.371 0 CA-C-O 117.224 -1.37 . . . . 0.0 111.331 167.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.2 156.77 63.81 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 CA-C-N 121.913 1.719 . . . . 0.0 111.47 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 83.9 t -66.75 -50.73 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.709 0.804 . . . . 0.0 110.076 -169.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -48.26 -45.15 34.1 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 124.616 1.166 . . . . 0.0 111.623 -174.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 61.2 p -92.19 -9.52 42.02 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 118.55 -0.738 . . . . 0.0 112.336 -174.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -50.21 -44.64 53.26 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.048 0.84 . . . . 0.0 111.602 -172.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.23 -24.99 75.55 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 123.388 0.518 . . . . 0.0 112.557 -177.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.402 HG13 ' HB3' ' A' ' 90' ' ' ALA . 13.2 mm -73.8 123.17 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 118.122 0.961 . . . . 0.0 109.773 -176.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -153.39 52.48 0.73 Allowed 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.719 165.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.4 m -146.95 99.7 3.21 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 153.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.81 134.17 38.06 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.3 t -125.48 161.65 26.65 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.6 tt -131.26 112.15 12.54 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 102.263 -3.236 . . . . 0.0 102.263 168.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.5 t -86.47 104.03 15.56 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 167.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.35 97.21 8.94 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.59 86.58 3.91 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 122.416 1.103 . . . . 0.0 108.272 -178.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.616 ' CD2' HD13 ' A' ' 45' ' ' LEU . 3.1 m-85 -68.37 87.67 0.31 Allowed 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 167.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.03 35.9 0.09 OUTLIER Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.91 -79.19 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.977 1.784 . . . . 0.0 113.365 -174.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 71.2 mtm180 -155.94 117.37 3.92 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.815 0.846 . . . . 0.0 109.99 -172.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -88.01 147.86 41.8 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 123.252 0.621 . . . . 0.0 109.73 167.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.52 -47.38 0.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.647 2.231 . . . . 0.0 110.335 172.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.4 p 157.13 82.25 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 128.536 2.734 . . . . 0.0 107.9 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.542 0.662 0 O-C-N 121.615 -0.678 . . . . 0.0 109.177 -171.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.613 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.4 m -70.24 65.73 0.28 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 129.195 2.998 . . . . 0.0 110.536 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -153.79 -56.26 0.11 Allowed 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 130.972 3.709 . . . . 0.0 103.321 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.18 -20.84 19.49 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 116.691 -1.623 . . . . 0.0 113.958 174.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.7 mt -40.47 138.91 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 120.968 1.713 . . . . 0.0 115.064 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -122.41 173.25 7.77 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.505 1.922 . . . . 0.0 110.509 -171.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -86.04 -24.5 26.35 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.753 0.821 . . . . 0.0 112.673 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.93 148.05 22.14 Favored 'General case' 0 C--O 1.231 0.11 0 O-C-N 121.004 -1.06 . . . . 0.0 110.209 174.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -120.02 97.0 5.4 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.24 1.416 . . . . 0.0 108.562 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.9 142.64 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 124.736 1.214 . . . . 0.0 108.779 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.67 148.39 27.44 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.761 1.224 . . . . 0.0 109.099 -174.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.9 t -136.18 111.16 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 -171.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 m -91.82 122.78 34.67 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 173.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -96.01 107.85 20.19 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.629 1.172 . . . . 0.0 108.8 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -96.28 86.93 4.34 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 122.763 1.268 . . . . 0.0 110.027 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.96 136.91 37.38 Favored 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 120.744 -1.222 . . . . 0.0 108.419 173.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.93 146.14 50.24 Favored 'General case' 0 CA--C 1.523 -0.08 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.94 143.1 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.58 166.64 23.06 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.166 1.786 . . . . 0.0 106.983 168.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -42.56 -43.72 3.86 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 124.233 1.013 . . . . 0.0 112.285 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.56 -34.09 0.23 Allowed Glycine 0 CA--C 1.534 1.223 0 C-N-CA 126.214 1.864 . . . . 0.0 114.663 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.18 96.5 49.28 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 119.034 1.417 . . . . 0.0 107.961 162.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -84.73 43.2 1.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 124.095 3.197 . . . . 0.0 109.441 -169.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.424 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 41.1 m0 -115.5 144.42 43.87 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -169.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -76.74 79.93 3.36 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -175.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -89.36 98.44 11.77 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.236 1.014 . . . . 0.0 109.042 -174.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.9 m -102.45 138.21 19.61 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -70.44 163.03 40.28 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 121.622 1.548 . . . . 0.0 108.71 166.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 67' ' ' MET . 2.4 t -80.08 -61.92 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -175.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -131.7 156.99 44.94 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 162.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -23.95 64.99 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.072 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.57 162.59 41.12 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 119.078 0.854 . . . . 0.0 111.029 174.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.2 pt -135.33 166.55 27.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 126.074 1.75 . . . . 0.0 109.33 173.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -111.28 135.55 51.65 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.3 1.84 . . . . 0.0 109.435 164.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -137.42 128.98 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.369 1.867 . . . . 0.0 108.689 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -82.1 82.49 7.65 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 120.699 -1.25 . . . . 0.0 109.5 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.0 mt 17.38 69.58 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 128.768 2.827 . . . . 0.0 112.237 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.45 -25.64 4.76 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.239 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -48.7 108.54 0.18 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.839 0.455 . . . . 0.0 111.471 172.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.1 p -75.11 108.99 8.21 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.064 1.346 . . . . 0.0 109.801 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.8 p -114.57 145.46 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 122.841 0.456 . . . . 0.0 110.284 173.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.38 131.2 34.72 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 124.403 1.081 . . . . 0.0 110.253 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.6 pp -142.88 92.66 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.569 1.148 . . . . 0.0 109.887 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.408 ' O ' HG22 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -78.36 133.22 37.6 Favored 'General case' 0 C--O 1.226 -0.144 0 O-C-N 121.432 -0.792 . . . . 0.0 111.618 -175.595 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -100.53 157.09 16.91 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 66.1 ttp85 -142.06 122.97 14.44 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.907 -0.568 . . . . 0.0 109.945 -175.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.43 154.77 36.1 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.52 1.128 . . . . 0.0 108.281 158.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -145.83 139.46 26.37 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 167.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.424 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 52.9 t-20 -82.8 118.53 23.47 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 120.177 1.353 . . . . 0.0 112.689 -172.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -100.83 -9.39 21.72 Favored 'General case' 0 C--N 1.346 0.442 0 C-N-CA 124.16 0.984 . . . . 0.0 113.222 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.37 142.44 36.01 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 119.857 1.208 . . . . 0.0 108.988 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.6 m -78.37 36.2 0.24 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.5 p -153.39 155.78 31.95 Favored Pre-proline 0 N--CA 1.451 -0.405 0 C-N-CA 125.591 1.557 . . . . 0.0 108.336 175.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.0 145.07 89.37 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 N-CA-C 108.235 -1.486 . . . . 0.0 108.235 169.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.0 p -117.55 178.14 4.5 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 168.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.1 t -124.27 126.43 46.06 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -98.26 109.17 3.75 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 107.167 -2.373 . . . . 0.0 107.167 175.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.58 49.37 1.8 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 162.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 143' ' ' THR . . . -61.82 143.89 55.64 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.375 0.67 . . . . 0.0 111.271 -175.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.12 155.89 27.27 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.754 174.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -151.66 147.22 26.47 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -103.4 100.77 10.65 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 170.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.6 p -89.06 83.52 2.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 CA-C-O 118.079 -0.962 . . . . 0.0 108.41 175.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.2 t 176.97 147.08 0.29 Allowed Pre-proline 0 C--O 1.232 0.162 0 C-N-CA 124.644 1.178 . . . . 0.0 109.496 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -64.26 -39.35 30.59 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 120.666 0.91 . . . . 0.0 110.342 156.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.1 ptp 177.9 -71.67 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.594 1.958 . . . . 0.0 107.976 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.15 -37.47 33.39 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.944 0.898 . . . . 0.0 112.859 -168.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.2 -118.05 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.315 0.646 . . . . 0.0 110.337 -174.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.0 -53.45 2.16 Favored Glycine 0 CA--C 1.526 0.72 0 O-C-N 121.216 -0.928 . . . . 0.0 112.652 -175.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -41.64 -58.86 1.81 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.844 1.258 . . . . 0.0 110.623 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -74.83 -8.61 56.97 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -53.67 117.72 3.36 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.36 0.982 . . . . 0.0 108.585 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 . . . . . 0 N--CA 1.45 -0.453 0 CA-C-O 121.264 0.555 . . . . 0.0 111.398 -159.9 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 CA--C 1.535 0.369 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.2 t 52.67 -143.52 0.7 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.173 0.989 . . . . 0.0 112.593 166.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.2 m -124.8 133.31 53.17 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 127.538 2.335 . . . . 0.0 105.864 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 86.8 mt -122.19 120.14 33.31 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 175.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -56.2 159.73 5.7 Favored Pre-proline 0 N--CA 1.447 -0.591 0 C-N-CA 123.864 0.865 . . . . 0.0 110.541 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -67.12 102.97 0.7 Allowed 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.202 2.601 . . . . 0.0 112.308 -169.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 122.63 -16.22 8.44 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -78.2 148.55 33.98 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 118.001 0.9 . . . . 0.0 110.877 -166.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.4 141.17 36.41 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.385 1.874 . . . . 0.0 109.173 -169.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 46.3 ttp -135.52 82.87 1.98 Allowed 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.621 1.168 . . . . 0.0 109.371 173.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -104.25 113.1 26.42 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.078 1.751 . . . . 0.0 107.725 171.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 40.4 mtm -137.29 126.62 15.26 Favored Pre-proline 0 C--O 1.235 0.337 0 CA-C-N 118.386 0.539 . . . . 0.0 111.748 -170.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -74.73 139.81 25.49 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.618 2.212 . . . . 0.0 112.517 173.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.7 t -128.99 151.04 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.1 p -118.28 142.16 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 170.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -144.53 158.31 43.82 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 118.948 0.795 . . . . 0.0 111.294 -175.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -162.28 168.61 22.03 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 127.671 2.389 . . . . 0.0 106.695 173.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 49.4 t -112.39 145.36 18.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 C-N-CA 124.252 1.021 . . . . 0.0 108.363 174.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -77.04 157.77 80.93 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 123.968 0.907 . . . . 0.0 110.924 -177.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -79.41 -22.65 7.96 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.723 2.282 . . . . 0.0 112.742 166.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -53.74 -37.12 63.03 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.234 1.013 . . . . 0.0 111.516 -171.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.2 tt -40.03 -34.09 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.534 1.934 . . . . 0.0 114.793 171.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.4 m -106.71 22.56 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 119.786 1.175 . . . . 0.0 112.956 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.1 -48.08 0.48 Allowed Pre-proline 0 CA--C 1.545 0.762 0 O-C-N 120.854 -1.154 . . . . 0.0 113.29 167.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -81.15 -165.73 0.36 Allowed 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.345 2.697 . . . . 0.0 110.374 -171.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.7 t -95.22 -51.23 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -31.85 -61.88 0.22 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 129.263 3.025 . . . . 0.0 113.499 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.2 p -92.5 -5.17 52.37 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 123.335 0.654 . . . . 0.0 112.641 -174.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -54.31 107.63 0.29 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.972 0.909 . . . . 0.0 111.295 -169.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 120.92 -27.22 6.54 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 123.98 0.8 . . . . 0.0 111.59 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 45.8 mm -64.7 125.67 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 118.168 0.984 . . . . 0.0 109.692 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -157.07 51.34 0.48 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.582 172.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.42 87.4 2.01 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 167.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.2 tp -88.88 89.31 7.93 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -160.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.6 t -102.01 171.95 7.21 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 122.443 1.116 . . . . 0.0 111.7 -171.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.97 108.33 2.38 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 -160.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.4 t -92.63 116.23 28.82 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 168.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.417 ' HE1' ' HB3' ' A' ' 82' ' ' ALA . 0.6 OUTLIER -114.47 114.23 25.53 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 118.644 0.656 . . . . 0.0 109.579 -179.05 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.466 ' O ' ' HB1' ' A' ' 82' ' ' ALA . 1.4 m -100.63 87.17 3.28 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.392 0.677 . . . . 0.0 111.34 -167.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -67.87 84.16 0.21 Allowed 'General case' 0 CA--C 1.54 0.56 0 O-C-N 122.044 -0.41 . . . . 0.0 110.513 173.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.3 22.39 0.05 OUTLIER Pre-proline 0 CA--C 1.556 1.209 0 N-CA-C 118.448 2.759 . . . . 0.0 118.448 -175.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.87 -81.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.021 2.481 . . . . 0.0 113.424 -168.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.5 ptm85 -155.6 140.78 17.51 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 119.866 1.212 . . . . 0.0 113.102 177.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.62 147.83 44.17 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 125.765 1.626 . . . . 0.0 106.97 175.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.38 -37.02 0.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.371 2.048 . . . . 0.0 113.52 -176.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.8 m 155.26 96.52 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 129.533 3.133 . . . . 0.0 108.653 -174.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 18.2 pttp . . . . . 0 CA--C 1.538 0.484 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.501 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.668 ' HB3' HD11 ' A' ' 28' ' ' ILE . . . . . . . . 0 N--CA 1.447 -0.598 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 83.4 p -153.72 172.93 16.52 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 156.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -79.06 -32.92 45.01 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.955 174.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -87.45 -41.47 13.52 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.279 1.031 . . . . 0.0 111.971 -170.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.668 HD11 ' HB3' ' A' ' 24' ' ' ALA . 61.1 mt 28.32 74.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 126.859 2.063 . . . . 0.0 112.655 -173.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.419 HD22 ' H ' ' A' ' 29' ' ' LEU . 2.3 mm? -70.02 164.72 23.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.696 170.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -65.02 -31.69 73.04 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -176.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.23 129.78 10.29 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 122.276 1.036 . . . . 0.0 113.376 -165.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -91.74 83.28 5.27 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 122.374 1.083 . . . . 0.0 108.513 -169.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.65 120.48 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 171.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.82 170.63 9.54 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.558 1.143 . . . . 0.0 109.193 -170.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.6 t -144.94 146.42 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 169.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.7 m -141.3 104.12 4.55 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -176.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -82.15 125.09 30.49 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 125.596 1.559 . . . . 0.0 110.258 -174.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -102.51 89.05 3.41 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 163.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -99.96 89.11 3.95 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 172.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -111.69 151.32 29.02 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 123.805 0.842 . . . . 0.0 110.415 -171.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.39 105.71 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.985 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.22 150.96 36.98 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 163.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.82 -29.28 4.43 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.595 0.758 . . . . 0.0 112.901 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -36.97 -40.04 0.47 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.605 1.574 . . . . 0.0 113.791 170.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.403 HD21 ' CD2' ' A' ' 47' ' ' TRP . 0.9 OUTLIER -109.32 120.13 46.38 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 162.524 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -84.33 14.62 2.39 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 121.451 1.434 . . . . 0.0 113.553 -169.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.49 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 41.1 m0 -79.25 156.64 28.03 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 121.969 0.89 . . . . 0.0 111.43 -177.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -74.9 138.81 42.66 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 104.262 -2.495 . . . . 0.0 104.262 158.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -143.99 128.87 18.42 Favored 'General case' 0 N--CA 1.458 -0.059 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.2 t -122.95 123.66 26.74 Favored Pre-proline 0 N--CA 1.444 -0.732 0 C-N-CA 125.311 1.444 . . . . 0.0 108.557 -168.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -74.81 146.64 33.73 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 123.958 3.106 . . . . 0.0 107.497 166.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.443 HG21 ' HB ' ' A' ' 66' ' ' ILE . 2.2 t -77.93 -58.59 3.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -170.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -122.51 163.91 19.06 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 103.41 -2.811 . . . . 0.0 103.41 155.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.1 tpt180 -58.07 -47.66 82.51 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 169.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -139.97 165.35 27.57 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 125.63 1.572 . . . . 0.0 110.27 -166.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.4 pt -141.79 162.8 20.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 C-N-CA 124.676 1.19 . . . . 0.0 108.226 175.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -106.4 139.41 40.92 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 162.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.05 81.33 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 175.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.7 mmm-85 -56.94 111.97 1.19 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.723 1.209 . . . . 0.0 110.687 -166.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.477 ' O ' HG22 ' A' ' 60' ' ' ILE . 33.5 mm 16.4 56.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 126.239 1.816 . . . . 0.0 113.185 -160.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.581 ' C ' ' HB1' ' A' ' 24' ' ' ALA . . . 125.45 -73.21 0.43 Allowed Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 22.19 86.52 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.347 2.259 . . . . 0.0 113.555 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.86 119.13 6.16 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.194 0.997 . . . . 0.0 111.541 -169.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.15 152.9 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 123.42 0.688 . . . . 0.0 110.481 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.75 126.09 51.84 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 126.471 1.908 . . . . 0.0 108.013 174.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.443 ' HB ' HG21 ' A' ' 52' ' ' VAL . 1.9 pp -125.36 113.49 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 168.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.87 106.49 10.93 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.27 0.628 . . . . 0.0 112.683 176.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -77.33 149.13 35.33 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 171.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 -139.01 138.28 37.08 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 123.418 0.449 . . . . 0.0 110.473 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.61 171.87 10.75 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.611 1.564 . . . . 0.0 110.046 164.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.6 136.45 15.36 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 177.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.49 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 37.6 t30 -78.12 128.49 33.88 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 120.258 1.39 . . . . 0.0 111.175 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 tp -118.95 26.01 9.82 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.671 1.988 . . . . 0.0 111.885 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -103.96 174.18 5.98 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.805 1.242 . . . . 0.0 110.201 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.3 p -97.06 11.37 36.42 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.043 1.337 . . . . 0.0 111.524 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.41 161.1 42.85 Favored Pre-proline 0 C--O 1.239 0.531 0 C-N-CA 125.071 1.348 . . . . 0.0 107.942 -177.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -56.4 158.7 14.9 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 121.382 1.388 . . . . 0.0 109.877 164.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.431 ' HG1' ' HE1' ' A' ' 47' ' ' TRP . 6.8 p -134.72 -177.83 4.79 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.848 2.459 . . . . 0.0 108.025 -176.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.1 t -138.6 140.46 38.97 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 159.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -94.46 93.73 1.7 Allowed Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 107.255 -2.338 . . . . 0.0 107.255 170.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -112.59 47.04 1.12 Allowed 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 167.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.62 170.4 16.39 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 171.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.5 t -144.6 158.96 43.54 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 166.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -84.9 155.17 21.8 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.242 1.417 . . . . 0.0 109.867 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -109.78 100.44 9.44 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 149.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.8 t -80.7 100.61 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 125.303 1.441 . . . . 0.0 107.477 174.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.6 t 172.27 151.25 0.21 Allowed Pre-proline 0 C--N 1.343 0.293 0 C-N-CA 126.825 2.05 . . . . 0.0 109.055 168.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -66.83 -49.31 1.57 Allowed 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 121.029 1.153 . . . . 0.0 109.584 153.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.1 ptt? -173.55 -72.7 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.989 1.715 . . . . 0.0 107.907 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.46 -40.47 85.35 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -171.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.46 -100.61 0.02 OUTLIER 'General case' 0 C--N 1.339 0.116 0 CA-C-N 117.912 0.324 . . . . 0.0 111.692 -170.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.09 -61.01 1.4 Allowed Glycine 0 CA--C 1.53 0.999 0 CA-C-O 119.447 -0.64 . . . . 0.0 111.799 -172.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.59 -56.67 5.69 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.837 1.255 . . . . 0.0 111.85 -176.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -72.97 5.0 3.6 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.405 1.082 . . . . 0.0 113.917 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -80.02 116.42 20.14 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 173.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 . . . . . 0 N--CA 1.45 -0.459 0 C-N-CA 119.253 -0.979 . . . . 0.0 112.055 -171.008 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . 0.255 6.3 t 50.16 -124.38 2.1 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.358 1.463 . . . . 0.0 111.962 170.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.0 m -145.16 151.28 38.19 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.66 2.384 . . . . 0.0 107.255 -172.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.533 HD11 ' HB2' ' A' ' 114' ' ' MET . 70.5 mt -135.8 132.67 37.0 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 171.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -64.19 158.15 65.95 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 125.04 1.336 . . . . 0.0 109.959 169.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.18 93.68 0.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.712 2.941 . . . . 0.0 112.539 -169.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 140.25 -28.7 2.46 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -77.93 150.55 34.01 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 117.594 0.697 . . . . 0.0 112.531 -155.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -86.18 155.84 20.57 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.82 2.048 . . . . 0.0 110.527 -174.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.533 ' HB2' HD11 ' A' ' 108' ' ' LEU . 19.2 ttm -148.75 89.22 1.67 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.414 1.086 . . . . 0.0 109.417 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -106.89 143.9 34.31 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.167 0.894 . . . . 0.0 110.657 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -150.09 107.63 3.21 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 124.147 0.979 . . . . 0.0 112.33 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.71 108.61 0.27 Allowed 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 124.961 3.774 . . . . 0.0 112.541 165.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.3 t -100.97 117.86 46.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 171.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.8 p -79.19 142.02 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 168.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -154.78 159.33 40.56 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -175.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -177.7 160.79 1.58 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.322 2.249 . . . . 0.0 109.928 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 94.6 t -121.41 131.8 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.6 1.16 . . . . 0.0 109.689 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.1 148.17 38.78 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -176.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -74.76 57.81 4.52 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 124.202 3.268 . . . . 0.0 112.698 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -104.02 -41.67 5.78 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.053 0.941 . . . . 0.0 109.833 162.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.8 tt -47.89 -42.9 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 124.361 1.064 . . . . 0.0 113.846 -169.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.2 m -78.83 51.05 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 O-C-N 121.064 -1.022 . . . . 0.0 111.166 176.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -133.7 -72.28 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 124.796 1.239 . . . . 0.0 111.147 173.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.08 136.75 45.69 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 121.833 1.688 . . . . 0.0 112.675 -175.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 97.6 t -40.6 -53.23 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 126.4 1.88 . . . . 0.0 109.751 178.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -33.19 -47.28 0.19 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 127.893 2.477 . . . . 0.0 113.759 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 35.1 p -106.42 -6.94 17.86 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -173.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -57.7 107.45 0.45 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.379 0.991 . . . . 0.0 111.031 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 132.14 -38.35 1.91 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.035 1.303 . . . . 0.0 109.895 -173.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 23.5 mm -70.17 121.94 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 O-C-N 122.186 -0.597 . . . . 0.0 111.045 -175.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -156.33 54.65 0.56 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 122.086 0.946 . . . . 0.0 111.016 166.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 66.6 m -146.84 93.4 2.27 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 159.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.1 tp -84.62 88.41 7.34 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.388 0.613 . . . . 0.0 109.677 -162.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.6 m -86.27 155.96 20.46 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.055 0.942 . . . . 0.0 110.88 -162.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 14.6 tp -123.06 131.18 53.59 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 170.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.0 p -114.01 107.45 15.69 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 165.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -109.77 91.89 3.83 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.927 0.891 . . . . 0.0 109.261 -175.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.5 p -78.93 93.11 5.0 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.458 0.703 . . . . 0.0 110.004 176.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -59.43 96.0 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 159.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.57 61.31 3.83 Favored Pre-proline 0 CA--C 1.549 0.928 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 172.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -86.94 -99.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 124.123 3.215 . . . . 0.0 110.149 174.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -127.72 133.86 49.55 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 124.47 1.108 . . . . 0.0 110.297 -176.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.86 117.23 42.25 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 126.831 2.052 . . . . 0.0 105.809 174.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.44 -26.77 6.96 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.836 2.358 . . . . 0.0 112.95 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.7 m 140.82 101.73 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 129.553 3.141 . . . . 0.0 108.927 -175.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.518 0 C-N-CA 123.58 0.752 . . . . 0.0 112.845 -178.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.418 0 CA-C-O 119.616 -0.23 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.1 t -146.55 58.43 1.19 Allowed 'General case' 0 C--N 1.344 0.363 0 C-N-CA 130.447 3.499 . . . . 0.0 107.91 13.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -157.24 -54.52 0.08 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.868 2.067 . . . . 0.0 105.677 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.1 mt -27.72 -24.03 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.564 1 C-N-CA 132.658 4.383 . . . . 0.0 116.946 174.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.4 mt -81.6 51.62 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 126.023 1.729 . . . . 0.0 110.649 -160.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.48 164.18 24.96 Favored 'General case' 0 C--N 1.334 -0.101 0 O-C-N 121.348 -0.845 . . . . 0.0 108.742 -176.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -74.86 73.88 2.12 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 122.558 1.17 . . . . 0.0 112.007 -175.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.46 160.37 40.28 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 129.854 3.262 . . . . 0.0 106.624 173.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -146.76 111.46 5.27 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -173.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.82 124.3 72.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -169.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.74 149.12 25.1 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 124.358 1.063 . . . . 0.0 109.336 -176.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.5 t -141.37 96.65 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -171.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.4 m -79.86 107.22 12.47 Favored 'General case' 0 C--O 1.221 -0.422 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 169.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -79.51 166.88 21.49 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 171.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -136.53 90.41 2.55 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 122.137 0.97 . . . . 0.0 111.972 167.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.81 127.25 32.39 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 158.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -132.42 150.87 52.08 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 124.497 1.119 . . . . 0.0 108.248 173.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.97 99.9 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 124.018 0.927 . . . . 0.0 109.339 -178.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.08 169.21 10.81 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.357 0.599 . . . . 0.0 110.058 168.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.29 147.5 35.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 169.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 113.77 -20.6 17.41 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -168.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.56 HD13 ' CD2' ' A' ' 144' ' ' PHE . 0.3 OUTLIER -137.62 95.36 11.29 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 123.77 0.828 . . . . 0.0 109.523 178.046 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -84.31 45.82 1.81 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.679 2.919 . . . . 0.0 110.45 -169.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.497 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 44.4 m0 -113.89 147.03 39.18 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.935 0.894 . . . . 0.0 109.787 -165.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -76.63 81.87 3.28 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 104.588 -2.375 . . . . 0.0 104.588 173.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -90.89 108.83 20.1 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.06 121.54 16.86 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -171.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -81.53 166.3 17.83 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.631 2.221 . . . . 0.0 108.7 168.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.402 ' H ' HG22 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -77.07 -40.41 30.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 122.114 -0.366 . . . . 0.0 111.249 177.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.64 175.26 13.89 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 172.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -60.35 -59.26 5.69 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 167.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -137.32 130.8 31.28 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 122.853 0.461 . . . . 0.0 112.098 -155.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.7 pt -99.86 175.85 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 169.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -126.97 150.89 49.18 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 152.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.6 m -130.35 131.31 65.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . 0.255 4.3 tpt180 -72.62 74.5 1.08 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 167.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.4 pt 15.68 51.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 131.111 3.764 . . . . 0.0 115.286 -176.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.12 -39.44 0.77 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.491 -169.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -36.01 109.58 0.09 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.743 1.217 . . . . 0.0 111.153 168.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.07 99.06 6.75 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.347 1.459 . . . . 0.0 109.068 -168.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 p -76.52 176.39 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.959 0.885 . . . . 0.0 110.809 -171.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.13 89.84 2.38 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 172.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.9 pp -105.48 118.98 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 173.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 89.6 mtp -77.27 140.56 40.09 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -111.73 145.08 39.94 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 168.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -140.86 135.32 31.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.956 0.902 . . . . 0.0 109.962 -177.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.39 90.97 1.7 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.691 1.996 . . . . 0.0 110.033 174.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -79.32 148.34 32.12 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 117.044 -1.455 . . . . 0.0 107.996 172.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.497 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 35.7 t30 -89.82 110.18 21.13 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 120.332 1.424 . . . . 0.0 111.469 172.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.3 tp -86.88 -4.65 59.2 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.379 1.071 . . . . 0.0 112.809 -176.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.2 171.17 14.96 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.397 -0.815 . . . . 0.0 109.873 -175.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.0 m -105.78 18.54 21.99 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.506 175.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.8 p -144.61 160.17 48.6 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 127.411 2.284 . . . . 0.0 106.428 170.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.07 152.77 79.6 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.523 1.482 . . . . 0.0 109.836 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.36 167.12 15.38 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.445 0.641 . . . . 0.0 111.146 166.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.4 t -98.64 168.24 10.29 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 113.888 -1.506 . . . . 0.0 107.834 156.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -145.26 63.8 0.46 Allowed Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 106.345 -2.702 . . . . 0.0 106.345 173.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.39 56.25 3.29 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 -176.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.51 147.66 32.11 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.148 -1.387 . . . . 0.0 111.177 -164.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 m -79.76 160.89 26.02 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 174.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -143.32 138.99 29.9 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 172.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.97 90.59 4.96 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 169.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.6 57.82 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 O-C-N 121.837 -0.539 . . . . 0.0 110.702 -176.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.1 t -171.17 145.0 1.8 Allowed Pre-proline 0 C--N 1.333 -0.144 0 O-C-N 121.538 -0.726 . . . . 0.0 111.484 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.87 -37.38 66.85 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 121.456 1.437 . . . . 0.0 108.763 164.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.5 ptm -179.95 -68.59 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.556 1.942 . . . . 0.0 107.617 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -90.25 -28.61 18.71 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.138 0.975 . . . . 0.0 112.831 -164.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.44 -114.56 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.396 0.278 . . . . 0.0 110.489 -168.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.27 -40.24 0.47 Allowed Glycine 0 CA--C 1.533 1.18 0 O-C-N 121.314 -0.866 . . . . 0.0 114.778 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -51.87 -65.15 0.61 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.11 1.455 . . . . 0.0 108.302 166.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -72.7 29.0 0.06 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.469 2.308 . . . . 0.0 112.173 177.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -105.18 101.3 10.86 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 168.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.8 p30 . . . . . 0 C--N 1.325 -0.491 0 C-N-CA 122.7 0.4 . . . . 0.0 111.313 177.971 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 CA--C 1.54 0.569 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . 0.32 13.2 t 52.5 -71.84 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 117.849 2.537 . . . . 0.0 117.849 161.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -159.65 143.75 14.78 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.592 1.557 . . . . 0.0 109.383 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.6 mt -151.77 140.95 21.32 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.217 1.007 . . . . 0.0 110.273 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.9 mp0 -74.89 161.28 78.27 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 127.085 2.154 . . . . 0.0 110.392 172.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -75.51 111.11 3.23 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.74 1.626 . . . . 0.0 113.21 -165.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 115.13 -12.13 19.8 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 176.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -85.77 152.09 23.31 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.2 -161.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -107.6 122.37 46.55 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.75 1.22 . . . . 0.0 109.311 -160.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.73 112.7 17.04 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 124.597 1.159 . . . . 0.0 110.213 177.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -143.05 145.87 33.3 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.759 0.709 . . . . 0.0 110.176 160.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 23.5 ptm -156.3 156.27 30.0 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-O 119.135 -0.46 . . . . 0.0 111.051 173.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.89 148.23 81.88 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.374 2.716 . . . . 0.0 111.996 171.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.6 t -126.23 134.6 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.93 1.692 . . . . 0.0 106.878 167.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.6 p -100.02 143.96 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.999 1.32 . . . . 0.0 108.015 174.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -158.95 146.85 17.85 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -176.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -164.77 95.34 0.71 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.034 0.533 . . . . 0.0 111.81 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.2 t -40.64 130.71 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 125.936 1.694 . . . . 0.0 112.99 -173.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.3 119.71 77.28 Favored Pre-proline 0 N--CA 1.44 -0.968 0 C-N-CA 125.277 1.431 . . . . 0.0 107.283 -169.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.13 55.8 4.67 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.147 2.565 . . . . 0.0 111.823 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -109.5 -28.68 8.78 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.997 2.119 . . . . 0.0 109.523 169.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.4 tt -54.98 -42.98 67.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -173.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.6 m -78.09 51.89 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 118.78 0.718 . . . . 0.0 111.037 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -139.42 -69.59 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.901 -177.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -73.48 152.41 48.9 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.295 1.996 . . . . 0.0 113.449 -175.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.5 p -55.27 -30.91 25.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.136 1.374 . . . . 0.0 111.886 175.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -36.23 -55.3 0.8 Allowed 'General case' 0 C--N 1.339 0.115 0 C-N-CA 126.691 1.996 . . . . 0.0 112.311 173.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.4 p -108.58 -54.93 2.45 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.121 -163.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 26.67 51.84 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.382 2.673 . . . . 0.0 115.229 169.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 144.57 -40.58 1.15 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -170.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 35.0 mm -55.64 119.55 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 169.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.96 45.35 0.39 Allowed 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 123.711 0.632 . . . . 0.0 109.737 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.43 91.6 1.99 Allowed 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 171.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.1 mp -76.07 150.06 37.36 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -172.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.7 t -148.21 175.57 10.95 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -178.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.5 tt -154.32 110.3 3.22 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 174.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.8 t -87.82 95.96 10.28 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.19 92.88 6.37 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -174.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.14 89.33 5.99 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 122.245 1.021 . . . . 0.0 110.584 -170.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.56 ' CD2' HD13 ' A' ' 45' ' ' LEU . 4.1 m-30 -78.14 98.19 5.73 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.733 173.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -153.05 37.66 0.11 Allowed Pre-proline 0 CA--C 1.552 1.032 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 172.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.54 ' CD ' HD12 ' A' ' 45' ' ' LEU . 69.6 Cg_endo -72.8 -90.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.694 0 CA-C-N 122.033 1.762 . . . . 0.0 113.557 -174.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 31.9 mtt85 -148.58 110.12 4.45 Favored 'General case' 0 C--N 1.34 0.187 0 O-C-N 121.352 -0.843 . . . . 0.0 109.211 -174.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -97.26 122.07 56.96 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 172.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -79.46 -51.68 0.06 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.55 2.167 . . . . 0.0 110.512 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 44.6 p -171.67 111.23 0.31 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.993 -0.527 . . . . 0.0 109.587 -167.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.7 pttm . . . . . 0 CA--C 1.538 0.506 0 C-N-CA 123.362 0.665 . . . . 0.0 112.398 172.621 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.624 ' N ' ' HG1' ' A' ' 63' ' ' THR . . . . . . . . 0 N--CA 1.446 -0.639 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.8 t -164.7 47.03 0.1 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.377 1.071 . . . . 0.0 109.822 -171.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -156.4 -51.39 0.08 Allowed 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 124.494 1.118 . . . . 0.0 108.372 -175.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.31 -27.73 69.23 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.782 175.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.531 ' C ' HD13 ' A' ' 29' ' ' LEU . 3.6 mt -80.81 131.73 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 C-N-CA 123.731 0.812 . . . . 0.0 112.165 -161.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.531 HD13 ' C ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -114.94 148.97 38.02 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 171.18 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -78.26 67.29 4.03 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 122.128 0.966 . . . . 0.0 112.154 -167.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.405 ' OE2' ' NZ ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -103.56 -169.54 1.66 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 129.556 3.142 . . . . 0.0 106.381 175.397 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -145.31 137.13 25.48 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.305 -0.872 . . . . 0.0 110.217 168.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.556 HD12 HG21 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -132.42 103.67 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 C-N-CA 126.162 1.785 . . . . 0.0 106.65 -177.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -79.4 131.1 36.0 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -177.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.421 HG11 ' CE1' ' A' ' 120' ' ' PHE . 52.1 t -113.1 132.76 61.03 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -177.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.2 m -106.7 101.53 10.97 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.299 1.44 . . . . 0.0 109.235 -173.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -79.05 84.22 5.07 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -171.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -84.19 83.61 7.91 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 122.931 1.348 . . . . 0.0 111.447 -172.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.74 123.49 31.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.699 176.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -131.22 142.87 50.23 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 173.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.7 t -135.78 141.91 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -117.71 157.09 27.12 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 161.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.95 -33.14 7.29 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.812 0.845 . . . . 0.0 112.299 -175.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -31.21 -44.69 0.11 Allowed Glycine 0 CA--C 1.531 1.089 0 C-N-CA 126.828 2.156 . . . . 0.0 114.323 165.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.646 HD13 ' CD2' ' A' ' 144' ' ' PHE . 0.5 OUTLIER -102.37 108.57 57.79 Favored Pre-proline 0 N--CA 1.454 -0.225 0 CA-C-N 119.475 1.638 . . . . 0.0 107.008 161.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.76 -3.51 12.41 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 121.148 1.232 . . . . 0.0 113.3 -164.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.512 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 47.6 m0 -73.34 154.73 39.98 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.591 1.156 . . . . 0.0 111.297 -167.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -76.6 81.75 3.26 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 171.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -95.65 124.42 39.66 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.6 m -125.8 138.08 31.3 Favored Pre-proline 0 CA--C 1.532 0.256 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -70.18 161.47 45.88 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 N-CA-C 108.377 -1.432 . . . . 0.0 108.377 161.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -77.78 -46.73 26.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 175.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.77 174.81 14.77 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 166.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -67.11 -33.42 75.43 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.118 0.417 . . . . 0.0 111.836 -174.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.76 161.72 39.78 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.025 0.93 . . . . 0.0 110.346 -171.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.5 pt -130.37 160.28 41.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 172.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -106.65 95.37 5.69 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.221 1.008 . . . . 0.0 109.359 168.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.2 t -77.54 167.35 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 168.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 23.1 mtm180 -128.35 98.47 5.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 171.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.1 pt 9.05 69.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 127.76 2.424 . . . . 0.0 114.725 -175.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.27 -34.26 2.74 Favored Glycine 0 C--O 1.22 -0.768 0 C-N-CA 124.807 1.194 . . . . 0.0 111.33 173.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -50.08 106.52 0.12 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 118.83 1.315 . . . . 0.0 112.245 -166.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.624 ' HG1' ' N ' ' A' ' 24' ' ' ALA . 87.2 m -67.82 108.94 3.17 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.648 1.179 . . . . 0.0 111.359 -171.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.1 p -86.81 176.48 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 123.299 0.64 . . . . 0.0 110.322 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -124.52 129.97 51.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.819 0.848 . . . . 0.0 109.471 161.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.5 pp -139.45 96.12 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.655 1.182 . . . . 0.0 110.661 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 35.7 ttm -77.59 100.05 5.97 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.934 0.894 . . . . 0.0 111.342 -174.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -77.65 164.52 25.23 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.886 -0.509 . . . . 0.0 110.92 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.8 ttm105 -144.94 138.39 26.85 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.542 1.137 . . . . 0.0 111.799 -177.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.19 149.51 48.96 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 130.041 3.336 . . . . 0.0 107.608 159.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -137.17 135.62 37.49 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 161.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.512 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 0.1 OUTLIER -79.89 83.6 5.79 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.644 1.111 . . . . 0.0 111.301 -172.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.42 75.98 8.36 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.923 1.289 . . . . 0.0 108.902 171.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.06 158.62 44.16 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 167.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.1 t -87.6 -1.22 57.8 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 119.148 -0.453 . . . . 0.0 111.88 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.11 160.83 41.79 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.788 1.235 . . . . 0.0 109.076 -175.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.37 139.93 32.66 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.18 2.587 . . . . 0.0 111.902 -170.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.3 p -105.59 -176.07 2.97 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.393 1.877 . . . . 0.0 110.69 -169.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.4 t -148.39 136.05 20.69 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 160.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -123.42 76.01 0.37 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -170.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.86 33.21 1.05 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.495 0.718 . . . . 0.0 110.812 -171.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.51 162.11 29.91 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.365 0.602 . . . . 0.0 111.733 -162.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.4 t -144.44 178.06 8.21 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.288 0.635 . . . . 0.0 109.802 175.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.17 164.85 26.75 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 125.955 1.702 . . . . 0.0 110.973 -167.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -120.82 86.73 2.62 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.927 1.691 . . . . 0.0 107.103 174.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.56 HG11 ' CD2' ' A' ' 95' ' ' PHE . 3.2 t -82.31 54.47 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.823 -164.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.2 t -171.47 143.21 1.48 Allowed Pre-proline 0 N--CA 1.457 -0.112 0 O-C-N 121.393 -0.817 . . . . 0.0 110.317 -169.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.02 -36.43 30.14 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 121.695 1.597 . . . . 0.0 108.044 169.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.5 ptp 177.31 -68.26 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 127.824 2.449 . . . . 0.0 106.745 176.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.87 -48.33 69.12 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.719 1.208 . . . . 0.0 113.055 -165.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.27 -102.3 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.669 -162.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.23 -61.04 0.25 Allowed Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.498 -0.612 . . . . 0.0 113.352 -173.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -45.59 -50.79 12.84 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.004 1.322 . . . . 0.0 111.216 177.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -72.93 5.19 3.45 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.906 1.283 . . . . 0.0 113.632 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.56 ' CD2' HG11 ' A' ' 86' ' ' VAL . 9.6 t80 -72.35 131.39 42.58 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 121.098 -1.001 . . . . 0.0 109.8 174.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 . . . . . 0 N--CA 1.44 -0.954 0 C-N-CA 119.822 -0.751 . . . . 0.0 112.878 172.215 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 . . . . . 0 CA--C 1.538 0.495 0 CA-C-O 120.758 0.313 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.9 t 42.99 -145.17 0.08 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.104 1.762 . . . . 0.0 112.989 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -119.22 124.66 47.28 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 127.586 2.354 . . . . 0.0 106.101 177.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.453 HD11 ' HG3' ' A' ' 114' ' ' MET . 97.3 mt -106.3 151.52 24.73 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 173.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.421 ' HB3' ' HD2' ' A' ' 110' ' ' PRO . 17.7 mt-10 -91.97 163.76 26.25 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 126.012 1.725 . . . . 0.0 108.394 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 109' ' ' GLU . 69.8 Cg_endo -70.73 79.88 1.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.647 2.898 . . . . 0.0 112.272 -167.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 157.85 -29.87 0.49 Allowed Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.821 -175.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -76.29 135.18 39.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.573 1.187 . . . . 0.0 112.034 -153.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -86.83 137.6 32.27 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.295 1.438 . . . . 0.0 110.57 -178.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.453 ' HG3' HD11 ' A' ' 108' ' ' LEU . 1.7 mmt -133.9 85.53 2.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.088 1.355 . . . . 0.0 109.532 176.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.68 128.25 45.12 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.35 0.66 . . . . 0.0 109.444 173.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 84.9 mtp -150.98 147.54 20.96 Favored Pre-proline 0 C--O 1.234 0.241 0 C-N-CA 123.399 0.68 . . . . 0.0 109.812 -165.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.18 146.28 63.25 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.785 2.323 . . . . 0.0 110.44 174.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.7 t -144.32 147.51 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.0 m -109.34 164.59 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 174.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.421 ' CE1' HG11 ' A' ' 35' ' ' VAL . 4.1 t80 -156.1 129.49 8.22 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.65 168.83 23.13 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 122.904 0.482 . . . . 0.0 110.476 168.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.556 HG21 HD12 ' A' ' 33' ' ' ILE . 18.2 t -119.14 129.46 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.809 1.243 . . . . 0.0 109.709 176.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.89 133.54 58.19 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 118.923 0.783 . . . . 0.0 110.249 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -56.34 -23.03 44.29 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.328 2.685 . . . . 0.0 114.767 -171.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -56.75 -13.68 2.72 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 119.182 0.901 . . . . 0.0 112.861 176.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.4 tt -46.05 -42.32 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 O-C-N 121.087 -1.008 . . . . 0.0 111.718 165.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.2 m -87.09 63.15 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 119.372 0.987 . . . . 0.0 110.9 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 51.8 mttt -130.27 -67.8 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 124.184 0.994 . . . . 0.0 112.345 164.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -85.27 162.66 11.34 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 121.8 1.666 . . . . 0.0 114.188 -160.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 99.2 t -53.96 -35.1 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 125.754 1.622 . . . . 0.0 110.874 176.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -38.54 -57.12 1.2 Allowed 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.475 1.51 . . . . 0.0 111.169 173.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 14.1 p -102.8 -53.45 2.85 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 123.965 0.906 . . . . 0.0 109.197 -163.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 26.15 55.34 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.152 2.581 . . . . 0.0 115.175 174.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 134.99 -36.98 1.99 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -176.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.1 mm -51.43 125.97 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 123.182 0.593 . . . . 0.0 109.864 173.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.405 ' NZ ' ' OE2' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -156.4 49.57 0.49 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.78 0.832 . . . . 0.0 109.79 175.726 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.18 89.91 1.77 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -178.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.431 HD22 HG22 ' A' ' 122' ' ' VAL . 2.0 mp -76.44 162.25 28.0 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 122.294 1.045 . . . . 0.0 108.81 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.4 t -155.03 178.79 9.8 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.94 88.53 1.47 Allowed 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 124.471 1.107 . . . . 0.0 109.029 165.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.1 t -75.72 107.26 7.77 Favored 'General case' 0 N--CA 1.457 -0.093 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -178.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -112.67 137.05 51.52 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 122.775 0.43 . . . . 0.0 109.888 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 32.2 m -118.45 91.51 3.58 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.532 1.533 . . . . 0.0 107.82 177.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.646 ' CD2' HD13 ' A' ' 45' ' ' LEU . 3.5 m-85 -72.27 97.72 2.05 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.946 178.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -156.11 58.28 1.71 Allowed Pre-proline 0 CA--C 1.551 1.018 0 N-CA-C 116.894 2.183 . . . . 0.0 116.894 -177.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.415 ' HD3' HD12 ' A' ' 45' ' ' LEU . 74.5 Cg_endo -80.68 -90.8 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.424 2.749 . . . . 0.0 112.445 175.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.17 104.97 2.85 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.658 0.663 . . . . 0.0 111.631 -171.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -79.3 140.12 56.4 Favored Pre-proline 0 N--CA 1.449 -0.522 0 O-C-N 121.547 -0.721 . . . . 0.0 109.173 174.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -84.35 60.17 6.08 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 121.981 1.787 . . . . 0.0 107.711 169.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 19.9 m 44.39 81.27 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.88 2.072 . . . . 0.0 113.514 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.7 pttt . . . . . 0 CA--C 1.543 0.677 0 CA-C-N 119.026 0.83 . . . . 0.0 112.111 -170.001 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.468 ' CB ' ' H ' ' A' ' 63' ' ' THR . . . . . . . . 0 N--CA 1.422 -1.845 0 N-CA-C 104.165 -2.532 . . . . 0.0 104.165 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.3 m -157.27 25.71 0.3 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -159.26 -55.13 0.06 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 -174.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.62 37.26 0.86 Allowed 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 112.699 -2.046 . . . . 0.0 110.892 -161.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.406 HD11 ' C ' ' A' ' 24' ' ' ALA . 7.8 mt -111.85 107.7 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 122.745 0.418 . . . . 0.0 109.895 -168.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -103.49 140.98 36.77 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.22 -29.85 34.69 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.516 1.926 . . . . 0.0 113.857 -169.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.09 148.6 6.03 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.953 1.301 . . . . 0.0 110.648 -178.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.5 mmmt -120.48 89.33 3.11 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.891 1.676 . . . . 0.0 108.677 -158.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.45 141.83 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 123.42 0.688 . . . . 0.0 110.348 -176.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -99.14 145.8 26.8 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.509 1.524 . . . . 0.0 108.54 -172.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.1 t -136.14 98.12 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 -173.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.6 m -88.12 105.76 17.71 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -83.74 109.23 17.33 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.651 1.18 . . . . 0.0 108.202 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -107.01 86.24 2.28 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.553 0.692 . . . . 0.0 110.055 -173.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.96 112.2 23.05 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.453 -0.78 . . . . 0.0 110.382 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -111.65 122.21 47.21 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.117 0.967 . . . . 0.0 109.668 -177.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.6 t -100.46 108.76 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 170.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.14 154.65 31.03 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 162.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.45 -38.28 8.9 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.42 0.688 . . . . 0.0 111.655 177.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -39.15 -34.77 0.36 Allowed Glycine 0 CA--C 1.53 1.031 0 C-N-CA 126.992 2.234 . . . . 0.0 114.694 172.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.445 HD21 ' CE3' ' A' ' 47' ' ' TRP . 0.4 OUTLIER -108.95 101.1 43.07 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 119.567 1.684 . . . . 0.0 108.497 165.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -83.37 46.19 2.04 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.877 3.051 . . . . 0.0 110.857 -170.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.522 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 44.7 m0 -116.06 157.13 25.17 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 125.034 1.334 . . . . 0.0 108.735 -172.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -74.3 141.66 45.26 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 162.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -147.44 113.82 5.94 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 169.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.0 t -100.15 111.4 62.19 Favored Pre-proline 0 N--CA 1.439 -1.011 0 C-N-CA 127.036 2.134 . . . . 0.0 107.058 -172.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -62.77 146.67 95.16 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.533 2.156 . . . . 0.0 107.757 167.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -75.79 -46.8 34.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -170.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.82 165.97 32.86 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 152.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -57.42 -41.1 79.72 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 118.366 0.53 . . . . 0.0 111.048 -174.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.95 158.36 43.87 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 122.95 0.5 . . . . 0.0 110.223 -176.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.4 pt -126.62 168.4 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 C-N-CA 123.461 0.705 . . . . 0.0 109.613 168.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -95.47 146.35 24.49 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 154.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.25 141.23 45.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 104.183 -2.525 . . . . 0.0 104.183 156.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -64.47 164.91 10.71 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 120.541 1.519 . . . . 0.0 107.774 160.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.422 HG22 ' HB3' ' A' ' 124' ' ' PRO . 3.8 mm -63.74 91.61 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.9 33.22 5.33 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.802 1.667 . . . . 0.0 113.783 178.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -102.3 107.02 17.92 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.034 1.417 . . . . 0.0 112.694 176.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.468 ' H ' ' CB ' ' A' ' 24' ' ' ALA . 15.9 m -66.71 113.7 5.04 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.114 1.366 . . . . 0.0 111.318 177.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.1 p -126.51 146.69 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 118.45 0.568 . . . . 0.0 110.373 169.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.21 137.96 31.93 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 125.516 1.526 . . . . 0.0 110.552 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -141.94 97.71 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 17.1 tmm? -78.92 126.56 30.86 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.936 1.294 . . . . 0.0 111.678 -176.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -102.35 143.91 31.5 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.829 1.252 . . . . 0.0 109.682 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 42.8 ttt85 -126.24 141.19 52.02 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 125.025 1.33 . . . . 0.0 109.283 -176.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.91 166.15 27.63 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.284 1.833 . . . . 0.0 109.903 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -153.95 147.76 25.4 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.308 1.043 . . . . 0.0 108.738 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.522 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 46.2 t-20 -83.95 115.75 22.46 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 119.879 1.218 . . . . 0.0 111.215 175.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 81.5 mt -106.75 16.32 24.57 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.621 1.169 . . . . 0.0 112.582 -178.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.28 164.76 12.9 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.416 -0.802 . . . . 0.0 109.726 169.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.0 m -96.83 30.02 2.82 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.864 176.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.3 p -149.57 161.3 32.12 Favored Pre-proline 0 N--CA 1.448 -0.528 0 C-N-CA 125.082 1.353 . . . . 0.0 108.363 178.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.72 121.55 8.25 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 121.555 1.503 . . . . 0.0 109.032 170.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.5 159.3 15.26 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.334 0.587 . . . . 0.0 110.885 171.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.9 t -97.93 158.63 15.42 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 162.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -153.15 77.79 0.21 Allowed Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 105.366 -3.094 . . . . 0.0 105.366 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.52 66.26 0.68 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 175.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.19 168.34 19.32 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.482 -166.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 35.3 m -106.39 159.15 16.36 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -147.77 143.91 27.86 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.958 -0.464 . . . . 0.0 110.341 171.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.98 101.26 12.7 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 166.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.6 p -87.7 81.17 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.0 t 176.54 150.72 0.34 Allowed Pre-proline 0 CA--C 1.529 0.164 0 C-N-CA 125.556 1.542 . . . . 0.0 109.15 178.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.65 -35.21 22.92 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 CA-C-N 119.364 0.809 . . . . 0.0 110.383 157.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.5 ptp 176.68 -67.05 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 127.163 2.185 . . . . 0.0 107.545 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.18 -41.75 33.66 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -169.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.33 -104.07 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.88 0.372 . . . . 0.0 111.816 -166.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.14 -54.67 0.59 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 123.925 0.774 . . . . 0.0 113.26 -172.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -47.25 -52.83 14.95 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.987 1.394 . . . . 0.0 110.927 176.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -74.22 10.21 1.34 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.401 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . 29.5 t80 -81.86 98.48 8.53 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 172.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 . . . . . 0 N--CA 1.452 -0.352 0 C-N-CA 117.66 -1.616 . . . . 0.0 109.752 179.541 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.2 pm0 . . . . . 0 CA--C 1.541 0.611 0 CA-C-O 120.569 0.223 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.4 -70.34 0.13 Allowed 'General case' 0 CA--C 1.529 0.163 0 O-C-N 121.623 -0.673 . . . . 0.0 112.121 178.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.1 t -157.46 146.87 20.09 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.186 0.994 . . . . 0.0 108.73 -176.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.6 mt -150.44 136.1 18.2 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.764 0.711 . . . . 0.0 110.589 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -76.29 163.65 64.98 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.487 1.115 . . . . 0.0 109.967 174.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.42 106.1 1.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.242 1.961 . . . . 0.0 111.651 -163.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 111.58 -3.05 27.73 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 124.098 0.856 . . . . 0.0 111.24 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -76.6 146.14 38.46 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 118.368 1.084 . . . . 0.0 110.888 -173.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -97.09 147.24 24.24 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.669 1.188 . . . . 0.0 109.25 -176.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 17.2 ttt -150.95 111.42 4.2 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 118.734 -0.651 . . . . 0.0 111.169 -173.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -132.28 146.55 52.07 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 119.74 1.155 . . . . 0.0 111.249 172.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 19.1 mmt -142.63 138.55 16.32 Favored Pre-proline 0 C--O 1.235 0.32 0 C-N-CA 125.18 1.392 . . . . 0.0 109.63 -171.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.89 144.3 27.29 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 121.933 1.756 . . . . 0.0 110.183 171.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.4 t -124.26 158.87 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 164.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.2 p -145.83 146.3 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -154.38 146.59 23.78 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -165.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -160.08 156.0 26.14 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 128.119 2.568 . . . . 0.0 108.776 164.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.6 p -78.45 150.31 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 O-C-N 121.796 -0.565 . . . . 0.0 109.672 171.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -82.64 125.42 75.92 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.175 167.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.422 ' HB3' HG22 ' A' ' 60' ' ' ILE . 37.9 Cg_endo -70.92 41.77 0.4 Allowed 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.672 2.914 . . . . 0.0 115.775 -177.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -112.7 -21.2 11.35 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 125.718 1.607 . . . . 0.0 111.036 168.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 16.2 tt -43.48 -41.76 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 119.691 1.132 . . . . 0.0 113.572 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.8 m -76.46 61.61 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 O-C-N 121.815 -0.553 . . . . 0.0 111.341 172.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -137.51 -66.09 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 117.698 -1.144 . . . . 0.0 113.05 170.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -76.91 154.39 33.63 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 CA-C-N 121.802 1.679 . . . . 0.0 113.638 -169.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.4 t -54.93 -37.1 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 125.76 1.624 . . . . 0.0 110.826 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -52.58 -47.13 67.07 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.87 1.268 . . . . 0.0 111.829 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 35.4 p -91.85 -51.57 5.16 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -173.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 15.77 60.71 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 129.278 3.031 . . . . 0.0 115.911 175.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 136.29 -33.92 2.31 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-O 119.143 -0.81 . . . . 0.0 111.77 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 10.2 mm -51.07 128.27 8.39 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 C-N-CA 124.302 1.041 . . . . 0.0 110.433 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -157.76 48.22 0.39 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.43 0.692 . . . . 0.0 111.005 176.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.3 p -140.7 88.49 2.19 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 175.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' A' ' 95' ' ' PHE . 2.1 tp -88.06 84.93 6.9 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 118.899 -1.121 . . . . 0.0 109.026 -160.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.2 m -87.95 143.51 27.06 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.879 -169.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.5 tt -116.36 118.23 32.16 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 160.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.3 t -98.29 102.6 14.39 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 173.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.01 129.47 34.87 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.291 1.436 . . . . 0.0 107.559 -177.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.4 p -114.74 93.48 4.34 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.13 1.372 . . . . 0.0 109.212 174.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -76.18 95.52 3.71 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 167.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.69 46.67 0.3 Allowed Pre-proline 0 CA--C 1.556 1.174 0 N-CA-C 117.369 2.359 . . . . 0.0 117.369 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.39 -83.36 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.538 2.826 . . . . 0.0 113.013 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -149.29 136.68 20.1 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 118.904 0.774 . . . . 0.0 110.295 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -117.3 139.26 25.81 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 164.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -84.16 -52.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 121.917 1.745 . . . . 0.0 108.793 169.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.5 m -169.89 150.99 3.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.667 2.387 . . . . 0.0 106.676 177.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 12.9 pttt . . . . . 0 CA--C 1.535 0.381 0 C-N-CA 125.464 1.506 . . . . 0.0 108.54 174.602 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.065 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -113.85 36.26 3.74 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.952 0.901 . . . . 0.0 110.741 -169.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -159.81 -51.22 0.05 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.936 2.094 . . . . 0.0 107.051 -174.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.9 mt -72.13 -7.13 47.33 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.831 -168.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.6 mt -78.24 70.78 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 O-C-N 120.687 -1.258 . . . . 0.0 109.242 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.452 HD13 ' N ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -85.14 167.84 15.38 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 169.329 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -81.51 56.03 2.83 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 120.745 -1.222 . . . . 0.0 114.217 -166.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -113.74 104.54 12.31 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 122.788 1.28 . . . . 0.0 109.718 167.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.2 tttp -76.38 85.19 3.14 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 169.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.1 tp -83.52 162.88 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 174.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.44 150.22 46.25 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -167.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 81.0 t -142.85 126.28 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -172.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.5 m -95.56 109.02 21.31 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.499 1.52 . . . . 0.0 107.632 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.809 ' CE1' HD12 ' A' ' 56' ' ' ILE . 15.3 m-85 -81.21 131.67 35.31 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.839 1.256 . . . . 0.0 109.133 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -126.87 86.68 2.54 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 122.786 1.279 . . . . 0.0 110.378 -170.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.24 105.76 18.0 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.153 -0.967 . . . . 0.0 109.937 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -109.19 147.16 32.98 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 176.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.1 p -140.46 148.31 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.399 1.08 . . . . 0.0 108.166 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.69 168.95 18.32 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 167.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.62 -31.41 16.0 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -170.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.62 -34.82 3.88 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.217 1.389 . . . . 0.0 113.385 172.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.621 HD13 ' CD2' ' A' ' 144' ' ' PHE . 0.5 OUTLIER -119.16 91.06 43.05 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 167.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -80.77 55.25 5.6 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.387 2.725 . . . . 0.0 109.255 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.519 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 41.4 m0 -114.65 147.86 38.99 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.609 1.163 . . . . 0.0 109.257 -174.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -75.47 80.42 2.51 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -89.49 100.0 12.89 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.868 0.867 . . . . 0.0 109.306 -170.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.1 t -103.43 122.08 46.27 Favored Pre-proline 0 N--CA 1.443 -0.817 0 C-N-CA 124.027 0.931 . . . . 0.0 109.6 -168.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -75.46 138.08 21.51 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 123.648 2.899 . . . . 0.0 107.8 163.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.2 t -79.69 -46.73 22.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.572 0.701 . . . . 0.0 109.407 -173.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -149.25 150.36 32.44 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.528 1.931 . . . . 0.0 106.772 173.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -61.77 -36.68 81.75 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 123.814 0.696 . . . . 0.0 110.617 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -146.68 151.12 36.71 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 122.652 0.381 . . . . 0.0 111.208 -174.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.809 HD12 ' CE1' ' A' ' 37' ' ' PHE . 64.5 mt -122.57 137.91 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 127.0 2.12 . . . . 0.0 106.866 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -98.42 152.43 19.5 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.238 1.015 . . . . 0.0 109.39 164.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -154.08 127.33 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 -170.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.9 mmt85 -74.75 86.84 2.2 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 166.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.7 pt 7.57 64.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 128.206 2.602 . . . . 0.0 115.008 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.79 -35.63 1.49 Allowed Glycine 0 CA--C 1.522 0.523 0 O-C-N 121.915 -0.491 . . . . 0.0 112.807 -174.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 62.7 tt0 -42.57 107.79 0.09 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.172 1.389 . . . . 0.0 111.999 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.56 102.76 8.09 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.425 1.09 . . . . 0.0 110.129 -177.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.0 p -76.31 178.74 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 122.036 0.922 . . . . 0.0 111.505 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.16 89.06 2.4 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 124.426 1.09 . . . . 0.0 108.676 168.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.751 HG12 HD11 ' A' ' 56' ' ' ILE . 2.5 pp -100.36 134.22 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 168.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 65.0 mtt -98.32 100.36 11.63 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 126.304 1.842 . . . . 0.0 110.913 -174.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -78.36 157.4 29.11 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -143.68 146.51 33.27 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.37 151.5 49.62 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 128.833 2.853 . . . . 0.0 106.173 166.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -143.81 139.53 29.38 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 166.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.519 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 43.5 t30 -79.1 114.83 18.36 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 120.039 1.291 . . . . 0.0 112.558 -177.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.7 mt -105.79 16.11 25.74 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 125.031 1.332 . . . . 0.0 112.548 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.6 175.44 9.87 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 163.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.8 t -103.57 17.3 24.39 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.103 0.561 . . . . 0.0 110.254 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -155.94 160.64 30.65 Favored Pre-proline 0 N--CA 1.45 -0.472 0 C-N-CA 127.075 2.15 . . . . 0.0 106.29 -174.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.27 124.81 11.22 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.481 1.454 . . . . 0.0 110.326 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.416 HG23 ' HD3' ' A' ' 149' ' ' PRO . 0.2 OUTLIER -86.58 177.79 7.27 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.398 0.618 . . . . 0.0 109.553 168.042 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.8 t -113.61 161.68 17.14 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 154.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.597 ' HA2' HD11 ' A' ' 45' ' ' LEU . . . -147.38 69.37 0.36 Allowed Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 107.728 -2.149 . . . . 0.0 107.728 -177.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.47 62.65 0.61 Allowed 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 177.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.39 161.64 27.86 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.542 -163.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -83.22 152.08 25.36 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.839 174.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -148.51 148.7 30.53 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.338 0.255 . . . . 0.0 110.647 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -109.04 101.85 10.89 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 125.773 1.629 . . . . 0.0 106.904 171.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.8 p -88.66 58.13 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.474 0 C-N-CA 123.963 0.905 . . . . 0.0 111.086 -176.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.6 t -167.26 145.16 4.03 Favored Pre-proline 0 N--CA 1.468 0.448 0 O-C-N 120.994 -1.066 . . . . 0.0 112.032 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -62.83 -56.77 0.53 Allowed 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.258 1.305 . . . . 0.0 108.805 168.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 23.3 ptp -171.36 20.69 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.886 0.874 . . . . 0.0 111.689 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -170.43 -77.31 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.291 0 O-C-N 121.558 -0.714 . . . . 0.0 109.519 -168.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -46.3 -94.22 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 126.271 1.829 . . . . 0.0 113.238 -169.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 60.71 -52.23 0.03 OUTLIER Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.939 1.257 . . . . 0.0 115.939 -172.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -45.17 -48.97 12.36 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 119.762 1.781 . . . . 0.0 111.34 174.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -71.68 -12.69 61.45 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.256 1.022 . . . . 0.0 113.047 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -71.49 94.98 1.33 Allowed 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 . . . . . 0 N--CA 1.442 -0.872 0 C-N-CA 118.274 -1.37 . . . . 0.0 110.346 -171.074 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 CA--C 1.538 0.496 0 CA-C-O 120.431 0.158 . . . . 0.0 111.315 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.541 HG23 ' H ' ' A' ' 107' ' ' THR . 9.2 t -157.68 -74.41 0.09 Allowed 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.531 0.332 . . . . 0.0 110.606 -168.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.541 ' H ' HG23 ' A' ' 106' ' ' THR . 0.9 OUTLIER -159.63 152.01 21.09 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -174.441 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 75.2 mt -148.48 137.69 21.85 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 124.225 1.01 . . . . 0.0 108.322 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -66.94 152.14 96.21 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 169.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.66 106.28 1.24 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.783 2.989 . . . . 0.0 111.136 -171.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 128.19 -23.38 5.21 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -176.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -78.14 142.5 38.0 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 117.808 0.804 . . . . 0.0 111.009 -162.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -100.18 128.92 46.17 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.34 1.856 . . . . 0.0 109.329 -173.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 52.7 ttp -126.87 85.84 2.43 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 126.104 1.761 . . . . 0.0 108.844 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.99 140.89 33.56 Favored 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 168.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 22.8 ptm -153.5 141.57 13.89 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 117.936 0.335 . . . . 0.0 111.887 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -72.22 148.11 49.14 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.717 2.278 . . . . 0.0 110.098 171.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.1 t -136.26 122.19 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 125.927 1.691 . . . . 0.0 107.026 174.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.1 p -99.45 143.15 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 125.762 1.625 . . . . 0.0 107.492 169.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.94 172.27 18.97 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 176.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -158.64 178.46 10.1 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.883 0.873 . . . . 0.0 109.715 164.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 73.5 t -110.22 135.32 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 123.74 0.816 . . . . 0.0 109.267 172.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.22 124.54 76.06 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 122.988 0.515 . . . . 0.0 112.068 -176.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.21 34.47 0.4 Allowed 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.199 2.599 . . . . 0.0 114.105 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.51 -15.04 21.89 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.04 0.936 . . . . 0.0 110.915 162.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 17.8 tt -52.1 -48.97 41.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 118.973 0.806 . . . . 0.0 112.586 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.8 m -80.52 64.08 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.081 0.552 . . . . 0.0 109.677 174.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 45.0 mttp -140.17 -65.21 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 124.271 1.028 . . . . 0.0 111.768 171.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.01 169.29 13.71 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 121.835 1.69 . . . . 0.0 111.443 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.9 t -71.96 -52.31 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 124.227 1.011 . . . . 0.0 109.843 -174.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -46.44 -51.69 14.63 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 125.197 1.399 . . . . 0.0 112.054 -173.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 17.2 p -86.14 -3.74 59.02 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -65.05 75.9 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.857 1.208 . . . . 0.0 111.607 -177.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 148.13 -34.54 1.2 Allowed Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -169.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 45.9 mm -66.86 114.24 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.3 pttt -156.1 47.17 0.47 Allowed 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.49 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.41 97.52 1.76 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 103.69 -2.708 . . . . 0.0 103.69 168.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.4 tp -78.04 162.66 26.55 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -170.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.5 t -151.69 171.61 17.4 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.599 -0.688 . . . . 0.0 109.488 173.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -149.5 100.04 2.96 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 103.908 -2.627 . . . . 0.0 103.908 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 31.1 m -87.5 93.79 9.52 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 173.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.13 134.13 36.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 172.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.7 m -120.06 87.33 2.72 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.992 0.917 . . . . 0.0 108.951 176.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.621 ' CD2' HD13 ' A' ' 45' ' ' LEU . 2.0 m-85 -68.24 84.55 0.25 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.928 0.891 . . . . 0.0 109.614 175.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -151.49 46.4 0.37 Allowed Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 178.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.52 -79.36 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.584 2.189 . . . . 0.0 112.731 -175.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.46 107.79 2.23 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.622 -0.674 . . . . 0.0 111.537 -173.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -78.89 144.05 63.23 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 173.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.416 ' HD3' HG23 ' A' ' 78' ' ' THR . 61.0 Cg_endo -72.41 -50.18 0.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.972 1.782 . . . . 0.0 107.992 160.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.9 t -179.5 -168.71 0.12 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 128.869 2.868 . . . . 0.0 105.32 169.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.589 0 C-N-CA 124.241 1.017 . . . . 0.0 111.184 174.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.818 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.8 t -73.07 51.35 0.3 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.385 1.874 . . . . 0.0 114.85 -167.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -76.07 -34.86 59.59 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 131.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 63.1 mt -108.47 -44.49 4.08 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -172.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.2 mt -35.4 137.78 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 126.614 1.966 . . . . 0.0 115.501 -164.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.9 mp -111.71 -82.85 0.58 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.147 1.379 . . . . 0.0 109.141 -174.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -172.85 -66.22 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.35 1.46 . . . . 0.0 108.997 -178.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -36.67 132.65 0.61 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 126.678 1.991 . . . . 0.0 113.598 -168.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -76.2 90.17 3.12 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.158 -1.837 . . . . 0.0 107.253 176.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.7 112.34 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 167.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.79 154.22 30.09 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.4 t -134.97 133.38 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 176.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 29.4 m -114.14 108.57 17.15 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -81.17 102.98 10.65 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.662 1.585 . . . . 0.0 108.945 176.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -98.42 87.1 3.77 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.857 0.836 . . . . 0.0 109.596 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.21 126.07 31.06 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.169 0.588 . . . . 0.0 110.614 175.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -129.65 146.44 51.43 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.797 1.239 . . . . 0.0 108.191 175.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.5 p -138.44 144.0 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 124.076 0.95 . . . . 0.0 108.991 177.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.21 165.48 19.54 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 166.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -43.62 -39.71 3.69 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.211 1.004 . . . . 0.0 112.185 -177.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -34.06 -36.55 0.06 OUTLIER Glycine 0 CA--C 1.535 1.282 0 C-N-CA 126.948 2.213 . . . . 0.0 115.01 171.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.45 HD13 ' CG ' ' A' ' 144' ' ' PHE . 0.2 OUTLIER -118.82 102.76 49.15 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 119.099 1.45 . . . . 0.0 107.871 161.645 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.43 40.94 1.05 Allowed 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.764 2.309 . . . . 0.0 111.223 -170.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.509 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 45.1 m0 -116.39 151.06 36.73 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.367 1.067 . . . . 0.0 110.614 -165.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -76.33 80.83 3.08 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -177.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -87.14 106.27 17.76 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.396 0.678 . . . . 0.0 109.35 -172.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.8 t -115.9 119.93 36.43 Favored Pre-proline 0 N--CA 1.443 -0.814 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -168.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.82 154.25 38.57 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 C-N-CA 124.118 3.212 . . . . 0.0 107.936 168.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 t -85.7 -58.95 3.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -168.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -132.45 162.19 31.79 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 162.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -61.46 -39.79 92.16 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 174.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.79 164.72 26.62 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.796 0.839 . . . . 0.0 112.496 -176.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.7 pt -132.47 162.0 40.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 124.521 1.129 . . . . 0.0 109.747 168.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -118.28 83.78 2.07 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 127.444 2.298 . . . . 0.0 110.067 -173.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.75 129.3 43.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 O-C-N 120.833 -1.167 . . . . 0.0 109.494 -178.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -78.37 96.32 5.3 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 174.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.447 HD13 HG21 ' A' ' 60' ' ' ILE . 0.7 OUTLIER -10.06 87.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.068 1.747 . . . . 0.0 114.966 -159.392 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.59 -31.66 4.74 Favored Glycine 0 C--O 1.222 -0.641 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 176.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -53.11 118.38 3.71 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 -175.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.67 HG22 ' CD1' ' A' ' 121' ' ' PHE . 20.2 p -71.23 115.69 10.67 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.745 2.018 . . . . 0.0 111.71 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.0 p -97.68 161.92 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 123.514 0.726 . . . . 0.0 110.112 169.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.492 HE21 ' HA ' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -105.36 120.01 40.52 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.231 1.012 . . . . 0.0 110.727 164.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.8 pp -130.18 116.56 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 171.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 35.4 mtm -79.57 107.81 12.63 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.156 0.982 . . . . 0.0 111.633 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -81.55 155.56 25.66 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 170.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.0 ttp-105 -137.95 144.86 41.41 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 174.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.72 159.01 28.87 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.103 2.161 . . . . 0.0 107.05 156.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -144.17 145.04 31.84 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 161.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.509 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 51.9 t-20 -83.45 105.57 14.5 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 120.743 1.611 . . . . 0.0 112.103 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.1 mp -102.27 36.39 2.15 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.095 1.358 . . . . 0.0 110.861 176.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.03 170.63 7.84 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.72 1.208 . . . . 0.0 109.331 163.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.5 m -105.09 15.47 27.52 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.753 0.821 . . . . 0.0 111.411 -177.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.7 p -141.38 162.11 49.11 Favored Pre-proline 0 C--O 1.239 0.504 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 169.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.44 141.65 96.07 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 120.978 1.119 . . . . 0.0 109.312 171.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.43 169.03 9.01 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 118.468 0.576 . . . . 0.0 110.326 167.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.9 t -94.38 157.07 16.19 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 159.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -124.17 152.7 17.37 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 105.271 -3.132 . . . . 0.0 105.271 165.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.22 -53.86 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 117.426 0.613 . . . . 0.0 109.787 -160.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 60.57 -179.35 0.1 Allowed 'General case' 0 C--N 1.342 0.243 0 CA-C-O 122.938 1.351 . . . . 0.0 113.88 173.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.0 m -135.21 164.21 28.21 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 146.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -155.53 164.47 38.62 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -173.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.09 98.33 4.72 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.629 HG22 HD13 ' A' ' 140' ' ' LEU . 51.2 t -89.32 72.04 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 125.361 1.465 . . . . 0.0 107.129 -175.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.0 t 178.83 152.28 0.49 Allowed Pre-proline 0 C--N 1.34 0.157 0 C-N-CA 125.455 1.502 . . . . 0.0 109.233 -174.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -67.49 -47.8 1.93 Allowed 'Trans proline' 0 N--CA 1.448 -1.197 0 N-CA-C 108.457 -1.401 . . . . 0.0 108.457 156.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.2 ptm -174.52 -78.37 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.661 1.984 . . . . 0.0 107.802 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.19 -38.22 81.77 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -168.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.71 -105.45 0.02 OUTLIER 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.199 0.454 . . . . 0.0 111.022 -173.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.38 -53.94 1.92 Allowed Glycine 0 CA--C 1.526 0.768 0 CA-C-O 119.286 -0.73 . . . . 0.0 112.722 -177.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.26 -54.11 9.44 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.612 1.206 . . . . 0.0 111.636 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -74.06 -3.59 30.32 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.767 1.227 . . . . 0.0 113.659 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -70.4 96.62 1.17 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 174.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 . . . . . 0 CA--C 1.531 0.24 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -162.19 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.539 0.532 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.6 t -130.27 -63.39 0.9 Allowed 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 124.212 1.005 . . . . 0.0 109.114 -177.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.1 t -158.33 149.0 20.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 172.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 89.2 mt -149.17 135.6 19.34 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 176.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -73.59 159.81 83.7 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.738 1.215 . . . . 0.0 109.955 173.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.23 102.73 1.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.486 2.124 . . . . 0.0 110.905 -165.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 125.05 -14.35 7.47 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 124.202 0.906 . . . . 0.0 110.953 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -76.82 138.31 39.75 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 118.49 1.145 . . . . 0.0 110.773 -166.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.03 144.92 26.68 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.94 1.296 . . . . 0.0 108.694 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 17.1 ttt -140.01 80.39 1.76 Allowed 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 123.34 0.656 . . . . 0.0 109.265 173.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -95.02 123.44 38.5 Favored 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 124.325 1.05 . . . . 0.0 108.321 168.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 24.5 mmt -134.1 129.56 20.01 Favored Pre-proline 0 C--O 1.235 0.32 0 C-N-CA 124.106 0.963 . . . . 0.0 109.844 -171.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -68.8 135.58 33.21 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 121.871 1.714 . . . . 0.0 109.248 172.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.9 t -110.06 129.42 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 166.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.1 p -95.52 134.76 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 157.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -155.92 151.62 27.25 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.67 ' CD1' HG22 ' A' ' 63' ' ' THR . 12.7 p90 -167.32 161.14 14.06 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 126.215 1.806 . . . . 0.0 107.206 -177.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 52.7 t -118.26 127.77 75.35 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 C-N-CA 125.669 1.588 . . . . 0.0 107.463 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.43 153.15 41.44 Favored Pre-proline 0 C--O 1.234 0.252 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -173.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.58 37.76 0.47 Allowed 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 124.359 3.373 . . . . 0.0 112.982 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -83.62 -37.66 22.59 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 165.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.3 tt -52.41 -35.46 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 123.878 0.871 . . . . 0.0 112.781 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.2 m -74.97 53.12 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 120.901 -1.124 . . . . 0.0 110.933 173.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -144.53 -70.65 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.748 1.619 . . . . 0.0 110.793 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.86 138.13 39.95 Favored 'Trans proline' 0 C--O 1.239 0.529 0 CA-C-N 122.148 1.803 . . . . 0.0 113.488 -176.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.9 t -55.94 -36.86 45.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 127.352 2.261 . . . . 0.0 109.602 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -47.7 -34.98 8.95 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.938 2.095 . . . . 0.0 112.744 174.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 72.1 p -107.09 -60.52 1.67 Allowed 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 123.013 0.196 . . . . 0.0 110.536 -174.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 28.28 49.75 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 129.088 2.955 . . . . 0.0 115.902 165.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 143.65 -29.3 2.0 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -172.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.8 mm -53.61 127.62 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.072 0 CA-C-N 117.863 0.831 . . . . 0.0 110.664 172.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.7 pttt -155.77 67.54 0.62 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 122.09 0.948 . . . . 0.0 111.547 169.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 42.4 m -147.94 105.08 3.63 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 141.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.1 tp -79.83 86.86 5.34 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -175.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -84.77 150.12 25.28 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.08 -168.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.629 HD13 HG22 ' A' ' 86' ' ' VAL . 28.5 tp -120.45 110.53 16.61 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 166.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.7 t -95.04 117.98 31.07 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 169.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.07 125.86 51.14 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -166.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.6 m -117.6 89.4 3.11 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.214 1.006 . . . . 0.0 109.98 -176.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.45 ' CG ' HD13 ' A' ' 45' ' ' LEU . 1.8 m-30 -67.1 94.59 0.35 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.603 0.761 . . . . 0.0 109.404 170.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -149.01 23.65 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.135 0 N-CA-C 118.08 2.622 . . . . 0.0 118.08 -176.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.445 ' CD ' HD12 ' A' ' 45' ' ' LEU . 59.5 Cg_endo -71.49 -75.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.672 0 CA-C-N 122.77 2.025 . . . . 0.0 113.897 -165.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 86.6 mmt-85 -146.28 121.75 10.36 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.776 0.716 . . . . 0.0 109.177 -167.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.53 117.54 28.98 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 125.648 1.579 . . . . 0.0 107.358 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -78.6 -23.5 8.33 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.71 2.273 . . . . 0.0 112.41 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 39.9 t 137.69 109.38 0.0 OUTLIER 'General case' 0 C--N 1.343 0.302 0 C-N-CA 129.278 3.031 . . . . 0.0 107.777 -175.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.372 0 C-N-CA 124.319 1.047 . . . . 0.0 110.958 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.607 ' N ' ' HG1' ' A' ' 63' ' ' THR . . . . . . . . 0 N--CA 1.446 -0.662 0 CA-C-O 120.777 0.322 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.2 t -162.25 45.92 0.15 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 123.882 0.873 . . . . 0.0 109.825 -171.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -155.67 -58.03 0.1 Allowed 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.411 ' H ' HD23 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -85.51 26.36 0.94 Allowed 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.147 -169.534 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 73.3 mt -119.23 108.87 24.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -169.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -98.58 -61.54 1.36 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.129 -171.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . 0.25 0.3 OUTLIER 177.23 -6.89 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.672 1.589 . . . . 0.0 114.488 145.654 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -51.19 122.42 7.67 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 120.752 1.615 . . . . 0.0 112.869 -173.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -77.66 98.14 5.35 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 127.928 2.491 . . . . 0.0 107.547 -173.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.407 HG12 HG11 ' A' ' 122' ' ' VAL . 5.6 tp -106.56 122.74 60.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.913 1.285 . . . . 0.0 109.435 -172.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.513 ' CE ' ' HB2' ' A' ' 55' ' ' ASP . 4.0 tmtp? -79.19 151.62 31.14 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.952 1.701 . . . . 0.0 109.212 -174.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.423 ' HB ' ' CG1' ' A' ' 56' ' ' ILE . 5.2 t -133.79 148.74 30.39 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 165.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.7 m -136.25 104.7 5.73 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.414 1.102 . . . . 0.0 108.338 -174.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -77.56 121.32 23.74 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -118.32 82.44 1.84 Allowed 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.65 126.86 31.71 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -126.95 89.33 2.96 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.897 0.856 . . . . 0.0 109.043 -174.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.4 p -79.02 126.91 39.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.679 172.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.38 169.46 13.57 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 171.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.55 124.07 12.7 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 161.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 151.48 -48.19 0.56 Allowed Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 107.268 -2.333 . . . . 0.0 107.268 -160.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mp -129.28 142.38 45.02 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 160.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.439 ' HD2' HG21 ' A' ' 78' ' ' THR . 83.0 Cg_endo -79.97 2.72 8.2 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 123.911 3.074 . . . . 0.0 111.93 170.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.42 ' CZ2' ' HB3' ' A' ' 108' ' ' LEU . 40.5 m0 -74.54 148.62 40.72 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.125 0.875 . . . . 0.0 111.745 -165.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -78.82 84.79 4.86 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 172.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -89.58 118.94 29.58 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 124.475 1.11 . . . . 0.0 108.709 177.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.0 m -124.86 139.29 33.11 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -74.67 171.49 18.1 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.339 2.026 . . . . 0.0 108.953 166.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -93.35 -53.66 8.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 123.763 0.825 . . . . 0.0 110.393 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -131.7 164.5 25.8 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 168.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -60.75 -43.6 97.76 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 168.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.513 ' HB2' ' CE ' ' A' ' 34' ' ' LYS . 22.4 p-10 -149.15 170.55 18.18 Favored 'General case' 0 N--CA 1.428 -1.551 0 C-N-CA 124.666 1.186 . . . . 0.0 110.805 -164.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.423 ' CG1' ' HB ' ' A' ' 35' ' ' VAL . 37.1 pt -137.65 176.39 7.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 167.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.88 161.58 23.83 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 148.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -131.22 148.23 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 102.158 -3.275 . . . . 0.0 102.158 170.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.72 118.51 27.27 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 120.855 1.661 . . . . 0.0 106.953 160.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.3 pt -15.57 89.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 C-N-CA 126.943 2.097 . . . . 0.0 113.255 -169.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.52 -43.91 1.32 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 124.37 0.986 . . . . 0.0 113.12 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -38.56 102.65 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.798 2.039 . . . . 0.0 113.431 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.607 ' HG1' ' N ' ' A' ' 24' ' ' ALA . 94.5 m -73.19 104.44 4.25 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.677 1.591 . . . . 0.0 111.265 -174.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.5 p -102.07 169.56 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 121.615 0.722 . . . . 0.0 110.524 174.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -117.35 127.38 53.99 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 126.263 1.825 . . . . 0.0 107.208 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.444 HD12 ' O ' ' A' ' 66' ' ' ILE . 1.7 pp -140.69 95.79 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 CA-C-O 121.864 0.84 . . . . 0.0 109.063 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 31.1 mtt -76.82 175.31 9.56 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.765 -0.584 . . . . 0.0 110.536 -175.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -133.28 170.47 15.4 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 124.228 1.011 . . . . 0.0 109.092 174.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -139.39 123.4 17.8 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 173.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.97 105.38 7.7 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.127 0.571 . . . . 0.0 110.869 168.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER -103.25 121.08 41.95 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.061 -0.4 . . . . 0.0 111.533 -171.759 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -82.12 85.07 6.84 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.114 0.483 . . . . 0.0 111.386 -173.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.3 mt -79.73 59.15 2.99 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.634 0.774 . . . . 0.0 109.958 171.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.91 155.23 47.12 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 170.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.8 m -79.55 -0.62 34.21 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.619 0.768 . . . . 0.0 112.369 177.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.1 p -128.83 163.29 46.33 Favored Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 124.761 1.224 . . . . 0.0 110.618 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -63.17 169.11 9.77 Favored 'Trans proline' 0 N--CA 1.444 -1.435 0 C-N-CA 121.041 1.161 . . . . 0.0 110.077 164.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.439 HG21 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -155.97 168.81 26.06 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 126.519 1.928 . . . . 0.0 107.152 -170.829 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.2 t -132.6 154.79 49.7 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.75 0.705 . . . . 0.0 111.622 176.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -125.57 64.42 0.57 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 127.248 2.356 . . . . 0.0 107.968 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.37 53.54 2.79 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 165.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.98 170.54 14.61 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.096 -171.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.1 m -125.19 162.21 25.17 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -146.93 159.02 44.06 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 118.764 0.711 . . . . 0.0 111.08 170.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.2 99.51 6.91 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 166.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.6 p -89.9 57.65 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.212 0 C-N-CA 124.154 0.982 . . . . 0.0 110.365 -175.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.5 t -165.95 148.18 6.27 Favored Pre-proline 0 N--CA 1.454 -0.249 0 O-C-N 121.506 -0.746 . . . . 0.0 110.699 -172.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.24 -30.68 30.5 Favored 'Trans proline' 0 N--CA 1.445 -1.38 0 N-CA-C 108.674 -1.318 . . . . 0.0 108.674 164.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.0 ptp 172.69 -63.85 0.01 OUTLIER 'General case' 0 C--N 1.347 0.462 0 C-N-CA 125.853 1.661 . . . . 0.0 109.759 -173.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -99.87 -33.25 10.62 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 124.776 1.23 . . . . 0.0 111.258 -164.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.16 -142.91 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.86 -47.58 0.78 Allowed Glycine 0 CA--C 1.531 1.075 0 O-C-N 121.278 -0.889 . . . . 0.0 112.434 -166.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -42.7 -54.08 4.21 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.047 1.339 . . . . 0.0 110.818 173.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -76.24 -16.2 59.87 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -48.91 137.41 12.77 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 118.79 0.723 . . . . 0.0 110.843 -173.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 . . . . . 0 N--CA 1.44 -0.972 0 O-C-N 123.583 0.552 . . . . 0.0 111.568 -173.453 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.9 t 52.7 -141.26 0.86 Allowed 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.493 1.517 . . . . 0.0 111.176 174.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.2 t -110.68 131.41 55.08 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 126.402 1.881 . . . . 0.0 106.741 172.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.42 ' HB3' ' CZ2' ' A' ' 47' ' ' TRP . 1.6 tp -124.34 131.43 53.51 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 125.102 1.361 . . . . 0.0 107.651 -176.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.456 ' HB3' ' HD2' ' A' ' 110' ' ' PRO . 10.5 mp0 -86.56 167.73 21.53 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 127.169 2.188 . . . . 0.0 111.273 -167.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 109' ' ' GLU . 49.9 Cg_endo -72.92 112.6 3.55 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.349 2.033 . . . . 0.0 112.446 -168.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 115.97 -12.72 17.27 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 124.403 1.002 . . . . 0.0 111.021 177.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -77.91 140.96 39.32 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 117.334 0.567 . . . . 0.0 112.438 -163.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -99.21 98.27 9.27 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.91 1.684 . . . . 0.0 108.787 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 11.0 ttp -77.56 85.98 3.91 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -94.28 59.59 2.62 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.994 0.902 . . . . 0.0 111.682 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 20.5 ttt -76.61 129.17 80.23 Favored Pre-proline 0 N--CA 1.437 -1.077 0 C-N-CA 123.814 0.846 . . . . 0.0 110.352 -171.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.66 150.88 31.73 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 121.93 1.753 . . . . 0.0 110.332 171.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.2 t -130.83 148.08 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 164.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.5 m -112.28 146.7 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -154.58 139.96 17.7 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 119.56 1.073 . . . . 0.0 112.635 -172.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -156.01 148.11 23.35 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.66 1.584 . . . . 0.0 108.069 163.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.407 HG11 HG12 ' A' ' 33' ' ' ILE . 61.6 t -88.26 141.45 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 166.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -75.51 155.46 85.55 Favored Pre-proline 0 N--CA 1.45 -0.467 0 C-N-CA 124.517 1.127 . . . . 0.0 110.061 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -65.03 -36.14 39.38 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.577 1.518 . . . . 0.0 112.17 166.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -44.77 -41.0 6.54 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 125.481 1.512 . . . . 0.0 113.395 -172.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -50.11 -37.94 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 125.021 1.329 . . . . 0.0 112.83 -177.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.0 m -89.3 51.26 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 119.17 0.896 . . . . 0.0 110.487 177.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . 0.35 0.0 OUTLIER -149.79 -53.5 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.823 0 CA-C-O 116.199 -1.858 . . . . 0.0 114.228 -175.221 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -83.33 169.89 12.27 Favored 'Trans proline' 0 C--N 1.351 0.67 0 CA-C-N 124.031 2.475 . . . . 0.0 111.838 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.2 t -67.59 -46.54 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.978 1.311 . . . . 0.0 110.871 -169.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.423 ' CD ' ' H ' ' A' ' 131' ' ' GLU . 2.1 mp0 -39.13 -54.58 1.73 Allowed 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 126.062 1.745 . . . . 0.0 112.225 -178.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 3.2 p -97.53 -41.03 8.36 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.128 -168.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 2.51 70.74 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 128.458 2.703 . . . . 0.0 115.882 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 134.27 -35.66 2.2 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 119.176 -0.791 . . . . 0.0 112.391 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 13.1 mm -49.33 138.27 4.78 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 C-N-CA 124.664 1.186 . . . . 0.0 109.948 173.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.3 pttm -157.67 51.97 0.45 Allowed 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.6 m -154.5 107.09 2.8 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 159.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.5 mp -75.78 85.72 2.77 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 169.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.1 t -81.14 150.98 28.48 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.3 tt -127.52 99.38 5.58 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.1 t -78.04 111.07 13.55 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 171.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -107.06 92.84 4.25 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.746 1.218 . . . . 0.0 108.537 -172.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.5 86.95 4.5 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 122.528 1.156 . . . . 0.0 109.48 -175.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -75.48 73.12 2.52 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 166.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -132.73 48.86 3.84 Favored Pre-proline 0 CA--C 1.552 1.044 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 174.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -77.61 -98.09 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 124.356 3.37 . . . . 0.0 113.752 -174.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.2 mmt180 -142.36 110.37 5.92 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.545 1.138 . . . . 0.0 109.315 -169.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -95.05 114.57 63.99 Favored Pre-proline 0 N--CA 1.451 -0.381 0 C-N-CA 124.793 1.237 . . . . 0.0 111.517 -167.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -74.2 -25.13 13.93 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.632 1.554 . . . . 0.0 111.138 165.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.6 t 80.33 127.18 0.04 OUTLIER 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.778 1.631 . . . . 0.0 109.824 -173.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 17.9 pttm . . . . . 0 CA--C 1.535 0.376 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.017 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.533 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.7 m -76.9 54.24 0.99 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.824 2.45 . . . . 0.0 112.253 -178.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -141.69 -54.19 0.45 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 130.275 3.43 . . . . 0.0 104.092 168.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.511 ' O ' HD22 ' A' ' 29' ' ' LEU . 49.2 mt -63.73 -34.06 77.04 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.908 1.283 . . . . 0.0 113.119 168.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 76.7 mt -69.15 100.04 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 119.575 1.08 . . . . 0.0 110.221 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.511 HD22 ' O ' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -90.03 -75.41 0.45 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 172.554 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -169.48 -28.63 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 164.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -59.05 128.25 36.28 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.46 1.104 . . . . 0.0 113.638 -163.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -79.93 109.79 14.7 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.924 -174.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.13 113.1 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 126.012 1.725 . . . . 0.0 108.679 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.35 157.07 21.59 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.054 -1.029 . . . . 0.0 109.084 -171.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.2 t -143.79 107.5 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-N 119.762 1.165 . . . . 0.0 109.596 -176.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.2 m -78.97 117.58 20.17 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.786 1.634 . . . . 0.0 107.816 167.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -79.61 156.32 27.72 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.337 0.655 . . . . 0.0 109.266 166.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -137.67 88.31 2.32 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.412 0.625 . . . . 0.0 111.511 170.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.06 128.9 36.4 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 120.939 -1.101 . . . . 0.0 110.507 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -133.73 150.21 51.49 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.186 0.994 . . . . 0.0 109.508 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.9 p -140.6 146.29 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 C-N-CA 123.518 0.727 . . . . 0.0 110.772 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.9 163.62 29.82 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.012 1.325 . . . . 0.0 107.463 168.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -37.75 -45.69 0.83 Allowed 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.989 1.715 . . . . 0.0 113.452 -172.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -36.88 -37.32 0.23 Allowed Glycine 0 CA--C 1.534 1.233 0 C-N-CA 126.482 1.991 . . . . 0.0 114.39 174.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.417 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 0.4 OUTLIER -113.48 105.88 54.71 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 161.15 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.93 9.56 3.26 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.138 1.892 . . . . 0.0 112.733 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.493 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 41.4 m0 -78.46 145.61 34.93 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 121.798 -0.564 . . . . 0.0 110.931 -168.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -78.56 85.39 4.62 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 103.338 -2.838 . . . . 0.0 103.338 172.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.71 88.18 3.0 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.625 1.17 . . . . 0.0 108.381 -168.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.0 m -91.37 136.59 26.77 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 119.182 -0.437 . . . . 0.0 110.381 -166.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -70.53 165.55 31.48 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 121.538 1.492 . . . . 0.0 108.595 161.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -97.67 -55.29 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.111 0 C-N-CA 123.573 0.749 . . . . 0.0 110.941 -176.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.22 152.76 47.6 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 170.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -64.99 -41.48 95.36 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.831 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.49 139.65 37.02 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.223 1.009 . . . . 0.0 110.027 -173.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.42 HD12 HG11 ' A' ' 64' ' ' VAL . 32.7 pt -104.99 164.02 4.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 125.352 1.461 . . . . 0.0 109.002 170.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -101.74 133.62 46.17 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 155.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.6 m -128.08 174.68 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 159.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -140.66 92.45 2.51 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -171.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.0 pt 8.22 87.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 127.66 2.384 . . . . 0.0 114.279 -171.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 107.86 -31.52 7.91 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 123.556 0.598 . . . . 0.0 112.949 -173.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -72.55 118.02 14.95 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 121.627 -0.925 . . . . 0.0 110.174 -168.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.3 p -68.3 126.83 30.81 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 127.431 2.293 . . . . 0.0 111.472 -174.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.42 HG11 HD12 ' A' ' 56' ' ' ILE . 9.9 p -113.74 160.07 13.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 157.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.62 125.34 49.32 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.737 1.215 . . . . 0.0 108.839 169.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -126.07 104.86 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 172.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.41 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 5.3 ppp? -83.34 167.61 17.42 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.959 172.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -137.05 155.0 50.21 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 171.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -125.56 129.81 50.44 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 168.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.68 108.52 12.11 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.671 2.388 . . . . 0.0 107.556 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.3 mtpt -104.73 124.16 48.91 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 118.154 -0.927 . . . . 0.0 109.09 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.493 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 32.3 t30 -78.37 85.46 4.49 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 119.517 1.053 . . . . 0.0 110.983 -175.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -78.12 68.89 4.25 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 174.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.3 135.48 13.08 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.781 0.832 . . . . 0.0 108.975 173.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.9 m -78.4 41.82 0.4 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.272 0.629 . . . . 0.0 110.246 172.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.1 p -148.31 154.26 41.83 Favored Pre-proline 0 N--CA 1.446 -0.671 0 C-N-CA 124.526 1.131 . . . . 0.0 107.989 169.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -66.95 150.41 82.94 Favored 'Trans proline' 0 N--CA 1.442 -1.545 0 N-CA-C 108.03 -1.565 . . . . 0.0 108.03 166.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.413 ' HG1' ' HE1' ' A' ' 47' ' ' TRP . 2.8 p -135.59 163.76 29.39 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.577 0.751 . . . . 0.0 109.302 175.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.1 t -118.88 136.21 54.16 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.636 0.775 . . . . 0.0 109.405 167.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -96.14 81.24 0.78 Allowed Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 176.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -106.38 53.29 0.7 Allowed 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 172.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.1 174.6 5.27 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.785 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.59 154.64 46.87 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 173.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -145.97 147.3 31.54 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -101.23 115.69 31.08 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 166.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.9 p -99.81 73.2 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.498 0 C-N-CA 124.24 1.016 . . . . 0.0 109.264 -176.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.0 t 177.56 148.46 0.34 Allowed Pre-proline 0 C--O 1.232 0.163 0 C-N-CA 123.645 0.778 . . . . 0.0 109.461 -178.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -66.3 -33.41 38.94 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 121.336 1.357 . . . . 0.0 109.754 162.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.0 ptp 177.83 -69.41 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.639 1.976 . . . . 0.0 107.933 177.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.67 -46.53 45.89 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 123.827 0.851 . . . . 0.0 113.203 -165.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.25 -101.06 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -162.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.93 -52.69 0.38 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.191 0.9 . . . . 0.0 114.032 -171.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -48.09 -52.84 18.66 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.306 1.553 . . . . 0.0 110.732 176.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 125' ' ' GLU . 15.1 m-85 -75.22 12.25 0.97 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.54 1.536 . . . . 0.0 114.768 176.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -92.39 108.08 19.7 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 171.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 . . . . . 0 CA--C 1.534 0.357 0 C-N-CA 118.41 -1.316 . . . . 0.0 112.698 -173.292 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.0 pm0 . . . . . 0 CA--C 1.539 0.551 0 CA-C-O 120.667 0.27 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.4 t -168.65 -72.3 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.094 0.958 . . . . 0.0 110.962 -177.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -158.77 151.06 21.49 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.6 1.16 . . . . 0.0 108.303 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 82.6 mt -144.34 148.0 34.19 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.443 ' HB3' ' HD2' ' A' ' 110' ' ' PRO . 3.6 mt-10 -88.86 175.41 4.06 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 123.969 0.908 . . . . 0.0 109.132 176.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 109' ' ' GLU . 33.2 Cg_endo -69.4 90.32 0.48 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.842 2.361 . . . . 0.0 114.469 -162.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 138.98 -23.39 2.9 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 123.731 0.681 . . . . 0.0 112.264 170.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -78.32 141.1 38.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 119.691 -0.804 . . . . 0.0 112.49 -146.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -84.05 113.44 21.03 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.621 1.569 . . . . 0.0 110.806 177.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 14.4 tpt -104.12 131.04 51.81 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 125.374 1.47 . . . . 0.0 107.235 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -155.03 139.44 16.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.056 0.389 . . . . 0.0 110.82 168.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 80.7 mtp -155.03 148.89 18.89 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.291 1.036 . . . . 0.0 109.544 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 67' ' ' MET . 49.5 Cg_endo -78.36 144.72 20.67 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.886 3.057 . . . . 0.0 112.701 170.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 25.0 t -118.83 121.53 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 168.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.2 p -79.54 146.32 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 169.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -155.19 146.99 23.32 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.256 0.48 . . . . 0.0 111.571 -171.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -156.62 153.22 28.22 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.271 1.429 . . . . 0.0 110.935 164.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 74.2 t -76.77 140.5 17.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 169.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.79 130.73 56.9 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 118.639 -0.696 . . . . 0.0 110.688 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -55.17 -30.46 71.22 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.191 2.594 . . . . 0.0 113.018 -178.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 16.0 mm-40 -36.28 -36.05 0.09 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.979 1.311 . . . . 0.0 113.418 172.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.7 tt -49.26 -36.72 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.4 m -87.67 54.31 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 119.24 0.927 . . . . 0.0 110.685 173.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -126.12 -74.67 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 117.508 -1.234 . . . . 0.0 111.983 171.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.67 156.37 40.05 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 CA-C-N 122.039 1.764 . . . . 0.0 112.538 -171.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 99.5 t -53.32 -44.21 53.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 125.137 1.375 . . . . 0.0 109.981 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -44.95 -51.58 9.62 Favored 'General case' 0 N--CA 1.426 -1.657 0 C-N-CA 128.216 2.606 . . . . 0.0 112.471 178.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 40.3 p -99.06 -8.07 25.83 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 119.052 -0.499 . . . . 0.0 111.869 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -44.41 112.38 0.41 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.989 0.916 . . . . 0.0 111.581 -178.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.47 -15.06 63.46 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 119.318 -0.712 . . . . 0.0 113.262 175.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 20.5 mm -64.97 123.78 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-N 119.016 1.408 . . . . 0.0 108.602 171.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 20.1 pttt -156.01 54.53 0.58 Allowed 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.032 0.444 . . . . 0.0 111.751 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.31 87.48 1.32 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 160.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.5 tp -82.79 88.16 6.77 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.242 -162.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 13.3 t -87.89 173.09 9.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.908 0.861 . . . . 0.0 111.329 -170.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.1 tt -145.39 111.15 5.46 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 171.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.6 p -91.81 97.97 11.32 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 124.999 1.32 . . . . 0.0 107.696 175.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.5 128.25 35.23 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 127.075 2.15 . . . . 0.0 108.71 -178.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.6 m -121.54 92.61 3.78 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 122.012 0.911 . . . . 0.0 109.494 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -75.77 90.49 2.89 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.014 -0.993 . . . . 0.0 110.068 174.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -148.02 41.38 0.25 Allowed Pre-proline 0 CA--C 1.553 1.068 0 N-CA-C 116.978 2.214 . . . . 0.0 116.978 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.79 -104.88 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.348 2.699 . . . . 0.0 112.859 -177.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -125.84 107.99 11.03 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.238 1.415 . . . . 0.0 110.661 -168.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -100.59 118.46 60.86 Favored Pre-proline 0 N--CA 1.453 -0.304 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 167.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.86 -50.02 0.07 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 121.781 1.654 . . . . 0.0 110.182 173.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.9 m -169.45 110.74 0.46 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.581 1.152 . . . . 0.0 110.981 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.543 0.679 0 C-N-CA 125.276 1.43 . . . . 0.0 112.808 170.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 61' ' ' GLY . . . . . . . . 0 N--CA 1.439 -0.989 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.3 t -156.08 42.95 0.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -158.34 -57.13 0.07 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 128.354 2.661 . . . . 0.0 104.709 -164.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 56.4 mt -75.75 -31.89 59.76 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 113.886 -1.506 . . . . 0.0 111.834 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.9 mt -66.0 112.62 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 O-C-N 121.964 -0.46 . . . . 0.0 111.753 -168.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.53 160.44 14.28 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 159.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -75.84 59.98 1.29 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.125 1.37 . . . . 0.0 111.323 -174.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.25 142.99 49.88 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.327 1.451 . . . . 0.0 107.496 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.3 mmmt -110.78 135.46 51.31 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.987 1.715 . . . . 0.0 109.252 -169.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.566 HG23 HG23 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -145.76 112.11 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-O 121.973 0.892 . . . . 0.0 109.878 -167.228 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.17 132.41 36.1 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.937 1.295 . . . . 0.0 109.295 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 t -113.36 121.28 65.25 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 C-N-CA 124.538 1.135 . . . . 0.0 108.209 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.63 126.7 31.1 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -102.46 95.89 6.56 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 173.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.417 ' CB ' HH22 ' A' ' 54' ' ' ARG . 6.4 t70 -118.46 81.07 1.62 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.895 0.855 . . . . 0.0 109.865 -178.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.72 148.3 22.24 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.751 0.821 . . . . 0.0 110.762 -174.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -132.99 152.59 51.94 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.407 1.083 . . . . 0.0 108.182 -172.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.6 t -135.91 146.26 29.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -146.46 174.64 11.21 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.239 0.542 . . . . 0.0 110.573 175.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.63 133.46 16.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 171.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 117.83 -45.98 1.2 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -162.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.501 HD12 ' HD3' ' A' ' 146' ' ' PRO . 0.5 OUTLIER -123.34 87.37 51.71 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 123.592 0.757 . . . . 0.0 109.693 174.491 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -81.8 43.96 1.62 Allowed 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.634 2.889 . . . . 0.0 109.292 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.436 ' CH2' ' HB2' ' A' ' 108' ' ' LEU . 43.0 m0 -114.91 140.47 48.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -175.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -79.09 81.3 5.37 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -85.75 98.92 11.0 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.7 m -87.37 135.0 35.05 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -177.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -66.77 156.25 66.79 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 N-CA-C 108.316 -1.455 . . . . 0.0 108.316 167.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.7 t -76.62 -45.71 32.46 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -168.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.66 176.9 12.01 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 163.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.417 HH22 ' CB ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -49.32 -45.08 44.95 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.63 0.772 . . . . 0.0 113.079 179.233 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -160.31 154.37 23.11 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 125.253 1.421 . . . . 0.0 107.797 -169.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.4 pt -113.12 164.67 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 C-N-CA 123.95 0.9 . . . . 0.0 109.022 175.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -121.43 118.56 29.7 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.848 1.259 . . . . 0.0 107.855 176.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.566 HG23 HG23 ' A' ' 33' ' ' ILE . 31.8 m -114.67 151.98 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 165.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -78.07 165.7 23.69 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 150.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.0 mm -6.69 -66.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 127.304 2.242 . . . . 0.0 114.136 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -130.14 21.3 4.92 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 118.868 -0.962 . . . . 0.0 114.723 -178.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -70.23 119.22 14.1 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 120.641 2.22 . . . . 0.0 110.948 -176.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.9 p -60.92 117.12 5.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.371 0.668 . . . . 0.0 109.452 172.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.5 p -110.85 149.34 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 165.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -102.7 122.72 45.02 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.677 1.991 . . . . 0.0 107.972 -177.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.2 pp -141.5 100.25 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 121.938 0.875 . . . . 0.0 110.047 -177.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 65.7 mtt -77.17 126.34 30.78 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.985 1.314 . . . . 0.0 110.334 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -96.84 137.11 36.42 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 172.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 27.2 ttt85 -110.35 135.9 50.36 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.294 1.037 . . . . 0.0 109.652 -176.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.16 147.06 48.26 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.512 1.525 . . . . 0.0 109.608 175.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -136.29 121.62 19.26 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 117.784 -1.103 . . . . 0.0 108.267 171.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.416 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 43.0 t-20 -80.27 113.88 18.77 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.668 1.122 . . . . 0.0 111.798 -173.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.2 mt -99.21 16.74 21.87 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.741 1.216 . . . . 0.0 112.666 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.53 176.54 9.32 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.437 -0.789 . . . . 0.0 110.384 173.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.4 m -111.24 20.88 16.91 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.98 165.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.7 p -147.26 156.07 46.42 Favored Pre-proline 0 N--CA 1.449 -0.497 0 C-N-CA 125.521 1.528 . . . . 0.0 108.202 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.06 120.08 7.0 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 121.508 1.472 . . . . 0.0 108.586 175.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.66 163.64 15.05 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 118.898 0.772 . . . . 0.0 109.582 172.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.0 t -103.48 137.12 42.01 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 162.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.7 86.07 0.4 Allowed Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 103.497 -3.841 . . . . 0.0 103.497 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.05 46.57 0.91 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.93 177.04 2.78 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.169 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -148.49 178.33 8.7 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -128.16 161.42 29.32 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 166.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.464 ' OD1' HG22 ' A' ' 87' ' ' THR . 0.6 OUTLIER -114.7 128.39 56.28 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 103.441 -2.799 . . . . 0.0 103.441 155.187 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.0 t -111.55 79.46 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 O-C-N 124.502 1.126 . . . . 0.0 108.804 175.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.464 HG22 ' OD1' ' A' ' 85' ' ' ASN . 0.7 OUTLIER -160.5 140.21 8.2 Favored Pre-proline 0 N--CA 1.444 -0.752 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.289 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.45 -38.59 19.2 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 N-CA-C 108.333 -1.449 . . . . 0.0 108.333 163.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.1 ptp -177.55 -57.3 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.645 1.578 . . . . 0.0 109.962 -177.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.5 -4.1 25.87 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 123.772 0.829 . . . . 0.0 113.222 -162.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -95.77 -109.27 0.14 Allowed 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -172.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.92 -61.89 0.2 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 123.742 0.687 . . . . 0.0 112.868 -174.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -51.04 -59.68 3.91 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.45 1.1 . . . . 0.0 110.687 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -73.24 51.03 0.31 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.508 1.123 . . . . 0.0 112.169 176.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -114.19 121.51 43.95 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 124.089 0.956 . . . . 0.0 108.434 172.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 . . . . . 0 N--CA 1.446 -0.636 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.953 171.978 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.8 t 155.24 -146.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 129.318 3.047 . . . . 0.0 107.072 176.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.0 t -117.18 137.77 52.12 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.168 1.787 . . . . 0.0 108.663 175.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.436 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -135.58 125.38 25.57 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.241 1.016 . . . . 0.0 110.372 -172.453 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -70.44 157.67 89.49 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.394 1.078 . . . . 0.0 111.636 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.18 114.1 3.71 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.636 2.224 . . . . 0.0 111.92 -167.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 116.57 -25.85 8.87 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -79.95 161.73 25.33 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 121.442 0.639 . . . . 0.0 112.583 -167.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -103.21 159.58 15.42 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.079 1.352 . . . . 0.0 111.288 -173.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 5.9 mtp -148.44 153.91 39.16 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.769 1.627 . . . . 0.0 109.165 174.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -147.01 153.8 40.48 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 150.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 11.9 mmt -128.02 124.93 23.37 Favored Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 124.527 1.131 . . . . 0.0 108.702 178.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -69.47 145.6 59.31 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 C-N-CA 122.008 1.805 . . . . 0.0 109.297 170.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.9 t -130.06 144.26 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 164.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.8 p -111.23 140.21 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 167.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -147.66 139.29 23.91 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 118.349 0.522 . . . . 0.0 109.646 -172.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -153.94 162.13 41.45 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 125.016 1.327 . . . . 0.0 108.84 164.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.483 HG21 HD12 ' A' ' 33' ' ' ILE . 96.1 t -87.34 176.51 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 123.254 0.622 . . . . 0.0 109.699 176.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -121.78 133.65 24.36 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 123.591 0.757 . . . . 0.0 110.75 172.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.18 -21.41 72.34 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.415 2.077 . . . . 0.0 113.473 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -59.89 -14.69 16.57 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 119.81 1.187 . . . . 0.0 111.953 -178.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.2 tt -56.58 -42.31 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 121.212 -0.93 . . . . 0.0 112.664 168.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.2 m -84.97 52.65 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 119.228 0.922 . . . . 0.0 110.84 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -123.62 -65.8 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 117.708 -1.139 . . . . 0.0 113.174 173.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.17 154.72 41.88 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 CA-C-N 121.836 1.692 . . . . 0.0 111.25 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.0 m -59.05 -36.5 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 124.744 1.218 . . . . 0.0 112.208 -173.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -61.73 -60.63 3.38 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.445 0.698 . . . . 0.0 110.138 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 82.1 p -83.1 -7.99 59.57 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 118.417 -0.801 . . . . 0.0 112.353 -173.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -33.98 -50.09 0.37 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.301 1.44 . . . . 0.0 113.703 175.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -84.55 -21.49 56.17 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 123.353 0.502 . . . . 0.0 112.155 -176.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 37.6 mm -77.79 118.11 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 O-C-N 122.054 -0.674 . . . . 0.0 109.777 -177.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.9 pttt -155.28 61.34 0.63 Allowed 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.719 168.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 24.9 p -144.39 87.98 1.91 Allowed 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 170.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.1 tp -83.35 78.07 9.69 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -162.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.5 m -79.18 122.68 26.57 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.098 -1.41 . . . . 0.0 109.818 -158.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.8 tt -79.07 129.48 34.49 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 168.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.5 t -153.69 122.51 6.38 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 165.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -158.24 171.0 21.0 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.481 0.712 . . . . 0.0 110.915 -177.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.4 m -115.69 117.55 30.6 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.099 1.76 . . . . 0.0 111.037 -176.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -79.61 100.32 7.75 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.959 1.304 . . . . 0.0 108.492 168.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -155.67 59.38 2.12 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -176.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.501 ' HD3' HD12 ' A' ' 45' ' ' LEU . 72.8 Cg_endo -79.76 -94.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.658 2.905 . . . . 0.0 112.732 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 78.6 mtt-85 -152.02 96.12 2.16 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.497 -0.752 . . . . 0.0 110.22 -158.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -91.16 123.55 64.09 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 118.752 -0.642 . . . . 0.0 111.098 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -69.89 -61.38 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.743 1.629 . . . . 0.0 110.47 172.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.8 t -157.27 117.22 3.44 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 121.767 -0.583 . . . . 0.0 111.223 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.559 0 C-N-CA 125.36 1.464 . . . . 0.0 110.577 170.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 119.614 -0.232 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.1 p -163.13 -147.65 0.12 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 160.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -77.31 -22.57 51.74 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.955 2.102 . . . . 0.0 110.42 164.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.2 mt -56.34 -16.4 5.54 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.915 1.286 . . . . 0.0 113.885 -178.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 74.7 mt -52.03 118.51 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 124.373 1.069 . . . . 0.0 110.959 -173.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 mp -93.83 -83.76 0.32 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.943 0.497 . . . . 0.0 110.892 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -175.23 -56.82 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.033 0.933 . . . . 0.0 109.834 -164.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.32 145.4 2.4 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 125.542 1.537 . . . . 0.0 113.473 -165.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.9 tttt -96.93 90.78 5.33 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 126.062 1.745 . . . . 0.0 106.585 -170.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.68 107.5 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 176.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.16 146.06 35.29 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -177.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.5 t -130.46 144.4 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 -176.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 29.7 m -130.84 95.2 3.78 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -171.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -77.22 88.09 3.67 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 124.141 0.977 . . . . 0.0 108.986 -176.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -79.97 83.42 5.88 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 122.66 1.219 . . . . 0.0 109.699 -174.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.25 102.82 15.48 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.531 1.132 . . . . 0.0 110.594 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -106.05 111.17 23.69 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.296 0.639 . . . . 0.0 110.158 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.5 p -77.31 147.84 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 168.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.38 154.62 41.1 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 167.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.79 -41.23 22.97 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.062 0.945 . . . . 0.0 111.742 -175.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -30.69 -43.25 0.07 OUTLIER Glycine 0 CA--C 1.53 1.006 0 C-N-CA 126.898 2.189 . . . . 0.0 113.758 169.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.449 HD21 ' CE3' ' A' ' 47' ' ' TRP . 1.3 tt -116.14 98.54 51.48 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 170.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -74.89 13.8 0.94 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.008 2.472 . . . . 0.0 115.222 -161.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.504 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 42.0 m0 -79.27 156.2 28.19 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.58 1.552 . . . . 0.0 113.079 -168.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -75.98 79.79 2.85 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 170.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -99.56 121.66 41.5 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.022 0.929 . . . . 0.0 108.718 -177.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.08 141.87 41.14 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 118.047 0.385 . . . . 0.0 110.269 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.92 161.15 45.79 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.907 1.738 . . . . 0.0 108.857 163.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.44 -50.38 19.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 177.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.04 165.57 30.39 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 159.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -61.76 -41.57 97.87 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.689 0.677 . . . . 0.0 110.127 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -145.92 157.61 43.89 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 123.726 0.81 . . . . 0.0 112.444 -160.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 50.1 pt -136.54 171.33 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 125.12 1.368 . . . . 0.0 109.252 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -125.01 85.99 2.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.87 1.668 . . . . 0.0 110.814 -178.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.1 t -76.16 127.94 37.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -177.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.87 101.12 9.22 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 167.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 mm -6.21 84.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 127.579 2.352 . . . . 0.0 113.371 -171.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.5 -0.51 49.7 Favored Glycine 0 CA--C 1.539 1.546 0 N-CA-C 115.413 0.925 . . . . 0.0 115.413 171.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -59.69 124.34 19.81 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.023 1.729 . . . . 0.0 109.396 163.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.78 111.75 21.04 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.438 1.095 . . . . 0.0 110.995 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.22 143.27 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.85 128.39 49.63 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.1 pp -143.9 93.17 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.135 1.374 . . . . 0.0 109.308 -173.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 46.6 ttm -73.6 135.96 43.89 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.124 0.969 . . . . 0.0 110.059 -173.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -99.69 141.17 32.84 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 174.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.3 ttt180 -110.85 132.34 54.29 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 174.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.09 141.75 44.24 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 127.052 2.141 . . . . 0.0 107.241 162.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -140.71 145.98 37.18 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 166.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.504 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 34.6 t30 -83.38 87.27 6.98 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 119.024 0.829 . . . . 0.0 113.019 -170.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -79.92 73.53 6.69 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.197 0.999 . . . . 0.0 109.224 172.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.15 140.26 17.46 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 164.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.7 t -78.35 35.4 0.22 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.785 1.175 . . . . 0.0 111.347 174.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.404 ' N ' ' HB3' ' A' ' 110' ' ' PRO . 1.3 p -146.41 154.57 49.29 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 126.392 1.877 . . . . 0.0 108.876 176.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.49 143.33 42.52 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.615 2.21 . . . . 0.0 109.242 176.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.483 ' HG1' ' HE1' ' A' ' 47' ' ' TRP . 4.5 p -117.44 176.72 5.03 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.51 1.124 . . . . 0.0 111.998 -175.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 m -133.43 126.08 30.42 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 103.18 -2.896 . . . . 0.0 103.18 -178.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -127.35 117.24 2.63 Favored Glycine 0 C--N 1.335 0.481 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -171.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? -139.54 -48.57 0.47 Allowed 'General case' 0 C--N 1.338 0.106 0 CA-C-N 117.738 0.769 . . . . 0.0 110.291 174.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 62.84 175.38 0.15 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.22 1.008 . . . . 0.0 110.408 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.3 t -111.3 146.8 36.39 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 165.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -122.18 89.67 3.16 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.254 1.422 . . . . 0.0 108.073 -173.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.73 85.25 4.75 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 174.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.7 t -79.04 70.09 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.844 1.258 . . . . 0.0 109.707 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.5 t -176.74 149.42 0.86 Allowed Pre-proline 0 N--CA 1.469 0.486 0 CA-C-N 119.325 0.966 . . . . 0.0 111.571 170.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -66.22 -37.31 25.14 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.266 1.31 . . . . 0.0 110.088 159.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 11.8 ptp 169.58 -68.67 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 128.305 2.642 . . . . 0.0 106.912 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.74 -45.35 65.01 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.94 0.896 . . . . 0.0 112.966 -170.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.19 -104.4 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.91 -166.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.97 -56.62 1.41 Allowed Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.47 -0.628 . . . . 0.0 112.488 -175.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -44.23 -55.08 5.13 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.594 1.158 . . . . 0.0 111.923 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -72.54 2.66 5.97 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.546 1.538 . . . . 0.0 114.014 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -73.89 90.84 1.94 Allowed 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.522 0.729 . . . . 0.0 109.55 -175.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 . . . . . 0 N--CA 1.447 -0.585 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.602 -167.896 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 . . . . . 0 CA--C 1.536 0.434 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.9 t 36.67 -124.15 0.17 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.987 1.715 . . . . 0.0 114.463 166.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.4 t -142.96 155.13 44.64 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.797 2.039 . . . . 0.0 107.624 -176.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.2 mt -142.63 141.78 31.97 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 170.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.442 ' HB3' ' HD2' ' A' ' 110' ' ' PRO . 2.5 mp0 -76.34 170.65 15.07 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.588 1.555 . . . . 0.0 108.994 171.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 109' ' ' GLU . 46.4 Cg_endo -71.9 106.59 2.04 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 121.807 1.671 . . . . 0.0 113.666 -166.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 116.51 -13.77 15.45 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 124.932 1.253 . . . . 0.0 110.801 172.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -82.4 176.89 9.06 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 123.627 0.251 . . . . 0.0 111.548 -163.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -118.86 144.0 46.63 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.073 0.949 . . . . 0.0 113.194 -150.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.25 84.29 1.95 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.102 1.761 . . . . 0.0 110.027 168.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -101.95 87.79 3.2 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 120.612 -1.305 . . . . 0.0 109.243 171.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 13.2 ttt -102.82 118.82 57.43 Favored Pre-proline 0 N--CA 1.442 -0.869 0 O-C-N 121.454 -0.779 . . . . 0.0 110.275 -167.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.64 152.77 77.62 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.145 1.897 . . . . 0.0 110.358 171.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.5 t -145.43 135.44 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.6 p -99.46 148.08 6.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 166.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -152.43 156.27 39.15 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 118.282 0.492 . . . . 0.0 112.047 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -173.11 176.78 2.89 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 127.149 2.18 . . . . 0.0 108.467 176.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.465 HG22 HD22 ' A' ' 138' ' ' LEU . 78.7 t -131.86 138.66 52.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 124.0 0.92 . . . . 0.0 108.967 176.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -82.88 146.81 53.17 Favored Pre-proline 0 CA--C 1.54 0.593 0 O-C-N 123.452 0.47 . . . . 0.0 111.255 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -56.98 -25.25 61.8 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.95 3.1 . . . . 0.0 113.615 177.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -42.22 -31.13 0.35 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.637 1.575 . . . . 0.0 113.09 175.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.3 tt -49.3 -46.14 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.6 m -85.5 57.07 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 119.425 1.011 . . . . 0.0 110.52 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -132.59 -64.55 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.484 1.114 . . . . 0.0 113.456 173.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -63.86 164.7 20.87 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 121.932 1.754 . . . . 0.0 111.882 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 89.3 t -77.39 -43.8 30.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -173.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -37.8 -46.6 0.94 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 129.037 2.935 . . . . 0.0 112.957 177.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 19.1 p -87.23 -61.93 1.61 Allowed 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -0.97 79.7 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 129.506 3.123 . . . . 0.0 115.098 -171.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 134.82 -44.11 1.21 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 -171.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 12.4 mm -53.46 118.25 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 123.038 0.535 . . . . 0.0 110.075 170.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -156.01 53.84 0.57 Allowed 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.881 168.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.83 91.87 2.4 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 167.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.465 HD22 HG22 ' A' ' 122' ' ' VAL . 1.5 mp -77.0 135.12 38.66 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 -176.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 6.7 t -136.9 150.46 48.24 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.76 106.35 10.43 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 102.785 -3.043 . . . . 0.0 102.785 170.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.6 t -79.61 92.98 5.4 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 172.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.37 121.82 27.19 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 174.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.63 108.85 13.04 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.894 0.878 . . . . 0.0 109.786 -178.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.449 ' CD2' HD13 ' A' ' 45' ' ' LEU . 3.9 m-30 -79.28 80.51 5.64 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.014 1.325 . . . . 0.0 112.792 -167.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -129.58 78.42 75.52 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -97.65 -106.98 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.873 1 C-N-CA 125.418 4.079 . . . . 0.0 111.223 167.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -137.85 113.06 9.25 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.083 1.753 . . . . 0.0 108.046 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -91.11 113.11 57.17 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 123.813 0.845 . . . . 0.0 108.756 170.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -77.23 65.38 7.91 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.131 1.887 . . . . 0.0 108.314 166.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.2 m 26.53 92.58 0.01 OUTLIER 'General case' 0 C--N 1.344 0.326 0 C-N-CA 128.688 2.795 . . . . 0.0 113.964 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.283 0 CA-C-N 119.038 0.835 . . . . 0.0 110.573 -156.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 61' ' ' GLY . . . . . . . . 0 N--CA 1.432 -1.351 0 N-CA-C 103.353 -2.832 . . . . 0.0 103.353 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.4 m -157.89 39.15 0.27 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.318 1.447 . . . . 0.0 109.145 162.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.18 -58.07 1.82 Allowed 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 104.767 -2.308 . . . . 0.0 104.767 -166.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.9 mt -124.87 41.55 3.49 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.432 1.493 . . . . 0.0 109.706 176.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.412 ' C ' HD13 ' A' ' 29' ' ' LEU . 44.3 mt -75.07 110.06 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 162.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.412 HD13 ' C ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -104.17 -174.12 2.47 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 170.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.42 -32.96 70.66 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.363 1.465 . . . . 0.0 114.855 -163.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -53.23 95.95 0.01 OUTLIER 'General case' 0 C--N 1.34 0.178 0 CA-C-O 123.048 1.404 . . . . 0.0 112.72 -173.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.3 ttpp -74.58 88.12 2.15 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 165.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.65 127.51 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.754 -172.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.44 134.28 33.62 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -174.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 t -118.03 139.18 46.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.5 m -113.2 104.55 12.46 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.825 1.25 . . . . 0.0 108.272 -174.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -79.96 148.22 31.29 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.764 173.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -144.19 86.96 1.86 Allowed 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 -175.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.64 90.66 8.5 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.983 1.313 . . . . 0.0 110.505 -173.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -93.09 106.55 18.5 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.513 0.673 . . . . 0.0 109.752 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.0 p -78.44 145.52 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 163.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -156.32 159.43 38.81 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 118.579 0.627 . . . . 0.0 110.266 176.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.31 132.69 29.13 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 172.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.21 -45.33 1.28 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 -160.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.25 97.37 19.94 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 123.699 0.799 . . . . 0.0 109.801 -178.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.82 11.29 2.8 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.525 2.817 . . . . 0.0 113.438 -174.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 42.0 m0 -76.29 145.66 39.46 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.074 -1.016 . . . . 0.0 111.352 -172.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -77.59 83.15 3.99 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 104.87 -2.271 . . . . 0.0 104.87 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -94.59 90.14 6.04 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.616 1.966 . . . . 0.0 108.514 -171.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.2 m -89.15 129.65 47.12 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -176.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.87 149.38 72.37 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 N-CA-C 108.165 -1.513 . . . . 0.0 108.165 164.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.3 -59.2 3.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -128.85 157.09 42.5 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 167.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.9 tpt85 -67.33 -34.36 77.18 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 173.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -134.3 169.47 17.17 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 125.576 1.55 . . . . 0.0 110.689 -174.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.5 pt -136.47 175.87 9.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 124.774 1.23 . . . . 0.0 107.88 166.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.35 136.8 53.17 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 165.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.9 m -126.04 135.1 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 170.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.85 96.04 2.03 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 165.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.438 HD12 ' HB3' ' A' ' 124' ' ' PRO . 4.8 pt 0.23 73.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.994 2.117 . . . . 0.0 114.389 -173.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . 133.28 -27.9 3.36 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 119.934 -0.37 . . . . 0.0 112.821 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -46.74 106.95 0.09 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.239 1.016 . . . . 0.0 111.414 176.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.434 HG22 ' CD1' ' A' ' 121' ' ' PHE . 1.1 p -65.0 113.48 3.91 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.83 0.852 . . . . 0.0 109.386 174.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.3 p -114.8 144.11 23.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 167.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.25 131.06 38.7 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.154 1.782 . . . . 0.0 107.978 176.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -145.67 93.49 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.37 144.61 34.0 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.979 -173.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -110.83 145.26 38.52 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 177.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.5 ttt-85 -118.84 121.29 39.68 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.667 1.187 . . . . 0.0 108.291 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.28 111.0 18.8 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.013 0.925 . . . . 0.0 109.653 169.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -107.98 118.36 36.54 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.975 0.91 . . . . 0.0 110.561 -176.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -79.73 94.32 5.72 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -162.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.5 mt -84.72 73.24 10.63 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.469 0.707 . . . . 0.0 110.556 168.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -127.94 167.83 16.09 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.168 0.987 . . . . 0.0 110.52 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.5 p -78.26 -29.62 48.12 Favored 'General case' 0 C--O 1.227 -0.127 0 C-N-CA 123.467 0.707 . . . . 0.0 111.466 174.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -147.92 162.32 31.67 Favored Pre-proline 0 N--CA 1.449 -0.508 0 C-N-CA 124.742 1.217 . . . . 0.0 108.456 -160.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -59.68 121.17 9.41 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.724 2.282 . . . . 0.0 111.044 -174.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.51 175.42 7.07 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.623 1.569 . . . . 0.0 110.113 -178.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.0 t -138.24 159.28 42.46 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 169.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -138.1 150.93 21.18 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 127.03 2.252 . . . . 0.0 108.551 -173.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.44 HE21 ' N ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -162.56 -39.22 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.21 0.604 . . . . 0.0 110.097 168.534 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.44 ' N ' HE21 ' A' ' 81' ' ' GLN . . . 61.58 -179.52 0.12 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.873 0.869 . . . . 0.0 113.023 176.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.1 t -119.31 166.63 12.78 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 144.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -141.89 88.78 2.14 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.756 1.265 . . . . 0.0 108.015 -176.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -79.13 89.08 4.83 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -177.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.8 t -79.69 86.65 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 173.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.8 t -175.16 151.33 1.33 Allowed Pre-proline 0 C--O 1.232 0.143 0 C-N-CA 125.055 1.342 . . . . 0.0 109.411 170.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.52 -34.61 7.16 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 121.011 1.14 . . . . 0.0 109.156 156.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.8 ptp 171.99 -70.38 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.91 2.484 . . . . 0.0 107.869 -177.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.69 -30.79 26.51 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -165.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.38 -112.93 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.011 0.368 . . . . 0.0 110.086 -177.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.24 -58.62 0.84 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 123.737 0.684 . . . . 0.0 112.735 -174.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -49.44 -53.67 21.67 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.998 0.919 . . . . 0.0 110.365 175.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -73.19 40.4 0.1 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.494 1.118 . . . . 0.0 112.919 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -103.06 140.31 37.46 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 173.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 . . . . . 0 C--O 1.223 -0.341 0 C-N-CA 118.394 -1.322 . . . . 0.0 111.405 173.331 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.2 t -115.3 -61.05 1.8 Allowed 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 124.813 1.245 . . . . 0.0 110.56 -172.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -161.96 146.23 12.55 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.039 1.336 . . . . 0.0 107.427 -178.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.431 HD11 ' HB2' ' A' ' 114' ' ' MET . 94.5 mt -147.79 134.46 19.93 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 174.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -64.55 156.4 77.7 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 127.382 2.273 . . . . 0.0 109.751 170.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.3 92.92 0.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.531 2.821 . . . . 0.0 111.65 -167.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 143.75 -27.32 2.06 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 124.562 1.077 . . . . 0.0 110.991 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -77.97 153.93 32.01 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -153.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -108.6 118.17 36.09 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.591 1.556 . . . . 0.0 110.19 -166.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.431 ' HB2' HD11 ' A' ' 108' ' ' LEU . 14.9 ttp -108.96 86.04 2.21 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 123.834 0.853 . . . . 0.0 110.868 178.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -77.26 129.39 35.84 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 156.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 25.6 mtp -143.35 136.58 13.97 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 118.587 0.63 . . . . 0.0 111.511 159.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -69.95 124.32 10.89 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 123.547 2.831 . . . . 0.0 111.296 171.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.2 t -91.18 152.24 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 160.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.8 p -121.46 143.7 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 167.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -148.65 135.53 19.93 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 118.633 0.651 . . . . 0.0 110.621 -173.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.434 ' CD1' HG22 ' A' ' 63' ' ' THR . 1.0 OUTLIER -159.55 149.05 18.31 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.156 1.382 . . . . 0.0 109.17 174.348 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 92.3 t -100.8 139.17 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.689 1.196 . . . . 0.0 111.441 -173.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -82.91 120.35 76.03 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 177.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.438 ' HB3' HD12 ' A' ' 60' ' ' ILE . 36.4 Cg_endo -58.16 -16.31 27.07 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.827 2.351 . . . . 0.0 113.754 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.87 -27.4 2.09 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 119.518 1.054 . . . . 0.0 111.965 168.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.02 -45.7 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 O-C-N 121.643 -0.66 . . . . 0.0 111.63 175.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.9 m -87.36 56.34 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 O-C-N 121.185 -0.947 . . . . 0.0 109.952 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -138.1 -59.72 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 117.14 -1.409 . . . . 0.0 113.762 175.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.95 161.44 18.42 Favored 'Trans proline' 0 C--N 1.347 0.489 0 CA-C-N 122.573 1.955 . . . . 0.0 113.237 -172.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.1 t -56.2 -36.66 46.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 125.843 1.657 . . . . 0.0 111.0 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -38.84 -54.1 1.65 Allowed 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 126.377 1.871 . . . . 0.0 112.053 176.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.5 p -106.28 -46.19 4.11 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.529 -166.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 14.72 67.05 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.305 2.642 . . . . 0.0 115.652 175.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 127.84 -24.36 5.16 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.676 -0.57 . . . . 0.0 111.676 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.2 mm -60.58 132.02 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 170.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 42.5 pttt -159.51 64.72 0.38 Allowed 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.784 0.802 . . . . 0.0 110.282 167.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 27.7 m -149.19 98.28 2.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 162.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.66 82.75 4.88 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -175.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.1 m -76.7 152.9 35.54 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.985 -169.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.2 tt -136.96 104.47 5.47 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.3 m -86.98 98.25 11.15 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 169.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.92 128.07 33.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 170.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.3 m -135.95 98.44 3.89 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.463 0.649 . . . . 0.0 109.89 -168.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -72.98 92.09 1.62 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.118 1.367 . . . . 0.0 112.111 -174.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -132.25 90.61 33.97 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.394 1.078 . . . . 0.0 113.386 170.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -109.4 -105.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.318 1 C-N-CA 125.381 4.054 . . . . 0.0 109.731 164.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.4 ptt-85 -160.34 124.49 3.66 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.59 1.556 . . . . 0.0 108.25 -174.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -95.78 133.69 25.13 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 123.24 0.616 . . . . 0.0 109.493 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -73.53 -63.16 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.146 1.898 . . . . 0.0 108.729 174.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.5 t -167.41 175.22 7.37 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.827 1.251 . . . . 0.0 107.98 162.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.5 0 C-N-CA 124.5 1.12 . . . . 0.0 111.859 -178.227 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.4 t -160.33 -157.85 0.58 Allowed 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 164.2 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.0 -18.24 61.99 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.953 1.701 . . . . 0.0 109.574 175.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.1 mt -68.1 2.41 2.16 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.641 1.177 . . . . 0.0 113.511 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.4 mt -67.71 126.21 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 121.036 1.744 . . . . 0.0 108.888 172.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.4 mp -126.16 163.0 24.08 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.36 0.664 . . . . 0.0 110.669 -178.074 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -78.56 70.26 4.87 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.703 0.801 . . . . 0.0 111.786 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.15 162.19 27.5 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 153.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -130.84 110.27 11.18 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -174.312 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.411 ' CG2' HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -112.13 125.14 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 -174.532 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -89.39 137.79 32.02 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -178.215 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.2 t -123.98 131.29 73.16 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.7 m -91.59 106.1 18.23 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.412 1.885 . . . . 0.0 108.087 -174.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -80.52 124.72 29.18 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -130.23 84.94 2.24 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 122.233 1.016 . . . . 0.0 111.617 -170.741 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.54 102.31 14.08 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.14 0.976 . . . . 0.0 109.706 177.7 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -99.18 122.25 42.12 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.393 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.6 p -113.01 133.56 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.089 0 C-N-CA 124.162 0.985 . . . . 0.0 109.071 174.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.11 176.15 8.95 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.543 1.137 . . . . 0.0 108.833 179.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.1 122.57 8.74 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 170.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.06 -32.52 1.16 Allowed Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -165.122 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mp -142.63 158.74 59.43 Favored Pre-proline 0 N--CA 1.456 -0.155 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 160.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -90.66 13.31 2.22 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.84 3.027 . . . . 0.0 112.171 165.686 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.444 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 41.7 m0 -78.63 139.76 38.51 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -162.49 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -76.72 83.78 3.34 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.495 ' CZ ' ' HB2' ' A' ' 70' ' ' ALA . 7.2 m-85 -87.71 89.34 7.96 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.317 175.04 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.5 m -87.9 112.9 52.06 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 171.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.1 142.02 54.66 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 N-CA-C 107.659 -1.708 . . . . 0.0 107.659 164.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.423 HG23 HE21 ' A' ' 53' ' ' GLN . 1.5 m -77.54 -41.37 29.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 O-C-N 122.396 -0.19 . . . . 0.0 111.408 -171.3 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.423 HE21 HG23 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -145.97 156.51 43.55 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 167.963 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -65.29 -36.62 84.64 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 177.782 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -151.6 143.75 23.96 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 122.762 0.425 . . . . 0.0 110.99 -174.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.0 pt -105.6 168.36 2.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 123.679 0.792 . . . . 0.0 109.416 174.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -94.05 141.92 27.98 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 152.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.76 123.61 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 157.808 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -75.52 78.82 2.54 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 172.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.411 HG23 ' CG2' ' A' ' 33' ' ' ILE . 2.9 pt 11.97 73.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 127.508 2.323 . . . . 0.0 112.923 -176.497 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.99 -33.44 3.7 Favored Glycine 0 C--O 1.222 -0.643 0 CA-C-O 118.448 -1.195 . . . . 0.0 112.054 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -62.1 140.78 58.39 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 120.225 2.012 . . . . 0.0 110.442 -178.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.13 112.15 16.05 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 127.942 2.497 . . . . 0.0 110.182 -174.041 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 p -79.67 169.01 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.104 0 O-C-N 121.818 -0.551 . . . . 0.0 109.63 174.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.409 HE21 ' HA ' ' A' ' 65' ' ' GLN . 5.2 tp60 -116.39 113.76 23.35 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 124.947 1.299 . . . . 0.0 107.96 156.262 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.4 pp -121.54 126.9 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 159.533 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 33.1 ttp -79.31 151.05 31.29 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 167.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.77 155.61 27.5 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 167.348 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -134.23 145.35 49.07 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.448 1.099 . . . . 0.0 109.299 172.229 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 49' ' ' PHE . . . -135.16 155.97 49.78 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 127.0 2.12 . . . . 0.0 105.943 151.072 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.0 mmmt -137.72 122.1 18.27 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 116.845 -1.55 . . . . 0.0 108.997 176.496 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.444 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 49.9 t-20 -78.22 85.49 4.38 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 121.472 1.942 . . . . 0.0 111.565 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.4 mt -79.1 68.89 5.18 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.788 1.235 . . . . 0.0 109.869 172.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.75 175.02 10.94 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 170.072 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.5 m -106.41 19.4 20.56 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.1 0.56 . . . . 0.0 110.346 173.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.4 p -146.6 161.05 39.6 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 125.777 1.631 . . . . 0.0 108.848 178.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -62.8 156.51 53.17 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 121.502 1.468 . . . . 0.0 110.247 173.568 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.37 162.91 31.27 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 171.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.9 t -116.61 108.22 15.67 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.2 121.61 5.59 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 105.625 -2.99 . . . . 0.0 105.625 162.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.66 -54.06 1.34 Allowed 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 170.734 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.39 178.41 0.16 Allowed 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.884 0.874 . . . . 0.0 110.984 172.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.62 141.63 33.43 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 153.055 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -107.4 162.85 13.55 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 122.681 0.392 . . . . 0.0 110.53 173.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -123.23 111.32 16.33 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 160.374 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.0 t -89.17 56.82 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.616 0.766 . . . . 0.0 110.008 -171.365 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.2 t -172.97 149.97 1.9 Allowed Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 119.911 1.232 . . . . 0.0 112.24 -177.56 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -64.84 -39.46 25.55 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 121.972 1.782 . . . . 0.0 109.676 162.697 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.4 ptp 173.49 -76.79 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 127.537 2.335 . . . . 0.0 108.044 176.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.418 ' HB3' HG13 ' A' ' 135' ' ' ILE . . . -62.16 -43.51 98.66 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 123.938 0.895 . . . . 0.0 112.666 -169.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.04 -103.82 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.718 -161.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.04 -53.91 1.4 Allowed Glycine 0 CA--C 1.527 0.829 0 CA-C-O 119.381 -0.677 . . . . 0.0 113.043 -177.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -45.84 -56.42 5.41 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.49 1.145 . . . . 0.0 110.984 176.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -74.35 4.72 5.42 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.606 1.162 . . . . 0.0 113.83 179.355 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -76.9 107.78 9.48 Favored 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 120.9 -1.125 . . . . 0.0 108.428 177.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 . . . . . 0 N--CA 1.447 -0.602 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.77 -172.712 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.474 0 CA-C-O 118.995 -0.526 . . . . 0.0 111.488 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.8 t 45.66 -148.36 0.11 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.499 1.52 . . . . 0.0 111.92 177.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -93.95 145.54 24.57 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.108 0.963 . . . . 0.0 108.913 176.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.1 mt -136.71 128.14 28.43 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 122.94 0.496 . . . . 0.0 109.897 177.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -54.74 165.21 0.97 Allowed Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 127.255 2.222 . . . . 0.0 110.738 160.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -76.25 126.17 8.99 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.244 1.963 . . . . 0.0 112.457 -172.027 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 98.02 5.16 57.46 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 124.012 0.815 . . . . 0.0 111.298 175.489 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -79.35 133.75 36.59 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 117.242 0.521 . . . . 0.0 110.737 -173.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -102.19 89.28 3.54 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.144 1.378 . . . . 0.0 109.694 -175.322 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.96 87.36 7.35 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -133.51 131.91 40.37 Favored 'General case' 0 CA--C 1.523 -0.075 0 CA-C-N 119.193 0.906 . . . . 0.0 111.411 169.506 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 60.0 mtt -153.07 147.11 18.57 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.173 0.989 . . . . 0.0 109.498 -170.519 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.29 146.84 40.96 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.678 2.919 . . . . 0.0 110.375 173.525 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 28.2 m -138.22 158.77 32.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 123.771 0.828 . . . . 0.0 108.891 165.319 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.6 m -114.6 161.01 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 124.097 0.959 . . . . 0.0 109.104 175.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -159.95 155.77 26.06 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.387 1.075 . . . . 0.0 108.164 -179.216 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -175.27 92.72 0.06 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.975 1.31 . . . . 0.0 111.529 -171.648 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.34 138.56 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 O-C-N 120.691 -1.256 . . . . 0.0 111.714 178.611 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.75 136.24 92.5 Favored Pre-proline 0 N--CA 1.469 0.51 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.487 173.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.57 -29.22 59.34 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.028 1.819 . . . . 0.0 112.104 172.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -44.6 -28.88 0.65 Allowed 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.534 1.533 . . . . 0.0 112.727 174.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 17.7 tt -47.69 -41.05 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 119.375 0.988 . . . . 0.0 112.817 174.345 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.3 m -87.01 58.39 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 119.573 1.079 . . . . 0.0 109.992 175.517 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.401 ' HG2' ' HD3' ' A' ' 129' ' ' PRO 0.486 1.0 OUTLIER -144.28 -52.63 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 117.933 2.568 . . . . 0.0 117.933 172.102 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.401 ' HD3' ' HG2' ' A' ' 128' ' ' LYS . 98.6 Cg_endo -76.79 161.21 33.7 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 CA-C-N 123.368 2.239 . . . . 0.0 112.26 -177.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.78 -42.16 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 124.826 1.25 . . . . 0.0 109.468 -172.404 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -43.26 -47.74 6.58 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 127.528 2.331 . . . . 0.0 112.382 177.254 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 24.2 p -92.95 -53.16 4.26 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -175.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 12.59 62.41 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 129.117 2.967 . . . . 0.0 115.44 -178.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 140.98 -38.73 1.52 Allowed Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -174.133 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.418 HG13 ' HB3' ' A' ' 90' ' ' ALA . 16.8 mm -55.34 113.65 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-N 117.434 0.617 . . . . 0.0 109.864 175.206 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 7.9 pttt -156.52 61.56 0.54 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 121.99 0.9 . . . . 0.0 108.925 169.659 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.89 89.53 1.47 Allowed 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 162.735 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.5 tp -74.99 160.16 30.9 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -171.407 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 12.0 t -153.36 164.75 37.59 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 174.242 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 14.7 tp -138.06 98.27 3.6 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 102.253 -3.24 . . . . 0.0 102.253 173.303 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.9 p -84.24 93.18 8.14 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 177.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.27 131.36 36.14 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 175.324 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.94 96.24 4.98 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.003 0.921 . . . . 0.0 108.677 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.415 ' CE1' ' CZ ' ' A' ' 49' ' ' PHE . 50.4 m-85 -89.62 87.63 7.1 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 125.652 1.581 . . . . 0.0 109.531 178.607 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -135.71 37.35 0.34 Allowed Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 125.378 1.471 . . . . 0.0 114.379 175.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.45 -85.4 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.156 2.571 . . . . 0.0 114.346 -172.638 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.46 91.38 1.57 Allowed 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.592 0.757 . . . . 0.0 110.352 -163.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -78.5 117.74 68.17 Favored Pre-proline 0 N--CA 1.451 -0.387 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 168.378 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.57 -29.42 7.37 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.551 2.167 . . . . 0.0 110.788 172.102 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 36.9 m 130.01 144.0 0.0 OUTLIER 'General case' 0 C--N 1.342 0.263 0 C-N-CA 130.632 3.573 . . . . 0.0 107.36 -167.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.2 pttm . . . . . 0 CA--C 1.534 0.358 0 C-N-CA 124.927 1.291 . . . . 0.0 109.267 177.562 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.486 0 CA-C-O 122.025 0.917 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.79 -11.43 59.99 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.529 1.532 . . . . 0.0 114.757 -147.196 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.35 -31.96 64.25 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 173.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.1 mp -108.09 14.46 25.11 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.023 1.329 . . . . 0.0 112.074 -176.27 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.4 mt -77.98 77.31 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 120.005 -1.684 . . . . 0.0 108.839 173.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.76 179.75 5.93 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.531 0.681 . . . . 0.0 109.893 179.238 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -94.48 59.43 2.51 Favored 'General case' 0 C--N 1.337 0.031 0 C-N-CA 123.827 0.851 . . . . 0.0 112.667 -167.021 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -115.18 160.9 19.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 151.664 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -133.76 88.38 2.47 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.0 tt -94.47 137.91 21.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 C-N-CA 124.477 1.111 . . . . 0.0 111.637 -163.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.441 ' HE2' ' CB ' ' A' ' 55' ' ' ASP . 0.1 OUTLIER -79.71 143.84 34.2 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.635 1.574 . . . . 0.0 109.781 -170.421 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.531 HG21 ' CE1' ' A' ' 120' ' ' PHE . 3.7 t -135.72 142.06 40.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.655 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 164.389 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.9 m -123.29 112.47 17.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 -177.721 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -78.52 89.76 4.48 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 172.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -78.23 85.25 4.4 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 118.492 -1.283 . . . . 0.0 108.395 178.576 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.5 115.78 17.54 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.832 174.758 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -122.94 175.54 6.52 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.595 1.158 . . . . 0.0 108.188 167.039 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.6 p -151.17 148.6 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 169.161 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -164.51 171.54 14.45 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.254 1.022 . . . . 0.0 108.869 -178.302 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.62 -165.36 0.22 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.354 1.462 . . . . 0.0 111.616 -175.4 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.73 52.98 4.26 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 112.123 -0.391 . . . . 0.0 112.123 -173.079 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.412 ' CD1' ' CD1' ' A' ' 144' ' ' PHE . 1.4 tt -111.7 83.77 4.77 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.122 0.969 . . . . 0.0 108.785 177.693 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -85.28 45.0 1.5 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.246 3.298 . . . . 0.0 109.736 -170.141 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.438 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 43.1 m0 -108.39 138.58 44.43 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -172.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.408 ' OE1' ' NZ ' ' A' ' 71' ' ' LYS . 73.2 tt0 -77.85 82.36 4.23 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 -178.503 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -90.26 122.01 32.79 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.715 1.206 . . . . 0.0 108.233 179.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 m -126.67 135.54 27.43 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.144 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -70.76 162.39 42.76 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 N-CA-C 108.146 -1.521 . . . . 0.0 108.146 161.433 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -60.18 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 175.117 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -144.06 154.13 42.91 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 164.773 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.03 -42.72 69.45 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 118.537 -0.744 . . . . 0.0 112.095 -175.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.441 ' CB ' ' HE2' ' A' ' 34' ' ' LYS . 23.7 p-10 -145.35 159.69 42.67 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 119.382 0.992 . . . . 0.0 113.189 -166.623 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.8 pt -133.82 159.79 42.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 125.768 1.627 . . . . 0.0 107.847 178.193 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -128.29 85.41 2.34 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.316 1.446 . . . . 0.0 109.124 178.189 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.8 m -80.44 141.83 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 O-C-N 121.255 -0.903 . . . . 0.0 110.689 -171.281 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -78.22 72.16 4.74 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 173.078 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.5 pt 19.01 64.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 127.437 2.295 . . . . 0.0 113.489 176.368 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 139.0 -43.8 1.14 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -172.58 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -59.68 130.3 46.16 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.648 -173.467 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.467 HG23 ' CD1' ' A' ' 121' ' ' PHE . 1.6 m -106.69 87.28 2.49 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.003 -146.106 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.72 144.19 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 CA-C-O 121.094 0.473 . . . . 0.0 110.696 -170.538 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.93 115.54 24.4 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.239 1.016 . . . . 0.0 108.591 168.817 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.8 pp -115.57 115.04 48.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 164.044 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -87.49 155.23 20.09 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.939 -0.475 . . . . 0.0 110.966 178.387 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -127.0 153.78 45.46 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 172.73 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -134.69 141.79 46.64 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.877 1.671 . . . . 0.0 107.898 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.34 115.58 7.98 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.805 2.042 . . . . 0.0 107.681 174.387 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.408 ' NZ ' ' OE1' ' A' ' 48' ' ' GLU . 3.0 mtmp? -114.73 124.42 51.73 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.29 0.95 . . . . 0.0 110.652 -176.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.438 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 46.9 t-20 -80.92 107.2 13.53 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.79 0.723 . . . . 0.0 112.932 -167.583 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.3 mp -99.08 30.4 3.45 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.495 1.118 . . . . 0.0 111.974 176.649 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.85 176.81 9.39 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.021 -1.049 . . . . 0.0 110.401 168.084 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.1 t -114.07 18.1 17.37 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.221 0.608 . . . . 0.0 109.929 161.646 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 p -146.65 156.42 48.61 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 125.639 1.576 . . . . 0.0 107.736 174.405 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -63.23 145.1 93.05 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 N-CA-C 108.122 -1.53 . . . . 0.0 108.122 172.138 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.5 p -123.08 168.25 12.61 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.644 0.735 . . . . 0.0 111.299 178.716 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.8 m -93.63 144.88 24.98 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 168.354 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -168.74 56.9 0.21 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 176.525 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.91 57.78 0.86 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.018 1.727 . . . . 0.0 108.405 -174.374 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.62 166.46 23.52 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.94 0.876 . . . . 0.0 112.879 -168.036 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.48 97.55 8.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 176.512 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -77.23 140.24 40.05 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.544 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -85.76 88.61 7.57 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -172.634 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -76.97 77.91 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 C-N-CA 125.043 1.337 . . . . 0.0 110.435 -176.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.8 t 178.88 147.64 0.39 Allowed Pre-proline 0 N--CA 1.46 0.029 0 C-N-CA 124.932 1.293 . . . . 0.0 109.343 173.324 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -66.75 -35.19 28.86 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.146 1.23 . . . . 0.0 110.274 158.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.0 ptp 175.36 -70.78 0.01 OUTLIER 'General case' 0 C--N 1.341 0.206 0 C-N-CA 126.902 2.081 . . . . 0.0 107.571 179.244 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.0 -36.61 48.59 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.962 0.905 . . . . 0.0 113.011 -167.788 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.77 -109.62 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.608 0.242 . . . . 0.0 111.58 -167.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.79 -49.69 0.84 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.417 1.008 . . . . 0.0 113.528 -176.111 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.55 -57.52 4.66 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.594 1.197 . . . . 0.0 109.802 172.254 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -73.69 5.01 4.31 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.498 1.919 . . . . 0.0 113.895 -178.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -85.72 126.58 34.08 Favored 'General case' 0 C--N 1.344 0.343 0 O-C-N 121.232 -0.918 . . . . 0.0 108.649 174.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 . . . . . 0 N--CA 1.452 -0.327 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.179 -179.459 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 CA--C 1.538 0.496 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.1 t -88.5 -165.78 1.42 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.051 0.94 . . . . 0.0 110.05 174.687 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.5 t -76.69 144.15 39.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.198 0.999 . . . . 0.0 110.04 -175.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 81.0 mt -127.25 134.87 50.01 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.538 1.135 . . . . 0.0 108.15 -179.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -69.55 157.08 90.44 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 170.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.43 100.21 0.88 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.373 2.716 . . . . 0.0 110.438 -170.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.31 -23.44 3.31 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -175.208 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -78.95 135.78 37.05 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 118.254 1.027 . . . . 0.0 111.707 -160.727 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -92.61 104.56 16.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.4 1.48 . . . . 0.0 109.375 178.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -90.56 135.13 33.9 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 174.042 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -151.46 154.99 37.65 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.625 0.37 . . . . 0.0 110.639 156.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 78.6 mtp -151.77 146.05 18.36 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.161 0.984 . . . . 0.0 109.578 171.495 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -66.12 137.97 50.17 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.126 2.55 . . . . 0.0 110.443 161.79 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.8 t -107.96 130.47 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 159.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.3 m -98.49 140.82 17.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 171.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.531 ' CE1' HG21 ' A' ' 35' ' ' VAL . 64.3 t80 -154.43 149.37 26.72 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -162.322 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.467 ' CD1' HG23 ' A' ' 63' ' ' THR . 41.1 p90 -164.5 170.29 16.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.415 1.886 . . . . 0.0 109.108 165.314 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 70.7 t -103.99 135.46 41.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 174.482 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -76.37 134.2 70.47 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 119.119 -0.467 . . . . 0.0 109.954 176.397 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -74.16 67.34 5.16 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.384 2.723 . . . . 0.0 110.292 171.42 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -133.52 -37.82 0.94 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 126.799 2.04 . . . . 0.0 111.027 176.565 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.4 tt -43.87 -41.66 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 125.012 1.325 . . . . 0.0 113.414 173.111 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.9 m -78.23 49.03 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 O-C-N 121.394 -0.816 . . . . 0.0 111.34 176.825 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.9 mttt -142.72 -64.51 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 117.521 -1.228 . . . . 0.0 111.617 -179.299 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.17 153.17 46.03 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 121.942 1.729 . . . . 0.0 112.736 -176.548 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.8 t -54.87 -35.54 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 125.838 1.655 . . . . 0.0 110.662 175.897 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -35.26 -59.16 0.53 Allowed 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 126.656 1.983 . . . . 0.0 112.309 175.79 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.5 p -106.94 -42.73 4.84 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.015 -166.068 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 14.07 63.15 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 128.389 2.675 . . . . 0.0 116.235 172.151 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 136.73 -36.73 1.95 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -177.272 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 29.8 mm -53.28 123.52 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 171.444 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.38 47.86 0.35 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.288 0.566 . . . . 0.0 112.102 177.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.5 p -143.65 89.04 2.03 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 105.809 -1.922 . . . . 0.0 105.809 174.025 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 tp -92.71 87.21 5.8 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.029 -159.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.5 t -97.86 155.85 16.87 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.457 0.703 . . . . 0.0 111.084 -166.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.76 133.25 55.98 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 160.704 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 44.5 m -90.94 105.77 18.06 Favored 'General case' 0 N--CA 1.46 0.043 0 O-C-N 123.902 0.751 . . . . 0.0 109.035 160.452 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -76.27 99.8 4.89 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 165.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 53.5 m -117.34 86.35 2.5 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.978 1.311 . . . . 0.0 107.524 175.18 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.412 ' CD1' ' CD1' ' A' ' 45' ' ' LEU . 48.2 m-85 -59.22 145.2 43.67 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.322 1.049 . . . . 0.0 112.828 174.392 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -166.85 52.69 0.25 Allowed Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.966 1.707 . . . . 0.0 112.342 -175.435 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.3 -90.04 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.679 2.252 . . . . 0.0 115.092 -168.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -155.16 179.55 9.04 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 129.697 3.199 . . . . 0.0 104.863 -175.119 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -147.13 94.56 4.54 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 118.488 0.585 . . . . 0.0 111.044 -171.462 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -91.94 -124.37 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.984 3.122 . . . . 0.0 108.954 176.664 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 85.5 p -123.2 123.76 41.5 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 120.356 1.435 . . . . 0.0 111.763 -172.706 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.595 0 C-N-CA 126.496 1.918 . . . . 0.0 109.237 174.333 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.631 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.75 11.9 0.95 Allowed 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 126.802 2.041 . . . . 0.0 115.322 -164.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -77.25 -39.12 49.44 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 159.452 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.4 mp -92.22 -37.91 12.41 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 117.209 -1.377 . . . . 0.0 113.016 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.2 mt -32.53 133.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -162.13 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 29' ' ' LEU . 2.5 mm? -105.91 -104.15 0.33 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.159 -173.618 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -173.59 -49.2 0.01 OUTLIER 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.058 1.343 . . . . 0.0 108.855 -171.348 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -38.78 134.6 0.95 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.002 1.721 . . . . 0.0 110.678 -178.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -100.97 86.65 3.1 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -165.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.98 115.01 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.436 1.494 . . . . 0.0 107.953 -171.424 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.99 160.01 29.48 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -173.641 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.0 t -148.74 145.19 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.1 m -138.55 100.28 4.05 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -170.053 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -78.11 145.0 36.0 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.018 0.527 . . . . 0.0 109.919 -176.177 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -127.63 82.75 2.11 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.913 0.863 . . . . 0.0 110.007 178.22 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.49 102.16 14.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 172.118 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -116.89 128.37 55.18 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 122.292 1.044 . . . . 0.0 112.126 -174.666 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.0 p -99.83 96.29 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.564 -174.252 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.12 171.1 10.5 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 122.048 0.928 . . . . 0.0 111.406 174.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.41 132.07 52.0 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 169.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 128.33 -39.28 1.92 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -170.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.484 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -131.56 95.57 23.21 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 117.56 0.68 . . . . 0.0 110.277 -176.363 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -83.94 50.94 3.27 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.956 2.437 . . . . 0.0 109.651 -176.136 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.484 ' CD2' ' CD2' ' A' ' 45' ' ' LEU . 44.4 m0 -107.91 135.56 49.1 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -173.649 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -79.36 84.5 5.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 103.484 -2.784 . . . . 0.0 103.484 179.246 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -102.04 86.15 2.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -171.598 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.3 m -88.04 129.14 51.2 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -167.28 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.09 122.49 9.58 Favored 'Trans proline' 0 N--CA 1.446 -1.277 0 N-CA-C 106.261 -2.246 . . . . 0.0 106.261 162.466 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.1 m -72.73 -32.08 39.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.181 0.515 . . . . 0.0 110.691 -168.387 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.02 161.98 34.16 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 150.265 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -62.65 -46.72 86.89 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 172.532 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -147.38 153.54 39.77 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 124.415 1.086 . . . . 0.0 111.659 -159.647 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.4 pt -133.13 179.23 4.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 126.326 1.851 . . . . 0.0 108.251 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -125.47 160.18 30.11 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.345 0.593 . . . . 0.0 110.21 149.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.6 t -116.72 145.97 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 127.99 2.516 . . . . 0.0 105.679 171.014 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 49.5 mmm-85 -91.37 100.81 13.53 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 168.021 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mt -33.2 115.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -148.243 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.58 -25.2 26.49 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.071 1.319 . . . . 0.0 110.936 -179.386 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -64.9 133.45 51.86 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.806 1.303 . . . . 0.0 112.422 -172.33 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.15 101.53 7.97 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 130.05 3.34 . . . . 0.0 110.818 -175.38 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.9 p -113.78 153.75 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.292 1.437 . . . . 0.0 109.491 -178.597 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -112.51 125.15 53.93 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 125.404 1.482 . . . . 0.0 109.343 -177.38 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.0 pp -128.48 122.86 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 167.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.412 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 66.4 mtt -76.09 168.44 20.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.614 174.164 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -136.17 143.21 44.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 161.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.7 ttt85 -121.01 118.7 30.5 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 179.546 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.3 105.15 9.24 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 125.822 1.649 . . . . 0.0 110.035 -177.216 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.29 121.09 44.36 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.064 -0.398 . . . . 0.0 110.749 -168.603 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.44 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 47.8 t-20 -78.38 111.9 14.85 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.803 -0.561 . . . . 0.0 111.912 -167.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.2 tp -98.41 11.24 38.77 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.812 0.845 . . . . 0.0 112.381 179.564 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.46 166.67 22.33 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.272 -0.893 . . . . 0.0 109.95 173.44 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 70.0 m -103.3 7.0 38.35 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.968 0.907 . . . . 0.0 111.835 171.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.34 159.61 38.79 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 126.134 1.773 . . . . 0.0 107.041 177.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.97 126.04 12.11 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.171 1.914 . . . . 0.0 111.255 -173.208 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.476 ' HG1' ' HE1' ' A' ' 47' ' ' TRP . 0.2 OUTLIER -80.49 173.53 12.51 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.821 0.849 . . . . 0.0 110.784 -178.998 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 50.7 p -131.45 72.03 1.49 Allowed 'General case' 0 C--O 1.232 0.137 0 C-N-CA 122.551 0.341 . . . . 0.0 110.426 -170.893 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.42 139.37 37.39 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.946 -0.462 . . . . 0.0 111.946 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -166.81 34.19 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.659 1.983 . . . . 0.0 109.44 169.222 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.58 159.08 34.47 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.33 0.652 . . . . 0.0 111.445 -165.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.9 t -87.77 131.51 34.48 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.704 0.764 . . . . 0.0 110.039 177.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.409 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -104.03 89.93 3.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.871 2.468 . . . . 0.0 105.572 175.509 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -77.0 91.92 3.67 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 120.882 -1.136 . . . . 0.0 107.935 -177.617 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 84' ' ' PHE . 7.8 t -78.11 72.57 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.612 1.165 . . . . 0.0 109.973 -174.043 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.9 t -168.73 134.76 1.49 Allowed Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 119.901 1.228 . . . . 0.0 113.389 173.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -74.1 67.72 5.04 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 122.386 2.057 . . . . 0.0 107.243 156.257 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 22.2 ptm 44.19 25.47 0.11 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 170.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -171.41 -58.26 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 119.384 0.993 . . . . 0.0 110.594 -168.411 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.61 -101.2 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -177.282 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 64.05 -52.1 0.08 OUTLIER Glycine 0 CA--C 1.538 1.481 0 N-CA-C 115.413 0.925 . . . . 0.0 115.413 -175.534 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -45.73 -47.63 15.33 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.553 1.541 . . . . 0.0 110.808 172.217 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -73.85 -12.69 60.75 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 127.012 2.125 . . . . 0.0 113.471 178.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.403 ' CD2' HD23 ' A' ' 138' ' ' LEU . 9.0 t80 -67.55 140.0 56.95 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.119 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.465 ' ND2' ' H ' ' A' ' 96' ' ' ASN . 1.4 p30 . . . . . 0 C--N 1.328 -0.361 0 C-N-CA 124.967 1.307 . . . . 0.0 110.765 -177.33 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.3 t 51.67 -146.64 0.47 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.441 1.096 . . . . 0.0 112.472 170.606 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.6 m -115.54 136.65 52.86 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.089 1.355 . . . . 0.0 108.542 -172.069 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 78.6 mt -128.44 147.95 50.69 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.39 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -73.29 156.42 89.15 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 172.354 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.23 85.87 0.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 124.88 3.72 . . . . 0.0 111.756 -173.064 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 152.74 -27.23 0.83 Allowed Glycine 0 CA--C 1.522 0.5 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.25 -177.777 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -77.86 143.45 37.79 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 118.085 0.942 . . . . 0.0 111.593 -157.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -105.21 96.9 6.84 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.811 1.244 . . . . 0.0 109.942 -175.603 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 15.4 tpt -83.92 89.21 7.18 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.114 1.365 . . . . 0.0 109.325 -177.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -99.21 134.21 42.4 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.256 0.622 . . . . 0.0 109.576 172.148 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 22.4 ptm -150.95 146.31 19.11 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.996 -0.526 . . . . 0.0 111.441 178.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 67' ' ' MET . 83.1 Cg_endo -79.58 147.77 20.05 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.883 3.055 . . . . 0.0 111.049 171.852 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.5 t -126.53 114.89 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 165.199 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.5 p -79.41 143.47 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 168.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -155.61 149.11 24.98 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.163 0.585 . . . . 0.0 109.949 -165.411 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.408 ' H ' ' ND2' ' A' ' 96' ' ' ASN . 18.6 p90 -171.18 118.98 0.48 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.36 1.464 . . . . 0.0 111.893 176.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.8 t -64.09 133.39 29.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 O-C-N 120.355 -1.466 . . . . 0.0 109.505 175.317 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -91.61 132.39 33.44 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 123.701 0.801 . . . . 0.0 109.8 -179.053 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -46.35 -31.52 9.55 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.402 3.401 . . . . 0.0 114.919 177.342 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -48.94 -24.2 1.4 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.783 1.633 . . . . 0.0 112.39 179.183 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.1 tt -49.01 -44.46 15.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 169.097 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.9 m -83.38 59.66 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 118.571 0.623 . . . . 0.0 109.895 174.354 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -111.0 -77.41 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 117.168 -1.396 . . . . 0.0 110.366 164.628 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.54 156.05 45.12 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 CA-C-N 121.885 1.709 . . . . 0.0 111.666 -177.384 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.6 m -62.16 -36.08 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 124.94 1.296 . . . . 0.0 112.045 -170.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -60.6 -64.46 0.94 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.147 0.979 . . . . 0.0 109.281 177.587 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 44.6 p -72.61 -15.43 61.73 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 118.509 -0.758 . . . . 0.0 111.568 -172.419 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.04 -41.52 5.53 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.768 0.713 . . . . 0.0 111.221 162.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.34 -29.17 74.38 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 112.237 -0.345 . . . . 0.0 112.237 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.3 mm -83.88 125.94 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 122.079 0.942 . . . . 0.0 110.39 -177.629 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 28.3 pttt -148.81 63.76 1.06 Allowed 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.506 153.751 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 11.7 m -150.15 95.33 2.26 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 158.416 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.403 HD23 ' CD2' ' A' ' 95' ' ' PHE . 1.2 tp -75.48 144.79 41.87 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -173.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.8 t -141.8 173.38 11.56 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.496 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.1 tt -150.63 111.28 4.25 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 177.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.45 92.94 8.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.515 1.126 . . . . 0.0 109.252 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.94 108.4 19.17 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.877 1.271 . . . . 0.0 108.783 179.406 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.66 89.09 3.58 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 122.009 0.909 . . . . 0.0 109.747 -177.358 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -71.23 85.57 0.77 Allowed 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.281 177.058 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.1 47.59 2.8 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -178.703 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -80.89 -105.74 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.279 2.653 . . . . 0.0 111.967 178.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -140.95 121.68 14.34 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.648 1.179 . . . . 0.0 108.528 -171.242 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.9 111.22 38.82 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 125.654 1.581 . . . . 0.0 107.118 -177.128 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.431 ' HD3' HG23 ' A' ' 78' ' ' THR . 26.6 Cg_endo -83.3 -4.85 11.07 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.293 2.662 . . . . 0.0 113.043 -172.742 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.9 t 131.51 103.71 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 129.972 3.309 . . . . 0.0 109.754 174.481 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.542 0.669 0 C-N-CA 125.256 1.423 . . . . 0.0 111.723 168.356 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.24 0 N-CA-C 104.354 -2.462 . . . . 0.0 104.354 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.6 t -147.88 49.54 1.06 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 122.493 1.14 . . . . 0.0 108.227 174.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -158.8 -57.42 0.07 Allowed 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 127.306 2.243 . . . . 0.0 106.309 -174.367 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.9 mt -65.53 -16.48 63.72 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.907 2.083 . . . . 0.0 112.878 -177.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.4 mt -75.67 78.51 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 O-C-N 121.21 -0.931 . . . . 0.0 110.267 -171.566 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.69 -127.7 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.555 1.142 . . . . 0.0 108.524 169.679 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -104.36 -51.33 3.13 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.57 1.548 . . . . 0.0 111.939 -164.506 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -43.1 102.07 0.03 OUTLIER 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.194 1.398 . . . . 0.0 113.351 -169.806 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.69 81.52 4.99 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 177.261 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -97.11 122.58 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -160.616 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.7 150.48 34.48 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.943 1.297 . . . . 0.0 108.199 -175.216 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.52 146.9 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 174.497 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.9 m -125.83 112.19 15.73 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -172.69 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -77.88 136.18 38.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.754 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -126.71 84.45 2.27 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 122.502 1.144 . . . . 0.0 108.965 177.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.91 95.75 10.28 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.374 1.07 . . . . 0.0 110.972 -176.753 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -98.63 109.5 22.24 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.375 0.67 . . . . 0.0 109.79 -177.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.0 p -79.24 148.86 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 164.388 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -151.04 158.71 44.44 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 171.216 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.05 -40.15 10.25 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.84 0.856 . . . . 0.0 112.109 -177.214 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -41.58 -31.98 0.76 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.812 1.672 . . . . 0.0 114.151 174.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.487 HD21 ' CE3' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -130.17 110.13 16.68 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 118.688 1.244 . . . . 0.0 108.471 170.488 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -75.27 0.95 8.4 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.294 1.996 . . . . 0.0 115.576 -164.035 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.517 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 42.2 m0 -79.57 153.45 29.46 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.38 1.472 . . . . 0.0 113.613 -159.844 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.42 ' O ' HG23 ' A' ' 50' ' ' VAL . 4.1 tt0 -77.47 77.46 4.0 Favored 'General case' 0 C--N 1.344 0.344 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.615 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -84.6 110.72 18.93 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.684 1.193 . . . . 0.0 109.098 -171.484 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 48' ' ' GLU . 42.9 t -122.78 118.81 28.25 Favored Pre-proline 0 N--CA 1.444 -0.758 0 C-N-CA 124.4 1.08 . . . . 0.0 108.645 -163.638 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -81.87 174.56 10.13 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 124.543 3.495 . . . . 0.0 108.554 168.367 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -98.6 -53.12 8.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 123.949 0.9 . . . . 0.0 110.845 -173.622 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -134.16 175.15 9.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 166.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.6 tpt85 -68.45 -33.15 73.68 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.392 168.636 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -144.67 173.44 11.82 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.842 1.257 . . . . 0.0 112.694 -162.861 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.1 pt -141.65 178.2 2.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 127.206 2.203 . . . . 0.0 106.788 165.567 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -132.27 162.77 30.16 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 146.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.23 136.92 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 126.953 2.101 . . . . 0.0 105.836 -175.199 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.94 88.66 3.5 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 163.205 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.2 pt 8.81 69.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 127.74 2.416 . . . . 0.0 114.63 178.469 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.55 -37.55 1.78 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 123.41 0.529 . . . . 0.0 112.305 -176.594 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -39.24 104.43 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.383 1.473 . . . . 0.0 110.849 177.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.59 HG23 ' CD1' ' A' ' 121' ' ' PHE . 1.2 m -87.46 88.45 7.68 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.353 -156.25 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 p -92.73 161.67 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 O-C-N 121.933 -0.479 . . . . 0.0 111.721 -168.434 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.46 HE21 ' HA ' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -102.98 126.74 50.28 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.959 1.303 . . . . 0.0 110.35 169.561 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.5 pp -131.33 114.03 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 107.319 -1.364 . . . . 0.0 107.319 167.443 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.0 ttp -77.86 161.52 27.55 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.378 0.671 . . . . 0.0 110.862 -176.861 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -134.57 150.96 50.78 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.436 1.094 . . . . 0.0 108.846 169.325 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 54.1 ttp85 -143.46 147.08 34.0 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.997 0.919 . . . . 0.0 110.111 -178.457 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.39 109.68 2.66 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.632 1.573 . . . . 0.0 111.765 -177.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -86.09 139.28 31.27 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.989 171.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.517 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 28.1 t30 -78.21 88.99 4.27 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.073 0.851 . . . . 0.0 112.127 168.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.9 mp -76.76 69.08 3.08 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 171.193 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -153.66 137.26 15.99 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 168.513 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.1 t -80.14 36.1 0.34 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.369 0.531 . . . . 0.0 110.754 178.083 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.8 p -149.91 155.47 37.98 Favored Pre-proline 0 C--O 1.237 0.395 0 C-N-CA 126.63 1.972 . . . . 0.0 106.995 174.307 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -63.23 148.14 93.3 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 N-CA-C 108.208 -1.497 . . . . 0.0 108.208 168.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.01 175.06 6.53 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.792 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.0 m -105.65 145.25 31.28 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.121 1.768 . . . . 0.0 106.875 175.39 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -133.65 126.14 4.2 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 107.096 -2.401 . . . . 0.0 107.096 172.494 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.18 54.77 0.12 Allowed 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 166.78 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.44 144.83 15.9 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.884 176.162 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.3 t -85.01 166.08 17.02 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 168.185 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -146.41 95.96 2.69 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -168.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.33 86.92 5.02 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 175.509 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.0 t -78.12 60.23 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.817 1.247 . . . . 0.0 108.776 -175.034 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.1 t -171.44 148.34 2.3 Favored Pre-proline 0 CA--C 1.522 -0.129 0 O-C-N 121.481 -0.762 . . . . 0.0 111.636 178.077 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -61.57 -41.26 40.99 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 121.758 1.639 . . . . 0.0 110.068 159.031 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.3 ptp 172.08 -77.72 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 127.124 2.17 . . . . 0.0 107.59 178.399 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.87 -29.87 63.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.634 1.174 . . . . 0.0 112.292 -170.287 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.9 -119.11 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -174.028 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.89 -50.56 2.25 Favored Glycine 0 CA--C 1.528 0.874 0 O-C-N 121.348 -0.845 . . . . 0.0 113.192 178.204 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -44.93 -54.54 6.38 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.159 0.984 . . . . 0.0 110.014 171.555 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -75.39 -4.26 38.41 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.508 1.923 . . . . 0.0 113.96 -179.053 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -69.37 133.55 47.95 Favored 'General case' 0 C--N 1.341 0.227 0 O-C-N 121.093 -1.004 . . . . 0.0 108.486 178.449 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 . . . . . 0 N--CA 1.453 -0.289 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.684 177.931 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 . . . . . 0 CA--C 1.535 0.403 0 CA-C-O 121.149 0.5 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.7 t -111.52 -57.68 2.22 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 128.711 2.804 . . . . 0.0 111.378 -167.6 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.8 t -163.65 140.34 6.97 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 122.849 0.46 . . . . 0.0 110.385 -170.845 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.661 HD11 ' HB2' ' A' ' 114' ' ' MET . 39.7 mt -139.32 143.73 37.96 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.207 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.444 ' HB3' ' HD2' ' A' ' 110' ' ' PRO . 2.8 mt-10 -80.44 172.95 8.53 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.76 1.224 . . . . 0.0 109.349 -179.48 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 109' ' ' GLU . 35.2 Cg_endo -68.0 79.89 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.535 2.823 . . . . 0.0 114.465 -162.041 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 147.87 -29.89 1.39 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.307 0.956 . . . . 0.0 112.181 172.107 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -82.21 158.56 23.51 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 118.226 -1.39 . . . . 0.0 112.318 -139.61 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -84.61 123.26 30.13 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 124.64 1.176 . . . . 0.0 110.268 179.59 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.661 ' HB2' HD11 ' A' ' 108' ' ' LEU . 0.9 OUTLIER -90.22 128.61 36.42 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 154.89 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -134.0 146.42 50.4 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 159.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 56.7 mtt -146.61 146.63 27.59 Favored Pre-proline 0 N--CA 1.453 -0.323 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 165.087 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -71.55 142.58 40.61 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 122.101 1.868 . . . . 0.0 109.412 160.232 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.4 t -115.77 143.83 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 164.026 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.0 p -102.28 145.49 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 174.608 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -145.9 138.09 25.36 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.335 0.516 . . . . 0.0 111.425 -176.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.59 ' CD1' HG23 ' A' ' 63' ' ' THR . 5.9 p90 -159.07 162.25 36.56 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.569 1.548 . . . . 0.0 107.43 160.559 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 94.8 t -104.72 131.27 54.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 174.789 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.18 135.23 47.85 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 175.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -75.49 57.85 5.0 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 124.578 3.519 . . . . 0.0 112.673 -176.414 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.24 -36.47 7.63 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 125.57 1.548 . . . . 0.0 109.864 168.3 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.8 tt -47.75 -46.57 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -169.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.3 m -81.19 53.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.448 -0.783 . . . . 0.0 110.785 -178.444 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -138.28 -64.51 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 117.661 -1.161 . . . . 0.0 112.085 -179.371 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.67 156.33 35.64 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 CA-C-N 121.961 1.736 . . . . 0.0 113.406 -176.053 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.2 t -54.11 -39.46 42.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 126.201 1.8 . . . . 0.0 110.742 177.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -45.92 -55.72 6.38 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.697 1.599 . . . . 0.0 111.8 -178.523 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.3 p -92.37 -42.89 9.53 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 118.633 -0.699 . . . . 0.0 111.442 -176.313 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 7.93 65.13 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 128.403 2.681 . . . . 0.0 116.129 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 142.37 -41.34 1.2 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -173.709 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.7 mm -57.27 120.13 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 CA-C-N 117.689 0.744 . . . . 0.0 110.178 177.23 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -157.38 66.45 0.5 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.672 0.749 . . . . 0.0 110.173 162.578 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 10.6 m -147.51 102.72 3.48 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 152.206 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.68 151.76 34.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -175.243 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.7 t -154.08 175.13 13.79 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.408 0.623 . . . . 0.0 109.647 -177.269 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.9 tp -153.7 97.13 2.07 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 103.216 -2.883 . . . . 0.0 103.216 -169.278 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.5 t -81.78 88.09 6.32 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 171.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.79 124.4 27.64 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 176.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.423 HG22 ' CD1' ' A' ' 145' ' ' TYR . 23.8 m -133.38 95.52 3.53 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.412 1.101 . . . . 0.0 109.229 -164.468 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -74.22 74.42 1.8 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.041 1.736 . . . . 0.0 111.94 -171.007 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.423 ' CD1' HG22 ' A' ' 143' ' ' THR . 38.8 m-85 -128.35 68.48 77.23 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.349 1.06 . . . . 0.0 113.758 179.566 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -87.69 -103.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.775 2.983 . . . . 0.0 110.666 167.502 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -156.26 99.66 1.94 Allowed 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.8 1.24 . . . . 0.0 108.907 -172.117 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -104.56 134.0 19.89 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 126.432 1.893 . . . . 0.0 106.403 167.614 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.0 -47.3 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.445 2.097 . . . . 0.0 110.638 178.304 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.2 t 166.65 112.4 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 129.202 3.001 . . . . 0.0 104.822 178.486 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.7 pttt . . . . . 0 CA--C 1.535 0.4 0 CA-C-N 119.584 1.083 . . . . 0.0 110.409 -168.921 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.703 0 CA-C-O 122.711 1.244 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.4 p -76.49 1.66 15.93 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 128.075 2.55 . . . . 0.0 114.58 -164.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -78.56 -21.38 48.78 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 164.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.6 mt -115.32 -26.73 7.48 Favored 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 125.43 1.492 . . . . 0.0 113.134 -171.204 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.7 mt -40.55 -72.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.966 1.706 . . . . 0.0 115.389 -170.555 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.461 HD23 ' N ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER 64.99 167.55 0.18 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 127.449 2.3 . . . . 0.0 113.096 -176.036 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -76.57 57.82 1.28 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.521 1.528 . . . . 0.0 111.537 -177.394 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.53 ' HB3' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -134.04 170.74 15.19 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 126.111 1.764 . . . . 0.0 107.041 173.525 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -150.38 111.61 4.4 Favored 'General case' 0 N--CA 1.422 -1.855 0 C-N-CA 124.462 1.105 . . . . 0.0 109.217 177.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.9 tt -93.26 144.34 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 174.018 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.73 152.18 20.39 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 125.83 1.652 . . . . 0.0 109.033 177.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.6 t -136.95 144.24 32.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 175.54 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.6 m -136.19 94.3 3.02 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -171.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -75.04 163.85 27.16 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -175.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -142.44 85.34 1.9 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 122.217 1.008 . . . . 0.0 109.406 -178.727 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.457 ' HB1' ' CE2' ' A' ' 49' ' ' PHE . . . -89.57 102.79 15.47 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 121.586 -0.696 . . . . 0.0 110.25 -179.614 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -95.46 168.32 10.78 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 123.432 0.693 . . . . 0.0 109.616 177.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.4 t -134.49 151.82 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 167.802 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.65 153.58 47.34 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 166.446 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.46 -35.89 13.89 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.856 0.862 . . . . 0.0 112.358 -174.643 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -37.19 -41.54 0.71 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.71 1.624 . . . . 0.0 113.511 172.111 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.642 HD21 ' CE3' ' A' ' 47' ' ' TRP . 3.9 tt -116.67 107.72 46.1 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 118.187 0.993 . . . . 0.0 108.388 175.023 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -78.35 21.1 0.71 Allowed 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.006 1.804 . . . . 0.0 114.92 -161.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.642 ' CE3' HD21 ' A' ' 45' ' ' LEU . 50.0 m0 -101.39 147.73 25.99 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.435 1.016 . . . . 0.0 113.212 -160.83 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -78.31 88.95 4.33 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 176.116 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.457 ' CE2' ' HB1' ' A' ' 39' ' ' ALA . 11.2 t80 -90.93 126.27 36.01 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 123.774 0.83 . . . . 0.0 109.053 -179.786 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.1 t -118.24 107.66 43.15 Favored Pre-proline 0 N--CA 1.439 -1.0 0 C-N-CA 125.73 1.612 . . . . 0.0 107.69 -167.324 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -66.14 128.59 19.86 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 122.773 2.316 . . . . 0.0 107.096 165.077 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.9 m -77.27 -36.84 24.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.125 0.488 . . . . 0.0 111.068 -174.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.77 171.11 15.25 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 158.726 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -76.17 -48.87 18.92 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 119.379 -0.928 . . . . 0.0 108.891 172.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -136.67 155.54 49.75 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 125.661 1.584 . . . . 0.0 111.251 -161.528 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.1 pt -135.52 172.92 15.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 125.723 1.609 . . . . 0.0 108.733 -179.454 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -122.21 143.67 49.44 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 126.251 1.82 . . . . 0.0 109.074 162.351 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.6 m -128.97 129.67 68.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 C-N-CA 125.378 1.471 . . . . 0.0 107.408 167.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.22 76.75 0.36 Allowed 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 166.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.53 HD11 ' HB3' ' A' ' 31' ' ' GLU . 0.4 OUTLIER 9.06 59.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 129.393 3.077 . . . . 0.0 115.513 -172.868 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.65 -35.58 1.4 Allowed Glycine 0 C--N 1.335 0.503 0 O-C-N 121.427 -0.796 . . . . 0.0 111.898 -172.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -55.69 129.88 40.99 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 170.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.3 136.93 32.74 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 122.977 0.511 . . . . 0.0 112.345 -177.415 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.2 p -120.33 153.7 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 123.756 0.823 . . . . 0.0 109.108 168.115 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.88 116.51 32.42 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.254 1.821 . . . . 0.0 107.467 173.501 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.4 pp -122.18 119.37 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 168.07 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.425 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 85.2 mtp -76.57 166.26 23.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.693 170.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -130.25 149.8 51.78 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 160.78 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -134.08 132.56 40.1 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 124.121 0.888 . . . . 0.0 109.326 173.876 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.36 165.24 14.1 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 127.659 2.383 . . . . 0.0 106.942 167.208 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.6 mttt -154.02 133.88 13.06 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 119.226 0.921 . . . . 0.0 110.183 174.262 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.525 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 49.3 t30 -84.97 84.78 7.6 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.774 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.7 mp -83.32 63.66 7.37 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.707 167.417 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.26 163.96 25.6 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 165.211 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.7 m -93.95 20.11 8.2 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 123.063 0.227 . . . . 0.0 110.621 176.193 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.3 p -146.16 160.91 41.39 Favored Pre-proline 0 N--CA 1.45 -0.463 0 C-N-CA 125.687 1.595 . . . . 0.0 107.656 177.359 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -66.02 159.76 47.73 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 121.13 1.22 . . . . 0.0 108.972 169.534 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.65 174.32 10.63 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 122.44 0.296 . . . . 0.0 110.846 171.244 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -122.85 152.97 40.22 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.877 1.271 . . . . 0.0 108.85 171.035 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -127.68 129.87 6.55 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 177.336 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.11 40.65 1.49 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.078 0.951 . . . . 0.0 109.147 168.708 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -50.87 145.11 7.55 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.344 1.058 . . . . 0.0 111.616 -175.293 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.8 t -82.13 139.52 34.33 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 118.923 -1.111 . . . . 0.0 108.833 176.163 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -114.41 89.93 3.21 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 -175.142 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -78.39 85.38 4.51 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 177.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.3 t -78.36 67.96 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 125.51 1.524 . . . . 0.0 108.055 -178.377 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.6 t -166.68 144.11 4.18 Favored Pre-proline 0 C--N 1.338 0.094 0 O-C-N 121.59 -0.694 . . . . 0.0 112.49 174.106 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -64.31 -39.74 28.44 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 121.613 1.542 . . . . 0.0 109.428 159.09 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.0 ptp 170.7 -70.17 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 128.242 2.617 . . . . 0.0 107.123 178.706 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -90.98 -27.28 18.78 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 124.273 1.029 . . . . 0.0 112.884 -168.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.26 -123.4 0.01 OUTLIER 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.508 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.75 -54.82 2.97 Favored Glycine 0 CA--C 1.527 0.79 0 O-C-N 121.654 -0.654 . . . . 0.0 112.006 177.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -47.0 -49.48 20.82 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.543 1.172 . . . . 0.0 111.273 174.185 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -72.03 -16.25 62.05 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.445 1.098 . . . . 0.0 113.181 179.398 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -61.61 124.38 20.52 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -178.166 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 . . . . . 0 N--CA 1.449 -0.506 0 CA-C-O 121.889 0.852 . . . . 0.0 111.43 -173.515 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 CA--C 1.531 0.247 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.483 HG23 ' H ' ' A' ' 107' ' ' THR 0.317 11.1 t 48.05 -81.43 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 127.713 2.405 . . . . 0.0 114.633 168.728 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.483 ' H ' HG23 ' A' ' 106' ' ' THR . 0.6 OUTLIER -158.95 149.35 19.61 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.082 1.353 . . . . 0.0 109.268 -178.564 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.0 mt -143.82 155.5 44.16 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 124.01 0.924 . . . . 0.0 108.835 174.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -94.72 166.55 14.89 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 125.468 1.507 . . . . 0.0 108.5 174.055 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.71 98.18 1.03 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.839 2.359 . . . . 0.0 111.67 -167.611 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.69 -24.57 2.46 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 123.551 0.596 . . . . 0.0 111.723 178.821 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -79.19 127.83 32.53 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 117.85 0.825 . . . . 0.0 111.826 -155.566 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -78.68 136.79 37.54 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 165.619 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 13.7 tpt -130.2 122.62 28.48 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 126.853 2.061 . . . . 0.0 107.863 -169.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -153.24 156.85 39.26 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 120.344 1.429 . . . . 0.0 112.299 177.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 6.2 ttt -155.07 142.38 13.8 Favored Pre-proline 0 N--CA 1.441 -0.898 0 C-N-CA 125.383 1.473 . . . . 0.0 107.149 -177.251 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 67' ' ' MET . 93.5 Cg_endo -74.31 144.78 33.4 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.642 2.894 . . . . 0.0 111.565 165.519 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.9 t -123.09 128.73 75.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 168.598 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.3 p -91.05 141.22 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 170.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -147.23 143.97 28.54 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.413 0.551 . . . . 0.0 111.617 -176.108 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -168.91 120.62 0.76 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 128.322 2.649 . . . . 0.0 106.731 175.295 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.8 p -82.49 146.66 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 119.698 1.136 . . . . 0.0 109.825 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -72.16 139.05 81.82 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 118.117 0.417 . . . . 0.0 110.064 176.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -76.55 61.13 6.76 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.404 2.736 . . . . 0.0 111.547 173.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . 0.253 9.8 pt-20 -135.17 -4.87 2.37 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 169.739 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -48.28 -42.99 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 119.201 0.91 . . . . 0.0 111.677 174.525 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.2 m -76.51 63.81 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 123.306 0.642 . . . . 0.0 110.413 174.406 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -123.06 -70.94 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 124.795 1.238 . . . . 0.0 111.181 170.468 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.53 156.65 36.34 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.161 1.907 . . . . 0.0 113.354 -169.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 84.3 t -54.16 -36.17 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.76 1.624 . . . . 0.0 110.057 176.278 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -47.46 -48.06 26.86 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.956 1.702 . . . . 0.0 112.024 176.144 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 22.3 p -93.55 -57.63 2.52 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -173.289 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 18.23 54.5 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 129.532 3.133 . . . . 0.0 115.529 176.063 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 146.2 -36.49 1.29 Allowed Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 -170.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 23.5 mm -57.52 132.72 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 172.486 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -158.8 53.57 0.42 Allowed 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 123.619 0.574 . . . . 0.0 110.277 161.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.6 p -149.77 98.51 2.75 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 176.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.2 mp -77.95 152.58 33.11 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.446 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.5 t -142.34 176.66 8.82 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 125.58 1.552 . . . . 0.0 107.236 170.473 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.2 tt -150.43 101.06 2.93 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 175.527 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.3 t -84.26 89.23 7.3 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.319 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.11 120.07 23.13 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 179.21 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.6 m -132.7 106.35 7.72 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.787 1.235 . . . . 0.0 108.553 -165.44 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.445 ' CD2' HD13 ' A' ' 45' ' ' LEU . 4.8 m-30 -90.19 96.57 10.73 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.868 1.267 . . . . 0.0 112.85 -160.359 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -138.49 76.64 36.18 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 178.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -91.53 -121.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.055 1 C-N-CA 125.94 4.427 . . . . 0.0 108.169 163.631 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.2 mmp_? -134.1 138.33 45.19 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.448 1.899 . . . . 0.0 107.132 179.142 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.93 114.88 55.87 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 174.671 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.63 -27.04 6.49 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.949 2.432 . . . . 0.0 112.272 -179.322 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.8 m 145.41 112.93 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 129.481 3.112 . . . . 0.0 109.086 -175.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.544 0.737 0 C-N-CA 125.012 1.325 . . . . 0.0 114.198 171.85 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 119.356 -0.354 . . . . 0.0 111.544 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.8 t -169.55 -146.45 0.05 Allowed 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 149.373 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -78.97 38.7 0.35 Allowed 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 130.01 3.324 . . . . 0.0 108.808 -178.547 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.4 mt -111.07 -21.29 12.04 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 127.969 2.508 . . . . 0.0 109.458 -170.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 27.6 mt -62.94 104.13 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 123.581 0.752 . . . . 0.0 111.839 -169.093 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.57 -150.87 0.17 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.889 0.876 . . . . 0.0 109.955 175.274 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -89.29 -37.41 14.94 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 129.237 3.015 . . . . 0.0 111.236 179.894 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -51.73 153.5 2.4 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.974 1.31 . . . . 0.0 113.493 -173.807 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -123.83 88.8 2.97 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 -176.951 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.19 131.93 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 125.19 1.396 . . . . 0.0 107.357 -179.538 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.6 ' HE3' ' HB2' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -97.48 152.94 18.48 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.348 1.059 . . . . 0.0 109.365 -168.906 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.416 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 65.4 t -131.27 132.59 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 174.758 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.7 m -110.54 112.4 24.29 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 173.009 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -81.56 86.21 6.4 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.642 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -88.27 84.49 6.86 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 122.241 1.02 . . . . 0.0 109.164 -173.781 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.3 105.23 17.21 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.361 0.664 . . . . 0.0 109.527 179.385 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -105.56 114.48 28.68 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.101 0.961 . . . . 0.0 108.828 -177.145 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.1 p -98.72 107.73 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 123.896 0.878 . . . . 0.0 109.865 176.623 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.06 155.59 19.37 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 167.565 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.25 -39.44 9.92 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.366 1.067 . . . . 0.0 111.741 178.47 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -40.18 -33.19 0.47 Allowed Glycine 0 CA--C 1.529 0.951 0 C-N-CA 126.144 1.83 . . . . 0.0 114.499 173.236 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.433 HD21 ' CE3' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -111.6 98.88 42.63 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 119.753 1.777 . . . . 0.0 108.523 168.312 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -83.86 45.53 1.81 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 124.057 3.171 . . . . 0.0 110.742 -167.533 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.534 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 44.7 m0 -115.69 145.92 42.32 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.571 1.148 . . . . 0.0 108.08 -172.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -76.4 82.58 3.14 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 175.782 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.99 116.26 31.62 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.736 1.214 . . . . 0.0 108.306 -172.718 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.3 m -129.52 147.48 65.39 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 118.233 0.469 . . . . 0.0 110.704 -173.276 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.89 160.53 47.53 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.264 1.976 . . . . 0.0 108.657 165.543 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -78.62 -59.44 3.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 -174.695 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -121.88 158.97 27.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 103.596 -2.742 . . . . 0.0 103.596 157.859 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -54.42 -38.73 66.59 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-O 120.943 0.401 . . . . 0.0 110.074 176.348 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.6 ' HB2' ' HE3' ' A' ' 34' ' ' LYS . 9.6 p-10 -153.3 163.12 40.47 Favored 'General case' 0 N--CA 1.424 -1.756 0 C-N-CA 126.423 1.889 . . . . 0.0 107.681 -166.739 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.6 pt -138.46 163.89 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 124.466 1.106 . . . . 0.0 108.205 170.256 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -106.93 133.05 52.16 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 104.535 -2.395 . . . . 0.0 104.535 165.415 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.2 m -119.57 129.06 75.8 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 172.704 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.5 mmm180 -76.21 74.88 3.04 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.203 -0.936 . . . . 0.0 108.702 175.281 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.0 mm 55.21 -95.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.911 1.284 . . . . 0.0 109.052 -173.613 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -97.51 30.52 9.08 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 124.559 1.076 . . . . 0.0 112.778 -169.455 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -83.63 95.79 8.47 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.949 1.7 . . . . 0.0 108.315 -177.195 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.11 89.68 0.13 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.831 1.253 . . . . 0.0 110.938 179.666 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.9 t -80.85 139.45 18.09 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.084 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 173.853 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.55 120.22 31.45 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 168.792 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.62 103.67 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.921 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 52.9 ttm -79.3 118.33 21.13 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.716 1.206 . . . . 0.0 111.81 -177.513 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -88.46 153.86 20.82 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.72 0.808 . . . . 0.0 110.462 175.841 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -125.82 133.76 51.89 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 124.317 1.047 . . . . 0.0 110.049 177.613 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -134.34 154.79 51.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 127.389 2.276 . . . . 0.0 107.104 158.213 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -157.54 136.1 11.31 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 104.937 -2.245 . . . . 0.0 104.937 175.884 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.534 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 59.6 t-20 -79.98 125.66 30.05 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.926 1.239 . . . . 0.0 111.807 -176.441 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.16 3.29 19.99 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.15 1.38 . . . . 0.0 112.27 -177.338 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.18 166.13 22.54 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.241 -0.912 . . . . 0.0 111.176 177.706 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.3 m -87.72 -8.77 55.63 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.988 0.915 . . . . 0.0 112.299 179.797 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.0 165.6 29.68 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 126.64 1.976 . . . . 0.0 106.362 178.409 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -57.41 154.96 32.59 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.949 1.766 . . . . 0.0 111.409 -177.19 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.34 164.59 20.06 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.42 0.629 . . . . 0.0 111.311 165.215 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.4 t -99.66 158.72 15.57 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 164.138 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.74 69.55 0.25 Allowed Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 107.973 -2.051 . . . . 0.0 107.973 -172.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -99.87 -58.82 1.83 Allowed 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.311 1.444 . . . . 0.0 108.546 178.863 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 64.33 -178.53 0.17 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.219 0.608 . . . . 0.0 111.62 178.146 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.0 m -136.61 134.93 37.89 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 168.588 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -114.83 170.82 8.05 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 126.197 1.799 . . . . 0.0 109.984 -173.06 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -131.4 107.97 9.29 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.927 1.291 . . . . 0.0 107.585 166.843 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.689 HG22 HD13 ' A' ' 140' ' ' LEU . 39.6 t -90.42 74.11 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.692 1.597 . . . . 0.0 108.569 179.655 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.8 t 177.15 148.27 0.32 Allowed Pre-proline 0 N--CA 1.466 0.366 0 C-N-CA 124.831 1.253 . . . . 0.0 110.776 177.88 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -65.33 -38.25 27.43 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 121.496 1.464 . . . . 0.0 110.482 159.539 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 11.1 ptp 171.55 -72.91 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 127.318 2.247 . . . . 0.0 107.547 175.225 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.58 -36.57 73.67 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.902 0.881 . . . . 0.0 112.908 -166.087 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.49 -105.94 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.302 0.241 . . . . 0.0 110.964 -173.863 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.86 -56.38 1.76 Allowed Glycine 0 CA--C 1.527 0.841 0 O-C-N 121.601 -0.687 . . . . 0.0 112.841 -176.287 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.5 -53.75 10.64 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.442 1.097 . . . . 0.0 111.476 -179.738 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -72.5 -8.44 55.12 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.332 1.453 . . . . 0.0 113.17 -178.128 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -64.02 117.14 6.63 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.492 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 121.977 0.894 . . . . 0.0 111.584 -165.855 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 CA--C 1.535 0.396 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.7 t -161.61 -71.54 0.06 Allowed 'General case' 0 C--O 1.23 0.078 0 O-C-N 121.605 -0.684 . . . . 0.0 111.477 -179.557 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.2 t -159.24 149.68 19.38 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.878 1.271 . . . . 0.0 107.783 -174.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.3 mt -155.28 145.59 21.9 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.513 0.725 . . . . 0.0 110.044 175.501 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -70.23 174.21 3.57 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 124.554 1.142 . . . . 0.0 110.966 168.488 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.08 97.78 1.08 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.934 3.089 . . . . 0.0 111.045 -171.284 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 125.16 -7.93 8.04 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-O 119.489 -0.617 . . . . 0.0 111.693 176.09 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -76.65 170.56 16.2 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 117.794 0.797 . . . . 0.0 111.114 -171.762 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.54 143.82 45.13 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.828 1.651 . . . . 0.0 110.125 -167.329 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 7.6 mtt -139.81 81.84 1.84 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.652 1.581 . . . . 0.0 109.3 170.289 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -103.98 118.79 37.51 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 120.845 -1.159 . . . . 0.0 108.014 169.729 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 77.2 mtp -141.23 140.68 21.38 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 118.816 0.734 . . . . 0.0 112.053 -174.384 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.72 140.61 32.65 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 123.06 2.506 . . . . 0.0 110.277 175.709 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 69.5 t -116.57 151.42 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 161.118 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.1 p -118.21 139.23 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 167.409 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -153.22 157.94 40.98 Favored 'General case' 0 N--CA 1.458 -0.062 0 CA-C-N 119.562 1.074 . . . . 0.0 113.189 -177.336 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -179.1 174.63 1.04 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 128.979 2.911 . . . . 0.0 106.168 -169.176 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 67.2 t -135.5 133.65 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 119.143 0.883 . . . . 0.0 110.862 178.583 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -76.66 138.16 66.7 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.945 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -71.01 -3.61 13.19 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.024 2.483 . . . . 0.0 111.799 -179.28 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.407 ' OE1' ' NZ ' ' A' ' 128' ' ' LYS . 13.8 mm-40 -36.0 -41.61 0.25 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.427 1.091 . . . . 0.0 111.313 159.484 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -58.23 -30.79 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 123.79 0.836 . . . . 0.0 113.063 -178.546 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.4 m -101.24 17.73 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.583 0.753 . . . . 0.0 111.816 175.897 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.407 ' NZ ' ' OE1' ' A' ' 125' ' ' GLU 0.354 6.3 pttt -79.83 -42.2 1.47 Allowed Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 170.927 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -86.95 -175.71 1.7 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.08 2.52 . . . . 0.0 110.981 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 94.7 t -80.71 -54.2 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 123.751 0.82 . . . . 0.0 109.684 173.099 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -46.11 -57.8 4.17 Favored 'General case' 0 N--CA 1.46 0.064 0 C-N-CA 124.848 1.259 . . . . 0.0 112.796 -169.067 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.7 p -82.95 -3.99 57.72 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 118.378 -0.82 . . . . 0.0 112.783 -175.608 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -47.49 -42.69 23.42 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.802 1.183 . . . . 0.0 112.814 -172.516 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.18 -25.03 76.19 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 122.858 0.266 . . . . 0.0 113.223 -179.205 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 25.6 mm -74.51 130.51 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 117.935 0.868 . . . . 0.0 110.734 -174.805 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.3 pttt -156.26 42.6 0.39 Allowed 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.213 164.666 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.1 p -134.05 84.28 2.1 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 106.536 -1.654 . . . . 0.0 106.536 170.965 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.8 tp -87.95 87.24 7.29 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -163.93 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.6 t -96.31 143.87 26.99 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.262 -166.292 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.689 HD13 HG22 ' A' ' 86' ' ' VAL . 4.4 tp -112.71 111.34 22.07 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 168.025 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.4 p -88.72 96.88 10.84 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 168.831 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.56 128.91 35.02 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 170.002 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.8 m -129.64 93.78 3.61 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.895 0.855 . . . . 0.0 109.482 -174.677 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -78.96 91.72 4.85 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.5 1.12 . . . . 0.0 111.121 -171.043 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.73 53.26 9.81 Favored Pre-proline 0 CA--C 1.549 0.923 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 179.542 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.66 -94.56 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.16 2.573 . . . . 0.0 111.27 175.78 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -157.43 140.43 15.21 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 118.089 -0.958 . . . . 0.0 109.164 178.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -109.91 150.61 41.62 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 165.187 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -74.64 -59.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.284 1.99 . . . . 0.0 109.224 169.919 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 37.1 p 179.32 94.41 0.02 OUTLIER 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.614 1.565 . . . . 0.0 107.922 -179.26 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 19.1 pttp . . . . . 0 CA--C 1.539 0.533 0 CA-C-N 118.281 0.491 . . . . 0.0 109.874 -178.968 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 79.0 p -109.38 62.13 0.6 Allowed 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 127.231 2.212 . . . . 0.0 110.735 -157.095 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -155.63 -60.33 0.11 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 102.887 -3.005 . . . . 0.0 102.887 172.384 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.744 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.2 pt? -68.8 27.76 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 128.238 2.615 . . . . 0.0 114.316 177.22 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.5 mt -97.14 60.07 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.265 0 O-C-N 120.472 -1.393 . . . . 0.0 107.823 173.377 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.21 -179.43 2.86 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.607 -167.747 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -75.39 56.83 0.87 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.521 1.128 . . . . 0.0 110.324 177.306 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.94 145.26 41.82 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.833 1.653 . . . . 0.0 106.751 176.754 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -131.43 127.59 37.77 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.235 2.214 . . . . 0.0 105.292 -169.727 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.567 HG23 HG23 ' A' ' 58' ' ' VAL . 1.3 tt -140.32 147.79 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 124.56 1.144 . . . . 0.0 108.587 -164.377 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.519 ' CE ' ' HB2' ' A' ' 55' ' ' ASP . 4.0 tmtp? -109.01 151.17 26.7 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.463 1.505 . . . . 0.0 109.782 -164.426 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.416 ' HB ' ' CG1' ' A' ' 56' ' ' ILE . 70.6 t -133.25 137.92 52.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 167.37 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.5 m -122.71 111.84 17.21 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -179.702 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -89.7 85.18 6.38 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 123.016 0.526 . . . . 0.0 110.246 -174.427 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -87.29 81.81 7.8 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 123.063 1.411 . . . . 0.0 110.909 -179.602 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.0 120.82 36.96 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 121.006 -1.059 . . . . 0.0 109.89 -176.597 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -125.8 160.69 29.18 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.259 1.024 . . . . 0.0 108.556 -179.892 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.93 151.25 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.077 0 C-N-CA 123.83 0.852 . . . . 0.0 109.249 -176.905 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.71 175.61 11.43 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.085 0.954 . . . . 0.0 110.437 178.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.51 124.11 6.57 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 170.251 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 127.38 -39.99 1.84 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -165.712 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.479 HD12 ' CD ' ' A' ' 146' ' ' PRO . 0.5 OUTLIER -127.87 87.46 55.69 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 123.652 0.781 . . . . 0.0 110.017 174.169 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -81.72 38.75 0.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 124.356 3.371 . . . . 0.0 110.199 -176.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.465 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 41.3 m0 -110.11 146.77 34.88 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -171.347 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.41 78.34 3.93 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 -175.036 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -95.06 109.76 21.77 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -170.45 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.9 m -111.84 139.83 22.69 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.631 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.05 162.8 36.6 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 N-CA-C 108.444 -1.406 . . . . 0.0 108.444 162.659 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.7 t -78.33 -45.68 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -178.665 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -156.01 175.74 13.56 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 166.476 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -50.54 62.5 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.496 0.589 . . . . 0.0 111.619 171.474 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.519 ' HB2' ' CE ' ' A' ' 34' ' ' LYS . 23.1 p-10 -156.22 161.78 40.24 Favored 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 123.959 0.904 . . . . 0.0 111.482 -164.809 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.416 ' CG1' ' HB ' ' A' ' 35' ' ' VAL . 36.1 pt -129.4 162.06 37.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 169.324 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -116.31 142.6 46.62 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 161.475 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.567 HG23 HG23 ' A' ' 33' ' ' ILE . 29.7 m -131.63 159.15 43.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 126.361 1.865 . . . . 0.0 106.133 175.106 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.3 mtm-85 -100.66 85.42 2.91 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 158.414 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.543 HG23 HG21 ' A' ' 33' ' ' ILE . 6.8 pt 35.87 43.7 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 127.379 2.271 . . . . 0.0 114.549 161.298 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 146.49 -29.81 1.59 Allowed Glycine 0 CA--C 1.525 0.687 0 O-C-N 121.004 -1.06 . . . . 0.0 111.618 -170.88 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -57.6 98.51 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.084 0.954 . . . . 0.0 110.137 173.755 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.411 HG22 ' CD1' ' A' ' 121' ' ' PHE . 0.3 OUTLIER -65.45 107.51 1.69 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.925 2.09 . . . . 0.0 111.558 -176.565 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.95 147.32 12.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 166.56 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.39 128.03 39.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.475 1.91 . . . . 0.0 108.644 172.72 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.7 pp -129.83 111.48 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 167.468 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.84 126.39 36.9 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 123.126 0.571 . . . . 0.0 112.253 178.593 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -89.97 158.31 17.43 Favored 'General case' 0 C--O 1.23 0.062 0 C-N-CA 123.856 0.863 . . . . 0.0 108.709 177.272 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -133.83 129.84 37.07 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.846 1.258 . . . . 0.0 109.09 176.723 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.11 150.14 51.51 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 128.26 2.624 . . . . 0.0 107.131 163.74 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -150.96 129.02 11.79 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 117.365 -1.302 . . . . 0.0 107.7 174.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.465 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 52.8 t-20 -78.79 116.91 19.44 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 120.803 1.638 . . . . 0.0 111.642 -170.6 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.6 mt -117.04 34.43 5.11 Favored 'General case' 0 C--N 1.345 0.379 0 C-N-CA 124.575 1.15 . . . . 0.0 112.028 179.008 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.15 175.95 6.58 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 154.204 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.7 t -95.94 16.53 17.53 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.192 0.597 . . . . 0.0 110.483 172.616 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 p -145.41 154.32 52.97 Favored Pre-proline 0 N--CA 1.45 -0.46 0 C-N-CA 124.972 1.309 . . . . 0.0 109.025 -176.102 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.14 147.32 78.98 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 N-CA-C 108.132 -1.526 . . . . 0.0 108.132 171.168 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.4 p -119.39 178.93 4.36 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 170.24 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.4 t -124.41 109.45 13.31 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 173.015 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.32 101.59 0.64 Allowed Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 108.527 -1.829 . . . . 0.0 108.527 175.011 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -125.51 47.79 2.15 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 165.711 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.29 -178.84 1.43 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 122.181 0.991 . . . . 0.0 108.541 159.415 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.74 -173.56 4.62 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 178.055 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -144.21 146.47 32.71 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.247 0.93 . . . . 0.0 111.778 167.72 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.2 96.19 9.44 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 167.304 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.9 p -85.58 65.74 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 CA-C-N 118.045 0.384 . . . . 0.0 110.603 177.821 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.1 t -164.84 143.88 5.64 Favored Pre-proline 0 C--O 1.233 0.191 0 O-C-N 121.161 -0.962 . . . . 0.0 112.201 -179.497 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.19 -33.29 31.48 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 N-CA-C 108.776 -1.278 . . . . 0.0 108.776 162.907 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 7.8 ptm 175.58 -70.09 0.01 OUTLIER 'General case' 0 C--N 1.343 0.304 0 C-N-CA 126.406 1.883 . . . . 0.0 108.127 -171.161 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -99.72 -19.66 16.65 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.765 1.226 . . . . 0.0 112.743 -161.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.72 -133.24 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 178.892 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.3 -45.42 0.35 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.137 0.875 . . . . 0.0 114.442 -174.812 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -49.34 -61.02 2.32 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.608 1.204 . . . . 0.0 108.636 167.61 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -75.8 54.34 0.8 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.41 1.884 . . . . 0.0 110.147 171.017 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -110.7 156.89 20.38 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 162.274 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.6 m120 . . . . . 0 N--CA 1.441 -0.899 0 C-N-CA 127.006 2.122 . . . . 0.0 109.676 -175.376 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 CA--C 1.538 0.482 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.8 t 52.14 -146.79 0.48 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.681 1.192 . . . . 0.0 112.231 170.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.55 122.66 45.33 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.058 1.743 . . . . 0.0 107.095 177.111 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.41 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -116.35 129.38 56.22 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.904 1.681 . . . . 0.0 108.615 -170.203 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -77.49 152.42 81.04 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 123.462 0.705 . . . . 0.0 111.673 -177.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.75 110.71 2.83 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.457 2.771 . . . . 0.0 112.111 -167.645 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 126.0 -31.68 4.02 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 108.27 -1.932 . . . . 0.0 108.27 -176.658 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -86.32 171.29 11.32 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 121.363 0.601 . . . . 0.0 112.206 -161.173 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.08 145.5 41.52 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.237 1.815 . . . . 0.0 110.649 -163.081 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.62 86.92 2.14 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.163 1.785 . . . . 0.0 107.678 166.015 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -125.28 129.42 49.97 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 121.633 -0.667 . . . . 0.0 110.731 169.774 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 81.5 mtp -153.94 146.4 17.42 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 122.938 0.495 . . . . 0.0 111.054 -170.364 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -66.93 137.29 44.36 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.608 2.872 . . . . 0.0 112.105 172.561 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 34.5 t -116.59 155.96 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 161.674 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.0 m -121.27 151.76 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 176.09 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -151.42 139.29 19.91 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 119.18 -0.438 . . . . 0.0 110.477 -171.021 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.411 ' CD1' HG22 ' A' ' 63' ' ' THR . 8.3 p90 -172.71 86.55 0.07 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.628 1.171 . . . . 0.0 110.462 -174.293 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.478 ' H ' HG21 ' A' ' 58' ' ' VAL . 41.5 t -49.72 143.1 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -166.1 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.33 123.74 84.44 Favored Pre-proline 0 CA--C 1.537 0.478 0 O-C-N 121.308 -0.87 . . . . 0.0 110.821 -174.454 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.409 ' CD ' HD12 ' A' ' 27' ' ' LEU . 34.6 Cg_endo -73.9 32.59 0.33 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.12 2.547 . . . . 0.0 113.483 177.339 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -87.28 -24.27 24.4 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.529 1.532 . . . . 0.0 108.67 160.585 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -46.46 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 C-N-CA 123.098 0.559 . . . . 0.0 111.576 -172.209 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.8 m -79.31 61.5 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 O-C-N 121.691 -0.63 . . . . 0.0 110.401 177.063 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -137.39 -65.01 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.597 0 CA-C-O 117.845 -1.074 . . . . 0.0 112.344 173.899 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.5 159.57 28.85 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 122.119 1.879 . . . . 0.0 113.917 -173.128 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 86.7 t -54.71 -35.94 34.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 126.024 1.73 . . . . 0.0 110.981 177.271 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -36.82 -55.95 0.87 Allowed 'General case' 0 C--N 1.34 0.157 0 C-N-CA 126.089 1.756 . . . . 0.0 111.817 175.27 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.0 p -105.9 -50.26 3.22 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 124.192 0.997 . . . . 0.0 109.826 -163.667 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 22.02 57.44 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 128.425 2.69 . . . . 0.0 115.508 173.501 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 135.26 -30.48 2.8 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 -177.298 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 13.0 mm -53.5 138.62 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-N 117.828 0.814 . . . . 0.0 109.274 173.691 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.8 pttt -158.87 54.96 0.42 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.571 0.701 . . . . 0.0 111.056 165.181 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.93 90.24 2.37 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -178.223 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.3 mp -76.44 85.57 3.17 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.089 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.2 m -77.3 107.25 9.57 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 176.527 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.2 tt -76.79 137.23 39.13 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 160.583 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 27.9 t -135.61 142.7 45.29 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 160.791 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -159.36 169.76 23.29 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 155.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 38.4 m -113.7 103.55 11.33 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 127.437 2.295 . . . . 0.0 108.333 173.366 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -71.12 100.2 2.0 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 172.367 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.07 50.47 0.69 Allowed Pre-proline 0 CA--C 1.553 1.072 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 -176.325 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.479 ' CD ' HD12 ' A' ' 45' ' ' LEU . 59.2 Cg_endo -75.9 -82.27 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.504 2.803 . . . . 0.0 113.991 -175.886 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 74.0 mtt85 -149.74 106.77 3.57 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.41 1.005 . . . . 0.0 112.019 -164.655 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -156.49 135.63 7.95 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 126.043 1.737 . . . . 0.0 106.932 169.792 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.13 -53.59 0.3 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.139 1.893 . . . . 0.0 112.609 173.473 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.3 p 177.18 109.41 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.67 0.788 . . . . 0.0 110.493 -166.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 55.9 pttt . . . . . 0 CA--C 1.537 0.467 0 O-C-N 121.303 -0.873 . . . . 0.0 109.896 -177.859 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.486 0 CA-C-O 122.025 0.917 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.79 -11.43 59.99 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.529 1.532 . . . . 0.0 114.757 -147.196 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.35 -31.96 64.25 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 173.879 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.1 mp -108.09 14.46 25.11 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.023 1.329 . . . . 0.0 112.074 -176.27 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.4 mt -77.98 77.31 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 120.005 -1.684 . . . . 0.0 108.839 173.641 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.76 179.75 5.93 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.531 0.681 . . . . 0.0 109.893 179.238 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -94.48 59.43 2.51 Favored 'General case' 0 C--N 1.337 0.031 0 C-N-CA 123.827 0.851 . . . . 0.0 112.667 -167.021 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -115.18 160.9 19.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 151.664 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -133.76 88.38 2.47 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -179.898 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.0 tt -94.47 137.91 21.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 C-N-CA 124.477 1.111 . . . . 0.0 111.637 -163.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.441 ' HE2' ' CB ' ' A' ' 55' ' ' ASP . 0.1 OUTLIER -79.71 143.84 34.2 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.635 1.574 . . . . 0.0 109.781 -170.421 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.531 HG21 ' CE1' ' A' ' 120' ' ' PHE . 3.7 t -135.72 142.06 40.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.655 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 164.389 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.9 m -123.29 112.47 17.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 -177.721 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -78.52 89.76 4.48 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 172.864 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -78.23 85.25 4.4 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 118.492 -1.283 . . . . 0.0 108.395 178.576 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.5 115.78 17.54 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.832 174.758 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -122.94 175.54 6.52 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.595 1.158 . . . . 0.0 108.188 167.039 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.6 p -151.17 148.6 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 169.161 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -164.51 171.54 14.45 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.254 1.022 . . . . 0.0 108.869 -178.302 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.62 -165.36 0.22 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.354 1.462 . . . . 0.0 111.616 -175.4 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.73 52.98 4.26 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 112.123 -0.391 . . . . 0.0 112.123 -173.079 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.412 ' CD1' ' CD1' ' A' ' 144' ' ' PHE . 1.4 tt -111.7 83.77 4.77 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.122 0.969 . . . . 0.0 108.785 177.693 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -85.28 45.0 1.5 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.246 3.298 . . . . 0.0 109.736 -170.141 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.438 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 43.1 m0 -108.39 138.58 44.43 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -172.909 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.408 ' OE1' ' NZ ' ' A' ' 71' ' ' LYS . 73.2 tt0 -77.85 82.36 4.23 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 -178.503 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -90.26 122.01 32.79 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.715 1.206 . . . . 0.0 108.233 179.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 m -126.67 135.54 27.43 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.144 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -70.76 162.39 42.76 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 N-CA-C 108.146 -1.521 . . . . 0.0 108.146 161.433 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -60.18 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 175.117 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -144.06 154.13 42.91 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 164.773 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.03 -42.72 69.45 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 118.537 -0.744 . . . . 0.0 112.095 -175.964 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.441 ' CB ' ' HE2' ' A' ' 34' ' ' LYS . 23.7 p-10 -145.35 159.69 42.67 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 119.382 0.992 . . . . 0.0 113.189 -166.623 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.8 pt -133.82 159.79 42.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 125.768 1.627 . . . . 0.0 107.847 178.193 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -128.29 85.41 2.34 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.316 1.446 . . . . 0.0 109.124 178.189 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.8 m -80.44 141.83 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 O-C-N 121.255 -0.903 . . . . 0.0 110.689 -171.281 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -78.22 72.16 4.74 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 173.078 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.5 pt 19.01 64.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 127.437 2.295 . . . . 0.0 113.489 176.368 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 139.0 -43.8 1.14 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -172.58 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -59.68 130.3 46.16 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.648 -173.467 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.467 HG23 ' CD1' ' A' ' 121' ' ' PHE . 1.6 m -106.69 87.28 2.49 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.003 -146.106 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.72 144.19 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 CA-C-O 121.094 0.473 . . . . 0.0 110.696 -170.538 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.93 115.54 24.4 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.239 1.016 . . . . 0.0 108.591 168.817 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.8 pp -115.57 115.04 48.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 164.044 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -87.49 155.23 20.09 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.939 -0.475 . . . . 0.0 110.966 178.387 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -127.0 153.78 45.46 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 172.73 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -134.69 141.79 46.64 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.877 1.671 . . . . 0.0 107.898 179.904 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.34 115.58 7.98 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.805 2.042 . . . . 0.0 107.681 174.387 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.408 ' NZ ' ' OE1' ' A' ' 48' ' ' GLU . 3.0 mtmp? -114.73 124.42 51.73 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.29 0.95 . . . . 0.0 110.652 -176.99 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.438 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 46.9 t-20 -80.92 107.2 13.53 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.79 0.723 . . . . 0.0 112.932 -167.583 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.3 mp -99.08 30.4 3.45 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.495 1.118 . . . . 0.0 111.974 176.649 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.85 176.81 9.39 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.021 -1.049 . . . . 0.0 110.401 168.084 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.1 t -114.07 18.1 17.37 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.221 0.608 . . . . 0.0 109.929 161.646 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 p -146.65 156.42 48.61 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 125.639 1.576 . . . . 0.0 107.736 174.405 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -63.23 145.1 93.05 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 N-CA-C 108.122 -1.53 . . . . 0.0 108.122 172.138 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.5 p -123.08 168.25 12.61 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.644 0.735 . . . . 0.0 111.299 178.716 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.8 m -93.63 144.88 24.98 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 168.354 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -168.74 56.9 0.21 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 176.525 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.91 57.78 0.86 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.018 1.727 . . . . 0.0 108.405 -174.374 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.62 166.46 23.52 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.94 0.876 . . . . 0.0 112.879 -168.036 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.48 97.55 8.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 176.512 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -77.23 140.24 40.05 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.544 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -85.76 88.61 7.57 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -172.634 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -76.97 77.91 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 C-N-CA 125.043 1.337 . . . . 0.0 110.435 -176.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.8 t 178.88 147.64 0.39 Allowed Pre-proline 0 N--CA 1.46 0.029 0 C-N-CA 124.932 1.293 . . . . 0.0 109.343 173.324 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -66.75 -35.19 28.86 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.146 1.23 . . . . 0.0 110.274 158.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.0 ptp 175.36 -70.78 0.01 OUTLIER 'General case' 0 C--N 1.341 0.206 0 C-N-CA 126.902 2.081 . . . . 0.0 107.571 179.244 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.0 -36.61 48.59 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.962 0.905 . . . . 0.0 113.011 -167.788 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.77 -109.62 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.608 0.242 . . . . 0.0 111.58 -167.732 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.79 -49.69 0.84 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.417 1.008 . . . . 0.0 113.528 -176.111 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.55 -57.52 4.66 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.594 1.197 . . . . 0.0 109.802 172.254 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -73.69 5.01 4.31 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.498 1.919 . . . . 0.0 113.895 -178.898 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -85.72 126.58 34.08 Favored 'General case' 0 C--N 1.344 0.343 0 O-C-N 121.232 -0.918 . . . . 0.0 108.649 174.871 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 . . . . . 0 N--CA 1.452 -0.327 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.179 -179.459 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 CA--C 1.538 0.496 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.1 t -88.5 -165.78 1.42 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.051 0.94 . . . . 0.0 110.05 174.687 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.5 t -76.69 144.15 39.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.198 0.999 . . . . 0.0 110.04 -175.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 81.0 mt -127.25 134.87 50.01 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.538 1.135 . . . . 0.0 108.15 -179.791 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -69.55 157.08 90.44 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 170.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.43 100.21 0.88 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.373 2.716 . . . . 0.0 110.438 -170.711 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.31 -23.44 3.31 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -175.208 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -78.95 135.78 37.05 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 118.254 1.027 . . . . 0.0 111.707 -160.727 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -92.61 104.56 16.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.4 1.48 . . . . 0.0 109.375 178.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -90.56 135.13 33.9 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 174.042 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -151.46 154.99 37.65 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.625 0.37 . . . . 0.0 110.639 156.922 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 78.6 mtp -151.77 146.05 18.36 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.161 0.984 . . . . 0.0 109.578 171.495 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -66.12 137.97 50.17 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.126 2.55 . . . . 0.0 110.443 161.79 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.8 t -107.96 130.47 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 159.852 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.3 m -98.49 140.82 17.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 171.845 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.531 ' CE1' HG21 ' A' ' 35' ' ' VAL . 64.3 t80 -154.43 149.37 26.72 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -162.322 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.467 ' CD1' HG23 ' A' ' 63' ' ' THR . 41.1 p90 -164.5 170.29 16.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.415 1.886 . . . . 0.0 109.108 165.314 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 70.7 t -103.99 135.46 41.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 174.482 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -76.37 134.2 70.47 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 119.119 -0.467 . . . . 0.0 109.954 176.397 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -74.16 67.34 5.16 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.384 2.723 . . . . 0.0 110.292 171.42 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -133.52 -37.82 0.94 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 126.799 2.04 . . . . 0.0 111.027 176.565 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.4 tt -43.87 -41.66 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 125.012 1.325 . . . . 0.0 113.414 173.111 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.9 m -78.23 49.03 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 O-C-N 121.394 -0.816 . . . . 0.0 111.34 176.825 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.9 mttt -142.72 -64.51 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 117.521 -1.228 . . . . 0.0 111.617 -179.299 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.17 153.17 46.03 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 121.942 1.729 . . . . 0.0 112.736 -176.548 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.8 t -54.87 -35.54 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 125.838 1.655 . . . . 0.0 110.662 175.897 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -35.26 -59.16 0.53 Allowed 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 126.656 1.983 . . . . 0.0 112.309 175.79 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.5 p -106.94 -42.73 4.84 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.015 -166.068 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 14.07 63.15 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 128.389 2.675 . . . . 0.0 116.235 172.151 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 136.73 -36.73 1.95 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -177.272 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 29.8 mm -53.28 123.52 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 171.444 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.38 47.86 0.35 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.288 0.566 . . . . 0.0 112.102 177.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.5 p -143.65 89.04 2.03 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 105.809 -1.922 . . . . 0.0 105.809 174.025 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 tp -92.71 87.21 5.8 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.029 -159.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.5 t -97.86 155.85 16.87 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.457 0.703 . . . . 0.0 111.084 -166.773 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.76 133.25 55.98 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 160.704 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 44.5 m -90.94 105.77 18.06 Favored 'General case' 0 N--CA 1.46 0.043 0 O-C-N 123.902 0.751 . . . . 0.0 109.035 160.452 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -76.27 99.8 4.89 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 165.708 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 53.5 m -117.34 86.35 2.5 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.978 1.311 . . . . 0.0 107.524 175.18 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.412 ' CD1' ' CD1' ' A' ' 45' ' ' LEU . 48.2 m-85 -59.22 145.2 43.67 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.322 1.049 . . . . 0.0 112.828 174.392 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -166.85 52.69 0.25 Allowed Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.966 1.707 . . . . 0.0 112.342 -175.435 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.3 -90.04 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.679 2.252 . . . . 0.0 115.092 -168.958 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -155.16 179.55 9.04 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 129.697 3.199 . . . . 0.0 104.863 -175.119 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -147.13 94.56 4.54 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 118.488 0.585 . . . . 0.0 111.044 -171.462 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -91.94 -124.37 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.984 3.122 . . . . 0.0 108.954 176.664 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 85.5 p -123.2 123.76 41.5 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 120.356 1.435 . . . . 0.0 111.763 -172.706 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.595 0 C-N-CA 126.496 1.918 . . . . 0.0 109.237 174.333 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.631 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.75 11.9 0.95 Allowed 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 126.802 2.041 . . . . 0.0 115.322 -164.9 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -77.25 -39.12 49.44 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 159.452 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.4 mp -92.22 -37.91 12.41 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 117.209 -1.377 . . . . 0.0 113.016 179.839 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.2 mt -32.53 133.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -162.13 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 29' ' ' LEU . 2.5 mm? -105.91 -104.15 0.33 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.159 -173.618 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -173.59 -49.2 0.01 OUTLIER 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.058 1.343 . . . . 0.0 108.855 -171.348 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -38.78 134.6 0.95 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.002 1.721 . . . . 0.0 110.678 -178.812 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -100.97 86.65 3.1 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -165.883 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.98 115.01 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.436 1.494 . . . . 0.0 107.953 -171.424 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.99 160.01 29.48 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -173.641 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.0 t -148.74 145.19 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 179.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.1 m -138.55 100.28 4.05 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -170.053 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -78.11 145.0 36.0 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.018 0.527 . . . . 0.0 109.919 -176.177 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -127.63 82.75 2.11 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.913 0.863 . . . . 0.0 110.007 178.22 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.49 102.16 14.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 172.118 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -116.89 128.37 55.18 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 122.292 1.044 . . . . 0.0 112.126 -174.666 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.0 p -99.83 96.29 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.564 -174.252 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.12 171.1 10.5 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 122.048 0.928 . . . . 0.0 111.406 174.843 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.41 132.07 52.0 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 169.903 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 128.33 -39.28 1.92 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -170.579 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.484 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -131.56 95.57 23.21 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 117.56 0.68 . . . . 0.0 110.277 -176.363 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -83.94 50.94 3.27 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.956 2.437 . . . . 0.0 109.651 -176.136 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.484 ' CD2' ' CD2' ' A' ' 45' ' ' LEU . 44.4 m0 -107.91 135.56 49.1 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -173.649 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -79.36 84.5 5.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 103.484 -2.784 . . . . 0.0 103.484 179.246 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -102.04 86.15 2.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -171.598 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.3 m -88.04 129.14 51.2 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -167.28 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.09 122.49 9.58 Favored 'Trans proline' 0 N--CA 1.446 -1.277 0 N-CA-C 106.261 -2.246 . . . . 0.0 106.261 162.466 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.1 m -72.73 -32.08 39.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.181 0.515 . . . . 0.0 110.691 -168.387 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.02 161.98 34.16 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 150.265 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -62.65 -46.72 86.89 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 172.532 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -147.38 153.54 39.77 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 124.415 1.086 . . . . 0.0 111.659 -159.647 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.4 pt -133.13 179.23 4.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 126.326 1.851 . . . . 0.0 108.251 179.892 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -125.47 160.18 30.11 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.345 0.593 . . . . 0.0 110.21 149.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.6 t -116.72 145.97 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 127.99 2.516 . . . . 0.0 105.679 171.014 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 49.5 mmm-85 -91.37 100.81 13.53 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 168.021 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mt -33.2 115.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -148.243 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.58 -25.2 26.49 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.071 1.319 . . . . 0.0 110.936 -179.386 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -64.9 133.45 51.86 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.806 1.303 . . . . 0.0 112.422 -172.33 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.15 101.53 7.97 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 130.05 3.34 . . . . 0.0 110.818 -175.38 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.9 p -113.78 153.75 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.292 1.437 . . . . 0.0 109.491 -178.597 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -112.51 125.15 53.93 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 125.404 1.482 . . . . 0.0 109.343 -177.38 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.0 pp -128.48 122.86 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 167.861 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.412 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 66.4 mtt -76.09 168.44 20.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.614 174.164 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -136.17 143.21 44.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 161.864 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.7 ttt85 -121.01 118.7 30.5 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 179.546 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.3 105.15 9.24 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 125.822 1.649 . . . . 0.0 110.035 -177.216 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.29 121.09 44.36 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.064 -0.398 . . . . 0.0 110.749 -168.603 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.44 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 47.8 t-20 -78.38 111.9 14.85 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.803 -0.561 . . . . 0.0 111.912 -167.783 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.2 tp -98.41 11.24 38.77 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.812 0.845 . . . . 0.0 112.381 179.564 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.46 166.67 22.33 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.272 -0.893 . . . . 0.0 109.95 173.44 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 70.0 m -103.3 7.0 38.35 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.968 0.907 . . . . 0.0 111.835 171.73 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.34 159.61 38.79 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 126.134 1.773 . . . . 0.0 107.041 177.974 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.97 126.04 12.11 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.171 1.914 . . . . 0.0 111.255 -173.208 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.476 ' HG1' ' HE1' ' A' ' 47' ' ' TRP . 0.2 OUTLIER -80.49 173.53 12.51 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.821 0.849 . . . . 0.0 110.784 -178.998 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 50.7 p -131.45 72.03 1.49 Allowed 'General case' 0 C--O 1.232 0.137 0 C-N-CA 122.551 0.341 . . . . 0.0 110.426 -170.893 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.42 139.37 37.39 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.946 -0.462 . . . . 0.0 111.946 -179.48 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -166.81 34.19 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.659 1.983 . . . . 0.0 109.44 169.222 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.58 159.08 34.47 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.33 0.652 . . . . 0.0 111.445 -165.445 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.9 t -87.77 131.51 34.48 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.704 0.764 . . . . 0.0 110.039 177.814 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.409 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -104.03 89.93 3.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.871 2.468 . . . . 0.0 105.572 175.509 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -77.0 91.92 3.67 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 120.882 -1.136 . . . . 0.0 107.935 -177.617 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 84' ' ' PHE . 7.8 t -78.11 72.57 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.612 1.165 . . . . 0.0 109.973 -174.043 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.9 t -168.73 134.76 1.49 Allowed Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 119.901 1.228 . . . . 0.0 113.389 173.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -74.1 67.72 5.04 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 122.386 2.057 . . . . 0.0 107.243 156.257 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 22.2 ptm 44.19 25.47 0.11 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 170.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -171.41 -58.26 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 119.384 0.993 . . . . 0.0 110.594 -168.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.61 -101.2 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -177.282 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 64.05 -52.1 0.08 OUTLIER Glycine 0 CA--C 1.538 1.481 0 N-CA-C 115.413 0.925 . . . . 0.0 115.413 -175.534 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -45.73 -47.63 15.33 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.553 1.541 . . . . 0.0 110.808 172.217 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -73.85 -12.69 60.75 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 127.012 2.125 . . . . 0.0 113.471 178.975 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.403 ' CD2' HD23 ' A' ' 138' ' ' LEU . 9.0 t80 -67.55 140.0 56.95 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.119 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.465 ' ND2' ' H ' ' A' ' 96' ' ' ASN . 1.4 p30 . . . . . 0 C--N 1.328 -0.361 0 C-N-CA 124.967 1.307 . . . . 0.0 110.765 -177.33 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.3 t 51.67 -146.64 0.47 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.441 1.096 . . . . 0.0 112.472 170.606 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.6 m -115.54 136.65 52.86 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.089 1.355 . . . . 0.0 108.542 -172.069 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 78.6 mt -128.44 147.95 50.69 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.39 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -73.29 156.42 89.15 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 172.354 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.23 85.87 0.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 124.88 3.72 . . . . 0.0 111.756 -173.064 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 152.74 -27.23 0.83 Allowed Glycine 0 CA--C 1.522 0.5 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.25 -177.777 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -77.86 143.45 37.79 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 118.085 0.942 . . . . 0.0 111.593 -157.925 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -105.21 96.9 6.84 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.811 1.244 . . . . 0.0 109.942 -175.603 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 15.4 tpt -83.92 89.21 7.18 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.114 1.365 . . . . 0.0 109.325 -177.951 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -99.21 134.21 42.4 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.256 0.622 . . . . 0.0 109.576 172.148 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 22.4 ptm -150.95 146.31 19.11 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.996 -0.526 . . . . 0.0 111.441 178.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 67' ' ' MET . 83.1 Cg_endo -79.58 147.77 20.05 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.883 3.055 . . . . 0.0 111.049 171.852 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.5 t -126.53 114.89 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 165.199 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.5 p -79.41 143.47 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 168.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -155.61 149.11 24.98 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.163 0.585 . . . . 0.0 109.949 -165.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.408 ' H ' ' ND2' ' A' ' 96' ' ' ASN . 18.6 p90 -171.18 118.98 0.48 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.36 1.464 . . . . 0.0 111.893 176.858 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.8 t -64.09 133.39 29.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 O-C-N 120.355 -1.466 . . . . 0.0 109.505 175.317 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -91.61 132.39 33.44 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 123.701 0.801 . . . . 0.0 109.8 -179.053 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -46.35 -31.52 9.55 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.402 3.401 . . . . 0.0 114.919 177.342 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -48.94 -24.2 1.4 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.783 1.633 . . . . 0.0 112.39 179.183 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.1 tt -49.01 -44.46 15.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 169.097 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.9 m -83.38 59.66 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 118.571 0.623 . . . . 0.0 109.895 174.354 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -111.0 -77.41 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 117.168 -1.396 . . . . 0.0 110.366 164.628 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.54 156.05 45.12 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 CA-C-N 121.885 1.709 . . . . 0.0 111.666 -177.384 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.6 m -62.16 -36.08 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 124.94 1.296 . . . . 0.0 112.045 -170.657 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -60.6 -64.46 0.94 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.147 0.979 . . . . 0.0 109.281 177.587 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 44.6 p -72.61 -15.43 61.73 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 118.509 -0.758 . . . . 0.0 111.568 -172.419 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.04 -41.52 5.53 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.768 0.713 . . . . 0.0 111.221 162.913 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.34 -29.17 74.38 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 112.237 -0.345 . . . . 0.0 112.237 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.3 mm -83.88 125.94 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 122.079 0.942 . . . . 0.0 110.39 -177.629 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 28.3 pttt -148.81 63.76 1.06 Allowed 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.506 153.751 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 11.7 m -150.15 95.33 2.26 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 158.416 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.403 HD23 ' CD2' ' A' ' 95' ' ' PHE . 1.2 tp -75.48 144.79 41.87 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -173.978 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.8 t -141.8 173.38 11.56 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.496 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.1 tt -150.63 111.28 4.25 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 177.855 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.45 92.94 8.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.515 1.126 . . . . 0.0 109.252 -179.545 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.94 108.4 19.17 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.877 1.271 . . . . 0.0 108.783 179.406 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.66 89.09 3.58 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 122.009 0.909 . . . . 0.0 109.747 -177.358 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -71.23 85.57 0.77 Allowed 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.281 177.058 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.1 47.59 2.8 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -178.703 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -80.89 -105.74 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.279 2.653 . . . . 0.0 111.967 178.914 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -140.95 121.68 14.34 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.648 1.179 . . . . 0.0 108.528 -171.242 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.9 111.22 38.82 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 125.654 1.581 . . . . 0.0 107.118 -177.128 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.431 ' HD3' HG23 ' A' ' 78' ' ' THR . 26.6 Cg_endo -83.3 -4.85 11.07 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.293 2.662 . . . . 0.0 113.043 -172.742 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.9 t 131.51 103.71 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 129.972 3.309 . . . . 0.0 109.754 174.481 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.542 0.669 0 C-N-CA 125.256 1.423 . . . . 0.0 111.723 168.356 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.24 0 N-CA-C 104.354 -2.462 . . . . 0.0 104.354 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.6 t -147.88 49.54 1.06 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 122.493 1.14 . . . . 0.0 108.227 174.962 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -158.8 -57.42 0.07 Allowed 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 127.306 2.243 . . . . 0.0 106.309 -174.367 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.9 mt -65.53 -16.48 63.72 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.907 2.083 . . . . 0.0 112.878 -177.777 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.4 mt -75.67 78.51 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 O-C-N 121.21 -0.931 . . . . 0.0 110.267 -171.566 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.69 -127.7 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.555 1.142 . . . . 0.0 108.524 169.679 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -104.36 -51.33 3.13 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.57 1.548 . . . . 0.0 111.939 -164.506 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -43.1 102.07 0.03 OUTLIER 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.194 1.398 . . . . 0.0 113.351 -169.806 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.69 81.52 4.99 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 177.261 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -97.11 122.58 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -160.616 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.7 150.48 34.48 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.943 1.297 . . . . 0.0 108.199 -175.216 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.52 146.9 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 174.497 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.9 m -125.83 112.19 15.73 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -172.69 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -77.88 136.18 38.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.754 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -126.71 84.45 2.27 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 122.502 1.144 . . . . 0.0 108.965 177.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.91 95.75 10.28 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.374 1.07 . . . . 0.0 110.972 -176.753 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -98.63 109.5 22.24 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.375 0.67 . . . . 0.0 109.79 -177.936 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.0 p -79.24 148.86 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 164.388 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -151.04 158.71 44.44 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 171.216 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.05 -40.15 10.25 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.84 0.856 . . . . 0.0 112.109 -177.214 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -41.58 -31.98 0.76 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.812 1.672 . . . . 0.0 114.151 174.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.487 HD21 ' CE3' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -130.17 110.13 16.68 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 118.688 1.244 . . . . 0.0 108.471 170.488 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -75.27 0.95 8.4 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.294 1.996 . . . . 0.0 115.576 -164.035 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.517 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 42.2 m0 -79.57 153.45 29.46 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.38 1.472 . . . . 0.0 113.613 -159.844 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.42 ' O ' HG23 ' A' ' 50' ' ' VAL . 4.1 tt0 -77.47 77.46 4.0 Favored 'General case' 0 C--N 1.344 0.344 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.615 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -84.6 110.72 18.93 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.684 1.193 . . . . 0.0 109.098 -171.484 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 48' ' ' GLU . 42.9 t -122.78 118.81 28.25 Favored Pre-proline 0 N--CA 1.444 -0.758 0 C-N-CA 124.4 1.08 . . . . 0.0 108.645 -163.638 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -81.87 174.56 10.13 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 124.543 3.495 . . . . 0.0 108.554 168.367 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -98.6 -53.12 8.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 123.949 0.9 . . . . 0.0 110.845 -173.622 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -134.16 175.15 9.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 166.638 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.6 tpt85 -68.45 -33.15 73.68 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.392 168.636 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -144.67 173.44 11.82 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.842 1.257 . . . . 0.0 112.694 -162.861 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.1 pt -141.65 178.2 2.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 127.206 2.203 . . . . 0.0 106.788 165.567 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -132.27 162.77 30.16 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 146.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.23 136.92 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 126.953 2.101 . . . . 0.0 105.836 -175.199 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.94 88.66 3.5 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 163.205 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.2 pt 8.81 69.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 127.74 2.416 . . . . 0.0 114.63 178.469 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.55 -37.55 1.78 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 123.41 0.529 . . . . 0.0 112.305 -176.594 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -39.24 104.43 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.383 1.473 . . . . 0.0 110.849 177.101 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.59 HG23 ' CD1' ' A' ' 121' ' ' PHE . 1.2 m -87.46 88.45 7.68 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.353 -156.25 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 p -92.73 161.67 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 O-C-N 121.933 -0.479 . . . . 0.0 111.721 -168.434 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.46 HE21 ' HA ' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -102.98 126.74 50.28 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.959 1.303 . . . . 0.0 110.35 169.561 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.5 pp -131.33 114.03 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 107.319 -1.364 . . . . 0.0 107.319 167.443 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.0 ttp -77.86 161.52 27.55 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.378 0.671 . . . . 0.0 110.862 -176.861 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -134.57 150.96 50.78 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.436 1.094 . . . . 0.0 108.846 169.325 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 54.1 ttp85 -143.46 147.08 34.0 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.997 0.919 . . . . 0.0 110.111 -178.457 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.39 109.68 2.66 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.632 1.573 . . . . 0.0 111.765 -177.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -86.09 139.28 31.27 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.989 171.721 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.517 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 28.1 t30 -78.21 88.99 4.27 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.073 0.851 . . . . 0.0 112.127 168.958 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.9 mp -76.76 69.08 3.08 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 171.193 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -153.66 137.26 15.99 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 168.513 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.1 t -80.14 36.1 0.34 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.369 0.531 . . . . 0.0 110.754 178.083 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.8 p -149.91 155.47 37.98 Favored Pre-proline 0 C--O 1.237 0.395 0 C-N-CA 126.63 1.972 . . . . 0.0 106.995 174.307 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -63.23 148.14 93.3 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 N-CA-C 108.208 -1.497 . . . . 0.0 108.208 168.522 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.01 175.06 6.53 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.792 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.0 m -105.65 145.25 31.28 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.121 1.768 . . . . 0.0 106.875 175.39 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -133.65 126.14 4.2 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 107.096 -2.401 . . . . 0.0 107.096 172.494 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.18 54.77 0.12 Allowed 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 166.78 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.44 144.83 15.9 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.884 176.162 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.3 t -85.01 166.08 17.02 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 168.185 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -146.41 95.96 2.69 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -168.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.33 86.92 5.02 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 175.509 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.0 t -78.12 60.23 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.817 1.247 . . . . 0.0 108.776 -175.034 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.1 t -171.44 148.34 2.3 Favored Pre-proline 0 CA--C 1.522 -0.129 0 O-C-N 121.481 -0.762 . . . . 0.0 111.636 178.077 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -61.57 -41.26 40.99 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 121.758 1.639 . . . . 0.0 110.068 159.031 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.3 ptp 172.08 -77.72 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 127.124 2.17 . . . . 0.0 107.59 178.399 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.87 -29.87 63.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.634 1.174 . . . . 0.0 112.292 -170.287 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.9 -119.11 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -174.028 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.89 -50.56 2.25 Favored Glycine 0 CA--C 1.528 0.874 0 O-C-N 121.348 -0.845 . . . . 0.0 113.192 178.204 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -44.93 -54.54 6.38 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.159 0.984 . . . . 0.0 110.014 171.555 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -75.39 -4.26 38.41 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.508 1.923 . . . . 0.0 113.96 -179.053 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -69.37 133.55 47.95 Favored 'General case' 0 C--N 1.341 0.227 0 O-C-N 121.093 -1.004 . . . . 0.0 108.486 178.449 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 . . . . . 0 N--CA 1.453 -0.289 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.684 177.931 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 . . . . . 0 CA--C 1.535 0.403 0 CA-C-O 121.149 0.5 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.7 t -111.52 -57.68 2.22 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 128.711 2.804 . . . . 0.0 111.378 -167.6 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.8 t -163.65 140.34 6.97 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 122.849 0.46 . . . . 0.0 110.385 -170.845 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.661 HD11 ' HB2' ' A' ' 114' ' ' MET . 39.7 mt -139.32 143.73 37.96 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.207 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.444 ' HB3' ' HD2' ' A' ' 110' ' ' PRO . 2.8 mt-10 -80.44 172.95 8.53 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.76 1.224 . . . . 0.0 109.349 -179.48 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 109' ' ' GLU . 35.2 Cg_endo -68.0 79.89 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.535 2.823 . . . . 0.0 114.465 -162.041 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 147.87 -29.89 1.39 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.307 0.956 . . . . 0.0 112.181 172.107 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -82.21 158.56 23.51 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 118.226 -1.39 . . . . 0.0 112.318 -139.61 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -84.61 123.26 30.13 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 124.64 1.176 . . . . 0.0 110.268 179.59 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.661 ' HB2' HD11 ' A' ' 108' ' ' LEU . 0.9 OUTLIER -90.22 128.61 36.42 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 154.89 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -134.0 146.42 50.4 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 159.698 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 56.7 mtt -146.61 146.63 27.59 Favored Pre-proline 0 N--CA 1.453 -0.323 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 165.087 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -71.55 142.58 40.61 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 122.101 1.868 . . . . 0.0 109.412 160.232 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.4 t -115.77 143.83 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 164.026 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.0 p -102.28 145.49 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 174.608 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -145.9 138.09 25.36 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.335 0.516 . . . . 0.0 111.425 -176.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.59 ' CD1' HG23 ' A' ' 63' ' ' THR . 5.9 p90 -159.07 162.25 36.56 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.569 1.548 . . . . 0.0 107.43 160.559 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 94.8 t -104.72 131.27 54.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 174.789 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.18 135.23 47.85 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 175.887 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -75.49 57.85 5.0 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 124.578 3.519 . . . . 0.0 112.673 -176.414 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.24 -36.47 7.63 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 125.57 1.548 . . . . 0.0 109.864 168.3 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.8 tt -47.75 -46.57 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -169.724 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.3 m -81.19 53.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.448 -0.783 . . . . 0.0 110.785 -178.444 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -138.28 -64.51 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 117.661 -1.161 . . . . 0.0 112.085 -179.371 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.67 156.33 35.64 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 CA-C-N 121.961 1.736 . . . . 0.0 113.406 -176.053 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.2 t -54.11 -39.46 42.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 126.201 1.8 . . . . 0.0 110.742 177.934 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -45.92 -55.72 6.38 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.697 1.599 . . . . 0.0 111.8 -178.523 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.3 p -92.37 -42.89 9.53 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 118.633 -0.699 . . . . 0.0 111.442 -176.313 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 7.93 65.13 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 128.403 2.681 . . . . 0.0 116.129 179.536 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 142.37 -41.34 1.2 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -173.709 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.7 mm -57.27 120.13 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 CA-C-N 117.689 0.744 . . . . 0.0 110.178 177.23 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -157.38 66.45 0.5 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.672 0.749 . . . . 0.0 110.173 162.578 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 10.6 m -147.51 102.72 3.48 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 152.206 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.68 151.76 34.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -175.243 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.7 t -154.08 175.13 13.79 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.408 0.623 . . . . 0.0 109.647 -177.269 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.9 tp -153.7 97.13 2.07 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 103.216 -2.883 . . . . 0.0 103.216 -169.278 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.5 t -81.78 88.09 6.32 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 171.733 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.79 124.4 27.64 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 176.809 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.423 HG22 ' CD1' ' A' ' 145' ' ' TYR . 23.8 m -133.38 95.52 3.53 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.412 1.101 . . . . 0.0 109.229 -164.468 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -74.22 74.42 1.8 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.041 1.736 . . . . 0.0 111.94 -171.007 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.423 ' CD1' HG22 ' A' ' 143' ' ' THR . 38.8 m-85 -128.35 68.48 77.23 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.349 1.06 . . . . 0.0 113.758 179.566 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -87.69 -103.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.775 2.983 . . . . 0.0 110.666 167.502 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -156.26 99.66 1.94 Allowed 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.8 1.24 . . . . 0.0 108.907 -172.117 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -104.56 134.0 19.89 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 126.432 1.893 . . . . 0.0 106.403 167.614 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.0 -47.3 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.445 2.097 . . . . 0.0 110.638 178.304 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.2 t 166.65 112.4 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 129.202 3.001 . . . . 0.0 104.822 178.486 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.7 pttt . . . . . 0 CA--C 1.535 0.4 0 CA-C-N 119.584 1.083 . . . . 0.0 110.409 -168.921 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.3 m . . . . . 0 CA--C 1.534 0.341 0 CA-C-O 121.663 0.744 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 47.5 29.27 1.34 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.661 1.584 . . . . 0.0 111.966 -161.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.42 ' HA ' HE21 ' A' ' 23' ' ' GLN . 0.0 OUTLIER -139.12 165.38 27.31 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 148.243 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -134.88 127.68 31.17 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 103.312 -2.847 . . . . 0.0 103.312 165.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.1 m -152.41 38.82 0.56 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.719 0.69 . . . . 0.0 111.331 -176.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -159.07 -49.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 127.594 2.358 . . . . 0.0 106.62 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.531 ' H ' HD22 ' A' ' 27' ' ' LEU . 2.7 mm? -61.4 -28.16 69.05 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.295 1.838 . . . . 0.0 111.482 178.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.4 mt -69.87 83.26 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 123.625 0.77 . . . . 0.0 109.518 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.25 152.18 23.0 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 161.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -78.68 55.09 1.61 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.28 0.945 . . . . 0.0 111.328 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.12 138.44 39.95 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 105.078 -2.194 . . . . 0.0 105.078 166.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -96.81 120.04 36.4 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 123.679 0.792 . . . . 0.0 109.043 -173.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -95.08 141.53 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 163.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.551 ' CE ' ' HB2' ' A' ' 55' ' ' ASP . 2.3 tmtp? -101.73 153.86 19.41 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 169.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 t -137.14 149.44 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 167.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.8 m -137.24 98.98 3.86 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 122.521 1.153 . . . . 0.0 108.132 -171.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -79.24 88.28 4.92 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 127.356 2.262 . . . . 0.0 110.306 -176.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -81.86 85.46 6.65 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 122.347 1.07 . . . . 0.0 109.584 175.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.59 101.01 8.91 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.918 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -99.84 148.99 23.85 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 176.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.0 p -139.83 144.36 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 124.709 1.203 . . . . 0.0 108.098 172.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.56 171.96 13.68 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.597 1.159 . . . . 0.0 108.334 174.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -32.72 -55.7 0.36 Allowed 'General case' 0 C--N 1.34 0.168 0 C-N-CA 126.384 1.873 . . . . 0.0 112.822 -176.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -36.69 -35.71 0.14 Allowed Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.906 2.193 . . . . 0.0 114.663 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.63 HD13 ' CD2' ' A' ' 144' ' ' PHE . 0.3 OUTLIER -120.44 94.75 48.92 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 118.42 1.11 . . . . 0.0 109.269 170.15 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -82.32 42.33 1.29 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.417 2.745 . . . . 0.0 110.866 -173.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.422 ' CE3' HD21 ' A' ' 45' ' ' LEU . 42.9 m0 -113.84 141.66 47.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -172.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -79.42 80.07 5.82 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 -176.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -86.72 89.77 8.05 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.508 1.523 . . . . 0.0 108.368 -176.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.4 m -89.43 129.96 45.43 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -175.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -68.76 153.66 72.66 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 N-CA-C 108.156 -1.517 . . . . 0.0 108.156 163.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.41 -55.07 10.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -131.19 161.76 31.47 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 165.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -64.64 -28.45 69.62 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 118.482 0.583 . . . . 0.0 109.54 173.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.551 ' HB2' ' CE ' ' A' ' 34' ' ' LYS . 24.6 p-10 -145.97 168.87 19.81 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 125.301 1.441 . . . . 0.0 112.048 -165.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.6 pt -137.71 166.67 24.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 124.447 1.099 . . . . 0.0 108.337 169.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -110.09 144.01 39.31 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 160.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -135.53 137.34 49.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 166.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.37 91.0 6.74 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 119.698 -1.876 . . . . 0.0 107.691 164.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.3 pt 21.76 63.39 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 127.398 2.279 . . . . 0.0 113.47 171.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.97 -36.82 1.88 Allowed Glycine 0 CA--C 1.526 0.725 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.751 -177.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -40.81 104.87 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.225 1.41 . . . . 0.0 111.752 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.594 HG23 ' CD1' ' A' ' 121' ' ' PHE . 0.2 OUTLIER -89.62 89.67 7.91 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.028 0.931 . . . . 0.0 109.473 -158.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.2 p -88.36 172.1 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 123.291 0.636 . . . . 0.0 111.503 -166.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -117.56 122.18 42.97 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 125.3 1.44 . . . . 0.0 107.575 171.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.91 109.06 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 175.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -78.1 166.47 22.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.478 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -136.17 150.03 48.86 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 169.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.1 ttm-85 -126.02 127.04 45.26 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.793 1.637 . . . . 0.0 107.287 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.63 108.74 10.75 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 125.741 1.617 . . . . 0.0 109.254 169.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -104.73 123.99 48.6 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.326 -0.859 . . . . 0.0 109.226 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -76.26 126.84 31.73 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 120.883 -1.136 . . . . 0.0 110.92 -172.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.4 mt -111.65 14.53 21.23 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.985 0.914 . . . . 0.0 112.627 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.99 175.3 10.7 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 121.301 -0.874 . . . . 0.0 110.979 175.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.2 t -108.25 3.78 23.97 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.931 0.893 . . . . 0.0 111.702 175.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 p -145.06 163.31 33.45 Favored Pre-proline 0 N--CA 1.45 -0.436 0 C-N-CA 126.886 2.074 . . . . 0.0 105.499 174.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.06 157.36 44.61 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.198 1.266 . . . . 0.0 110.925 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.99 172.88 10.09 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 122.617 0.367 . . . . 0.0 110.177 166.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.0 t -107.25 166.06 10.92 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 160.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.534 ' HA2' HD11 ' A' ' 45' ' ' LEU . . . -155.25 73.4 0.25 Allowed Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 108.205 -1.958 . . . . 0.0 108.205 -176.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.38 62.62 0.63 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.7 154.19 28.77 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.821 -1.081 . . . . 0.0 112.659 -164.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.4 m -83.99 144.86 28.85 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.72 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -131.4 153.37 49.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.302 1.041 . . . . 0.0 109.569 171.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.07 109.53 11.97 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 171.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.48 HG11 ' CD2' ' A' ' 95' ' ' PHE . 2.7 t -95.57 63.62 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.46 0.062 0 C-N-CA 122.769 0.427 . . . . 0.0 111.551 -175.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.6 t -165.54 142.5 4.63 Favored Pre-proline 0 N--CA 1.454 -0.231 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.929 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -65.8 -39.34 20.46 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 N-CA-C 107.983 -1.583 . . . . 0.0 107.983 167.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 7.9 ptp 179.81 -74.92 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.42 2.288 . . . . 0.0 107.739 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.01 98.08 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 124.8 1.24 . . . . 0.0 113.273 -164.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.6 -101.67 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.743 -164.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.93 -65.44 0.33 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 123.329 0.49 . . . . 0.0 112.065 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -44.34 -51.26 8.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.449 1.5 . . . . 0.0 111.207 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -73.64 11.14 0.88 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.475 1.11 . . . . 0.0 113.893 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.48 ' CD2' HG11 ' A' ' 86' ' ' VAL . 8.8 t80 -82.7 128.77 34.68 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 119.157 0.889 . . . . 0.0 109.741 172.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -81.02 122.8 27.75 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.494 176.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 80.0 tttt 73.12 57.93 0.11 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.28 1.432 . . . . 0.0 110.546 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.4 p -58.4 -31.27 42.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.209 1.004 . . . . 0.0 113.006 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -152.74 175.2 13.1 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 171.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 12.2 t -163.95 165.51 22.55 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -67.96 165.37 17.92 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 167.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 75.1 m 61.43 67.51 0.78 Allowed 'General case' 0 C--O 1.23 0.044 0 C-N-CA 124.163 0.985 . . . . 0.0 110.425 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -54.58 134.46 46.65 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.9 p -64.29 -66.44 0.54 Allowed 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.213 1.005 . . . . 0.0 109.958 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -68.37 146.92 52.8 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.824 0.85 . . . . 0.0 109.29 175.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.0 t -160.04 -71.28 0.07 Allowed 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -175.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.2 t -156.3 140.56 16.58 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.019 1.328 . . . . 0.0 108.701 -169.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.433 HD11 ' HB2' ' A' ' 114' ' ' MET . 88.5 mt -148.69 146.34 28.1 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 118.581 0.628 . . . . 0.0 110.237 176.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -77.98 165.86 47.64 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 126.112 1.765 . . . . 0.0 110.783 168.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.75 80.01 2.14 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 124.493 3.462 . . . . 0.0 112.278 -166.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 159.38 -34.23 0.47 Allowed Glycine 0 CA--C 1.522 0.515 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.783 172.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.49 153.43 31.37 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -152.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.6 mp0 -91.2 107.23 19.06 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.764 2.425 . . . . 0.0 109.762 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.433 ' HB2' HD11 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -85.4 132.64 34.19 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 160.259 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -145.46 139.05 26.58 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 161.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 14.8 mmt -143.47 142.36 20.98 Favored Pre-proline 0 N--CA 1.453 -0.28 0 C-N-CA 124.262 1.025 . . . . 0.0 108.51 -168.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.01 147.37 38.47 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.504 2.136 . . . . 0.0 109.853 169.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.1 t -124.56 157.37 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 163.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 p -136.17 143.56 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -157.09 131.81 8.74 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -167.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.594 ' CD1' HG23 ' A' ' 63' ' ' THR . 14.3 p90 -156.36 126.63 6.57 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 119.207 0.912 . . . . 0.0 108.654 173.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.1 t -76.85 142.92 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 119.127 -0.463 . . . . 0.0 110.151 -174.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -81.07 129.33 67.65 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 119.14 -0.457 . . . . 0.0 110.748 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -57.13 -20.1 36.51 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.335 2.023 . . . . 0.0 113.985 176.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -53.21 -22.29 6.46 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 120.068 1.304 . . . . 0.0 111.67 172.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.6 tt -49.69 -43.76 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 O-C-N 121.697 -0.627 . . . . 0.0 111.892 169.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.9 m -84.4 57.25 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 119.791 1.178 . . . . 0.0 110.753 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -127.07 -68.31 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 118.028 -0.987 . . . . 0.0 112.516 169.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -79.94 157.66 23.97 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 121.965 1.777 . . . . 0.0 114.09 -166.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 95.2 t -53.79 -34.18 24.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.725 1.61 . . . . 0.0 110.827 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -37.12 -53.92 1.0 Allowed 'General case' 0 C--N 1.338 0.103 0 C-N-CA 126.301 1.84 . . . . 0.0 112.194 172.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 19.2 p -107.01 -56.1 2.24 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -164.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 29.17 53.12 0.09 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 128.108 2.563 . . . . 0.0 115.271 171.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 136.12 -35.32 2.15 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -174.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.0 mm -52.92 115.75 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 123.187 0.595 . . . . 0.0 110.573 170.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 31.0 pttt -156.93 62.95 0.51 Allowed 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.786 170.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.4 m -142.97 96.69 2.97 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 160.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.26 83.06 4.53 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -172.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.12 123.29 26.19 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -168.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.0 tt -98.11 103.67 15.63 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 39.9 t -84.74 100.22 11.36 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 170.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.85 136.17 33.15 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 172.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.6 m -124.82 87.46 2.72 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.672 0.749 . . . . 0.0 109.437 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.63 ' CD2' HD13 ' A' ' 45' ' ' LEU . 2.3 m-85 -72.59 88.88 1.27 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.838 175.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -154.43 52.4 0.75 Allowed Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 117.209 2.3 . . . . 0.0 117.209 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.404 ' HD3' HD12 ' A' ' 45' ' ' LEU . 59.7 Cg_endo -75.2 -87.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.962 2.441 . . . . 0.0 112.565 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 57.7 mtm180 -149.98 126.51 10.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.008 0.822 . . . . 0.0 110.437 -175.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -108.04 135.79 19.84 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 125.038 1.335 . . . . 0.0 108.801 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -72.44 -67.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.443 2.095 . . . . 0.0 110.717 171.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.3 m -175.47 91.24 0.05 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.602 1.961 . . . . 0.0 108.484 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.492 0 CA-C-N 118.315 0.507 . . . . 0.0 110.517 173.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.8 p . . . . . 0 C--O 1.234 0.266 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -75.75 61.15 1.37 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.279 0.945 . . . . 0.0 109.287 170.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 156.11 168.98 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.277 1 C-N-CA 131.99 4.116 . . . . 0.0 107.676 172.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -144.06 15.46 1.71 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.299 0.64 . . . . 0.0 112.154 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.03 22.01 0.41 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 128.53 2.732 . . . . 0.0 114.798 -159.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -76.64 -36.34 57.44 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 152.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 mp -92.21 -103.82 0.11 Allowed 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 125.89 1.676 . . . . 0.0 109.305 175.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.2 mt 31.95 71.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 126.613 1.965 . . . . 0.0 113.818 -172.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -79.4 157.16 27.65 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.779 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -81.76 78.14 8.52 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 122.566 1.174 . . . . 0.0 109.91 -176.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.694 ' HB3' HD11 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -137.42 -172.13 3.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.037 -1.892 . . . . 0.0 107.077 168.088 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -138.65 138.41 37.78 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.127 1.371 . . . . 0.0 110.187 171.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.44 HG23 HG13 ' A' ' 58' ' ' VAL . 5.0 tp -124.24 113.31 36.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.521 1.528 . . . . 0.0 108.457 -176.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -83.74 149.45 26.45 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 138' ' ' LEU . 27.9 t -146.73 89.14 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 118.924 0.784 . . . . 0.0 109.154 -174.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.5 m -75.56 106.3 7.03 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.616 1.166 . . . . 0.0 108.467 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.457 ' CZ ' HD12 ' A' ' 56' ' ' ILE . 2.8 m-30 -81.52 159.61 24.12 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.252 1.421 . . . . 0.0 109.902 174.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -142.46 87.56 2.02 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.92 0.867 . . . . 0.0 112.034 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.26 126.82 35.36 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.37 -0.831 . . . . 0.0 110.897 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -130.67 149.7 52.2 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.941 1.296 . . . . 0.0 109.066 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.9 p -139.28 146.77 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 C-N-CA 124.714 1.206 . . . . 0.0 108.807 175.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.55 174.61 12.33 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.104 0.961 . . . . 0.0 110.004 -177.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.4 115.21 1.35 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 168.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 139.79 -34.51 2.02 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 108.934 -1.667 . . . . 0.0 108.934 -167.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.552 HD12 ' CD ' ' A' ' 146' ' ' PRO . 0.6 OUTLIER -140.45 94.46 8.44 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 123.521 0.729 . . . . 0.0 109.126 173.654 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.486 ' HD2' HG21 ' A' ' 78' ' ' THR . 58.0 Cg_endo -80.33 50.82 3.67 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 124.086 3.191 . . . . 0.0 109.409 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.489 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 35.5 m0 -116.96 148.64 41.23 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.427 1.091 . . . . 0.0 109.831 -168.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -75.09 89.83 2.48 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 104.781 -2.303 . . . . 0.0 104.781 173.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -113.08 118.68 35.45 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.213 1.805 . . . . 0.0 107.465 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.6 m -137.97 144.79 45.32 Favored Pre-proline 0 CA--C 1.53 0.192 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -177.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.23 162.4 38.69 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.992 1.795 . . . . 0.0 108.648 166.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.51 -51.38 12.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 123.207 0.603 . . . . 0.0 110.204 176.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -127.74 159.03 36.01 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 168.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.7 tpt180 -62.29 -39.93 94.58 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 167.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.63 144.97 44.33 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 123.941 0.896 . . . . 0.0 109.448 -171.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.503 HD11 HG21 ' A' ' 66' ' ' ILE . 70.2 mt -105.88 152.45 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 C-N-CA 126.057 1.743 . . . . 0.0 106.532 170.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -126.76 87.41 2.65 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.396 1.078 . . . . 0.0 108.599 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.44 HG13 HG23 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -90.08 151.27 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.412 ' O ' HD13 ' A' ' 60' ' ' ILE . 19.3 mmt180 -59.44 -103.87 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.861 -1.149 . . . . 0.0 109.411 164.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.694 HD11 ' HB3' ' A' ' 31' ' ' GLU . 26.2 mm -148.76 43.6 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 126.389 1.876 . . . . 0.0 106.123 -172.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.62 -7.88 5.56 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 116.087 -0.506 . . . . 0.0 113.712 -174.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -51.04 105.58 0.11 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.05 1.34 . . . . 0.0 109.588 171.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.94 106.55 0.72 Allowed 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.473 1.509 . . . . 0.0 109.304 175.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -105.23 137.36 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 173.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.13 123.99 29.46 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 173.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.503 HG21 HD11 ' A' ' 56' ' ' ILE . 1.6 pp -123.63 111.74 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 164.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.409 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 0.7 OUTLIER -76.21 158.14 31.94 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.947 172.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -129.92 147.09 51.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 173.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.26 141.64 30.91 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 167.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.03 78.57 0.97 Allowed 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 122.192 0.996 . . . . 0.0 109.657 165.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -112.29 141.87 45.48 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.075 -155.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.489 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 22.6 t-20 -78.72 125.78 29.83 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.226 0.921 . . . . 0.0 112.751 -173.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.5 mt -127.49 53.13 1.77 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.344 1.457 . . . . 0.0 109.251 167.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -113.61 167.25 10.76 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 126.466 1.907 . . . . 0.0 110.712 -177.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.7 m -80.22 -22.77 41.45 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.4 1.08 . . . . 0.0 110.85 173.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.0 p -147.6 164.55 22.14 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 125.768 1.627 . . . . 0.0 107.758 -167.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.31 122.63 10.64 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.351 1.367 . . . . 0.0 110.21 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.486 HG21 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -81.59 177.08 9.14 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.477 0.656 . . . . 0.0 109.734 173.16 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.1 t -110.48 156.71 20.47 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 161.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -149.45 81.17 0.19 Allowed Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 106.473 -2.651 . . . . 0.0 106.473 -174.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.91 60.46 1.37 Allowed 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 168.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.7 167.3 3.66 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.258 -177.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 39.2 m -98.86 152.64 19.52 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -148.4 151.98 36.2 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 164.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.99 122.66 48.29 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 170.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.0 p -104.47 55.21 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 C-N-CA 123.733 0.813 . . . . 0.0 111.851 -164.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.9 t -178.79 147.9 0.55 Allowed Pre-proline 0 C--N 1.333 -0.139 0 O-C-N 121.068 -1.02 . . . . 0.0 109.895 -166.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.8 -34.01 41.57 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 N-CA-C 108.9 -1.231 . . . . 0.0 108.9 166.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.0 ptp 177.62 -72.41 0.01 OUTLIER 'General case' 0 C--N 1.342 0.241 0 C-N-CA 126.764 2.026 . . . . 0.0 107.846 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.43 -31.49 67.28 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 124.39 1.076 . . . . 0.0 113.677 -162.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.44 -102.54 0.07 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.452 0.168 . . . . 0.0 111.415 -164.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.7 -59.0 0.2 Allowed Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.566 1.079 . . . . 0.0 113.611 -173.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -45.94 -52.33 11.81 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.129 0.965 . . . . 0.0 110.205 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -74.71 13.25 0.66 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.964 1.706 . . . . 0.0 114.027 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -83.15 128.16 34.24 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 169.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . 0.319 2.2 m-80 -81.19 61.65 4.81 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-O 122.396 1.093 . . . . 0.0 111.887 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -73.84 125.25 27.74 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 164.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.7 p -168.99 143.17 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 127.448 2.299 . . . . 0.0 105.155 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 29.5 62.69 0.15 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.476 1.91 . . . . 0.0 113.251 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -179.0 -37.52 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.479 1.112 . . . . 0.0 110.361 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -39.32 -32.85 0.12 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.564 2.346 . . . . 0.0 115.959 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 44.2 t -48.94 140.03 9.41 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.921 0.888 . . . . 0.0 112.331 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -62.66 79.44 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.57 1.148 . . . . 0.0 111.502 175.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.0 t -71.27 64.39 0.38 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.124 1.77 . . . . 0.0 110.516 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -150.05 -66.31 0.21 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.833 1.653 . . . . 0.0 107.352 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . 0.352 10.1 t 57.84 -81.7 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 126.713 2.005 . . . . 0.0 113.563 171.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -160.92 148.07 15.36 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 -176.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 73.4 mt -148.48 133.27 17.95 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 175.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -63.44 159.62 49.1 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 126.793 2.037 . . . . 0.0 111.403 174.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -64.2 92.24 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.275 3.317 . . . . 0.0 112.415 -169.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 125.17 -6.1 8.2 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 124.725 1.155 . . . . 0.0 112.618 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -76.44 130.0 37.36 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 118.822 1.311 . . . . 0.0 111.845 -166.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -94.62 101.32 13.18 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.257 1.423 . . . . 0.0 110.05 -168.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 17.6 ttt -103.93 124.19 48.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.443 1.497 . . . . 0.0 109.765 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.14 153.06 41.74 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 156.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 42.8 mtm -155.06 151.32 22.72 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 123.214 0.606 . . . . 0.0 110.83 168.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 67' ' ' MET . 70.2 Cg_exo -53.65 138.7 67.5 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 124.653 3.568 . . . . 0.0 112.39 162.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.6 t -119.49 151.39 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 157.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.8 p -112.14 143.52 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 124.002 0.921 . . . . 0.0 108.542 175.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -156.06 151.82 27.29 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.084 0.402 . . . . 0.0 111.916 -171.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -157.98 170.2 22.86 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.296 1.838 . . . . 0.0 109.029 165.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.413 ' HB ' HG21 ' A' ' 33' ' ' ILE . 88.5 t -92.84 146.93 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 170.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -88.01 126.11 62.16 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-O 118.676 -0.678 . . . . 0.0 111.339 174.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -60.23 -16.01 37.97 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.339 2.026 . . . . 0.0 113.806 174.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -49.01 -25.78 2.18 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 119.877 1.217 . . . . 0.0 111.147 166.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 10.9 tt -53.5 -43.02 51.71 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 O-C-N 121.133 -0.979 . . . . 0.0 112.914 172.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.1 m -84.87 53.48 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 119.753 1.16 . . . . 0.0 110.025 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -134.7 -67.03 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 117.693 -1.146 . . . . 0.0 112.337 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.6 154.46 31.0 Favored 'Trans proline' 0 C--N 1.347 0.492 0 CA-C-N 122.024 1.759 . . . . 0.0 113.467 -170.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 96.3 t -55.11 -33.89 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 125.478 1.511 . . . . 0.0 110.928 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -36.53 -55.52 0.84 Allowed 'General case' 0 C--N 1.339 0.124 0 C-N-CA 126.246 1.818 . . . . 0.0 112.238 173.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 17.4 p -104.22 -56.06 2.26 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -164.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 26.51 52.02 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 128.789 2.836 . . . . 0.0 115.329 170.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 141.66 -36.49 1.7 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -173.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 12.8 mm -51.87 121.26 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.124 0.57 . . . . 0.0 110.089 172.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -157.21 57.2 0.51 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.018 0.527 . . . . 0.0 111.659 177.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 9.7 m -149.08 90.8 1.78 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 161.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.55 ' O ' HG13 ' A' ' 35' ' ' VAL . 2.5 tp -84.52 87.77 7.27 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.789 -161.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.9 t -79.77 175.17 10.86 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 122.278 1.037 . . . . 0.0 110.697 -171.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.8 tt -143.83 105.49 4.31 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 103.873 -2.64 . . . . 0.0 103.873 164.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.4 p -86.95 100.16 12.39 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 174.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.66 130.9 44.63 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 126.209 1.804 . . . . 0.0 108.284 -176.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.7 m -125.52 90.34 3.2 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.564 1.145 . . . . 0.0 109.608 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.513 ' CG ' HD13 ' A' ' 45' ' ' LEU . 2.0 m-30 -69.3 88.11 0.44 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.421 0.688 . . . . 0.0 110.125 171.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.07 44.46 0.34 Allowed Pre-proline 0 CA--C 1.553 1.082 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 176.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.552 ' CD ' HD12 ' A' ' 45' ' ' LEU . 58.0 Cg_endo -73.97 -82.98 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.593 2.195 . . . . 0.0 113.482 -177.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 42.0 mmt180 -149.63 123.4 9.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.362 0.983 . . . . 0.0 110.332 -171.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.91 116.79 61.94 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 125.29 1.436 . . . . 0.0 109.234 -174.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.482 ' HD3' HG23 ' A' ' 78' ' ' THR . 83.8 Cg_endo -84.25 -36.03 0.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.051 2.501 . . . . 0.0 113.421 -176.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.3 t 158.62 138.33 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 128.055 2.542 . . . . 0.0 107.848 -169.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.279 0 C-N-CA 127.132 2.173 . . . . 0.0 107.755 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 CA--C 1.54 0.595 0 CA-C-O 120.854 0.359 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 36.12 44.01 0.24 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.863 1.665 . . . . 0.0 111.162 -159.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.445 ' HA ' HE21 ' A' ' 23' ' ' GLN . 0.0 OUTLIER -152.91 171.11 18.82 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 129.872 3.269 . . . . 0.0 102.787 163.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -140.49 116.69 10.57 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 103.471 -2.789 . . . . 0.0 103.471 169.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.4 m -152.46 35.09 0.51 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.16 0.981 . . . . 0.0 110.347 177.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -159.33 -56.41 0.06 Allowed 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 127.993 2.517 . . . . 0.0 106.482 -157.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.7 pp -91.74 -7.51 49.48 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.134 1.374 . . . . 0.0 112.585 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.4 mt -72.2 104.19 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.222 0 CA-C-N 119.386 0.994 . . . . 0.0 110.035 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -95.24 171.42 8.73 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 155.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -80.73 30.51 0.31 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -163.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -83.02 111.2 18.64 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 122.77 1.271 . . . . 0.0 110.758 177.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -74.59 91.52 2.33 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 127.08 2.152 . . . . 0.0 106.165 171.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.8 tp -100.24 123.46 53.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.205 1.002 . . . . 0.0 108.835 -177.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -84.42 148.79 26.4 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.183 0.993 . . . . 0.0 108.962 -175.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.2 t -134.25 146.82 30.63 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.3 m -146.75 105.32 3.81 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -169.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -76.17 163.57 26.94 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.729 0.812 . . . . 0.0 110.02 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -136.36 85.53 2.15 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 122.678 1.227 . . . . 0.0 110.222 166.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.99 99.3 6.01 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 177.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -92.84 146.88 23.31 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.7 t -128.91 136.75 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 168.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -124.3 162.2 24.27 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -43.18 -44.22 5.04 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.025 0.93 . . . . 0.0 111.043 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -48.06 -30.72 7.63 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 126.77 2.128 . . . . 0.0 115.323 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.447 HD13 ' CD2' ' A' ' 144' ' ' PHE . 1.3 tt -121.99 101.75 41.58 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 120.478 2.139 . . . . 0.0 110.495 -178.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -85.51 38.68 0.65 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 124.114 3.21 . . . . 0.0 112.192 -171.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.45 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 42.5 m0 -114.74 140.83 48.57 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -177.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -79.97 80.43 6.38 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -175.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -85.11 94.59 8.89 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.6 m -88.09 135.46 33.28 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.54 156.25 66.39 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 N-CA-C 108.686 -1.313 . . . . 0.0 108.686 165.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -79.76 -59.7 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -176.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -128.22 168.3 15.65 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 157.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -62.99 -43.15 99.57 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 170.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -139.65 165.42 27.3 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 126.37 1.868 . . . . 0.0 109.546 -164.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.6 pt -138.95 177.22 5.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 171.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -124.33 159.2 30.85 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 150.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -129.43 143.38 41.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 173.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.5 mmt85 -79.44 97.16 6.28 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 161.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.4 pt -4.86 79.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 127.442 2.297 . . . . 0.0 114.978 -172.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.53 -37.11 2.03 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.717 -0.49 . . . . 0.0 112.593 -175.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -41.95 107.83 0.08 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.187 1.395 . . . . 0.0 111.911 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.37 105.2 2.09 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.695 0.798 . . . . 0.0 109.844 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -76.25 177.65 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.732 0.777 . . . . 0.0 110.079 177.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -145.04 89.65 1.98 Allowed 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.016 0.926 . . . . 0.0 108.626 172.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.3 pp -110.01 117.37 54.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 32.6 mtm -92.48 111.82 23.54 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.469 1.908 . . . . 0.0 111.927 -177.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -84.59 154.89 22.32 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.137 0.575 . . . . 0.0 109.739 174.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.2 ttm-85 -134.54 138.96 45.06 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.679 1.591 . . . . 0.0 108.021 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.8 106.82 4.7 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.794 1.638 . . . . 0.0 110.201 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER -112.52 129.45 56.35 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.044 0.537 . . . . 0.0 112.22 -174.057 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.45 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 36.2 t-20 -77.9 115.1 17.38 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.486 0.585 . . . . 0.0 111.379 -167.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 69.6 mt -107.95 39.1 2.02 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.688 1.195 . . . . 0.0 111.35 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -111.36 173.27 6.42 Favored 'General case' 0 CA--C 1.526 0.029 0 C-N-CA 124.263 1.025 . . . . 0.0 110.037 169.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.3 p -89.05 -5.47 57.86 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 125.048 1.339 . . . . 0.0 111.829 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 p -140.76 162.94 46.1 Favored Pre-proline 0 N--CA 1.449 -0.476 0 C-N-CA 124.618 1.167 . . . . 0.0 109.37 -171.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.96 111.0 3.06 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 122.16 1.907 . . . . 0.0 109.249 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.26 177.68 8.65 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.036 0.835 . . . . 0.0 109.569 174.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.9 t -124.17 137.26 54.56 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 165.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.05 117.61 4.19 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.804 1.669 . . . . 0.0 109.586 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.75 47.39 2.54 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 124.634 1.173 . . . . 0.0 108.566 175.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.2 144.52 15.64 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.15 -174.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.7 t -87.39 175.26 8.07 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 119.583 -0.847 . . . . 0.0 108.738 166.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -155.13 89.42 1.21 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -161.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -78.79 90.53 4.66 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.2 t -79.35 59.18 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 123.323 0.649 . . . . 0.0 110.965 -175.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.3 t -174.79 148.97 1.22 Allowed Pre-proline 0 N--CA 1.465 0.312 0 CA-C-N 119.505 1.048 . . . . 0.0 112.595 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -57.92 -52.75 5.36 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 121.627 1.551 . . . . 0.0 109.205 158.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.42 -83.64 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.345 1.858 . . . . 0.0 107.42 177.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.49 ' HB3' HG13 ' A' ' 135' ' ' ILE . . . -59.03 -32.15 69.48 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -172.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.56 -109.6 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -168.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.08 -51.9 1.68 Allowed Glycine 0 CA--C 1.53 0.981 0 O-C-N 121.506 -0.746 . . . . 0.0 113.051 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -52.95 -58.62 6.36 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.651 1.226 . . . . 0.0 109.16 170.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -74.19 49.04 0.34 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.993 1.317 . . . . 0.0 111.611 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -126.48 130.85 51.44 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 173.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -138.97 106.45 5.56 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 174.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -88.79 -80.88 0.28 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 150.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.7 p -151.62 65.68 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.618 1.167 . . . . 0.0 108.146 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 62.74 173.39 0.14 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.47 1.108 . . . . 0.0 110.332 -167.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 46.7 t -79.24 55.53 1.88 Allowed 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.489 -0.757 . . . . 0.0 109.869 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -83.65 105.23 14.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 9.9 p -61.6 154.64 24.43 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 172.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -155.69 161.36 40.77 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 175.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.5 p -142.96 122.59 13.29 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -170.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.8 mp0 -77.61 45.9 0.51 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.883 1.273 . . . . 0.0 112.999 -169.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.1 t 39.25 -133.2 0.18 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.564 1.946 . . . . 0.0 113.06 168.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.2 t -125.34 153.65 43.0 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.621 1.968 . . . . 0.0 108.833 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.442 HD11 ' HB2' ' A' ' 114' ' ' MET . 81.9 mt -136.96 123.35 20.73 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 176.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -58.8 154.71 35.32 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 171.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.71 94.58 0.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.996 3.131 . . . . 0.0 111.3 -170.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 137.8 -26.85 2.85 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 124.536 1.065 . . . . 0.0 110.873 -173.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -78.28 154.1 31.23 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 117.664 0.732 . . . . 0.0 111.264 -166.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -117.51 133.97 55.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.428 1.091 . . . . 0.0 110.651 -174.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.442 ' HB2' HD11 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -99.15 142.09 31.08 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 127.034 2.134 . . . . 0.0 106.815 169.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -146.98 133.31 19.54 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.202 1.401 . . . . 0.0 107.286 172.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 79.7 mtp -147.3 135.97 11.23 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 118.207 0.458 . . . . 0.0 110.937 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -73.34 147.27 41.47 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.735 2.29 . . . . 0.0 109.92 168.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.2 t -129.41 124.52 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 168.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.1 p -88.11 151.66 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 166.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -157.96 135.87 10.68 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -175.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -146.06 159.75 42.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.379 0.672 . . . . 0.0 110.249 153.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 39.4 t -100.78 119.24 48.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 169.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.37 139.62 78.67 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -74.05 29.46 0.33 Allowed 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.591 2.861 . . . . 0.0 114.297 -176.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -87.26 -24.58 24.32 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.426 1.09 . . . . 0.0 110.382 170.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 17.0 tt -56.09 -44.9 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 118.153 0.433 . . . . 0.0 112.053 -176.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.4 m -80.61 56.32 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 O-C-N 121.513 -0.742 . . . . 0.0 110.452 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 49.6 mttp -139.52 -67.03 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.608 0 CA-C-O 117.715 -1.136 . . . . 0.0 112.247 174.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.96 156.94 30.79 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.02 1.813 . . . . 0.0 113.539 -169.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 86.2 t -55.09 -35.09 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 125.495 1.518 . . . . 0.0 110.808 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -36.39 -56.75 0.77 Allowed 'General case' 0 C--N 1.338 0.1 0 C-N-CA 126.109 1.763 . . . . 0.0 111.908 174.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.2 p -102.62 -54.22 2.7 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.441 -164.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 22.11 53.6 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 128.932 2.893 . . . . 0.0 115.019 173.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 146.45 -41.45 0.99 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 -170.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.49 HG13 ' HB3' ' A' ' 90' ' ' ALA . 19.3 mm -58.09 119.62 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 169.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.02 39.29 0.31 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.86 0.362 . . . . 0.0 111.232 -178.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.4 94.49 1.71 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 177.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.58 147.02 32.27 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -169.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.5 t -136.5 172.44 13.01 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.0 tt -145.3 114.77 7.17 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 103.38 -2.822 . . . . 0.0 103.38 171.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.72 102.62 15.03 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 177.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -86.03 87.89 7.49 Favored 'General case' 0 CA--C 1.527 0.069 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.82 89.4 5.24 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 122.665 1.221 . . . . 0.0 110.596 177.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.447 ' CD2' HD13 ' A' ' 45' ' ' LEU . 4.0 m-30 -69.05 80.77 0.32 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.836 1.654 . . . . 0.0 110.46 175.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -125.86 84.21 61.35 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 125.446 1.499 . . . . 0.0 113.813 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -105.45 -118.82 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.931 1 C-N-CA 125.988 4.459 . . . . 0.0 109.643 168.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -143.59 149.14 36.93 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 123.674 0.789 . . . . 0.0 109.728 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -144.85 143.67 21.73 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 126.531 1.933 . . . . 0.0 106.445 -176.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -87.19 -51.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.592 2.195 . . . . 0.0 111.727 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.5 m 167.07 101.58 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 128.947 2.899 . . . . 0.0 107.364 -176.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt . . . . . 0 CA--C 1.544 0.723 0 C-N-CA 123.877 0.871 . . . . 0.0 109.505 -176.581 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.3 m . . . . . 0 CA--C 1.535 0.398 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.405 ' OE2' ' NZ ' ' A' ' 97' ' ' LYS . 10.5 tt0 41.69 56.72 3.27 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.376 1.47 . . . . 0.0 111.183 -177.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -140.66 162.25 35.83 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.669 1.588 . . . . 0.0 110.045 -173.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.462 ' HB2' ' OG1' ' A' ' 63' ' ' THR . . . -147.1 67.61 1.15 Allowed 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.859 1.664 . . . . 0.0 107.701 -177.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.9 t -164.94 34.63 0.06 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.855 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -160.13 -51.14 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -167.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.6 mp -77.95 -27.82 49.38 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.616 -172.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.0 mt -70.73 129.07 34.71 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.062 0 C-N-CA 123.897 0.879 . . . . 0.0 112.881 -156.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.15 162.97 14.38 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.819 1.248 . . . . 0.0 108.467 172.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -80.8 74.36 7.76 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 122.177 0.989 . . . . 0.0 110.205 -176.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.25 -174.19 4.22 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.909 1.684 . . . . 0.0 107.608 174.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.3 mtmt -126.83 156.3 41.54 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.882 1.273 . . . . 0.0 108.093 162.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 tp -137.28 155.5 32.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 162.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.35 156.01 30.86 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.409 1.084 . . . . 0.0 108.671 -167.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.511 HG21 ' CE1' ' A' ' 120' ' ' PHE . 4.7 t -139.08 142.11 34.62 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.6 m -136.43 106.03 6.15 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -173.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -85.68 93.47 8.85 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.389 2.276 . . . . 0.0 110.427 -174.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -79.96 85.96 5.52 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 174.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.88 110.74 19.63 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.196 0.598 . . . . 0.0 111.039 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -111.85 153.78 26.13 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.653 1.181 . . . . 0.0 109.986 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.4 p -144.71 147.03 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.416 1.086 . . . . 0.0 108.977 173.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -159.34 170.67 21.31 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.914 0.885 . . . . 0.0 109.896 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -37.7 113.11 0.25 Allowed 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.841 1.656 . . . . 0.0 110.25 171.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 135.46 -39.21 1.7 Allowed Glycine 0 CA--C 1.523 0.557 0 N-CA-C 108.235 -1.946 . . . . 0.0 108.235 -165.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.405 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 1.7 mt -139.96 111.32 7.33 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 125.089 1.355 . . . . 0.0 107.375 169.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.93 8.04 4.7 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.793 2.328 . . . . 0.0 111.512 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.405 ' CD2' ' CD2' ' A' ' 45' ' ' LEU . 38.8 m0 -77.34 139.72 39.82 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.214 -0.929 . . . . 0.0 109.914 -165.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -78.63 84.7 4.72 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -83.91 93.05 7.94 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 127.172 2.189 . . . . 0.0 109.003 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.5 m -88.31 127.17 58.05 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -176.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -68.18 143.38 58.91 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 N-CA-C 108.226 -1.49 . . . . 0.0 108.226 164.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.2 m -77.74 -49.51 21.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-O 121.284 0.564 . . . . 0.0 109.982 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -130.31 162.43 29.03 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 164.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -62.69 -41.42 99.11 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 165.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -149.6 166.86 28.01 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 124.28 1.032 . . . . 0.0 110.87 -160.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.4 pt -137.78 154.71 29.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 124.807 1.243 . . . . 0.0 108.708 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -89.39 143.79 26.55 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 156.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.0 m -128.1 130.54 69.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 162.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -63.66 76.28 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.168 1.387 . . . . 0.0 108.802 172.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.5 mm 60.04 -74.46 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 126.162 1.785 . . . . 0.0 111.146 -172.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -131.14 62.8 0.64 Allowed Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 -176.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -102.38 105.84 16.5 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.131 1.372 . . . . 0.0 110.236 -175.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.462 ' OG1' ' HB2' ' A' ' 24' ' ' ALA . 50.2 m -69.94 88.86 0.58 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.366 1.466 . . . . 0.0 110.131 -171.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.5 p -98.81 147.99 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 121.262 0.553 . . . . 0.0 110.775 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.88 126.82 35.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.699 1.6 . . . . 0.0 108.981 173.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.6 pp -130.12 112.18 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 164.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.74 176.42 9.35 Favored 'General case' 0 C--N 1.333 -0.125 0 O-C-N 121.741 -0.599 . . . . 0.0 110.709 168.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -137.48 156.88 47.64 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 169.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 59.9 mtp85 -120.11 131.6 55.11 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 169.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.34 109.25 10.95 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.485 1.114 . . . . 0.0 109.286 174.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -96.54 124.82 40.66 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 119.011 -0.519 . . . . 0.0 110.081 -172.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -78.77 88.27 4.63 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -169.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.9 mt -78.04 65.93 3.55 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.166 0.986 . . . . 0.0 109.945 171.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -134.9 152.25 51.58 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.587 1.155 . . . . 0.0 109.299 173.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.8 p -91.93 -3.43 55.95 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.983 1.313 . . . . 0.0 112.399 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.9 p -142.53 166.84 18.56 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 174.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -58.61 157.48 27.33 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 CA-C-N 120.397 1.178 . . . . 0.0 111.627 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.08 177.65 5.96 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.363 1.065 . . . . 0.0 109.219 173.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 t -140.83 143.24 34.69 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -134.27 124.61 3.59 Favored Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 107.548 -2.221 . . . . 0.0 107.548 -175.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.81 55.18 1.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 166.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.51 154.37 41.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.484 -164.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.34 126.89 31.73 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.07 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -116.47 138.3 51.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 167.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -130.91 94.46 3.61 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.478 HG11 ' CE2' ' A' ' 95' ' ' PHE . 3.7 t -85.31 72.24 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 123.55 0.74 . . . . 0.0 110.153 -176.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.6 t -169.25 147.7 3.34 Favored Pre-proline 0 N--CA 1.45 -0.45 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 175.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.74 -44.91 12.14 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 N-CA-C 108.021 -1.569 . . . . 0.0 108.021 161.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 3.0 ptm -174.25 -84.12 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.806 1.642 . . . . 0.0 108.026 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.98 -31.64 71.23 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.362 1.865 . . . . 0.0 115.231 -168.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.18 -105.76 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 117.927 0.331 . . . . 0.0 111.326 -168.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.05 -58.48 0.56 Allowed Glycine 0 CA--C 1.534 1.277 0 O-C-N 121.804 -0.56 . . . . 0.0 113.171 -174.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.56 -41.67 73.61 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.193 1.497 . . . . 0.0 111.551 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -76.24 7.28 4.4 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.536 1.135 . . . . 0.0 113.893 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.478 ' CE2' HG11 ' A' ' 86' ' ' VAL . 8.8 t80 -82.5 144.69 30.25 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 165.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -97.24 109.09 21.92 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 172.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.405 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 9.4 tptp -155.65 39.71 0.39 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.457 0.703 . . . . 0.0 110.433 168.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 10.2 p -55.32 -44.87 77.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -167.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -155.76 149.51 25.19 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 170.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 14.0 t -175.89 173.21 2.33 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -172.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -47.1 134.87 10.36 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.373 0.669 . . . . 0.0 110.459 164.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 43.4 t -72.65 75.81 1.1 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.707 0.765 . . . . 0.0 110.094 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -63.23 134.87 56.61 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.623 173.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.7 t -162.9 165.9 24.6 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 169.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.476 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 1.7 pm0 -85.9 -25.35 26.2 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 127.277 2.231 . . . . 0.0 110.763 -173.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.2 t 49.76 -149.79 0.23 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.042 1.337 . . . . 0.0 112.58 170.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.71 149.32 31.79 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.824 1.65 . . . . 0.0 109.199 -177.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.8 mt -143.09 146.07 33.45 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.658 0.783 . . . . 0.0 110.219 172.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -70.08 158.67 86.82 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 129.863 3.265 . . . . 0.0 110.75 171.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.51 105.98 1.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.565 2.843 . . . . 0.0 111.936 -168.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 116.87 -7.98 16.91 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 123.933 0.778 . . . . 0.0 111.824 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -77.81 164.84 24.84 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 117.635 0.717 . . . . 0.0 111.216 -175.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -119.32 126.45 51.47 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.584 0.754 . . . . 0.0 110.392 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 15.6 tpt -91.27 123.81 34.99 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -146.28 141.59 27.48 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 123.238 0.336 . . . . 0.0 110.507 158.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 87.2 mtp -150.42 149.65 27.0 Favored Pre-proline 0 N--CA 1.451 -0.385 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 166.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -73.32 137.32 25.61 Favored 'Trans proline' 0 N--CA 1.445 -1.343 0 C-N-CA 122.121 1.881 . . . . 0.0 111.76 172.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.4 t -99.34 150.05 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 159.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.77 138.72 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.511 ' CE1' HG21 ' A' ' 35' ' ' VAL . 3.3 t80 -152.96 137.07 16.41 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.237 0.472 . . . . 0.0 111.201 -165.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -155.78 158.9 38.92 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.275 1.83 . . . . 0.0 107.528 160.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.8 t -87.52 159.07 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 175.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -100.46 133.24 21.46 Favored Pre-proline 0 C--O 1.236 0.378 0 CA-C-N 118.692 0.678 . . . . 0.0 111.272 173.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -72.38 46.67 0.99 Allowed 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.937 2.425 . . . . 0.0 114.011 175.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.51 -7.69 11.62 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.263 1.025 . . . . 0.0 113.401 163.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.2 tt -51.65 -40.74 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 118.794 0.725 . . . . 0.0 111.068 170.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.3 m -83.2 56.26 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.331 1.052 . . . . 0.0 110.749 171.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -113.3 -79.22 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.462 0 CA-C-O 117.573 -1.204 . . . . 0.0 109.145 165.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -78.59 163.02 27.1 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.025 1.817 . . . . 0.0 111.901 -176.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.8 p -62.18 -44.29 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 123.737 0.815 . . . . 0.0 110.683 -174.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -46.34 -56.0 6.49 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.296 1.438 . . . . 0.0 111.704 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 35.0 p -88.69 -10.57 48.01 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 118.365 -0.826 . . . . 0.0 112.543 -174.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -48.07 -42.36 28.43 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.361 0.982 . . . . 0.0 111.766 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -76.65 -25.33 65.39 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 123.54 0.591 . . . . 0.0 112.612 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 24.8 mm -76.37 128.81 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 117.923 0.861 . . . . 0.0 108.84 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -156.66 56.38 0.55 Allowed 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.5 m -155.34 108.93 2.82 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 160.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.94 84.07 5.75 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -174.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.96 147.89 32.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.921 -171.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.6 tt -118.79 110.56 17.37 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.4 t -87.94 108.26 19.11 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 171.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.2 131.19 54.93 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.815 1.246 . . . . 0.0 108.112 177.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.4 m -129.47 89.84 2.9 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.423 0.63 . . . . 0.0 110.749 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -69.98 78.71 0.48 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 169.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.47 46.33 1.36 Allowed Pre-proline 0 CA--C 1.55 0.973 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 174.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.86 -89.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.222 2.614 . . . . 0.0 113.38 -176.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -157.8 112.81 2.69 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.241 -0.912 . . . . 0.0 110.487 -172.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -116.2 142.62 29.59 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 123.65 0.78 . . . . 0.0 109.465 176.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -76.4 66.56 7.19 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.914 1.742 . . . . 0.0 109.61 166.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.4 t 38.05 92.29 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 129.078 2.951 . . . . 0.0 114.846 172.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt . . . . . 0 CA--C 1.534 0.343 0 C-N-CA 123.738 0.815 . . . . 0.0 111.629 -178.421 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 CA--C 1.535 0.369 0 CA-C-O 122.205 1.002 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 36.53 39.94 0.11 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.172 1.789 . . . . 0.0 111.505 -159.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -159.36 162.61 35.9 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 169.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -127.24 140.41 52.24 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 156.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.8 p -157.38 40.66 0.3 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 122.064 0.935 . . . . 0.0 110.974 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -156.08 -52.26 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 127.297 2.239 . . . . 0.0 106.172 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.3 mt -56.93 -29.51 63.16 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.836 1.654 . . . . 0.0 111.502 174.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.2 mt -72.51 80.96 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 123.824 0.849 . . . . 0.0 110.85 -174.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.531 ' HB2' HD11 ' A' ' 60' ' ' ILE . 2.4 mm? -74.59 -168.95 0.76 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 151.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -71.78 -42.51 67.04 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.66 1.184 . . . . 0.0 111.322 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -40.61 128.1 2.49 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 125.301 1.44 . . . . 0.0 114.703 -161.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -97.5 88.21 4.32 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 125.538 1.535 . . . . 0.0 107.424 -168.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -82.35 119.9 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 175.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.49 138.42 31.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 -177.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.419 ' HB ' ' CG1' ' A' ' 56' ' ' ILE . 3.8 t -121.89 147.59 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 176.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.5 m -140.43 94.27 2.72 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 -174.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -76.0 163.21 27.38 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.204 1.402 . . . . 0.0 108.983 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -146.61 88.5 1.77 Allowed 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.875 0.845 . . . . 0.0 110.583 -167.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.62 111.06 16.7 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.793 0.837 . . . . 0.0 111.025 176.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -118.21 136.74 53.46 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.5 t -132.03 143.46 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -134.93 163.54 29.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 169.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -24.79 -59.05 0.06 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 127.233 2.213 . . . . 0.0 113.242 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -32.78 -42.89 0.16 Allowed Glycine 0 CA--C 1.532 1.106 0 C-N-CA 126.774 2.13 . . . . 0.0 114.71 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.584 HD13 ' CD2' ' A' ' 144' ' ' PHE . 0.2 OUTLIER -109.15 106.62 59.0 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 118.86 1.33 . . . . 0.0 108.238 165.079 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -82.17 5.08 6.57 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.276 1.984 . . . . 0.0 112.498 -173.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.407 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 43.1 m0 -79.8 146.3 32.36 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 122.384 1.088 . . . . 0.0 111.792 -165.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -77.54 82.36 3.98 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -93.36 106.85 18.77 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.603 1.561 . . . . 0.0 108.192 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.0 m -101.44 118.92 58.92 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -70.81 166.68 28.11 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 121.186 1.257 . . . . 0.0 109.112 164.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -94.54 -58.32 3.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 C-N-CA 123.853 0.861 . . . . 0.0 110.762 -174.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -132.23 175.18 9.48 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 165.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.3 tpt85 -69.79 -43.03 72.96 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 165.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -135.98 170.08 16.57 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 125.842 1.657 . . . . 0.0 113.283 -158.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.419 ' CG1' ' HB ' ' A' ' 35' ' ' VAL . 30.6 pt -143.74 167.24 12.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 127.068 2.147 . . . . 0.0 107.502 173.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -117.92 140.85 49.14 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 161.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.4 t -131.58 129.95 62.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.651 1.58 . . . . 0.0 106.76 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.3 mmt-85 -76.35 94.84 3.67 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 168.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.531 HD11 ' HB2' ' A' ' 29' ' ' LEU . 5.6 pt -7.66 76.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 127.558 2.343 . . . . 0.0 115.806 -167.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 134.06 -27.04 3.35 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 124.558 1.075 . . . . 0.0 112.858 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -41.32 111.32 0.21 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.263 1.425 . . . . 0.0 111.65 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.49 99.67 1.65 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.17 1.388 . . . . 0.0 110.264 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.2 p -104.96 150.58 7.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 175.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.28 132.6 52.14 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.471 1.108 . . . . 0.0 109.584 178.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.1 pp -138.76 96.93 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 C-N-CA 125.008 1.323 . . . . 0.0 108.026 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.404 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 0.0 OUTLIER -78.29 166.49 22.63 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -174.272 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -134.25 149.14 50.92 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 26.3 ttt-85 -132.04 122.66 25.82 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -123.15 105.9 10.31 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.539 1.536 . . . . 0.0 109.154 174.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -95.6 131.91 41.31 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.407 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 49.3 t-20 -75.45 142.68 42.92 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.042 0.837 . . . . 0.0 109.663 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.71 -7.26 6.78 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.462 1.905 . . . . 0.0 111.68 -174.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.35 151.14 33.03 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.174 0.897 . . . . 0.0 109.29 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.7 m -84.26 14.38 4.4 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -154.2 163.64 23.41 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 175.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.8 160.64 17.29 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.09 1.86 . . . . 0.0 112.212 -175.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.24 165.22 26.66 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 123.301 0.64 . . . . 0.0 110.126 176.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.7 t -111.17 145.45 38.62 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 168.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -138.0 83.9 0.24 Allowed Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -112.04 -21.93 11.28 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.018 0.927 . . . . 0.0 112.119 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.15 -175.97 0.12 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 165.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.5 t -124.11 168.78 12.43 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 118.214 -1.394 . . . . 0.0 107.987 141.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -148.24 88.75 1.67 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 122.726 1.251 . . . . 0.0 108.956 -166.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -78.22 88.98 4.28 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 120.847 -1.158 . . . . 0.0 107.882 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.6 p -78.75 69.48 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.473 0 C-N-CA 125.463 1.505 . . . . 0.0 110.691 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.6 t -176.53 142.05 0.55 Allowed Pre-proline 0 N--CA 1.464 0.252 0 CA-C-N 119.425 1.012 . . . . 0.0 109.736 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -67.05 -58.61 0.14 Allowed 'Trans proline' 0 N--CA 1.446 -1.314 0 N-CA-C 108.777 -1.278 . . . . 0.0 108.777 166.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 26.2 ptm -171.42 11.37 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -171.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -173.49 -51.93 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 119.163 0.892 . . . . 0.0 110.317 -162.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.25 -124.55 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.667 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.19 -44.09 1.07 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 120.417 -1.427 . . . . 0.0 112.762 -170.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.59 -58.18 4.06 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.408 1.083 . . . . 0.0 110.837 174.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -74.29 -25.1 59.39 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.258 1.023 . . . . 0.0 113.447 -177.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -41.04 120.68 1.39 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.745 1.218 . . . . 0.0 109.302 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -76.95 68.61 3.14 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.803 0.729 . . . . 0.0 111.422 -168.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.17 125.95 21.04 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 172.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 43.3 t -40.8 -56.2 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 125.551 1.54 . . . . 0.0 110.992 -165.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -111.14 -85.52 0.56 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 170.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 48.8 t -171.65 -39.55 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.229 1.011 . . . . 0.0 111.255 -172.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -58.44 158.98 6.77 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.353 0.661 . . . . 0.0 111.975 -177.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 5.1 p -64.0 164.37 10.62 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.292 1.037 . . . . 0.0 111.963 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -93.4 122.45 35.84 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 174.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.6 m -162.35 102.7 1.09 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.017 0.927 . . . . 0.0 109.086 -176.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -73.38 54.33 0.43 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.567 1.147 . . . . 0.0 112.285 172.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.0 t 40.85 -131.51 0.37 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.538 1.535 . . . . 0.0 113.315 165.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.0 t -132.16 147.89 52.45 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.067 2.147 . . . . 0.0 108.167 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.402 HD11 ' HB2' ' A' ' 114' ' ' MET . 95.1 mt -134.19 142.29 47.36 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.406 0.683 . . . . 0.0 109.883 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -68.98 164.25 49.2 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.365 1.866 . . . . 0.0 110.372 167.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.06 76.77 2.5 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 124.682 3.588 . . . . 0.0 112.735 -169.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 153.71 -21.22 0.7 Allowed Glycine 0 CA--C 1.521 0.433 0 CA-C-O 119.357 -0.691 . . . . 0.0 113.285 169.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.9 155.67 32.66 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 118.14 0.97 . . . . 0.0 111.772 -159.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -106.44 101.45 10.91 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.89 1.276 . . . . 0.0 110.887 -165.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.402 ' HB2' HD11 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -83.79 85.81 7.24 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.136 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -106.64 105.11 14.98 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.862 1.265 . . . . 0.0 108.851 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 46.7 mtt -146.87 141.49 16.09 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 119.729 1.15 . . . . 0.0 112.936 -174.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 67' ' ' MET . 95.3 Cg_endo -83.87 145.51 11.37 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.138 2.559 . . . . 0.0 113.622 176.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 24.1 t -117.8 150.81 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 126.403 1.881 . . . . 0.0 106.512 170.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.2 m -118.74 147.44 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.868 1.267 . . . . 0.0 108.301 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -157.55 159.16 36.85 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.629 0.65 . . . . 0.0 112.747 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -163.17 158.19 21.43 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 126.661 1.984 . . . . 0.0 108.426 166.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 29.7 t -102.29 147.35 9.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 124.699 1.199 . . . . 0.0 108.768 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -80.97 161.78 62.0 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 123.398 0.679 . . . . 0.0 110.149 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.467 ' HB3' HD12 ' A' ' 60' ' ' ILE . 87.4 Cg_endo -101.94 28.25 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.89 3.06 . . . . 0.0 112.425 166.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -84.41 -40.54 17.67 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 168.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.7 tt -39.3 -47.38 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.112 1.365 . . . . 0.0 113.681 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.8 m -79.27 55.7 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 O-C-N 121.553 -0.717 . . . . 0.0 110.627 175.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -140.99 -66.61 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.491 0 CA-C-O 117.485 -1.245 . . . . 0.0 111.711 175.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.4 158.43 44.46 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 CA-C-N 121.927 1.724 . . . . 0.0 112.54 -175.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.2 t -55.61 -46.8 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 124.7 1.2 . . . . 0.0 110.141 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -46.17 -50.33 15.77 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.985 1.314 . . . . 0.0 112.684 -175.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 27.2 p -101.52 -6.74 23.53 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -174.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -37.84 107.82 0.07 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.839 1.256 . . . . 0.0 112.152 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.03 -30.53 8.56 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.587 -1.118 . . . . 0.0 113.132 176.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 43.2 mm -58.79 129.3 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 C-N-CA 124.321 1.048 . . . . 0.0 109.863 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -158.54 49.13 0.37 Allowed 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.4 m -149.4 92.55 1.95 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 162.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.08 89.58 5.97 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -171.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 13.2 t -78.01 175.35 10.16 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 122.247 1.022 . . . . 0.0 109.383 -176.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.17 98.34 3.08 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 169.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.3 m -79.81 95.36 6.0 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 174.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -76.67 126.4 30.92 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 171.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 26.6 m -122.51 89.91 3.2 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.584 ' CD2' HD13 ' A' ' 45' ' ' LEU . 3.1 m-85 -84.83 91.34 7.98 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.155 -173.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -151.04 47.39 0.44 Allowed Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 116.876 2.176 . . . . 0.0 116.876 -175.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.2 -111.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.398 2.732 . . . . 0.0 110.763 173.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -136.05 116.49 13.71 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.693 1.133 . . . . 0.0 108.928 -168.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -93.19 143.54 26.9 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 164.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -71.54 -55.36 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.882 1.721 . . . . 0.0 108.419 167.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.6 t -177.37 126.25 0.14 Allowed 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.158 1.783 . . . . 0.0 107.791 172.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 27.4 pttt . . . . . 0 CA--C 1.537 0.474 0 C-N-CA 123.144 0.577 . . . . 0.0 111.321 160.693 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.456 -0.167 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 39.68 36.87 0.28 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.931 1.692 . . . . 0.0 112.559 -172.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -155.64 165.71 35.73 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 177.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -144.05 136.62 26.93 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 102.015 -3.328 . . . . 0.0 102.015 160.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.3 t -155.5 35.12 0.37 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 121.508 1.958 . . . . 0.0 111.11 176.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -160.37 -60.74 0.06 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -164.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.43 39.94 0.62 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 112.628 -2.078 . . . . 0.0 112.246 -165.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.9 mt -119.37 62.59 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 123.486 0.714 . . . . 0.0 110.688 -167.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -76.96 149.63 35.95 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.024 1.33 . . . . 0.0 109.602 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.0 54.61 1.62 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -165.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.8 98.09 7.83 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 166.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.76 81.78 5.97 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 122.125 0.964 . . . . 0.0 108.65 -168.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.292 0.0 OUTLIER -79.92 131.83 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.629 -173.173 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.97 150.66 24.73 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 126.79 2.036 . . . . 0.0 106.999 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.7 m -135.94 120.11 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.26 111.92 18.79 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 176.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -79.48 89.69 5.05 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 176.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -78.35 80.58 4.75 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 122.608 1.194 . . . . 0.0 108.019 -174.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.91 126.05 30.51 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -133.8 147.33 51.23 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.3 p -145.25 147.98 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 124.097 0.959 . . . . 0.0 108.815 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -130.3 168.46 16.86 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 166.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.48 -34.86 11.91 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.235 1.014 . . . . 0.0 111.891 -178.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -34.93 -38.8 0.14 Allowed Glycine 0 CA--C 1.532 1.11 0 C-N-CA 126.28 1.895 . . . . 0.0 113.734 169.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.758 HD13 ' CD2' ' A' ' 144' ' ' PHE . 0.6 OUTLIER -116.6 96.58 48.57 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 118.225 1.012 . . . . 0.0 108.283 163.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -82.92 42.55 1.31 Allowed 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 123.424 2.75 . . . . 0.0 111.332 -168.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 41.5 m0 -112.81 147.19 37.46 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 -176.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.401 ' CD ' ' HZ2' ' A' ' 71' ' ' LYS . 12.0 tt0 -77.14 80.93 3.65 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 -178.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -90.9 87.04 6.47 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 m -95.64 128.39 38.08 Favored Pre-proline 0 N--CA 1.454 -0.257 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -67.4 153.15 77.62 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 N-CA-C 107.3 -1.846 . . . . 0.0 107.3 160.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -57.96 4.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.638 0.732 . . . . 0.0 109.092 -173.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -120.06 159.09 25.48 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 103.199 -2.889 . . . . 0.0 103.199 157.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -23.01 67.09 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.946 0.794 . . . . 0.0 110.652 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -139.88 167.6 21.74 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 125.561 1.545 . . . . 0.0 109.952 -171.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.41 168.95 21.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 172.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.3 p-10 -129.84 147.62 51.63 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.339 0.656 . . . . 0.0 111.218 166.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.2 m -141.84 122.99 12.54 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.57 56.27 3.89 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 121.413 1.915 . . . . 0.0 109.999 -173.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mt 58.8 116.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 124.642 1.177 . . . . 0.0 109.004 -164.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.28 -51.74 4.42 Favored Glycine 0 CA--C 1.525 0.718 0 O-C-N 119.994 -1.691 . . . . 0.0 113.945 172.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -26.39 100.5 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.444 2.298 . . . . 0.0 112.081 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.5 p -76.89 128.2 34.13 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.722 -0.612 . . . . 0.0 110.461 -172.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 p -123.62 149.43 27.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 C-N-CA 125.268 1.427 . . . . 0.0 109.041 177.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.02 122.86 36.96 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 125.164 1.385 . . . . 0.0 107.276 164.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.7 pp -114.67 130.74 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 157.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 35.8 ttp -76.97 140.53 40.46 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 169.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -109.29 158.71 17.61 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 166.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 43.7 ttm-85 -138.13 140.93 40.13 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.353 1.461 . . . . 0.0 108.727 -175.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.7 96.72 1.78 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.12 1.768 . . . . 0.0 108.846 166.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.401 ' HZ2' ' CD ' ' A' ' 48' ' ' GLU . 4.7 mtmp? -95.09 126.11 40.21 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -79.94 121.41 25.42 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.607 1.094 . . . . 0.0 112.399 -170.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.4 mp -108.87 26.76 10.2 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.262 1.025 . . . . 0.0 111.598 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.17 171.66 14.62 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 120.987 -1.071 . . . . 0.0 112.223 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.4 p -79.47 -34.59 41.33 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.645 1.978 . . . . 0.0 110.479 170.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 66.5 p -123.99 179.84 0.99 Allowed Pre-proline 0 N--CA 1.456 -0.152 0 C-N-CA 127.149 2.18 . . . . 0.0 108.979 -174.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -54.41 161.51 5.48 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 CA-C-N 119.309 0.789 . . . . 0.0 111.345 160.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.47 173.9 10.4 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 157.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.6 t -102.85 162.11 13.19 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 151.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.603 ' HA2' HD11 ' A' ' 45' ' ' LEU . . . -151.41 60.27 0.41 Allowed Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -88.31 -39.11 14.63 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.537 0.735 . . . . 0.0 109.051 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.05 178.08 0.15 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.367 1.067 . . . . 0.0 112.841 169.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.5 m -125.87 148.09 49.28 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 173.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -137.98 160.85 38.24 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.619 0.768 . . . . 0.0 110.345 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.76 113.36 20.07 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 164.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.8 p -95.08 59.4 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 123.714 0.805 . . . . 0.0 112.127 -173.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.8 t -174.5 150.04 1.41 Allowed Pre-proline 0 C--N 1.333 -0.121 0 O-C-N 121.539 -0.725 . . . . 0.0 110.682 -175.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.21 -33.66 30.24 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 N-CA-C 108.99 -1.196 . . . . 0.0 108.99 162.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.3 ptp 174.99 -71.8 0.01 OUTLIER 'General case' 0 C--N 1.341 0.23 0 C-N-CA 127.023 2.129 . . . . 0.0 107.913 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.76 -31.02 51.78 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -163.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.33 -110.51 0.06 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.476 0.179 . . . . 0.0 111.264 -168.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.16 -56.28 0.1 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.312 0.958 . . . . 0.0 113.31 -169.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.83 -49.54 19.88 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.376 1.588 . . . . 0.0 112.287 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -72.74 -4.67 32.81 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.283 1.033 . . . . 0.0 113.41 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.401 ' CE1' ' CE2' ' A' ' 120' ' ' PHE . 6.1 t80 -62.64 131.92 50.6 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -116.05 127.84 55.22 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 123.515 0.51 . . . . 0.0 112.166 174.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.3 -43.02 0.33 Allowed 'General case' 0 C--O 1.227 -0.087 0 C-N-CA 123.101 0.56 . . . . 0.0 110.597 160.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . 0.338 4.9 p 48.3 -83.02 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 125.897 1.679 . . . . 0.0 111.753 -168.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 38.76 -109.93 0.08 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.032 2.133 . . . . 0.0 111.351 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 42.3 t -107.84 143.48 36.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 170.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -46.43 -62.08 1.52 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.617 0.644 . . . . 0.0 109.81 171.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 11.8 t -63.55 126.73 28.49 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.71 1.204 . . . . 0.0 109.997 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -74.39 56.09 0.64 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.227 1.811 . . . . 0.0 109.551 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.299 3.1 p 60.34 -68.49 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.159 1.784 . . . . 0.0 114.016 177.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -53.6 143.26 20.48 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.511 1.124 . . . . 0.0 112.207 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.8 t -156.33 -70.47 0.11 Allowed 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.009 0.924 . . . . 0.0 111.137 -176.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.6 m -159.69 135.0 8.23 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 -164.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 69.0 mt -149.47 146.37 27.38 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.926 0.89 . . . . 0.0 109.058 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.26 170.7 12.83 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 126.324 1.85 . . . . 0.0 109.567 167.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.01 88.16 1.27 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 124.607 3.538 . . . . 0.0 111.093 -173.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 151.23 -30.19 0.97 Allowed Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 173.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.27 145.87 41.52 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.688 -151.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -96.29 89.71 5.19 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.974 1.71 . . . . 0.0 110.975 -170.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.96 119.15 26.87 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 176.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -154.13 132.51 11.98 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 122.762 0.425 . . . . 0.0 109.869 168.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 39.2 mtt -156.01 156.93 31.05 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 123.589 0.756 . . . . 0.0 110.373 -168.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.23 140.57 22.33 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.801 3.0 . . . . 0.0 111.688 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.8 t -126.37 136.29 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 170.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.0 m -105.57 157.45 6.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 CA-C-N 117.849 0.295 . . . . 0.0 110.526 173.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.401 ' CE2' ' CE1' ' A' ' 95' ' ' PHE . 6.2 t80 -156.72 139.17 14.86 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -170.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -157.8 173.03 17.42 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.743 1.617 . . . . 0.0 109.779 169.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 9.4 p -129.59 143.39 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 118.743 -0.646 . . . . 0.0 110.229 169.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -76.18 153.59 84.36 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 118.671 0.669 . . . . 0.0 109.588 175.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -58.63 -21.26 54.49 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.325 2.684 . . . . 0.0 112.132 170.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -41.47 -33.85 0.48 Allowed 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 126.637 1.975 . . . . 0.0 113.258 176.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.4 tt -54.53 -42.46 59.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.896 0.771 . . . . 0.0 112.661 175.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.1 m -84.3 54.13 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 119.088 0.858 . . . . 0.0 109.901 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -135.74 -65.52 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 117.637 -1.173 . . . . 0.0 112.252 175.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -74.53 149.47 39.15 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 CA-C-N 121.977 1.742 . . . . 0.0 111.079 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.4 p -64.44 -35.38 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 124.124 0.969 . . . . 0.0 110.75 -174.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -45.45 -48.99 13.8 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.1 1.76 . . . . 0.0 112.245 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.9 p -91.23 -66.53 0.92 Allowed 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 41.56 -72.01 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.693 2.797 . . . . 0.0 115.87 -175.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -87.14 -23.01 42.5 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.319 1.438 . . . . 0.0 111.234 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.9 mm -56.95 126.69 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 117.816 0.808 . . . . 0.0 109.949 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -156.01 58.41 0.59 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.921 172.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.9 m -150.01 88.67 1.54 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 167.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.0 mp -74.64 85.98 2.12 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.5 t -83.68 140.07 32.38 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.634 -1.166 . . . . 0.0 107.867 174.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.9 tt -114.22 103.94 11.6 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 169.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.3 p -86.7 104.83 16.47 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 176.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.38 128.91 50.37 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.589 1.556 . . . . 0.0 108.401 -176.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.4 m -114.98 91.55 3.65 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.526 1.131 . . . . 0.0 109.324 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.758 ' CD2' HD13 ' A' ' 45' ' ' LEU . 2.4 m-85 -71.41 88.17 0.88 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.599 1.159 . . . . 0.0 109.638 174.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -155.93 59.64 2.14 Favored Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 174.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.492 ' HD3' HD12 ' A' ' 45' ' ' LEU . 62.6 Cg_endo -79.96 -78.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.936 2.424 . . . . 0.0 111.979 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -146.79 132.72 19.13 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.553 0.615 . . . . 0.0 109.467 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -131.98 135.56 26.81 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 125.867 1.667 . . . . 0.0 106.611 175.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -77.21 -61.93 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.15 1.9 . . . . 0.0 109.97 171.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 41.8 t -176.84 97.67 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.639 1.575 . . . . 0.0 107.708 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.454 -0.266 0 N-CA-C 104.15 -2.537 . . . . 0.0 104.15 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -77.7 58.19 1.78 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.679 0.752 . . . . 0.0 110.616 -177.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.87 -67.53 0.22 Allowed 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 126.729 2.011 . . . . 0.0 107.628 160.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' A' ' 61' ' ' GLY . . . -163.69 -70.36 0.04 OUTLIER 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 138.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.0 t -166.23 -136.59 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 144.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -73.03 -27.55 61.83 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.474 1.109 . . . . 0.0 109.413 168.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -68.76 6.47 0.85 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -173.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.435 ' CG1' ' HB3' ' A' ' 24' ' ' ALA . 81.7 mt -58.99 122.14 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 120.847 1.658 . . . . 0.0 110.043 177.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.68 157.21 17.22 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 118.785 0.721 . . . . 0.0 110.999 175.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.67 -27.65 69.06 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.074 0.95 . . . . 0.0 113.03 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -51.76 114.0 1.15 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.97 0.908 . . . . 0.0 111.953 -174.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.63 98.04 8.17 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 127.067 2.147 . . . . 0.0 108.747 -171.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.0 tt -109.13 136.62 44.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 126.277 1.831 . . . . 0.0 110.748 -170.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.9 tptp -98.64 157.53 16.19 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 124.918 1.287 . . . . 0.0 110.897 -168.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.426 HG11 ' CZ ' ' A' ' 37' ' ' PHE . 82.3 t -133.65 160.68 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 C-N-CA 124.306 1.042 . . . . 0.0 108.63 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.4 m -145.46 102.48 3.71 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.615 1.166 . . . . 0.0 109.319 172.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.426 ' CZ ' HG11 ' A' ' 35' ' ' VAL . 90.0 m-85 -78.6 88.56 4.52 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.055 1.342 . . . . 0.0 108.13 175.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -80.06 85.36 5.65 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 121.415 -0.803 . . . . 0.0 109.191 -174.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.82 134.71 34.29 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 121.839 -0.538 . . . . 0.0 111.329 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -144.09 147.01 33.19 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 126.405 1.882 . . . . 0.0 109.66 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.9 t -132.77 147.97 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 125.34 1.456 . . . . 0.0 108.402 177.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -146.96 174.29 11.65 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.031 0.932 . . . . 0.0 109.931 174.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -49.28 121.81 5.36 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 169.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.77 -43.21 1.3 Allowed Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 108.078 -2.009 . . . . 0.0 108.078 -163.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.537 HD13 ' CG ' ' A' ' 144' ' ' PHE . 0.6 OUTLIER -130.74 97.76 20.66 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 123.308 0.643 . . . . 0.0 111.067 177.183 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -84.72 41.71 1.02 Allowed 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.78 2.987 . . . . 0.0 110.271 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.456 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 43.2 m0 -114.77 136.9 52.57 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.601 0.76 . . . . 0.0 109.315 -171.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -79.16 80.81 5.48 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -89.98 89.36 7.68 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 124.238 1.015 . . . . 0.0 108.99 -176.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.9 m -84.81 129.7 55.65 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.22 166.18 30.46 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 121.436 1.424 . . . . 0.0 108.464 161.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.38 -56.21 5.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 123.862 0.865 . . . . 0.0 109.437 -176.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.79 164.44 24.06 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 161.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -63.55 -46.77 84.44 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 165.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -131.04 149.99 52.36 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 126.249 1.819 . . . . 0.0 110.108 -164.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.0 pt -134.81 167.97 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 167.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -110.56 134.24 52.57 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 166.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.0 157.91 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 165.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.5 mtm180 -109.15 114.27 27.84 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.422 HD13 HG21 ' A' ' 60' ' ' ILE . 0.9 OUTLIER -37.8 117.34 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -147.117 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.694 ' O ' ' HB2' ' A' ' 24' ' ' ALA . . . 111.43 -46.36 1.18 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 -172.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -53.63 109.59 0.47 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 117.767 0.784 . . . . 0.0 112.846 -166.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.2 p -56.44 122.03 10.99 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.938 1.295 . . . . 0.0 111.221 172.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.06 137.6 42.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 166.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -77.78 128.56 34.21 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.824 1.25 . . . . 0.0 108.569 167.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.1 pp -146.3 88.6 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.974 0.91 . . . . 0.0 108.971 174.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.93 147.16 41.19 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 121.385 -0.822 . . . . 0.0 110.276 -177.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -98.14 159.24 15.07 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 166.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -135.96 118.51 15.89 Favored 'General case' 0 C--O 1.227 -0.099 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 172.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -110.69 154.89 23.22 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 126.608 1.963 . . . . 0.0 109.081 172.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -154.95 123.74 6.15 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 -176.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.456 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 35.6 t30 -80.77 112.66 18.35 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 119.302 0.956 . . . . 0.0 110.836 -173.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.35 5.1 51.66 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.721 1.208 . . . . 0.0 112.742 -176.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.37 176.79 9.01 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.792 0.724 . . . . 0.0 110.538 175.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.6 t -105.64 20.73 18.43 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.739 0.816 . . . . 0.0 109.96 175.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.2 160.48 30.85 Favored Pre-proline 0 N--CA 1.447 -0.612 0 C-N-CA 127.086 2.154 . . . . 0.0 106.708 -174.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.71 160.44 40.44 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 C-N-CA 121.161 1.241 . . . . 0.0 109.442 172.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.38 164.18 26.25 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-O 120.776 0.322 . . . . 0.0 110.663 166.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.57 95.18 5.21 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.989 2.116 . . . . 0.0 105.693 -177.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.0 96.52 0.78 Allowed Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 107.756 -2.137 . . . . 0.0 107.756 177.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -125.05 50.33 1.77 Allowed 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 169.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.38 176.82 0.32 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.805 0.812 . . . . 0.0 110.872 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -146.04 162.48 37.8 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.91 169.82 17.33 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 123.578 0.751 . . . . 0.0 110.336 -172.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -119.91 111.52 18.04 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 163.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.2 t -95.43 77.59 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.177 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.1 t -176.07 145.55 0.75 Allowed Pre-proline 0 C--O 1.232 0.142 0 C-N-CA 124.153 0.981 . . . . 0.0 110.207 171.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.94 -38.0 40.68 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 121.259 1.306 . . . . 0.0 110.064 158.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.9 ptp 172.02 -68.08 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 127.835 2.454 . . . . 0.0 107.759 174.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.5 -39.5 46.1 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -167.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.74 -104.68 0.04 OUTLIER 'General case' 0 C--O 1.228 -0.055 0 C-N-CA 123.101 0.561 . . . . 0.0 110.427 -174.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.27 -58.78 2.8 Favored Glycine 0 CA--C 1.523 0.55 0 O-C-N 121.855 -0.528 . . . . 0.0 111.853 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -47.64 -48.95 28.52 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.927 0.864 . . . . 0.0 110.613 174.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -74.7 3.96 7.05 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.152 1.381 . . . . 0.0 113.882 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -76.95 107.92 9.63 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 171.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -71.06 80.86 0.67 Allowed 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.644 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -63.84 143.84 57.53 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 164.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.1 t -52.4 138.29 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.554 0.742 . . . . 0.0 111.57 -172.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -69.15 66.81 0.16 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.813 1.245 . . . . 0.0 111.574 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 34.9 t -150.11 140.26 22.12 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 125.385 1.474 . . . . 0.0 108.847 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -76.38 67.82 2.65 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.725 1.21 . . . . 0.0 108.993 176.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 38.2 t -159.79 153.98 23.53 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 174.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -97.19 -3.36 41.06 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.543 -0.742 . . . . 0.0 112.495 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.7 m 95.43 161.83 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 128.823 2.849 . . . . 0.0 108.467 -168.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 62.15 -178.38 0.13 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.818 2.047 . . . . 0.0 113.066 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.431 HG23 ' H ' ' A' ' 107' ' ' THR . 2.5 t -177.08 -82.15 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.069 1.347 . . . . 0.0 111.504 172.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.431 ' H ' HG23 ' A' ' 106' ' ' THR . 14.8 t -155.47 149.92 26.05 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.962 1.305 . . . . 0.0 108.025 -169.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.1 mt -154.03 127.52 8.62 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 123.873 0.869 . . . . 0.0 109.437 175.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -63.2 158.15 58.02 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 126.401 1.88 . . . . 0.0 110.256 164.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.47 110.53 3.0 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.481 2.121 . . . . 0.0 111.38 -169.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 115.17 -15.75 18.15 Favored Glycine 0 C--N 1.334 0.467 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -77.86 156.32 30.46 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 117.476 0.638 . . . . 0.0 110.873 -174.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.61 153.56 39.15 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.753 1.221 . . . . 0.0 110.687 -167.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 42.4 ttm -149.47 88.58 1.57 Allowed 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.094 1.358 . . . . 0.0 108.687 -168.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -89.72 130.17 36.03 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 118.585 0.629 . . . . 0.0 109.888 164.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -126.48 92.58 44.9 Favored Pre-proline 0 N--CA 1.452 -0.358 0 C-N-CA 125.327 1.451 . . . . 0.0 107.908 -171.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -55.37 126.12 21.45 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.723 2.282 . . . . 0.0 110.184 169.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.1 t -121.57 147.38 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 170.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.8 p -119.75 142.02 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 171.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -145.81 148.79 33.29 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 118.161 0.437 . . . . 0.0 111.147 -172.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -157.88 141.91 15.87 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.55 1.14 . . . . 0.0 110.098 165.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 24.0 t -70.54 134.35 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 164.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.422 ' C ' ' H ' ' A' ' 125' ' ' GLU . 1.5 t70 -88.41 138.55 30.18 Favored Pre-proline 0 N--CA 1.451 -0.406 0 C-N-CA 123.971 0.908 . . . . 0.0 109.939 -173.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -72.02 34.53 0.29 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.09 2.527 . . . . 0.0 114.331 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.422 ' H ' ' C ' ' A' ' 123' ' ' ASP . 37.7 tt0 -107.55 -21.78 12.77 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 130.071 3.348 . . . . 0.0 108.507 172.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.7 tt -58.22 -39.12 72.18 Favored 'Isoleucine or valine' 0 C--N 1.345 0.372 0 O-C-N 121.117 -0.99 . . . . 0.0 111.249 172.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.1 m -77.27 61.62 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 123.37 0.668 . . . . 0.0 109.956 172.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -130.92 -78.48 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 117.359 -1.305 . . . . 0.0 111.403 173.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -73.04 160.21 46.19 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 CA-C-N 122.011 1.754 . . . . 0.0 111.105 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 84.5 t -65.07 -44.66 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 124.553 1.141 . . . . 0.0 109.113 -171.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -48.31 -64.38 0.81 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.335 1.854 . . . . 0.0 110.095 177.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 35.7 p -75.94 -19.96 58.34 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 118.357 -0.83 . . . . 0.0 111.63 -172.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -44.65 -39.31 4.96 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.932 0.787 . . . . 0.0 111.186 168.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -57.72 -54.6 36.01 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 175.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 21.9 mm -64.26 132.4 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 124.6 1.16 . . . . 0.0 111.728 -174.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -158.65 41.57 0.25 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.181 165.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.8 p -140.8 89.64 2.27 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 170.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.4 tp -84.79 144.88 28.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -166.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.5 t -149.61 153.02 36.42 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -176.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.493 ' H ' HD13 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -114.06 145.8 41.1 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 146.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 26.6 t -98.84 116.97 32.28 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 164.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.23 124.9 49.48 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.137 1.375 . . . . 0.0 107.383 178.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.5 m -114.63 89.88 3.2 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.537 ' CG ' HD13 ' A' ' 45' ' ' LEU . 2.1 m-30 -67.53 83.52 0.17 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 170.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.16 50.65 1.16 Allowed Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 178.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.471 ' CD ' HD12 ' A' ' 45' ' ' LEU . 87.9 Cg_endo -74.73 -106.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.264 2.643 . . . . 0.0 110.254 176.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -147.22 123.52 10.93 Favored 'General case' 0 C--N 1.337 0.058 0 CA-C-N 119.363 0.983 . . . . 0.0 109.292 -175.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -111.3 143.67 28.91 Favored Pre-proline 0 N--CA 1.45 -0.463 0 C-N-CA 124.892 1.277 . . . . 0.0 108.353 175.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.0 -51.28 0.17 Allowed 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 121.939 1.759 . . . . 0.0 109.135 171.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 61.8 p -175.75 174.28 2.22 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.282 1.833 . . . . 0.0 107.147 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.4 pttt . . . . . 0 CA--C 1.535 0.377 0 C-N-CA 124.759 1.224 . . . . 0.0 109.201 172.576 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.535 0.372 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -76.24 52.3 0.74 Allowed 'General case' 0 CA--C 1.539 0.525 0 O-C-N 120.585 -1.322 . . . . 0.0 107.47 154.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 168.67 164.74 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 128.393 2.677 . . . . 0.0 108.893 -173.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -155.03 19.67 0.44 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.814 1.246 . . . . 0.0 113.238 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 t -77.42 23.95 0.2 Allowed 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.174 -1.579 . . . . 0.0 113.456 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -75.9 -30.91 58.96 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 153.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -107.21 -44.54 4.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.614 1.165 . . . . 0.0 112.822 -175.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.1 mt -19.22 115.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 126.432 1.893 . . . . 0.0 115.146 -164.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.561 ' HB2' HD12 ' A' ' 60' ' ' ILE . 5.7 mp -103.78 -178.26 3.61 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.262 -161.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -69.2 -48.12 62.94 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.685 1.994 . . . . 0.0 110.733 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.599 ' HB3' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -60.54 151.08 29.56 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.799 0.809 . . . . 0.0 111.814 -174.779 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.63 98.54 7.69 Favored 'General case' 0 N--CA 1.418 -2.051 0 C-N-CA 127.233 2.213 . . . . 0.0 107.285 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . 0.31 0.0 OUTLIER -80.05 122.04 34.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 170.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.544 ' CE ' ' HB2' ' A' ' 55' ' ' ASP . 2.7 tmtp? -75.87 150.54 37.59 Favored 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.6 t -129.66 143.08 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 172.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.8 m -141.78 98.05 3.27 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -173.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -76.38 159.06 30.84 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.895 -172.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -131.05 84.0 2.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 122.761 1.267 . . . . 0.0 107.916 169.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.35 86.1 7.22 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 164.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -93.36 157.82 16.04 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.496 0.718 . . . . 0.0 109.089 170.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.2 p -140.2 110.98 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 123.499 0.72 . . . . 0.0 109.478 175.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.93 164.32 15.2 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.115 166.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.81 -39.44 8.39 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.921 1.288 . . . . 0.0 112.999 -176.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -46.19 -26.21 2.15 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.819 1.676 . . . . 0.0 113.985 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.731 HD11 ' HA2' ' A' ' 80' ' ' GLY . 0.3 OUTLIER -121.05 97.18 48.16 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 162.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -82.73 47.54 2.48 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.207 1.938 . . . . 0.0 110.296 -170.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.496 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 43.6 m0 -112.54 148.33 34.72 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.471 1.108 . . . . 0.0 109.502 -170.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -76.79 80.55 3.39 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 175.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -93.29 101.72 13.98 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 124.329 1.052 . . . . 0.0 108.251 -177.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.7 m -101.97 132.47 21.56 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-O 119.26 -0.4 . . . . 0.0 110.058 -172.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.38 141.34 51.04 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 N-CA-C 107.802 -1.653 . . . . 0.0 107.802 162.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.474 HG13 ' H ' ' A' ' 53' ' ' GLN . 13.2 p -77.58 -52.53 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 121.477 0.656 . . . . 0.0 110.031 -177.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.474 ' H ' HG13 ' A' ' 52' ' ' VAL . 3.1 mp0 -127.55 158.96 36.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 104.122 -2.547 . . . . 0.0 104.122 153.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -66.88 -44.91 79.65 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 174.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.544 ' HB2' ' CE ' ' A' ' 34' ' ' LYS . 20.7 p-10 -130.24 167.22 18.8 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 126.361 1.864 . . . . 0.0 111.07 -170.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.8 pt -143.07 175.49 4.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 125.11 1.364 . . . . 0.0 108.114 169.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -119.31 132.33 55.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 169.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.6 m -124.46 126.14 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.638 0.775 . . . . 0.0 108.96 172.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -72.68 77.43 1.1 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 168.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.599 HD11 ' HB3' ' A' ' 31' ' ' GLU . 19.5 mt 28.29 58.54 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 127.877 2.471 . . . . 0.0 111.798 169.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.6 -27.47 2.83 Favored Glycine 0 CA--C 1.523 0.557 0 O-C-N 122.131 -0.355 . . . . 0.0 113.195 -174.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -50.02 118.39 2.88 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.038 0.535 . . . . 0.0 111.342 171.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.4 p -88.94 107.27 18.92 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.338 1.455 . . . . 0.0 109.951 -177.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 t -96.06 139.07 19.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 174.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.8 120.35 23.94 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 163.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.34 111.05 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.413 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 76.8 mtp -76.49 171.22 14.97 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.39 0.676 . . . . 0.0 110.747 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -141.31 151.14 43.36 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 163.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.4 ttm105 -127.02 139.07 53.28 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 172.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.88 112.16 8.61 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.554 1.942 . . . . 0.0 108.152 173.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.0 mtmt -103.98 130.09 51.6 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.721 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.496 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 52.6 t-20 -78.26 101.97 7.41 Favored 'General case' 0 C--N 1.339 0.12 0 CA-C-N 119.44 1.018 . . . . 0.0 111.512 -176.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.9 mt -91.62 7.92 39.21 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.761 0.824 . . . . 0.0 113.014 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.91 162.94 27.2 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.858 1.208 . . . . 0.0 109.714 171.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.0 p -79.1 -9.21 59.49 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.045 1.338 . . . . 0.0 111.543 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.58 165.2 29.93 Favored Pre-proline 0 N--CA 1.447 -0.603 0 C-N-CA 126.38 1.872 . . . . 0.0 107.686 -168.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -61.27 148.43 92.94 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 121.14 1.226 . . . . 0.0 109.764 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.7 p -126.79 169.52 13.13 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 165.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.3 t -90.32 173.57 8.05 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 159.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.731 ' HA2' HD11 ' A' ' 45' ' ' LEU . . . -170.49 57.07 0.19 Allowed Glycine 0 N--CA 1.438 -1.185 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 176.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.69 -42.56 34.12 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 169.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 64.34 179.24 0.17 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.679 1.192 . . . . 0.0 110.873 174.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.8 m -120.16 136.15 54.72 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 172.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -105.57 148.75 26.94 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.151 0.58 . . . . 0.0 110.354 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -124.66 102.85 7.8 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 156.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.9 t -92.44 59.36 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 124.12 0.968 . . . . 0.0 108.839 -170.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.3 t -171.19 147.29 2.19 Favored Pre-proline 0 N--CA 1.461 0.108 0 O-C-N 121.499 -0.751 . . . . 0.0 111.664 -176.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -64.77 -40.41 22.21 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.381 1.387 . . . . 0.0 109.316 160.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 11.7 ptp 173.73 -71.76 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 127.523 2.329 . . . . 0.0 108.291 173.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.402 ' HB3' HG13 ' A' ' 135' ' ' ILE . . . -69.23 -43.8 73.31 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 123.571 0.748 . . . . 0.0 112.801 -164.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.49 -102.84 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.248 0.619 . . . . 0.0 110.595 -170.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.9 -52.75 1.67 Allowed Glycine 0 CA--C 1.53 1.026 0 CA-C-O 119.425 -0.653 . . . . 0.0 112.809 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -48.3 -50.63 29.33 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.039 1.419 . . . . 0.0 111.016 174.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -72.38 -4.98 33.22 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.082 1.753 . . . . 0.0 113.792 178.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -75.45 108.14 8.05 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -76.18 167.77 21.26 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.631 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -133.69 -179.59 5.63 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 174.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.9 p -73.14 68.79 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 122.118 0.961 . . . . 0.0 108.498 171.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 29.93 43.63 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 130.131 3.372 . . . . 0.0 114.543 -177.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 11.5 t 157.4 -69.39 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 127.462 2.305 . . . . 0.0 109.413 177.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -72.06 136.53 46.67 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.115 0.483 . . . . 0.0 112.035 -154.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 78.5 m -73.15 -39.44 65.67 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.68 0.792 . . . . 0.0 110.739 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 175.24 -171.25 0.06 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 130.63 3.572 . . . . 0.0 103.822 -175.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 41.5 m -150.45 -5.73 0.31 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.258 1.39 . . . . 0.0 113.372 -174.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.7 mp0 -57.43 -40.26 78.0 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.682 1.993 . . . . 0.0 111.529 -167.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . 0.325 5.0 t 57.98 -78.67 0.02 OUTLIER 'General case' 0 C--O 1.232 0.173 0 C-N-CA 126.268 1.827 . . . . 0.0 114.699 165.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.3 m -162.56 142.45 9.5 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 125.83 1.652 . . . . 0.0 107.53 -169.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 26.3 mt -149.67 140.69 22.93 Favored 'General case' 0 C--O 1.232 0.17 0 O-C-N 123.335 0.397 . . . . 0.0 111.255 174.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -52.39 161.45 1.06 Allowed Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 128.91 2.884 . . . . 0.0 111.413 159.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -77.23 125.29 7.72 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.454 2.769 . . . . 0.0 111.602 -173.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.59 -10.82 32.87 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 124.437 1.018 . . . . 0.0 111.167 175.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -79.0 144.77 34.37 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -164.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -93.04 101.18 13.51 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.054 1.742 . . . . 0.0 109.127 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.55 125.39 29.92 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 161.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -146.31 126.66 13.98 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.156 1.382 . . . . 0.0 107.536 172.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 68.1 mtp -148.89 151.43 34.9 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 118.113 0.415 . . . . 0.0 111.002 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 67' ' ' MET . 84.0 Cg_endo -76.1 145.11 27.49 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 123.843 3.029 . . . . 0.0 110.378 165.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.2 t -116.59 156.4 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 155.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.0 m -122.47 141.73 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 171.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -153.9 148.12 25.86 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -171.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -157.62 175.84 13.4 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 128.501 2.72 . . . . 0.0 106.569 173.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 87.5 t -126.64 137.4 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 C-N-CA 123.111 0.564 . . . . 0.0 109.543 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -71.54 144.11 88.42 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 119.557 -0.259 . . . . 0.0 111.213 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -58.82 -25.14 75.23 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.0 2.467 . . . . 0.0 112.891 172.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -43.9 -30.16 0.66 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.663 1.185 . . . . 0.0 113.244 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.0 tt -52.52 -42.02 38.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 175.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.5 m -91.75 55.66 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 118.391 0.541 . . . . 0.0 110.332 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -129.71 -70.33 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.371 0 CA-C-O 117.224 -1.37 . . . . 0.0 111.331 167.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.2 156.77 63.81 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 CA-C-N 121.913 1.719 . . . . 0.0 111.47 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 83.9 t -66.75 -50.73 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.709 0.804 . . . . 0.0 110.076 -169.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -48.26 -45.15 34.1 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 124.616 1.166 . . . . 0.0 111.623 -174.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 61.2 p -92.19 -9.52 42.02 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 118.55 -0.738 . . . . 0.0 112.336 -174.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -50.21 -44.64 53.26 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.048 0.84 . . . . 0.0 111.602 -172.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.23 -24.99 75.55 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 123.388 0.518 . . . . 0.0 112.557 -177.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.402 HG13 ' HB3' ' A' ' 90' ' ' ALA . 13.2 mm -73.8 123.17 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 118.122 0.961 . . . . 0.0 109.773 -176.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -153.39 52.48 0.73 Allowed 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.719 165.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.4 m -146.95 99.7 3.21 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 153.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.81 134.17 38.06 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.3 t -125.48 161.65 26.65 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.6 tt -131.26 112.15 12.54 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 102.263 -3.236 . . . . 0.0 102.263 168.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.5 t -86.47 104.03 15.56 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 167.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.35 97.21 8.94 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.59 86.58 3.91 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 122.416 1.103 . . . . 0.0 108.272 -178.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.616 ' CD2' HD13 ' A' ' 45' ' ' LEU . 3.1 m-85 -68.37 87.67 0.31 Allowed 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 167.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.03 35.9 0.09 OUTLIER Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.91 -79.19 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.977 1.784 . . . . 0.0 113.365 -174.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 71.2 mtm180 -155.94 117.37 3.92 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.815 0.846 . . . . 0.0 109.99 -172.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -88.01 147.86 41.8 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 123.252 0.621 . . . . 0.0 109.73 167.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.52 -47.38 0.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.647 2.231 . . . . 0.0 110.335 172.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.4 p 157.13 82.25 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 128.536 2.734 . . . . 0.0 107.9 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.542 0.662 0 O-C-N 121.615 -0.678 . . . . 0.0 109.177 -171.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.448 HG22 ' H ' ' A' ' 22' ' ' GLU . 8.2 p . . . . . 0 CA--C 1.533 0.32 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.448 ' H ' HG22 ' A' ' 21' ' ' VAL . 61.0 mt-10 -67.67 66.49 0.09 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.16 0.891 . . . . 0.0 109.969 161.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 171.36 91.83 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 130.04 3.336 . . . . 0.0 106.577 169.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.58 15.65 9.09 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -170.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.4 m -70.24 65.73 0.28 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 129.195 2.998 . . . . 0.0 110.536 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -153.79 -56.26 0.11 Allowed 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 130.972 3.709 . . . . 0.0 103.321 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.18 -20.84 19.49 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 116.691 -1.623 . . . . 0.0 113.958 174.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.7 mt -40.47 138.91 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 120.968 1.713 . . . . 0.0 115.064 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -122.41 173.25 7.77 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.505 1.922 . . . . 0.0 110.509 -171.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -86.04 -24.5 26.35 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.753 0.821 . . . . 0.0 112.673 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.93 148.05 22.14 Favored 'General case' 0 C--O 1.231 0.11 0 O-C-N 121.004 -1.06 . . . . 0.0 110.209 174.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -120.02 97.0 5.4 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.24 1.416 . . . . 0.0 108.562 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.9 142.64 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 124.736 1.214 . . . . 0.0 108.779 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.67 148.39 27.44 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.761 1.224 . . . . 0.0 109.099 -174.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.9 t -136.18 111.16 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 -171.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 m -91.82 122.78 34.67 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 173.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -96.01 107.85 20.19 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.629 1.172 . . . . 0.0 108.8 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -96.28 86.93 4.34 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 122.763 1.268 . . . . 0.0 110.027 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.96 136.91 37.38 Favored 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 120.744 -1.222 . . . . 0.0 108.419 173.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.93 146.14 50.24 Favored 'General case' 0 CA--C 1.523 -0.08 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.94 143.1 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.58 166.64 23.06 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.166 1.786 . . . . 0.0 106.983 168.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -42.56 -43.72 3.86 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 124.233 1.013 . . . . 0.0 112.285 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.56 -34.09 0.23 Allowed Glycine 0 CA--C 1.534 1.223 0 C-N-CA 126.214 1.864 . . . . 0.0 114.663 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.18 96.5 49.28 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 119.034 1.417 . . . . 0.0 107.961 162.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -84.73 43.2 1.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 124.095 3.197 . . . . 0.0 109.441 -169.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.424 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 41.1 m0 -115.5 144.42 43.87 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -169.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -76.74 79.93 3.36 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -175.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -89.36 98.44 11.77 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.236 1.014 . . . . 0.0 109.042 -174.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.9 m -102.45 138.21 19.61 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -70.44 163.03 40.28 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 121.622 1.548 . . . . 0.0 108.71 166.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 67' ' ' MET . 2.4 t -80.08 -61.92 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -175.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -131.7 156.99 44.94 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 162.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -23.95 64.99 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.072 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.57 162.59 41.12 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 119.078 0.854 . . . . 0.0 111.029 174.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.2 pt -135.33 166.55 27.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 126.074 1.75 . . . . 0.0 109.33 173.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -111.28 135.55 51.65 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.3 1.84 . . . . 0.0 109.435 164.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -137.42 128.98 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.369 1.867 . . . . 0.0 108.689 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -82.1 82.49 7.65 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 120.699 -1.25 . . . . 0.0 109.5 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.0 mt 17.38 69.58 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 128.768 2.827 . . . . 0.0 112.237 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.45 -25.64 4.76 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.239 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -48.7 108.54 0.18 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.839 0.455 . . . . 0.0 111.471 172.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.1 p -75.11 108.99 8.21 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.064 1.346 . . . . 0.0 109.801 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.8 p -114.57 145.46 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 122.841 0.456 . . . . 0.0 110.284 173.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.38 131.2 34.72 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 124.403 1.081 . . . . 0.0 110.253 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.6 pp -142.88 92.66 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.569 1.148 . . . . 0.0 109.887 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.408 ' O ' HG22 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -78.36 133.22 37.6 Favored 'General case' 0 C--O 1.226 -0.144 0 O-C-N 121.432 -0.792 . . . . 0.0 111.618 -175.595 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -100.53 157.09 16.91 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 66.1 ttp85 -142.06 122.97 14.44 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.907 -0.568 . . . . 0.0 109.945 -175.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.43 154.77 36.1 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.52 1.128 . . . . 0.0 108.281 158.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -145.83 139.46 26.37 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 167.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.424 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 52.9 t-20 -82.8 118.53 23.47 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 120.177 1.353 . . . . 0.0 112.689 -172.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -100.83 -9.39 21.72 Favored 'General case' 0 C--N 1.346 0.442 0 C-N-CA 124.16 0.984 . . . . 0.0 113.222 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.37 142.44 36.01 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 119.857 1.208 . . . . 0.0 108.988 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.6 m -78.37 36.2 0.24 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.5 p -153.39 155.78 31.95 Favored Pre-proline 0 N--CA 1.451 -0.405 0 C-N-CA 125.591 1.557 . . . . 0.0 108.336 175.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.0 145.07 89.37 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 N-CA-C 108.235 -1.486 . . . . 0.0 108.235 169.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.0 p -117.55 178.14 4.5 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 168.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.1 t -124.27 126.43 46.06 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -98.26 109.17 3.75 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 107.167 -2.373 . . . . 0.0 107.167 175.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.58 49.37 1.8 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 162.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 143' ' ' THR . . . -61.82 143.89 55.64 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.375 0.67 . . . . 0.0 111.271 -175.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.12 155.89 27.27 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.754 174.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -151.66 147.22 26.47 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -103.4 100.77 10.65 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 170.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.6 p -89.06 83.52 2.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 CA-C-O 118.079 -0.962 . . . . 0.0 108.41 175.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.2 t 176.97 147.08 0.29 Allowed Pre-proline 0 C--O 1.232 0.162 0 C-N-CA 124.644 1.178 . . . . 0.0 109.496 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -64.26 -39.35 30.59 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 120.666 0.91 . . . . 0.0 110.342 156.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.1 ptp 177.9 -71.67 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.594 1.958 . . . . 0.0 107.976 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.15 -37.47 33.39 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.944 0.898 . . . . 0.0 112.859 -168.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.2 -118.05 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.315 0.646 . . . . 0.0 110.337 -174.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.0 -53.45 2.16 Favored Glycine 0 CA--C 1.526 0.72 0 O-C-N 121.216 -0.928 . . . . 0.0 112.652 -175.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -41.64 -58.86 1.81 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.844 1.258 . . . . 0.0 110.623 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -74.83 -8.61 56.97 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -53.67 117.72 3.36 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.36 0.982 . . . . 0.0 108.585 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -65.65 131.19 45.73 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.264 0.555 . . . . 0.0 111.398 -159.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -83.75 79.74 9.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -172.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.4 m -51.78 147.47 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.55 1.14 . . . . 0.0 112.91 -174.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 36.85 -114.16 0.1 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.376 2.27 . . . . 0.0 111.904 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 29.4 p -156.3 138.42 14.59 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 51.79 60.78 3.6 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -169.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 15.2 p -53.79 147.02 12.53 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.712 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 48.94 64.43 1.72 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.832 0.853 . . . . 0.0 110.664 -174.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.32 58.92 0.4 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.988 1.315 . . . . 0.0 110.851 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -63.28 -32.52 73.95 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.348 1.059 . . . . 0.0 112.838 -169.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.2 t 52.67 -143.52 0.7 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.173 0.989 . . . . 0.0 112.593 166.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.2 m -124.8 133.31 53.17 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 127.538 2.335 . . . . 0.0 105.864 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 86.8 mt -122.19 120.14 33.31 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 175.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -56.2 159.73 5.7 Favored Pre-proline 0 N--CA 1.447 -0.591 0 C-N-CA 123.864 0.865 . . . . 0.0 110.541 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -67.12 102.97 0.7 Allowed 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.202 2.601 . . . . 0.0 112.308 -169.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 122.63 -16.22 8.44 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -78.2 148.55 33.98 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 118.001 0.9 . . . . 0.0 110.877 -166.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.4 141.17 36.41 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.385 1.874 . . . . 0.0 109.173 -169.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 46.3 ttp -135.52 82.87 1.98 Allowed 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.621 1.168 . . . . 0.0 109.371 173.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -104.25 113.1 26.42 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.078 1.751 . . . . 0.0 107.725 171.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 40.4 mtm -137.29 126.62 15.26 Favored Pre-proline 0 C--O 1.235 0.337 0 CA-C-N 118.386 0.539 . . . . 0.0 111.748 -170.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -74.73 139.81 25.49 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.618 2.212 . . . . 0.0 112.517 173.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.7 t -128.99 151.04 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.1 p -118.28 142.16 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 170.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -144.53 158.31 43.82 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 118.948 0.795 . . . . 0.0 111.294 -175.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -162.28 168.61 22.03 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 127.671 2.389 . . . . 0.0 106.695 173.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 49.4 t -112.39 145.36 18.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 C-N-CA 124.252 1.021 . . . . 0.0 108.363 174.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -77.04 157.77 80.93 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 123.968 0.907 . . . . 0.0 110.924 -177.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -79.41 -22.65 7.96 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.723 2.282 . . . . 0.0 112.742 166.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -53.74 -37.12 63.03 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.234 1.013 . . . . 0.0 111.516 -171.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.2 tt -40.03 -34.09 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.534 1.934 . . . . 0.0 114.793 171.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.4 m -106.71 22.56 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 119.786 1.175 . . . . 0.0 112.956 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.1 -48.08 0.48 Allowed Pre-proline 0 CA--C 1.545 0.762 0 O-C-N 120.854 -1.154 . . . . 0.0 113.29 167.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -81.15 -165.73 0.36 Allowed 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.345 2.697 . . . . 0.0 110.374 -171.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.7 t -95.22 -51.23 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -31.85 -61.88 0.22 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 129.263 3.025 . . . . 0.0 113.499 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.2 p -92.5 -5.17 52.37 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 123.335 0.654 . . . . 0.0 112.641 -174.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -54.31 107.63 0.29 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.972 0.909 . . . . 0.0 111.295 -169.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 120.92 -27.22 6.54 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 123.98 0.8 . . . . 0.0 111.59 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 45.8 mm -64.7 125.67 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 118.168 0.984 . . . . 0.0 109.692 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -157.07 51.34 0.48 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.582 172.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.42 87.4 2.01 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 167.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.2 tp -88.88 89.31 7.93 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -160.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.6 t -102.01 171.95 7.21 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 122.443 1.116 . . . . 0.0 111.7 -171.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.97 108.33 2.38 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 -160.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.4 t -92.63 116.23 28.82 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 168.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.417 ' HE1' ' HB3' ' A' ' 82' ' ' ALA . 0.6 OUTLIER -114.47 114.23 25.53 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 118.644 0.656 . . . . 0.0 109.579 -179.05 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.466 ' O ' ' HB1' ' A' ' 82' ' ' ALA . 1.4 m -100.63 87.17 3.28 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.392 0.677 . . . . 0.0 111.34 -167.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -67.87 84.16 0.21 Allowed 'General case' 0 CA--C 1.54 0.56 0 O-C-N 122.044 -0.41 . . . . 0.0 110.513 173.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.3 22.39 0.05 OUTLIER Pre-proline 0 CA--C 1.556 1.209 0 N-CA-C 118.448 2.759 . . . . 0.0 118.448 -175.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.87 -81.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.021 2.481 . . . . 0.0 113.424 -168.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.5 ptm85 -155.6 140.78 17.51 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 119.866 1.212 . . . . 0.0 113.102 177.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.62 147.83 44.17 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 125.765 1.626 . . . . 0.0 106.97 175.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.38 -37.02 0.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.371 2.048 . . . . 0.0 113.52 -176.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.8 m 155.26 96.52 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 129.533 3.133 . . . . 0.0 108.653 -174.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 18.2 pttp . . . . . 0 CA--C 1.538 0.484 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.501 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 CA--C 1.532 0.268 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . 0.255 3.3 tt0 27.78 64.57 0.1 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.491 2.316 . . . . 0.0 112.775 -174.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -173.06 141.34 0.96 Allowed 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 100.601 -3.851 . . . . 0.0 100.601 -168.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.668 ' HB3' HD11 ' A' ' 28' ' ' ILE . . . -74.91 -57.37 3.95 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 118.441 -1.304 . . . . 0.0 113.053 -143.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 83.4 p -153.72 172.93 16.52 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 156.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -79.06 -32.92 45.01 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.955 174.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -87.45 -41.47 13.52 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.279 1.031 . . . . 0.0 111.971 -170.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.668 HD11 ' HB3' ' A' ' 24' ' ' ALA . 61.1 mt 28.32 74.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 126.859 2.063 . . . . 0.0 112.655 -173.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.419 HD22 ' H ' ' A' ' 29' ' ' LEU . 2.3 mm? -70.02 164.72 23.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.696 170.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -65.02 -31.69 73.04 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -176.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.23 129.78 10.29 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 122.276 1.036 . . . . 0.0 113.376 -165.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -91.74 83.28 5.27 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 122.374 1.083 . . . . 0.0 108.513 -169.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.65 120.48 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 171.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.82 170.63 9.54 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.558 1.143 . . . . 0.0 109.193 -170.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.6 t -144.94 146.42 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 169.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.7 m -141.3 104.12 4.55 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -176.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -82.15 125.09 30.49 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 125.596 1.559 . . . . 0.0 110.258 -174.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -102.51 89.05 3.41 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 163.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -99.96 89.11 3.95 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 172.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -111.69 151.32 29.02 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 123.805 0.842 . . . . 0.0 110.415 -171.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.39 105.71 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.985 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.22 150.96 36.98 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 163.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.82 -29.28 4.43 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.595 0.758 . . . . 0.0 112.901 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -36.97 -40.04 0.47 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.605 1.574 . . . . 0.0 113.791 170.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.403 HD21 ' CD2' ' A' ' 47' ' ' TRP . 0.9 OUTLIER -109.32 120.13 46.38 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 162.524 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -84.33 14.62 2.39 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 121.451 1.434 . . . . 0.0 113.553 -169.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.49 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 41.1 m0 -79.25 156.64 28.03 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 121.969 0.89 . . . . 0.0 111.43 -177.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -74.9 138.81 42.66 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 104.262 -2.495 . . . . 0.0 104.262 158.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -143.99 128.87 18.42 Favored 'General case' 0 N--CA 1.458 -0.059 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.2 t -122.95 123.66 26.74 Favored Pre-proline 0 N--CA 1.444 -0.732 0 C-N-CA 125.311 1.444 . . . . 0.0 108.557 -168.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -74.81 146.64 33.73 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 123.958 3.106 . . . . 0.0 107.497 166.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.443 HG21 ' HB ' ' A' ' 66' ' ' ILE . 2.2 t -77.93 -58.59 3.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -170.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -122.51 163.91 19.06 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 103.41 -2.811 . . . . 0.0 103.41 155.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.1 tpt180 -58.07 -47.66 82.51 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 169.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -139.97 165.35 27.57 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 125.63 1.572 . . . . 0.0 110.27 -166.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.4 pt -141.79 162.8 20.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 C-N-CA 124.676 1.19 . . . . 0.0 108.226 175.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -106.4 139.41 40.92 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 162.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.05 81.33 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 175.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.7 mmm-85 -56.94 111.97 1.19 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.723 1.209 . . . . 0.0 110.687 -166.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.477 ' O ' HG22 ' A' ' 60' ' ' ILE . 33.5 mm 16.4 56.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 126.239 1.816 . . . . 0.0 113.185 -160.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.581 ' C ' ' HB1' ' A' ' 24' ' ' ALA . . . 125.45 -73.21 0.43 Allowed Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 22.19 86.52 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.347 2.259 . . . . 0.0 113.555 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.86 119.13 6.16 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.194 0.997 . . . . 0.0 111.541 -169.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.15 152.9 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 123.42 0.688 . . . . 0.0 110.481 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.75 126.09 51.84 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 126.471 1.908 . . . . 0.0 108.013 174.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.443 ' HB ' HG21 ' A' ' 52' ' ' VAL . 1.9 pp -125.36 113.49 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 168.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.87 106.49 10.93 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.27 0.628 . . . . 0.0 112.683 176.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -77.33 149.13 35.33 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 171.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 -139.01 138.28 37.08 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 123.418 0.449 . . . . 0.0 110.473 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.61 171.87 10.75 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.611 1.564 . . . . 0.0 110.046 164.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.6 136.45 15.36 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 177.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.49 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 37.6 t30 -78.12 128.49 33.88 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 120.258 1.39 . . . . 0.0 111.175 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 tp -118.95 26.01 9.82 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.671 1.988 . . . . 0.0 111.885 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -103.96 174.18 5.98 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.805 1.242 . . . . 0.0 110.201 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.3 p -97.06 11.37 36.42 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.043 1.337 . . . . 0.0 111.524 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.41 161.1 42.85 Favored Pre-proline 0 C--O 1.239 0.531 0 C-N-CA 125.071 1.348 . . . . 0.0 107.942 -177.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -56.4 158.7 14.9 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 121.382 1.388 . . . . 0.0 109.877 164.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.431 ' HG1' ' HE1' ' A' ' 47' ' ' TRP . 6.8 p -134.72 -177.83 4.79 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.848 2.459 . . . . 0.0 108.025 -176.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.1 t -138.6 140.46 38.97 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 159.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -94.46 93.73 1.7 Allowed Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 107.255 -2.338 . . . . 0.0 107.255 170.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -112.59 47.04 1.12 Allowed 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 167.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.62 170.4 16.39 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 171.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.5 t -144.6 158.96 43.54 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 166.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -84.9 155.17 21.8 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.242 1.417 . . . . 0.0 109.867 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -109.78 100.44 9.44 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 149.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.8 t -80.7 100.61 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 125.303 1.441 . . . . 0.0 107.477 174.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.6 t 172.27 151.25 0.21 Allowed Pre-proline 0 C--N 1.343 0.293 0 C-N-CA 126.825 2.05 . . . . 0.0 109.055 168.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -66.83 -49.31 1.57 Allowed 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 121.029 1.153 . . . . 0.0 109.584 153.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.1 ptt? -173.55 -72.7 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.989 1.715 . . . . 0.0 107.907 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.46 -40.47 85.35 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -171.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.46 -100.61 0.02 OUTLIER 'General case' 0 C--N 1.339 0.116 0 CA-C-N 117.912 0.324 . . . . 0.0 111.692 -170.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.09 -61.01 1.4 Allowed Glycine 0 CA--C 1.53 0.999 0 CA-C-O 119.447 -0.64 . . . . 0.0 111.799 -172.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.59 -56.67 5.69 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.837 1.255 . . . . 0.0 111.85 -176.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -72.97 5.0 3.6 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.405 1.082 . . . . 0.0 113.917 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -80.02 116.42 20.14 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 173.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -72.19 88.34 1.13 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 119.253 -0.979 . . . . 0.0 112.055 -171.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm 136.66 72.16 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 129.854 3.262 . . . . 0.0 109.309 167.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 15.2 t -97.67 -56.91 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 124.195 0.998 . . . . 0.0 111.978 -175.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -76.44 75.04 3.19 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -157.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 13.6 t -149.06 51.15 0.97 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.996 0.903 . . . . 0.0 109.454 164.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -80.67 61.72 4.46 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.59 0.71 . . . . 0.0 110.245 -176.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 51.1 t -164.99 51.09 0.11 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 172.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -85.67 165.52 16.91 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.045 -156.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.8 t -159.44 152.42 21.95 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -119.74 44.52 2.37 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.011 1.324 . . . . 0.0 108.124 162.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . 0.255 6.3 t 50.16 -124.38 2.1 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.358 1.463 . . . . 0.0 111.962 170.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.0 m -145.16 151.28 38.19 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.66 2.384 . . . . 0.0 107.255 -172.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.533 HD11 ' HB2' ' A' ' 114' ' ' MET . 70.5 mt -135.8 132.67 37.0 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 171.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -64.19 158.15 65.95 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 125.04 1.336 . . . . 0.0 109.959 169.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.18 93.68 0.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.712 2.941 . . . . 0.0 112.539 -169.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 140.25 -28.7 2.46 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -77.93 150.55 34.01 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 117.594 0.697 . . . . 0.0 112.531 -155.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -86.18 155.84 20.57 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.82 2.048 . . . . 0.0 110.527 -174.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.533 ' HB2' HD11 ' A' ' 108' ' ' LEU . 19.2 ttm -148.75 89.22 1.67 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.414 1.086 . . . . 0.0 109.417 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -106.89 143.9 34.31 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.167 0.894 . . . . 0.0 110.657 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -150.09 107.63 3.21 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 124.147 0.979 . . . . 0.0 112.33 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.71 108.61 0.27 Allowed 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 124.961 3.774 . . . . 0.0 112.541 165.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.3 t -100.97 117.86 46.84 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 171.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.8 p -79.19 142.02 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 168.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -154.78 159.33 40.56 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -175.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -177.7 160.79 1.58 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.322 2.249 . . . . 0.0 109.928 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 94.6 t -121.41 131.8 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.6 1.16 . . . . 0.0 109.689 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.1 148.17 38.78 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -176.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -74.76 57.81 4.52 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 124.202 3.268 . . . . 0.0 112.698 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -104.02 -41.67 5.78 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.053 0.941 . . . . 0.0 109.833 162.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.8 tt -47.89 -42.9 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 124.361 1.064 . . . . 0.0 113.846 -169.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.2 m -78.83 51.05 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 O-C-N 121.064 -1.022 . . . . 0.0 111.166 176.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -133.7 -72.28 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 124.796 1.239 . . . . 0.0 111.147 173.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.08 136.75 45.69 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 121.833 1.688 . . . . 0.0 112.675 -175.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 97.6 t -40.6 -53.23 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 126.4 1.88 . . . . 0.0 109.751 178.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -33.19 -47.28 0.19 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 127.893 2.477 . . . . 0.0 113.759 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 35.1 p -106.42 -6.94 17.86 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -173.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -57.7 107.45 0.45 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.379 0.991 . . . . 0.0 111.031 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 132.14 -38.35 1.91 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.035 1.303 . . . . 0.0 109.895 -173.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 23.5 mm -70.17 121.94 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 O-C-N 122.186 -0.597 . . . . 0.0 111.045 -175.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -156.33 54.65 0.56 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 122.086 0.946 . . . . 0.0 111.016 166.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 66.6 m -146.84 93.4 2.27 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 159.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.1 tp -84.62 88.41 7.34 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.388 0.613 . . . . 0.0 109.677 -162.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.6 m -86.27 155.96 20.46 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.055 0.942 . . . . 0.0 110.88 -162.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 14.6 tp -123.06 131.18 53.59 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 170.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.0 p -114.01 107.45 15.69 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 165.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -109.77 91.89 3.83 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.927 0.891 . . . . 0.0 109.261 -175.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.5 p -78.93 93.11 5.0 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.458 0.703 . . . . 0.0 110.004 176.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -59.43 96.0 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 159.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.57 61.31 3.83 Favored Pre-proline 0 CA--C 1.549 0.928 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 172.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -86.94 -99.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 124.123 3.215 . . . . 0.0 110.149 174.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -127.72 133.86 49.55 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 124.47 1.108 . . . . 0.0 110.297 -176.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.86 117.23 42.25 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 126.831 2.052 . . . . 0.0 105.809 174.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.44 -26.77 6.96 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.836 2.358 . . . . 0.0 112.95 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.7 m 140.82 101.73 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 129.553 3.141 . . . . 0.0 108.927 -175.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.518 0 C-N-CA 123.58 0.752 . . . . 0.0 112.845 -178.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.6 m . . . . . 0 C--O 1.232 0.169 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -74.27 67.65 1.41 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 122.306 1.05 . . . . 0.0 109.642 176.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.81 -76.79 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 128.53 2.732 . . . . 0.0 104.365 173.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.415 ' H ' ' HB2' ' A' ' 25' ' ' SER . . . -165.68 -58.06 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.374 1.87 . . . . 0.0 110.979 147.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.415 ' HB2' ' H ' ' A' ' 24' ' ' ALA . 25.1 t -146.55 58.43 1.19 Allowed 'General case' 0 C--N 1.344 0.363 0 C-N-CA 130.447 3.499 . . . . 0.0 107.91 13.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -157.24 -54.52 0.08 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.868 2.067 . . . . 0.0 105.677 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.1 mt -27.72 -24.03 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.564 1 C-N-CA 132.658 4.383 . . . . 0.0 116.946 174.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.4 mt -81.6 51.62 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 126.023 1.729 . . . . 0.0 110.649 -160.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.48 164.18 24.96 Favored 'General case' 0 C--N 1.334 -0.101 0 O-C-N 121.348 -0.845 . . . . 0.0 108.742 -176.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -74.86 73.88 2.12 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 122.558 1.17 . . . . 0.0 112.007 -175.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.46 160.37 40.28 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 129.854 3.262 . . . . 0.0 106.624 173.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -146.76 111.46 5.27 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -173.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.82 124.3 72.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -169.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.74 149.12 25.1 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 124.358 1.063 . . . . 0.0 109.336 -176.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.5 t -141.37 96.65 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -171.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.4 m -79.86 107.22 12.47 Favored 'General case' 0 C--O 1.221 -0.422 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 169.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -79.51 166.88 21.49 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 171.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -136.53 90.41 2.55 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 122.137 0.97 . . . . 0.0 111.972 167.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.81 127.25 32.39 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 158.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -132.42 150.87 52.08 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 124.497 1.119 . . . . 0.0 108.248 173.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.97 99.9 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 124.018 0.927 . . . . 0.0 109.339 -178.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.08 169.21 10.81 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.357 0.599 . . . . 0.0 110.058 168.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.29 147.5 35.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 169.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 113.77 -20.6 17.41 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -168.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.56 HD13 ' CD2' ' A' ' 144' ' ' PHE . 0.3 OUTLIER -137.62 95.36 11.29 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 123.77 0.828 . . . . 0.0 109.523 178.046 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -84.31 45.82 1.81 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.679 2.919 . . . . 0.0 110.45 -169.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.497 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 44.4 m0 -113.89 147.03 39.18 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.935 0.894 . . . . 0.0 109.787 -165.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -76.63 81.87 3.28 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 104.588 -2.375 . . . . 0.0 104.588 173.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -90.89 108.83 20.1 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.06 121.54 16.86 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -171.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -81.53 166.3 17.83 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.631 2.221 . . . . 0.0 108.7 168.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.402 ' H ' HG22 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -77.07 -40.41 30.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 122.114 -0.366 . . . . 0.0 111.249 177.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.64 175.26 13.89 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 172.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -60.35 -59.26 5.69 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 167.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -137.32 130.8 31.28 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 122.853 0.461 . . . . 0.0 112.098 -155.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.7 pt -99.86 175.85 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 169.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -126.97 150.89 49.18 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 152.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.6 m -130.35 131.31 65.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . 0.255 4.3 tpt180 -72.62 74.5 1.08 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 167.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.4 pt 15.68 51.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 131.111 3.764 . . . . 0.0 115.286 -176.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.12 -39.44 0.77 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.491 -169.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -36.01 109.58 0.09 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.743 1.217 . . . . 0.0 111.153 168.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.07 99.06 6.75 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.347 1.459 . . . . 0.0 109.068 -168.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 p -76.52 176.39 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.959 0.885 . . . . 0.0 110.809 -171.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.13 89.84 2.38 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 172.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.9 pp -105.48 118.98 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 173.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 89.6 mtp -77.27 140.56 40.09 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -111.73 145.08 39.94 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 168.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -140.86 135.32 31.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.956 0.902 . . . . 0.0 109.962 -177.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.39 90.97 1.7 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.691 1.996 . . . . 0.0 110.033 174.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -79.32 148.34 32.12 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 117.044 -1.455 . . . . 0.0 107.996 172.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.497 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 35.7 t30 -89.82 110.18 21.13 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 120.332 1.424 . . . . 0.0 111.469 172.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.3 tp -86.88 -4.65 59.2 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.379 1.071 . . . . 0.0 112.809 -176.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.2 171.17 14.96 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.397 -0.815 . . . . 0.0 109.873 -175.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.0 m -105.78 18.54 21.99 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.506 175.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.8 p -144.61 160.17 48.6 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 127.411 2.284 . . . . 0.0 106.428 170.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.07 152.77 79.6 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.523 1.482 . . . . 0.0 109.836 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.36 167.12 15.38 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.445 0.641 . . . . 0.0 111.146 166.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.4 t -98.64 168.24 10.29 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 113.888 -1.506 . . . . 0.0 107.834 156.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -145.26 63.8 0.46 Allowed Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 106.345 -2.702 . . . . 0.0 106.345 173.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.39 56.25 3.29 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 -176.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.51 147.66 32.11 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.148 -1.387 . . . . 0.0 111.177 -164.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 m -79.76 160.89 26.02 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 174.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -143.32 138.99 29.9 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 172.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.97 90.59 4.96 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 106.236 -1.765 . . . . 0.0 106.236 169.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.6 57.82 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 O-C-N 121.837 -0.539 . . . . 0.0 110.702 -176.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.1 t -171.17 145.0 1.8 Allowed Pre-proline 0 C--N 1.333 -0.144 0 O-C-N 121.538 -0.726 . . . . 0.0 111.484 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.87 -37.38 66.85 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 121.456 1.437 . . . . 0.0 108.763 164.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.5 ptm -179.95 -68.59 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.556 1.942 . . . . 0.0 107.617 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -90.25 -28.61 18.71 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.138 0.975 . . . . 0.0 112.831 -164.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.44 -114.56 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.396 0.278 . . . . 0.0 110.489 -168.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.27 -40.24 0.47 Allowed Glycine 0 CA--C 1.533 1.18 0 O-C-N 121.314 -0.866 . . . . 0.0 114.778 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -51.87 -65.15 0.61 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.11 1.455 . . . . 0.0 108.302 166.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -72.7 29.0 0.06 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.469 2.308 . . . . 0.0 112.173 177.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -105.18 101.3 10.86 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 168.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -53.88 139.38 33.83 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 122.7 0.4 . . . . 0.0 111.313 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -121.5 135.63 55.01 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.9 m -75.21 -40.17 43.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 122.691 0.396 . . . . 0.0 111.625 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -120.45 -59.33 1.78 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.266 1.026 . . . . 0.0 110.248 -169.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 19.2 t 54.09 50.15 17.23 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.926 0.891 . . . . 0.0 111.668 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -157.9 -69.47 0.09 Allowed 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 59.7 m -101.54 172.81 6.74 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 166.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -137.56 176.37 8.77 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 126.185 1.794 . . . . 0.0 106.331 167.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.9 t -87.94 -17.63 30.9 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.748 0.703 . . . . 0.0 112.212 -159.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -85.5 -59.73 2.23 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.208 0.603 . . . . 0.0 109.885 -169.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . 0.32 13.2 t 52.5 -71.84 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 117.849 2.537 . . . . 0.0 117.849 161.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -159.65 143.75 14.78 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.592 1.557 . . . . 0.0 109.383 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.6 mt -151.77 140.95 21.32 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.217 1.007 . . . . 0.0 110.273 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.9 mp0 -74.89 161.28 78.27 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 127.085 2.154 . . . . 0.0 110.392 172.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -75.51 111.11 3.23 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.74 1.626 . . . . 0.0 113.21 -165.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 115.13 -12.13 19.8 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 176.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -85.77 152.09 23.31 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.2 -161.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -107.6 122.37 46.55 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.75 1.22 . . . . 0.0 109.311 -160.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.73 112.7 17.04 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 124.597 1.159 . . . . 0.0 110.213 177.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -143.05 145.87 33.3 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.759 0.709 . . . . 0.0 110.176 160.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 23.5 ptm -156.3 156.27 30.0 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-O 119.135 -0.46 . . . . 0.0 111.051 173.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.89 148.23 81.88 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.374 2.716 . . . . 0.0 111.996 171.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.6 t -126.23 134.6 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 125.93 1.692 . . . . 0.0 106.878 167.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.6 p -100.02 143.96 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.999 1.32 . . . . 0.0 108.015 174.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -158.95 146.85 17.85 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -176.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -164.77 95.34 0.71 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.034 0.533 . . . . 0.0 111.81 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.2 t -40.64 130.71 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 125.936 1.694 . . . . 0.0 112.99 -173.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.3 119.71 77.28 Favored Pre-proline 0 N--CA 1.44 -0.968 0 C-N-CA 125.277 1.431 . . . . 0.0 107.283 -169.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.13 55.8 4.67 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.147 2.565 . . . . 0.0 111.823 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -109.5 -28.68 8.78 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.997 2.119 . . . . 0.0 109.523 169.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.4 tt -54.98 -42.98 67.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -173.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.6 m -78.09 51.89 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 118.78 0.718 . . . . 0.0 111.037 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -139.42 -69.59 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.901 -177.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -73.48 152.41 48.9 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.295 1.996 . . . . 0.0 113.449 -175.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.5 p -55.27 -30.91 25.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.136 1.374 . . . . 0.0 111.886 175.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -36.23 -55.3 0.8 Allowed 'General case' 0 C--N 1.339 0.115 0 C-N-CA 126.691 1.996 . . . . 0.0 112.311 173.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.4 p -108.58 -54.93 2.45 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.121 -163.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 26.67 51.84 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.382 2.673 . . . . 0.0 115.229 169.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 144.57 -40.58 1.15 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -170.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 35.0 mm -55.64 119.55 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 169.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.96 45.35 0.39 Allowed 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 123.711 0.632 . . . . 0.0 109.737 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.43 91.6 1.99 Allowed 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 171.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.1 mp -76.07 150.06 37.36 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -172.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.7 t -148.21 175.57 10.95 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -178.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.5 tt -154.32 110.3 3.22 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 174.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.8 t -87.82 95.96 10.28 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.19 92.88 6.37 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -174.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.14 89.33 5.99 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 122.245 1.021 . . . . 0.0 110.584 -170.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.56 ' CD2' HD13 ' A' ' 45' ' ' LEU . 4.1 m-30 -78.14 98.19 5.73 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.733 173.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -153.05 37.66 0.11 Allowed Pre-proline 0 CA--C 1.552 1.032 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 172.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.54 ' CD ' HD12 ' A' ' 45' ' ' LEU . 69.6 Cg_endo -72.8 -90.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.694 0 CA-C-N 122.033 1.762 . . . . 0.0 113.557 -174.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 31.9 mtt85 -148.58 110.12 4.45 Favored 'General case' 0 C--N 1.34 0.187 0 O-C-N 121.352 -0.843 . . . . 0.0 109.211 -174.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -97.26 122.07 56.96 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 172.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -79.46 -51.68 0.06 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.55 2.167 . . . . 0.0 110.512 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 44.6 p -171.67 111.23 0.31 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.993 -0.527 . . . . 0.0 109.587 -167.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.7 pttm . . . . . 0 CA--C 1.538 0.506 0 C-N-CA 123.362 0.665 . . . . 0.0 112.398 172.621 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.1 t . . . . . 0 CA--C 1.539 0.53 0 N-CA-C 110.751 -0.092 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 48.06 63.73 1.93 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.572 1.149 . . . . 0.0 112.102 173.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.0 -4.12 2.21 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 124.257 1.023 . . . . 0.0 112.691 -177.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.77 120.59 15.75 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 116.758 -1.977 . . . . 0.0 108.263 -107.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.8 t -164.7 47.03 0.1 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.377 1.071 . . . . 0.0 109.822 -171.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -156.4 -51.39 0.08 Allowed 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 124.494 1.118 . . . . 0.0 108.372 -175.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.31 -27.73 69.23 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.782 175.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.531 ' C ' HD13 ' A' ' 29' ' ' LEU . 3.6 mt -80.81 131.73 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 C-N-CA 123.731 0.812 . . . . 0.0 112.165 -161.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.531 HD13 ' C ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -114.94 148.97 38.02 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 171.18 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -78.26 67.29 4.03 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 122.128 0.966 . . . . 0.0 112.154 -167.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.405 ' OE2' ' NZ ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -103.56 -169.54 1.66 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 129.556 3.142 . . . . 0.0 106.381 175.397 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -145.31 137.13 25.48 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.305 -0.872 . . . . 0.0 110.217 168.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.556 HD12 HG21 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -132.42 103.67 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 C-N-CA 126.162 1.785 . . . . 0.0 106.65 -177.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -79.4 131.1 36.0 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -177.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.421 HG11 ' CE1' ' A' ' 120' ' ' PHE . 52.1 t -113.1 132.76 61.03 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -177.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.2 m -106.7 101.53 10.97 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.299 1.44 . . . . 0.0 109.235 -173.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -79.05 84.22 5.07 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -171.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -84.19 83.61 7.91 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 122.931 1.348 . . . . 0.0 111.447 -172.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.74 123.49 31.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.699 176.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -131.22 142.87 50.23 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 173.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.7 t -135.78 141.91 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -117.71 157.09 27.12 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 161.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.95 -33.14 7.29 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.812 0.845 . . . . 0.0 112.299 -175.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -31.21 -44.69 0.11 Allowed Glycine 0 CA--C 1.531 1.089 0 C-N-CA 126.828 2.156 . . . . 0.0 114.323 165.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.646 HD13 ' CD2' ' A' ' 144' ' ' PHE . 0.5 OUTLIER -102.37 108.57 57.79 Favored Pre-proline 0 N--CA 1.454 -0.225 0 CA-C-N 119.475 1.638 . . . . 0.0 107.008 161.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.76 -3.51 12.41 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 121.148 1.232 . . . . 0.0 113.3 -164.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.512 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 47.6 m0 -73.34 154.73 39.98 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.591 1.156 . . . . 0.0 111.297 -167.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -76.6 81.75 3.26 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 171.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -95.65 124.42 39.66 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.6 m -125.8 138.08 31.3 Favored Pre-proline 0 CA--C 1.532 0.256 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -70.18 161.47 45.88 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 N-CA-C 108.377 -1.432 . . . . 0.0 108.377 161.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -77.78 -46.73 26.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 175.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.77 174.81 14.77 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 166.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -67.11 -33.42 75.43 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.118 0.417 . . . . 0.0 111.836 -174.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.76 161.72 39.78 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.025 0.93 . . . . 0.0 110.346 -171.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.5 pt -130.37 160.28 41.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 172.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -106.65 95.37 5.69 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.221 1.008 . . . . 0.0 109.359 168.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.2 t -77.54 167.35 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 168.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 23.1 mtm180 -128.35 98.47 5.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 171.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.1 pt 9.05 69.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 127.76 2.424 . . . . 0.0 114.725 -175.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.27 -34.26 2.74 Favored Glycine 0 C--O 1.22 -0.768 0 C-N-CA 124.807 1.194 . . . . 0.0 111.33 173.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -50.08 106.52 0.12 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 118.83 1.315 . . . . 0.0 112.245 -166.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.2 m -67.82 108.94 3.17 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.648 1.179 . . . . 0.0 111.359 -171.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.1 p -86.81 176.48 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 123.299 0.64 . . . . 0.0 110.322 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -124.52 129.97 51.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.819 0.848 . . . . 0.0 109.471 161.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.5 pp -139.45 96.12 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.655 1.182 . . . . 0.0 110.661 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 35.7 ttm -77.59 100.05 5.97 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.934 0.894 . . . . 0.0 111.342 -174.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -77.65 164.52 25.23 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.886 -0.509 . . . . 0.0 110.92 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.8 ttm105 -144.94 138.39 26.85 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.542 1.137 . . . . 0.0 111.799 -177.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.19 149.51 48.96 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 130.041 3.336 . . . . 0.0 107.608 159.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -137.17 135.62 37.49 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 161.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.512 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 0.1 OUTLIER -79.89 83.6 5.79 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.644 1.111 . . . . 0.0 111.301 -172.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.42 75.98 8.36 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.923 1.289 . . . . 0.0 108.902 171.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.06 158.62 44.16 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 167.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.1 t -87.6 -1.22 57.8 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 119.148 -0.453 . . . . 0.0 111.88 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.11 160.83 41.79 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.788 1.235 . . . . 0.0 109.076 -175.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.37 139.93 32.66 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.18 2.587 . . . . 0.0 111.902 -170.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.3 p -105.59 -176.07 2.97 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.393 1.877 . . . . 0.0 110.69 -169.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.4 t -148.39 136.05 20.69 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 160.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -123.42 76.01 0.37 Allowed Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -170.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.86 33.21 1.05 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.495 0.718 . . . . 0.0 110.812 -171.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.51 162.11 29.91 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.365 0.602 . . . . 0.0 111.733 -162.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.4 t -144.44 178.06 8.21 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.288 0.635 . . . . 0.0 109.802 175.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.17 164.85 26.75 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 125.955 1.702 . . . . 0.0 110.973 -167.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -120.82 86.73 2.62 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.927 1.691 . . . . 0.0 107.103 174.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.56 HG11 ' CD2' ' A' ' 95' ' ' PHE . 3.2 t -82.31 54.47 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.823 -164.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.2 t -171.47 143.21 1.48 Allowed Pre-proline 0 N--CA 1.457 -0.112 0 O-C-N 121.393 -0.817 . . . . 0.0 110.317 -169.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.02 -36.43 30.14 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 121.695 1.597 . . . . 0.0 108.044 169.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.5 ptp 177.31 -68.26 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 127.824 2.449 . . . . 0.0 106.745 176.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.87 -48.33 69.12 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.719 1.208 . . . . 0.0 113.055 -165.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.27 -102.3 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.669 -162.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.23 -61.04 0.25 Allowed Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.498 -0.612 . . . . 0.0 113.352 -173.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -45.59 -50.79 12.84 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.004 1.322 . . . . 0.0 111.216 177.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -72.93 5.19 3.45 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.906 1.283 . . . . 0.0 113.632 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.56 ' CD2' HG11 ' A' ' 86' ' ' VAL . 9.6 t80 -72.35 131.39 42.58 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 121.098 -1.001 . . . . 0.0 109.8 174.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -81.41 95.64 7.12 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 119.822 -0.751 . . . . 0.0 112.878 172.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -119.73 176.17 5.52 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.865 1.266 . . . . 0.0 109.981 164.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.9 m -79.69 -154.0 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 124.194 0.998 . . . . 0.0 108.906 162.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -77.08 -179.57 5.66 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.332 -0.855 . . . . 0.0 110.857 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.8 t 64.72 -163.28 0.26 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.538 1.135 . . . . 0.0 111.431 174.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -171.11 -178.01 2.33 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.409 1.884 . . . . 0.0 107.311 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 65.4 m 75.32 168.81 0.28 Allowed 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 126.481 1.913 . . . . 0.0 111.555 -175.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -122.97 68.36 0.98 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 164.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 21.0 p -75.89 78.13 2.79 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 173.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -78.46 43.34 0.46 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.807 1.243 . . . . 0.0 111.168 -175.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.9 t 42.99 -145.17 0.08 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.104 1.762 . . . . 0.0 112.989 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -119.22 124.66 47.28 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 127.586 2.354 . . . . 0.0 106.101 177.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.453 HD11 ' HG3' ' A' ' 114' ' ' MET . 97.3 mt -106.3 151.52 24.73 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 173.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.421 ' HB3' ' HD2' ' A' ' 110' ' ' PRO . 17.7 mt-10 -91.97 163.76 26.25 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 126.012 1.725 . . . . 0.0 108.394 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 109' ' ' GLU . 69.8 Cg_endo -70.73 79.88 1.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.647 2.898 . . . . 0.0 112.272 -167.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 157.85 -29.87 0.49 Allowed Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.821 -175.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -76.29 135.18 39.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.573 1.187 . . . . 0.0 112.034 -153.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -86.83 137.6 32.27 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.295 1.438 . . . . 0.0 110.57 -178.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.453 ' HG3' HD11 ' A' ' 108' ' ' LEU . 1.7 mmt -133.9 85.53 2.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.088 1.355 . . . . 0.0 109.532 176.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.68 128.25 45.12 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.35 0.66 . . . . 0.0 109.444 173.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 84.9 mtp -150.98 147.54 20.96 Favored Pre-proline 0 C--O 1.234 0.241 0 C-N-CA 123.399 0.68 . . . . 0.0 109.812 -165.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.18 146.28 63.25 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.785 2.323 . . . . 0.0 110.44 174.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.7 t -144.32 147.51 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.0 m -109.34 164.59 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 174.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.421 ' CE1' HG11 ' A' ' 35' ' ' VAL . 4.1 t80 -156.1 129.49 8.22 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.65 168.83 23.13 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 122.904 0.482 . . . . 0.0 110.476 168.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.556 HG21 HD12 ' A' ' 33' ' ' ILE . 18.2 t -119.14 129.46 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.809 1.243 . . . . 0.0 109.709 176.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.89 133.54 58.19 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 118.923 0.783 . . . . 0.0 110.249 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -56.34 -23.03 44.29 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.328 2.685 . . . . 0.0 114.767 -171.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -56.75 -13.68 2.72 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 119.182 0.901 . . . . 0.0 112.861 176.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.4 tt -46.05 -42.32 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 O-C-N 121.087 -1.008 . . . . 0.0 111.718 165.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.2 m -87.09 63.15 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 119.372 0.987 . . . . 0.0 110.9 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 51.8 mttt -130.27 -67.8 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 124.184 0.994 . . . . 0.0 112.345 164.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -85.27 162.66 11.34 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 121.8 1.666 . . . . 0.0 114.188 -160.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 99.2 t -53.96 -35.1 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 125.754 1.622 . . . . 0.0 110.874 176.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -38.54 -57.12 1.2 Allowed 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.475 1.51 . . . . 0.0 111.169 173.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 14.1 p -102.8 -53.45 2.85 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 123.965 0.906 . . . . 0.0 109.197 -163.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 26.15 55.34 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.152 2.581 . . . . 0.0 115.175 174.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 134.99 -36.98 1.99 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -176.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.1 mm -51.43 125.97 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 123.182 0.593 . . . . 0.0 109.864 173.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.405 ' NZ ' ' OE2' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -156.4 49.57 0.49 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.78 0.832 . . . . 0.0 109.79 175.726 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.18 89.91 1.77 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -178.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.431 HD22 HG22 ' A' ' 122' ' ' VAL . 2.0 mp -76.44 162.25 28.0 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 122.294 1.045 . . . . 0.0 108.81 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.4 t -155.03 178.79 9.8 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.94 88.53 1.47 Allowed 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 124.471 1.107 . . . . 0.0 109.029 165.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.1 t -75.72 107.26 7.77 Favored 'General case' 0 N--CA 1.457 -0.093 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -178.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -112.67 137.05 51.52 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 122.775 0.43 . . . . 0.0 109.888 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 32.2 m -118.45 91.51 3.58 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.532 1.533 . . . . 0.0 107.82 177.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.646 ' CD2' HD13 ' A' ' 45' ' ' LEU . 3.5 m-85 -72.27 97.72 2.05 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.946 178.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -156.11 58.28 1.71 Allowed Pre-proline 0 CA--C 1.551 1.018 0 N-CA-C 116.894 2.183 . . . . 0.0 116.894 -177.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.415 ' HD3' HD12 ' A' ' 45' ' ' LEU . 74.5 Cg_endo -80.68 -90.8 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.424 2.749 . . . . 0.0 112.445 175.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.17 104.97 2.85 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.658 0.663 . . . . 0.0 111.631 -171.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -79.3 140.12 56.4 Favored Pre-proline 0 N--CA 1.449 -0.522 0 O-C-N 121.547 -0.721 . . . . 0.0 109.173 174.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -84.35 60.17 6.08 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 121.981 1.787 . . . . 0.0 107.711 169.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 19.9 m 44.39 81.27 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.88 2.072 . . . . 0.0 113.514 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.7 pttt . . . . . 0 CA--C 1.543 0.677 0 CA-C-N 119.026 0.83 . . . . 0.0 112.111 -170.001 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 38.92 57.03 1.95 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.782 1.633 . . . . 0.0 112.194 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -143.47 165.69 26.85 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 122.82 1.295 . . . . 0.0 111.076 176.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.468 ' CB ' ' H ' ' A' ' 63' ' ' THR . . . -149.16 95.17 2.34 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 110.829 -2.896 . . . . 0.0 104.165 175.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.3 m -157.27 25.71 0.3 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -159.26 -55.13 0.06 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 -174.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.62 37.26 0.86 Allowed 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 112.699 -2.046 . . . . 0.0 110.892 -161.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.406 HD11 ' C ' ' A' ' 24' ' ' ALA . 7.8 mt -111.85 107.7 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 122.745 0.418 . . . . 0.0 109.895 -168.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -103.49 140.98 36.77 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.22 -29.85 34.69 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.516 1.926 . . . . 0.0 113.857 -169.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.09 148.6 6.03 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.953 1.301 . . . . 0.0 110.648 -178.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.5 mmmt -120.48 89.33 3.11 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.891 1.676 . . . . 0.0 108.677 -158.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.45 141.83 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 123.42 0.688 . . . . 0.0 110.348 -176.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -99.14 145.8 26.8 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.509 1.524 . . . . 0.0 108.54 -172.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.1 t -136.14 98.12 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 -173.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.6 m -88.12 105.76 17.71 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -83.74 109.23 17.33 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.651 1.18 . . . . 0.0 108.202 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -107.01 86.24 2.28 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.553 0.692 . . . . 0.0 110.055 -173.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.96 112.2 23.05 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.453 -0.78 . . . . 0.0 110.382 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -111.65 122.21 47.21 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.117 0.967 . . . . 0.0 109.668 -177.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.6 t -100.46 108.76 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 170.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.14 154.65 31.03 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 162.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.45 -38.28 8.9 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.42 0.688 . . . . 0.0 111.655 177.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -39.15 -34.77 0.36 Allowed Glycine 0 CA--C 1.53 1.031 0 C-N-CA 126.992 2.234 . . . . 0.0 114.694 172.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.445 HD21 ' CE3' ' A' ' 47' ' ' TRP . 0.4 OUTLIER -108.95 101.1 43.07 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 119.567 1.684 . . . . 0.0 108.497 165.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -83.37 46.19 2.04 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.877 3.051 . . . . 0.0 110.857 -170.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.522 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 44.7 m0 -116.06 157.13 25.17 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 125.034 1.334 . . . . 0.0 108.735 -172.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -74.3 141.66 45.26 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 162.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -147.44 113.82 5.94 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 169.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.0 t -100.15 111.4 62.19 Favored Pre-proline 0 N--CA 1.439 -1.011 0 C-N-CA 127.036 2.134 . . . . 0.0 107.058 -172.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -62.77 146.67 95.16 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.533 2.156 . . . . 0.0 107.757 167.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -75.79 -46.8 34.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -170.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.82 165.97 32.86 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 152.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -57.42 -41.1 79.72 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 118.366 0.53 . . . . 0.0 111.048 -174.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.95 158.36 43.87 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 122.95 0.5 . . . . 0.0 110.223 -176.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.4 pt -126.62 168.4 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 C-N-CA 123.461 0.705 . . . . 0.0 109.613 168.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -95.47 146.35 24.49 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 154.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.25 141.23 45.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 104.183 -2.525 . . . . 0.0 104.183 156.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -64.47 164.91 10.71 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 120.541 1.519 . . . . 0.0 107.774 160.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.422 HG22 ' HB3' ' A' ' 124' ' ' PRO . 3.8 mm -63.74 91.61 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.9 33.22 5.33 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.802 1.667 . . . . 0.0 113.783 178.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -102.3 107.02 17.92 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.034 1.417 . . . . 0.0 112.694 176.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.468 ' H ' ' CB ' ' A' ' 24' ' ' ALA . 15.9 m -66.71 113.7 5.04 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.114 1.366 . . . . 0.0 111.318 177.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.1 p -126.51 146.69 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 118.45 0.568 . . . . 0.0 110.373 169.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.21 137.96 31.93 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 125.516 1.526 . . . . 0.0 110.552 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -141.94 97.71 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 17.1 tmm? -78.92 126.56 30.86 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.936 1.294 . . . . 0.0 111.678 -176.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -102.35 143.91 31.5 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.829 1.252 . . . . 0.0 109.682 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 42.8 ttt85 -126.24 141.19 52.02 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 125.025 1.33 . . . . 0.0 109.283 -176.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.91 166.15 27.63 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.284 1.833 . . . . 0.0 109.903 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -153.95 147.76 25.4 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.308 1.043 . . . . 0.0 108.738 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.522 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 46.2 t-20 -83.95 115.75 22.46 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 119.879 1.218 . . . . 0.0 111.215 175.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 81.5 mt -106.75 16.32 24.57 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.621 1.169 . . . . 0.0 112.582 -178.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.28 164.76 12.9 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.416 -0.802 . . . . 0.0 109.726 169.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.0 m -96.83 30.02 2.82 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.864 176.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.3 p -149.57 161.3 32.12 Favored Pre-proline 0 N--CA 1.448 -0.528 0 C-N-CA 125.082 1.353 . . . . 0.0 108.363 178.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.72 121.55 8.25 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 121.555 1.503 . . . . 0.0 109.032 170.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.5 159.3 15.26 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.334 0.587 . . . . 0.0 110.885 171.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.9 t -97.93 158.63 15.42 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 162.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -153.15 77.79 0.21 Allowed Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 105.366 -3.094 . . . . 0.0 105.366 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.52 66.26 0.68 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 175.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.19 168.34 19.32 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.482 -166.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 35.3 m -106.39 159.15 16.36 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -147.77 143.91 27.86 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.958 -0.464 . . . . 0.0 110.341 171.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.98 101.26 12.7 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 166.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.6 p -87.7 81.17 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.0 t 176.54 150.72 0.34 Allowed Pre-proline 0 CA--C 1.529 0.164 0 C-N-CA 125.556 1.542 . . . . 0.0 109.15 178.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.65 -35.21 22.92 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 CA-C-N 119.364 0.809 . . . . 0.0 110.383 157.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.5 ptp 176.68 -67.05 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 127.163 2.185 . . . . 0.0 107.545 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.18 -41.75 33.66 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -169.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.33 -104.07 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.88 0.372 . . . . 0.0 111.816 -166.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.14 -54.67 0.59 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 123.925 0.774 . . . . 0.0 113.26 -172.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -47.25 -52.83 14.95 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.987 1.394 . . . . 0.0 110.927 176.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -74.22 10.21 1.34 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.401 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . 29.5 t80 -81.86 98.48 8.53 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 172.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -67.49 148.73 51.12 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 117.66 -1.616 . . . . 0.0 109.752 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? 61.87 69.17 0.65 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.294 1.038 . . . . 0.0 110.116 -176.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.8 m -71.27 153.07 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.374 166.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 51.13 -138.58 1.04 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.18 0.992 . . . . 0.0 111.068 175.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 7.4 t -167.62 60.97 0.08 Allowed 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 44.4 t80 48.62 -111.03 0.41 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.642 0.777 . . . . 0.0 109.777 -172.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 19.6 p -70.86 4.52 2.51 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.941 1.696 . . . . 0.0 114.156 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.6 t80 101.75 156.5 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 127.989 2.516 . . . . 0.0 110.78 168.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 28.1 m -80.25 -94.7 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.341 1.056 . . . . 0.0 109.777 -173.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 9.2 pm0 -61.72 162.23 8.92 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.93 0.892 . . . . 0.0 111.273 171.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.4 -70.34 0.13 Allowed 'General case' 0 CA--C 1.529 0.163 0 O-C-N 121.623 -0.673 . . . . 0.0 112.121 178.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.1 t -157.46 146.87 20.09 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.186 0.994 . . . . 0.0 108.73 -176.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.6 mt -150.44 136.1 18.2 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.764 0.711 . . . . 0.0 110.589 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -76.29 163.65 64.98 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.487 1.115 . . . . 0.0 109.967 174.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.42 106.1 1.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.242 1.961 . . . . 0.0 111.651 -163.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 111.58 -3.05 27.73 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 124.098 0.856 . . . . 0.0 111.24 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -76.6 146.14 38.46 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 118.368 1.084 . . . . 0.0 110.888 -173.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -97.09 147.24 24.24 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.669 1.188 . . . . 0.0 109.25 -176.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 17.2 ttt -150.95 111.42 4.2 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 118.734 -0.651 . . . . 0.0 111.169 -173.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -132.28 146.55 52.07 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 119.74 1.155 . . . . 0.0 111.249 172.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 19.1 mmt -142.63 138.55 16.32 Favored Pre-proline 0 C--O 1.235 0.32 0 C-N-CA 125.18 1.392 . . . . 0.0 109.63 -171.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.89 144.3 27.29 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 121.933 1.756 . . . . 0.0 110.183 171.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.4 t -124.26 158.87 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 164.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.2 p -145.83 146.3 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -154.38 146.59 23.78 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -165.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -160.08 156.0 26.14 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 128.119 2.568 . . . . 0.0 108.776 164.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.6 p -78.45 150.31 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 O-C-N 121.796 -0.565 . . . . 0.0 109.672 171.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -82.64 125.42 75.92 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.175 167.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.422 ' HB3' HG22 ' A' ' 60' ' ' ILE . 37.9 Cg_endo -70.92 41.77 0.4 Allowed 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.672 2.914 . . . . 0.0 115.775 -177.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -112.7 -21.2 11.35 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 125.718 1.607 . . . . 0.0 111.036 168.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 16.2 tt -43.48 -41.76 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 119.691 1.132 . . . . 0.0 113.572 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.8 m -76.46 61.61 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 O-C-N 121.815 -0.553 . . . . 0.0 111.341 172.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -137.51 -66.09 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 117.698 -1.144 . . . . 0.0 113.05 170.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -76.91 154.39 33.63 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 CA-C-N 121.802 1.679 . . . . 0.0 113.638 -169.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.4 t -54.93 -37.1 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 125.76 1.624 . . . . 0.0 110.826 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -52.58 -47.13 67.07 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.87 1.268 . . . . 0.0 111.829 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 35.4 p -91.85 -51.57 5.16 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -173.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 15.77 60.71 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 129.278 3.031 . . . . 0.0 115.911 175.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 136.29 -33.92 2.31 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-O 119.143 -0.81 . . . . 0.0 111.77 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 10.2 mm -51.07 128.27 8.39 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 C-N-CA 124.302 1.041 . . . . 0.0 110.433 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -157.76 48.22 0.39 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.43 0.692 . . . . 0.0 111.005 176.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.3 p -140.7 88.49 2.19 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 175.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' A' ' 95' ' ' PHE . 2.1 tp -88.06 84.93 6.9 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 118.899 -1.121 . . . . 0.0 109.026 -160.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.2 m -87.95 143.51 27.06 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.879 -169.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.5 tt -116.36 118.23 32.16 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 160.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.3 t -98.29 102.6 14.39 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 173.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.01 129.47 34.87 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.291 1.436 . . . . 0.0 107.559 -177.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.4 p -114.74 93.48 4.34 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.13 1.372 . . . . 0.0 109.212 174.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -76.18 95.52 3.71 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 167.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.69 46.67 0.3 Allowed Pre-proline 0 CA--C 1.556 1.174 0 N-CA-C 117.369 2.359 . . . . 0.0 117.369 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.39 -83.36 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.538 2.826 . . . . 0.0 113.013 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -149.29 136.68 20.1 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 118.904 0.774 . . . . 0.0 110.295 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -117.3 139.26 25.81 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 164.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -84.16 -52.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 121.917 1.745 . . . . 0.0 108.793 169.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.5 m -169.89 150.99 3.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.667 2.387 . . . . 0.0 106.676 177.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 12.9 pttt . . . . . 0 CA--C 1.535 0.381 0 C-N-CA 125.464 1.506 . . . . 0.0 108.54 174.602 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 0 N--CA 1.467 0.411 0 CA-C-O 122.209 1.004 . . . . 0.0 108.965 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 25.42 49.28 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.163 1.785 . . . . 0.0 111.764 -149.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -169.06 162.4 10.91 Favored 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 130.205 3.402 . . . . 0.0 104.67 177.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.95 98.91 3.88 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 175.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -113.85 36.26 3.74 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.952 0.901 . . . . 0.0 110.741 -169.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -159.81 -51.22 0.05 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.936 2.094 . . . . 0.0 107.051 -174.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.9 mt -72.13 -7.13 47.33 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.831 -168.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.6 mt -78.24 70.78 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 O-C-N 120.687 -1.258 . . . . 0.0 109.242 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.452 HD13 ' N ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -85.14 167.84 15.38 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 169.329 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -81.51 56.03 2.83 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 120.745 -1.222 . . . . 0.0 114.217 -166.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -113.74 104.54 12.31 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 122.788 1.28 . . . . 0.0 109.718 167.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.2 tttp -76.38 85.19 3.14 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 169.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.1 tp -83.52 162.88 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 174.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.44 150.22 46.25 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -167.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 81.0 t -142.85 126.28 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -172.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.5 m -95.56 109.02 21.31 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.499 1.52 . . . . 0.0 107.632 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.809 ' CE1' HD12 ' A' ' 56' ' ' ILE . 15.3 m-85 -81.21 131.67 35.31 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.839 1.256 . . . . 0.0 109.133 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -126.87 86.68 2.54 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 122.786 1.279 . . . . 0.0 110.378 -170.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.24 105.76 18.0 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.153 -0.967 . . . . 0.0 109.937 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -109.19 147.16 32.98 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 176.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.1 p -140.46 148.31 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.399 1.08 . . . . 0.0 108.166 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.69 168.95 18.32 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 167.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.62 -31.41 16.0 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -170.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -44.62 -34.82 3.88 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.217 1.389 . . . . 0.0 113.385 172.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.621 HD13 ' CD2' ' A' ' 144' ' ' PHE . 0.5 OUTLIER -119.16 91.06 43.05 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 167.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -80.77 55.25 5.6 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.387 2.725 . . . . 0.0 109.255 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.519 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 41.4 m0 -114.65 147.86 38.99 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.609 1.163 . . . . 0.0 109.257 -174.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -75.47 80.42 2.51 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -89.49 100.0 12.89 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.868 0.867 . . . . 0.0 109.306 -170.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.1 t -103.43 122.08 46.27 Favored Pre-proline 0 N--CA 1.443 -0.817 0 C-N-CA 124.027 0.931 . . . . 0.0 109.6 -168.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -75.46 138.08 21.51 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 123.648 2.899 . . . . 0.0 107.8 163.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.2 t -79.69 -46.73 22.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.572 0.701 . . . . 0.0 109.407 -173.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -149.25 150.36 32.44 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.528 1.931 . . . . 0.0 106.772 173.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -61.77 -36.68 81.75 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 123.814 0.696 . . . . 0.0 110.617 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -146.68 151.12 36.71 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 122.652 0.381 . . . . 0.0 111.208 -174.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.809 HD12 ' CE1' ' A' ' 37' ' ' PHE . 64.5 mt -122.57 137.91 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 127.0 2.12 . . . . 0.0 106.866 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -98.42 152.43 19.5 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.238 1.015 . . . . 0.0 109.39 164.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -154.08 127.33 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 -170.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.9 mmt85 -74.75 86.84 2.2 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 166.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.7 pt 7.57 64.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 128.206 2.602 . . . . 0.0 115.008 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.79 -35.63 1.49 Allowed Glycine 0 CA--C 1.522 0.523 0 O-C-N 121.915 -0.491 . . . . 0.0 112.807 -174.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 62.7 tt0 -42.57 107.79 0.09 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.172 1.389 . . . . 0.0 111.999 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.56 102.76 8.09 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.425 1.09 . . . . 0.0 110.129 -177.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.0 p -76.31 178.74 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 122.036 0.922 . . . . 0.0 111.505 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.16 89.06 2.4 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 124.426 1.09 . . . . 0.0 108.676 168.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.751 HG12 HD11 ' A' ' 56' ' ' ILE . 2.5 pp -100.36 134.22 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 168.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 65.0 mtt -98.32 100.36 11.63 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 126.304 1.842 . . . . 0.0 110.913 -174.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -78.36 157.4 29.11 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -143.68 146.51 33.27 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.37 151.5 49.62 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 128.833 2.853 . . . . 0.0 106.173 166.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -143.81 139.53 29.38 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 166.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.519 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 43.5 t30 -79.1 114.83 18.36 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 120.039 1.291 . . . . 0.0 112.558 -177.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.7 mt -105.79 16.11 25.74 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 125.031 1.332 . . . . 0.0 112.548 178.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.6 175.44 9.87 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 163.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.8 t -103.57 17.3 24.39 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.103 0.561 . . . . 0.0 110.254 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -155.94 160.64 30.65 Favored Pre-proline 0 N--CA 1.45 -0.472 0 C-N-CA 127.075 2.15 . . . . 0.0 106.29 -174.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.27 124.81 11.22 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.481 1.454 . . . . 0.0 110.326 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.416 HG23 ' HD3' ' A' ' 149' ' ' PRO . 0.2 OUTLIER -86.58 177.79 7.27 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.398 0.618 . . . . 0.0 109.553 168.042 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.8 t -113.61 161.68 17.14 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 154.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.597 ' HA2' HD11 ' A' ' 45' ' ' LEU . . . -147.38 69.37 0.36 Allowed Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 107.728 -2.149 . . . . 0.0 107.728 -177.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.47 62.65 0.61 Allowed 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 177.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.39 161.64 27.86 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.542 -163.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -83.22 152.08 25.36 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.839 174.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -148.51 148.7 30.53 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.338 0.255 . . . . 0.0 110.647 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -109.04 101.85 10.89 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 125.773 1.629 . . . . 0.0 106.904 171.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.8 p -88.66 58.13 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.474 0 C-N-CA 123.963 0.905 . . . . 0.0 111.086 -176.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.6 t -167.26 145.16 4.03 Favored Pre-proline 0 N--CA 1.468 0.448 0 O-C-N 120.994 -1.066 . . . . 0.0 112.032 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -62.83 -56.77 0.53 Allowed 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.258 1.305 . . . . 0.0 108.805 168.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 23.3 ptp -171.36 20.69 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.886 0.874 . . . . 0.0 111.689 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -170.43 -77.31 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.291 0 O-C-N 121.558 -0.714 . . . . 0.0 109.519 -168.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -46.3 -94.22 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 126.271 1.829 . . . . 0.0 113.238 -169.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 60.71 -52.23 0.03 OUTLIER Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.939 1.257 . . . . 0.0 115.939 -172.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -45.17 -48.97 12.36 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 119.762 1.781 . . . . 0.0 111.34 174.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -71.68 -12.69 61.45 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.256 1.022 . . . . 0.0 113.047 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -71.49 94.98 1.33 Allowed 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -80.51 92.02 5.84 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 118.274 -1.37 . . . . 0.0 110.346 -171.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.99 61.99 1.19 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.356 0.598 . . . . 0.0 109.838 163.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.8 p -71.65 138.18 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 169.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -174.76 121.0 0.23 Allowed 'General case' 0 CA--C 1.526 0.056 0 C-N-CA 125.091 1.357 . . . . 0.0 107.802 167.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 71.3 m 45.01 -119.17 0.74 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.424 1.09 . . . . 0.0 109.864 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -144.72 10.67 1.39 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.429 1.092 . . . . 0.0 111.102 171.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 45.7 t -174.81 125.63 0.28 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 -169.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -87.72 68.56 9.48 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 119.416 1.007 . . . . 0.0 110.658 -157.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.6 m 73.61 -43.63 0.55 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.931 1.692 . . . . 0.0 112.019 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -37.15 130.42 0.86 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.932 1.693 . . . . 0.0 111.315 167.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.541 HG23 ' H ' ' A' ' 107' ' ' THR . 9.2 t -157.68 -74.41 0.09 Allowed 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.531 0.332 . . . . 0.0 110.606 -168.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.541 ' H ' HG23 ' A' ' 106' ' ' THR . 0.9 OUTLIER -159.63 152.01 21.09 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -174.441 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 75.2 mt -148.48 137.69 21.85 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 124.225 1.01 . . . . 0.0 108.322 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -66.94 152.14 96.21 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 169.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.66 106.28 1.24 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.783 2.989 . . . . 0.0 111.136 -171.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 128.19 -23.38 5.21 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -176.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -78.14 142.5 38.0 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 117.808 0.804 . . . . 0.0 111.009 -162.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -100.18 128.92 46.17 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.34 1.856 . . . . 0.0 109.329 -173.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 52.7 ttp -126.87 85.84 2.43 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 126.104 1.761 . . . . 0.0 108.844 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.99 140.89 33.56 Favored 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 168.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 22.8 ptm -153.5 141.57 13.89 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 117.936 0.335 . . . . 0.0 111.887 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -72.22 148.11 49.14 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.717 2.278 . . . . 0.0 110.098 171.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.1 t -136.26 122.19 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 125.927 1.691 . . . . 0.0 107.026 174.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.1 p -99.45 143.15 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 125.762 1.625 . . . . 0.0 107.492 169.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.94 172.27 18.97 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 176.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -158.64 178.46 10.1 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.883 0.873 . . . . 0.0 109.715 164.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 73.5 t -110.22 135.32 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 123.74 0.816 . . . . 0.0 109.267 172.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.22 124.54 76.06 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 122.988 0.515 . . . . 0.0 112.068 -176.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.21 34.47 0.4 Allowed 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.199 2.599 . . . . 0.0 114.105 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.51 -15.04 21.89 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.04 0.936 . . . . 0.0 110.915 162.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 17.8 tt -52.1 -48.97 41.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 118.973 0.806 . . . . 0.0 112.586 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.8 m -80.52 64.08 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.081 0.552 . . . . 0.0 109.677 174.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 45.0 mttp -140.17 -65.21 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 124.271 1.028 . . . . 0.0 111.768 171.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.01 169.29 13.71 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 121.835 1.69 . . . . 0.0 111.443 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.9 t -71.96 -52.31 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 124.227 1.011 . . . . 0.0 109.843 -174.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -46.44 -51.69 14.63 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 125.197 1.399 . . . . 0.0 112.054 -173.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 17.2 p -86.14 -3.74 59.02 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -65.05 75.9 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.857 1.208 . . . . 0.0 111.607 -177.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 148.13 -34.54 1.2 Allowed Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -169.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 45.9 mm -66.86 114.24 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.3 pttt -156.1 47.17 0.47 Allowed 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.49 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.41 97.52 1.76 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 103.69 -2.708 . . . . 0.0 103.69 168.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.4 tp -78.04 162.66 26.55 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -170.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.5 t -151.69 171.61 17.4 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.599 -0.688 . . . . 0.0 109.488 173.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -149.5 100.04 2.96 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 103.908 -2.627 . . . . 0.0 103.908 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 31.1 m -87.5 93.79 9.52 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 173.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.13 134.13 36.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 172.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.7 m -120.06 87.33 2.72 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.992 0.917 . . . . 0.0 108.951 176.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.621 ' CD2' HD13 ' A' ' 45' ' ' LEU . 2.0 m-85 -68.24 84.55 0.25 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.928 0.891 . . . . 0.0 109.614 175.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -151.49 46.4 0.37 Allowed Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 178.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.52 -79.36 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.584 2.189 . . . . 0.0 112.731 -175.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.46 107.79 2.23 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.622 -0.674 . . . . 0.0 111.537 -173.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -78.89 144.05 63.23 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 173.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.416 ' HD3' HG23 ' A' ' 78' ' ' THR . 61.0 Cg_endo -72.41 -50.18 0.25 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.972 1.782 . . . . 0.0 107.992 160.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.9 t -179.5 -168.71 0.12 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 128.869 2.868 . . . . 0.0 105.32 169.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.589 0 C-N-CA 124.241 1.017 . . . . 0.0 111.184 174.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.456 -0.159 0 CA-C-O 122.205 1.002 . . . . 0.0 108.77 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 74.31 158.77 0.21 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.64 1.576 . . . . 0.0 111.227 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.578 ' O ' HG23 ' A' ' 63' ' ' THR . 3.0 mp0 60.65 -113.62 0.58 Allowed 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 -168.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -175.24 4.67 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.562 1.545 . . . . 0.0 111.862 136.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.8 t -73.07 51.35 0.3 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.385 1.874 . . . . 0.0 114.85 -167.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -76.07 -34.86 59.59 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 131.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 63.1 mt -108.47 -44.49 4.08 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -172.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.2 mt -35.4 137.78 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 126.614 1.966 . . . . 0.0 115.501 -164.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.9 mp -111.71 -82.85 0.58 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.147 1.379 . . . . 0.0 109.141 -174.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -172.85 -66.22 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.35 1.46 . . . . 0.0 108.997 -178.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -36.67 132.65 0.61 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 126.678 1.991 . . . . 0.0 113.598 -168.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -76.2 90.17 3.12 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 113.158 -1.837 . . . . 0.0 107.253 176.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.7 112.34 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 167.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.79 154.22 30.09 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.4 t -134.97 133.38 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 176.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 29.4 m -114.14 108.57 17.15 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -81.17 102.98 10.65 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.662 1.585 . . . . 0.0 108.945 176.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -98.42 87.1 3.77 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.857 0.836 . . . . 0.0 109.596 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.21 126.07 31.06 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.169 0.588 . . . . 0.0 110.614 175.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -129.65 146.44 51.43 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.797 1.239 . . . . 0.0 108.191 175.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.5 p -138.44 144.0 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 124.076 0.95 . . . . 0.0 108.991 177.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.21 165.48 19.54 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 166.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -43.62 -39.71 3.69 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.211 1.004 . . . . 0.0 112.185 -177.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -34.06 -36.55 0.06 OUTLIER Glycine 0 CA--C 1.535 1.282 0 C-N-CA 126.948 2.213 . . . . 0.0 115.01 171.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.45 HD13 ' CG ' ' A' ' 144' ' ' PHE . 0.2 OUTLIER -118.82 102.76 49.15 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 119.099 1.45 . . . . 0.0 107.871 161.645 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.43 40.94 1.05 Allowed 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.764 2.309 . . . . 0.0 111.223 -170.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.509 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 45.1 m0 -116.39 151.06 36.73 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.367 1.067 . . . . 0.0 110.614 -165.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -76.33 80.83 3.08 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -177.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -87.14 106.27 17.76 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.396 0.678 . . . . 0.0 109.35 -172.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.8 t -115.9 119.93 36.43 Favored Pre-proline 0 N--CA 1.443 -0.814 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -168.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.82 154.25 38.57 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 C-N-CA 124.118 3.212 . . . . 0.0 107.936 168.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 t -85.7 -58.95 3.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -168.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -132.45 162.19 31.79 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 162.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -61.46 -39.79 92.16 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 174.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.79 164.72 26.62 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.796 0.839 . . . . 0.0 112.496 -176.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.7 pt -132.47 162.0 40.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 124.521 1.129 . . . . 0.0 109.747 168.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -118.28 83.78 2.07 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 127.444 2.298 . . . . 0.0 110.067 -173.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.75 129.3 43.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 O-C-N 120.833 -1.167 . . . . 0.0 109.494 -178.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -78.37 96.32 5.3 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 174.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.447 HD13 HG21 ' A' ' 60' ' ' ILE . 0.7 OUTLIER -10.06 87.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.068 1.747 . . . . 0.0 114.966 -159.392 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.59 -31.66 4.74 Favored Glycine 0 C--O 1.222 -0.641 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 176.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -53.11 118.38 3.71 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 -175.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.67 HG22 ' CD1' ' A' ' 121' ' ' PHE . 20.2 p -71.23 115.69 10.67 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.745 2.018 . . . . 0.0 111.71 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.0 p -97.68 161.92 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 123.514 0.726 . . . . 0.0 110.112 169.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.492 HE21 ' HA ' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -105.36 120.01 40.52 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.231 1.012 . . . . 0.0 110.727 164.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.8 pp -130.18 116.56 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 171.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 35.4 mtm -79.57 107.81 12.63 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.156 0.982 . . . . 0.0 111.633 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -81.55 155.56 25.66 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 170.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.0 ttp-105 -137.95 144.86 41.41 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 174.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.72 159.01 28.87 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.103 2.161 . . . . 0.0 107.05 156.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -144.17 145.04 31.84 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 161.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.509 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 51.9 t-20 -83.45 105.57 14.5 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 120.743 1.611 . . . . 0.0 112.103 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.1 mp -102.27 36.39 2.15 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.095 1.358 . . . . 0.0 110.861 176.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.03 170.63 7.84 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.72 1.208 . . . . 0.0 109.331 163.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.5 m -105.09 15.47 27.52 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.753 0.821 . . . . 0.0 111.411 -177.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.7 p -141.38 162.11 49.11 Favored Pre-proline 0 C--O 1.239 0.504 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 169.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.44 141.65 96.07 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 120.978 1.119 . . . . 0.0 109.312 171.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.43 169.03 9.01 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 118.468 0.576 . . . . 0.0 110.326 167.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.9 t -94.38 157.07 16.19 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 159.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -124.17 152.7 17.37 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 105.271 -3.132 . . . . 0.0 105.271 165.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.22 -53.86 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 117.426 0.613 . . . . 0.0 109.787 -160.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 60.57 -179.35 0.1 Allowed 'General case' 0 C--N 1.342 0.243 0 CA-C-O 122.938 1.351 . . . . 0.0 113.88 173.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.0 m -135.21 164.21 28.21 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 146.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -155.53 164.47 38.62 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -173.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.09 98.33 4.72 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.629 HG22 HD13 ' A' ' 140' ' ' LEU . 51.2 t -89.32 72.04 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 125.361 1.465 . . . . 0.0 107.129 -175.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.0 t 178.83 152.28 0.49 Allowed Pre-proline 0 C--N 1.34 0.157 0 C-N-CA 125.455 1.502 . . . . 0.0 109.233 -174.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -67.49 -47.8 1.93 Allowed 'Trans proline' 0 N--CA 1.448 -1.197 0 N-CA-C 108.457 -1.401 . . . . 0.0 108.457 156.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.2 ptm -174.52 -78.37 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.661 1.984 . . . . 0.0 107.802 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.19 -38.22 81.77 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -168.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.71 -105.45 0.02 OUTLIER 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.199 0.454 . . . . 0.0 111.022 -173.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.38 -53.94 1.92 Allowed Glycine 0 CA--C 1.526 0.768 0 CA-C-O 119.286 -0.73 . . . . 0.0 112.722 -177.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.26 -54.11 9.44 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.612 1.206 . . . . 0.0 111.636 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -74.06 -3.59 30.32 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.767 1.227 . . . . 0.0 113.659 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -70.4 96.62 1.17 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 174.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -49.69 -44.79 48.23 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -162.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -73.41 74.48 1.39 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.886 0.766 . . . . 0.0 109.148 172.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.9 p -67.98 -39.01 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 123.774 0.83 . . . . 0.0 110.033 173.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -167.12 173.14 9.39 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 127.848 2.459 . . . . 0.0 105.958 177.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 52.7 t -164.04 137.3 5.28 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 177.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -54.87 -47.27 74.46 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.311 0.505 . . . . 0.0 110.183 175.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 57.5 m -75.55 67.25 2.03 Favored 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 172.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -66.2 158.91 27.59 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 169.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.7 m -84.38 -120.92 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -175.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -30.76 105.89 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.024 2.13 . . . . 0.0 113.479 174.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.6 t -130.27 -63.39 0.9 Allowed 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 124.212 1.005 . . . . 0.0 109.114 -177.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.1 t -158.33 149.0 20.42 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 172.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 89.2 mt -149.17 135.6 19.34 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 176.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -73.59 159.81 83.7 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.738 1.215 . . . . 0.0 109.955 173.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.23 102.73 1.4 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.486 2.124 . . . . 0.0 110.905 -165.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 125.05 -14.35 7.47 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 124.202 0.906 . . . . 0.0 110.953 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -76.82 138.31 39.75 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 118.49 1.145 . . . . 0.0 110.773 -166.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.03 144.92 26.68 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.94 1.296 . . . . 0.0 108.694 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 17.1 ttt -140.01 80.39 1.76 Allowed 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 123.34 0.656 . . . . 0.0 109.265 173.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -95.02 123.44 38.5 Favored 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 124.325 1.05 . . . . 0.0 108.321 168.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 24.5 mmt -134.1 129.56 20.01 Favored Pre-proline 0 C--O 1.235 0.32 0 C-N-CA 124.106 0.963 . . . . 0.0 109.844 -171.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -68.8 135.58 33.21 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 121.871 1.714 . . . . 0.0 109.248 172.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.9 t -110.06 129.42 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 166.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.1 p -95.52 134.76 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 157.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -155.92 151.62 27.25 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.67 ' CD1' HG22 ' A' ' 63' ' ' THR . 12.7 p90 -167.32 161.14 14.06 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 126.215 1.806 . . . . 0.0 107.206 -177.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 52.7 t -118.26 127.77 75.35 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 C-N-CA 125.669 1.588 . . . . 0.0 107.463 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.43 153.15 41.44 Favored Pre-proline 0 C--O 1.234 0.252 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -173.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.58 37.76 0.47 Allowed 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 124.359 3.373 . . . . 0.0 112.982 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -83.62 -37.66 22.59 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 165.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.3 tt -52.41 -35.46 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 123.878 0.871 . . . . 0.0 112.781 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.2 m -74.97 53.12 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 120.901 -1.124 . . . . 0.0 110.933 173.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -144.53 -70.65 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.748 1.619 . . . . 0.0 110.793 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.86 138.13 39.95 Favored 'Trans proline' 0 C--O 1.239 0.529 0 CA-C-N 122.148 1.803 . . . . 0.0 113.488 -176.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.9 t -55.94 -36.86 45.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 127.352 2.261 . . . . 0.0 109.602 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -47.7 -34.98 8.95 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.938 2.095 . . . . 0.0 112.744 174.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 72.1 p -107.09 -60.52 1.67 Allowed 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 123.013 0.196 . . . . 0.0 110.536 -174.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 28.28 49.75 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 129.088 2.955 . . . . 0.0 115.902 165.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 143.65 -29.3 2.0 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -172.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.8 mm -53.61 127.62 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.072 0 CA-C-N 117.863 0.831 . . . . 0.0 110.664 172.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.7 pttt -155.77 67.54 0.62 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 122.09 0.948 . . . . 0.0 111.547 169.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 42.4 m -147.94 105.08 3.63 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 141.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.1 tp -79.83 86.86 5.34 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -175.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -84.77 150.12 25.28 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.08 -168.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.629 HD13 HG22 ' A' ' 86' ' ' VAL . 28.5 tp -120.45 110.53 16.61 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 166.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.7 t -95.04 117.98 31.07 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 169.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.07 125.86 51.14 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -166.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.6 m -117.6 89.4 3.11 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.214 1.006 . . . . 0.0 109.98 -176.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.45 ' CG ' HD13 ' A' ' 45' ' ' LEU . 1.8 m-30 -67.1 94.59 0.35 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.603 0.761 . . . . 0.0 109.404 170.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -149.01 23.65 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.135 0 N-CA-C 118.08 2.622 . . . . 0.0 118.08 -176.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.445 ' CD ' HD12 ' A' ' 45' ' ' LEU . 59.5 Cg_endo -71.49 -75.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.672 0 CA-C-N 122.77 2.025 . . . . 0.0 113.897 -165.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 86.6 mmt-85 -146.28 121.75 10.36 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.776 0.716 . . . . 0.0 109.177 -167.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.53 117.54 28.98 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 125.648 1.579 . . . . 0.0 107.358 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -78.6 -23.5 8.33 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.71 2.273 . . . . 0.0 112.41 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 39.9 t 137.69 109.38 0.0 OUTLIER 'General case' 0 C--N 1.343 0.302 0 C-N-CA 129.278 3.031 . . . . 0.0 107.777 -175.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.372 0 C-N-CA 124.319 1.047 . . . . 0.0 110.958 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.3 t . . . . . 0 N--CA 1.456 -0.154 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -79.78 101.24 8.35 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.532 -0.73 . . . . 0.0 109.67 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.58 -9.57 0.22 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 166.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.45 126.0 28.43 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 115.872 -2.331 . . . . 0.0 110.22 -92.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.2 t -162.25 45.92 0.15 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 123.882 0.873 . . . . 0.0 109.825 -171.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -155.67 -58.03 0.1 Allowed 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.411 ' H ' HD23 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -85.51 26.36 0.94 Allowed 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.147 -169.534 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 73.3 mt -119.23 108.87 24.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -169.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -98.58 -61.54 1.36 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.129 -171.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . 0.25 0.3 OUTLIER 177.23 -6.89 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.672 1.589 . . . . 0.0 114.488 145.654 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -51.19 122.42 7.67 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 120.752 1.615 . . . . 0.0 112.869 -173.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -77.66 98.14 5.35 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 127.928 2.491 . . . . 0.0 107.547 -173.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.407 HG12 HG11 ' A' ' 122' ' ' VAL . 5.6 tp -106.56 122.74 60.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.913 1.285 . . . . 0.0 109.435 -172.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.513 ' CE ' ' HB2' ' A' ' 55' ' ' ASP . 4.0 tmtp? -79.19 151.62 31.14 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.952 1.701 . . . . 0.0 109.212 -174.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.423 ' HB ' ' CG1' ' A' ' 56' ' ' ILE . 5.2 t -133.79 148.74 30.39 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 165.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.7 m -136.25 104.7 5.73 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 122.414 1.102 . . . . 0.0 108.338 -174.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -77.56 121.32 23.74 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -118.32 82.44 1.84 Allowed 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.65 126.86 31.71 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -126.95 89.33 2.96 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.897 0.856 . . . . 0.0 109.043 -174.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.4 p -79.02 126.91 39.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.679 172.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.38 169.46 13.57 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 171.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.55 124.07 12.7 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 161.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 151.48 -48.19 0.56 Allowed Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 107.268 -2.333 . . . . 0.0 107.268 -160.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mp -129.28 142.38 45.02 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 160.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.439 ' HD2' HG21 ' A' ' 78' ' ' THR . 83.0 Cg_endo -79.97 2.72 8.2 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 123.911 3.074 . . . . 0.0 111.93 170.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.42 ' CZ2' ' HB3' ' A' ' 108' ' ' LEU . 40.5 m0 -74.54 148.62 40.72 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.125 0.875 . . . . 0.0 111.745 -165.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -78.82 84.79 4.86 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 172.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -89.58 118.94 29.58 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 124.475 1.11 . . . . 0.0 108.709 177.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.0 m -124.86 139.29 33.11 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -74.67 171.49 18.1 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.339 2.026 . . . . 0.0 108.953 166.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -93.35 -53.66 8.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 123.763 0.825 . . . . 0.0 110.393 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -131.7 164.5 25.8 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 168.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -60.75 -43.6 97.76 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 168.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.513 ' HB2' ' CE ' ' A' ' 34' ' ' LYS . 22.4 p-10 -149.15 170.55 18.18 Favored 'General case' 0 N--CA 1.428 -1.551 0 C-N-CA 124.666 1.186 . . . . 0.0 110.805 -164.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.423 ' CG1' ' HB ' ' A' ' 35' ' ' VAL . 37.1 pt -137.65 176.39 7.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 167.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.88 161.58 23.83 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 148.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -131.22 148.23 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 102.158 -3.275 . . . . 0.0 102.158 170.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.72 118.51 27.27 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 120.855 1.661 . . . . 0.0 106.953 160.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.3 pt -15.57 89.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 C-N-CA 126.943 2.097 . . . . 0.0 113.255 -169.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.52 -43.91 1.32 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 124.37 0.986 . . . . 0.0 113.12 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -38.56 102.65 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.798 2.039 . . . . 0.0 113.431 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 94.5 m -73.19 104.44 4.25 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.677 1.591 . . . . 0.0 111.265 -174.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.5 p -102.07 169.56 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 121.615 0.722 . . . . 0.0 110.524 174.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -117.35 127.38 53.99 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 126.263 1.825 . . . . 0.0 107.208 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.444 HD12 ' O ' ' A' ' 66' ' ' ILE . 1.7 pp -140.69 95.79 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 CA-C-O 121.864 0.84 . . . . 0.0 109.063 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 31.1 mtt -76.82 175.31 9.56 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.765 -0.584 . . . . 0.0 110.536 -175.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -133.28 170.47 15.4 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 124.228 1.011 . . . . 0.0 109.092 174.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -139.39 123.4 17.8 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 173.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.97 105.38 7.7 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.127 0.571 . . . . 0.0 110.869 168.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER -103.25 121.08 41.95 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.061 -0.4 . . . . 0.0 111.533 -171.759 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -82.12 85.07 6.84 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.114 0.483 . . . . 0.0 111.386 -173.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.3 mt -79.73 59.15 2.99 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.634 0.774 . . . . 0.0 109.958 171.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.91 155.23 47.12 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 170.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.8 m -79.55 -0.62 34.21 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.619 0.768 . . . . 0.0 112.369 177.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.1 p -128.83 163.29 46.33 Favored Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 124.761 1.224 . . . . 0.0 110.618 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -63.17 169.11 9.77 Favored 'Trans proline' 0 N--CA 1.444 -1.435 0 C-N-CA 121.041 1.161 . . . . 0.0 110.077 164.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.439 HG21 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -155.97 168.81 26.06 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 126.519 1.928 . . . . 0.0 107.152 -170.829 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.2 t -132.6 154.79 49.7 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.75 0.705 . . . . 0.0 111.622 176.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -125.57 64.42 0.57 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 127.248 2.356 . . . . 0.0 107.968 176.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.37 53.54 2.79 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 165.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.98 170.54 14.61 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.096 -171.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.1 m -125.19 162.21 25.17 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -146.93 159.02 44.06 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 118.764 0.711 . . . . 0.0 111.08 170.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.2 99.51 6.91 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 166.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.6 p -89.9 57.65 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.212 0 C-N-CA 124.154 0.982 . . . . 0.0 110.365 -175.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.5 t -165.95 148.18 6.27 Favored Pre-proline 0 N--CA 1.454 -0.249 0 O-C-N 121.506 -0.746 . . . . 0.0 110.699 -172.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.24 -30.68 30.5 Favored 'Trans proline' 0 N--CA 1.445 -1.38 0 N-CA-C 108.674 -1.318 . . . . 0.0 108.674 164.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.0 ptp 172.69 -63.85 0.01 OUTLIER 'General case' 0 C--N 1.347 0.462 0 C-N-CA 125.853 1.661 . . . . 0.0 109.759 -173.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -99.87 -33.25 10.62 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 124.776 1.23 . . . . 0.0 111.258 -164.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.16 -142.91 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.86 -47.58 0.78 Allowed Glycine 0 CA--C 1.531 1.075 0 O-C-N 121.278 -0.889 . . . . 0.0 112.434 -166.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -42.7 -54.08 4.21 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.047 1.339 . . . . 0.0 110.818 173.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -76.24 -16.2 59.87 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -48.91 137.41 12.77 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 118.79 0.723 . . . . 0.0 110.843 -173.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -67.42 112.8 4.83 Favored 'General case' 0 N--CA 1.44 -0.972 0 O-C-N 123.583 0.552 . . . . 0.0 111.568 -173.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.5 pttm -152.73 136.91 16.49 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.103 0.961 . . . . 0.0 108.522 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.9 m -154.11 -179.75 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 127.321 2.248 . . . . 0.0 106.846 -176.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.2 tp60 62.63 37.19 13.1 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.194 0.997 . . . . 0.0 112.384 167.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 38.1 t 70.41 145.67 0.06 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.91 1.684 . . . . 0.0 111.917 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -52.1 -43.92 64.16 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.733 -0.605 . . . . 0.0 111.35 175.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 13.7 t 33.76 55.47 0.55 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.593 1.957 . . . . 0.0 112.333 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -115.04 108.26 16.44 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.081 -164.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 t -179.77 153.25 0.53 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.71 2.004 . . . . 0.0 105.984 160.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.65 17.58 4.58 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 123.574 0.547 . . . . 0.0 109.882 168.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.9 t 52.7 -141.26 0.86 Allowed 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.493 1.517 . . . . 0.0 111.176 174.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.2 t -110.68 131.41 55.08 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 126.402 1.881 . . . . 0.0 106.741 172.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.42 ' HB3' ' CZ2' ' A' ' 47' ' ' TRP . 1.6 tp -124.34 131.43 53.51 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 125.102 1.361 . . . . 0.0 107.651 -176.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.456 ' HB3' ' HD2' ' A' ' 110' ' ' PRO . 10.5 mp0 -86.56 167.73 21.53 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 127.169 2.188 . . . . 0.0 111.273 -167.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 109' ' ' GLU . 49.9 Cg_endo -72.92 112.6 3.55 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.349 2.033 . . . . 0.0 112.446 -168.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 115.97 -12.72 17.27 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 124.403 1.002 . . . . 0.0 111.021 177.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -77.91 140.96 39.32 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 117.334 0.567 . . . . 0.0 112.438 -163.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -99.21 98.27 9.27 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.91 1.684 . . . . 0.0 108.787 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 11.0 ttp -77.56 85.98 3.91 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -94.28 59.59 2.62 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.994 0.902 . . . . 0.0 111.682 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 20.5 ttt -76.61 129.17 80.23 Favored Pre-proline 0 N--CA 1.437 -1.077 0 C-N-CA 123.814 0.846 . . . . 0.0 110.352 -171.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.66 150.88 31.73 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 121.93 1.753 . . . . 0.0 110.332 171.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.2 t -130.83 148.08 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 164.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.5 m -112.28 146.7 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -154.58 139.96 17.7 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 119.56 1.073 . . . . 0.0 112.635 -172.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -156.01 148.11 23.35 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.66 1.584 . . . . 0.0 108.069 163.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.407 HG11 HG12 ' A' ' 33' ' ' ILE . 61.6 t -88.26 141.45 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 166.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -75.51 155.46 85.55 Favored Pre-proline 0 N--CA 1.45 -0.467 0 C-N-CA 124.517 1.127 . . . . 0.0 110.061 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -65.03 -36.14 39.38 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.577 1.518 . . . . 0.0 112.17 166.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -44.77 -41.0 6.54 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 125.481 1.512 . . . . 0.0 113.395 -172.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -50.11 -37.94 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 125.021 1.329 . . . . 0.0 112.83 -177.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.0 m -89.3 51.26 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 119.17 0.896 . . . . 0.0 110.487 177.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . 0.35 0.0 OUTLIER -149.79 -53.5 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.823 0 CA-C-O 116.199 -1.858 . . . . 0.0 114.228 -175.221 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -83.33 169.89 12.27 Favored 'Trans proline' 0 C--N 1.351 0.67 0 CA-C-N 124.031 2.475 . . . . 0.0 111.838 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.2 t -67.59 -46.54 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.978 1.311 . . . . 0.0 110.871 -169.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.423 ' CD ' ' H ' ' A' ' 131' ' ' GLU . 2.1 mp0 -39.13 -54.58 1.73 Allowed 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 126.062 1.745 . . . . 0.0 112.225 -178.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 3.2 p -97.53 -41.03 8.36 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.128 -168.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 2.51 70.74 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 128.458 2.703 . . . . 0.0 115.882 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 134.27 -35.66 2.2 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 119.176 -0.791 . . . . 0.0 112.391 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 13.1 mm -49.33 138.27 4.78 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 C-N-CA 124.664 1.186 . . . . 0.0 109.948 173.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.3 pttm -157.67 51.97 0.45 Allowed 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.6 m -154.5 107.09 2.8 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 159.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.5 mp -75.78 85.72 2.77 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 169.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.1 t -81.14 150.98 28.48 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.3 tt -127.52 99.38 5.58 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.1 t -78.04 111.07 13.55 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 171.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -107.06 92.84 4.25 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.746 1.218 . . . . 0.0 108.537 -172.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.5 86.95 4.5 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 122.528 1.156 . . . . 0.0 109.48 -175.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -75.48 73.12 2.52 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 166.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -132.73 48.86 3.84 Favored Pre-proline 0 CA--C 1.552 1.044 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 174.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -77.61 -98.09 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 124.356 3.37 . . . . 0.0 113.752 -174.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.2 mmt180 -142.36 110.37 5.92 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.545 1.138 . . . . 0.0 109.315 -169.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -95.05 114.57 63.99 Favored Pre-proline 0 N--CA 1.451 -0.381 0 C-N-CA 124.793 1.237 . . . . 0.0 111.517 -167.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -74.2 -25.13 13.93 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.632 1.554 . . . . 0.0 111.138 165.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.6 t 80.33 127.18 0.04 OUTLIER 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.778 1.631 . . . . 0.0 109.824 -173.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 17.9 pttm . . . . . 0 CA--C 1.535 0.376 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.017 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.45 -0.435 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -63.25 96.72 0.11 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 170.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.408 ' HA ' ' NE2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER 98.09 71.69 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 129.91 3.284 . . . . 0.0 110.018 174.571 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.37 57.13 2.72 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -162.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.7 m -76.9 54.24 0.99 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.824 2.45 . . . . 0.0 112.253 -178.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -141.69 -54.19 0.45 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 130.275 3.43 . . . . 0.0 104.092 168.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.511 ' O ' HD22 ' A' ' 29' ' ' LEU . 49.2 mt -63.73 -34.06 77.04 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.908 1.283 . . . . 0.0 113.119 168.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 76.7 mt -69.15 100.04 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 119.575 1.08 . . . . 0.0 110.221 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.511 HD22 ' O ' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -90.03 -75.41 0.45 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 172.554 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -169.48 -28.63 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 164.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -59.05 128.25 36.28 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.46 1.104 . . . . 0.0 113.638 -163.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -79.93 109.79 14.7 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.924 -174.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.13 113.1 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 126.012 1.725 . . . . 0.0 108.679 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.35 157.07 21.59 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.054 -1.029 . . . . 0.0 109.084 -171.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.2 t -143.79 107.5 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-N 119.762 1.165 . . . . 0.0 109.596 -176.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.2 m -78.97 117.58 20.17 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.786 1.634 . . . . 0.0 107.816 167.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -79.61 156.32 27.72 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.337 0.655 . . . . 0.0 109.266 166.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -137.67 88.31 2.32 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.412 0.625 . . . . 0.0 111.511 170.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.06 128.9 36.4 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 120.939 -1.101 . . . . 0.0 110.507 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -133.73 150.21 51.49 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.186 0.994 . . . . 0.0 109.508 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.9 p -140.6 146.29 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 C-N-CA 123.518 0.727 . . . . 0.0 110.772 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.9 163.62 29.82 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.012 1.325 . . . . 0.0 107.463 168.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -37.75 -45.69 0.83 Allowed 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.989 1.715 . . . . 0.0 113.452 -172.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -36.88 -37.32 0.23 Allowed Glycine 0 CA--C 1.534 1.233 0 C-N-CA 126.482 1.991 . . . . 0.0 114.39 174.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.417 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 0.4 OUTLIER -113.48 105.88 54.71 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 161.15 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.93 9.56 3.26 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.138 1.892 . . . . 0.0 112.733 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.493 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 41.4 m0 -78.46 145.61 34.93 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 121.798 -0.564 . . . . 0.0 110.931 -168.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -78.56 85.39 4.62 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 103.338 -2.838 . . . . 0.0 103.338 172.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.71 88.18 3.0 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.625 1.17 . . . . 0.0 108.381 -168.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.0 m -91.37 136.59 26.77 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 119.182 -0.437 . . . . 0.0 110.381 -166.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -70.53 165.55 31.48 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 121.538 1.492 . . . . 0.0 108.595 161.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -97.67 -55.29 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.111 0 C-N-CA 123.573 0.749 . . . . 0.0 110.941 -176.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.22 152.76 47.6 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 170.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -64.99 -41.48 95.36 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.831 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.49 139.65 37.02 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.223 1.009 . . . . 0.0 110.027 -173.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.42 HD12 HG11 ' A' ' 64' ' ' VAL . 32.7 pt -104.99 164.02 4.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 125.352 1.461 . . . . 0.0 109.002 170.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -101.74 133.62 46.17 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 155.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.6 m -128.08 174.68 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 159.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -140.66 92.45 2.51 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -171.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.0 pt 8.22 87.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 127.66 2.384 . . . . 0.0 114.279 -171.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 107.86 -31.52 7.91 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 123.556 0.598 . . . . 0.0 112.949 -173.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -72.55 118.02 14.95 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 121.627 -0.925 . . . . 0.0 110.174 -168.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.3 p -68.3 126.83 30.81 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 127.431 2.293 . . . . 0.0 111.472 -174.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.42 HG11 HD12 ' A' ' 56' ' ' ILE . 9.9 p -113.74 160.07 13.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 157.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.62 125.34 49.32 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.737 1.215 . . . . 0.0 108.839 169.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -126.07 104.86 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 172.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.41 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 5.3 ppp? -83.34 167.61 17.42 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.959 172.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -137.05 155.0 50.21 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 171.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -125.56 129.81 50.44 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 168.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.68 108.52 12.11 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.671 2.388 . . . . 0.0 107.556 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.3 mtpt -104.73 124.16 48.91 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 118.154 -0.927 . . . . 0.0 109.09 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.493 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 32.3 t30 -78.37 85.46 4.49 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 119.517 1.053 . . . . 0.0 110.983 -175.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -78.12 68.89 4.25 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 174.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.3 135.48 13.08 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.781 0.832 . . . . 0.0 108.975 173.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.9 m -78.4 41.82 0.4 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.272 0.629 . . . . 0.0 110.246 172.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.1 p -148.31 154.26 41.83 Favored Pre-proline 0 N--CA 1.446 -0.671 0 C-N-CA 124.526 1.131 . . . . 0.0 107.989 169.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -66.95 150.41 82.94 Favored 'Trans proline' 0 N--CA 1.442 -1.545 0 N-CA-C 108.03 -1.565 . . . . 0.0 108.03 166.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.413 ' HG1' ' HE1' ' A' ' 47' ' ' TRP . 2.8 p -135.59 163.76 29.39 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.577 0.751 . . . . 0.0 109.302 175.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.1 t -118.88 136.21 54.16 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.636 0.775 . . . . 0.0 109.405 167.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -96.14 81.24 0.78 Allowed Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 176.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -106.38 53.29 0.7 Allowed 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 172.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.1 174.6 5.27 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.785 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.59 154.64 46.87 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 173.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -145.97 147.3 31.54 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -101.23 115.69 31.08 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 166.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.9 p -99.81 73.2 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.498 0 C-N-CA 124.24 1.016 . . . . 0.0 109.264 -176.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.0 t 177.56 148.46 0.34 Allowed Pre-proline 0 C--O 1.232 0.163 0 C-N-CA 123.645 0.778 . . . . 0.0 109.461 -178.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -66.3 -33.41 38.94 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 121.336 1.357 . . . . 0.0 109.754 162.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.0 ptp 177.83 -69.41 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.639 1.976 . . . . 0.0 107.933 177.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.67 -46.53 45.89 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 123.827 0.851 . . . . 0.0 113.203 -165.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.25 -101.06 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -162.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.93 -52.69 0.38 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.191 0.9 . . . . 0.0 114.032 -171.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -48.09 -52.84 18.66 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.306 1.553 . . . . 0.0 110.732 176.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 125' ' ' GLU . 15.1 m-85 -75.22 12.25 0.97 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.54 1.536 . . . . 0.0 114.768 176.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -92.39 108.08 19.7 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 171.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -78.36 78.16 4.83 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 118.41 -1.316 . . . . 0.0 112.698 -173.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -124.17 89.11 3.02 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 125.168 1.387 . . . . 0.0 107.583 162.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.6 m -137.6 131.35 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 170.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -165.68 127.87 2.02 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 90.9 m -78.3 63.28 3.16 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -165.47 -166.4 0.97 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -176.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 28.3 p -58.17 103.05 0.12 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 122.27 1.033 . . . . 0.0 110.878 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -41.58 -44.25 2.97 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 126.713 2.005 . . . . 0.0 111.902 177.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 67.5 m -152.35 -95.08 0.05 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 127.56 2.344 . . . . 0.0 106.913 168.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.0 pm0 -83.99 -167.78 1.88 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.816 0.846 . . . . 0.0 111.7 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.4 t -168.65 -72.3 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.094 0.958 . . . . 0.0 110.962 -177.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -158.77 151.06 21.49 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.6 1.16 . . . . 0.0 108.303 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 82.6 mt -144.34 148.0 34.19 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.443 ' HB3' ' HD2' ' A' ' 110' ' ' PRO . 3.6 mt-10 -88.86 175.41 4.06 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 123.969 0.908 . . . . 0.0 109.132 176.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 109' ' ' GLU . 33.2 Cg_endo -69.4 90.32 0.48 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.842 2.361 . . . . 0.0 114.469 -162.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 138.98 -23.39 2.9 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 123.731 0.681 . . . . 0.0 112.264 170.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -78.32 141.1 38.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 119.691 -0.804 . . . . 0.0 112.49 -146.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -84.05 113.44 21.03 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.621 1.569 . . . . 0.0 110.806 177.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 14.4 tpt -104.12 131.04 51.81 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 125.374 1.47 . . . . 0.0 107.235 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -155.03 139.44 16.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.056 0.389 . . . . 0.0 110.82 168.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 80.7 mtp -155.03 148.89 18.89 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.291 1.036 . . . . 0.0 109.544 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 67' ' ' MET . 49.5 Cg_endo -78.36 144.72 20.67 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.886 3.057 . . . . 0.0 112.701 170.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 25.0 t -118.83 121.53 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 168.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.2 p -79.54 146.32 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 169.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -155.19 146.99 23.32 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.256 0.48 . . . . 0.0 111.571 -171.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -156.62 153.22 28.22 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.271 1.429 . . . . 0.0 110.935 164.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 74.2 t -76.77 140.5 17.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 169.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.79 130.73 56.9 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 118.639 -0.696 . . . . 0.0 110.688 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -55.17 -30.46 71.22 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.191 2.594 . . . . 0.0 113.018 -178.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 16.0 mm-40 -36.28 -36.05 0.09 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.979 1.311 . . . . 0.0 113.418 172.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.7 tt -49.26 -36.72 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.4 m -87.67 54.31 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 119.24 0.927 . . . . 0.0 110.685 173.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -126.12 -74.67 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 117.508 -1.234 . . . . 0.0 111.983 171.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.67 156.37 40.05 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 CA-C-N 122.039 1.764 . . . . 0.0 112.538 -171.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 99.5 t -53.32 -44.21 53.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 125.137 1.375 . . . . 0.0 109.981 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -44.95 -51.58 9.62 Favored 'General case' 0 N--CA 1.426 -1.657 0 C-N-CA 128.216 2.606 . . . . 0.0 112.471 178.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 40.3 p -99.06 -8.07 25.83 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 119.052 -0.499 . . . . 0.0 111.869 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -44.41 112.38 0.41 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.989 0.916 . . . . 0.0 111.581 -178.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.47 -15.06 63.46 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 119.318 -0.712 . . . . 0.0 113.262 175.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 20.5 mm -64.97 123.78 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-N 119.016 1.408 . . . . 0.0 108.602 171.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 20.1 pttt -156.01 54.53 0.58 Allowed 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.032 0.444 . . . . 0.0 111.751 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.31 87.48 1.32 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 160.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.5 tp -82.79 88.16 6.77 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.242 -162.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 13.3 t -87.89 173.09 9.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.908 0.861 . . . . 0.0 111.329 -170.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.1 tt -145.39 111.15 5.46 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 105.036 -2.209 . . . . 0.0 105.036 171.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.6 p -91.81 97.97 11.32 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 124.999 1.32 . . . . 0.0 107.696 175.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.5 128.25 35.23 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 127.075 2.15 . . . . 0.0 108.71 -178.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.6 m -121.54 92.61 3.78 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 122.012 0.911 . . . . 0.0 109.494 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -75.77 90.49 2.89 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.014 -0.993 . . . . 0.0 110.068 174.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -148.02 41.38 0.25 Allowed Pre-proline 0 CA--C 1.553 1.068 0 N-CA-C 116.978 2.214 . . . . 0.0 116.978 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.79 -104.88 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.348 2.699 . . . . 0.0 112.859 -177.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -125.84 107.99 11.03 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.238 1.415 . . . . 0.0 110.661 -168.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -100.59 118.46 60.86 Favored Pre-proline 0 N--CA 1.453 -0.304 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 167.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.86 -50.02 0.07 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 121.781 1.654 . . . . 0.0 110.182 173.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.9 m -169.45 110.74 0.46 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.581 1.152 . . . . 0.0 110.981 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.543 0.679 0 C-N-CA 125.276 1.43 . . . . 0.0 112.808 170.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.459 HG22 ' H ' ' A' ' 22' ' ' GLU . 8.7 p . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.459 ' H ' HG22 ' A' ' 21' ' ' VAL . 4.1 tt0 -78.08 59.57 2.23 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.289 -1.507 . . . . 0.0 107.976 166.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 172.18 160.04 0.1 Allowed 'General case' 0 N--CA 1.445 -0.71 1 C-N-CA 132.703 4.401 . . . . 0.0 105.646 177.137 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 61' ' ' GLY . . . -130.51 129.5 42.96 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 103.996 -2.594 . . . . 0.0 103.996 155.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.3 t -156.08 42.95 0.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -158.34 -57.13 0.07 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 128.354 2.661 . . . . 0.0 104.709 -164.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 56.4 mt -75.75 -31.89 59.76 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 113.886 -1.506 . . . . 0.0 111.834 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.9 mt -66.0 112.62 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 O-C-N 121.964 -0.46 . . . . 0.0 111.753 -168.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.53 160.44 14.28 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 159.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -75.84 59.98 1.29 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.125 1.37 . . . . 0.0 111.323 -174.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.25 142.99 49.88 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.327 1.451 . . . . 0.0 107.496 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.3 mmmt -110.78 135.46 51.31 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.987 1.715 . . . . 0.0 109.252 -169.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.566 HG23 HG23 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -145.76 112.11 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-O 121.973 0.892 . . . . 0.0 109.878 -167.228 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.17 132.41 36.1 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.937 1.295 . . . . 0.0 109.295 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 t -113.36 121.28 65.25 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 C-N-CA 124.538 1.135 . . . . 0.0 108.209 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.63 126.7 31.1 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -102.46 95.89 6.56 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 173.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.417 ' CB ' HH22 ' A' ' 54' ' ' ARG . 6.4 t70 -118.46 81.07 1.62 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.895 0.855 . . . . 0.0 109.865 -178.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.72 148.3 22.24 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.751 0.821 . . . . 0.0 110.762 -174.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -132.99 152.59 51.94 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.407 1.083 . . . . 0.0 108.182 -172.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.6 t -135.91 146.26 29.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -146.46 174.64 11.21 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.239 0.542 . . . . 0.0 110.573 175.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.63 133.46 16.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 171.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 117.83 -45.98 1.2 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -162.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.501 HD12 ' HD3' ' A' ' 146' ' ' PRO . 0.5 OUTLIER -123.34 87.37 51.71 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 123.592 0.757 . . . . 0.0 109.693 174.491 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -81.8 43.96 1.62 Allowed 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.634 2.889 . . . . 0.0 109.292 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.436 ' CH2' ' HB2' ' A' ' 108' ' ' LEU . 43.0 m0 -114.91 140.47 48.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -175.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -79.09 81.3 5.37 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -85.75 98.92 11.0 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.7 m -87.37 135.0 35.05 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -177.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -66.77 156.25 66.79 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 N-CA-C 108.316 -1.455 . . . . 0.0 108.316 167.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.7 t -76.62 -45.71 32.46 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -168.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.66 176.9 12.01 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 163.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.417 HH22 ' CB ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -49.32 -45.08 44.95 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.63 0.772 . . . . 0.0 113.079 179.233 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -160.31 154.37 23.11 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 125.253 1.421 . . . . 0.0 107.797 -169.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.4 pt -113.12 164.67 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 C-N-CA 123.95 0.9 . . . . 0.0 109.022 175.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -121.43 118.56 29.7 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.848 1.259 . . . . 0.0 107.855 176.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.566 HG23 HG23 ' A' ' 33' ' ' ILE . 31.8 m -114.67 151.98 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 165.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -78.07 165.7 23.69 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 150.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.0 mm -6.69 -66.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 127.304 2.242 . . . . 0.0 114.136 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -130.14 21.3 4.92 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 118.868 -0.962 . . . . 0.0 114.723 -178.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -70.23 119.22 14.1 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 120.641 2.22 . . . . 0.0 110.948 -176.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.9 p -60.92 117.12 5.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.371 0.668 . . . . 0.0 109.452 172.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.5 p -110.85 149.34 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 165.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -102.7 122.72 45.02 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.677 1.991 . . . . 0.0 107.972 -177.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.2 pp -141.5 100.25 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 121.938 0.875 . . . . 0.0 110.047 -177.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 65.7 mtt -77.17 126.34 30.78 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.985 1.314 . . . . 0.0 110.334 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -96.84 137.11 36.42 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 172.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 27.2 ttt85 -110.35 135.9 50.36 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.294 1.037 . . . . 0.0 109.652 -176.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.16 147.06 48.26 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.512 1.525 . . . . 0.0 109.608 175.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -136.29 121.62 19.26 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 117.784 -1.103 . . . . 0.0 108.267 171.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.416 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 43.0 t-20 -80.27 113.88 18.77 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.668 1.122 . . . . 0.0 111.798 -173.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.2 mt -99.21 16.74 21.87 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.741 1.216 . . . . 0.0 112.666 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.53 176.54 9.32 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.437 -0.789 . . . . 0.0 110.384 173.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.4 m -111.24 20.88 16.91 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.98 165.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.7 p -147.26 156.07 46.42 Favored Pre-proline 0 N--CA 1.449 -0.497 0 C-N-CA 125.521 1.528 . . . . 0.0 108.202 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.06 120.08 7.0 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 121.508 1.472 . . . . 0.0 108.586 175.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.66 163.64 15.05 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 118.898 0.772 . . . . 0.0 109.582 172.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.0 t -103.48 137.12 42.01 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 162.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.7 86.07 0.4 Allowed Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 103.497 -3.841 . . . . 0.0 103.497 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.05 46.57 0.91 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.93 177.04 2.78 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.169 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -148.49 178.33 8.7 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -128.16 161.42 29.32 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 166.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.464 ' OD1' HG22 ' A' ' 87' ' ' THR . 0.6 OUTLIER -114.7 128.39 56.28 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 103.441 -2.799 . . . . 0.0 103.441 155.187 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.0 t -111.55 79.46 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 O-C-N 124.502 1.126 . . . . 0.0 108.804 175.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.464 HG22 ' OD1' ' A' ' 85' ' ' ASN . 0.7 OUTLIER -160.5 140.21 8.2 Favored Pre-proline 0 N--CA 1.444 -0.752 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.289 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.45 -38.59 19.2 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 N-CA-C 108.333 -1.449 . . . . 0.0 108.333 163.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.1 ptp -177.55 -57.3 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.645 1.578 . . . . 0.0 109.962 -177.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.5 -4.1 25.87 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 123.772 0.829 . . . . 0.0 113.222 -162.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -95.77 -109.27 0.14 Allowed 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -172.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.92 -61.89 0.2 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 123.742 0.687 . . . . 0.0 112.868 -174.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -51.04 -59.68 3.91 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.45 1.1 . . . . 0.0 110.687 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -73.24 51.03 0.31 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.508 1.123 . . . . 0.0 112.169 176.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -114.19 121.51 43.95 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 124.089 0.956 . . . . 0.0 108.434 172.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -78.18 66.08 3.7 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.953 171.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -73.45 76.24 1.42 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 164.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.5 p -61.27 167.88 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 165.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 76.53 148.57 0.1 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.534 1.934 . . . . 0.0 113.116 176.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 14.4 p -71.48 -24.83 62.06 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.794 174.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -48.66 142.78 5.73 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.71 1.204 . . . . 0.0 112.191 -173.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 79.0 m -127.55 146.67 50.44 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 125.804 1.642 . . . . 0.0 107.412 -175.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -81.58 21.79 0.77 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -168.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.6 p -80.89 71.46 7.84 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 175.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -8.76 -76.25 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 128.583 2.753 . . . . 0.0 113.713 -177.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.8 t 155.24 -146.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 129.318 3.047 . . . . 0.0 107.072 176.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.0 t -117.18 137.77 52.12 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.168 1.787 . . . . 0.0 108.663 175.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.436 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -135.58 125.38 25.57 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.241 1.016 . . . . 0.0 110.372 -172.453 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -70.44 157.67 89.49 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.394 1.078 . . . . 0.0 111.636 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.18 114.1 3.71 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.636 2.224 . . . . 0.0 111.92 -167.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 116.57 -25.85 8.87 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -79.95 161.73 25.33 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 121.442 0.639 . . . . 0.0 112.583 -167.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -103.21 159.58 15.42 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.079 1.352 . . . . 0.0 111.288 -173.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 5.9 mtp -148.44 153.91 39.16 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.769 1.627 . . . . 0.0 109.165 174.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -147.01 153.8 40.48 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 150.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 11.9 mmt -128.02 124.93 23.37 Favored Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 124.527 1.131 . . . . 0.0 108.702 178.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -69.47 145.6 59.31 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 C-N-CA 122.008 1.805 . . . . 0.0 109.297 170.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.9 t -130.06 144.26 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 164.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.8 p -111.23 140.21 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 167.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -147.66 139.29 23.91 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 118.349 0.522 . . . . 0.0 109.646 -172.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -153.94 162.13 41.45 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 125.016 1.327 . . . . 0.0 108.84 164.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.483 HG21 HD12 ' A' ' 33' ' ' ILE . 96.1 t -87.34 176.51 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 123.254 0.622 . . . . 0.0 109.699 176.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -121.78 133.65 24.36 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 123.591 0.757 . . . . 0.0 110.75 172.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.18 -21.41 72.34 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.415 2.077 . . . . 0.0 113.473 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -59.89 -14.69 16.57 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 119.81 1.187 . . . . 0.0 111.953 -178.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.2 tt -56.58 -42.31 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 121.212 -0.93 . . . . 0.0 112.664 168.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.2 m -84.97 52.65 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 119.228 0.922 . . . . 0.0 110.84 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -123.62 -65.8 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 117.708 -1.139 . . . . 0.0 113.174 173.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.17 154.72 41.88 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 CA-C-N 121.836 1.692 . . . . 0.0 111.25 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 34.0 m -59.05 -36.5 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 124.744 1.218 . . . . 0.0 112.208 -173.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -61.73 -60.63 3.38 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.445 0.698 . . . . 0.0 110.138 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 82.1 p -83.1 -7.99 59.57 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 118.417 -0.801 . . . . 0.0 112.353 -173.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -33.98 -50.09 0.37 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.301 1.44 . . . . 0.0 113.703 175.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -84.55 -21.49 56.17 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 123.353 0.502 . . . . 0.0 112.155 -176.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 37.6 mm -77.79 118.11 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 O-C-N 122.054 -0.674 . . . . 0.0 109.777 -177.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.9 pttt -155.28 61.34 0.63 Allowed 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.719 168.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 24.9 p -144.39 87.98 1.91 Allowed 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 170.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.1 tp -83.35 78.07 9.69 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -162.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.5 m -79.18 122.68 26.57 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.098 -1.41 . . . . 0.0 109.818 -158.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.8 tt -79.07 129.48 34.49 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 168.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.5 t -153.69 122.51 6.38 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 165.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -158.24 171.0 21.0 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.481 0.712 . . . . 0.0 110.915 -177.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.4 m -115.69 117.55 30.6 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.099 1.76 . . . . 0.0 111.037 -176.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -79.61 100.32 7.75 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.959 1.304 . . . . 0.0 108.492 168.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -155.67 59.38 2.12 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -176.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.501 ' HD3' HD12 ' A' ' 45' ' ' LEU . 72.8 Cg_endo -79.76 -94.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.658 2.905 . . . . 0.0 112.732 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 78.6 mtt-85 -152.02 96.12 2.16 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.497 -0.752 . . . . 0.0 110.22 -158.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -91.16 123.55 64.09 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 118.752 -0.642 . . . . 0.0 111.098 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -69.89 -61.38 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.743 1.629 . . . . 0.0 110.47 172.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.8 t -157.27 117.22 3.44 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 121.767 -0.583 . . . . 0.0 111.223 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.559 0 C-N-CA 125.36 1.464 . . . . 0.0 110.577 170.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.1 t . . . . . 0 CA--C 1.537 0.445 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 40.43 40.39 0.86 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.584 1.554 . . . . 0.0 111.708 -164.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 176.0 135.65 0.05 Allowed 'General case' 0 N--CA 1.447 -0.583 2 N-CA-C 99.725 -4.176 . . . . 0.0 99.725 -174.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.02 -57.15 4.82 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 116.832 -1.947 . . . . 0.0 111.047 -154.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.1 p -163.13 -147.65 0.12 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 160.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -77.31 -22.57 51.74 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.955 2.102 . . . . 0.0 110.42 164.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.2 mt -56.34 -16.4 5.54 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.915 1.286 . . . . 0.0 113.885 -178.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 74.7 mt -52.03 118.51 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 124.373 1.069 . . . . 0.0 110.959 -173.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 mp -93.83 -83.76 0.32 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.943 0.497 . . . . 0.0 110.892 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -175.23 -56.82 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.033 0.933 . . . . 0.0 109.834 -164.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.32 145.4 2.4 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 125.542 1.537 . . . . 0.0 113.473 -165.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.9 tttt -96.93 90.78 5.33 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 126.062 1.745 . . . . 0.0 106.585 -170.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.68 107.5 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 176.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.16 146.06 35.29 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -177.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.5 t -130.46 144.4 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 -176.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 29.7 m -130.84 95.2 3.78 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -171.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -77.22 88.09 3.67 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 124.141 0.977 . . . . 0.0 108.986 -176.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -79.97 83.42 5.88 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 122.66 1.219 . . . . 0.0 109.699 -174.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.25 102.82 15.48 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.531 1.132 . . . . 0.0 110.594 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -106.05 111.17 23.69 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.296 0.639 . . . . 0.0 110.158 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.5 p -77.31 147.84 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 168.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.38 154.62 41.1 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 167.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.79 -41.23 22.97 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.062 0.945 . . . . 0.0 111.742 -175.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -30.69 -43.25 0.07 OUTLIER Glycine 0 CA--C 1.53 1.006 0 C-N-CA 126.898 2.189 . . . . 0.0 113.758 169.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.449 HD21 ' CE3' ' A' ' 47' ' ' TRP . 1.3 tt -116.14 98.54 51.48 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 170.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -74.89 13.8 0.94 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.008 2.472 . . . . 0.0 115.222 -161.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.504 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 42.0 m0 -79.27 156.2 28.19 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.58 1.552 . . . . 0.0 113.079 -168.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -75.98 79.79 2.85 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 170.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -99.56 121.66 41.5 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.022 0.929 . . . . 0.0 108.718 -177.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.08 141.87 41.14 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 118.047 0.385 . . . . 0.0 110.269 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.92 161.15 45.79 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.907 1.738 . . . . 0.0 108.857 163.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.44 -50.38 19.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 177.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.04 165.57 30.39 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 159.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -61.76 -41.57 97.87 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 118.689 0.677 . . . . 0.0 110.127 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -145.92 157.61 43.89 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 123.726 0.81 . . . . 0.0 112.444 -160.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 50.1 pt -136.54 171.33 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 125.12 1.368 . . . . 0.0 109.252 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -125.01 85.99 2.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.87 1.668 . . . . 0.0 110.814 -178.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.1 t -76.16 127.94 37.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -177.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.87 101.12 9.22 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 167.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 mm -6.21 84.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 127.579 2.352 . . . . 0.0 113.371 -171.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.5 -0.51 49.7 Favored Glycine 0 CA--C 1.539 1.546 0 N-CA-C 115.413 0.925 . . . . 0.0 115.413 171.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -59.69 124.34 19.81 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.023 1.729 . . . . 0.0 109.396 163.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.78 111.75 21.04 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.438 1.095 . . . . 0.0 110.995 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.22 143.27 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.85 128.39 49.63 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.1 pp -143.9 93.17 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.135 1.374 . . . . 0.0 109.308 -173.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 46.6 ttm -73.6 135.96 43.89 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.124 0.969 . . . . 0.0 110.059 -173.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -99.69 141.17 32.84 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 174.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.3 ttt180 -110.85 132.34 54.29 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 174.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.09 141.75 44.24 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 127.052 2.141 . . . . 0.0 107.241 162.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -140.71 145.98 37.18 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 166.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.504 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 34.6 t30 -83.38 87.27 6.98 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 119.024 0.829 . . . . 0.0 113.019 -170.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -79.92 73.53 6.69 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.197 0.999 . . . . 0.0 109.224 172.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.15 140.26 17.46 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 164.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.7 t -78.35 35.4 0.22 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.785 1.175 . . . . 0.0 111.347 174.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.404 ' N ' ' HB3' ' A' ' 110' ' ' PRO . 1.3 p -146.41 154.57 49.29 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 126.392 1.877 . . . . 0.0 108.876 176.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.49 143.33 42.52 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.615 2.21 . . . . 0.0 109.242 176.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.483 ' HG1' ' HE1' ' A' ' 47' ' ' TRP . 4.5 p -117.44 176.72 5.03 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.51 1.124 . . . . 0.0 111.998 -175.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 m -133.43 126.08 30.42 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 103.18 -2.896 . . . . 0.0 103.18 -178.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -127.35 117.24 2.63 Favored Glycine 0 C--N 1.335 0.481 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -171.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? -139.54 -48.57 0.47 Allowed 'General case' 0 C--N 1.338 0.106 0 CA-C-N 117.738 0.769 . . . . 0.0 110.291 174.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 62.84 175.38 0.15 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.22 1.008 . . . . 0.0 110.408 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.3 t -111.3 146.8 36.39 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 165.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -122.18 89.67 3.16 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.254 1.422 . . . . 0.0 108.073 -173.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.73 85.25 4.75 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 174.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.7 t -79.04 70.09 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.844 1.258 . . . . 0.0 109.707 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.5 t -176.74 149.42 0.86 Allowed Pre-proline 0 N--CA 1.469 0.486 0 CA-C-N 119.325 0.966 . . . . 0.0 111.571 170.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -66.22 -37.31 25.14 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.266 1.31 . . . . 0.0 110.088 159.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 11.8 ptp 169.58 -68.67 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 128.305 2.642 . . . . 0.0 106.912 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.74 -45.35 65.01 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.94 0.896 . . . . 0.0 112.966 -170.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.19 -104.4 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.91 -166.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.97 -56.62 1.41 Allowed Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.47 -0.628 . . . . 0.0 112.488 -175.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -44.23 -55.08 5.13 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.594 1.158 . . . . 0.0 111.923 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -72.54 2.66 5.97 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.546 1.538 . . . . 0.0 114.014 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -73.89 90.84 1.94 Allowed 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.522 0.729 . . . . 0.0 109.55 -175.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -82.99 80.82 8.91 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.602 -167.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.0 -60.78 1.84 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 123.766 0.827 . . . . 0.0 110.14 171.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.5 p -133.27 149.88 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 124.123 0.969 . . . . 0.0 109.067 -168.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -78.79 -51.65 9.46 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.526 0.731 . . . . 0.0 109.441 176.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 16.3 t -82.45 99.47 9.47 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 173.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -69.29 65.1 0.16 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.882 1.273 . . . . 0.0 112.9 -177.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 51.4 t -163.31 68.46 0.2 Allowed 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 124.978 1.311 . . . . 0.0 108.663 172.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -73.6 145.6 45.3 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -163.31 111.96 1.26 Allowed 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 -161.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -80.23 50.27 1.23 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.02 0.928 . . . . 0.0 112.315 -171.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.9 t 36.67 -124.15 0.17 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.987 1.715 . . . . 0.0 114.463 166.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.4 t -142.96 155.13 44.64 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.797 2.039 . . . . 0.0 107.624 -176.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.2 mt -142.63 141.78 31.97 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 170.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.442 ' HB3' ' HD2' ' A' ' 110' ' ' PRO . 2.5 mp0 -76.34 170.65 15.07 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.588 1.555 . . . . 0.0 108.994 171.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 109' ' ' GLU . 46.4 Cg_endo -71.9 106.59 2.04 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 121.807 1.671 . . . . 0.0 113.666 -166.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 116.51 -13.77 15.45 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 124.932 1.253 . . . . 0.0 110.801 172.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -82.4 176.89 9.06 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 123.627 0.251 . . . . 0.0 111.548 -163.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -118.86 144.0 46.63 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.073 0.949 . . . . 0.0 113.194 -150.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.25 84.29 1.95 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.102 1.761 . . . . 0.0 110.027 168.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -101.95 87.79 3.2 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 120.612 -1.305 . . . . 0.0 109.243 171.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 13.2 ttt -102.82 118.82 57.43 Favored Pre-proline 0 N--CA 1.442 -0.869 0 O-C-N 121.454 -0.779 . . . . 0.0 110.275 -167.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.64 152.77 77.62 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.145 1.897 . . . . 0.0 110.358 171.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.5 t -145.43 135.44 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.6 p -99.46 148.08 6.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 166.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -152.43 156.27 39.15 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 118.282 0.492 . . . . 0.0 112.047 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -173.11 176.78 2.89 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 127.149 2.18 . . . . 0.0 108.467 176.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.465 HG22 HD22 ' A' ' 138' ' ' LEU . 78.7 t -131.86 138.66 52.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 124.0 0.92 . . . . 0.0 108.967 176.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -82.88 146.81 53.17 Favored Pre-proline 0 CA--C 1.54 0.593 0 O-C-N 123.452 0.47 . . . . 0.0 111.255 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -56.98 -25.25 61.8 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.95 3.1 . . . . 0.0 113.615 177.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -42.22 -31.13 0.35 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.637 1.575 . . . . 0.0 113.09 175.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.3 tt -49.3 -46.14 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.6 m -85.5 57.07 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 119.425 1.011 . . . . 0.0 110.52 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -132.59 -64.55 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.484 1.114 . . . . 0.0 113.456 173.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -63.86 164.7 20.87 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 121.932 1.754 . . . . 0.0 111.882 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 89.3 t -77.39 -43.8 30.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -173.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -37.8 -46.6 0.94 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 129.037 2.935 . . . . 0.0 112.957 177.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 19.1 p -87.23 -61.93 1.61 Allowed 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -0.97 79.7 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 129.506 3.123 . . . . 0.0 115.098 -171.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 134.82 -44.11 1.21 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 -171.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 12.4 mm -53.46 118.25 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 123.038 0.535 . . . . 0.0 110.075 170.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.2 pttt -156.01 53.84 0.57 Allowed 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.881 168.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.83 91.87 2.4 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 167.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.465 HD22 HG22 ' A' ' 122' ' ' VAL . 1.5 mp -77.0 135.12 38.66 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 -176.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 6.7 t -136.9 150.46 48.24 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.76 106.35 10.43 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 102.785 -3.043 . . . . 0.0 102.785 170.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.6 t -79.61 92.98 5.4 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 172.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.37 121.82 27.19 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 174.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.63 108.85 13.04 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.894 0.878 . . . . 0.0 109.786 -178.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.449 ' CD2' HD13 ' A' ' 45' ' ' LEU . 3.9 m-30 -79.28 80.51 5.64 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.014 1.325 . . . . 0.0 112.792 -167.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -129.58 78.42 75.52 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -97.65 -106.98 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.873 1 C-N-CA 125.418 4.079 . . . . 0.0 111.223 167.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -137.85 113.06 9.25 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.083 1.753 . . . . 0.0 108.046 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -91.11 113.11 57.17 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 123.813 0.845 . . . . 0.0 108.756 170.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -77.23 65.38 7.91 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.131 1.887 . . . . 0.0 108.314 166.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.2 m 26.53 92.58 0.01 OUTLIER 'General case' 0 C--N 1.344 0.326 0 C-N-CA 128.688 2.795 . . . . 0.0 113.964 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.283 0 CA-C-N 119.038 0.835 . . . . 0.0 110.573 -156.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.6 p . . . . . 0 CA--C 1.537 0.469 0 N-CA-C 102.603 -3.11 . . . . 0.0 102.603 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -79.26 61.17 3.29 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 122.648 2.476 . . . . 0.0 109.17 168.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.06 159.99 1.37 Allowed 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 131.657 3.983 . . . . 0.0 104.703 178.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 61' ' ' GLY . . . -136.36 133.59 36.96 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 103.353 -2.832 . . . . 0.0 103.353 149.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.4 m -157.89 39.15 0.27 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.318 1.447 . . . . 0.0 109.145 162.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.18 -58.07 1.82 Allowed 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 104.767 -2.308 . . . . 0.0 104.767 -166.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.9 mt -124.87 41.55 3.49 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.432 1.493 . . . . 0.0 109.706 176.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.412 ' C ' HD13 ' A' ' 29' ' ' LEU . 44.3 mt -75.07 110.06 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 162.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.412 HD13 ' C ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -104.17 -174.12 2.47 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 170.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.42 -32.96 70.66 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.363 1.465 . . . . 0.0 114.855 -163.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -53.23 95.95 0.01 OUTLIER 'General case' 0 C--N 1.34 0.178 0 CA-C-O 123.048 1.404 . . . . 0.0 112.72 -173.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.3 ttpp -74.58 88.12 2.15 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 165.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.65 127.51 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.754 -172.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.44 134.28 33.62 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -174.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 t -118.03 139.18 46.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.5 m -113.2 104.55 12.46 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.825 1.25 . . . . 0.0 108.272 -174.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -79.96 148.22 31.29 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.764 173.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -144.19 86.96 1.86 Allowed 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 -175.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.64 90.66 8.5 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.983 1.313 . . . . 0.0 110.505 -173.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -93.09 106.55 18.5 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.513 0.673 . . . . 0.0 109.752 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.0 p -78.44 145.52 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 163.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -156.32 159.43 38.81 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 118.579 0.627 . . . . 0.0 110.266 176.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.31 132.69 29.13 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 172.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.21 -45.33 1.28 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 -160.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.25 97.37 19.94 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 123.699 0.799 . . . . 0.0 109.801 -178.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.82 11.29 2.8 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.525 2.817 . . . . 0.0 113.438 -174.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 42.0 m0 -76.29 145.66 39.46 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.074 -1.016 . . . . 0.0 111.352 -172.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -77.59 83.15 3.99 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 104.87 -2.271 . . . . 0.0 104.87 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -94.59 90.14 6.04 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.616 1.966 . . . . 0.0 108.514 -171.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.2 m -89.15 129.65 47.12 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -176.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.87 149.38 72.37 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 N-CA-C 108.165 -1.513 . . . . 0.0 108.165 164.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.3 -59.2 3.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -128.85 157.09 42.5 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 167.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.9 tpt85 -67.33 -34.36 77.18 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 173.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -134.3 169.47 17.17 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 125.576 1.55 . . . . 0.0 110.689 -174.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.5 pt -136.47 175.87 9.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 124.774 1.23 . . . . 0.0 107.88 166.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.35 136.8 53.17 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 165.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.9 m -126.04 135.1 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 170.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.85 96.04 2.03 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 165.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.438 HD12 ' HB3' ' A' ' 124' ' ' PRO . 4.8 pt 0.23 73.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.994 2.117 . . . . 0.0 114.389 -173.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . 133.28 -27.9 3.36 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 119.934 -0.37 . . . . 0.0 112.821 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -46.74 106.95 0.09 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.239 1.016 . . . . 0.0 111.414 176.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.434 HG22 ' CD1' ' A' ' 121' ' ' PHE . 1.1 p -65.0 113.48 3.91 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.83 0.852 . . . . 0.0 109.386 174.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.3 p -114.8 144.11 23.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 167.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.25 131.06 38.7 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.154 1.782 . . . . 0.0 107.978 176.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -145.67 93.49 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.37 144.61 34.0 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.979 -173.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -110.83 145.26 38.52 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 177.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.5 ttt-85 -118.84 121.29 39.68 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.667 1.187 . . . . 0.0 108.291 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.28 111.0 18.8 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.013 0.925 . . . . 0.0 109.653 169.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -107.98 118.36 36.54 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.975 0.91 . . . . 0.0 110.561 -176.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -79.73 94.32 5.72 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -162.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.5 mt -84.72 73.24 10.63 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.469 0.707 . . . . 0.0 110.556 168.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -127.94 167.83 16.09 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.168 0.987 . . . . 0.0 110.52 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.5 p -78.26 -29.62 48.12 Favored 'General case' 0 C--O 1.227 -0.127 0 C-N-CA 123.467 0.707 . . . . 0.0 111.466 174.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -147.92 162.32 31.67 Favored Pre-proline 0 N--CA 1.449 -0.508 0 C-N-CA 124.742 1.217 . . . . 0.0 108.456 -160.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -59.68 121.17 9.41 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.724 2.282 . . . . 0.0 111.044 -174.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.51 175.42 7.07 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 125.623 1.569 . . . . 0.0 110.113 -178.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.0 t -138.24 159.28 42.46 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 169.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -138.1 150.93 21.18 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 127.03 2.252 . . . . 0.0 108.551 -173.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.44 HE21 ' N ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -162.56 -39.22 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.21 0.604 . . . . 0.0 110.097 168.534 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.44 ' N ' HE21 ' A' ' 81' ' ' GLN . . . 61.58 -179.52 0.12 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.873 0.869 . . . . 0.0 113.023 176.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.1 t -119.31 166.63 12.78 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 144.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -141.89 88.78 2.14 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.756 1.265 . . . . 0.0 108.015 -176.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -79.13 89.08 4.83 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -177.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.8 t -79.69 86.65 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 173.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.8 t -175.16 151.33 1.33 Allowed Pre-proline 0 C--O 1.232 0.143 0 C-N-CA 125.055 1.342 . . . . 0.0 109.411 170.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.52 -34.61 7.16 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 121.011 1.14 . . . . 0.0 109.156 156.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.8 ptp 171.99 -70.38 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.91 2.484 . . . . 0.0 107.869 -177.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.69 -30.79 26.51 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -165.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.38 -112.93 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.011 0.368 . . . . 0.0 110.086 -177.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.24 -58.62 0.84 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 123.737 0.684 . . . . 0.0 112.735 -174.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -49.44 -53.67 21.67 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.998 0.919 . . . . 0.0 110.365 175.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -73.19 40.4 0.1 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.494 1.118 . . . . 0.0 112.919 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -103.06 140.31 37.46 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 173.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -74.21 162.72 28.65 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 118.394 -1.322 . . . . 0.0 111.405 173.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? 54.13 56.47 6.97 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.111 0.958 . . . . 0.0 109.714 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.9 p -72.55 146.08 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 170.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 70.7 153.7 0.12 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.383 1.873 . . . . 0.0 113.608 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 67.02 142.7 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.874 1.669 . . . . 0.0 111.705 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -61.52 -179.74 0.19 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.837 0.855 . . . . 0.0 111.592 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 13.4 t -153.29 51.31 0.72 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 167.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 6.5 p90 179.19 164.25 0.91 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.591 1.956 . . . . 0.0 105.835 -164.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.8 t -126.69 49.9 1.99 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 122.736 1.255 . . . . 0.0 109.188 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.39 69.85 1.66 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 173.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.2 t -115.3 -61.05 1.8 Allowed 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 124.813 1.245 . . . . 0.0 110.56 -172.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -161.96 146.23 12.55 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.039 1.336 . . . . 0.0 107.427 -178.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.431 HD11 ' HB2' ' A' ' 114' ' ' MET . 94.5 mt -147.79 134.46 19.93 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 174.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -64.55 156.4 77.7 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 127.382 2.273 . . . . 0.0 109.751 170.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.3 92.92 0.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.531 2.821 . . . . 0.0 111.65 -167.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 143.75 -27.32 2.06 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 124.562 1.077 . . . . 0.0 110.991 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -77.97 153.93 32.01 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -153.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -108.6 118.17 36.09 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.591 1.556 . . . . 0.0 110.19 -166.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.431 ' HB2' HD11 ' A' ' 108' ' ' LEU . 14.9 ttp -108.96 86.04 2.21 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 123.834 0.853 . . . . 0.0 110.868 178.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -77.26 129.39 35.84 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 156.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 25.6 mtp -143.35 136.58 13.97 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 118.587 0.63 . . . . 0.0 111.511 159.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -69.95 124.32 10.89 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 123.547 2.831 . . . . 0.0 111.296 171.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.2 t -91.18 152.24 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 160.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.8 p -121.46 143.7 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 167.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -148.65 135.53 19.93 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 118.633 0.651 . . . . 0.0 110.621 -173.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.434 ' CD1' HG22 ' A' ' 63' ' ' THR . 1.0 OUTLIER -159.55 149.05 18.31 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.156 1.382 . . . . 0.0 109.17 174.348 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 92.3 t -100.8 139.17 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.689 1.196 . . . . 0.0 111.441 -173.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -82.91 120.35 76.03 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 177.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.438 ' HB3' HD12 ' A' ' 60' ' ' ILE . 36.4 Cg_endo -58.16 -16.31 27.07 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.827 2.351 . . . . 0.0 113.754 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.87 -27.4 2.09 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 119.518 1.054 . . . . 0.0 111.965 168.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.02 -45.7 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 O-C-N 121.643 -0.66 . . . . 0.0 111.63 175.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.9 m -87.36 56.34 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 O-C-N 121.185 -0.947 . . . . 0.0 109.952 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -138.1 -59.72 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 117.14 -1.409 . . . . 0.0 113.762 175.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.95 161.44 18.42 Favored 'Trans proline' 0 C--N 1.347 0.489 0 CA-C-N 122.573 1.955 . . . . 0.0 113.237 -172.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.1 t -56.2 -36.66 46.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 125.843 1.657 . . . . 0.0 111.0 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -38.84 -54.1 1.65 Allowed 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 126.377 1.871 . . . . 0.0 112.053 176.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.5 p -106.28 -46.19 4.11 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.529 -166.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 14.72 67.05 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.305 2.642 . . . . 0.0 115.652 175.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 127.84 -24.36 5.16 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.676 -0.57 . . . . 0.0 111.676 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.2 mm -60.58 132.02 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 170.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 42.5 pttt -159.51 64.72 0.38 Allowed 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.784 0.802 . . . . 0.0 110.282 167.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 27.7 m -149.19 98.28 2.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 162.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.66 82.75 4.88 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -175.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.1 m -76.7 152.9 35.54 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.985 -169.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.2 tt -136.96 104.47 5.47 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.3 m -86.98 98.25 11.15 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 169.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.92 128.07 33.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 170.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.3 m -135.95 98.44 3.89 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.463 0.649 . . . . 0.0 109.89 -168.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -72.98 92.09 1.62 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.118 1.367 . . . . 0.0 112.111 -174.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -132.25 90.61 33.97 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.394 1.078 . . . . 0.0 113.386 170.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -109.4 -105.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.318 1 C-N-CA 125.381 4.054 . . . . 0.0 109.731 164.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.4 ptt-85 -160.34 124.49 3.66 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.59 1.556 . . . . 0.0 108.25 -174.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -95.78 133.69 25.13 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 123.24 0.616 . . . . 0.0 109.493 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -73.53 -63.16 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.146 1.898 . . . . 0.0 108.729 174.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.5 t -167.41 175.22 7.37 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.827 1.251 . . . . 0.0 107.98 162.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.5 0 C-N-CA 124.5 1.12 . . . . 0.0 111.859 -178.227 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.7 t . . . . . 0 CA--C 1.537 0.467 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 18.45 54.3 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.924 2.49 . . . . 0.0 114.039 -162.524 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.43 -80.66 0.15 Allowed 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 102.406 -3.183 . . . . 0.0 102.406 167.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -161.24 -80.07 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 126.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.4 t -160.33 -157.85 0.58 Allowed 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 164.2 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.0 -18.24 61.99 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.953 1.701 . . . . 0.0 109.574 175.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.1 mt -68.1 2.41 2.16 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.641 1.177 . . . . 0.0 113.511 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.4 mt -67.71 126.21 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 121.036 1.744 . . . . 0.0 108.888 172.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.4 mp -126.16 163.0 24.08 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.36 0.664 . . . . 0.0 110.669 -178.074 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -78.56 70.26 4.87 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.703 0.801 . . . . 0.0 111.786 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.15 162.19 27.5 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 153.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -130.84 110.27 11.18 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -174.312 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.411 ' CG2' HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -112.13 125.14 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 -174.532 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -89.39 137.79 32.02 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -178.215 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.2 t -123.98 131.29 73.16 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.7 m -91.59 106.1 18.23 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.412 1.885 . . . . 0.0 108.087 -174.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -80.52 124.72 29.18 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -130.23 84.94 2.24 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 122.233 1.016 . . . . 0.0 111.617 -170.741 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.54 102.31 14.08 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.14 0.976 . . . . 0.0 109.706 177.7 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -99.18 122.25 42.12 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.393 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.6 p -113.01 133.56 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.089 0 C-N-CA 124.162 0.985 . . . . 0.0 109.071 174.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.11 176.15 8.95 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.543 1.137 . . . . 0.0 108.833 179.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.1 122.57 8.74 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 170.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.06 -32.52 1.16 Allowed Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -165.122 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mp -142.63 158.74 59.43 Favored Pre-proline 0 N--CA 1.456 -0.155 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 160.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -90.66 13.31 2.22 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.84 3.027 . . . . 0.0 112.171 165.686 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.444 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 41.7 m0 -78.63 139.76 38.51 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -162.49 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -76.72 83.78 3.34 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.495 ' CZ ' ' HB2' ' A' ' 70' ' ' ALA . 7.2 m-85 -87.71 89.34 7.96 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.317 175.04 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.5 m -87.9 112.9 52.06 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 171.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.1 142.02 54.66 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 N-CA-C 107.659 -1.708 . . . . 0.0 107.659 164.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.423 HG23 HE21 ' A' ' 53' ' ' GLN . 1.5 m -77.54 -41.37 29.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 O-C-N 122.396 -0.19 . . . . 0.0 111.408 -171.3 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.423 HE21 HG23 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -145.97 156.51 43.55 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 167.963 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -65.29 -36.62 84.64 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 177.782 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -151.6 143.75 23.96 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 122.762 0.425 . . . . 0.0 110.99 -174.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.0 pt -105.6 168.36 2.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 123.679 0.792 . . . . 0.0 109.416 174.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -94.05 141.92 27.98 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 152.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.76 123.61 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 157.808 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -75.52 78.82 2.54 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 172.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.411 HG23 ' CG2' ' A' ' 33' ' ' ILE . 2.9 pt 11.97 73.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 127.508 2.323 . . . . 0.0 112.923 -176.497 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.99 -33.44 3.7 Favored Glycine 0 C--O 1.222 -0.643 0 CA-C-O 118.448 -1.195 . . . . 0.0 112.054 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -62.1 140.78 58.39 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 120.225 2.012 . . . . 0.0 110.442 -178.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.13 112.15 16.05 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 127.942 2.497 . . . . 0.0 110.182 -174.041 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 p -79.67 169.01 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.104 0 O-C-N 121.818 -0.551 . . . . 0.0 109.63 174.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.409 HE21 ' HA ' ' A' ' 65' ' ' GLN . 5.2 tp60 -116.39 113.76 23.35 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 124.947 1.299 . . . . 0.0 107.96 156.262 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.4 pp -121.54 126.9 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 159.533 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 33.1 ttp -79.31 151.05 31.29 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 167.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.77 155.61 27.5 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 167.348 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -134.23 145.35 49.07 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.448 1.099 . . . . 0.0 109.299 172.229 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 49' ' ' PHE . . . -135.16 155.97 49.78 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 127.0 2.12 . . . . 0.0 105.943 151.072 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.0 mmmt -137.72 122.1 18.27 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 116.845 -1.55 . . . . 0.0 108.997 176.496 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.444 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 49.9 t-20 -78.22 85.49 4.38 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 121.472 1.942 . . . . 0.0 111.565 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.4 mt -79.1 68.89 5.18 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.788 1.235 . . . . 0.0 109.869 172.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.75 175.02 10.94 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 170.072 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.5 m -106.41 19.4 20.56 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.1 0.56 . . . . 0.0 110.346 173.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.4 p -146.6 161.05 39.6 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 125.777 1.631 . . . . 0.0 108.848 178.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -62.8 156.51 53.17 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 121.502 1.468 . . . . 0.0 110.247 173.568 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.37 162.91 31.27 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 171.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.9 t -116.61 108.22 15.67 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.2 121.61 5.59 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 105.625 -2.99 . . . . 0.0 105.625 162.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.66 -54.06 1.34 Allowed 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 170.734 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.39 178.41 0.16 Allowed 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.884 0.874 . . . . 0.0 110.984 172.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.62 141.63 33.43 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 153.055 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -107.4 162.85 13.55 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 122.681 0.392 . . . . 0.0 110.53 173.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -123.23 111.32 16.33 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 160.374 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.0 t -89.17 56.82 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.616 0.766 . . . . 0.0 110.008 -171.365 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.2 t -172.97 149.97 1.9 Allowed Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 119.911 1.232 . . . . 0.0 112.24 -177.56 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -64.84 -39.46 25.55 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 121.972 1.782 . . . . 0.0 109.676 162.697 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.4 ptp 173.49 -76.79 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 127.537 2.335 . . . . 0.0 108.044 176.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.418 ' HB3' HG13 ' A' ' 135' ' ' ILE . . . -62.16 -43.51 98.66 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 123.938 0.895 . . . . 0.0 112.666 -169.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.04 -103.82 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.718 -161.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.04 -53.91 1.4 Allowed Glycine 0 CA--C 1.527 0.829 0 CA-C-O 119.381 -0.677 . . . . 0.0 113.043 -177.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -45.84 -56.42 5.41 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.49 1.145 . . . . 0.0 110.984 176.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -74.35 4.72 5.42 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.606 1.162 . . . . 0.0 113.83 179.355 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -76.9 107.78 9.48 Favored 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 120.9 -1.125 . . . . 0.0 108.428 177.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -83.7 77.42 9.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.77 -172.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.35 163.97 0.36 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.175 158.128 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.8 t -77.53 -103.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 176.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -164.65 171.42 14.44 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -168.252 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 3.7 t 66.33 -157.91 0.25 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.254 1.022 . . . . 0.0 109.658 -179.232 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -72.05 -11.99 61.01 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.409 1.004 . . . . 0.0 113.213 -170.177 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 50.5 t 72.38 -51.49 0.7 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.74 1.616 . . . . 0.0 113.327 177.013 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -61.06 77.24 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.353 1.461 . . . . 0.0 111.132 174.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.8 m -78.07 -21.18 50.96 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.762 1.625 . . . . 0.0 109.931 178.489 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.9 -60.91 2.7 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.26 1.424 . . . . 0.0 111.488 171.483 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.8 t 45.66 -148.36 0.11 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.499 1.52 . . . . 0.0 111.92 177.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -93.95 145.54 24.57 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.108 0.963 . . . . 0.0 108.913 176.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.1 mt -136.71 128.14 28.43 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 122.94 0.496 . . . . 0.0 109.897 177.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -54.74 165.21 0.97 Allowed Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 127.255 2.222 . . . . 0.0 110.738 160.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -76.25 126.17 8.99 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.244 1.963 . . . . 0.0 112.457 -172.027 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 98.02 5.16 57.46 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 124.012 0.815 . . . . 0.0 111.298 175.489 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -79.35 133.75 36.59 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 117.242 0.521 . . . . 0.0 110.737 -173.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -102.19 89.28 3.54 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.144 1.378 . . . . 0.0 109.694 -175.322 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.96 87.36 7.35 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -133.51 131.91 40.37 Favored 'General case' 0 CA--C 1.523 -0.075 0 CA-C-N 119.193 0.906 . . . . 0.0 111.411 169.506 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 60.0 mtt -153.07 147.11 18.57 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.173 0.989 . . . . 0.0 109.498 -170.519 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -73.29 146.84 40.96 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.678 2.919 . . . . 0.0 110.375 173.525 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 28.2 m -138.22 158.77 32.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 123.771 0.828 . . . . 0.0 108.891 165.319 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.6 m -114.6 161.01 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 124.097 0.959 . . . . 0.0 109.104 175.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -159.95 155.77 26.06 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.387 1.075 . . . . 0.0 108.164 -179.216 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -175.27 92.72 0.06 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.975 1.31 . . . . 0.0 111.529 -171.648 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.34 138.56 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 O-C-N 120.691 -1.256 . . . . 0.0 111.714 178.611 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.75 136.24 92.5 Favored Pre-proline 0 N--CA 1.469 0.51 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.487 173.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.57 -29.22 59.34 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.028 1.819 . . . . 0.0 112.104 172.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -44.6 -28.88 0.65 Allowed 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.534 1.533 . . . . 0.0 112.727 174.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 17.7 tt -47.69 -41.05 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 119.375 0.988 . . . . 0.0 112.817 174.345 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.3 m -87.01 58.39 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 119.573 1.079 . . . . 0.0 109.992 175.517 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.401 ' HG2' ' HD3' ' A' ' 129' ' ' PRO 0.486 1.0 OUTLIER -144.28 -52.63 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 117.933 2.568 . . . . 0.0 117.933 172.102 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.401 ' HD3' ' HG2' ' A' ' 128' ' ' LYS . 98.6 Cg_endo -76.79 161.21 33.7 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 CA-C-N 123.368 2.239 . . . . 0.0 112.26 -177.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.78 -42.16 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 124.826 1.25 . . . . 0.0 109.468 -172.404 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -43.26 -47.74 6.58 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 127.528 2.331 . . . . 0.0 112.382 177.254 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 24.2 p -92.95 -53.16 4.26 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -175.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 12.59 62.41 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 129.117 2.967 . . . . 0.0 115.44 -178.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 140.98 -38.73 1.52 Allowed Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -174.133 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.418 HG13 ' HB3' ' A' ' 90' ' ' ALA . 16.8 mm -55.34 113.65 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-N 117.434 0.617 . . . . 0.0 109.864 175.206 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 7.9 pttt -156.52 61.56 0.54 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 121.99 0.9 . . . . 0.0 108.925 169.659 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.89 89.53 1.47 Allowed 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 162.735 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.5 tp -74.99 160.16 30.9 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -171.407 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 12.0 t -153.36 164.75 37.59 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 174.242 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 14.7 tp -138.06 98.27 3.6 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 102.253 -3.24 . . . . 0.0 102.253 173.303 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.9 p -84.24 93.18 8.14 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 177.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.27 131.36 36.14 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 175.324 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.94 96.24 4.98 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.003 0.921 . . . . 0.0 108.677 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.415 ' CE1' ' CZ ' ' A' ' 49' ' ' PHE . 50.4 m-85 -89.62 87.63 7.1 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 125.652 1.581 . . . . 0.0 109.531 178.607 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -135.71 37.35 0.34 Allowed Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 125.378 1.471 . . . . 0.0 114.379 175.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.45 -85.4 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 123.156 2.571 . . . . 0.0 114.346 -172.638 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.46 91.38 1.57 Allowed 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.592 0.757 . . . . 0.0 110.352 -163.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -78.5 117.74 68.17 Favored Pre-proline 0 N--CA 1.451 -0.387 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 168.378 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.57 -29.42 7.37 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.551 2.167 . . . . 0.0 110.788 172.102 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 36.9 m 130.01 144.0 0.0 OUTLIER 'General case' 0 C--N 1.342 0.263 0 C-N-CA 130.632 3.573 . . . . 0.0 107.36 -167.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.2 pttm . . . . . 0 CA--C 1.534 0.358 0 C-N-CA 124.927 1.291 . . . . 0.0 109.267 177.562 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.1 t . . . . . 0 CA--C 1.537 0.461 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -73.62 67.11 1.09 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 159.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 146.46 154.08 0.0 OUTLIER 'General case' 0 C--N 1.339 0.132 1 C-N-CA 132.349 4.26 . . . . 0.0 108.096 -171.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -153.2 28.55 0.51 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 122.025 0.917 . . . . 0.0 110.126 -167.389 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.79 -11.43 59.99 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.529 1.532 . . . . 0.0 114.757 -147.196 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.35 -31.96 64.25 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 173.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.1 mp -108.09 14.46 25.11 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.023 1.329 . . . . 0.0 112.074 -176.27 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.4 mt -77.98 77.31 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 120.005 -1.684 . . . . 0.0 108.839 173.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.76 179.75 5.93 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.531 0.681 . . . . 0.0 109.893 179.238 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -94.48 59.43 2.51 Favored 'General case' 0 C--N 1.337 0.031 0 C-N-CA 123.827 0.851 . . . . 0.0 112.667 -167.021 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -115.18 160.9 19.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 151.664 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -133.76 88.38 2.47 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.0 tt -94.47 137.91 21.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 C-N-CA 124.477 1.111 . . . . 0.0 111.637 -163.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.441 ' HE2' ' CB ' ' A' ' 55' ' ' ASP . 0.1 OUTLIER -79.71 143.84 34.2 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.635 1.574 . . . . 0.0 109.781 -170.421 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.531 HG21 ' CE1' ' A' ' 120' ' ' PHE . 3.7 t -135.72 142.06 40.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.655 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 164.389 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.9 m -123.29 112.47 17.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 -177.721 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -78.52 89.76 4.48 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 172.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -78.23 85.25 4.4 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 118.492 -1.283 . . . . 0.0 108.395 178.576 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.5 115.78 17.54 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.832 174.758 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -122.94 175.54 6.52 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.595 1.158 . . . . 0.0 108.188 167.039 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.6 p -151.17 148.6 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 169.161 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -164.51 171.54 14.45 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.254 1.022 . . . . 0.0 108.869 -178.302 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.62 -165.36 0.22 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.354 1.462 . . . . 0.0 111.616 -175.4 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.73 52.98 4.26 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 112.123 -0.391 . . . . 0.0 112.123 -173.079 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.412 ' CD1' ' CD1' ' A' ' 144' ' ' PHE . 1.4 tt -111.7 83.77 4.77 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.122 0.969 . . . . 0.0 108.785 177.693 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -85.28 45.0 1.5 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.246 3.298 . . . . 0.0 109.736 -170.141 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.438 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 43.1 m0 -108.39 138.58 44.43 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -172.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.408 ' OE1' ' NZ ' ' A' ' 71' ' ' LYS . 73.2 tt0 -77.85 82.36 4.23 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 -178.503 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -90.26 122.01 32.79 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.715 1.206 . . . . 0.0 108.233 179.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 m -126.67 135.54 27.43 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.144 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -70.76 162.39 42.76 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 N-CA-C 108.146 -1.521 . . . . 0.0 108.146 161.433 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -60.18 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 175.117 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -144.06 154.13 42.91 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 164.773 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.03 -42.72 69.45 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 118.537 -0.744 . . . . 0.0 112.095 -175.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.441 ' CB ' ' HE2' ' A' ' 34' ' ' LYS . 23.7 p-10 -145.35 159.69 42.67 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 119.382 0.992 . . . . 0.0 113.189 -166.623 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.8 pt -133.82 159.79 42.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 125.768 1.627 . . . . 0.0 107.847 178.193 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -128.29 85.41 2.34 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.316 1.446 . . . . 0.0 109.124 178.189 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.8 m -80.44 141.83 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 O-C-N 121.255 -0.903 . . . . 0.0 110.689 -171.281 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -78.22 72.16 4.74 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 173.078 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.5 pt 19.01 64.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 127.437 2.295 . . . . 0.0 113.489 176.368 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 139.0 -43.8 1.14 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -172.58 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -59.68 130.3 46.16 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.648 -173.467 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.467 HG23 ' CD1' ' A' ' 121' ' ' PHE . 1.6 m -106.69 87.28 2.49 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.003 -146.106 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.72 144.19 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 CA-C-O 121.094 0.473 . . . . 0.0 110.696 -170.538 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.93 115.54 24.4 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.239 1.016 . . . . 0.0 108.591 168.817 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.8 pp -115.57 115.04 48.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 164.044 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -87.49 155.23 20.09 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.939 -0.475 . . . . 0.0 110.966 178.387 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -127.0 153.78 45.46 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 172.73 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -134.69 141.79 46.64 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.877 1.671 . . . . 0.0 107.898 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.34 115.58 7.98 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.805 2.042 . . . . 0.0 107.681 174.387 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.408 ' NZ ' ' OE1' ' A' ' 48' ' ' GLU . 3.0 mtmp? -114.73 124.42 51.73 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.29 0.95 . . . . 0.0 110.652 -176.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.438 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 46.9 t-20 -80.92 107.2 13.53 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.79 0.723 . . . . 0.0 112.932 -167.583 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.3 mp -99.08 30.4 3.45 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.495 1.118 . . . . 0.0 111.974 176.649 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.85 176.81 9.39 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.021 -1.049 . . . . 0.0 110.401 168.084 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.1 t -114.07 18.1 17.37 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.221 0.608 . . . . 0.0 109.929 161.646 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 p -146.65 156.42 48.61 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 125.639 1.576 . . . . 0.0 107.736 174.405 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -63.23 145.1 93.05 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 N-CA-C 108.122 -1.53 . . . . 0.0 108.122 172.138 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.5 p -123.08 168.25 12.61 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.644 0.735 . . . . 0.0 111.299 178.716 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.8 m -93.63 144.88 24.98 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 168.354 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -168.74 56.9 0.21 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 176.525 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.91 57.78 0.86 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.018 1.727 . . . . 0.0 108.405 -174.374 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.62 166.46 23.52 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.94 0.876 . . . . 0.0 112.879 -168.036 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.48 97.55 8.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 176.512 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -77.23 140.24 40.05 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.544 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -85.76 88.61 7.57 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -172.634 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -76.97 77.91 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 C-N-CA 125.043 1.337 . . . . 0.0 110.435 -176.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.8 t 178.88 147.64 0.39 Allowed Pre-proline 0 N--CA 1.46 0.029 0 C-N-CA 124.932 1.293 . . . . 0.0 109.343 173.324 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -66.75 -35.19 28.86 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.146 1.23 . . . . 0.0 110.274 158.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.0 ptp 175.36 -70.78 0.01 OUTLIER 'General case' 0 C--N 1.341 0.206 0 C-N-CA 126.902 2.081 . . . . 0.0 107.571 179.244 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.0 -36.61 48.59 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.962 0.905 . . . . 0.0 113.011 -167.788 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.77 -109.62 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.608 0.242 . . . . 0.0 111.58 -167.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.79 -49.69 0.84 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.417 1.008 . . . . 0.0 113.528 -176.111 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.55 -57.52 4.66 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.594 1.197 . . . . 0.0 109.802 172.254 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -73.69 5.01 4.31 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.498 1.919 . . . . 0.0 113.895 -178.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -85.72 126.58 34.08 Favored 'General case' 0 C--N 1.344 0.343 0 O-C-N 121.232 -0.918 . . . . 0.0 108.649 174.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -72.71 91.0 1.43 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.179 -179.459 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.436 ' H ' ' HD2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -68.77 -20.22 64.35 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.833 1.253 . . . . 0.0 113.24 177.732 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.1 t 37.84 61.61 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 126.75 2.02 . . . . 0.0 111.992 177.464 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.38 68.78 0.36 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.133 1.373 . . . . 0.0 110.301 -177.109 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 17.6 p 177.73 -30.79 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.652 2.381 . . . . 0.0 109.972 -172.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -143.43 67.79 1.29 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 176.07 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 14.2 p -151.67 173.78 14.27 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.803 1.241 . . . . 0.0 109.024 179.595 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -67.48 114.51 6.21 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.173 0.589 . . . . 0.0 110.372 -165.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.7 t -80.73 -28.7 36.48 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.916 0.486 . . . . 0.0 112.062 -175.438 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 34.87 62.81 0.5 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.335 1.854 . . . . 0.0 114.081 176.039 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.1 t -88.5 -165.78 1.42 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.051 0.94 . . . . 0.0 110.05 174.687 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.5 t -76.69 144.15 39.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.198 0.999 . . . . 0.0 110.04 -175.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 81.0 mt -127.25 134.87 50.01 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.538 1.135 . . . . 0.0 108.15 -179.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -69.55 157.08 90.44 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 170.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.43 100.21 0.88 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.373 2.716 . . . . 0.0 110.438 -170.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.31 -23.44 3.31 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -175.208 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -78.95 135.78 37.05 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 118.254 1.027 . . . . 0.0 111.707 -160.727 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -92.61 104.56 16.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.4 1.48 . . . . 0.0 109.375 178.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -90.56 135.13 33.9 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 174.042 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -151.46 154.99 37.65 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.625 0.37 . . . . 0.0 110.639 156.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 78.6 mtp -151.77 146.05 18.36 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.161 0.984 . . . . 0.0 109.578 171.495 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -66.12 137.97 50.17 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.126 2.55 . . . . 0.0 110.443 161.79 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.8 t -107.96 130.47 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 159.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.3 m -98.49 140.82 17.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 171.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.531 ' CE1' HG21 ' A' ' 35' ' ' VAL . 64.3 t80 -154.43 149.37 26.72 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -162.322 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.467 ' CD1' HG23 ' A' ' 63' ' ' THR . 41.1 p90 -164.5 170.29 16.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.415 1.886 . . . . 0.0 109.108 165.314 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 70.7 t -103.99 135.46 41.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 174.482 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -76.37 134.2 70.47 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 119.119 -0.467 . . . . 0.0 109.954 176.397 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -74.16 67.34 5.16 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.384 2.723 . . . . 0.0 110.292 171.42 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -133.52 -37.82 0.94 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 126.799 2.04 . . . . 0.0 111.027 176.565 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.4 tt -43.87 -41.66 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 125.012 1.325 . . . . 0.0 113.414 173.111 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.9 m -78.23 49.03 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 O-C-N 121.394 -0.816 . . . . 0.0 111.34 176.825 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.9 mttt -142.72 -64.51 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 117.521 -1.228 . . . . 0.0 111.617 -179.299 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.17 153.17 46.03 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 121.942 1.729 . . . . 0.0 112.736 -176.548 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.8 t -54.87 -35.54 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 125.838 1.655 . . . . 0.0 110.662 175.897 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -35.26 -59.16 0.53 Allowed 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 126.656 1.983 . . . . 0.0 112.309 175.79 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.5 p -106.94 -42.73 4.84 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.015 -166.068 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 14.07 63.15 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 128.389 2.675 . . . . 0.0 116.235 172.151 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 136.73 -36.73 1.95 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -177.272 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 29.8 mm -53.28 123.52 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 171.444 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.38 47.86 0.35 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.288 0.566 . . . . 0.0 112.102 177.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.5 p -143.65 89.04 2.03 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 105.809 -1.922 . . . . 0.0 105.809 174.025 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 tp -92.71 87.21 5.8 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.029 -159.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.5 t -97.86 155.85 16.87 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.457 0.703 . . . . 0.0 111.084 -166.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.76 133.25 55.98 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 160.704 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 44.5 m -90.94 105.77 18.06 Favored 'General case' 0 N--CA 1.46 0.043 0 O-C-N 123.902 0.751 . . . . 0.0 109.035 160.452 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -76.27 99.8 4.89 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 165.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 53.5 m -117.34 86.35 2.5 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.978 1.311 . . . . 0.0 107.524 175.18 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.412 ' CD1' ' CD1' ' A' ' 45' ' ' LEU . 48.2 m-85 -59.22 145.2 43.67 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.322 1.049 . . . . 0.0 112.828 174.392 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -166.85 52.69 0.25 Allowed Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.966 1.707 . . . . 0.0 112.342 -175.435 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.3 -90.04 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.679 2.252 . . . . 0.0 115.092 -168.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -155.16 179.55 9.04 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 129.697 3.199 . . . . 0.0 104.863 -175.119 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -147.13 94.56 4.54 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 118.488 0.585 . . . . 0.0 111.044 -171.462 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -91.94 -124.37 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.984 3.122 . . . . 0.0 108.954 176.664 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 85.5 p -123.2 123.76 41.5 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 120.356 1.435 . . . . 0.0 111.763 -172.706 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.595 0 C-N-CA 126.496 1.918 . . . . 0.0 109.237 174.333 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.3 p . . . . . 0 N--CA 1.464 0.265 0 CA-C-O 122.042 0.925 . . . . 0.0 112.026 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 46.38 34.06 2.14 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.894 1.678 . . . . 0.0 112.276 176.482 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 166.68 157.1 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 128.332 2.653 . . . . 0.0 105.903 -172.58 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -151.74 2.55 0.39 Allowed 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -172.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.75 11.9 0.95 Allowed 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 126.802 2.041 . . . . 0.0 115.322 -164.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -77.25 -39.12 49.44 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 159.452 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.4 mp -92.22 -37.91 12.41 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 117.209 -1.377 . . . . 0.0 113.016 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.2 mt -32.53 133.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -162.13 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 29' ' ' LEU . 2.5 mm? -105.91 -104.15 0.33 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.159 -173.618 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -173.59 -49.2 0.01 OUTLIER 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.058 1.343 . . . . 0.0 108.855 -171.348 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -38.78 134.6 0.95 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.002 1.721 . . . . 0.0 110.678 -178.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -100.97 86.65 3.1 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -165.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.98 115.01 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.436 1.494 . . . . 0.0 107.953 -171.424 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.99 160.01 29.48 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -173.641 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.0 t -148.74 145.19 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.1 m -138.55 100.28 4.05 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -170.053 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -78.11 145.0 36.0 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.018 0.527 . . . . 0.0 109.919 -176.177 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -127.63 82.75 2.11 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.913 0.863 . . . . 0.0 110.007 178.22 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.49 102.16 14.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 172.118 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -116.89 128.37 55.18 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 122.292 1.044 . . . . 0.0 112.126 -174.666 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.0 p -99.83 96.29 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.564 -174.252 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.12 171.1 10.5 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 122.048 0.928 . . . . 0.0 111.406 174.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.41 132.07 52.0 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 169.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 128.33 -39.28 1.92 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -170.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.484 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -131.56 95.57 23.21 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 117.56 0.68 . . . . 0.0 110.277 -176.363 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -83.94 50.94 3.27 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.956 2.437 . . . . 0.0 109.651 -176.136 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.484 ' CD2' ' CD2' ' A' ' 45' ' ' LEU . 44.4 m0 -107.91 135.56 49.1 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -173.649 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -79.36 84.5 5.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 103.484 -2.784 . . . . 0.0 103.484 179.246 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -102.04 86.15 2.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -171.598 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.3 m -88.04 129.14 51.2 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -167.28 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.09 122.49 9.58 Favored 'Trans proline' 0 N--CA 1.446 -1.277 0 N-CA-C 106.261 -2.246 . . . . 0.0 106.261 162.466 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.1 m -72.73 -32.08 39.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.181 0.515 . . . . 0.0 110.691 -168.387 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.02 161.98 34.16 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 150.265 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -62.65 -46.72 86.89 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 172.532 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -147.38 153.54 39.77 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 124.415 1.086 . . . . 0.0 111.659 -159.647 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.4 pt -133.13 179.23 4.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 126.326 1.851 . . . . 0.0 108.251 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -125.47 160.18 30.11 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.345 0.593 . . . . 0.0 110.21 149.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.6 t -116.72 145.97 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 127.99 2.516 . . . . 0.0 105.679 171.014 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 49.5 mmm-85 -91.37 100.81 13.53 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 168.021 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mt -33.2 115.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -148.243 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.58 -25.2 26.49 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.071 1.319 . . . . 0.0 110.936 -179.386 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -64.9 133.45 51.86 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.806 1.303 . . . . 0.0 112.422 -172.33 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.15 101.53 7.97 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 130.05 3.34 . . . . 0.0 110.818 -175.38 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.9 p -113.78 153.75 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.292 1.437 . . . . 0.0 109.491 -178.597 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -112.51 125.15 53.93 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 125.404 1.482 . . . . 0.0 109.343 -177.38 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.0 pp -128.48 122.86 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 167.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.412 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 66.4 mtt -76.09 168.44 20.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.614 174.164 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -136.17 143.21 44.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 161.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.7 ttt85 -121.01 118.7 30.5 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 179.546 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.3 105.15 9.24 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 125.822 1.649 . . . . 0.0 110.035 -177.216 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.29 121.09 44.36 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.064 -0.398 . . . . 0.0 110.749 -168.603 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.44 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 47.8 t-20 -78.38 111.9 14.85 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.803 -0.561 . . . . 0.0 111.912 -167.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.2 tp -98.41 11.24 38.77 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.812 0.845 . . . . 0.0 112.381 179.564 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.46 166.67 22.33 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.272 -0.893 . . . . 0.0 109.95 173.44 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 70.0 m -103.3 7.0 38.35 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.968 0.907 . . . . 0.0 111.835 171.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.34 159.61 38.79 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 126.134 1.773 . . . . 0.0 107.041 177.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.97 126.04 12.11 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.171 1.914 . . . . 0.0 111.255 -173.208 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.476 ' HG1' ' HE1' ' A' ' 47' ' ' TRP . 0.2 OUTLIER -80.49 173.53 12.51 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.821 0.849 . . . . 0.0 110.784 -178.998 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 50.7 p -131.45 72.03 1.49 Allowed 'General case' 0 C--O 1.232 0.137 0 C-N-CA 122.551 0.341 . . . . 0.0 110.426 -170.893 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.42 139.37 37.39 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.946 -0.462 . . . . 0.0 111.946 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -166.81 34.19 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.659 1.983 . . . . 0.0 109.44 169.222 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.58 159.08 34.47 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.33 0.652 . . . . 0.0 111.445 -165.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.9 t -87.77 131.51 34.48 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.704 0.764 . . . . 0.0 110.039 177.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.409 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -104.03 89.93 3.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.871 2.468 . . . . 0.0 105.572 175.509 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -77.0 91.92 3.67 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 120.882 -1.136 . . . . 0.0 107.935 -177.617 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 84' ' ' PHE . 7.8 t -78.11 72.57 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.612 1.165 . . . . 0.0 109.973 -174.043 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.9 t -168.73 134.76 1.49 Allowed Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 119.901 1.228 . . . . 0.0 113.389 173.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -74.1 67.72 5.04 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 122.386 2.057 . . . . 0.0 107.243 156.257 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 22.2 ptm 44.19 25.47 0.11 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 170.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -171.41 -58.26 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 119.384 0.993 . . . . 0.0 110.594 -168.411 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.61 -101.2 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -177.282 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 64.05 -52.1 0.08 OUTLIER Glycine 0 CA--C 1.538 1.481 0 N-CA-C 115.413 0.925 . . . . 0.0 115.413 -175.534 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -45.73 -47.63 15.33 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.553 1.541 . . . . 0.0 110.808 172.217 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -73.85 -12.69 60.75 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 127.012 2.125 . . . . 0.0 113.471 178.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.403 ' CD2' HD23 ' A' ' 138' ' ' LEU . 9.0 t80 -67.55 140.0 56.95 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.119 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.465 ' ND2' ' H ' ' A' ' 96' ' ' ASN . 1.4 p30 -71.21 127.95 34.29 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.967 1.307 . . . . 0.0 110.765 -177.33 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -161.06 -50.45 0.05 OUTLIER 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 122.478 0.311 . . . . 0.0 110.65 -174.793 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . 0.326 2.4 p 47.8 -95.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.985 1.314 . . . . 0.0 111.809 -175.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -165.18 178.75 6.74 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.201 1.401 . . . . 0.0 107.336 173.526 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 90.3 m 54.52 42.61 31.22 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.382 1.073 . . . . 0.0 111.469 175.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -106.18 163.73 12.57 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.385 1.074 . . . . 0.0 108.505 171.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 59.6 m -134.39 139.39 45.56 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 177.663 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -166.79 -42.46 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.853 0.861 . . . . 0.0 109.083 175.403 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.3 p -22.85 109.2 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 127.808 2.443 . . . . 0.0 111.855 162.783 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -78.41 -15.98 58.09 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -159.359 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.3 t 51.67 -146.64 0.47 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.441 1.096 . . . . 0.0 112.472 170.606 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.6 m -115.54 136.65 52.86 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.089 1.355 . . . . 0.0 108.542 -172.069 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 78.6 mt -128.44 147.95 50.69 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.39 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -73.29 156.42 89.15 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 172.354 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.23 85.87 0.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 124.88 3.72 . . . . 0.0 111.756 -173.064 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 152.74 -27.23 0.83 Allowed Glycine 0 CA--C 1.522 0.5 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.25 -177.777 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -77.86 143.45 37.79 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 118.085 0.942 . . . . 0.0 111.593 -157.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -105.21 96.9 6.84 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.811 1.244 . . . . 0.0 109.942 -175.603 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 15.4 tpt -83.92 89.21 7.18 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.114 1.365 . . . . 0.0 109.325 -177.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -99.21 134.21 42.4 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.256 0.622 . . . . 0.0 109.576 172.148 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 22.4 ptm -150.95 146.31 19.11 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.996 -0.526 . . . . 0.0 111.441 178.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 67' ' ' MET . 83.1 Cg_endo -79.58 147.77 20.05 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.883 3.055 . . . . 0.0 111.049 171.852 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.5 t -126.53 114.89 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 165.199 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.5 p -79.41 143.47 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 168.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -155.61 149.11 24.98 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.163 0.585 . . . . 0.0 109.949 -165.411 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.408 ' H ' ' ND2' ' A' ' 96' ' ' ASN . 18.6 p90 -171.18 118.98 0.48 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.36 1.464 . . . . 0.0 111.893 176.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.8 t -64.09 133.39 29.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 O-C-N 120.355 -1.466 . . . . 0.0 109.505 175.317 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -91.61 132.39 33.44 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 123.701 0.801 . . . . 0.0 109.8 -179.053 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -46.35 -31.52 9.55 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.402 3.401 . . . . 0.0 114.919 177.342 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -48.94 -24.2 1.4 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.783 1.633 . . . . 0.0 112.39 179.183 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.1 tt -49.01 -44.46 15.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 169.097 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.9 m -83.38 59.66 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 118.571 0.623 . . . . 0.0 109.895 174.354 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -111.0 -77.41 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 117.168 -1.396 . . . . 0.0 110.366 164.628 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.54 156.05 45.12 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 CA-C-N 121.885 1.709 . . . . 0.0 111.666 -177.384 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.6 m -62.16 -36.08 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 124.94 1.296 . . . . 0.0 112.045 -170.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -60.6 -64.46 0.94 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.147 0.979 . . . . 0.0 109.281 177.587 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 44.6 p -72.61 -15.43 61.73 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 118.509 -0.758 . . . . 0.0 111.568 -172.419 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.04 -41.52 5.53 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.768 0.713 . . . . 0.0 111.221 162.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.34 -29.17 74.38 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 112.237 -0.345 . . . . 0.0 112.237 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.3 mm -83.88 125.94 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 122.079 0.942 . . . . 0.0 110.39 -177.629 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 28.3 pttt -148.81 63.76 1.06 Allowed 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.506 153.751 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 11.7 m -150.15 95.33 2.26 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 158.416 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.403 HD23 ' CD2' ' A' ' 95' ' ' PHE . 1.2 tp -75.48 144.79 41.87 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -173.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.8 t -141.8 173.38 11.56 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.496 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.1 tt -150.63 111.28 4.25 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 177.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.45 92.94 8.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.515 1.126 . . . . 0.0 109.252 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.94 108.4 19.17 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.877 1.271 . . . . 0.0 108.783 179.406 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.66 89.09 3.58 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 122.009 0.909 . . . . 0.0 109.747 -177.358 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -71.23 85.57 0.77 Allowed 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.281 177.058 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.1 47.59 2.8 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -178.703 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -80.89 -105.74 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.279 2.653 . . . . 0.0 111.967 178.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -140.95 121.68 14.34 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.648 1.179 . . . . 0.0 108.528 -171.242 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.9 111.22 38.82 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 125.654 1.581 . . . . 0.0 107.118 -177.128 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.431 ' HD3' HG23 ' A' ' 78' ' ' THR . 26.6 Cg_endo -83.3 -4.85 11.07 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.293 2.662 . . . . 0.0 113.043 -172.742 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.9 t 131.51 103.71 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 129.972 3.309 . . . . 0.0 109.754 174.481 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.542 0.669 0 C-N-CA 125.256 1.423 . . . . 0.0 111.723 168.356 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 122.31 1.052 . . . . 0.0 108.427 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 23.08 50.72 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.94 1.696 . . . . 0.0 112.229 -146.308 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.21 155.29 11.35 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 127.879 2.471 . . . . 0.0 104.405 174.542 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -122.32 125.96 47.07 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 104.354 -2.462 . . . . 0.0 104.354 156.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.6 t -147.88 49.54 1.06 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 122.493 1.14 . . . . 0.0 108.227 174.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -158.8 -57.42 0.07 Allowed 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 127.306 2.243 . . . . 0.0 106.309 -174.367 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.9 mt -65.53 -16.48 63.72 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.907 2.083 . . . . 0.0 112.878 -177.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.4 mt -75.67 78.51 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 O-C-N 121.21 -0.931 . . . . 0.0 110.267 -171.566 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.69 -127.7 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.555 1.142 . . . . 0.0 108.524 169.679 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -104.36 -51.33 3.13 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.57 1.548 . . . . 0.0 111.939 -164.506 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -43.1 102.07 0.03 OUTLIER 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.194 1.398 . . . . 0.0 113.351 -169.806 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.69 81.52 4.99 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 177.261 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -97.11 122.58 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -160.616 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.7 150.48 34.48 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.943 1.297 . . . . 0.0 108.199 -175.216 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.52 146.9 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 174.497 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.9 m -125.83 112.19 15.73 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -172.69 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -77.88 136.18 38.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.754 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -126.71 84.45 2.27 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 122.502 1.144 . . . . 0.0 108.965 177.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.91 95.75 10.28 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.374 1.07 . . . . 0.0 110.972 -176.753 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -98.63 109.5 22.24 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.375 0.67 . . . . 0.0 109.79 -177.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.0 p -79.24 148.86 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 164.388 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -151.04 158.71 44.44 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 171.216 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.05 -40.15 10.25 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.84 0.856 . . . . 0.0 112.109 -177.214 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -41.58 -31.98 0.76 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.812 1.672 . . . . 0.0 114.151 174.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.487 HD21 ' CE3' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -130.17 110.13 16.68 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 118.688 1.244 . . . . 0.0 108.471 170.488 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -75.27 0.95 8.4 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.294 1.996 . . . . 0.0 115.576 -164.035 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.517 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 42.2 m0 -79.57 153.45 29.46 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.38 1.472 . . . . 0.0 113.613 -159.844 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.42 ' O ' HG23 ' A' ' 50' ' ' VAL . 4.1 tt0 -77.47 77.46 4.0 Favored 'General case' 0 C--N 1.344 0.344 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.615 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -84.6 110.72 18.93 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.684 1.193 . . . . 0.0 109.098 -171.484 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 48' ' ' GLU . 42.9 t -122.78 118.81 28.25 Favored Pre-proline 0 N--CA 1.444 -0.758 0 C-N-CA 124.4 1.08 . . . . 0.0 108.645 -163.638 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -81.87 174.56 10.13 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 124.543 3.495 . . . . 0.0 108.554 168.367 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -98.6 -53.12 8.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 123.949 0.9 . . . . 0.0 110.845 -173.622 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -134.16 175.15 9.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 166.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.6 tpt85 -68.45 -33.15 73.68 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.392 168.636 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -144.67 173.44 11.82 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.842 1.257 . . . . 0.0 112.694 -162.861 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.1 pt -141.65 178.2 2.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 127.206 2.203 . . . . 0.0 106.788 165.567 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -132.27 162.77 30.16 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 146.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.23 136.92 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 126.953 2.101 . . . . 0.0 105.836 -175.199 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.94 88.66 3.5 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 163.205 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.2 pt 8.81 69.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 127.74 2.416 . . . . 0.0 114.63 178.469 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.55 -37.55 1.78 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 123.41 0.529 . . . . 0.0 112.305 -176.594 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -39.24 104.43 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.383 1.473 . . . . 0.0 110.849 177.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.59 HG23 ' CD1' ' A' ' 121' ' ' PHE . 1.2 m -87.46 88.45 7.68 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.353 -156.25 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 p -92.73 161.67 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 O-C-N 121.933 -0.479 . . . . 0.0 111.721 -168.434 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.46 HE21 ' HA ' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -102.98 126.74 50.28 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.959 1.303 . . . . 0.0 110.35 169.561 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.5 pp -131.33 114.03 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 107.319 -1.364 . . . . 0.0 107.319 167.443 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.0 ttp -77.86 161.52 27.55 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.378 0.671 . . . . 0.0 110.862 -176.861 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -134.57 150.96 50.78 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.436 1.094 . . . . 0.0 108.846 169.325 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 54.1 ttp85 -143.46 147.08 34.0 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.997 0.919 . . . . 0.0 110.111 -178.457 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.39 109.68 2.66 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.632 1.573 . . . . 0.0 111.765 -177.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -86.09 139.28 31.27 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.989 171.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.517 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 28.1 t30 -78.21 88.99 4.27 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.073 0.851 . . . . 0.0 112.127 168.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.9 mp -76.76 69.08 3.08 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 171.193 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -153.66 137.26 15.99 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 168.513 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.1 t -80.14 36.1 0.34 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.369 0.531 . . . . 0.0 110.754 178.083 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.8 p -149.91 155.47 37.98 Favored Pre-proline 0 C--O 1.237 0.395 0 C-N-CA 126.63 1.972 . . . . 0.0 106.995 174.307 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -63.23 148.14 93.3 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 N-CA-C 108.208 -1.497 . . . . 0.0 108.208 168.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.01 175.06 6.53 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.792 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.0 m -105.65 145.25 31.28 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.121 1.768 . . . . 0.0 106.875 175.39 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -133.65 126.14 4.2 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 107.096 -2.401 . . . . 0.0 107.096 172.494 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.18 54.77 0.12 Allowed 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 166.78 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.44 144.83 15.9 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.884 176.162 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.3 t -85.01 166.08 17.02 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 168.185 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -146.41 95.96 2.69 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -168.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.33 86.92 5.02 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 175.509 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.0 t -78.12 60.23 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.817 1.247 . . . . 0.0 108.776 -175.034 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.1 t -171.44 148.34 2.3 Favored Pre-proline 0 CA--C 1.522 -0.129 0 O-C-N 121.481 -0.762 . . . . 0.0 111.636 178.077 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -61.57 -41.26 40.99 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 121.758 1.639 . . . . 0.0 110.068 159.031 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.3 ptp 172.08 -77.72 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 127.124 2.17 . . . . 0.0 107.59 178.399 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.87 -29.87 63.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.634 1.174 . . . . 0.0 112.292 -170.287 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.9 -119.11 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -174.028 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.89 -50.56 2.25 Favored Glycine 0 CA--C 1.528 0.874 0 O-C-N 121.348 -0.845 . . . . 0.0 113.192 178.204 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -44.93 -54.54 6.38 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.159 0.984 . . . . 0.0 110.014 171.555 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -75.39 -4.26 38.41 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.508 1.923 . . . . 0.0 113.96 -179.053 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -69.37 133.55 47.95 Favored 'General case' 0 C--N 1.341 0.227 0 O-C-N 121.093 -1.004 . . . . 0.0 108.486 178.449 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -75.8 85.66 2.79 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.684 177.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -54.57 123.11 12.11 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 166.228 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.2 t -58.71 126.27 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -177.572 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -82.31 48.47 1.28 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.87 0.868 . . . . 0.0 110.001 -169.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 44.2 t -167.13 143.11 4.28 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.58 1.552 . . . . 0.0 108.589 -173.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -75.96 72.57 2.83 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.914 0.485 . . . . 0.0 110.278 -178.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 26.9 p -135.17 53.03 2.0 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 124.904 1.282 . . . . 0.0 109.355 178.625 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -155.17 145.54 22.0 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -170.753 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 47.0 m 58.99 88.14 0.07 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.876 1.67 . . . . 0.0 112.17 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -53.9 154.34 4.1 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.568 1.147 . . . . 0.0 111.7 176.414 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.7 t -111.52 -57.68 2.22 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 128.711 2.804 . . . . 0.0 111.378 -167.6 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.8 t -163.65 140.34 6.97 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 122.849 0.46 . . . . 0.0 110.385 -170.845 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.661 HD11 ' HB2' ' A' ' 114' ' ' MET . 39.7 mt -139.32 143.73 37.96 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.207 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.444 ' HB3' ' HD2' ' A' ' 110' ' ' PRO . 2.8 mt-10 -80.44 172.95 8.53 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.76 1.224 . . . . 0.0 109.349 -179.48 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 109' ' ' GLU . 35.2 Cg_endo -68.0 79.89 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.535 2.823 . . . . 0.0 114.465 -162.041 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 147.87 -29.89 1.39 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.307 0.956 . . . . 0.0 112.181 172.107 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -82.21 158.56 23.51 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 118.226 -1.39 . . . . 0.0 112.318 -139.61 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -84.61 123.26 30.13 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 124.64 1.176 . . . . 0.0 110.268 179.59 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.661 ' HB2' HD11 ' A' ' 108' ' ' LEU . 0.9 OUTLIER -90.22 128.61 36.42 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 154.89 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -134.0 146.42 50.4 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 159.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 56.7 mtt -146.61 146.63 27.59 Favored Pre-proline 0 N--CA 1.453 -0.323 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 165.087 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -71.55 142.58 40.61 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 122.101 1.868 . . . . 0.0 109.412 160.232 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.4 t -115.77 143.83 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 164.026 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.0 p -102.28 145.49 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 174.608 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -145.9 138.09 25.36 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.335 0.516 . . . . 0.0 111.425 -176.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.59 ' CD1' HG23 ' A' ' 63' ' ' THR . 5.9 p90 -159.07 162.25 36.56 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.569 1.548 . . . . 0.0 107.43 160.559 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 94.8 t -104.72 131.27 54.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 174.789 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.18 135.23 47.85 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 175.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -75.49 57.85 5.0 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 124.578 3.519 . . . . 0.0 112.673 -176.414 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.24 -36.47 7.63 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 125.57 1.548 . . . . 0.0 109.864 168.3 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.8 tt -47.75 -46.57 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -169.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.3 m -81.19 53.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.448 -0.783 . . . . 0.0 110.785 -178.444 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -138.28 -64.51 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 117.661 -1.161 . . . . 0.0 112.085 -179.371 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.67 156.33 35.64 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 CA-C-N 121.961 1.736 . . . . 0.0 113.406 -176.053 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.2 t -54.11 -39.46 42.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 126.201 1.8 . . . . 0.0 110.742 177.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -45.92 -55.72 6.38 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.697 1.599 . . . . 0.0 111.8 -178.523 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.3 p -92.37 -42.89 9.53 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 118.633 -0.699 . . . . 0.0 111.442 -176.313 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 7.93 65.13 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 128.403 2.681 . . . . 0.0 116.129 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 142.37 -41.34 1.2 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -173.709 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.7 mm -57.27 120.13 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 CA-C-N 117.689 0.744 . . . . 0.0 110.178 177.23 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -157.38 66.45 0.5 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.672 0.749 . . . . 0.0 110.173 162.578 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 10.6 m -147.51 102.72 3.48 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 152.206 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.68 151.76 34.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -175.243 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.7 t -154.08 175.13 13.79 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.408 0.623 . . . . 0.0 109.647 -177.269 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.9 tp -153.7 97.13 2.07 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 103.216 -2.883 . . . . 0.0 103.216 -169.278 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.5 t -81.78 88.09 6.32 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 171.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.79 124.4 27.64 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 176.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.423 HG22 ' CD1' ' A' ' 145' ' ' TYR . 23.8 m -133.38 95.52 3.53 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.412 1.101 . . . . 0.0 109.229 -164.468 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -74.22 74.42 1.8 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.041 1.736 . . . . 0.0 111.94 -171.007 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.423 ' CD1' HG22 ' A' ' 143' ' ' THR . 38.8 m-85 -128.35 68.48 77.23 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.349 1.06 . . . . 0.0 113.758 179.566 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -87.69 -103.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.775 2.983 . . . . 0.0 110.666 167.502 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -156.26 99.66 1.94 Allowed 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.8 1.24 . . . . 0.0 108.907 -172.117 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -104.56 134.0 19.89 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 126.432 1.893 . . . . 0.0 106.403 167.614 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.0 -47.3 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.445 2.097 . . . . 0.0 110.638 178.304 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.2 t 166.65 112.4 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 129.202 3.001 . . . . 0.0 104.822 178.486 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.7 pttt . . . . . 0 CA--C 1.535 0.4 0 CA-C-N 119.584 1.083 . . . . 0.0 110.409 -168.921 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 94.8 t . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 67.49 -148.04 0.15 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.992 0.917 . . . . 0.0 110.907 -178.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.507 ' NE2' ' H ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -71.7 98.95 2.02 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 125.127 1.371 . . . . 0.0 108.878 -170.483 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.43 59.46 2.96 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 122.711 1.244 . . . . 0.0 111.04 -152.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.4 p -76.49 1.66 15.93 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 128.075 2.55 . . . . 0.0 114.58 -164.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -78.56 -21.38 48.78 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 164.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.6 mt -115.32 -26.73 7.48 Favored 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 125.43 1.492 . . . . 0.0 113.134 -171.204 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.7 mt -40.55 -72.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.966 1.706 . . . . 0.0 115.389 -170.555 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.461 HD23 ' N ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER 64.99 167.55 0.18 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 127.449 2.3 . . . . 0.0 113.096 -176.036 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -76.57 57.82 1.28 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.521 1.528 . . . . 0.0 111.537 -177.394 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.53 ' HB3' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -134.04 170.74 15.19 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 126.111 1.764 . . . . 0.0 107.041 173.525 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -150.38 111.61 4.4 Favored 'General case' 0 N--CA 1.422 -1.855 0 C-N-CA 124.462 1.105 . . . . 0.0 109.217 177.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.9 tt -93.26 144.34 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 174.018 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.73 152.18 20.39 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 125.83 1.652 . . . . 0.0 109.033 177.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.6 t -136.95 144.24 32.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 175.54 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.6 m -136.19 94.3 3.02 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -171.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -75.04 163.85 27.16 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -175.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -142.44 85.34 1.9 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 122.217 1.008 . . . . 0.0 109.406 -178.727 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.457 ' HB1' ' CE2' ' A' ' 49' ' ' PHE . . . -89.57 102.79 15.47 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 121.586 -0.696 . . . . 0.0 110.25 -179.614 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -95.46 168.32 10.78 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 123.432 0.693 . . . . 0.0 109.616 177.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.4 t -134.49 151.82 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 167.802 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.65 153.58 47.34 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 166.446 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.46 -35.89 13.89 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.856 0.862 . . . . 0.0 112.358 -174.643 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -37.19 -41.54 0.71 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.71 1.624 . . . . 0.0 113.511 172.111 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.642 HD21 ' CE3' ' A' ' 47' ' ' TRP . 3.9 tt -116.67 107.72 46.1 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 118.187 0.993 . . . . 0.0 108.388 175.023 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -78.35 21.1 0.71 Allowed 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.006 1.804 . . . . 0.0 114.92 -161.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.642 ' CE3' HD21 ' A' ' 45' ' ' LEU . 50.0 m0 -101.39 147.73 25.99 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.435 1.016 . . . . 0.0 113.212 -160.83 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -78.31 88.95 4.33 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 176.116 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.457 ' CE2' ' HB1' ' A' ' 39' ' ' ALA . 11.2 t80 -90.93 126.27 36.01 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 123.774 0.83 . . . . 0.0 109.053 -179.786 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.1 t -118.24 107.66 43.15 Favored Pre-proline 0 N--CA 1.439 -1.0 0 C-N-CA 125.73 1.612 . . . . 0.0 107.69 -167.324 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -66.14 128.59 19.86 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 122.773 2.316 . . . . 0.0 107.096 165.077 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.9 m -77.27 -36.84 24.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.125 0.488 . . . . 0.0 111.068 -174.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.77 171.11 15.25 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 158.726 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -76.17 -48.87 18.92 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 119.379 -0.928 . . . . 0.0 108.891 172.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -136.67 155.54 49.75 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 125.661 1.584 . . . . 0.0 111.251 -161.528 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.1 pt -135.52 172.92 15.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 125.723 1.609 . . . . 0.0 108.733 -179.454 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -122.21 143.67 49.44 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 126.251 1.82 . . . . 0.0 109.074 162.351 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.6 m -128.97 129.67 68.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 C-N-CA 125.378 1.471 . . . . 0.0 107.408 167.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.22 76.75 0.36 Allowed 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 166.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.53 HD11 ' HB3' ' A' ' 31' ' ' GLU . 0.4 OUTLIER 9.06 59.85 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 129.393 3.077 . . . . 0.0 115.513 -172.868 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.65 -35.58 1.4 Allowed Glycine 0 C--N 1.335 0.503 0 O-C-N 121.427 -0.796 . . . . 0.0 111.898 -172.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -55.69 129.88 40.99 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 170.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.3 136.93 32.74 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 122.977 0.511 . . . . 0.0 112.345 -177.415 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.2 p -120.33 153.7 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 123.756 0.823 . . . . 0.0 109.108 168.115 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.88 116.51 32.42 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.254 1.821 . . . . 0.0 107.467 173.501 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.4 pp -122.18 119.37 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 168.07 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.425 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 85.2 mtp -76.57 166.26 23.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.693 170.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -130.25 149.8 51.78 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 160.78 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -134.08 132.56 40.1 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 124.121 0.888 . . . . 0.0 109.326 173.876 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.36 165.24 14.1 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 127.659 2.383 . . . . 0.0 106.942 167.208 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.6 mttt -154.02 133.88 13.06 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 119.226 0.921 . . . . 0.0 110.183 174.262 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.525 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 49.3 t30 -84.97 84.78 7.6 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.774 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.7 mp -83.32 63.66 7.37 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.707 167.417 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.26 163.96 25.6 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 165.211 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.7 m -93.95 20.11 8.2 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 123.063 0.227 . . . . 0.0 110.621 176.193 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.3 p -146.16 160.91 41.39 Favored Pre-proline 0 N--CA 1.45 -0.463 0 C-N-CA 125.687 1.595 . . . . 0.0 107.656 177.359 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -66.02 159.76 47.73 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 121.13 1.22 . . . . 0.0 108.972 169.534 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.65 174.32 10.63 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 122.44 0.296 . . . . 0.0 110.846 171.244 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -122.85 152.97 40.22 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.877 1.271 . . . . 0.0 108.85 171.035 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -127.68 129.87 6.55 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 108.569 -1.812 . . . . 0.0 108.569 177.336 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.11 40.65 1.49 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.078 0.951 . . . . 0.0 109.147 168.708 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -50.87 145.11 7.55 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.344 1.058 . . . . 0.0 111.616 -175.293 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.8 t -82.13 139.52 34.33 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 118.923 -1.111 . . . . 0.0 108.833 176.163 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -114.41 89.93 3.21 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 -175.142 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -78.39 85.38 4.51 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 177.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.3 t -78.36 67.96 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 125.51 1.524 . . . . 0.0 108.055 -178.377 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.6 t -166.68 144.11 4.18 Favored Pre-proline 0 C--N 1.338 0.094 0 O-C-N 121.59 -0.694 . . . . 0.0 112.49 174.106 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -64.31 -39.74 28.44 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 121.613 1.542 . . . . 0.0 109.428 159.09 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.0 ptp 170.7 -70.17 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 128.242 2.617 . . . . 0.0 107.123 178.706 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -90.98 -27.28 18.78 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 124.273 1.029 . . . . 0.0 112.884 -168.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.26 -123.4 0.01 OUTLIER 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.508 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.75 -54.82 2.97 Favored Glycine 0 CA--C 1.527 0.79 0 O-C-N 121.654 -0.654 . . . . 0.0 112.006 177.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -47.0 -49.48 20.82 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.543 1.172 . . . . 0.0 111.273 174.185 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -72.03 -16.25 62.05 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.445 1.098 . . . . 0.0 113.181 179.398 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -61.61 124.38 20.52 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -178.166 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -79.43 78.64 5.94 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.889 0.852 . . . . 0.0 111.43 -173.515 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -55.75 146.82 20.23 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.837 1.255 . . . . 0.0 110.75 167.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.4 p -153.72 158.36 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 173.001 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -156.33 151.51 26.49 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 -174.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 31.9 p -87.08 -56.69 3.26 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 123.32 0.387 . . . . 0.0 110.574 172.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -171.83 98.02 0.17 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.749 1.219 . . . . 0.0 108.072 179.603 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 45.5 t 59.61 89.54 0.06 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.054 1.341 . . . . 0.0 112.576 176.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 62.23 -169.7 0.18 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.237 0.615 . . . . 0.0 111.532 176.611 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.8 t -149.72 48.32 0.94 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 122.603 1.192 . . . . 0.0 108.407 163.194 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -138.91 -55.27 0.6 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.062 1.345 . . . . 0.0 107.411 175.598 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.483 HG23 ' H ' ' A' ' 107' ' ' THR 0.317 11.1 t 48.05 -81.43 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 127.713 2.405 . . . . 0.0 114.633 168.728 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.483 ' H ' HG23 ' A' ' 106' ' ' THR . 0.6 OUTLIER -158.95 149.35 19.61 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.082 1.353 . . . . 0.0 109.268 -178.564 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.0 mt -143.82 155.5 44.16 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 124.01 0.924 . . . . 0.0 108.835 174.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -94.72 166.55 14.89 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 125.468 1.507 . . . . 0.0 108.5 174.055 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.71 98.18 1.03 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.839 2.359 . . . . 0.0 111.67 -167.611 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.69 -24.57 2.46 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 123.551 0.596 . . . . 0.0 111.723 178.821 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -79.19 127.83 32.53 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 117.85 0.825 . . . . 0.0 111.826 -155.566 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -78.68 136.79 37.54 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 165.619 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 13.7 tpt -130.2 122.62 28.48 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 126.853 2.061 . . . . 0.0 107.863 -169.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -153.24 156.85 39.26 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 120.344 1.429 . . . . 0.0 112.299 177.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 6.2 ttt -155.07 142.38 13.8 Favored Pre-proline 0 N--CA 1.441 -0.898 0 C-N-CA 125.383 1.473 . . . . 0.0 107.149 -177.251 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 67' ' ' MET . 93.5 Cg_endo -74.31 144.78 33.4 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.642 2.894 . . . . 0.0 111.565 165.519 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.9 t -123.09 128.73 75.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 168.598 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.3 p -91.05 141.22 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 170.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -147.23 143.97 28.54 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.413 0.551 . . . . 0.0 111.617 -176.108 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -168.91 120.62 0.76 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 128.322 2.649 . . . . 0.0 106.731 175.295 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.8 p -82.49 146.66 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 119.698 1.136 . . . . 0.0 109.825 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -72.16 139.05 81.82 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 118.117 0.417 . . . . 0.0 110.064 176.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -76.55 61.13 6.76 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.404 2.736 . . . . 0.0 111.547 173.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . 0.253 9.8 pt-20 -135.17 -4.87 2.37 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 169.739 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -48.28 -42.99 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 119.201 0.91 . . . . 0.0 111.677 174.525 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.2 m -76.51 63.81 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 123.306 0.642 . . . . 0.0 110.413 174.406 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -123.06 -70.94 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 124.795 1.238 . . . . 0.0 111.181 170.468 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.53 156.65 36.34 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.161 1.907 . . . . 0.0 113.354 -169.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 84.3 t -54.16 -36.17 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.76 1.624 . . . . 0.0 110.057 176.278 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -47.46 -48.06 26.86 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.956 1.702 . . . . 0.0 112.024 176.144 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 22.3 p -93.55 -57.63 2.52 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -173.289 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 18.23 54.5 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 129.532 3.133 . . . . 0.0 115.529 176.063 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 146.2 -36.49 1.29 Allowed Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 -170.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 23.5 mm -57.52 132.72 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 172.486 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -158.8 53.57 0.42 Allowed 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 123.619 0.574 . . . . 0.0 110.277 161.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.6 p -149.77 98.51 2.75 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 176.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.2 mp -77.95 152.58 33.11 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.446 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.5 t -142.34 176.66 8.82 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 125.58 1.552 . . . . 0.0 107.236 170.473 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.2 tt -150.43 101.06 2.93 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 175.527 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.3 t -84.26 89.23 7.3 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.319 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.11 120.07 23.13 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 179.21 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.6 m -132.7 106.35 7.72 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.787 1.235 . . . . 0.0 108.553 -165.44 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.445 ' CD2' HD13 ' A' ' 45' ' ' LEU . 4.8 m-30 -90.19 96.57 10.73 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.868 1.267 . . . . 0.0 112.85 -160.359 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -138.49 76.64 36.18 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 178.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -91.53 -121.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.055 1 C-N-CA 125.94 4.427 . . . . 0.0 108.169 163.631 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.2 mmp_? -134.1 138.33 45.19 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.448 1.899 . . . . 0.0 107.132 179.142 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.93 114.88 55.87 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 174.671 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.63 -27.04 6.49 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.949 2.432 . . . . 0.0 112.272 -179.322 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.8 m 145.41 112.93 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 129.481 3.112 . . . . 0.0 109.086 -175.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.544 0.737 0 C-N-CA 125.012 1.325 . . . . 0.0 114.198 171.85 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.482 HG22 ' H ' ' A' ' 22' ' ' GLU . 8.2 p . . . . . 0 CA--C 1.54 0.588 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.482 ' H ' HG22 ' A' ' 21' ' ' VAL . 24.5 tt0 -70.89 85.43 0.68 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.425 1.012 . . . . 0.0 110.113 -179.983 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 109.46 117.6 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.391 1 C-N-CA 133.055 4.542 . . . . 0.0 102.798 -170.143 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.39 -56.85 6.28 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 115.029 -2.668 . . . . 0.0 111.544 -135.26 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.8 t -169.55 -146.45 0.05 Allowed 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 149.373 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -78.97 38.7 0.35 Allowed 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 130.01 3.324 . . . . 0.0 108.808 -178.547 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.4 mt -111.07 -21.29 12.04 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 127.969 2.508 . . . . 0.0 109.458 -170.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 27.6 mt -62.94 104.13 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 123.581 0.752 . . . . 0.0 111.839 -169.093 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.57 -150.87 0.17 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.889 0.876 . . . . 0.0 109.955 175.274 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -89.29 -37.41 14.94 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 129.237 3.015 . . . . 0.0 111.236 179.894 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -51.73 153.5 2.4 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.974 1.31 . . . . 0.0 113.493 -173.807 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -123.83 88.8 2.97 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 -176.951 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.19 131.93 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 125.19 1.396 . . . . 0.0 107.357 -179.538 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.6 ' HE3' ' HB2' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -97.48 152.94 18.48 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.348 1.059 . . . . 0.0 109.365 -168.906 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.416 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 65.4 t -131.27 132.59 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 174.758 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.7 m -110.54 112.4 24.29 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 173.009 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -81.56 86.21 6.4 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.642 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -88.27 84.49 6.86 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 122.241 1.02 . . . . 0.0 109.164 -173.781 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.3 105.23 17.21 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.361 0.664 . . . . 0.0 109.527 179.385 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -105.56 114.48 28.68 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.101 0.961 . . . . 0.0 108.828 -177.145 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.1 p -98.72 107.73 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 123.896 0.878 . . . . 0.0 109.865 176.623 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.06 155.59 19.37 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 167.565 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.25 -39.44 9.92 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.366 1.067 . . . . 0.0 111.741 178.47 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -40.18 -33.19 0.47 Allowed Glycine 0 CA--C 1.529 0.951 0 C-N-CA 126.144 1.83 . . . . 0.0 114.499 173.236 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.433 HD21 ' CE3' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -111.6 98.88 42.63 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 119.753 1.777 . . . . 0.0 108.523 168.312 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -83.86 45.53 1.81 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 124.057 3.171 . . . . 0.0 110.742 -167.533 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.534 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 44.7 m0 -115.69 145.92 42.32 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.571 1.148 . . . . 0.0 108.08 -172.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -76.4 82.58 3.14 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 175.782 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.99 116.26 31.62 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.736 1.214 . . . . 0.0 108.306 -172.718 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.3 m -129.52 147.48 65.39 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 118.233 0.469 . . . . 0.0 110.704 -173.276 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.89 160.53 47.53 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.264 1.976 . . . . 0.0 108.657 165.543 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -78.62 -59.44 3.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 -174.695 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -121.88 158.97 27.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 103.596 -2.742 . . . . 0.0 103.596 157.859 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -54.42 -38.73 66.59 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-O 120.943 0.401 . . . . 0.0 110.074 176.348 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.6 ' HB2' ' HE3' ' A' ' 34' ' ' LYS . 9.6 p-10 -153.3 163.12 40.47 Favored 'General case' 0 N--CA 1.424 -1.756 0 C-N-CA 126.423 1.889 . . . . 0.0 107.681 -166.739 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.6 pt -138.46 163.89 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 124.466 1.106 . . . . 0.0 108.205 170.256 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -106.93 133.05 52.16 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 104.535 -2.395 . . . . 0.0 104.535 165.415 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.2 m -119.57 129.06 75.8 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 172.704 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.5 mmm180 -76.21 74.88 3.04 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.203 -0.936 . . . . 0.0 108.702 175.281 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.0 mm 55.21 -95.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.911 1.284 . . . . 0.0 109.052 -173.613 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -97.51 30.52 9.08 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 124.559 1.076 . . . . 0.0 112.778 -169.455 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -83.63 95.79 8.47 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.949 1.7 . . . . 0.0 108.315 -177.195 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.11 89.68 0.13 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.831 1.253 . . . . 0.0 110.938 179.666 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.9 t -80.85 139.45 18.09 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.084 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 173.853 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.55 120.22 31.45 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 168.792 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.62 103.67 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.921 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 52.9 ttm -79.3 118.33 21.13 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.716 1.206 . . . . 0.0 111.81 -177.513 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -88.46 153.86 20.82 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.72 0.808 . . . . 0.0 110.462 175.841 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -125.82 133.76 51.89 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 124.317 1.047 . . . . 0.0 110.049 177.613 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -134.34 154.79 51.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 127.389 2.276 . . . . 0.0 107.104 158.213 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -157.54 136.1 11.31 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 104.937 -2.245 . . . . 0.0 104.937 175.884 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.534 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 59.6 t-20 -79.98 125.66 30.05 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.926 1.239 . . . . 0.0 111.807 -176.441 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.16 3.29 19.99 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.15 1.38 . . . . 0.0 112.27 -177.338 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.18 166.13 22.54 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.241 -0.912 . . . . 0.0 111.176 177.706 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.3 m -87.72 -8.77 55.63 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.988 0.915 . . . . 0.0 112.299 179.797 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.0 165.6 29.68 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 126.64 1.976 . . . . 0.0 106.362 178.409 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -57.41 154.96 32.59 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.949 1.766 . . . . 0.0 111.409 -177.19 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.34 164.59 20.06 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.42 0.629 . . . . 0.0 111.311 165.215 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.4 t -99.66 158.72 15.57 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 164.138 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.74 69.55 0.25 Allowed Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 107.973 -2.051 . . . . 0.0 107.973 -172.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -99.87 -58.82 1.83 Allowed 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.311 1.444 . . . . 0.0 108.546 178.863 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 64.33 -178.53 0.17 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.219 0.608 . . . . 0.0 111.62 178.146 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.0 m -136.61 134.93 37.89 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 168.588 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -114.83 170.82 8.05 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 126.197 1.799 . . . . 0.0 109.984 -173.06 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -131.4 107.97 9.29 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.927 1.291 . . . . 0.0 107.585 166.843 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.689 HG22 HD13 ' A' ' 140' ' ' LEU . 39.6 t -90.42 74.11 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.692 1.597 . . . . 0.0 108.569 179.655 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.8 t 177.15 148.27 0.32 Allowed Pre-proline 0 N--CA 1.466 0.366 0 C-N-CA 124.831 1.253 . . . . 0.0 110.776 177.88 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -65.33 -38.25 27.43 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 121.496 1.464 . . . . 0.0 110.482 159.539 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 11.1 ptp 171.55 -72.91 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 127.318 2.247 . . . . 0.0 107.547 175.225 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.58 -36.57 73.67 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.902 0.881 . . . . 0.0 112.908 -166.087 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.49 -105.94 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.302 0.241 . . . . 0.0 110.964 -173.863 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.86 -56.38 1.76 Allowed Glycine 0 CA--C 1.527 0.841 0 O-C-N 121.601 -0.687 . . . . 0.0 112.841 -176.287 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.5 -53.75 10.64 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.442 1.097 . . . . 0.0 111.476 -179.738 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -72.5 -8.44 55.12 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.332 1.453 . . . . 0.0 113.17 -178.128 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -64.02 117.14 6.63 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.492 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -78.46 74.17 5.01 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.977 0.894 . . . . 0.0 111.584 -165.855 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -56.5 124.22 17.46 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.097 1.359 . . . . 0.0 110.103 179.149 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.1 t -75.57 71.41 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.706 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 62.64 -77.47 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.156 1.782 . . . . 0.0 111.218 -177.465 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 15.4 t -179.65 -63.69 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 125.869 1.668 . . . . 0.0 108.327 -175.741 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -78.28 59.74 2.37 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.661 1.184 . . . . 0.0 110.997 -173.96 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 9.9 t -118.84 -65.26 1.19 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.226 1.41 . . . . 0.0 108.243 175.929 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.46 -51.18 70.5 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.184 0.594 . . . . 0.0 110.529 177.731 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 51.0 46.16 26.79 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.876 1.67 . . . . 0.0 115.384 165.039 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -71.7 153.13 42.24 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 118.62 -1.232 . . . . 0.0 108.384 157.854 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.7 t -161.61 -71.54 0.06 Allowed 'General case' 0 C--O 1.23 0.078 0 O-C-N 121.605 -0.684 . . . . 0.0 111.477 -179.557 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.2 t -159.24 149.68 19.38 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.878 1.271 . . . . 0.0 107.783 -174.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.3 mt -155.28 145.59 21.9 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.513 0.725 . . . . 0.0 110.044 175.501 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -70.23 174.21 3.57 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 124.554 1.142 . . . . 0.0 110.966 168.488 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.08 97.78 1.08 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.934 3.089 . . . . 0.0 111.045 -171.284 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 125.16 -7.93 8.04 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-O 119.489 -0.617 . . . . 0.0 111.693 176.09 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -76.65 170.56 16.2 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 117.794 0.797 . . . . 0.0 111.114 -171.762 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.54 143.82 45.13 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.828 1.651 . . . . 0.0 110.125 -167.329 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 7.6 mtt -139.81 81.84 1.84 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.652 1.581 . . . . 0.0 109.3 170.289 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -103.98 118.79 37.51 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 120.845 -1.159 . . . . 0.0 108.014 169.729 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 77.2 mtp -141.23 140.68 21.38 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 118.816 0.734 . . . . 0.0 112.053 -174.384 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.72 140.61 32.65 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 123.06 2.506 . . . . 0.0 110.277 175.709 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 69.5 t -116.57 151.42 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 161.118 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.1 p -118.21 139.23 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 167.409 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -153.22 157.94 40.98 Favored 'General case' 0 N--CA 1.458 -0.062 0 CA-C-N 119.562 1.074 . . . . 0.0 113.189 -177.336 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -179.1 174.63 1.04 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 128.979 2.911 . . . . 0.0 106.168 -169.176 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 67.2 t -135.5 133.65 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 119.143 0.883 . . . . 0.0 110.862 178.583 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -76.66 138.16 66.7 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.945 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -71.01 -3.61 13.19 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.024 2.483 . . . . 0.0 111.799 -179.28 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.407 ' OE1' ' NZ ' ' A' ' 128' ' ' LYS . 13.8 mm-40 -36.0 -41.61 0.25 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.427 1.091 . . . . 0.0 111.313 159.484 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -58.23 -30.79 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 123.79 0.836 . . . . 0.0 113.063 -178.546 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.4 m -101.24 17.73 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.583 0.753 . . . . 0.0 111.816 175.897 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.407 ' NZ ' ' OE1' ' A' ' 125' ' ' GLU 0.354 6.3 pttt -79.83 -42.2 1.47 Allowed Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 170.927 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -86.95 -175.71 1.7 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.08 2.52 . . . . 0.0 110.981 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 94.7 t -80.71 -54.2 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 123.751 0.82 . . . . 0.0 109.684 173.099 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -46.11 -57.8 4.17 Favored 'General case' 0 N--CA 1.46 0.064 0 C-N-CA 124.848 1.259 . . . . 0.0 112.796 -169.067 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.7 p -82.95 -3.99 57.72 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 118.378 -0.82 . . . . 0.0 112.783 -175.608 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -47.49 -42.69 23.42 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.802 1.183 . . . . 0.0 112.814 -172.516 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.18 -25.03 76.19 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 122.858 0.266 . . . . 0.0 113.223 -179.205 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 25.6 mm -74.51 130.51 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 117.935 0.868 . . . . 0.0 110.734 -174.805 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.3 pttt -156.26 42.6 0.39 Allowed 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.213 164.666 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.1 p -134.05 84.28 2.1 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 106.536 -1.654 . . . . 0.0 106.536 170.965 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.8 tp -87.95 87.24 7.29 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -163.93 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.6 t -96.31 143.87 26.99 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.262 -166.292 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.689 HD13 HG22 ' A' ' 86' ' ' VAL . 4.4 tp -112.71 111.34 22.07 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 168.025 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.4 p -88.72 96.88 10.84 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 168.831 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.56 128.91 35.02 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 170.002 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.8 m -129.64 93.78 3.61 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.895 0.855 . . . . 0.0 109.482 -174.677 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -78.96 91.72 4.85 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.5 1.12 . . . . 0.0 111.121 -171.043 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.73 53.26 9.81 Favored Pre-proline 0 CA--C 1.549 0.923 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 179.542 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.66 -94.56 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.16 2.573 . . . . 0.0 111.27 175.78 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -157.43 140.43 15.21 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 118.089 -0.958 . . . . 0.0 109.164 178.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -109.91 150.61 41.62 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 165.187 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -74.64 -59.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.284 1.99 . . . . 0.0 109.224 169.919 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 37.1 p 179.32 94.41 0.02 OUTLIER 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.614 1.565 . . . . 0.0 107.922 -179.26 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 19.1 pttp . . . . . 0 CA--C 1.539 0.533 0 CA-C-N 118.281 0.491 . . . . 0.0 109.874 -178.968 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 CA--C 1.541 0.612 0 CA-C-O 120.588 0.232 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 45.31 39.4 4.28 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.214 1.406 . . . . 0.0 111.563 -169.725 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 164.69 62.52 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 129.963 3.305 . . . . 0.0 104.063 -175.151 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.79 73.29 6.53 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.218 -169.536 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 79.0 p -109.38 62.13 0.6 Allowed 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 127.231 2.212 . . . . 0.0 110.735 -157.095 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -155.63 -60.33 0.11 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 102.887 -3.005 . . . . 0.0 102.887 172.384 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.744 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.2 pt? -68.8 27.76 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 128.238 2.615 . . . . 0.0 114.316 177.22 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.5 mt -97.14 60.07 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.265 0 O-C-N 120.472 -1.393 . . . . 0.0 107.823 173.377 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.21 -179.43 2.86 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.607 -167.747 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -75.39 56.83 0.87 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.521 1.128 . . . . 0.0 110.324 177.306 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.94 145.26 41.82 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.833 1.653 . . . . 0.0 106.751 176.754 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -131.43 127.59 37.77 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.235 2.214 . . . . 0.0 105.292 -169.727 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.567 HG23 HG23 ' A' ' 58' ' ' VAL . 1.3 tt -140.32 147.79 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 124.56 1.144 . . . . 0.0 108.587 -164.377 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.519 ' CE ' ' HB2' ' A' ' 55' ' ' ASP . 4.0 tmtp? -109.01 151.17 26.7 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.463 1.505 . . . . 0.0 109.782 -164.426 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.416 ' HB ' ' CG1' ' A' ' 56' ' ' ILE . 70.6 t -133.25 137.92 52.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 167.37 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.5 m -122.71 111.84 17.21 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -179.702 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -89.7 85.18 6.38 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 123.016 0.526 . . . . 0.0 110.246 -174.427 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -87.29 81.81 7.8 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 123.063 1.411 . . . . 0.0 110.909 -179.602 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.0 120.82 36.96 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 121.006 -1.059 . . . . 0.0 109.89 -176.597 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -125.8 160.69 29.18 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.259 1.024 . . . . 0.0 108.556 -179.892 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.93 151.25 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.077 0 C-N-CA 123.83 0.852 . . . . 0.0 109.249 -176.905 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.71 175.61 11.43 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.085 0.954 . . . . 0.0 110.437 178.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.51 124.11 6.57 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 170.251 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 127.38 -39.99 1.84 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -165.712 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.479 HD12 ' CD ' ' A' ' 146' ' ' PRO . 0.5 OUTLIER -127.87 87.46 55.69 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 123.652 0.781 . . . . 0.0 110.017 174.169 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -81.72 38.75 0.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 124.356 3.371 . . . . 0.0 110.199 -176.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.465 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 41.3 m0 -110.11 146.77 34.88 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -171.347 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.41 78.34 3.93 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 -175.036 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -95.06 109.76 21.77 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -170.45 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.9 m -111.84 139.83 22.69 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.631 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.05 162.8 36.6 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 N-CA-C 108.444 -1.406 . . . . 0.0 108.444 162.659 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.7 t -78.33 -45.68 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -178.665 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -156.01 175.74 13.56 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 166.476 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -50.54 62.5 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.496 0.589 . . . . 0.0 111.619 171.474 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.519 ' HB2' ' CE ' ' A' ' 34' ' ' LYS . 23.1 p-10 -156.22 161.78 40.24 Favored 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 123.959 0.904 . . . . 0.0 111.482 -164.809 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.416 ' CG1' ' HB ' ' A' ' 35' ' ' VAL . 36.1 pt -129.4 162.06 37.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 169.324 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -116.31 142.6 46.62 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 161.475 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.567 HG23 HG23 ' A' ' 33' ' ' ILE . 29.7 m -131.63 159.15 43.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 126.361 1.865 . . . . 0.0 106.133 175.106 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.3 mtm-85 -100.66 85.42 2.91 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 158.414 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.543 HG23 HG21 ' A' ' 33' ' ' ILE . 6.8 pt 35.87 43.7 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 127.379 2.271 . . . . 0.0 114.549 161.298 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 146.49 -29.81 1.59 Allowed Glycine 0 CA--C 1.525 0.687 0 O-C-N 121.004 -1.06 . . . . 0.0 111.618 -170.88 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -57.6 98.51 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.084 0.954 . . . . 0.0 110.137 173.755 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.411 HG22 ' CD1' ' A' ' 121' ' ' PHE . 0.3 OUTLIER -65.45 107.51 1.69 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.925 2.09 . . . . 0.0 111.558 -176.565 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.95 147.32 12.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 166.56 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.39 128.03 39.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.475 1.91 . . . . 0.0 108.644 172.72 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.7 pp -129.83 111.48 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 167.468 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.84 126.39 36.9 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 123.126 0.571 . . . . 0.0 112.253 178.593 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -89.97 158.31 17.43 Favored 'General case' 0 C--O 1.23 0.062 0 C-N-CA 123.856 0.863 . . . . 0.0 108.709 177.272 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -133.83 129.84 37.07 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.846 1.258 . . . . 0.0 109.09 176.723 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.11 150.14 51.51 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 128.26 2.624 . . . . 0.0 107.131 163.74 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -150.96 129.02 11.79 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 117.365 -1.302 . . . . 0.0 107.7 174.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.465 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 52.8 t-20 -78.79 116.91 19.44 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 120.803 1.638 . . . . 0.0 111.642 -170.6 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.6 mt -117.04 34.43 5.11 Favored 'General case' 0 C--N 1.345 0.379 0 C-N-CA 124.575 1.15 . . . . 0.0 112.028 179.008 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.15 175.95 6.58 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 154.204 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.7 t -95.94 16.53 17.53 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.192 0.597 . . . . 0.0 110.483 172.616 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 p -145.41 154.32 52.97 Favored Pre-proline 0 N--CA 1.45 -0.46 0 C-N-CA 124.972 1.309 . . . . 0.0 109.025 -176.102 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.14 147.32 78.98 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 N-CA-C 108.132 -1.526 . . . . 0.0 108.132 171.168 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.4 p -119.39 178.93 4.36 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 170.24 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.4 t -124.41 109.45 13.31 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 173.015 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.32 101.59 0.64 Allowed Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 108.527 -1.829 . . . . 0.0 108.527 175.011 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -125.51 47.79 2.15 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 165.711 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.29 -178.84 1.43 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 122.181 0.991 . . . . 0.0 108.541 159.415 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.74 -173.56 4.62 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 178.055 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -144.21 146.47 32.71 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 119.247 0.93 . . . . 0.0 111.778 167.72 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.2 96.19 9.44 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 167.304 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.9 p -85.58 65.74 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 CA-C-N 118.045 0.384 . . . . 0.0 110.603 177.821 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.1 t -164.84 143.88 5.64 Favored Pre-proline 0 C--O 1.233 0.191 0 O-C-N 121.161 -0.962 . . . . 0.0 112.201 -179.497 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.19 -33.29 31.48 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 N-CA-C 108.776 -1.278 . . . . 0.0 108.776 162.907 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 7.8 ptm 175.58 -70.09 0.01 OUTLIER 'General case' 0 C--N 1.343 0.304 0 C-N-CA 126.406 1.883 . . . . 0.0 108.127 -171.161 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -99.72 -19.66 16.65 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.765 1.226 . . . . 0.0 112.743 -161.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.72 -133.24 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 178.892 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.3 -45.42 0.35 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.137 0.875 . . . . 0.0 114.442 -174.812 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -49.34 -61.02 2.32 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.608 1.204 . . . . 0.0 108.636 167.61 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -75.8 54.34 0.8 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.41 1.884 . . . . 0.0 110.147 171.017 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -110.7 156.89 20.38 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 162.274 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -51.12 -50.26 59.19 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 127.006 2.122 . . . . 0.0 109.676 -175.376 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt 55.12 44.41 27.93 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.884 159.615 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.0 p -60.34 128.36 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.782 -176.288 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -78.6 65.6 3.91 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -178.573 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 32.9 t -158.61 151.79 22.69 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 125.163 1.385 . . . . 0.0 107.601 -175.199 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -71.29 53.08 0.19 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.404 1.482 . . . . 0.0 112.409 -177.788 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 68.6 m -81.54 66.92 7.29 Favored 'General case' 0 C--N 1.334 -0.081 0 C-N-CA 124.221 1.008 . . . . 0.0 108.571 -179.132 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 64.0 t80 116.05 117.09 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 129.587 3.155 . . . . 0.0 107.812 -172.108 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 91.3 m -152.19 87.97 1.35 Allowed 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 174.577 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -53.22 -28.77 28.69 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.935 1.694 . . . . 0.0 114.408 -173.364 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.8 t 52.14 -146.79 0.48 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.681 1.192 . . . . 0.0 112.231 170.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.55 122.66 45.33 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.058 1.743 . . . . 0.0 107.095 177.111 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.41 ' HB2' ' CH2' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -116.35 129.38 56.22 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.904 1.681 . . . . 0.0 108.615 -170.203 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -77.49 152.42 81.04 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 123.462 0.705 . . . . 0.0 111.673 -177.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.75 110.71 2.83 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.457 2.771 . . . . 0.0 112.111 -167.645 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 126.0 -31.68 4.02 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 108.27 -1.932 . . . . 0.0 108.27 -176.658 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -86.32 171.29 11.32 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 121.363 0.601 . . . . 0.0 112.206 -161.173 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.08 145.5 41.52 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.237 1.815 . . . . 0.0 110.649 -163.081 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.62 86.92 2.14 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.163 1.785 . . . . 0.0 107.678 166.015 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -125.28 129.42 49.97 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 121.633 -0.667 . . . . 0.0 110.731 169.774 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 81.5 mtp -153.94 146.4 17.42 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 122.938 0.495 . . . . 0.0 111.054 -170.364 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -66.93 137.29 44.36 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.608 2.872 . . . . 0.0 112.105 172.561 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 34.5 t -116.59 155.96 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 161.674 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.0 m -121.27 151.76 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 176.09 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -151.42 139.29 19.91 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 119.18 -0.438 . . . . 0.0 110.477 -171.021 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.411 ' CD1' HG22 ' A' ' 63' ' ' THR . 8.3 p90 -172.71 86.55 0.07 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.628 1.171 . . . . 0.0 110.462 -174.293 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.478 ' H ' HG21 ' A' ' 58' ' ' VAL . 41.5 t -49.72 143.1 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -166.1 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.33 123.74 84.44 Favored Pre-proline 0 CA--C 1.537 0.478 0 O-C-N 121.308 -0.87 . . . . 0.0 110.821 -174.454 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.409 ' CD ' HD12 ' A' ' 27' ' ' LEU . 34.6 Cg_endo -73.9 32.59 0.33 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.12 2.547 . . . . 0.0 113.483 177.339 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -87.28 -24.27 24.4 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.529 1.532 . . . . 0.0 108.67 160.585 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -46.46 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 C-N-CA 123.098 0.559 . . . . 0.0 111.576 -172.209 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.8 m -79.31 61.5 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 O-C-N 121.691 -0.63 . . . . 0.0 110.401 177.063 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -137.39 -65.01 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.597 0 CA-C-O 117.845 -1.074 . . . . 0.0 112.344 173.899 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.5 159.57 28.85 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 122.119 1.879 . . . . 0.0 113.917 -173.128 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 86.7 t -54.71 -35.94 34.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 126.024 1.73 . . . . 0.0 110.981 177.271 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -36.82 -55.95 0.87 Allowed 'General case' 0 C--N 1.34 0.157 0 C-N-CA 126.089 1.756 . . . . 0.0 111.817 175.27 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.0 p -105.9 -50.26 3.22 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 124.192 0.997 . . . . 0.0 109.826 -163.667 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 22.02 57.44 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 128.425 2.69 . . . . 0.0 115.508 173.501 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 135.26 -30.48 2.8 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 -177.298 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 13.0 mm -53.5 138.62 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-N 117.828 0.814 . . . . 0.0 109.274 173.691 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.8 pttt -158.87 54.96 0.42 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.571 0.701 . . . . 0.0 111.056 165.181 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.93 90.24 2.37 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -178.223 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.3 mp -76.44 85.57 3.17 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.089 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.2 m -77.3 107.25 9.57 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 176.527 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.2 tt -76.79 137.23 39.13 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 160.583 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 27.9 t -135.61 142.7 45.29 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 160.791 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -159.36 169.76 23.29 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 155.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 38.4 m -113.7 103.55 11.33 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 127.437 2.295 . . . . 0.0 108.333 173.366 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -71.12 100.2 2.0 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 172.367 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.07 50.47 0.69 Allowed Pre-proline 0 CA--C 1.553 1.072 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 -176.325 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.479 ' CD ' HD12 ' A' ' 45' ' ' LEU . 59.2 Cg_endo -75.9 -82.27 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.504 2.803 . . . . 0.0 113.991 -175.886 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 74.0 mtt85 -149.74 106.77 3.57 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.41 1.005 . . . . 0.0 112.019 -164.655 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -156.49 135.63 7.95 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 126.043 1.737 . . . . 0.0 106.932 169.792 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.13 -53.59 0.3 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.139 1.893 . . . . 0.0 112.609 173.473 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.3 p 177.18 109.41 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.67 0.788 . . . . 0.0 110.493 -166.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 55.9 pttt . . . . . 0 CA--C 1.537 0.467 0 O-C-N 121.303 -0.873 . . . . 0.0 109.896 -177.859 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.1 t . . . . . 0 CA--C 1.537 0.461 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -73.62 67.11 1.09 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 159.511 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 146.46 154.08 0.0 OUTLIER 'General case' 0 C--N 1.339 0.132 1 C-N-CA 132.349 4.26 . . . . 0.0 108.096 -171.868 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -153.2 28.55 0.51 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 122.025 0.917 . . . . 0.0 110.126 -167.389 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.79 -11.43 59.99 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.529 1.532 . . . . 0.0 114.757 -147.196 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.35 -31.96 64.25 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 173.879 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.1 mp -108.09 14.46 25.11 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.023 1.329 . . . . 0.0 112.074 -176.27 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.4 mt -77.98 77.31 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 120.005 -1.684 . . . . 0.0 108.839 173.641 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.76 179.75 5.93 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.531 0.681 . . . . 0.0 109.893 179.238 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -94.48 59.43 2.51 Favored 'General case' 0 C--N 1.337 0.031 0 C-N-CA 123.827 0.851 . . . . 0.0 112.667 -167.021 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -115.18 160.9 19.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 151.664 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -133.76 88.38 2.47 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -179.898 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.0 tt -94.47 137.91 21.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 C-N-CA 124.477 1.111 . . . . 0.0 111.637 -163.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.441 ' HE2' ' CB ' ' A' ' 55' ' ' ASP . 0.1 OUTLIER -79.71 143.84 34.2 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.635 1.574 . . . . 0.0 109.781 -170.421 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.531 HG21 ' CE1' ' A' ' 120' ' ' PHE . 3.7 t -135.72 142.06 40.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.655 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 164.389 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.9 m -123.29 112.47 17.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 -177.721 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -78.52 89.76 4.48 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 172.864 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -78.23 85.25 4.4 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 118.492 -1.283 . . . . 0.0 108.395 178.576 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.5 115.78 17.54 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.832 174.758 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -122.94 175.54 6.52 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.595 1.158 . . . . 0.0 108.188 167.039 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.6 p -151.17 148.6 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 169.161 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -164.51 171.54 14.45 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.254 1.022 . . . . 0.0 108.869 -178.302 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 60.62 -165.36 0.22 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.354 1.462 . . . . 0.0 111.616 -175.4 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.73 52.98 4.26 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 112.123 -0.391 . . . . 0.0 112.123 -173.079 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.412 ' CD1' ' CD1' ' A' ' 144' ' ' PHE . 1.4 tt -111.7 83.77 4.77 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.122 0.969 . . . . 0.0 108.785 177.693 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -85.28 45.0 1.5 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.246 3.298 . . . . 0.0 109.736 -170.141 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.438 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 43.1 m0 -108.39 138.58 44.43 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -172.909 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.408 ' OE1' ' NZ ' ' A' ' 71' ' ' LYS . 73.2 tt0 -77.85 82.36 4.23 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 -178.503 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -90.26 122.01 32.79 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.715 1.206 . . . . 0.0 108.233 179.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 m -126.67 135.54 27.43 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.144 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -70.76 162.39 42.76 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 N-CA-C 108.146 -1.521 . . . . 0.0 108.146 161.433 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -60.18 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 175.117 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -144.06 154.13 42.91 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 164.773 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.03 -42.72 69.45 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 118.537 -0.744 . . . . 0.0 112.095 -175.964 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.441 ' CB ' ' HE2' ' A' ' 34' ' ' LYS . 23.7 p-10 -145.35 159.69 42.67 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 119.382 0.992 . . . . 0.0 113.189 -166.623 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.8 pt -133.82 159.79 42.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 125.768 1.627 . . . . 0.0 107.847 178.193 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -128.29 85.41 2.34 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.316 1.446 . . . . 0.0 109.124 178.189 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.8 m -80.44 141.83 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 O-C-N 121.255 -0.903 . . . . 0.0 110.689 -171.281 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -78.22 72.16 4.74 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 173.078 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.5 pt 19.01 64.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 127.437 2.295 . . . . 0.0 113.489 176.368 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 139.0 -43.8 1.14 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -172.58 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -59.68 130.3 46.16 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.648 -173.467 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.467 HG23 ' CD1' ' A' ' 121' ' ' PHE . 1.6 m -106.69 87.28 2.49 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.003 -146.106 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.72 144.19 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 CA-C-O 121.094 0.473 . . . . 0.0 110.696 -170.538 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.93 115.54 24.4 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.239 1.016 . . . . 0.0 108.591 168.817 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.8 pp -115.57 115.04 48.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 164.044 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -87.49 155.23 20.09 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.939 -0.475 . . . . 0.0 110.966 178.387 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -127.0 153.78 45.46 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 172.73 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -134.69 141.79 46.64 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.877 1.671 . . . . 0.0 107.898 179.904 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.34 115.58 7.98 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.805 2.042 . . . . 0.0 107.681 174.387 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.408 ' NZ ' ' OE1' ' A' ' 48' ' ' GLU . 3.0 mtmp? -114.73 124.42 51.73 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.29 0.95 . . . . 0.0 110.652 -176.99 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.438 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 46.9 t-20 -80.92 107.2 13.53 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.79 0.723 . . . . 0.0 112.932 -167.583 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.3 mp -99.08 30.4 3.45 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.495 1.118 . . . . 0.0 111.974 176.649 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.85 176.81 9.39 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.021 -1.049 . . . . 0.0 110.401 168.084 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.1 t -114.07 18.1 17.37 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.221 0.608 . . . . 0.0 109.929 161.646 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 p -146.65 156.42 48.61 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 125.639 1.576 . . . . 0.0 107.736 174.405 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -63.23 145.1 93.05 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 N-CA-C 108.122 -1.53 . . . . 0.0 108.122 172.138 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.5 p -123.08 168.25 12.61 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.644 0.735 . . . . 0.0 111.299 178.716 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.8 m -93.63 144.88 24.98 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 168.354 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -168.74 56.9 0.21 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 176.525 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.91 57.78 0.86 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.018 1.727 . . . . 0.0 108.405 -174.374 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.62 166.46 23.52 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.94 0.876 . . . . 0.0 112.879 -168.036 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.48 97.55 8.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 176.512 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -77.23 140.24 40.05 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.544 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -85.76 88.61 7.57 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -172.634 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -76.97 77.91 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 C-N-CA 125.043 1.337 . . . . 0.0 110.435 -176.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.8 t 178.88 147.64 0.39 Allowed Pre-proline 0 N--CA 1.46 0.029 0 C-N-CA 124.932 1.293 . . . . 0.0 109.343 173.324 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -66.75 -35.19 28.86 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.146 1.23 . . . . 0.0 110.274 158.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 10.0 ptp 175.36 -70.78 0.01 OUTLIER 'General case' 0 C--N 1.341 0.206 0 C-N-CA 126.902 2.081 . . . . 0.0 107.571 179.244 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.0 -36.61 48.59 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.962 0.905 . . . . 0.0 113.011 -167.788 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.77 -109.62 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.608 0.242 . . . . 0.0 111.58 -167.732 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.79 -49.69 0.84 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.417 1.008 . . . . 0.0 113.528 -176.111 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.55 -57.52 4.66 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.594 1.197 . . . . 0.0 109.802 172.254 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -73.69 5.01 4.31 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.498 1.919 . . . . 0.0 113.895 -178.898 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -85.72 126.58 34.08 Favored 'General case' 0 C--N 1.344 0.343 0 O-C-N 121.232 -0.918 . . . . 0.0 108.649 174.871 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -72.71 91.0 1.43 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.179 -179.459 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.436 ' H ' ' HD2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -68.77 -20.22 64.35 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.833 1.253 . . . . 0.0 113.24 177.732 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.1 t 37.84 61.61 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 126.75 2.02 . . . . 0.0 111.992 177.464 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.38 68.78 0.36 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.133 1.373 . . . . 0.0 110.301 -177.109 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 17.6 p 177.73 -30.79 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.652 2.381 . . . . 0.0 109.972 -172.629 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -143.43 67.79 1.29 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 176.07 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 14.2 p -151.67 173.78 14.27 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.803 1.241 . . . . 0.0 109.024 179.595 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -67.48 114.51 6.21 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.173 0.589 . . . . 0.0 110.372 -165.635 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.7 t -80.73 -28.7 36.48 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.916 0.486 . . . . 0.0 112.062 -175.438 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 34.87 62.81 0.5 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.335 1.854 . . . . 0.0 114.081 176.039 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.1 t -88.5 -165.78 1.42 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.051 0.94 . . . . 0.0 110.05 174.687 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.5 t -76.69 144.15 39.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.198 0.999 . . . . 0.0 110.04 -175.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 81.0 mt -127.25 134.87 50.01 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.538 1.135 . . . . 0.0 108.15 -179.791 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -69.55 157.08 90.44 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 170.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.43 100.21 0.88 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.373 2.716 . . . . 0.0 110.438 -170.711 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.31 -23.44 3.31 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -175.208 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -78.95 135.78 37.05 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 118.254 1.027 . . . . 0.0 111.707 -160.727 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -92.61 104.56 16.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.4 1.48 . . . . 0.0 109.375 178.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -90.56 135.13 33.9 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 174.042 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -151.46 154.99 37.65 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.625 0.37 . . . . 0.0 110.639 156.922 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 78.6 mtp -151.77 146.05 18.36 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.161 0.984 . . . . 0.0 109.578 171.495 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -66.12 137.97 50.17 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.126 2.55 . . . . 0.0 110.443 161.79 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.8 t -107.96 130.47 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 159.852 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.3 m -98.49 140.82 17.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 171.845 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.531 ' CE1' HG21 ' A' ' 35' ' ' VAL . 64.3 t80 -154.43 149.37 26.72 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -162.322 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.467 ' CD1' HG23 ' A' ' 63' ' ' THR . 41.1 p90 -164.5 170.29 16.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.415 1.886 . . . . 0.0 109.108 165.314 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 70.7 t -103.99 135.46 41.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 174.482 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -76.37 134.2 70.47 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 119.119 -0.467 . . . . 0.0 109.954 176.397 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -74.16 67.34 5.16 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.384 2.723 . . . . 0.0 110.292 171.42 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -133.52 -37.82 0.94 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 126.799 2.04 . . . . 0.0 111.027 176.565 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.4 tt -43.87 -41.66 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 125.012 1.325 . . . . 0.0 113.414 173.111 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.9 m -78.23 49.03 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 O-C-N 121.394 -0.816 . . . . 0.0 111.34 176.825 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.9 mttt -142.72 -64.51 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 117.521 -1.228 . . . . 0.0 111.617 -179.299 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.17 153.17 46.03 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 121.942 1.729 . . . . 0.0 112.736 -176.548 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.8 t -54.87 -35.54 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 125.838 1.655 . . . . 0.0 110.662 175.897 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -35.26 -59.16 0.53 Allowed 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 126.656 1.983 . . . . 0.0 112.309 175.79 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.5 p -106.94 -42.73 4.84 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.015 -166.068 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 14.07 63.15 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 128.389 2.675 . . . . 0.0 116.235 172.151 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 136.73 -36.73 1.95 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -177.272 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 29.8 mm -53.28 123.52 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 171.444 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.38 47.86 0.35 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.288 0.566 . . . . 0.0 112.102 177.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.5 p -143.65 89.04 2.03 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 105.809 -1.922 . . . . 0.0 105.809 174.025 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 tp -92.71 87.21 5.8 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.029 -159.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.5 t -97.86 155.85 16.87 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.457 0.703 . . . . 0.0 111.084 -166.773 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.76 133.25 55.98 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 160.704 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 44.5 m -90.94 105.77 18.06 Favored 'General case' 0 N--CA 1.46 0.043 0 O-C-N 123.902 0.751 . . . . 0.0 109.035 160.452 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -76.27 99.8 4.89 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 165.708 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 53.5 m -117.34 86.35 2.5 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.978 1.311 . . . . 0.0 107.524 175.18 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.412 ' CD1' ' CD1' ' A' ' 45' ' ' LEU . 48.2 m-85 -59.22 145.2 43.67 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.322 1.049 . . . . 0.0 112.828 174.392 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -166.85 52.69 0.25 Allowed Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.966 1.707 . . . . 0.0 112.342 -175.435 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.3 -90.04 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.679 2.252 . . . . 0.0 115.092 -168.958 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -155.16 179.55 9.04 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 129.697 3.199 . . . . 0.0 104.863 -175.119 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -147.13 94.56 4.54 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 118.488 0.585 . . . . 0.0 111.044 -171.462 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -91.94 -124.37 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.984 3.122 . . . . 0.0 108.954 176.664 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 85.5 p -123.2 123.76 41.5 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 120.356 1.435 . . . . 0.0 111.763 -172.706 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.595 0 C-N-CA 126.496 1.918 . . . . 0.0 109.237 174.333 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.3 p . . . . . 0 N--CA 1.464 0.265 0 CA-C-O 122.042 0.925 . . . . 0.0 112.026 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 46.38 34.06 2.14 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.894 1.678 . . . . 0.0 112.276 176.482 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 166.68 157.1 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 128.332 2.653 . . . . 0.0 105.903 -172.58 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -151.74 2.55 0.39 Allowed 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -172.502 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.75 11.9 0.95 Allowed 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 126.802 2.041 . . . . 0.0 115.322 -164.9 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -77.25 -39.12 49.44 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 159.452 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.4 mp -92.22 -37.91 12.41 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 117.209 -1.377 . . . . 0.0 113.016 179.839 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.2 mt -32.53 133.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -162.13 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 29' ' ' LEU . 2.5 mm? -105.91 -104.15 0.33 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.159 -173.618 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -173.59 -49.2 0.01 OUTLIER 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.058 1.343 . . . . 0.0 108.855 -171.348 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -38.78 134.6 0.95 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.002 1.721 . . . . 0.0 110.678 -178.812 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -100.97 86.65 3.1 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -165.883 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.98 115.01 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.436 1.494 . . . . 0.0 107.953 -171.424 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.99 160.01 29.48 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -173.641 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.0 t -148.74 145.19 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 179.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.1 m -138.55 100.28 4.05 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -170.053 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -78.11 145.0 36.0 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.018 0.527 . . . . 0.0 109.919 -176.177 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -127.63 82.75 2.11 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.913 0.863 . . . . 0.0 110.007 178.22 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.49 102.16 14.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 172.118 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -116.89 128.37 55.18 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 122.292 1.044 . . . . 0.0 112.126 -174.666 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.0 p -99.83 96.29 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.564 -174.252 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.12 171.1 10.5 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 122.048 0.928 . . . . 0.0 111.406 174.843 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.41 132.07 52.0 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 169.903 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 128.33 -39.28 1.92 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -170.579 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.484 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -131.56 95.57 23.21 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 117.56 0.68 . . . . 0.0 110.277 -176.363 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -83.94 50.94 3.27 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.956 2.437 . . . . 0.0 109.651 -176.136 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.484 ' CD2' ' CD2' ' A' ' 45' ' ' LEU . 44.4 m0 -107.91 135.56 49.1 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -173.649 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -79.36 84.5 5.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 103.484 -2.784 . . . . 0.0 103.484 179.246 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -102.04 86.15 2.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -171.598 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.3 m -88.04 129.14 51.2 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -167.28 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.09 122.49 9.58 Favored 'Trans proline' 0 N--CA 1.446 -1.277 0 N-CA-C 106.261 -2.246 . . . . 0.0 106.261 162.466 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.1 m -72.73 -32.08 39.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.181 0.515 . . . . 0.0 110.691 -168.387 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.02 161.98 34.16 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 150.265 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -62.65 -46.72 86.89 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 172.532 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -147.38 153.54 39.77 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 124.415 1.086 . . . . 0.0 111.659 -159.647 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.4 pt -133.13 179.23 4.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 126.326 1.851 . . . . 0.0 108.251 179.892 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -125.47 160.18 30.11 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.345 0.593 . . . . 0.0 110.21 149.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.6 t -116.72 145.97 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 127.99 2.516 . . . . 0.0 105.679 171.014 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 49.5 mmm-85 -91.37 100.81 13.53 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 168.021 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mt -33.2 115.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -148.243 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.58 -25.2 26.49 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.071 1.319 . . . . 0.0 110.936 -179.386 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -64.9 133.45 51.86 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.806 1.303 . . . . 0.0 112.422 -172.33 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.15 101.53 7.97 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 130.05 3.34 . . . . 0.0 110.818 -175.38 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.9 p -113.78 153.75 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.292 1.437 . . . . 0.0 109.491 -178.597 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -112.51 125.15 53.93 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 125.404 1.482 . . . . 0.0 109.343 -177.38 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.0 pp -128.48 122.86 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 167.861 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.412 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 66.4 mtt -76.09 168.44 20.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.614 174.164 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -136.17 143.21 44.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 161.864 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.7 ttt85 -121.01 118.7 30.5 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 179.546 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.3 105.15 9.24 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 125.822 1.649 . . . . 0.0 110.035 -177.216 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.29 121.09 44.36 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.064 -0.398 . . . . 0.0 110.749 -168.603 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.44 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 47.8 t-20 -78.38 111.9 14.85 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.803 -0.561 . . . . 0.0 111.912 -167.783 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.2 tp -98.41 11.24 38.77 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.812 0.845 . . . . 0.0 112.381 179.564 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.46 166.67 22.33 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.272 -0.893 . . . . 0.0 109.95 173.44 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 70.0 m -103.3 7.0 38.35 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.968 0.907 . . . . 0.0 111.835 171.73 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.34 159.61 38.79 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 126.134 1.773 . . . . 0.0 107.041 177.974 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.97 126.04 12.11 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.171 1.914 . . . . 0.0 111.255 -173.208 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.476 ' HG1' ' HE1' ' A' ' 47' ' ' TRP . 0.2 OUTLIER -80.49 173.53 12.51 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.821 0.849 . . . . 0.0 110.784 -178.998 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 50.7 p -131.45 72.03 1.49 Allowed 'General case' 0 C--O 1.232 0.137 0 C-N-CA 122.551 0.341 . . . . 0.0 110.426 -170.893 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.42 139.37 37.39 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.946 -0.462 . . . . 0.0 111.946 -179.48 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -166.81 34.19 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.659 1.983 . . . . 0.0 109.44 169.222 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.58 159.08 34.47 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.33 0.652 . . . . 0.0 111.445 -165.445 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.9 t -87.77 131.51 34.48 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.704 0.764 . . . . 0.0 110.039 177.814 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.409 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -104.03 89.93 3.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.871 2.468 . . . . 0.0 105.572 175.509 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -77.0 91.92 3.67 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 120.882 -1.136 . . . . 0.0 107.935 -177.617 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 84' ' ' PHE . 7.8 t -78.11 72.57 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.612 1.165 . . . . 0.0 109.973 -174.043 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.9 t -168.73 134.76 1.49 Allowed Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 119.901 1.228 . . . . 0.0 113.389 173.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -74.1 67.72 5.04 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 122.386 2.057 . . . . 0.0 107.243 156.257 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 22.2 ptm 44.19 25.47 0.11 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 170.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -171.41 -58.26 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 119.384 0.993 . . . . 0.0 110.594 -168.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.61 -101.2 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -177.282 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 64.05 -52.1 0.08 OUTLIER Glycine 0 CA--C 1.538 1.481 0 N-CA-C 115.413 0.925 . . . . 0.0 115.413 -175.534 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -45.73 -47.63 15.33 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.553 1.541 . . . . 0.0 110.808 172.217 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -73.85 -12.69 60.75 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 127.012 2.125 . . . . 0.0 113.471 178.975 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.403 ' CD2' HD23 ' A' ' 138' ' ' LEU . 9.0 t80 -67.55 140.0 56.95 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.119 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.465 ' ND2' ' H ' ' A' ' 96' ' ' ASN . 1.4 p30 -71.21 127.95 34.29 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.967 1.307 . . . . 0.0 110.765 -177.33 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -161.06 -50.45 0.05 OUTLIER 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 122.478 0.311 . . . . 0.0 110.65 -174.793 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . 0.326 2.4 p 47.8 -95.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.985 1.314 . . . . 0.0 111.809 -175.875 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -165.18 178.75 6.74 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.201 1.401 . . . . 0.0 107.336 173.526 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 90.3 m 54.52 42.61 31.22 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.382 1.073 . . . . 0.0 111.469 175.982 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -106.18 163.73 12.57 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.385 1.074 . . . . 0.0 108.505 171.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 59.6 m -134.39 139.39 45.56 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 177.663 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -166.79 -42.46 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.853 0.861 . . . . 0.0 109.083 175.403 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.3 p -22.85 109.2 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 127.808 2.443 . . . . 0.0 111.855 162.783 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -78.41 -15.98 58.09 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -159.359 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.3 t 51.67 -146.64 0.47 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.441 1.096 . . . . 0.0 112.472 170.606 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.6 m -115.54 136.65 52.86 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.089 1.355 . . . . 0.0 108.542 -172.069 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 78.6 mt -128.44 147.95 50.69 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.39 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -73.29 156.42 89.15 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 172.354 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.23 85.87 0.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 124.88 3.72 . . . . 0.0 111.756 -173.064 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 152.74 -27.23 0.83 Allowed Glycine 0 CA--C 1.522 0.5 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.25 -177.777 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -77.86 143.45 37.79 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 118.085 0.942 . . . . 0.0 111.593 -157.925 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -105.21 96.9 6.84 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.811 1.244 . . . . 0.0 109.942 -175.603 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 15.4 tpt -83.92 89.21 7.18 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.114 1.365 . . . . 0.0 109.325 -177.951 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -99.21 134.21 42.4 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.256 0.622 . . . . 0.0 109.576 172.148 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 22.4 ptm -150.95 146.31 19.11 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 118.996 -0.526 . . . . 0.0 111.441 178.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 67' ' ' MET . 83.1 Cg_endo -79.58 147.77 20.05 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.883 3.055 . . . . 0.0 111.049 171.852 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.5 t -126.53 114.89 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 165.199 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.5 p -79.41 143.47 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 168.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -155.61 149.11 24.98 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.163 0.585 . . . . 0.0 109.949 -165.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.408 ' H ' ' ND2' ' A' ' 96' ' ' ASN . 18.6 p90 -171.18 118.98 0.48 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.36 1.464 . . . . 0.0 111.893 176.858 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.8 t -64.09 133.39 29.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 O-C-N 120.355 -1.466 . . . . 0.0 109.505 175.317 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -91.61 132.39 33.44 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 123.701 0.801 . . . . 0.0 109.8 -179.053 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -46.35 -31.52 9.55 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.402 3.401 . . . . 0.0 114.919 177.342 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -48.94 -24.2 1.4 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.783 1.633 . . . . 0.0 112.39 179.183 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.1 tt -49.01 -44.46 15.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 169.097 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.9 m -83.38 59.66 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 118.571 0.623 . . . . 0.0 109.895 174.354 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -111.0 -77.41 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 117.168 -1.396 . . . . 0.0 110.366 164.628 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -74.54 156.05 45.12 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 CA-C-N 121.885 1.709 . . . . 0.0 111.666 -177.384 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.6 m -62.16 -36.08 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 124.94 1.296 . . . . 0.0 112.045 -170.657 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -60.6 -64.46 0.94 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.147 0.979 . . . . 0.0 109.281 177.587 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 44.6 p -72.61 -15.43 61.73 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 118.509 -0.758 . . . . 0.0 111.568 -172.419 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.04 -41.52 5.53 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.768 0.713 . . . . 0.0 111.221 162.913 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.34 -29.17 74.38 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 112.237 -0.345 . . . . 0.0 112.237 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.3 mm -83.88 125.94 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 122.079 0.942 . . . . 0.0 110.39 -177.629 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 28.3 pttt -148.81 63.76 1.06 Allowed 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.506 153.751 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 11.7 m -150.15 95.33 2.26 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 158.416 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.403 HD23 ' CD2' ' A' ' 95' ' ' PHE . 1.2 tp -75.48 144.79 41.87 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -173.978 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.8 t -141.8 173.38 11.56 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.496 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.1 tt -150.63 111.28 4.25 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 177.855 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.45 92.94 8.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.515 1.126 . . . . 0.0 109.252 -179.545 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.94 108.4 19.17 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.877 1.271 . . . . 0.0 108.783 179.406 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.66 89.09 3.58 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 122.009 0.909 . . . . 0.0 109.747 -177.358 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -71.23 85.57 0.77 Allowed 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.281 177.058 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.1 47.59 2.8 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -178.703 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -80.89 -105.74 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.279 2.653 . . . . 0.0 111.967 178.914 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -140.95 121.68 14.34 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.648 1.179 . . . . 0.0 108.528 -171.242 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.9 111.22 38.82 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 125.654 1.581 . . . . 0.0 107.118 -177.128 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.431 ' HD3' HG23 ' A' ' 78' ' ' THR . 26.6 Cg_endo -83.3 -4.85 11.07 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.293 2.662 . . . . 0.0 113.043 -172.742 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.9 t 131.51 103.71 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 129.972 3.309 . . . . 0.0 109.754 174.481 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.542 0.669 0 C-N-CA 125.256 1.423 . . . . 0.0 111.723 168.356 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 122.31 1.052 . . . . 0.0 108.427 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 23.08 50.72 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.94 1.696 . . . . 0.0 112.229 -146.308 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.21 155.29 11.35 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 127.879 2.471 . . . . 0.0 104.405 174.542 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -122.32 125.96 47.07 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 104.354 -2.462 . . . . 0.0 104.354 156.676 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.6 t -147.88 49.54 1.06 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 122.493 1.14 . . . . 0.0 108.227 174.962 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -158.8 -57.42 0.07 Allowed 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 127.306 2.243 . . . . 0.0 106.309 -174.367 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.9 mt -65.53 -16.48 63.72 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.907 2.083 . . . . 0.0 112.878 -177.777 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.4 mt -75.67 78.51 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 O-C-N 121.21 -0.931 . . . . 0.0 110.267 -171.566 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.69 -127.7 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.555 1.142 . . . . 0.0 108.524 169.679 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -104.36 -51.33 3.13 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.57 1.548 . . . . 0.0 111.939 -164.506 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -43.1 102.07 0.03 OUTLIER 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.194 1.398 . . . . 0.0 113.351 -169.806 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.69 81.52 4.99 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 177.261 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -97.11 122.58 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -160.616 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.7 150.48 34.48 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.943 1.297 . . . . 0.0 108.199 -175.216 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.52 146.9 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 174.497 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.9 m -125.83 112.19 15.73 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -172.69 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -77.88 136.18 38.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.754 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -126.71 84.45 2.27 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 122.502 1.144 . . . . 0.0 108.965 177.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.91 95.75 10.28 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.374 1.07 . . . . 0.0 110.972 -176.753 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -98.63 109.5 22.24 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.375 0.67 . . . . 0.0 109.79 -177.936 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.0 p -79.24 148.86 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 164.388 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -151.04 158.71 44.44 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 171.216 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.05 -40.15 10.25 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.84 0.856 . . . . 0.0 112.109 -177.214 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -41.58 -31.98 0.76 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.812 1.672 . . . . 0.0 114.151 174.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.487 HD21 ' CE3' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -130.17 110.13 16.68 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 118.688 1.244 . . . . 0.0 108.471 170.488 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -75.27 0.95 8.4 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.294 1.996 . . . . 0.0 115.576 -164.035 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.517 ' CD1' ' HA ' ' A' ' 72' ' ' ASN . 42.2 m0 -79.57 153.45 29.46 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.38 1.472 . . . . 0.0 113.613 -159.844 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.42 ' O ' HG23 ' A' ' 50' ' ' VAL . 4.1 tt0 -77.47 77.46 4.0 Favored 'General case' 0 C--N 1.344 0.344 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.615 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -84.6 110.72 18.93 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.684 1.193 . . . . 0.0 109.098 -171.484 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 48' ' ' GLU . 42.9 t -122.78 118.81 28.25 Favored Pre-proline 0 N--CA 1.444 -0.758 0 C-N-CA 124.4 1.08 . . . . 0.0 108.645 -163.638 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -81.87 174.56 10.13 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 124.543 3.495 . . . . 0.0 108.554 168.367 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -98.6 -53.12 8.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 123.949 0.9 . . . . 0.0 110.845 -173.622 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -134.16 175.15 9.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 166.638 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.6 tpt85 -68.45 -33.15 73.68 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.392 168.636 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -144.67 173.44 11.82 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.842 1.257 . . . . 0.0 112.694 -162.861 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.1 pt -141.65 178.2 2.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 127.206 2.203 . . . . 0.0 106.788 165.567 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -132.27 162.77 30.16 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 146.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.23 136.92 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 126.953 2.101 . . . . 0.0 105.836 -175.199 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.94 88.66 3.5 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 163.205 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.2 pt 8.81 69.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 127.74 2.416 . . . . 0.0 114.63 178.469 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.55 -37.55 1.78 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 123.41 0.529 . . . . 0.0 112.305 -176.594 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -39.24 104.43 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.383 1.473 . . . . 0.0 110.849 177.101 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.59 HG23 ' CD1' ' A' ' 121' ' ' PHE . 1.2 m -87.46 88.45 7.68 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.353 -156.25 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 p -92.73 161.67 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 O-C-N 121.933 -0.479 . . . . 0.0 111.721 -168.434 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.46 HE21 ' HA ' ' A' ' 65' ' ' GLN . 1.0 OUTLIER -102.98 126.74 50.28 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.959 1.303 . . . . 0.0 110.35 169.561 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.5 pp -131.33 114.03 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 107.319 -1.364 . . . . 0.0 107.319 167.443 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.0 ttp -77.86 161.52 27.55 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.378 0.671 . . . . 0.0 110.862 -176.861 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -134.57 150.96 50.78 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.436 1.094 . . . . 0.0 108.846 169.325 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 54.1 ttp85 -143.46 147.08 34.0 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.997 0.919 . . . . 0.0 110.111 -178.457 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.39 109.68 2.66 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.632 1.573 . . . . 0.0 111.765 -177.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -86.09 139.28 31.27 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.989 171.721 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.517 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 28.1 t30 -78.21 88.99 4.27 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.073 0.851 . . . . 0.0 112.127 168.958 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.9 mp -76.76 69.08 3.08 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 171.193 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -153.66 137.26 15.99 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 168.513 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.1 t -80.14 36.1 0.34 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.369 0.531 . . . . 0.0 110.754 178.083 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.8 p -149.91 155.47 37.98 Favored Pre-proline 0 C--O 1.237 0.395 0 C-N-CA 126.63 1.972 . . . . 0.0 106.995 174.307 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -63.23 148.14 93.3 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 N-CA-C 108.208 -1.497 . . . . 0.0 108.208 168.522 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.01 175.06 6.53 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.792 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.0 m -105.65 145.25 31.28 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.121 1.768 . . . . 0.0 106.875 175.39 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -133.65 126.14 4.2 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 107.096 -2.401 . . . . 0.0 107.096 172.494 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.18 54.77 0.12 Allowed 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 166.78 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.44 144.83 15.9 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.884 176.162 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.3 t -85.01 166.08 17.02 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 168.185 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -146.41 95.96 2.69 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -168.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.33 86.92 5.02 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 175.509 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.0 t -78.12 60.23 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.817 1.247 . . . . 0.0 108.776 -175.034 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.1 t -171.44 148.34 2.3 Favored Pre-proline 0 CA--C 1.522 -0.129 0 O-C-N 121.481 -0.762 . . . . 0.0 111.636 178.077 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -61.57 -41.26 40.99 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 121.758 1.639 . . . . 0.0 110.068 159.031 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.3 ptp 172.08 -77.72 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 127.124 2.17 . . . . 0.0 107.59 178.399 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.87 -29.87 63.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.634 1.174 . . . . 0.0 112.292 -170.287 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.9 -119.11 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -174.028 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.89 -50.56 2.25 Favored Glycine 0 CA--C 1.528 0.874 0 O-C-N 121.348 -0.845 . . . . 0.0 113.192 178.204 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -44.93 -54.54 6.38 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.159 0.984 . . . . 0.0 110.014 171.555 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -75.39 -4.26 38.41 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.508 1.923 . . . . 0.0 113.96 -179.053 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -69.37 133.55 47.95 Favored 'General case' 0 C--N 1.341 0.227 0 O-C-N 121.093 -1.004 . . . . 0.0 108.486 178.449 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -75.8 85.66 2.79 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.684 177.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -54.57 123.11 12.11 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 166.228 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.2 t -58.71 126.27 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -177.572 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -82.31 48.47 1.28 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.87 0.868 . . . . 0.0 110.001 -169.857 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 44.2 t -167.13 143.11 4.28 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.58 1.552 . . . . 0.0 108.589 -173.904 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -75.96 72.57 2.83 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.914 0.485 . . . . 0.0 110.278 -178.577 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 26.9 p -135.17 53.03 2.0 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 124.904 1.282 . . . . 0.0 109.355 178.625 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -155.17 145.54 22.0 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -170.753 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 47.0 m 58.99 88.14 0.07 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.876 1.67 . . . . 0.0 112.17 -179.924 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -53.9 154.34 4.1 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.568 1.147 . . . . 0.0 111.7 176.414 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.7 t -111.52 -57.68 2.22 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 128.711 2.804 . . . . 0.0 111.378 -167.6 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.8 t -163.65 140.34 6.97 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 122.849 0.46 . . . . 0.0 110.385 -170.845 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.661 HD11 ' HB2' ' A' ' 114' ' ' MET . 39.7 mt -139.32 143.73 37.96 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.207 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.444 ' HB3' ' HD2' ' A' ' 110' ' ' PRO . 2.8 mt-10 -80.44 172.95 8.53 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.76 1.224 . . . . 0.0 109.349 -179.48 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 109' ' ' GLU . 35.2 Cg_endo -68.0 79.89 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 123.535 2.823 . . . . 0.0 114.465 -162.041 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 147.87 -29.89 1.39 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.307 0.956 . . . . 0.0 112.181 172.107 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -82.21 158.56 23.51 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 118.226 -1.39 . . . . 0.0 112.318 -139.61 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -84.61 123.26 30.13 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 124.64 1.176 . . . . 0.0 110.268 179.59 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.661 ' HB2' HD11 ' A' ' 108' ' ' LEU . 0.9 OUTLIER -90.22 128.61 36.42 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 154.89 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -134.0 146.42 50.4 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 159.698 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 56.7 mtt -146.61 146.63 27.59 Favored Pre-proline 0 N--CA 1.453 -0.323 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 165.087 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -71.55 142.58 40.61 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 122.101 1.868 . . . . 0.0 109.412 160.232 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.4 t -115.77 143.83 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 164.026 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.0 p -102.28 145.49 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 174.608 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -145.9 138.09 25.36 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.335 0.516 . . . . 0.0 111.425 -176.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.59 ' CD1' HG23 ' A' ' 63' ' ' THR . 5.9 p90 -159.07 162.25 36.56 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.569 1.548 . . . . 0.0 107.43 160.559 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 94.8 t -104.72 131.27 54.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 174.789 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.18 135.23 47.85 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 175.887 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -75.49 57.85 5.0 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 124.578 3.519 . . . . 0.0 112.673 -176.414 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.24 -36.47 7.63 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 125.57 1.548 . . . . 0.0 109.864 168.3 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.8 tt -47.75 -46.57 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -169.724 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.3 m -81.19 53.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.448 -0.783 . . . . 0.0 110.785 -178.444 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -138.28 -64.51 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 117.661 -1.161 . . . . 0.0 112.085 -179.371 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.67 156.33 35.64 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 CA-C-N 121.961 1.736 . . . . 0.0 113.406 -176.053 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.2 t -54.11 -39.46 42.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 126.201 1.8 . . . . 0.0 110.742 177.934 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -45.92 -55.72 6.38 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.697 1.599 . . . . 0.0 111.8 -178.523 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.3 p -92.37 -42.89 9.53 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 118.633 -0.699 . . . . 0.0 111.442 -176.313 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 7.93 65.13 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 128.403 2.681 . . . . 0.0 116.129 179.536 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 142.37 -41.34 1.2 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -173.709 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.7 mm -57.27 120.13 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 CA-C-N 117.689 0.744 . . . . 0.0 110.178 177.23 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -157.38 66.45 0.5 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.672 0.749 . . . . 0.0 110.173 162.578 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 10.6 m -147.51 102.72 3.48 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 152.206 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.68 151.76 34.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -175.243 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.7 t -154.08 175.13 13.79 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.408 0.623 . . . . 0.0 109.647 -177.269 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 11.9 tp -153.7 97.13 2.07 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 103.216 -2.883 . . . . 0.0 103.216 -169.278 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.5 t -81.78 88.09 6.32 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 171.733 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.79 124.4 27.64 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 176.809 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.423 HG22 ' CD1' ' A' ' 145' ' ' TYR . 23.8 m -133.38 95.52 3.53 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.412 1.101 . . . . 0.0 109.229 -164.468 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -74.22 74.42 1.8 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.041 1.736 . . . . 0.0 111.94 -171.007 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.423 ' CD1' HG22 ' A' ' 143' ' ' THR . 38.8 m-85 -128.35 68.48 77.23 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.349 1.06 . . . . 0.0 113.758 179.566 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -87.69 -103.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.775 2.983 . . . . 0.0 110.666 167.502 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -156.26 99.66 1.94 Allowed 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.8 1.24 . . . . 0.0 108.907 -172.117 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -104.56 134.0 19.89 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 126.432 1.893 . . . . 0.0 106.403 167.614 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.0 -47.3 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.445 2.097 . . . . 0.0 110.638 178.304 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.2 t 166.65 112.4 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 129.202 3.001 . . . . 0.0 104.822 178.486 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.7 pttt . . . . . 0 CA--C 1.535 0.4 0 CA-C-N 119.584 1.083 . . . . 0.0 110.409 -168.921 . . . . . . . . 0 0 . 1 stop_ save_